<SEC-DOCUMENT>0001193125-25-180865.txt : 20250814
<SEC-HEADER>0001193125-25-180865.hdr.sgml : 20250814
<ACCEPTANCE-DATETIME>20250814164626
ACCESSION NUMBER:		0001193125-25-180865
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		90
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250814
DATE AS OF CHANGE:		20250814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eledon Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001404281
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36620
		FILM NUMBER:		251220372

	BUSINESS ADDRESS:	
		STREET 1:		19800 MACARTHUR BLVD.
		STREET 2:		SUITE 250
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612
		BUSINESS PHONE:		949-238-8090

	MAIL ADDRESS:	
		STREET 1:		19800 MACARTHUR BLVD.
		STREET 2:		SUITE 250
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Novus Therapeutics, Inc.
		DATE OF NAME CHANGE:	20170511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tokai Pharmaceuticals Inc
		DATE OF NAME CHANGE:	20070622
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K/A
<SEQUENCE>1
<FILENAME>eldn-20241231.htm
<DESCRIPTION>10-K/A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-08-14T16:27:15.4679+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:eldn="http://www.eledon.com/20241231" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>10-K/A</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_7944eb07-0907-4bba-9467-ff3806cfd616" name="dei:AmendmentFlag" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c">true</ix:nonNumeric><ix:nonNumeric id="F_509b0020-a55d-422b-b129-923a0e0592fe" name="dei:DocumentFiscalPeriodFocus" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c">FY</ix:nonNumeric><ix:nonNumeric id="F_f0f2f6d8-6ab9-4220-9be8-9d9463520cc2" name="dei:EntityCentralIndexKey" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c">0001404281</ix:nonNumeric><ix:nonFraction id="F_9a89652e-6946-4431-87fe-50db88208800" name="us-gaap:CommitmentsAndContingencies" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_7db7a889-a436-4319-b161-e52ce75ec2b4" name="us-gaap:CommitmentsAndContingencies" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_51220781-3cc8-4cb6-858a-6cda531d29d7" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c">http://fasb.org/srt/2025#ChiefExecutiveOfficerMember</ix:nonNumeric><ix:nonFraction id="F_49cee393-18e3-4648-b5d8-3eb7be1b8087" name="us-gaap:NumberOfReportableSegments" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" unitRef="U_Segment" decimals="INF" format="ixt:num-dot-decimal">1</ix:nonFraction><ix:nonFraction id="F_5853a7a4-cb72-4798-821a-733264c3ef61" name="us-gaap:PreferredStockValue" contextRef="C_cf8e646f-26aa-4125-8f19-71c8b7b07c17" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_c28ce8de-197a-4f3f-9904-8e00f34bd0bf" name="us-gaap:PreferredStockValue" contextRef="C_eacde0ed-4c02-4709-92f2-d1a867f74b43" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_87be77a3-13bd-421e-9cd7-c93000cef4f1" name="us-gaap:PreferredStockValue" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_159afcc3-d066-4b5b-b4ad-7e01474c1944" name="us-gaap:PreferredStockValue" contextRef="C_badcfa13-507d-429b-9dee-2e0d08eb9c29" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_216519ab-59aa-4af1-9fab-606834bbb418" name="us-gaap:PreferredStockValue" contextRef="C_c9ddc65a-8b52-48ef-898a-ad6a8da8614d" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_0af8023e-7ef3-4515-a7a7-678b84c987ec" name="us-gaap:PreferredStockValue" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_6bb67e40-7995-438a-8c0a-20c0a769173d" name="us-gaap:PreferredStockValue" contextRef="C_4e98b79e-91fc-4e20-9732-817693c930ab" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_c377af31-8b8b-42b5-9eae-9f9fb6815960" name="us-gaap:PreferredStockValue" contextRef="C_25aac8fb-8999-48c0-9388-bb4417dbd19e" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_c6895469-f099-4775-83e9-d61a31e2f6fe" name="us-gaap:PreferredStockValue" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_7a49ba59-b1e6-4d93-bc53-ad26ea9e9103" name="us-gaap:PreferredStockValue" contextRef="C_3599cba8-8efc-4581-af6d-86c0dfa8c474" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_3ecf4669-c43c-48e7-8139-38d3d48178bf" name="us-gaap:PreferredStockValue" contextRef="C_b96fc6ba-37aa-4cd4-a5d5-3bec6407f9e1" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_b7cc2b0b-bf5a-4561-9ed3-8272893f1903" name="us-gaap:PreferredStockValue" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_2a99917e-c2e2-45cf-b60a-d41b5d89eba1" name="us-gaap:PreferredStockValue" contextRef="C_d5073177-cf57-43ab-a425-174fa4e3220b" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_f2ebfc2b-8b13-4228-bc2d-fad05f7d9efa" name="us-gaap:PreferredStockValue" contextRef="C_c2c9a382-79a3-4da2-9405-110cffced194" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_1303f048-cd42-4ee1-9b21-e85795fc53bb" name="us-gaap:PreferredStockValue" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_6bc77dc0-e7bb-4f64-9a27-5fac7e301766" name="us-gaap:PreferredStockValue" contextRef="C_7c4a8f01-0913-45fc-a8e1-2c98ad756cf8" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_0dada35c-b9ab-4d7c-908e-93714dd5302f" name="us-gaap:PreferredStockValue" contextRef="C_5e4181d3-32bb-4105-807d-d8ddef98922a" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_c911075b-c1e4-44d9-bc77-3ee81c355044" name="us-gaap:PreferredStockValue" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_340180a0-3a27-4a0d-8de8-cd273d95f58c" name="us-gaap:PreferredStockValue" contextRef="C_6aa424ab-8817-4180-b5c7-60582405c85e" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_cd553f55-0d93-4b97-8756-5443f53b6f9b" name="us-gaap:PreferredStockValue" contextRef="C_e2f48d5e-c74e-4701-855c-ac8c4f15fd2c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_aac64cdf-40ce-4e29-82c3-c243c042d20f" name="us-gaap:PreferredStockValue" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_987f1dac-17cd-48c8-99fd-7394ead1371b" name="us-gaap:PreferredStockValue" contextRef="C_81e90e3c-c0f5-4f40-8209-ed87e745d4b3" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_f28eec08-2fa6-4243-b694-0b4d71ef0a06" name="us-gaap:PreferredStockValue" contextRef="C_a9a6298f-64b0-403f-9753-1954555ffed1" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_a65f2652-7b7d-4f58-9664-7b9d2fb6a05a" name="us-gaap:PreferredStockValue" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_3435e4db-2763-4d2f-8c7a-737f3a13270a" name="us-gaap:PreferredStockValue" contextRef="C_6081fd86-dcbc-49fe-ac41-4cb855d48774" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_2951b263-900f-4b8d-a786-60aa356956ac" name="us-gaap:PreferredStockValue" contextRef="C_0dfa6572-7fa2-4beb-9686-2196c62325d5" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_53bb6073-43e0-4db5-9b19-9926bcc63d4a" name="us-gaap:PreferredStockValue" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_0bb67f5b-fcbc-4b89-907c-5702aef7f8c6" name="us-gaap:PreferredStockValue" contextRef="C_7ebd9556-342d-4273-9d4e-cbafb9ae6e10" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_586405c0-5bfb-4612-b423-2372508e93d4" name="us-gaap:PreferredStockValue" contextRef="C_58cde265-0a3e-4c69-87c1-a6052820869a" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_bb70f791-1438-45ad-a7f7-20802b5dd599" name="us-gaap:PreferredStockValue" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" unitRef="U_USD" xsi:nil="true"></ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="eldn-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="C_814f6c12-39d8-48c7-97a5-4f0838b03063"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_81e90e3c-c0f5-4f40-8209-ed87e745d4b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8221208b-b06c-4f4e-8484-c94ceca23b1b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_82dde098-0756-4a72-8753-5533b164777f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_834dcb4b-a7e6-4a63-a26e-6cacde80edc9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_835f8a45-f710-4451-9172-67b1911d289e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8667a5df-16be-4759-b647-3b7cea2a8885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:AnelixisTherapeuticsIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-14</xbrli:startDate><xbrli:endDate>2020-09-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_868ad39e-5065-4cf8-9dff-9d2c9a7d135b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXOnePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_869cb76b-dd81-4314-8818-8ae015c49078"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8a2e70e3-2ed3-407e-a0af-d1a1cd2c2189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8a905dd9-947f-4771-b0bd-22e599ecb244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8b40a221-b271-45e7-abea-861aa3e69388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8bba3766-4964-4ab7-92aa-e8434203d2c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXOneNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8e654e4d-37e7-47fa-95fa-928b05de9595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_903fb9de-3a55-4a71-b923-06cf285c9991"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_90ef02a4-12ca-42a1-b6d6-2dc5a6c517a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_91faf8d0-851e-4099-aa01-277d6ae86c25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_929233e8-37d7-4ad4-af4a-17c57fc92607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_942a2564-5176-4190-a212-2b973ceb1a34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9451594c-6f06-454d-8721-5fd66258a715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-05</xbrli:startDate><xbrli:endDate>2023-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_953b5115-083a-4e43-b335-55592f074714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_95a8ebd2-ec0a-42f8-b597-f3c09a2afecc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_96eaecbb-fb70-46b6-9d46-a5b4e45e90ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_976894d0-7795-4a81-a79e-bce2709115dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_97d0a02e-f66e-4785-bdd9-f6ec23959807"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_980b621d-2497-459b-aea6-bca6da258067"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:EGenesisIncCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_985693c8-676f-400c-b568-99fadda31a60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_99d14f13-477d-408b-bc26-79d5db50d8a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_99fb4269-13f1-4e54-8343-39a92e170c3a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9a124087-424a-4448-9099-a03821a98b86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a69091e-a043-4048-aac2-1fd5f048fc3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b1e52ec-b18a-43ab-830e-8986ff39379c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:GuggenheimSecuritiesLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:EquityDistributionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-20</xbrli:startDate><xbrli:endDate>2024-09-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9d1c5679-7ad3-40bf-a3c6-7a10ff14887e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a02b7bbf-5219-43e5-a35f-53b985449b45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0877070-bafd-4ecc-ba7e-d06767488cad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:TimeBasedVestingRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a101b2be-54a1-4e3e-a107-2e740e2bd083"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a1649612-1e62-4a97-af6c-7dc0028db1ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a19cc353-9e67-42d2-ad34-2b95ddbd1abe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a32ed886-8fef-46ca-80f4-2e27d332c237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">eldn:OticPharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a38140f4-e70a-4ed0-9849-5332d035c44d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3a07715-3a73-4dad-aa92-b1e0504bed50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3d14d16-847d-4ad0-a2c1-7bbc3743fb74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a5a3e2c8-59f9-48bb-8c4e-73be100cce2f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a9a6298f-64b0-403f-9753-1954555ffed1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aa96c567-6409-4b20-bc86-f6e9b7a82fa9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aee009b0-e9e5-4357-a86f-519c7e46e328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b10e5573-542e-4cad-822f-93a7ae68952b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b245d8ef-b745-4fa1-9b3e-7439a1b246db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b289a523-bf02-496a-822a-4cb3cec3e3fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b33d77f0-6276-40fa-bd85-4b5a8ba275fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b526d623-851d-4505-bda0-f3f5d7eef6d4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b53bd15c-c7fb-4b11-aa17-fa905055dc5f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b7466cab-5f74-4129-8342-29bcf1a495a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b96fc6ba-37aa-4cd4-a5d5-3bec6407f9e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_badcfa13-507d-429b-9dee-2e0d08eb9c29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bc089e60-cdab-4f8a-b783-246e7d7a6af1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">eldn:CommonAndPreferredWarrantsOutstandingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c0555d1b-b168-446f-b8aa-3b629d5033dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c0d65a75-73a7-4e65-8ca9-7aa239bd0a7a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c0e69edb-7d74-4a88-a331-7063c41b32d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c208ba17-2b6e-4d20-979a-92018e7e32ca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c2abaa52-1d0a-4fbe-81ab-c8a8f777bb72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c2c9a382-79a3-4da2-9405-110cffced194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c71a399f-d8f4-4adf-af71-acd5010523cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">eldn:CommonAndPreferredWarrantsOutstandingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c8bb3042-d8d0-4c46-81bd-3419e2c5ac60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:PerformanceBasedVestingRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-20</xbrli:startDate><xbrli:endDate>2024-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c9c85a29-4958-462d-81cd-61348312f2ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c9ddc65a-8b52-48ef-898a-ad6a8da8614d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cc04c70c-694e-4769-aaa2-e6dd4cce3bb0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cc736700-2f11-4c70-bf4c-ca225ad3a533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cded1be0-5d08-4e82-82d6-d067b4958eae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cf8e646f-26aa-4125-8f19-71c8b7b07c17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d0e34266-9d94-4045-9e3a-77a1916c58ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d2875a70-0df4-4171-877a-c58e658fdb69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d34a853c-0615-409b-9ae6-5bd5c50e65b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d3633a35-1914-4b59-95c7-b92462feeda6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d3a91ef5-d925-4944-988e-a6b6d2a5d9fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d4a180ea-02bd-45bf-a264-14e6d8208750"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d5073177-cf57-43ab-a425-174fa4e3220b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d59b82b7-5627-447f-ac66-5fb9c579fdfe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-30</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d6bb14ee-c9e1-48c2-ae0d-ce419b3af00d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d72d64e3-d62a-4889-85a3-c71622485ea4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d73e41e0-eaac-4f7a-8f85-cc17e8daac55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d77b851a-bf31-477b-8902-1719de442c66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d91ae884-2a3f-49df-8b4f-3a13d684a3c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d9bfbaaa-b100-4fc8-b32a-b4ace9e85c13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_da4527f2-1073-4974-bdac-4a2aee446741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dd1985ed-08be-42aa-8575-546c5561d12a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e001cf60-2e45-48f9-8cca-188f9699760d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:OneBillionAggregateNetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e18de94d-dbd0-4d3d-ba53-59c1f412228b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e2ccd3a2-63bb-47ec-b90f-f9427e33d6b7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e2f48d5e-c74e-4701-855c-ac8c4f15fd2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e3e45846-797e-4cc7-afc4-00734dc1c256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e551203c-60a1-40e8-b225-d4b5814f0ce2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e61ec573-6c46-4c35-990d-5570f66dbe16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandFourteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e6ea7a2e-1ed7-4d2e-84d7-ac031499af66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:OneBillionAggregateNetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e7daa38f-05c1-4b99-a56a-2c538503eda6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e94a88c0-62d2-43ee-872d-543df3558f56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ea3f0ca6-47b7-45eb-83f1-2f6de59e3fc8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eacde0ed-4c02-4709-92f2-d1a867f74b43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ead3ee91-638a-450a-b9ec-8e6ef46d7412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ebb38758-a918-4acf-8a02-3282e3612134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eda51110-4aff-4f77-8d77-cdbe3953f41b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandTwentyLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-10</xbrli:startDate><xbrli:endDate>2024-07-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ef6e410b-a061-4861-8ad7-1774585b21aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f0263327-04ec-403c-a565-39214d3f5d1b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f23c46e0-c8ff-4ddb-ac90-024320e43941"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-30</xbrli:startDate><xbrli:endDate>2024-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f24c5a06-77ee-4dae-8ad5-bc7f8a9e6e82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f4538f07-445c-4906-94ce-ef1f81c11a69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f48d3944-f038-454f-abca-5e5d8376ef70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f5e378e9-ea4d-4446-a3d6-8653372fe095"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f5f2d779-981c-4cdb-8478-acd05d3606c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6739b83-64c1-4196-bfa3-188e64be71c2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6bd4419-9bd8-464e-acfd-beb0e29ce4ce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SeriesX1ExchangeAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-11</xbrli:startDate><xbrli:endDate>2022-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f732926d-a8cc-4c74-8a1a-38d77cf24a4e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fa6b5f79-cd28-4846-8782-687a801dd0e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202307Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fcab1302-ac86-4137-9866-3e47197201e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fcf8616b-2c3d-4413-a5ce-5cd91ad0ca6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fd236f0b-9227-41ed-9c2f-f887ba0032a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fd5b7956-4959-43cd-b4c5-b1fde759c23c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fe356c11-e5db-4e96-910b-23f6c7c1d931"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fef3fa93-e31c-43ff-af41-915dfb55b4a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_00ec3738-b3f5-498d-9035-0c48bdd6391a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0147f0c4-d22d-434d-ab8c-fd254e6c658d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_01c9b5c7-df17-42c2-ae7f-2df53dfe3244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_02359b89-94e1-443c-ac29-3c67769f2cb8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_06358e90-5416-4479-9715-a95bcd5b9a71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0723a7a1-cd73-4940-a506-fa467676eccd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_073a4072-2ff4-4bf0-b2f2-2ca40d8d96dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_07a68ee8-82a0-456f-b6d3-9977f22a230f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_08679ab6-cc43-46fb-afd1-83c5b1aabc73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0b035996-e88b-4943-8f18-048510a13840"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0dc4367e-b5ab-45fd-bb01-b6a7fb4da26f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0dce47b6-63c7-4639-ba01-f701282d1487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0dfa6572-7fa2-4beb-9686-2196c62325d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0e3da0b7-263b-4845-ab86-210db978af57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_10891653-0f3f-4d75-9cd2-9876d5144cac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_112a5426-12b2-4e40-9850-361e43b7c9ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_11604e1d-447f-4412-9cf1-8945676ed077"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandTwentyLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_123dd2d0-784a-4967-948a-9369c11c3f3a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_126dec65-5fb2-4ba4-8e32-3d122533acdf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_133e23b5-720c-48df-8aef-367581072be4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_135b1839-bc7f-467e-abbf-3856e1bcb1f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_13e69911-29ff-4b45-829c-2ae93e92cdf1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_14e122c7-b47c-4847-aa31-c23b1f2dafec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_158bedf1-d0f5-4588-aa11-06610c5badeb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1799d415-8c33-49ff-820b-a0512ecbe050"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_19e1b622-4072-4fc0-a0fc-410862aa012d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1cbafbb3-bb44-48c7-9275-169d82fbcccc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1eb7071c-d34e-4235-bcb4-1e3102fea0ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1edc7735-5746-454a-98ed-a4e3221fb98a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-06</xbrli:startDate><xbrli:endDate>2024-05-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1f217616-88b1-493b-aa9a-fb67de956fa7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1f268d5e-cf5e-403a-87e4-658902565516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1fc4725b-505d-42ee-8598-9b1205ab938a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:SeptemberTwoThousandAndTwentyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2067bb42-a2a2-40c2-9cbe-fb3a2abee295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2091d266-9d3c-4b0a-b436-3f24223bba88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_217e35bf-2776-4ae6-b1a7-3ae6aa8a1aff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21d6ff86-6d7f-4b9d-adfb-5a4f1d7aa8b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_23b4279a-d29c-45cc-a819-b328ff1a900e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-29</xbrli:startDate><xbrli:endDate>2024-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_24109039-0361-41e1-a825-54d3c79fb5d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_254d6b43-9430-4433-b644-3ad4de1829ee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-04</xbrli:startDate><xbrli:endDate>2024-09-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_25aac8fb-8999-48c0-9388-bb4417dbd19e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_26899444-530f-4870-a095-0c5c5401b54a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_272a92d8-c7c2-4314-90c3-9d41142b0d01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_274b34fb-7eb0-4bfc-a200-1ceb17964d37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_27edf0db-9055-4e22-b38b-18ca7e450835"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2a66afd3-0d1f-4b4b-9cb7-38a0c6a60d81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ae5e0b5-102e-4000-812f-5d62270f8a6d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2bbbd4e0-640b-45ce-a5fe-e896670755b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2cce5c4d-219e-4cc1-af1c-7a19e05a994d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2d4f29f9-5681-4ad7-bf0a-2f27534f1c56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2f08b426-f498-4cef-82ca-9a6f0e57cf67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:TimeBasedAndPerformanceBasedVestingRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2fbd8e54-c07a-4e1c-b971-6c9f65cf8c76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_306cf456-d3e1-471c-88e6-bff01256a178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_30f84d62-e30b-473f-9c61-8ef1e1832085"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_320ec943-bc2b-449e-8081-892254217c23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-08</xbrli:startDate><xbrli:endDate>2024-07-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32469e8b-bd12-46a1-aa1e-6207f9cfe051"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3599cba8-8efc-4581-af6d-86c0dfa8c474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_368c6272-dda1-47db-a6e7-2d38cfded7e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_37cfa2dd-f2e8-40b3-b4ed-4aaa93f648d9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3991e991-873c-4c8a-a9a0-9c14307b5dc0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_39ebfb29-081c-4957-9c07-bd845544fac6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3af4da93-98a8-414a-b035-34ccd64d6382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3f5369ce-0e85-4351-974f-ce7061c1e396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4117a814-e099-4153-b353-7f02194ab5a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_412fba80-a3f2-4e2e-a9dc-8ece19b8f909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-29</xbrli:startDate><xbrli:endDate>2024-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_41f23dcf-6538-4d0e-8ab7-5ea52de4f018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_41f693fb-c3db-4b97-a334-95618d32533c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_44e95282-fdaa-4791-b948-243de3cf859c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_45654a12-fdcb-4ab8-aa38-1e9adb0677f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_463fd8a9-edbf-489e-aaf7-3a59cf541462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46b5adb0-3c28-4e8a-a89e-80ec27d1c833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:FiveHundredMillionAggregateNetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47180cae-052a-4fcf-aff0-dd86481a6ea5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_471dec7e-d30c-458a-93d0-bda067fa6254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-29</xbrli:startDate><xbrli:endDate>2024-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_478dbeb4-70d8-4365-82b4-495e16a9644d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4815e24c-4159-4500-b666-85aff53dcfc5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:FiveHundredMillionAggregateNetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_482d4d7b-2e9a-44ff-9fde-c5756f5cc547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_48ea6ed9-0d04-4f10-a10e-a2919aae308d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_496b6f07-43d9-4f3d-abc8-59c28e2608e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b4a0a48-83b4-4a31-a7d8-6183de985fc4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c665ca9-bab8-40bc-b5cb-2233b3df82bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4d0808f1-2220-4b2f-9620-f1ac2986d605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4e5c52f4-44ed-4d03-b98e-acba67aad85d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4e98b79e-91fc-4e20-9732-817693c930ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4f05b713-9469-4acf-b62a-b4a410770fdc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4f78b74c-03a0-4b7c-8ace-e89af1719000"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-06</xbrli:startDate><xbrli:endDate>2024-05-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4fc8440b-61a6-4b7b-8aa2-aa0f00a4ad4f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_50d65f8a-54ee-42c3-8b17-0043d0fbcc9c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_50e1d626-a270-4890-bdf3-98ed401c6ece"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_51337a7e-dc7e-43f7-9229-34f04adbdb0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5139fbdc-2a80-417c-851b-8e6f70ab7358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_534c07a6-4f81-40db-bf98-8c91a0f6d3a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:PerformanceBasedVestingRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-13</xbrli:startDate><xbrli:endDate>2024-06-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5399ff8f-db17-415f-bfac-019c294b34eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5479bff8-22b2-4dea-8a74-3bba75d07bd5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_55014fe0-62df-4c18-b96a-3dfee38784c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_550f904f-a665-4c4c-a926-3bccfcba9c6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SeriesX1ExchangeAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-11</xbrli:startDate><xbrli:endDate>2022-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_57faa905-6146-4e17-b55a-72db880840e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5811ade9-283f-4370-8161-f228fe085c9f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_584b9a09-2946-4d4b-8bd8-27f45b3d9605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58cde265-0a3e-4c69-87c1-a6052820869a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5953effb-3051-4f13-ace1-184eb0e02dcb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5b4148f0-d4f9-403c-af32-f52bc3bd07f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5bac50df-0bf9-4fac-8dc9-1288781f48d4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5dc4d3d6-be01-4bf6-aebf-77b1734fcf32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5e4181d3-32bb-4105-807d-d8ddef98922a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5fed5aba-bded-4202-86e4-abacffb2f839"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6064f4bc-c353-4924-b4c3-bc53d3720064"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6081fd86-dcbc-49fe-ac41-4cb855d48774"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_60bed74c-0075-4313-9b4a-3fbb4bcd7484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_625d824a-477d-49cd-8fc7-67814f7675af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6312f08b-35c4-4f52-9485-e4c1a9839b7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_63e0c2a9-691e-4547-a6ac-0d3fdf91d1aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6430dce4-296d-43c0-8a5c-29414ed1adfc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_647ab198-415d-40e9-bf66-98868d7ffd37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_68b6bf49-13a1-4dad-b84d-1a3baa6fc701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6aa424ab-8817-4180-b5c7-60582405c85e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6c58a12b-7549-4626-92cd-993c292715da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6e303928-4d0c-4180-838a-ad93da24f889"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6e372f90-3029-4434-82dd-cdd9e2a4e75d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:AnelixisTherapeuticsLlcAndOticPharmaLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6ebbbef7-421a-4712-a110-6e65b3cc06a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_70083239-1fc0-451c-a02f-8a7644368a3a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_703721ac-e233-4584-a2ed-617913379b0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_75369811-d279-4dfd-81ed-953e9c67bff2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-19</xbrli:startDate><xbrli:endDate>2024-04-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7736993d-d675-48ac-bc9d-ee436b89e189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_77fcb03b-d40c-4c83-a674-4d30ef20d74d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_78ce3cbc-2a87-434a-8808-3ae02d70968a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_78d65748-c663-4c56-aa09-66c64ed912e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_79dd679d-8ad0-49ca-9c6c-b276bb345850"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7aba1847-593e-4b0d-b134-5757cbcbdffb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-12</xbrli:startDate><xbrli:endDate>2022-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7b6aa460-03c5-4aa2-a129-7a2742c51c6c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7be301e3-88b5-4832-845c-9d8ac104e793"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-06</xbrli:startDate><xbrli:endDate>2024-05-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7c4a8f01-0913-45fc-a8e1-2c98ad756cf8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7df810c1-d21e-4e6b-a46f-01bf18c4ed77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7e567fbb-8b59-43a4-a885-68d6c65b7935"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7e668069-76a8-40b4-854c-5268227f0ca1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7ebd9556-342d-4273-9d4e-cbafb9ae6e10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7f10a0e1-7bb1-4217-8c81-fe3de5a1918e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>eldn:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_Milestone"><xbrli:measure>eldn:Milestone</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="z-index:2;min-height:0.75in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:1.5pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">on</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p><p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Form </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0ff43625-7109-40d7-9376-e45fc443a49f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K/A</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Amendment No. 1)</span></p><p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Mark One)</span></p><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:11pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_314f8320-0215-4fd7-8a7a-788a446fa044" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6cd874dc-f20d-4551-8844-d7a2abe9d181" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_84d71443-7e4c-48c1-9904-1ba6d54bc387" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_883c6648-de0a-4474-8026-30a67f47e789" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OR</span></p><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:11pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_164abffb-ce49-445e-8f17-da7aa8b91379" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the transition period from</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                      </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                    </span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission file number</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_573c911a-0960-4433-acc8-c54e3ce18210" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">001-36620</span></ix:nonNumeric></span></p><p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:23pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e93c73ae-18be-4e72-965f-ca3d66752850" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:23pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p><p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"/>
     <td style="width:50%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9.5pt;"><ix:nonNumeric id="F_3a579729-160e-4b95-8d00-914e92f7532a" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9.5pt;"><ix:nonNumeric id="F_5db5ee90-fa5e-49ee-a099-f198cf221d8a" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">20-1000967</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">incorporation or organization)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(I.R.S. Employer</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"/>
     <td style="width:50%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_e45890fb-6dd7-4866-9e5a-c6e5baf8ace8" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">19800 MacArthur Boulevard</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;"><ix:nonNumeric id="F_e2e45139-d270-4a6b-bfb3-df0e718d616b" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 250</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_7595b205-d68e-4576-b404-ff80dc66e198" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Irvine</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;"><ix:nonNumeric id="F_f8d27dd1-3e24-44c3-abdf-d12d16d4dac4" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_57f1b84c-89b3-42cd-8863-4771abe1c0db" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">92612</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8d707af6-349b-4f4e-a28a-7d5db5372ab4" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(949) </span></ix:nonNumeric></span><span style="font-size:8.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ab6c9074-04fc-437a-aa02-3087abf38fa9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">238-8090</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Registrant&#8217;s telephone number, including area code)</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:33%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:33%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:32%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of Class</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading Symbol(s)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of Exchange on Which Registered</span></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_528020e1-f38f-4f5b-ae26-07114fb10595" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock, $0.001 par value</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_76865578-c1d7-41dd-964d-86e019f1b32f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ELDN</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_f08a6672-9ad9-445d-9a15-33aca6df55ad" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-kerning:none;min-width:fit-content;">&#160;Capital Market</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p><p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_33bf5355-c1db-450d-b607-b85d5c2c31f5" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityWellKnownSeasonedIssuer"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dc06e0e6-35ac-47d5-ab69-20acd9b77bc4" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityVoluntaryFilers"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9ef2bd09-c4bd-4f63-b304-e4bd2abb5660" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    No  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8849de84-ad4a-4d0f-ad51-ec5d9492ab53" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    No  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:28%;box-sizing:content-box;"/>
     <td style="width:2%;box-sizing:content-box;"/>
     <td style="width:40%;box-sizing:content-box;"/>
     <td style="width:28%;box-sizing:content-box;"/>
     <td style="width:2%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_1a4f8560-33e4-45ec-a855-afbce4ec62ae" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_94e1fd86-d4ba-4a1a-8811-6da61532f7d0" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_64b9172b-bde3-406e-95fe-fd16f72f865e" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation of the effectiveness of its internal control over financial reporting under Section 404(b) of Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by registered public accounting firm that prepared or issued its audit report </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_08edf177-24ca-4fac-b619-c33a8bbad1f6" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant  included in the filing reflect the correction of an error to previously issued financial statements </span><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_fd74ac3b-4b5b-4600-bd30-cc47a6b56679" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b</span><span style="color:#231f20;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). </span><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_680ee18b-bde1-49ac-a82c-90eb00577aa8" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:DocumentFinStmtRestatementRecoveryAnalysisFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  &#9744;    No  </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a691a516-08a9-4a66-aa21-3bde33639c94" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2024, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates was $</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad2cb2f7-f925-4dca-a521-f3bb355dad8e" contextRef="C_3af4da93-98a8-414a-b035-34ccd64d6382" name="dei:EntityPublicFloat" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">64,885,717</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, b</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ased on the last reported sale price of such stock on the Nasdaq Global Market as of such date.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of August 13, 2025, the registrant had </span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d96c3a31-2b16-491b-9e0c-f565f7a39d0a" contextRef="C_ef6e410b-a061-4861-8ad7-1774585b21aa" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">59,881,775</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, shares of Common Stock, $0.001 par value per share, outstanding.</span></p><div style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ae63a6a1-f721-419d-a209-8487f9cb0e78" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true" continuedAt="F_ae63a6a1-f721-419d-a209-8487f9cb0e78_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:continuation id="F_ae63a6a1-f721-419d-a209-8487f9cb0e78_1"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive proxy statement for its 2025 Annual Meeting of Stockholders, that was filed with the Securities and Exchange Commission on April 29, 2025, are incorporated by reference into Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDE</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:9%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:82.46%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.54%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">   </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:12pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-2.277%;padding-left:2.227%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART I</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 1.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_business"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 1A.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 1B.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 1C.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 2.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 3.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 4.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_ii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART II</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 5.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:12.25pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-2.319%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_market_for_registrants_common_equ"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 6.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_reserved"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reserved</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 7.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:12.25pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-2.319%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7_managements_discussion_analysis_f"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 7A.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7a_quantitative_qualitative_disclos"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 8.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_8_financial_statements_supplementar"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 9.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:12.25pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-2.319%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9_changes_in_disagreements_with_acc"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 9A.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9a_controls_procedures"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 9B.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9b_or_information"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 9C.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign_jur"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspection</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_iii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART III</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 10.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_10_directors_executive_ficers_corpo"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 11.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_11_executive_compensation"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Executive Compensation</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 12.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:12.25pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-2.319%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_12_beneficial_owner_stockholder"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 13.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:12.25pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-2.319%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_13_related_party_transactions"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 14.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_14_principal_accounting_fees"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal Accountant Fees and Services</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_iv"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART IV</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 15.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_15_exhibits_financial_statement_sch"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exhibits and Financial Statement Schedules</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 16.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_16_form_10k_summary"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#signatures"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Signatures</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#index_to_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Index to Financial Statements</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXPLANATORY NOTE</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span><ix:nonNumeric id="F_14fee835-3207-42e9-8a4f-712b4041c2d0" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:AmendmentDescription" continuedAt="F_14fee835-3207-42e9-8a4f-712b4041c2d0_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In this Amendment No. 1 on Form 10-K/A (</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Amendment No. 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">), unless the context requires otherwise, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Eledon</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">we</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">our</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">us</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">means Eledon Pharmaceuticals, Inc. (formerly Novus Therapeutics, Inc.) and all of its wholly-owned subsidiaries.</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_14fee835-3207-42e9-8a4f-712b4041c2d0_1"><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Amendment No. 1 amends the Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc. for the fiscal year ended December 31, 2024, as filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 20, 2025 (the &#8220;Original Report&#8221;) to restate for the effects of material errors in the previously issued financial statements as of and for the years ended December 31, 2024 and 2023.   </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">See Note 1. Description of Business (As Restated)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 12</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restatement of Previously Issued Consolidated Financial Statements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Notes to Financial Statements included in this Amendment No. 1 for additional information and reconciliation of the previously reported amounts to the restated amounts.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has not filed, and does not intend to file, amendments to the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024, June 30, 2024 or September 30, 2024 (the &#8220;Impacted 2024 Quarterly Reports&#8221;), which will be restated prospectively with the corresponding 2025 quarterly filings. Accordingly, investors should rely only on the financial information and other disclosures regarding these restated periods in this Amendment No. 1 or in future filings with the SEC (as applicable), and not on any previously issued or filed reports, earnings releases or similar communications relating to these periods. The financial information that has been previously filed or otherwise reported for the periods covered by the Original Report and the Impacted 2024 Quarterly Reports is superseded by the information in this Amendment No. 1 (as to the fiscal years ended December 31, 2024 and December 31, 2023 included in the Original Report, and, solely with respect to the information included under the caption &#8220;Restatement of Interim Financial Information&#8221; in Note 12 of the Notes to Consolidated Financial Statements included in this Amendment No. 1, as to the information included in the Impacted 2024 Quarterly Reports) as well as by the restated financial information related to the quarters ended March 31, 2024, June 30, 2024 and September 30, 2024 that will be included prospectively in the corresponding 2025 quarterly filings.  The Company also expects to file an amendment to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the &#8220;2025 Form 10-Q&#8221; and, together with the Original Report and the Impacted 2024 Quarterly Reports, the &#8220;Impacted Reports&#8221;) to restate the unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2025 and March 31, 2024 included in the 2025 Form 10-Q with respect to the material errors described in Note 1 and Note 12 under the caption &#8220;Restatement of Previously Issued Consolidated Financial Statements.&#8221; The errors did not result in any impact on the Company&#8217;s cash and short-term investment position, liquidity, or results of operations.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Amendment No. 1 presents the Original Report, as amended and restated to date, with further modifications as necessary to reflect the restatement described herein. The following items have been amended to reflect the restatement:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1A. Risk Factors</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8. Financial Statements and Supplementary Data</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9A. Controls and Procedures</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by Items 10, 11, 12, 13 and 14 of Part III of this Report is incorporated by reference to the Company&#8217;s definitive proxy statement, which was filed with the SEC on April 29, 2025 (the &#8220;2025 Proxy Statement&#8221;). The information contained in the 2025 Proxy Statement is not impacted by the restatement described herein.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, in accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), Item 15 of Part IV of the Original Report is being amended and restated solely to include as exhibits the certifications of our principal executive officer and principal financial officer required by Rule 13a-14(a) under the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise expressly noted herein, this Amendment No. 1 does not amend, modify or update any other information set forth in the Original Report. Furthermore, this Amendment No. 1 does not change any previously reported financial results, except as necessary to reflect the restatement described herein, nor does it reflect events occurring after the filing date of the Original Report. Information not affected by this Amendment No. 1 remains unchanged and reflects the disclosures made at the time the Original Report was filed. Accordingly, this Amendment No. 1 should be read in conjunction with our filings made with the SEC subsequent to the filing of the Original Report, including any amendment to those filings.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Special Note Regarding Forward-Looking Statements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report on Form 10-K as amended by this Amendment No. 1 (together, the &#8220;Annual Report on Form 10-K&#8221;) contains &#8220;forward-looking statements&#8221; as defined by the Private Securities Litigation Reform Act of 1995, which statements involve substantial risks and uncertainties. Any statements other than statements of historical or current fact in this Annual Report on Form 10-K are forward looking statements. In some instances, you can identify forward-looking statements by the use of words such as &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;estimates,&#8221; &#8220;intends,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;targets,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; and similar expressions, although not all forward-looking statements include such identifying words. Forward-looking statements include, but are not limited to statements regarding:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our product development plans, expectations for and the timing of commencement, enrollment, completion, data, and release of results of clinical trials for our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our estimates regarding expenses, capital requirements and needs for additional financing;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our strategies with respect to our preclinical and clinical development programs, including our expectations regarding the production of clinical quantities of our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our plans, strategy and timing to obtain and maintain regulatory approvals of our product candidates; </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding competitive conditions for our product candidates; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations about our future financial performance or condition.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we believe that we have a reasonable basis for each forward looking statement contained in this Annual Report on Form 10-K, actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including the factors listed under &#8220;Risk Factor Summary&#8221; below. These risks and uncertainties, as well as other risks and uncertainties that could cause the Company&#8217;s actual results to differ significantly from the forward-looking statements contained herein, are described in greater detail in Part I, Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Forward-looking statements contained in this Annual Report on Form 10-K are based on our current beliefs, assumptions, expectations, estimates and projections, which may be impacted by known or unknown factors. Any forward-looking statements contained in this Annual Report on Form 10-K speak only as of the date hereof and not as of any future date, and the Company expressly disclaims any intent to update any forward-looking statements, whether as a result of new information, future events or otherwise. You are therefore cautioned not to place undue reliance on the forward-looking statements included in this Annual Report on Form 10-K.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market data and certain other statistical information used in this Annual Report on Form 10-K are based on independent industry publications, governmental publications, reports by market research firms or other independent sources. Some data are also based on our good faith estimates. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISK FACTOR SUMMARY</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following summarizes the principal factors that make an investment in the Company speculative or risky, all of which are more fully described in Part I, Item 1A, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K. This summary should be read in conjunction with the Risk Factors section and should not be relied upon as an exhaustive summary of the material risks facing our business. The occurrence of any of these risks could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this report and those we may make from time to time. You should consider all of the risk factors described in our public filings when evaluating our business.</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our short operating history and shifts in our business strategy may make it difficult to evaluate the success of our business to date and to assess our future viability.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant operating losses since our inception and expect that we will continue to incur losses over the next several years and may never achieve or maintain profitability. </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will require additional funding to be able to complete the development of our lead drug candidate. If we are unable to raise such capital, or if we are unable to do so on acceptable terms, we will be forced to significantly alter our business strategy, substantially curtail our current operations, or liquidate and cease operations altogether.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Issuances of our common stock, including common stock that may be issuable pursuant to outstanding warrants or other convertible securities as well as shares and warrants issued or issuable in connection with our recent private placement transactions, could result in significant dilution and could cause our stock price to fall.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates are in the early stages of clinical development and may not be successfully developed. If we are unable to successfully develop and commercialize these or any other product candidate, or if we experience significant delays in doing so, our business will be materially harmed.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unfavorable global economic conditions could have a material adverse effect on our business.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adverse conditions in the financial markets, including bank failures, could adversely affect our liquidity and financial performance.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drug development involves a lengthy and expensive process with an uncertain outcome, including failure to demonstrate safety and efficacy to the satisfaction of the U.S. Food and Drug Administration (&#8220;FDA&#8221;) or similar regulatory authorities outside the United States. We may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development, formulation and commercialization of our product candidates.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of non-clinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials, and there is a risk that additional non-clinical and/or clinical safety studies will be required by the FDA or similar regulatory authorities outside the United States or that subsequent studies will not match results seen in prior studies.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delays or difficulties in the enrollment of patients in clinical trials could delay or prevent our receipt of necessary regulatory approvals and increase expenses for the development of our product candidates.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If serious adverse events or unacceptable side effects are identified during the development of our product candidates, we may need to abandon or limit our development of some of our product candidates.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future success depends on our ability to retain executives and key employees and to attract, retain and motivate qualified personnel in the future.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals, or the approvals may be for a narrow indication, we may not be able to commercialize our product candidates, and our ability to generate revenue may be materially impaired.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legislation regulating the pharmaceutical and healthcare industries may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and affect the prices we may obtain.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our internal computer systems, or those of our third-party collaborators, service providers, contractors or consultants, may fail or suffer security breaches, disruptions, or incidents, which could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The compromise of privacy, security, integrity or confidentiality of sensitive information related to our business or failure to comply with confidentiality and data privacy obligations could have a material adverse effect on our business.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if any of our product candidates receives marketing approval, we may fail to achieve the degree of market acceptance by physicians, patients, third-party payers and others in the medical community necessary for commercial success.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our current product candidates, or a future product candidate receives marketing approval and we, or others, later discover that the product is less effective than previously believed or causes undesirable side effects that were not previously identified, our ability to market the product could be compromised.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The insurance coverage and reimbursement status of newly-approved products is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for new or current products could limit our ability to market those products and decrease our ability to generate revenue.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our reliance on third parties for the manufacture of our product candidates for non-clinical and clinical trials, and for eventual commercialization, increases the risk that we will not have sufficient quantities of our product candidates or products at an acceptable cost and quality, which could delay, prevent or impair our development or commercialization efforts.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We depend on contract research organizations (&#8220;CROs&#8221;) and other contracted third parties to perform non-clinical and clinical testing and certain other research and development activities. As a result, the outcomes of the activities performed by these organizations will be, to a certain extent, beyond our control.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to obtain and maintain intellectual property protection for our technology and products or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to ours, and our ability to successfully commercialize our technology and products may be impaired.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Public health crises, including pandemics or epidemics, could adversely affect our business.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our stock price could be volatile, and the market price of our common stock may drop unexpectedly.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we fail to establish and maintain proper and effective internal control over financial reporting, our operating results and our ability to operate our business could be harmed. </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provisions in our corporate charter and under Delaware law could make an acquisition of the Company more difficult and may prevent attempts by our stockholders to replace or remove our current management.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WEBSITE REFERENCES</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In this Annual Report on Form 10-K, we make references to our website at www.eledon.com. References to our website through this Form 10-K are provided for convenience only and the content on our website does not constitute a part of, and shall not be deemed incorporated by reference into, this Annual Report on Form 10-K.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> I</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1_business"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1. B</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">usiness.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon is a clinical stage biotechnology company using our immunology expertise in targeting the CD40 Ligand (&#8220;CD40L&#8221;) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (&#8220;ALS&#8221;). Our lead compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that we believe has broad therapeutic potential. We believe the central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is engineered to potentially both improve safety and provide pharmacokinetic, pharmacodynamic, and dosing advantages compared to other anti-CD40 approaches. The CD40L/CD40 pathway is recognized for its prominent role in immune regulation. CD40L is primarily expressed on activated CD4+ T cells, platelets and endothelial cells while the CD40 receptor is constitutively expressed on antigen presenting cells such as macrophages and dendritic cells, as well as B cells. By blocking CD40L and not the CD40 receptor, tegoprubart inhibits both the CD40 and CD11 costimulatory signaling pathways, providing the potential for improved efficacy compared to anti-CD40 receptor approaches. Blocking CD40L also increases polarization of CD4+ lymphocytes to Tregs, a specialized subpopulation of T cells that act to suppress an immune response, thus creating a more tolerogenic environment, which may play a therapeutic role in autoimmune diseases and in the prevention of allograft rejection after solid organ transplantation.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is designed to negate the risk of thrombolytic events seen in the first generation of anti-CD40L antibodies by introducing structural modifications that have been shown in preclinical models to eliminate binding to the Fc&#947; receptors associated with platelet activation without altering the binding of tegoprubart to CD40L. In non-human primate studies, dosing of tegoprubart up to 200 mg/kg per week for 26 weeks, demonstrated no adverse events regarding coagulation, platelet activation or thromboembolism.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 1: Mechanism overview of CD40L inflammatory signaling and tegoprubart site of action</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117130267_0.jpg" alt="img117130267_0.jpg" style="width:382px;height:298px;"/></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 1: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interaction of CD40 with CD40L on immune cells mediates activation of the co-stimulatory immune pathway, controlling &#8220;cross talk&#8221; between the adaptive and innate immune systems. Blocking CD40L shifts polarization away from pro-inflammatory signaling to T-cell anergy, apoptosis, and polarization to a &#8220;T-reg&#8221; environment. (Source: Adapted from Kant et al., Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022, AJKD.)</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strategy</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business strategy is to optimize the clinical and commercial value of tegoprubart and become a global biopharmaceutical company with a focused immunology franchise. Our strategy is to develop tegoprubart for the prevention of rejection of allograft (i.e., transplanting an organ from one human to another) and xenograft (i.e., transplanting an organ from an animal to a human) organs and cells, and for the treatment of ALS. We selected our indications based on preclinical and clinical data that was generated with either tegoprubart or historical anti-CD40L molecules. In January 2023, we announced plans to prioritize and focus resources on our kidney transplantation programs, discontinue the Company funded islet cell transplantation program and the IgAN program. We also remain committed to further progressing ALS clinical development and are working with key stakeholders on potential next steps to do so. However, we are unable to continue our clinical development of tegoprubart for people with ALS without additional financing.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following chart summarizes the status of our current clinical development programs. Details for each program are outlined below.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117130267_1.jpg" alt="img117130267_1.jpg" style="width:672px;height:260px;"/></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acquisition</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2020, we acquired Anelixis Therapeutics, Inc. (&#8220;Anelixis&#8221;), the company that owned and controlled the intellectual property related to tegoprubart. See </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Notes to Financial Statements included in this Annual Report on Form 10-K, for further details of grants and licenses related to this acquisition.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to our acquisition of Anelixis, we focused on developing medicines for patients with disorders of the ear, nose, and throat (&#8220;ENT&#8221;). In June 2020, we announced that our lead program did not achieve statistical significance for the primary efficacy endpoints in the treatment of acute otitis media. As a result of this failure to achieve the primary study endpoint, we suspended the clinical development of our legacy ENT assets while we assessed potential development strategies. Following the June 2020 announcement, we significantly curtailed development expenses as we sought to identify strategic alternatives that would maximize stockholder value. As a result of these activities, we acquired Anelixis and raised additional capital in September 2020, as described above. After acquiring Anelixis, we terminated our ENT activities and returned our product rights to the original license holders in July 2021.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of Tegoprubart for the Prevention of Allograft Rejection in Kidney Transplantation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2023, we announced plans to prioritize and focus resources on our kidney transplantation programs. We are first focusing on kidney transplantation as this is the most common type of solid organ transplantation in the U.S. with an estimated 260,000 Americans living with a transplanted kidney. There are an estimated 27,000 kidneys transplanted annually in the U.S. Approximately 100,000 people in the U.S. are on a waiting list where they typically wait an average 3-5 years for a kidney transplant while about 5,000 people in the U.S. in need of a kidney transplant die each year waiting for a suitable kidney. Approximately 11% of U.S. people on the waiting list are waiting for a repeat transplant. There remains a critical shortage of kidneys and other organs available for transplantation.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There has been little innovation in immunosuppression therapy for organ transplant patients over the past 30 years. The standard of care immunosuppressive drugs used post-transplant have been shown to reduce the risk of organ rejection, but they are also associated with potentially toxic side effects. Organ transplant recipients require immunosuppression on a lifelong basis, and any disruption in the immunosuppression therapy can trigger transplant rejection. Calcineurin inhibitors (&#8220;CNI&#8221;s) are a critical component of most immunosuppressive regimens to prevent acute and long-term kidney transplant rejection. However, chronic exposure to CNIs (tacrolimus is the drug most commonly used) is associated with nephrotoxicity, hypertension, new onset diabetes due to pancreatic beta cell toxicity, as well as central nervous system (&#8220;CNS&#8221;) side effects, like tremor. Over time, these CNI side effects may significantly damage the transplanted kidneys or result in a requirement for reduced exposures to CNIs which can lead to an increased risk of rejection. Moreover, CNS side effects like tremors may result in patients decreasing their adherence to their medicines. Today, an implanted kidney is expected to fail within 10-15 years on average using currently available immunosuppression options. The fact that American transplant patients are on average in their 50s means that many of them will ultimately need a second or even third transplant procedure during their lifetime or a return to dialysis.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The central role of CD40L signaling in generating pro-inflammatory responses makes it a highly attractive candidate for therapeutic intervention in the protection of transplanted organs and prevention of transplant rejection. Results from prior studies demonstrate that targeting and blocking CD40L has the potential for better efficacy and improved safety, including reduced risk of nephrotoxicity, diabetes, hypertension, and other side effects associated with standard-of-care CNIs such as tacrolimus.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart seeks to address challenges associated with current immunosuppressive transplantation regimens using CNI-based therapies. The ability to prevent acute and chronic transplant rejection without the need for CNIs has the potential to transform the clinical management of preventing graft rejection by mitigating the adverse events associated with CNIs and improving long-term graft survival, thus potentially decreasing the need for repeat kidney transplants and increasing organ availability for other patients on the wait list. By identifying and advancing novel strategies in immunosuppression including targeting the CD40L pathway, we may be able to help organs remain functional for longer and potentially throughout the natural lifespan of each recipient.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In aggregated data from the published studies referenced in Figure 1 below, non-human primates undergoing allograft renal transplantation receiving anti-CD40L monotherapy (e.g., 5c8, AI794, IDEC-131) had longer average survival than both those receiving anti-CD40 monotherapy (e.g., 4D11, cH5D12, Chi220, ASKP1240), tacrolimus monotherapy or untreated controls (Figure 2).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 2: Inhibition of CD40L improved survival vs. CD40 inhibition in non-human primate kidney transplantation monotherapy studies</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117130267_2.jpg" alt="img117130267_2.jpg" style="width:672px;height:326px;"/></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 2: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Kaplan-Meir estimates of the probability of rejection free survival by treatment group from eleven published studies of allograft kidney transplant in non-human primates. Sources: Perrin, 2022; Song, 2014; Song, 2016; Duan, 2017. Note: In aggregated data from published studies, NHPs receiving anti-CD40L (e.g., 5c8, AI794, IDEC-131) immunomodulation monotherapy post kidney transplantation had longer average survival than those receiving anti-CD40 monotherapy (e.g., 4D11, cH5D12, Chi220, ASKP1240), tacrolimus monotherapy or untreated controls. Tac = tacrolimus. Meta-analysis is not based on head-to-head studies. Differences between any individual programs may vary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have received regulatory approvals in the United States, Canada, the United Kingdom and Australia, for a Phase 1b clinical trial of tegoprubart in up to 36 subjects, replacing tacrolimus as an immunosuppressive regimen component in patients undergoing de novo kidney transplantation. Each participant will receive rabbit antithymocyte globulin induction and a maintenance regimen consisting of tegoprubart, mycophenolate mofetil, and corticosteroids. The primary endpoint of the study is safety. Other endpoints include glomerular filtration rate (&#8220;eGFR&#8221;), characterizing the pharmacokinetic profile of tegoprubart, and the incidence of biopsy proven rejection. The first subject in the Phase 1b study was dosed in July 2022.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Better graft function as assessed by eGFR has been associated with improved long-term patient and graft survival and is an early predictor of future graft failure. Historical studies have reported average eGFRs generally in the low 50 mL/min/1.73m2 range during the first year after kidney transplant using current standard of care immunosuppression. An eGFR of 50 mL/min/1.73m2 or below indicates chronic kidney disease.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We reported interim safety and efficacy results from the Phase 1b clinical trial in March 2023, and provided updated data in November 2023 and June 2024. At the time of the June 2024 update, which reported data as of April 3, 2024, results from the 13 participants in the Phase 1b trial support tegoprubart&#8217;s potential to protect organs from rejection while improving renal function in patients undergoing kidney transplantation. As mentioned above, data from historical studies using standard of care, calcineurin inhibitor-based, immunosuppression therapy typically report aggregate mean estimated eGFRs of approximately 53 mL/min/1.73m&#178; during the first year after kidney transplant. In the ongoing Phase 1b trial, as of April 3, 2024, mean eGFR was above 60 mL/min/1.73m&#178; at each reported time points after day 30, with an overall mean eGFR of 70.5 mL/min/1.73m&#178; for all the reported time points after day 30 post-transplant. Two participants completed 12 months on therapy post-transplant, and both demonstrated mean eGFRs above 90 mL/min/1.73m&#178; at one-year post-transplant. The interim results demonstrated that tegoprubart is generally safe and well tolerated in patients undergoing de novo kidney transplantation. As of April 3, 2024, three subjects have discontinued the study due to hair loss and fatigue, viral infection, and rejection, respectively. There have been no cases of hyperglycemia, new onset diabetes, or tremor, all of which are side effects often associated with standard of care immunosuppression therapy. There have been no cases of graft loss or death.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2022, we received Investigational New Drug (&#8220;IND&#8221;) application clearance from the FDA for our controlled, Phase 2 BESTOW trial of tegoprubart for the prevention of transplant rejection in persons receiving a kidney transplant. The BESTOW study is a multi-center, two-arm, active comparator, head-to-head superiority clinical study, and will enroll approximately 120 participants undergoing kidney transplantation in the U.S. and other countries to evaluate the safety, pharmacokinetics, and efficacy of tegoprubart compared to the calcineurin inhibitor tacrolimus. The study&#8217;s primary objective is to assess graft function as measured by estimated eGFR at 12 months post-transplant in participants treated with tegoprubart compared to tacrolimus. Secondary objectives will include assessment of graft survival, biopsy-proven acute rejection, and the incidence of new onset diabetes mellitus after transplant. The BESTOW study is running in parallel to the ongoing Phase 1b clinical trial of tegoprubart in kidney transplantation. The first subject in the BESTOW study was dosed in August 2023. On September 4, 2024, we announced the completion of enrollment in the BESTOW study.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2023, we enrolled the first participant in a Phase 2 open-label extension study which is designed to evaluate the long-term safety, pharmacokinetics, and efficacy of tegoprubart in participants who have completed one year of treatment in either the ongoing Phase 1b study or the Phase 2 BESTOW study.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of tegoprubart for the Prevention of Allograft Rejection in Xenotransplantation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While inhibition of CD40L has shown it may play an important role in immunosuppression in allograft kidney transplantation, this mechanism of action has also demonstrated that it may be a promising option in xenotransplantation (i.e., transplanting an organ from an animal to a human).</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2023, we entered into a non-exclusive collaborative research agreement with eGenesis, Inc., (&#8220;eGenesis&#8221;), under which eGenesis gained access to tegoprubart for preclinical and clinical xenotransplantation studies in support of eGenesis&#8217; kidney, heart and islet cell xenotransplantation programs.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of tegoprubart for the Prevention of Allograft Rejection in Islet Cell Transplantation (&#8220;ICT&#8221;)</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Type 1 diabetes (&#8220;T1D&#8221;) is a T cell mediated autoimmune disease with progressive loss of insulin producing pancreatic beta cells and affects approximately 2 million persons in the United States. Approximately 33% of people with T1D report impaired awareness of hypoglycemia regardless of continuous glucose monitoring or automated insulin usage. Approximately 12% of people with T1D experience recurrent severe hypoglycemic events annually, putting them at higher risk for adverse outcomes. Approximately 5% to 8% of adults with T1D experience diabetic ketoacidosis annually, often as a result of poor glycemic control. ICT is gaining attention as a thera</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">peutic option for T1D because it can restore physiological insulin secretion, minimize the risk of hypoglycemic unawareness, and reduce the risk of death due to severe hypoglycemia. The advances made in this field over the past decade have improved patient outcomes, and the procedure has been evolving from an experimental treatment to a clinical treatment option</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A number of issues are believed to continue to hamper the overall success of ICT and to need to be addressed in order for there to be widespread clinical acceptance. These include the acute loss of transplanted islets with current immunosuppressive treatments, particularly those with CNI-based therapies, due to islet cell toxicity and alloreactive immunologic responses to transplanted islets. Over time, the progressive loss of islet cells and decline in islet cell function can lead to the need for multiple transplants in order for T1D patients to have optimal response to blood glucose levels and possibly achieve insulin independence. Tegoprubart seeks to address the challenges associated with current ICT immunosuppressive regimens using CNI-based therapies, by replacing the CNIs with tegoprubart to prevent rejection and protect the transplanted cells. We believe that tegoprubart may unlock the ICT market by potentially improving islet cell graft survival and reduce the side effects associated with standard of care regimens</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Historical studies in nonhuman primate models of ICT have demonstrated that treatment with anti-CD40L antibodies induces long term islet cell function and graft survival, even as a monotherapy. Tegoprubart has shown pre-clinical, proof-of-concept efficacy in a non-human primate model of T1D, where animals undergoing ICT maintained glucose control and sustained levels of C-peptide with chronic tegoprubart treatment for up to a year. Compared to combination immunosuppressive therapy including CNIs, tegoprubart monotherapy was more effective in preventing long term islet cell rejection, associated with better graft function, and showed an improved safety profile.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2022, the FDA granted orphan designation to tegoprubart for the prevention of allograft rejection in pancreatic islet cell transplantation.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2024, we announced that tegoprubart would be utilized in an investigator-initiated trial, conducted at the University of Chicago Medicine's Transplantation Institute. This pilot study is assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with T1D mellitus undergoing islet cell transplantation. The Company is not funding this trial but is providing tegoprubart for use in the study.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 29, 2024, positive data were reported for the first three islet transplant recipients in the study, potentially demonstrating the first human cases of insulin independence achieved using an anti-CD40L monoclonal antibody therapy without the use of tacrolimus. The first two subjects achieved insulin independence and normal hemoglobin A1C (HbA1c) levels, a measure of average blood glucose, post-transplant. The third subject, decreased insulin use by more than 60% three days following the procedure and continues on insulin independence trajectory typically observed one-to-two months post-transplant. Subjects in the study received islet transplants combined with induction therapy and for chronic maintenance therapy, mycophenolate mofetil plus tegoprubart given every third week by intravenous infusion. The first two subjects achieved insulin independence and presented stable islet graft function at approximately three months and six months post-transplant, respectively. Islet engraftment, measured by graft function standardized to the number of islets infused, was three to five times higher than three comparable subjects who received tacrolimus-based immunosuppression, suggesting treatment with tegoprubart results is less toxic to transplanted islet cells resulting in improved graft survival and function. Treatment was generally well tolerated in all subjects with no unexpected adverse events or hypoglycemic episodes. After initial islet transplant, the first participant reduced insulin requirements by over 60% and normalized blood glucose control. As of October 29, 2024, the first patient had achieved insulin independence within approximately a week after a second islet transplantation procedure.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of Tegoprubart for ALS</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ALS is a progressive, paralytic disorder characterized by degeneration of motor neurons in the brain and spinal cord. In the U.S., the incidence is estimated at approximately 5,000 cases per year with a prevalence of approximately 30,000 cases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">overall. Despite 3 approved drugs, in most cases, death from respiratory failure occurs between 3 to 5 years from diagnosis, with 50% of patients living at least 3 years from diagnosis and only 20% of patients living at least 5 years from diagnosis.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While the exact pathogenic mechanism of ALS is still not fully understood, there is strong evidence indicating that neuroinflammation plays an important role in the disease&#8217;s pathogenesis. Neuroinflammation in ALS is characterized by the infiltration of lymphocytes and macrophages into the central nervous system, and the activation of microglia and reactive astrocytes. Reactive astrocytes and microglia as well as infiltrating lymphocytes, dendritic cells, monocytes, macrophages and immune complexes have been identified in cerebrospinal fluid and neural tissues in both animal models of ALS and at autopsy in ALS patients.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is designed to block CD40L binding to CD40, thereby potentially inhibiting neuroinflammatory pathways leading to disease progression in ALS. In vitro proof-of-concept studies have shown that tegoprubart binds to CD40L in human cells and blocks CD40L binding on antigen presenting cells and activated T cells. The potential for therapeutic benefit of CD40L blockage in treating ALS has been demonstrated in a SOD1 mouse model of ALS, where a murine anti-CD40L antibody, MR1 (as defined below), prolonged survival and delayed the onset of neurological disease progression. These pathophysiological manifestations are believed to be due to reduced immune cell infiltration of macrophages into skeletal muscle and their destroying denervated nerves. The plasticity of the nervous system to repair itself in the absence of this immune cell attack is believed to result in improved neuromuscular junction occupancy and improved muscle function. Blocking CD40L signaling also prevents pro-inflammatory polarization of lymphocytes, reduced neuroinflammation and improved motor neuron survival in rodent ALS models (Figure 3).</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 3: Blocking CD40L Improves Survival and Pathophysiology Associated with ALS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117130267_3.jpg" alt="img117130267_3.jpg" style="width:657px;height:257px;"/></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 3: Anti-CD40L (&#8220;MR1&#8221;) treatment decreases CD68+ macrophages, improves neuromuscular junction occupancy and improves motor neuron survival.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (A) Quantification of reduction of CD68+ macrophages by anti-CD40L treatment at day 100. (White bar, control IgG); gray bar (anti-CD40L&#8211;treatment); black bar (untreated age-matched non-transgenic mice) (B) Quantification of neuromuscular occupancy in SOD1 mice prior to overt symptoms (day 70) versus after symptom onset (day 85) treated with an IgG control antibody (vehicle) or anti-CD40L antibody. (C) Quantitative comparison of lumbar spinal cord motor neuron counts per mm2 in IgG vehicle control (White bar) versus anti-CD40L treated mice (grey bar) at day 100 (Lincecum, 2010).</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2018, the FDA granted orphan drug designation to tegoprubart for ALS. In 2019, we completed a single ascending dose Phase 1 study of tegoprubart in healthy volunteers and people with ALS. In this study, the doses of tegoprubart studied were well tolerated in healthy adult subjects and adults with ALS. Tegoprubart demonstrated low anti-drug antibody responses that were not dose related, linear dose proportionality across the dose ranges, and a half-life of up to 26 days.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2020, we initiated a Phase 2a, open-label, multi-center study to evaluate the safety and tolerability of multiple doses of tegoprubart in adult subjects with ALS. Fifty-four subjects with ALS were enrolled into the study in the United States and Canada at 13 ALS treatment sites. Ascending doses of tegoprubart were administered as IV infusions to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four sequentially enrolling cohorts. The first two cohorts consisted of nine participants, and the last two cohorts of 18 participants each. All enrolled subjects received six infusions of tegoprubart over a 12-week period. Blood samples for target engagement, and exploratory biomarkers for inflammation and neurodegeneration were taken and analyzed. Participant-focused clinical outcomes were also assessed. In May 2022, we completed the Phase 2a study and released positive topline results. Tegoprubart successfully met the primary endpoints of safety and tolerability. Fifty of the fifty-four subjects completed all six study infusions, and adverse events were typical of an ALS patient population. Tegoprubart was well-tolerated, and no drug-related serious adverse events were observed. No new safety signals emerged. Anti-drug antibodies (&#8220;ADAs&#8221;) were present in less than 5 percent of samples. All ADAs were of low titer and did not impact tegoprubart drug levels. Tegoprubart target engagement was demonstrated in all dose cohorts with increasing target engagement in a dose-dependent manner, plateauing at the 4 and 8 mg / kg dosing levels using CD40L and CXCL13 biomarkers related to T cell and B cell function, respectively. Tegoprubart exposure decreased inflammatory biomarker levels, in a dose dependent manner, in 20 of 32 pro-inflammatory proteins. Pro-inflammatory biomarkers reduced included biomarkers also associated with IgA nephropathy and kidney transplant rejection, such as IgA, IgE, IgM, C3, CXCL9, and CXCL10.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are seeking to further progress ALS clinical development and plan to work with key stakeholders on potential next steps to do so. However, we will be unable to continue our clinical development of tegoprubart for people with ALS without additional financing specific for our ALS program, and we can provide no assurances that we will be able to obtain financing on acceptable terms or at all.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of Tegoprubart for IgA Nephropathy</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2023, the Company announced the deprioritization of its IgAN program and all IgAN clinical development activities were discontinued in 2023. IgAN is the leading cause of chronic glomerulonephritis, a state of inflammation producing damage to the filtering part of the kidney. Disease manifestation and clinical presentation involves renal dysfunction characterized by proteinuria with a slow relentless course. Approximately 30%-40% of persons living with IgAN ultimately reach end stage renal disease (&#8220;ESRD&#8221;). The standard of care for ESRD is dialysis or kidney transplant, which represents a significant economic burden as well as a major impact on a patient&#8217;s quality of life. With an estimated prevalence of approximately 150,000 persons in the United States, IgAN is one of the most common autoimmune glomerulonephropathies. In the United States, oral budesonide Tarpeyo was approved for use in IgAN by the FDA in December 2021 and Kinpeygo received conditional approval by the European Medicines Agency (&#8220;EMA&#8221;) in July 2022.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2022, we received IND clearance from the FDA to evaluate tegoprubart for the treatment of IgAN. The Phase 2 global study was a 96-week open-label, dose ranging trial, and included both a high dose and a low dose cohort. The primary endpoint was change in urinary protein:creatinine ratio at week twenty-four. Secondary endpoints included change in estimated eGFR at week 96 as well as safety and tolerability. The first subject was dosed in May 2022. We reported interim safety data from the Phase 2 high dose cohort in March 2023.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon&#8217;s success depends in part on our ability to obtain and maintain proprietary protection for our product candidates, novel discoveries, product technologies and other know-how, to operate without infringing on the proprietary rights of others and to prevent others from infringing our proprietary rights. We seek to protect our product candidates by, among other methods, filing U.S. and foreign patent applications related to our proprietary technology, inventions and improvements that are important to the development and implementation of our business. We also rely on trademarks, trade secrets, know-how, continuing technological innovation and potential in-licensing opportunities to develop and maintain proprietary protection for our product candidates.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our intellectual property portfolio includes issued patents and pending patent applications directed toward (i) isolated antibodies and (ii) methods of treatment using the isolated antibodies that block the interaction of CD40L and CD40 to treat CD40L-related diseases or disorders. We own and have exclusive rights to six active patent families, of which three families are exclusively licensed and the rest are wholly-owned by Eledon. The first exclusively-licensed family is directed to methods for treating amyotrophic lateral sclerosis with antibodies and includes two issued United States patents and 14 issued foreign patents (Japan, Hong Kong, Belgium, Germany, Denmark, Spain, Finland, France, Great Britain, Ireland, Italy, the Netherlands, Sweden, and Switzerland). Absent any patent term adjustments or extensions, patents in this family expire in December 2029. The second exclusively-licensed family is directed to tegoprubart, with 13 pending applications, and issued patents including four issued United States patents and 23 issued foreign patents (Australia, Belgium, Switzerland, China, Germany, Denmark, France, Great Britain, Hong Kong, Ireland, Israel, India, Italy, Japan, South Korea, Mexico, the Netherlands, New Zealand, Russia, Sweden, Singapore). Absent any term adjustments or extensions, patents in this family</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expire in February 2036. The third exclusively-licensed family is directed to tegoprubart, with 17 pending applications, including one pending United States patent application, and issued patents, including one issued United States patent and four issued foreign patents (China, Hong Kong, Mexico, Russia). Absent any term adjustments or extensions, patents in this family expire in May 2038. Our Eledon-owned patent families are directed to methods for treating neurodegenerative disorders, kidney disorders, and transplant rejection. We have recently nationalized two of our Eledon-owned patent families in the United States, Europe, Australia, Canada, China, Japan, South Korea, Mexico, and Singapore, and one of our Eledon-owned patent families is at the Patent Cooperation Treaty stage. Absent any term adjustments or extensions, any patents to issue from the pending applications in these patent families would expire in May 2043, and November 2044, respectively.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsequent to our acquisition of Anelixis, we undertook a strategic review of the legacy ENT assets. We concluded this review and determined that the best path forward was to terminate license agreements associated with these ENT assets and return the rights to the original license holders, which we did in July 2021. There was no financial impact to returning these assets.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patents extend for varying periods according to the date of patent filing or grant and the legal term of patents in various countries where patent protection is obtained. The actual protection afforded by a patent, which can vary from country to country, depends on the type of patent, the scope of its coverage and the availability of legal remedies in the country.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon also protects its proprietary information by requiring its employees, consultants, contractors, and other advisors to execute nondisclosure and assignment of invention agreements upon commencement of their respective employment or engagement. In addition, Eledon also requires confidentiality or service agreements from third parties that receive confidential information or materials.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements included in this Annual Report on Form 10-K under the caption &#8220;Grants and Licenses&#8221; for further information about the Company&#8217;s intellectual property.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The biotechnology and pharmaceutical industries are characterized by continuing technological advancement and significant competition. While we believe that our product candidates, technology, knowledge, experience and scientific resources provide us with competitive advantages, we face competition from major pharmaceutical and biotechnology companies, academic institutions, governmental agencies and public and private research institutions, among others. Any product candidates that we successfully develop and commercialize will compete with existing therapies and new therapies that may become available in the future. Key product features that would affect our ability to effectively compete with other therapeutics include the efficacy, safety and convenience of our products. The availability of reimbursement from the government and other third-party payors will also significantly affect the pricing and competitiveness of our products. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the companies against which we may compete have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical studies, obtaining regulatory approvals and marketing approved products than we do. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical study sites and patient registration for clinical studies, as well as in acquiring technologies complementary to, or necessary for, our programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The competitive conditions faced by the Company are also described in greater detail in Part I, Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K under the caption &#8220;We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.&#8221;</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of tegoprubart or any future product candidates, nor do we have plans to develop our own manufacturing operations in the foreseeable future. We currently rely on third parties for raw materials and the manufacturing of drug substance and drug product for non-clinical and clinical activities. As of the date of this Annual Report, we have not experienced any difficulty in obtaining raw materials required with respect to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the manufacturing of tegoprubart. We believe we have enough drug substance and drug product on hand and manufacturing capacity with our third-party manufacturing providers to meet forecasted clinical trial demand.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also rely on third parties to label, store and distribute drug product for our non-clinical and clinical trials.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Regulation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government authorities in the United States, including federal, state, and local authorities, and in other countries, extensively regulate, among other things, the manufacturing, research and clinical development, marketing, labeling, and packaging, storage, distribution, post-approval monitoring and reporting, advertising and promotion, and export and import of pharmaceutical and biological products, such as those we are developing. Pricing of such products is also subject to regulation in many countries. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local, and foreign statutes and regulations require the expenditure of substantial time and financial resources.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Government Regulation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and its implementing regulations, and biologics under the FDCA and the Public Health Service Act (&#8220;PHSA&#8221;) and its implementing regulations. FDA approval is required before any new unapproved drug or biologic or dosage form, including a new use of a previously approved drug, can be marketed in the U.S. Drugs and biologics are also subject to other federal, state, and local statutes and regulations. If we fail to comply with applicable FDA or other requirements at any time during the product development process, clinical testing, approval process or after approval, we may become subject to administrative or judicial sanctions. These sanctions could include the FDA&#8217;s refusal to approve pending applications, license suspension or revocation, withdrawal of an approval, untitled or warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties or criminal prosecution. Any FDA enforcement action could have a material adverse effect on us.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process required by the FDA before product candidates may be marketed in the United States generally involves the following:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">completion of extensive preclinical laboratory tests and preclinical animal studies, all performed in accordance with the Good Laboratory Practices (&#8220;GLP&#8221;) regulations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission to the FDA of an IND which must become effective before human clinical trials may begin and must be updated annually;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approval by an independent institutional review board (&#8220;IRB&#8221;) or ethics committee representing each clinical site before each clinical trial may be initiated;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the product candidate for each proposed indication;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">completion of manufacturing scale up and stability studies, all performed in accordance with the Good Manufacturing Practices (&#8220;GMP&#8221;) regulations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preparation of and submission to the FDA of a biologics license application (&#8220;BLA&#8221;) or a new drug application, or NDA, after completion of all pivotal clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential review of the product application by an FDA advisory committee, where appropriate and if applicable;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a determination by the FDA within 60 days of its receipt of a BLA or NDA to file the application for review;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of an FDA pre-approval inspection of the manufacturing facilities where the proposed product is produced to assess compliance with current Good Manufacturing Practices (&#8220;cGMP&#8221;) regulations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential FDA audit of the clinical trial sites that generated the data in support of the BLA or NDA; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA review and approval of a BLA or NDA prior to any commercial marketing or sale of the product.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preclinical and clinical testing and approval process requires substantial time, effort, and financial resources, and we cannot be certain that any approvals for our product candidates will be granted on a timely basis, if at all.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An IND is a request for authorization from the FDA to administer an investigational new drug product to humans in clinical trials. The central focus of an IND submission is on the general investigational plan and the protocol(s) for human trials. The IND also includes results of animal and in vitro studies assessing the toxicology, pharmacokinetics, pharmacology, and pharmacodynamic characteristics of the product; chemistry, manufacturing, and controls information; and any available human data or literature to support the use of the investigational new drug. An IND must become effective before human clinical trials may begin. An IND will automatically become effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to the proposed clinical trials. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before clinical trials can begin. Accordingly, submission of an IND may or may not result in the FDA allowing clinical trials to commence. The FDA may impose a clinical hold at any time during clinical trials and may impose a partial clinical hold that would limit trials, for example, to certain doses or for a certain length of time.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Trials</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical trials involve the administration of the investigational new drug to human subjects under the supervision of qualified investigators in accordance with Good Clinical Practices (&#8220;GCPs&#8221;) which include the requirement that all research subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety, and the efficacy criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. Additionally, approval must also be obtained from each clinical trial site&#8217;s IRB before the trials may be initiated, and the IRB must monitor the trial until completed. There are also requirements governing the reporting of ongoing clinical trials and clinical trial results to public registries.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The clinical investigation of a drug is generally divided into three phases. Although the phases are usually conducted sequentially, they may overlap or be combined.</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 1. The drug is initially introduced into healthy human subjects or patients with the target disease or condition. These studies are designed to evaluate the safety, dosage tolerance, metabolism and pharmacologic actions of the investigational new drug in humans, the side effects associated with increasing doses, and if possible, to gain early evidence on effectiveness.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 2. The drug is administered to a limited patient population to evaluate dosage tolerance and optimal dosage, identify possible adverse side effects and safety risks, and preliminarily evaluate efficacy.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 3. The drug is administered to an expanded patient population, generally at geographically dispersed clinical trial sites to generate enough data to evaluate dosage, clinical effectiveness and safety, to establish the overall benefit-risk relationship of the investigational new drug product, and to provide an adequate basis for physician labeling.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, the FDA may condition approval of a BLA or NDA for a product candidate on the sponsor&#8217;s agreement to conduct additional clinical trials after approval. In other cases, a sponsor may voluntarily conduct additional clinical trials after approval to gain more information about the drug. Such post-approval studies are typically referred to as Phase 4 clinical trials.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sponsors must also report to the FDA, within certain timeframes, serious and unexpected adverse reactions, any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator&#8217;s brochure, or any findings from other studies or animal or in vitro testing that suggest a significant risk in humans exposed to the product candidate. The FDA, the IRB, or the clinical trial sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk. Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board or committee. This group provides authorization for whether or not a trial may move forward at designated check points based on access to certain data from the trial. We may also suspend or terminate a clinical trial based on evolving business objectives or competitive climate.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The clinical trial process can take three to ten years or more to complete, and there can be no assurance that the data collected will support FDA approval or licensure of the product. Results from one trial are not necessarily predictive of results from later trials.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A drug being studied in clinical trials may be made available to individual patients in certain circumstances. Pursuant to the 21st Century Cures Act (&#8220;Cures Act&#8221;) which was signed into law in December 2016, the manufacturer of an investigational drug for a serious disease or condition is required to make available, such as by posting on its website, its policy on evaluating and responding to requests for individual patient access to such investigational drug (compassionate use). This requirement applies on the later of 60 calendar days after the date of enactment of the Cures Act or the first initiation of a Phase 2 or Phase 3 trial of the investigational drug. At this time, Eledon does not have a program for the compassionate use of an investigational product outside of a clinical trial as it is not applicable to our investigational products.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Submission of a BLA or NDA to the FDA</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assuming successful completion of all required testing (e.g., completion of pivotal clinical trials) in accordance with all applicable regulatory requirements, detailed investigational new drug product information is submitted to the FDA in the form of a BLA or NDA requesting approval to market the product for one or more indications. Under federal law, the submission of most BLAs and NDAs is subject to an application user fee and these fees are typically increased on an annual basis. Applications for orphan drug products are exempted from the BLA and NDA user fees and may be exempted from product and establishment user fees, unless the application includes an indication for other than a rare disease or condition. No application user fees were paid for tegoprubart in calendar 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A BLA or NDA for a new molecular entity must include all relevant data available from pertinent preclinical studies and clinical trials, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing, controls, and proposed labeling, among other things. Data can come from company-sponsored clinical trials intended to test the safety and effectiveness of a use of a product, or from several alternative sources, including investigator-initiated trials that are not sponsored by Eledon. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and effectiveness of the investigational new drug product to the satisfaction of the FDA.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once a BLA or NDA for a new molecular entity has been submitted, the FDA&#8217;s goal is to review the application within ten months after it accepts the application for filing, or, if the application relates to an unmet medical need in a serious or life-threatening indication, six months after the FDA accepts the application for filing. The review process is often significantly extended by the FDA&#8217;s requests for additional information or clarification.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before approving a BLA or NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA or NDA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA is required to refer an application for a novel drug to an advisory committee or explain why such referral was not made. Typically, an advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The FDA&#8217;s Decision on a BLA or NDA</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA evaluates a BLA to determine whether the data demonstrate that the biologic is safe, pure, and potent, or effective, and an NDA to determine whether the drug is safe and effective. After the FDA evaluates the BLA or NDA and conducts inspections of manufacturing facilities where the product will be produced, it may issue an approval letter or a Complete Response Letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. A Complete Response Letter indicates that the review cycle of the application is complete, and the application is not ready for approval. A Complete Response Letter may require additional clinical data or an additional pivotal Phase 3 clinical trial(s), or other significant, expensive and time-consuming requirements related to clinical trials, preclinical studies or manufacturing. Even if such additional information is submitted, the FDA may ultimately decide that the BLA or NDA does not satisfy the criteria for approval and issue a denial. The FDA could also approve the BLA or NDA with a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;) plan to mitigate risks, which could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">proposed labeling, development of adequate controls and specifications, or a commitment to conduct one or more post-market studies or clinical trials. Such post-market testing may include Phase 4 clinical trials and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization. Also, new government requirements, including those resulting from new legislation, may be established, or the FDA&#8217;s policies may change, which could delay or prevent regulatory approval of our products under development.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pediatric Trials and Exclusivity</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Pediatric Research Equity Act of 2003 (&#8220;PREA&#8221;) as amended, BLAs and NDAs must contain data to assess the safety and effectiveness of an investigational new drug product for the claimed indications in all relevant pediatric populations and to support dosing and administration for each pediatric subpopulation for which the drug is safe and effective. A sponsor who is planning to submit a marketing application for a drug product that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration must submit an initial Pediatric Study Plan (&#8220;PSP&#8221;) within sixty days of an end-of-phase 2 meeting or as may be agreed between the sponsor and the FDA. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults or full or partial waivers if certain criteria are met. The FDA and the sponsor must reach agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials, and/or other clinical development programs. The requirements for pediatric data do not apply to any drug for an indication for which orphan designation has been granted. In the future we may seek pediatric approval for tegoprubart applications in connection with renal and islet cell transplantations, which may require the submission of a PSP.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pediatric exclusivity is another type of non-patent exclusivity in the United States and, if granted, provides for the attachment of an additional six months of marketing protection to the term of any existing regulatory exclusivity, including the five-year and three-year non-patent and orphan exclusivity. This six-month exclusivity may be granted if a BLA or NDA sponsor submits pediatric data that fairly respond to a written request from the FDA for such data. The data do not need to show the product to be effective in the pediatric population studied; rather, if the clinical trial is deemed to fairly respond to the FDA&#8217;s request, the additional protection is granted. If reports of FDA-requested pediatric trials are submitted to and accepted by the FDA within the statutory time limits, whatever statutory or regulatory periods of exclusivity or patent protection covering the product are extended by six months. This is not a patent term extension, but it effectively extends the regulatory period during which the FDA cannot accept or approve another application relying on the BLA or NDA sponsor&#8217;s data.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Post-Approval Requirements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual user fee requirements for any marketed products and the establishments at which such products are manufactured, as well as new application fees for supplemental applications with clinical data.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drug manufacturers are subject to periodic unannounced inspections by the FDA and state agencies for compliance with cGMP requirements. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting and documentation requirements upon us and any third-party manufacturers that we may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely, and expect to continue to rely, on third parties for the production of clinical quantities of our product candidates and expect to rely in the future on third parties for the production of commercial quantities. Future FDA and state inspections may identify compliance issues at our facilities or at the facilities of our contract manufacturers that may disrupt production, distribution, or require substantial resources to correct. In addition, discovery of previously unknown problems with a product or the failure to comply with applicable requirements may result in restrictions on a product, manufacturer or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">holder of an approved BLA or NDA, including withdrawal or recall of the product from the market or other voluntary, FDA-initiated or judicial action that could delay or prohibit further marketing. Also, new government requirements, including those resulting from new legislation, may be established, or the FDA&#8217;s policies may change, which could delay or prevent regulatory approval of our products under development.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, untitled or warning letters or holds on post-approval clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal of the FDA to approve pending BLAs or NDAs or supplements to approved BLAs or NDAs, or suspension or revocation of licenses or withdrawal of approvals;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure or detention, or refusal to permit the import or export of products; or</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA strictly regulates marketing, labeling, advertising, and promotion of products that are placed on the market. Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Orphan Designation and Exclusivity</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may grant orphan drug designation to drugs intended to treat a rare disease or condition that affects fewer than 200,000 individuals in the United States, or if it affects more than 200,000 individuals in the United States, there is no reasonable expectation that the cost of developing and making the drug for this type of disease or condition will be recovered from sales in the United States.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages, and user-fee waivers. In addition, if a product is the first to receive FDA approval for the indication for which it has orphan designation, the product is entitled to orphan drug exclusivity, which means the FDA may not approve any other application to market the same drug for the same indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority over the product with orphan exclusivity. The Company received orphan drug designations for tegoprubart for the treatment of ALS and prevention of allograft rejection in pancreatic islet cell transplantation.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Term Restoration</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending upon the timing, duration, and specifics of the FDA approval of the use of our product candidates, some of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, commonly referred to as the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent restoration term of up to five years as compensation for patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14 years from the product&#8217;s approval date. The patent term restoration period is generally one-half the time between the effective date of an IND and the submission date of a BLA or NDA, plus the time between the submission date and the approval of that application, except that the review period is reduced by any time during which the applicant failed to exercise due diligence. Only one patent applicable to an approved product is eligible for the extension and the application for the extension must be submitted prior to the expiration of the patent and within 60 days of the product&#8217;s approval. The U.S. Patent and Trademark Office, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, we may apply for restoration of the patent term for one of our currently owned or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant BLA or NDA.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Abbreviated New Drug Applications for Generic Drugs</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 1984, with passage of the Hatch-Waxman Amendments, Congress authorized the FDA to approve generic drugs that are the same as drugs previously approved by the FDA under the NDA provisions of the statute. To obtain approval of a generic drug, an applicant must submit an abbreviated new drug application (&#8220;ANDA&#8221;) to the agency. In support of such applications, a generic manufacturer may rely on the preclinical and clinical testing previously conducted for a drug product previously approved under an NDA, known as the reference listed drug (&#8220;RLD&#8221;).</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specifically, in order for an ANDA to be approved, the FDA must find that the generic version is identical to the RLD with respect to the active ingredients, the route of administration, the dosage form, and the strength of the drug. At the same time, the FDA must also determine that the generic drug is &#8220;bioequivalent&#8221; to the innovator drug. Under the statute, a generic drug is bioequivalent to an RLD if &#8220;the rate and extent of absorption of the generic drug do not show a significant difference from the rate and extent of absorption of the listed drug.&#8221;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon approval of an ANDA, the FDA indicates that the generic product is &#8220;therapeutically equivalent&#8221; to the RLD and it assigns a therapeutic equivalence rating to the approved generic drug in its publication &#8220;Approved Drug Products with Therapeutic Equivalence Evaluations,&#8221; also referred to as the &#8220;Orange Book.&#8221; Physicians and pharmacists consider an &#8220;AB&#8221; therapeutic equivalence rating to mean that a generic drug is fully substitutable for the RLD. In addition, by operation of certain state laws and numerous health insurance programs, the FDA&#8217;s designation of an &#8220;AB&#8221; rating often results in substitution of the generic drug without the knowledge or consent of either the prescribing physician or patient.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDCA provides a period of five years of non-patent exclusivity for a new drug containing a new chemical entity. In cases where such exclusivity has been granted, an ANDA may not be filed with the FDA until the expiration of five years unless the submission is accompanied by a Paragraph IV certification, in which case the applicant may submit its application four years following the original product approval. The FDCA also provides for a period of three years of exclusivity if the NDA includes reports of one or more new clinical investigations, other than bioavailability or bioequivalence studies, that were conducted by or for the applicant and are essential to the approval of the application. This three-year exclusivity period often protects changes to a previously approved drug product, such as a new dosage form, route of administration, combination or indication.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hatch-Waxman Patent Certification and the 30-Month Stay</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon approval of an NDA or a supplement thereto, NDA sponsors are required to list with the FDA each patent with claims that cover the applicant&#8217;s product or a method of using the product. Each of the patents listed by the NDA sponsor is published in the Orange Book. When an ANDA applicant files its application with the FDA, the applicant is required to certify to the FDA concerning any patents listed for the reference product in the Orange Book, except for patents covering methods of use for which the ANDA applicant is not seeking approval.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specifically, the applicant must certify with respect to each patent that:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the required patent information has not been filed;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the listed patent has expired;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the listed patent has not expired, but will expire on a particular date and approval is sought after patent expiration; or</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the listed patent is invalid, unenforceable or will not be infringed by the new product.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A certification that the new product will not infringe the already approved product&#8217;s listed patents or that such patents are invalid or unenforceable is called a Paragraph IV certification. If the applicant does not challenge the listed patents or indicates that it is not seeking approval of a patented method of use, the ANDA application will not be approved until all the listed patents claiming the referenced product have expired.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the ANDA applicant has provided a Paragraph IV certification to the FDA, the applicant must also send notice of the Paragraph IV certification to the NDA and patent holders once the ANDA has been accepted for filing by the FDA. The NDA and patent holders may then initiate a patent infringement lawsuit in response to the notice of the Paragraph IV certification. The filing of a patent infringement lawsuit within 45 days after the receipt of a Paragraph IV certification</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">automatically prevents the FDA from approving the ANDA until the earlier of 30 months after the receipt of the Paragraph IV notice, expiration of the patent, or a decision in the infringement case that is favorable to the ANDA applicant.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">European Union/Rest of World Government Regulation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to regulations in the United States, we will be subject to a variety of regulations in other jurisdictions governing, among other things, clinical trials and any commercial sales and distribution of our products. The cost of establishing a regulatory compliance system for numerous varying jurisdictions can be very significant. Although many of the issues discussed above with respect to the United States apply similarly in the context of the European Union (&#8220;EU&#8221;) and in other jurisdictions, the approval process varies between countries and jurisdictions and can involve additional product testing and additional administrative review periods. The time required to obtain approval in other countries and jurisdictions might differ from and be longer than that required to obtain FDA approval. Regulatory approval in one country or jurisdiction does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country or jurisdiction may negatively impact the regulatory process in others.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Whether or not we obtain FDA approval for a product candidate, we must obtain the requisite approvals from regulatory authorities in foreign countries prior to the commencement of clinical trials or marketing of the product in those countries. Certain countries outside of the United States have a similar process that requires the submission of a clinical trial application much like the IND prior to the commencement of human clinical trials. In the EU, for example, a clinical trial authorization application (&#8220;CTA&#8221;) must be submitted for each clinical protocol to each country&#8217;s national health authority and an independent ethics committee, much like the FDA and IRB, respectively. Once the CTA is accepted in accordance with a country&#8217;s requirements, the clinical trial may proceed.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The requirements and process governing the conduct of clinical trials vary from country to country. In all cases, the clinical trials are conducted in accordance with GCP the applicable regulatory requirements, and the ethical principles that have their origin in the Declaration of Helsinki.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To obtain regulatory approval of an investigational medicinal product under EU regulatory systems, we must submit a marketing authorization application. The content of the BLA or NDA filed in the United States is like that required in the EU, except, among other things, country-specific document requirements.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For other countries outside of the EU, such as countries in Eastern Europe, Latin America or Asia, the requirements governing product licensing, pricing, and reimbursement vary from country to country.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Countries that are part of the EU, as well as countries outside of the European Union, have their own governing bodies, requirements, and processes with respect to the approval of pharmaceutical and biologic products. If we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Authorization Procedures in the EU</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicines can be authorized in the EU by using either the centralized authorization procedure or national authorization procedures.</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Centralized procedure. The EMA implemented the centralized procedure for the approval of human medicines to facilitate marketing authorizations that are valid throughout the European Economic Area (&#8220;EEA&#8221;). This procedure results in a single marketing authorization issued by the EMA that is valid across the EEA. The centralized procedure is compulsory for human medicines that are: derived from biotechnology processes, such as genetic engineering, contain a new active substance indicated for the treatment of certain diseases, such as HIV/AIDS, cancer, diabetes, neurodegenerative disorders or autoimmune diseases and other immune dysfunctions, and officially designated orphan medicines.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For medicines that do not fall within these categories, an applicant has the option of submitting an application for a centralized marketing authorization to the European Commission following a favorable opinion by the EMA, as long as the medicine concerned is a significant therapeutic, scientific or technical innovation, or if its authorization would be in the interest of public health.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">National authorization procedures. There are also two other possible routes to authorize medicinal products in several EU countries, which are available for investigational medicinal products that fall outside the scope of the centralized procedure:</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Decentralized procedure. Using the decentralized procedure, an applicant may apply for simultaneous authorization in more than one EU country of medicinal products that have not yet been authorized in any EU country and that do not fall within the mandatory scope of the centralized procedure.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mutual recognition procedure. In the mutual recognition procedure, a medicine is first authorized in one EU Member State, in accordance with the national procedures of that country. Following this, further marketing authorizations can be sought from other EU countries in a procedure whereby the countries concerned agree to recognize the validity of the original, national marketing authorization.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, a Pediatric Investigation Plan (&#8220;PIP&#8221;) or a request for waiver or deferral, is required for submission prior to submitting a marketing authorization application. A PIP describes, among other things, proposed pediatric trials and their timing relative to clinical trials in adults. A PIP will be submitted to EMA and other EU countries, as required. The PIP will need to be submitted early during product development before marketing authorization applications are submitted. The timing of PIP submission cannot be after initiation of pivotal trials or confirmatory (phase 3) trials. In the future we may seek pediatric approval for tegoprubart applications in connection with renal and islet cell transplantations, which may require the submission of a PIP.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exclusivity of New Chemical Entities and New Fixed Dose Combinations</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, new chemical entities, sometimes referred to as new active substances as well as new fixed dose combinations, qualify for eight years of data exclusivity upon marketing authorization and an additional two years of market exclusivity. This data exclusivity, if granted, prevents regulatory authorities in the EU from referencing the innovator&#8217;s data to assess a generic (abbreviated) application for eight years, after which a generic application can be submitted, and the innovator&#8217;s data may be referenced, but not approved for two years. The overall ten-year period will be extended to a maximum of eleven years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exceptional Circumstances/Conditional Approval</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Orphan drugs or drugs with unmet medical needs may be eligible for EU approval under exceptional circumstances or with conditional approval. Approval under exceptional circumstances may be applicable to orphan products and is used when an applicant is unable to provide comprehensive data on the efficacy and safety under normal conditions of use because the indication for which the product is intended is encountered so rarely that the applicant cannot reasonably be expected to provide comprehensive evidence, when the present state of scientific knowledge does not allow comprehensive information to be provided, or when it is medically unethical to collect such information. Conditional marketing authorization may be applicable to orphan medicinal products, medicinal products for seriously debilitating or life-threatening diseases, or medicinal products to be used in emergency situations in response to recognized public threats. Conditional marketing authorization can be granted on the basis of less complete data than is normally required in order to meet unmet medical needs and in the interest of public health, provided the risk-benefit balance is positive, it is likely that the applicant will be able to provide the comprehensive clinical data, and unmet medical needs will be fulfilled. Conditional marketing authorization is subject to certain specific obligations to be reviewed annually.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accelerated Review</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the centralized procedure in the EU, the maximum timeframe for the evaluation of a marketing authorization application is 210 days (excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the EMA&#8217;s Committee for Medicinal Products for Human Use, or CHMP). Accelerated evaluation might be granted by the CHMP in exceptional cases, when a medicinal product is expected to be of a major public health interest, particularly from the point of view of therapeutic innovation. In this circumstance, EMA ensures that the opinion of the CHMP is given within 150 days, excluding clock stops.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pharmaceutical Coverage, Pricing and Reimbursement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant uncertainty exists as to the coverage and reimbursement status of any products for which we obtain regulatory approval. In the United States and in other countries, sales of any products for which we receive regulatory approval for commercial sale will depend in part on the availability of coverage and reimbursement from third-party payors. Third-party payors include government authorities, managed care providers, private health insurers and other organizations. The process for determining whether a payor will provide coverage for a product may be separate from the process for setting the reimbursement rate that the payor will pay for the product. Third-party payors may limit coverage to specific products on an approved list, or formulary, which might not include all of the FDA-approved products for a particular indication. Moreover, a payor&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third-party payors are increasingly challenging the price and examining the medical necessity and cost-effectiveness of medical products and services, in addition to their safety and efficacy. In order to obtain coverage and reimbursement for any product that might be approved for sale, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain regulatory approvals. Our product candidates may not be considered medically necessary or cost-effective. If third-party payors do not consider a product to be cost-effective compared to other available therapies, they may not cover the product after approval as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow a company to sell its products at a profit.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. government, state legislatures and foreign governments have shown significant interest in implementing cost containment programs to limit the growth of government-paid healthcare costs, including price controls, restrictions on reimbursement and requirements for substitution of generic products for branded prescription drugs. By way of example, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, collectively (the &#8220;Affordable Care Act&#8221;), contains provisions that may reduce the profitability of drug products, including, for example, increased rebates for drugs sold to Medicaid programs, extension of Medicaid rebates to Medicaid managed care plans, mandatory discounts for certain Medicare Part D beneficiaries and annual fees based on pharmaceutical companies&#8217; share of sales to federal healthcare programs. Since its enactment, there have been several judicial, administrative, executive and congressional challenges to certain aspects of the Affordable Care Act. In addition, other legislative changes have been proposed and adopted in the United States since the Affordable Care Act was enacted. For example, the American Rescue Plan Act of 2021 eliminates the statutory Medicaid drug rebate cap, for single source and innovator multiple source drugs, beginning in January 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, The Inflation Reduction Act of 2022, (the &#8220;IRA&#8221;), includes several provisions that may impact our business to varying degrees, including provisions that reduce the out-of-pocket cap for Medicare Part D beneficiaries to $2,000 starting in 2025; impose new manufacturer financial liability on certain drugs under Medicare Part D; allow the U.S. government to negotiate Medicare Part B and Part D price caps for certain high-cost drugs without generic competition; require companies to pay rebates to Medicare for certain drug prices that increase faster than inflation; and delay until January 1, 2032 the rebate rule that would limit the fees that pharmacy benefit managers can charge. Further, under the IRA, orphan drugs are exempted from the Medicare drug price negotiation program, but only if they have one orphan designation and for which the only approved indication is for that disease or condition. If a product receives multiple orphan designations or has multiple approved indications, it may not qualify for the orphan drug exemption. Further, judicial challenges to the IRA may have an impact on the implementation of the IRA&#8217;s provisions; and the overall effects of the IRA on our business and the healthcare industry in general is not yet known. Adoption of further government controls, measures and tightening of restrictive policies in jurisdictions with existing controls and measures could limit payments for pharmaceuticals.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In European countries, governments influence the price of pharmaceutical products through their pricing and reimbursement rules and control of national healthcare systems that fund a large part of the cost of those products to consumers. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed to by the government. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost-effectiveness of a product candidate to currently available therapies. Other member states allow companies to fix their own prices for medicines but monitor and control company profits. The downward pressure on healthcare costs in general, particularly prescription drugs, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. In addition, in some countries, cross-border imports from low-priced markets exert commercial pressure on pricing within a country.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The marketability of any products for which we receive regulatory approval for commercial sale may suffer if the government and third-party payors fail to provide adequate coverage and reimbursement. In addition, the emphasis on cost containment measures in the United States and other countries has increased, and we expect will continue to increase the pressure on pharmaceutical pricing. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Healthcare Laws and Compliance Requirements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we obtain regulatory approval for any of our product candidates, we may be subject to various federal and state laws targeting fraud and abuse in the healthcare industry. These laws may impact, among other things, our proposed sales, marketing and education programs. In addition, we may be subject to patient privacy regulation by both the federal government and the states in which we conduct our business. The laws that may affect our ability to operate include:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, to induce, or in return for, the purchase or recommendation of an item or service reimbursable under a federal healthcare program, such as the Medicare and Medicaid programs;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">federal civil and criminal false claims laws and civil monetary penalty laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other third-party payors that are false or fraudulent;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Health Insurance Portability and Accountability Act of 1996, (&#8220;HIPAA&#8221;), which created new federal criminal statutes that prohibit executing a scheme to defraud any healthcare benefit program and making false statements relating to healthcare matters;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal transparency laws, including the provision of the Affordable Care Act referred to as the federal Physician Payment Sunshine Act, that requires drug and biologics manufacturers to disclose payments and other transfers of value provided to physicians and teaching hospitals and ownership interests of physicians and their immediate family members;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;) and its implementing regulations, which imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws that may apply to items or services reimbursed by any third-party payor, including commercial insurers, and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Affordable Care Act broadened the reach of the fraud and abuse laws by, among other things, amending the intent requirement of the federal Anti-Kickback Statute and the applicable criminal healthcare fraud statutes contained within 42 U.S.C. &#167; 1320a-7b. Pursuant to the statutory amendment, a person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it in order to have committed a violation. In addition, the Affordable Care Act provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act or the civil monetary penalties statute. Many states have adopted laws similar to the federal Anti-Kickback Statute, some of which apply to the referral of patients for healthcare items or services reimbursed by any source, not only the Medicare and Medicaid programs.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also subject to the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) which prohibits improper payments or offers of payments to foreign governments and their officials for the purpose of obtaining or retaining business. Safeguards we implement to discourage improper payments or offers of payments by our employees, consultants, and others may be ineffective, and violations of the FCPA and similar laws may result in severe criminal or civil sanctions, or other liabilities or proceedings against us, any of which would likely harm our reputation, business, financial condition and result of operations.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, exclusion from participation in government healthcare programs, such as Medicare and Medicaid and imprisonment, damages, fines and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employees</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 20, 2025, Eledon had 31 employees, all of whom are full-time. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Information</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Otic Pharma, Ltd. (&#8220;Otic&#8221;) was founded in the State of Israel in 2008. In 2015, Otic established U.S. operations and moved its corporate headquarters to Irvine, California. In 2017, Otic consummated a reverse merger with Tokai Pharmaceuticals, Inc. (&#8220;Tokai&#8221;), a Delaware corporation that was incorporated on March 26, 2004, pursuant to which, among other things, Tokai purchased from Otic and its stockholders all of the common and preferred shares of Otic in exchange for the issuance of a certain number of shares of common stock of Tokai (the &#8220;Reverse Merger&#8221;). Following the Reverse Merger, Tokai changed its name to Novus Therapeutics, Inc. On September 14, 2020, the Company acquired Anelixis Therapeutics, Inc. (&#8220;Anelixis&#8221;), a Delaware Corporation, after which Anelixis became a wholly owned subsidiary of the Company. On January 4, 2021, the Company changed its name from Novus Therapeutics, Inc. to Eledon Pharmaceuticals, Inc.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive offices are located at 19800 MacArthur Boulevard, Suite 250, Irvine, California 92612. The Company also has a research and development office in Burlington, Massachusetts. Our telephone number is (949) 238-8090 and our website is www.eledon.com.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are advised to read this Annual Report on Form 10-K in conjunction with other reports and documents that we file from time to time with the Securities and Exchange Commission (&#8220;SEC&#8221;). In particular, please read our definitive proxy statement, which will be filed with the SEC in connection with our 2025 annual meeting of stockholders, our quarterly reports on Form 10-Q and any current reports on Form 8-K that we may file from time to time. You may obtain copies of these reports after the date of this annual report directly from us or from the SEC at its website at www.sec.gov. We make our periodic and current reports available on our internet website, free of charge, as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1A. Ris</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">k Factors.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">An investment in shares of our common stock involves a high degree of risk. You should carefully consider the following risk factors, as well as the other information in this Annual Report on Form 10-K and in our other public filings. The occurrence of any of these risks could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this report and those we may make from time to time. You should consider all of the risk factors described in our public filings when evaluating our business.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Operations</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our short operating history and shifts in our business strategy may make it difficult to evaluate the success of our business to date and to assess our future viability.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical stage biopharmaceutical company. Our ongoing operations to date have been limited to organizing and staffing the Company, business planning, raising capital, acquiring and developing technology, identifying potential product candidates and pursuing non-clinical and clinical trials. We have not yet demonstrated our ability to successfully manufacture drug product in large enough quantities and with stability to support additional clinical trials, execute pivotal clinical trials, obtain marketing approvals, manufacture a commercial scale product or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful product commercialization. It can take many years to develop a new medicine from the time it is discovered to when it is available for treating patients. Consequently, any predictions made about our future success or viability based on our short operating history to date may not be as accurate as they could be if we had a longer operating history. In addition, as a result of the acquisition of Anelixis and our decision to discontinue our Company funding of the islet cell transplantation program and the IgAN program, our future business, prospects, financial position and operating results could be significantly different than those in historical periods or previously projected by our management.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as an early-stage business, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. To successfully market any of our current or future product candidates, we will need to transition from a company with a clinical development focus to a company capable of supporting commercial activities. We may not be successful in such a transition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have incurred significant operating losses since our inception and expect that we will continue to incur losses over the next several years and may never achieve or maintain profitability.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant annual net operating losses in every year since our inception. We have no products approved for commercial sale and have not generated any revenue from product sales to date, and we continue to incur significant research and development and other general and administrative expenses related to our ongoing operations. If tegoprubart or any future product candidates we develop are not successfully developed and approved, we may never generate any revenue from sales of products. The Company has experienced recurring net losses and negative cash flows from operating activities since its inception. The Company&#8217;s net loss for the year ended December 31, 2024 is $36.2 million. As of December 31, 2024, the Company had cash and cash equivalents and short-term investments of $140.2 million, working capital of $132.2 million and an accumulated deficit of $355.6 million. We have not generated any revenues from product sales, have not completed the development of any product candidate and may never have a product candidate approved for commercialization. We expect it will be several years, if ever, before we have a product candidate ready for commercialization. We have financed our operations to date primarily through the sale of preferred and common stock, and the sale of warrants and have devoted substantially all of our financial resources and efforts to research and development, including preclinical studies and our clinical trials. Our net losses may fluctuate significantly from quarter to quarter and year to year and will depend, in part, on the rate at which we incur expenses and our ability to generate revenue. Net losses and negative cash flows have had, and will continue to have, an adverse effect on our stockholders&#8217; equity and working capital.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We anticipate that we will continue to incur significant expenses as we:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conduct non-clinical and clinical development of our product candidates or any future product candidate;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seek to identify and acquire additional product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">acquire or in-license other products and technologies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">enter into collaboration arrangements with regards to product discovery or development;</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">develop manufacturing processes;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seek marketing approvals for any of our product candidates that successfully complete clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish a sales, marketing, and distribution infrastructure to commercialize any products for which we may obtain marketing approval;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintain, expand, and protect our intellectual property portfolio;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hire additional personnel;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">add operational, financial and management information systems and personnel, including personnel to support our product development and planned future commercialization efforts; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">operate as a public company.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To become and remain profitable, we must develop and eventually commercialize a product or products with significant market potential. This will require us to be successful in a range of challenging activities, including completing clinical trials of our product candidates, obtaining marketing approval for these product candidates and manufacturing, marketing and selling those products for which we obtain marketing approval. We may never succeed in these activities, including if we do not have available financial resources to allow us to pursue clinical trials and other clinical development activities, and, even if we are successful, we may never generate revenues that are significant or large enough to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of the Company, could impair our ability to raise capital, maintain our non-clinical and clinical development efforts, and expand our business or continue our operations and may require us to raise additional capital that may dilute the ownership interest of common stockholders. A decline in the value of the Company could also cause stockholders to lose all or part of their investment.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will require additional funding to be able to complete the development of our lead drug candidate. If we are unable to raise capital, we will be forced to significantly alter our business strategy, substantially curtail our current operations, or liquidate and cease operations altogether.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In view of our expectation to incur significant losses for the foreseeable future, we will be required to raise additional capital resources in the future in order to fund our operations. We can also provide no assurance that other funding will be available to us, will be obtained on terms favorable to us or will provide us with sufficient funds to meet our objectives. If we are unable to raise such capital, or if we are unable to do so on acceptable terms, we will be forced to significantly alter our business strategy, substantially curtail our current operations, or liquidate and cease operations altogether. For example, we are currently unable to continue our clinical development of tegoprubart for people with ALS without additional financing, and we can provide no assurances that we will be able to obtain financing on acceptable terms or at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our funding needs may fluctuate significantly based on a number of factors, such as:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, progress, results and costs of formulation development and manufacture of drug product to support non-clinical and clinical development of our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we enter into additional collaboration arrangements regarding product discovery or development, or acquire or in-license products or technologies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish additional collaborations with favorable terms, if at all;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs, timing, and outcome of regulatory review of our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of future commercialization activities, including product sales, marketing, manufacturing and distribution, for any of our product candidates for which we receive marketing approval;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">revenue, if any, received from commercial sales of our product candidates, should any of our product candidates receive marketing approval; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Identifying potential product candidates and conducting formulation development, non-clinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, our product candidates,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for several years, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Even if we generate positive clinical data or are able to successfully commercialize one or more of our product candidates, additional financing may not be available to us on acceptable terms, or at all.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In addition to the dilution of our current stockholders&#8217; ownership as a result of the 2023 Private Placement, the 2024 Private Placement and the 2024 Underwritten Offering, we currently have a significant number of securities outstanding that are exercisable for our common stock, which could result in significant additional dilution and downward pressure on our stock price. Future issuances of our common stock, including common stock that may be issuable pursuant to outstanding warrants or other convertible securities, could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, there were 59,789,275 shares of our common stock outstanding and warrants to purchase 33,052,744 shares of our common stock outstanding. The issuance of shares of common stock in the 2023 Private Placement, the 2024 Private Placement and the 2024 Underwritten Offering (each as defined and described in Part II, Item 7. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), diluted the ownership interests of our existing stockholders. The issuance of shares of common stock pursuant to our &#8220;at-the-market&#8221; equity offering program or upon exercise of pre-funded warrants or common warrants issued in the initial closing of the 2023 Private Placement, the pre-funded warrants issued in the 2024 Private Placement and the pre-funded warrants issued in the 2024 Underwritten Offering would result in significant additional dilution to our current stockholders, which could adversely affect the price of our common stock and the terms on which we could raise additional capital. If we sell additional shares of common stock, convertible securities or other equity securities, investors may be materially diluted by subsequent sales. Such sales may also result in material dilution to our existing stockholders, and new investors could gain rights, preferences and privileges senior to the holders of our common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates are in the early stages of clinical development and may not be successfully developed. If we are unable to successfully develop and commercialize these or any other product candidate, or if we experience significant delays in doing so, our business will be materially harmed.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently do not have any products that have gained regulatory approval. We have invested substantially all of our efforts and financial resources in the development of our lead drug candidate tegoprubart, including funding non-clinical studies, clinical trials, drug formulation and the manufacturing of clinical trial materials. Our ability to generate product revenues, which we do not expect will occur for several years, if ever, will depend heavily on the successful development and eventual commercialization of one or more drug candidates. As a result, our business is substantially depending on our ability to successfully complete the development of and obtain approval for one of our potential future additional product candidates.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not yet demonstrated an ability to successfully overcome many of the risks and uncertainties frequently encountered by companies in new and rapidly evolving fields, particularly in the pharmaceutical area. For example, to execute our business plan, we will need to successfully:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain additional financing in order to advance our drug product through clinical development, and to manufacture, obtain regulatory approval for and commercialize our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">execute formulation, manufacturing, clinical, and non-clinical development activities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manufacture drug product at commercial scale;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish and confirm commercially acceptable stability (shelf-life) of our drug products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in-license or acquire other product candidates and advance them through clinical development;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain required regulatory approvals for the development and commercialization of tegoprubart or other product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintain, leverage, and expand our intellectual property portfolio;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">build and maintain robust sales, distribution and marketing capabilities, either on our own or in collaboration with strategic partners;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">gain market acceptance for any approved and marketed drug products;</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain and maintain adequate product pricing and reimbursement;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">develop and maintain any strategic relationships we elect to enter; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manage our spending as costs and expenses increase due to product manufacturing, non-clinical development, clinical trials, regulatory approvals, post-marketing commitments, and commercialization.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unsuccessful in accomplishing these objectives, we may not be able to successfully develop and commercialize our or other product candidates, and our business will suffer.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Public health crises, including pandemics or epidemics could adversely affect our business.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business and operations, including but not limited to ongoing or planned research and development activities may be impacted by public health crises. For example, our business was adversely affected by the COVID-19 pandemic, which also caused significant disruption in the operations of third parties upon whom we rely. Other future public health crises, including any future pandemics or epidemics could have a similar impact on our business. We may experience, as we did with the COVID-19 pandemic, disruptions as a result of future public health crisis, such as a future pandemic or epidemic, that could severely impact our operations and development activities, including, but not limited to:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations in employee resources or forced furlough of government employees;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in manufacturing of our drug candidates due to increased competition for manufacturing capacity as a result of the pandemic;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limitations in employee resources that would otherwise be focused on the conduct of our development activities, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal of the FDA to accept data from clinical trials in affected geographies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in procuring drug substance and/or in manufacturing drug product due to limitations in employee resources or forced furloughs at our contract manufacturing organizations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in initiation of future clinical trials, including delays in receiving authorization from local regulatory authorities to initiate such clinical trials; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays or disturbances in enrollment and trial execution, for example, because clinical trial sites may be unable to operate normally, or patients may elect to forego visits to medical facilities or undertake voluntary medical procedures.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of the foregoing factors, or other effects of any public health crisis, including any future pandemic or epidemic, could materially affect our business, possibly to a significant degree. The severity and duration of any such impacts cannot be predicted.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unfavorable global economic conditions could adversely affect our business, financial condition and results of operations</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The global economy, including the financial and credit markets, continues to experience extreme volatility and disruptions, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates, increases in inflation rates, elevated interest rates and uncertainty about economic stability. Likewise, the current conflicts in Ukraine and the Middle East have created extreme volatility in the global capital markets and global economic consequences, including disruptions of the global supply chain and energy markets. A severe or prolonged economic downturn or continued volatility in the financial and credit markets could negatively impact our ability to obtain necessary debt or equity financing in a timely manner or on favorable terms, if at all. The severity and duration of any such impacts cannot be predicted. Any such failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies or cause us to delay our clinical development plans, research and development programs or commercialization efforts, out-license intellectual property rights to our product candidates or sell unsecured assets, or a combination of the above. Any of these actions could materially harm our business. For example, we do not currently have sufficient liquidity to fund the continued clinical development of tegoprubart for people with ALS without additional financing, notwithstanding the positive topline results of our Phase 2a study of tegoprubart for adult subjects with ALS.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, inflation has increased throughout the U.S. economy in the past few years. As a result of inflation, we have experienced and may continue to experience cost increases, including costs of clinical trials and research and development of our product candidates, production costs, the price of labor, administration and other costs of doing business. Although we may continue to take measures to mitigate the impact of this inflation, if these measures are not effective, our business, financial condition, results of operations and liquidity could be materially adversely affected. Further, in an inflationary environment, cost increases may outpace our expectations, causing us to use our cash and other liquid assets faster than forecasted. If this happens, we may need to raise more capital to fund our operations than expected, and such capital may not be available in sufficient amounts or on reasonable terms, if at all.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adverse conditions in the financial markets, including bank failures, could adversely affect our liquidity and financial performance.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently maintain domestic cash deposits, for short term operating requirements, in Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insured banks, which exceed the FDIC insurance limits. Our additional cash and cash equivalents are held in accounts managed by third&#8209;party financial institutions and consist primarily of cash invested in money market funds and government bonds. Bank failures, events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, or concerns or rumors about such events, may lead to widespread demands for customer withdrawals and liquidity constraints that may result in market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank failed and was taken into receivership by the FDIC. At that time, we maintained deposits amounting to approximately 78% of our total cash at Silicon Valley Bank. On March 26, 2023, the assets, deposits and loans of Silicon Valley Bank were acquired by First-Citizens Bank &amp; Trust Company. In response to the failure of Silicon Valley Bank, we diversified our cash deposits into money market funds, U.S. treasuries and U.S. government agency securities and, as of the date of this report, our total cash maintained in FDIC insured banking accounts is less than 3% of our total cash and cash equivalents and short-term investments. The failure of a bank, or other adverse conditions in the financial or credit markets impacting financial institutions at which we maintain balances, could adversely impact our liquidity and financial performance. There can be no assurance that our deposits in excess of the FDIC or other comparable insurance limits will be backstopped by the U.S. or any applicable foreign government in the future or that any bank or financial institution with which we do business will be able to obtain needed liquidity from other banks, government institutions or by acquisition in the event of a future failure or liquidity crisis. Additionally, our cash investments outside of FDIC insured bank accounts are subject to general credit, liquidity, market, and interest rate risks. If the carrying value of an investment exceeds the fair value, and the decline in fair value is deemed to be other-than-temporary, we are required to write down the value of the investment, which could materially harm our results of operations and financial condition and could limit our access to liquidity.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Drug development involves a lengthy and expensive process with an uncertain outcome, including failure to demonstrate safety and efficacy to the satisfaction of the FDA or similar regulatory authorities outside the United States. We may incur additional costs or experience delays in completing, or ultimately be unable to complete, the formulation and commercialization of our product candidates.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given the early stage of development for our product candidates, the risk of failure is high. Before obtaining marketing approval from regulatory authorities for the sale of any product candidate, we must conduct non-clinical trials and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in humans. Formulation and device development, non-clinical and clinical testing are all expensive activities, difficult to design and implement, and can take years to complete. Failure can occur at any time during the development program, including during the clinical trial process. Further, the results of non-clinical studies and early clinical trials of our product candidates, as well as earlier generation formulations may not be predictive of the results of later-stage clinical trials. Interim results of a clinical trial do not necessarily predict final results. Moreover, non-clinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in non-clinical and clinical trials have nonetheless failed to obtain marketing approval of their products. There is a risk that additional non-clinical and/or clinical safety studies will be required by the FDA or similar regulatory authorities outside the United States and/or that subsequent studies will not match results seen in prior studies. It is impossible to predict when or if any of our product candidates will prove effective, safe and well-tolerated in humans or will receive regulatory approval.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may experience delays in our clinical trials, and we do not know whether planned clinical trials will begin or enroll subjects on time, need to be redesigned or be completed on schedule, if at all. There can be no assurance that the FDA or equivalent foreign regulatory bodies will approve investigational new drug applications and allow us to start clinical trials for any of our product candidates in the future, including for islet cell transplant. Once a clinical trial has commenced, there is also no assurance that the FDA or equivalent foreign regulatory body will not put any of our product candidates on clinical</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hold. We may experience numerous unforeseen events during, or as a result of, clinical trials that could delay or prevent our ability to receive marketing approval or commercialize our product candidates. Clinical trials may be delayed, suspended or prematurely terminated for a variety of reasons, such as:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay or failure in reaching agreement with the FDA or a comparable foreign regulatory authority on a trial design that we want to execute;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay or failure in obtaining authorization to commence a trial or inability to comply with conditions imposed by a regulatory authority regarding the scope or design of a clinical trial;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in reaching, or failure to reach, agreement on acceptable clinical trial contracts or clinical trial protocols with prospective trial sites;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in completing formulation development and manufacturing as a prerequisite to commencing clinical work;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inability, delay, or failure in identifying and maintaining a sufficient number of trial sites, many of which may already be engaged in other clinical programs;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay or failure in recruiting and enrolling suitable subjects to participate in a trial;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay or failure in having subjects complete a trial or return for post-treatment follow-up;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical sites and investigators deviating from trial protocol, failing to conduct the trial in accordance with regulatory requirements, or dropping out of a trial;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lack of adequate funding to continue the clinical trial, including the incurrence of unforeseen costs due to enrollment delays, requirements to conduct additional clinical trials and increased expenses associated with the services of our contract research organizations (&#8220;CROs&#8221;) and other third parties;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon product development programs;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of patients required for clinical trials of our product candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate, or participants may drop out of these clinical trials at a higher rate than we anticipate;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may experience delays or difficulties in the enrollment of patients that our product candidates are designed to target;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may have difficulty partnering with experienced CROs and study sites that can identify patients that our product candidates are designed to target and run our clinical trials effectively;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulators or IRBs may require that we or our investigators suspend or terminate clinical research for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of clinical trials of our product candidates may be greater than we anticipate;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our product candidates may be insufficient or inadequate; or</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there may be changes in governmental regulations or administrative actions. For example, the Trump administration recently issued an Executive Order that pauses the FDA&#8217;s rulemaking ability and could affect recently finalized FDA rules that have not yet taken effect. The extent to which such existing or future executive orders impact the healthcare regulatory environment remains uncertain and could materially impact our development and commercialization activities. In addition, our development and commercialization activities could be harmed or delayed by a shutdown of the U.S. government, including the FDA. For example, a prolonged shutdown may significantly delay the FDA's ability to timely review and process any submissions we may file or cause other regulatory delays, which could materially and adversely affect our business. </span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are required to conduct additional clinical trials or other testing of our product candidates beyond those that we currently contemplate, if we are unable to successfully complete clinical trials of our product candidates or other testing, if the results of these trials or tests are not positive or are only modestly positive, or if there are safety concerns, we may:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be delayed in obtaining marketing approval for our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not obtain marketing approval at all;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain approval for indications or patient populations that are not as broad as intended or desired;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain approval with labeling that includes significant use or distribution restrictions or safety warnings that would reduce the potential market for our products or inhibit our ability to successfully commercialize our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be subject to additional post-marketing restrictions and/or testing requirements; or</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">have the product removed from the market after obtaining marketing approval.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product development costs will also increase if we experience delays in testing or marketing approvals. We do not know whether any of our non-clinical studies or clinical trials will need to be restructured or will be completed on schedule, or at all. Significant non-clinical or clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize our product candidates or may allow our competitors to bring products to market before we do and impair our ability to successfully commercialize our product candidates and may harm our business and results of operations.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we experience delays or difficulties in the enrollment of patients in clinical trials, our receipt of necessary regulatory approvals could be delayed or prevented and expenses for the development of our product candidates could increase.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to initiate or continue clinical trials for our product candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials to demonstrate safety and efficacy. We do not know whether the ongoing or planned clinical trials will enroll subjects in a timely fashion, require redesign of essential trial elements or be completed on its projected schedule. In addition, competitors may have ongoing clinical trials for product candidates that treat related or the same indications as our product candidates, and patients who would otherwise be eligible for our clinical trials may instead enroll in clinical trials of our competitors&#8217; product candidates. Our inability to enroll a sufficient number of patients for our clinical trials would result in significant delays and could require us to abandon one or more clinical trials altogether.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patient enrollment is affected by other factors including:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the eligibility criteria for the study in question;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the perceived risks and benefits of the product candidate under study;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the efforts to facilitate timely enrollment in clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inability to identify and maintain a sufficient number of trial sites, many of which may already be engaged in other clinical trial programs, including some that may be for the same disease indication;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patient referral practices of physicians;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the proximity and availability of clinical trial sites for prospective patients;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ambiguous or negative interim results of our clinical trials, or results that are inconsistent with earlier results;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">feedback from regulatory authorities, IRBs, ethics committees (&#8220;ECs&#8221;), or data safety monitoring boards, or results from earlier stage or concurrent non-clinical and clinical trials, that might require modifications to the protocol;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">decisions by regulatory authorities, IRBs, ECs, or the Company, or recommendations by data safety monitoring boards, to suspend or terminate clinical trials at any time for safety issues or for any other reason; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unacceptable risk-benefit profile or unforeseen safety issues or adverse effects.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enrollment delays in our clinical trials may result in increased development costs for our product candidates, which would cause the value of the Company to decline and limit our ability to obtain additional financing.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our ability to conduct clinical trials in some jurisdictions outside of the United States may be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently have clinical trial sites in regions outside the United States, including Asia, the European Union and the United Kingdom, and we will continue to conduct future clinical trials in these markets. Our ability to conduct clinical trials at sites located outside the United States is subject to numerous risks unique to conducting business in jurisdictions outside the United States, including:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulty in establishing or managing relationships with qualified CROs, physicians and clinical trial sites;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">different local standards for the conduct of clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulty in complying with various and complex import laws and regulations when shipping drugs to certain countries;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the potential burden of complying with a variety of laws, medical standards and regulatory requirements, including the regulation of pharmaceutical and biotechnology products and treatments; </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lack of consistency in standard of care from country to country;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">diminished protection of intellectual property in some countries;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">instability in economic or political conditions, including inflation, recession and actual or anticipated military conflicts, social upheaval or political uncertainty;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign exchange fluctuations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cultural differences in medical practice and clinical research; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in country or regional regulatory requirements.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ongoing conflict in Ukraine and the resulting imposition of economic and other sanctions by the United States, European Union and many other nations on Russia, individuals in Russia, Russian businesses and the Russian central bank, or any escalation of tensions in the region, could have a broader impact that expands into other countries. The ongoing conflict in the Middle East could have similar impacts. Although the length and impact of any military action and expansion of the conflict into other countries are highly unpredictable, if either conflict spreads or has effects on additional countries, we may experience disruptions or delays in our plans to conduct clinical trial activities in affected regions outside the United States.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If severe adverse events or unacceptable side effects are identified during the development of our product candidates, we may need to abandon or limit our development of some of our product candidates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our product candidates are associated with severe adverse events or unacceptable side effects in non-clinical or clinical trials or have characteristics that are unexpected, we may need to interrupt, delay or abandon their development or limit development to more narrow uses or subpopulations in which the adverse event or undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. Any occurrences of clinically significant adverse events or unacceptable side effects with our product candidates may harm our business, financial condition and prospects significantly.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is an early&#8209;product candidate, and the side effect profile in humans has not been fully established. Currently unknown, drug-related side effects may be identified through ongoing and future clinical trials and, as such, these possible drug-related side effects could affect patient recruitment, the ability of enrolled subjects to complete the trial, or result in potential product liability claims.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our future success depends on our ability to retain executives and key employees and to attract, retain and motivate qualified personnel in the future.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are highly dependent on the product development, clinical and business development expertise of the principal members of our management, scientific and clinical team. Although we have entered into employment agreements with our executives and key employees, each of them may terminate their employment with us at any time. We do not maintain &#8220;key person&#8221; insurance for any of our executives or other employees. Our recent decision to discontinue the islet cell transplantation program and IgAN program and uncertainties regarding our financial condition may increase the likelihood that employees depart in the foreseeable future.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recruiting and retaining qualified scientific, clinical, manufacturing, sales and marketing personnel is critical to our success. Due to the small size of the Company and the limited number of employees, each of our executives and key employees serves in a critical role. The loss of the services of our executive officers or other key employees could impede the achievement of our development and commercialization objectives and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory approval of, and commercialize products. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating drug product, non-clinical development, clinical development, regulatory strategy, and commercial strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to provide services to us. If we are unable to continue to attract and retain high quality personnel, our ability to pursue our growth strategy will be limited.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Regulatory Approval of Our Product Candidates and Other Compliance Matters</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals, or the approvals may be for a narrow indication, we may not be able to commercialize our product candidates, and our ability to generate revenue may be materially impaired.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates must be approved by the FDA pursuant to a new drug application in the United States and by other regulatory authorities outside the United States prior to commercialization in the respective regions. The process of obtaining marketing approvals, both in the United States and outside the United States, is expensive and takes several years, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Failure to obtain marketing approval for a product candidate will prevent us from commercializing the product candidate. We have not received approval to market any of our product candidates from regulatory authorities in any country. We have no experience in filing and supporting the applications necessary to gain marketing approvals for our products and may engage third-party consultants to assist in this process. Securing marketing approval requires the submission of extensive non-clinical and clinical data, and other supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s safety and efficacy. Securing marketing approval also requires the submission of information about the product formulation and manufacturing process to, and inspection of manufacturing facilities by, the regulatory authorities. Our product candidates may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional non-clinical, clinical or other data. In addition, varying interpretations of the data obtained from non-clinical and clinical trials could delay, limit or prevent marketing approval of a product candidate. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may also cause delays in or prevent the approval of an application.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any marketing approval we ultimately obtain may be for fewer or more limited indications than requested or subject to restrictions or post-approval commitments that render the approved product not commercially viable or its market potential significantly impaired. In addition, regulatory agencies may not approve the labeling claims that are necessary or desirable for the successful commercialization of our product candidates.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to market and sell our products in the EU and other international jurisdictions outside of the United States, we or our third-party collaborators must obtain separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and may require additional non-clinical, clinical or health outcome data. In addition, the time required to obtain approval may differ substantially amongst international jurisdictions. The regulatory approval process outside the United States generally includes all the risks associated with obtaining FDA approval. In addition to regulatory approval, in many countries outside the United States, it is required that the product be approved for reimbursement before the product can be approved for sale in that country.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we experience delays in obtaining approval or if we fail to obtain approval of our product candidates, the commercial prospects for our product candidates may be harmed and our ability to generate revenues will be materially impaired.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any product candidate for which we obtain marketing approval will be subject to extensive post-marketing regulatory requirements and could be subject to post-marketing restrictions or withdrawal from the market, and we may be subject to penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our products, when and if any of them are approved.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates and the activities associated with their development and commercialization, including their testing, manufacture, recordkeeping, labeling, storage, approval, advertising, promotion, sale and distribution, are subject to comprehensive regulations that are specific to those defined by regulatory authorities in the countries where the product is approved. In the United States and other countries that follow the International Conference on Harmonization, these requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, cGMP requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, including periodic inspections by the FDA and other regulatory authorities, requirements regarding the distribution of samples to physicians and recordkeeping.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA, or other regulatory authorities, may also impose requirements for costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of the product. The FDA closely regulates the post-approval marketing and promotion of drugs to ensure drugs are marketed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA imposes stringent restrictions on manufacturers&#8217; communications regarding use of their products and if we promote our products beyond their approved indications, we may be subject to enforcement action for off-label promotion. Violations of the FDCA relating to the promotion of prescription drugs may lead to investigations alleging violations of federal and state healthcare fraud and abuse laws, as well as state consumer protection laws.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, later discovery of previously unknown adverse events or other problems with our products, manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various results, including:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on such products, manufacturers, or manufacturing processes;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the labeling or marketing of a product;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on product distribution or use;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">requirements to conduct post-marketing studies or clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">warning or untitled letters;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">withdrawal of the products from the market;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal to approve pending applications or supplements to approved applications that we submit;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recall of products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, restitution or disgorgement of profits or revenues;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">suspension or withdrawal of marketing approvals;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal to permit the import or export of our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure; or</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-compliance with EU requirements regarding safety monitoring or pharmacovigilance, and with requirements related to the development of products for the pediatric population, can also result in significant financial penalties. Similarly, failure to comply with the EU&#8217;s requirements regarding the protection of personal information can also lead to significant penalties and sanctions.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legislation regulating the pharmaceutical and healthcare industries may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and affect the prices we may obtain.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes intended to contain healthcare costs and modify the regulation of drug and biologic products. These and other regulatory changes could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any product candidates for which we obtain marketing approval.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, on August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022, which, among other things, includes policies that are designed to have a direct impact on drug prices and reduce drug spending by the federal government, which took effect in 2023. The Inflation Reduction Act of 2022 requires drug manufacturers to pay rebates to Medicare if they increase prices faster than inflation for certain drugs used by Medicare beneficiaries. The mechanics of the rebate calculation would mimic those of the Medicaid rebate, but the expansion of inflation-based rebates may further complicate pricing strategies. The Inflation Reduction Act of 2022 or other similar legislation could have the effect of reducing the prices we can charge and reimbursement we receive for our products, thereby reducing our profitability.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that additional state and federal healthcare reform measures and regulations will be adopted in the future. Any of these measures and regulations could limit the amounts that federal and state governments will pay for healthcare products and services, result in reduced demand for our product candidates or additional pricing pressures and affect our product development, testing, marketing approvals and post-market activities.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent administrative law cases decided by the U.S. Supreme Court in 2024 may create uncertainty with respect to actions taken by regulatory agencies to interpret, implement and enforce federal legislation. For example, in its June 2024 decision in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loper Bright Enterprises v. Raimondo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loper</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#8221;), the U.S. Supreme Court overturned the longstanding Chevron doctrine, under which courts were required to give deference to regulatory agencies&#8217; reasonable interpretations of ambiguous federal statutes. The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loper</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> decision could result in legal challenges to regulations and guidance issued by federal agencies that are currently applicable to or will be applicable to our business, including those issued by the FDA and the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;). Further, the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loper</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> decision may result in increased regulatory uncertainty, inconsistent judicial interpretations and delays in or other impacts to the agency rulemaking process, which could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Laws, restrictions, and other regulatory measures are also imposed by healthcare laws and regulations in international jurisdictions and in those jurisdictions we face the same issues as in the United States regarding difficulty and cost for us to obtain marketing approval and commercialization of our product candidates and which may affect the prices we may obtain.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some countries, particularly the countries of the EU, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product. To obtain reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. If reimbursement of our products is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business could be harmed, possibly materially.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business operations and relationships with healthcare providers, physicians, third-party payers, and customers will be subject to applicable anti-kickback, fraud and abuse and other broadly applicable healthcare laws, which could expose us to criminal sanctions, civil penalties, program exclusion, contractual damages, reputational harm and diminished profits and future earnings.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Healthcare providers, physicians and third-party payers will play a primary role in the recommendation and prescription of any product candidates for which we receive marketing approval. Our current and future arrangements may expose us to broadly applicable fraud and abuse and other healthcare laws that may constrain the business or financial arrangements and relationships through which we would market, sell and distribute the products for which we receive marketing approval. Even though we will not control referrals of healthcare services or bill directly to Medicare, Medicaid or other third-party payers, federal and state healthcare laws are and will be applicable to our business. Such laws include, but are not limited to federal false claims, false statements and civil monetary penalties laws, including the federal civil False Claims Act (&#8220;FCA&#8221;), the federal Anti-Kickback Statute, the federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), patient data privacy and security regulation, including, in the United States, HIPAA, as amended by the Health Information Technology for Clinical Health Act of 2009 (&#8220;HITECH&#8221;), the federal transparency requirements under the Physician Payments Sunshine Act, and analogous state, local or foreign law.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pharmaceutical and other healthcare companies have been prosecuted under these laws for a variety of promotional and marketing activities, such as: providing free trips, free goods, sham consulting fees and grants and other monetary benefits to prescribers; reporting to pricing services inflated average wholesale prices that were then used by federal programs to set reimbursement rates; engaging in off-label promotion; and submitting inflated best price information to the Medicaid Rebate Program to reduce liability for Medicaid rebates. Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, disgorgement, fines, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, additional oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of our operations. If any of the physicians or other healthcare providers or entities with whom we expect to do business are found to be not in compliance with applicable laws, that person or entity may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Laws, restrictions, and other regulatory measures are also imposed by anti-kickback, fraud and abuse, and other healthcare laws and regulations in international jurisdictions, and in those jurisdictions we face the same issues as in the United State regarding exposure to criminal sanctions, civil penalties, program exclusion, contractual damages, reputational harm, and diminished profits and future earnings.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We depend on our information systems and those of our third-party collaborators, service providers, contractors or consultants, which may fail or suffer cybersecurity incidents that could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on our information systems and infrastructure to effectively manage our business, including our clinical trials and studies. Our information systems and infrastructure, and those of our current or future third-party collaborators, service providers, contractors and consultants are vulnerable to damage from cybersecurity incidents, including computer viruses, denial-of-service attacks, hacking, phishing and other social engineering attacks, unauthorized access or use resulting from malware, as well as disruptions due to natural disasters, terrorism, war, mistakes or technical errors, including due to software updates and telecommunication and electrical failures. We may also experience cybersecurity incidents stemming from persons inside our organizations (including employees or contractors), or other persons with access to information systems inside our organization. Attacks on information systems are increasing in their frequency, levels of persistence, sophistication and intensity, and they are being conducted by increasingly sophisticated and organized foreign governments, groups and individuals with a wide range of motives and expertise. Further, cybersecurity threats and the techniques used in cyberattacks change, develop and evolve rapidly, including from emerging technologies, such as advanced forms of artificial intelligence and quantum computing. In addition to extracting or accessing sensitive information, such attacks could include the deployment of harmful malware, ransomware, denial-of-service attacks, social engineering and other means to affect service reliability and threaten the security, confidentiality, integrity and availability of information. The prevalent use of mobile devices that access sensitive information also increases the risk of data security incidents which could lead to the loss of confidential information or other intellectual property. Information system disruptions, even if inadvertent, may limit or disable our access or important third parties&#8217; access to our systems. While to our knowledge none of the cybersecurity incidents we have experienced to date have had a material adverse impact on our business, financial condition or operations, if such an event were to occur and cause interruptions in our operations or the operations of third-party collaborators, service providers, contractors or consultants, it could result in a material disruption of our development programs and significant reputational, financial, legal, regulatory, business or operational harm. The costs to us to mitigate, investigate and respond to potential security incidents, breaches, disruptions, network security problems, bugs, viruses, worms, malicious software programs and security vulnerabilities could be significant, and while we have implemented security measures to protect our data security and information systems, our efforts to address these problems may not be successful, and these problems could result in unexpected interruptions, delays, cessation of service and other harm to our business and our competitive position. Moreover, data security incidents and other security breaches can be difficult to detect, and any delay in identifying them may lead to increased harm.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The compromise of privacy, security, integrity or confidentiality of sensitive information related to our business or failure to comply with confidentiality and data privacy obligations could have a material adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of our business, we collect, store and transmit large amounts of confidential information, including intellectual property, proprietary business information and personal information. For example, the loss of clinical trial data from completed, ongoing or planned clinical trials for our product candidates could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any real or perceived security breach affects our information systems (or those of our third-party collaborators, service providers, contractors or consultants), or results in the loss of or accidental, unlawful or unauthorized access to, use of, release of, or other processing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of personally identifiable information or damage to our data or applications or other data or applications relating to our technology or product candidates, or inappropriate disclosure of confidential or proprietary information, we could be found to have violated applicable U.S. and international privacy, data protection and other laws, which could subject us to litigation and governmental investigations and proceedings by federal, state and local regulatory entities in the U.S. and by international regulatory entities, resulting in exposure to material civil and/or criminal liability. and the further development of our product candidates could be delayed. Such a breach may require notification to governmental agencies, the media or individuals pursuant to various foreign, domestic (federal and state) privacy and security laws, if applicable, including HIPAA, as amended by HITECH, and its implementing rules and regulations, as well as regulations promulgated by the Federal Trade Commission and state breach notification laws. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to cybersecurity incidents.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any failure or perceived failure by us or any third-party collaborators, service providers, contractors or consultants to comply with our privacy, confidentiality, data security or similar obligations, or any data security incidents or other security breaches that result in the accidental, unlawful or unauthorized access to, use of, release of, processing of, or transfer of sensitive information, including personally identifiable information, may result in negative publicity, harm to our reputation, governmental investigations, enforcement actions, regulatory fines, litigation or public statements against us, could cause third parties to lose trust in us or could result in claims by third parties, including those that assert that we have breached our privacy, confidentiality, data security or similar obligations, any of which could have a material adverse effect on our reputation, business, financial condition or results of operations. To the extent we maintain individually identifiable health information, we could be subject to fines and penalties (including civil and criminal) under HIPAA for any failure by us or our business associates to comply with HIPAA&#8217;s requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">European data collection is governed by restrictive regulations governing the collection, use, processing and cross-border transfer of personal information.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may collect, process, use or transfer personal information from individuals located in the European Economic Area in connection with our business, including in connection with conducting clinical trials in the EEA. Additionally, if any of our product candidates are approved, we may seek to commercialize those products in the EEA. The collection and use of personal health data in the EEA is governed by the provisions of the General Data Protection Regulation ((EU) 2016/679) (the &#8220;GDPR&#8221;), along with other European Union and country-specific laws and regulations. The United Kingdom and Switzerland have also adopted data protection laws and regulations. These legislative acts (together with regulations and guidelines) impose requirements relating to having legal bases for processing personal data relating to identifiable individuals and transferring such data outside of the EEA, including to the United States, providing details to those individuals regarding the processing of their personal data, keeping personal data secure, having data processing agreements with third parties who process personal data, responding to individuals&#8217; requests to exercise their rights in respect of their personal data, reporting security breaches involving personal data to the competent national data protection authority and affected individuals, appointing data protection officers or corporate representatives, conducting data protection impact assessments and record-keeping. The GDPR imposes additional responsibilities and liabilities in relation to personal data that we process, and we may be required to put in place additional mechanisms ensuring compliance with the new data protection rules. Failure to comply with the requirements of the GDPR and related national data protection laws of the member states of the European Economic Area and other states in the European Economic Area may result in substantial fines, other administrative penalties and civil claims being brought against us, which could have a material adverse effect on our business, financial condition and results of operations. European data protection authorities may interpret the GDPR and national laws differently and may impose additional requirements, which adds to the complexity of processing personal data in or from the EEA or United Kingdom. Guidance on implementation and compliance practices are often updated or otherwise revised.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could harm our business.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our non-clinical or clinical development or production efforts. Our failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to the Commercialization of Our Product Candidates</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if any of our product candidates receives marketing approval, we may fail to achieve the degree of market acceptance by physicians, patients, third-party payers and others in the medical community necessary for commercial success.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of our product candidates receives marketing approval, we may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payers and others in the medical community. In addition, physicians, patients and third-party payers may prefer other novel products to ours. If our product candidates do not achieve an adequate level of acceptance, we may not generate significant product revenues and we may not become profitable. The degree of market acceptance of our product candidates, if approved for commercial sale, will depend on a number of factors, including:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the efficacy and safety and potential advantages and disadvantages compared to alternative treatments;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to offer our products for sale at competitive prices;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the convenience and ease of administration compared to alternative treatments;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the strength of our marketing and distribution support;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of third-party coverage and adequate reimbursement, including patient cost-sharing programs such as copays and deductibles;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to develop or partner with third-party collaborators to develop companion diagnostics;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence and severity of any side effects; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any restrictions on the use of our products together with other medications.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our current product candidates, or a future product candidate receives marketing approval and we, or others, later discover that the product is less effective than previously believed or causes undesirable side effects that were not previously identified, the ability to market the product could be compromised.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical trials are conducted in carefully defined subsets of patients who have agreed to enter into clinical trials. Consequently, it is possible that our clinical trials may indicate an apparent beneficial effect of a product candidate that is greater than the actual positive effect in a broader patient population or alternatively fail to identify undesirable side effects. If, following approval of a product candidate, we, or others, discover that the product is less effective than previously believed or causes undesirable side effects that were not previously identified, any of the following events could occur:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may withdraw their approval of the product or seize the product;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the product may be required to be recalled or changes may be required to the way the product is administered;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional restrictions may be imposed on the marketing of, or the manufacturing processes for, the product;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may require the addition of labeling statements, such as a &#8220;black box&#8221; warning or a contraindication;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the creation of a Medication Guide outlining the risks of the previously unidentified side effects for distribution to patients;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional restrictions may be imposed on the distribution or use of the product via a Risk Evaluation and Mitigation Strategy;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we could be sued and held liable for harm caused to patients;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the product may become less competitive; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our reputation may suffer.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these events could have a material and adverse effect on our operations and business. The commercial prospects for our product candidates may be harmed and our ability to generate revenues will be materially impaired.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We currently have no marketing and sales force. If we are unable to establish effective marketing and sales capabilities or enter into agreements with third parties to market and sell our product candidates, we may not be able to effectively market and sell our product candidates, if approved, or generate product revenues.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently do not have a marketing or sales team for the marketing, sales and distribution of any of our product candidates that are able to obtain regulatory approval. In order to commercialize any product candidates, we must build on a territory-by-territory basis marketing, sales, distribution, managerial and other non-technical capabilities or make arrangements with third parties to perform these services, and we may not be successful in doing so. If our product candidates receive regulatory approval, we intend to establish an internal sales and marketing team with technical expertise and supporting distribution capabilities to commercialize our product candidates, which will be expensive and time-consuming, will require significant attention of our executive officers to manage and may nonetheless fail to effectively market and sell our product candidates. Any failure or delay in the development of our internal sales, marketing and distribution capabilities would adversely impact the commercialization of any of our products that we obtain approval to market. With respect to the commercialization of all or certain of our product candidates, we may choose to collaborate, either globally or on a territory-by-territory basis, with third parties that have direct sales forces and established distribution systems, either to augment our own sales force and distribution systems or in lieu of our own sales force and distribution systems. If we are unable to enter into such arrangements when needed on acceptable terms or at all, we may not be able to successfully commercialize any of our product candidates that receive regulatory approval, or any such commercialization may experience delays or limitations. If we are not successful in commercializing our product candidates, either on our own or through collaborations with one or more third parties, our future product revenue will suffer, and we may incur significant additional losses.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The development and commercialization of new drug products is highly competitive. We face competition with respect to our current product candidates and will face competition with respect to any product candidates that we may seek to develop or commercialize in the future, from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. There are several large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of products for the treatment of the disease indications for which we are developing our product candidates. Some of these competitive products and therapies are based on scientific approaches that are the same as or similar to our approach, and others are based on entirely different approaches. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specifically, there are a number of companies developing competing anti-CD40 and anti-CD40L therapeutics in clinical trials for transplant, autoimmune or central nervous system indications, including: Novartis, Sanofi, UCB, Amgen (post-acquisition of Horizon Therapeutics), Bristol Myers Squibb, Tonix Pharmaceuticals and Kiniksa Pharmaceuticals. Most of these companies are larger than Eledon and have significantly greater resources to develop their drug candidates.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If approved, we expect that tegoprubart will face competition from numerous FDA-approved therapeutics for the prevention of transplant rejection, including PROGRAF</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, ASTAGRAF XL</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, ENVARSUS XR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, NULOJIX</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, CELLCEPT</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, MYFORTIC</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and numerous other branded and generic immunosuppressive agents. Multiple companies are working on islet cell and kidney transplant solutions that may ultimately potentially negate the need for immunosuppressive agents in these indications altogether.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that tegoprubart will face competition from FDA-approved therapeutics for the treatment of ALS including RADICAVA&#174;, riluzole, and numerous other branded and generic immunosuppressive agents. Multiple pharmaceutical and biotechnology companies, including but not limited to Biogen, Ionis Pharmaceuticals, Alexion Pharmaceuticals, Orion Pharma, Orphazyme, AZTherapies, Voyager Therapeutics, Apic Bio, Brainstorm Cell Therapeutics, and Cytokinetics, are also working on competing ALS pharmaceutical, gene therapy and cell therapy approaches.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that we may develop. In addition, our ability to compete may be affected in many cases by insurers or other third-party payers seeking to encourage the use of generic products.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generic products are currently available, with additional generic products expected to become available over the coming years, potentially creating pricing pressure. If our product candidates achieve marketing approval, we expect that they will be priced at a significant premium over competitive generic products.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the companies against which we are competing or against which we may compete in the future have significantly greater financial resources and expertise in research and development, manufacturing, conducting non-clinical studies, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The insurance coverage and reimbursement status of newly approved products is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for new or current products could limit our ability to market those products and decrease our ability to generate revenue.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The availability and extent of reimbursement by governmental and private payers is essential for most patients to be able to afford expensive treatments. Sales of our product candidates will depend substantially, both domestically and internationally, on the extent to which the costs of our product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payers. If reimbursement is not available, or is available only to limited levels, we may not be able to successfully commercialize our product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products. In the United States, the principal decisions about reimbursement for new medicines are typically made by CMS, as CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare. Private payers tend to follow CMS to a substantial degree. It is difficult to predict what CMS will decide with respect to reimbursement for fundamentally novel products such as ours, as there is no body of established practices and precedents for these new products. Reimbursement agencies in Europe may be more conservative than CMS. Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Europe, Canada, and other countries has and will continue to put pressure on the pricing and usage of our product candidates. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. In general, the prices of medicines under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for medicines but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the United States, the reimbursement for our products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, increasing efforts by governmental and third-party payers, in the United States and internationally, to cap or reduce healthcare costs may cause such organizations to limit both coverage and level of reimbursement for new products approved and, as a result, they may not cover or provide adequate payment for our product candidates. Increased expense is incurred to cover costs of health outcome focused research used to generate data necessary to justify the value of our products in order to secure reimbursement. We expect to experience pricing pressures in connection with the sale of any of our product candidates, due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products into the healthcare market.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, many private payers contract with commercial vendors who sell software that provide guidelines that attempt to limit utilization of, and therefore reimbursement for, certain products deemed to provide limited benefit to existing alternatives. Such organizations may set guidelines that limit reimbursement or utilization of our products.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that we may develop.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical trials and will face an even greater risk if we commercially sell any products that we may develop. If we cannot successfully defend against claims that our product candidates or products caused injuries, we will incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in decreased demand for any product candidates or products that we may develop; injury to our reputation and significant negative media attention; withdrawal of clinical trial participants; significant costs to defend the related litigation; substantial monetary awards to trial participants or patients; loss of revenue; reduced resources of our management to pursue our business strategy; and the inability to commercialize any products that we may develop.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently hold $10.0 million in product liability insurance coverage in the aggregate, with a per incident limit of $10.0 million, which may not be adequate to cover all liabilities that we may incur. We may need to increase our insurance coverage as we expand our clinical trials or if we commence commercialization of our product candidates. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Dependence on Third Parties</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We contract with third parties for the manufacture of our product candidates for non-clinical and clinical trials and expect to continue to do so for commercialization. This reliance on third parties increases the risk that we will not have sufficient quantities of our product candidates or products at an acceptable cost and quality, which could delay, prevent or impair our development or commercialization efforts.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have utilized, and intend to continue utilizing, third parties to formulate, manufacture, package, and distribute clinical supplies of our drug candidates. We have no experience in manufacturing and do not have any manufacturing facilities. Currently, we rely on third parties for the manufacturing of drug substance and drug product for non-clinical and clinical activities. Our manufacturing vendors utilize proprietary cell culture media, cell lines, buffers, manufacturing equipment, manufacturing supplies, and storage buffers for the manufacturing of tegoprubart and other product candidates. These materials are custom-made and available from only a limited number of sources. Although we believe that our third-party suppliers maintain a significant supply of these materials and equipment on hand, any sustained disruption in this supply, could adversely affect our operations. We do not have any long-term agreements in place with our current suppliers. If we are required to change manufacturers, we may experience delays associated with finding an alternate manufacturer that is properly qualified to produce supplies of our products and product candidates in accordance with regulatory requirements and our specifications. Any delays or difficulties in obtaining or in manufacturing, packaging or distributing approved product candidates could negatively impact our clinical trials.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to rely on third-party manufacturers or third-party collaborators for the manufacture of commercial supply of any other product candidates for which our collaborators or we obtain marketing approval. Despite drug substance and product risk management, this reliance on third parties presents a risk that we will not have sufficient quantities of our product candidates or products or such quantities at an acceptable cost or quality, which could delay, prevent or impair our development or commercialization efforts. For example, these third parties experienced disruptions in their operations in conjunction with the COVID-19 pandemic. Any delay or performance failure on the part of our existing or future manufacturers of drug substance or drug products could delay clinical development or marketing approval. We do not currently have arrangements in place for redundant supply. If suppliers cannot supply us with our requirements, we may be required to identify alternative manufacturers, which would lead us to incur added costs and delays in identifying and qualifying any such replacement.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Formulations and devices used in early studies are not final formulations and devices for commercialization. Additional changes may be required by the FDA or other regulatory authorities on specifications and storage conditions. These may require additional studies and may result in a delay in our clinical trials and commercialization activities.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also expect to rely on other third parties to label, store, and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development or marketing approval of our product candidates or commercialization of our products, producing additional losses and depriving us of potential product revenue.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be unable to establish any agreements with third-party manufacturers or to do so on acceptable terms. Even if we are able to establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reliance on the third party for regulatory compliance and quality assurance;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the possible breach of the manufacturing agreement by the third party;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the possible misappropriation of our proprietary information, including our trade secrets and know-how; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The third parties we rely on for manufacturing and packaging are also subject to regulatory review, and any regulatory compliance problems with these third parties could significantly delay or disrupt our clinical or commercialization activities. Third-party manufacturers may not be able to comply with cGMP regulations or similar regulatory requirements outside the United States. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our products. Additionally, macro-economic conditions may adversely affect these third parties, causing them to suffer liquidity or operational problems. If a key third-party vendor becomes insolvent or is forced to lay off workers assisting with our projects, our results and development timing could suffer.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates and any products that we may develop may compete with other product candidates and products for access to manufacturing facilities. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current and anticipated future dependence upon others for the manufacture of our product candidates or products may adversely affect our future profit margins and our ability to commercialize any products that receive marketing approval on a timely and competitive basis.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We depend on CROs and other contracted third parties to perform non-clinical and clinical testing and certain other research and development activities. As a result, the outcomes of the activities performed by these organizations will be, to a certain extent, beyond our control.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The nature of outsourcing a substantial portion of our business will require that we rely on CROs and other contractors to assist us with research and development, clinical testing activities, patient enrollment, data collection, and regulatory submissions to the FDA or other regulatory bodies. As a result, our success will depend partially on the success of these third parties in performing their responsibilities. Although we intend to pre-qualify our CROs and other contractors and we believe that the contractors selected will be fully capable of performing their contractual obligations, we cannot directly control the adequacy and timeliness of the resources and expertise that they apply to these activities. Additionally, macro-economic conditions may affect our development partners and vendors, which could adversely affect their ability to timely perform their tasks. If our contractors do not perform their obligations in an adequate and timely manner, the pace of clinical development, regulatory approval and commercialization of our drug candidates could be significantly delayed, and our prospects could be adversely affected.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Intellectual Property</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to obtain and maintain intellectual property protection for our technology and products or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to ours, and our ability to successfully commercialize our technology and products may be impaired.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends in large part on our ability to obtain and maintain patent protection in relevant countries with respect to our proprietary technology and products. We seek to protect our proprietary position by filing patent applications in the United States and internationally that are related to our novel technologies and product candidates. This patent portfolio includes issued patents and pending patent applications covering pharmaceutical compositions and methods of use.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent prosecution process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. We may choose not to seek patent protection for certain innovations and may choose not to pursue patent protection in certain jurisdictions, and under the laws of certain jurisdictions, patents or other intellectual property rights may be unavailable or limited in scope. It is also possible that we will fail to identify patentable aspects of our discovery and non-clinical development output before it is too late to obtain patent protection. Moreover, in some circumstances, we may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that we license from third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. For example, India and China do not allow patents for methods of treating the human body. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot know with certainty whether we were the first to make the inventions claimed in our owned or licensed patents or pending patent applications, or that we were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued which protect our technology or products, in whole or in part, or which effectively prevent others from commercializing competitive technologies and products. Changes in either the patent laws or interpretation of the patent laws in the EU, the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risks described pertaining to our patents and other intellectual property rights also apply to the intellectual property rights that we license, and any failure to obtain, maintain and enforce these rights could have a material adverse effect on our business. In some cases, we may not have control over the prosecution, maintenance or enforcement of the patents that we license, and our licensors may fail to take the steps that we believe are necessary or desirable in order to obtain, maintain and enforce the licensed patents. Any inability on our part to protect adequately our intellectual property may have a material adverse effect on our business, operating results and financial position.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The United States Patent and Trademark Office (&#8220;USPTO&#8221;) and various non-U.S. governmental patent agencies require compliance with several procedural, documentary, fee payment and other similar provisions during the patent application process. In certain situations, non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors might be able to enter the market and this circumstance would have a material adverse effect on our business.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we have acquired rights to tegoprubart and other product candidates through a license agreement with The ALS Therapy Development Institute, and may in the future enter into other license agreements with third parties for other intellectual property rights or assets. These license agreements may impose various diligence, milestone payment, royalty, and other obligations on us. If we fail to comply with our obligations under these agreements, or we are subject to a bankruptcy, we may be required to make certain payments to the licensor, we may lose the exclusivity of our license, or the licensor may have the right to terminate the license, in which event we would not be able to develop or market products covered by the license. Additionally, the milestone and other payments associated with these licenses will make it less profitable for us to develop our drug candidates than if we had developed the licensed technology internally.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, patent prosecution of our licensed technology may be controlled solely by the licensor. If our licensors fail to obtain and maintain patent or other protection for the proprietary intellectual property we license from them, we could lose our rights to the intellectual property or our exclusivity with respect to those rights, and our competitors could market competing products using the intellectual property. In certain cases, we may control the prosecution of patents resulting from licensed technology. In the event we breach any of our obligations related to such prosecution, we may incur significant liability to our licensing partners. If disputes over intellectual property and other rights that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time-consuming and unsuccessful.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial success depends upon our ability, and the ability of our collaborators, to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing the proprietary rights of third parties. There is considerable intellectual property litigation in the biotechnology and pharmaceutical industries. We may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our products and technology, including interference or derivation proceedings before the USPTO. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are found to infringe a third party&#8217;s intellectual property rights, we could be required to obtain a license from such third party to continue developing and marketing our products and technology. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. We could be forced, including by court order, to cease commercializing the infringing technology or product. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations, which could materially harm our business. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because competition in our industry is intense, competitors may infringe or otherwise violate our issued patents, patents of our licensors or other intellectual property. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents. In addition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly, or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly. We may also elect to enter into license agreements in order to settle patent infringement claims or to resolve disputes prior to litigation, and any such license agreements may require us to pay royalties and other fees that could be significant. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may need to license certain intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A third party may hold intellectual property, including patent rights, that are important or necessary to the development of our products. It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our products, in which case we would be required to obtain a license from these third parties on commercially reasonable terms, or our business could be harmed, possibly materially. If we were not able to obtain a license or are not able to obtain a license on commercially reasonable terms, our business could be harmed, possibly materially.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to seeking patents for some of our technology and product candidates, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. Any NDAs or similar agreements entered into by the Company may not be with all relevant parties, or adequately protect the confidentiality of our trade secrets. Moreover, to the extent we enter into such agreements, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate them, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims of misappropriation of trade secrets from former employers of Company personnel.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of our employees and certain of our directors were previously employed at or affiliated with research foundations or other biotechnology or pharmaceutical companies. Although we try to ensure that our employees and directors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these employees or directors have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such employee&#8217;s or director&#8217;s former employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Common Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We expect our stock price to be volatile, and the market price of our common stock may drop unexpectedly.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market price of our common stock could be subject to significant fluctuations. Market prices for securities of early-stage pharmaceutical, biopharmaceutical, and other life sciences companies have historically been particularly volatile. Some of the factors that may cause the market price of our common stock to fluctuate include:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">uncertainties regarding our financial condition and our ability to raise sufficient capital to fund our ongoing operations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain regulatory approvals for our product candidates or other product candidates, and delays or failures to obtain such approvals;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure of any of our product candidates, if approved, to achieve commercial success;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issues in manufacturing our approved products, if any, or product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the results of our current and any future clinical trials of our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the entry into, or termination of, key agreements, including key commercial partner agreements;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the initiation of, material developments in, or conclusion of litigation to enforce or defend any of our intellectual property rights or defend against the intellectual property rights of others;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announcements by commercial partners or competitors of new commercial products, clinical progress, or the lack thereof, significant contracts, commercial relationships, or capital commitments;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the introduction of technological innovations or new therapies that compete with our potential products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the loss of key employees;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in estimates or recommendations by securities analysts, if any, who cover our common stock;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">general and industry-specific economic conditions that may affect our research and development expenditures;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the structure of healthcare payment systems; </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">period-to-period fluctuations in our financial results; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">future issuances of shares of common stock.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, the stock markets in general have experienced substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations may also adversely affect the trading price of our common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the past, following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly harm our profitability and reputation.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to establish and maintain effective internal controls, our operating results and ability to operate our business could be harmed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ensuring that we will have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently. Our management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). Our management is likewise required, on a quarterly basis, to evaluate the effectiveness of our disclosure controls and procedures, and to disclose any material weaknesses and any changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, such controls.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described Part II Item 9A. Controls and Procedures of this Annual Report on Form 10-K, we have identified a material weakness in our internal control over financial reporting. In addition, a material weakness in our internal control over financial reporting existed previously which was initially disclosed as of June 30, 2024 and effectively remediated as of December 31, 2024. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. If we are unable to remediate the existing material weakness or otherwise maintain effective internal control over financial reporting, the accuracy and timing of our financial reporting, and our stock price, may be adversely affected and we may be unable to maintain compliance with the applicable stock exchange listing requirements. Additionally, as we become a larger company, we will become subject to Section 404(b) of the Sarbanes-Oxley Act, which requires our independent auditors to document and test our internal controls. These additional requirements are costly, and our auditors may identify control deficiencies.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Implementing any changes to our internal controls may distract the officers and employees of the Company, entail substantial costs to modify its existing processes and take significant time to complete. These changes may not, however, be effective in maintaining the adequacy of the internal controls of the Company, and any failure to maintain that adequacy, or consequent inability to produce accurate financial statements on a timely basis, could increase operating costs and harm the business. In addition, investors&#8217; perceptions that the internal controls of the Company are inadequate or that we are unable to produce accurate financial statements on a timely basis may harm the stock price of the Company.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Provisions in our corporate charter documents and under Delaware law could make an acquisition of the Company, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provisions in our corporate charter and bylaws may discourage, delay or prevent a merger, acquisition or other change in control of the Company that stockholders may consider favorable, including transactions in which our stockholders might otherwise receive a premium for their shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition, because our Board is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by stockholders to replace or remove the current management by making it more difficult for stockholders to replace members of our Board. Among other things, these provisions:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish a classified Board such that not all members of the Board are elected at one time;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">allow the authorized number of our directors to be changed only by resolution of our Board;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limit the manner in which stockholders can remove directors from our Board;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and nominations to our Board;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require that stockholder actions must be effected at a duly called stockholder meeting and prohibit actions by our stockholders by written consent;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limit who may call stockholder meetings;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">authorize our Board to issue preferred stock without stockholder approval, which could be used to institute a &#8220;poison pill&#8221; that would work to dilute the stock ownership of a potential hostile acquirer, effectively preventing acquisitions that have not been approved by our Board; and</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require the approval of the holders of at least 75% of the votes that all our stockholders would be entitled to cast to amend or repeal certain provisions of the Company&#8217;s charter or bylaws.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We do not expect to pay any cash dividends in the foreseeable future.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to retain our future earnings to fund the development and growth of our business. As a result, capital appreciation, if any, of our common stock will be the sole source of gain, if any, for any stockholders for the foreseeable future.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1B. Unresolve</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">d Staff Comments.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p><div><ix:nonNumeric id="F_71806869-9f6e-4100-87c8-4df4f85c8c78" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true" continuedAt="F_71806869-9f6e-4100-87c8-4df4f85c8c78_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strategy and Oversight</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and data related to our clinical studies and employees, or our information systems and the data contained therein.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We retain a Chief Information Consultant to collaborate with the company, including the Chief Financial Officer, and Executive Leadership Team, to help identify, assess and manage the company&#8217;s cybersecurity threats and risks. This group identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example, automated tools, subscribing to reports and services that identify cybersecurity threats, analyzing reports of threats and actors, and evaluating threats reported to us. We also use a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e97c9497-644c-41d2-8b38-af23bcbf74a9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> security management vendor to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending on the environment, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our information systems, including, for example, incident detection and response policy, route risk assessments, data encryption, network security controls, data segregation, access controls, physical security, asset management, tracking and disposal, systems monitoring, penetration testing, and cybersecurity insurance. As part of our information security program, we provide mandatory periodic training for all employees on how to identify potential cybersecurity risks and protect our resources and information. This training is supplemented by firmwide testing initiatives, including periodic phishing tests.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e98dc4d9-9626-4195-a2a8-2d9e88b0f906" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assessment and management of material risks from cybersecurity threats are </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_69d2104e-354a-4658-b6fa-5fd6ad0ed0af" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into our overall risk management processes.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> For example, the Chief Information Consultant works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. In addition, our </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d109f845-d4d9-43d6-b23c-b65558e02dbc" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.</span></ix:nonNumeric></span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we do not believe that known risks from cybersecurity threats, including as a result of any previous cybersecurity incidents that we are aware of, have </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dce23013-1974-4fa0-bc83-33bc4066e486" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">materially affected</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. However, we can give no assurance that we have detected or protected against all such cybersecurity incidents or threats. For a description of the risks from cybersecurity threats that may materially affect us and how they may do so, see our risk factors under Part I. Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K, including the risk factor titled &#8220;</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a65a0bf6-b2bd-4b3f-9993-db7028aeab45" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We depend on our information systems and those of our third-party collaborators, service providers, contractors or consultants</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which may fail or suffer cybersecurity incidents that could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.&#8221;</span></p><div><ix:nonNumeric id="F_e3420dda-c0ee-4942-a6f6-63dc8a2b1f8c" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true" continuedAt="F_e3420dda-c0ee-4942-a6f6-63dc8a2b1f8c_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board addresses our cybersecurity risk management as part of its general oversight function. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2b514667-7ccc-4c2a-b4a2-d7f8ac933f69" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true" continuedAt="F_2b514667-7ccc-4c2a-b4a2-d7f8ac933f69_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5de1dd25-9bf1-45c4-a9fc-7942b03ca187" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of </span></ix:nonNumeric></span><span style=""></span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_71806869-9f6e-4100-87c8-4df4f85c8c78_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e3420dda-c0ee-4942-a6f6-63dc8a2b1f8c_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2b514667-7ccc-4c2a-b4a2-d7f8ac933f69_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">risks </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from cybersecurity threats.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.</span></p><div><ix:nonNumeric id="F_2ed960ef-b957-4a05-aaa1-a2fb676698ff" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_f6e58ff5-f0ce-4854-a469-39a67d4af9ba" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_791ef562-86cd-465c-9081-bb232a82bc43" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6c78b257-0bc1-4b46-9bd9-5e1a9fb178f5" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span></ix:nonNumeric></span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_eab47a41-4d18-4eaf-bf9f-2c0cc191de73" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.</span></p></ix:nonNumeric></div></ix:continuation></div></ix:continuation></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2. Pr</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">operties.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive offices are located in Irvine, California. We lease approximately 5,817 square feet of office space under an operating lease that expires on June 30, 2027. Additionally, we have an operating lease for approximately 6,138 square feet of office space in Burlington, Massachusetts, that expires on November 21, 2027.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3. Legal</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Proceedings.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither we nor any of our subsidiaries is a party to, and none of their respective property is the subject of, any material legal proceeding, although we are from time-to-time party to legal proceedings that arise in the ordinary course of our business.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 4. Mine Saf</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ety Disclosures.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_ii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> II</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_5_market_for_registrants_common_equ"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5. Market for Registrant&#8217;s Common Equity, Related Stoc</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">kholder Matters and Issuer Purchases of Equity Securities.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Market Information</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is traded on the Nasdaq Capital Market under the symbol &#8220;ELDN&#8221;.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 17, 2025, there were approximately 48 stockholders of record of our common stock.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividends</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never declared or paid, and do not anticipate declaring or paying in the foreseeable future, any cash dividends on our common stock. Future determination as to the declaration and payment of dividends, if any, will be at the discretion of our Board and will depend on then existing conditions, including our operating results, financial condition, contractual restrictions, capital requirements, business prospects and other factors that our Board may deem relevant.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_6_reserved"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 6. [R</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eserved.]</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7_managements_discussion_analysis_f"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7. Management&#8217;s Discussion and Analysis of </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Condition and Results of Operations.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is intended to help the reader understand the results of operations and financial condition of the Company. The Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our audited consolidated financial statements and notes thereto for the year ended December 31, 2024. In addition to historical information, this Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. See &#8220;Special Note Regarding Forward-Looking Statements&#8221; in this Annual Report on Form 10-K. Our actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under the Part I, Item 1A. Risk Factors section and elsewhere in this report, as well as, in other reports and documents we file with the Securities and Exchange Commission from time to time. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of this Annual Report on Form 10-K.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RECENT DEVELOPMENTS</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business strategy is to optimize the clinical and commercial value of tegoprubart and become a global biopharmaceutical company with a focused immunology franchise. Tegoprubart targets the CD40 ligand (also known as CD40L). Blocking CD40L has been shown to inhibit multiple costimulatory receptors including CD40 and CD11, key components of how immune cells communicate with one another. Blocking CD40L also increases polarization of lymphocytes into Tregs, a specialized subpopulation of T cells that act to suppress immune response.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe the central role of CD40L signaling in generating pro-inflammatory responses makes it an attractive candidate for therapeutic intervention in the protection of transplanted organs and the prevention of transplant rejection, as well as modulating immune responses in autoimmune disease, and in neuroinflammation. Blocking the activation of the CD40L pathway has been shown to slow disease progression and pathology in preclinical models of autoimmunity and neurodegeneration, and to prevent acute and long-term allograft transplant rejection in multiple animal species.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We continue to focus on the development of tegoprubart for the prevention of rejection of allograft (i.e., transplanting an organ from one human to another) and xenograft (i.e., transplanting an organ from an animal to a human) organs and cells. Our mission is to both extend the functional life of transplanted organ and reduce side effect of current immunosuppressive treatments such as kidney toxicity, high blood pressure, and tremor.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is being evaluated in multiple kidney transplantation studies, including a Phase 1b trial, the Phase 2 BESTOW trial, and a Phase 2 open-label extension study, all designed to assess safety, pharmacokinetics, and efficacy compared to standard-of-care immunosuppression. Interim data suggest improved renal function and reduced immunosuppressive-related adverse events. Additionally, an investigator-initiated islet cell transplantation study has shown potential in achieving insulin independence without the use of calcineurin inhibitors, supporting further exploration in Type 1 diabetes. We also continue to explore xenotransplantation applications, an emerging area of scientific and commercial interest. Our collaboration with eGenesis, Inc. supports preclinical and clinical studies in kidney, heart, and islet cell transplantation.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Update</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2023, we announced our decision to prioritize resources on our kidney transplantation programs, discontinue the Company funded islet cell transplantation program and the IgAN program. We also remain committed to further progressing ALS clinical development and are working with key stakeholders on potential next steps to do so. However, we are unable to continue our clinical development of tegoprubart for people with ALS without additional financing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financing Activities</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2022 Exchange Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 11, 2022, we entered into an exchange agreement (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange Agreement&#8221;) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., MSI BVF SPV, L.L.C. (collectively, the &#8220;BVF Exchanging Stockholders&#8221;), pursuant to which the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchanging Stockholders exchanged (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange&#8221;) 550,000 shares of our common stock for 9,899.99 shares of Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock. For information regarding the terms of our Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-Voting Convertible Preferred Stock, see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders&#8217; Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements included in this Annual Report on Form 10-K.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, we entered into a Securities Purchase Agreement (the &#8220;2023 Securities Purchase Agreement&#8221;) with certain institutional and accredited investors, pursuant to which we agreed to issue and sell to the investors in a private placement (the &#8220;2023 Private Placement&#8221;) (i) in an initial closing, (a) an aggregate of 15,151,518 shares (the &#8220;Shares&#8221;) of our common stock, $0.001 par value per share, or pre-funded warrants in lieu thereof (the &#8220;Pre-Funded Warrants&#8221;), and (b) common stock warrants exercisable into an aggregate of 15,151,518 shares of common stock (or Pre-Funded Warrants in lieu thereof) (the &#8220;Common Warrants&#8221; and, together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;); (ii) in a second closing (the &#8220;Second Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of 20,202,024 shares of common stock (or Pre-Funded Warrants); and (iii) in a third closing (the &#8220;Third Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of 25,252,530 shares of common stock (or Pre-Funded Warrants), in each case subject to customary adjustments as provided in the 2023 Securities Purchase Agreement, Pre-Funded Warrant or Common Warrant, as applicable. Each Common Warrant has an exercise price of $3.00 per share and expires five years after issuance. The Pre-Funded Warrants are exercisable immediately and until exercised in full, with an exercise price of $0.001 per share. The Pre-Funded Warrants and Common Warrants are subject to specified beneficial ownership limitations, which are generally set at 9.99% of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed 19.99% unless otherwise permitted. The Shares, the Warrants, and the shares of common stock issuable upon the exercise of the Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, the initial closing occurred, and we received gross proceeds of $35.0 million, or net proceeds of approximately $33.0 million after deducting underwriting discounts and commissions and offering expenses, in exchange for 8,730,168 shares of common stock and Pre-Funded Warrants to purchase 6,421,350 shares of common stock.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 8, 2024, the Second Closing occurred, and the Company received gross proceeds of $2.1 million, or net proceeds of approximately $2.0 million after deducting underwriting discounts and commissions and offering expenses, in exchange for 909,088 shares of common stock.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 30, 2024, and October 1, 2024, the Third Closing occurred, and the Company received gross proceeds of $4.0 million, or net proceeds of approximately $3.8 million after deducting underwriting discounts and commissions and offering expenses, in exchange for 1,727,400 shares of common stock.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2023 Private Placement, the Company filed on May 18, 2023, a registration statement on Form S-3 (the &#8220;2023 Registration Statement&#8221;) with the SEC to register for resale the Shares and the shares of common stock issuable upon the exercise of the Warrants. The 2023 Registration Statement became effective on June 2, 2023.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Conversion Agreement of Non-Voting Convertible Preferred Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 16, 2023, Cormorant Global Healthcare Master Fund LP provided us notice of its intention to convert (i) 1,782 shares of Series X Non-Voting Convertible Preferred Stock for 99,000 shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X Non-Voting Convertible Preferred Stock, and (ii) 7,883.586 shares of Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock for 437,977 shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock. The conversion was completed on May 23, 2023. For information regarding the terms of our Series X and Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock, see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders&#8217; Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements included in this Annual Report on Form 10-K.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Pre-Funded Warrants from 2023 Securities Purchase Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, Armistice Capital Master Fund Ltd. (the &#8220;Exercising Stockholder&#8221;) exercised Pre-Funded Warrants to purchase 501,197 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 14, 2023, the Company issued 501,197 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 2, 2023, the Exercising Stockholder exercised Pre-Funded Warrants to purchase 653,000 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On November 6, 2023, the Company issued 653,000 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 30, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase 600,000 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On January 30, 2024, the Company issued 600,000 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 7, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase 583,000 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On May 9, 2024, the Company issued 583,000 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 11, 2024, the Exercising Stockholder exercised their remaining Pre-Funded Warrants to purchase 240,000 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 11, 2024, the Company issued 240,000 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 6, 2024, we entered into a Securities Purchase Agreement (the &#8220;2024 Securities Purchase Agreement&#8221;) with certain institutional and accredited investors, pursuant to which we agreed to issue and sell to the investors in a private placement (the &#8220;2024 Private Placement&#8221;) an aggregate of 13,110,484 shares (the &#8220;2024 Shares&#8221;) of our common stock at a price of $2.37 per share, and pre-funded warrants (the &#8220;2024 Pre-Funded Warrants&#8221;) at a price of $2.369 per underlying share, which are exercisable to purchase 7,989,516 shares of common stock at an exercise price of $0.001 per share. The 2024 Pre-Funded Warrants were issued in lieu of shares of common stock and are exercisable immediately and until exercised in full. The 2024 Pre-Funded Warrants are subject to specified beneficial ownership limitations (equal to 4.99% or 9.99% as determined by holder of each such warrant) of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed 19.99% unless otherwise permitted. The 2024 Shares, the 2024 Pre-Funded Warrants, and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Private Placement resulted in gross proceeds to the Company of $50.0 million, or net proceeds of approximately $48.1 million after deducting offering costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Private Placement, on May 24, 2024, we filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC to register for resale the 2024 Shares and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants. The 2024 Registration Statement became effective on June 5, 2024.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Equity Distribution Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 20, 2024, we entered into an Open Market Sale Agreement (the &#8220;Sales Agreement&#8221;) with Guggenheim Securities, LLC (&#8220;Guggenheim Securities&#8221;) to sell shares of our common stock, having aggregate sales proceeds of up to $75.0 million, from time to time, through an &#8220;at the market&#8221; equity offering program under which Guggenheim Securities will act as sales agent. In connection with the Sales Agreement, we filed on September 20, 2024 a registration statement on Form S-3 containing a prospectus and prospectus supplement (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement became effective on October 2, 2024. As of December 31, 2024, we have not sold any shares under the Sales Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 29, 2024, we entered into an underwriting agreement with Leerink Partners, LLC, as representative of the several underwriters named therein (the &#8220;Underwriters&#8221;) in connection with the underwritten offering, issuance and sale by the Company (the &#8220;2024 Underwritten Offering&#8221;) of 18,356,173 shares of our common stock, at an offering price of $3.65 per share, and pre-funded warrants at a price of $3.649 per pre-funded warrant, which are exercisable to purchase 4,931,507 shares of our common stock at an exercise price of $0.001 per share (the &#8220;Offering Pre-Funded Warrants&#8221;).</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Underwritten Offering closed on October 30, 2024 and resulted in gross proceeds of $85 million, or net proceeds of approximately $79.5 million after deducting underwriting discounts and commissions and offering expenses. The 2024 Underwritten Offering was made pursuant to the Shelf Registration Statement and a prospectus supplement relating to the 2024 Underwritten Offering dated October 29, 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A holder of the Offering Pre-Funded Warrants (together with its affiliates) may not exercise any portion of an Offering Pre-Funded Warrant to the extent that the that, after giving effect to such exercise, the holder (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates) would beneficially own in excess of 4.99% (or, at the holder&#8217;s option upon issuance, 9.99%) of the number of shares of the our common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of such Offering Pre-Funded Warrants.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, 33,052,744 warrants were exercisable into common stock (after rounding for fractional shares and subject to beneficial ownership conversion blockers). The shares of common stock underlying the registered direct and private placement warrants are registered for offer and sale under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), pursuant to our effective registration statements on Forms S-1.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Preferred Stock Warrants</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, 50,207.419 warrants were exercisable into Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock which are convertible into 2,789,301 shares of common stock (after rounding for fractional shares and subject to beneficial ownership conversion blockers). For information regarding the terms of our Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock, see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements included in this Annual Report on Form 10-K.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Operations Overview</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operating expenses consist primarily of costs associated with research and development activities and general and administrative activities.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses, which consist primarily of costs associated with our product research and development efforts, are expensed as incurred. Research and development expenses consist primarily of:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">personnel costs, including salaries, benefits, stock-based compensation and travel expenses, for employees engaged in research and development functions;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenses incurred under agreements with contract research organizations, or (&#8220;CROs&#8221;), and sites that conduct our non-clinical studies and clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenses associated with manufacturing materials for use in non-clinical studies and clinical trials and developing external manufacturing capabilities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">costs of outside consultants engaged in research and development activities, including their fees and travel expenses; </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other expenses related to our non-clinical studies and clinical trials and expenses related to our regulatory activities; and</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payments made under our third-party license agreements.</span></div></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses consist primarily of personnel costs that include salaries, benefits and travel expenses for our executive, finance, and other administrative functions, and stock-based compensation expense. General and administrative expenses also include professional fees for expenses incurred under agreements with third parties relating to public relations, audit, tax and legal services, including legal expenses to pursue patent protection of our intellectual property; and our information technology, facilities and other related expenses, including rent, maintenance of facilities, insurance and supplies.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds represents the initial recognition of warrant liabilities at fair value in excess of proceeds received, as well as subsequent period remeasurements of these warrant liabilities at fair value. These remeasurements reflect changes in market conditions, such as fluctuations in stock price, volatility, interest rates, and other valuation inputs that impact the fair value of the liability.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CRITICAL ACCOUNTING POLICIES AND SIGNIFICANT JUDGMENTS AND ESTIMATES</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management&#8217;s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amount of assets, liabilities, and expenses and the disclosure of contingent assets and liabilities as of the date of the financial statements. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience, known trends and events, and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued Research and Development Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the process of preparing our consolidated financial statements, we are required to estimate our accrued research and development expenses. This process involves reviewing open contracts, communicating with our personnel and vendors to identify services that have been performed on our behalf and estimating the level of service performed and the associated costs incurred for the services when we have not yet been invoiced or otherwise notified of the actual costs. The majority of our service providers invoice us in arrears for services performed, on a pre-determined schedule or when contractual milestones are met; however, some require advance payments. We make estimates of our accrued expenses as of each balance sheet date in our consolidated financial statements based on facts and circumstances known to us at that time. Examples of estimated accrued research and development expenses include fees paid to:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CROs in connection with performing research and development services on our behalf;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other providers in connection with clinical trials; </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">vendors in connection with non-clinical development activities; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">vendors related to product manufacturing, development and distribution of clinical supplies.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We base our expenses related to clinical trials on our estimates of the services received and efforts expended pursuant to contracts with multiple CROs that conduct and manage clinical trials on our behalf. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the clinical expense. Payments under some of these contracts depend on factors such as the successful enrollment of patients and the completion of clinical trial milestones. When determining accruals, we estimate the time period over which services will be performed, enrollment of patients, number of sites activated and level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from our estimate, we adjust the accrual or prepaid accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reporting expenses that are too high or too low in any particular period. To date, we have not made any material adjustments to our prior estimates of accrued research and development expenses.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSU&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrants are accounted for as either derivative liabilities or as equity instruments depending on the specific terms of the underlying agreement. Warrants that are equity-classified instruments and recorded in additional paid-in capital at issuance are not subject to remeasurement. The Common Warrants and the Subsequent Closing Warrants (as defined in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholder&#8217;s Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements) issued in the 2023 Private Placement are liability classified and recorded at fair value using the Black-Scholes option-pricing model at issuance, with any subsequent changes in fair value recognized in the consolidated statements of operations. We periodically evaluate changes in facts and circumstances that could impact the classification of warrants. As of December 31, 2024, the Subsequent Closing Warrants were settled or expired and only the Common Warrants remain.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-Process Research and Development</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts allocated to in-process research and development (&#8220;IPR&amp;D&#8221;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We first assess qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, we determine it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of our annual qualitative assessment, we concluded that it is not more likely than not that IPR&amp;D was impaired for any of the periods presented.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is set forth in Note 2. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of the Notes to Financial Statements included in this Annual Report on Form 10-K.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RESULTS OF OPERATIONS</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comparison of the Years Ended December 31, 2024 and 2023</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides comparative results of operations for the years ended December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:41.608%;box-sizing:content-box;"/>
     <td style="width:1.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.082%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.082%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.082%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.04%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.542%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Variance</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% Variance</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51,964</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,312</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,652</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,613</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,688</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,925</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,577</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(70,577</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(43,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(27,577</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-64</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,924</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,674</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,250</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(76,211</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,111</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss before income taxes</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(35,753</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(116,537</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80,784</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(431</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(431</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-100</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss and comprehensive loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(36,184</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(116,537</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80,353</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the period-over-period changes in research and development expenses for the periods presented (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:47.97%;box-sizing:content-box;"/>
     <td style="width:3.061%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.462%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:3.061%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.482000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:3.061%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.903%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - kidney transplantation programs</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,452</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,940</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,512</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - other development programs</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,186</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,880</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manufacturing</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,448</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,048</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,400</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,292</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,512</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,780</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,277</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,491</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,786</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">189</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">135</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total research and development expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51,964</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,312</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,652</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses increased $21.7 million for the year ended December 31, 2024, compared to the year ended December 31, 2023. The increase was primarily due to the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $15.5 million in Tegoprubart - kidney transplantation programs, primarily with external CROs, related to increased activities in our Phase 1b, Phase 2 BESTOW and Phase 2 open-label extension trials for kidney transplantation;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a decrease of $2.9 million in Tegoprubart - other development programs, primarily with external CROs, related to our IgAN program that was completed in 2023; </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $4.4 million in manufacturing costs, primarily with contract manufacturing organizations, for the increased production of drug substance and drug product clinical trial supply;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $1.8 million in personnel-related expenses due to an increase in headcount to support ongoing clinical development programs;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $2.8 million in stock-based compensation expense, primarily due to the recognition of expense for the achievement of performance-based vesting criteria during the year ended December 31, 2024; and</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $0.1 million in other operating expenses.</span></div></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the period-over-period changes in general and administrative expenses for the periods presented (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:53.561%;box-sizing:content-box;"/>
     <td style="width:3.041%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.385%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:3.041%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.964%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:3.041%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.964%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional Fees</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,212</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,680</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,532</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,414</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,839</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">575</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,845</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,054</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,791</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,142</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,115</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total general and administrative expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,613</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,688</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,925</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses increased $5.9 million for the year ended December 31, 2024, compared to the year ended December 31, 2023. The increase was primarily due to the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $1.5 million in professional fees and consulting fees primarily driven by increased audit and legal services;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $0.6 million in personnel-related expenses due to increased headcount; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $3.8 million in stock-based compensation expense, primarily due to the recognition of expense for the achievement of performance-based vesting criteria during the year ended December 31, 2024.</span></div></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $1.3 million increase in other income, net was primarily due to an increase in interest income, driven by higher balances of our cash and cash equivalents and short-term investments during the year ended December 31, 2024 as compared to the year ended December 31, 2023.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024, the fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds increased by $107.1 million to $30.9 million. The change was primarily due to the reversal of $59.1 million in warrant liabilities associated with the Subsequent Closing Warrants, which were settled or expired in 2024, partially offset by increase in the fair value of Common Warrants of $27.8 million. This is compared to $76.2 million in fair value of the Common Warrants and the Subsequent Closing Warrants for the year ended December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Provision for Income Taxes</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $0.4 million provision for income taxes for the year ended December 31, 2024, is the result of a change in the effective state tax rate used to remeasure deferred tax liability related to indefinite-lived assets.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LIQUIDITY AND CAPITAL RESOURCES</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sources of Liquidity</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company had cash and cash equivalents and short-term investments of $140.2 million, working capital of $132.2 million and an accumulated deficit of $355.6 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not have any approved products for commercial sale and have never generated revenue from product sales and have incurred significant net losses since our inception and expect to continue to incur net operating losses for the foreseeable future. We do not expect to receive any revenue from any product candidates that we develop unless and until we obtain regulatory approval and commercialize our product candidates or enter into collaborative arrangements with third parties. We currently have no credit facility or committed sources of capital. To date, our operations have been financed primarily by net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">proceeds from the sale of preferred and common stock, and the sale of warrants. Additionally, in view of our expectation to incur significant losses for the foreseeable future we will be required to raise additional capital resources in the future in order to fund our operations, although the availability of, and our access to, such resources is not assured.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have based this estimate on assumptions that may prove to be incorrect, and we could utilize our available resources sooner than we currently expect. To finance our operations beyond that point we will need to raise additional capital, which cannot be assured. Further, from time to time, our operating plans may change, and we may need additional funds to meet operational needs for clinical studies sooner than planned or to fund additional clinical studies. For example, we do not currently have sufficient liquidity to fund the continued clinical development of tegoprubart for people with ALS without additional financing. We will continue to monitor our liquidity position in light of various financing alternatives and may pursue additional financing or other alternatives to allow us to continue our product development. However, there can be no assurance such financing or other alternatives will be available to us on acceptable terms, or at all, which could force us to significantly alter our business strategy, substantially curtail our current operations, or liquidate and cease operations altogether.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Cash Requirements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our primary use of cash is to fund operating expenses, which consist of clinical research and development expenses, manufacturing expenses, legal and compliance expenses, compensation and related expenses, and general overhead costs. Cash used to fund operating expenses is impacted by the timing of when we pay or prepay these expenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect our expenses to increase in connection with our ongoing activities, particularly as we expand our clinical program with tegoprubart, continue the research and development of, and seek marketing approval for, our product candidates. In addition, if we obtain marketing approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will continue to require additional financing in order to advance our drug product through clinical development, to manufacture, obtain regulatory approval for and to commercialize our product candidates, to develop, acquire or in-license other potential product candidates, and to fund operations for the foreseeable future. Therefore, we will seek to raise additional capital through equity offerings, debt financings or other capital sources, including potentially collaborations, licenses and other similar arrangements. The ability to raise substantial additional capital will depend on many factors, including:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the initiation, progress, timing, costs and results of our ongoing and future clinical trials of tegoprubart, including as such activities may be adversely impacted by global events or macroeconomic conditions; </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of global macroeconomic trends and uncertainties, which continue to experience volatility and disruptions, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates, increases in inflation rates, rising interest rates and uncertainty about economic stability;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and scope of indications we decide to pursue for tegoprubart development; </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost, timing and outcome of regulatory review of any biologics license application, or BLA, we may submit for tegoprubart;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs and timing of manufacturing for tegoprubart, if approved;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our efforts to enhance operational systems and our ability to attract, hire and retain qualified personnel, including personnel to support the development of tegoprubart;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs associated with being a public company; </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the terms and timing of establishing and maintaining collaborations, licenses and other similar arrangements;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or in-license other product candidates and technologies; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost associated with commercializing tegoprubart, if approved for commercial sale.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Conditions in the financial and credit markets may also limit the availability of funding or increase the cost of funding. As a result of any of the foregoing factors, adequate additional funding may not be available to us on acceptable terms on a timely basis, or at all. The severity and duration of any such impacts cannot be predicted. Any such failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies or cause us to delay our clinical development plans, research and development programs or commercialization efforts, out-license intellectual property rights to our product candidates or sell unsecured assets, or a combination of the above. Any of these actions could materially harm our business. The issuance of shares of common stock in the 2023 Private Placement, the 2024 Private Placement and the 2024 Underwritten Offering diluted the ownership interests of our existing stockholders, and to the extent that we raise additional capital through the sale of additional equity, including through our &#8220;at the market&#8221; equity offering program, or convertible debt securities in the future, our stockholders&#8217; ownership interests may be further diluted, and the terms of these securities may also include liquidation or other preferences that adversely affect our stockholders&#8217; rights. Debt financing, if available, would result in fixed payment obligations and may involve agreements that include restrictive covenants that limit our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends, that could adversely impact our ability to conduct our business. If we raise funds through collaborations, licenses and other similar arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to us. Please see Part I, Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of this Annual Report on Form 10-K for additional risks associated with our substantial capital requirements and the challenges we may face in raising capital.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We lease our office facilities in Irvine, California and Burlington, Massachusetts under non-cancelable operating leases that expire in June 2027 and November 2027, respectively. As of December 31, 2024, we expect to make total lease payments of $1.1 million through November 2027.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We enter into contracts in the normal course of business with third-party contract organizations for preclinical and clinical studies, manufacture and supply of our preclinical and clinical materials and providing other services and products for operating purposes. Contracts for preclinical and clinical studies and other services generally provide for termination following a certain period after notice, and therefore we believe that our non-cancelable obligations under these agreements are not material. We do not have any long-term manufacturing and supply agreements with our third-party contract manufacturers but enter into specific contracts on an as needed basis for individual batch production runs.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary of our net cash flow activity for the years ended December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.72%;box-sizing:content-box;"/>
     <td style="width:1.72%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.92%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.72%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.92%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(47,271</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(39,527</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(70,314</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(45,287</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">133,522</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,017</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net change in cash and cash equivalents</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,937</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(51,797</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Activities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024, operating activities used $47.3 million of cash, which primarily consisted of our net loss of $36.2 million. Operating activities include adjustments for certain non-cash charges including $30.9 million due to a change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds, accretion of investment discounts of $2.8 million, partially offset by $13.1 million of stock-based compensation, $0.4 million of operating lease amortization, and $0.4 million of deferred tax provision. Net operating assets and liabilities changed by $8.7 million, primarily driven by an increase in accounts payable and accrued expenses of $7.7 million and a decrease in prepaid expenses and other assets of $1.3 million.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2023, operating activities used $39.5 million of cash, which resulted from our net loss of $116.5 million and the changes in operating activities described below. Operating activities include adjustments for certain non-cash charges including $76.2 million due to a change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds, $6.5 million of stock-based compensation, and $0.4 million of operating lease</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amortization, partially offset by accretion of investment discounts of $1.2 million. Net operating assets and liabilities changed by $4.9 million, primarily driven by a decrease in accounts payable and accrued expenses of $2.6 million, a decrease in operating lease liability of $0.4 million and an increase in prepaid expenses and other assets of $2.0 million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing Activities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in investing activities for the year ended December 31, 2024 was $70.3 million. We purchased $156.1 million of short-term investments, which was partially offset by the maturing of $85.8 million of our short-term investments during the year.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in investing activities for the year ended December 31, 2023 was $45.3 million. We purchased $78.3 million of short-term investments, which was partially offset by the maturing of $33.0 million of our short-term investments during the year.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financing Activities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities for the year ended December 31, 2024 consisted of the following: $79.5 million in net proceeds from the 2024 Underwritten Offering, involving the sale of 18.4 million shares of the common stock and pre-funded warrants to purchase 4.9 million shares of common stock; $48.1 million in net proceeds from the 2024 Private Placement, involving the sale of 13.1 million shares of common stock and pre-funded warrants to purchase 8.0 million shares of common stock; $1.9 million in net proceeds from the Second Closing, involving the sale of 0.9 million shares of common stock; $3.8 million in net proceeds from the Third Closing, involving the sale of 1.7 million shares of common stock; and $0.2 million from exercise of stock options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities for the year ended December 31, 2023 consisted of the 2023 Private Placement, totaling $33.0 million in net proceeds from the sale of 8.7 million shares of common stock and pre-funded warrants to purchase 6.4 million shares of common stock.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7a_quantitative_qualitative_disclos"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7A. Quantitative and Qualitati</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ve Disclosures About Market Risk.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Per &#167;229.305 of Regulation S-K, the Company, designated a Smaller Reporting Company as defined in &#167;229.10(f)(1) of Regulation S-K, is not required to provide the disclosure required by this Item.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_8_financial_statements_supplementar"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8. Financial Statement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s and Supplementary Data.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Report of Independent Registered Public Accounting Firm, our consolidated financial statements and accompanying notes listed under Part IV, Item 15. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exhibits, Financial Statement Schedules </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of this Annual Report on Form 10-K are set forth beginning on page F-1 immediately following the signature page hereof and incorporated by reference herein.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9_changes_in_disagreements_with_acc"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9. Changes in and Disagreements with Accoun</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tants on Accounting and Financial Disclosure.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9a_controls_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9A. Controls</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and Procedures.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the end of the period covered by this Annual Report on Form 10-K, our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on this evaluation as of December 31, 2024 and as disclosed in the Original Report, management concluded that our disclosure controls and procedures were effective at the reasonable assurance level. Subsequent to the Original Report, management, under the supervision of our principal executive officer and principal financial officer, re-evaluated the assessment of effectiveness of our disclosure controls and procedures in connection with the restatement described herein and material weakness identified in the course of preparing our unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2025. Based upon that re-evaluation, management has concluded that our disclosure controls and procedures were not effective, at the reasonable assurance level, as of December 31, 2024, in light of the material weakness identified in our internal control over financial reporting.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal Control Over Financial Reporting</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Report on Internal Control Over Financial Reporting</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control system is designed to provide reasonable assurance to our management and Board regarding the preparation and fair presentation of published financial statements. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2024. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO Framework&#8221;) in its 2013</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Internal Control&#8212;Integrated Framework.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Management believes that the COSO Framework is a suitable framework for its evaluation of financial reporting because it is free from bias, permits reasonably consistent qualitative and quantitative measurements of our internal control over financial reporting, is sufficiently complete so that those relevant factors that would alter a conclusion about the effectiveness of our internal control over financial reporting are not omitted and is relevant to an evaluation of internal control over financial reporting.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 20, 2025, we filed the Original Report. At that time, our principal executive officer and principal financial officer had performed the foregoing assessment and concluded that our internal control over financial reporting was effective as of December 31, 2024. In the course of preparing the Company&#8217;s unaudited consolidated financial statements as of and for the three and six months ended June 30, 2025, our management concluded that the Series X and Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> non-voting convertible preferred stock, $0.001 par value (&#8220;Preferred Stock&#8221;) should be treated as a separate class of common stock for purposes of calculating earnings per share in accordance with ASC 260-10, &#8220;Earnings Per Share&#8221; and the Company must instead present earnings per share under the two-class method. Additionally, our management concluded that the Preferred Stock does not meet the criteria for permanent equity classification and must be classified as temporary equity under ASC 480-10-S99-3A.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result, our management, including our principal executive officer and principal financial officer, determined that there existed a material weakness in our internal control over financial reporting related to our accounting for equity instruments for the periods covered by each of the Impacted Reports. A material weakness is a deficiency, or a combination of deficiencies, in the internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected in a timely basis. Specifically, our management determined that we did not maintain effective controls to timely identify and account for equity instruments with complex terms, including certain provisions within our Preferred Stock. This material weakness resulted in the material misstatement of each of the Impacted Reports and, if not remediated, could result in further material misstatements to our annual or interim consolidated financial statements that would not be prevented or detected. Due to this material weakness, our management re-assessed the effectiveness of the Company&#8217;s internal control over financial reporting and concluded that our internal control over financial reporting was not effective as of December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Remediation of Material Weakness</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management has implemented remediation steps to address the material weakness described above and to improve our internal control over financial reporting. In the fourth quarter of 2024, we enhanced our processes to strengthen the identification and evaluation of complex accounting matters, including engaging with independent technical accounting experts to advise and review complex financial matters, ensuring appropriate technical analysis, documentation, and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">oversight prior to the preparation of our financial statements, hiring of internal financial expertise within the corporate accounting department, and strengthening financial disclosure and technical guidance resources. However, the enhanced controls were not applied to equity instruments issued in prior periods, including the Preferred Stock at issue. As a result, the classification error was not identified until a subsequent review. Management is in the process of refining these processes to ensure that previously issued instruments are periodically reassessed in the context of evolving technical guidance and accounting interpretations.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Completed Remediation of Prior Year&#8217;s Material Weakness</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the course of preparing our unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2024, our management concluded that the Common Warrants and Subsequent Closing Warrants do not meet the conditions to be classified as equity instruments under ASC 815-40, &#8220;Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity,&#8221; and must instead be recorded as liabilities on our consolidated balance sheet at their fair value and remeasured at fair value for each subsequent reporting period. In light of this determination, on August 13, 2024, management and the Audit Committee of our Board together concluded that our previously issued (i) audited consolidated financial statements as of and for the year ended December 31, 2023 included in our Annual Report on Form 10-K filed with the SEC on March 28, 2024 and (ii) unaudited condensed consolidated financial statements as of and for (a) the three months ended March 31, 2024 included in our Quarterly Report on Form 10-Q filed with the SEC on May 15, 2024, (b) the three and nine months ended September 30, 2023 included in our Quarterly Report on Form 10-Q filed with the SEC on November 9, 2023 and (c) the three and six months ended June 30, 2023 included in our Quarterly Report on Form 10-Q filed with the SEC on August 10, 2023 (together, the &#8220;Prior Year&#8217;s Impacted Reports&#8221;) were each materially misstated.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result, our management, including our principal executive officer and principal financial officer, determined that there existed a material weakness (the &#8220;Prior Year&#8217;s Material Weakness&#8221;) identified in our internal control over financial reporting related to our accounting for equity instruments for the periods covered by each of the Prior Year&#8217;s Impacted Reports. Specifically, our management determined that we did not maintain effective controls to timely identify and account for complex derivative type financial instruments. The Prior Year&#8217;s Material Weakness resulted in the material misstatement of each of the Prior Year&#8217;s Impacted Reports.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As previously disclosed, in August 2024, the Company immediately implemented a plan to address and remediate the Prior Year&#8217;s Material Weakness described above and to improve our internal control over financial reporting. As part of the remediation plan, management identified and implemented a number of actions including, but not limited to, the following actions:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Engaged with independent technical accounting experts to advise and review complex financial matters, ensuring appropriate technical analysis, documentation, and oversight prior to the preparation of our financial statements.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hiring of internal financial expertise within the corporate accounting department.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Implemented an accounting standards compliance framework to ensure timely adoption and assessment of evolving accounting standards.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strengthened financial disclosure and technical guidance resources.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the fourth quarter of the year ended December 31, 2024, we completed the testing necessary to conclude that the Prior Year&#8217;s Material Weakness had been remediated. However, as discussed above under </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#8220;Management&#8217;s Report on Internal Control Over Financial Reporting&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,  in the course of preparing the Company&#8217;s unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2025, the Company concluded that it had incorrectly classified the Preferred Stock, issued in prior periods, as permanent equity in the consolidated balance sheets. Management will continue to implement the remediation plan described above under </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#8220;Remediation of Material Weakness&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, with a focus on evaluating previously issued financial instruments and any unusual or complex transactions, to ensure they are appropriately assessed in light of current technical guidance and accounting interpretations.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a non-accelerated filer, we are not required to provide an attestation report on our internal control over financial reporting issued by the Company&#8217;s independent registered public accounting firm.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other than as described above, there have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) of the Exchange Act) during the quarter ended December 31, 2024, that have materially</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">affected, or are reasonably likely to materially affect, our internal control over financial reporting. In the course of preparing the Company&#8217;s consolidated financial statements as of and for the three and six months ended June 30, 2025, the Company identified the material weakness described above and, in response, our management is implementing the remediation steps described above.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9b_or_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9B. Other </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Insider Trading Arrangements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_70daaf9f-17d4-414c-9859-6775f1475cbd" contextRef="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_fa3681eb-4d33-43c5-90f0-7f756e385b8b" contextRef="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_87b77f6b-cd7a-407d-bd61-9ea2b04acfdc" contextRef="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_26b42070-4a38-4aaa-9f20-5bbb2c36768a" contextRef="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9c_disclosure_regarding_foreign_jur"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9C. Disclosure Regarding Foreign J</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">urisdictions that Prevent Inspection.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> III</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_10_directors_executive_ficers_corpo"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 10. Directors, Executive Off</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">icers and Corporate Governance.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 10 is incorporated herein by reference to information in our proxy statement for our 2025 Annual Meeting of Stockholders (the &#8220;2025 Proxy Statement&#8221;), which we filed with the SEC on April 29, 2025, including under headings &#8220;Proposal 1: Election of Class II Directors,&#8221; &#8220;Executive Officers,&#8221; &#8220;Corporate Governance&#8212;Director Nomination Process,&#8221; &#8220;Corporate Governance&#8212; Committees of the Board&#8221; and &#8220;Corporate Governance&#8212;Insider Trading Policy and Procedures.&#8221;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bc323d64-f566-474b-8998-db7c266905b9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code is available on the Corporate Governance section of our website, which is located at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">http://ir.eledon.com/corporate-governance/governance-overview</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We intend to disclose on our website any amendments to, or waivers from, the code of business conduct and ethics that are required to be disclosed pursuant to the disclosure requirements of Item 5.05 of Form 8-K within four business days following the date of the amendment or waiver.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_11_executive_compensation"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 11. Executive Compensation.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 11 is incorporated herein by reference to information in our 2025 Proxy Statement, including under headings &#8220;Executive Compensation,&#8221; and &#8220;Director Compensation&#8221;.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_12_beneficial_owner_stockholder"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 12 is incorporated herein by reference to information in our 2025 Proxy Statement, including under headings &#8220;Stock Ownership and Reporting&#8212;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Securities Authorized for Issuance Under Equity Compensation Plans&#8221;.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_13_related_party_transactions"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 13. Certain Relationships and Related Transactions, and Director Independence.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 13 is incorporated herein by reference to information in our 2025 Proxy Statement, including under headings &#8220;Corporate Governance&#8212;Policies and Procedures for Related Person Transactions,&#8221; &#8220;Corporate Governance,&#8221; and &#8220;Corporate Governance&#8212;Committees of the Board.&#8221;.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_14_principal_accounting_fees"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 14. Principal Accountant Fees and Services.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 14 is incorporated herein by reference to information in our 2025 Proxy Statement, including under headings &#8220;Proposal 4: Ratification of the Appointment of Independent Registered Public Accounting Firm&#8221;.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iv"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> IV</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_15_exhibits_financial_statement_sch"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 15. Exhibits, Financi</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">al Statement Schedules.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following documents are filed as part of this Annual Report on Form 10-K:</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Statements:</span></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Report of Independent Registered Public Accounting Firm, our consolidated financial statements and accompanying notes are set forth beginning on page F-1 immediately following the signature page of this Amendment No. 1 on Form 10-K.</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Statement Schedules:</span></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The financial statement schedules are omitted as they are either not applicable or the information required is presented in the financial statements and notes thereto under Part II, Item 8. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibits:</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7.12%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:22.32%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:15.16%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:19.34%;box-sizing:content-box;"/>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="5" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Incorporated by Reference</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed with</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">  </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit Description</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
     <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing Date</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Original Report</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Herewith</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520246314/d26397dex21.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Agreement and Plan of Merger, dated September 14, 2020, by and among Novus Therapeutics, Inc., Nautilus Merger Sub 1, Inc., Nautilus Merger Sub 2, LLC and Anelixis Therapeutics, Inc.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 15, 2020</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312514354857/d793658dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restated Certificate of Incorporation of Novus Therapeutics, Inc., a Delaware corporation, dated September 22, 2014</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2014</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312517170677/d393884dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Amendment to Certificate of Incorporation of Novus Therapeutics, Inc. (effecting, among other things a reverse stock-split), filed with the Secretary of the State of Delaware on May 9, 2017</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 15, 2017</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312517170677/d393884dex32.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Amendment to Certificate of Incorporation of Novus Therapeutics, Inc. (effecting, among other things a change in the corporation&#8217;s name to &#8220;Novus Therapeutics, Inc.&#8221;), filed with the Secretary of the State of Delaware on May 9, 2017</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 15, 2017</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7.12%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:22.32%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:15.16%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:19.34%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;3.4</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520264806/d18987dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Amendment to the Restated Certificate of Incorporation of Novus Therapeutics, Inc., (effecting, among other things a reverse stock-split) effective as of October 5, 2020</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 6, 2020</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000110465921000921/tm211620d1_ex3-1.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Amendment to the Restated Certificate of Incorporation of Novus Therapeutics, Inc., (effecting, among other things a change in the corporation&#8217;s name to &#8220;Eledon Pharmaceuticals, Inc.&#8221;) effective as of January 5, 2021</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 5, 2021</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.6</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312517211880/d406180dex34.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amended and Restated Bylaws of Eledon Pharmaceuticals, Inc.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 5, 2021</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520041903/d888744dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Designations of Series X Convertible Preferred Stock</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 19, 2020</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520246314/d26397dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Designations of Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> Convertible Preferred Stock</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 15, 2020</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312517211880/d406180dex41.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Common Stock Certificate</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-A/A</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">June 23, 2017</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312519135059/d740901dex41.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Warrant</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 2, 2019</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312519135059/d740901dex42.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Placement Agent Warrant</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 2, 2019</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520008426/d873828dex41.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Common Stock Purchase Warrant</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 16, 2020</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459021016828/nvus-ex45_320.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Description of Securities</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 31, 2021</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex4_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex4_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Tranche A Warrant to Purchase Common Stock or Pre-Funded Warrants</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024053934/eldn-ex4_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 7, 2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024118497/eldn-ex4_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 30, 2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7.12%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:22.32%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:15.16%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:19.34%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312524222880/d893946dex12.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Open Market Sales Agreement by and between the Registrant and Guggenheim Securities, LLC dated September 20, 2024</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282260</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 20, 2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Securities Purchase Agreement, dated April 28, 2023</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex10_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Registration Rights Agreement, dated April 28, 2023</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024053934/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Securities Purchase Agreement, dated May 6, 2024</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 7, 2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024053934/eldn-ex10_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Registration Rights Agreement, dated May 6, 2024</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 7, 2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023049046/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Indemnification Agreement to be entered into with each of the directors and officers of Eledon</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 21, 2023</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex10_7.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fourth Amendment to Lease Agreement, dated March 12, 2024, by and between Newport Gateway Office LLC and Eledon Pharmaceuticals, Inc.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex10_8.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease Agreement, dated September 4, 2024, by and between Blanchard Group LLC and Eledon Pharmaceuticals, Inc.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459018007314/nvus-ex1011_429.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tokai Pharmaceuticals, Inc. 2007 Stock Incentive Plan</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 2, 2018</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459018019519/nvus-ex102_213.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tokai Pharmaceuticals, Inc. 2014 Stock Incentive Plan</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 7, 2018</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459018019519/nvus-ex103_212.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Novus Therapeutics, Inc., 2014 Employee Stock Purchase Plan</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 7, 2018</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459021016828/nvus-ex108_318.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Executive Employment Agreement, dated September 9, 2020, between Novus Therapeutics, Inc. and David-Alexandre C. Gros, M.D.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 31, 2021</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex10_3.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David-Alexandre Gros, M.D. Letter Agreement, dated April 27, 2023</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7.12%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:22.32%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:15.16%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:19.34%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex10_14.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David-Alexandre Gros, M.D. Letter Agreement, dated December 16, 2024</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459021016828/nvus-ex1010_316.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Executive Employment Agreement, dated March 15, 2021, between Eledon Pharmaceuticals, Inc. and Paul Little</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 31, 2021</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex10_4.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Steve Perrin, Ph.D. Letter Agreement, dated April 27, 2023</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459021016828/nvus-ex1011_319.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Novus Therapeutics, Inc., 2020 Long Term Incentive Plan</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 31, 2021</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024082730/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. 2020 Long Term Incentive Plan, as amended</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 10, 2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.19*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459022011698/eldn-ex1012_1073.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Performance Stock Option Agreement, dated February 1, 2022, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 24, 2022</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.20</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017022016935/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amended and Restated License Agreement by and between ALS Therapy Development Foundation, Inc. and Anelixis Therapeutics, Inc, dated February 18, 2020</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 11, 2022</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.21</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017022016935/eldn-ex10_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">First Amendment to Restated License Agreement between ALS Therapy Development Foundation, Inc. and Anelixis Therapeutics, Inc. dated September 5, 2020</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 11, 2022</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017022016935/eldn-ex10_3.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">License Agreement between Lonza Sales AG and Anelixis Therapeutics, LLC, dated September 11, 2018</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 11, 2022</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024038091/eldn-ex10_22.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Stock Option Agreement, dated May 1, 2023, between Eledon Pharmaceuticals, Inc. and each of David-Alexandre C. Gros, M.D., Steve Perrin, Ph D., Bryan Smith and Paul Little</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 28, 2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7.12%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:22.32%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:15.16%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:19.34%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.24*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024038091/eldn-ex10_23.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Amendment to Stock Option Agreement, dated December 30, 2023, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D., Steve Perrin, Ph D., Bryan Smith and Paul Little</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 28, 2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.25*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex10_25.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Amendment to Stock Option Agreement, dated June 13, 2024, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D., Steve Perrin, Ph D., Bryan Smith and Paul Little</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.26*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex10_26.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Amendment to Stock Option Agreement, dated November 20, 2024, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D., Steve Perrin, Ph D., Bryan Smith and Paul Little</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex19_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. Insider Trading Policy</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459020011260/nvus-ex211_11.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Subsidiaries of the Registrant</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 17, 2020</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex23_1.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consent of Crowe LLP, independent registered public accounting firm</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex23_2.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consent of KMJ Corbin &amp; Company LLP, independent registered public accounting firm</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex31_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex31_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">70</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7.12%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:22.32%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:15.16%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:19.34%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex31_3.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.4</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex31_4.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.1#</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex32_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.2</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">#</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-ex32_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.3#</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex32_3.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.4#</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex32_4.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024038091/eldn-ex97_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Incentive Compensation Recoupment Policy</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 28, 2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">71</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7.12%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:22.32%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:15.16%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:19.34%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">INLINE XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">INLINE XBRL Taxonomy Extension Schema with Embedded Linkbase Documents</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover page formatted as INLINE XBRL and contained in Exhibit 101</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indicates a management contract or compensatory plan</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">#</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">These certifications are not deemed filed by the SEC and are not to be incorporated by reference in any filing we make under the Securities Act of 1933 or the Securities Exchange Act of 1934, irrespective of any general incorporation language in any filings.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_16_form_10k_summary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 16. Form </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K Summary.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">72</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="signatures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNAT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">URES</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:49%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:47%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: August 14, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros, M.D.</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">and Director (Principal</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Executive Officer and Duly Authorized Officer)</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: August 14, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Paul Little</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Paul Little</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:28.2%;box-sizing:content-box;"/>
     <td style="width:1.92%;box-sizing:content-box;"/>
     <td style="width:40%;box-sizing:content-box;"/>
     <td style="width:1.92%;box-sizing:content-box;"/>
     <td style="width:27.96%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
    </tr>
    <tr style="height:15.85pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros, M.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal Executive Officer)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Paul Little</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Paul Little</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Keith A. Katkin</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chairman of the Board of Directors</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Keith A. Katkin</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jan Hillson, M.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Jan Hillson, M.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ James Robinson</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">James Robinson</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Allan Kirk, M.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Allan Kirk, M.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ John S. McBride</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">John S. McBride</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ June Lee, M.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June Lee, M.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Steven Perrin</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President, Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Steven Perrin</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">73</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="index_to_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEX TO CONSOLIDATED FINANC</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IAL STATEMENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:94.54%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report_independent_pub_acctg_firm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (Crowe LLP PCAOB ID#: </span><span><ix:nonNumeric id="F_28d5f453-25ec-4b58-a82a-b8058765d103" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:AuditorFirmId"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">173</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#kmj_opinion"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (KMJ Corbin &amp; Company LLP PCAOB ID#: </span><span><ix:nonNumeric id="F_39bea8dc-acef-45cb-8713-fe8bacc8fd52" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="dei:AuditorFirmId"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2024 and 2023</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(As Restated)</span></p></td>
     <td style="padding-top:0in;text-indent:18pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="margin-left:1.067%;text-indent:-2.345%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:12.25pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-2.319%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_statements_operat"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2024 and 2023</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(As Restated)</span></p></td>
     <td style="padding-top:0in;text-indent:18pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="margin-left:1.067%;text-indent:-2.345%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:12.25pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-2.319%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#equity"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) for the Years Ended December 31, 2024 and 2023 (As Restated)</span></a></p></td>
     <td style="padding-top:0in;text-indent:18pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="margin-left:1.067%;text-indent:-2.345%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:12.25pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-2.319%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_statements_cash_f"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0in;text-indent:18pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="margin-left:1.067%;text-indent:-2.345%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_condensed_consolidated_financia"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements (As Restated)</span></a></p></td>
     <td style="padding-top:0in;text-indent:18pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="margin-left:1.067%;text-indent:-2.345%;padding-left:2.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="report_independent_pub_acctg_firm"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Board of Directors and Stockholders of<br/>Eledon Pharmaceuticals, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_237bc1c3-351a-418d-b095-6ebfcf230aa3" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:AuditorOpinionTextBlock" escape="true" continuedAt="F_237bc1c3-351a-418d-b095-6ebfcf230aa3_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of Eledon Pharmaceuticals, Inc. (the "Company") as of December 31, 2024, and the related consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders&#8217; equity (deficit), and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Explanatory Paragraph &#8211; Restatement</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 12 to the financial statements, the 2024 financial statements have been restated to correct a misstatement.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Audit Matter</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.  The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#ff0000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Classification and Valuation of Pre-Funded Warrants</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in Note 2, Summary of Significant Accounting Policies, and Note 8, Stockholder&#8217;s Equity, to the consolidated financial statements, the Company accounts for issued pre-funded warrants either as a liability or equity in accordance with ASC 815-40, Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period with any change in the fair value of the warrants recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. The Common Warrants and the Subsequent Closing Warrants (as defined in Note 8) issued in the 2023 Private Placement are liability classified and recorded at fair value</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_237bc1c3-351a-418d-b095-6ebfcf230aa3_1" continuedAt="F_237bc1c3-351a-418d-b095-6ebfcf230aa3_2"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">using the Black-Scholes option-pricing model at issuance, with any subsequent changes in fair value recognized in the consolidated statements of operations. Determining the proper classification of pre-funded warrants as either a derivative liability or as equity instruments requires significant management judgment in assessing the specific terms and conditions. The valuation of the derivative liability for liability classified pre-funded warrants also requires management judgment in determining the fair value.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The classification and valuation of warrants was determined to be a critical audit matter because of the complexity and significant judgment involved in determining the accounting for the pre-funded warrants and the significant audit effort, including the use of specialists, in assessing management&#8217;s conclusions and inputs to its calculation of fair value.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit procedures to evaluate the classification and fair market value of the pre-funded warrants included:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining and inspecting the securities purchase agreements to evaluate the contractual terms of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluating management's technical accounting analysis on the classification of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consulting with specialists on the classification and valuation of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Developing an independent expectation of the valuation of the liability-classified warrants to compare to management&#8217;s valuation.</span></div></div></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_09c7985a-ba50-4650-871e-a2f38eadedaa" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Crowe LLP</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company's auditor since 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_191f7a1d-f0f2-4883-a8d7-a7dc5ffc45b2" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Los Angeles, CA</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 20, 2025, Except for Note 12, as to which the date is August 14, 2025</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="kmj_opinion"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Board of Directors and Stockholders of<br/>Eledon Pharmaceuticals, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_237bc1c3-351a-418d-b095-6ebfcf230aa3_2"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of Eledon Pharmaceuticals, Inc. (the &#8220;Company&#8221;) as of December 31, 2023, the related consolidated statements of operations and comprehensive loss, convertible stock and stockholders&#8217; equity (deficit) and cash flows for the year then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restatement of 2023 Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 12 to the consolidated financial statements, the 2023 consolidated financial statements have been restated to correct certain misstatements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fe1c0535-66fe-4cef-96ba-31eed1f3623f" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KMJ Corbin &amp; Company LLP</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We served as the Company's auditor from 2019 to 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a1dbea2b-9057-4e14-8146-b6bcd9ce2622" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Glendora, California</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/>March 28, 2024 (except for previously disclosed adjustments to 2023, as to which the date is August 19, 2024, Note 10, as to which the date is March 20, 2025, and Note 12, as to which the date is August 14, 2025)</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELEDON PHARMACEUTICALS, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TED BALANCE SHEETS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:67.367%;box-sizing:content-box;"/>
     <td style="width:1.7%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.617%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.7%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.617%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(As Restated)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ASSETS</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f8df1bd-07e0-442f-b3d2-085c969abb1d" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,549</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1908b2bb-7a23-45a1-ad0b-1f15a307209d" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,612</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_956ff5cc-2cdd-498e-98f4-002f47d8b921" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a75f223-97a9-48d4-ba40-2d621370488d" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5bdd7e26-1363-4418-b7aa-3a6006d41e94" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,552</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f48b62c8-7279-4a6f-8628-0c149ad35d64" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,027</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9e8c848-c6a8-4b4d-95cb-95b88fe5adf9" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143,730</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a16807c-92bb-4aed-b798-86554a423c37" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,129</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use asset, net</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06149a75-5238-4750-8174-b7c198dcea05" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">926</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcfdf2f6-6156-4263-a3e8-fd00672c2017" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">In-process research and development</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12a92682-ce69-4050-bc72-97830e341c4f" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:InProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,386</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f734c20b-75cd-4057-b109-8ae0794496c8" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="eldn:InProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,386</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41caf978-8139-4341-8cf5-6b5b324118c1" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">363</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32d402ea-4778-4548-9dc5-ecc2dfd30f9e" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">186</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b119ac6-c7bb-4249-8f72-dcb26380c851" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">177,405</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c4b6dc1-192a-4011-8b13-4c7987ffb08f" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,066</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6352198b-a33e-4463-899d-b540a81edb6d" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,833</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7bc22f53-b94b-40f2-ac78-8b56832f72fa" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">967</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current operating lease liability</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b5f2506-7146-404e-8bbe-5a3bc518a60f" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">314</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_108f0cdf-fa5f-435a-9f48-8e66bfd36bc5" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">383</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8dcb8c94-5ef4-4f32-94f6-afed44393d5e" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,430</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4de91b5-dee1-4cc7-9b61-28b10daa612c" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,545</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8b84219-e90b-4648-bb89-528fc9ca6ab2" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,577</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77c94b1f-921b-4f50-8659-88bf59dd0e17" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,895</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liability</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2338d0ab-5c25-40d2-b8cc-e8726e2c1823" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,183</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_579742ef-0e6e-4f73-a3de-bc1c2af41632" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,752</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-current operating lease liability</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46900c23-675b-421d-a14f-1a71583dd00d" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">640</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4759fab-8a83-4fab-827c-bfa98c8aa4f1" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,865</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39ca4604-b05c-4156-8bab-3720206fe902" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e833f28a-6940-4cfb-bab9-3b199ae3f2be" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,265</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc99b33a-e0f0-4487-a7ea-b97baf7c0732" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,858</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_9a89652e-6946-4431-87fe-50db88208800;"><span style="-sec-ix-hidden:F_7db7a889-a436-4319-b161-e52ce75ec2b4;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies (Note 6)</span></span></span></span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37a035c0-dfeb-431c-a547-567568509610" contextRef="C_217e35bf-2776-4ae6-b1a7-3ae6aa8a1aff" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d33d6a34-ef75-4224-b889-4ea42b34557c" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and 2023:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8273b344-4683-4b6f-8285-65c3a89537b0" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f966ae95-1500-4239-b8b8-8b477973cc51" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9b7e732-7a9a-4309-a397-7f837dd21265" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a07000c3-5011-4e74-9685-8c4b7aba4935" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb0a5930-0106-4f75-883c-99f66c2718dd" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_71d03a4f-7ed9-4a75-a261-ead672c32370" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9ccdad73-24b8-4463-8300-2b701792fbca" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_161385ce-506e-4980-9e6a-53123ecb1eee" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2d586f5-fb52-4f3e-884f-21236443d1c9" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f67006eb-3f17-46d4-a253-8b5ccb72cde6" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9a48cd1-e7cc-4f70-87bc-6c20b80d6b74" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4ea7e820-97a5-4d28-9787-0c4dd570c34c" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a099c11-f99a-4476-b55b-60ce94a93bc1" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fe088520-43e1-41ad-9136-6ed63a003c16" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb75b510-f58b-4208-912b-61ec20874fdf" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2fd4b4b4-6af6-4166-9d57-942406b5a55a" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d11f5400-4632-40a9-805e-fc073c06358b" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_19cfa5da-6ace-4693-8e98-8b017e7ac1b1" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25e9e52f-4e41-437d-969d-c715615c1a8f" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1ee4ddc-3ebd-4a65-a14f-26e76f741fe7" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fa65db2-2585-4631-ac20-46b61ff6bdee" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_917da941-bbc4-4a41-884e-24733db66a32" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5fbf1b1-f01b-4cac-9be2-08625653b8d1" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3bc403cf-c650-404b-aa4a-5755537e792c" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">200,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and 2023; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab499240-2651-4a96-b26f-f934ea9ea8a4" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_acbbd2d6-7e01-4e7a-901d-0e4058de56f5" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">59,789,275</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a88442d3-722c-4be9-8225-348b9b1a0472" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_af2b9e89-9e84-4287-bc95-f32e0960b3ec" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">24,213,130</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023, respectively</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90ce1e1d-9238-4271-a9c1-35ed6b6ef692" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5fe4e60-0806-4d2a-9cc0-09b34a5f9671" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3">24</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31066fba-87e9-4e98-9a4f-4fd42e67292f" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">417,946</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35f904ea-fd38-49af-8b3a-62a5a56d40f2" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">270,892</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive income</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05553df1-6a94-442e-836b-7e7d634d78a4" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1540b00c-829e-450d-8ceb-5aa35822f80c" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">355,586</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a01c4fed-dd1b-4568-a666-782450b17ec5" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">319,402</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c95f407-baea-464a-a507-34a2119dd4fc" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,446</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97e3f323-9b75-4bfa-8ace-625b5369af86" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">48,486</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8676d41-f96d-42c5-a57e-aec15488d237" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">177,405</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1dafdfcb-42e9-487c-8085-5a7359823239" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,066</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_statements_operat"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> OPERATIONS AND COMPREHENSIVE LOSS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:63.52%;box-sizing:content-box;"/>
     <td style="width:1.9%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:14.34%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.9%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:14.34%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d05347e-9c92-47ef-8743-2cd8d03c7fe7" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,964</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ce8ec93-08e3-4e8b-865a-777e9d4f6b3f" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,312</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b793163-4600-41da-811d-3c3bf5d8c39f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,613</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f48c5164-4ca0-4be3-bd77-0cfaa3bce718" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,688</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2224f0d-179d-4372-8ba3-60333d591745" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70,577</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a90405ac-aec2-4b55-8633-0e10cc5b598c" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9ed97ef-8086-48fe-9281-12d8719e660b" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,924</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc422591-4686-4e72-9306-1c280e23a039" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,674</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_585793ae-896f-4acd-af74-99000ed0a6e3" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30,900</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d97d5fc-367c-438f-b82c-07c2b71be235" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss before income taxes</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_135e4d92-0aa3-4fa7-bcba-60baa4882968" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">35,753</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7b366ea-3a42-48e6-83ba-a1b07bc06b4e" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f7d8c35-56e7-431b-aac0-522fa4bc46ac" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss and comprehensive loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1653b45a-6239-46cf-b46e-becbf1dee545" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21a904bb-85c2-4ed1-a779-f6fd440e2786" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock (As Restated)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47cf2248-dcc4-4e56-8826-707476784fc0" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_23817ed7-b2f8-4646-ac2c-b9654798881f" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.66</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b72f65a8-b7a0-4959-bcc7-9581fd57e8ef" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_20878036-9008-4bb3-a6c8-544a70e6ff29" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">3.74</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98ce297f-72f5-4800-9f25-c04814f7c11b" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_48e48405-be63-43f5-a6b0-cb4f65f7dc60" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">48,543,787</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_749ad1ab-17d7-46fe-9f02-52f97219d59d" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_95aab2d1-e11a-40fa-9a94-b97b4e3155be" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">24,619,197</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock (As Restated)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_621a7e3d-73d9-429b-9175-045e6b26360f" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cc3f500e-089e-491a-87f2-3e028f06bd37" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">36.61</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef495554-bba2-407d-bf93-5c9c3d9de31a" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_23bc2ec8-ea73-45e6-ae6a-3a310fd83c8a" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">207.58</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted (As Restated)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93a77664-9e5b-4e96-9f30-0c74d695aed8" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9ebe5e9f-eeb0-49cf-8bf5-c15f0c30e6ff" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dbd12e6-35be-40ae-8930-e8afeea80567" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0120be94-985d-454a-bb45-64ecdb90c880" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">118,268</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="equity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF CONVERTIBLE STOCK AND ST</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except share data)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:24.305%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.941%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.201%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.701%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:3.961%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.701%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.321%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.321%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.321%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.321%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.901%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="22" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stockholders' Equity (Deficit)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Non-Voting Convertible<br/>Preferred Stock</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series X Non-Voting Convertible Preferred Stock</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional <br/>Paid-In</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated Other Comprehensive</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Stockholders'</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Income</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deficit</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity (Deficit)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2022 (As Restated)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3575f098-81f7-46e7-804e-359c58af10c9" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">117,970</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc07868b-2059-44f2-ad6d-bdd1dc04e178" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">57,378</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce8723d0-5380-4145-8e80-e4714c47a165" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,204</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7fab98e-63b4-439e-a26c-9039b4073a08" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,017</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_523f3521-4cca-4684-af16-aff8532b14bb" contextRef="C_625d824a-477d-49cd-8fc7-67814f7675af" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">13,776,788</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_939f1bab-21ec-41e1-97aa-555a55a9993d" contextRef="C_625d824a-477d-49cd-8fc7-67814f7675af" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_631fb343-f47e-40ef-93fa-1f07f1e2ed34" contextRef="C_f48d3944-f038-454f-abca-5e5d8376ef70" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">226,639</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_002b3409-6378-4410-a21c-70cbacc035df" contextRef="C_da4527f2-1073-4974-bdac-4a2aee446741" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">202,865</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32b306fe-2533-4501-a7b0-05e35d9876d7" contextRef="C_703721ac-e233-4584-a2ed-617913379b0c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,788</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock and pre-funded warrants in connection with the 2023 Securities Purchase Agreement, net of issuance costs</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c84fdb52-f163-4e03-a6a6-7c79d7c91332" contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,730,168</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3727e2b9-78e0-44aa-91cf-34db11dd6bba" contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f9d8551-dceb-49f5-bd7a-c19b6e60ccc1" contextRef="C_0b035996-e88b-4943-8f18-048510a13840" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,008</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3e5e067-a56c-4fa5-b4a1-1fde41bd987b" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,017</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23e0a552-4347-43d8-8ceb-311a3c6d1044" contextRef="C_9a124087-424a-4448-9099-a03821a98b86" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">1,782</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_280e040a-19ca-45e5-b356-65b8aae3a832" contextRef="C_9a124087-424a-4448-9099-a03821a98b86" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">866</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ab54fe7-7dc0-489b-857a-1fabceed0b65" contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">99,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63870446-a010-4fa7-a3ac-45031374c460" contextRef="C_0b035996-e88b-4943-8f18-048510a13840" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">866</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a259d38a-274b-464e-a283-bf92b21e1492" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">866</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with conversion of X</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-size:4.69pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c53e0e6e-8051-459d-a0c7-b5411d4ee912" contextRef="C_70083239-1fc0-451c-a02f-8a7644368a3a" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">7,884</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6829c7e5-bf74-4887-bbd8-359e04ed0530" contextRef="C_70083239-1fc0-451c-a02f-8a7644368a3a" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,835</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d41e7506-7fa4-4d56-9fed-eb0afd8e8c57" contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">437,977</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac92b5c0-4ffc-4fe9-872c-208b556e8b34" contextRef="C_0b035996-e88b-4943-8f18-048510a13840" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,834</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24ad16db-ed6a-4fc2-8006-e84c8c665f1d" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,834</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with exercise of pre-funded warrants</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d09ebac-4866-4719-addf-58e29a05cea5" contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,154,197</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9dadcb91-145d-4996-b635-c620e3e317e9" contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31b34de9-6a17-4422-8468-d737bed3bfc7" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with vesting of restricted stock units</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74a7f9ef-7ad9-464a-82e5-9a7f327598db" contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4a99e88-350e-4c33-8848-f964f4ecdaa3" contextRef="C_0b035996-e88b-4943-8f18-048510a13840" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98d1bdb0-4d36-48a4-a8ac-ccc63debf5f9" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss and comprehensive loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bebf4141-ed42-440b-ad93-34e74eabeac2" contextRef="C_0e3da0b7-263b-4845-ab86-210db978af57" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7835df00-b7f8-475e-a065-380747f29a05" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023 (As Restated)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c735aab-8288-42c4-9177-ce9f6dc66f56" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40e7f747-fe58-4d60-a07f-e99e43df6f00" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_440e6118-ce50-4935-b77f-6ca627c67bf7" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15ec244f-b416-48eb-bd9e-b3198065906d" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdb87fbf-4145-444d-822f-9fc1195c4410" contextRef="C_24109039-0361-41e1-a825-54d3c79fb5d1" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">24,213,130</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a202c385-eadd-4f6f-a132-a9aab3e2b43d" contextRef="C_24109039-0361-41e1-a825-54d3c79fb5d1" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ac1b208-963d-4814-af5e-59f3c309d87b" contextRef="C_985693c8-676f-400c-b568-99fadda31a60" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">270,892</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c09f361-821b-470c-adb6-ec2a1925805f" contextRef="C_aa96c567-6409-4b20-bc86-f6e9b7a82fa9" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">319,402</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c47fcd1-3146-4026-81ec-e12b70308417" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">48,486</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock and pre-funded warrants in connection with the 2024 Securities Purchase Agreement, net of issuance costs</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0fe023ff-1561-4a81-91a0-ce0d0a8eec83" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">13,110,484</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba599328-80a5-4d61-8fbc-a75a09eb0f66" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5eb3f52-69f8-4192-843f-46b1c25216fa" contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,051</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_697b370a-375a-4351-b18b-1c221940b6ce" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,064</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_526ef8b0-8476-43e8-a4a0-2b7405488bb2" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,636,488</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f037c323-1ab5-4a3a-bfde-6738a8cc1006" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ebad9d0-da48-4cdb-bb39-2e70b82d4691" contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf" name="eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,152</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c373bcf-dc60-4454-94c2-a3cc741bd7b5" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,155</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with exercise of pre-funded warrants</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cff72f3-eb50-4d02-b6ff-23f36a44d5a1" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,423,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03c5d9f8-1eab-41ca-b142-161d8c65e22c" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b3e6ab1-b397-4330-b8c8-62b8e20301ff" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs.</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b6f222e-0edb-483a-8661-f4ea996f90cf" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">18,356,173</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d14b5904-d27d-43ca-bfb7-fe540e029788" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04995872-45d5-4447-8594-cfebf714cdbb" contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf" name="eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,515</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f109697a-4cc8-458b-8acf-91524b26f744" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,533</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock Option Exercise</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35f88a6a-22c2-4263-9761-5fa6c76992ba" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d45d1397-b758-468a-98ec-29e2eb61f51d" contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d14e77c-9905-495d-86a1-6b15184d42ae" contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0117da66-8b50-4c9f-94a0-856e088b3127" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">215</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share based compensation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5c20df3-a278-47c3-a5b6-d18906196f18" contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0af11a37-8f53-450c-a9f7-f8e597b612e9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ed5d92b-7cb7-4e7a-8b02-e7d89272d714" contextRef="C_d4a180ea-02bd-45bf-a264-14e6d8208750" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78d80fc7-f4df-4369-9fc0-e0663287d038" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0de407de-f5c2-42eb-bb6a-1f5d9e8d5766" contextRef="C_4fc8440b-61a6-4b7b-8aa2-aa0f00a4ad4f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04ad097f-aa77-433a-8c81-0fdd096a90b2" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024 (As Restated)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b99f4417-a579-424d-bceb-63a23a9cce93" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f2fa3bd-a60c-4424-b4d2-cec537a5a243" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02fd66d6-0e07-49c2-9cb6-7ed9d9eee791" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2bc2a0b-fe81-464d-98ee-c2e5084512ba" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93fd4f86-7387-4116-895c-e42e67f804f7" contextRef="C_f24c5a06-77ee-4dae-8ad5-bc7f8a9e6e82" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">59,789,275</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a44beb69-0c16-4a65-a556-7c94c9c738af" contextRef="C_f24c5a06-77ee-4dae-8ad5-bc7f8a9e6e82" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f6c0556-74ba-47a7-8819-628ad1b0a33c" contextRef="C_112a5426-12b2-4e40-9850-361e43b7c9ab" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">417,946</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b1070c8-3ad8-4f53-a41a-cc2517b799ce" contextRef="C_7736993d-d675-48ac-bc9d-ee436b89e189" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_537d92ee-ed7c-4e39-8951-106de3829470" contextRef="C_a5a3e2c8-59f9-48bb-8c4e-73be100cce2f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">355,586</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01d8fae8-44bf-46d5-b11f-c67a1529739b" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,446</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_statements_cash_f"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED S</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TATEMENTS OF CASH FLOWS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:71.32%;box-sizing:content-box;"/>
     <td style="width:1.48%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.860000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.48%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.860000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows used in operating activities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a016639-ee1c-4857-bfa8-a770abff3001" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab8d7fbe-5963-4ddf-9bb5-f008674892d2" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on lease termination</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef299f73-9286-4a45-be3a-c862945f426b" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:GainLossOnTerminationOfLease" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of operating lease right-of-use asset</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54ecc01e-3c74-4298-bfed-0233cd849092" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">359</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1501f6bb-fb46-4520-af5d-e7280f362b18" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">374</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accretion of investment discounts</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43211058-3745-4785-b65e-731317890a8f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:AccretionOnInvestmentDiscounts" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,799</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_084468dc-3a43-44c8-bb24-0cbbd5912cb8" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:AccretionOnInvestmentDiscounts" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,203</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ecc2efd-66f5-4b7b-a5ee-3c796a8a6f78" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_edbb23c8-9858-4b21-a471-c40d579f4016" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebea1eee-2feb-4592-8d74-02c0f0f00152" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30,900</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07d68179-fe81-498d-b911-a9301eebbbed" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax provision</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0b290b4-6cdf-43c1-8a64-a0399e9405ef" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_279ce85a-df36-4928-8d75-94a61d95f2b9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,298</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52f2b7e0-7b71-458a-b507-da68a07682f0" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,954</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable, accrued expenses and other liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d278986-6f45-473f-9d49-1e817e53acc9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:AccountsPayableAccruedExpensesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,751</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a73ae0f-4b7e-4b3b-83eb-6aa345c2033c" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:AccountsPayableAccruedExpensesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,600</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_859cbd29-4162-4344-8db2-3dd069a2c203" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">339</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9feca346-0c9d-467a-81be-1a198ff61c65" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">363</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d7c1a1a-d80f-41ce-9e84-4d31286164d3" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,271</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c94b1bee-7b87-49e3-a07f-0d33728b810e" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">39,527</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of available-for-sale short-term investments</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee9d1da7-310d-45e6-8a84-3242ca572612" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">156,131</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a355387-d743-4258-a976-81230f86ada5" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,287</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from maturities of available-for-sale short-term investments</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15c17476-9afb-4d4a-8ae8-bc03d8bc98c2" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">85,817</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6c26281-b827-4585-bd11-83625d076220" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4556050e-c3ea-4241-af6f-eff9ac348a78" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">70,314</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6dc2acef-d95f-45c9-b7b1-5003d5a3fdce" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">45,287</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuances of common stock and pre-funded warrants, net</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_325189bf-780f-4d4e-bad2-1cb2cb1d5212" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133,307</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f097b9e8-47ab-4885-9a2f-3e4d29949f45" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,017</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from exercise of stock options</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b7b7654-2c5b-4504-a00d-9e805657d2e2" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">215</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d0b2fd5-804a-4342-8608-6009040a9fd6" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133,522</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04504901-0d6c-4feb-8026-bb23d96e3176" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,017</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net change in cash and cash equivalents</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f3fd69b-af48-40bf-9938-111479b02bc9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,937</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05bad1da-c1bb-4644-b333-bfc54d945810" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">51,797</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at beginning of year</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee01e893-0c49-40fd-b00d-7ae456c2903f" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,612</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36f7e884-2098-4e6d-b81a-63313615c706" contextRef="C_703721ac-e233-4584-a2ed-617913379b0c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,409</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at end of year</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24536c63-e820-45e0-9cd4-fd3e3d8052e9" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,549</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_609c4853-0757-43b7-a74f-ac060c9b9134" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,612</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosure of non-cash investing and financing activities</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash activities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock exchanged for X and X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc2d5bc2-63e7-4aa3-849b-0c14c4087069" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on available-for-sale securities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56b1b134-bed4-49f5-b938-de66454956e0" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:UnrealizedGainOnAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase in operating right-of-use lease asset and liability due to new lease</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f88f995-9e4a-4f91-b0e5-86f0e8e49b6b" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">920</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Settlement of warrant liability into common stock due to exercise</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12a1efeb-0304-424c-97fa-126fdba00ab0" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">446</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_condensed_consolidated_financia"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLID</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATED FINANCIAL STATEMENTS</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f019b7d1-4cfa-40d6-9e5f-1fd46bf3fdde" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 1. Description of Business (As Restated)</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 Ligand (&#8220;CD40L&#8221;) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (&#8220;ALS&#8221;). The Company&#8217;s lead compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that we believe has broad therapeutic potential. Unless otherwise indicated, references to the terms &#8220;Eledon,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;we,&#8221; or the &#8220;Company&#8221; refer to Eledon Pharmaceuticals, Inc. and its wholly owned subsidiaries, on a consolidated basis.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f8b3c584-53ab-4fc3-82b2-07d12a0b6605" contextRef="C_8667a5df-16be-4759-b647-3b7cea2a8885" name="us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 14, 2020</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, Eledon acquired Anelixis Therapeutics, Inc. (&#8220;Anelixis&#8221;), a privately held clinical stage biotechnology company developing a next generation anti-CD40L antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases. The Company maintains its corporate headquarters in Irvine, California and has research and development facilities in Burlington, Massachusetts.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restatement of Previously Issued Consolidated Financial Statements</span></p><p style="text-indent:5.393%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.111%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the course of preparing the Company&#8217;s Condensed Consolidated Financial Statements as of and for the three and six months ended June 30, 2025, the Company reassessed the rights and preferences of its Series X and Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> non-voting convertible preferred stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b0622d5-758f-46cd-beb6-91cb8794f54a" contextRef="C_8bba3766-4964-4ab7-92aa-e8434203d2c8" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ab9818e0-05de-4392-a08f-23729e24d3a8" contextRef="C_482d4d7b-2e9a-44ff-9fde-c5756f5cc547" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value (&#8220;Preferred Stock&#8221;), and concluded that, because they are substantially identical to those of its common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd8bbebe-250b-4101-8ad3-530f794f1f91" contextRef="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value, the Preferred Stock should be treated as a separate class of common stock for purposes of calculating earnings per share in accordance with </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounting Standards Codification (&#8220;ASC&#8221;) 260-10, &#8220;Earnings Per Share.&#8221; As a result, the Company determined that it should have presented earnings per share under the two-class method in prior reporting periods.</span></p><p style="text-indent:5.391%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, in connection with this reassessment, the Company concluded that it had incorrectly classified the Preferred Stock as permanent equity in the consolidated balance sheets. The Preferred Stock includes a provision that, upon the occurrence of a fundamental transaction (which includes a third-party tender or exchange offer) in which more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d38b581e-488c-4ff5-a1ad-6b63f8e73123" contextRef="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68" name="eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> percent of the common stockholders receive cash or other assets, the holders of Preferred Stock, upon any subsequent conversion, are entitled to receive the same form of consideration, even if they did not participate in the original transaction. Because this feature may result in settlement in cash or other non-equity consideration upon an event outside the Company&#8217;s control, the Preferred Stock does not meet the criteria for permanent equity classification and is instead classified as temporary equity under ASC 480-10-S99-3A. Although a tender offer is not considered probable as of the current reporting date and redemption is not deemed probable, the existence of this provision requires classification as temporary equity. The Preferred Stock is not subsequently remeasured to its redemption value because redemption is not considered probable.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain consolidated financial statements and financial information are presented herein as restated. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">See Note 12</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restatement of Previously Issued Consolidated Financial Statements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for further information.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:nonNumeric id="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_74ed45d1-a61d-4fe9-994b-e0b3e8051eb9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5707aec0-808f-4550-962b-eb7a8d2b04ec" contextRef="C_6e372f90-3029-4434-82dd-cdd9e2a4e75d" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" unitRef="U_pure" scale="-2" decimals="INF">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#8220;Otic&#8221;). Otic owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28dc08fe-94af-4905-a339-eff05f03490d" contextRef="C_a32ed886-8fef-46ca-80f4-2e27d332c237" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" unitRef="U_pure" scale="-2" decimals="INF">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#8217;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#8217;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d1035bc6-2bc3-405b-8030-cd3eac3e3445" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#8220;ROU&#8221;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_27b32f83-4a0c-4f93-843e-8dfc727c22e7" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a3cd47bf-8a10-40a6-802a-65e17b64c7fa" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments with original maturities of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_339aaf1f-bf51-4ada-b267-8c1746678ef7" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months or less</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> when purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds, U.S. government securities and U.S. government agency securities. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_d717e096-86a6-4d1f-8e22-6f997654b534" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:RisksAndUncertaintiesPolicyTextBlock" escape="true" continuedAt="F_d717e096-86a6-4d1f-8e22-6f997654b534_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all of the Company&#8217;s long-lived assets were located in the United States. The Company&#8217;s products will require approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#8217;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e_1" continuedAt="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_d717e096-86a6-4d1f-8e22-6f997654b534_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_54585fe9-f0a9-42ed-b446-089772ba0b86" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reportable Segments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#8217;s Chief Executive Officer and the Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d631344-f273-4fd8-9599-76948093dcdf" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9e3bd518-2fd9-4f41-8a2d-b5bd3875f7f0" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Long-Lived Assets</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64df13c3-cb22-47fa-a939-949ba21b9ad4" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_45b04960-66bd-45a6-9e5c-4d932c6a7d17" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairments of long-lived assets have been identified during the years presented.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ec021d43-66c3-4ab5-bccd-3429aa1e3683" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:InProcessResearchAndDevelopmentPolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-Process Research and Development</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts allocated to in-process research and development (&#8220;IPR&amp;D&#8221;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#8217;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;D was impaired for any of the periods presented.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_ea377e56-5321-4fe4-863a-4bf008c82e02" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true" continuedAt="F_ea377e56-5321-4fe4-863a-4bf008c82e02_1"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e_2" continuedAt="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_ea377e56-5321-4fe4-863a-4bf008c82e02_1"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#8217;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_cf38e618-0730-474b-a5d0-8841d747e7a7" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true" continuedAt="F_cf38e618-0730-474b-a5d0-8841d747e7a7_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share (As Restated)</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net loss per share are calculated using the two-class method in accordance with ASC Topic 260, Earnings Per Share. The two-class method allocates undistributed losses to the Company&#8217;s outstanding common stock, and the Preferred Stock, based on each class&#8217;s proportionate share of the total weighted-average shares outstanding. Since the Company has never declared dividends, net loss and undistributed losses are equivalent.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. The process is used for both common stock and Preferred Stock. As the rights and preferences of the Preferred Stock are substantially identical to each other, they are considered a single class of common stock for earnings per share purposes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#8217;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023 includ</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c9c8210-e1fc-4dec-be2a-df6e439755b1" contextRef="C_8a905dd9-947f-4771-b0bd-22e599ecb244" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">12,443,755</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c886242-20fd-41a3-b71e-1e72364329b2" contextRef="C_2cce5c4d-219e-4cc1-af1c-7a19e05a994d" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">5,776,270</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> respectively, shares underlying pre-funded warrants to purchase common shares. </span><span><ix:nonNumeric id="F_b3b1d995-4d25-4b66-b36e-2fb4842e5a95" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true" continuedAt="F_b3b1d995-4d25-4b66-b36e-2fb4842e5a95_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c06ddc19-43da-4281-8bee-07d2d760ff8b" contextRef="C_cded1be0-5d08-4e82-82d6-d067b4958eae" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), these shares are deemed to be issued for purposes of basic earnings per share.</span></ix:nonNumeric></span></p><div><ix:continuation id="F_b3b1d995-4d25-4b66-b36e-2fb4842e5a95_1" continuedAt="F_b3b1d995-4d25-4b66-b36e-2fb4842e5a95_2"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The calculation of basic and diluted earnings per share for our common stock and Preferred Stock is as follows:</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b3b1d995-4d25-4b66-b36e-2fb4842e5a95_2"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:60.06%;box-sizing:content-box;"/>
           <td style="width:1.86%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:16.279999999999998%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:1.86%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:15.940000000000001%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(As Restated)</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb362159-2cde-41f7-8e42-5ef5549ea73c" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e24009e4-3dc3-46b7-8d09-f26a51fe820d" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">48,543,787</ix:nonFraction></ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e0afbd8-6c3e-40d3-b617-45475b758f5e" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7c2ab5cf-1959-4e90-ada0-c5ce700e99fa" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">24,619,197</ix:nonFraction></ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1f3be3a-ec11-49e2-b013-8bd2e045357c" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4638c5f4-6b7a-4921-8d04-32385a54ca1a" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02a6b408-af9d-4381-96fc-718aec6aa4d8" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_19c32688-d6a9-49dd-8bd0-8d4c163b7d3d" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">118,268</ix:nonFraction></ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss used in the calculation of basic and diluted loss per share</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de387fb1-cf9e-4e64-934e-b68664a936f2" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_825bb0da-ed3a-4666-8be9-330877640548" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss available to common stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d459bfe-79b1-4052-bc45-70b0b4ed3a20" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">31,992</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_638055b4-6721-4571-b167-e29c8073b7de" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">91,987</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, common stock, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9ad3498-6e49-459a-a2e0-b8c09d55012f" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1e3e3c58-56e0-4852-8e21-2bf288119443" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.66</ix:nonFraction></ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e24d2a78-7632-4682-96e4-e06f0fffe045" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6136d952-c019-4854-a3a8-39733003ae00" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">3.74</ix:nonFraction></ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss available to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed6cad2e-a38b-4355-ba8c-0d82e11b2b33" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,192</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_435ca709-3d7e-4a53-85cc-ebfbb216ecc6" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">24,550</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72942157-97b5-4826-a39e-82a22d69d8e5" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_950e8dec-fc1e-4496-820e-599fa70deb58" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">36.61</ix:nonFraction></ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86903f68-7bfe-4f9a-8aec-063bb6cd061c" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_536ba4c4-0660-44b9-9777-2501ee7b3730" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">207.58</ix:nonFraction></ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
         </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e_3" continuedAt="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e_4"><div><ix:continuation id="F_cf38e618-0730-474b-a5d0-8841d747e7a7_1"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. </span><span><ix:nonNumeric id="F_12193c9a-b38d-4f10-b14b-664ad0e5d231" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true" continuedAt="F_12193c9a-b38d-4f10-b14b-664ad0e5d231_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_12193c9a-b38d-4f10-b14b-664ad0e5d231_1" continuedAt="F_12193c9a-b38d-4f10-b14b-664ad0e5d231_2">
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:57.76%;box-sizing:content-box;"/>
           <td style="width:1.72%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:17.4%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:1.72%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:17.4%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options outstanding and other equity awards</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0185f435-99f2-4a2c-9d76-7ff82cf836af" contextRef="C_63e0c2a9-691e-4547-a6ac-0d3fdf91d1aa" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,007,789</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e98d034-dae1-4dc0-8078-55bc3a1f1aef" contextRef="C_e94a88c0-62d2-43ee-872d-543df3558f56" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">14,909,155</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common and preferred warrants outstanding</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09e11daf-af09-4e1c-8c94-6912da8c555a" contextRef="C_c71a399f-d8f4-4adf-af71-acd5010523cd" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,567,751</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37900f6b-4dc1-420b-8eda-316731cca7f5" contextRef="C_bc089e60-cdab-4f8a-b783-246e7d7a6af1" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,577,332</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89d6ec8b-9a50-476e-965d-46bad5fa938f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">24,575,540</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc0a8318-b7e9-4548-8715-48b6812f719a" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">33,486,487</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></ix:continuation></div></ix:continuation></div><div><ix:continuation id="F_12193c9a-b38d-4f10-b14b-664ad0e5d231_2"></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a28d014b-4249-4ed8-8416-168c2867f5c3" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_256e544c-65a9-4eb5-b112-495257912c89" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true" continuedAt="F_256e544c-65a9-4eb5-b112-495257912c89_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#8220;not more likely than not&#8221; that a tax benefit will be sustained, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a894d82-d2de-44cc-883c-175723871738" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. </span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4e0f3a39-0db4-4368-a387-7bc28b56a840" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" continuedAt="F_4e0f3a39-0db4-4368-a387-7bc28b56a840_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">second step is to measure the tax benefit as the largest amount that is </span></ix:nonNumeric></span><span style=""></span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_256e544c-65a9-4eb5-b112-495257912c89_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4e0f3a39-0db4-4368-a387-7bc28b56a840_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">more </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47949667-c7a2-4f4f-ae44-7ea3edf96f0a" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:IncomeTaxExaminationLikelihoodOfFavorableSettlement" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% likely of being realized upon settlement.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Notes to Financial Statements.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b7d3205-54b1-421b-b676-35da0d360d0b" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:StockholdersEquityPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for issued warrants either as a liability or equity in accordance with ASC 815-40 Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (&#8220;ASC 815-40&#8221;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_463c1cf0-abff-4464-b663-53969ee707b6" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Adopted Accounting Pronouncements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1158294c-babc-432f-973f-d300e89afeb5" contextRef="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">early adoptions</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> permitted. The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_16ef8141-b1c6-47ca-ad00-e41383e8166b" contextRef="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ASU 2023-07, effective </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_508ce448-47ca-48f3-9558-3c39d4e498e3" contextRef="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7712dc1d-a9a4-4011-822b-bcc63ba16768" contextRef="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t impact the consolidated financial statements. See Note 10, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for disclosures related to the adoption of ASU 2023-07.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements Issued But Not Adopted</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#8217;s present or future financial position, results of operations or cash flows.</span></p></ix:nonNumeric></div></ix:continuation></div><div><ix:nonNumeric id="F_e721086c-0fcc-4ce2-83d7-36ebe8c140a8" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock" escape="true" continuedAt="F_e721086c-0fcc-4ce2-83d7-36ebe8c140a8_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 3. Short-Term Investments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The objectives of the Company&#8217;s investment policy are to preserve principal, meet the Company's liquidity requirements and safeguard invested funds. Short-term investments consist of U.S. government securities and U.S. government agency securities. The Company has classified these investments as available-for-sale securities, as the sale of such investments may be required prior to maturity to implement management strategies, and therefore has classified all</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e721086c-0fcc-4ce2-83d7-36ebe8c140a8_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">investments with maturity dates beyond three months at the date of purchase as current assets in the accompanying consolidated balance sheets. Any premium or discount arising at purchase is amortized and/or accreted to interest income as an adjustment to yield using the straight-line method over the life of the instrument. The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts to maturity. Investments are reported at their estimated fair value. Unrealized gains and losses are included in accumulated other comprehensive loss as a component of stockholders' equity until realized.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1753d653-be46-4852-9a45-857b5520d354" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of short-term investments, which were classified as available-for-sale securities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:32.294%;box-sizing:content-box;"/>
         <td style="width:1.8%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.577%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.14%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.577%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.32%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.577%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.14%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.577%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c55d5ac-7d24-40e4-8b7a-b202dea57199" contextRef="C_869cb76b-dd81-4314-8818-8ae015c49078" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,603</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b7dd9af-8543-4413-b863-6ef34c11e4ff" contextRef="C_869cb76b-dd81-4314-8818-8ae015c49078" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd543d03-1618-4b59-bf3f-233d7810a5eb" contextRef="C_869cb76b-dd81-4314-8818-8ae015c49078" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc8bbb18-5673-4a0e-8b63-ccb959e9b773" contextRef="C_869cb76b-dd81-4314-8818-8ae015c49078" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e365deb-3766-4ea2-8506-3426dfadc980" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,603</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_798e55ed-4a24-48b6-bbf9-1727a753b681" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ffa60f7e-ce36-488c-9ef6-fd3c9e0a84dd" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f11e2ce9-1f81-46fd-899e-ec6b26375ea4" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4cc6622-8b5d-4870-977c-8f453da0c626" contextRef="C_5953effb-3051-4f13-ace1-184eb0e02dcb" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,213</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c96f82b9-4783-4277-a9e2-c07564f385c1" contextRef="C_5953effb-3051-4f13-ace1-184eb0e02dcb" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6cc13983-a4be-4c6d-a8e3-025de848110e" contextRef="C_5953effb-3051-4f13-ace1-184eb0e02dcb" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_861f1619-e2e9-4d9c-b202-50357c8f627c" contextRef="C_5953effb-3051-4f13-ace1-184eb0e02dcb" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,213</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d76b504e-1373-4b8a-b97e-8ddd26b44d65" contextRef="C_79dd679d-8ad0-49ca-9c6c-b276bb345850" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,277</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e94f390-9eab-44d2-95f5-18893496ba5d" contextRef="C_79dd679d-8ad0-49ca-9c6c-b276bb345850" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a64f960-7c77-464f-80a1-03b1007ed496" contextRef="C_79dd679d-8ad0-49ca-9c6c-b276bb345850" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fbac446-b45e-47b9-88ff-f36dff4cd56c" contextRef="C_79dd679d-8ad0-49ca-9c6c-b276bb345850" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,277</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a1e3dce-8dc3-467c-916b-9761a37b4dee" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca980ade-71d1-4d60-b820-de814880b19c" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b1d1e31-a8da-4e3f-98a2-cea8420139ba" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44218f71-c063-4280-8d6b-7b0ca5c66d79" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All of the Company's available-for-sale securities have a stated maturity of less than one year.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><div><ix:nonNumeric id="F_cff65c21-ed80-409c-96d8-1dd3cb30fb3e" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:FairValueDisclosuresTextBlock" escape="true" continuedAt="F_cff65c21-ed80-409c-96d8-1dd3cb30fb3e_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4. Fair Value Measurements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities are recorded at fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies fair value measurements using a three-level hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1&#8212;Quoted market prices (unadjusted) in active markets for identical assets and liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2&#8212;Observable inputs other than quoted market prices included in Level 1, such as quoted market prices for markets that are not active or other inputs that are observable or can be corroborated by observable market data.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, including certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. These fair values are obtained from independent pricing services which utilize Level 1 and Level 2 inputs.</span></div></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_cff65c21-ed80-409c-96d8-1dd3cb30fb3e_1" continuedAt="F_cff65c21-ed80-409c-96d8-1dd3cb30fb3e_2"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5113d52e-845e-48b5-8fc6-d37155603a26" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.387%;box-sizing:content-box;"/>
         <td style="width:1.78%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.323%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.12%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.323%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.323%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.12%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.323%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c468a8d-2261-4afc-acc9-57418760abc7" contextRef="C_5fed5aba-bded-4202-86e4-abacffb2f839" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0d0e814-27ff-43a6-b158-af5792ad3c85" contextRef="C_21d6ff86-6d7f-4b9d-adfb-5a4f1d7aa8b8" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasuries</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_198ccddc-0ab8-4f61-9bf0-52faf2bef5d0" contextRef="C_95a8ebd2-ec0a-42f8-b597-f3c09a2afecc" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,464</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ff7770f-d127-4854-a4f9-0b4d9e72bb48" contextRef="C_37cfa2dd-f2e8-40b3-b4ed-4aaa93f648d9" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,464</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ceea0d5-45d7-49a3-8767-b25475dda279" contextRef="C_1799d415-8c33-49ff-820b-a0512ecbe050" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67e1437a-e79e-4818-94d4-6b8a0cf69b33" contextRef="C_08679ab6-cc43-46fb-afd1-83c5b1aabc73" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,464</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b2aa3b2-16b5-4d85-b513-57e0fdfccefa" contextRef="C_a02b7bbf-5219-43e5-a35f-53b985449b45" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,679</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f200c814-70ac-474e-af67-0b75857285a4" contextRef="C_48ea6ed9-0d04-4f10-a10e-a2919aae308d" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4c84050-ab48-457f-b306-06e58f02a24d" contextRef="C_50e1d626-a270-4890-bdf3-98ed401c6ece" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18f5fb16-4b5a-484d-b3e3-135ad607bba4" contextRef="C_08679ab6-cc43-46fb-afd1-83c5b1aabc73" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b1f5e8a-9a20-4165-9b0a-18ac7cba212b" contextRef="C_a02b7bbf-5219-43e5-a35f-53b985449b45" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16ce117e-604f-40b5-a12d-526553f2d1cd" contextRef="C_1799d415-8c33-49ff-820b-a0512ecbe050" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3133d5a9-ae60-4576-b8b5-0b6e8fb7d6f4" contextRef="C_08679ab6-cc43-46fb-afd1-83c5b1aabc73" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">137,093</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5742a498-c912-4c23-819c-8f4d91731192" contextRef="C_a02b7bbf-5219-43e5-a35f-53b985449b45" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138,308</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.387%;box-sizing:content-box;"/>
         <td style="width:1.78%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.323%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.12%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.323%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.323%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.12%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.323%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_553ac30b-c7c0-42cc-89db-efca565e5c1b" contextRef="C_fcab1302-ac86-4137-9866-3e47197201e3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06e44c3a-4b77-4f2a-ad40-dc604a5177a5" contextRef="C_f5e378e9-ea4d-4446-a3d6-8653372fe095" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eeefdfd0-986e-441c-8117-8b9f0637f641" contextRef="C_fcf8616b-2c3d-4413-a5ce-5cd91ad0ca6f" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12cb7248-0f6e-4d6f-a0eb-b7402e528375" contextRef="C_32469e8b-bd12-46a1-aa1e-6207f9cfe051" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe1921bc-ea0e-4003-90d0-f634b49a24eb" contextRef="C_9d1c5679-7ad3-40bf-a3c6-7a10ff14887e" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,213</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb6252d5-aea3-4446-b89c-87a02941b14f" contextRef="C_0723a7a1-cd73-4940-a506-fa467676eccd" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,213</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adc4f7d6-28fb-4cff-90e4-b8e38e18bbbd" contextRef="C_19e1b622-4072-4fc0-a0fc-410862aa012d" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,277</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_778372a0-a004-4a7d-8fee-50ba444e705e" contextRef="C_fef3fa93-e31c-43ff-af41-915dfb55b4a7" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,277</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0f29e01-b159-4428-b1cd-739b470d3e24" contextRef="C_44e95282-fdaa-4791-b948-243de3cf859c" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8203d4af-8d4d-439a-bcf4-59e130c7cf25" contextRef="C_32469e8b-bd12-46a1-aa1e-6207f9cfe051" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a19f403e-83cd-47d0-a905-ca00cbb5d6c4" contextRef="C_fcf8616b-2c3d-4413-a5ce-5cd91ad0ca6f" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c0311cd-fb2c-4dbd-89e4-9fb46693a6fc" contextRef="C_44e95282-fdaa-4791-b948-243de3cf859c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f23b5f23-0e9f-4cae-88eb-ed57a38dbb5a" contextRef="C_32469e8b-bd12-46a1-aa1e-6207f9cfe051" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,736</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0737bea5-99a7-4511-8e66-44f703320d25" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's warrant liabilities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:27.514%;box-sizing:content-box;"/>
         <td style="width:6.879%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.758000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:3.199%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.758000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.46%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.498000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:3.439%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.498000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89f95c1f-5e63-4c84-879a-9f06fa499717" contextRef="C_6c58a12b-7549-4626-92cd-993c292715da" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,865</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9d7891b-60e2-4cfd-a0d5-887627faeff4" contextRef="C_30f84d62-e30b-473f-9c61-8ef1e1832085" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,865</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:27.514%;box-sizing:content-box;"/>
         <td style="width:6.879%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.758000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:3.199%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.758000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.46%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.498000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:3.439%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.498000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d63d336-9024-4868-a5b7-c9511113985d" contextRef="C_2bbbd4e0-640b-45ce-a5fe-e896670755b5" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba65a803-9485-4897-a68e-01890b244369" contextRef="C_976894d0-7795-4a81-a79e-bce2709115dd" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_cff65c21-ed80-409c-96d8-1dd3cb30fb3e_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1848f1d9-1f4f-42c8-b503-80c484732999" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.2%;box-sizing:content-box;"/>
         <td style="width:6.48%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:28.32%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecf57b29-6072-4e8e-b308-9af4c27a077d" contextRef="C_976894d0-7795-4a81-a79e-bce2709115dd" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21338f6a-dc25-4aaa-8a15-01d3d76802ae" contextRef="C_834dcb4b-a7e6-4a63-a26e-6cacde80edc9" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30,900</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Settlement of warrant liability</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ed7b4a4-3ab3-4e7a-b5cd-ba76b3b099c6" contextRef="C_834dcb4b-a7e6-4a63-a26e-6cacde80edc9" name="eldn:SettlementOfWarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">446</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9da32012-7fca-4815-aa61-22bde4fb31f6" contextRef="C_30f84d62-e30b-473f-9c61-8ef1e1832085" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,865</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes the reversal of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1938e13a-1610-4f97-8b40-e292a24fd6a1" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">59.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in warrant liabilities associated with the Subsequent Closing Warrants (as defined in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), which expired and or settled as of year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_565f9814-fef3-4efb-83c1-1157ca46e8f2" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 5. Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d0fc516-21b3-47a3-ab69-d62d2aff2eb3" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:56.709%;box-sizing:content-box;"/>
         <td style="width:2.32%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:16.697%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.32%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:17.956%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1036d0fd-f1e8-4c12-a3ec-f62dd57e17bd" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:PrepaidClinicalExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,915</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a06cd4e6-ae1f-417e-863f-ac8ed6dcebd8" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="eldn:PrepaidClinicalExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,128</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid insurance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b83cba81-2dce-4031-a4b2-6aa1af663464" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">693</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48cd9820-6cab-46e3-8111-60caae7660b1" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">624</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_307a051b-0337-4946-93a7-4e5941979a12" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">215</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b77129e-5b0d-4731-b501-ef1594e3ed6a" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">185</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa491fb5-ba3e-42ee-85df-1b8bec0761f4" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">729</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35f0ab61-f8a0-4cee-b953-a1f95278772e" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">90</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d90bb84-dce7-416f-bcf5-362d230f2dcb" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,552</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_068c2eef-a1bc-4c5a-933b-6c7e4fa40519" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,027</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0b855a18-5293-402b-984a-850826beb250" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other liabilities consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.08%;box-sizing:content-box;"/>
         <td style="width:2.34%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:18.119999999999997%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.34%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:18.119999999999997%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01857d0b-8fbb-4b9f-8be8-bc2fb9cb05b7" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:AccruedClinicalCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,642</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4cee5a07-eda5-4b31-9b7f-932532b1544e" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="eldn:AccruedClinicalCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">451</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and related expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8eaa0894-2bf0-4cbc-9edf-4bdc8f5634a4" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:WorkersCompensationLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,601</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ced85266-fade-498d-bd4d-2bf5038c7ca9" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:WorkersCompensationLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,003</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c441e72-8bbf-4286-bda1-c644c62d4f1e" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1663e0c-da17-4537-8339-f7ea50297f91" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c369cb4d-3858-4d04-b896-882c3f1ccacd" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a1786b2-3ee9-403a-9d2f-21dd761a79ed" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f12662bf-2c68-42c3-9570-90d749ae74af" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,430</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24a385b7-f6ac-4319-960d-91f8ee9c8074" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,545</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_07046c25-12dd-45bb-83f3-df514a6a67a0" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_07046c25-12dd-45bb-83f3-df514a6a67a0_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases office space under various operating leases. Total rent expense for all operating leases in the consolidated statements of operations and comprehensive loss was approximately</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9cc2888b-7212-4e28-8321-e478491d07e8" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_91663755-92b8-4a3b-9680-75c1b9d3ff07" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for each of the years ended December 31, 2024 and 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 19, 2024, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8792d787-5934-44b7-9482-8ce7f19a63f8" contextRef="C_d3633a35-1914-4b59-95c7-b92462feeda6" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38-month</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6502260-34d2-4430-910d-e86c9ed32c56" contextRef="C_75369811-d279-4dfd-81ed-953e9c67bff2" name="eldn:AreaOfOfficeSpace" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">5,817</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Irvine, California, that expires on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_670c76ed-289f-46f9-b28d-630ea038d06e" contextRef="C_75369811-d279-4dfd-81ed-953e9c67bff2" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2027</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Irvine Lease Agreement&#8221;). On April 19, 2024, in conjunction with the Irvine Lease Agreement, the Company terminated an existing operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09459e19-d780-4a20-9b33-9641314240af" contextRef="C_b10e5573-542e-4cad-822f-93a7ae68952b" name="eldn:AreaOfOfficeSpace" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">5,197</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Irvine, California, that was set to expire on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ad8d5c69-6a7a-4e8e-90c7-876dd324f071" contextRef="C_7aba1847-593e-4b0d-b134-5757cbcbdffb" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On April 19, 2024, the effective date of the Irvine Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3334cc4e-e6c1-43d5-b30f-d449ad234431" contextRef="C_d3633a35-1914-4b59-95c7-b92462feeda6" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_07046c25-12dd-45bb-83f3-df514a6a67a0_1" continuedAt="F_07046c25-12dd-45bb-83f3-df514a6a67a0_2"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 4, 2024, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_711a92a6-3ece-485d-bdb3-7cbe1dae00d5" contextRef="C_6312f08b-35c4-4f52-9485-e4c1a9839b7c" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36-month</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_126abc90-e3e7-4170-9579-2e4a689b55ac" contextRef="C_254d6b43-9430-4433-b644-3ad4de1829ee" name="eldn:AreaOfOfficeSpace" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">6,138</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Burlington, Massachusetts, that expires on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7fc609e2-55c1-4cc2-91bb-d4c023546698" contextRef="C_254d6b43-9430-4433-b644-3ad4de1829ee" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 21, 2027</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Burlington Lease Agreement&#8221;). The existing lease expired on November 20, 2024. On November 21, 2024, the effective date of the Burlington Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b51113ba-8f01-48cc-8fd7-760b77db1fe3" contextRef="C_9a69091e-a043-4048-aac2-1fd5f048fc3f" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_50ce70b3-ea02-4aee-b1b2-5068a8f8f9e2" contextRef="C_9a69091e-a043-4048-aac2-1fd5f048fc3f" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determines if a contract contains a lease at inception. Our office leases have a remaining term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_15ef3a70-4c5b-4944-9715-31c2b91a3a5c" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:LesseeOperatingLeaseRemainingTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3 years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and do not include options to extend the leases for additional periods.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities as adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, we estimate incremental secured borrowing rates corresponding to the maturities of the leases. As we have </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_107fbe02-f35e-4c34-9875-72619b0e81a4" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding debt nor committed credit facilities, secured or otherwise, we estimate this rate based on prevailing financial market conditions, comparable company and credit analysis, and management&#8217;s judgment.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our leases contain rent escalations over the lease term. We recognize expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we do not currently have any lease agreement with lease and non-lease components, we elected to account for lease and non-lease components as separate components.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term disclosures include only those leases with a term greater than one month and 12 months or less, and expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less, that do not include an option to purchase the underlying asset that we are reasonably certain to exercise, are not recorded on the consolidated balance sheet.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6bafce89-c748-4481-bf2f-59fcd9276c8a" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total operating lease expense were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.833%;box-sizing:content-box;"/>
         <td style="width:1.88%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.203000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.88%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.203000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66d34ea2-f928-4a58-bdc6-436fa0794584" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">407</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49a49638-7a08-445e-b3ef-5051791021ea" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">400</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a) </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Includes variable operating lease expenses, which are immaterial.</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3c1c914b-4b0d-48b6-9e4b-7483679bec9d" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other supplemental cash flow information related to leases were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64%;box-sizing:content-box;"/>
         <td style="width:2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.299999999999999%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.84%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.860000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of lease liability:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f04c557-31eb-43b7-86e1-e23b6105b5da" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">378</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0483af9-81a4-499e-8e39-f213f2399842" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">378</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.433%;box-sizing:content-box;"/>
         <td style="width:1.38%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.403%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.38%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.403%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_89e00e45-97b4-44a3-9846-05258da43da2" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_20cde874-ab79-4f4a-8082-1747a6151bd7" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7ef1b14-9eeb-4c2b-a277-f426041b99ba" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4">9.46</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c2a7779-99ad-446b-8e1b-6d4162ccc861" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4">2.49</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_07046c25-12dd-45bb-83f3-df514a6a67a0_2" continuedAt="F_07046c25-12dd-45bb-83f3-df514a6a67a0_3"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_302e0426-06f8-400e-8ff4-65a4e354dd95" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:70.514%;box-sizing:content-box;"/>
         <td style="width:2.941%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:24.544999999999998%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ab70cd0-2cf7-4eb0-9932-74e7e2fd4507" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">391</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f31200c-e4df-4b01-aeb7-95c6abffdbd0" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">403</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78f8c6dc-1883-4a3e-8abb-4d1be8300afa" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">293</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9539bf1-fe1e-412e-8fdc-bdb4b76ffcb2" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,087</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less imputed interest</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_762840ad-fddc-458a-9a9e-ab5f34c61259" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of lease liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a07d47d1-0bf6-4515-8c3c-ddf8a054333a" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3">954</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less current portion of operating lease liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c645e57-31c8-4fae-b001-2be05a9f680b" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">314</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-current operating lease liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31f3ab52-7ff3-4042-aff1-0b2468c2f9ad" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">640</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Grants and Licenses</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ALS Therapy Development Foundation, Inc. License Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2015, Anelixis executed a License Agreement (the &#8220;Agreement&#8221;), which is an exclusive patent rights agreement with ALS Therapy Development Foundation, Inc. (&#8220;ALS TDI&#8221;) for certain patents and &#8220;know-how&#8221; of ALS TDI. This agreement continues until the licensee terminates the agreement with ninety days written notice. The Agreement requires license fees payable to ALS TDI, subject to the achievement of certain milestones and other conditions.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The first and second milestones of the Agreement are the dosing of the first subjects in a first toxicity study in non-human primates and the dosing of the first patient in a Phase I Clinical Trial, respectively. Both of these milestones were achieved as of December 31, 2018 and 2017. The fee due for the achievement of these milestones was</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e62e8835-104a-4348-9462-9a8341c1f58b" contextRef="C_c208ba17-2b6e-4d20-979a-92018e7e32ca" name="eldn:FeeDueForMilestonesAchieved" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_5b43aec2-b3da-489f-ad25-07465aca9f74" contextRef="C_91faf8d0-851e-4099-aa01-277d6ae86c25" name="eldn:FeeDueForMilestonesAchieved" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million each. During 2018 and 2017, Anelixis issued $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41e62d48-2e57-4554-ad20-875313011e2b" contextRef="C_77fcb03b-d40c-4c83-a674-4d30ef20d74d" name="us-gaap:StockIssued1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1329e3c5-1c15-4f08-b034-3bba8a0545e9" contextRef="C_01c9b5c7-df17-42c2-ae7f-2df53dfe3244" name="us-gaap:StockIssued1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million wort</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">h of its common stock in lieu of making a cash payment. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_314d10fd-4fc3-4355-9510-6172cca90b41" contextRef="C_97d0a02e-f66e-4785-bdd9-f6ec23959807" name="eldn:NumberOfMilestonesAchieved" unitRef="U_Milestone" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_d3a67182-939d-4efd-94b6-58ea47c9e0a3" contextRef="C_45654a12-fdcb-4ab8-aa38-1e9adb0677f1" name="eldn:NumberOfMilestonesAchieved" unitRef="U_Milestone" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> milestones achieved during </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 or 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Agreement was amended and restated in February 2020, and a first amendment to the restated license agreement was executed in September 2020. As amended in September 2020, the remaining milestone payments for a first licensed product total</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ada0c7d-733c-46dc-9254-82c5e37c1d88" contextRef="C_a3a07715-3a73-4dad-aa92-b1e0504bed50" name="eldn:RemainingMilestonePaymentsForFirstLicensedProduct" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In the event that the Company develops a second licensed product, the Company is obligated to pay up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8eb2d0d-1267-40bd-8b6b-9afb3a65f37b" contextRef="C_d0e34266-9d94-4045-9e3a-77a1916c58ff" name="eldn:RegulatoryMilestonePaymentsObligation" unitRef="U_USD" scale="6" decimals="INF">2.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional milestone payments.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the milestone payments, the Company is required to pay ALS TDI an amended annual license maintenance fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47eec310-424c-443a-b776-805cd1173ce4" contextRef="C_a101b2be-54a1-4e3e-a107-2e740e2bd083" name="eldn:AnnualLicenseMaintenanceFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million beginning on the earlier of January 1, 2022, the Company&#8217;s first sublicense, or change in control, as defined in the Agreement. The Company has made a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_301b9681-1047-4de2-bd55-21d3b52d7fae" contextRef="C_97d0a02e-f66e-4785-bdd9-f6ec23959807" name="eldn:AnnualLicenseMaintenanceFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fa961710-ed1b-4898-b2cd-99893160abc9" contextRef="C_45654a12-fdcb-4ab8-aa38-1e9adb0677f1" name="eldn:AnnualLicenseMaintenanceFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_db98a9ac-aecc-4fe6-8862-3fb83337f1e9" contextRef="C_814f6c12-39d8-48c7-97a5-4f0838b03063" name="eldn:AnnualLicenseMaintenanceFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million annual license maintenance fee in each year since 2022.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, the Company is required to pay ALS TDI fees based on reaching certain levels of annual net sales of any product produced with t</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he patent rights. A royalty in the low single digits will be due on aggregate net sales. Upon the first calendar year of reaching $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_889ed867-3f2f-46ef-ae8f-d6cf8df6cd07" contextRef="C_4815e24c-4159-4500-b666-85aff53dcfc5" name="eldn:AggregateNetSalesAchievement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">500.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in aggregate net sales, the Company will be required to pay ALS TDI a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de1634fc-28a2-451d-997f-a3b4bd493611" contextRef="C_46b5adb0-3c28-4e8a-a89e-80ec27d1c833" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Upon the first calendar year of reaching $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc72bfb1-1169-4def-857a-758f435a7de9" contextRef="C_e6ea7a2e-1ed7-4d2e-84d7-ac031499af66" name="eldn:AggregateNetSalesAchievement" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion in aggregate net sales, the Company is obligated to pay ALS TDI a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a850fa1-e497-499a-b953-57c2d7ec34b8" contextRef="C_e001cf60-2e45-48f9-8cca-188f9699760d" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lonza Sales AG Inc. License Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2018, Anelixis executed a License Agreement (the &#8220;Lonza Agreement&#8221;), which is a manufacturing know-how rights agreement with Lonza Sales AG Inc. (&#8220;Lonza&#8221;) for the use of certain processes and know-how related to the manufacture of tegoprubart. The Lonza Agreement continues until the later of the last Valid Claim (as defined therein) or ten years from the First Commercial Sale of tegoprubart, as defined and subject to the conditions therein. A royalty in the low single digits will be due on aggregate net sales of tegoprubart that is manufactured by Lonza or any other third-party or licensee.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_07046c25-12dd-45bb-83f3-df514a6a67a0_3"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">eGenesis, Inc. Collaboration Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2022, and subsequently amended in January 2023, Eledon executed a non-exclusive collaborative research agreement with eGenesis, Inc. (the &#8220;eGenesis Agreement&#8221;), under which eGenesis will gain access to tegoprubart for eGenesis&#8217; ongoing preclinical research and development xenotransplant studies of human-compatible organs and cells for the treatment of organ failure. eGenesis will pay Eledon for supplies of tegoprubart based on the number of study days per animal needed for the eGenesis preclinical xenotransplant studies to offset manufacturing expenses. As of year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company offset $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_644aabc1-646b-4aad-88d1-0f343d949379" contextRef="C_980b621d-2497-459b-aea6-bca6da258067" name="eldn:ManufacturingExpensesOffset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of manufacturing expenses. The eGenesis agreement continues until September 2025, unless terminated earlier by either party.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Matters</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and its subsidiaries are not a party to or the subject of any claim or lawsuit that individually or in the aggregate is anticipated to have a material effect on the Company&#8217;s results of operations, financial condition or cash flows.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnifications</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnification. The Company&#8217;s exposure under these agreements is unknown because it involves future claims that may be made against the Company but have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future because of these indemnification obligations. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9bbaa886-efd4-4bb3-9f17-00702b403056" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amounts associated with such indemnifications have been recorded to date.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_568b5a34-9af0-44af-a70f-6ed6a2c30463" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:ContingentLiability" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f0e776f8-55fc-41dd-9422-65f05ab9d1f3" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="eldn:ContingentLiability" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> contingent liabilities requiring accrual at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_fa847f77-1728-43f2-9f49-6cef3f950b06" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_fa847f77-1728-43f2-9f49-6cef3f950b06_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a6082c5-97f2-4691-a772-119407fe36ef" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss before income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.72%;box-sizing:content-box;"/>
         <td style="width:1.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.92%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.92%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses before income taxes:</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S.</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26b5bdec-d421-4dc6-a5ba-0d24053bd2ff" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">35,951</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8f35955-a1cf-494d-86d7-02c94207daf6" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,736</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-U.S.</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4f7f1a5-9db1-4cb8-978a-d06cfe4d71f4" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">198</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_794abb90-09b1-4fdf-8d58-e535b80f1161" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3">199</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8afa6e8-8f5b-42b2-b925-465417321f1d" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">35,753</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0f2bce4-5eb0-49e0-89da-48c5b56b493c" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_fa847f77-1728-43f2-9f49-6cef3f950b06_1" continuedAt="F_fa847f77-1728-43f2-9f49-6cef3f950b06_2"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5404a62f-3dc6-4142-9ddc-188eb4082c55" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision for income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.88%;box-sizing:content-box;"/>
         <td style="width:3.4%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:3.4%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.68%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current income tax provision</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9eda4d71-ebf2-419f-b1b2-8fe5b4844fe2" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred income tax provision</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a6d5abc-1472-46ce-b8df-7f4dc1a1a9d4" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b25a551-9041-49af-aec2-ee065d7ce469" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on its review, the Company concluded that it was more likely than not that they would not realize the benefit of a portion of its deferred tax assets in the future. This conclusion was based on historical and projected operating performance, as well as the Company&#8217;s expectation that its operations will not generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets within the statutory carryover periods. Therefore, the Company has a valuation allowance on its deferred tax assets as of December 31, 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ce245383-9a5a-445a-8d7f-3b303f5fa4e7" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.913%;box-sizing:content-box;"/>
         <td style="width:1.94%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.783000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.94%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.422%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Statutory federal income tax rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10739608-a2e7-45e2-a789-1273e4a75693" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,508</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c928c5d-8811-4659-b355-a17c53ee2759" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">24,473</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal tax benefits</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b627d60-8c6c-41fc-94e8-311a2b4d1232" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:StateIncomeTaxesNetOfFederalTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">908</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26db604d-8423-45f5-bea3-4fc8bb731432" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:StateIncomeTaxesNetOfFederalTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,170</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4cde875-b746-4a4c-bc36-be341634a624" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxReconciliationTaxCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,358</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18f3e8f0-45ce-4268-85bd-47050b88084c" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeTaxReconciliationTaxCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">972</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18c3eebc-1ae3-4788-a670-dc71475ec161" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,819</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b22b7c2-1ecc-48c1-b128-8091c2542744" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">728</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent items</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_760eea96-c380-493b-acba-16f66db20b82" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:IncomeTaxReconciliationPermanentItems" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_699d6e6e-d970-403f-87ee-233f21cdc5c8" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:IncomeTaxReconciliationPermanentItems" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6028a22b-e878-4b7a-9f29-09016d4b265f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,273</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f3835c5-0469-40c1-b9f1-5c5b294f2569" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,078</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State rate differential</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c550b74a-dd3f-4f7f-beef-bf7fc7a6267b" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:IncomeTaxReconciliationStateTaxRateDifferential" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">490</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d34f8f97-c632-45f2-a4e3-4fe9247ebd7e" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:IncomeTaxReconciliationStateTaxRateDifferential" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NOL true-up</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_151caad9-750e-4292-a913-1f88b52f35d0" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:NOLTrueUp" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8cc7432-1185-4028-880a-8912527a26a8" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="eldn:NOLTrueUp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_730c0585-6431-462d-a132-a03784e56ef2" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77ae1b42-c650-4bf4-b32d-55bba996bfa6" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">566</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49f9a72f-d37c-41db-adb0-1e944597acf5" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,137</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a2945bf-a448-4255-bfbe-e3fd00400604" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,200</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20eeb237-795e-4a65-ba47-3d2ebe22fcfe" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4769c9d3-8362-4beb-9d1e-7a7acda9e674" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_fa847f77-1728-43f2-9f49-6cef3f950b06_2" continuedAt="F_fa847f77-1728-43f2-9f49-6cef3f950b06_3"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d4244896-2a60-4b5a-9db1-e62dde1e8c8f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.72%;box-sizing:content-box;"/>
         <td style="width:1.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.92%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.92%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_457fbe6c-475c-4ad4-8c11-25c790151196" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,740</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1bac235-e980-4e94-835f-ff206afef15a" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,089</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f08ea28-b279-4758-9745-a31deb22d14c" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,560</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fb900b2-77e0-4831-82e3-2479682a41c6" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,202</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec867dd5-3ade-4563-838c-3704ac5ca62a" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">366</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fd86db6-4110-4843-871a-d5dcd5952139" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">475</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research expenditures</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73fad6f0-b4f2-4988-ba23-91573edf495f" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,809</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4973c93-f0e7-4580-bebb-ada2b9172f0c" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,567</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03cfecd9-cf53-475c-bf81-96c14976f366" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,281</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5855195-9f8b-4378-9e8c-efee7ad18f3f" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,085</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad6abb28-2932-4cc1-af6d-52237ae2fdb3" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:DeferredTaxAssetsDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,056</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58b81bcd-1b13-4feb-9e1f-25e1d4e86b42" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="eldn:DeferredTaxAssetsDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,319</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_daec3b04-4e62-4bd0-8223-8684893a17e4" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">225</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c5c2d1f-ba3e-4218-aad1-1156eaa2c18f" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="eldn:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">91</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f0a44c3-82aa-41c8-ba63-279235c475f5" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,037</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46759fb1-db2d-459f-b537-d375a4c46708" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,828</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01114c6c-c6b8-4090-8bfc-9a68b532cf4f" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:DeferredTaxAssetsRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">218</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aad4acab-b4c3-4778-84c3-0df812824497" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="eldn:DeferredTaxAssetsRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">87</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquired IPR&amp;D</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0fe3567b-e289-4691-a9d2-2abeda5a96be" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,623</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a7f24f9-a4e5-4916-b15c-769b8b873d29" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,682</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ffe73aa3-6bb8-488c-915d-265dd2677923" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,841</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ddd71de-7be6-4689-899f-dcb40694d24a" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,769</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47e5746c-f3c6-44be-b2f8-4de762f8698d" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,379</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbfdd4d0-1a33-4fc0-9e75-57b4f2edd418" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,811</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax liabilities</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_764b8da3-fdbc-4889-abb0-870081e9776a" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,183</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3ff8f4b-3e9f-4c70-a526-235f6fcb356d" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,752</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_31917eea-c5d9-42df-8e90-4d5d8a46704f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:61.448%;box-sizing:content-box;"/>
         <td style="width:2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.277000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.277000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the beginning of the year</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddd2be48-de9a-4efa-b935-527e8b507eb7" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,636</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_748dd557-ca1b-4029-a7b4-1b40abe0db59" contextRef="C_703721ac-e233-4584-a2ed-617913379b0c" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,664</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in the current year</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39619e94-e351-4147-ba8f-7f1e8ae97b04" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,596</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7000276-a4f2-4b40-85a9-7a17d1dc15be" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">972</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in prior years</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71c5021f-a32f-448f-907a-92badc33b87a" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a12659f1-967b-49e1-a381-e0a60a5fa6ea" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the end of the year</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c43b15a-54f8-4e54-8b57-74427ba7d48c" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,232</ix:nonFraction></span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9ceb0e7-2a0a-438a-923f-ab36176c4781" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,636</ix:nonFraction></span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The deferred income tax assets have been offset by a valuation allowance, as realization is dependent on future earnings, if any, the timing and amount of which are uncertain. The net valuatio</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c93916fc-33cd-4165-bae9-9daca0ff02fd" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023 to December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The net valuation allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3df13df2-ab6c-415b-8895-328b8acad629" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2022 to December 31, 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s accounting for deferred taxes involves the evaluation of a number of factors concerning the realizability of its net deferred tax assets. The Company primarily considered such factors as its history of operating losses, the nature of the Company&#8217;s deferred tax assets, and the timing, likelihood, and amount, if any, of future taxable income during the periods in which those temporary differences and carryforwards become deductible. At present, the Company does not believe that it is more likely than not that the deferred tax assets will be realized; accordingly, a valuation allowance has been established.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fcc26a50-ab11-41af-95e0-017088fde1c6" contextRef="C_2fbd8e54-c07a-4e1c-b971-6c9f65cf8c76" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">88.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59938733-957a-4e57-b87d-da0f55f01cd4" contextRef="C_b33d77f0-6276-40fa-bd85-4b5a8ba275fe" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">68.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, available to reduce future taxable income. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company also has state net operating loss carryforwards of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_438ac45d-9f19-4948-87cb-f8ce6e800561" contextRef="C_2a66afd3-0d1f-4b4b-9cb7-38a0c6a60d81" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">37.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d4e821e-a061-42d7-b4ae-d4ba7c141544" contextRef="C_13e69911-29ff-4b45-829c-2ae93e92cdf1" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Both the federal and state net operating loss carryforwards incurred before 2018 begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e8e99bf5-4711-41a8-8b0b-42196baf6fb4" contextRef="C_50d65f8a-54ee-42c3-8b17-0043d0fbcc9c" name="eldn:NetOperatingLossCarryforwardsExpirationPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2035</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if not utilized. The federal net operating losses incurred since 2018 of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_986693e6-b709-4cc5-8524-d6b5fbb05799" contextRef="C_2fbd8e54-c07a-4e1c-b971-6c9f65cf8c76" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">87.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million do not expire. The state net operating losses begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1c82677e-d771-4474-8f4b-8031f96f54e4" contextRef="C_ea3f0ca6-47b7-45eb-83f1-2f6de59e3fc8" name="eldn:NetOperatingLossCarryforwardsExpirationPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2035</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal research and development tax credit carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97c6411e-1df4-46a2-8280-4c4f3a821a73" contextRef="C_2fbd8e54-c07a-4e1c-b971-6c9f65cf8c76" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47e9ab2d-0780-47d9-9d9a-62a09055e0ac" contextRef="C_b33d77f0-6276-40fa-bd85-4b5a8ba275fe" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. If not utilized, the carryforwards will begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3473415d-6b39-4553-bcc5-a9b5dd638718" contextRef="C_50d65f8a-54ee-42c3-8b17-0043d0fbcc9c" name="eldn:TaxCreditCarryforwardExpirationPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2036</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9d810203-901d-4492-8bc0-00aa77b0dd57" contextRef="C_929233e8-37d7-4ad4-af4a-17c57fc92607" name="eldn:TaxCreditCarryforwardExpirationDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has state research and development credit carryforwards or approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a010c24e-e5b5-4605-a399-a46e39b025ee" contextRef="C_2a66afd3-0d1f-4b4b-9cb7-38a0c6a60d81" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63f379aa-5f77-4dd7-8338-d790f8276735" contextRef="C_13e69911-29ff-4b45-829c-2ae93e92cdf1" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, which will begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ef8738b1-f29f-45f3-bc9e-81b3f2f31d59" contextRef="C_929233e8-37d7-4ad4-af4a-17c57fc92607" name="eldn:TaxCreditCarryforwardExpirationPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2030</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> if not utilized</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Internal Revenue Code (IRC) Sections 382 and 383, annual use of the Company&#8217;s net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8756da1d-398c-474c-b062-6a67e9a037e3" contextRef="C_647ab198-415d-40e9-bf66-98868d7ffd37" name="eldn:PercentageOfCumulativeChangeInOwnership" unitRef="U_pure" scale="-2" decimals="INF">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% occurs within a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6b661a91-2c8c-478f-a2a3-2bddb9ea5240" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="eldn:PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has not completed an IRC Section 382/383 analysis regarding the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_fa847f77-1728-43f2-9f49-6cef3f950b06_3"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limitation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of net operating loss and research and development credit carryforwards. Due to the existence of the valuation allowance, future changes in the Company&#8217;s unrecognized tax benefits will not impact the Company&#8217;s effective tax rate.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s ability to use its remaining net operating loss and tax credit carryforwards may be further limited if the Company experiences a Section 382 ownership change in connection with future changes in our stock ownership.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the Company files income tax returns in the U.S. Federal jurisdiction, California and Massachusetts. The Company&#8217;s tax years for 2018 and forward are subject to examination by the Federal and California tax authorities due to the carryforward of unutilized net operating losses and research and development credits.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s policy is to recognize interest expense and penalties related to income tax matters as a component of income tax expense. There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3043952b-62ff-441d-8e77-e52d897e47f4" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_123ca131-8f97-48da-8aee-37f4aa16be3b" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued interest and penalties associated with uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d422efb5-43be-41de-a693-8b56f8a4cf43" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_b62d1154-e3a8-45c2-b92a-9b285dd0c212" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any interest or penalties in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 or 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_2553cacf-11e1-45ab-938c-63a2fcfd0436" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true" continuedAt="F_2553cacf-11e1-45ab-938c-63a2fcfd0436_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 8. Stockholders&#8217; Equity (As Restated)</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdf65ed3-578d-4020-af63-01b8bb65437a" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> authorized shares of preferred stock with a par value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2916ff36-5ae3-48df-be52-30189fe8e69a" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> non-voting convertible preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a518e81b-acee-4c26-a1bf-266f87f3c691" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_03fa5a9a-da65-4a09-a217-5fbfdbfa0044" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares designated; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e731b35a-ea44-43a4-8c5c-7dc9b1f8a393" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0bbb0365-0780-4274-981f-8dd96a5f61d3" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_315c0dbd-0a69-4efe-9cb6-5e597be831b5" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e97f73d7-739f-4a66-8721-822156463bb6" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued and outstand</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ing at December 31, 2024 and 2023, and </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_296a3573-63a3-41eb-8203-540651d9d9f5" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e49d23ce-7ecb-4b3e-a31c-ac1ef84fa00d" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares designated; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce1fb67e-568b-49a3-b1e2-9c4f215a28d4" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cb74f4f3-92c8-4f2e-864a-32603404fa11" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_508d514c-f9d4-4590-8f3a-6ea4a105f6ef" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b0409420-ab4c-40c8-ad06-9526179d63e9" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding at December 31, 2024 and 2023.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each share of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or X non-voting convertible preferred stock (the &#8220;Preferred Stock&#8221;) is convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef8982e1-e7c3-48b7-a160-15dfa4a14cd9" contextRef="C_a3d14d16-847d-4ad0-a2c1-7bbc3743fb74" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1f0690b0-739e-42c7-ab57-d599f4dc577d" contextRef="C_cc04c70c-694e-4769-aaa2-e6dd4cce3bb0" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">55.5556</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, at the option of the holder at any time, subject to certain limitations, including, that the holder will be prohibited from converting the Preferred Stock into common stock if, as a result of such conversion, the holder, together with its affiliates, would beneficially own a number of shares of common stock above a conversion blocker, which is initially set at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8535d7aa-f30a-4662-9ee5-556119946294" contextRef="C_60bed74c-0075-4313-9b4a-3fbb4bcd7484" name="eldn:ConversionOfPreferredStockConversionBlockerPercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_5ad02dde-6958-45de-8b1e-a6c8e9f58ea5" contextRef="C_fd236f0b-9227-41ed-9c2f-f887ba0032a9" name="eldn:ConversionOfPreferredStockConversionBlockerPercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec1dc148-8d21-4319-b4a1-ee8571879dde" contextRef="C_b245d8ef-b745-4fa1-9b3e-7439a1b246db" name="eldn:ConversionOfPreferredStockConversionBlockerPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6dd3eda7-c849-478a-a43a-d7f66ec9bf6e" contextRef="C_14e122c7-b47c-4847-aa31-c23b1f2dafec" name="eldn:ConversionOfPreferredStockConversionBlockerPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">9.9</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total common stock then issued and outstanding immediately following the conversion of such shares of Series X Preferred Stock or Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Stock, respectively. The holder of the Preferred Stock is entitled to receive dividends on shares of the Preferred Stock equal (on an as-if-converted-to-common-stock basis and without regard to any beneficial ownership limitations) to and in the same form as dividends actually paid on shares of the common stock. No other dividends will be paid on shares of the Preferred Stock. In the event of any liquidation, dissolution or winding up, the holder of the Preferred Stock will be entitled to receive out of the assets, whether capital or surplus, the same amount that a holder of common stock would receive if the Preferred Stock were fully converted to common stock, which amounts shall be paid pari passu with all holders of common stock. Shares of the Preferred Stock will generally have no voting rights, except as required by law and except that the consent of a majority of the holders of either series of outstanding Preferred Stock will be required to amend the terms of such series.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Preferred Stock includes a provision that, in the event of a tender or exchange offer by a third party in which more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d282fe75-0aa5-4ca9-b852-c4526926c0c0" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the common stockholders receive cash or other assets, allows holders of Preferred Stock, upon any subsequent conversion, to redeem their shares for the same form of consideration. Because this redemption right may be triggered by an event outside the Company&#8217;s control and could result in settlement in cash, the Preferred Stock is classified as temporary equity. As of the current reporting date, a tender offer is not probable, and the preferred stock is not deemed probable of becoming redeemable. Because redemption is not considered probable, the Preferred Stock is not subsequently remeasured to its redemption value.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2022 Exchange Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 11, 2022, the Company entered into an exchange agreement (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange Agreement&#8221;) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., MSI BVF SPV, L.L.C. (collectively, the &#8220;BVF Exchanging Stockholders&#8221;), pursuant to which the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchanging Stockholders exchanged (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8126ed4-a688-4fef-a66a-9803bb3c7736" contextRef="C_550f904f-a665-4c4c-a926-3bccfcba9c6b" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">550,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80dc29cb-e556-4129-b518-6effdff91c11" contextRef="C_f6bd4419-9bd8-464e-acfd-beb0e29ce4ce" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9,899.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Ser</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ies X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_2553cacf-11e1-45ab-938c-63a2fcfd0436_1" continuedAt="F_2553cacf-11e1-45ab-938c-63a2fcfd0436_2"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, the Company entered into a Securities Purchase Agreement (the &#8220;2023 Securities Purchase Agreement&#8221;) with certain investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#8220;2023 Private Placement&#8221;) (i) in an initial closing, (a) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fcc3c70b-2dfb-4069-8c6c-3605ff808826" contextRef="C_99fb4269-13f1-4e54-8343-39a92e170c3a" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,151,518</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0fc7f544-49c7-4bf8-9eca-436402c99538" contextRef="C_99fb4269-13f1-4e54-8343-39a92e170c3a" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share, or pre-funded warrants in lieu thereof (the &#8220;Pre-Funded Warrants&#8221;), and (b) common stock warrants exercisable into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a385674-4d11-4c3a-b700-ed52962324cf" contextRef="C_99fb4269-13f1-4e54-8343-39a92e170c3a" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,151,518</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants in lieu thereof) (the &#8220;Common Warrants&#8221; and, together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;); (ii) in a second closing (the &#8220;Second Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bbc60d85-28e7-491c-9394-449652e7a5d4" contextRef="C_fd5b7956-4959-43cd-b4c5-b1fde759c23c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">20,202,024</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants); and (iii) in a third closing (the &#8220;Third Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45e27183-e107-4a4d-8cc0-10ccb584a6af" contextRef="C_07a68ee8-82a0-456f-b6d3-9977f22a230f" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">25,252,530</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants), in each case subject to customary adjustments as provided in the 2023 Securities Purchase Agreement, Pre-Funded Warrant or Common Warrant, as applicable. Each Common Warrant has an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4af5a7fa-3731-47c1-bb4e-078b02a8f7c9" contextRef="C_7f10a0e1-7bb1-4217-8c81-fe3de5a1918e" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expires five years after issuance. The Pre-Funded Warrants are exercisable immediately and until exercised in full, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac660010-6d2f-43d1-a3cd-7341e8147aba" contextRef="C_e18de94d-dbd0-4d3d-ba53-59c1f412228b" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pre-Funded Warrants and Common Warrants are subject to specified beneficial ownership limitations, which are generally set at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fe60dd7-7e4c-47c9-a747-26b56e40dcf6" contextRef="C_02359b89-94e1-443c-ac29-3c67769f2cb8" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ac40f25a-8c09-4afa-a190-f464fc529696" contextRef="C_78d65748-c663-4c56-aa09-66c64ed912e1" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d7e8491-6482-41a4-ac06-df17b05f0cb7" contextRef="C_4c665ca9-bab8-40bc-b5cb-2233b3df82bc" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f7935d59-8e1f-4b4b-936d-1564d8b562d3" contextRef="C_6e303928-4d0c-4180-838a-ad93da24f889" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">19.99</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% unless otherwise permitted. The Shares, the Warrants, and the shares of common stock issuable upon the exercise of the Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 5, 2023, the initial closing occurred, and the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_659c3a15-0cfb-4c80-955d-f26e9c2b413f" contextRef="C_9451594c-6f06-454d-8721-5fd66258a715" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">35.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_284244a6-17aa-4ee5-83f7-f210c4cee95d" contextRef="C_9451594c-6f06-454d-8721-5fd66258a715" name="eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">33.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6cea88d5-7ae6-4967-bc03-67295bf618d6" contextRef="C_942a2564-5176-4190-a212-2b973ceb1a34" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">8,730,168</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock and Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7074705-9e75-46f7-b61b-2da5624a1049" contextRef="C_8e654e4d-37e7-47fa-95fa-928b05de9595" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,421,350</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 8, 2024, the Second Closing occurred, and the Company received gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3aba21fe-b318-400a-9c6e-82e9f28a0f0c" contextRef="C_320ec943-bc2b-449e-8081-892254217c23" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27742a8e-112e-4089-9106-079966a7e827" contextRef="C_320ec943-bc2b-449e-8081-892254217c23" name="eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6e6e83b-c1bf-4a76-935d-1e2bdc051e3b" contextRef="C_26899444-530f-4870-a095-0c5c5401b54a" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">909,088</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 30, 2024, and October 1, 2024, the Third Closing occurred, and the Company received gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c87b69c-7581-444d-9b10-1bd2eb6a48c3" contextRef="C_d59b82b7-5627-447f-ac66-5fb9c579fdfe" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_50a91529-d4ec-4a32-8ba2-0be8f66bfec2" contextRef="C_463fd8a9-edbf-489e-aaf7-3a59cf541462" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_095e9a14-f308-48b9-b4d4-65d3353980b6" contextRef="C_d59b82b7-5627-447f-ac66-5fb9c579fdfe" name="eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_27b106b3-04fe-4c9a-8fd0-d5fce603eafa" contextRef="C_463fd8a9-edbf-489e-aaf7-3a59cf541462" name="eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.8</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c190a72-9fff-474d-9deb-933367c49a59" contextRef="C_5bac50df-0bf9-4fac-8dc9-1288781f48d4" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_827cebbe-58db-4d70-8286-a4a066648a0f" contextRef="C_478dbeb4-70d8-4365-82b4-495e16a9644d" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,727,400</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2023 Private Placement, the Company filed on May 18, 2023, a registration statement on Form S-3 (the &#8220;2023 Registration Statement&#8221;) with the SEC to register for resale the Shares and the shares of common stock issuable upon the exercise of the Warrants. The 2023 Registration Statement became effective on June 2, 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company concluded that the Common Warrants, and the potential issuance of Pre-Funded Warrants in lieu of additional shares of common stock in the Second Closing and Third Closing (the &#8220;Subsequent Closing Warrants&#8221;) do not meet the conditions to be classified as equity instruments under ASC 815-40 and must instead be recorded as liabilities on the Company&#8217;s consolidated balance sheets at their fair value and remeasured at fair value for each subsequent reporting period.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The valuation of the Common Warrants and the Subsequent Closing Warrants is adjusted to fair value (Level 3) at each balance sheet date until the Common Warrants and the Subsequent Closing Warrants are settled or expired.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e03c8242-6937-420b-8295-17be74984cca" contextRef="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, and as of the issuance date:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:47.149%;box-sizing:content-box;"/>
         <td style="width:1.48%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:20.823999999999998%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:3.481%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:23.064999999999998%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac77b033-3f01-4dfd-b9f3-a2f9dee35d82" contextRef="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">96.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_051980a0-9a09-4971-ad78-a1a895fd2a51" contextRef="C_4f05b713-9469-4acf-b62a-b4a410770fdc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">89.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42441149-04f1-43d2-bc3e-543bf9b24736" contextRef="C_4f05b713-9469-4acf-b62a-b4a410770fdc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">94.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1adae245-f8fa-4bd1-bc7c-ac5a753fef1f" contextRef="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26254f62-b93f-441f-9ec9-22b1d02ac582" contextRef="C_4f05b713-9469-4acf-b62a-b4a410770fdc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af829974-27f8-4bb0-af4c-7c750008657b" contextRef="C_4f05b713-9469-4acf-b62a-b4a410770fdc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_30ccc539-a660-4fe8-b2f5-f2068f74eca4" contextRef="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_519dda44-9a03-4b2f-a8f5-4f121f43cd8b" contextRef="C_99d14f13-477d-408b-bc26-79d5db50d8a2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><ix:nonNumeric id="F_d6c98cad-703a-4008-a187-989c441deca9" contextRef="C_0147f0c4-d22d-434d-ab8c-fd254e6c658d" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share price</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49964a6e-1107-4d5f-ac65-e395c31cfd52" contextRef="C_e2ccd3a2-63bb-47ec-b90f-f9427e33d6b7" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">4.14</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af3b3dce-9846-46a9-a981-8021dea15f84" contextRef="C_274b34fb-7eb0-4bfc-a200-1ceb17964d37" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.80</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_2553cacf-11e1-45ab-938c-63a2fcfd0436_2" continuedAt="F_2553cacf-11e1-45ab-938c-63a2fcfd0436_3"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Conversion Agreement of Non-Voting Convertible Preferred Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">O</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n May 16, 2023, Cormorant Global Healthcare Master Fund LP provided notice to convert (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf31efd1-9739-45fa-a4ae-d9883c24bb25" contextRef="C_ead3ee91-638a-450a-b9ec-8e6ef46d7412" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,782</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series X Non-Voting Convertible Preferred Stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21f997e4-7c60-4a22-ac73-6e5fe176d579" contextRef="C_90ef02a4-12ca-42a1-b6d6-2dc5a6c517a1" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">99,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X Non-Voting Convertible Preferred Stock, and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3aaea1d8-7380-46ba-8b47-558158cd1c0d" contextRef="C_a1649612-1e62-4a97-af6c-7dc0028db1ef" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,883.586</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6773a2c0-b9a2-4d6d-bab1-d89f7b03e224" contextRef="C_d6bb14ee-c9e1-48c2-ae0d-ce419b3af00d" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">437,977</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock. The conversion was completed on May 23, 2023.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 6, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;2024 Securities Purchase Agreement&#8221;) with certain institutional and accredited investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#8220;2024 Private Placement&#8221;) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0acdb35b-d702-4200-8c42-4a84ab15a767" contextRef="C_4f78b74c-03a0-4b7c-8ace-e89af1719000" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">13,110,484</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the &#8220;2024 Shares&#8221;) of the Company&#8217;s common stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93d62d9e-0d7d-4161-8485-1f292b9395ea" contextRef="C_368c6272-dda1-47db-a6e7-2d38cfded7e4" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.37</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and pre-funded warrants (the &#8220;2024 Pre-Funded Warrants&#8221;) at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89221519-c0ab-4dc7-b8b6-4fb1312a4b86" contextRef="C_953b5115-083a-4e43-b335-55592f074714" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">2.369</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per underlying share, which are exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3728e568-5157-417c-a28d-2eab8c134f50" contextRef="C_953b5115-083a-4e43-b335-55592f074714" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">7,989,516</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f69df320-7351-4c9b-8eda-f4eb42768819" contextRef="C_953b5115-083a-4e43-b335-55592f074714" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The 2024 Pre-Funded Warrants were issued in lieu of shares of common stock and are exercisable immediately and until exercised in full. The 2024 Pre-Funded Warrants are subject to specified beneficial ownership limitations (equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bfdf59dd-1024-4ec5-80c3-3fe8e5ddc9ec" contextRef="C_1edc7735-5746-454a-98ed-a4e3221fb98a" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0eab92c3-6579-41fd-8345-0d8b0ba2925d" contextRef="C_7be301e3-88b5-4832-845c-9d8ac104e793" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% as determined by holder of each such warrant) of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6872b42e-bbdb-4434-ba46-8b3a1dd4ec4e" contextRef="C_7be301e3-88b5-4832-845c-9d8ac104e793" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">19.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% unless otherwise permitted. The 2024 Shares, the 2024 Pre-Funded Warrants, and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Pre-Funded Warrants were classified as a component of permanent stockholders&#8217; equity within additional paid-in-capital. The 2024 Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In addition, the 2024 Pre-Funded Warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Private Placement resulted in gross proceeds to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f700165-d908-4795-a2d4-e940814cc641" contextRef="C_4f78b74c-03a0-4b7c-8ace-e89af1719000" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79cf9a96-4a84-4b57-a4c7-d70c20529ca4" contextRef="C_4f78b74c-03a0-4b7c-8ace-e89af1719000" name="eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">48.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Private Placement, the Company filed on May 24, 2024, a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC to register for resale the 2024 Shares and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants. The 2024 Registration Statement became effective on June 5, 2024.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Equity Distribution Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 20, 2024, the Company entered into an Open Market Sale Agreement (the &#8220;Sales Agreement&#8221;) with Guggenheim Securities, LLC (&#8220;Guggenheim Securities&#8221;) to sell shares of the Company&#8217;s common stock, having aggregate sales proceeds of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00f485fc-2a62-4575-b347-03df53a3a410" contextRef="C_9b1e52ec-b18a-43ab-830e-8986ff39379c" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">75.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, from time to time, through an &#8220;at the market&#8221; equity offering program under which Guggenheim Securities will act as sales agent. In connection with the Sales Agreement, the Company filed on September 20, 2024 a registration statement on Form S-3 containing a prospectus and prospectus supplement (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement became effective on October 2, 2024. As of the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024, the Company has not sold any shares under the Sales Agreement.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 29, 2024, the Company entered into an underwriting agreement with Leerink Partners, LLC, as representative of the several underwriters named therein (the &#8220;Underwriters&#8221;) in connection with the underwritten offering, issuance and sale by the Company (the &#8220;2024 Underwritten Offering&#8221;) of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88c0f574-fa36-4148-895a-ca934cd8bd7f" contextRef="C_412fba80-a3f2-4e2e-a9dc-8ece19b8f909" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,356,173</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock, at an offering price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ab790cd-250f-4026-bb1f-e4084ed6273e" contextRef="C_cc736700-2f11-4c70-bf4c-ca225ad3a533" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.65</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and pre-funded warrants at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea4e6315-b6cd-4608-96db-d9621ca1ba9c" contextRef="C_0dce47b6-63c7-4639-ba01-f701282d1487" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">3.649</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per pre-funded warrant, which are exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46b582d0-9710-4763-aa3d-982423c564d6" contextRef="C_cc736700-2f11-4c70-bf4c-ca225ad3a533" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,931,507</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c08a7c74-b11d-411f-b212-bce4be167aba" contextRef="C_cc736700-2f11-4c70-bf4c-ca225ad3a533" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;Offering Pre-Funded Warrants&#8221;).</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_2553cacf-11e1-45ab-938c-63a2fcfd0436_3" continuedAt="F_2553cacf-11e1-45ab-938c-63a2fcfd0436_4"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Offering Pre-Funded Warrants were classified as a component of permanent stockholders&#8217; equity within additional paid-in-capital. The Offering Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In addition, the Offering Pre-Funded Warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Underwritten Offering closed on October 30, 2024 and resulted in gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d160ce2-0cee-43f9-b589-6a1787cf7cc5" contextRef="C_f23c46e0-c8ff-4ddb-ac90-024320e43941" name="eldn:ProceedsFromIssuanceOffering" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a8be0a8-a12c-400c-83c5-1185039c2b29" contextRef="C_f23c46e0-c8ff-4ddb-ac90-024320e43941" name="eldn:ProceedsFromIssuanceOfNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">79.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting underwriting discounts and commissions and offering expenses. The 2024 Underwritten Offering was made pursuant to the Shelf Registration Statement and a prospectus supplement relating to the 2024 Underwritten Offering dated October 29, 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A holder of the Offering Pre-Funded Warrants (together with its affiliates) may not exercise any portion of an Offering Pre-Funded Warrant to the extent that the that, after giving effect to such exercise, the holder (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates) would beneficially own in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b17cccbd-e531-4650-ad05-57216b671685" contextRef="C_23b4279a-d29c-45cc-a819-b328ff1a900e" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (or, at the holder&#8217;s option upon issuance, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afc281e4-b012-4569-91ce-adc1b2ecc752" contextRef="C_471dec7e-d30c-458a-93d0-bda067fa6254" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%) of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of such Offering Pre-Funded Warrant.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Pre-Funded Warrants from 2023 Securities Purchase Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, Armistice Capital Master Fund Ltd. (the &#8220;Exercising Stockholder&#8221;) exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f11de2d-01cc-4288-a560-a9c4fab218f2" contextRef="C_b53bd15c-c7fb-4b11-aa17-fa905055dc5f" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">501,197</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa750470-6e97-49b7-bc33-3904ca39044c" contextRef="C_b53bd15c-c7fb-4b11-aa17-fa905055dc5f" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 14, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea299a8e-87ec-4e6d-8666-e0d33834ca1b" contextRef="C_7df810c1-d21e-4e6b-a46f-01bf18c4ed77" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">501,197</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 2, 2023, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc589547-1085-47e2-8710-c5c2b299c79a" contextRef="C_d9bfbaaa-b100-4fc8-b32a-b4ace9e85c13" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">653,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6712fdff-5bd1-4493-924d-b1adbc94f65d" contextRef="C_d9bfbaaa-b100-4fc8-b32a-b4ace9e85c13" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On November 6, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96871949-e078-4144-a120-eff3e21d047f" contextRef="C_aee009b0-e9e5-4357-a86f-519c7e46e328" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">653,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 30, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbf6ccd4-073d-4c74-aa0c-859a21fc8189" contextRef="C_2067bb42-a2a2-40c2-9cbe-fb3a2abee295" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">600,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a746884a-155a-4164-b7f3-54c176749e47" contextRef="C_2067bb42-a2a2-40c2-9cbe-fb3a2abee295" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On January 30, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd8a5789-130d-4e5a-8a0c-632ac4abad5d" contextRef="C_2067bb42-a2a2-40c2-9cbe-fb3a2abee295" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">600,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 7, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_567a3015-73f6-47f4-8d80-615966c6e7c3" contextRef="C_7b6aa460-03c5-4aa2-a129-7a2742c51c6c" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">583,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a685facd-d01f-42e5-86dd-331984a188e6" contextRef="C_7b6aa460-03c5-4aa2-a129-7a2742c51c6c" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On May 9, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_559fe00a-92cc-468f-bb76-1df7e4b90f1f" contextRef="C_78ce3cbc-2a87-434a-8808-3ae02d70968a" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">583,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 11, 2024, the Exercising Stockholder exercised their remaining Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9f5f6ad-7484-4d2e-85dd-dff9b879fcbd" contextRef="C_c9c85a29-4958-462d-81cd-61348312f2ed" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">240,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d3c97cf-46e0-42c7-bf7e-f40a633536cb" contextRef="C_c9c85a29-4958-462d-81cd-61348312f2ed" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 11, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35abaf8c-60cf-4467-92f8-1988c5985098" contextRef="C_c9c85a29-4958-462d-81cd-61348312f2ed" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">240,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20d14dc0-be7a-47af-a321-dcdea52fdcf1" contextRef="C_f24c5a06-77ee-4dae-8ad5-bc7f8a9e6e82" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">33,052,744</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants were exercisable into common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2553cacf-11e1-45ab-938c-63a2fcfd0436_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_baf24390-7be4-462d-bb75-c22b2c95ce6f" contextRef="C_5479bff8-22b2-4dea-8a74-3bba75d07bd5" name="eldn:ScheduleOfWarrantActivityTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the warrants to purchase common stock activity:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:40.5%;box-sizing:content-box;"/>
         <td style="width:1.44%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:16.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.44%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:16.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:16.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Warrant Activity</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d56c4b34-01ef-4d1a-8ecb-2f273d93282c" contextRef="C_073a4072-2ff4-4bf0-b2f2-2ca40d8d96dd" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,788,032</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8863c6f-3a01-40be-a394-c69694077215" contextRef="C_e7daa38f-05c1-4b99-a56a-2c538503eda6" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,776,270</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fae3e350-64e5-40ce-b935-bb8bf2b6f2bf" contextRef="C_f6739b83-64c1-4196-bfa3-188e64be71c2" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">21,564,302</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e988749c-df98-47ca-833f-c09952594207" contextRef="C_7e668069-76a8-40b4-854c-5268227f0ca1" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a976804-3f23-42c1-b623-6cbc96f0b6dd" contextRef="C_6064f4bc-c353-4924-b4c3-bc53d3720064" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,921,023</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5976319f-82c2-4a7a-ac3f-bc01e60dadec" contextRef="C_d73e41e0-eaac-4f7a-8f85-cc17e8daac55" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,921,023</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
         <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96072613-c4ae-4f98-b10b-3d4ccc5eed7b" contextRef="C_7e668069-76a8-40b4-854c-5268227f0ca1" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed3aa0c5-dfa7-4edc-ac6a-44a33a98c610" contextRef="C_6064f4bc-c353-4924-b4c3-bc53d3720064" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,423,000</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4f9ac55-dbd8-4ac1-8f80-5e8d8186631c" contextRef="C_d73e41e0-eaac-4f7a-8f85-cc17e8daac55" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,423,000</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60db0a73-64cd-496b-bfd8-f30e7e35d544" contextRef="C_7e668069-76a8-40b4-854c-5268227f0ca1" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9,581</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6bb07d51-dfa5-4629-9ec3-870f0717f5b9" contextRef="C_6064f4bc-c353-4924-b4c3-bc53d3720064" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1e42ff3-e825-43cd-b8ea-6fc66a890866" contextRef="C_d73e41e0-eaac-4f7a-8f85-cc17e8daac55" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9,581</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b69733c-b1f6-42ee-a66e-fc82be029fef" contextRef="C_a38140f4-e70a-4ed0-9849-5332d035c44d" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,778,451</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b3c8f7f-f1c9-4021-a685-9a24d56d421b" contextRef="C_e3e45846-797e-4cc7-afc4-00734dc1c256" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">17,274,293</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_033219a7-8cf8-4a09-b7d5-3b515c7758a3" contextRef="C_c0e69edb-7d74-4a88-a331-7063c41b32d0" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">33,052,744</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d1b873e7-835b-4300-8a67-1a6859f582e4" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:40.492%;box-sizing:content-box;"/>
         <td style="width:1.44%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:16.297%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.9%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.837%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.2%;box-sizing:content-box;"/>
         <td style="width:17.836%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date Issued</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Shares of Common Stock Issuable</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration Date</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af75aa62-cb8c-4c38-8d95-3d86907850dc" contextRef="C_47180cae-052a-4fcf-aff0-dd86481a6ea5" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,586</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2059784-393e-483a-bc3f-6c065f49b01b" contextRef="C_47180cae-052a-4fcf-aff0-dd86481a6ea5" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">18.90</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_c87b3f04-51e3-4c29-8b5f-f4951b8a31e0" contextRef="C_47180cae-052a-4fcf-aff0-dd86481a6ea5" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd8a204b-6923-4667-ba1e-39b7cd580eec" contextRef="C_c2abaa52-1d0a-4fbe-81ab-c8a8f777bb72" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,591</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_587adb3f-fd6b-4a20-bbaf-f01bfd4f7801" contextRef="C_c2abaa52-1d0a-4fbe-81ab-c8a8f777bb72" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">18.90</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_6df5faa4-8b59-4a9a-a843-e65bdabf31c1" contextRef="C_c2abaa52-1d0a-4fbe-81ab-c8a8f777bb72" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3376c62f-71d0-4968-a22e-995b66f6315a" contextRef="C_6ebbbef7-421a-4712-a110-6e65b3cc06a4" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">247,264</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fbc3290b-a31a-4c3d-8c6f-21759f0a3aa4" contextRef="C_6ebbbef7-421a-4712-a110-6e65b3cc06a4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.96</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_f7bfdd7c-e9af-4b06-8bfd-1af379a17d09" contextRef="C_6ebbbef7-421a-4712-a110-6e65b3cc06a4" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4e8aed2-4f11-46fe-bd92-899132df15aa" contextRef="C_2ae5e0b5-102e-4000-812f-5d62270f8a6d" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">71,800</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97940635-3095-43f9-87fe-94ed284002c3" contextRef="C_2ae5e0b5-102e-4000-812f-5d62270f8a6d" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.96</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_8f8ea1c8-023e-479b-91d7-cb76fe98d71c" contextRef="C_2ae5e0b5-102e-4000-812f-5d62270f8a6d" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d5a8344-ddc4-4b67-9657-3389c88b2206" contextRef="C_1fc4725b-505d-42ee-8598-9b1205ab938a" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">298,692</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f538729-9da5-44a0-adf9-8c85251dfc6c" contextRef="C_1fc4725b-505d-42ee-8598-9b1205ab938a" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.08</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_5ae8c080-f0da-495a-961d-fc9834f44317" contextRef="C_1fc4725b-505d-42ee-8598-9b1205ab938a" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 14, 2025</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43963401-7107-4a13-9c1c-c8e12130211b" contextRef="C_1f217616-88b1-493b-aa9a-fb67de956fa7" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,151,518</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80064116-3aae-422a-9984-7e40ac056f93" contextRef="C_1f217616-88b1-493b-aa9a-fb67de956fa7" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.00</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_65460197-e310-428e-8b04-c6417eb272c6" contextRef="C_1f217616-88b1-493b-aa9a-fb67de956fa7" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 5, 2028</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2021 pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a53c7799-418d-4983-8f84-80598da1e235" contextRef="C_f5f2d779-981c-4cdb-8478-acd05d3606c9" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">509,117</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1313f5a9-eb59-4b3c-9179-9c210d989532" contextRef="C_f5f2d779-981c-4cdb-8478-acd05d3606c9" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_8fb93037-7ecf-43a2-b41d-cd93126697ff" contextRef="C_f5f2d779-981c-4cdb-8478-acd05d3606c9" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2030</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ef1c34c-cbde-4895-b298-24468a73a83e" contextRef="C_41f23dcf-6538-4d0e-8ab7-5ea52de4f018" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,844,153</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7eb2044-a1ef-41ae-b051-05345d3ce86b" contextRef="C_41f23dcf-6538-4d0e-8ab7-5ea52de4f018" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0595dde2-4b7b-489d-ad2e-21ae31aa4459" contextRef="C_7e567fbb-8b59-43a4-a885-68d6c65b7935" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,989,516</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6eede576-31f2-48cf-a485-88b311788b8c" contextRef="C_7e567fbb-8b59-43a4-a885-68d6c65b7935" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_242933f7-3a9f-42ae-bf46-7ffb01d120af" contextRef="C_00ec3738-b3f5-498d-9035-0c48bdd6391a" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,931,507</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40c626d1-dc67-4ccb-a577-6d1a2df8c3a5" contextRef="C_00ec3738-b3f5-498d-9035-0c48bdd6391a" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92fa408d-b2aa-478e-872b-87b8159a7abd" contextRef="C_c0e69edb-7d74-4a88-a331-7063c41b32d0" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">33,052,744</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred Stock Warrants</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2709887c-828c-4e1a-80e0-c40c9b9234c6" contextRef="C_57faa905-6146-4e17-b55a-72db880840e2" name="eldn:ScheduleOfWarrantActivityTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a059ccb9-cc57-47cf-9292-1fd4b44e01d6" contextRef="C_868ad39e-5065-4cf8-9dff-9d2c9a7d135b" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,207.419</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants exercisable into Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Stock which are convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e026f5cb-3f5b-4369-bf4c-b77803a81b63" contextRef="C_868ad39e-5065-4cf8-9dff-9d2c9a7d135b" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,789,301</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:54.52%;box-sizing:content-box;"/>
         <td style="width:2.44%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:41.04%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Series X</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Convertible Preferred Warrant Activity</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c55e08e-3f7a-4126-a555-d59577eb0f22" contextRef="C_5dc4d3d6-be01-4bf6-aebf-77b1734fcf32" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,207.419</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed and replaced</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9b94621-24ef-405a-b6eb-a87081436b1f" contextRef="C_1f268d5e-cf5e-403a-87e4-658902565516" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
         <td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1cca46a8-e1a1-4feb-8744-198a252a4794" contextRef="C_1f268d5e-cf5e-403a-87e4-658902565516" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc809dc7-55da-4985-8198-805b33276c5f" contextRef="C_1f268d5e-cf5e-403a-87e4-658902565516" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e469ec4a-0906-4ca6-9cab-6d9be9bce201" contextRef="C_dd1985ed-08be-42aa-8575-546c5561d12a" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,207.419</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Warrants were issued on September 14, 2020, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be5e5825-23ef-442e-9b87-29520ae9f255" contextRef="C_4117a814-e099-4153-b353-7f02194ab5a1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.96</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and an expiration date of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8529d840-7193-438d-ae2f-d16599f5a25d" contextRef="C_4117a814-e099-4153-b353-7f02194ab5a1" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 14, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:nonNumeric id="F_270d7590-1658-47b0-b163-cb102b7d10b8" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_270d7590-1658-47b0-b163-cb102b7d10b8_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 9. Stock-Based Compensation</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Option Plans</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5abdba55-b089-400c-8229-1b75240600ae" contextRef="C_2d4f29f9-5681-4ad7-bf0a-2f27534f1c56" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For stock options granted to the Company&#8217;s board of directors (the &#8220;Board&#8221;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e1aab80a-4815-4142-a6fe-f5eec372a748" contextRef="C_d34a853c-0615-409b-9ae6-5bd5c50e65b2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0e7ec50f-1144-4161-bb97-73d764caf5e0" contextRef="C_4d0808f1-2220-4b2f-9620-f1ac2986d605" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months that vested stock options granted to Board members may be exercised upon termination. </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2024, the Company held its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;). At the Annual Meeting, the Company&#8217;s stockholders approved an amendment to the Company's 2020 Long Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan, as amended, (i) reflects an increase in the limit on the aggregate number of shares of the Company&#8217;s common stock that may be delivered pursuant to all awards granted under the 2020 Incentive Plan by an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53e1ffba-5d2f-4478-a895-3823b247bd7b" contextRef="C_eda51110-4aff-4f77-8d77-cdbe3953f41b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,500,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares so that the new aggregate share limit under the 2020 Plan is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83f24e6f-04df-43f6-a2ce-8e1077e5f5b1" contextRef="C_eda51110-4aff-4f77-8d77-cdbe3953f41b" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">17,960,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, and (ii) extends the date through which the Company may grant new awards under the 2020 Plan from November 15, 2030 to April 28, 2034.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 1, 2023, the Company issued stock option awards to its employees with both time-based and performance-based vesting requirements, totaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_895ff8a9-b47d-498f-a5d2-b6de561a73f3" contextRef="C_2f08b426-f498-4cef-82ca-9a6f0e57cf67" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,381,857</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options, with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b95ca9a6-69a5-4411-8573-ba09461df919" contextRef="C_a0877070-bafd-4ecc-ba7e-d06767488cad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,476,372</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the granted stock options subject to the Company&#8217;s customary time-based vesting schedule. The remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fad8e743-4744-4242-a3a1-393d90ef3118" contextRef="C_2f08b426-f498-4cef-82ca-9a6f0e57cf67" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,905,485</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options granted are subject to both customary time-based vesting requirements and performance-based vesting requirements that are based on the same clinical development milestones applicable to the Second Closing and Third Closing of the 2023 Private Placement as specified in the 2023 Securities Purchase Agreement.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the Company amended the performance-based vesting requirements with its named executive officers and other employees that upon the Second Closing and Third Closing, a full or prorated amount of each closing installment shall vest based on the percentage of funding received relative to the total funding opportunity represented by the investors&#8217; Second Closing and Third Closing subscription amounts. On June 13, 2024 and November 20, 2024, the performance-based vesting requirement based on the milestones applicable to the Second Closing and Third Closing were satisfied and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ccec66df-a8ac-42d5-9e16-9ce5a95e6fa4" contextRef="C_534c07a6-4f81-40db-bf98-8c91a0f6d3a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cc3f7a48-be33-4dbc-8611-4b51b41fd286" contextRef="C_c8bb3042-d8d0-4c46-81bd-3419e2c5ac60" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,763,085</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options were issued.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2014 Stock Incentive Plan (the &#8220;2014 Plan&#8221;) was closed to new grants following the approval of the 2020 Plan, and therefore, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05443e49-badf-47f8-b9d8-c79be32e9c5b" contextRef="C_e61ec573-6c46-4c35-990d-5570f66dbe16" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares reserved for issuance under the 2014 Plan as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The number of shares reserved for issuance under the 2020 Plan and Employee Stock Purchase Plan was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca981868-0565-46a4-910a-a7f6f4781c31" contextRef="C_11604e1d-447f-4412-9cf1-8945676ed077" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,373,242</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a967c949-08f0-4005-861c-3a1d87407f8b" contextRef="C_41f693fb-c3db-4b97-a334-95618d32533c" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">24,077</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, respectively, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_270d7590-1658-47b0-b163-cb102b7d10b8_1" continuedAt="F_270d7590-1658-47b0-b163-cb102b7d10b8_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_690d71fb-6168-4e44-aa19-2222db4905b6" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:40.708%;box-sizing:content-box;"/>
         <td style="width:1.06%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.762%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.54%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.282%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.06%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.762%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.54%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.282%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under Options</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ce86a9b-f63c-4686-b320-392a542ccfd9" contextRef="C_703721ac-e233-4584-a2ed-617913379b0c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,218,033</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65709970-a33b-480a-a0ed-519b6baf569e" contextRef="C_703721ac-e233-4584-a2ed-617913379b0c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.69</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_ef1decf9-16e7-4378-a265-b54fd83397a8" contextRef="C_8221208b-b06c-4f4e-8484-c94ceca23b1b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.1</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a923529-1db9-4d30-a29f-397cbf4e4433" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">11,026,451</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85315282-8d6a-479d-93f2-72be7a7e9932" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.10</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e6afa7d-f070-4212-9ba7-543815f04a4f" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">862,631</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa59597c-4093-460f-85eb-1a3a0928341e" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.07</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6eee271d-6f80-43d8-8b71-f2bf6ee6084b" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,381,853</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cce648d-d39c-4072-883b-3d812fa39591" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.21</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_55d81e17-462c-44c3-9e49-1a118555c21a" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.9</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4ffabf2-168a-4abc-a1f6-b22b5d36ae32" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">235</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a48e9553-46b7-48d0-a7ff-0f241782f695" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">622,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e95e1324-049a-40a9-9d47-74124cdf9597" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.22</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1309e7f-d3b9-4616-9548-0e6ac262f63f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f9bff5c-0d52-4ee7-abbb-a2e593956ad9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.30</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b74cd90-4f84-4fde-a278-0dda74eaffbd" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">316,465</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8fa8d7bb-e3a6-49f9-a61f-2ab86ca9db66" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">7.29</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8de1d018-02d9-41ad-9faf-b8bda6c4e741" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,637,388</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_032bf373-bdab-4df3-9028-7e77d85c2394" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.02</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_a07e0d58-3668-47dc-813a-1aa7eb552434" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00d56ad1-1e9c-4082-841f-5921f6ffbf86" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,628</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options vested and expected to vest as of<br/>&#160;&#160;&#160;December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17f01a6e-bb97-447c-8b6a-a13ece018b0e" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,637,388</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2bd2f391-8bbb-46fe-b42d-c6e55bc70edf" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.02</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_87da72de-cd30-49d8-9cda-041412392285" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_852cffcd-1b1a-4ab1-b4c1-48f9f0303b87" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,628</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options exercisable as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e846af4-df10-429a-a09a-1dcf4ca1f053" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,667,177</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f7f83c7-86f3-4f1d-a432-789ff6e81ff8" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.37</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_ac0b1079-a621-44f2-894b-2363affabde7" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.8</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03e744c1-bdc2-4818-8bdc-9479a59a8069" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,898</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that had exercise prices that were lower than the fair value per share of the common stock on the date of exercise. The aggregate intrinsic value of options exercised during the year ended December 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80260ae4-4f65-4f50-b8c5-5f8eac4750cd" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5691c8eb-8ba1-4aba-9b8b-d3ff85829778" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:42.72%;box-sizing:content-box;"/>
         <td style="width:2.54%;box-sizing:content-box;"/>
         <td style="width:26.1%;box-sizing:content-box;"/>
         <td style="width:2.54%;box-sizing:content-box;"/>
         <td style="width:26.1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f623413-fa0e-4fc4-8ab4-e2a2340485fb" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">101.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99e1e962-c86d-48ba-975d-e3d835d0f490" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">90.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31c2ca25-41cf-4fb9-9a25-6d558969173d" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be56f339-c947-4f52-bebc-141dbd9a1763" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0f35d3d3-f2e7-442b-9db4-09360198e8ca" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c3ebbfe9-1ad1-4954-8657-32609095980c" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Estimated dividend yield</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_caadd450-ae88-4de7-8226-fbf950003f1f" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9ddf396-fc90-4582-bb3a-3ab8734ffd56" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The per share weighted average grant date fair value of stock options granted during the years ended December 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1db8a0c7-7c06-4075-8e6d-02072cfb99cd" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.93</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e7a79ac-95a2-4e80-88dd-935800c6f2b3" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.60</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Units</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_734fb079-45ce-465d-8aee-925501ad89a8" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the RSU activity, as follows:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.72%;box-sizing:content-box;"/>
         <td style="width:1.26%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.38%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.92%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under RSUs</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Grant Date Fair Value</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_536c2b38-3990-4afd-ba03-bf508645d75c" contextRef="C_135b1839-bc7f-467e-abbf-3856e1bcb1f4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80b2f08d-2a39-45d6-b6b5-ca9922f8cdaf" contextRef="C_135b1839-bc7f-467e-abbf-3856e1bcb1f4" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.47</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_164f0aea-6989-435c-8f30-6e9b26af8fd8" contextRef="C_f732926d-a8cc-4c74-8a1a-38d77cf24a4e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f35364f0-0e9c-4d92-b4f2-3acd0251d743" contextRef="C_f732926d-a8cc-4c74-8a1a-38d77cf24a4e" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.47</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8fa6b3c6-c145-41f5-825f-7c4bcf489b08" contextRef="C_4e5c52f4-44ed-4d03-b98e-acba67aad85d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99ebdccb-affa-45f7-a548-66a44c7cae1c" contextRef="C_4e5c52f4-44ed-4d03-b98e-acba67aad85d" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49857fa0-d2c1-4d60-9999-cbefbb5f2b3b" contextRef="C_1eb7071c-d34e-4235-bcb4-1e3102fea0ef" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">46,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff1fe6b0-9fd9-4ab5-8801-e5d0c8aa86df" contextRef="C_1eb7071c-d34e-4235-bcb4-1e3102fea0ef" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.97</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae1f657d-c565-463e-b5e5-38293107c11a" contextRef="C_55014fe0-62df-4c18-b96a-3dfee38784c1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72b262e3-032f-44f8-a1a6-db65830baebf" contextRef="C_55014fe0-62df-4c18-b96a-3dfee38784c1" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_716f50af-bca7-479d-adb4-cb72b0a7118a" contextRef="C_4b4a0a48-83b4-4a31-a7d8-6183de985fc4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">46,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe44a730-d970-4fe2-ba9c-5873be7cf2fe" contextRef="C_4b4a0a48-83b4-4a31-a7d8-6183de985fc4" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.97</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_270d7590-1658-47b0-b163-cb102b7d10b8_2"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation Expense</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_465d5b54-cbb0-4717-baa1-37586183d7b4" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total compensation expense related to all of the Company&#8217;s stock-based awards for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 was comprised of the following (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.47%;box-sizing:content-box;"/>
         <td style="width:2.46%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:19.304%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.46%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:19.304%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation classified as:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fabcaca-573d-45e1-a378-4cfd769006e6" contextRef="C_5b4148f0-d4f9-403c-af32-f52bc3bd07f6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,277</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d189e292-e3f5-413f-b5c5-fd96404e3fb4" contextRef="C_0dc4367e-b5ab-45fd-bb01-b6a7fb4da26f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,491</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b43cdde8-5dce-40b0-8420-7a8f8c4dbb6c" contextRef="C_b289a523-bf02-496a-822a-4cb3cec3e3fc" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,845</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5075b569-00b7-4bca-ba5f-ba5154b7e35f" contextRef="C_1cbafbb3-bb44-48c7-9275-169d82fbcccc" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,054</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8fe8499-253b-4468-90a8-32e59e3421f9" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1cd718f-cc35-417e-a1bf-979e78b5605e" contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested equity awards wa</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61bae522-7ae3-44dc-af97-28e8267e8b6c" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">17.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over an estimated weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_17cb9da2-96ae-4657-83ce-fa51974ca6e7" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.4</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_2517bc10-42c7-4f9d-b5e0-e789a6e173f2" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. Segment Reporting</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company currently operates and manages its business as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7527155e-ec9e-456f-95e7-d23701138414" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:NumberOfReportableSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment, to develop therapies to protect transplanted organs and prevent rejection. The Company's chief operating decision maker (the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;CODM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;), is the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_51220781-3cc8-4cb6-858a-6cda531d29d7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5f8da7c8-f73f-427a-8280-3828bcbdb438" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:FactorsUsedToIdentifyEntitysReportableSegments"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.</span></ix:nonNumeric></span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_49cee393-18e3-4648-b5d8-3eb7be1b8087;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment entity, </span><span><ix:nonNumeric id="F_52d2d798-3a56-49e6-ae3d-7389452fc750" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. </span><span><ix:nonNumeric id="F_76ac7946-5c89-4b53-9d46-795811f2ceca" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true" continuedAt="F_76ac7946-5c89-4b53-9d46-795811f2ceca_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant segment expenses, as provided to the CODM, are presented as the following:</span></ix:nonNumeric></span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_76ac7946-5c89-4b53-9d46-795811f2ceca_1" continuedAt="F_76ac7946-5c89-4b53-9d46-795811f2ceca_2"></ix:continuation></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_76ac7946-5c89-4b53-9d46-795811f2ceca_2" continuedAt="F_76ac7946-5c89-4b53-9d46-795811f2ceca_3"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:70.026%;box-sizing:content-box;"/>
         <td style="width:1.66%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.078000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.16%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.078000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - kidney transplantation programs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09843e49-44bc-40bd-94cc-b7760a1c701b" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="eldn:Tegoprubart-KidneyTransplantationPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,452</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58902951-6484-416a-96ee-4516115f9f10" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="eldn:Tegoprubart-KidneyTransplantationPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,940</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - other development programs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_645cbbf2-5457-4ce0-9c8f-93e94a223bc3" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="eldn:Tegoprubart-OtherDevelopmentPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">306</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de2cad68-59c4-4738-8122-3d02efb279a8" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="eldn:Tegoprubart-OtherDevelopmentPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,186</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manufacturing</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad9930f2-9599-40d8-8ffe-13de5bed4c12" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="us-gaap:ManufacturingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,448</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a8abc7a-bcad-4009-886a-5887e6bb928b" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="us-gaap:ManufacturingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,048</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c626ecc-b7ea-4091-826e-c8833dcfd343" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="eldn:Personnel-RelatedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,706</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8de1e641-5192-4f46-b6a9-648f625af12b" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="eldn:Personnel-RelatedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,351</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15924408-fbc5-4f8c-abe2-3754c3755a87" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a993aa55-043e-47cc-be89-2592fc6ec961" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2054701-673c-4b62-b878-455d45336c7f" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a019045a-614b-458a-b98e-2a55cfce9f80" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,930</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68a33a76-4db9-4b90-b475-7379e7b26571" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70,577</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1b2733f-f5e2-40d3-8777-0b9aa63f830a" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98d34765-9c0d-4e71-8f81-539ca7c78e8c" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">70,577</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24d158d4-3666-4fd5-a684-1fdaa8bfde29" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">43,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc43c840-9e0b-4da9-946b-5ec61ee258b6" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,924</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ec8a5ad-d687-42ac-a9c6-d2709b6565da" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,674</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2cef754-f051-40c1-83cc-7116b605538d" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30,900</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64b24c9d-74e8-4499-b3e0-3bec71fa404e" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36dfe4e2-d12e-4645-8d2f-8ddcf51a2fd6" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment and net loss</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c82b2569-503a-42e2-8b56-3cfe64645fcf" contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4e3ed88-4cfa-40fa-9c48-f1ef5b1d899e" contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></ix:continuation></div></ix:nonNumeric></div><div><ix:continuation id="F_76ac7946-5c89-4b53-9d46-795811f2ceca_3"></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_71ed61e5-3513-45a2-bc03-cbc0c2970237" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 11. Subsequent Events</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has evaluated events subsequent to December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through the filing date of this Annual Report on Form 10-K. Any material subsequent events that occurred during this time have been properly recognized or disclosed in the consolidated financial statements and accompanying notes.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_fd41f0db-b004-41e1-971b-54e00e5662df" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ErrorCorrectionTextBlock" escape="true" continuedAt="F_fd41f0db-b004-41e1-971b-54e00e5662df_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 12. Restatement of Previously Issued Consolidated Financial Statements</span></p><p style="text-indent:5.391%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the course of preparing the Company&#8217;s Condensed Consolidated Financial Statements as of and for the three and six months ended June 30, 2025, the Company reassessed the rights and preferences of its Preferred Stock, and concluded</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_fd41f0db-b004-41e1-971b-54e00e5662df_1" continuedAt="F_fd41f0db-b004-41e1-971b-54e00e5662df_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">that, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">because they are substantially identical to those of its common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d533dba1-5e3b-43dc-8962-cadfec76962a" contextRef="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value, the Preferred Stock should be treated as a separate class of common stock for purposes of calculating earnings per share in accordance with ASC 260-10, &#8220;Earnings Per Share.&#8221; As a result, the Company determined that it should have presented earnings per share under the two-class method in prior reporting periods.</span></p><p style="text-indent:5.393%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.111%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, in connection with this reassessment, the Company concluded that it had incorrectly classified the Preferred Stock as permanent equity in the consolidated balance sheets. The Preferred Stock includes a provision that, upon the occurrence of a fundamental transaction (which includes a third-party tender or exchange offer) in which more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_522c1865-497c-4ef3-9e80-e46c72342f9f" contextRef="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68" name="eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> percent of the common stockholders receive cash or other assets, entitles holders of Preferred Stock, upon any subsequent conversion, are entitled to receive the same form of consideration, even if they did not participate in the original transaction. Because this feature may result in settlement in cash or other non-equity consideration upon an event outside the Company&#8217;s control, the Preferred Stock does not meet the criteria for permanent equity classification and is instead classified as temporary equity under ASC 480-10-S99-3A. Although a tender offer is not considered probable as of the current reporting date and redemption is not deemed probable, the existence of this provision requires classification as temporary equity. The Preferred Stock is not subsequently remeasured to its redemption value because redemption is not considered probable.</span></p><p style="text-indent:5.405%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;margin-right:1.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of these conclusions, the Company determined that a correction was necessary with respect to the classification of Preferred Stock as temporary equity and the presentation of earnings per share under the two-class method.</span></p><p style="text-indent:5.405%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accordingly, the accompanying financial statements as of and for the year ended December 31, 2024 and December 31, 2023, and related notes hereto, have been restated to correct the classification of the Preferred Stock as temporary equity and to include EPS calculations under the two-class method.</span></p><p style="text-indent:5.405%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.333%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3" contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" escape="true" continuedAt="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_1"><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The impact of the correction of the misstatements is summarized below (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5c8b624-96b7-45f1-b580-df376cc2eb85" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2bececed-0dfa-4d52-aee8-9fb7011c44f2" contextRef="C_5139fbdc-2a80-417c-851b-8e6f70ab7358" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2023 and 2022:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39705e1f-831d-4514-9e2a-d7638ddb966d" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7eb84436-2ae3-43aa-975b-37fda47d6b93" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2bb7a99-279f-4197-9f2b-acbc89cdb9e9" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6bce14b5-bc35-4824-814f-a5a3f0f8c7df" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bfae1464-9754-4084-8f40-55bc11baf9eb" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4f9abaab-8bc0-4007-af47-46ee144921ce" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ef87a10-7ea2-4484-b82b-0899cdc00d3a" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d6f9260c-bb47-4b3d-95cf-cad8fb6fc217" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">117,970</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_665988d1-6740-4942-8adb-ae921e7246eb" contextRef="C_cf8e646f-26aa-4125-8f19-71c8b7b07c17" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa65f308-ace5-4c51-8894-284f83702ee1" contextRef="C_eacde0ed-4c02-4709-92f2-d1a867f74b43" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_729b32e2-65c2-49ee-bb64-a66fbb57d869" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31fae4b2-52f1-4f5a-b59b-971ddf246443" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1ff88ae9-dc16-41c7-a414-ee902d61d0c2" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74d356e8-0ab2-4abf-9438-ab97d0888cb0" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_49776d42-3eda-4bd2-bd45-42883a314ddc" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3083d76c-dd75-45c0-9691-23b1c0c9a757" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_22849508-8c5f-44ed-9d63-974263199092" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ae84f01-63b3-4fff-bb2d-0d12176bb556" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ec4344d7-3ff4-4001-bd44-b82887a4b4e0" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,204</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ff512c0-ba02-4ed7-a87e-00b87ef8cccb" contextRef="C_badcfa13-507d-429b-9dee-2e0d08eb9c29" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_802d8464-20d0-42f3-95a9-b63c379109f5" contextRef="C_c9ddc65a-8b52-48ef-898a-ad6a8da8614d" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ae63ab0-9525-4336-a658-65d42fc90fd4" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2f95c36-2912-42d1-b815-85af4f9a4a19" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_96711a7e-14c6-469e-bd62-29615aca27cd" contextRef="C_5139fbdc-2a80-417c-851b-8e6f70ab7358" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2023 and 2022:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48acf8ab-8fa0-4d86-a57a-48c3b84217fe" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7d830f40-1a2e-41c9-965d-eb247b8e6b93" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2500f0e1-e104-48b7-bf84-44e26bd15e60" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_471c9448-11dc-4b63-95de-2eff30bb918e" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d533923-cf8f-42f9-8b64-ddde9329d533" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b84aa5a3-545b-4005-9d3a-5c3641127e1b" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_621767d5-bfa8-4d21-94e9-a61609b1ef83" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0b6aa5e2-f949-4bf8-977e-c6b00684b7fb" contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">117,970</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_5853a7a4-cb72-4798-821a-733264c3ef61;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c28ce8de-197a-4f3f-9904-8e00f34bd0bf;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_87be77a3-13bd-421e-9cd7-c93000cef4f1;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfa2d55a-09c2-4124-ba29-d923c2cc3b7d" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0eb9a227-7525-41d4-83b3-4587e3b9811c" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48f1ecc3-0ad2-4d92-b76e-3710a276fabf" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fa9a1f9e-62e2-4f37-8aad-f84cb17b4faa" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f7bce03-8fe8-4a7f-8236-fb71ca9db6ff" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_72b04844-ffbb-4334-b76e-77138be405d9" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7a2c2cd-ffa7-4d9f-a57c-b03bd147e9d9" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1e09418d-ef8e-4f8c-853b-5cdd1478669e" contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,204</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_159afcc3-d066-4b5b-b4ad-7e01474c1944;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_216519ab-59aa-4af1-9fab-606834bbb418;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_0af8023e-7ef3-4515-a7a7-678b84c987ec;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66ca4312-bb98-4b78-9263-6226875e759c" contextRef="C_272a92d8-c7c2-4314-90c3-9d41142b0d01" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">326,586</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b70a61e3-a8d6-4407-b3e4-9fc0cfe349f1" contextRef="C_e551203c-60a1-40e8-b225-d4b5814f0ce2" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09e45218-7dd6-4698-939c-097668215e9f" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">270,892</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f9a3326-6a9b-47d7-b642-3dfdf8c07fc6" contextRef="C_272a92d8-c7c2-4314-90c3-9d41142b0d01" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,208</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dabf7ab9-0330-428b-b188-9a6afc73e0bb" contextRef="C_e551203c-60a1-40e8-b225-d4b5814f0ce2" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c590fb1a-790c-4307-ba68-232a255d40cf" contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">48,486</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_fd41f0db-b004-41e1-971b-54e00e5662df_2" continuedAt="F_fd41f0db-b004-41e1-971b-54e00e5662df_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_1" continuedAt="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_2">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37543765-ffc4-4de0-a63f-d4d00b57148c" contextRef="C_217e35bf-2776-4ae6-b1a7-3ae6aa8a1aff" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1e6e4e42-4159-452e-b5bf-320073f7137e" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ec35dbd-c6b9-4940-b5d4-20c428c49a6e" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4e4d265b-399e-4e0f-a112-99616d9d7d3d" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3008785b-674c-443a-948e-dd3d7928464a" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_dc10896c-53bd-4ade-b0a4-7ea8f2804b28" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2bae0912-0609-4a54-8d09-8d53ea449ebc" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9f585e51-4a02-4814-bf63-a1d965697fc2" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ad504129-dc36-429e-9cff-27ad808f1024" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a95b0d9a-9abc-47b7-aa8e-ee7192b2b2c2" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_756d68ff-253b-4bd0-ad3a-28f8f02350c8" contextRef="C_4e98b79e-91fc-4e20-9732-817693c930ab" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89b538d3-10e6-416a-8ea5-41a27a00d60f" contextRef="C_25aac8fb-8999-48c0-9388-bb4417dbd19e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f380ba07-5473-4438-b632-fb34e8e40b5f" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ccfce52-3946-4188-acca-62bf7e900acc" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_bcfedb91-eda8-4ed3-95f8-76459badb018" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37c817c7-fe67-4f04-8dda-4b4b2824bb51" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_87e053f0-1fed-4548-9ca7-ae0e8dff01ab" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef5f2c05-a1df-40b1-adc2-9c52a6f9637c" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e75c41ab-fc41-4b8a-aa0a-e1ef0e76ceed" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_729969df-a14f-41d5-9334-6ee32dca39ad" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_eae48fd2-ebc0-41ba-961b-fd19e2001357" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3a474c0-c8db-435b-9c4a-b77cc743da5b" contextRef="C_3599cba8-8efc-4581-af6d-86c0dfa8c474" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d32b722-be23-4704-9745-047877d4a414" contextRef="C_b96fc6ba-37aa-4cd4-a5d5-3bec6407f9e1" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8168450a-606d-4cb8-992b-fc0e44a9fc84" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c3db165-ad5e-45b9-965a-c8568f4d39ed" contextRef="C_217e35bf-2776-4ae6-b1a7-3ae6aa8a1aff" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d0d50e60-e77c-4eec-8fa7-7ab9ea8494df" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13c79936-0f65-4a7e-8c1c-d88e476969f0" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_43ee66f7-988b-4d42-9c39-c88760021b47" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4b9b0cb-b71c-42ca-a103-cecf7c4dd591" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_809e6e44-2a8d-457b-ba77-889fdbda3255" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_566bece9-5eb3-45a5-9067-7d5d61e47b01" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f206e532-c129-4877-979b-f268c4b15ecd" contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_80087297-b9be-4090-940a-ffa2a70a6a4c" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_538fee67-f70b-4d6c-9b75-ed4606d7950d" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_6bb67e40-7995-438a-8c0a-20c0a769173d;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c377af31-8b8b-42b5-9eae-9f9fb6815960;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c6895469-f099-4775-83e9-d61a31e2f6fe;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c79fd526-90c7-4990-9041-4663cb797220" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9675f328-9974-4e6f-b1f6-c9ab7d7d6e09" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_830c46b2-2ad5-4cf7-ac04-fbb7463b371b" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e203700e-97d2-497f-a561-cbac8901f53c" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d4419a0-5569-4b84-bf19-343c57361f88" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fa63c90f-f26e-4f92-a671-9cecbf3e5a93" contextRef="C_82dde098-0756-4a72-8753-5533b164777f" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fad76950-f992-4aff-bf0f-03f1a09374ae" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7731f399-e547-4173-83de-30d224f26c75" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_7a49ba59-b1e6-4d93-bc53-ad26ea9e9103;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_3ecf4669-c43c-48e7-8139-38d3d48178bf;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_b7cc2b0b-bf5a-4561-9ed3-8272893f1903;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa4b03ba-6908-4f05-9e94-0bcf8da0027f" contextRef="C_d91ae884-2a3f-49df-8b4f-3a13d684a3c4" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">473,640</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8fbbc2d-7a75-4220-8659-6b739f32ddbf" contextRef="C_96eaecbb-fb70-46b6-9d46-a5b4e45e90ec" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_222fc5ee-732a-434d-a402-c52f0250d01b" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">417,946</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fa9726d-1c1e-4093-ad61-b29544b80365" contextRef="C_d91ae884-2a3f-49df-8b4f-3a13d684a3c4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">118,140</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4000b572-3777-459d-b0ab-6642d9466add" contextRef="C_96eaecbb-fb70-46b6-9d46-a5b4e45e90ec" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6108df94-5a99-4667-bb95-044615b9ec8c" contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,446</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.44%;box-sizing:content-box;"/>
         <td style="width:1.9%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.38%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.9%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.38%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended<br/>&#160;December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a90637d8-9854-4f3c-8b15-313aac0a75dc" contextRef="C_3991e991-873c-4c8a-a9a0-9c14307b5dc0" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7d5d632c-d366-4162-a386-94f6330dff11" contextRef="C_3991e991-873c-4c8a-a9a0-9c14307b5dc0" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">4.73</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_220736a5-dfd0-48bc-a81d-daa61176f5ee" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ae10671d-ee8d-427f-8813-7f5e731423aa" contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">3.74</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff3bf7e2-6536-4a97-aaaa-83db4535c88a" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f9884bae-d11d-4e88-94b0-19f09ae21d3c" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">207.58</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c281bc88-75ed-4465-852f-600320dc6d94" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3d079a98-0488-413d-b09d-109d7356343e" contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">118,268</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended<br/>&#160;December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cff7c2f8-fcf5-4d74-9593-ee9d3d7f7a72" contextRef="C_5399ff8f-db17-415f-bfac-019c294b34eb" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f040a969-8476-4c26-8357-5801a62907f2" contextRef="C_5399ff8f-db17-415f-bfac-019c294b34eb" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.75</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_713654e4-bc84-4f99-8adf-bf415f0590ad" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_17cd2686-60da-4deb-8a5d-a8e9be709e41" contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.66</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f064b9e-c471-4f4f-b349-1cad5fe5d91f" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_98b8d3fb-3723-471a-9212-121fe5957844" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">36.61</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7488b15b-11eb-4db6-b276-8fbc0395bd47" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9110b11c-f8cf-403c-b5c5-7dff7b6939b3" contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:continuation></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restatement of Interim Financial Information</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The misstatements described above were also material to the Company's unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2024, as of and for the three and six months ended June 30, 2024 and as of and for the three and nine months ended September 30, 2024. The Company has restated its unaudited Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations and Comprehensive Loss, and Condensed</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_fd41f0db-b004-41e1-971b-54e00e5662df_3" continuedAt="F_fd41f0db-b004-41e1-971b-54e00e5662df_4"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) for the quarterly and year to date periods ended March 31, 2024, June 30, 2024 and September 30, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><ix:continuation id="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_2" continuedAt="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_3"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The restated impact of the correction of the misstatements is summarized below (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>March 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7cd8b63-ab7e-4793-bc5d-067ba8422f26" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_69b69135-51aa-49ad-91b9-76af78b157d8" contextRef="C_d77b851a-bf31-477b-8902-1719de442c66" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at March 31, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75f4b60b-a0b5-425d-b72a-b681c200bf98" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3e775ffd-8c0a-4d2d-9744-4d415e1875ae" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_167d426c-d249-476a-92d6-bff5e79f282f" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_19ded6f6-addd-4b2d-a03c-c6e3f8e476ba" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54a88389-1e29-49df-90fa-10a9f379acb4" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d524f863-da3a-403b-8349-cdd5c95abc23" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_68226f5b-fc68-4f26-9670-c869803fb979" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a02123cc-ab18-479c-b50e-849c4ca18dfe" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4c5ac1a-ad46-45cf-a5d2-b37639ce4680" contextRef="C_d5073177-cf57-43ab-a425-174fa4e3220b" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33933a10-6460-4a90-93b9-553ad81b6369" contextRef="C_c2c9a382-79a3-4da2-9405-110cffced194" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d2af216-ae72-49e9-9b2e-cbc643805762" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f3cea41-094a-4d23-b633-ab978ec17e1e" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b00c4294-563e-4d5f-bab3-c5ee1322bee4" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23fada61-9339-463c-827e-a22d1c6a84ee" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_5b7b9356-943e-47c4-bf34-f1eab60374fd" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e324b6e1-1aa6-49ec-9fa6-5b2c23be2e8e" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_8f965b1c-7c32-406a-8f12-218e2e72fdfd" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_520a1b4e-d4ce-475e-86d7-d7e2f87ff5bc" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f9c4a121-0dae-4019-b564-2c52d7287849" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43a4fe62-b3a9-4fb9-b3a0-dcd1f51b24a4" contextRef="C_7c4a8f01-0913-45fc-a8e1-2c98ad756cf8" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e354a55d-64e5-4af8-9f1c-39c1c60a9ced" contextRef="C_5e4181d3-32bb-4105-807d-d8ddef98922a" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c97a506-0f42-498f-9366-69801b8deafc" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d1a5a7e-ec31-4191-8d31-c1ef5d7b7d67" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_feeadb83-a9c9-426f-98b1-4402100c1388" contextRef="C_d77b851a-bf31-477b-8902-1719de442c66" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at March 31, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e489da95-7f99-46d8-a746-0d80b5188146" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b9c93e53-736f-4c0d-b9d0-35c0ad678995" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4964d6bf-d3fa-46dd-9603-b5f39d87e5be" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7d82cd09-98da-4fa8-8443-596f6f1b04f2" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba5700b4-ad28-44b0-81db-7d12b2488d52" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_60ca2a21-88fb-4334-940a-62f54f091632" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4e771937-0ad3-4707-afb0-e182e49b3aed" contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d266be15-2097-455c-a87e-0f5bcd7a6465" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_2a99917e-c2e2-45cf-b60a-d41b5d89eba1;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f2ebfc2b-8b13-4228-bc2d-fad05f7d9efa;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_1303f048-cd42-4ee1-9b21-e85795fc53bb;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d6a3cde-a77a-4c22-a87d-ef3289135f0f" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_329aecf7-bc43-4caf-8d18-35ef3d0cb35f" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3381a0a0-9ee1-4e64-8205-d3ce2674edee" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9e10801d-7519-4135-aaaf-7c7f18560309" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db9f6e06-b244-4c37-b6ab-b06439d5e07f" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b4525d36-f34c-4878-8bd8-c6779f7e0a53" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_57050bcd-c6af-49f9-aedc-e0d685ea25cf" contextRef="C_835f8a45-f710-4451-9172-67b1911d289e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fb5b555b-d49a-41f9-ae29-2da74944ca8b" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_6bc77dc0-e7bb-4f64-9a27-5fac7e301766;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_0dada35c-b9ab-4d7c-908e-93714dd5302f;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c911075b-c1e4-44d9-bc77-3ee81c355044;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0710b8de-5644-4d38-93c5-e99b6bad1320" contextRef="C_133e23b5-720c-48df-8aef-367581072be4" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">328,280</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b967598d-16d2-4b44-ae16-f3f77f9fc4a2" contextRef="C_496b6f07-43d9-4f3d-abc8-59c28e2608e3" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0513da6-243c-489e-ac9e-0cd07d4654af" contextRef="C_584b9a09-2946-4d4b-8bd8-27f45b3d9605" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">272,586</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5653903-8b2d-4105-b28d-61e68ef3c654" contextRef="C_133e23b5-720c-48df-8aef-367581072be4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">14,728</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6eb62c71-a479-4340-8242-10a132c5d6b7" contextRef="C_496b6f07-43d9-4f3d-abc8-59c28e2608e3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0142b32b-b20e-422a-afeb-1e7fbc27aa76" contextRef="C_584b9a09-2946-4d4b-8bd8-27f45b3d9605" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">70,422</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.44%;box-sizing:content-box;"/>
         <td style="width:1.9%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.38%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.9%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.38%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Three Months<br/>Ended March 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a482bc17-8c2a-4c71-bdf5-eec0d89ba2b4" contextRef="C_306cf456-d3e1-471c-88e6-bff01256a178" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_812161b7-706a-4807-afd4-6915df31057e" contextRef="C_306cf456-d3e1-471c-88e6-bff01256a178" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.79</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90bbf0dd-ae91-4193-8d8f-6e095625c923" contextRef="C_68b6bf49-13a1-4dad-b84d-1a3baa6fc701" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a1437eba-4777-46e7-ab0a-067a3025b187" contextRef="C_68b6bf49-13a1-4dad-b84d-1a3baa6fc701" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.65</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06479add-ce6a-460e-8043-b384d48e58b6" contextRef="C_fa6b5f79-cd28-4846-8782-687a801dd0e7" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_70e69d78-1b73-41b7-a225-9727b2fa5c70" contextRef="C_fa6b5f79-cd28-4846-8782-687a801dd0e7" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">36.12</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5959fe68-3790-4d58-b38a-fc68aa78a3a0" contextRef="C_fa6b5f79-cd28-4846-8782-687a801dd0e7" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3459b488-7b2b-4e73-a744-717756ba0aba" contextRef="C_fa6b5f79-cd28-4846-8782-687a801dd0e7" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_fd41f0db-b004-41e1-971b-54e00e5662df_4" continuedAt="F_fd41f0db-b004-41e1-971b-54e00e5662df_5"><div><ix:continuation id="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_3" continuedAt="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_4">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f060f7a-06fe-4ff9-ba65-1a9ffc397dc8" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7e46650b-9470-496b-8282-b78bda605512" contextRef="C_06358e90-5416-4479-9715-a95bcd5b9a71" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at June 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_821a9ac6-2b4e-4867-85b3-45b9778911f4" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f2e8a2c5-4c34-4093-923b-c40e5e878fbe" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1c0a277-fc6b-49b9-9f20-67cc8b5dcfa7" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_bc9aecd7-a0b6-4739-8c04-08d7683655ce" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc8f5fde-f3a6-479d-bec2-c3aabec1e04d" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9a097077-6cd9-4efd-8349-1fb2f031d034" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9146c003-7bb0-465b-9c14-d0bae7a4205c" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d0932cc3-794a-4192-bdc4-90e23e8019f8" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b946dbc-d5c0-42dd-b21c-53b676807475" contextRef="C_6aa424ab-8817-4180-b5c7-60582405c85e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0946ea8-110c-4ebd-827f-c7efdaa5e643" contextRef="C_e2f48d5e-c74e-4701-855c-ac8c4f15fd2c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_664a1a75-04ba-4f32-a39a-d25b79d6a024" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03b2a915-5500-4b43-8fb0-c51ddb2264a7" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_541f7342-1c21-4a47-8fc5-90be638ecc78" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22ca762b-043d-42d3-a63f-ff6f0e44a60c" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_718715f0-1dbc-4b8b-b3ac-d61781bd9312" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94b373d3-8331-48bf-8212-611af6cc3b25" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b1d0eb11-872f-4d92-9166-028b4ac31dc7" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b8212f93-cdf5-4661-9a81-638175a8625b" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d1454aba-c93d-428b-9c83-26e78228e59d" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27990713-f97f-4b29-9d40-0c4f385ad1c3" contextRef="C_81e90e3c-c0f5-4f40-8209-ed87e745d4b3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4697220-585c-4389-9fde-72d71bd80708" contextRef="C_a9a6298f-64b0-403f-9753-1954555ffed1" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99ffc34b-fc28-43d8-bb8a-70be3adf3552" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17392be0-153d-4a93-bba5-b942e10fd81a" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cf7ae36f-f9d5-4dbb-96a3-b0d6dbf22cf6" contextRef="C_06358e90-5416-4479-9715-a95bcd5b9a71" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at June 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbcf100f-05bc-4f24-a32c-0413ff30dcfe" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_aaff0366-5d77-408c-9aef-1beafa79d264" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48aaa48a-008c-4715-b870-d2e6f41bca92" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c2ba38c5-8f47-421d-bc90-6fe8d8bbb5cb" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a25c343c-65c9-4ffb-8cc4-b8bbf8d362f9" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d64d60dc-1d59-4f5f-a756-394abb49288e" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9bf89f35-0362-4d6f-a646-854da53a5762" contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2081faef-ea12-4243-bcc7-02f550419022" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_340180a0-3a27-4a0d-8de8-cd273d95f58c;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_cd553f55-0d93-4b97-8756-5443f53b6f9b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_aac64cdf-40ce-4e29-82c3-c243c042d20f;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ed9fd15-4c13-435f-9279-fd62e3a1368a" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a319422e-972a-40ba-a998-cf8177e032e5" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67294f36-e2f3-45fa-8e93-c410623e0bfa" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0c985389-1402-4d31-b7d8-0bd72ea56151" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df5d2dc2-3126-411e-9b81-45030d684257" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_31398114-36b2-4caf-b87f-53dd2c30fece" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_75a85c40-341e-42b4-a31e-907d044b4cb8" contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_37246569-8880-4a23-bc6a-83233afbcc48" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_987f1dac-17cd-48c8-99fd-7394ead1371b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f28eec08-2fa6-4243-b694-0b4d71ef0a06;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_a65f2652-7b7d-4f58-9664-7b9d2fb6a05a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35eb6b01-8354-43bc-8537-115bbe4c95da" contextRef="C_c0d65a75-73a7-4e65-8ca9-7aa239bd0a7a" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">379,400</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b63a028-a921-49e5-986f-7d5483c306d6" contextRef="C_51337a7e-dc7e-43f7-9229-34f04adbdb0b" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f98a22fa-0286-4b96-bdf5-68f212d70049" contextRef="C_3af4da93-98a8-414a-b035-34ccd64d6382" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">323,706</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae2cd256-16fa-40f8-82ac-b68a7a985288" contextRef="C_c0d65a75-73a7-4e65-8ca9-7aa239bd0a7a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">8,501</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fdbbb67-73df-4472-bf22-23cbe3e656e3" contextRef="C_51337a7e-dc7e-43f7-9229-34f04adbdb0b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_809c7921-e90b-496d-951b-40c35ac4c5e4" contextRef="C_3af4da93-98a8-414a-b035-34ccd64d6382" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">64,195</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:46.359%;box-sizing:content-box;"/>
         <td style="width:1.381%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.964%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.381%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.964%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.641%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.964%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.381%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.964%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Three Months<br/>Ended June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Six Months<br/>Ended June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0329fce8-3cd3-4898-bbda-7dc3b5551b4b" contextRef="C_10891653-0f3f-4d75-9cd2-9876d5144cac" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_932b557a-ef2f-4b9b-9f6b-198bb094dfe8" contextRef="C_10891653-0f3f-4d75-9cd2-9876d5144cac" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.06</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9146b80-0b36-40d6-a910-089bdebb5345" contextRef="C_8a2e70e3-2ed3-407e-a0af-d1a1cd2c2189" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_20ce1306-4968-4eec-9fd7-308b5c3992ae" contextRef="C_8a2e70e3-2ed3-407e-a0af-d1a1cd2c2189" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.92</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92badeb1-222b-4ac6-a038-0fb0046e835c" contextRef="C_6430dce4-296d-43c0-8a5c-29414ed1adfc" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f6b197a1-1bde-4a5d-9a79-4d02371898ee" contextRef="C_6430dce4-296d-43c0-8a5c-29414ed1adfc" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.90</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7240d684-c2d2-4dff-a208-622f6af6bb06" contextRef="C_c0555d1b-b168-446f-b8aa-3b629d5033dc" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_43ee9c9e-4c64-46c8-a0fe-89c62c82c31f" contextRef="C_c0555d1b-b168-446f-b8aa-3b629d5033dc" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.61</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ce52e45-27c1-4cae-80ff-0c2fdedbd7a2" contextRef="C_fe356c11-e5db-4e96-910b-23f6c7c1d931" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b93a00d7-3e96-4134-9f35-cb7c835a40de" contextRef="C_fe356c11-e5db-4e96-910b-23f6c7c1d931" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">51.29</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92039c64-02c3-4cc4-af78-3293f336c07f" contextRef="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ba34e7b6-19f0-4b0c-ac89-1c57d3a1e268" contextRef="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">89.60</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_339a224e-29eb-43f5-a976-210a935334ca" contextRef="C_fe356c11-e5db-4e96-910b-23f6c7c1d931" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_06cb61bf-2ed8-46a4-a3fe-3c566529a08f" contextRef="C_fe356c11-e5db-4e96-910b-23f6c7c1d931" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab97e132-3711-469b-aa88-26966e0563d3" contextRef="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0d4d1997-a005-446f-ab35-b641bddb3868" contextRef="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_fd41f0db-b004-41e1-971b-54e00e5662df_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_4" continuedAt="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_5">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.138%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>September 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df1a060f-0f66-40c9-8c76-4523f0b57da4" contextRef="C_a19cc353-9e67-42d2-ad34-2b95ddbd1abe" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cacb72f9-6fc7-4b41-be6b-4c917c97e02b" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at September 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e126c93-3c93-440f-a09e-f5b0ac5fb547" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6fe8a9aa-7454-447b-84be-6dbeae82d1f0" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b7e361c-f6ea-4cf0-b68a-b9b3ceb7e24e" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4b3b7768-1c2c-4ba5-b4d8-4aa574253439" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0086ed46-e4c3-43e0-a022-8085de9e36ca" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9984ff40-e7ba-48b1-820d-041e47225b7c" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_94b60f3c-c0c6-4b4b-b7a4-a33f857c754c" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_80e1d659-af9f-48e3-b7b9-9bb83319f99a" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f4ec16e-c679-4041-9158-c99885f3211c" contextRef="C_6081fd86-dcbc-49fe-ac41-4cb855d48774" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4339764-c319-4b18-8e03-e8f609771c5d" contextRef="C_0dfa6572-7fa2-4beb-9686-2196c62325d5" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adbc7ec8-d184-444d-8aba-7b9c46e8443d" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0ae6e55-ab3c-40fe-b77f-67007ea4475a" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_bedeffee-8eaf-4b35-861e-b2b984afd8e2" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c59d028f-cdc7-4d87-87fa-a94e4aff0d78" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_aa3af9c2-e9c6-4379-8d74-99f4c7f27415" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b43af5ea-9467-4d7c-92ec-53c769f56ea6" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4e171f38-f4ff-4824-8cfa-54a9bdf929f6" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_31cd0082-9365-4da8-b47d-0c8d1609c2d2" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9b930572-0a22-4e00-94d6-225462ceda47" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed5030cf-c03c-4c18-8dac-3f5b40c5acf7" contextRef="C_7ebd9556-342d-4273-9d4e-cbafb9ae6e10" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eff35eca-08b5-4761-b625-13df83a5c088" contextRef="C_58cde265-0a3e-4c69-87c1-a6052820869a" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5865de58-4306-4215-89e2-d99a0d949121" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,151</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_112a70aa-6bfe-46f6-a990-96497d8a2896" contextRef="C_a19cc353-9e67-42d2-ad34-2b95ddbd1abe" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a9d3cb8b-9f72-4faf-b7ef-f00f6989ab35" contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at September 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_561a0490-dff0-4cd6-860b-447686d650e0" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_5876229c-f098-42d5-832f-bf1136561866" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9cba6729-e9d8-4243-bbf1-5b1e99593b5a" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_27a32e78-cb04-46da-aab1-2b1060394e3d" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62201e14-e56b-4f1f-9ba5-1afbf560066c" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_8c4ea1ab-89fa-48a9-acf1-f2efe93d0b5b" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_efd19ca0-49f9-46a4-8917-62238b2b3ab6" contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0f35cfd5-bf66-421b-bdb3-746c8e795f71" contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_3435e4db-2763-4d2f-8c7a-737f3a13270a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_2951b263-900f-4b8d-a786-60aa356956ac;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_53bb6073-43e0-4db5-9b19-9926bcc63d4a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9d23e26-1a3f-448f-ba54-3beb35576471" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0ff67ca9-1e9d-4c4a-9340-9b9c543cc42c" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4764e025-57f7-4159-ba5c-dc4796264e24" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e04313d0-8399-4cf3-9f61-2fc4530732d6" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a2e2ff5-beaa-493f-a859-01b6fff3cb46" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_aa4118a1-2728-4320-b793-a607058dd2c1" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_bfd48b3c-c39e-43ab-9046-94279d088d6a" contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f2b88f04-1d6c-4c6e-ba17-8bab158f3b18" contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_0bb67f5b-fcbc-4b89-907c-5702aef7f8c6;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_586405c0-5bfb-4612-b423-2372508e93d4;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_bb70f791-1438-45ad-a7f7-20802b5dd599;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c26a618f-247c-417e-a8ca-95ce88bb02be" contextRef="C_8b40a221-b271-45e7-abea-861aa3e69388" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">386,884</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47d8e516-ef79-491e-a595-bf1867fd2771" contextRef="C_126dec65-5fb2-4ba4-8e32-3d122533acdf" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b5e5e69-bee7-4467-9b9a-e885ae5933d6" contextRef="C_b526d623-851d-4505-bda0-f3f5d7eef6d4" name="us-gaap:AdditionalPaidInCapitalPreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">331,190</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9c1a36d-24e3-4123-b79b-dd3f977db455" contextRef="C_8b40a221-b271-45e7-abea-861aa3e69388" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,058</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1351b12c-fa77-422a-b013-2765a254ce09" contextRef="C_126dec65-5fb2-4ba4-8e32-3d122533acdf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,694</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3fa9bdc-9830-4024-aef8-5125edc28131" contextRef="C_b526d623-851d-4505-bda0-f3f5d7eef6d4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,364</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:46.359%;box-sizing:content-box;"/>
         <td style="width:1.381%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.964%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.381%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.964%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.641%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.964%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.381%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.964%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Three Months<br/>Ended September 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Nine Months<br/>Ended September 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss attributable to common shares - diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0aabfb9a-0cab-41c6-9901-be0e23041183" contextRef="C_d3a91ef5-d925-4944-988e-a6b6d2a5d9fe" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">17,504</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63e36139-a3e5-4176-8c99-a8778f67f371" contextRef="C_d2875a70-0df4-4171-877a-c58e658fdb69" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,703</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dacf846d-76bb-449d-ba1d-faa7209c609d" contextRef="C_f0263327-04ec-403c-a565-39214d3f5d1b" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">61,086</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09ec60d4-1b98-480e-9161-5b321d65404b" contextRef="C_3f5369ce-0e85-4351-974f-ce7061c1e396" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,230</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca9f4d96-85fb-46fc-b86f-be4f66f8532b" contextRef="C_d3a91ef5-d925-4944-988e-a6b6d2a5d9fe" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.32</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54759b4e-4f77-4f15-b78d-182a82c7572c" contextRef="C_d2875a70-0df4-4171-877a-c58e658fdb69" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.28</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08ae77ec-1e36-479d-8bd3-a7ed0715d80c" contextRef="C_f0263327-04ec-403c-a565-39214d3f5d1b" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.42</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ce11896-f92b-40d4-a54c-f497b28cb805" contextRef="C_3f5369ce-0e85-4351-974f-ce7061c1e396" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.23</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stocks - basic</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7de1f2ee-513e-4144-bc2c-0b503dccc729" contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,666</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_101d38d7-4f39-4800-a570-38948e3faec6" contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">852</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47fd73b3-1375-40d7-9bcb-5750b6308483" contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">58.21</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_680c959e-8671-4e3f-a751-9bf00f4f977b" contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">7.44</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8090e972-deb0-43eb-8842-d24099c20836" contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7df83913-3be6-49e2-85ec-7e24f8574bcb" contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss attributable to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stocks - diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b87a80db-b190-4a1f-9afc-3c380ca0c566" contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,801</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2f8885a-df1e-4e65-b54a-9edfae74937b" contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,856</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99f47fb8-76a1-4bd1-94d1-fc76b919fe47" contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">15.73</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8f12eba-19d2-4b41-939a-1818e7128c84" contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">68.60</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bac895b4-7813-4cd5-becc-b067528e0fa8" contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c271ec97-0b1a-496e-9cd1-bfca67d98a9d" contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">114,508</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:continuation></div></ix:continuation></div><div><ix:continuation id="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3_5"></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>eldn-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We hereby consent to the incorporation by reference in Registration Statement Nos. 333-200413, 333-203032, 333-210058, 333-216432, 333-232428, 333-237380, 333-255173 and 333-273900 on Form S-8 and Registration Statement Nos. 333-254890, 333-272052, 333-279711 and 333-282260 on Form S-3 of our report dated March 20, 2025, relating to the consolidated financial statements of Eledon Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K/A of Eledon Pharmaceuticals, Inc. for the year ended December 31, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                                                                                    </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Crowe LLP</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Los Angeles, California</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">August 14, 2025</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>eldn-ex23_2.htm
<DESCRIPTION>EX-23.2
<TEXT>
<html>
 <head>
  <title>EX-23.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1.01in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.2</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We hereby consent to the incorporation by reference in Registration Statement Nos. 333-200413, 333-203032, 333-210058, 333-216432, 333-232428, 333-237380, 333-255173 and 333-273900 on Form S-8 and Registration Statement Nos. 333-254890, 333-272052, 333-279711 and 333-282260 on Form S-3 of our report dated March 28, 2024 (except for previously disclosed adjustments to 2023, as to which the date is August 19, 2024 and Note 10, as to which the date is March 20, 2025, and Note 12, as to which the date is August 14, 2025), relating to the 2023 consolidated financial statements of Eledon Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K/A of Eledon Pharmaceuticals, Inc. for the year ended December 31, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                                                                                     </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ KMJ Corbin &amp; Company LLP</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Glendora, California</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">August 14, 2025</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>4
<FILENAME>eldn-ex31_3.htm
<DESCRIPTION>EX-31.3
<TEXT>
<html>
 <head>
  <title>EX-31.3</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.3</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATIONS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, David-Alexandre C. Gros, M.D., certify that:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of Eledon Pharmaceuticals, Inc.; </font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and </font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions): </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting. </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:47%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:3.74%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:47.26%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: August 14, 2025</font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.4
<SEQUENCE>5
<FILENAME>eldn-ex31_4.htm
<DESCRIPTION>EX-31.4
<TEXT>
<html>
 <head>
  <title>EX-31.4</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.4</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATIONS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Paul Little, certify that:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of Eledon Pharmaceuticals, Inc.; </font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></div></div><div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and </font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions): </font></div></div><div class="item-list-element-wrapper" style="margin-left:5.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.5108231948175064%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and </font></div></div><div class="item-list-element-wrapper" style="margin-left:5.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.5108231948175064%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting. </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:47.251%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:3.499%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:47.251%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: August 14, 2025</font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Paul Little</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paul Little</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.3
<SEQUENCE>6
<FILENAME>eldn-ex32_3.htm
<DESCRIPTION>EX-32.3
<TEXT>
<html>
 <head>
  <title>EX-32.3</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="z-index:2;min-height:0.75in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;" id="exhibit_321"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 32.3</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with this Amendment No. 1 to the Annual Report on Form 10-K/A of Eledon Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), the undersigned, David-Alexandre C. Gros, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.752626672113803%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1).</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of <br>1934; and </font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.752626672113803%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2).</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:5%;box-sizing:content-box;"></td>
     <td style="width:45%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: August 14, 2025</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.4
<SEQUENCE>7
<FILENAME>eldn-ex32_4.htm
<DESCRIPTION>EX-32.4
<TEXT>
<html>
 <head>
  <title>EX-32.4</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="z-index:2;min-height:0.75in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;" id="exhibit_322"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 32.4</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with this Amendment No. 1 to the Annual Report on Form 10-K/A of Eledon Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), the undersigned, Paul Little, Chief Financial and Accounting Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.752626672113803%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1).</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of <br>1934; and </font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.752626672113803%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2).</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:5%;box-sizing:content-box;"></td>
     <td style="width:45%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: August 14, 2025</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Paul Little</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paul Little</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img117130267_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117130267_0.jpg
M_]C_X14Z17AI9@  34T *@    @ " $2  ,    !  $   $:  4    !
M;@$;  4    !    =@$H  ,    !  (   $Q  (    ?    ?@$R  (    4
M    G0$[  (    -    L8=I  0    !    P    .P /0D    G$  ]"0
M "<0061O8F4@4&AO=&]S:&]P(#(T+C4@*%=I;F1O=W,I #(P,C0Z,#(Z,C<@
M,#DZ-34Z-30 =VEN9&]W<R!U<V5R      .@ 0 #     ?__  "@ @ $
M 0  !C>@ P $     0  !-@         !@$#  ,    !  8   $:  4    !
M   !.@$;  4    !   !0@$H  ,    !  (   (!  0    !   !2@("  0
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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M34ZPB8X'B3PLNRRRUVZP[C^ _JM3>*O%=P7X,K/JWT/+P6T9'3ZJVV!KK65
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M?Z;=T220 !W),!5OVA7I)8)\7D>>OL4KK]75N8"WCGYH'KX^K?;_ "F^H?\
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M_>/WE NQ*+K!<0:L@?1R:CLM'_7 /TK?^"O;;3_P:7!'Q'_._P"]1QRZT?\
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M;F1O=W,@=7-E<AP"!0 74&]W97)0;VEN="!0<F5S96YT871I;VXX0DE-!"4
M     ! 0!"7_&+6X&:N/1:5&SS?#.$))300Z      %#    $     $
M  MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN
M=&5R3F%M951%6%0    P $@ 4  @ $, ;P!L &\ <@ @ $P 80!S &4 <@!*
M &4 =  @ $, 4  T #  ,@ U "\ -  U #( -0 @ %  0P!, #8 ( !# &P
M80!S ', ( !$ '( :0!V &4 <@      #W!R:6YT4')O;V93971U<$]B:F,
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M      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M     %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6)
M;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M             $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X
M;$!Y            "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !0
M9U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N
M=$8C4FQT                4V-L(%5N=$8C4')C0%D            08W)O
M<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M   ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M        "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 9     !
M  $!D     $  3A"24T$)@      #@             _@   .$))300-
M   $    6CA"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))301$       0
M     @   D    )      #A"24T$'@      !      X0DE-!!H      U$
M   &              38   &-P    X 1 !$ $0 ( !0 &D 8P!T '4 <@!E
M ', +0 Q     0                         !              8W   $
MV                      !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   $
MV     !29VAT;&]N9P  !C<    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P  !-@     4F=H=&QO;F<
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M# P,# P,# P,# P,# P,_\  $0@ ?0"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M 0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87
MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W
MAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B$P4R@9$4
MH;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B
M\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>W
MQ__:  P# 0 "$0,1 #\ ]5226=U#(NNO'3L2PU/+0_)O;]*NLDM8VJ?;]IR7
M->VK_1,KMO\ ]%ZH)H)B+-),CJN-3<<>MK\G);!=10W<YLZM]9Y+::-W_#VU
M(?[0ZC]+]GG9X&ZO=_FSZ?\ X,N8ZGE]!S&LP\/K+>BNZ3D/.M?TLEA^S>J]
M][F?:65V.O9?^D_3VWUV76?S7K4KF55VLMPOK<TE]S'/==:[>*"[T-U;M]WK
MNK^S^RM[*\:_])D9?J)OJ/6O)=Z1TOS_ /07N*>K8[[6T7M?B7O,5UW@-WGP
MIN8ZS'N=_P '5=ZBNKA^E9G1Z:;#U'ZQ?M/'NH8U]&:"T;06;,CTK7/LK_/>
M[_#;+/5N_H_J+IL*^[%R1T_)<ZRMX)P[WF7';K9B7O\ \)?4WWU6_3R*/YS]
M-CW6VFR#1^U1B"+'V?P=)))).6*22224I))))2DDDDE*22224I))))2DDDDE
M/__0]561TR7XWVQW\YFN.2Z>=K],9O\ UO$90Q:&=N&%D%OTO2?'QVE4\*/L
M6-M^CZ-4?#8U,GN&2&Q\V-G3.FW-%=V+2^L%QVN8" ;+&Y=SOZUF577DO_X:
MM<HYO4*:K/0^JM#\FPVDN%.VNLM=_1W^][NH^JS)O_7J_L=%N_\ 0U6>G:NP
MNM%-3K")C@>)/"R[+++7;K#N/X#^JU-XJ\5W!?@RL^K?0\O!;1D=/JK;8&NM
M94#40Z&^I7ZE);9M]OI6-W_S?Z-7.I,?9B665B;Z/UBG_C*OTK6_]=A]#_\
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M;?0?_A5DT7XG5F9#>O48YZKB5%[:R(#:VAKW,R=UK,9_I6?I+:K,CV4Y'O\
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M5[-SK@UKGW^E6UNW^I6E=]6^GE_ON>QCFO#FDM#B7EGN;86[O;M]]G\_D?\
M:BZRO]&I.Z'TPV>H+W- =N8UKJP&>YUVVK]'NK_2/^DUWJ?X/U/33APC42_!
M!XB"#'3^\Z=3:*6MK;L87DD-8 T.=])[FM_Z2H=6M=?:SIK"6L>WU<QS2015
M.QE+7#Z+LNP.9_Q%61_(38/1.FXMM=E+S9;4XO:YQ8YT%ME99+6#;7^G>_V?
MGJHU]EF3D6M)8[(R;&;MNX!F.WT&;OW?>RY__7$R==#:"30!%7_T6T   UH#
M6M #6@0 !]%K0/S6H-MS8>&V>F:G!MC]I=!(W;-OYWM^F[\Q,RQUVYM-[0\
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MIN9B4Y3!M%K XM/+2?I5N_E,=[%3GNI]&,4Y-0^C5E7M;\'/-W_HU"7R^13
MU+S'Y/\ _]3U5))))36NQK'O+F/VS!D:'0;=O#O9_P!_0_L61&E[@3R=T_\
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M9HT&)<[W?O[$%6&QAM L=K^;&I\U$=5=@9>4YF'DY@ML8PG'9O#=E>,QP?\
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M+Y:)$A6JX ) )@=R>P\5/H<NP!D$1]KLLR!_5M>ZRG_P$UJG>TYEIZ943NL
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M(0      5P    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
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MT  ' !H !0 I #5A8W-P05!03     !!1$)%                     0
M]M8  0    #3+4%$0D4
M                      ID97-C    _    '1C<')T   !<    "MW='!T
M   !G    !1!,D(P   !L   H@9!,D(R   !L   H@9!,D(Q  "CN   H@9"
M,D$P  %%P  ".+1",D$Q  -^=  ".+1",D$R  6W*  ".+1G86UT  ?OW
MD)%D97-C         !I5+E,N(%=E8B!#;V%T960@*%-73U I('8R
M
M                                     '1E>'0     0V]P>7)I9VAT
M(#(P,# @061O8F4@4WES=&5M<RP@26YC+@  6%E:(        +5:  "\9P
MDC!M9G0R      0#"0   0                    $
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MU.OE[/7N!.\2\"#Q+/(X\T/T3O59]F/W:OAN^6_Z;/MD_%;]1/XO_Q?__P
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M@H.;:*KD@9F)?J;:@.!V^Z,3@&-CJ)^;@"9/4YQ_@",Y=)H%@$P?H9F6@1<
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MKP.7HJ=]JKB%PJ-RIL-S0)^LHT-@*9PVH$],09D<GCLV]I: G7T=\Y7(E$
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MB=6-FK/>B$E\SZ\:ANYK5:JCA>U9'J9ZA31%X:+&A,PP^I_LA,07@: <A@0
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MM(R+(K#4K]MZ5ZP#JZMHZ:=YJ#%6WZ-+I;!#_)^5I)XOG)R&H#$7%9P7CYL
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MD&N Z+TCCE]PZ;>\C)5@:[*&BR9/.JVRBB4] *EJB9,H]J9(B>,/VJ<$B0(
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MN<E_KKHMM)MO[;2;L"U?AZ]1K/I.>ZIPJUP\@*8@I_4HW*+(FZ 0L**XBT@
M (OK@ "$M-"?>/-UU\I9>(-FKL1O>%M7$;[6>'U&L[F3>-HU![4(>5@@]K)W
M>:X'Z[+9>T4  (GY@ "$8L^?@&YUF\E^?V=F<,.,?JU6SKW6?D1&<;AT?BDT
MV;/,?E @]K#^?I\(9[#J?^<  (H6@ "$2LZ%A\5U;\A\AD%F0\*%A/I6F;R]
MA"%&/[=+@YXTOK*1@X$A"Z^5@_@(YJ\H@_X  (HO@ "$1LU\CQ9U7\=LC1EF
M(,%RBV=6=KN;BAI&)+8HB4@TM;%FB/XA+*Y)B>0)7:V;AE4  (I%@ "$.<R8
MEH5U6,9XE =F'<!PD?!6:KJ7D$E&(;45CR0TQ+!5CM\A6JT@CWL)S*Q"AJ
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M>(,@@*;>A(%*C:O)3H#AB]ZS48"'BB^<9X!1B,.$U( RAXQLAH NAH%3#(!
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MF8J==IF3EP2+<I;BE*=XLY1EDG-E,9(;D()0MI SCNXZRHZGC=PA%XYMCB\
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M=#F3GZ;L=+R"L:-\=4]Q!:!%=?Q><YU*=L5*O)JH=Z(U5YB^>&L;0)EK>.P
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MG]Z/[:*)G/-^_)\6FC5M5IO:E[9:^)C:E89'H)8YD^4RNY0[DXD9A)16D.H
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M? &&'Z_%>[1V-*N>>Y!ECJ>R>Y93^Z01>\A!.*#I?!HLCY[)?&D25*"=?*\
M (C$@ "4U;,9A"R%C*[#@S1UL*J3@F5D_*:I@=A3;Z,'@7] O9_@@5LL+YVT
M@6<2/Y\_@@D  (@A@ "43K(?C%.$[*W/BL)T^ZFDB6!D6:6QB#]2UJ(8AVA
M/9[RAM@KTIRZAL$2*YX&ALH  (>3@ "3N[%3E)*$5*T$DG!T6:C<D(ACLJ3I
MCM]22J% C80_R)X?C*$K@9O;C*@2&YSNBN(  (<9@ "3*K"WG/F#RZQFFDMS
MU*@XE]5C+Z1!E:U1SJ"4D^4_9IU9DL,K0)L+DQ,2$)ORC#8  (:S@ "2OK E
MI86#8*O5HDMS:*>EGTIBQJ.MG*=1;J !FHX_&YR_F7HK$)I&F)02"9L,C#(
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M@NEY8KC]@?1J7K0F@2Y:EJ^/@+5)]JM,@'0X&J>L@&PD$Z6!@)0*WZ:#@28
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MJI5WU;5:IQYHQK!KH_99#ZNSH65(FJ=>G^4W%*.FGPHCJJ#\F!T+P*"TA_(
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MB11M?<)SAYY?%[T1AF=0);?4A85 7K,!A0(O2J\"A-\;K:T=A80%$JJ;@VX
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MKSYM/K[AJY-?";DXJ%M0*K/,IC- A:[7I,XON:JPH$4<LZ@QDV<&R*5&A)8
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MHGT5@R9."WUV@I@RDWWM@B4-3'[2@8/1;GJ&DAB]97J\D!FHH7KWCC"3#7M
MC&E\JGNABMUE>'P,B7)-"7QVB"$QK7S>AQX,>'V-A/S/\WERG.F[[WFJF@NG
M+7GMET&1I'H_E)A[9GJEDAQD6WLBC^=,&7N3C>$PW'OJC'\+PGQWA_/.LWB;
MI]*ZLWC4I!^E\GD5H'&0<GEJG.9Z2GG6F9%C5GI3EH1+/GK,D^8P(7L5DH(+
M*7N-AXO-KG?QLM.YL'@JKDZDZGAEJ;^/;'BYI51Y6GDLH31BA7FNG7%*A'HA
MFDLO@WI<F'(*JGK+AS;,Y'=SO?&XXW>JN*"D$'?<LS6.BW@GK>MX@7B;J0EA
MQ'DGI+=)Y7F<H6LN_'G!G4X*0GHMAO#,57<>R3ZX2G=1PR.C7W=WO."-RW>U
MML)WR'@DL2]A('BPK'M)5'DGJ/(N?7E!GV\)\'FOAKC&?H@8<(JS_(<S<;Z@
MDH9R<MJ,&X71<^YVMX5'=0M@7(3<=C5(M(2>=U4MQ83T>%((W(9/>6#%1H:
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MBD"5PI3JB1^$QI+'B UR]I#-AP]@&X\3AD%,.8V6A94VP(Q^A1L<_(S=A68
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MN9J22)'@M5N!(X^NL/-O.(VAK+]<JHO8J5))-XI@IT@T4HDPHM<;-XD8DF<
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MD-V(0YU\CT)X1YJAC;UG=)?WC%A5T96!BQI"_)-[BC4N;)(,B=$4RI,;B4
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M;@!^5ZM[;Q=O7:@#<"]?>:3 <4M.C*&[<F@\09\W<W<GS9WW="0-+Z"X<\4
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MEL1[KJ:6E,ULF*,%DNQ<NI^AD3E,"9R%C]$Z,IG=CO0F6Y@_CUL-0IDGB/<
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M=5!QQ[3)=8QCD;">=>E4BJRI=F)$=JD)=O RZZ8F=W4>Q*4P=Y(&(*4A>,4
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MF^9P"[ 2F;9AQJO)EYE2OJ>OE<1"XJ/VE((QTJ#>E'H>?I\NDJ<'3IUXA/$
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M>[AEJKYR>T58)KFU>OU)UK4D>O<ZB+$#>Q(IGJWR>S@5;JW>>P0 HZ?3?2X
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MH&!E/;G,GAI7L;35F^Y)9+ 6FCHZ.JO2F;8IMZA]F'D6A:=-CSH"C:"S@;H
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M<V6<!XCX=%6*[H@,=3)XN8<_=@AE<8:-=N)1!X8&=[P[$87 >'@@]H9J>,<
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MHS*6R(-%H(B%K8)VG:QSF8'"FLI@Q($WF"9- (#-E?(WQX!VE+H>48!LDE<
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M>TZ.$)!B>WU^(8[&>Z=M (U8>]A:X(P-?!A'CHL!?%\R?HIC?)$8?HM\?&P
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MJ,R)]8O8I>EYW(I$HLUHW(C)G[=7$H>(G0]$0(:+FTDOYH6]FBD6OH7ACV$
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M@CV DIAN@=MQA)8M@7EAD)03@290>Y(W@.H^*I"S@,(IWH_B@*D/TI&2@*H
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MK<1]PY3TJMQND9*:IZA>@I!6I)%-M(Y;HE$[SXS&H/4H'XNOFR$/'(OYBC<
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MB$=S\*$DAWAEM9X\AJU6GYMYA?%&EICZA5PU&Y</A0(A6I9"A10(O)7?@]$
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M9W]I]; X:0A<@*SE:HQ.&*F\; (^AZ;B;5PM/:3K;FL8N:67;FP!B:*J< (
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MC8IH**IUC'):KZ;CBUA,7Z-YBE@]'J!HB9HL7YX8B6@8TIVVB8,#(YBV@A\
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M;C)=S[HY;MA0];9";YQ#1;)W<&XT6Z\N<3$C<ZU*<9P.M:[H<.8  )W >"D
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MD?Y=%+1'D,A0/[ 8CX)"E*P;CFPS\:B;C>$CIZ8RCD40(J99BND  )C?@
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M9!F3H(469HF#EX2<:,)R/X1':M%?N(0+;,I+\8/R;JPV@80@<$@<985A<.8
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MDNZ.)'UED95^"GTZD ]L\GT9CG=:]7T.C/A'UWT9B[$S''TDBMT9QWS[BF8
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M;'J&*XOW;?YW#HKE;VAFRXGT<,!568DE<@M"D8B3<S\MWXA]=!X38HI]<ZP
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MF+6!FH5XEQ=RA82)E3EB9X.IDT91;8+RD8H_58)ED$(K;X'[D!T1Y8(>C!D
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M<]MX[I.(=*5JTI'9=61;>Y!1=AY+#([U=M0Y+HWZ=W0E#HW4=[L+'([(=WT
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MG<YU=HY"G 5G.HR7F>]8!(KVE\Q'ZHF3EAHVCXB,E6LC-(?IE!4*MH<0ASX
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M>AUL,IN[>F%>S9EX>IQ0?)=8>MQ [)6!>QTOTY0\>T\;]Y1G>S$$=)' ?$P
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MHBMJ I>-H'M<BY4GGEQ.')+,G$0^TI#$FQDN)X]+F? ;!X[-DD8$V(M2@T8
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M?VQ@.*2O?U!3@:'9?RM%XY\F?P0W,9S0?O0FG9MP?O(2DIR&?N,  )+H@
M (  @ !KO::'AO)?V:.EAG=3):#'A>1%A9X+A5 VV)NKA.4F;YHHA-42DIL#
MA+@  )'&@    (  @ !K9*6WCGU?D:+2C:]2WY_GC+)%.IT>B[LVAIJ\BQLF
M.YDEBTH2I9FHB:$  )#;@    (  @ !K)*4/EA!?5*(FE/52G)\SDY]$\YQ?
MDEDV0)GTD;,EZ9AAD;P2@IBMC(,  ) G@    (  @ !J\*2AG>-?5J&DG*A2
MF9Z8FO=$V)NBF58V,YD7F,\E_)=JEN<2JI>IC)X "X^*@ @  (  @ !AL[A\
M8(E5]+5\8E))H;*09!@\8:_#9<,MNZV,9R4<DJU$9[@(7*ZD9VL  )-8<M@
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M@_%4QZZ!@Y=(HZLD@RH[FZ?Q@L$M;Z5(@H,=):00@J *)Z/,@CD  (WC@
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M>_>2C7$7?$^"6'(??(QQ&7,>?+E>N'0E?.E+/'4>?1@V-775?38<\W5W?0,
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MK)>."&L]J7)]P6Q4I?)LEVU?HFM:I6Y]GTU'M6^*G0,S5F__FW@:Q&Y'DAD
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M@PZ%KG=_@O-VA'?J@K!F37A2@E)5'WC'@?M"EGE(@;0N5WF2@784Z7E-@5,
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M7?!^$8>M8,=OTX<=8VI@1X:X9=M/=(9Q:"<]*X9F:CLHO(;M:[D.!HC^:T<
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MB4]Y-G[8B--K GZ;B"-;PGY>AU9+C7XWAI<Y_7XLA@DF47XDA=D-#7YZA*,
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M9:AQ*HZP9Z!CLHV9:7]5&8RD:T-%-HO<;.4SM8M];D4?CHPG;N &:HOV;O
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MCHQM.H<:C<Y?XX8GC,I1=X4PBZ="&81IBK(Q8(/>BC(>*8.CBHD&BX+SA&P
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M;$)DHI9J;8Y8#I3+;LQ*/Y--;_L[-)(1<0DJ5I&"<<H6%9+<<84 <XYP=#,
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MDPIAL9 7DC55$HYYD0%':8S3C[$XO(MTCM,H<(J>CP05&8K'C* !&H;1@+X
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M<:M8:Y[B<GI,:)S)<SP_=9K1<_4Q$9E(=(T@D)C>=,,,CIH9=%4  (D4>^4
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MELU6OYFNEB1*Q9=LE.\]O94HDZPOJY-*DV<?L9);D>\,OY'LB)\  (2<@
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M=AQ,BJB"=HI!!*7_=NHTBJ.F=S,FNJ'U=VT6":)==RD$PI\&>.$  (0^@
M (  @ !6_ZFM?2-,4*<J?4I U:2=?4XT7J(W?3\FDJ!T?3,6&Z"7?18$_YSO
M?A8  (->@    (  @ !6NJB@A"U,*:82A!9 N:-U@\<T0:$"@VPF=)\T@T<6
M'9\M@X<%/ILA@GH  (*M@    (  @ !6A:?2BT-,$Z4RBOU JJ*#BF<T,I_^
MB<\F79XAB<H5_YX1B38%39FK@Y8  ((6@    (  @ !68J<TDGY,#*1ZDB)
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ME720,ER\D\R &E\^D?MO!F&;D"1=$6/BCF]*$V7<C/,UOV;EB^$=CV4SBXP
MS'ZH@(J>G5B[GV&/<UN(G/=_65X-FEMN2F!LE[]<6F*XE6%):&2YDVDU-V6R
MDC<=.F0$D#8 P7ZZ@(*>'5?8J3:.ZEJEI@Q^PUTCHJ=MLE][GTY;T&'$G%A(
M]6/"F@<TPV2BF.4<RV,-DW@ N'[)@'R;-G"R6/>,U7',7&!]9W+Q7Y!LO'0;
M8HQ:X75$961'P79G:!,R\G=H:F 97G?-:UH  (  <AV9X6V'8HV+HV[N90]\
M,7!!9VEKHW&,::%9Y7+1:[Y&YG0';;HR.'3U;V 8TG3);]P  (  =LB8A6JA
M;""*/VQ ;<=[$6V];U5JA6\F<,98[G"#<BA&&'')<W0QF7*E='P88W(F=),
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MFXF$LF,[F:%UCF4.EW5E;F;#E3I47FAMDSU"+VG2D;(NDVHND2465FH5C>4
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M<[)]:W&H=,!O*7*A=:U?Z'.-=H=/3W1Z=TL]9W5/=_LICG6]>&D0 W;L=_
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MH+-Y3VI_GK1K"FN>G%%;T&RAF=Y+IVV=E](Z16Y?EJXG%6X)E64.IW"1B>@
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M>DMP^7@+>MQCC'AY>TE5+'C:>YE%M'D_>^$TBWFI?!LA&7G ?" (JGNA?)8
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M5]II@(G[6O!<LHE\7=Y.I(DG8)L_-(C^8QLM\XE*92D9?XKY9?,!]8H49Q@
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M?_)D[W]_@"-84G]5@"=*M7\A@ P\!W[X?_ KLW[I?^48,W[S?^@"C7^]?_@
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M7JA='Y$48/U1"9 A8SA#S(]194XU%X[,9Q\D/H\<:%L/:9%M9_H  (8B;F0
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MA(M94H?FA'=-:(<@A"] =H94@] R6H6P@XHB@(58@XD/,X4A@T<  (  @
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M9$-0]9D;9?Q%GY>]9Z(Y!9:$:28JZI7%:E8:)I:':K4'%Y6<:N0  ("7=Q0
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MB&!.+Y$ZB#M"YX_FA\0VD(Z&AS8HW(U^AP88MXUSAT<'*XJCA-D  (  @
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M:*=$HZ)9:=XYI*"V:P$MH9]);  ?P)Z_;)$.QJ _;"@  )AW;RL  (  ??\
M (  @ !.2Z(+;W%$*Z!K<$XY,Y[%<1$M*YU,<:0?C)RE<?8.P)W9<8X -98
M=0D  (  @    (  @ !-UZ!J=F!#RI[3=O XY)TH=U4LZYN>=Y$?6)K7=YP.
MV)NI=UX <9/:>E0  (  @    (  @ !-<Y\3?55#?YV#?:(XJYO/?; LMYHW
M?9X?)IE=?8P.T9GE?;4 L)()?LX  (  @    (  @ !-))X#A%E#2IQSA'$X
M@9JVA#(LF9D(@]\?"I@2@^0.JIAW@WL M9"9@'L  (  @    (  @ !,\9TI
MBX]#*)N4BX8X9)G0BP@LAI@0BHX?$Y;SBJ\.V9<>B$0 W8]G@)8  (  @
M (  @ "ISEKJ4ZF9K5W'5WR(\V"&6S5W4&,L7LQDJ&6Z8D-0X6@5994[PFG=
M:*,C)6EP:ND#YWEG;,NGPE:C7B"8%%G@8/Z'AUSN8\9V#5_89GAC@&*?:1!/
MUF4B:XTZTV;G;= B9678;VP#R'F<<6>EW%+,:(V61U95:G.%^UFG;$QTE5S&
M;AQB,E^[;]].MF)><9 YY608<Q4AL6*Q=!D#K7G*=F*C^4]3<MV4>E,@<]J$
M/%:A=-1S'UGQ=<A@X5T4=KM-F5_0=Z@Y 6%\>'@A"F $>/D#E7GR>O6B,DQ
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M4X".I&1E5UA^]F:56P9N.FBW7HA<86K%8>9)46RI91<TLVX&9^T;UVV":9L
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MA+6'/%4!A&1X*U@Q@_IH%5LE@X)7#%WC@Q)$U6 D@KDQ&F#T@H$92&&E@J$
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M7+Z"4V? 7[=SMFFA8HED VMO93=3&6TG9\! V&ZN:AHLQV^2; (387#G;%(
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MBT][YUI]BIYMQ5T8B;Q>EE]_B,A.9&&NA^T\^F-+AT(IZ6,GAO\1LV>PAD,
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M9-UUTFP!9Q=H6&V#:3)9C6[N:RE)F'! ;/\X(W%>;IXD@G&\;[(+976";XH
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MD.5PLV#4C_9C9&+0CKM5#&24C6M%GV8>C% TU&<*BZ4B+F78B^D*LVWJASP
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M:]]I<W$Z;7U<NG)/;OY/$'-%<& _XG0N<9HO(73?<I8;IG2Z<N($GWFQ="@
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ME8UEA&@:E(Y8]VEPDR)+96J#D9X\O6M8D( LBFN%D%\9T&JTCH@$;'B'@OT
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M<=-=5'>0<O5177@E<_5$47BB=-$V(WD+=8TER'E@=@,1]7GX=9X  (  >>(
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M49A6!XOM5-Q*=XNI5_T]G(N56N0O&HO7764>"(TI7OH)@(YJ7RD  (  :6D
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M=L11B'\*=X5&/7\?>!PYW7\7>(XL(W\4>.(<)7\H>/$)6G^T>9D  (  @
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M5S])O)-$6> ^Q9*G7%TRB))$7ILD9Y*(8$\2V)3G8)D!U)$*8FD  (  <?@
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M>JE&#(>X>RT[6(=4>W4O@(;5>Y<B!(:3>Z81J(;E>XL"<(2"?5<  (  @
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M6YT]-)PM7:PRPIMO7XXFVYKY8208PYN]8>H(EYO.8E   (Q#:5$  (  >:D
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M?9 Z;9'V?>TP,I%/??@DPY"(?=H70I!S?<@(4HWP?G@  (-%@    (  @
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MS7SU@3B3@UJ^3>Z%0UUA4B!V6U_]5CEF?6**6B]5@63Y7?M#/6<788\O3VA
M9+$6JFEU9E0  (  ;=*1>5695YF#U5B[6OYU+5NV7DIE?UZ-8794HV$Q9'A"
M@&-J9THNN61=:;<63F9@:MH  (  <K"/FE#D84F" E1M8]=SF5>Y9E!D EK/
M:*]35EVE:O)!8U_Q;1 MT6"=;MH5L6/@;XH  (  =V*-RDR3:NN 1U!S;*=Q
M]50!;E9BM%=2;_)2*5I9<7A :ERO<N<M$UT*=!@5.&&X=',  (  >W:,'$BN
M=(9^Q4S;=7MPDE"M=F-A8%0L=SQ1-%=<> T_E%F[>-0L<5FZ>7L4U5_G>:P
M (  ?O.*L45(?AM]A$FX?DUO>DW$?G)@9E%V?HQ03E2_?JD^]%<=?M0K]5;
M?PD4AUYD?U@  (  @ ")B$);AYY\?D<&APUNETM$AFU?GD\>A<U/E%)^A4,^
M6%34A-\KFU1,A,0455VBA/H  (  @ "(H3_PD/][LD3*CZUMXDDPCDI? 4TF
MC/-/ U"5B] ]RU+<BODK+5)'BL84*EWKB9L  (  @ "'_SX1FAY['$,,F!9M
M5D>*E?5>ADN2D_).H$\*DD4]@E%%D1TJX5"MD1,3WUYIC4   (  @ "('6'L
M3@QZPV0'4AULL68F5A==FV@Y6>Q-5FHN79$[I&O:8.\G\FR88ZD.DW#K9&@
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M>Z=S@%#A?!=F-E1'?&]7WU=6?+5(>UGV?/DWLEN0?4,D]EK,?8D-4FE\?@D
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M5I%NG&:W6=QA@VBI70M36&I]8!5#XFPA8NHRTFUE96@?1&U/9PH''W3J9[\
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M@;EH8%7/@<9;X5BQ@:9.4%LR@7,_H%TF@4\O=5W$@4L=#%Y^@8@&V'1O@6D
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M7?=B4FIX8)%6-FPC8Q%(V&V=96DZ)F[=9X@IFF^?:3<5QW!]::T X'Z&;"H
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MAL!=1%N[AH]1>5X+AA=$H%_CA8DVB6$(A2DFM&!AA284!F54A40!,'W^@,X
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M9#)6&V]19C1*L'"7:!T^-W&L:=\P'G)^:UD?U7*S;#\,,'98;"   (  =-$
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MBNQ2)F*JBJ5&_V1NB?4ZS&65B2TM2V78B,P=J&4FB2H+66T^AJH  (  @
M (  @ !8\X-<3&!.JX.63]U#A(0$4SXW"H2:5F$HO(6 60(75H>)6EP$<8?5
M6Z(  (  :34  (  ?AI7>'].4WQ-A'_55HI">8!@67$V+(#Q7!LH$X&Q7DD6
M\8,S7T,$C80(8&X  (  ;?$  (  @ !62'M:6K-,5'P?74!!>WS)7ZHU/GU?
M8=<G4WX"8Y$6:W[[9"\$BH"V958  (  <R0  (  @ !5*W>B8?5+,7B28_U
M5GE59>0T6'GW9YHFB'I_:.85TWKX:2\$<WW<:F\  (  >"   (  @ !4&G0Y
M:4=**752:LX_578O;#8S8G;0;6PEXG<W;E@51W>$;EX$6GMI;^,  (  ?'(
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M2M=#8(UJ3C8XU8V#46DLO8W_5$0>58]?5E<,@)'=5O8  (F*7#0  (  ;*T
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M;4P^37RP;G S_GTV;V@H<7U]<"(:^WVF<&P+$WZ&<(<  (  =E4  (  @
M (  @ !&^'DQ=%T]E7HM=1TS7'K+=:<GYGL%=@,:<GKG=A,*U'PV=FP  (
M>T<  (  @    (  @ !&3W;0>VP\ZW@#>] RO7B\>_@G77CM?  9^GB$>_L*
M;7IO?*T  (  ?W@  (  @    (  @ !%TW3;@KP\AW9$@N R;W<@@I\G.G<Y
M@DL:)'9R@EL*SGBU@@8  (  @    (  @    (  @ ! F9E%2*LWLIBM2^4M
MHYB43M0AJIE143L2>9PR4E,#4IF^5&   (2R7XH  (  < T  (  @  _-Y6\
M3P0V5)6.4=DL+)695&(@2Y9 5F81;IBA5R\#"94563\  (&N9$   (  =0$
M (  @  ^09(657@U.I(95^$K'I(^6@(?.I+76Z 0H)3#7!\"TI#/7BX  (
M:2,  (  >70  (  @  ];XY]6_TT4(Z?7?8J&([57ZD>9X]D8.@/_Y#782H"
MJHT&8SH  (  ;E8  (  ?5@  (  @  \FHL48IHS=(MI9"8I1(NM970=F8PB
M9DL/IXT09F<"F8G%:(<  (  = 0  (  @    (  @  [RX?R:5TRIHB':H$H
MD(CE:VL=!HE":_$//XFD:]8"IH<#;C   (  >3L  (  @    (  @  [%84I
M<"DQ](7^<.\G^(9W<7D<C8:_<;0.YX:N<88"EH3%=%,  (  ?9@  (  @
M (  @  Z?(*[=PHQ78//=WPG=H1E=ZX<+H27=Z@.HX1)=Y(";H,">BL  (
M@    (  @    (  @  Z#8"J?B<PYX'V?D\G"X*L?C$;XX+,?@$.D8)<?BX"
MB8&(?O\  (  @    (  @    (  @    /__  #__P  __\  &UF=#(
M! ,)   !                     0                    $   $   (
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M>9P4?Z-^98-,?\9^A6J%?_Y^P%&_@&-_/3D @1* #_S%?GR+-.2U?F.);,Q
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MWWRR@Q>=RFBD@G.8H%39@=V3/4%7@7*-?BZ @1:')\J@AL>\#[><A8JV :0
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M.X7J<W6K?G!@=0JCIUL3=KV;=T7W>)R2QC%1>J^)8=<@?Q5R&L.:?QES.:^
M?RAT3IK)?T!U:(6J?V1VEW!B?Y9WY5LS?]AY3D8>@#YZ]3%^@-Y\_=6C?69\
MF<)R?8M\FJYH?;-\HYFX?>)\P82>?AY\^V]I?FU]3UI1?M%]LD5F?UU^-S$
M@"%^Y-0C>_.'%,#7?"B&!*SM?&"% IA2?*F$*(-E?0&#:VY<?7""PEEQ??&"
M&$2X?IB!<#"1?W6 M-*>>K*1=+]$>N^/::M@>S6-;I;U>XR+C((N? &)U&U5
M?(F()5B??26&9D0=?>>$BS O?MR"9]$N>:B;QKW=>>J8S:G^>CF5W96B>IV2
M_($%>QV0+6Q;>\"-=%?=?'.*ET.0?4R'@2_:?E6#]\_Y>-FF$KRL>1VB,*C2
M>6V>0I2#>=B:6H ">F26?6MW>Q"2G%<M>]F.GD,3?,B*22^2?>*%8<[]>#6P
M3+NS>'JK?:?7>,>FC)..>32AE'\G><N<IFK!>H27I5:8>U:2;4*K?%>,V2]7
M?8&&G\XY=[RZ:+KO> "TJJ<(>$>NKI*\>*^HFWYA>4NBCFH9>A.<;588>O&6
M!$)2>_J/*2\F?3"'L<VO=VK$7KI<=ZR]IJ9?=^BVE)((>$6O6GVY>."H)&F)
M>:^@UE6D>IJ9/$'_>["1+B[_?.^(E<@)A])Q!;8ZANAR1J.WAA]S=I!VA6]T
MIWS!A,YU\&C?A#MW7%4E@[%XZD&'@T-ZO"Y[@OE\^<;<AD=ZY;4TA7Y['Z*G
MA,E[6H]TA"E[I7O-@YM\"F@!@R%\BU1?@K1]($#N@F9]W"XG@CI^R\6SA.&$
MRK0 A"V$ J&B@X&#0HY:@O6"GGK%@GF"&F<;@A>!K%.?@<J!1$!A@9V YBW>
M@8Z @\1:@Z6.CK*9@O2,Y* B@EF+/(T,@=R)IWF?@7^(-F8G@3B&SE+B@0.%
M7C_>@.Z#V"V=@/:"'L,.@J280+%.@?:5OI[@@663-HO;@/*0L'B5@)Z.-F5+
M@'&+TU([@%&)4C]M@%.&H"UF@'&#E<'U@=NA]; [@3*>FYW2@**;)(K;@#27
MI'>P?^F4*62(?\"0KE&I?[>-&S\)?\Z).BTW?_^$Y,$2@3VKFZ]9@)BG8ISM
M@ 2B]HGY?Y>><7;G?U>9\F/E?SJ595$N?S.0K3ZW?UZ+G2T0?Z"&"<!D@,:U
M*JZF@"6P#9PM?XNJH8DV?Q:E"78R?MF?>&-'?LR9UU"X?M*4 #YP?P*-PBSP
M?U&'!+_M@'2^H:X>?]6XF)N*?S&R&HB)?J^K7W66?F^DKV+*?FF=\E!;?GV6
M_#XR?KN/G2S7?Q*'U;EWD*YP1JD2CN9QDI?XC4QRT(8>B]1T$7/1BFEU;F%:
MB0=V\D\9AZ5XFST#AE!ZCRNFA0=\\[A^CT1YE:@LC9QYZI<%C!1Z0X4WBJ=Z
MKG+WB4I[-F"5A_Q[W4YLAK!\FCR)A75]B"M^A$-^LK=ZC?F"RZ<$C&."/Y7[
MBN&!MH0LB86!2W(+B#N ^5_-AP2 ODW,A=" C#P=A*Z :BM:@Y. 5+9HC,6,
M *7;BSF*G93#B<B)-H,FB'"'Z7$:ASV&ME\&AAJ%CTTTA/^$8CN[@_F#+"LZ
M@OF!U[5.B\R5)J37BD.2]I.[B-F0P8(2AX^.CW LAF2,:%X^A5N*3TR@A%*(
M'3MA@UZ%R"L@@G.#-K1:BPV>2:/@B8F;39+(B""8.8$MAMN5'&]@A;:2 5V4
MA*V.X4PD@[>+J3L5@MF(-"L)@@"$;;.2BG:G5:,8B/>CAY'_AXR?C(!JAD:;
M?&ZRA2F7:ET)A"F31DN_@S*.^CK8@F:*:"KV@:&%?++VB@*P2*)WB(BKI)%4
MAQFFN7_ A<RAIFX4A+&<D5R @\"79TM=@M*2"SJB@@B,7BKG@5*&8K*(B:ZY
M(:'ZB#BSGY#"AL*MLW\IA6RGCVV.A$ZA:EP6@V&;,$L)@H&4Q#IK@<2."RK:
M@1.''ZM:F<!ONYPCERMQ"HQ.E,=R47O2DH%SHFKKD$-U$5G?C@)VJ4D:B[9X
M9CB:B61Z<RD&AP-\[*J3F']X@9MQE@%XYXN/DZ=Y6'L:D65YWFHZCR]ZA%E!
MC/Y[2TB4BL)\+#A(B(1]0BD'AC5^F:G#ET.!+)I_E-B OHJRDH* 7GHZD$^
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ML8Q"FN*51'V-E\:2SFY^E+>05%]7D;*-W5!(CKB+:$&UB[J(YS/)B+6&2"=
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MZ['T9&"T4I\99I^N5XO8:.BH+7B1:VNB!V5M;BF;T%*G<1657$ _=$".C"[
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M?Q]^II>O=YB"W8I\>"6"NGR2>+&";FX0>4B""5]*>@"!IE!=>N:!3$'F>^6
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M@5!YV&9J@0AZ>5B8@-I[)4K&@,%[WCUI@+A\IC"<@-1]@R4G@0Y^<HOZ@%"
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MC=I\I3 YBM5]:B>]A]Y^12"IA1-_(FK*FM: 2V$]F$R 4E=8E9* .DU DK*
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M36-9A^)]KUEHANE][T\MA>%^'D3LA.%^53KF@_%^HC%<@Q]^_"B7@FY_6B%
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MCG5[N$@%C'=\*S[BBG!\L#7_B')]5"VPAHM^!28HA,A^OQ_]@SA_<F*"D,&
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M83][/$439UM\/S=$;=-]:BKC=&I^O9DJ0NZ =HP92*^ 97YX3D" 5' \4]>
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M>F]_8WI(6 Z!CF_E6_"!D&4#7\*!:%FI8ZB!+4X<9\" ^T*B;!: V#?'<)6
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M^3$D@0]_,"M4@,I_?"8H@)9_T2&:@)Z &QX%@,2 5   __\  /__  #__P
M;69T,0     #!"$   $                    !
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M=)=USG>8<\UYFG+->YMQS'V;<,M_G&_+@)UORX"=;\N G6_+@)UORX"=;\N
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M@*:<T("CI<^ H:;.@*&FSH"AILZ H:;.@*&FSH"AILZ H:;.@*&FSH"AILZ
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MPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#_YXW&O^;1"[_FTQ
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MA(;@@(N-W'R1DMIYEY;8=IR9U7.@F]1QI9W3;ZF?TFZNH-)MLZ'1;+FBT6O
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M#O^4/1[_G4 I_Z0^,O^K/SO_L4)"^+A'2>V^3D_EQE=3VL9>7\N^9'&^MFJ
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M=LR:FG?-F9EWS9B9=\V8F7?-F)EWS9B9=\V8F7?-F)EWS9B9=\V8_WXB!O^
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MD7Z%IHR&C*"(C9&:A966EH*>FI* IYV/?[*>C8#!GHR R9Z+@,J=BH#+FXJ
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M6$#\J5A _*E80/RI6$#\J5A _*E80/RI6$#\J5A _*E8QK@$ +;$! "JTP4
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M?<ICX'[#9.!_O6;?@+=GWX"W9]^ MV??@+=GWX"W9]^ MV??@+=GWX"W9]^
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M9TK@[&=*W^QG2M_L9TK?[&=*W^QG2M_L9TK?[&=*W^QG_YP- -NQ!@#*O0<
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ML4<CRZM2,L&E6D"XGV),L)EI5ZB4<&"ACW=GFXM^;I:(AG.1A8YXC(*6?(B
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M=%2PYW56K.=U5JSG=5:LYW56K.=U5JSG=5:LYW56K.=U_X,2 ?^6$0#_J!$
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M<F62ZG%GC^IP9X[J<&>.ZG!GCNIP9X[J<&>.ZG!GCNIP_W,5 O^%$P'_E!0
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M3$;:[4Q$V/E/0]C[3T/8^T]#V/M/0]C[3T/8^T]#V/M/VYH  ,JI @"[LP(
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M)0/_920$_VXJ!O]V- O_>CT1_WI&&/]X3R#[=%@H]F]A+_%K;#;M9W8\Z6.
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M6D^K[EM/JOI;4:;Z6U&F^EM1IOI;4:;Z6U&F^EM1IOI;_X ) .&2 0#1H 0
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M.#WB^S@]XOLX/>+[.#WB^S@]XOLXQJ$  +>K  "JM   GKX  )/) @"(U 8
M?^X. 'GM&P%Q[2<#:NXR"&3N.PU>[D,36.Y+%U/N4AI0[UD>3.]@($GO9R-'
M[V\E1/!W)T'P@"D_\(HJ/?&5+#OQH2TY\JXN./*^+S?ST"\W\^<O-O'S+S;Q
M\R\V\?,O-O'S+S;Q\R\V\?,ON:<  *NP  "?NP  DL8  (;0 0![W04 =/<1
M &WW' %F^"8#7_@O!EKY. I4^4 .4/I'$4SZ3A1(^U461?M;&$+[8AI _&@<
M/?QP'3K]>!\X_8(@-OV-(C3^F",R_J0D,?^Q)3#_OR8O_\\F+O_C)B[_XR8N
M_^,F+O_C)B[_XR8N_^,FK:T  )^W  "2P@  ALT  'G:  !P\@@ :/\1 &'_
M&@%:_R,#5/\K!$__,P9*_SL(1O]""T/_20U _T\./?]5$#K_6Q$X_V$3-?]H
M%#/_;Q4P_W@6+O^"%RS_C1DJ_YD:*?^D&BC_KQLG_[H<)O_''";_QQPF_\<<
M)O_''";_QQPF_\<<H;0  )._  "&R@  >-8  &SB  !C_ < 7/\/ %7_%@%/
M_QX"2?\F T3_+@1 _S0%//\[!CG_00<V_T8(,_],"#'_40DN_U<*+/]="BK_
M9 LH_VP,)?]U#2/_?PXA_XH/(/^5$![_H! >_Z@1'?^Q$1W_L1$=_[$1'?^Q
M$1W_L1$=_[$1E;P  (;'  !YTP  :^   %[M  !6_P, 3_\, $G_$@%#_QD!
M/O\@ CG_)P,U_RT#,O\S!"[_. 0K_ST%*/]"!2;_1P4D_TP&(O]1!B#_5P8=
M_UX'&_]E!QG_;@@7_W@(%?^#"!/_C0D3_Y8)$O^>"1+_G@D2_YX)$O^>"1+_
MG@D2_YX)_T(M _]",@3_2#($_TPV!O]./ C_4$<._U!2%?].7QK_2VL?_TAW
M)/]%@R?_0HXJ_T&7+/\_H"[_/Z<O_SZN,/\]M3'_/;PR_SS%,O\\SC/_.]\S
M_SOJ-/\[\S3_._LT_SS_,_X\_S/\/?\T]C__-?4__S7U/_\U]3__-?4__S7U
M/_\U_T,L _]$, 3_2C $_TXT!O]1.@C_4T8._U)1%?]171K_3FD@_TMT)/](
M@"C_18LK_T.5+?]"G2__0:4P_T"L,?\_LS+_/[HS_S["-/\^S#3_/MPU_SWH
M-?\]\37_/OHU_3[_-?L__S3X/_\V\D'_-_!!_S?P0?\W\$'_-_!!_S?P0?\W
M_T0L _]'+@/_32X$_U$R!?]4.0C_5T0._U9/%?]46AO_468@_TYR)?]+?2G_
M2(@L_T:2+O]%FS#_1*(R_T.I,_]"L#3_0K<U_T&_-O]!R3;_0-<W_T#E-_U
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M65^,[EE?C/M888K]5V&)_5=AB?U788G]5V&)_5=AB?U7_V\, /]_"0#?C0,
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M2DBP_TI(L/]*2+#_2DBP_TI(L/]*XH8  ,Z4  #"H0  MJD  *NQ  "AN@$
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M4&YW[T]N=_Q.;G?_36]W_TQO=_],;W?_3&]W_TQO=_],_V0- /]R"@#P?@8
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M2EB._TE8CO])6([_25B._TE8CO])_W$! ."   #/C   Q)8" +N> @"RI
MJ:H% **L%0";K"8"E*LT!XRJ/P^%J$@7?J90'GBD6"5SHEXK;J%E,&J?;#1E
MGG,Y89U[/%Z;A$!:FHY#5YF:1529IT=2F;9(49G*2%&8YDA1E_5(49?_1U&6
M_T=1EO]'49;_1U&6_T=1EO]']G<  -B%  #)D0  OYL! +2B  "KJ   H;
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M-T"W_S= M_\WSHL  +^8  "RH0  IZD  )RP  "1N   AL " 'O(!P!TRQ(
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MCPXK]9T/*O:K$"GVO! H]LX1)_?F$2?U\1$G]?$1)_7Q$2?U\1$G]?$1HZ@
M ):R  "(NP  >\4  &_.  !BUP  5MX  $[P!P!*^A  1OL9 $+[(@$__"H!
M._TR CC].0(U_C\#,OY& S#_3 0N_U,%*_]:!2G_8@8G_VL&)/]V!R/_@@@A
M_Y ((/^="1__JPD>_[H)'?_)"1S_W0D<_]T)'/_="1S_W0D<_]T)F+   (JZ
M  !\Q   ;\T  &+8  !5W@  2>0  $3[!0 __PX ._\5 #C_'  T_R0!,?\K
M 2W_,0$J_S8")_\\ B7_0@(C_T@"(/]. Q[_50,<_UT#&?]G!!?_<@05_W\$
M%/^,!1/_F@42_Z8%$?^R!1'_O 41_[P%$?^\!1'_O 41_[P%C+@  'W"  !O
MS   8M@  %3?  !'Y0  /O$  #G_ 0 T_PL ,/\0 "S_%@ I_QP )O\B "+_
M)P$?_RP!'/\Q 1K_-@$8_SP!%?]! 1/_2 (1_T\"$/]7 @W_80(,_VP""O]Y
M @G_A@,(_Y(#!_^= P;_I0,&_Z4#!O^E P;_I0,&_Z4#_S$Q O\V+@+_.B\"
M_SLR _\[.03_.T,%_SE/!_\X7 K_-F@-_S1T$/\R@!+_,8L4_S"4%O\PFQ?_
M+Z(7_R^H&/\NKQG_+K49_RZ\&?\NQ1K_+L\:_R[@&O\NZQK_+O0:_R[\&OPO
M_QG[+_\:^B[_&_HN_QSZ+O\<^B[_'/HN_QSZ+O\<_S,O O\Y+ +_/2T"_SXP
M _\_-@3_/T$%_SU-!_\\60K_.F4._SAR$?\V?1/_-8@5_S21%_\SF1C_,Z 9
M_S*F&?\RK!K_,;,:_S&Z&_\QPAO_,<P;_S'=&_\QZ1O],?,;^C+[&_@R_QOW
M,O\<]C'_'?4Q_Q[U,?\>]3'_'O4Q_Q[U,?\>_S4L O\\*@+_0"H"_T(M _]#
M- 3_1#\%_T)*!_]!5@K_/V(._SUN$?\[>A3_.806_SB.&/\WEAG_-IT:_S:D
M&_\UJAS_-; <_S6W'?\UOQW_-<D=_#78'?HUYQWW-?$=]#7Z'?(U_Q[Q-?\?
M\#7_(.\T_R'O-/\A[S3_(>\T_R'O-/\A_S@J O\_)P+_0R8"_T8I O]),@/_
M23P%_TA'!_]&4PO_1%\/_T)J$O] =A7_/H 8_SR*&?\\DAO_.YH<_3J@'?PZ
MIQW[.:T>^CFT'_DYO!_X.<8?]CG3'_(YY!_O.? ?[#KZ'^HY_R'I.?\CZ#G_
M).<Y_R3G.?\EYSG_)><Y_R7G.?\E_SPG O]#(P+_2"("_TPF O]/+P/_4#D%
M_TY#!_],3PO_2EL/_TAF$_]%<1;\0WP9^D*&&_A!CASV0)8>]3^='_,_HR#R
M/JH@\3ZQ(? ^N2'N/L,A[3[/(>H^XB'F/^\AXS[Y(^$]_R7?/?\GWCW_*-P]
M_RC</?\HW#W_*-P]_RC</?\H_S\C ?]'( '_3!X!_U$D O]5+ /_5C4$_U4_
M!O]32@K^4%8/^DYB$_9+;1?S27<:\$>!'.Y&BA[L19(@ZT29(>E#H"+H0Z<C
MYD.N(^5"MB3D0L DXD/,)-]#X"3;0^TEUD+X*--"_RK10O\KST'_*\Y!_RS.
M0?\LSD'_+,Y!_RS.0?\L_T,@ ?]*' '_4!L!_U<A ?];* +_7#(#_UL[!OQ9
M1@GV5E$.\51=$^U1:!?I3W(:YDU\'>1+A2#B2HXAX$F5(]Y(G"3<1Z,FVD>K
M)]A&LRC51KPHTT;(*=%&W"K-1^PJR4;W+,=&_R[$1O\OPT;_+\)&_R_!1O\O
MP4;_+\%&_R_!1O\O_T8= ?].& '_5A@!_UP> ?]@)0+_8BT#_&(W!?1@00CN
M74P-Z%I8$N-88Q??56X;VU)W']A0@"+43XDDT4V0)\],ERC-3)XJRTNF*\E*
MK2S'2K<MQDK"+L1*T2_!2^<OO4KT,;M*_S*X2O\RMTO_,[9+_S.V2_\SMDO_
M,[9+_S.V2_\S_TH: ?]2%0'_6A8!_V$; ?]F(0'^:"D"]&@R ^QG/ ;E9$@+
MWV%4$-E>7A?26VD<SEAR(,M6>R3(5(,GQ5*+*L-1DBS!4)DNOT^A+[U/J#&[
M3K$RN4Z\,[=.RC2U3N$TLD[Q-:]/_3:M3_\VK$__-JM/_S:K3_\VJT__-JM/
M_S:K3_\V_TT7 ?]5$@'_7Q0 _V88 /]K'0'X;20![6XL N5M-@3=:T,(U&=/
M$,UD6A?(8&0=Q%UM(L%;=B:]67XINU>%++A6C2^V590QM%2<,[)3I#2P4JTV
MK5*W-ZQ2Q3BJ4MHXIU+M.:53^CFC4_\YHE/_.:%4_SBA5/\XH53_.*%4_SBA
M5/\X_T\4 ?]9$ #_8Q( _VH4 /]O&0#R<A\ YG0F =UT,0+3<3\(RVU+#\5I
M5A? 9F =NV-I(K=@<2>T7GDKL5R +JY;B#&L68\SJEB7-:=7GS>E5Z@YHU:S
M.J%6P#N?5M(\G5;I/)M7^#R:5_\\F5C_.YA8_SN86/\ZF%C_.IA8_SJ86/\Z
M_U(2 ?]<#@#_9A  _VT1 /IS% #K=Q@ X'D? -1Y+0++=CP'Q')(#KYO4Q:X
M:UP=LVAE(J]E;2>L8W4KJ6%\+Z9?A#*C7HLUH5V3-YY<FSF<6Z0[F5JO/9=:
MNSZ66LP_E%KE/Y);]3Z16_\^D%S_/9!<_SR/7/\\CUS_/(]<_SR/7/\\_U41
M /]?#0#_:0X _W$. /5W$ #F>Q$ V7T8 ,Y]*@+%>SD&OG=%#K=T4!6Q<%D<
MK6UB(JAJ:2>E:'$LH69X+YYD@#.;8H<VF&&/.)9@F#N37Z$]D5ZK/X]>N$"-
M7LA!BU[A08I?\T")7_\_B6#_/HA@_SZ(8/\]B&#_/8A@_SV(8/\]_U</ /]B
M# #_; P ^'0, .EZ# #>?@P TH$5 ,B!)P' ?S8&N'Q"#;)X316L=58;IW)?
M(J)O9B>>;&XLFVIU,)=H?#.49X0VD66,.8YDE3R,8YX^B6*H0(=BM4*%8L5"
MA&+>0X-C\4*"8_U!@F3_0()D_S^"9/\_@F3_/X)D_S^"9/\__UD. /]D"P#_
M;@H ZG<( -M]" #4@@H S(02 ,.%) &[@S0%LX! #*U\2Q2F>50;H79<(9QS
M9":8<6LKE&]R+Y%M>3..:X$VBVJ).8AHDCR%9YL_@F:F08!FLD-^9L%$?6;9
M1'QG[T-\9_Q!?&C_0'QH_T!\:/\_?&C_/WQH_S]\:/\__UL, /]G"0#W<0<
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M:W/_0FQS_T%L<_] ;'/_0&QS_T!L<_] _V$% /IN 0#=>0  T((" ,>)! #
MC@0 N9$, +&2&P"IDBL#HI X")N-0P^4BDP7CHA4'8F%6R.$@V(H@(%I+7Q_
M<#%X?G<U=7Q_.'%[B#QN>I(_:WF=06AXJD-F>+A$97C,165XYT1E>/=#9GC_
M0F9X_T%F>/] 9GC_0&9X_T!F>/] _V0# .YQ  #8?   RX4" ,., P"[D0,
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M/$^1_SQ/D?\\Y'0  ,^!  #"C   N)8  *V<  "CH0  F*@  )"J#0"+JQL
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MG!\\PZL@.\.\(3K#U2$[PNXA.<#Y(CB__R0XO_\D.+__)#B__R0XO_\DO9$
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M""3QN @C\<P((O+E""+P\P@B[_4((N_U""+O]0@B[_4(GJ8  )&O  "$N
M=\$  &K)  !=T   4=<  $;=   _Z@4 //8. #GV%P V]R  ,_<H #'X,  N
M^38!*_D] 2GZ1 $G^DH")?M2 B/[6@(@_&,#'OQN QS]>P,;_HD$&?Z8!!C_
MJ 07_[<$%O_(!!;_X 06_^0$%O_D!!;_Y 06_^0$DZX  (6W  !XP   :LD
M %W2  !0V0  1-\  #KD   U]P, ,O\, "[_$@ K_QH */\A ";_)P C_RT
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M-(Y7\#2-5_TSC%C_,XQ8_S*,6/\QC%C_,8Q8_S&,6/\Q_U$, /];"0#_8P@
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M-W)H_S9R:/\U<FC_-7)H_S5R:/\U_UD" /9E  #=;@  SW8! ,=[ P# ?P0
MN8 , +&"&@"J@BH"HX W!9U]0@N7>TL1DGA4%XUV6QN)=&(@A7)I)(%Q<"=^
M;W<K>VY_+GAMB#%V;)(T<VN<-G!JJ#AN:K<Z;6K).FQJY#IM:_4X;6O_-VUK
M_S9M:_\V;6O_-FUK_S9M:_\V_UL  .MG  #9<0  S'D  ,-^ @"[@@, M(0)
M *V%& "FA2@!GX0U!9F"0 J3?TD0C7U2%HE[61N$>6 ?@'=G(WQU;B=Y='4J
M=G-]+G-RAC%P<9 T;7";-FMOISAI;[4Z:&_'.F=OXCIG;_0X:&__-VAO_S9H
M;_\V:&__-FAO_S9H;_\V_UX  .1J  #3=   R'P  +^! 0"WA0$ KX<' *B)
M%0"AB24!FX@S!)2&/@F.A$</B8%0%81_5QI_?EX>>WQE(GAZ;"9T>7,J<7A[
M+6YWA#!K=HXS:'69-F9TI3AD<[,Y8G/$.F)SX#IB<_,X8W/_-V-S_S9C<_\V
M8W/_-F-S_S9C<_\V_V$  .!M  #/=P  Q'\  +N%  "SB0  JHL# *.,$P"<
MC2,!EHPP Y"+/ B*B44.A(=.$W^%51A[@UP==X)C(7. :B5O?W$I;'UY+&E\
M@B]F>XLR8WJ7-6!YHS=>>;$X77G".5QYW3E=>?$X77C^-UYX_S9>>/\U7GC_
M-5YX_S5>>/\U]60  -QP  #*>@  P(,  +:)  "NC0  I(\  )V1$ "7DB
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MFRQ(FJDM1YFZ+4::T"U&F.LM1I?Y+D:6_RY&EO\N1I;_+D:6_RY&EO\NT7<
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M&#:]RA@WO.<7-;OV&36Z_QHTN?\;-+G_&S2Y_QLTN?\;N(\  *J8  "?GP
MDZ8  (>L  ![LP  ;[D  &.^  !8Q 0 4,@, $W(%P!,R24 2LHQ $?*.P%%
MRD0"0\I, T'*5 0^REP&/,ID!SK+;@DXRW@*-LN%##3+D@TRRZ(.,<NR#S#,
MQP\PR^4.+\GU#R[(_1$NQ_\2+L?_$B['_Q(NQ_\2KI<  *&>  "5I0  B:T
M 'RT  !PNP  9,$  %G&  !.RP, 1= ( #[5#@ ]U1H /-8F #O7,0 YV#L
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M A#[W0(0^^D"$/OI A#[Z0(0^^D"CZL  (&T  !SO0  9L8  %G-  !+TP
M0-D  #7>   LXP  )O$  "3^"@ A_Q  '_\6 !S_'  9_R( %_\H !7_+@ 3
M_S4 $O\\ !#_0P ._TP #?]6  O_8@ )_V\ "/]_ 0?_D $%_Z !!/^N 03_
MO $#_\<! __' 0/_QP$#_\<!@[0  '6]  !GQ@  6L\  $O5   _W   ,^$
M "GE   A[   'OT  !K_!0 7_PP %?\0 !+_%  0_QD #O\>  W_(P +_R@
M"/\N  ;_-0 #_ST  /]&  #_40  _UT  /]K  #_>P  _XL  /^9  #_I0
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M(*=&\R&E1O\AHT;_(J)&_R&B1O\AHD;_(:)&_R&B1O\A_T4. /]+"@#_4PP
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M*H!8_RJ 6/\I@%C_*8!8_RF 6/\I_T\" /U9  #B8   U6<  ,QJ P#&; 4
MP&P. +=M'0"P;BP!JFPY!*5J1 B@:$X-FV97$9=D7A648F49D6!L'(Y?<QZ+
M7GLAB5V")(9<BR:$6Y0H@5N>*G]:JBQ]6K<M?%K)+GI:XRYZ6_4M>ES_+'E<
M_RMZ7/\J>ES_*GI<_RIZ7/\J_U$  /);  #>9   SVH  ,=N @# < 0 NG ,
M +)Q&@"K<2D!I7 W Y]N0@>:;$L,EFI4$9)H7!6.9F,8BV5I&XAC<!Z%8G@A
M@F%_)(!@B"9]7Y$I>U^<*WA>IRUV7K4N=5[&+W1>X2]T7_,N=%__+'1@_RMT
M8/\K=&#_*W1@_RMT8/\K_U,  .A>  #99P  RVT  ,-Q 0"[<P( M7,) *UU
M%P"G=2<!H70T YMR/P>5<$D+D6Y2$(QL612):F 8A6EG&X)H;AY_9G4A?65]
M)'IDA29W9(\I=6.:*W)BI2UP8K,O;V+$+VYBWB]N8_(N;F/^+6YC_RQN8_\K
M;F/_*VYC_RMN8_\K_U4  .5@  #3:0  R'   +]T  "W=P$ L'<' *AX%0"B
M>20 G'@R I9V/0:1=$<+C')/#XAP5Q.$;UX7@&UD&GUL:QUZ:W,@=VIZ(W1I
M@R9R:(TI;V>7+&UGHRYK9K$O:6;!,&EFVS!I9_ O:6?]+6EG_RQJ9_\K:F?_
M*VIG_RMJ9_\K_E@  .%C  #/;   Q',  +MX  "S>@  JWH$ *1[$@">?"(
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MG"M6>ZDL5'NY+5-[SBU4>NHM5'KY+%1Y_RM5>?\J57G_*E5Y_RI5>?\JX64
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M(T.4R"-#E.4C0Y+U)$.1_R1#D/\D0Y#_)$.0_R1#D/\DRG4  +N!  "PBP
MI)$  )J5  "/F0  @YT  '2B  !NHPL :J07 &:E)0!CI3$!7Z0[ UND1 58
MI$L(5:-3"U*C6@U/HF$03:)H$TJA<15'H'L81*"&&D*?DQQ GZ(=/I^R'CV?
MQAX]G^,=/9WT'CV<_Q\\F_\?/)O_(#R;_R \F_\@PGP  +6(  "ID   GI8
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M""G"^PDHP?\**,'_"RC!_PLHP?\+J)4  )V;  "1H@  A*D  'BO  !KM0
M7[L  %2_  !)PP  /\@$ #;-"0 SSA$ ,L\< #'/)P PT#$ +] Z "[10P M
MT4P *])5 "K27P$HTVD!)]-V 273A (DU)0"(M2F B'5N0(AU=("(-/K B#2
M]@,?T?\$']'_!!_1_P0?T?\$GYL  )2B  "'J0  >;$  &VX  !@O@  5,,
M $G'   ^RP  -= ! "W5!@ EVPL )-X2 "/>'  BWR4 (> N "#@-P ?X4
M'N%* !WB4P <XUX &^-J !KD>  8Y(@!%^6: 1;FK $5YL !%.?= 1/E[P$3
MX_H!$^/Z 1/C^@$3X_H!EJ(  (FI  ![L0  ;KD  &'   !4Q@  2,H  #W/
M   STP  *MD  "+> @ >ZPH '.P0 !OM%P 9[1\ %^XF !7N+0 4[S4 $_ ]
M !'P1@ 0\5  #_);  [R:0 -\W@ #/2*  OUG  *]:X "?;"  GVV0 (]>T
M"/7M  CU[0 (]>T BZD  'VR  !ON@  8L(  %7)  !'S@  .](  #'8   G
MW0  '^$  !GH   6^ 8 %/H- !+[$@ 0_!< #OP=  W](P ,_2D "OXP  C_
M.  &_T$  _],  #_6   _V8  /]W  #_B0  _YL  /^K  #_NP  _\X  /_/
M  #_SP  _\\ ?[(  '&Z  !CPP  5LL  $C1   ZU@  +]T  "7A   <Y0
M%.D  !'W   /_P$ #?\)  O_#0 (_Q  !O\4  /_&   _QX  /\C  #_*@
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M"L8Q]PS#,?\.P3'_#\ Q_P^_,?\/OS'_$+\Q_Q"_,?\0_S83 /\Y#P#_/A
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M&Y1&_QN31O\;DT?_&Y-'_QN31_\;_T(% /]* 0#R4   X50! -E6!0#350D
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M(758_R%U6/\A_TT  .57  #37P  R&0  +]G  "W:   L6<' *EH% "C:20
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MG"-B9JDE8&:Y)E]FS29?9N@F8&;Y)&!F_R-@9O\C86;_(F%F_R)A9O\BZ%@
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M(U!VQB10=N,C4'7U(U%U_R)1=/\A473_(5%T_R%1=/\AV&,  ,5M  "X=@
MKGT  *6"  ":@P  C8,  (2$ P!]A1  >88> '6'*P%QAS8";88_!&F%1P=E
MA$\*8H-6#5^#7 ]<@F,26H%K%5> <QA4?WT:47^('$]^E!]-?J(@2WVQ(4I]
MQ")*?>$A2WST(4M[_R!+>_\@2WO_($M[_R!+>_\@T&<  ,!R  "T>P  JH(
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M%CF7_!8XEO\7.)7_%SB5_Q<XE?\7NWH  *^%  "DC   F)$  (V5  "!F@
M=9T  &B@  !;I   5J4, %.F%P!1IR, 3Z<O $RG. %*IT$!2*=) D:G4 1#
MIU@%0:=?!C^F: @]IG(*.J9]"SBFB@TVI9D.-*6I#S.ENP\SI=0/,Z3N#S*B
M^Q RH?\1,J'_$3*A_Q$RH?\1M((  *B,  "=D@  DI<  (:<  !YH0  ;:4
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M AC*_P(8RO\"FYD  (^?  ""I@  =:T  &BS  !<N0  4+T  $3!   YQ
M,,@  "C, 0 @T 8 &=4+ !;7$  5V!D %=DB !39*P 3VC0 $]H] !+;2  1
MW%, $=U? !#=;0 0WGX #M^1  [@I  -X+@ #.#2  O?[0 ,WO< #-W[  S=
M^P ,W?L DI\  (6G  !WK@  :K4  %V\  !0P0  1,4  #C)   NS0  )=$
M ![5   6V@$ $=X& !#G#0 .YQ( #>@9  SH(0 +Z2D "NHQ  GJ.P 'ZT4
M!>M1  3K7@ #ZVX  >N   #JE   ZJ<  .N\  #KT@  Z^D  .SO  #L[P
M[.\ AZ<  'FO  !KMP  7KX  %'%  !#R0  -\T  "W1   CU@  &]L  !/?
M   .XP  #.X"  KV"@ ']@X !?82  /V&   ]1X  /4E  #U+@  ]3<  /9"
M  #V3@  ]ET  /9N  #V@0  ]I4  />G  #WMP  ^,<  /C0  #XT   ^-
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M ?\.BP'_#I(!_PZ8 ?\.G0'_#J,!_@ZH ?P.K@'[#K4 ^@Z^ /@.R0#U#ML
M\@[J .X.]0#L#O\!ZP__ >H/_P'J$/\!Z1#_ >D0_P'I$/\!_R(? /\B' #_
M(1P _Q\@ /\?*0#_'#0 _QI  /\73 '_%5@!_Q1C ?\3;@'_$W<!_A.  ?P3
MB 'Z$HX!^1*5 ?@2F@'V$J !]1*F ?02K 'S$K,!\1*\ ? 2QP'M$M@!Z1/H
M >83]0'D%/\!XA3_ N$5_P+A%?\"X!7_ N 5_P+@%?\"_R4; /\F%P#_)!8
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M"ZXP_PNN,/\+K3#_"ZTP_PNM,/\+_S,, /\V!@#_/ D _SX, /T]$ #O/!4
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M%85'_Q6%1_\5_S\  .Q(  #=3P  SU,  ,95  # 4P, NU$, +-2&0"M4RD
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MG!IN5JD;;%:X'&M6RQUJ5N8<:E?W&VI7_QIJ5_\9:U?_&6M7_QEK5_\9ZTP
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M85ZT'6!>QQU@7N,=8%[U'&!>_QM@7O\:85[_&F%>_QIA7O\:Y%(  ,]<  #
M9   MFD  *QL  "C;   F6D  ))J"P",:A8 AVLD ()K, %^:CH">FE#!'9H
M2P9S9U((<&=9"FUF8 UK968/:&1N$69D=A1D8X 68F.+&&!BEQI>8J0<7&*R
M'5MBQ1U;8N$=6V+T'%MB_QM<8O\:7&+_&EQB_QI<8O\:X%4  ,M?  "]9P
MLFP  *EP  "?;P  E&P  (QM" "&;A, @F\A 'UO+0%Y;S@"=6Y! W)M205N
M;% ':VM7"FEK7@QF:F4.9&EL$6%I=!-?:'X676>)&%MGE1I99J(;5V:P'%9F
MPQU69M\=5F;S'%=F_QM79O\:5V;_&E=F_QI79O\:VUD  ,=B  "Z:@  KW
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M&$=V_!A'=O\81W7_%T=U_Q='=?\7R64  +IO  "N=P  I'T  )A_  "+?P
M?G\  '.!  !L@PD :(03 &6%( !BABP 7X8V 5R&/P)9A48#5X5.!52%50=2
MA%P)3X-C"TV#:PU+@G0/2()_$4:!C!-$@9H50H"I%D& NA9 @-(607_M%D%^
M^Q9!??\607W_%D%]_Q9!??\6PFH  +5U  "J?0  GX(  )*#  "%A   >84
M &J)  !DB@, 8(P0 %V-&P!;CB< 6(XR %6..P%3CD,"4(Y* TZ-4@5,C5D&
M28Q@"$>,: I%BW(,0HM]#D"*B0\^BI@1/(JG$CN*N!(ZBL\2.XCK$CN'^A,[
MAO\3.X;_$SN&_Q,[AO\3O'$  *][  "E@P  F8<  (R(  !_B0  <XP  &60
M  !<DP  5Y4, %26%@!2EB( 4)<M $V7-@!+ES\!29=' D>73@-%EE4$0Y9=
M!4&6908^E6\(/)5Z"3J5APLXE94,-I2E#364M@XTE,P--)/I#322^ XTD/\/
M-)#_#S20_P\TD/\/M7@  *J"  ">B   DXT  (:.  !YD   ;9,  &&7  !5
MFP  39X& $F?$ !'GQL 1J F $2@, !#H3H 0:%" 3^A20$]H5$".Z%9 CFA
M80,WH&L$-:!V!3.@@P8QH)(',*"B""Z@LP@NH,D(+I_G""V=]PDMG/\*+9O_
M"BV;_PHMF_\*KX   *.)  "7C@  C9,  '^5  !RF   9IP  %N@  !/I
M1:<  #ZI#  \JA0 .JH? #FJ*0 XJS( -ZL[ #6K0P TK$L ,JQ3 3&L7 $O
MK&8"+:QQ BNL?P,JK(X#**R>!">LL 0FK,4$)JOD R6I]00EJ/\%):?_!26G
M_P4EI_\%IXD  )N/  "1E   A)D  'B>  !KH@  7Z8  %.J  !(K0  /;
M #2S P OM0X +;46 "RU(  KMBD *K8R "FW.@ HMT, )[=, ":X50 DN%\
M([AK "*X> $@N(@!'[B9 1VYJP$<N< !'+C? 1RV\@$;M?P"&[3_ ANT_P(;
MM/\"GX\  )25  "(FP  >Z$  &ZF  !BJP  5K   $JS   _M@  -;D  "R\
M   DOP8 '\(- !W"%  <PAX &\,F !K#+P 9Q#@ &,1! !?$2@ 6Q54 %<5A
M !3&;P 3QG\ $L:1 !''I  0Q[D #\?4 !#&[@ 0Q/H $,/_ !##_P 0P_\
MEY8  (N<  !^H@  <:D  &2O  !8M   2[@  $"[   UO@  *\$  "/%   ;
MR0$ %,P& !#0"P .T1$ #=$9  W1(0 ,T2H #-$T  O2/@ *TDD "=-5  G3
M8@ (TW( !M2$  74F  $U*L  ]7   '5W  !U>T  =7V  '5]@ !U?8 CIT
M ("D  !SJP  9K$  %FX  !,O0  /\   #3#   JQP  (<H  !G.   2T@
M#=8!  G;!0 &W T !-P1  /=&  !WB   -XH  #?,0  X#P  .%'  #B5
MXV,  .-T  #DB   Y)L  .6N  #EP0  Y=4  .;G  #FYP  YN< @Z0  '6L
M  !HLP  6KL  $W!  ! Q   ,\@  "C,   ?T   %]0  !#9   +W0  !>$
M  #D    Y0<  .8-  #G$0  Z!8  .D=  #J)0  ZRX  .TY  #O10  \%,
M /%D  #Q=@  \HH  /.<  #SK0  ]+L  /3(  #TR   ],@ =ZT  &JU  !<
MO0  3\0  $#)   SS0  )]$  !W6   4W   #N    CC   !Y@   .H   #N
M    [@   .\$  #P"@  \0X  /,2  #T&   ]B   /@J  #Z-0  _4,  /Y2
M  #_8P  _W8  /^)  #_F@  _Z8  /^P  #_L   _[  _Q8C /\5(0#_$2$
M_PTD /\)*P#_!C< _P-$ /\ 40#_ %T _P!H /\ <@#_ 'L _P"# /\ B@#_
M )$ _P"6 /\ G #_ *$ _0"F /L K #Y +, ]P"[ /4 Q0#S -$ \@#D /$
M\0#O /H [@#_ .X _P#M /\ [0#_ .T _P#M /\ _QD@ /\8'0#_%1T _Q ?
M /\.*0#_##0 _PI! /\'30#_!5D _P1D /\$;@#_ W< _P.  /\#AP#_ XT
M_0*3 /L"F0#Y IX ]P*D /4"J@#S ;  \0&X .\!P@#M <\ ZP'C .H![P#H
M OL YP3_ .8%_P#F!O\ Y@;_ .8&_P#F!O\ _QP; /\;&0#_%Q@ _Q4= /\3
M)0#_$3  _Q ] /\.20#_#%4 _PM@ /\+:@#]"W, ^PM\ /D*@P#W"HH ]0J0
M /0*E@#S"IL \0JA .\)IP#M":X ZPFV .@)P #F"<T Y GB .(*\ #?"_L
MW@S_ -P-_P#<#?\ VPW_ =L-_P';#?\!_Q\7 /\>$P#_&Q( _QP9 /\;(@#_
M&"P _Q4X /\31 #^$E  ^1%; /409@#S$&\ \!!W .X0?P#L$(8 ZA", .D0
MD@#H$)@ Y@^> .4/I0#C#ZP X0^T . /O@#>#\P VA#A -41\ #2$OL SQ+_
M <X3_P'-$_\!S1/_ <P3_P',$_\!_R(2 /\B#P#_(0\ _R(4 /\B' #_("<
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M")PQ_PB<,?\(_S   /\U  #O.   XCH  -LY! #6-0D SC03 ,8V(@"_.#$
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MGP]^1*L0?$6Y$7M%RQ%Z1>81>4;W$7A&_Q!X1O\0>$;_#WA&_P]X1O\/\#\
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M%&91PQ5E4MX595+R%&52_Q-E4O\295+_$F52_Q)E4O\2Y$H  ,]3  # 6@
MM5X  *Q@  "B7@  FED  )):"P"-6Q8 B%PC (1<+P" 6SH!?5M# GE:2P-V
M65($=%A8!G%87P=O5V8);5=M"VM6=0UI5GX/9U:)$655E1)C5:$48E6O%6%5
MP19@5=L68%;Q%6!6_A1@5O\385;_$F%6_Q)A5O\2X$T  ,M6  "]70  LF$
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M%5)A^Q128?\34V'_$E-A_Q)38?\2T58  ,!?  "S9@  J6L  )QK  "0:@
MA6<  'UI  !W:@T <VL7 &]K) !L;"\ :6PX 69K00)C:TD#86M0!%YJ5P9<
M:ET'6FEE"5AI;0M5:'8-4VB!#U%GC1%/9YH23F>I%$UGN11,9\\43&;K%$UF
M^Q--9O\23F7_$DYE_Q).9?\2S%H  +QC  "P:@  I6\  )AN  ",;0  @&P
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M#CUW_PX]=_\.O&@  *]R  "D>0  EGH  (AZ  !\>@  <'P  &-_  !<@@
M5X0+ %.%% !1AB  3X8J $Z'- !,ASP!2H=$ 4B'2P)&AU,"1(9: T*&8@1
MAFP&/H5V!SN%@P@YA9$*.(2@"S:$L0LVA,8+-H/D"S:"]@LV@?\,-H#_##:
M_PPV@/\,MF\  *IX  "??P  D'X  (-_  !W@   :X(  %Z'  !5B@  3HP&
M $J.$ !(CQH 1X\E $60+P!$D#@ 0I!  $"01P$_D$\!/9!6 CN07P(YD&@#
M-X]S!#6/@ 4SCXX&,8^>!S".KP<OCL,'+X[A!R^,] @OB_\(+XK_""^*_PDO
MBO\)L'8  *5_  "8A   BH0  'V%  !PAP  98H  %J.  !/D@  1I4  $&8
M#  ^F!0 /9D? #N9*  ZFC$ .9HZ #>:0@ VFDH -9I2 3.:6@$QFF0!+YIO
M BV:>P(LFHH#*IJ: RF:K 0HFL $)YG> R>7\@0GEOT%)Y7_!2>5_P4GE?\%
MJ7X  )Z%  "2B0  A(H  ':,  !JCP  7I,  %27  !)FP  0)\  #>B!  R
MHPX ,:,7 #"D(0 NI"H +:0R "RE.@ KI4, *J5+ "FE5  HI5X )J5I "6E
M=@$CI84!(J66 2"FJ $?I;L!'J77 1ZD[P$>HOL"'J'_ AZA_P(>H?\"HH8
M )>,  "+CP  ?9$  &^4  !CF   5YT  $VA  !#I0  .*@  #"K   HK@<
M)*\0 ".O%P AKR$ (+ I !^P,0 >L#H ';%" !RQ3  ;L58 &K%A !FR;P 8
MLGX %K*0 !6RH@ 4LK8 $[+. !.QZP 3K_D $Z[_ 1.N_P$3KO\!FHT  )"2
M  "$EP  =9H  &B?  !;HP  4*@  $6L   [L   ,;(  ">U   @N   &+H'
M !2\#@ 3O!4 $KP> !&])@ 1O2X $+TW !"^00 .ODP #KY7  V^90 ,OW0
M"[^&  J^F0 (OJP ![["  >^WP (OO  "+WZ  B]_  (O?P DY0  (>9  !Z
MGP  ;*4  &"J  !3KP  1[,  #RV   QN   )[L  !^^   7P0  $<0!  S(
M"  (R0X !\D4  ;)'  %R20 !,HL  /*-@ "RD   ,M,  #+60  RV@  ,MY
M  #,C   RY\  ,NS  #+R   S.(  ,SO  #,\0  S/$ BIH  'RA  !OIP
M8JT  %6S  !(N   .[L  #"^   FP0  '<0  !7(   /RP  "LX   32 @
MTPH  -,/  #4%   U1H  -8B  #7*@  V30  -H_  #<2P  W%H  -UJ  #=
M?0  W9$  -VD  #>M@  WL@  -[>  #>X@  WN( ?Z(  '&I  !DL   5K<
M $F\   \P   +\0  "3'   ;RP  $\\   W2   'U@   -L   #>    WP,
M . )  #A#@  XA(  .,7  #E'@  YB<  .@Q  #J/0  [$L  .Q:  #M;
M[H   .Z4  #NI0  [K0  .["  #NQ@  [L8 =*H  &:R  !8N0  2\   #W%
M   OR0  ),T  !G1   1U@  "]L   />    X0   .4   #H    Z0   .H
M  #K!@  [0L  .\/  #P$P  \AH  /0C  #W+@  ^3L  /M*  #\6P  _6T
M /V   #^DP  _J(  /ZM  #^KP  _J\ _Q ? /\.'0#_"AT _P$@ /\ * #_
M #4 _P!! /\ 3@#_ %H _P!E /\ ;@#_ '< _P!_ /X A@#\ (P ^P"2 /D
MEP#X )P ]P"B /8 IP#U *T \P"U /( O0#Q ,D [P#< .X ZP#M /< [ #_
M .L _P#J /\ Z@#_ .H _P#J /\ _Q,< /\1&0#_#1D _P8< /\#)0#_ #$
M_P ^ /\ 2@#_ %8 _P!A /\ :P#] ', ^@![ /< @P#U (D ] "/ /( E #Q
M )D \ "? .X I #M *L [ "R .H N@#H ,8 YP#6 .4 Z #D /4 XP#^ .(
M_P#A /\ X0#_ .$ _P#A /\ _Q48 /\3% #_#Q0 _PT9 /\+(@#_""T _P0Y
M /\!1@#_ %$ _@!< /H 9@#V &\ \@!W .\ ?@#M (4 ZP"+ .H D0#H )8
MYP"< .8 H0#D *@ XP"O .$ N #? ,, W0#1 -L Y@#9 /, UP#] -4"_P#4
M O\ U /_ -0#_P#4 _\ _Q@3 /\5$ #_$@\ _Q(5 /\1'0#_#B@ _PPT /\*
M00#Y"$P ]097 /$&80#M!FH Z05R .8%>@#D!8$ X@6' . &C0#?!I( W0:8
M -L&G@#9!J4 UP:M -0&M0#2!L  T ?/ ,X(Y0#,"?0 R@O_ ,@,_P#'#/\
MQPS_ ,8,_P#&#/\ _QL. /\9# #_& T _Q@1 /\7& #_%"( ^Q$N /,0.@#M
M#D8 Z U2 .4-7 #A#64 W@UM -L-=0#8#7P U0V" -,-B0#1#8\ T V5 ,X-
MG #-#J, RPZK ,D.M #(#L  Q@[/ ,,0Y@# $?4 O1+_ +P2_P"[$O\ NA+_
M ;H2_P&Z$O\!_Q\* /\<! #_'P@ _Q\- /\=$@#X&AL [A8F .84,P#@$S\
MVA-+ -035@#0$U\ SA1H ,L4;P#)%'< QQ5] ,85A #$%8H PQ61 ,$6F #
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MI 26+Z\$E2^]!),OSP21,.@%CS#X!8TQ_P6-,?\%C#'_!8PQ_P6,,?\%_RT
M .HU  #<.@  SCT  ,8\  # -P( NS,- +,T&0"N-B< J3<T *4W0 "B-TH
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M"G5 PPMT0-T+<T'Q"W)!_PIR0?\*<D'_"7)!_PER0?\)Z3P  -5%  #%2P
MNDX  +!.  "G2P  HD8  )M&#@"61QH D4@G (Y(,P"*2#T AT=& 81'3@&"
M1E4"@$9< WY%8@1\16D$>D5P!7A$> 9V1($(=$2+"7)$E@IP1*(+;T2O#&Y$
MP QM1=D-;$7O#&M%_0MK1O\+:T;_"FM&_PIK1O\*Y4   ,])  #!3P  M5(
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M#EM1^@U;4?\,6U'_#%M1_PM;4?\+UDH  ,-3  "V60  JUP  )Y:  "360
MBU0  (16 P!^5A  >E<: '97)@!S6#$ <%<Z &U70@%J5TD":%90 F965P-D
M5EX$8E5E!6!5;0=>578(756!"EM5C0M95)H-6%2G#E95N ]65<P/5E7I#E95
M^0U65?\-5U3_#%=4_PQ75/\,T4T  ,!6  "S7   IUX  )I=  "/7   AE@
M ']9  !Y6@T =%L7 '%;(P!N6RX :ULW &A;0 %E6T<!8UI. F%:50-?6EP$
M75IC!5Q::P9:670(6%E_"E99BPM469@-4UBF#E)9M@Y16<H/45GG#E%8^ U2
M6/\-4EC_#%)8_PQ26/\,S5$  +Q9  "P7P  HV$  )9@  "+7P  @5L  'E=
M  !S7@P ;UX5 &M?( !H7RL 9F U &-@/0%A7T4!7U], EU?4P-;7UH$65YA
M!5=>:0957G((4UY]"5%=B0M0798,3EVD#4U=M Y,7<@.3%WF#DU=]PU-7/\,
M35S_#$Y<_PQ.7/\,R50  +E<  "M8P  GV,  ))C  "'8@  ?&   '1A  !N
M8@D :6,2 &9C'0!C9"@ 860R %YD.P!<9$,!6F1* EAD40)69%@#5&1?!%)C
M9P508W '3F-Z"$QBA@I+8I0+26*B#$ABL@U'8L<-1V+D#4AA]@Q(8?\,2&#_
M"TE@_PM)8/\+Q%@  +5@  "J9@  FV8  (UF  ""90  =F0  &YE  !H9@4
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M? 0T?XH$,G^:!3%^J@8P?KT&,'[:!C!]\ 8P>_T&,'O_!C!Z_P8P>O\&L&P
M *1U  "4=0  AG4  'EV  !N=P  8WD  %=]  !/@0  1X0  $*&#  _AQ,
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M !B?GP 7G[( %I_) !:>Z  6G/< %IO_ 1>;_P$7F_\!G8,  (^&  ""A@
M=(<  &>+  !;CP  4),  $:8   \G   ,Z   "NC   CI@  '*@+ !JI$0 8
MJ1@ %ZDA !:J*0 5JC$ %*HY !.J0P 3JTT $JM8 !&K90 0JW0 #JN&  ZK
MF0 -JZP #*O!  RJWP ,J?( #:C\  VH_P -J/\ EHH  (F,  !ZC0  ;)$
M &"5  !4F@  29\  #^C   UIP  *ZH  ".N   ;L   %+,!  ^U"@ -MA
M#+86  NV'P *MB< ";8O  BV.0 'MT, !K=/  2W6P #MVH  K=[  "WC@
MMZ$  +:T  "VRP  MN4  +7Q  "U]P  M?< CY$  (&4  !REP  99P  %BA
M  !,I@  0:L  #>O   LL@  ([4  !JX   3NP  #KT   G !0 #P0T  ,$1
M  #!%P  PAX  ,(F  #"+P  PSD  ,1$  #$4   Q%X  ,5O  #%@0  Q94
M ,6H  #%O   Q-$  ,3F  #$[@  Q.X AI@  'F>  !KHP  7:D  %"N  !$
MLP  -[8  "RY   BO   &;\  !'"   ,Q0  !L@   #+    S <  ,P-  #-
M$0  S18  ,X=  #/)   T"T  -(X  #41   U%(  -5A  #5<P  UH<  -:;
M  #6K0  U[\  -C.  #8W0  V-T >Z   &ZF  !@K0  4[,  $6X   XO
M*[\  "'"   7Q@  $,D   K,   "T    -0   #7    V    -H%  #;"P
MW X  -X3  #?&0  X2$  .,J  #E-@  YT,  .=3  #H9   Z7<  .F,  #J
MGP  ZJX  .JZ  #JPP  ZL, <*@  &*O  !5M@  1[P  #G    LQ   (,@
M !;,   .T   !]0   #9    W0   .$   #C    Y    .8   #G 0  Z0<
M .L,  #L$   [A4  / =  #S)P  ]C,  /=#  #X5   ^68  /EZ  #ZC@
M^IX  /NI  #[L   ^[  _PL; /\'&0#_ !D _P < /\ )0#_ #( _P _ /\
M2P#_ %< _P!B /\ :P#_ ', _0![ /L @@#Z (@ ^ "- /< D@#V )@ ]0"=
M /0 H@#S *D \0"P .\ N #N ,, [ #1 .L Y@#I /, Z #^ .@ _P#H /\
MZ #_ .@ _P#H /\ _PX8 /\*%0#_ 10 _P 8 /\ (@#_ "X _P [ /\ 1P#_
M %, _0!> /H 9P#W &\ ]0!W /, ?@#R (0 \ ") .\ CP#N )0 [ ": .L
MGP#I *4 Z "L .8 M #D +\ XP#, .$ X@#? /  W@#[ -X _P#= /\ W0#_
M -P _P#< /\ _Q 3 /\-$0#_!A  _P(5 /\ '@#_ "D _P V /\ 0@#Z $X
M] !9 /$ 8@#N &L [ !R .H >0#H '\ YP"% .4 BP#D )  X@"6 .$ G #?
M *( W0"I -H L0#8 +L U0#( -( W0#1 .T T #Y ,\ _P#. /\ S0#_ ,T
M_P#- /\ _Q$/ /\.#0#_# T _PL2 /\'&0#_ B0 _P P /8 / #O $D Z@!3
M .< 70#D &8 X0!M -\ = #= 'L VP"! -D A@#6 (P U "2 -( F #0 )X
MS@"F ,P K@#* +@ R #$ ,8 UP#% .H PP#W ,( _P#! ?\ P +_ , "_P#
M O\ _Q0+ /\0!@#_$ D _Q . /\.% #_"AX ]08I .L$-@#C T( WP-. -L$
M5P#6!&  TP1H - $;P#.!78 S 5\ ,H%@@#)!8@ QP6. ,8%E #$!9L P@6C
M , &JP"^!K4 O0;" +L(U "Z">D MPOX +4,_P"T#/\ M S_ +0,_P"T#/\
M_Q<$ /\4  #_%@, _Q0) /\1#@#R#A4 Z PA -X*+@#6"SL T Q' ,P,40#)
M#%H Q@UB ,0-:@#"#7$ P UW +\-?0"]#H, O Z* +H.D0"Y#I@ MPZ@ +8.
MJ0"T#[0 L@_! +$0U "N$>L JQ+Z *D2_P"H$_\ IQ/_ *<3_P"G$_\ _QH
M /\;  #Y&P  ZQD  .44!@#E$ X V0X7 ,\1)@#($C0 Q!-  +\42P"\%%0
MN15= +<59 "U%6L M!5Q +(5> "Q%GX KQ:% *X6C "L%I0 JQ>< *D7I@"G
M&+  IAB] *08SP"B&N< GQKW )T;_P&<&_\!G!O_ 9L;_P&;&_\!_QT  /<A
M  #H)   W24  -0A 0#/&P@ RA<1 ,(:( "\'"T MQTZ +,>10"P'D\ K1Y7
M *L>7P"I'V8 J!]L *8?<P"E'WD HQ^  *(?AP"@((\ GR"8 )T@H@";(*P!
MFB&Y 9@AR@&6(N0!E"/U 9(C_P&1(_\!D"/_ 9 C_P&0(_\!_R(  .LI  #=
M+@  SR\  ,<M  #!)P, O2(- +8C&@"P)2@ K"8T *@F0 "E)TD HB=2 * G
M6@">)V$ G"=G )LG;0"9)W0 F"=[ 98G@@&5)XL!DR>4 9$HG@&0**D!CBBU
M HTIQ@*+*=\"B2KR H<J_P*&*O\"ABK_ H8J_P*&*O\"]"@  .,Q  #1-@
MQ3@  +PV  "V,   LBL) *LL% "F+2( HBXO )XN.@";+D0 F"]- )8O50"4
M+EP DBYB ) N:0&/+F\!C2YV 8PN?@&*+H8"B"Z/ H<NF@*%+Z4#@R^R X(O
MP@.!,-H#?S#O WTQ_@-],?\#?#'_ WPQ_P-\,?\#[2\  -LW  #)/0  OCX
M +,\  "L.   IS,$ *(R$0"=-!T F34J )4U-0"2-4  CS5) (TU4 "+-5<
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M!V9 ^09E0/\&94#_!F5 _P5E0/\%W#X  ,=&  "Y2P  K$P  *!*  "71P
MD4,  (M#" "&0Q( @D0> 'Y$*0![130 >44] '9%10!T1$P!<D13 7!$60%N
M1& ";$-G FM#;P-I0W<$9T.!!69#C09D0YD&8D.G!V%$M@A@1,H(8$3F"%]%
M^ =?1?\'8$7_!F!$_P9@1/\&UD$  ,-)  "V3@  IT\  )M-  "22P  C$<
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M!U%/_P913_\&R4L  +E3  "K5P  G%8  (]5  "%5   ?%   '51  !P4@D
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M?01 8HL%/V*:!CYBJ@8]8KP'/&+6!SUA[P8]8?T&/F#_!CY@_P8^8/\&N5D
M *MA  ":80  BV$  ']A  !T80  :6$  %]B  !99   5&8) %%G$0!.9QH
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M BMXHP(J>+4"*GC, BIWZ@(J=OD#*G7_ RIT_P,J=/\#JFH  )IM  ");
M?&T  '!M  !F;@  6W$  %!U  !(>   07L  #I^!0 V?PX -( 6 #.!(  R
M@2@ ,($P "^".  N@D  +8)( "R"4  K@EH *H)D "B"<  F@G\!)8*/ 22"
MH $C@K(!(H+) 2*!YP$B?_<!(G[_ B)]_P(B??\"I7$  )-Q  "#<0  =G$
M &QR  !@=0  5G@  $Q\  !#@   .X,  #.&   MB0H *HH1 "F+&0 GBR(
M)HLJ "6,,0 DC#D (XQ" "*-2@ AC50 ((U> !^-:P =C7D '(V* !N-G  9
MC:X &(S$ !B,XP 9BO4 &8G_ 1F(_P$9B/\!G7<  (QV  !]=@  <G<  &5Y
M  !:?   4(   $:$   \B0  -(P  "V0   EDP( 'Y4, !V6$@ <EAH &Y<B
M !J7*@ 9ES( &)@Z !>80P 6F$T %9A8 !289  3F', $9B$ !"8E@ 0F*D
M#IB_  Z7W0 /EO( $)7\ !"4_P 0E/\ E7T  (5\  !X?   :WX  %^!  !4
MA@  2HH  $"/   VDP  +9<  "::   >G0  %Z # !*B#  0HQ( $*,9  ^C
M(0 .I"D #J0Q  VD.@ ,I$4 "Z10  JD7  )I&H !Z1[  :CC@ $HZ$  J.T
M  .BRP #HN8  Z'S  .A^P #H?L C8,  '^"  !QA   9(<  %B,  !-D0
M0I8  #B:   OG@  )J(  !ZE   7J   $:L   RN!P 'KPT  Z\2  *O&0 !
MKR$  *\I  "P,@  L#P  +!'  "P4P  L&$  +!Q  "P@P  KY<  *^J  "O
MOP  KMD  *[K  "N]   KO0 AXD  'B*  !JC@  79,  %&8  !%G0  .Z(
M #"F   GJ@  'JX  !:Q   0M   "[8   6Y P  N@H  +H.  "Z$P  NQD
M +LA  "\*   O#$  +T\  "^2   OE8  +YE  "^=P  OHP  +Z?  "]LP
MOL<  +[>  "]ZP  O>L ?Y(  '"5  !BF@  59\  $FE   ]JP  ,J\  "BT
M   >M@  %;D   Z\   )OP   L(   #$    Q00  ,8*  #&#@  QQ(  ,@8
M  #)'P  RB<  ,PP  #./   SDD  ,]9  #/:@  SWX  ,^3  #/I@  S[@
M ,_(  #/VP  S]L =YP  &BA  !;IP  3JX  $&T   TMP  *+H  !V]   3
MP   #<0   ;'    R@   ,X   #0    T0   -("  #3"   U0P  -80  #9
M%0  VQP  -TD  #@+P  XCP  .-+  #D7   Y&\  .6#  #EF   Y:D  .6V
M  #EPP  Y<, ;*4  %^L  !1L@  1+D  #6\   HP   ',0  !+(   ,RP
M \\   #3    V    -P   #?    WP   .$   #C    Y ,  .8(  #H#0
MZ1$  .P8  #N(@  \2X  /,\  #T30  ]5\  /9S  #WAP  ]YD  /BE  #X
ML   ^+  _P,7 /\ %0#_ !4 _P 8 /\ (P#_ "\ _P \ /\ 2 #_ %0 _P!>
M /\ 9P#] &\ ^P!V /D ?0#X (, ]@"( /4 C@#T ), \@"8 /$ G@#P *0
M[@"K .T LP#K +T Z@#+ .@ X0#G /$ Y@#] .4 _P#D /\ Y #_ .0 _P#D
M /\ _P<3 /\ $0#_ !$ _P 5 /\ 'P#_ "L _P W /\ 1 #^ $\ ^@!: /<
M8P#T &L \@!R /  >0#O '\ [0"$ .L B@#J (\ Z "4 .< F@#E *  Y "G
M .( KP#@ +D W@#& -P V@#: .P V #Y -8 _P#6 /\ UP#_ -@ _P#8 /\
M_PH0 /\##@#_  T _P 2 /\ &@#_ "8 _  R /< /P#T $H \0!5 .T 7@#J
M &8 Z !N .4 = #C 'H X@"  .  A0#> (L W "0 -L E@#8 )P U0"C -,
MJP#1 +4 S@#! ,P T0#+ .< R0#U ,@ _P#( /\ R #_ ,@ _P#( /\ _PP,
M /\&" #_ @H _P / /\ %0#\ "  \0 L .P .0#I $4 Y0!/ .$ 60#> &$
MVP!H -< ;P#4 '4 T@![ -  @ #. (8 S ", ,L D@#) )@ QP"@ ,4 J ##
M +$ P0"\ +\ RP"] ., O #R +L _0"[ /\ N@#_ +H _P"Z /\ _PX% /\)
M  #_"04 _P8+ /\!$ #P !D Y@ E .$ ,@#< #\ U@!) -$ 4P#. %L RP!C
M ,@ :@#& '  Q0!V ,, >P#! ($ P "' +X C@"\ )0 NP"< +D I "W *X
MM0"Y +, R "Q -\ L 'O *\!^P"N O\ K0/_ *T#_P"M _\ _Q   /\.  #_
M#0  ]@L# /('"@#B 1$ VP(= -(#*P#, S< R 1# ,0$30#!!%8 O@5= +P%
M9 "Z!6L N 5Q +<%=@"U!7P LP:# +(&B0"P!I$ KP>9 *T'H0"K!ZL J0BW
M *@)Q@"F"MT I0OP *,,_0"B#?\ H0W_ *$-_P"@#?\ _Q$  /P2  #L$P
MXA,  -L/ P#6"0L S@@4 ,8*(@# ##  O T\ +@-1@"U#4\ L@Y7 + .7P"N
M#F4 K0YK *L.<0"J#G@ J Y^ *</A0"E#XT I ^6 *(0GP"@$*D GQ"U )T1
MQ0";$=X F1+Q )<3_P"6%/\ E13_ )44_P"4%/\ _Q4  .T;  #@'P  TA\
M ,D;  #$% 4 P1 . +H2&P"T$RD L!0U *P50 "I%4D IA52 *0660"B%F
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M 7<K^0%V*_\!=BO_ 74K_P%U*O\!Y2P  - T  #!.   LS@  *@U  "B,0
MG2T  )DJ#@"4*Q@ D"PD (TM, "*+3H ARU# (4M2@"#+5$ @2Y8 ( N7@!^
M+F0 ?2YK 'LN<P%Y+GL!>"Z% 78NCP%T+YL!<R^H G$OM@)P,,D";S#E FXQ
M]P)M,?\";3'_ FTQ_P)M,?\"WS(  ,DY  "[/@  K#T  *$Z  ":-P  E3,
M ) Q"@",,10 AS(@ (0S*P"!,S4 ?S,^ 'TS1@![,TT >3-4 '<S6@!V,V$
M=#-G 7(T;P%Q-'<!;S2! 6XTC )L-)@":C6E FDULP-H-<8#9S;B V8V]0-F
M-O\"9C;_ F8V_P)F-O\"V#<  ,0^  "U0@  ID$  )L_  "3/   C3@  (@V
M!P"$-Q$ @#<< 'PX)P!Z.#$ =SDZ '4Y0@!S.4D <3E0 ' Y5P!N.5T ;#ED
M 6LY:P%I.70!:#E^ F8YB0)D.94#8SJB V(ZL0-A.L,#8#O@!%\[\P-?._\#
M7SO_ U\[_P)?._\"T3L  ,!"  "P10  H40  )5#  "-0   AST  (([ @!]
M.PX >3P8 '4](P!S/2T <#TV &X]/P!L/48 :SU- &D]4P!G/5H 9CUA 60]
M: %C/7$!83Y[ E\^A@)>/I,#7#Z@ UL_KP1:/\$$6C_=!%D_\@19/_\#63__
M UD__P-9/_\#S#\  +Q&  "K2   G$<  )%&  "(1   @D   'P_  !W0 P
M<T 5 &]!( !L02H :D$S &A!.P!F0D, 9$)* &-!4 !A05< 8$)> 5Y"90%=
M0FX"6T)X EI"A -80I #5T*>!%9#K0150[\$5$/:!%1#\0140_X#5$/_ U1#
M_P-40_\#R$(  +A)  "G2P  F$H  (U)  "#1P  ?4,  '9#  !Q1 H ;402
M &I%'0!G12< 9$4P &)%. !@13\ 7T5' %U%30!;150 6D9; 5E&8P%71FP!
M5D9V E1&@0-31HX#4D><!%!'JP101[T$3T?6!4]'[P1/1_T$3T?_ T]'_P-0
M1_\#Q$4  +5-  "C30  E4P  (E+  !_2@  >$8  '%'  !L1P< :$@0 &1(
M&@!A220 7TDM %U)-0!;23T 64E$ %=)2@!625$ 54I9 51*80%22FD!44IT
M D]*?P-.2HP#34J;!$Q+J@1+2[P$2DO3!4I+[@1+2_T$2TK_ TM*_P-+2O\#
MP4@  +)0  "@3P  D4\  (5.  ![30  <TD  &Q*  !G2P0 8DP. %],%P!<
M32$ 6DTJ %A-,@!633H 5$U! %-.2 !23D\ 4$Y7 4].7P%.3F<!3$YR DM.
M?0))3HL#2$Z9!$=/J 1&3[H$1D_1!$9/[01&3OP$1D[_ T=._P-'3O\#O4P
M *Y2  "<40  C5$  (%1  !W4   ;DP  &=.  !B3P  75 - %I0% !741X
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M CA=HP,W7;4#-EW+ S9<Z ,W7/D#-UO_ SA;_P,X6O\#LE<  *!:  "/60
M@5D  '59  !K60  8%H  %9;  !170  3%X" $A@#0!%8!0 1&$> $)B)@!
M8BX /V(V #YC/@ ]8T4 /&-- #MC50 Y8UX .&-H 39C= $U8X$!,V.1 C)C
MH0(Q8[,",6/( C%BYP(Q8?@",6'_ C)@_P(R8/\"KEP  )M=  "*70  ?%T
M '!=  !F70  7%X  %)@  !,8@  164  $%F"@ ^9Q$ /&@: #MH(@ Y:2L
M.&DR #=J.@ V:D$ -6I) #1J4@ S:EL ,6IE #!J< $N:GX!+6J. 2QJGP$K
M:K !*FK& 2IIY0$J:/8"*V?_ BMG_P(K9_\"J6$  )5@  "$8   =V   &QA
M  !B80  6&,  $YF  !':   0&L  #IN!0 V;PX -' 5 #-P'@ R<28 ,'$N
M "]Q-0 N<CT +7)% "QR30 K<E< *G)A "ER;0 G<GL )G*+ "1RG $C<JX!
M(W+# 2-QX@$C</0!(V__ 2-N_P$C;O\!H64  (YD  !_9   <F0  &AE  !>
M9@  5&D  $EL  !";P  .W(  #1U   N> H *WD1 "IY&  I>B$ )WHH "9Z
M,  E>S@ )'M  "-[2  B>U( (7M< "![:  ??'8 '7R& !Q[F  ;>ZH &GN_
M !I[W@ :>?( &WC^ !MW_P$;=_\!F6D  (AI  !Y:0  ;6D  &-J  !9;
M3V\  $5S   ]=P  -7H  "Y]   G@0, (H,- ""$$@ ?A!H '80B !R%*@ ;
MA3$ &H4Y !F%0@ 8ADP %X96 !:&8P 5AG$ %(:! !*&DP 1AJ8 $86[ !"%
MU@ 1@^\ $8+[ !*"_P 2@?\ D6X  (%M  !T;@  :6X  %UP  !3<P  27<
M $!\   W@   +X,  ">'   AB@  &HT& !6/#0 3D!, $I : !*0(@ 1D"H
M$)$R !"1.P /D40 #I%/  V17  ,D6H "Y%Z  J1C0 (D)\ !Y"S  >/R0 '
MC^8 !X[T  B-_  (C?\ B7,  'MS  !O<P  8W4  %=X  !-?0  0X$  #F&
M   PB@  *(X  "&1   :E0  $Y<   Z:"  +G X "9P3  B<&@ 'G"( !IPJ
M  2<,P #G#T  IU(  "=5   G6(  )QR  "<A   G)<  )NJ  ";OP  FML
M )KL  ":]0  F?@ @GD  '9Y  !H>@  7'X  %&"  !&AP  /(P  #*1   I
ME0  (9D  !F=   2H   #J,   FF!0 #IPP  *<0  "G%0  J!P  *@C  "H
M*P  J30  *D_  "I2P  J5D  *EH  "I>@  J8X  *FA  "HM0  J,L  *?D
M  "G[P  I_, ?8   &^!  !AA   58D  $F.   ^E   -)D  "J>   AH@
M&:8  !*I   -K   !Z\   "R    LP<  +,,  "S$   M!4  +0;  "U(@
MMBL  +<U  "W0   N$X  +A=  "X;@  N((  +B7  "XJ@  M[X  +?2  "W
MY@  M^H =H@  &>+  !:D   3I8  $*<   WH@  +*<  "*K   9KP  $;,
M  NV   $N0   +P   "^    O@   +\&  # "P  P0\  ,(3  ##&0  Q"
M ,4I  #'-   R$(  ,E1  #)8@  R74  ,F*  #)GP  RK$  ,K!  #)T0
MR=D ;I,  &"8  !3G@  1J0  #JK   OL   )+4  !FX   0O   "K\   '!
M    Q    ,@   #*    R@   ,P   #- P  S@@  - -  #1$   TQ8  -8>
M  #:*   W30  -Y#  #?5   WV<  .!\  #@D0  X*0  ."R  #@O@  X,,
M9I\  %FF  !,K0  /[0  #*X   DO   &+\  !##   (QP   ,H   #-
MT0   -4   #8    V0   -L   #=    WP   .$$  #C"@  Y0X  .<3  #J
M'   [2<  / U  #Q1@  \E@  /-K  #S@   ])0  /2C  #TK@  ]+( _P 3
M /\ $0#_ !$ _P 5 /\ 'P#_ "P _P Y /\ 10#_ %  _P!: /X 8P#[ &L
M^0!R /< > #U 'X ] "$ /( B0#Q (X \ "3 .X F0#M )\ [ "F .H K@#H
M +@ Y@#% .4 VP#C .T X@#[ .( _P#A /\ X0#_ .$ _P#A /\ _P 0 /\
M#@#_  T _P 2 /\ &P#_ "@ _P T /X 00#[ $P ]P!6 /0 7P#Q &8 [P!M
M .P = #J 'H Z0!_ .< A0#F (H Y0"/ ., E0#A )L X "B -X J@#; +0
MV0#  -8 T #3 .@ T@#W -$ _P#1 /\ T #_ -  _P#0 /\ _P - /\ "0#_
M  H _P / /\ %@#[ "( ]P O /0 .P#P $< [0!1 .D 6@#E &( X@!I .
M;P#> '4 W !Z -H @ #8 (4 U0"+ -, D0#1 )< SP"> ,T I@#+ *\ R0"Z
M ,< R0#% .( Q #R ,, _@#" /\ P0#_ ,( _P#" /\ _P,& /\  0#_  8
M_P , /D $0#Q !T ZP I .< -@#C $$ WP!+ -L 5 #5 %P T@!C ,\ :@#-
M '  RP!U ,D >P#( (  Q@"& ,4 C ## ), P0": +\ H@"] *L NP"V +D
MQ "W -H M@#M +0 ^@"T /\ M #_ +0 _P"T /\ _P0  /\   #_    _P &
M .P #0#E !8 W@ B -< +P#1 #L S0!% ,H 3@#& %< Q !> ,$ 9 "_ &H
MO0!P +P =0"Z 'L N0"! +< AP"U (X LP"5 +( G@"P *< K@"R *P OP"J
M -$ J #H *@ ]P"G /\ IP#_ *8 _P"F /\ _P8  /\%  #Q P  Z    .$
M!P#5 !  S0 ; ,< )P## #, OP ^ +P 2 "Y %$ M@!8 +0 7P"R &4 L !J
M *\ < "M '8 K !\ *H @@"I (D IP"1 *4 F@"C *0 H0"N *  NP"> <T
MG0+F )P$] ";!/\ F@7_ )H%_P"9!?\ _PH  /$.  #D$   V0\  ,X+  #(
M PL P@ 3 +P"'P"W RP LP0W + %0@"M!DH J@92 *@'60"F!U\ I0=E *,'
M:P"B"'$ H AW )\(?@"="(4 FPF. )H)EP"8"J$ E@JL )4+N@"3"\P D@SE
M ) -]@"/#O\ C@[_ (X._P"-#O\ ]A$  .87  #6&P  QQD  +X5  "Y$
MMPH- +$+%P"L#20 J XP *4..P"B#D0 GP], )T/4P";#UH F@]@ )@09@"7
M$&P E1!R ),0>0"2$($ D!"* (\1E "-$9\ BQ&J (H2N "($LL AA/F (44
M]P"#%?\ @Q7_ ((5_P""%?\ [1H  -PA  #*)0  NR(  +$?  "K&@  J10&
M *42$0"@%!X G!4J )D5-0"6%CX E!9' )(63@"0%E4 CA=; (P780"+%V<
MB1=M (@7= "&&'P A1B& (,9D "!&9L @!JG 'X:M0!]&\< ?!SB 'H=]0!Y
M'?\ >!W_ '@=_P!X'?\ Y2(  - I  "_+   L"H  *<G  "@(P  G1\  )H:
M#@"5'!@ D1TD (X>+P",'CD B1Y! (<?20"%'U  @Q]6 ((?7 " 'V( ?Q]I
M 'T@< !\('@ >B"! 'DAC !W(9< =2*D '0BL@!S(\, <B/? ' D\P!O)/\
M;R3_ &XD_P!N)/\ W2D  ,@P  "W,@  J#   )XN  "7*@  DR<  ) C"@",
M(Q, B"0? (0E*@"")30 @"8] 'TF1 !\)DL >B92 '@F6 !W)EX =29E '0G
M; !R)W0 <2=] &\HB !N*)0 ;"BA &LIKP%J*< !:2K; 6<J\0%G*_\!9BO_
M 68J_P%F*O\!U"\  ,(V  "O-@  H34  )8T  "0,   BBT  (<J!@"#*1
M?RH: 'PK)0!Y*R\ =RPX '4L0 !S+$< <2Q- ' L5 !N+%H ;2QA &LM: !J
M+7  :"UZ &<NA0!E+I$!9"Z> 6(OK %A+[T!83#5 6 P[P%?,/T!7S#_ 5\P
M_P%?,/\!S30  +P[  "I.@  FSH  ) X  ")-0  @S(  '\P 0![+PX =S 6
M '0P(0!Q,2L ;S$T &TQ/ !K,4, :C%* &@R4 !G,E< 93)= &0R90!B,FT
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M? %2/8D!43V7 4\]I@)./K<"3C[- DX^Z0)-/OH"3C[_ 4X]_P%./?\!P#\
M *Y#  "<0P  CD,  ()"  !Z0   <ST  &T\  !H/04 9#T. &$^%P!>/B$
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M 4%)H@) 2;,"/TK' C]*Y0(_2?<"0$G_ D!(_P) 2/\!MDD  *)*  "12@
M@TH  '=*  !N20  944  %Y'  !92   54D( %%*$ !/2A@ 3$HA $I+*0!)
M2S$ 1TLX $9,/P!%3$8 1$Q. $--5@!"35\ 04UH $!-= $^38$!/4V0 3Q-
MH $[3K$".D[& CI.Y ([3?8".TW_ 3M,_P$\3/\!LTT  )Y,  "-3   ?TP
M '1,  !J3   8$H  %E+  !43   4$T% $Q.#@!)3Q4 1T\> $5/)@!$4"X
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M 2E=W@$J7/(!*EO^ 2M;_P$K6O\!HU4  (]5  !_50  <E4  &=6  !>5@
M5%<  $Q9  !%6P  /UT  #I?!  V8 T -&$3 #)B'  Q8B, ,&(K "]C,@ N
M8SH +6-" "QC2@ J9%, *61= "AD:0 G9'8 )F2& "5DEP D9*D (V2] ")D
MV@ C8_$ (V+] 21A_P$D8?\!G%@  (E8  !Z60  ;ED  &-9  !:6@  4%P
M $A>  !!8   .F,  #1F   O: H +&D0 "II%P I:A\ *&HF "=J+@ F:S4
M)6L] "1K1@ C:T\ (FQ9 "!L90 ?;'( 'FR" !ULE  <;*8 &VNZ !IKU  ;
M:NX '&G\ !QH_P <:/\ E5P  (-<  !U7   :5T  %]=  !67@  3&$  $-D
M   \9P  -6H  "]M   H< 0 (W(- "%R$@ @<QH 'W,A !YS*  ==#  ''0X
M !MT0  :=$H &714 !=U8  6=6X %75^ !1UD  3=*( $G2V !%TSP 2<^P
M$G+Z !-Q_P 3<?\ CF   'U@  !O80  96$  %MB  !19   2&<  #YK   W
M;@  ,'$  "EU   B>   ''L' !=]#@ 6?1, %7T; !1^(@ 3?BH $GXQ !%^
M.@ 1?D0 $'].  ]_6@ .?V@ #7]X  Q_B@ +?IT "GZP  E]Q@ *?>0 "GST
M  M[_0 +>O\ AF4  '=E  !J90  868  %9H  !,:P  0F\  #ES   Q=P
M*GH  "-^   <@0  %80  !"'"  -B0X #(D4  R)&P +B2, "HDK  F),P (
MB3T !HE(  6)5  $B6$  HEQ  &)@P  B98  (BI  "'O@  A]H  (;L  "&
M]0  AOH ?FH  '%J  !G:P  6VP  %!P  !&=   /'@  #-]   J@0  (X4
M !R(   5C   $(\   R2!@ &DPP  I,1  "4%@  E!T  )0D  "5+   E34
M )5   "53   EED  )9I  "5>@  E8X  )2A  "4M0  D\P  )+F  "2\@
MDO< >'   &UP  !@<@  5'4  $EY   _?@  -8,  "R(   CC0  &Y$  !24
M   /EP  "IH   2= P  G@D  )\.  "?$@  H!<  * =  "A)0  HBT  *(W
M  "C0P  HU   *-?  "C<0  HX0  **9  "BK0  H<(  *'<  "AZP  H/(
M<W8  &9W  !9>P  38   $*%   XBP  +I   "25   ;F@  %)X   ZA   )
MI    J<   "J    JP0  *L*  "L#0  K1$  *T6  "N'   KR0  + M  "Q
M.0  L48  +)5  "R9@  LGD  +*.  "QHP  LK<  +'*  "QX   L>D ;'X
M %^"  !2AP  1HT  #N3   PF0  )IX  !RC   3IP  #:L   >N    L@
M +4   "W    N    +D"  "Y"   N@P  +L0  "\%   O1L  +\C  #!+0
MPCH  ,))  ##6@  PVP  ,2"  #$EP  Q*L  ,2\  #$RP  Q-H 98D  %B.
M  !+E0  /YL  #.B   HJ   ':T  !2Q   -M@  !KD   "\    OP   ,,
M  #$    Q0   ,8   #'    R00  ,H)  #+#0  S1$  ,\8  #2(0  U2T
M -8\  #830  V5\  -IS  #:B@  VYX  -NN  #;N@  W,, 7I8  %&<  !$
MHP  .*H  "RQ   @MP  %;L   V^   $P@   ,4   #)    S0   -    #2
M    T@   -4   #6    V0   -L   #>!0  X H  .(/  #E%@  Z"   .PM
M  #M/@  [5$  .YE  #O>@  [X\  /"?  #PJP  \+, _P 0 /\ #@#_  X
M_P 2 /\ '0#_ "D _P U /\ 00#_ $T _@!6 /L 7P#X &8 ]@!M /0 = #R
M 'D \0!_ /  A #N (D [0"/ .L E0#J )L Z "B .8 J@#E +, XP#  .$
MT@#@ .H WP#Y -T _P#= /\ W0#_ -X _P#> /\ _P - /\ "@#_  D _P /
M /\ & #_ "0 _@ Q /L /0#X $@ ] !2 /  6@#M &( ZP!I .D ;P#G '4
MY0!Z ., ?P#B (4 X "* -X D #< )8 V@"= -@ I0#5 *\ T@"Z -  R@#.
M ., S0#T ,L _P#+ /\ RP#_ ,L _P#+ /\ _P ( /\  P#_  4 _P , /P
M% #W !\ \@ K .\ -P#K $( YP!, .0 50#@ %T W0!D -H :@#8 '  U0!U
M -( >@#0 (  SP"% ,T BP#+ )( R0"9 ,< H0#% *H PP"U ,$ PP"_ -H
MO@#N +T _ "\ /\ O #_ +P _P"\ /\ _P   /\   #_    ^0 ' /$ $ #J
M !H Y  E -\ ,0#; #P UP!' -( 4 #. %< RP!> ,D 90#& &H Q0!P ,,
M=0#! 'H P "  +X A@"\ (T N@"4 +D G "W *4 M0"P +, O0"Q ,\ KP#H
M *X ^ "N /\ K0#_ *T _P"M /\ _P   /\   #]    [@ ! ., # #: !0
MT0 ? ,P *P#( #8 Q0!  ,( 2@"_ %( O !9 +H 7P"X &4 M@!J +0 ;P"S
M '4 L0!Z +  @0"N (@ K0"/ *L F "I *$ IP"K *4 N "C ,@ H@#B *$
M\P"@ /X H #_ *  _P"@ /\ _P   /8   #J    X    -, !@#)  \ P@ 8
M +T ) "Y "\ M@ Z +0 0P"Q $P K@!3 *P 60"J %\ J0!D *< :@"F &\
MI !U *, >P"A (( H "* )X DP"< )T F@"G )@ M "6 ,, E0#< )0 [P"3
M /L DP#_ ), _P"2 /\ ^04  .H+  #<#0  RPH  ,(%  "\  H M@ 1 +$
M' "N "@ J@ S *< /0"D $4 H@!- *  4P"> %D G !? )L 9 ": &H F !P
M )< =@"5 'X DP"& )(!CP"0 9D C@*D (P"L0"+ \  B076 (@&[0"(!_H
MAPC_ (8(_P"&"/\ [P\  -X4  #*%0  O!(  +,0  "N#   JP8- *<#%0"B
M!2  GP<L )P(-@"9"#\ EPE' )4)3@"3"50 D0I: ) *7P"."F4 C0IK (L*
M<@"*"WD B N" (<+C "%#)< @PRB ($-L " #<  ?PW8 'T.[P!\#_T >P__
M 'L0_P![$/\ YA<  -$>  "]'0  KQP  *89  "A%0  GA $ )T-#P"8#AD
ME XE )$/+P"/$#D C!!! (H02 "($$\ AQ!5 (406P"$$6$ @A%G ( 1;@!_
M$74 ?1%^ 'P2B !Z$I0 >!*@ '<3K@!U$[X =!35 ',5[@!Q%OT <1;_ '$6
M_P!P%O\ W!\  ,8E  "S)0  I2,  )PA  "6'@  DAD  )$4"P"-%!0 B14?
M (86*0"#%C, @1<\ ( 70P!^%TH ?!=0 'H75@!Y&%P =QAB '88:0!T&'$
M<QEZ '$9A !O&I  ;AJ= &P;JP!K'+L :AS0 &D=[ !H'OL :![_ &<>_P!G
M'O\ T28  +TJ  "K*@  G2H  ),H  "-)0  B"(  (8=!@"#&Q  ?QP: 'P=
M) !Z'2X =QXV '8>/@!T'D4 <A]+ '$?40!O'U@ ;A]> &P?90!K(&T :2!V
M &@A@0!F(8T 92*: &,BJ !B([@ 82/- & DZ0!@)/H 7R3_ %\D_P!?)/\
MRBP  +8O  "D+P  EB\  (PM  "%*@  @"@  'TD  !Z(@T =B,5 ',C( !Q
M)"D ;R0R &TD.@!K)4$ :B5' &@E30!F)50 925: &0F80!B)FD 829R %\G
M?0!>)XH 72B7 %LII0!:*;4 6BK* %DJYP!8*O@ 6"K_ %@J_P!8*O\ Q3$
M *\S  ">,P  D#,  (8R  !_+P  >2T  '4J  !R* H ;R@2 &LI&P!I*24
M9RHM &4J-0!C*CT 8BI# & J2@!?*U  7BM7 %PK7@!;+&8 62QO %@M>@!7
M+8< 5BZ5 %0NHP!3+[, 4R_' %(OY0!2+_< 4B__ %(O_P!2+_\ P38  *HV
M  "9-@  BS8  ($U  !Y,P  <S$  &\O  !K+@8 :"T0 &0N& !B+B$ 8"\J
M %XO,0!<+SD 6R]  %DO1@!8+TT 5S!3 %8P6P!4,6, 4S%L %(R=P!1,H0
M3S.2 $XSH0!-,[$ 333% 4PTXP%,-/8 3#3_ $PT_P!,,_\ NSD  *8Y  "5
M.0  ASD  'PY  !T-P  ;C0  &DS  !E,@( 83(- %XR% !<,QX 6C,F %@S
M+@!6,S4 530\ %,T0P!2-$H 4310 % U6 !.-6  339J $PV=0!+-X( 2C>0
M $DXGP!(.+ !1SC# 4<XX0%'./4!1SC_ 4<X_P%'./\!MSL  *(\  "1/
M@SP  '@\  !P.@  :C<  &0V  !@-@  7#8+ %DW$@!6-QH 5#<C %(W*P!0
M-S( 3S@Y $TX0 !,.$< 2SA. $HY50!).5X 2#IH $<Z<P!&.X  13N. $0\
MG@!#/*X!0CS" 4(]WP%"//,!0CS_ 4(\_P%"._\!LST  )X^  "-/@  ?SX
M '4^  !L/0  9CH  & Y  !;.@  5SH( %,[$ !1.Q@ 3CL@ $P[* !+.R\
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M #-(V0 T2/  -$?] #1'_P U1O\ ID0  ))%  ""1@  =48  &I&  !A10
M640  %%$  !,1@  2$<  $1'"@!!2!  /TD8 #U)(  \22< .DHN #E*-@ X
M2CT -TM$ #9+3  U2U4 -$Q? #-,:@ R3'< ,4R& #!,EP O3:@ +DV[ "Y-
MU0 N3.\ +TS] "]+_P P2_\ H4<  (Y(  !^2   <4@  &9)  !=2   54@
M $Q)  !'2@  0DL  #],!@ [30X .4X5 #=.'0 V3R0 -4\K #-/,P R4#H
M,5!" #!02@ O45( +E%< "U19P L474 *U&$ "I2E0 I4J8 *5*Y "A2T@ I
M4>X *5#\ "I0_P J3_\ G$H  (E*  !Z2P  ;4L  &-,  !:3   44P  $A-
M  !#3P  /5   #E2 @ U4PP ,U02 #%4&0 P52$ +E4H "U5+P L5C< *U8^
M "I61@ I5D\ *%=9 "=79  F5W( )5>! "17D@ C5Z0 (E>W ")7SP B5^P
M(U;Z "-5_P D5?\ EDT  (1.  !U3@  :4X  %]/  !63P  35   $52   _
M4P  .58  #-8   O6@@ *UL/ "I;%0 H7!T )UPD "9<*P E7#, )%TZ "-=
M0P B74P (5U6 "!>80 ?7FX 'EY^ !U>CP <7J$ &UZT !I=S  ;7>D &USY
M !Q;_P <6_\ D%$  'Y1  !P40  9%(  %M2  !24P  2E0  $%7   [60
M-5L  "Y>   H8 , )&(, ")C$0 A8Q@ 'V0@ !YD)P =9"X '&0V !ME/@ :
M94< &651 !AE70 796H %F5Z !5EBP 499X $V6Q !)ER  29.< $V/W !1B
M_P 48O\ B50  'A5  !K50  8%8  %=6  !/5P  1ED  #U<   V7P  ,&(
M "ED   C9P  '6H' !EL#@ 8;!, %FT: !5M(0 4;2D %&TP !-M.0 2;D(
M$6Y, !!N6  /;F4 #FYU  UNAP -;IH #&VM  MMP@ +;.  #&OS  UK_0 -
M:O\ @ED  ')9  !F60  7%H  %1:  !*7   05\  #EC   Q9@  *FD  "1L
M   =;P  %W(  !)U"0 /=P\ #G<4  YW&P -=R, #'<J  MW,P *=SP "7='
M  AW4@ '=U\ !7=O  1W@  #=Y0  7:G  !VNP !==4  73K  )T]@ "=/P
M>UT  &U=  !B7@  65X  $Y@  !%8P  /&<  #-K   K;@  )'(  !YU   7
M>0  $GP   U_!@ )@0P !8$1  .!%@ "@1T  8$D  "!+0  @C8  ()   ""
M3   @ED  ()H  "">0  @HT  (&@  " M   @,L  '_G  !^\@  ?OD =&(
M &AB  !>8@  4V0  $EG   _:P  -G   "UT   E>   'GP  !>    1@P
M#88   B)!  "BPH  (L.  "+$P  C!@  (P?  "-)@  C2\  (XY  ".1
MCE$  (Y@  ".<0  CH4  (Z9  "-K0  C,,  (S?  "+[@  B_8 ;F@  &1G
M  !8:0  36P  $)Q   X=@  +WL  "9_   >A   %H@  !",   ,CP  !I(
M  "5    E@<  )<,  "7#P  F!,  )D8  ":'P  FR8  )LP  "<.P  G$@
M )Q7  "<:   G'L  )R0  ";I0  F[H  )K0  ":YP  FO$ :FT  %YO  !1
M<@  1G<  #M\   Q@@  )X<  !Z,   6D0  $)4   J9   $G    *    "B
M    HP$  *,&  "D"P  I0X  *82  "G%P  J!X  *HF  "K,0  JSX  *Q-
M  "L70  K'   *R%  "LFP  JZ\  *O#  "KV0  JN@ 9'4  %=Y  !+?@
M/X0  #2*   ID   'Y8  !:;   0GP  ":,   &G    J@   *X   "P
ML    +$   "R P  M @  +4-  "V$   MQ4  +D=  "[)@  O#,  +U!  "]
M4@  O60  +YY  "^D   O:0  +VW  "]Q@  O=< 7'\  %"%  !$BP  .)(
M "R9   AGP  %Z0  !"I   )K@   +(   "V    N0   +T   "_    OP
M ,    #!    PP   ,0%  #&"@  QPX  ,D3  #+'   SB8  - U  #110
MTE<  -)K  #3@@  TY<  -.I  #2N   TL0 58P  $F3   ]F@  ,*(  "6H
M   :K@  $;0   FY    O0   ,$   #$    R    ,L   #-    S0   ,\
M  #0    T@   -0   #8    V@8  -T,  #@$0  XQH  .8G  #G.   Z$H
M .E=  #J<@  ZX@  .N;  #LJ   [+( _P - /\ "P#_  L _P 0 /\ &@#_
M "8 _P R /\ /0#_ $@ ^P!2 /@ 6@#V &( \P!I /$ ;P#P '4 [@!Z .P
M?P#K (0 Z0"* .@ D #F )8 Y "= .( I0#A *\ WP"[ -T RP#; .8 V0#W
M -@ _P#8 /\ UP#_ -< _P#4 /\ _P ( /\ ! #_  0 _P - /\ %0#^ "$
M^@ L /< . #T $, \ !- .T 50#J %T YP!D .0 :@#B '  X !U -X >@#=
M '\ VP"% -D BP#5 )$ TP"9 -$ H #/ *H S0"U ,L Q #) -T R #Q ,<
M_P#& /\ Q@#_ ,8 _P#' /\ _P   /\   #_    _P * /@ $0#Q !P [  G
M .D ,@#F #T X@!' -T 4 #9 %@ U0!? -( 90#0 &H S@!P ,P =0#* 'H
MR0!_ ,< A0#% (P PP"4 ,$ G "_ *4 O0"P +L O0"Z -  N #K +< ^P"V
M /\ M@#_ +8 _P"V /\ _P   /\   #]    \P % .D #@#A !8 VP A -4
M+0#1 #< S@!! ,H 2@#' %( Q !9 ,( 7P#  &4 O@!J +P ;P"[ '0 N0!Z
M +< @ "V (< M ". +( EP"P *  K@"J *T MP"K ,@ J0#C *@ ]0"G /\
MIP#_ *< _P"F /\ _P   /X   #Q    Y0   -< "@#- !$ QP < ,( )@"_
M #$ O  [ +H 1 "W $P M !3 +( 60"Q %\ KP!D *T :0"L &\ J@!T *D
M>@"G ($ I@") *0 D0"B )L H "E )X L@"= ,$ FP#: )H [P"9 /T F #_
M )@ _P"8 /\ _0   /    #A    T0   ,8 ! "]  T MP 5 +, ( "P "L
MK0 U *L /@"H $8 I@!- *0 5 "C %D H0!? *  9 "> &D G0!N )L =0":
M 'L F "# )8 C "5 )8 DP"A )$ K0"/ +L C0#/ (P Z0"+ /@ C #_ (P
M_P", /\ \P(  .('  #,!P  OP0  +<   "Q  @ JP 0 *< &0"D "0 H  N
M )X -P"< $  F@!' )@ 3@"6 %0 E0!9 ), 7@"2 &0 D !I (\ ;P"- '8
MBP!^ (H B "( )( A@"= (4 J0"# +@ @0#* (  Y0"  /4 ?P#_ '\ _P!_
M /\ Z T  - 0  "^$   L0X  *@-  "C"   H (, )P $P"8 !T E0 G )(
M,0"0 #D C@%! (P!2 "* DX B0)4 (<"60"& E\ A -D (,#:P"! W( @ 1Z
M 'X$A !]!8X >P6: 'D&IP!X!K4 =@?( '4(XP!U"?0 = K_ ',*_P!S"O\
MW14  ,07  "Q%P  I18  )P3  "6$0  E T$ ),(#0".!Q4 BPD@ (@)*@"%
M"C, @PL[ ($+0@" "TD ?@M/ 'T,5 ![#%H >@Q@ '@,9P!W#&X =0UV '0-
M@ !R#8P < V9 &\.I@!M#K4 ; [) &L/Y@!J$/< :1#_ &D0_P!I$/\ T!T
M +D>  "H'@  FQT  )(;  "+&0  B!4  (<1!P"%#A  @0\: 'X0) ![$"T
M>1 V '<1/0!V$40 =!%* ',14 !Q$58 <!%< &X28@!M$FH :Q)S &D3?0!H
M$XD 9A.6 &44HP!C%;, 8A7& &(6XP!A%O8 8!?_ & 7_P!@%_\ QR(  + C
M  "?)   DB,  (DB  ""(   ?AT  'P9  !Z%0T =Q45 '06'P!Q%B@ ;Q<P
M &X7. !L%S\ :Q=% &D82P!H&%$ 9AA8 &487@!C&68 8AEO & 9>0!?&H4
M71N2 %P;H0!;'+  6AS# %D=X !8'O0 6![_ %@>_P!8'O\ OR<  *DH  "9
M*   BR@  ((G  ![)0  =B,  ',@  !Q' D ;AP1 &L<&@!I'2, 9QTL &4=
M,P!C'CH 8AY! & >1P!?'DT 7AY4 %P?6P!;'V( 62!K %@@=@!6(8( 52&0
M %0BG@!3(JX 4B/  %$CW0!1)/( 423_ %$D_P!1(_\ N2L  *,L  "3+
MABT  'PL  !T*@  ;R@  &LE  !I(@4 9B$. &,B%@!A(A\ 7R,G %TC+P!<
M(S8 6B,] %DD0P!7)$H 5B10 %4D5P!3)5\ 4B5H %$F<P!/)G\ 3B>- $TH
MG !,**P 2RF^ $LIV@!**?$ 2BG_ $LI_P!+*?\ LRX  )XO  ".,   @3
M '<O  !O+@  :BL  &4J  !C)P$ 7R<, %PG$P!:)QL 6"@D %8H*P!5*#(
M4R@Y %(I0 !0*48 3RE- $XI5 !-*EP 3"IE $HK< !)*WP 2"R+ $<MF@!&
M+:H 12Z\ $4NU@!%+N\ 12[^ $4N_P!%+?\ KC$  )HR  "),P  ?#,  '(S
M  !K,0  92\  & M  !=+   62P) %8L$ !4+!@ 4BP@ % L* !.+2\ 32TV
M $PM/ !*+4, 22U* $@N40!'+ED 1B]C $4P;0!#,'H 0C&) $$QF !!,J@
M0#*[ #\RTP _,NX 0#+] $ R_P! ,O\ JC,  )8U  "&-0  >38  &XU  !F
M-0  83(  %PP  !7,   5# & %$P#@!.,!4 3#$= $HQ)0!(,2P 1S$R $8Q
M.0!$,4  0S)' $(R3P!!,U< 0#-@ #\T:P ^-7@ /36' #PVE@ [-J< .S:Y
M #HVT0 Z-NT .S;\ #LV_P [-O\ IC8  )(W  "".   =3@  &LX  !C-P
M738  %<S  !3-   3S0# $LT# !)-!( 1C4: $4U(@!#-2D 034O $ U-@ _
M-CT /C9$ #TW3  \-U4 .SA> #HX:0 Y.78 .#F% #<ZE0 W.J4 -CJX #4Z
MSP V.NP -CK[ #8Y_P W.?\ HC@  (XY  !^.@  <CL  &@[  !?.@  63D
M %,V  !.-P  2C@  $8X"@!$.1  03D7 #\Y'P ^.28 /#DM #LZ-  Z.CL
M.3M" #@[2@ W.U, -CQ< #4\9P T/70 ,SV# #,^DP R/J0 ,3ZV #$^S0 Q
M/NH ,3[Z #(]_P R/?\ GCL  (L\  ![/   ;CT  &0]  !</0  53P  $XZ
M  !).P  13P  $$]!P ^/0X /#T5 #H^'  Y/B, -SXJ #8_,0 U/S@ -#]
M #- 2  R0%  ,4!: #!!90 O07( +D*! "U"D0 M0J( +$*U "M"RP L0ND
M+$+Y "U!_P M0?\ F3T  (<^  !W/P  :S\  &%   !9/P  4C\  $D^  !$
M/P  0$   #Q!!  Y0@T -T(2 #5#&0 S0R$ ,D,H #%$+P P1#8 +T0] "Y%
M10 M14X +$58 "M&8P J1F\ *49^ "A&CP G1Z$ )D>S "9'R0 F1N< )T;X
M "A%_P H1?\ E4   ()!  !S0@  9T(  %Y"  !50@  3D(  $5"   _1
M.T4  #=&   T1PH ,4@0 "](%@ N21X +$DE "M)+  J23, *4HZ "A*0@ G
M2DL )DM5 "5+8  D2VT (TM\ ")+C0 A3)\ (4RQ "!,QP @2^8 (4OW ")*
M_P B2O\ D$,  'Y$  !O1   9$4  %I%  !210  2D8  $%'   \2   -TD
M #)+   N30< *TX. "E.$P G3QH )D\A "5/*  D3S  (U W ")0/P A4$@
M(%!2 !]170 >46H '5%Y !Q1B@ ;49P &E&O !E1Q0 94>0 &E#V !M/_P <
M3_\ BD8  'E'  !K1P  8$@  %9(  !.2   1TD  #Y+   Y3   ,TX  "Y0
M   H4P( )%0+ ")5$  @518 'U8> !Y6)  =5BP '%8S !M7.P :5T0 &5=.
M !A760 76&8 %5AU !18AP 46)H $U>L !)7P@ 25^$ $U;T !15_P 45?\
MA$D  '1*  !F2P  7$L  %-+  !+3   1$T  #Q/   U40  +U0  "E6   D
M60  'EL' !I=#0 871( %UT9 !9>(  57B< %%XN !->-P 27D  $5]* !%?
M50 07V( #U]Q  Y?@P -7Y8 #5^I  Q>O@ ,7MH #5WP  U<_  .7/\ ?DT
M &Y.  !B3@  6$\  $]/  !(4   0%(  #A4   P5P  *EH  "1=   ?7P
M&6(! !-E"0 19@\ $&84  ]F&P .9R( #6<I  UG,@ ,9SL "V=%  IG4  )
M9UT !V=L  9G?0 %9Y  !&:C  )FMP #9<\ !&7I  1D]0 $9/P =U$  &E2
M  !=4@  5%(  $Q3  !#50  .U@  #-;   K7@  )6$  !]D   99P  $VH
M  ]M!@ +< P "'#_XO_B24-#7U!23T9)3$4 ! D1  =P%@ %<!T !' D  -P
M+  "<#4  ' _  !P2@  <%<  '!E  !P=@  <(H  &^>  !OL@  ;L@  &WE
M  !M\@  ;?D <%8  &-6  !95@  45<  $=8   ^6P  -E\  "YB   F9@
M'VH  !EM   3<   #G,   MV!  %> L  7@/  !Y$P  >1D  'D?  !Z)@
M>B\  'HY  !Z1   >E   'I?  !Z<   >H,  'J8  !ZK   ><(  'C?  !X
M[P  =_< :EL  %];  !66P  3%P  $)@   Y8P  ,&@  "AL   @<   &70
M !-W   .>P  "7X   2! @  @@@  (,-  "#$   A!0  (49  "&(   AB@
M (<Q  "'/   ATD  (=7  "':   AWL  (>0  "&I0  A;H  (73  "$Z@
MA/0 96   %Q@  !180  1F0  #QI   R;0  *7(  "%W   9>P  $H    V#
M   (AP   HH   "-    C@0  (X)  "/#0  D!   )$4  "2&0  DR   )0I
M  "5,P  E4   )9.  "67P  E7(  )6(  "5G0  E+(  )3(  "3X@  D^X
M864  %9F  !*:@  /VX  #5T   K>0  (7\  !F$   1B0  #(T   :1
ME    )@   ":    FP   )P"  "=!P  G@L  )\.  "A$@  HA@  *,@  "E
M*0  IC8  *9$  "F50  IF@  *9]  "FE   I:D  *2]  "DT0  I.0 6VP
M $]P  !#=0  .'L  "V!   CAP  &8T  !&2   +EP  !)P   "@    HP
M *8   "H    J0   *H   "L    K00  *X)  "P#0  L1$  +,7  "U(
MMBL  +<Z  "W2P  N%P  +AQ  "XB   N)T  +BQ  "WP@  M]  5'8  $A\
M   \@@  ,8D  ":0   ;EP  $IT   RB   #IP   *L   "N    L@   +8
M  "X    N    +H   "[    O0   +X   # !0  P0L  ,,0  #&%@  R2
M ,HN  #+/@  S%   ,QD  #->@  S9$  ,VD  #-M   S<  38,  $&*   U
MD0  *9D  !Z@   3I@  #*P   .Q    M@   +H   "^    P@   ,8   #(
M    R    ,H   #+    S0   ,X   #0    T@$  -4(  #9#@  W14  .$A
M  #B,0  Y$,  .56  #F:P  YH(  .>6  #GI0  YK  _P ) /\ !0#_  8
M_P . /\ %@#_ "$ _P M /\ . #] $, ^0!- /4 50#R %T \ !C .X :0#L
M &\ Z@!T .D >@#G '\ Y@"% .0 BP#C )$ X0"9 -\ H0#< *H V@"V -<
MQ@#5 .$ TP#T -( _P#1 /\ T0#_ ,\ _P#* /\ _P ! /\   #_  $ _P ,
M /\ $@#Z !T ]@ H /, ,P#P #X [ !( .@ 4 #E %@ X@!> -\ 9 #= &H
MVP!O -D = #6 'H U !_ -( A0#0 (P S@"3 ,P G #) *4 QP"P ,8 O@#$
M -0 P@#N ,$ _@#  /\ P #_ +\ _P"^ /\ _P   /\   #_    ^@ ' /$
M#P#K !@ Y@ C .( +@#@ #@ VP!" -4 2P#1 %( S@!9 ,L 7P#) &4 QP!J
M ,8 ;P#$ '0 P@!Z ,$ @ "_ (8 O0". +L E@"Y *  MP"J +8 MP"T ,H
ML@#F +$ ^ "P /\ KP#_ *\ _P"P /\ _P   /\   #W    Z@ " .$ # #7
M !, T  = ,P * #) #( Q@ \ ,( 10"_ $T O !3 +H 60"X %\ MP!D +4
M:0"T &X L@!T +$ >@"O (  K0"( *P D0"J )H J "E *8 L0"D ,$ HP#<
M *$ \@"A /\ H #_ *  _P"A /\ _P   /<   #H    V0   ,L " ## !
MO0 8 +D (@"V "P M  V +( /P"O $< K !- *L 5 "I %D IP!> *8 8P"E
M &@ HP!N *( = "@ 'H G@"" )P BP"; )4 F0"? )@ K "6 +H E #/ ),
MZP"2 /L D@#_ )( _P"1 /\ ]P   .<   #3    Q@   +L  @"S  P K0 2
M *H ' "G "8 I  P *, . "@ $  G@!' )P 3@": %, F0!8 )< 70"6 &,
ME0!H ), ;@"2 '0 D !\ (\ A0"- (\ BP": (H IP"( +4 A@#' (4 Y "$
M /4 A #_ (, _P"# /\ [    -,   #! 0  M    *P   "F  < H  . )T
M%@": "  EP I )4 ,@"3 #H D0!! (\ 2 "- $T C !3 (L 6 ") %T B !C
M (< :0"% &\ @P!W (( @ "  (H ?@"6 'T HP![ +  >@#" 'D W0!X /$
M=P#] '@ _P!X /\ W@H  ,0+  "R#   I@L  )T(  "9!   E0 * )$ $0".
M !D BP C (D + "' #0 A0 [ (, 0@"" $@ @ !. '\ 4P!] %@ ? !> 'L
M9 !Y &H > !R '8 >P!T (8 <P"2 '$ GP!P *T ;@"^ &T!U@!M NT ; /Z
M &P#_P!L _\ SA   +<1  "F$@  FA$  )$0  "+#@  B0L# (<%# "$ 1,
M@0$< 'X")0!\ RX >@,V '@$/ !W!$, =05( '0%3@!S!50 <059 ' &7P!N
M!F8 ;09N &L'> !J!X, : B0 &<)G0!E":P 9 F\ &,*U !C"^P 8@SZ &(,
M_P!B#/\ PQ8  *T7  "=&   D!@  (<6  "!%   ?1$  'P.!@!\"@X > H6
M '4+'P!R"R@ < PP &\,-P!M##X ; Q$ &L-2@!I#4\ : U5 &<-7 !E#6,
M8PYK &(.=0!@#H$ 7PZ. %T/G !<$*L 6Q"] %H0U@!9$?  61'] %D1_P!9
M$?\ N1L  *4=  "4'@  B!X  'X=  !X&P  =!@  '$5  !Q$0D ;Q 1 &P0
M&0!I$"( 9Q$J &81,@!D$3D 8Q$_ &(110!@$DL 7Q)1 %T26 !<$E\ 6A-H
M %D3<@!7%'T 5A2+ %05F0!3%:D 4A:Z %$6T@!1%^T 41?] %$7_P!1%_\
MLB   )XB  ".(@  @2,  '<B  !P(0  ;!X  &D;  !G& 0 9A4. &,6%0!A
M%AX 7Q8F %T6+0!<%S0 6A<[ %D700!8&$< 5AA- %485 !3&%P 4AED %$9
M;@!/&GH 3AN( $T;EP!+'*8 2ARX $H=SP!)'>L 21W[ $D=_P!*'?\ K"0
M )@E  "()@  >R<  '$F  !J)0  9B,  &(A  !@'@  7AP+ %L;$@!9'!H
M5QPB %4<*0!4'#  4QTW %$=/0!0'4, 3QU* $T>40!,'E@ 2Q]A $D?:P!(
M('< 1R"% $8AE !$(J0 1"*V $,BS !#(^D 0R/Z $,C_P!#(O\ IB<  ),I
M  "#*@  =BH  &TJ  !E*0  8"<  %PE  !9(P  5R$' %4A#P!2(18 4"$>
M $XA)0!-(BP 3"(S $HB.0!)(D  2")& $<C30!%(U4 1"1> $,D:0!")74
M0":# #\FD@ ^)Z, /B>T #TGR@ ]*.@ /2CY #TG_P ^)_\ HBH  (XK  !_
M+0  <BT  &@M  !A+   7"L  %@H  !4)@  428$ $XE#0!,)1, 2B8: $@F
M(@!')BD 128O $0F-@!#)SP 02=# $ G2P _*%, /BE< #TI9@ \*G( .RJ!
M #HKD  Y*Z$ ."RR #<LR  W+.8 ."SX #@L_P X+/\ G2P  (HN  ![+P
M;S   &4P  !=+P  6"X  %,K  !0*@  3"H  $DJ"P!&*A$ 1"H7 $(J'P!!
M*B4 /RHL #XK,P ]*SD /"M  #LL2  Z+%  .2U9 #@N9  W+G  -B]_ #4O
MCP T,)\ ,S"Q #(PQP R,.4 ,S#W #,P_P T+_\ F2\  (<Q  !W,@  :S(
M &(R  !:,@  5#$  $\O  !++0  1RX  $0N" !!+@X /RX4 #TN'  [+B(
M.2\I #@O+P W+S8 -C ^ #4P1@ U,4X -#%7 #,R8@ R,FX ,3-] # SC0 O
M-)X +C2P "TTQ0 M-., +C3V "\S_P O,_\ E3$  (,S  !T-   :#4  %XU
M  !7-   430  $LR  !&,0  0C(  #\R!0 \,@T .3,2 #@S&0 V,R  -#,F
M #,S+0 R-#0 ,30[ # U0P P-4P +S95 "XV8  M-VP +#=[ "LWBP J.)P
M*3BN "@XPP H..( *3CU "HW_P J-_\ DC0  '\U  !Q-@  93<  %LW  !4
M-P  338  $<V  !"-0  /38  #HV @ W-PL -#<0 #(W%@ Q.!T +S@D "XX
M*P M.3( +#DY "LY00 J.DD *CI3 "D[7@ H.VH )SMY "8\B0 E/)L )#RM
M ",\P@ C/.  )#ST "4[_P E._\ C38  'PX  !M.0  8CD  %@Z  !1.0
M2CD  $0Y   ].0  .3H  #4[   R.P@ +SP. "T]%  L/1H *CTA "D]*  H
M/B\ )SXV "8^/@ E/T< )#]0 "- 6P B0&@ (4!V "! AP ?09D 'T&K !Y!
MP  >0=X 'T#S !] _@ @/_\ B3D  '@Z  !I.P  7CP  %4\  !-/   1SP
M $ \   X/0  -#X  #!    M004 *D(, "="$0 F0Q@ )$,> "-#)0 B0RP
M(40S "!$.P ?1$0 'D5. !U%60 <164 &T5T !I%A0 91I< &4:I !A&O@ 7
M1=P &$7Q !E$_0 :1/\ A#P  ',]  !F/@  6S\  %(_  !*/P  1#\  #U
M   V00  ,4,  "Q$   G1@$ )$<* "%(#P @210 'DD; !U)(@ <22D &THP
M !I*.  92D$ &$I+ !=+50 62V( %4MQ !1+@@ 32Y0 $DNG !)+O  12]D
M$DKP !-*_  42?\ ?S\  &]   !A00  5T(  $Y"  !'0@  04(  #I#   R
M10  +4<  "A)   C2P  'DT& !M/#0 84!$ %U 7 !90'@ 54"4 %% L !-1
M-  243T $5%' !%14@ 045\ #U)M  Y2?@ -49$ #5&D  Q1N  ,4=$ #5#L
M  U0^@ .3_\ >4,  &I$  !=1   4T4  $M%  !$10  /D8  #9(   O2@
M*4P  "1/   ?40  &E,  !16"0 15PX $%@3 !!8&0 /6"  #E@H  U8,  -
M6#D #%A#  M83@ *6%H "%AH  =8>0 &6(P !5B?  18LP $5\H !5?F  57
M\P &5OP <T8  &1'  !92   4$@  $A(  !!20  .DH  #)-   K4   )5(
M "!5   :6   %5H  !!=!@ ,8 P "F 0  E@%0 (8!P !V C  5@*P $8#0
M V ]  %@20  8%4  &!C  !@<P  8(8  %^:  !?K@  7\0  %[B  !>\
M7O@ ;$H  %]+  !52P  3$P  $5,   ]3@  -5   "Y3   G5@  (%D  !I<
M   57P  $&(   UE!  (9PL  V<.  !H$P  :!@  &@?  !I)@  :2X  &DX
M  !I0P  :4\  &E=  !I;0  :8   &F4  !HJ0  :+\  &?<  !F[@  9O<
M9D\  %I/  !13P  2D\  $%1   X5   ,%<  "A;   A7@  &F(  !1E   0
M:   #&L   =N P !< D  ' -  !Q$   <10  '(:  !S(0  <R@  ',Q  !S
M/   =$@  '-6  !S9@  <WD  '..  !SHP  <KD  ''2  !QZP  </0 85,
M %93  !/4P  154  #M8   R7   *F   ")D   ;:   %&P   ]O   +<@
M!G8   !Y    >@8  'H*  ![#@  ?!$  'T5  !^&P  ?R(  ( J  " -0
M@$$  (!/  " 7P  @'$  ("&  " G0  ?[(  '[*  !^Y0  ??$ 7%@  %18
M  !)6@  /UT  #5A   L90  (VH  !MO   4<P  #G<   E[   #?P   ((
M  "$    A@$  (8&  "("@  B0T  (H0  "+%0  C!L  (XB  "/+   CS@
M (]&  "/5@  CV@  (]^  "/E0  CJL  (W!  "-W   C.L 65T  $Y?  !#
M8@  .&8  "YL   D<0  ''<  !1\   .@0  "(4   ")    C0   )    "2
M    DP   )0   "6 P  EP@  )@,  ":#P  FQ,  )T:  "?(P  H"X  * \
M  "@3   H%X  *!T  "?C   GZ(  )^W  ">RP  GN  4V0  $=H   \;0
M,7,  "=Y   =?P  %(4   V+   &D    )0   "8    G    )\   "A
MH@   *0   "E    IP   *@$  "J"0  K T  *T2  "P&0  LB,  +(Q  "R
M0@  LE0  +)I  "R@   LI@  +&L  "ROP  L<X 3&X  $!S   U>@  *H$
M !^(   5C@  #I4   ::    GP   *0   "H    K    *\   "Q    L0
M +,   "U    M@   +@   "Z    O 8  +X,  # $0  PQD  ,4F  #%-P
MQDD  ,9=  #'<@  QXH  ,B?  #(KP  R+P 1GH  #F!   NB0  (I   !>8
M   /GP  !Z4   "J    KP   +,   "W    O    +\   #!    P@   ,0
M  #%    QP   ,D   #+    S0   ,\#  #2"@  UA   -P:  #=*@  WCP
M -]0  #@90  X7L  .&1  #BH@  XJT _P " /\   #_  , _P , /\ $P#_
M !T _P H /X ,P#[ #X ]P!( /, 4 #P %< [0!> .L 9 #H &D YP!O .4
M= #C 'D X@!_ .  A0#> (P W "3 -D G #6 *8 TP"Q -$ P #/ -H S@#Q
M ,P _P#+ /\ RP#_ ,8 _P#! /\ _P   /\   #_    _P ( /L $ #V !D
M\@ D .\ +@#M #D Z !" ., 2P#@ %( W0!9 -D 7P#6 &0 TP!I -$ ;@#/
M '0 S@!Y ,P ?P#* (8 R ". ,8 E@#$ *  P@"K ,  N0"^ ,T O #J +L
M_ "Z /\ N@#_ +H _P"V /\ _P   /\   #^    ]  $ .L #0#D !0 WP ?
M -L *0#8 #, TP ] ,X 10#* $T QP!3 ,4 60## %\ P0!D +\ :0"] &X
MNP!S +H >0"X (  M@"( +0 D "R )H L0"E *\ L@"M ,0 K #A *L ]@"J
M /\ J@#_ *H _P"J /\ _P   /T   #N    X@   -4 "@#- !$ QP 9 ,0
M(P#! "T OP W +L /P"W $< M0!. +( 4P"P %D KP!> *T 8P"L &@ JP!M
M *D <P"H 'H I@"! *0 B@"C )0 H0"? )\ K "> +L G #2 )L [@": /\
MF@#_ )D _P"9 /\ _@   .X   #>    RP   ,$ !0"Y  T M  4 +$ '@"N
M "< JP P *H .0"G $$ I !( *( 30"A %, GP!8 )X 70"= &( FP!G )H
M;0"8 ', EP![ )4 A "4 (X D@"9 )  I@". +0 C0#( (P Y@"+ /D B@#_
M (H _P"+ /\ \    -L   #'    N@   +    "H  H I  0 *  & "= "$
MFP J )H ,P"8 #L E@!! )0 2 "2 $T D0!2 (\ 5P". %P C !A (L 9P"*
M &X B !U (< ?@"% (@ @P"4 (( H "  *\ ?P#  'X W0!] /( ?0#_ 'T
M_P!] /\ X    ,8   "U    J@   *(   ";  4 E0 - )( $P"0 !P C0 D
M (L +0"* #0 B  [ (8 0@"% $< @P!- (( 4@"! %< ?P!< 'X 8@!] &@
M>P!P 'H >0!X (, =@"/ '4 G !T *H <@"Z '$ T0!P .P < #[ '  _P!P
M /\ S00  +<&  "G!P  FP8  ),$  ".    B@ ( (8 #P"$ !8 @0 > '\
M)P!] "X ?  V 'H / !Y $( =P!' '8 3 !U %( <P!7 '( 70!Q &, ;P!K
M &X = !L 'X :P"* &D F !H *8 9P"V &8 RP!E .< 90#W &4 _P!E /\
MP P  *L-  ";#@  CPX  (8-  "!"P  ?@<! 'P!"P!Y !$ =P 8 '4 (0!S
M "D <0 P &\ -@!N #P ; !" &L 1P!J $T :0!2 &@ 6 !F %\ 90!G &,
M< !B 7H 8 &' %\"E0!> J, 7 .S %P#QP!;!.0 6P7T %L&_@!;!O\ M1
M *$2  "1$P  A1,  'P2  !V$0  <PX  '(,! !Q!PT ;@02 &P$&P!I!2,
M9P4J &8&,0!D!C< 8P8] &('0P!A!TD 7P=. %X(50!="%P 6PEC %H);0!8
M"G@ 5PJ% %8+DP!4"Z( 4PNS %(,QP!2#.0 40WU %$-_P!1#?\ K14  )D7
M  ")&   ?1D  '08  !M%P  :A0  &<1  !G#@< 9@P. &,,%0!A#!T 7PPE
M %T-+ !<#3, 6PTY %H-/P!8#44 5PU+ %8.40!5#ED 4PYA %(.:P!0#W8
M3A"# $T0D@!,$*( 2Q"R $H1R !)$>4 21'W $D2_P!)$?\ I1D  )(<  "#
M'0  =AX  &T=  !F'   8AH  %\7  !>% $ 7A$* %L0$0!9$1@ 5Q$@ %41
M)P!4$2X 4Q$T %$1.P!0$D$ 3Q)' $X23@!,$E4 2Q-> $D39P!(%', 1A2
M $45CP!$%9\ 0Q:P $(6Q0!"%^, 0A?V $(7_P!"%_\ GQT  (P@  !](0
M<2(  &@B  !A(0  7!\  %D<  !7&0  518& %05#@!1%10 3Q8< $X6(P!,
M%BH 2Q8P $H6-P!)%ST 1Q=# $872@!%&%( 0QA: $(99 !!&7  /QI] #X;
MC0 ]&YT /!RN #L<PP ['.$ .QWU #L<_P \'/\ FB$  (<C  !X)   ;"4
M &,E  !<)   5R,  %,@  !1'@  3QP" $T;# !+&A$ 2!L8 $<;( !%&R8
M1!LM $,<,P!"'#D 0!Q  #\=1P ^'4\ /1Y8 #P>8@ Z'VT .1][ #@@BP W
M(9L -B&M #4AP0 U(=\ -2'S #8A_P V(?\ EB,  (,F  !T)P  :"@  %\H
M  !8)P  4R8  $\D  !,(@  22   $<@"0!$'P\ 0A\5 $ @'  _(", /B I
M #P@+P [(38 .B$] #DA1  X(DP -R)5 #8C7P T(VL ,R1Y #(EB0 Q)9H
M,"6K # FOP O)MP ,";R # F_P Q)?\ D28  '\H  !Q*@  92H  %PJ  !5
M*@  3RD  $LH  !()0  1"0  $$D!0 _) T /202 #LD&0 Y)!\ -R0F #8D
M+  U)3, -"4Z #,F00 R)DH ,2=3 # G70 O*&D +BEW "TIAP L*9@ *RJJ
M "HJO0 J*MH *RKQ "LJ_@ L*?\ C2@  'PJ  !M+   8BT  %DM  !1+0
M3"P  $<K  !#*   /R@  #PH @ Y* L -R@0 #4H%@ S*!P ,B@C # H*0 O
M*3  +RHW "XJ/P M*T< +"M1 "LL6P J+&< *2UU "@MA0 G+9< )BZH "4N
MO  E+M@ )B[P "8N_0 G+?\ BBL  '@M  !J+@  7R\  %8O  !.+P  2"X
M $,M   _+   .RP  #<L   T+ D ,BP. # M$P N+1H +2T@ "LM)P J+BT
M*BXU "DO/0 H+T4 )S!. "8P60 E,64 )#%S ",Q@P B,I4 (3*G "$RNP @
M,M0 (3+O "(Q_  B,?\ ABT  '4O  !G,   7#$  %,Q  !+,0  13$  $ P
M   [,   -C   #,P   P,08 +3$- "LQ$0 I,A< *#(> "<R)  E,RL )3,R
M "0S.@ C-$, (C1, "$U5P @-6, 'S5Q !XV@0 =-I, '#:E !LVN0 ;-M(
M'#;M !TV^P =-?\ @C   '$R  !C,P  630  % T  !)-   0C,  #TS   W
M,P  ,30  "XU   K-0( *#8+ "4W$  D-Q4 (C<; "$X(@ @."@ 'S@P !XX
M-P =.4  '#E) !LZ5  :.F  &3IN !@Z?P 7.Y$ %SND !8[MP 5.]  %CKL
M !<Z^@ 8.?\ ?3(  &TT  !@-0  538  $TV  !&-@  0#8  #HV   T-@
M+C@  "HY   F.@  (SL( " \#@ >/1( '3T8 !P]'P ;/B4 &CXM !D^-  7
M/CT %C]' !4_40 4/UX %#]L !- ?  20(\ $4"B !% M@ 00,X $3_K !(_
M^0 2/O\ >34  &DW  !<.   4CD  $HY  !#.0  /3D  #<Y   Q.@  *SP
M "<]   B/P  'D$$ !I""P 80Q  %T,5 !5$&P 41"( $T0I !-$,0 21#H
M$45# !!%3@ 015L #D5I  Y%>0 -18P #46?  Q%L@ +1<D #$7E  U$]@ -
M1/\ =#D  &4Z  !8.P  3SL  $<\  ! /   .CP  #0\   N/@  *$   "-"
M   ?1   &D8  !5("  22@T $4H2 !!*&  /2QX #DLE  U++0 -2S8 #$M
M  M+2@ *2U8 "4MD  A+=  '2X< !4N:  1+K@ $2L0 !4K@  5*\  &2?H
M;CP  & ]  !4/@  2SX  $0^   ]/@  -S\  #%    J0@  )$4  !]'   :
M20  %4P  !%.!0 .40L "U$0  I1%  )41L "%$B  =1*0 %43( !%([  -2
M1@ !4E(  %)?  !2;P  4H$  %&6  !1J0  4;\  %#<  !0[@  4/< :$
M %M!  !000  2$$  $%!   [0@  -$,  "U%   F2   ($L  !M-   64
M$5,   Y5!  *6 H !E@.  )8$@  61<  %D=  !9)0  62T  %DV  !900
M64T  %I:  !::0  67P  %F0  !9I0  6+H  %C5  !7[   5_8 8T0  %9%
M  !-10  144  #]%   W1P  +TD  "A,   B3P  &U(  !95   16   #5H
M  E= P $7PD  & -  !@$   810  &$9  !B(   8B<  &(Q  !B.P  8D<
M &)5  !C9   8G8  &*+  !BH   8;8  &'/  !@Z@  8/4 74@  %))  !*
M2   0T@  #I*   R30  *E   "-3   <5P  %EH  !%=   -8   "&,   -F
M 0  9P8  &@+  !I#@  :A$  &L5  !L&P  ;2(  &TJ  !M-   ;4   &U.
M  !M70  ;6\  &V$  !LF@  ;+   &O(  !KY@  :O, 6$T  $Y-  !(3
M/DX  #51   L5   )%@  !U<   68   $&0   QG   ':P   6X   !P
M<@,  '('  !S"P  =0X  '81  !W%@  >!P  'DC  !Z+0  >CD  'I'  !Z
M5@  >6@  'I\  !YE   >*H  'C!  !WWP  =^\ 5%$  $Q1  !"4@  .%4
M "]9   F7@  'F(  !9G   0:P  "V\   5S    =P   'H   !\    ?@
M '\"  " !@  @0H  (,-  "$$0  AA4  (@<  "))0  BC   (H^  ")30
MB5\  (ES  "(BP  B*(  (>Y  "'T0  AN@ 4E8  $=7   \6@  ,E\  "AD
M   ?:0  %F\  !!T   *>0   GT   "!    A0   (@   "*    C    (T
M  "/    D 0  )((  "3#   E1   )<5  "9'0  FR<  )LT  ";1   FE8
M )IJ  "9@@  FIH  )BP  "8QP  E]X 2UP  $!@   U90  *VH  "%Q   7
M=P  $'T   F#   !B    (P   "1    E0   )@   ":    FP   )T   "?
M    H    *(   "D!0  I@H  *@.  "J%   K1T  *TJ  "M.0  K4L  *U?
M  "M=P  K)   *NG  "KN@  J\L 168  #EK   N<0  (W@  !E_   0A@
M"8T   "3    F    )T   "A    I0   *@   "K    JP   *X   "O
ML0   +,   "U    MP$  +D'  "\#0  OQ,  ,(?  #"+@  PD   ,)4  #!
M:P  P8,  ,";  #!K0  P;P /G(  #)X   G@   '(@  !*0   *EP   )T
M  "C    J    *T   "R    M@   +D   "[    O    +X   #     P@
M ,0   #&    R    ,L   #.!0  T0T  -84  #7(P  V#4  -E)  #:7@
MVW4  -N,  #<GP  W*L _P   /\   #_    _P ) /\ $ #_ !D _@ D /P
M+P#Y #D ] !# /  2P#M %( Z@!9 .< 7P#D &0 X@!I .  ;@#> ', W !Y
M -H ?P#7 (8 U ". -$ E@#/ *$ S "L ,H NP#( -( Q@#N ,8 _P#% /\
MQ0#_ +\ _P"Z /\ _P   /\   #_    _@ % /< #@#R !4 [@ ? .L *@#I
M #0 XP ] -X 10#9 $T U !3 -$ 60#. %X S !C ,H : #) &T QP!S ,4
M>0## (  P0"( +\ D "] )L NP"F +D M "W ,@ M@#F +4 ^P"T /\ M #_
M +, _P"N /\ _P   /\   #X    [0   .4 "P#= !$ UP : -( ) #/ "X
MRP W ,< 0 ## $< P !. +X 4P"\ %D N@!> +@ 8P"V &@ M0!M +, <P"Q
M 'D KP"! *T B@"K )0 J0"@ *@ K0"F +X I0#; *0 ] "D /\ HP#_ *,
M_P"B /\ _P   /8   #F    UP   ,L !@#$  X O@ 5 +L 'P"Y "@ MP Q
M +0 .@"P $$ K0!( *L 3@"I %, IP!8 *8 7 "D &$ HP!G *$ ; "@ ',
MG@!Z )T @P"; (X F0"9 )< I@"6 +8 E0#, )0 ZP"3 /T DP#_ ), _P"3
M /\ ]P   .0   #0    P0   +<  @"O  L JP 1 *< &0"E "( HP K *(
M,P"? #L G !" )L 2 "9 $T EP!2 )8 5P"5 %L DP!A )( 9@"0 &T CP!T
M (T ?0", (< B@"3 (@ H "' *\ A0#" (4 X@"$ /< A #_ (0 _P"$ /\
MY0   ,T   "\    KP   *8   ">  < F@ . )8 % "4 !T D@ E )$ +0"0
M #4 C0 \ (P 0@"* $< B !, (< 40"& %8 A !; (, 8 "! &< @ !N 'X
M=P!] ($ >P"- 'H F@!X *D =P"Z '8 TP!V .\ =@#^ '4 _P!U /\ T
M +L   "K    GP   )<   "0  ( BP + (@ $ "& !< A  @ (( )P"! "\
M?P U 'T / !\ $$ >P!& 'D 2P!X %  =P!5 '8 6P!T &$ <P!I '$ <0!P
M 'L ;@"' &T E0!K *, :@"T &H R0!I .@ :0#Y &D _P!I /\ P    *P
M  "< @  D (  (@   "#    ?P & 'L #0!Y !( =P : '8 (@!T "D <P P
M '$ -@!P #P ;P!! &T 1@!L $L :P!0 &H 5@!H %P 9P!D &4 ; !D '8
M8P"" &$ D !@ )\ 7P"O %X PP!> .$ 7@#T %T _P!= /\ M <  * )  "0
M"P  A L  'P*  !W!P  = 0  '$ "0!O  \ ;0 5 &L ' !I ", :  J &<
M,0!E #8 9  \ &, 00!B $8 8 !, %\ 4@!> %@ 70!? %L : !: '( 6 !^
M %< C !6 )L 50"K %0 O@!4 -H 4P#O %0 ^P!4 /\ J0T  )8.  "'$
M>A   '(0  !L#@  :0P  &<) P!F! L 9  0 &( %P!@ !X 7@ E %T *P!<
M #$ 6@ W %D / !8 $( 5P%' %8!3@!5 E0 4P)< %(#90!1 V\ 3P1[ $X$
MB@!-!9D 3 6I $L%O !*!M0 2@?M $H'^0!*!_\ H1   (X2  !^%   <Q0
M &H4  !D$P  8!$  %X/  !=#04 70D- %H&$@!8!QD 5@<@ %4')P!3!RT
M4@@S %$(. !0"#X 3PE$ $X)2@!,"5$ 2PI9 $H*8@!("VT 1PMZ $8,B !$
M#)@ 0PRI $(-O !"#=4 0@WN $(-^P!"#?\ FA0  (<6  !X&   ;!D  &,9
M  !=&   618  %83  !4$0  5 X( %,-#@!1#10 3PT; $T-(@!,#2@ 2PTN
M $H-- !)#3H 1PY! $8.1P!%#D\ 1 Y7 $(/80!!$&P /Q!Y #X0B  ]$9@
M.Q&I #L1O  Z$=8 .A'P #H2_0 [$?\ DQ@  ($:  !S'   9QT  %X=  !8
M'   4QL  % 8  !.%@  3!,# $P1"P!*$!  2!$7 $81'@!%$20 1!$J $(1
M, !!$3< 0!(] #\21  ]$DP /!-4 #L37@ Y%&D .!1V #<5A0 V%98 -!:G
M #06N@ S%M, ,Q;N #06_  T%O\ CAL  'P=  !N'P  8R   %H@  !3(
M3AX  $H=  !(&@  1A@  $46!P!#%0X 0143 #\5&@ ^%2  /14G #L5+0 Z
M%C, .18Z #@600 W%TD -1=1 #086P S&68 ,AES # :@P O&I0 +ANE "T;
MN  M&]  +1OL "X;^P N&_\ BAX  '@@  !J(@  7R,  %8C  !/(@  2B$
M $8@  !#'@  01L  #\: P ]&@P .QD1 #D9%@ W&AT -AHC #4:*0 T&C
M,QLV #$;/@ P'$8 +QQ/ "X=60 M'60 +!YQ "L?@0 J'Y( *1^D "@@MP G
M(,X )R#K "@@^@ I'_\ AB   '0C  !G)   7"4  %,E  !,)0  1R0  $(C
M   _(0  /1\  #H>   W'@D -1X. #,>$P Q'AH ,!X@ "\>)@ N'RT +1\S
M "P@.P K($, *B%, "DA5@ H(F( )B)O "4C?P D(Y  (R.B "(DM0 B),P
M(B3I ",D^0 D(_\ @B,  '$E  !C)@  62<  % H  !))P  0R<  #\F   [
M)   ."(  #4B   R(@8 ,"(- "XB$0 L(A< *B(= "DB(P H(RH )R,Q "8D
M.  E)4$ )"5* ",F5  B)F  (2=M " G?0 ?)X\ 'BBA !XHM  =*,H '2CH
M !XH^  ?)_\ ?B4  &XG  !@*0  5BD  $TJ  !&*@  02D  #PH   W)P
M-"8  # F   M)@, *R<+ "@G$  G)Q0 )2<: "0G(0 C*"< (B@N "$I-@ @
M*3X 'RI( !XJ4@ =*UX '"MK !LK>P :+(T &2R? !@LL@ 8+,D &"SG !DK
M]P :*_\ >B<  &HJ  !=*P  4RP  $HL  !#+   /BL  #DK   T*@  ,"H
M "LJ   I*P  )BL( ",L#@ B+!( ("P8 !\L'@ >+24 '2TL !PM,P ;+CP
M&BY% !DO4  8+UP %R]I !8P>0 5,(L %#"> !0PL0 3,,< $S#E !0P]@ 5
M+_\ =BH  &<L  !:+0  4"X  $@N  !!+@  .RX  #8M   Q+0  +"T  "<O
M   D+P  (3 % !\Q#  <,1  &S(5 !HR'  9,B( &#(I !<S,0 6,SD %3-#
M !0T30 3-%D $C1G !$U=P 1-8D $#6< ! UL  .-<8 #S3D ! T]0 0-/\
M<BP  &,N  !7,   33   $4P   ^,   .#   #,P   O,   *3$  "0R   A
M,P  '34" !HV"0 7-PX %3<3 !0X&0 3.!\ $C@F !(X+@ 1.38 $#E  ! Y
M2P ..5< #CID  TZ=  ,.H8 ##J9  LYK  *.<$ "CG>  LY\0 ,./P ;B\
M %\Q  !3,@  2C,  $(S   [,P  -C,  #$R   L,P  )S0  "$V   =.
M&3D  !4[!@ 2/0P $#X0 ! ^%0 ./AP #CXC  T^*@ ,/C, ##X\  L_1P *
M/U( "#]@  <_;P &/X$ !3^4  0_J  #/KP !#[7  4^[  %/O< :3,  %LT
M  !0-0  1S4  #\U   Y-0  -#4  "XU   I-P  (S@  !X[   :/   %C\
M !)!!  .0PH #$0.  I$$P )1!D "$0@  =$)P &1"\ !40X  -%0@ "14X
M $5;  !%:@  17P  $60  !$I   1+D  $31  !$Z@  0_4 9#8  %<W  !,
M.   0S@  #PX   W.   ,3@  "LY   E.P  (#T  !I    60@  $D0   Y'
M!  +20D !TH-  1+$0 !2Q8  $L<  !+(P  2RL  $LT  !+/@  3$D  $Q7
M  !,9@  3'<  $N,  !+H0  2[4  $K.  !*Z0  2O4 7SH  %([  !(.P
M0#L  #H[   T.P  +CP  "<^   B00  '$,  !9&   220  #DL   M. P '
M4 @  E$,  !1$   4A,  %,8  !3'P  4R8  %,O  !3.0  4T4  %-2  !3
M80  4W(  %.'  !2G   4K$  %'*  !1YP  4?0 63X  $X^  !%/@  /CX
M #@^   P0   *4(  "-$   =1P  %TH  !)-   .4   "U,   95 @  5P<
M %@+  !9#@  6A$  %H5  !;&@  7"$  %PJ  !<-   7#\  %Q-  !<6P
M7&P  %R!  !;EP  6ZT  %K%  !:Y   6?, 5$(  $I"  !"0@  /$(  #1#
M   L1@  )4D  !Y,   73P  $E,   Y6   *60  !5L   !>    8 0  &$(
M  !B#   8PX  &01  !E%@  9AP  &<C  !G+0  9SD  &=&  !G50  9V8
M &=Z  !FD0  9:@  &7   !DW@  9/  3T8  $=&  ! 10  -T<  "]*   F
M30  'U$  !A5   260  #5P   A@   "8P   &8   !H    :@   &L$  !L
M"   ;0P  &\.  !P$@  <A<  ',=  !T)@  =#(  '0_  !T3@  <U\  '1R
M  !SB@  <J$  '&X  !QU   <.P 3$H  $5*   [2P  ,DX  "E2   @5@
M&%L  !)?   -9   !V@   !K    ;P   '(   !U    =@   '<   !Y @
M>@8  'P*  !^#@  @!$  ((6  "$'@  A"D  (0V  "$10  A%8  (-J  "#
M@0  @ID  (&Q  " R0  @.4 2DX  #]0   U4P  *U<  ")<   98@  $F<
M  QL   %<0   '4   !Y    ?0   ($   "#    A0   (8   "(    B0
M (L$  "-"   CPT  )(0  "4%@  EB   )8L  "6.P  EDP  )5@  "5=@
ME)   ).G  "2O0  DM4 1%4  #E9   O70  )&,  !II   2;P  #'4   1[
M    @    (4   ")    C0   )$   "3    E    )8   "8    F@   )P
M  ">    H 8  *(+  "E$   J!<  *DC  "I,0  J4,  *E6  "H;0  IH<
M *>>  "FLP  I<< /EX  #)C   G:@  '7   !-X   ,?P   X4   "+
MD0   )8   ";    GP   *(   "D    I0   *<   "I    JP   *T   "P
M    L@   +4"  "W"0  NQ   +X8  "^)@  OC@  +Y+  "]80  O'H  +N4
M  "ZJ0  NKD -VH  "MP   @>   %H    V(   %CP   )8   "<    H@
M *<   "L    L    +,   "V    MP   +D   "[    O0   +\   #"
MQ0   ,@   #*    S@@  -(0  #5&P  U2P  -1   #45P  TVX  -2&  #4
MFP  TZL _P   /\   #_    _P % /\ #@#_ !4 _  @ /D *@#V #0 \0 ]
M .T 1@#I $T Y@!3 .0 60#A %X W@!C -P : #9 &X U0!S -, >0#0 (
MS@"( ,L D0#) )P Q@"G ,0 MP#" ,P P #L +\ _P"^ /\ O0#_ +< _P"R
M /\ _P   /\   #_    ^@ ! /, "P#M !( Z  ; .4 )0#D "X WP X -@
M0 #2 $< S@!. ,L 5 #( %D Q@!> ,0 8P#" &< P !M +\ <P"] 'H NP"!
M +D BP"V )4 M "A +( KP"P ,( K@#C *X ^@"L /\ K0#_ *D _P"F /\
M_P   /\   #R    Y@   -T !P#2  X S0 6 ,H ( #( "D Q0 R ,  .@"\
M $( N0!( +< 3@"U %, LP!8 +$ 70"P &( K@!G *P ; "J ', J0![ *<
MA "E (X HP": *$ J "? +D G@#2 )T \@"< /\ G0#_ )P _P"9 /\ _
M .X   #=    S    ,$  @"Z  P M@ 2 +( &@"P ", KP L *T - "I #P
MI@!" *0 2 "B $T H !2 )X 5P"= %L G !@ )H 9@"9 &P EP!T )4 ?0"3
M (< D0"3 )  H0". +$ C0#& (P Z "+ /T C #_ (P _P", /\ [0   -@
M  #%    MP   *P   "F  @ H0 . )\ %0"= !X FP F )H +@"7 #4 E0 \
M ), 0@"1 $< D !, (X 40"- %4 BP!: (H 8 ") &8 AP!M (4 =@"$ (
M@@", (  F@!_ *D ?0"\ 'P W !\ /4 ? #_ 'P _P!\ /\ V0   ,$   "Q
M    I    )P   "4  , D  , (T $0"+ !@ B0 @ (D * "' "\ A0 V (,
M/ "" $$ @ !& '\ 2P!] $\ ? !4 'L 6@!Y &  > !G '8 < !U 'H <P"&
M '$ DP!P *( ;P"T &X S !N .T ;@#^ &X _P!N /\ Q    *\   "@
ME    (P   "&    @0 ( 'X #@!\ !0 >P ; 'D (@!X "D =P P '4 -@!T
M #L <@!  '$ 10!P $H ;P!/ &T 5 !L %L :P!B &D :@!H '0 9@"  &4
MC@!C )T 8@"M &$ P@!A .0 80#X &$ _P!A /\ M    *    "1    A@
M 'X   !Y    =0 # '$ "P!O !  ;0 6 &P '0!K "0 :P J &D , !H #8
M9@ [ &4 0 !D $4 8P!* &$ 3P!@ %8 7P!= %T 90!< &\ 6@!Z %D B !8
M )@ 5P"H %8 NP!6 -@ 5@#Q %8 _P!6 /\ J $  )0%  "%!P  >@<  '(&
M  !L!   :0$  &< !P!D  T 8P 1 &$ & !@ !\ 7P E %X *P!= #  6P V
M %H .P!9 $  6 !% %< 2P!6 %$ 50!8 %, 80!2 &H 4 !V $\ A !. ),
M30"D $P M@!, ,T 3 #K $P ^@!, /\ G0D  (L+  !\#0  < T  &@-  !B
M#   7PH  %T& 0!< 0D 6@ . %@ $P!7 !D 5@ @ %4 )@!3 "L 4@ Q %$
M-@!0 #L 3P!! $X 1P!- $T 2P!5 $H 70!) &< 1P!S $8 @ !% )  1 "A
M $, L@!# ,@ 0P#F $, ]0!# /\ E0T  (,/  !T$   :1$  & 1  !:$
M5@X  %0-  !3"@0 4P8+ %$#$ !/ 14 3@$; $P!(0!+ 2< 2@(L $D",@!(
M C< 1P,] $4#0P!$ TH 0P11 $($6@! !60 /P5P #X&?@ ]!HX / >? #L'
ML0 Z!\8 .@?C #H'\P Z"/P CA   'P2  !N%   8A4  %H5  !4%   4!,
M $T1  !+#@  2PT& $H*# !)"!$ 1P@6 $4('0!$"", 0@@H $$)+@! "3,
M/PDY #X*0  ]"D< / I/ #H+6  Y"V, . QO #8,?@ U#(X - V? #,-L0 R
M#<< ,@WC #(-]  R#?X B!,  '<5  !I%P  7A@  %48  !/&   2A8  $<5
M  !%$P  0Q " $,." !"#0X 0 T2 #\-&  ]#1\ / TD #L-*@ Y#3  . XW
M #<./0 V#D4 -0Y- #,/5P R#V( ,1!N "\0?0 N$(X +1&@ "P1L@ K$<@
M*Q'F "L1]@ L$?\ @Q8  '(9  !D&@  61L  %$;  !+&P  1AH  $(8   _
M%P  /A0  #P2!  [$0H .A 0 #@0%0 W$!L -1$A #01)P S$2T ,A$S # 1
M.@ O$D( +A)+ "T35  K$U\ *A1L "D4>P H%(P )Q6> "85L  E%<8 )17D
M "45]@ F%?\ ?AD  &X;  !@'0  5AX  $T>  !''@  0AT  #X<   Z&@
M.!@  #<6   U%0< -!0- #(4$@ P%!< +Q0= "T4(P L%2H *Q4P "H5-P I
M%C\ *!9( "<74@ F&%T )!AJ ",9>0 B&8H (1F< " 9KP ?&<0 'QGB " 9
M]  @&?\ >AL  &H>  !='P  4R   $H@  !$(   /A\  #H>   W'0  -!P
M #(9   P&00 +A@+ "P8$  J&!0 *1@: "<8(  F&28 )1DM "0:-0 C&CT
M(AM& "$;4  @'%L 'QUH !X==P ='8@ '!Z; !L>K0 :'L, &A[@ !H=\P ;
M'?\ =QT  &<@  !:(0  4"(  $@B  !!(@  .R(  #<A   S(   ,!\  "T=
M   K'0  *!T( "8=#@ E'1( (QT7 "$='0 A'20 (!XJ !\>,@ >'SH '1]#
M !P@30 ;(5D &B%F !DA=0 8(H< %R*9 !8BK  5(L$ %2+? !4A\@ 6(?X
M<R   &0B  !7(P  320  $4E   ^)   .20  #0C   P(@  +"(  "DA   F
M(0  )"$& "(A#  @(1  'B$5 !TB&P ;(B$ &R(H !HC+P 9(S@ &"1! !<D
M2P 6)5< %25D !0F<P 3)H4 $B:8 !$FJP 1)L  $";= !$E\0 2)?T <"(
M &$D  !4)@  2B8  $(G   \)@  -B8  #$E   M)0  *20  "8D   B)0
M'R4# !TF"@ ;)@X &2<2 !@G&  7)Q\ %B<E !4H+0 4*#4 $RD^ !(I20 1
M*54 $2IB ! J<0 /*H, #BJ6  XJJ0 -*KT #2K7  TJ[@ .*?L ;"0  %TF
M  !1*   2"@  $ I   Y*   -"@  "\H   K)P  )R<  "(H   >*0  &RH
M !@K!P 6*PT %"P1 !,L%@ 2+!P $2TC ! M*@ 0+3( #RX\  XN1@ -+E(
M#2Y?  PO;@ ++W\ "B^2  DOI0 )+KD ""[0  DNZ0 *+O< :"<  %HI  !.
M*@  12L  #TK   W*P  ,2H  "TJ   I*@  )"H  " K   ;+0  &"X  !4O
M!  2,0H $#(.  \R$P .,AD #3(@  TR)P ,,B\ "S,X  HS0@ ),TX "#-;
M  8T:@ %-'L !#..  ,SH@ ",[8  C/-  ,SYP $,O, 9"H  %8L  !++0
M0BT  #HM   T+0  +RP  "LL   F+   (BT  !TO   9,0  %3(  !(T P /
M-@D ##@-  HX$0 ).!8 "#@=  <X)  &."P !#@T  ,X/@ ".4H  #E7   Y
M90  .7<  #F+   XGP  .+,  #C*   XY@  -_( 7RT  %(N  !(+P  /S
M #@O   R+P  +2\  "DO   D,   'S$  !HS   5-0  $C<   \Y P ,.P@
M"#T-  4^$  #/A0  #X:   ^(0  /B@  #XQ   _.P  /T8  #]3   _80
M/W,  #^'   ^G   /K   #W'   ]Y   /?( 6C   $XR  !$,@  /#(  #4R
M   P,0  *S$  "8R   @-   &S8  !8X   2.P  #ST   P_ P (00@ !$,,
M  !##@  1!(  $46  !%'0  120  $4M  !&-@  1D(  $9.  !&70  1FX
M $6"  !%F   1*T  $3$  !#XP  0_( 530  $HU  !!-0  .34  #,T   N
M-   *#4  "(W   =.@  %SP  !(_   /00  #$0   A& 0 #2 8  $D*  !*
M#0  2Q   $P4  !-&0  3B   $XH  !.,@  33T  $Y*  !.6   36D  $U]
M  !,E   3*H  $O!  !+X0  2O( 4#@  $8X   ].   -S@  #$W   J.0
M)#L  !X]   80   $T,   ]&   +20  !TL   ).    4 0  %$(  !2"P
M4PX  %01  !5%0  5AL  %<C  !7+   5S@  %=$  !74@  5F,  %9W  !6
MC@  5:4  %2]  !3W0  4_  2SP  $(\   [.P  -3L  "T\   F/P  'T(
M !E%   32   #DL   M/   %40   %0   !7    6 $  %H%  !;"   7 P
M %T.  !?$0  8!8  &(=  !B)@  8C$  &(^  !A3   85T  &%P  !@B
M8*   %^W  !>U   7>X 1T   #\_   Z/P  ,4   "E#   A1@  &DH  !-.
M   .40  "E4   18    6P   %X   !A    8P   &0!  !E!   9P@  &@+
M  !J#@  ;!(  &X7  !O(   ;RH  &\V  !N10  ;E4  &YH  !M?P  ;9@
M &RP  !KR@  :N@ 1$0  #Y#   U1   *T<  "-+   ;3P  $U0   Y8   (
M7    F    !D    9P   &L   !M    ;P   '    !R    = (  '4&  !W
M"@  >0X  'P2  !^&   ?R(  '\N  !_/0  ?DT  'UA  !]=P  ?)   'NH
M  !ZP   >=\ 0T<  #E)   O3   )5   !Q5   46P  #F    =E    :@
M &X   !R    =@   'D   !\    ?@   '\   "!    @P   (4   "' P
MB@@  (P-  "/$0  DAD  )(E  "2,P  DD0  )%7  "0;0  CX8  (Z?  "-
MM0  C,T /4X  #)1   H5@  'EP  !5B   .:   !VX   !T    >0   'X
M  ""    A@   (D   ",    C@   )    "2    E    )8   "8    FP
M )X&  "A#   I!$  *8;  "F*0  ICH  *5-  "E8@  I'L  *.4  "AJP
MH;\ -E<  "Q<   A8@  %VD   ]P   '=P   'X   "$    B@   (\   "4
M    F    )L   ">    GP   *(   "D    I@   *@   "K    K0   +
M  "S!   MPP  +L2  "['P  NS   +M#  "Z6   N7   +>+  "WH0  M[,
M,&(  "5I   :<   $'@   F     B    (\   "6    FP   *$   "F
MJ@   *X   "P    L0   +0   "V    N    +L   "]    P    ,,   #'
M    RP,  ,\,  #3%0  TB4  -(X  #13@  T&4  ,]^  #-E@  S*D _P
M /\   #_    _P # /\ "P#\ !$ ^0 ; /< )0#S "\ [@ X .D 0 #F $@
MX@!. -\ 5 #< %D V0!> -4 8P#3 &@ T !M ,X <P#+ 'H R "" ,8 C ##
M )< P "C +X L@"\ ,@ N@#J +D _P"X /\ L0#_ *H _P"G /\ _P   /\
M  #[    ]@   .T !P#G  \ X@ 6 -\ ( #> "D V0 S -$ .P#, $( R !(
M ,4 3@#" %, P !8 +X 70"\ &( N@!G +D ;0"W '0 M0![ +( A0"P )
MK@"< *P J@"I +T IP#> *8 ^0"E /\ HP#_ )T _P"; /\ _0   /8   #K
M    WP   -$  P#*  P Q0 2 ,, &P#  "0 O@ L +D -0"V #P LP!# +
M2 "N $X K !2 *L 5P"I %P IP!A *8 9P"D &T H@!T *  ?0"> (@ G "5
M )H HP"8 +0 E@#- )4 \0"4 /\ E0#_ )  _P". /\ \P   .8   #1
MP@   +@   "Q  @ K0 / *H %@"H !X J  G *8 +P"B #8 GP \ )T 0@";
M $< F0!, )< 40"6 %4 E !: ), 8 "1 &8 D !N (X =@", ($ B@"- (@
MFP"& *P A0#! (0 Y@"# /T A #_ (, _P"! /\ Y    ,L   "Z    K
M *(   "<  0 F  , )8 $0"4 !D DP A )( * "/ #  C0 V (L / ") $$
MB !& (8 2P"% $\ A !4 (( 6@"! &  ?P!G 'X ;P!\ 'H >@"& '@ E !W
M *0 =0"W '0 U !S /0 = #_ '0 _P!T /\ RP   +8   "F    F@   )(
M  "*    A@ ( (, #@"! !0 @0 ; (  (P!_ "H ?0 P 'L -@!Z #L > !
M '< 10!U $D = !. ', 5 !Q %H < !A &X :0!M ', :P!_ &D C0!H )T
M9P"N &8 QP!E .H 9@#_ &8 _P!G /\ N    *0   "5    B@   ($   !\
M    =@ $ '0 # !R !  <0 6 '  '0!P "0 ;@ J &T , !K #4 :@ Z &D
M/P!H $0 9P!) &4 3@!D %0 8P!; &$ 8P!@ &T 7@!Y %T AP!; )8 6@"H
M %D O0!9 -\ 60#X %H _P!: /\ J    )4   "'    >P   ',   !N
M:@ ! &< " !E  X 9  2 &, & !C !\ 8@ E &$ *@!? #  7@ U %T .@!<
M #X 6P!$ %D 20!8 $\ 5P!6 %8 7@!4 &@ 4P!S %$ @0!0 )$ 3P"B $X
MM0!. -  3@#P $X _P!/ /\ G    (D   ![ P  < ,  &@#  !B 0  7P
M %T ! !;  L 60 / %@ % !7 !D 5P @ %8 )0!5 "H 4P P %( - !1 #D
M4  _ $\ 1 !. $L 30!2 $L 6@!* &, 20!O $< ? !& (P 10"= $4 L !$
M ,< 1 #H $0 ^@!% /\ D@0  ( '  !Q"@  9@H  %X*  !9"0  50<  %0$
M  !2  < 4  , $\ $ !. !4 30 ; $P ( !+ "8 2@ K $D , !( #4 1P Z
M $8 0 !% $8 0P!. $( 5@!! %\ 0 !K #X >  ] (@ / "9 #P JP \ ,$
M.P#@ #L ]  [ /\ B0H  '@,  !J#@  7PX  %<.  !1#@  30P  $L+  !*
M" ( 200) $@ #0!& !$ 10 6 $0 ' !# "$ 0@ F $$ *P _ #$ /@ V #T
M/  \ $, .P!* #H 4@ Y %P . !H #8 =0 U (4 - "6 #0 J  S +P ,P#8
M #, [P S /L @@T  '$/  !D$   61$  %$1  !+$0  1Q   $0.  !"#0
M00L% $$'"P _!0X /@,2 #P"&  [ AT .@,B #D#*  X RT -P,R #8$.0 U
M!#\ - 5' #,%4  Q!EH , 9F "\'<P N!X, +0>5 "P'IP K![H *P?2 "L'
MZP K!_< ?1   &P1  !?$P  5!0  $P4  !&%   0A,  #X2   \$   .@X!
M #H-!@ Z"@P . D0 #8(%  U"!D - D? #())  Q"2D , DO "\*-@ N"CT
M+0I% "P+3@ K"UD *0QE "@,<P G#(, )@V5 "4-IP D#;L (PW2 ",-ZP C
M#?< >!(  &@4  !;%@  41<  $@7  !"%@  /18  #D5   W$P  -1$  #,0
M P S#@@ ,@T- # -$0 O#18 +0T; "P-(0 K#2< *@TM "D.-  H#CL )PY$
M "4.3@ D#UD (Q!E "$0<P @$(0 'Q"6 !X0J0 =$+T '!#8 !T0[@ =$/D
M<Q0  &06  !7&   31D  $49   _&0  .A@  #47   R%@  ,!4  "X3   M
M$00 +! * "L0#@ I$!( *! 8 "80'@ E$"0 )! J ",1,0 B$3D (1%" " 2
M2P >$E8 '1-C !P3<0 :$X( &125 !@4IP 7%+L %Q/4 !<3[@ 8$_H <!8
M & 9  !4&@  2AL  $(<   \&P  -AL  #(:   O&0  +!@  "H6   H% $
M)A,' "43#  C$Q  (A,5 " 3&@ ?$R$ 'A0G !T4+@ <%38 &Q4_ !H620 9
M%E0 &!=A !87<  5&($ %!B3 !,8I@ 2&+H $A?2 !(7[  3%_H ;!D  %T;
M  !1'0  1QT  #\>   Y'0  -!T  "\<   K&P  *!H  "89   D&   (A<$
M " 7"@ >%PX '!<2 !H7%P 9&!X &1@D !@9+  7&30 %AH] !4:1P 4&U(
M$QM? !(<;@ 1''\ $!R2 ! <I0 /'+D #AS0  X;Z@ /&_@ :1L  %H=  !.
M'P  11\  #T@   V'P  ,1\  "T>   I'0  )1T  ",<   @&P  '1L! !L;
M!P 9' T %QP0 !8<%0 5'!L %!TB !,=*0 2'C$ $1XZ !$?10 0'U  #R!=
M  X@;  -('P #2"/  P@H@ +(+4 "R#*  L@Y0 ,'_0 91T  %<?  !,(0
M0B$  #HA   T(0  +R$  "H@   F'P  (Q\  " >   ='@  &2   !8@!  4
M( L $B$. !$A$P 1(AD $"(?  \B)@ .(R\ #B,W  TC00 ,)$T "R19  HD
M9P ))'@ ""2+  <DG@ ')+$ !B3'  8CXP '(_$ 8A\  %0A  !)(P  0",
M #@C   R(P  +",  "@B   D(0  (2$  !XA   :(0  %B,  !,D P 1)0@
M#R8-  XG$0 -)Q8 #"<=  LG(P *)RL "2@T  @H/@ '*$D !BA5  4I9  $
M*70  RF'  (IFP !**\  "C%  $HX0 !)_  7B(  %$D  !&)0  /24  #4E
M   O)0  *B0  "8D   B(P  'R,  !LD   8)0  %"8  !$H P /*0@ #"P,
M  HL$  (+!0 !RP:  8L(0 %+"@  RTP  (M.@ !+44  "U2   N8   +G$
M "V$   MF0  +:T  "S"   LX   +/  6B0  $TF  !#)P  .B<  #,G   M
M)P  *"8  "0F   A)@  '28  !DG   5*0  $2L   \L P -+@< "3 ,  8Q
M#@ #,1(  3(7   R'@  ,B4  #(M   R-@  ,T(  #-.   S70  ,VT  #.!
M   RE@  ,JL  #'!   QWP  ,?  5B<  $HI   _*@  -RH  # J   K*0
M)R@  ",H   >*0  &BH  !8L   2+@  #S    TQ @ *- < !34+  (V#@
M-Q   #@4   X&@  ."(  #@J   Y,P  .3X  #E*   Y60  .6D  #E]   X
MDP  .*@  #>_   WW@  -O  42L  $8L   \+   -"P  "XL   J*P  )2L
M " L   ;+0  %R\  !,Q   0,P  #34   DW @ %.@8  3L*   \#0  /0\
M #X2   _%P  0!X  $ E  ! +P  0#H  $!&  ! 5   0&4  #]X   _CP
M/J8  #Z]   ]W   /?  32X  $(O   Y+P  ,B\  "TN   H+@  (B\  !TP
M   8,@  $S4  ! W   ,.@  "3P   4^    000  $((  !#"P  1 T  $80
M  !'%   2!D  $@A  !(*@  2#4  $A!  !(3P  2&   $=S  !'B@  1J(
M $6Y  !%V0  1/  2#(  #XR   V,@  ,#$  "LQ   E,@  'S0  !DV   3
M.0  $#P   P_   (0@   T0   !&    2 (  $H%  !+"   3 L  $X.  !/
M$0  414  %(<  !2)0  4C   %(\  !12@  45H  %%M  !0A   3YT  $ZU
M  !-T@  3>X 0S8  #LV   T-0  +S0  "<U   A.   &CL  !0^   000
M#$0   ='   "2@   $T   !/    40   %,"  !4!0  50@  %<+  !9#@
M6Q$  %T7  !='P  72H  %TV  !<1   7%0  %MG  !;?@  6I<  %FO  !8
MRP  5^H /SD  #@Y   S.   *SD  ",\   </P  %4,  !!'   +2@  !4X
M  !1    5    %<   !:    7    %T   !?    8 0  &('  !D"P  9@X
M &@2  !K&0  :R,  &HN  !J/   :DT  &E?  !H=0  9X\  &:H  !EP@
M9., /3T  #<\   N/0  )4   !U$   620  $$T   I1   $50   %H   !=
M    8    &,   !F    :    &H   !K    ;0   &\"  !Q!@  = H  '8.
M  !Y$P  >QL  'LG  !Z-0  >44  'A9  !X;0  =X8  ':?  !UMP  =-(
M/$$  #)"   H10  ($H  !=.   05   "ED   )>    8P   &<   !K
M;P   '(   !U    =P   'D   ![    ?0   '\   ""    A ,  (<)  "*
M#@  CA,  (\>  ".*P  CCL  (U.  "+8P  BGP  (J5  "(K0  A\4 -D<
M "Q+   B3P  &54  !!;   *80   6<   !M    <@   '<   ![    ?P
M (,   "&    B    (H   "-    CP   )$   "4    EP   )H!  "=!P
MH0T  *44  "D(0  I#$  *-$  "B60  H'   )^+  "=H@  G;< ,%   "55
M   ;6P  $F(   MI   !<    '<   !]    @P   (@   "-    D0   )4
M  "8    F@   )P   "?    H0   *,   "F    J0   *P   "P    M <
M +@.  "Z&   NB<  +DY  "X3@  MV4  +9^  "UE@  LZL *5L  !YB   4
M:0  #'$   )Y    @0   (D   "/    E@   )L   "@    I    *@   "K
M    K    *\   "R    M    +8   "Y    O    ,    #$    R    ,T'
M  #2$   TAT  -$O  #01   SUL  ,US  #+C0  RJ$ _P   /\   #[
M^@   /P " #X  \ ]0 7 /0 ( #Q "H ZP S .8 .P#B $, W@!) -H 3P#6
M %0 TP!9 -  7@#. &, RP!H ,D ;@#& '4 PP!] ,$ A@"^ )( NP"> +D
MK@"V ,, M #H +, _P"O /\ I0#_ )X _P"; /\ _0   /<   #R    \
M .<  P#A  P W  2 -@ &P#6 "0 T@ M ,P -@#& #T P@!# +\ 20"\ $X
MN@!3 +@ 6 "V %T M0!B +, 9P"Q &X KP!V *P ?P"J (H J "7 *4 I@"C
M +D H0#9 *  ^0"> /\ F #_ )( _P"/ /\ \P   .P   #C    TP   ,@
M  #!  D O0 / +L %@"Y !\ MP G +, +P"O #< K  ] *H 0P"H $@ I@!-
M *0 4@"C %8 H0!; )\ 80"> &< G !O )H > "7 (, E0"0 ), G@"1 +
MD #( (X \ "- /\ B@#_ (4 _P"" /\ YP   -T   #&    N    *X   "H
M  0 I0 , *$ $@"A !D H  B )\ *0"; #  F  W )8 /0"3 $( D@!' )
M2P"/ %  C0!5 (P 6@"* &$ B !H (< < "% 'L @P"( ($ E@!_ *< ?0"\
M 'P XP!\ /T ? #_ '@ _P!V /\ U@   ,    "O    HP   )D   "3
MCP ) (T #@"+ !0 B@ < (H (P"( "H A0 P (, -@"" #L @ !  '\ 10!^
M $H ? !/ 'L 5 !Z %H > !A '8 :0!U ', <P"  '$ C@!O )\ ;@"R &T
MSP!L /0 ; #_ &L _P!I /\ P    *L   ";    CP   (<   "     ?  $
M 'H # !X !$ >  7 '@ '@!W "0 =0 J ', , !Q #4 <  Z &X /P!M $0
M; !) &L 3@!J %0 : !; &< 8P!E &T 9 !X &( AP!@ )< 7P"J %X P@!>
M .D 7@#_ %X _P!= /\ K    )D   "*    ?P   '<   !Q    ;0   &H
M" !I  X :  2 &< & !G !\ 9P E &4 *@!C "\ 8@ T &$ .0!@ #X 7P!#
M %X 2 != $X 6P!5 %H 70!8 &< 5P!R %4 @0!4 )$ 4P"C %( N !1 -P
M40#Y %( _P!2 /\ G0   (L   !\    <0   &D   !D    8    %X !0!<
M  L 6P / %L % !: !D 6@ ? %D )0!7 "H 5@ O %4 - !4 #@ 4P ] %(
M0P!0 $D 3P!0 $X 6 !- &( 2P!M $H >@!) (L 2 "= $< L0!' ,P 1@#P
M $< _P!' /\ D    'X   !P    9@   %X   !9    5@   %,  0!2  @
M4  - $\ $ !/ !4 3@ : $X ( !- "4 3  J $H +@!) #, 2  X $< /@!&
M $0 10!+ $0 4P!# %T 00!H $  =0 _ (4 /@"7 #T JP ] ,, /0#F #T
M^P ^ /\ AP   '4#  !H!@  70<  %4&  !0!@  3 0  $H!  !)  0 1P *
M $8 #@!% !$ 10 6 $0 &P!# "  0@ E $$ *@!  "\ /P T #X .@ ] $
M.P!' #H 3P Y %D . !D #< <0 V ($ -0"3 #0 I@ T +L - #= #0 ]0 U
M /\ ?@8  &T)  !@"P  5@P  $X,  !("P  1 H  $((  ! !0$ /P$' #X
M"P ]  X /  2 #L %P [ !P .@ A #D )0 W "H -@ P #4 -0 T #P ,P!#
M #( 3  Q %4 , !@ "\ ;0 N 'T +0"/ "P H@ L +8 + #0 "P [@ L /P
M=PH  &<,  !:#@  4 X  $D.  !##@  /@T  #L,   Y"P  . D# #<%"  V
M @T -0$0 #0 $P S !@ ,@ = #$ (@ P "< +P L "X ,@ M #@ + !  "L
M20 J %( *0!= "@ :P G 7H )@&, "4 GP E +( )0#* "4 Z  E /< <@T
M &(.  !6$   3!$  $01   ^$0  .1   #8/   S#@  ,0T! # +!0 P" H
M+P8- "X%$0 L!!0 *P,9 "H#'@ I R, * 0I "<$+P F!34 )04] "0%1@ C
M!E  (@9< "$':0 @!WD 'P>+ !X'G0 >![  '0;& !T&XP =!?, ;0X  %X1
M  !2$@  2!,  $ 3   Z$P  -1(  #$1   N$   + \  "H. P J#0< *0L+
M "@)#@ G"1$ )0@6 "0(&P C"2  (@DF "$)+  @"C, 'PH[ !X+1  ="T\
M' Q; !L,:0 :#'D & R+ !@,G@ 7#+  %@S% !8,X0 6"_  :1   %H2  !.
M%   114  #T5   W%0  ,10  "T3   J$@  *!$  "80 0 D$ 0 (PX( ",-
M#  B# \ ( P3 !\,&  >#1T '0TC !P-*@ ;#3( &@XZ !@.1  7#E  %@]<
M !4/:@ 3$'L $A"- !$0H  1$+, $ _) ! /Y  1#_( 91(  %<4  !+%@
M0A<  #H7   T%P  +Q8  "H5   G%   )!,  "(3   @$@, 'A$& !T0"0 <
M$ T &P\0 !D0%0 8$!L %Q A !80*  5$3  %!$Y !,10P 2$DX $1): ! 2
M:0 0$WD #A.,  X3G@ -$[$ #1+%  P2X0 -$O$ 8A0  %06  !)&   /QD
M #<9   Q&0  +!@  "@7   D%@  (18  !\5   <% ( &A,$ !D2!@ 7$@L
M%1(. !02$@ 3$Q@ $A,? !$3)@ 1%"T $!0V  \500 .%4P #A97  T690 ,
M%W4 "Q>'  H7F@ )%JT "!;!  @6W0 )%>X 7Q8  %$8  !&&@  /1H  #4;
M   O&@  *AH  "49   B&   'Q@  !P7   9%@$ %Q8# !46!  3%@D $18-
M ! 7$0 /%Q8 #A<<  X8(P -&"H #!DS  P9/  +&D< "AI3  D:80 '&W$
M!AN#  4;EP $&JH  QJ_  ,9V@ $&>P 7!@  $X:  !#'   .AP  #,<   L
M'   )QP  ",;   @&@  '1D  !H9   7& $ %1@" !(9!  0&P< #AL,  T<
M$  ,'!, "QP9  H<'P )'2< "!TO  <>.0 &'D, !!Y0  ,?7@ "'VX  1^
M   ?E0  'JD  !Z]   =V   '>P 6!H  $L<  !!'@  .!X  # >   J'@
M)1T  "$<   >'   &QL  !@;   6&P$ $QL" !$<!  .'@< #!\+  H@#@ (
M(!( !B$7  4A'0 $(20  B(L  $B-0  (D   "--   C6@  (VL  "-^   C
MDP  (J<  "*\   AUP  (>T 51T  $@?   ^(   -2   "X@   H(   (Q\
M " >   ='0  &AT  !8=   3'@  $1\"  X@!  -(@< "B0+  8E#0 $)1
M B84   F&@  )B$  "<I   G,@  )ST  "=)   H5P  *&<  "=[   GD
M)Z4  ":[   FU@  )>T 42   $4A   [(@  ,B(  "PB   F(0  (B$  !X@
M   ;'P  &"   !0@   1(@  #R,   TE P *)@8 !B@*  ,I#0  *P\  "P2
M   L%P  +!X  "PF   M+P  +3D  "U&   M5   +60  "UW   LC0  +*0
M "NZ   KU@  *NX 32(  $$D   X)   ,"0  "DD   D(P  (2(  !TB   9
M(@  %2,  !(D   /)@  #2@   HJ @ &+ 4  BX)   O"P  , X  #(0   S
M%0  ,QL  #,B   S*P  ,S8  #-"   S4   ,V   #-S   RB@  ,J$  #&X
M   PU@  ,.\ 224  #XF   T)P  +2<  "@F   C)0  'R0  !LE   6)@
M$B@  ! J   -+   "BX   8P 0 ",@0  #0'   U"@  -PP  #@.   Z$@
M.A<  #H?   Z)P  .C(  #H^   Z3   .EP  #IO   YA@  .)X  #BV   W
MU   -N\ 1"D  #HI   Q*0  *RD  "8H   B)P  '2@  !@I   3*P  $"X
M  TP   ),@  !34   $W    .0(  #L%   \"   /@L  #\-  !!$   0Q0
M $,;  !#(P  0RX  $,Y  !#1P  0E<  $)J  !!@0  0)H  #^R   ^SP
M/N\ /RP  #8L   O+   *BL  "4J   ?*P  &2T  !0O   0,@  #34   @X
M   $.@   #P    _    00   $,"  !%!0  1@@  $@+  !*#@  3!$  $T6
M  !-'@  32@  $TT  !,0@  3%$  $MD  !+>P  2I0  $FM  !(R@  1^P
M.S   #,O   M+P  *"T  "(O   ;,0  %30  ! W   -.@  "#T   )
M0P   $8   !(    2@   $P   !. 0  3P0  %$'  !3"P  50X  %@2  !9
M&0  6"(  %@N  !7/   5TL  %9>  !6<P  58T  %2G  !2P@  4N8 .#,
M #$R   L,0  )3(  !TU   6.   $3P   Q    '1    $<   !*    30
M %    !3    50   %<   !9    6@   %P#  !>!P  80L  &0.  !F$P
M9QP  &8G  !F-   940  &17  !D:P  8H4  &&?  !@N0  7MP -3<  # U
M   H-P  (#H  !@]   10@  #$8   9*    3P   %,   !6    60   %P
M  !?    80   &0   !E    9P   &D   !L 0  ;@8  '$+  !T#P  =Q4
M '<@  !V+0  =CT  '5/  !T8P  <WL  '*5  !PKP  ;\D -3H  "L[   B
M/P  &D,  !)(   ,30  !5(   !7    7    &    !D    :    &L   !N
M    <0   ',   !U    =P   'H   !\    ?P   (($  "&"@  B@\  (P7
M  "+)   BC,  (E%  "'6P  AG(  (6+  "#I0  @KP +T   "5$   <20
M$TX   U4   $6@   &$   !F    :P   &\   !T    >0   'T   "
M@P   (4   "'    B@   (P   "/    D@   )8   "9 @  G@D  *(0  "B
M&@  H2D  * [  "?4   G6<  )J!  ":F0  F:\ *4D  !].   55   #EL
M  5B    :0   '    !W    ?0   ((   "&    BP   (\   "3    E0
M )<   ":    G0   *    "C    I@   *H   "N    L@   +<*  "[$0
MNA\  +DP  "W10  M5P  +1T  "QC@  KZ0 (E0  !A;   08@  !VH   !S
M    >P   ((   ")    D    )4   ":    GP   *,   "F    J    *L
M  "N    L    +,   "V    N@   +T   #"    QP   ,P!  #3"P  U!4
M -,F  #1.@  T%$  ,UH  #+@0  RI8 _    /8   #R    \0   /, !0#T
M  P \@ 3 /  ' #M "4 Z  N .( -@#> #X V0!$ -0 2@#1 $\ S@!4 ,L
M60#) %X Q@!C ,0 :0#! '  O@!X +P @0"Y (T M@": +, JP"Q ,  KP#F
M *X _P"E /\ F@#_ )0 _P"/ /\ ]    .P   #H    YP   -\   #9  D
MT@ 0 ,\ %P#/ "  S  H ,8 , #  #< O  ^ +D 1 "W $D M0!. +, 4P"Q
M %< KP!= *T 8@"K &D J0!Q *< >@"E (4 H@"3 *  H@"= +8 FP#4 )D
M^0"6 /\ C0#_ (@ _P"$ /\ Z    -\   #9    R0   +\   "X  0 M0 -
M +, $@"Q !H L  B *T *@"I #$ I@ X *0 /0"B $, H !( )X 3 "< %$
MFP!6 )D 7 "7 &( E0!I ), <@"1 'T CP"+ (T F@"+ *P B0#% (@ [@"&
M /\ ?P#_ 'H _P!X /\ V0   ,T   "[    K@   *4   "?    G  ) )D
M#P"9 !4 F0 = )@ ) "4 "L D0 Q (X -P", #P BP!! (D 1@"( $L A@!0
M (4 50"# %L @@!B (  :P!^ '4 ? "" 'H D@!X *, =P"Y '8 X !U /\
M<@#_ &X _P!L /\ QP   +4   "E    F0   (\   ")    A0 $ (0 # ""
M !$ @@ 7 (( '@"  "4 ?@ K 'P ,0!Z #8 >0 [ '< 0 !V $0 =0!) ',
M3P!R %4 < !< &\ 9 !M &X ; !Z &H B@!H )L 9P"O &8 S !E /4 9 #_
M &$ _P!@ /\ M    *    "0    A0   'T   !W    <P   '  " !O  X
M;P 2 &\ & !O !\ ;0 E &L *@!I #  :  T &< .0!F #X 90!# &, 2 !B
M $X 80!5 %\ 7@!> &< 7 !S %L @@!9 ), 6 "F %< OP!7 .H 5P#_ %8
M_P!4 /\ H0   (X   !_    =0   &P   !H    9    &$ ! !@  L 7P /
M %\ $P!? !D 7P ? %T )0!< "H 6P O %D ,P!8 #@ 5P ] %8 0P!5 $D
M4P!0 %( 6 !1 &$ 4 !M $X >P!- (P 3 "? $L M0!* -P 2@#Z $H _P!*
M /\ D@   (    !R    9P   %\   !:    5P   %4  0!3  < 4@ , %(
M$ !2 !0 4@ : %$ 'P!/ "0 3@ I $T +@!, #, 2P X $H /0!) $, 2 !*
M $8 4@!% %P 1 !G $, =0!" (8 00"8 $  K@!  ,L /P#R $  _P!  /\
MA0   '0   !G    70   %4   !/    3    $H   !(  0 1P * $< #0!&
M !$ 1@ 5 $8 &@!% !\ 1  D $, *0!" "T 00 S #\ .  ^ #X /0!% #P
M3@ [ %< .@!B #D ;P X (  -P"3 #8 IP V ,  -@#H #8 _@ V /\ ?
M &L   !> @  5 ,  $T#  !' P  0P$  $$    _  $ /@ ' #T "P ]  X
M/  1 #P %@ \ !H .@ ? #D )  X "D -P N #8 ,P U #H - !! #, 20 R
M %, ,0!> #  :P O 'L +@". "T H@ M +@ +0#= "T ^  N /\ <P$  &0%
M  !7!P  30@  $8(  ! "   .P<  #@%   W P  -@ $ #4 "  T  P -  /
M #0 $@ S !8 ,@ ; #$ (  P "0 +P I "X +P M #8 +  ] "L 10 J $\
M*0!: "@ 9P G '< )@") "8 G0 E +, )0#/ "4 \  F /\ ;08  %X)  !2
M"P  2 P  $ ,   Z"P  -@L  #(*   P"   +@8" "X#!@ M  H +  - "P
M$  K !, *@ 7 "D '  H "  )P E "8 *P E #( )  Y ", 0@ B $L (@!7
M "$ 9  @ ', 'P"% !\ F0 > *X '@#' !X Z0 ? /H : D  %D,  !-#0
M0PX  #P.   V#@  ,0T  "T-   J#   * L  "<)!  F!@@ )@0+ "4##@ D
M 1  ) $4 "(!&  A 1T (0 B "  *  ? "X '@$V !T!/P < 4D &P%4 !H!
M80 : 7  &0&" !@ E@ 8 *H & #! !@ X0 8 /0 8PP  %4.  !)#P  0!
M #@0   R$   +0\  "D.   F#@  (PT  "(, P @"P8 ( D) !\'#  >!@X
M'@41 !P%%0 ;!1H &@4? !H%)0 9!2L & 4S !<&/  6!D8 %@92 !4'7P 4
M!VX $P>  !('E  2!J< $@6\ !($V0 2 ^\ 7PX  %$/  !&$   /!$  #41
M   O$0  *A$  "80   B$   ( \  !T. @ <#04 &@T' !H+"@ 9"@T & D0
M !<)$@ 6"1< %0D< !0)(@ 4"BD $PHQ !(*.@ 2"T4 $0M1 ! ,7P /#&X
M#@R   X,E  -"Z< #0NZ  T*T@ -"NH 7 \  $X1  !#$@  .A,  #(3   L
M$P  )Q(  ",1   ?$0  '!   !H0 @ 8#P0 %@X' !4."0 4#0L $PP- !(,
M$  2#!0 $0P: !$-(  0#2@ #PTP  X..P -#D8 #0Y1  P/7@ +#VT "@]_
M  D/DP )#Z8 " ZY  @.T  '#N@ 6!$  $L2  ! $P  -Q0  # 4   I%
M)10  "$3   =$@  &A(  !<1 @ 5$04 $Q ' !(0"0 1#PH $ X,  X.#@ .
M#Q( #1 8  T0'@ ,$"4 #! M  L1-@ *$4$ "1%-  @26@ '$FH !A)\  42
MD  $$J0  Q&X  ,1SP "$>@ 51(  $D4   ^%0  -18  "T6   G%@  (A4
M !X4   ;%   &!,  !42 P 3$@4 $A$' ! 1"0 /$0H #1$+  P2#@ +$A$
M"A(5  D3&P )$R( "!,J  <4,P %%#X !!5*  ,56  "%6<  15Z   5C@
M%:,  !2W   4SP  $^D 4A0  $86   [%P  ,A<  "L7   E%P  (18  !P6
M   9%0  %A0! !03!  2$P8 $1((  \2"  .$PD #!0*  H5#0 (%A  !A83
M  46&0 $%Q\  Q<G  (8,  !&#L  !E'   950  &60  !EW   9C   &*(
M !BW   7SP  %^H 3Q8  $,8   Y&0  ,!D  "D9   C&0  'Q@  !L7   8
M%@  %14" !,5!0 1% 8 $!0&  X5!P ,%@@ "A<*  <9#  $&@X  AL2  $;
M%@  &QT  !PD   <+0  '#@  !U$   =4@  '6(  !UU   =B@  '*   !RV
M   ;T   &NL 3!@  $ :   V&P  +1L  "8;   A&@  '1D  !D9   7&
M%!<# !(6!  0%P0 #A<$  P9!0 *&@< !QP)  ,="P  'PT  " 0   @%
M(1H  "$B   A*@  (34  ")!   B3P  (E\  ")R   AB   (9\  ""V   ?
MT0  '^T 2!H  #T<   S'0  *QT  "0=   @'   '!L  !@:   6&0$ $QD!
M !$9 0 .&@$ #!P"  H= P ''P4  R$(   B"@  ) P  "8.   F$@  )A@
M "<?   G)P  )S(  "<^   G2P  )UP  "=N   FA0  )IT  "6T   DT0
M(^X 1!T  #D?   P'P  *!\  ",>   >'0  &QP  !@;   4'   $1P   X=
M   -'P  "B$   8B 0 #) 0  "8&   H"   *@L  "L-   M$   +14  "T<
M   M)   +BX  "XZ   N2   +5@  "UJ   M@0  +)H  "NR   JT   *>\
M0"   #8A   M(0  )B$  "$@   ='P  &AX  !8>   2'P  #R$   TB   *
M)   !B8   (H    *P(  "T$   O!@  , D  #(,   T#@  -1(  #48   U
M(   -2H  #4V   U0P  -5,  #1F   T?   ,Y8  #*O   QS0  ,.\ /",
M #(D   J)   )",  " B   <(0  %R$  !,C   0)0  #2<   DI   %*P
M 2X    P    ,@   #0!   V!   . 8  #H)   \#0  /A   #X4   ^'
M/B8  #XQ   ^/P  /4X  #UA   \=P  .Y$  #JK   YR0  ..T -R<  "\G
M   H)@  (R4  !\D   9)0  %"8  ! H   -*P  "2X   4P    ,P   #4
M   X    .@   #P    ^ 0  0 ,  $('  !$"@  1@T  $D1  !)%P  2"$
M $@L  !'.@  1TD  $9;  !%<0  1(L  $.E  !"PP  0>@ -"H  "PJ   G
M*   (B<  !PH   6*@  $2T   TP   ),P   S8    Y    /    #X   !!
M    0P   $8   !(    2@   $P#  !.!@  4 H  %,.  !4$P  5!P  %,G
M  !3-   4T,  %)5  !1:@  4(,  $^>  !-N0  3.  ,"T  "LL   F*P
M'RP  !@N   2,@  #34   @Y   "/0   $    !#    1@   $D   !,
M3@   %$   !3    50   %<   !9 0  7 8  %\*  !B#@  8Q4  &,?  !B
M+   83P  &!.  !?8@  7GL  %R6  !;L   6<\ +S   "HO   B,   &C,
M !,W   ..P  "#\   %$    2    $P   !/    4@   %4   !8    6P
M %T   !@    8@   &0   !F    :0   &T%  !P"P  =!   '08  !S)0
M<C0  ')%  !P60  ;W$  &V+  !KI@  :L  +C,  "4U   =.   %#P   Y!
M   '1P   $P   !1    50   %D   !=    80   &4   !H    :P   &T
M  !O    <@   '0   !W    >@   'X   ""!   A@L  (H1  ")'   B"L
M (8]  "$4@  @V<  (&!  !_FP  ?K( *3H  " ]   60@  #T@   A.
M5    %H   !@    9    &D   !N    <@   '8   !Z    ?0   (    ""
M    A0   (@   "+    C@   )(   "6    FP,  * ,  "B$P  H"$  )\S
M  "=1P  FEX  )AW  "7CP  E:< (T,  !E(   13@  "54   !<    8P
M &H   !Q    =@   'L   "     A@   (H   ".    D0   ),   "6
MF0   )P   "@    HP   *<   "K    L    +8$  "\#0  NA<  +DH  "W
M/   M%(  +)J  "OA0  K9P '$X  !-4   +7    60   !L    =    'P
M  "#    B0   (\   "4    F@   )\   "B    I    *<   "J    K@
M +$   "T    N    +P   #!    QP   ,T   #4!0  V!   -4>  #3,0
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M__________________________________________\
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M_/W^_VUF=#$      P0A   !                     0
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MA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VO?
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MQ\S-"0S+TPHMQ]0*6;+8"X">S2N:F,%0JY:X9[>5M76\E+1^OI2SA;^0LH7
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MFW^YP)N(O;Z9B<"\E8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+.
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M@*6/TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]*
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ME*^$PY"OA<2-KH7%BJZ&QHBMAL:'K8?&A:V(QX.MB<>!K8O'@*R+QX"LB\>
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M'DZ-^B];AO(_9X#K3G%[Y5MY=N!E@''=;(1NVG*(:]EWBVG7>HUGUGZ.9M6
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M#$FI]!1EF>8E>([<.8:(U$^0AL]@EX3,;9R#R76@?\=XHGW&>Z1ZQ7VF><2
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MJK!YPZ>MA,>?JH3+F*B#S9"GA-")I8;2A*2*TX"DD--_I9?2?Z:@T'^EILZ
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MQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZP7VAN\%[I+O >J>[P'FJO,!XKKS
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ME)O3>IB?T7B<HM!WGZ3.=:*FS72FJ,URJ:G,<:VJS'"RJ\MPMJO+;[RKR'#
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M)"J4_S YBO\Z18'_1D]Z_5%8<OA87FOU7F-E\F5H8.]L:UWM<FY:ZWEP5^J
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MKRD1^KLI$^S(+!/>V#<0T^%!'LG?23"\VE%$K]-85J'-7V:4R&5TB,1L@'S
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M.B[_P#LN_],[+?_K/"W_ZSPM_^L\+?_K/"W_ZSPM_^L\+?_K/+BP  "HO
MFLD  (S9  "!]0, >?\0 6[_%@-E_Q\&7O\G"U?_, ]1_S<32_\^%T;_11E!
M_TP;/?]2'3G_6!\V_U\A-/]F(C'_;B0O_W<E+?^ )BO_C"@I_Y<I*/^B*B?_
MK2LF_[DL)O_)+2;_R2TF_\DM)O_)+2;_R2TF_\DM)O_)+:JW  ":Q0  B],
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M3D+F^T]#W?M11-3\4T7/_%1%S_Q41<_\5$7/_%1%S_Q41<_\5.&5  #+I@
MN[   *Z[ 0"BR ( F-4% )#X#P&)^" $@O@N"WGY-Q-P^3\;:/E&(F#Z32A:
M^E0M5/I<,4_[935+^VTX1_QW.T/\@ST__9 _//V?03K^KT,X_\9$-__J13;\
M_44[\O]$/NK_1#[F_T8^YO]&/N;_1C[F_T8^YO]&/N;_1M"?  "]K   KK4
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M'QO_\!\;__ ?&__P'QO_\!\;__ ?&__P'Z2U  "5P@  AL\  '?>  !K]
M8O\# %G_"P%1_Q$!2O\7 D3_'P,__R8$.O\M!3;_- 8R_SH'+O] ""O_1@@H
M_TP))?]2"2+_60H@_V(+'?]K#!K_=@T7_X0.%?^2#Q3_H! 3_ZT1$_^Z$1/_
MPQ(3_\,2$__#$A/_PQ(3_\,2$__#$I>^  "&S   =]L  &GG  !<_0  5/\
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M45X>_T]J)?]-=RO_2H,O_TB.,_]&F#;_1*$X_T.I.O]"L#S_0K@]_T'!/O]
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M7TZQ]F!1JO9@4Z7V8%6A]F!5H?9@5:'V8%6A]F!5H?9@5:'V8/]W" #KC
MTYL  ,:H @"[L0( LKL" *K'!@"BTPH G=8: 976+ :,U#H1@])&'7K03R=R
MSE@Q:LU@.&3+:#]>RG)%6,I\253)B$U/R9513,FE4TK)N51)RMQ31\CW54C
M_%A*N/M93++[6DZM^EI.K?I:3JWZ6DZM^EI.K?I:3JWZ6O]_  #<DP  RJ(
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M-CGE_S@YY?\X.>7_.#GE_S@YY?\X.>7_.,B>  "VJ0  J+(  )N]  "/R
M@]0  'GH!P!S_!(!:_T= F3])P1>_C$(6/X[#5/_0Q%-_TL52?]3&$7_6AI!
M_V,=/O]L'SO_=B$W_X(C-/^0)3+_GR<P_[ H+O_(*2W_ZBHL__\J+/__*B_Y
M_RHO^?\J+_G_*B_Y_RHO^?\J+_G_*KFF  "JK@  G+D  ([%  "!T0  ==X
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M"0W_TPD-_],)#?_3"9&\  "!R0  <M<  &3D  !4ZP  2_\  $3_   ]_P0
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M\E24//!2G3_N4:9![%"O0^I/ND3H3L=$YD_=1>%/[D7=3OM(U$__2<A1_TK
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M7UZ0^%YAC/E<8XKZ6V2'^UIEAOM998;[666&^UEEAOM998;[6?]F#0#_=P,
MXX<  -.3 0#*G@0 PJ<$ +NO! "UM@T KK<A J6V,@F=LS\5E+!*((RM4RN$
MJELT?:AC/':E:D-PHW)*:J%[3V6@AE1@GI%86YV?6UB=L%U6G<==5IWK7%>:
M^EM:E?I:7)'[65Z._%A?C?Q77XW\5U^-_%=?C?Q77XW\5_]J"@#_?   W(P
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M2TFM_TQ*J_],2JO_3$JK_TQ*J_],2JO_3.E_  #1D   PIX  +6G  "JKP
MH+@  );! @",RP< A-4- (#5'@%YU2X%<M0\#&S31Q1ETE ;7]%9(5K18B=5
MT&LL4=!U,$W/@31)SXXW1L^=.430KCM"T,8[0]#J.D#-_3X^R_] 0,/_0D&]
M_T-"N?]$0KG_1$*Y_T1"N?]$0KG_1-V(  #'F   N*,  *NK  "@M   E;X
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M'2KW_QTJ]_\=*O?_';.C  "DJP  E[8  (G!  ![RP  ;]8  &/?  !;]08
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M56YZ_%-O>?]1<'?_3W%V_TUQ=?],<77_3'%U_TQQ=?],<77_3/];#@#_:00
M]G<  -V"  #0BP, R9,% ,29!@"^GA  MI\D JZ=- BFFD$3GY9,'9B352>1
MD%XOBXUE-X6*;3V B'5#>X5^2':#B$QR@I-0;H"@4VM_KE5H?\)69W_C56B
M^E-I?O]1:GS_3VM[_TUL>?],;'G_3&QY_TQL>?],;'G_3/]># #_; $ YGH
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M3%F-_TM;BO]*6XK_2EN*_TI;BO]*6XK_2O]H  #E>0  T8<  ,62  "[G
ML:(  *FI  "AL0( F[,5 )6S* *.LC8)AK!"$G^N3!MXK%0C<JI<*FRH9#%G
MIVPV8J5U.UVD?T!9HXI#5:*71U&AITE/H;I*3J+924Z@]4E.G_])4)G_25*6
M_TA4DO]'5)+_1U22_T=4DO]'5)+_1_]N  #>?P  RHT  +Z8  "SH   JJ<
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M-SVX_S<]N/\W/;C_-]&&  # E0  LI\  *6G  ":KP  CK<  (._  !XQP,
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M":*G  "3L0  A;L  ';&  !IT   6]H  $[@  !#Y0  /OL! #K_#  V_Q,
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M1W]G^$5^:/]#?FC_07UG_S]\9_\^?&?_/7QG_SU\9_\]?&?_/?]2#@#_70,
M_6D  .%R  #6>@( SG\% ,J#" #%AA( O(<F ;6&-@:N@T,/IX!.&*%\6"";
M>6 GEG=I+9)T<#..<GDWBG"!/(9NBS^#;95#?VRA17QKKD=Z:[](>&O=2'AL
M]D9X;/]$=VS_0G=K_T!W:O\_=VK_/G=J_SYW:O\^=VK_/O]4# #_7P  \FP
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M0V=X_T%H=O\_:';_/VAV_S]H=O\_:';_/_];! #W:0  W78  ,V   ##B
MNXX  +23 0"MEPD IY@: *"8+ .9ECH*DI1%$HR23QJ&CU<B@(U?*'N+9RYV
MB6\S<H=W.&V%@3QIA(M 9H*70V*!I49@@;9'7H'-1UZ![T9?@?]$8'__0F%]
M_T%B>_\_8WK_/V-Z_S]C>O\_8WK_/_]>  #I;0  UGD  ,B$  "^C   MI,
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M.U"/_SM0C_\[4(__.^MM  #3?   PXD  +>3  "LF@  HI\  )FE  ".JP
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M(;Z/  "OF@  HJ$  ):I  "*L   ?;@  '&_  !FQ@  6\P" %#2!P!'V@P
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M Q7_LP04_],$%/[T!!/\_P,3^O\#$_G_ Q/Y_P,3^?\#$_G_ YVE  "/K@
M@+@  '+"  !DRP  5M,  $G:   ^WP  -.0  "[T   K_PH */\0 "7_%P B
M_Q\ '_\F !S_+0 9_S0 %_\\ !3_1 $2_TX!$/]9 0[_9P$,_W<!"_^* @K_
MGP()_[4""/_5 @?_] ('__\"!___ @?__P('__\"!___ I&M  ""N   <\(
M &3,  !6U0  2-T  #OB   PYP  )^X  "/_   @_P0 '/\, !G_$0 6_Q8
M$_\; !'_(0 ._R< #?\N  K_-@ '_SX !/](  #_5   _V(! /]S 0#_AP$
M_YT! /^R 0#_R@$ _^H! /_S 0#_\P$ __,! /_S 82W  !TP0  9<P  %;8
M  !'WP  .>4  "WJ   C[@  '/T  !C_   5_P  $?\$  __"P -_PX "?\1
M  ;_%0 #_QH  /\@  #_)@  _RX  /\W  #_00  _TT  /]<  #_;0  _X(
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MX#O"%M\[TA;:.^@7U#KV&M Z_QS-.O\>RSK_'LHZ_Q_$._\?P#S_'L \_Q[
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M-)-5]C.25?\RD5;_,8]6_S"-5O\NC%?_+8Q7_RV,5_\MC%?_+?])#@#_404
M_UH! .YB  #?9P, V&H& -5K"@#-;14 Q6XI ;YM.02W:T<+L6A2$:QF7!BH
M9&4=I&)M(J%@=2:>7GXIFUV&+9A<CR^56IDRDUFD-)!9L#:.6< VC%G;-XI9
M\S:)6O\TB%O_,X=;_S&&6_\PA5O_+X5;_R^%6_\OA5O_+_]+# #_5   ^UX
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M-G-H_S5S9_\S<V;_,G-F_S)S9O\R<V;_,O]1! #_7   XF<  -)P  #'=@
MP'H  +I] @"T?PP K8$= *>!+@*@?SP(FGU'#Y5Z41:0>%H<BW9B(8=T:2:#
M<G$K?W%Z+WQO@S)X;HTU=6V8.')LI3MP:[0\;FO)/&UKZ3MM;/XY;6S_-VYL
M_S5N:_\T;FK_,FYJ_S)N:O\R;FK_,O]3  #T7P  WFH  ,US  ##>@  NWX
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MC ( G(X4 )>/)@&1CC0%BXQ "X6*2A& B%,8>X9;'7:%8R)R@VHG;H)R*VJ
M>R]G?X8S8WZ1-F!]GCE=?*XZ6WS!.UM\XSI;?/HX7'O_-UU[_S5>>?\T7W?_
M,U]W_S-?=_\S7W?_,_Y<  #A:@  S74  ,!^  "VA@  KHL  *6.  ";D0
ME9,1 )"4(@&+DS$#A9(]"7^12 ]ZCU$6=8U9&W&,8"!LBF@E:(EP*62'>2UA
MAH,Q786/-%J$G#97@ZPX58._.56#X3A5@ODW5H+_-5:!_S18?_\S67W_,EE]
M_S)9??\R67W_,N]@  #;;@  QWH  +N#  "RBP  J)   )^3  "4E@  C9D.
M (F:'@"$FBX"?IDZ!WF710UTEDX3;Y56&&J37AUFDF4A8I%M)EZ/=BI;CH$M
M5XV-,%2,FC-1C*HU3XR]-4^,WC5/B_<T3XK_,U")_S)1AO\Q4H3_,5*$_S%2
MA/\Q4H3_,>IE  #2<P  PG\  +:(  "LD   HI0  )B8  ",G   A)\* ("@
M&0!\H2D!=Z V!7*?00IMGDL/:)U3%&2<6QE@FV,=7)IK(5B9="55F'XI49>*
M+$Z6F"Y+EJ@P2I:\,4F6W#!)E/8P29/_,$F2_S!*D/\O2XW_+TN-_R]+C?\O
M2XW_+^)K  #*>0  O(4  +&/  "FE   FYD  )&=  "&H@  >J8# ':G$P!S
MJ"0 ;J@R VJH/09EIT<+8:90#UVE6!19I& 85:-H'%*C<1].HGPC2Z&()DBA
MEBA%H*8J1*&Z*T.AVBI#G_4K0IW_*T*<_RQ"F_\L1)?_*T27_RM$E_\K1)?_
M*]=R  ##@   MHP  *J4  "?F0  E)X  (FC  !^J   <*X  &JP#@!HL1T
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M#S#(TP\PQO00+L3_$RW"_Q4LP?\6*\#_%RO _Q<KP/\7*\#_%[B-  "JEP
MGIX  )&E  "$K   >+(  &NY  !@OP  5,,  $K( @! S0< .M(. #G2&P X
MTR@ -],U #;40  TU4L!,]55 3'68 (OUFP#+==Z!"O8BP4JV)T%*-FQ!B?:
MS08GU^\&)M3_"272_PLDT?\,(]#_#2/0_PTCT/\-(]#_#:Z6  "@G0  E*0
M (:L  !YM   ;+L  &#"  !4Q@  2,L  #[0   UU00 +=T* "SA$P KXA\
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M  #_\   __\  /__  #__P  __\  /__ (VK  !]M0  ;K\  &#(  !2T
M0]<  #?=   KX@  (N8  !GJ   5^0  $O\  !#_"  ._PX #/\1  G_%@ &
M_QP  _\B  #_*@  _S,  /\]  #_20  _U<  /]I  #_?@  _Y4  /^L  #_
MQP  _^@  /_Z  #_^@  __H  /_Z ("U  !POP  8<D  %+3  !#VP  ->$
M "GF   >Z@  %>X  !#X   ._P  "_\   C_   $_P8  /\*  #_#@  _Q$
M /\5  #_&P  _R,  /\K  #_-@  _T,  /]3  #_90  _WH  /^1  #_I@
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M&J]!]QRM0?\=JT'_':E!_QRI0?\<ID'_&Z5!_QNE0?\;I4'_&_\]$ #_0@D
M_T@% /]-" #_4 L ^5$/ .M0%0#A3R  V% Q ,]000+)3TX%Q$Y:"<!,9 V]
M2VT0NDIV$[=)?A6U2(<7LT>/&;%'EQNO1J <K4:J'JM%MA^I1<8?IT;@(*1&
M]""A1O\AGT?_()Y'_R">1_\?FT?_'II'_QZ:1_\>FD?_'O] #0#_1@0 _TP
M /A2 @#H500 X54( .)5#0#551D S%<L ,57/ *_5DH&NE55"K937PZR4F@2
MKU!Q%:Q/>1BJ3H$:J$V*':5,DA^C3)P@H4NF(I]+L2.=2\ DFTO8)9E+\"66
M3/\DE4S_))1,_R.33/\BD4W_(9%-_R&13?\AD4W_(?]""@#_20  _U$  .97
M  #=6P$ U5P% -);"0#+7!0 PUXH +Q>. *V748&L5M1"JU96P^I6&03IE9L
M%Z-5=!J@5'T=GE.%'YM2CB*949<DEU"A)I50K2>24+PHD5#0*(Y0["B-4?XG
MBU'_)HM1_R6*4O\DB5+_(XA2_R.(4O\CB%+_(_]%!P#_2P  \%4  -];  #3
M8   S&$# ,AA!@##81$ NV0D +5D- *O8T(%JF%."J5?5P^A76 4GEQH&)M;
M<!N867@>E5B!(9-7BB205I,FCE6>*(M5J2J)5+<KAU3+*X55Z2N$5?PJ@U;_
M*(-6_R>"5O\E@5;_)(%6_R2!5O\D@5;_)/]' P#_3P  YU@  -E@  #-9
MQF8! ,%F! "[9@X M&D@ *YI,0*H:#\%HV9*"I]E5 ^:8UT4EV%E&)-@;1R0
M7G4?CEU](HM<AB6(6Y HA5J:*H-9IBR 6;0M?UG'+GU9YBU\6OHL>UK_*GM;
M_RA[6_\G>UK_)GI:_R5Z6O\E>EK_)?])  #[4@  XUP  -)C  #':   P&L
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M*&IF_R=J9O\G:F;_)_]0  #G6P  TV8  ,5N  "[<P  LW<  *MY  "D> ,
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M(#^:R" _F>L?/YC_(#Z6_R$^E?\A/Y3_(3^4_R$_E/\A/Y3_(<UP  "\?0
ML(@  *2/  "9E   CI@  (.=  !WH   ::0  &"G" !=J!0 6ZDD %FI,0%6
MJ3P"4ZE%!%"H3@9-J%<)2JA?#$>G: Y$IW,10:9_%#ZFC18\IIT7.J:O&#FF
MQQ@YI>H8.*/_&C>A_QLWH/\<-Y__'#>?_QPWG_\<-Y__',1X  "UA0  J8\
M )V5  "2F@  AI\  'JC  !NJ   8JP  %6P  !0L@X 3K(; $VS* !+LS4
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M Q[+_P0>RO\%'<G_!AW)_P8=R?\&'<G_!JB4  "<F@  D*$  (*H  !TKP
M9[8  %N\  !.P   0\,  #G'   OS   )] $ !_6"@ ;VA  &]L: !K;)@ :
MW#$ &=T\ !C=2  8WE4 %]]B !;@<@ 5X(4 %.&: !/BL0 2X\\ $N#T !+>
M_P$1W?\!$=O_ A';_P(1V_\"$=O_ IZ:  "2H0  A*D  ':Q  !HN   6[\
M $[$  !"R   -\P  "W0   DU0  '-L  !7?!0 4Z0X $NH4 !'K'0 0ZR8
M#NPP  [M.@ -[D8 "^Y3  KO8@ )\'0 "/&)  ?RH  %\KH !/'D  +Q_0 "
M[_\  ^W_  /M_P #[?\  ^W_ )6A  "&J0  >+(  &FZ  !;P@  3<@  $#,
M   TT0  *M8  "';   9X   $N0   _P 0 -^0H "_H/  G[%0 '^QP !/PD
M  '\+   _#<  /Q"  #\4   _&$  /UU  #\C   _*0  /S!  #\ZP  _/\
M /W_  #]_P  _?\  /W_ (FI  !YL@  :KL  %S$  !.S   /]$  #+7   G
MW0  '>$  !7E   .Z   "O$   C]   %_P,  ?\)  #_#@  _Q(  /\7  #_
M'P  _R<  /\Q  #_/@  _TT  /]?  #_=0  _XT  /^F  #_P@  _^<  /_\
M  #__P  __\  /__ 'RS  !LO   7<8  $[/   _U@  ,=T  "7B   :Y@
M$>H   SN   %\@   /\   #_    _P   /\   #_!0  _PH  /\.  #_$@
M_Q@  /\A  #_*P  _SD  /]*  #_70  _W,  /^,  #_I   _[D  /_4  #_
MW@  _]X  /_> /\8+ #_&2D _QDH /\5*P#_$#  _PLX ?\#1 '_ %$!_P!>
M ?\ ; '_ '@!_P"" ?\ C '_ )0!_P"< /\ H@#_ *@ _P"O /\ M@#_ +X
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M ](D^07/)?\&S27_!\LE_PC*)?\(RB3_",HD_PC*)/\(RB3_"/\N% #_,1
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M-/\/L33_#[ T_Q"O-/\0KC3_#ZXT_P^N-/\/KC3_#_\U#@#_. < _SP" /]
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M%YA!_Q>80?\6ET'_%9=!_Q670?\5ET'_%?\[!@#_/P  ^48  .5+  #<3@
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M''96_QMV5O\;=E;_&_]%  #L3@  VE@  ,E>  "_8@  MV0  +%C  "K80@
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M(DYYPR)->.4B37?[(4YW_Q].=O\>3W7_'4]U_QU/=?\=3W7_'=]<  #(:
MN7(  *YZ  "E@   FH(  (Z"  " @P  >84" '2&$0!QB"  ;H@N 6J(.0)G
MAT,%8X=,"&"&4PM=A5L.6H1C$5>$:Q14@W4748* &DZ!C1Q+@9L>28&L'TB
MP2!'@.,?1W_Z'DA^_QY(??\=27S_'$E\_QQ)?/\<27S_'-9A  #";@  M'@
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M$#.<_Q(SFO\2,YG_$S.9_Q,SF?\3,YG_$[UW  "O@P  HXL  )B1  "-E0
M@9D  '.<  !GGP  6Z(  $^F  !'J0@ 1*H2 $.J'P!!JRL 0*LW #^L00 ]
MK$H!.ZQ3 CFL7 ,WK&<$-:QS!3*L@08PK)$'+JRC""VLN DLK-D(+*KU"BNH
M_PLJIO\,*J7_#2JE_PTJI?\-*J7_#;6   "HBP  G)$  )&6  "%G   >*
M &NE  !?J   4ZP  $BO   ]L@  -K4+ #2U%0 SMB$ ,K8L #&W-P PMT$
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M  O2_P$+TO\!"]+_ 9J8  ".GP  @*8  '*M  !DM   5[H  $F_   ]P@
M,L8  "C)   ?S0  %]$  !'6   ,VP4 "-X+  ;?$0 %WQH !. D  +A+@ !
MXCH  .-'  #D5@  Y&<  .5[  #FD@  YJH  .?(  #G\   Z/\  .C_  #H
M_P  Z/\  .C_ )&?  ""IP  =*\  &6W  !7O@  2<,  #S'   PRP  )<\
M !S4   4V0  #MT   GA   "Y0   .D&  #I#0  Z1$  .H8  #K(0  [2L
M .\W  #Q10  \E8  /-H  #S?@  ])<  /6P  #VT   ]_,  /?_  #W_P
M]_\  /?_ (6G  !VL   9K@  %C!  !*R   .\P  "[1   CU@  &=P  !'@
M   ,XP  !.<   #J    ]0   /0   #U!0  ]0L  /8/  #V%   ^!T  /HG
M  #\-   _T,  /]5  #_:0  _X$  /^:  #_L@  _\\  /_M  #_^0  __D
M /_Y 'BP  !HN@  6<,  $O+   [T0  +=@  "'=   6X@  #N8   CJ
M[0   /    #X    _P   /\   #_    _P   /\&  #_#   _Q   /\8  #_
M(@  _S   /]   #_4P  _VD  /^!  #_F0  _Z\  /_#  #_U0  _]4  /_5
M /\3* #_$R4 _Q$E /\-)P#_!BT _P U /\ 00#_ $\ _P!< /\ :0#_ '0
M_P!^ /\ B #_ )  _P"7 /\ G0#_ *0 _P"J /\ L #_ +< _P#  /\ S #_
M -\ _P#L /\ ^ #_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\6
M)0#_%B( _Q0A /\0(P#_"B@ _P P /\ /0#_ $L _P!8 /\ 9 #_ '  _P!Z
M /\ A #_ (P _P"3 /\ F@#_ *  _P"F /\ K0#_ +0 _P"\ /X R #] -D
M^P#I /H ]@#Y /\ ^ #_ /@ _P#X /\ ^ #_ /D _P#Y /\ ^0#_ /\:(@#_
M&AX _Q@= /\3'@#_#B( _PHL /\'.0#_ T8 _P!3 /\ 8 #_ &L _P!V /\
M?P#_ (@ _P"/ /\ E@#_ )T _P"C /X J0#\ +  ^@"Y /< Q #U -( \P#F
M /( ] #Q /\ \ #_ .\ _P#O /\ [P#_ /  _P#P /\ \ #_ /\>'0#_'AD
M_QP7 /\7& #_$QX _Q$H /\.- #_#$$ _PI. /\(6P#_!V8 _P9Q /\&>@#_
M!H, _@:+ /P&D@#Z!ID ^ :? /8&I@#T!JT \@:U / %P #M!<X ZP7D .D&
M\P#F"/\ Y0K_ .0+_P#D"_\!Y O_ >0+_P'D"_\!Y O_ ?\A& #_(1, _R 1
M /\;$@#_'!H _QHD /\6+P#_$SP _Q%) /\050#\#F$ ^0YK /8.=0#T#GX
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M!;8E_P6U)?\&M27_!K4E_P6U)?\%M27_!?\L#0#_+04 _RX! /\Q!0#_,0L
M_2\0 /$K& #G*24 WR@S -@H0@#1*D\ S2M: ,DK90''*VX!Q"QV L(L?@+
M+(8#OBR. [TLE@.[+)X$N2RG!+@LL06V++\%M2W1!;$MZ@:N+OL'JR[_"*DN
M_PBH+O\(J"W_"*@M_PBH+?\(J"W_"/\O" #_,0  _S4  /8W  #J-@( YS,(
M .0O#P#9+AL SS$L ,DS/ #$-$D P#55 ;PU7P*Z-6@"MS5P [4T> 2S-( %
ML32(!K TD :N-)D'K#2B"*LTK FI-+D)IS3*"J4UY0JA-?@+GS7_#)TU_PR=
M-?\+G#7_"YPU_PN<-?\+G#7_"_\S @#_-0  ]CH  .4^  #<0   U#T$ -(W
M"0#+.!4 PSHF +T]-@"X/D0!M#Y0 ;$]6@.N/6,$K#UK!:D\<P:G/'L(ICR#
M":0[BPJB.Y0+H#N=#)X[J V=.[0.FSO%#ID[X Z6._0/E#S_#Y(\_P^2//\.
MD3S_#9$\_PV1//\-D3S_#?\U  #_.0  ZD$  -U&  #01P  R48  ,9!!0#
M0!$ N4(A +-$,@"O14 !JT5+ J=%50.D1%X%H41F!Y]#;@B=0W8*FT)^"YE"
MA@V708\.E4&9#Y-!I!&10; 2D$' $HY!V1*+0?$2B4+_$HA"_Q&(0O\0AT+_
M$(="_P^'0O\/AT+_#_\X  #S/0  XT<  -),  #(3@  P$T  +M* @"V1PX
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M%/)#  #?3P  RU@  +U=  "S80  JV(  *)@  ";7   E5X0 )!@'P",82X
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M'%IBOQQ98M\<66+W&EIB_QE:8?\76V'_%EMA_Q5;8?\56V'_%>=-  #/60
MOV(  +-H  "I;0  GFT  )-K  "):0  @VL) ']M%0!\;B4 >&XR 75N/0)Q
M;D8$;FU/!VML5@EH;%X,96ME#V-J;1%@:78476F!%EMHC1A89YL:5F>J&U5G
MO1Q49]P<5&?V&E1F_QA59O\7567_%E9E_Q569?\55F7_%>)1  #*70  NV8
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M%D-Y_Q5#>/\41'?_%$1V_Q-$=O\31';_$\U?  "[:P  KG0  *1\  "7?@
MBGT  ']^  !R?P  9H,  &&$" !>AA, 7(<A %J'+@!8AS@!58=" E.'2@-0
MAU(%3H9:!TN&8@E)A6P+1H5W#4.$@P]!A)(1/X2B$CV$M1,\A,\3/(+P$CR!
M_Q(]@/\2/7__$CU^_Q$]?O\1/7[_$<5F  "U<0  JGL  )^"  "2@@  A8(
M 'F#  !MA@  7XH  %B- 0!4C@\ 4H\; %"/)P!/D#, 39 ] 4N010))D$X#
M1I!6!$2/7P5"CV@'/X]S"3V.@ LZCH\,.(Z@#3>.LPXVCLP.-HWO#C6+_PXU
MB?\/-8C_#S:'_P\VA_\/-H?_#[YM  "P>0  I8(  )F'  ",B   ?X@  '**
M  !FC0  6I$  %"5  !)EPD 1Y@3 $68( !$F2L 0YDV $&:0 ! FD@!/II1
M CR:6@(ZFF0#-YIO!369?08SF8P',9F=""^9L @NF<H(+ICM""Z6_PHME/\*
M+9/_"RV2_PLMDO\++9+_"[9U  "J@0  GH@  ).-  "&C@  >(\  &N2  !?
ME0  5)D  $F=  ! H   .J(- #BC%P WHR( -J0M #6D-P TI$$ ,Z5+ #&E
M5 $PI5X!+J5J 2RE> (JI8@#**6: R>EK00FI<8#)J3K!"6B_P4EH/\&))__
M!B2>_P<DGO\'))[_!Z]^  "CB   EXX  (V3  !^E0  <)@  &.;  !7GP
M3*(  $*F   XJ0  +ZP# "JN#@ IKA@ **\C ">O+0 FL#< );!! "2P2P C
ML58 (K%C "&Q<0 ?L8( 'K*4 1RRJ0$;LL$!&['G 1NO_@(:K?\"&JS_ QJK
M_P,:J_\#&JO_ ZB(  ";CP  D90  (2:  !VGP  :*(  %NE  !/J0  1*T
M #FP   OLP  )K8  !ZY!0 8NPX %[L6 !>\(  6O"H %;TU !2]0  3ODL
M$KY8 !*^9P 1OW@ $+^, !# H@ .P+H #L#A  ^]^P /O/\ $+K_ 1"Z_P$0
MNO\!$+K_ 9^/  "4E0  AYL  'FA  !KIP  7JP  %*Q  !%M   .K8  "^Y
M   EO   ';\  !7#   /Q@4 "\H-  G*%  (RAT !\HG  ?*,@ &RSX !<M+
M  3,6@ #S&H  LQ^  ',E   S*L  ,W(  #,[0  S/\  ,O_  '*_P !RO\
M <K_ )>6  "*G   ?*,  &ZJ  !@L   4K8  $6Y   YO   +K\  "/#   ;
MQ@  $\H   W-   (T0   =0)  #4#@  U14  -8>  #8)P  V3$  -L^  #<
M2P  W5L  -YN  #>A   WYL  -^T  #>V0  W_<  -__  #?_P  W_\  -__
M (V=  !_I0  <*P  &&S  !3N@  1;\  #C"   LQ@  (<D  !C-   0T0
M"]4   3:    W@   . !  #A"0  X@X  .03  #E&P  YR0  .DO  #K/
M[4L  .Y=  #N<0  [XD  /"B  #PO   \.,  ._Y  #P_P  \/\  /#_ (&E
M  !RK0  8[4  %2]  !&Q   -\@  "K,   ?T   %=4   [:   'W@   .(
M  #F    Z0   .H   #L    [@4  .\,  #Q$   \Q<  /4@  #X*P  ^SD
M /U*  #^7@  _W0  /^-  #_I@  _\   /_A  #_]0  __4  /_U '2N  !E
MMP  5L   $?(   XS0  *M(  !W8   3W0  #.(   /F    Z0   .P   #P
M    \P   /0   #V    ^    /H   #]!P  _PT  /\2  #_&P  _R@  /\W
M  #_2@  _UX  /]V  #_CP  _Z8  /^Z  #_T0  _]$  /_1 /\/) #_#B(
M_PLA /\#) #_ "D _P R /\ /@#_ $P _P!9 /\ 90#_ '  _P!Z /\ A #_
M (P _P"2 /\ F0#_ )\ _P"E /\ JP#_ +( _P"Z /\ Q0#_ -, _P#G /\
M] #_ /\ _@#_ /\ _P#^ /\ _@#_ /X _P#^ /\ _@#_ /\1(0#_$!X _PT=
M /\''P#_ ", _P M /\ .@#_ $@ _P!5 /\ 80#_ &P _P!V /\ ?P#_ (<
M_P". /\ E0#_ )L _P"A /\ IP#^ *X _0"V /P P #[ ,T ^0#B /@ \ #W
M /P ]@#_ /4 _P#U /\ ]0#_ /4 _P#U /\ ]0#_ /\5'0#_$QH _Q 9 /\+
M&0#_ !T _P I /\ -@#_ $, _P!0 /\ 7 #_ &< _P!Q /\ >@#^ (, _ "*
M /H D0#Y )< ^ "= /< HP#U *H ] "R /( NP#Q ,@ [P#< .X [ #M /H
MZP#_ .H _P#J /\ Z@#_ .H _P#J /\ Z@#_ /\8&0#_%A4 _Q,3 /\.$P#_
M"QH _P<D /\", #_ #X _P!+ /\ 5P#_ &( _ !L /@ =0#U 'X \@"% /$
MC #O ), [@"9 .P H #K *8 Z0"N .< MP#F ,, Y #4 .( Z0#A /< WP#_
M -T _P#= /\ W0#_ -T _P#= /\ W0#_ /\;$P#_&A  _Q8. /\2#@#_$A4
M_P\? /\,*P#_"3@ _P9% /L#40#W EP \@)F .X"< #J G@ YP*  .8#AP#D
M XX X@.5 .$#G #?!*, W02K -L$M #8!<  U@70 -,&YP#0"/@ S@K_ ,P+
M_P#+#/\ RPS_ ,L+_P#+"_\ RPO_ /\?$ #_'@L _QH' /\9"P#_&!$ _Q89
M /\2) #Z$#  \PX^ .X-2@#I#%8 Y0QA .(,:@#>#7, VPU[ -D-@P#6#8H
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M Z$F_P.A)O\#H2;_ _\I  #_*   ]BT  .<P  #?+P  V2L$ -8B"@#.(Q8
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M"O8V  #F0   T4@  ,--  "Y3@  L4T  *E)  "D108 GT83 )I((P"623(
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M$V90O!-E4-@39%#S$F10_Q!D4/\/9%#_#F5/_PUE3_\,94__#.Q!  #43
MPU0  +99  "L7   H%H  )=7  "15   BU4, (97&0"#6"< @%DT 'U9/P%Z
M64@#=UA0!'186 9R5U\';U=F"6U6;@MK5G<-:%6!#V95C1%D5)H28E2I$V!4
MNA1?5-,47E3R$UY4_Q%?5/\/7U3_#E]3_PU?4_\-7U/_#>=$  #/4   OU@
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M$D]A_Q%/8?\04&#_#E!@_PY08/\-4&#_#=E/  ##6@  M&,  *EI  ";:
MCV<  (1G  !Y90  <V<  &]I#@!L:AL :6LH &=L- !D;#T!8FQ& E]K3@1=
M:U8%6FI=!UAJ90E6:6X+4VEX#5%HA ].:)(03&>A$DMGLA))9\D226?K$DEF
M_Q!*9O\/2F7_#DME_PU+9/\-2V3_#=%4  "^7@  L6<  *9M  "7;   BFL
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M"CAX_PHX>/\*.'C_"KYD  "P;P  I7@  )9Y  "'>0  >WD  '!Z  !D?
M6(   %"#  !+A0H 2(84 $>'( !%B"L 1(@U $.(/@!!B4<!0(E/ 3Z(6 (\
MB&$#.HAL!#>(> 4UB(<&,XB8!S*'J@<PB, ',(?D!S"%^P@P@_\(,(+_"#"!
M_P@P@?\(,('_"+=K  "J=@  H'\  )!^  ""?@  =G\  &J   !>@P  4X<
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M :.&  "7C   C9$  'V2  !ME0  8)@  %2<  !(H   /J0  #2G   JJP
M(:X  !FQ   2LP< #[40  ZU%P .M2$ #;4K  VU-@ ,MD$ "[9.  JV7  )
MMFP "+9_  >VE  &MJH !;;%  :VZ@ 'M?\ "+3_  BS_P )LO\ ";+_ )J-
M  "0DP  A)@  '2<  !EH   5Z0  $NH  ! K   -;   "JS   AM0  &+@
M !&[   ,O@( !L +  + $0 !P1D  ,$B  #"*P  PC8  ,-"  ##4   Q%\
M ,1Q  #$AP  Q)T  ,2U  #$V@  Q/8  ,/_  ##_P  P_\  ,/_ ).4  "'
MF@  >*   &JF  !<K   3[$  $&U   UMP  *;H  !^]   6P   $,,   K&
M   #R@   ,P%  #,#   S1$  ,X8  #.(0  T"H  -$U  #30P  U%(  -1C
M  #5>   U8\  -6G  #6P@  UND  -;]  #6_P  UO\  -;_ (J;  ![H@
M;*D  %ZP  !0M@  0KH  #2]   HP0  '<0  !3'   -RP  !LX   #2
MUP   -D   #:!0  W L  -T0  #?%0  X1T  .,G  #E,P  YT(  .A4  #H
M9P  Z7X  .F7  #JKP  ZLX  .OO  #K_@  Z_\  .O_ 'VC  !NJP  7[(
M %&Z  !"P   -,,  "?'   ;RP  $L\   O3   "V    -T   #A    Y
M .4   #G    Z0   .L'  #M#0  [Q$  /$9  #T)   ]S$  /E!  #Z50
M^FH  /N$  #[G0  _+8  /S2  #][0  _?0  /WT '&L  !AM0  4KT  $3$
M   TR0  )LT  !K2   0V   "-T   #A    Y0   .@   #L    [P   /$
M  #S    ]0   /<   #Y 0  ^P@  /X.  #_%0  _R$  /\O  #_00  _U8
M /]M  #_AP  _Z   /^V  #_R@  _]0  /_4 /\+( #_!QX _P = /\ ( #_
M "4 _P N /\ .P#_ $D _P!6 /\ 8@#_ &T _P!V /\ ?P#_ (< _P". /\
ME #_ )H _P"@ /\ I@#_ *T _P"U /\ O@#_ ,L _P#A /\ \ #^ /T _0#_
M /T _P#] /\ _0#_ /P _P#Y /\ ^0#_ /\-'0#_"QH _P09 /\ &@#_ !\
M_P J /\ -P#_ $4 _P!1 /\ 7@#_ &@ _P!R /\ >@#_ (( _P") /\ D #_
M )8 _P"< /X H@#\ *D ^P"P /D N0#X ,8 ]@#9 /4 ZP#T /D \P#_ /(
M_P#S /\ \P#_ /, _P#S /\ \P#_ /\0&0#_#A4 _P@4 /\ % #_ !D _P E
M /\ ,@#_ $  _P!, /\ 60#_ &, _@!M /P =0#Z 'T ^0"$ /< BP#V )$
M] "7 /, G@#R *0 \ "L .X M #M ,  ZP#/ .D Y@#H /4 Y@#_ .< _P#F
M /\ Y0#_ .4 _P#E /\ Y0#_ /\2% #_$!  _PP/ /\#$ #_ !4 _P @ /\
M+ #_ #H _P!' /H 4P#W %X ] !G /$ < #O '@ [0!_ .L A@#J (P Z "3
M .< F0#E *  XP"G .$ L #? +H W0#) -L X #8 /  UP#^ -4 _P#4 /\
MTP#_ -, _P#3 /\ TP#_ /\5$ #_$@P _PX) /\+# #_"1( _P,: /\ )@#]
M #, ] !  .\ 30#K %@ Z !A .4 :@#B '( X !Z -X @ #< (< V@". -@
ME0#4 )P T@"C -  K #. +8 S #$ ,H V0#( .T QP#[ ,4 _P#$ ?\ PP'_
M ,0!_P#$ ?\ Q '_ /\8"P#_%04 _Q   /\0!@#_#PT _PP4 /P''P#Q RL
MYP Y .( 1@#> 5$ V@); -4"9 #2 VP SP-T ,T$>P#+!(( R@2) ,@%D #&
M!9@ Q 6@ ,(&J0#!!K0 OP;! +T(U0"[">P N O] +8,_P"U#?\ M W_ +0-
M_P"T#?\ M W_ /\;!0#_&   _Q<  /\6  #[$P8 ^A . .X,%@#C"2( V@DP
M -,*/@#."TH R@Q5 ,<-7@#%#6< P@YO ,$.=@"_#GX O0^% +P/C0"Z$)4
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M O\F  #R*0  XS$  -(T  #(-   P#   +LI @"X(PX L28< *PH*P"H*C@
MI"M$ *$L3@"?+5< G2U? )LM9P&9+6X!F"YU 98N?0*4+H8"DRZ0 I$NF@./
M+J8#C2ZS XPNQ0.*+^$$AR_V!(4O_P2$+_\#A"__ X,O_P.#+_\#@R__ _LI
M  #K,0  V3@  ,D\  "_/   MCD  + R  "L+0L IR\7 *(Q)@">,S0 FC1
M )@U2@"5-5, DS5; 9$U8@&/-6D"C35Q HPU>0.*-8(#B#6+!(8UE@2$-:(%
M@C6O!8$UP 9_-MP&?3;T!GLV_P5[-O\%>C;_!'HV_P1Z-?\$>C7_!/4M  #D
M-P  T#\  ,)#  "W1   K4   *<Z  "C-@8 G3<3 )DY(@"5.B\ DCP[ (\\
M1@",/$\!BCQ7 8@\7@*&/&4"A#QM X(\=02 /'T$?SR'!7T\D@9[.YX'>3NL
M!W<[O AV/-4(=#SQ"',\_P=R//\&<CS_!7(\_P5R._\%<CO_!?$R  #>/0
MR40  +Q(  "P20  ID8  )]!  ";/0$ E3T0 )$_'0"-02L BD(X (=#0@"$
M0TL!@D-3 8!#6P)^0F(#?$)I!'I"<05X0GH&=D&$!W1!CPAR09L(<$&I"6]!
MN0IM0= *;$'N"6M"_PAJ0O\':D'_!FI!_P9J0?\%:D'_!>TW  #60@  Q$D
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M#%A/_0M83_\)64__"%E._P=93O\'64[_!]]#  #'30  N%0  *Q9  "=5P
MD54  (A4  "!4   >U($ '=3$0!T5!X <54K &]6-@!L5D !:E9( 6A64 )F
M5E<#9%9>!&)59@5@56\'755X"%M4A I95)$+5U2@#%53L U44\4-4U/F#%-3
M_ M34_\)5%+_"%12_PA44O\'5%+_!]I&  ##4   M5@  *A;  "96@  C5@
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M"$5?_P=%7_\'15__!\A2  "X7   JV0  )MD  ",8P  @&,  '9C  !J8@
M8V0  %]F!@!;9Q$ 66@= %=I*0!6:C, 5&H\ %)J10%0:DP!3FI4 DQJ7 -*
M:F4$2&EO!49I>@=$:8@(0FB8"4!HJ0H_:+T*/FC>"3YG]PD^9O\(/V7_!S]E
M_P<_9/\'/V3_!\-7  "S80  IVD  )9H  "'9P  >V<  '%G  !E:   7&H
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M [%J  "E=   E78  (5U  !X=0  ;74  &%W  !7>@  3'X  $.!   [A0
M-8@) #*)$0 QB1L ,(DE "^*+P NBC@ +8M! "R+2@ JBU0 *8M? "B+:P F
MBWH!)(N+ 2.+G@$BB[,!(8S. 2&*\0$@B/\"((;_ B"%_P(AA?\"(87_ JMR
M  "A?   CWL  (!Z  !S>@  9GP  %M_  !0@@  1H8  #R*   TC0  +)$
M ":3#  DE!, (Y0< "*5)@ AE2\ ()4X !^60@ >EDP '998 !R69  :EW0
M&9>& !B7F0 7EZX %9?) !:5[@ 6D_\!%I+_ 1:1_P$6D/\!%I#_ :5[  "9
M@P  B8$  'N   !L@@  7X0  %2(  !)BP  /Y   #64   MEP  )9H  !V>
M 0 6H P %*$2 !2A&P 3H24 $J$N !&B.  1HD, $*)/  ^B7  .HVL #:-]
M  VCD@ ,HZ< "J+   NBY@ ,H/X #9__  V>_P -G?\ #9W_ )Z$  "2B0
M@X@  '.(  !EBP  6(X  $R2  !!EP  -YL  "Z>   DH@  '*4  !6H   /
MJP0 "JX,  >M$@ &K1L !:TD  2N+@ "KCD  :Y%  "N4@  KF$  *YS  "N
MAP  KIT  *ZT  "NU0  K?0  *W_  "L_P  J_\  *O_ ):+  ",D   >Y
M &N2  !=E@  4)H  $2?   YHP  +Z<  "6K   <K@  %+$   ZT   )MP
M ;@)  "X#@  N10  +D<  "Z)0  NB\  +LZ  "\1P  O%8  +QG  "\>P
MO)$  +RI  "\Q   O.L  +O^  "[_P  N_\  +O_ )"2  "#F   <YL  &.?
M  !5HP  1Z@  #NM   PL0  );0  !NW   2N@  #+T   6_    PP   ,0"
M  #%"@  Q0X  ,84  #'&P  R"0  ,HN  #,.@  S4D  ,U9  #-;   SH,
M ,Z;  #-M0  SMH  ,[V  #-_P  S?\  ,W_ (:9  !WH   ::8  %JL  !,
ML@  /K8  #"Y   DO   &;\  !'"   *Q0   LD   #,    T    -$   #2
M 0  TP@  -4-  #7$0  VA@  -PA  #?+   X3H  .)*  #C70  Y'(  .2+
M  #EI0  Y<   .7F  #E^   Y?\  .7_ 'JA  !KJ0  7*\  $VV   _O
M,+\  "/#   7QP  #\H   ?.    T0   -8   #<    WP   .    #B
MY    .8#  #H"0  Z0X  .P5  #N'@  \2L  /0Z  #U30  ]F$  /=Y  #X
MDP  ^*T  /G&  #YY   ^?,  /GS &VJ  !>L@  3[H  $#!   QQ0  (LD
M !;.   -T@  !-@   #=    X0   .0   #H    ZP   .T   #O    \0
M /,   #V    ^ ,  /H+  #]$0  _QL  /\I  #_.P  _T\  /]F  #_?P
M_YD  /^O  #_PP  _]8  /_6 /\$' #_ !D _P 9 /\ ' #_ "( _P K /\
M. #_ $8 _P!3 /\ 7@#_ &D _P!R /\ >@#_ (( _P") /\ CP#_ )4 _P";
M /\ H0#_ *@ _P"O /\ N0#_ ,4 _P#9 /X [ #] /L ^P#_ /L _P#[ /\
M^@#_ /0 _P#P /\ \ #_ /\'& #_ 14 _P 4 /\ %@#_ !L _P F /\ - #_
M $( _P!. /\ 6@#_ &0 _P!M /\ =0#_ 'T _P"$ /\ B@#] )  _ "6 /H
MG0#Y *, ^ "K /< M #U +\ ] #. /, Y@#Q /8 \ #_ .\ _P#O /\ [@#_
M .X _P#J /\ Z@#_ /\+% #_!A$ _P 0 /\ $ #_ !8 _P B /\ +@#_ #P
M_P!) /\ 5 #^ %\ ^P!H /D < #W '@ ]0!_ /, A0#R (L \ "2 .\ F #M
M )\ [ "F .H K@#H +D YP#' .4 W@#C /  X@#^ .  _P#@ /\ X0#_ .$
M_P#A /\ X0#_ /\-$ #_"0T _P$, /\ # #_ !( _P < /\ * #\ #8 ^0!#
M /8 3@#R %D [P!B .P :P#J '( Z !Y .8 @ #D (8 X@", .$ DP#? )H
MW0"A -L J@#8 +0 U0#  -( TP#0 .H S@#Z ,T _P#- /\ S0#_ ,P _P#,
M /\ S #_ /\0# #_# < _P," /\ " #_  X _P 6 /8 (@#P "\ [  \ .D
M2 #E %, X0!< -X 90#; &P UP!S -0 >@#2 (  T "' ,X C@#, )4 R@"=
M ,@ I0#& *\ Q "[ ,( RP#  .4 O@#U +T _P"\ /\ O #_ +P _P"\ /\
MO #_ /\1!0#_#@  _PH  /\( 0#_! H ^  0 .D &@#C "@ W@ U -D 00#3
M $P SP!6 ,L 7P#) &8 Q@!N ,0 = #" 'L P0"" +\ B0"] )  O "8 +H
MH0"X *L M@"W +0 QP"R .  L0'R *\"_P"N _\ K03_ *T$_P"M!/\ K03_
M /\4  #_$   _P\  /(-  #J"@  Z0,) -T $@#4 !\ S0$M ,@".@#$ T4
MP -0 +T$60"[!6$ N05H +<&;P"U!G8 M =] +('A "Q"(P KPB5 *T)G@"K
M":@ J@JU *@*Q0"F"]\ I WT *(._P"@#O\ GP[_ )\._P"?#O\ GP[_ /\7
M  #_$P  [Q@  .09  #;%@  TA " ,\)"P#("!8 P0HD +P,,@"W#3X M Y)
M +$.4P"O$%L K1!C *L0:@"I$7$ J!%X *81@ "E$8@ HQ*1 *$2FP"@$Z8
MGA.S )P3PP";%-X EQ;T )46_P"4%_\ DQ?_ )(7_P"2%O\ DA;_ /\:  #T
M'0  Y2,  -4E  #*)   PAT  +X6! "[$!  M!,= *\5*P"K%C@ IQA# *49
M30"B&58 H!I= )X;90"=&VP FQQS )H<>P"8'(, EQV- )4=EP"3'J( DAZO
M ) >OP"/']@ C"#Q 8D@_P&((/\!AR#_ 8<@_P&&(/\!AB#_ ?H>  #K)@
MVBT  ,HP  "^+@  M2@  + B  "N&PP J!T7 *,?)@"?(3, G"(^ )DC2 "7
M)%$ E219 ),E8 "2)6< D"9N (XF=@"-)G\ BR:( 8HGDP&()YX!AB>K 80G
MNP&#*-$!@"CN 7XI_P%]*?\!?"C_ 7PH_P%\*/\!?"C_ ?4D  #C+@  SS4
M ,$X  "T-@  JS$  *4L  "B)@8 GB83 )DH(0"5*BX DBLY (\L1 "-+4P
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M!60\^@1D//\#8SO_ V,[_P-C._\"8SO_ N4U  #-/P  O48  *Y'  "?10
ME4,  (Y   ")/   A#P* ( ]% !]/B( >C\N 'A . !U04( <T%* ')!40%P
M05D!;D%@ FQ!9P)J07 #:$%Y V=!A 1E09$%8T&?!6%!K@9@0<(&7D'B!EY!
M^05=0?\$74#_ UU _P-=0/\#74#_ ]\Y  #(0P  N4H  *E+  ";20  D$<
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M!$U-_P1.3/\#3DS_ \Y$  "\3@  KE0  )Q3  ".4@  @U$  'I0  !R30
M;$\  &A0"P!E414 8U(A &%3+ !?4S8 750_ %M41P!:5$X!6%16 59470)4
M5&8#4E-O U!3>P1.4X@%3%.7!DM3IP=)4[H'2%/5!TA2\P9(4O\%2%'_!$E1
M_P1)4/\#25#_ \I(  "Y4@  JE<  )A6  "*50  ?U0  '93  !L40  9U,
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M [Q5  "M7P  G&   (M?  !]7P  <E\  &A?  !=8   56(  $]D  !+9@H
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M 25ZF0$C>JP!(GK% 2)YZ0$B=_\!(G;_ 2)U_P(B=/\"(W3_ JQH  "=;@
MBFT  'ML  !O;   96P  %IN  !0<0  174  #UX   V?   +G\" "F!#0 G
M@A0 )H(> "6")P D@B\ (X,X "*#0@ A@TL ((16 !^$8@ >A'$ '(2" !N$
ME0 :A*D &(3! !B#Y@ 8@?T &8#_ 1E__P$9?O\!&7[_ :9P  "5<P  A'(
M '9Q  !K<0  7G,  %1V  !)>0  /WT  #>!   OA   )X@  ""+!0 ;C0X
M&HT5 !F-'@ 8CB< %XXP !:..0 5CD, %(]/ !./6P 2CVH $8][ !"/CP /
MCZ0 #H^[  V/X  .C?H #XO_ !"*_P 0B?\ $(G_ *%Z  ".>0  ?G<  ')W
M  !D>   6'L  $U^  !"@@  .88  "^*   GC@  ()$  !B5   2F 4 #IH.
M  V:%  ,FAT "YHF  N:,  *FCL "9I&  B:4P &FV$ !9IR  2:A@ "FIL
M )JQ  &9SP "F?   IC_  27_P %EO\ !9;_ )F!  "'?P  >GX  &M^  !=
M@0  4(4  $6)   [C0  ,9(  "B6   ?F0  &)T  !&@   ,HP( !J4*  &E
M$   I18  *8?  "F*   IC(  *<]  "G2@  IU@  *=H  "G?   IY$  *:H
M  "FPP  I>D  *7\  "E_P  I/\  *3_ )&'  ""A@  <H8  &.(  !5C
M29$  #V6   RF@  *)X  !^B   7I@  $*D   NL   $KP   +$&  "Q#
MLA$  +(7  "S'P  LR@  +0R  "U/P  M4T  +5=  "U<   M88  +6=  "U
MM@  M=P  +3W  "T_P  M/\  +3_ (N/  !ZC@  :I$  %N5  !-F@  0)\
M #6D   JJ   (*P  !:P   /M   ";<   &Y    O0   +X   "^!@  OPP
M , 0  #!%@  PAT  ,,G  #%,@  QD   ,91  #'8P  QW@  ,>1  #'J0
MQ\<  ,?L  #'_@  Q_\  ,?_ (.7  !QF@  89X  %*C  !%J0  .*X  "RS
M   @MP  %KH   Z]   &P    ,,   #'    R0   ,H   #,    S0,  ,X)
M  #0#@  TA,  -0;  #8)0  VS(  -U"  #=5   WFD  -Z!  #>G   W[4
M -_9  #?\P  W_\  -__ '>?  !HI@  6:T  $JS   [N   +;L  !^_   4
MP@  #,8   /)    S    -    #5    V0   -H   #<    W@   .    #B
M!0  Y L  .<0  #J&   [20  / R  #Q1   \E@  /-O  #TB@  ]*0  /2_
M  #TWP  ]/,  /3T &JH  !;KP  3+<  #V]   MP0  '\8  !/*   +S@
M -(   #7    W    .    #E    YP   .D   #K    [0   .\   #Q
M\P   /8'  #Y#@  _!8  /\B  #_,P  _T<  /]=  #_=@  _Y$  /^I  #_
MO@  _]@  /_; /\ & #_ !8 _P 5 /\ & #_ !X _P G /\ -@#_ $, _P!/
M /\ 6@#_ &0 _P!M /\ =0#_ 'T _P"$ /\ B@#_ )  _P"6 /\ G #_ *,
M_P"K /\ M #^ +\ _0#/ /L YP#Z /@ ^0#_ /D _P#Y /\ ]0#_ .X _P#I
M /\ YP#_ /\ % #_ !$ _P 1 /\ $@#_ !< _P C /\ ,0#_ #X _P!* /\
M5@#_ &  _P!H /\ < #_ '@ _0!^ /P A0#Z (L ^0"1 /@ F #W )X ]0"F
M /0 K@#R +D \0#' .\ X #N /( [ #_ .P _P#L /\ ZP#_ .4 _P#@ /\
MW@#_ /\#$ #_  X _P - /\ #0#_ !, _P > /\ *P#_ #@ _P!% /X 4 #[
M %H ^ !C /4 :P#S '( \0!Y .\ ?P#N (8 [ ", .H D@#I )D YP"@ .8
MJ0#D +, X0#  .  TP#> .L W #[ -L _P#: /\ V@#_ -D _P#4 /\ T@#_
M /\'#0#_  D _P & /\ "0#_  \ _P 8 /L )0#X #( ]0 _ /( 2@#M %0
MZ@!= .< 90#D &P X@!S .  >@#> (  W "& -H C0#7 )0 U "; -( I #/
M *T S0"Y ,L R0#) .0 R #V ,8 _P#% /\ Q@#_ ,< _P#' /\ QP#_ /\*
M!@#_ 0  _P   /\ ! #_  L ]  2 .\ 'P#J "P Y0 X .( 0P#= $X V0!7
M -0 7P#1 &< S@!M ,P = #* 'H R "  ,8 AP#% (X PP"6 ,$ G@"_ *@
MO0"S +H P@"Y -L MP#P +4 _P"V /\ M0#_ +4 _P"U /\ M0#_ /\,  #_
M!   _P   /X   #V  , Z  - .  %P#9 "0 T0 Q ,T / #* $< Q@!1 ,,
M60#  &  O@!G +P ;@"Z '0 N0![ +< @@"U (D LP"1 +( F@"P *0 K@"O
M *P O0"J -  J #K *< ^P"F /\ I@#_ *4 _P"E /\ I0#_ /\-  #_!P
M] D  .H)  #B!   V@ ' ,\ $0#( !P P@ I +X -0"[ $  MP!* +0 4P"R
M %L L !B *X : "L &\ JP!U *D ?0"H (0 I@"- *0 E@"C *  H0"K )\!
MN0"= \P G 3H )H&^0"9!_\ F C_ )<(_P"7"/\ EPC_ /\0  #W$   Z!0
M -P5  #.$0  Q@T  ,($"P"\ !0 MP$A +(#+@"N!3H JP9$ *@(30"F"%4
MI E< *(*8P"@"FH GPMQ )T+> "<"X  F@R) )D,DP"7#)X E0VJ )0-N "2
M#<P D [J (X0_ ",$/\ BQ#_ (L0_P"+$/\ BA#_ /L3  #M&@  W2   ,PA
M  "_'0  MQ<  +,1  "R"PT JPT9 *<.)@"C#S, GQ ^ )T11P":$5  F!)7
M )827@"5$V4 DQ-L )(3<P"0%'P CQ2% (T5CP"+%9H BA6G (@6M0"&%LD
MA!?G ((8^P" &?\ ?QG_ '\9_P!_&/\ ?QC_ /4:  #D(P  SRD  , J  "S
M)@  JB(  *4<  "D%0@ H!03 )L6(0"7&"T E!DX )$:0@"/&TL C1Q2 (L<
M60")'6  B!UG (8>;P"%'G< @Q^  ((?BP" 'Y< ?B"C 'T@L@![(,4 >2'D
M '<B^0!V(O\ =2+_ '0A_P!T(?\ ="'_ .\A  #;*P  QS$  +8Q  "I+@
MH"H  )LF  "8(0$ E1X0 ) @&P"-(2@ B2,S (<D/0"%)$8 @R5. ($F50!_
M)EP ?B9C 'PG:P![)W, >2=\ '@HAP!V*), ="B@ 7(HKP%Q*<$!;RG@ 6TI
M]P%L*?\!:RG_ 6LI_P%K*/\!:RC_ >@H  #0,@  P#@  *XW  "A-0  F#(
M )(M  ".*0  BR<, (<H%P"#*B, @"LO 'XL.0!\+$( >BU* '@N40!W+E@
M=2Y@ ',O9P!R+V\ <"]Y 6\O@P%M+Y !:R^= 6DOK %H,+X!9S#; 64P]0%D
M,/\!8S#_ 6,O_P%C+_\!8R__ >(N  #*.   NCT  *@\  ":.@  D3<  (HS
M  "&,   @RX) '\O$P![,!\ >#(K '8S-0!T,SX <C1& ' T3@!O-54 ;35<
M &PU9 !J-6P!:#5U 6<U@ %E-8P!8S6: F$VJ0)@-KL"7S;6 ETV\P)=-O\"
M7#;_ 5PU_P%<-?\!7#3_ =PS  #%/   M$$  *)   "5/@  BSP  (0Y  !_
M-@  >S0$ '<U$ !T-QP <3@G &\Y,@!M.3L :SI# &HZ2P!H.U( 9SM9 &4[
M80%C.VD!8CMR 6 [?0%>.XH"7#N7 EL[IP)9.[@#6#O_XO_B24-#7U!23T9)
M3$4 !@G2 U<[\0)6._\"5CO_ E8Z_P%6.O\!5CG_ =0W  # 00  KT0  )U#
M  "00@  A4   'X^  !Y.P  =#H  '$Z#@!M/!@ :STD &D^+P!G/S@ 93]
M &1 2 !B0$\ 84!7 %] 7@%=0&8!7$!O 5I >@)80(<"5D"5 E1 I -30+8#
M4D#/ U% [P-00/\"4#__ E __P)1/O\!43[_ <\[  "]10  JD<  )E&  "+
M10  @40  'E"  !T/@  ;S\  &M # !G014 94(A &-#*P!A0S4 7T0^ %Y$
M10!=14T 6T54 %E%7 %8160!5D5M 51%> )2184"4423 T]$HP--1;0#3$7,
M TM%[0-+1/\"2T3_ DM#_P),0O\"3$+_ LH_  "Y2   IDH  )5)  "'2
M?4<  '5%  !N0@  :4,  &5$"0!B11, 7T8> %U'* !<2#( 6D@[ %E)0P!7
M24H 5DE2 %1)60%326$!44EK 4])=@)-28("2TF1 TI)H0-(2;,#1TG* T9)
M[ -&2/\"1DC_ D='_P)'1O\"1T;_ L9#  "V3   HDP  )%,  "$2P  >4H
M '!)  !I1@  9$<  %])!@!<2A  6DL; %A,)0!63"\ 54TX %--0 !234@
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M C=4_P(W4_\".%/_ KI/  "I5@  E54  (54  !X5   ;50  &14  !85
M4E8  $Y7  !*60D 1UH1 $9:&P!$6R4 0ULN $)<-@!!7#X /UQ& #Y=3P ]
M75< .UUA #I=; $X77D!-EV( 31=F0(S7:L",5W" C%<Y0(Q6_P",5K_ C%9
M_P(R6?\!,EC_ ;94  "D60  D%@  (!8  !S5P  :5<  &!8  !460  3EL
M $A=  !#7P0 0& . #YA%P ]82  .V(I #IB,@ Y8CH .&-" #=C2P V8U0
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M :9F  "190  ?V0  '%D  !F9   760  %)F  !(:0  /VP  #=O   P<P
M*78  ")Y"  ?>Q  'GL7 !Q['P ;>R@ &GLP !E\.0 8?$, %WQ. !9\6@ 5
M?&< %'UX !)]BP 1?9\ $'VU  ]]U0 0>_4 $7G_ !%X_P 2=_\ $G?_ )YK
M  "*:@  >FD  &UI  !B:0  5VH  $QM  !#<   .70  #%X   I>P  (G\
M !N"   4A0D $880 !&&%P 0AQ\ $(<H  Z',0 .ASL #8=&  R'4P +AV$
M"H=Q  F'A  'AY@ !H:N  6&R0 &A>P !X3_  B#_P )@O\ "8+_ )5Q  "#
M;P  =&X  &EN  !<;P  4'(  $9U   \>0  ,GT  "J!   BA0  &XD  !2,
M   /CP, "I(+  :2$0 $DA@  I(@  &2*0  DC,  ),^  "32P  DUD  )-I
M  "3>P  DI   )*F  "1OP  D>4  )#Z  "/_P  C_\  (__ (UW  !]=0
M<'0  &)U  !5>   27P  #^    TA   *XD  "*-   :D0  $Y0   Z7   )
MFP   9T(  "=#@  G1,  )X:  ">(@  GRL  )\U  "@0@  H%   *!?  "@
M<0  H(<  )^=  "?M0  GMH  )WV  "=_P  G/\  )S_ (9]  !X?   :7P
M %M_  !.@P  08@  #:,   LD0  (Y8  !J:   2G@  #:$   :D    IP
M *D#  "I"@  J@X  *L3  "L&0  K2(  *XK  "O-P  KT4  *]4  "O9@
MKWL  *Z4  "NJP  KLD  *[O  "M_P  K?\  *W_ (&$  !QA   88<  %.+
M  !&D   .98  "Z;   CH   &J0  !*H   ,K   !*\   "R    M@   +<
M  "W @  N @  +D-  "Z$@  NQ@  +TA  "^*P  P#@  ,!(  # 6@  P6X
M ,&&  #!H   P;H  ,'C  # ^0  P/\  ,#_ 'F-  !HD   690  $N:   ]
MH   ,:4  "6K   :KP  $;,   NX   "NP   +X   #!    Q    ,4   #&
M    QP   ,@%  #*"P  S \  ,X5  #0'P  TRL  -4Z  #53   UF   -AW
M  #8D@  V*P  -G)  #9[   V?L  -C_ '"9  !@G@  4:0  $.J   UL
M*+8  !RZ   1O@  "<$   #%    R    ,L   #/    T@   -,   #6
MV    -L   #=    WP<  .(-  #E$P  Z!T  .PJ  #M/   [5$  .YG  #O
M@0  [YP  /"W  #PTP  \.P  /#T &>F  !8K0  2;0  #JZ   JO@  ',(
M !#&   'R@   ,X   #2    U@   -P   #@    XP   .0   #F    Z
M .L   #M    [P   /("  #U"@  ^!$  /P<  #_+   _S\  /]5  #_;@
M_XH  /^D  #_N@  _]$  /_A /\ % #_ !( _P 2 /\ % #_ !D _P E /\
M,@#_ #\ _P!+ /\ 5@#_ &  _P!H /\ < #_ '@ _P!_ /\ A0#_ (L _P"1
M /\ F #_ )X _@"F /T K@#\ +D ^@#( /D X@#X /0 ]P#_ /8 _P#V /\
M[P#_ .< _P#B /\ W@#_ /\ $0#_  X _P . /\ #P#_ !0 _P @ /\ +0#_
M #H _P!& /\ 40#_ %L _P!C /X :P#\ ', ^@!Y /D @ #W (8 ]@", /4
MD@#S )D \@"@ /  J0#N +, [0#! .L U@#J .X Z0#^ .< _P#G /\ Y0#_
M -T _P#5 /\ T0#_ /\ #0#_  H _P ( /\ "0#_ !  _P ; /\ * #_ #4
M_P!  /H 2P#V %4 \P!> /$ 9@#N &T [ !T .L >@#I (  YP"& .8 C0#D
M ), X@"; .  HP#> *T W "Y -H R@#7 .8 U #X -( _P#2 /\ T@#_ ,X
M_P#) /\ Q@#_ /\ " #_  , _P   /\  P#_  T _  6 /< (@#S "X [P Z
M .P 10#H $\ Y !8 .$ 8 #> &< VP!M -D = #5 'H TP"  -$ AP#/ (X
MS0"5 ,L G@#) *< QP"S ,4 P@## -P P0#Q +\ _P"_ /\ O@#_ +X _P"]
M /\ NP#_ /\   #_    _P   /\   #V  @ [@ 1 .< &P#A "< W0 S -D
M/@#3 $D SP!2 ,L 60#( &$ Q@!G ,0 ;0#" ', P !Z +\ @ "] (@ NP"0
M +D F "X *( M0"M +, NP"Q ,X L #J *\ _ "M /\ K0#_ *X _P"N /\
MK@#_ /\"  #_    _0   /(   #H    W@ , -, %0#, "$ R  L ,0 . #!
M $( O0!+ +H 4P"X %H M@!A +0 9P"R &T L !T *\ >@"M (( K "* *H
MDP"H )T I@"H *0 M0"B ,8 H0#C )\ ]@"> /\ G@#_ )X _P"> /\ G@#_
M /\&  #[    [@4  .($  #5    RP & ,, #P"] !D N  E +0 ,0"Q #L
MK@!% *P 30"I %4 IP!; *4 8@"D &@ H@!N *$ =0"? 'P G@"% )P C@":
M )@ F "D )8 L "5 ,$ DP#< )( \@"1 /\ D #_ )  _P"/ /\ CP#_ /T*
M  #P#@  X1$  ,X0  #"#0  NP<  +< "@"Q !( K  > *@ *0"E #0 H@ ^
M )\ 1P"= $\ FP!6 )D!7 "7 6, E@)I )0"< "3 W@ D0.  ) $B@".!)4
MC 6A (H%K@")!KX APC8 (8)\ "$"O\ @PO_ (,+_P"#"_\ @PO_ /80  #F
M%P  TAP  , :  "S%@  K!(  *@-  "F!PT H@46 )T'(@"9"2X E@HX )0+
M00"2#$H D Q1 (X-6 ",#5X BPUE (D-; "(#G0 A@Y] (4.AP"##I, @0^?
M ( 0K0!^$+X ?1#; 'H1] !X$O\ =Q+_ '<2_P!W$O\ =Q+_ .\7  #;(0
MQB0  +0C  "H(   H!P  )L7  "9$00 F X0 ),0&P"/$2< C!(R (D3/ "'
M$T0 A11, (,44P"!%5H @!5@ 'X6: !]%F\ >Q9X 'D7@P!X%X\ =AB< '08
MJ@!S&;L <AG4 &\:\0!N&_\ ;1O_ &T:_P!M&O\ ;1K_ .<@  #0*0  O"L
M *LJ  ">*   EB0  ) @  "-'   C!<, (@8%@"$&B( @1LM 'X<-P!\'4
M>AU( 'D>3P!W'E4 =A]< '0?8P!S'VL <2!T ' @?P!N(8L ;"&8 &LAIP!I
M(K@ :"+/ &8B[@!E(_\ 9"/_ &0B_P!D(O\ 9"'_ . F  #(+P  M#$  *,P
M  "6+@  C2L  (<H  "$)   @B ( 'X@$@![(AX >",I '4D,P!S)3P <25#
M ' F2P!N)E( ;2=9 &LG8 !J)V@ :2AQ &<H>P!E*(@ 9"F5 &(II !@*;4
M7RG+ %XJ[ !<*O\ 7"G_ %PI_P!<*?\ 7"C_ -@L  ##-0  K34  )TT  "0
M,P  AC$  ( M  !\*P  >2@# '8G$ !R*1H <"HE &TK+P!K+#@ :BQ  &@M
M1P!G+4X 92Y5 &0N70!C+F4 82]N %\O> !>+X0 7"^2 %HOH0%9+[(!6##(
M 58PZ0%5,/X!52__ %4O_P!5+O\ 52[_ - Q  "].@  J#D  )<X  "*-P
M@#8  'HR  !U,   <BX  &XN#0!K+Q8 :3 A &8Q*P!D,C0 8S(] &$S1 !@
M,TL 7S12 %TT6@!<-&( 6C1K %DU=0!7-8( 5360 50UGP%2-; !437& 5 U
MYP%/-?T!3S7_ 4\T_P%/-/\!3S/_ <LV  "X/0  HSP  )(\  "%.P  >SH
M '0W  !O-0  ;#,  &@T"@!E-1, 8C8> & W* !>-S$ 73@Z %LX00!:.4@
M63E0 %<Y5P!6.E\ 5#IH %,Z<P!1.G\!3SJ- 4XZG0%,.JX!2SK# 4HZY0%)
M.OP!23G_ 4DY_P%)./\!2CC_ <<Z  "S0   GC\  (X_  "!/@  =ST  ' [
M  !J.   9C@  &(Y!P!?.A$ 7#L; %H[)0!9/"X 5STW %8]/@!4/D8 4SY-
M %(^50!1/ET 3S]F $T_< !,/WT!2C^+ 4@_FP%'/ZP!13_! 40_XP%$/OL!
M1#[_ 40]_P%$/?\!13S_ <,^  "O0P  FD(  (I"  !]00  <T   &L_  !E
M/   8#P  %P^! !9/@\ 5S\8 %5 (@!302L 4D$T %!"/ !/0D, 3D)+ $U#
M4@!+0UH 2D-D $A#;@!'0WL!14.) 4-#F0%"0ZL!0$/  3]#X0$_0_D!/T+_
M 3]!_P% 0?\!0$#_ ;]!  "J10  ED4  (9%  !Y1   ;T0  &="  !@/P
M6T$  %="  !40PT 4405 $]%'P!.12@ 3$8Q $M&.0!*1T$ 24=( $A'4 !&
M1U@ 14=A $-(; !"2'@!0$B' 3Y(EP$\2*D!.TB^ 3I(WP$Z1_@!.D;_ 3I%
M_P$[1?\!.T3_ ;M%  "F2   DD<  ()'  !V1P  :T<  &-&  !;0P  5D4
M %)'  !.2 H 3$D2 $I)' !(2B4 1THN $9+-@!%2SX 0TM& $),30!!3%8
M0$Q? #Y,:@ \3'8 .TR% 3E,E0$W3*<!-DR\ 35,W0$U2_<!-4O_ 35*_P$V
M2?\!-DG_ ;A)  "B2P  CDH  'Y*  !R2@  :$H  %])  !52   4$H  $Q+
M  !)3 < 1DT0 $1.&0!"3R( 04\K $!0,P _4#L /E!# #Q12@ [45, .E%<
M #A19P W47, -5&" #-1DP$R4:4!,%&Z 2]1V@$O4/8!+T__ 3!._P$P3O\!
M,$W_ ;1-  "=30  BDT  'I-  !N30  9$T  %M-  !130  2T\  $90  !"
M4@, /U,- #U4%0 \5!X .E4G #E5+P X53< -U8_ #961P U5E  ,U99 #)7
M9  P5W$ +U>  "U7D0 K5Z, *E>X "E7U@ I5O4 *57_ "I4_P$J4_\!*E+_
M :]1  "840  A5$  '90  !J4   8%   %A1  !.4@  1U,  $%5   [6
M.%D* #5:$0 T6AH ,ULB #);*P Q6S, +UP[ "Y<0P M7$P +%Q6 "M=8  I
M76T *%U\ "9=C@ D7:$ (UVU ")=T@ B7/, (EO_ "-:_P C6?\ )%C_ *A5
M  "25   @%0  '%4  !F5   7%0  %15  !*5@  0U@  #Q;   V70  ,& %
M "UA#@ K814 *F(= "EB)0 H8BX )V,V "9C/@ E8T< (V-1 ")D7  A9&D
M'V1Y !YDB@ <9)X &V2S !EDS@ :8_$ &V'_ !M@_P <8/\ '%__ *%9  ",
M6   >U@  &U8  !B6   65@  %!9  !'6P  /EX  #=@   Q8P  *F8  "1I
M"0 A:A  (&H7 !]J(  >:R@ '6LP !QK.0 ;:T( &FQ, !EL6  7;&4 %FQT
M !1LA@ 3;)H $FRO !%LR@ 1:^\ $FG_ !-H_P 3:/\ $V?_ )E=  "%70
M=5P  &A<  !>7   55P  $M>  !"80  .60  #)G   K:@  )&T  !YP 0 7
M<PL %701 !1T&  3="$ $G4I !%U,@ 1=3L $'5&  ]U4@ .=5\ #75N  QU
M@0 +=94 "G6J  ATPP )=.< "G/]  MQ_P ,<?\ #'#_ )%B  !_80  <&$
M &1A  !:80  3V(  $5E   \:   ,VP  "MO   D<@  '78  !=Y   1? 0
M#7\,  M_$@ *?QD "7\B  A_*@ &?S0 !7\_  1_2P "?U@  7]G  !_>0
M?XX  '^C  !^NP  ?>   'WW  !\_P  >_\  'O_ (EG  !X9P  :V8  &%F
M  !49P  26D  #]M   U<0  +'4  "1Y   =?   %H   !"#   ,A@( !HD*
M  &)#P  B10  (H;  "*(P  BRP  (LW  "+0P  BU   (M?  "+<0  BX8
M (N<  "*LP  B=,  (CS  "(_P  A_\  (?_ ()M  !S;   :&P  %IM  !.
M;P  0G,  #AW   N>P  )8   !V$   5B   $(P   N/   $D@   )0&  "5
M#   E1   )85  "7'   F"0  )@N  "9.0  F4<  )E6  "9:   F7T  )F4
M  "8JP  E\@  );N  "6_P  E?\  )7_ 'MT  !O<P  87,  %-V  !&>@
M.W\  #"$   FB   '8T  !22   .E@  "9D   &<    H    *$   "B!@
MH@P  *00  "E%   I1P  *<D  "H+P  J#T  *E,  "I7@  J7(  *B)  "H
MH@  J+P  *?E  "F^P  IO\  *7_ '=[  !H>P  67X  $N"   ^AP  ,HT
M ">2   =EP  %)P   Z@   'I    *@   "K    K@   *\   "P    L00
M +,*  "T#@  M1,  +8;  "X)   NC$  +I   "Z4@  NV4  +M]  "ZEP
MNK$  +K2  "Z\P  N?\  +G_ &^#  !?A@  48L  $.0   VEP  *IT  !^B
M   5IP  #:P   6P    M    +<   "[    O@   +\   #     P0   ,,!
M  #$!P  Q0T  ,<1  #*&0  S20  ,XS  #/1   T%@  -!N  #1B   T*0
M -#!  #1Y@  T?@  -'_ &>/  !7E   29H  #NA   NIP  (:T  !:S   .
MN   !KP   #     PP   ,8   #+    S0   ,X   #0    T0   -0   #6
M    V@(  -P)  #?#P  XQ<  .8D  #G-@  Z$D  .E?  #J>   ZY0  .NO
M  #KS   [.@  .SV %^>  !0I   0JL  #2R   FN0  &;X   ["   $Q0
M ,H   #-    T0   -@   #;    WP   .    #B    Y    .8   #I
MZP   .X   #Q!0  ]0T  /D6  #\)0  _3D  /Y/  #_9P  _X(  /^=  #_
MM0  _\L  /_D /\ $0#_  \ _P / /\ $0#_ !8 _P B /\ +P#_ #L _P!'
M /\ 4@#_ %L _P!D /\ ; #_ ', _P!Z /\ @ #_ (8 _P", /X DP#] )D
M^P"A /H J0#X +0 ]P#" /8 V@#U /$ ] #_ /, _P#S /\ Z0#_ .  _P#8
M /\ TP#_ /\ #@#_  L _P * /\ "P#_ !$ _P = /\ *@#_ #8 _P!! /\
M3 #_ %8 _@!? /L 9@#Y &T ]P!T /4 >@#T (  \@"& /  C0#O )0 [0";
M .P I #J *X Z0"Z .< S0#E .D Y #[ ., _P#B /\ W@#_ -$ _P#, /\
MR #_ /\ "0#_  0 _P ! /\ ! #_  X _P 8 /\ ) #] #  ^P [ /< 1@#S
M %  [P!9 .P 8 #J &< YP!N .8 = #D 'H X@"  .  AP#> (X W "5 -H
MG@#6 *@ U "S -$ PP#/ -\ S@#T ,P _P#+ /\ RP#_ ,4 _P"_ /\ O #_
M /\  @#_    _P   /\   #]  L ]P 3 /$ '@#M "H Z@ U .< 0 #B $H
MW0!2 -D 6@#5 &$ T@!G -  ;0#. ', S !Z ,H @ #( (< Q@"/ ,0 F #"
M *$ P "M +X NP"\ -  N@#M +D _@"X /\ N #_ +< _P"S /\ L #_ /\
M  #_    _P   /D   #N  4 Y0 . -X & #8 ", T@ N ,\ .0#+ $, QP!,
M ,0 5 #! %L OP!A +P 9P"[ &T N0!S +< >@"U ($ M ") +( D@"P )L
MKP"G *P M "K ,8 J0#D *< ^ "F /\ I@#_ *4 _P"E /\ I #_ /\   #_
M    ]0   .H   #>    T  * ,@ $@#" !T O@ H +L ,P"Y #T M0!& +(
M30"P %4 K0!; *P 80"J &< J !M *< <P"E 'H I "" *( C "@ )8 GP"A
M )T K@"; +X F0#8 )< \0"6 /\ E@#_ )< _P"7 /\ EP#_ /\   #U
MYP$  -0   #)    P  $ +@ #@"S !8 KP A *L + "H #8 I@ _ *, 1P"A
M $\ GP!5 )T 6P"; &$ F@!G )@ ;@"7 '4 E0!] )0 A@"2 )$ D "< (X
MJ0", +@ BP#- (D ZP"( /T B #_ (@ _P"( /\ B #_ /D&  #I#   U X
M ,,,  "W"0  L (  *L "0"F !  H@ : )X )0"; #  F  Y )8 00"4 $D
MD@!0 )  5@". %P C0!B (L :0"* '  B !X (< @0"% (P A "8 (( I0"
M +0 ?@#( 'T!YP!\ OD >P/_ 'L$_P![!/\ >P3_ /$.  #>%0  Q14  +04
M  "I$0  H0X  )X*  "; PP EP 3 ), '@"0 2D C0(S (H#/ "(!$, A@5+
M (4&40"#!E< @@=> ( '9 !_"&P ?0AT 'P(?@!Z"8D > F6 '<*HP!U"K,
M<PO' '(,Y@!P#?L < W_ &\-_P!O#?\ ;PW_ .@6  #0'@  N1T  *D<  "=
M&@  E18  ) 3  "/#@, C@H. (D+%P"&#", @PTM ( --@!^#CX ? Y& 'L.
M30!Y#U, >!!: '8080!U$&@ <Q!Q '$1>P!P$8< ;A&4 &P1H@!K$K( :1+'
M &@3YP!F$_T 913_ &44_P!E$_\ 91/_ -\>  #&)   L"0  * C  "4(0
MBQ\  (8;  "#%P  @A(( '\1$@!\$AT >10H '84,0!T%3H <A9! '$62 !O
M%T\ ;A=6 &P770!K&&0 :1AM &@9=P!F&8, 9!F0 &,:GP!A&J\ 8!K$ %X;
MY !='/L 7!S_ %P;_P!<&_\ 7!O_ -4E  "]*@  J"D  )@I  ",*   @R4
M 'TB  !Y'P  >!L# '89#P!R&A@ ;QPC &T=+0!K'34 :1X] &@>1 !F'TL
M91]2 &,@60!B(&$ 82!I %\A<P!=(7\ 7"&- %HBG !9(JP 5R+  %8CX0!5
M(_D 5"/_ %0B_P!4(O\ 5"+_ ,TK  "V+@  HBX  )(N  "%+0  ?"L  '8H
M  !R)@  ;R,  &TA# !J(A4 9R,? &4D*0!C)#$ 8B4Y & F00!?)D@ 729/
M %PG5@!;)UT 62=F %@H< !6*'P 5"B* %,IF0!1*:H 4"F^ $\IW@!.*?<
M32G_ $TI_P!-*/\ 3BC_ ,@P  "P,@  G#(  (PR  " ,0  =C   ' M  !K
M*P  :"D  &8H"0!C*!$ 8"D< %XJ)0!<*RX 6RLV %DL/0!8+$0 5RU, %4M
M4P!4+5L 4RUC %$N;@!0+GH 3BZ( $POEP!++Z@ 22^[ $@OVP!(+_8 1R__
M $<N_P!'+?\ 2"W_ ,0T  "K-0  ES4  (<U  ![-0  <C0  &LR  !F+P
M8BX  %\M!0!<+A  6B\8 %@P(@!6,"L 53$S %,Q.@!2,D( 43)) % R4 !.
M,U@ 33-A $LS:P!*,W< 2#2% $<TE0!%-*8 0S2Y $(TU@!"-/0 0C3_ $(S
M_P!",O\ 0C+_ , X  "G.   DS@  (,X  !W.   ;3<  &8V  !A,P  73(
M %DR @!7,PT 5#05 %(U'P!1-2@ 3S8P $XV. !,-S\ 2S=& $HW3@!).%8
M1SA? $8X:0!$.'4 0SB# $$YDP! .:0 /CFX #TYTP \.?, /#C_ #TW_P ]
M-_\ /3;_ +L[  "B.P  CSL  '\[  !S.P  :CH  &(Y  !=-P  6#8  %0W
M  !1. L 3SD3 $TY' !+.B4 2CHM $@[-0!'.SP 1CQ$ $4\2P!$/%, 0CQ<
M $$]9P _/7, /CV! #P]D0 Z/:, .3VV #@]T0 W/?( -SS_ #@[_P X._\
M.#K_ +8]  ">/@  BSX  'P^  !O/@  9CT  %X]  !8.P  4SH  $\[  !,
M/ @ 23T1 $<^&0!&/R( 1#\J $,_,@!"0#H 04!! $! 20 ^05$ /4%: #Q!
M9  Z07  .$%_ #=!CP U0J$ -$*T #)"S@ R0?  ,D#_ #- _P S/_\ -#[_
M +%   ":0   AT   'A!  !L00  8D   %M   !4/P  3C\  $I   !&004
M1$(. $)#%@! 0Q\ /T0G #Y$+P \1#< .T4^ #I%1@ Y14X .$98 #9&8@ U
M1FX ,T9\ #%&C0 P1I\ +D:S "U&S  M1N\ +47_ "Y$_P N0_\ +D/_ *Q#
M  "60P  @T,  '1#  !H0P  7T,  %=#  !00P  2$,  $1%  !!1@$ /D<,
M #Q($P Z2!P .4DD #A)+  V230 -4H[ #1*0P S2DP ,DI5 #!+7P O2VL
M+4MZ "Q+BP J2YT *$NQ "=+R@ G2^T )TK_ "A)_P H2/\ *4?_ *=&  "1
M1@  ?T8  '!&  !E1@  6T8  %1&  !,1P  1$@  #]*   [2P  -TP) #5-
M$  S3A@ ,DX@ #%/*  P3S  +T\X "Y/0  L4$@ *U!2 "I07  H4&@ )U!W
M "50B  D4)L (E"O "%0R  @4.L (4__ ")._P B3?\ (TW_ *%)  ",20
M>DD  &Q*  !A2@  6$H  %!*  !)2P  0$P  #M.   U4   ,5($ "U3#0 L
M5!0 *E0< "E5)  H52P )U4S "95/  E5D4 )%9. ")660 A5F4 'U9T !Y6
MA0 <5I@ &U:L !E6Q0 95ND &E7_ !M4_P ;4_\ '%+_ )M-  "&30  =4T
M &A-  !=30  5$T  $U.  !%3P  /%$  #93   Q50  *U@  "9:"0 C6Q
M(EL7 "%<'P @7"< 'UPN !U<-P <74  &UU* !I=50 876$ %UUP !5=@0 4
M794 $UVJ !%=P@ 17>< $EO^ !-:_P 36O\ %%G_ )11  " 40  <%$  &11
M  !940  45$  $E2  !!4P  .%8  #)9   K6P  )5X  !]A P :8PP &&01
M !=D&0 69"$ %60I !1E,0 393H $F5$ !%E4  095T #V5K  YE?0 -99$
M#&6E  IDO  *9.  "V/Y  QB_P -8?\ #6'_ (U5  !Z50  :U4  %]5  !6
M50  3E4  $17   \60  -%P  "Q?   F8@  'V4  !EH   3:P4 $&T-  YN
M$@ -;AH #&XB  QN*P +;C0 "FX^  AN2@ ';E< !FYE  1N=@ ";HH  &V?
M  !MM@  ;-8  &SS  %K_P ":O\  VK_ (5:  !T6@  9EH  %Q9  !360
M2%H  #]=   V8   +F,  "9G   ?:@  &6T  !-Q   .= , "G<*  5W$  !
M=Q4  '<<  !W)   >"T  '@W  !X0P  >%   'A>  !X;P  >(0  'B9  !W
ML   =LT  '7P  !U_P  =/\  '3_ 'Y?  !N7P  8EX  %E>  !-7P  0F(
M #EE   P:   )VP  !]P   8=   $G<   U[   (?@   H (  "!#0  @1$
M ((7  "#'@  @R8  (0P  "$.P  A$@  (17  "$:   A'P  (23  "#J@
M@L4  ('K  "!_@  @/\  (#_ '=E  !I9   7V,  %)D  !'9P  /&L  #%O
M   H<P  ('<  !A\   1?P  #(,   :'    B@   (P#  ","0  C0X  (X1
M  "/%P  D!X  )$G  "2,@  DC\  )).  "27P  DG,  )*+  "1H@  D;P
M )#E  "/_   CO\  ([_ '%K  !F:@  6&L  $MM   _<0  -'8  "I[   @
M@   %X4  !")   +C0  !)$   "5    F    )D   ": P  FP@  )P-  ">
M$0  GQ8  * >  "B*   HC4  *-$  "C50  HVD  **   "BF@  H;,  *#8
M  "@]@  G_\  )__ &YQ  !?<@  474  $1Y   W?@  +(0  "&*   7CP
M$)0   J9   !G0   *    "D    IP   *@   "I    J@   *P&  "M"P
MKQ   + 5  "R'@  M"D  +0Y  "T2@  M5T  +5S  "UC@  M:@  +3&  "S
M[0  LO\  ++_ &9Z  !7?0  28(  #R'   OC@  (Y0  !B:   0GP  ":0
M  "I    K0   +    "T    MP   +@   "Y    NP   +P   "^ @  P @
M ,(.  #$%   QQX  ,@L  #)/0  RE   ,IF  #*?P  RIL  ,JX  #*W0
MRO4  ,K_ %Z&  !/BP  09$  #.8   GGP  &Z4  !&K   )L    +4   "Y
M    O0   ,$   #&    R    ,D   #+    S    ,X   #0    T@   -0%
M  #9#   W1(  .$>  #B+@  XT(  .17  #E;P  YHP  .:H  #EQ0  Y><
M .;V %:4  !(FP  .J(  "RI   ?L   $[8   N\    P0   ,4   #)
MS0   -(   #6    V@   -L   #>    X    .(   #D    YP   .D   #M
M    \ H  /01  #X'P  ^3(  /I(  #[7P  _'H  /V7  #]KP  _<<  /WD
M /\ #@#_  T _P , /\ #@#_ !, _P > /\ *@#_ #8 _P!" /\ 30#_ %<
M_P!? /\ 9P#_ &X _P!T /\ >@#_ ($ _0"' /P C0#Z )0 ^0"< /< I0#U
M *\ ] "\ /, SP#Q .P \ #^ .\ _P#O /\ XP#_ -< _P#. /\ R@#_ /\
M"@#_  8 _P $ /\ " #_ !  _P 9 /\ )0#_ #$ _P ] /\ 1P#^ %$ ^P!9
M /D 80#V &@ ] !N /, = #Q 'H [P"! .X AP#L (X Z@"6 .@ GP#F *D
MXP"U .( Q@#@ ., WP#X -T _P#= /\ U #_ ,D _P#" /\ O@#_ /\  P#_
M    _P   /\  0#_  T _P 4 /T ( #Z "L ]P V /, 00#O $L [ !4 .@
M6P#F &( XP!H .$ ;@#? '0 W !Z -H @0#8 (@ U "0 -( F #/ *( S0"N
M ,L O #) -, QP#P ,8 _P#$ /\ Q #_ +L _P"V /\ LP#_ /\   #_
M_P   /\   #W  @ \  0 .L &@#G "4 Y  P .$ .P#< $4 U0!- -$ 50#.
M %L RP!B ,D 9P#' &T Q0!S ,, >@#! ($ OP") +T D@"[ )P N0"G +<
MM0"U ,@ LP#F +( ^P"Q /\ L #_ *X _P"J /\ IP#_ /\   #_    _@
M /$   #E  ( W  - -, % #- !\ R@ J ,< - #$ #X P !' +P 3@"Z %4
MMP!; +4 80"S &< L@!M +  <P"N 'H K "" *H BP"H )4 IP"@ *4 K0"C
M +X H0#; *  ] "? /\ G@#_ )\ _P"= /\ FP#_ /\   #\    [@   .
M  #0    Q0 ( +X $ "Y !D M0 C +, +@"P #< K0!  *H 2 "H $\ I0!5
M *, 6P"B &  H !F )\ ; "= ', FP![ )H A "8 (X E@": )4 IP"3 +<
MD0#, )  [ "/ /\ C@#_ (X _P". /\ CP#_ /P   #O    VP   ,D   "]
M    M0 " *X # "I !, I0 = *( )P"@ #$ G0 Z )H 0@"8 $D E@!/ )0
M50"3 %L D0!@ )  9P". &T C0!U (L ?@") (D B "5 (8 H@"% +$ @P#$
M ($ Y "  /D ?P#_ (  _P"  /\ @ #_ /0"  #@"0  QP@  +<'  "L P
MI@   *  !P";  \ F  7 )4 (0"2 "H CP S (T / "+ $, B0!) (< 4 "&
M %4 A !; (, 80"! &@ @ !P 'X >0!\ (0 >P"0 'D G0!X *P =@"^ '4
MW0!S /0 <P#_ ', _P!S /\ <P#_ .D-  #/$   N1   *D0  ">#@  EPL
M ),&  "0  L C  1 (D &@"& "0 @P N ($ -@!_ #X ?0!$ 'P 2P!Z %$
M>0!7 '< 70!V &0 = !L ',!=0!Q 8  ;P*- &X"F@!L ZH :P.[ &D$U@!H
M!O$ : ?_ &<'_P!G!_\ 9P?_ -\4  ##%P  KA<  )X6  "3%0  BQ(  (80
M  "$# ( @P8- ( #% !\!1X >0<H '<(, !U"#@ <PE  '()1@!P"DP ;PI3
M &T+60!L"V$ :@MI &D,<@!G#'X 9@R+ &0-F0!B#:D 80V[ & -V !>#O,
M70[_ %T._P!=#O\ 70[_ -0<  "Y'0  I!X  )4=  ")'   @1H  'L7  !X
M$P  >! & '<-#P!S#A@ < XB &X/*P!L$#, :A [ &D00@!G$4D 9A%/ &01
M5@!C$ET 81)F & 2;P!>$GL 7!.( %L3EP!9$Z< 5Q2Z %84U0!5%?, 5!7_
M %05_P!4%?\ 5!3_ ,HB  "P(@  G2,  (TC  "!(@  >2$  ',>  !O&P
M;A<  &T3# !J%!0 9Q4> &46)P!C%B\ 81<W & 7/@!>&$4 71A+ %P94@!:
M&5H 61EB %<:; !6&G< 5!J% %(;E !1&Z0 3QNW $X;T !-'/$ 3!S_ $P<
M_P!-'/\ 31O_ ,,F  "J)P  EB<  (<H  ![)P  <B8  &PD  !H(0  9AX
M &0;" !B&Q$ 7QP: %T=(P!;'BL 6AXS %@?.@!7'T$ 5B!( %0@3P!3(%<
M42%? % A:0!.(70 32&" $LBD0!)(J( 2"*T $<BS0!&(^\ 12/_ $4B_P!&
M(O\ 1B'_ +PJ  "D*P  D2L  ((L  !V*P  ;2H  &8I  !B)@  7R0  %TB
M! !;(0X 6"(6 %8C'P!4)"@ 4R0P %(E-P!0)3X 3R9% $XF3 !,)E0 2R=<
M $DG9@!()W$ 1B=_ $4HCP!#**  02BR $ HRP _*.T /RC_ #\H_P! )_\
M0"?_ +<M  "?+@  C"\  'TO  !Q+P  :"X  &$M  !=*P  6B@  %<G  !4
M)PP 4B@3 % I' !.*24 32HL $LJ- !**SL 22M" $@L20!&+%$ 12Q: $0L
M9 !"+6\ 0"U] #\MC0 ]+9X /"VP #HMR  Z+>L .BW_ #HM_P Z+/\ .BS_
M +(P  ";,0  B#(  'DR  !M,@  9#(  %TQ  !8+P  52P  %$L  !/+0D
M3"T1 $HN&0!)+R( 1R\J $8P,0!%,#@ 0S _ $(Q1P!!,4\ 0#%7 #XQ80 ]
M,FT .S)[ #DRBP X,IP -C*O #4RQP T,ND -#+_ #4Q_P U,?\ -3#_ *TS
M  "6-   A#4  '4U  !I-0  8#4  %DT  !4,P  4#   $PQ  !),08 1S(/
M $4S%@!#,Q\ 0C0G $ T+@ _-38 /C4] #TU1  \-DP .C95 #DV7P W-FL
M-C9X #0WB0 R-YH ,3>M "\WQ0 O-^@ +S;^ # U_P P-?\ ,#3_ *DV  "2
M-@  @#<  '(X  !F.   73<  %8W  !0-@  2S0  $<U  !$-@, 03<- #\X
M%  ^.!P /#DD #LY+  Z.3, .3HZ #@Z0@ V.DH -3I3 #0[70 R.V@ ,#MV
M "\[AP M.YD +#NL "H[PP I.^8 *CK] "HZ_P K.?\ +#C_ *0X  "..0
M?#H  &XZ  !C.@  6CH  %,Z  !-.@  1C@  $(Z   _.P  /#P+ #H\$0 X
M/1D -STA #8^*0 T/C  ,SXW #(_/P Q/T< ,#]0 "X_6@ M0&8 *T!T "E
MA  H0)< )D"J "5 P0 D0.4 )#_\ "4^_P F/?\ )CW_ )\[  "*/   >#T
M &H]  !?/0  5CT  $\]  !)/0  0CT  #P^   Y/P  -D$( #1!#P R0A8
M,4(> "]#)0 N0RT +4,T "Q$/  K1$0 *D1- "A$6  G16, )45Q "-%@@ B
M194 ($6H !]%OP >1., 'T3[ !]#_P @0O\ (4'_ )H^  "%/P  =$   &=
M  !<0   4T   $Q   !&0   /D$  #A#   T10  ,$8# "U'#0 K2!( *D@:
M "E((@ H22D )TDQ "5).0 D24$ (TI* ")*50 @2F$ 'TIO !U*?P ;2I(
M&DJF !A*O0 72N  &$GZ !E(_P :1_\ &D?_ )5"  " 0@  <$,  &-#  !8
M0P  4$,  $E#  !"1   .T4  #5'   P20  *TL  "9-"0 D3A  (DX6 "%/
M'0 @3R4 'T\L !Y/-0 =3ST '%!' !I040 94%T %U!K !90?  44(\ $U"D
M !%0N@ 14-X $4_X !)._P 33?\ %$W_ (]%  ![1@  :T8  %]'  !51P
M34<  $9'   _1P  -TH  #%,   K3@  )E   "!3 P <50P &E81 !E6&  7
M5B  %E8G !56,  45CD $U=" !)730 15UD $%=H  ]7>0 .5XP #5>@  M7
MM@ +5M0 "U;T  Q5_P -5/\ #E/_ (A)  !V2@  9TH  %M*  !12@  2DH
M $-*   [3   ,TX  "Q1   F5   (58  !M9   57 < $5X- !!>$P 07AH
M#EXB  Y>*@ -7C, #%X]  M>2  *7E0 "%YB  =><P %7H8  UZ;  )>L0 "
M7<P  EWN  -<_P $6_\ !5O_ (%.  !P3@  8DX  %=.  !.3@  1TX  #Y/
M   V40  +E0  "=7   A6@  &UT  !5@   08P, #&8+  AG$  &9Q4 !6<<
M  1G)  "9RT  6<W  !G0@  9TX  &=<  !G;0  9X   &:5  !FK   9<<
M &7K  !D_   9/\  &/_ 'I2  !J4P  75(  %12  !+4@  0E,  #E5   P
M6   *%L  "%?   :8@  %&4  !!H   ,:P$ !FX)  !O#@  ;Q(  &\8  !P
M'P  <"<  '$P  !Q.P  <4@  '%6  !Q9@  <7D  '&/  !PIP  ;\$  &_G
M  !N_   ;?\  &W_ '-8  !E5P  6E<  %%6  !&5P  /%H  #)=   J80
M(F0  !IH   4;   #F\   IR   $=@   '@%  !X"P  >0X  'H3  ![&0
M?"   'TI  !],P  ?4   'U.  !]7@  ?7(  'V(  !\H0  ?+H  'OB  !Z
M^@  >?\  'C_ &U=  !@7   5UP  $M=  ! 7P  -6,  "MG   C:P  &F\
M !-S   .=P  "'L   )^    @@   (,!  "$!@  A0L  (8/  "($P  B1D
M (HA  "+*P  BS<  (Q&  "+5@  BVD  (N   "+F0  BK,  (G8  "(]P
MB/\  (?_ &AC  !>8@  46(  $1E   X:0  +FX  "1S   :>   $WT   V!
M   &A0   (D   "-    D    )(   "2    E 4  )4*  "7#@  F!(  )H8
M  ";(0  G"T  )T\  "=3   G%\  )QV  ";D0  FZL  )K)  ":\   F?\
M )C_ &5I  !7:0  26P  #UQ   P=@  )7P  !N!   2AP  #(P   21
ME0   )D   "=    H    *$   "B    I    *4!  "G!P  J0P  *H1  "M
M&   KR(  *\P  "O00  KU0  *]K  "NA0  KJ$  *Z^  "MY@  K/P  *S_
M %YQ  !/=   0GD  #5_   HA0  '8P  !.2   ,F    YT   "B    I@
M *H   "N    L    +$   "S    M    +8   "X    N@0  +P*  "^$
MP1<  ,,D  ##-0  Q$D  ,1>  #%=P  Q9,  ,6O  #%T0  P_(  ,/_ %9\
M  !'@@  .H@  "R/   @E@  %)T   VC   #J0   *X   "R    MP   +L
M  "_    P@   ,(   #%    Q@   ,@   #*    S0   ,\   #2"   U0X
M -L8  #=)P  WCH  -]0  #@:   X(0  .&A  #AO0  X>(  .#T $Z+  !
MD@  ,ID  "6A   8J   #J\   6U    N@   +\   #$    R    ,X   #1
M    U    -4   #8    V@   -T   #?    X@   .0   #G    ZP4  .\.
M  #T&0  ]2L  /9!  #W6   ^'(  /F0  #YJP  ^,0  /CA /\ "P#_  @
M_P ) /\ # #_ !( _P : /\ )@#_ #( _P ^ /\ 2 #_ %( _P!: /\ 8@#_
M &D _P!O /\ =0#^ 'L _ "! /L B #Y (\ ]P"7 /4 H #S *H \@"W .\
MR0#M .8 [ #[ .L _P#K /\ W0#_ ,X _P#& /\ P@#_ /\ ! #_    _P
M /\ !0#_  T _P 5 /\ (0#_ "P _P X /\ 0P#] $P ^0!4 /< 7 #T &,
M\@!I /  ;P#N '4 [ ![ .H @@#H (D YP"1 .0 F@#B *0 X "P -T P #:
M -P V #T -4 _P#3 /\ RP#_ ,$ _P"[ /\ MP#_ /\   #_    _P   /\
M  #_  H _0 1 /D &P#V "< ]  R /  / #L $8 Z !. .0 5@#A %P W@!C
M -P : #9 &X U0!T -( >P#0 (( S0"* ,L DP#( )T Q@"H ,0 MP#! ,P
MP #K +X _P"] /\ O0#_ +0 _P"N /\ JP#_ /\   #_    _P   /H   #R
M  4 Z@ . .4 %@#@ "$ W0 K -L -@#3 #\ S@!( ,H 3P#' %8 Q !< ,(
M80#  &< O@!M +P <P"Z 'H N "" +8 BP"T )8 L@"A +  KP"N ,$ K0#@
M *L ]P"J /\ J0#_ *8 _P"A /\ GP#_ /\   #_    ]P   .@   #<
MT  * ,H $0#% !L P@ E +\ +P"\ #@ N !! +4 2 "R $\ L !5 *X 6P"L
M &$ J@!F *@ ; "G ', I0![ *, A "A (X GP": )T IP"; +@ F@#0 )D
M[P"8 /\ EP#_ )8 _P"4 /\ D@#_ /\   #V    Y    -(   #%    NP %
M +4 #@"P !4 K  ? *H *0"H #( I0 Z *( 0@"@ $D G@!/ )P 50": %H
MF !@ )8 9@"5 &P DP!T )( ?0"0 (< C@"3 (P H0"+ +  B@#% (@ Y@"'
M /L A@#_ (< _P"' /\ A@#_ /@   #E    S0   +T   "S    J@   *,
M"@"? !$ FP 9 )D (P"7 "P E0 T )( / "0 $, C@!) (P 3P"* %0 B0!:
M (< 8 "& &8 A !N (, =P"! ($ ?P"- 'X FP!\ *H >P"\ 'H VP!X /4
M> #_ '@ _P!X /\ > #_ .T   #1 @  NP(  *P!  "B    FP   )8 !0"1
M  T C0 4 (L '0"( "8 A@ N (0 -@"" #T @ !# 'X 20!] $\ ? !5 'H
M6P!Y &$ =P!I '4 <0!T 'P <@"( '$ E@!O *4 ;@"V &T S@!L .X :P#_
M &L _P!K /\ :P#_ -\+  #"#   K@P  )X,  "3"P  C <  (@"  "%  D
M@0 0 '\ %P!\ "  >@ H '@ , !V #@ =  ^ ', 1 !Q $H < !0 &X 5@!M
M %T ; !D &H ;0!H '< 9P"$ &4 D@!D *$ 8P"R &$ R0!@ .D 8 #\ &
M_P!@ /\ 8 #_ - 0  "V$0  HA(  ),2  "($0  @ \  'P-  !Y"0$ > ,+
M '4 $0!S !H <  C &X!*P!L 3, :@(Y &D#0 !G T8 9@1, &4$4@!C!5D
M8@5A & %:@!?!G0 70:! %P'CP!:!Y\ 60>P %<'Q@!6">< 5@K[ %4*_P!5
M"O\ 5@K_ ,85  "M%P  F1@  (H8  !_%P  =A8  '$3  !N$   ;0T% &T)
M#0!J"10 9PH= &4*)@!C"RX 8@PU & ,/ !?#$( 7@U( %P-3P!;#58 60U>
M %@.: !6#G, 50Z  %,.CP!1#I\ 4 ZQ $X.R !-$.H 31#] $T0_P!-$/\
M31#_ +P;  "E'   DAT  (,>  !W'0  ;QP  &D:  !F%P  9!0  &00" !B
M#Q  7Q 8 %T0(0!;$2D 6A$Q %@2. !7$CX 5A)% %023 !3$U, 41-; % 3
M90!.%'  3!1] $L4C !)%)P 1Q6N $85Q0!%%>@ 11;^ $46_P!%%?\ 117_
M +4?  ">(0  BR(  'PB  !Q(@  :"$  &(?  !?'0  7!H  %L7 @!:%0T
M5Q84 %46'0!4%R4 4A@M %$8- !/&#L 3AE" $T92 !+&E  2AI8 $@:8@!'
M&FT 11MZ $,;B0!"&YH 0!NL #\;P@ ^'.4 /1S\ #X<_P ^&_\ /AO_ *\C
M  "8)   AB4  '<F  !L)@  8R4  %TD  !9(@  5A\  %0=  !3' L 41P2
M $X=&@!-'2( 2QXI $H>,0!)'S< 1Q\^ $8@10!%($T 0R!5 $(@7P! (6H
M/R%W #TAAP [(9@ .2&J #@BP  W(N, -R+[ #<B_P X(?\ ."'_ *HF  "4
M)P  @2D  ',I  !G*0  7RD  %@H  !4)@  42,  $\B  !,(@< 2B(0 $@B
M%P!'(Q\ 120F $0D+@!")#0 024[ $ E0P _)4H /293 #PF7  Z)F< .29U
M #<GA  U)Y8 -">H #(GO@ Q)^$ ,2?Y #(F_P R)O\ ,R7_ *4I  "/*@
M?2P  &\L  !D+0  6RP  %4K  !0*@  3"@  $HF  !')P0 1"<- $(H% !!
M*!P /RDC #XI*P ]*3( /"HY #LJ0  Y*D@ ."M0 #8K6@ U*V4 ,RMR #$K
M@@ P+)0 +BRG "PLO  K+-X +"SX "PK_P M*O\ +2K_ *$L  "++0  >2X
M &LO  !@+P  6"\  %$N  !,+@  2"P  $4K  !!*P  /RP+ #TL$0 [+1D
M.BXA #DN*  W+B\ -B\V #4O/@ T+T4 ,R]. #$P6  P,&, +C!P "PP@  J
M,)( *3"E "<PN@ F,-P )C#W "<O_P H+_\ *"[_ )PN  "',   =C$  &@R
M  !=,@  53(  $XQ  !(,0  1#   $ O   \,   .C$) #<Q$  V,A8 -3(>
M #,S)0 R,RP ,3,S # T.P O-$, +31, "PT5@ J-6$ *35N "<U?@ E-9
M(S6C "(UN0 A-=D (33V "(T_P C,_\ (S+_ )@Q  "#,P  <C0  &4T  !:
M-0  434  $LT  !%-   0#0  #HS   W-   -#4& #(V#@ P-Q, +S<; "XW
M(@ M."D *S@Q "HX.  I.4  *#E) "8Y4P E.5\ (SEL "$Z?  @.HX 'CJB
M !PZMP ;.=4 '#GU !TX_P =./\ 'C?_ ),T  !_-@  ;C<  &$W  !7-P
M3C<  $@W  !"-P  /#<  #4X   R.0  +SH" "P["P J/!$ *3P8 "@]'P F
M/28 )3TN "0]-0 C/CT (CY& " ^4  ?/EP '3]I !L_>0 :/XP &#^@ !8_
MM0 5/M( %C[S !<]_P 8//\ &#S_ (XW  !Z.   :CD  %XZ  !3.@  2SH
M $4Z   _.@  .3H  #(\   N/@  *4   "9!"  D0@X (D(4 "%"&P @0R,
M'T,J !Y#,@ <0SH &T1# !I$30 81%D %T1G !5$=P 31(H $D2> !%$LP 0
M1-  $$/R !%"_P 20O\ $T'_ (D[  !V/   9CT  %H]  !0/0  2#T  $(]
M   \/0  -CX  "]    J0@  )40  "%& P =2 P &TD1 !E)%P 821X %TDF
M !9)+@ 52C8 %$I  !-*2@ 12E8 $$ID  ]*=  .2H< #4J;  Q*L  *2LH
M"TGL  Q(_P -1_\ #4?_ (,^  !Q/P  8D   %9   !-0   14   #]    Y
M00  ,D(  "M%   F1P  (4D  !Q+   63@< $U . !)0$P 14!D $% A  ]0
M*0 .4#$ #5 [  U11@ +45$ "E%?  E1;P '4($ !5"6  -0JP "4,4  T_H
M  -/^P %3O\ !DW_ 'U"  !K0P  740  %)$  !*1   0T,  #Q$   U10
M+D<  "=*   A3   '$\  !=1   25 , #E<*  M8$  *6!4 "%@<  =8)  &
M6"P !5@V  -80  !6$P  %A:  !8:0  6'P  %B1  !7IP  5\   %;E  !6
M^0  5?\  %7_ '9'  !F1P  64@  $]'  !'1P  0$<  #A(   P2@  *4T
M ")0   <4P  %E4  !%8   -6P( "5X)  1?#@  7Q(  %\8  !@'P  8"<
M & P  !@.P  8$<  &!4  !@8P  8'8  &"+  !?H@  7[L  %_B  !>^0
M7?\  %W_ &]+  !A3   54P  $Q+  !$2P  .TP  #).   K40  (U0  !Q7
M   66P  $5X   U@   (8P   F8'  !G#   9P\  &@3  !I&0  :B$  &HI
M  !J-   :D   &I-  !J70  :F\  &J%  !JG0  :;8  &C=  !H]P  9_\
M &;_ &E1  !<4   4E   $I/   _4   -5,  "U6   D60  '5T  !9@   0
M9   #&<   9J    ;@   &\#  !P"   <0T  '(0  !T%   =1L  '8C  !W
M+   =S@  '9&  !V5@  =F@  '9^  !VEP  =;$  '33  !S]0  <_\  '+_
M &-6  !850  4%0  $15   Y6   +UL  "9?   =8P  %6<  !!L   *<
M!',   !V    >@   'P   !\ P  ?@@  '\,  "!$   @A0  (0;  "%)
MAB\  (8]  "&30  A5\  (5U  "%CP  A*D  (/)  ""\0  @?\  (#_ %];
M  !66@  25L  #U>   R80  )V8  !YK   5<   #G4   EY   !?@   ($
M  "%    B    (H   "+    C0$  (X&  "0"P  D0\  ),4  "5&P  ER8
M )<T  "71   EU8  )9L  "5A@  E:(  )3!  "3Z@  DO\  )+_ %UA  !/
M80  0F0  #9I   J;@  'W0  !5Y   .?P  !X0   ")    C@   )(   "6
M    F    )H   ";    G0   )\   "A P  HP@  *4-  "G$P  J1P  *HH
M  "J.0  JDL  *IA  "I>@  J)D  *BU  "GW0  I_@  *;_ %9H  !(;
M.G   "YV   B?0  %X0   Z*   'D    )8   ":    GP   *,   "G
MJ@   *L   "M    KP   +$   "S    M0   +@%  "Z#   O1(  , <  #
M+0  P$   +]5  "_;@  OHL  +ZH  "^R0  O>\  +S^ $YT  ! >0  ,G\
M "6'   9C@  $)4   ><    H@   *<   "L    L    +4   "Y    O
M +T   "_    P0   ,,   #&    R    ,H   #- @  T L  -42  #6(0
MUS0  -A)  #98   VGP  -J:  #;M0  V]D  -OR $:"   XB0  *Y   !V8
M   2H   "J<   "N    M    +D   "^    P@   ,@   #+    S@   ,\
M  #2    U    -8   #:    W0   -\   #B    Y@   .H*  #O$P  \"4
M /(Z  #S40  ]&L  /2)  #UI0  ];\  /7= /\ !@#_  , _P % /\ "P#_
M !  _P 7 /\ (@#_ "T _P Y /\ 1 #_ $T _P!5 /\ 70#_ &0 _P!J /\
M< #] '8 ^P!\ /D @P#W (H ]0"2 /, FP#P *8 [@"S .L Q #I .0 YP#Y
M .8 _P#E /\ TP#_ ,< _P"_ /\ NP#_ /\   #_    _P   /\  @#_  L
M_P 2 /\ '0#_ "@ _P S /\ /@#\ $< ^ !/ /0 5P#Q %T [@!C .P :0#J
M &\ Z !U .8 ? #D (, X@"+ -\ E0#< )\ V0"K -4 NP#2 -0 SP#R ,T
M_P#, /\ Q0#_ +H _P"T /\ L #_ /\   #_    _P   /\   #_  8 ^0 /
M /4 %P#S "( \0 M .T -P#G $  X@!) -\ 4 #; %< UP!= -0 8P#1 &@
MSP!N ,P =0#* 'P R "$ ,4 C0#" )@ P "D +T L@"[ ,8 N0#H +@ _0"W
M /\ M@#_ *T _P"G /\ HP#_ /\   #_    _P   /4   #K  $ Y  , -X
M$P#9 !P TP F -$ , #, #H R !" ,0 2@#  %  O0!6 +L 7 "Y &$ MP!G
M +4 ;0"S '0 L0!\ *\ A0"M )  J@"< *@ J@"F +L I0#: *, ]0"C /\
MH@#_ )X _P": /\ EP#_ /\   #^    [P   -\   #0    QP ' ,$ #P"\
M !< N0 @ +< *@"U #, L  [ *T 0P"K $D J !/ *8 50"D %H HP!@ *$
M9@"? &T G0!T )P ?0": (@ F "4 )8 H@"4 +( D@#) )$ ZP"1 /\ D #_
M )  _P", /\ B@#_ /P   #L    V0   ,<   "Z    L0 " *L # "G !(
MI  ; *$ ) "@ "P G@ U )L / "8 $, E@!) )0 3P"2 %0 D !: (\ 7P"-
M &8 BP!M (D =@"( (  A@", (0 F@"" *H @0"^ (  X "  /D ?P#_ '\
M_P!_ /\ ?@#_ /$   #8    P@   +,   "H    H    )D !P"5  X D@ 5
M )  '@". "8 C0 N (H -@"' #T A0!# (0 20"" $X @0!4 '\ 60!^ &
M? !G 'H ;P!Y 'H =P"& '4 E !T *, <@"U '( SP!Q /$ < #_ '  _P!P
M /\ <0#_ .$   #$    L    *(   "7    D0   (L  @"&  L @P 1 ($
M& !_ "$ ?0 I 'P , !Y #< >  ] '8 0P!T $D <P!. '( 5 !P %H ;P!B
M &T :@!K '0 :@"  &@ C@!G )T 90"O &4 Q@!D .@ 9 #] &, _P!C /\
M9 #_ ,\%  "V!P  HP@  )0(  ")!P  @@,  'X   ![  8 =P . '4 $P!R
M !L <0 C &\ *P!M #( ;  X &H /@!I $0 9P!) &8 3P!E %8 8P!= &(
M90!@ &\ 7P![ %T B0!< )D 6P"J %D OP!9 .$ 6 #X %@ _P!8 /\ 60#_
M ,(,  "J#0  EPX  (D.  !]#@  =@T  '$*  !O!@  ;0 * &L $ !I !8
M9P > &4 )@!C "T 80 S &  .0!? #\ 70!% %P 2P!; %( 6@!9 %@ 8@!7
M &P 50!X %, A@!2 )8 40"G %  NP!/ =L 3@+T $X#_P!.!/\ 3@/_ +@0
M  "A$@  CA,  '\3  !T$P  ;!(  &<0  !E#@  8PL# &,&# !A!!$ 7@,9
M %P$(0!;!2@ 608O %@&-0!6!SL 50=" %0'2 !3"$\ 40A6 % )7P!."6D
M30EV $L*A !)"I0 2 JF $<*N@!&"M@ 10OS $4,_P!%#/\ 10S_ + 4  "9
M%@  AQ@  '@9  !M&   91<  %\6  !<$P  6A$  %H.!@!:# T 5PP4 %4,
M' !3#20 4@TK % -,0!/#C@ 3@X^ $T.10!+#DT 2@Y5 $@/7@!'#V@ 10]U
M $,0A !!$)4 0!"F #X0NP ]$-P /1'V #T1_P ]$/\ /A#_ *D9  "2&P
M@1P  '(=  !G'0  7QP  %D;  !5&0  4Q8  %(3  !2$0H 4! 0 $X1& !,
M$2  2A(G $D2+@!($S0 1Q,[ $430@!$$TD 0Q12 $$46P _%&4 /A5R #P5
M@0 Z%9( .!6D #<5N0 U%=@ -1;U #86_P V%O\ -Q7_ *,<  "-'@  >R
M &TA  !B(0  6B$  %0?  !0'@  31L  $P9  !+%@8 218. $<7%0!%%QP
M1!@D $(8*@!!&#$ 0!DX #\9/P ]&48 /!I/ #H:6  Y&F, -QMO #4;?@ S
M&Y  ,ANB # ;MP O&], +QSS "\;_P P&_\ ,!O_ )T?  "((@  =R,  &DD
M  !>)   5B0  % C  !+(@  2"   $8=  !%' ( 0QP, $$<$@ _'1D /ATA
M #P>)P ['BX .A\U #D?/  W'T0 -A], #0@5@ S(&  ,2!M "\@?  M(8X
M+"&@ "HAM0 I(=  *2'R "DA_P J(/\ *R#_ )DB  "$)0  <R8  &4G  !;
M)P  4R<  $PF  !')0  1"0  $(A   _(0  /2$) #LA$  Y(A8 ."(> #8C
M)0 U(RL -"0R #,D.0 R)$$ ,"1* "\E4P M)5X *R5K "HE>@ H)8P )B6?
M "0ELP C)<X (R7P "0E_P E)/\ )23_ )0E  " )P  ;RD  &(J  !7*@
M3RH  $DI  !$*   0"<  #TF   Z)0  -R8& #4F#@ T)Q0 ,B<; #$H(@ P
M*"D +R@P "TI-P L*3\ *RE' "DI40 H*EP )BII "0J>  C*HH (2J= !\J
ML@ >*LP 'BKO !\I_P @*?\ (2C_ ) H  !\*@  ;"L  %\L  !4+   3"P
M $8L  !!*P  /"L  #@J   U*@  ,BL# # K#  N+!$ +2P8 "PL'P J+28
M*2TM "@M-  G+CP )BY% "0N3P C+EH (2]G !\O=@ =+X@ '"^; !HOL  8
M+\H &"[M !DN_P ;+?\ &RW_ (PK  !X+0  :"X  %LO  !1+P  22\  $,O
M   ^+@  .2X  #0N   P+@  +2\  "LP"@ I,1  )S$5 "8Q'  E,B, )#(J
M ",R,0 A,SD (#-" !\S3  =,U< &S-D !HT=  8-(8 %C2: !0SK@ 3,\@
M$S/L !0S_P 5,O\ %C'_ (<N  !T+P  93$  %@Q  !.,@  1C(  $ Q   [
M,0  -C$  #$Q   K,P  *#0  "4U!@ C-@T (382 " W&0 ?-R  'C<G !TX
M+@ ;.#8 &C@_ !DX20 7.54 %3EB !0Y<0 2.80 $3F8 ! YK0 ..,< #CCK
M ! X_P 0-_\ $3;_ (,Q  !P,@  830  %4T  !+-   1#0  #TT   X-
M,S0  "TU   H-P  )#D  " Z @ =.PL &SP0 !D]%0 8/1P %STC !8]*P 5
M/C, %#X\ !(^1@ 1/E( $#Y?  \^;P ./H$ ##Z5  L^J0 */L$ "CWD  L]
M^P ,//\ #3O_ 'TT  !K-@  73<  %$W  !(-P  03<  #LW   U-P  ,#<
M "HY   E.P  (#T  !P_   7008 %$,- !)#$@ 10Q@ $4,? !!$)P /1"\
M#D0Y  U$0P ,1$X "T1;  E$:@ '1'P !D20  1#I0 "0[T  T/@  -#]@ $
M0O\ !D'_ '@X  !G.0  63H  $XZ  !%.@  /CH  #@Z   S.@  +3L  "<]
M   A0   '$(  !=$   31@, #TD*  U*#P ,2A0 "TH;  E*(P (2BL !THT
M  5*/@ $2DD  DI6  !*90  2G<  $J+  !*H0  2;D  $G=  !)]0  2/\
M $C_ '(\  !B/0  53X  $H^  !"/0  /#T  #8]   O/@  *4   "-"   =
M10  %T<  !-*   /3 ( "T\)  =0#0 #41$  %$7  !1'@  428  %$O  !1
M.0  440  %)1  !28   47(  %&'  !1G0  4;4  %#8  !0]0  3_\  $__
M &Q   !=00  44$  $=!  ! 0   .4   #)!   J0P  )$8  !Y(   72P
M$DX   Y1   +4P$ !E8'  !7#   6!   %@3  !9&0  6B$  %HI  !:,P
M6C\  %I,  !:6@  6FP  %J!  !9F0  6;$  %C1  !8]   5_\  %?_ &5%
M  !810  344  $5$   ^1   -44  "U'   E2@  'DT  !A0   24P  #E8
M  I9   $7    %X$  !?"0  8 T  &$0  !B%0  8QL  &0C  !D+0  9#@
M &1%  !D5   9&8  &1[  !CDP  8ZT  &+,  !A\@  8?\  &#_ %]*  !3
M2@  2DD  $-(   Y20  +TP  "=/   ?4@  &%4  !)9   -70  "&    )C
M    9@   &@!  !I!0  :@H  &L-  !M$0  ;A8  ' =  !Q)@  <3$  ' ^
M  !P3@  <%\  '!S  !OC0  ;Z<  &[&  !M[P  ;/\  &S_ %I/  !03@
M2$T  #U.   S40  *50  "!8   87   $6    QD   &:    &L   !O
M<@   '0   !U    =P0  '@)  !Z#0  ?!   'T6  !_'@  @"@  ( U  "
M10  ?U8  ']K  !_A   ?J   'V^  !\Z0  >_\  'K_ %94  !.4P  0E0
M #=6   L6@  (E\  !AC   1:   "VT   -R    =@   'H   !]    @
M (,   "$    A@   (<"  ")!P  BPP  (T0  "0%@  DA\  )(L  "2.P
MDDT  )%B  "1>@  CY<  (^T  ".X0  C/L  (S_ %59  !(6@  .UT  "]A
M   D9@  &6P  !%R   *=P   GT   ""    A@   (L   ".    D0   ),
M  "5    EP   )D   ";    G00  )\*  "B#P  I!8  *8A  "F,0  ID,
M *57  "D<   HXX  *.K  "AT   H/4  )__ $YA  ! 9   ,VD  "=N   ;
M=0  $7P   N#    B0   (X   "3    F    )T   "A    I    *4   "G
M    J0   *L   "M    L    +(   "U"   N X  +P6  "\)0  O#<  +M,
M  "Z9   N8$  +>B  "WP   M^H  +?\ $9K   Y<   *W<  !]_   3A@
M"XX   &5    FP   *$   "F    JP   +    "S    MP   +<   "Z
MO    +\   #!    Q    ,<   #*    S04  -$.  #4&0  U"L  -1   #3
M6   TW0  -.2  #2L   TM,  -+R #YY   Q@   (X@  !>1   -F0   Z
M  "G    K@   +,   "X    O0   ,(   #&    R@   ,H   #-    SP
M -(   #5    V0   -T   #?    XP   .<%  #K#P  [!\  .TS  #N2P
M[V0  .^"  #PGP  \;D  /'8 /\   #_    _P $ /\ "0#_  X _P 5 /\
M'@#_ "D _P T /\ /P#_ $@ _P!0 /\ 6 #_ %X _P!E /T :P#[ '$ ^0!W
M /@ ?@#V (4 \P"- /$ EP#N *( ZP"O .@ P #F .  XP#X .( _P#; /\
MRP#_ ,$ _P"Y /\ M #_ /\   #_    _P   /\   #_  D _P 0 /\ &0#_
M ", _P N /T .0#Y $( ]0!* /( 4@#N %@ ZP!> .D 9 #F &H Y !P .(
M=@#? 'T W0"& -D CP#5 )H T0"G ,X M@#+ ,X R0#P ,< _P#% /\ NP#_
M +0 _P"M /\ J0#_ /\   #_    _P   /\   #[  ( ]@ - /$ $P#M !X
M[  H .D ,@#C #L W0!$ -@ 2P#3 %$ T !8 ,T 70#+ &, R0!H ,8 ;P#$
M '8 P@!^ +\ AP"\ )( N@"? +< K0"U ,$ L@#D +$ _0"O /\ K #_ *4
M_P"@ /\ G #_ /\   #_    ^P   .X   #D    W  ( -, $ #/ !@ RP B
M ,D *P#& #0 P0 ] +T 1 "Z $L MP!1 +4 5@"R %P L !A *X 9P"L &X
MJ@!V *@ ?P"F (H HP"6 *$ I0"? +8 G0#1 )P \P"; /\ G #_ )8 _P"3
M /\ D #_ /\   #V    YP   -,   #&    O0 # +@ #0"S !, L0 < *\
M)0"N "X J0 V *8 /0"C $0 H0!* )\ 3P"= %4 FP!: )H 8 "8 &8 E@!N
M )0 =P"2 ($ D ". (X G ", *T B@## (D Z "( /\ B0#_ (< _P"% /\
M@@#_ /,   #C    S    +P   "P    IP   *$ " ">  \ FP 6 )D 'P"8
M "< E@ O ), -P"1 #T C@!# (P 20"+ $X B0!4 (< 60"% &  A !G ((
M;P"  'H ?@"& 'P E !Z *0 >0"X '@ V !W /< > #_ '@ _P!W /\ =0#_
M .8   #+    MP   *@   ">    E@   (\ ! "+  P B  2 (< &0"% "$
MA  I (( , !_ #< ?0 ] 'P 0P!Z $@ >0!- '< 4P!V %D = !A '( :0!Q
M ', ;P!_ &T C0!L )T :@"O &D R !H .T :0#_ &D _P!I /\ :0#_ -(
M  "X    I0   )<   "-    A@   ($   !\  @ >0 . '< % !V !P =  C
M ', *P!Q #$ ;P W &X /0!L $, :P!( &H 3@!H %0 9P!; &4 8P!C &T
M8@!X &  AP!? )8 70"H %T O@!< .0 7 #[ %P _P!< /\ 7 #_ ,(   "J
M 0  F ,  (D$  !_ @  >    '0   !P  0 ;0 , &L $0!I !< :  > &8
M)0!E "P 8P R &( . !@ #T 7P!# %X 20!< $\ 6P!6 %H 7@!8 &@ 5P!S
M %4 @0!4 )$ 4@"C %$ MP!1 -8 40#U %$ _P!1 /\ 4@#_ +8'  "?"0
MC0L  'X,  !S"P  ; H  &@'  !E P  8P ' &$ #0!? !, 70 : %P (0!;
M "< 60 M %@ ,P!6 #D 50 _ %0 10!3 $L 40!2 %  6@!/ &0 30!O $P
M?0!* (T 20"? $@ L@!' ,P 1P#O $8 _P!' /\ 1P#_ *P,  "5#@  @Q
M '40  !K$   8P\  %X.  !;#   6@D" %D$"@!7  \ 50 5 %, ' !2 ",
M40 I $\ +P!. #4 30$[ $P!00!* D@ 20)/ $@"5P!& V$ 10-M $,#>@!"
M XL 0 .< #\#KP ^ \@ /03J #T%_  ]!O\ /@;_ *00  ".$@  ?!,  &X4
M  !D%   7!,  %82  !3$0  40X  % ,!0!0"0P 3P<1 $T'%P!+"!\ 20@E
M $@)*P!'"3$ 1@DX $0*/@!#"D4 0@I- $ +50 _"U\ /0MK #P+>0 Z#(H
M. R< #<,KP U#,< -0SI #4-_0 U#?\ -@S_ )T3  "'%0  =A<  &D8  !>
M&   5A@  % 7  !-%0  2A,  $D1  !)#@< 2 T. $8-$P!$#1H 0PXA $(.
M* ! #BX /PXU #X//  ]#T, .Q!+ #H05  X$%X -A!K #00>0 R$(H ,1"<
M "\0L  M$,D +1'L "T1_P N$?\ +Q#_ )<6  ""&0  <1L  &0<  !9'
M41P  $P;  !'&@  1!@  $,5  !"$P( 01(+ $ 1$  ^$A< /!(> #L3)0 Z
M$RL .!,R #<3.0 V%$  -!1( #,440 Q%%P ,!5H "X5=P L%8@ *A6: "@5
MK@ G%<< )A7J "<5_P H%?\ *17_ )$:  !]'   ;1X  & ?  !6'P  3A\
M $@>  !#'0  0!P  #X:   ]&   .Q<' #D6#@ X%Q0 -A<; #48(@ S&"@
M,A@O #$9-@ P&3T +AE& "T:3P K&ED *AIF "@:=  F&H8 )!J9 "(:K0 A
M&L4 (!KH "$:_@ B&O\ (QK_ (T=  !Y'P  :2$  %PB  !2(@  2B(  $0A
M   _(0  /"   #D>   X&P  -1P$ #0<#0 R'!( ,!T8 "\='P N'24 +1XL
M "L>,P J'CL *1]# "<?30 F'U< )!]D "(?<@ @'X0 'Q^7 !T?JP ;'\,
M&Q_G !L?_0 ='_\ 'A[_ (D@  !U(@  92,  %DD  !/)0  1R4  $$D   \
M(P  .",  #4B   S(   ," ! "XA"@ L(1  *R$5 "HB'  H(B, )R(I "8C
M,  E(S@ (R-! "(D2@ A)%4 'R1A !TD<  ;)(( &225 !<DJ@ 6),$ %23E
M !8D_  7(_\ &2/_ (4B  !Q)   8B8  %8G  !,)P  1"<  #XG   Y)@
M-28  #$E   N)   *R4  "DE!P G)@X )283 "0G&0 C)R  (B<G "$H+@ @
M*#8 'B@^ !TH2  ;*5, &2E? !@I;@ 6*8  %"F4 !(IJ  1*<  $2CD !$H
M^P 3*/\ %"?_ ( E  !N)P  7R@  %,I  !)*@  0BD  #LI   V*0  ,B@
M "XH   J*   )BD  "0J!  B*PP ("L1 !\L%@ =+!T '"PD !LM*P :+3,
M&"T\ !<M10 6+E  %"Y= !(N;  1+GX $"Z2  XNIP -+;T #2W?  TM^0 .
M+/\ $"S_ 'PH  !J*@  6RL  % L  !&+   /RP  #DL   T*P  +RL  "LK
M   F+   (BX  !\O   <, D &C$. !DQ$P 7,1H %C(A !4R*  4,C  $S(Y
M !(S0P 1,TX $#-;  XS:0 -,WH ##..  HSH@ (,KD "#+9  @R]  *,?\
M"S'_ '<K  !F+0  6"X  $TO  !#+P  /"X  #8N   Q+@  +2X  "DN   C
M,   'S(  !LS   7-04 %#8, !(W$0 1-Q8 $3<= ! X)  /."P #C@U  TX
M/P ,.$H "SA7  DX90 '.'8 !3B*  ,XGP !-[4  3?3  (W\0 #-O\ !3;_
M ',N  !B,   5#$  $DQ  !!,0  .3$  #0Q   O,   *S   "4R   @,P
M&S8  !<X   3.@( $#P)  T]#@ ,/1, "ST9  H](0 )/2D "#TQ  8^.P %
M/D8  SY2  $^80  /G(  #Z&   ]G   /;(  #W0   \\   //\  #S_ &TR
M  !=,P  4#0  $8T   ^-   -S0  #(S   M,P  )S0  "(V   =.   &#H
M !0]   0/P( #4$(  E##0 &1!$  T06  )$'0  1"0  $0M  !$-@  1$$
M $1.  !$7   1&T  $2!  !$F   0Z\  $/-  !"\   0O\  $+_ &@V  !8
M-P  3#@  $,X   [-P  -38  # V   I-P  (SD  !X[   8/0  $T   !!"
M   -10$ "$<'  -)#   20\  $H3  !+&0  2R   $LH  !+,@  2ST  $Q)
M  !,5P  2V@  $M]  !+E   2JP  $K*  !)[P  2?\  $G_ &(Z  !4.P
M23L  $ [   Y.@  ,SD  "PZ   E/   'S\  !E!   31   $$<   Q)   (
M3    D\%  !0"@  4 T  %$0  !2%0  5!L  %0C  !4+   5#<  %1$  !4
M4@  5&,  %1W  !4CP  4Z@  %+&  !2[0  4?\  %'_ %P_  !//P  13\
M #X^   W/0  +SX  "=    @0P  &48  !-)   /3   "T\   92    5
M %<"  !8!P  60L  %H.  !;$0  718  %X=  !?)@  7S$  %X]  !>3
M7ET  %YQ  !=B0  7:,  %S!  !;ZP  6O\  %K_ %9$  !+0P  0T(  #Q!
M   R0@  *44  "%(   :2P  $TX   Y2   *50   UD   !;    7@   &
M  !B @  8P8  &4*  !F#@  :!$  &H7  !K'P  :RD  &LV  !K10  :U8
M &IJ  !J@@  :9T  &B[  !GYP  9O\  &7_ %%(  !(2   048  #='   L
M2@  (TT  !M1   350  #ED   A=   !80   &0   !G    :@   &P   !N
M    <    '(%  !S"0  =0T  '<1  !Z&   >R$  'LN  !Z/0  >DX  'EB
M  !Y>0  >)8  '>S  !UX   =/P  '/_ $Y-  !'3   .TT  #!/   F4P
M'%@  !-<   -80  !F8   !J    ;P   '(   !V    >0   'P   !]
M?P   ($   "# @  A@<  (@,  "+$0  CA@  (XD  ".,P  C40  (Q8  "+
M;P  BHP  (FJ  "(SP  AO<  (7_ $U1  !!4P  -%4  "E:   >7P  %&4
M  UJ   %<    '8   ![    ?P   (,   "'    B@   (T   ".    D0
M ),   "5    F    )H%  "=#   H!$  *,:  "C*   HCH  *%.  "@90
MH($  )Z@  "=P0  F^X  )K_ $99   Y7   +6$  "%G   6;@  #G4   5[
M    @0   (<   "-    D@   )8   ":    G0   )\   "A    I    *8
M  "H    JP   *X   "Q P  M L  +@1  "Y'@  N2\  +A#  "W6@  M78
M +27  "TM0  L>(  +#\ #]D   Q:0  )6\  !AW   /?P  !H<   ".
ME    )H   "@    I0   *H   "N    L0   +(   "U    MP   +H   "\
M    OP   ,,   #&    R0   ,X*  #2$P  TB,  -$W  #03P  SFH  ,V*
M  #*JP  R\L  ,OO #=Q   I>   '8   !&)   (D0   )H   "A    IP
M *T   "S    N0   +X   #"    Q0   ,8   #)    S    ,X   #2
MU0   -H   #>    X0   .4   #J"P  ZQ<  .HK  #J0P  ZEX  .IZ  #K
MF0  Z[4  .O5 /\   #_    _P ! /\ !P#_  T _P 2 /\ &P#_ "4 _P O
M /\ .@#_ $, _P!+ /\ 4P#_ %H _0!@ /L 9@#Z &L ^ !R /8 > #T (
M\0") .\ D@#L )T Z0"J .8 O #C -P WP#W -T _P#, /\ O@#_ +4 _P"P
M /\ K0#_ /\   #_    _P   /\   #_  8 _P - /\ % #_ !\ _P I /L
M,P#W #T \P!% .\ 30#L %, Z !9 .4 7P#C &4 X !J -T <0#: '@ U@"
M -( B@#/ )4 S "B ,@ L@#% ,D P@#M ,  _P"[ /\ L #_ *@ _P"D /\
MH0#_ /\   #_    _0   /H   #X    \  ) .P $0#H !D YP C .4 +0#>
M #8 U@ ^ -$ 1@#- $P R@!2 ,@ 6 #% %T PP!C ,  :0"^ '  O !X +D
M@0"W (T M ": +$ J0"N +P K #A *H _ "H /\ H #_ )D _P"6 /\ E #_
M /\   #Y    \@   .<   #;    T0 $ ,H #0#' !0 Q  = ,( )@"_ "\
MNP W +< /P"T $4 L0!+ *X 40"L %8 J@!< *@ 80"F &@ HP!P *$ >0"?
M (0 G0"1 )H H "8 +$ E@#, )4 \0"4 /\ D0#_ (L _P"( /\ A@#_ /<
M  #L    W@   ,D   "\    M    *\ "@"K !  J0 7 *@ ( "G "@ H@ P
M )\ . "< #X F@!$ )@ 2@"6 $\ E !5 ), 6@"1 &$ CP!H (T <0"+ 'L
MB0"( (< EP"% *@ @P"^ ($ Y "  /\ @ #_ 'P _P![ /\ >0#_ .D   #7
M    P0   +$   "F    G0   )< !0"4  T D@ 2 )  &@"/ "( C@ J (L
M,0") #@ AP ^ (4 0P"# $@ @0!. '\ 5 !^ %H ? !A 'H :0!X ', =@!_
M '4 C@!S )\ <0"S '  T !O /8 ;P#_ &\ _P!M /\ ; #_ -H   "_
MK    )X   "3    C    (4   ""  D ?P / 'X %0!] !P ?  D 'H *P!W
M #$ =0 W '0 /0!R $( <0!( &\ 30!N %, ; !: &L 8@!I &P 9P!X &8
MA@!D )< 8@"J &$ P@!@ .L 80#_ &$ _P!A /\ 8 #_ ,4   "M    FP
M (T   "#    ?    '<   !R  4 <  , &X $0!L !< ;  > &L )0!I "P
M9P Q &8 -P!D #T 8P!" &( 2 !@ $X 7P!5 %T 70!< &8 6@!R %D @ !7
M )  5@"C %4 N0!4 -X 5 #[ %0 _P!5 /\ 50#_ +8   "?    C0   '\
M  !U    ;@   &D   !F  $ 8P ) &$ #@!@ !, 7P 9 %X ( != "8 6P L
M %H ,@!8 #< 5P ] %8 0P!5 $D 4P!0 %( 6 !1 &$ 3P!L $X >@!, (H
M2P"< $H L0!) ,X 20#S $D _P!) /\ 2@#_ *H!  "4!0  @@<  '0(  !J
M"   8P8  %X$  !;    60 % %< # !6 !  5  5 %, &P!2 "( 40 H %
M+0!. #, 30 X $P /@!+ $4 2@!, $@ 5 !' %T 1@!H $0 =0!# (4 00"8
M $  JP!  ,4 /P#J #\ _P!  /\ 0 #_ * (  "*"P  >0T  &P-  !A#0
M6@T  %4+  !2"0  4 8  $\"" !.  T 3  2 $L %P!* !X 20 C $< *0!&
M "\ 10 T $0 .@!" $$ 00!( $  4  ^ %H /0!D #P <@ Z (( .0"4 #@
MIP W +X -@#C #8 ^0 V /\ -P#_ )@-  "##@  <A   &41  !;$0  4Q
M $X0  !*#@  2 T  $<* P!'!PH 100. $0"$P!" AH 00(@ $ #)0 ^ RL
M/00Q #P$-P [!#X .@5% #D%3@ W!5< -@5B #0&<  R!H  ,0:2 # &I0 O
M!;L +@7= "X&]0 M!_\ +@?_ )$0  !]$0  ;!,  %\4  !5%   3A0  $@3
M  !$$@  01   $ .  ! #08 0 H, #X)$  \"18 .PH< #D*(@ X"B@ -PLN
M #8+-0 U"SL ,PM# #(,3  P#%8 +PQA "T,;P K#'\ *@R2 "@,I0 G#+L
M)0S= "4-]0 F#?\ )PW_ (L2  !W%   9Q8  %L7  !1&   21<  $,7   _
M%0  /!0  #H2   Y$0$ .0\( #@.#0 W#A( -0X8 #0.'P R#B4 ,0\L # /
M,@ O$#H +1!" "P02P J$%4 *!!A "80;P D$(  (Q"3 "$0IP ?$+T 'A#@
M !X1]P ?$/\ (!#_ (84  !S%P  8QD  %<:  !-&P  11H  $ :   [&0
M.!@  #46   T%   ,Q($ #(2"P Q$A  +Q(5 "T2'  L$R( *Q,I "H3,  H
M$S< )Q0_ "842  D%%, (A1? " 5;0 ?%7X '161 !L5I0 9%;L &!7> !@5
M^  9%/\ &A3_ ((7  !O&@  7QP  %,=  !*'0  0AT  #P=   W'   -!L
M #$:   O&0  +A8  "P7"  K%@X *1<3 "@7&0 G&"  )1@F "08+0 C&#0
M(AD] " 91@ >&5$ '1E= !L::P 9&GP %QJ/ !4:HP 4&;H $AG; !,9]@ 4
M&?\ %1C_ 'T:  !K'0  7!\  % @  !'(   /R   #D?   T'P  ,1X  "T=
M   K'   *1L  "<;!0 E&PP )!P1 "(<%@ A'!T (!TC !\=*@ >'3( '!XZ
M !L>1  9'DX %QY; !8>:0 4'WH $AZ- !$>H@ 0'K@ #A[8  \>]0 0'?\
M$1W_ 'H=  !G'P  62$  $TB  !$(@  /"(  #8B   R(0  +B$  "H@   G
M(   )!\  "(@ @ @( H 'B$/ !TA%  <(1H &R(A !DB)P 8(B\ %R(X !4C
M00 4(TP $B-8 !$C9P 0(W@ #B.+  TCGP ,([0 "R/0  LB\  ,(O\ #2'_
M '8?  !D(@  5B,  $LD  !!)   .B0  #0D   O(P  *R,  "@C   D(P
M(",  !TD   ;)0< &28- !<F$0 6)A< %2<> !0G)0 3)RP $B<U !$H/P 0
M*$H #BA6  TH9  ,*'0 "BB'  DHFP ')[$ !2?,  8G[  ')OX "";_ '$B
M  !@)   4R8  $@G   _)P  -R8  #$F   M)@  *24  "4E   B)0  '2<
M !DH   6*@0 %"L+ !(L$  1+!0 $"P; ! L(@ .+"D #BTR  TM.P ++48
M"BU2  @M8  &+7  !"V#  (MF   +*X  "S)   LZP !*_P  BO_ &TE  !=
M)P  3R@  $4I   \*0  -2D  "\H   K*   )R<  ",G   ?*   &RH  !<L
M   3+@( $# (  XQ#0 -,1( ##$7  LQ'@ *,28 "#(N  <R-P %,D(  S).
M  $R7   ,FP  #)_   RE0  ,:P  #''   PZ@  ,/P  ##_ &@I  !8*@
M3"L  $$L   Y+   ,BL  "TK   I*@  )2H  " K   <+   %RX  !,P   0
M,@( #C0'  HW#  '-Q  !3<4  ,W&P "-R(  #<J   X,P  .#X  #A*   X
M6   .&@  #A\   WD@  -ZD  #;%   VZ@  -OT  #7_ &,L  !4+@  2"\
M #XO   V+@  ,"X  "LM   G+0  (BT  !TO   8,0  %#,  ! U   .-P$
M"CH'  8["P "/ X  #T2   ^%P  /AX  #XF   ^+P  /CH  #Y&   ^5
M/F0  #YW   ^CP  /:<  #W#   \Z0  //T  #O_ %XP  !0,0  1#(  #LR
M   T,0  +C   "DO   D,   'C(  !DT   4-@  $#D   T[   */0  !4 %
M  !!"@  0@T  $,0  !$%   11H  $8B  !&*P  1C4  $9!  !&3P  1E\
M $9S  !%B@  1:0  $3   !#Z   0_X  $+_ %@T  !+-0  034  #DU   R
M-   +3,  "8T   @-0  &C@  !0Z   0/0  #4    E"   $10   $<#  !(
M!P  2@L  $L.  !,$0  3A4  $\<  !/)0  3R\  $\\  !/2@  3UH  $YM
M  !.A0  3:   $R\  !+YP  2_X  $K_ %,Y  !'.0  /CD  #<X   Q-P
M*3<  "$Y   ;/   %3\  !!"   ,10  !T@   )*    30   $\   !1!
M4@<  %0+  !5#@  5Q$  %D7  !:'P  62D  %DV  !91   650  %AG  !8
M?P  5YH  %:W  !5XP  5/T  %3_ $X]  !#/0  /#P  #4[   L/   )#X
M !Q!   51   $$@   M+   %3@   %$   !4    5P   %D   !;    70(
M %X&  !@"P  8@X  &02  !G&   9R(  &8N  !F/   9DT  &5@  !E=P
M9),  &.Q  !AW0  8/P  %__ $E"  !!00  .C\  #!    F0P  'D8  !5*
M   03@  "E(   -6    6@   %T   !@    8P   &4   !G    :0   &L!
M  !M!0  ;PH  '(.  !U$@  =QL  '8F  !V-0  =48  '19  !T;P  <XL
M '*I  !PS0  ;_<  &[_ $9&  ! 10  -48  "I(   @3   %U$  !!6   )
M6@   5\   !C    :    &L   !O    <@   '4   !W    >0   'L   !]
M    @ ,  (,(  "&#0  B1,  (H=  "**P  B3P  (A/  "&9@  A8$  (2@
M  ""P@  @?   '__ $9+   Z3   +D\  "-3   86   $%X   ED    :0
M &\   !T    >    'P   "!    A    (<   "(    BP   (X   "0
MDP   )8   "9!P  G0T  *$4  "@(0  H#$  )Y$  "=6P  G'8  )F6  "9
MM0  EN4  )7^ #]2   R50  )EH  !M@   19P  "6T   !T    >P   ($
M  "&    BP   )    "4    EP   )D   "<    GP   *$   "D    IP
M *H   "M    L08  +4-  "X%@  MR8  +8Y  "U4   M&H  +*)  "PJ@
MKL\  *WU #=<   K80  'F@  !-P   +>    (    "'    C@   )4   ":
M    GP   *0   "H    K    *T   "P    LP   +4   "X    NP   +\
M  ##    QP   ,L%  #1#@  T1L  - N  #/10  S5\  ,M^  #)G@  R+X
M ,7I "]I   C<   %GD   V!   !BP   ),   ";    H@   *@   "N
MM    +@   "]    P    ,(   #%    R    ,L   #.    T0   -8   #;
M    WP   .0   #H!@  ZQ$  .HC  #J.@  Z50  .=R  #EDP  X[,  ./4
M /\   #_    _P   /\ ! #_  L _P 0 /\ %P#_ "$ _P K /\ -0#_ #X
M_P!' /\ 3@#_ %4 _ !; /H 80#X &8 ]@!M /0 <P#R 'L [P"$ .T C@#J
M )D Y@"G ., N0#? -4 VP#W -8 _P#  /\ L@#_ *H _P"E /\ H@#_ /\
M  #_    _@   /P   #\  , _@ + /\ $0#_ !H _0 D /D +@#T #@ \ !
M .P 2 #I $X Y@!4 .( 6@#? %\ W !E -@ :P#4 '( T ![ ,T A0#* )$
MQP"> ,, K@#  ,4 O0#K +L _P"P /\ I #_ )P _P"8 /\ E0#_ /\   #Z
M    ]    /$   #R    Z@ % .< #@#B !4 X0 > .$ * #8 #$ T  Y ,L
M0 #( $< Q0!- ,( 4P"_ %@ O0!> +L 9 "Y &L M@!S +0 ? "Q (@ K@"5
M *L I "H +@ I@#< *, ^P"? /\ E0#_ (\ _P"+ /\ B0#_ /D   #O
MYP   -\   #/    R    ,$ "@"_ !$ O  8 +L (0"Y "H M  R +$ .@"N
M $  JP!& *@ 3 "F %$ HP!6 *$ 7 "? &, G0!J )L <P"9 'X E@", )0
MFP"2 *T D #' (X \ "- /\ A@#_ (  _P!] /\ ? #_ .T   #@    T0
M +\   "S    J@   *8 !0"B  T H0 3 *  &P"? ", FP K )@ ,@"5 #D
MDP _ )$ 1 "/ $H C@!/ (P 50"* %L B !C (8 :P"$ '8 @@"" (  D@!^
M *, ? "Z 'H X0!Y /\ =P#_ '( _P!P /\ ;P#_ -T   #+    M@   *<
M  "=    E    (X  0"+  H B0 0 (@ %0"' !T AP E (0 + "" #( ?P X
M 'T /0![ $, >0!( '@ 3@!V %0 =0!; ', 8P!Q &X ;P!Z &T B0!L )H
M:@"N &D S !H /8 9P#_ &4 _P!D /\ 8P#_ ,H   "T    H0   ),   ")
M    @@   'L   !X  4 =@ , '4 $0!T !@ <P ? '( )0!P "P ;@ R &P
M-P!J #P :0!" &@ 2 !F $X 90!5 &, 70!B &8 8 !R %X @ != )( 6P"E
M %H O@!9 .D 60#_ %D _P!8 /\ 6 #_ +D   "B    D    (,   !Y
M<0   &T   !I  $ 9@ ) &4 #@!D !, 8P 9 &, ( !A "8 8  L %X ,0!<
M #< 6P \ %H 0@!8 $@ 5P!/ %8 5P!4 &  4P!L %$ >0!0 (H 3P"> $X
MM !- -H 30#[ $T _P!- /\ 30#_ *H   "4    @@   '4   !K    9
M &    !=    6@ % %@ # !7 !  5@ 5 %8 &P!5 "$ 4P G %( + !1 #$
M3P W $X /0!- $, 3 !* $H 4@!) %L 2 !F $8 <P!% (0 1 "7 $, K !"
M ,D 0@#Q $( _P!# /\ 0P#_ )X   ")    > ,  &H$  !A!   6@,  %4!
M  !2    4  " $X "0!-  T 3  1 $L %P!* !P 20 B $@ )P!' "T 10 R
M $0 . !# #X 0@!% $$ 30 _ %8 /@!A #T ;@ [ 'X .@"1 #D I@ X +\
M. #H #@ _P Y /\ .0#_ )4#  " !P  ;PD  &(*  !8"P  40H  $P(  !)
M!@  1P,  $8 !@!$  L 0P / $( $P!! !@ 00 > #\ (P ^ "D /0 N #L
M-  Z #H .0!! #@ 20 W %( -@!= #0 :@ S 'H ,@", #$ H0 P +@ +P#>
M "\ ^0 O /\ , #_ (P)  !X#   : T  %P.  !2#@  2PX  $4-  !!#
M/PH  #X( @ ]! @ / $- #L $  Z !4 .0 : #@ (  V "4 -0 K #0 ,  S
M #< ,@ ^ #$ 1@ O %  +@!: "T 9P K '< *@") "D G0 H +, )P#1 "<
M\@ G /\ )P#_ (8,  !R#@  8Q   %81  !-$0  11$  $ 0   \#P  .0X
M #<-   V"P0 -@@* #4&#@ T!1( ,@07 #$%'  P!2( +P4H "X&+@ M!C0
M*P8\ "H&1  I!TX )P=9 "8'90 D!W4 (P>' "('FP @!K  ( ;+ !\%[0 ?
M!OX 'P?_ ( .  !M$0  7A(  %(3  !($P  01,  #L3   W$@  -!$  #(0
M   P#P$ , T& # +"P O"A  +0H4 "P+&0 J"Q\ *0LE "@,*P G##( )@PZ
M "0,0P C#$T (0U8 " -90 >#74 ' V( !H-G  9#;$ & S* !<,ZP 7#?P
M& S_ 'L1  !I$P  6A4  $X6  !%%@  /18  #@5   S%0  ,!0  "T3   K
M$@  *A # "H/"  I#@T * X1 "8.%@ E#QT ) \C ",/*0 A$#$ (! Y !X0
M0@ =$$P &Q!8 !D09@ 7$'8 %1") !00G@ 2$+, $1#. !$0[@ 2$/X $A#_
M '<3  !E%0  5Q<  $L8  !"&0  .AD  #08   P%P  +!<  "D6   G%0
M)A0! "42!  C$@L (A(/ "$2%  @$AH 'A,@ !T3)P <$RX &A,V !D40  7
M%$H %A16 !049  2%'0 $12' ! 4G  .%+$ #13*  T4ZP .$_X #A/_ ',5
M  !A&   4QH  $@;   _&P  -QL  #(:   M&@  *1D  "88   D&   (A<
M " 6 0 >%@@ '18- !L7$@ :%Q< &1<= !@8)  6&"L %1@T !08/0 2&4@
M$1E4 ! 98@ .&7( #1F$  P9F  *&:T "1C&  D8YP )&/H "A?_ &\8  !>
M&@  4!P  $4=   \'0  -1T  "\=   J'   )AL  ",;   A&@  'AH  !P:
M   :&P4 &!L, !8<$  5'!4 %!P; !,<(@ 2'2D $1TQ ! =.P .'44 #1Y1
M  P>7@ *'FT "1Z   <>E  %':H  QW"  ,=Y@ $'/@ !1S_ &L:  !;'0
M31X  $(?   Z'P  ,A\  "T?   H'@  )!X  "$=   >'0  '!T  !@>   5
M'P( $R ) !(A#@ 0(1( $"$8  XA'P .(B8 #2(N  PB-P *(D$ "2)-  <B
M6@ %(FD  R)\  $BD0  (J@  "'    AY0  (/@  "#_ &<=  !7'P  2B$
M $ A   W(@  ,"$  "HA   F(   (B   !\?   <'P  &2   !8A   2(P(
M$"0'  XF#  ,)A  "R85  HF'  ))B( ""8J  8G,P $)ST  R=)  $G5@
M)V8  "=Y   GCP  )J8  ":_   EY   )?D  "3_ &,@  !4(@  1R,  #TD
M   T)   +B,  "@C   D(@  (2(  !XA   :(@  %R,  !,D   0)@( #B@'
M  LJ"P (*PX !BL3  0K&  "*Q\  2PG   L,   +#H  "Q%   L4P  +&,
M "QV   LC   *Z0  "N^   JY   *OH  "G_ %\C  !0)0  1"8  #HF   R
M)@  *R8  "8E   C)   'R0  !LD   7)0  %"<  !$I   .*P( "RT&  <O
M"P $, X  # 1   Q%0  ,1P  #$C   R+   ,C8  #)"   R3P  ,E\  #)R
M   QB0  ,:(  #"\   PY   +_L  "__ %HG  !,*   0"D  #<I   O*0
M*2@  "4G   A)@  '"<  !@H   4*@  $2P   XN   +, $ !S(%  ,T"0
M-0P  #8/   W$@  .!@  #@@   X*   .#(  #D]   Y2P  .5L  #AN   X
MA0  -Y\  #>Z   VY   -?P  #7_ %4J  !(+   /2P  #0L   M*P  *"H
M "0I   >*@  &2L  !0M   1+P  #3$   HT   '-@   C@$   Z!P  .PH
M #T-   ^$   0!0  $ ;  ! )   0"X  $ Y  ! 1P  0%8  $!I  ! @
M/YL  #ZW   ]XP  //P  #S_ % O  !#+P  .2\  #(O   L+0  )RP  " M
M   :+P  %3$  !$S   --@  "3@   4[    /0   $ !  !!!   0P<  $4+
M  !&#@  2!$  $H6  !*'@  2B@  $HT  !)0@  25$  $ED  !(>P  2)<
M $>T  !&X   1?P  $3_ $HS   _,P  -C,  # Q   J,   (S$  !PS   6
M-0  $3@   T[   (/@   T$   !#    1@   $@   !*    3 0  $X'  !/
M"P  40X  %02  !5&0  52(  %0N  !4/   5$L  %->  !3=   4I   %&N
M  !0UP  3_L  $[_ $4W   \-P  -38  "\T   F-0  'C<  !<Z   1/0
M#$$   =$    2    $H   !-    4    %,   !5    5P   %@"  !;!@
M70L  %\.  !B$P  8AL  &(G  !B-   844  &!7  !@;0  7XD  %VG  !<
MS   6O@  %G_ $$\   Z.P  -#D  "HZ   A/   &$   !%#   ,1P  !DL
M  !/    4P   %8   !9    7    %\   !A    8P   &4   !G 0  :@4
M &T*  !P#@  <Q4  '(@  !R+0  <3T  '!/  !O90  ;H   &V?  !KP0
M:?$  &C_ #]    Y/@  +C\  "1"   :1@  $DH   Q/   $5    %@   !=
M    80   &4   !H    :P   &X   !Q    <P   '4   !X    >P   'X#
M  "!"@  A0\  (<7  "&)   A30  (1&  ""70  @78  '^6  !^M@  ?.<
M 'K_ #]$   S10  *$@  !U,   34@  #%<   -=    8P   &@   !M
M<0   '8   !Z    ?@   ($   "#    A@   (D   "+    C@   )(   "5
M 0  F0D  )X0  ">&@  G2D  )P\  ":4@  F&P  ):+  "4J@  DM0  )#Z
M #A+   L3@  (%,  !59   -8    V<   !N    =    'H   "     A
M (H   ".    D@   )4   "7    F@   )T   "@    HP   *<   "K
MKP   +0)  "X$   MQX  +4P  "S1@  L6   *]^  "LH   J\$  *GN #%5
M   D6P  &&$   YI   %<0   'D   "!    B    (\   "4    F@   )\
M  "D    J    *D   "L    KP   +,   "U    N0   +T   #!    Q@
M ,L   #1"@  TQ0  -$E  #0.P  S50  ,IQ  #(D@  Q;,  ,/> "EB   <
M:0  $7$   =[    A    (T   "5    G0   *,   "I    KP   +0   "Y
M    O    +X   #"    Q0   ,@   #,    T    -0   #:    WP   .0
M  #J    [@P  .T:  #L+P  ZDD  .AE  #FA@  Y*4  .+& /\   #_
M_P   /P  0#\  @ _@ . /\ % #_ !T _P F /\ , #_ #H _P!" /\ 20#^
M %  ^P!6 /D 7 #V &( ] !H /( ;P#P '8 [0!_ .H B0#G )4 Y "C .
MM0#; -  U0#V ,H _P"V /\ J #_ )\ _P": /\ E@#_ /\   #[    ]@
M /,   #S    ]@ ) /H #@#] !8 ^P @ /< *@#R #, [0 [ .D 0P#F $D
MX@!/ -X 50#; %L U@!@ -( 9P#/ &X S !V ,D @ #& (P P@": +\ J@"[
M ,$ N #I +8 _P"G /\ F@#_ )( _P"- /\ B@#_ /H   #Q    Z@   .<
M  #G    Y  ! .  "P#; !$ V@ : -L (P#1 "P R@ T ,8 .P#" $( OP!(
M +P 3@"Z %, N !9 +8 7P"S &8 L0!N *X =P"L (, J0"1 *8 H0"C +4
MH #8 )X ^P"5 /\ BP#_ (4 _P"  /\ ?@#_ .\   #C    V@   -,   #&
M    OP   +D !@"W  X M  4 +0 '0"S "4 K@ M *L - "G #L I !! *$
M1@"? $P G0!1 )L 5P"9 %X EP!E )4 ;@"3 'D D "' (X EP", *D B0#$
M (@ [P"% /\ ? #_ '8 _P!S /\ <@#_ .    #0    Q@   +8   "I
MH0   )T  0"9  H F  0 )@ %@"7 !X E  F )$ +0"/ #0 C  Z (H /P"(
M $4 AP!* (4 4 "# %8 @0!> (  9@!^ '$ ? !] 'D C0!W *  =0"V ',
MWP!R /\ ;@#_ &D _P!G /\ 90#_ ,P   "^    JP   )T   "3    B@
M (4   ""  4 @  - '\ $0!_ !@ @  @ 'T )@!Z "T =P S '4 . !T #X
M<@!# '  20!O $\ ;0!6 &P 7@!J &@ : !U &< A !E )8 9 "K &( R0!A
M /8 8 #_ %P _P!; /\ 6@#_ +T   "I    EP   (D   !^    >    ',
M  !O  $ ;0 ) &P #@!K !, :P 9 &H ( !H "8 9@ L &4 ,@!C #< 8@ \
M &  0@!? $@ 70!/ %P 5P!: &$ 60!M %< >P!6 (X 50"B %, NP!2 .D
M4@#_ %  _P!/ /\ 3P#_ *T   "8    A@   '@   !N    9P   &,   !@
M    70 % %P "P!; !  6P 5 %L &P!: "$ 6  F %8 + !4 #$ 4P V %(
M/ !1 $( 3P!) $X 40!- %L 2P!F $H = !) (4 2 "9 $< L0!& -@ 1@#\
M $4 _P!% /\ 10#_ )\   ")    >    &P   !B    6P   %8   !3
M40 " $\ " !/  T 3@ 1 $X %@!- !P 3  A $H )@!) "P 2  Q $< -P!%
M #T 1 !$ $, 3 !" %4 0 !@ #\ ;@ ^ 'X /0"2 #P J0 [ ,< .P#S #L
M_P [ /\ / #_ ),   !^    ;@   &$   !8    40   $P   !)    1P
M $4 !0!$  L 0P . $, $@!# !< 0@ = $  (@ _ "< /@ L #T ,@ [ #@
M.@ _ #D 1P X %  -P!; #4 :  T '@ ,P", #( H@ Q +P ,0#G #$ _P R
M /\ ,P#_ (D   !V P  9@4  %D'  !0!P  208  $,%  !  P  /@$  #P
M P [  @ .@ - #H $  Y !0 .0 9 #< '@ V ", -0 H #0 +@ S #0 ,@ [
M #  0P O $P +@!7 "T 9  L ', *P"' "H G  I +4 *0#< "D ^P I /\
M*@#_ ($$  !N"   7PH  %,+  !*"P  0@L  #T*   Y"0  -@@  #4%   T
M @8 ,P * #( #@ Q !$ ,0 5 #  &@ O !\ +@ D "P *@ K #  *@ W "D
M/P H $D )P!4 "8 8  D &\ (P"" "( EP A *X (0#, "$ \P A /\ (@#_
M 'L)  !H#   6@T  $X.  !%#@  /0X  #@-   S#0  , P  "X+   M"0,
M+08( "P$#  K @\ *@$2 "D!%P H 1P )P A "8 )P E "T )  T ",!/0 B
M 48 (0%1 !\!70 > 6P ' %_ !L E  : *H &@#% !H ZP 9 /\ &@#_ '4,
M  !D#@  50\  $H0  ! $   .1   #,0   O#P  + X  "D.   G#0$ )PP%
M "<*"@ F" T )0<0 "0&%  B!AD (08? " ')  ?!RL '@<R !T'.@ <"$0
M&@A/ !D(7  7"&L %@A] !4'D0 4!Z< $P:_ !(%Y  2!?H $@7_ '$.  !?
M$   41$  $82   ]$@  -A(  # 2   K$0  *!$  "40   C$   (@X$ "$-
M!P A# L ( L. !\+$@ ="Q< ' P< !L,(@ :#"D &0PQ !@,.0 6#4, %0U/
M !,-7  2#6L $ U^  \-D@ .#:< #0R^  T,X  -#/4 #0S_ &T0  !<$0
M3A,  $,4   Z%   ,A0  "T4   H$P  )1,  "(2   @$0  'A$# !P0!0 <
M#P@ &P\, !H.$  9#Q0 %P\: !8/(0 5$"@ %! P !(0.0 1$$0 $!!0  X0
M70 -$&L #!!\  L0D  )$*4 "!"\  <0WP '$/0 !P__ &D1  !8%   2Q4
M $ 6   W%@  ,!8  "H6   F%0  (A4  !\4   =$P  &A," !D2!  7$@8
M%A(* !42#@ 4$A( $A(8 !$3'@ 1$R4 $!,N  X3-P -%$  #!1+  L46  )
M%&< !Q1X  84C0 $%*,  Q.[  (3W0 !$O0  A+_ &43  !5%@  2!<  #T8
M   T&   +1@  "@8   C%P  (!<  !T6   :%0  &!4" !85!  4%04 $A8(
M !$6#0 0%Q  #A<5  X7&P -%R( #!<I  L8,@ )&#P !QA'  485  $&&,
M AAU  $8BP  %Z$  !>Y   7W0  %O4  !;_ &$6  !2&   11H  #L:   R
M&@  *QH  "4:   A&0  'A@  !L8   8%P  %A<" !07 P 2& 4 $!D'  X;
M"P ,&P\ "QL3  H;&  ('!\ !QPF  4<+P $'#@  AQ$   =40  '6   !UR
M   <B   '*   !NY   ;W@  &O8  !K_ %X8  !/&@  0AP  #@<   O'0
M*1P  ",<   ?&P  '!H  !D9   7&0$ %!D" !(: P 0&P0 #AT'  P>"P )
M'PX !B 1  4@%@ #(!P  2$C   A*P  (34  "%    A3@  (5T  "%O   A
MA@  ()X  ""X   ?W@  'O@  ![_ %H;  !+'0  /QX  #4?   M'P  )QX
M "(=   >'0  &QP  !@;   5&P  $AP  ! = @ .'P0 #"$&  DB"@ %(PT
M B00   E$P  )1D  "8@   F*   )C(  "8]   F2@  )EH  "9L   F@P
M)9P  "6W   DWP  (_D  "/_ %4>  !'(   /"$  #(A   K(0  )2   " ?
M   ='@  &AT  !8>   3'@  $"    XA   ,(P( ""4%  4G"0  * L  "H.
M   K$0  +!8  "P=   L)0  +"X  "PZ   L1P  +%8  "QI   L@   *YH
M "JU   IWP  *?L  "C_ %$B  !$(P  ."0  "\D   H(P  (R(  !\A   <
M(   %R   !,A   0(P  #B0   LF   (*   !"H$   L!P  +@D  # ,   Q
M#P  ,Q,  #,9   S(0  ,RH  #,U   S0P  ,U(  #-E   R>P  ,I<  #&S
M   PW@  +_L  "[_ $PE   _)@  -2<  "TF   G)0  (B0  !XC   9(P
M%"0  !$F   .*   "RH   <L   #+P   #$"   S!   -0<  #<*   Y#0
M.A   #L5   ['0  .R8  #LQ   [/@  .TX  #M@   Z=P  .9(  #BP   W
MVP  -OP  #7_ $<I   [*@  ,BH  "LI   E)P  (28  !LG   5*   $2H
M  XL   *+P  !C$   $T    -@   #@    [ 0  /00  #\'  !!"@  0PX
M $41  !%&   12$  $4L  !$.0  1$@  $1;  !#<0  0HT  $&K  ! T@
M/_H  #[_ $(M   X+@  +RT  "DK   D*@  '2H  !<L   1+@  #3$   DT
M   $-P   #H    \    /P   $$   !$    1@   $@#  !*!P  3 L  $X.
M  !0$P  4!P  % G  !/-   3T,  $]5  !.:@  388  $RD  !*R@  2?@
M $C_ #XR   U,0  +B\  "DN   @+@  &3$  !(S   .-P  "3H   (]
M0    $0   !'    20   $P   !/    40   %,   !5 0  6 8  %H+  !=
M#@  7Q4  %X@  !>+   73P  %Q.  !;8P  6GX  %B=  !7P   5?(  %3_
M #HV   S-   +3(  "0S   ;-@  $SD   X]   (00   $4   !)    3
M %    !3    5@   %D   !;    70   &    !B    90   &@%  !K"P
M;Q   &\8  !N)0  ;30  &U&  !K6P  :G4  &B4  !FM@  9.D  &+_ #@Y
M   R-P  *#D  !X[   5/P  #D0   =)    30   %(   !6    6@   %X
M  !B    90   &@   !K    ;0   '    !S    =@   'D   !]!   @0L
M (41  "$'0  @BP  ( ^  !^5   ?FL  'N*  !ZJ@  =]8  '7] #@]   L
M/@  (D$  !=&   /2P  !U$   !7    7    &(   !F    :P   &\   !T
M    >    'L   !^    @    (,   "&    B@   (T   "1    E@,  )L,
M  "=$P  FR$  )HS  "720  E&(  )-_  "0H   CL4  (SS #%$   E2
M&DT  !!3   (6@   &$   !H    ;@   '0   !Y    ?P   (0   ")
MC0   )$   "3    E@   )D   "=    H    *0   "H    K    +(#  "W
M#0  MQ<  +4H  "R/@  L%8  *QS  "JE   J;0  *7E "I/   >5   $EL
M  IB    :@   ',   ![    @@   (D   ".    E    )H   "?    I
M *8   "I    K0   +    "S    MP   +L   #     Q0   ,L   #1!
MU0X  -,=  #0,@  S4L  ,IF  #&AP  PJD  ,'+ ");   68@  #&L   %T
M    ?0   (<   "0    EP   )X   "D    JP   +$   "V    N@   +P
M  #     Q    ,@   #+    SP   -0   #:    X    .8   #K    \08
M / 3  #N)P  [#\  .I;  #G>@  Y)L  ."[ /\   #[    ]@   /,   #T
M  4 ]@ , /H $0#_ !D _P B /\ + #_ #4 _P ] /\ 10#\ $P ^@!2 /<
M6 #U %X \P!D /$ :@#N '( [ !Z .D A0#E )$ X0"@ -T L@#8 ,X T@#V
M ,$ _P"M /\ G@#_ )8 _P"0 /\ C #_ /H   #R    [    .D   #I
M[  % /( # #X !( ]P ; /4 )0#P "X ZP W .8 /@#B $4 W0!+ -@ 4 #3
M %8 T !< ,T 8@#* &H R !R ,4 ? #" (@ O@"6 +H J "W +\ M #H *X
M_P"= /\ D #_ (@ _P"# /\ @ #_ /    #E    W@   -H   #;    W
M -@ !P#1  X T0 5 -( '@#+ "< Q0 O ,  -P"] #T N@!$ +< 20"U $\
ML@!5 +  6P"N &$ K !I *D <P"G '\ I "- *$ G@"> +( FP#5 )D _ ",
M /\ @@#_ 'L _P!V /\ = #_ .(   #3    R@   ,<   "\    M@   +
M 0"O  L K  1 *T & "M "  J  H *0 +P"@ #8 G0 \ )L 0@"9 $< EP!-
M )4 4P"3 %D D0!A (\ :@", '4 B@"# (@ E "& *< @P#" (( \ !\ /\
M<P#_ &T _P!J /\ : #_ ,\   #!    N0   *T   "@    F    )0   "1
M  8 D  - )  $@"/ !D C@ A (L * "( "\ A@ U (0 .@"" $  @ !% 'X
M2P!\ %( >@!9 '@ 8@!V &P = !Y '( B0!Q )T ;P"T &T WP!L /\ 90#_
M &  _P!> /\ 7 #_ +X   "Q    H    )(   ")    @@   'P   !Z  $
M>  ) '< #@!X !0 =P : '0 (0!R "< <  M &X ,P!L #@ :P ^ &D 1 !H
M $H 9@!1 &0 6@!C &0 80!P %\ ?P!> ), 70"I %P R !; /< 5P#_ %0
M_P!2 /\ 40#_ +    "?    C0   '\   !T    ;@   &H   !F    90 $
M &, "P!C !  8P 5 &, &P!A "$ 7P G %T + !< #( 6@ W %D /0!7 $,
M5@!+ %4 4P!3 %P 4@!H %  =P!/ (D 3@"? $T N@!, .D 2P#_ $D _P!'
M /\ 1P#_ *(   "-    ?    &X   !E    7@   %D   !7    50 ! %0
M!P!3  T 4P 1 %0 %@!2 !L 40 A $\ )@!. "L 3  Q $L -P!* #T 20!$
M $< 3 !& %8 1 !A $, < !" ($ 00"7 $  KP _ -< /P#_ #X _P ] /\
M/@#_ )0   !_    ;P   &,   !9    40   $T   !*    2    $< ! !'
M  H 1@ . $8 $0!' !8 10 < $0 (0!" "8 00 K $  ,0 ^ #< /0 ^ #P
M1P Z %  .0!; #@ :0 W 'H -@"/ #4 IP U ,8 - #U #0 _P T /\ -0#_
M (@   !T    90   %@   !/    2    $,    _    /0   #P  @ \  <
M.P , #L #P [ !( .@ 7 #D '  W "$ -@ F #4 +  T #( ,P Y #$ 00 P
M $L +P!6 "X 8P M ', + "( "P H  K +L *P#J "L _P K /\ + #_ '\
M  !L    70$  %$"  !( P  0 ,  #L"   W    -    #,    R  4 ,@ )
M #( #0 Q !  ,0 3 #  &  O !T +0 B "P *  K "X *@ U "D /0 H $8
M)P!1 "8 7@ E &X ) "" ", F0 C +, (@#> "( _P C /\ ) #_ '<   !E
M!   5@8  $L'  !""   .@@  #4'   P!@  +04  "P#   K  , *@ ' "D
M"P I  X *0 1 "@ %0 G !D )@ > "4 )  D "H (P Q "( .0 A $, ( !.
M !\ 6@ > &D '0!\ !P DP ; *P &P#- !L ]@ ; /\ ' #_ ' %  !?"
M40H  $8+   ]"P  -0L  # +   K"@  * D  "4(   D!P( (P0& ",""0 B
M 0P (@ / "$ $@ @ !8 'P ; !X (  = "8 '  N !L -@ : #\ &0!* !@
M5P 7 &8 %@!X !4 CP 5 *8 % ## !0 [@ 4 /\ %0#_ &L(  !;"P  30P
M $(-   Y#0  ,0T  "P-   G#0  (PP  "$,   ?"P$ '@H% !T("  =!@L
M' 4- !P$$  ;!!0 &008 !D$'@ 8!", %P0K !8$,P 5!#P % 1' !,#5  2
M V, $0-U ! "B@ 0 :( #P"\  \ Y0 / /X $ #_ &<+  !7#0  20X  #X/
M   U#P  +@\  "@/   D#@  ( X  !T.   ;#0$ &0T$ !@,!P 8"PD %PD,
M !<)#@ 6"1( %0D6 !0)&P 3"2$ $@DH !(),  1"3H $ E%  \)4@ ."6$
M#0ES  P(B  +")\ "@>W  H&VP *!?8 "@3_ &,-  !3#@  1A   #L1   R
M$0  *Q$  "40   A$   '1   !H/   8#P$ %@X$ !4.!P 4#0D $PT+ !,,
M#0 2#!  $0P4 ! ,&0 0#!\ #PPG  X-+P -#3D # U%  L-40 )#6  " UQ
M  8-A@ %#9T ! RT  ,,T@ "#/$  @O_ %\.  !0$   0Q$  #@2   O$@
M*!(  ",2   >$0  &Q$  !@1   5$ ( %! % !(0!P 1#PD $ \* ! .#  .
M#@X #@\2  T/%P ,$!T #! D  H0+  )$#8 "!!!  803@ %$%T  Q!O  $0
MA   $)P   ^T   .U   #O,   [_ %P0  !-$@  0!,  #84   M%   )A0
M "$3   <$P  &1(  !82   4$0, $A$& !$1"  0$ H #A +  T1"P ,$0T
M"Q(1  H2%0 )$AH "!(A  83*0 %$S,  Q,^  (32P  $UH  !-L   3@@
M$IL  !*T   1UP  $?4  !'_ %@2  !)%   /14  #,6   K%@  )!4  !\5
M   :%   %Q0  !03 0 3$@0 $1(' ! 2"0 .$@D #1()  L3"@ )% T !Q4/
M  86$P $%A@  Q8?  (6)P  %S   !<[   72   %U@  !=J   6@   %ID
M !6T   5V0  %/<  !/_ %44  !&%@  .A<  # 8   H&   (A<  !T6   9
M%@  %A4  !,4 P 2$P8 $!,'  \3!P -% < "Q4(  D6"0 && P  QH.  $:
M$0  &A8  !L<   ;)   &RT  !LX   ;1@  '%4  !MG   ;?0  &Y<  !JS
M   9VP  &/D  !?_ %$6  !#&   -QD  "X:   F&@  (!D  !L8   8%P
M%18! !,5!0 1%00 #Q4$  T6!  +%P4 "1D&  8:"  "' H  !X-   @$
M(!,  " 9   @(0  (2H  "$U   A0@  (5(  "!D   @>@  'Y4  !^Q   >
MVP  '?H  !S_ $T9   _&P  -!P  "L<   D'   'AL  !H:   7&   %!<"
M !(7 @ 0& $ #1D!  L: @ (' , !1T$  (?!@  (0@  ",+   E#@  )A$
M "86   F'@  )R<  "<R   G/P  )DX  "9@   F=P  )9(  "2O   CV@
M(OL  "'_ $@=   \'@  ,1\  "@>   B'@  '1P  !D;   6&@  $AH  ! ;
M   -'   "QT   @?   $(0   2,"   E!   )P8  "D)   L#   +@\  "X3
M   N&@  +B,  "XN   N.P  +DH  "U<   M<@  +(X  "NL   JU   *?L
M "C_ $0@   X(0  +B$  "8A   @(   '!X  !@=   4'0  $!X   X?   +
M(0  !R,   ,E    )P   "D    L 0  +@,  # &   S"@  -0T  #81   V
M%P  -A\  #8I   V-@  -D4  #57   U;0  -(D  #*H   QSP  ,/H  "__
M #\D   T)   *R0  "0C   ?(0  &R   !8@   1(0  #B,   HE   &*
M BH    M    +P   #(    T    -P   #D#   [!@  /@H  $ .  !!$@
M01H  $ E  ! ,0  0$   #]2   ^9P  /8(  #RB   ZQP  .?@  #C_ #HH
M   P*   *2<  ",E   ?(P  &"0  !(E   .*   "BH   4M    ,    #,
M   V    .    #L    ^    0    $(   !% @  1P8  $H*  !-#@  314
M $P?  !,*P  2SH  $I,  !)80  2'P  $>;  !%OP  0_,  $+_ #8L   M
M*P  )RD  ",G   ;*   %"H   XM   *,   !#,    W    .@   #T   !
M    0P   $8   !(    2P   $T   !0    4P$  %8&  !9"P  6Q   %L9
M  !:)0  630  %A&  !76@  570  %23  !2M0  4.H  $__ #,P   L+@
M)RP  !XM   6+P  $#(   HV   #.@   #\   !"    1@   $D   !,
M3P   %(   !5    6    %H   !=    8    &,   !G!@  :PP  &P2  !K
M'@  :RP  &D]  !G4@  9FH  &2)  !AJP  7]P  %W_ #$S   L,0  (C(
M !DU   1.0  "CT   )"    1P   $P   !0    5    %@   !;    7P
M &(   !E    :    &L   !N    <0   '4   !Y    ?08  ((-  ""%@
M@"0  'XU  !\20  >V$  'A_  !VGP  <\8  '#W #$V   F.   '#L  !)
M   +10   DL   !1    5@   %L   !@    90   &D   !N    <@   '8
M  !Y    ?    'X   ""    A0   (D   ".    DP   )@&  "<#@  FQH
M )@K  "60   DED  )%S  "-E0  B[4  (CH "L^   @00  %4<   U-   "
M5    %L   !A    :    &X   !S    >0   'X   "#    B    (P   "/
M    D@   )4   "9    G0   *$   "E    J@   +    "W!P  N!$  +4A
M  "R-0  KTT  *II  "HB   IJ@  *+1 "-(   83@  #E0   1<    9
M &T   !U    ?    (,   ")    CP   )4   ";    H    *,   "F
MJ0   *T   "Q    M0   +D   "^    Q    ,H   #2    V@H  -86  #2
M*0  SD$  ,I<  #%?   PIT  ,&] !Q5   17   !V4   !N    =P   '\
M  "(    D    )@   "?    I0   *T   "S    N    +H   "^    P@
M ,8   #*    S@   -,   #:    X    .<   #M    \P   /0.  #R'@
M[S8  .Q1  #H;@  Y)   -^Q                       ! P0%!@@)"@L-
M#@\1$A,4%A<8&AL<'1\@(2(D)28H*2HK+2XO,#(S-#8W.#D[/#T^0$%"1$5&
M1TE*2TU.3U!24U155UA96UQ=7F!A8F-E9F=I:FML;F]P<7-T=7=X>7I\?7Z
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M________________________________________________
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M^/GZ^_S]_O]M9G0Q      ,$(0   0                    $
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MH#X:_ZA')O^N433_KUM%_ZUE5_BI;VCMHWAYXYM_A]N2A934BXR>SX61ILN
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M_ZUE5_BI;VCMHWAYXYM_A]N2A934BXR>SX61ILN E:S'?)FQQ7F>M<)VH[G
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MQVZLG\=NK)_';JR?QVZLG\?_GAX$_YTI"?^I,@[_MCH4^L)#'_#.2B[GW4]
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M;+2RO6RTLKW_FAL#_YDF"/^G+0K_M38/^<$_%^[.1B/DW$PRW>=/2<_H5E[
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M5%;_HU16_Z-45O^C5%;_HU16_Z-45O^C5%;_HU16_Z-45O^C5%;_HU39N@4
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MVH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?_@QP#_X G!_][,PW_AC@1_XY
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M9DC_F'%6^Y-\8O2-AFWNAXYWZ("5@.1ZG(?@=:*,W7*HD=IOKY78;;>9U6O
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M8E#VRF)0]LIB4/;*8E#VRF)0]LIB4/;*8E#VRF+_HPL UK@& ,;$!P"[U D
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M?53#X7U4P^%]5,/A?53#X7U4P^%]5,/A?53#X7W_AQ,!_YP2 ?^N$0#:P@H
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M:EVD[VI=I.]J7:3O:EVD[VK_>1$!_XP. /^>#0#<K@@ TKL) ,S("0#'U@X
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M)CK_KR8Y_[HG./_*)SC_W"@X_]PH./_<*#C_W"@X_]PH./_<*#C_W"BUKP
MI[H  )K&  "-U   @>8! 'K_$ %P_Q@"9_\A!5__*0=8_S$*4O\Y#4W_00])
M_T@11?]/$T+_511 _UP5/?]B%CO_:1<Y_W 8-_]Y&37_@ADS_XP:,O^7&S#_
MH1LO_ZH<+_^U'"[_OQPN_[\<+O^_'"[_OQPN_[\<+O^_'"[_OQRIM0  FL(
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M7VZ,]U]NC/=?;HSW7VZ,]U__;!,!_WT/ ?^-$ #_FQ  ]*@/ .6U#0#5OQ
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M1T7AS$=%X.A'1=_V1D7>_T1%WO]$1=[_1$7>_T1%WO]$1=[_1$7>_T39EP
MQZ8  +BP  "LN0$ HL4" )C1!@"/ZPT B>X? H#N*P9X[30,<.T]$VCM1AEB
M[4X>7>U7(UGM8"=5[6@J4NUQ+4_M>2],[8,R2NZ--$?NF#5%[J4W0^^S.$+P
MQ#A!\-\Y0>_O.$#M_3A [/\X0.S_.$#L_SA [/\X0.S_.$#L_SC+H   NJL
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M%B?_PA8G_\<6)__'%B?_QQ8G_\<6)__'%B?_QQ:DM   EL   (?,  !ZV@
M;>L  &3_!0!<_PX!5/\4 4W_' )(_R0$0O\L!3[_,P8Z_SD'-O] "#/_10@P
M_TL)+O]1"BO_5PHI_UT+)_]D"R3_; PB_W8-(/^ #1[_C X=_Y<.'/^A#AO_
MK \;_ZX/&_^N#QO_K@\;_ZX/&_^N#QO_K@^7O   B,D  'G6  !KXP  7_8
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M O]M& +_=QT"_WXD _^$+ 7^AS4)]8@^$.V'2!CE@U0BWGY?+M1X:3C.<W-
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M47Y]_U%^??]1?GW_47Y]_U'_8Q0!_W(/ ?^!$ #_C1$ _)@2 .RA$P#?JA8
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M64^NQEE/KN184:[V5%.N_U!4K/]-5*S_352L_TU4K/]-5*S_352L_TW_?0
MWX\  ,Z=  ##J ( N; " +"Z @"HQ 4 H<P/ )O,(P*2RC,*B<@_%8'&21]Y
MQ%(H<L):,&O!83=FOV@\8;YP05R]>$58O(%)5+R+3%&[ED].NZ-13+NS4DJ[
MQE)*N^113+OV3DVZ_TM.N?])3KG_24ZY_TE.N?])3KG_24ZY_TGOA0  U)4
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M+CWH_"X]Y_\M/>?_+3WG_RT]Y_\M/>?_+3WG_RW%GP  M:D  *BQ  "<O
MD,<  (32 0!ZWP8 =/03 &WT( )F]"H$7_0T"%KU/0M4]44/3_5,$DSU511)
M]ET71O9E&$3V;AI!]G<</_>!'3WWC1\[]YD@.?BF(3CXM2(W^<@B-OGC(C;X
M\R(V]_PB-O?\(C;W_"(V]_PB-O?\(C;W_"*WI@  J:X  )RY  "0Q   @\\
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M"A3_LPH4_[,*%/^S"A3_LPJ3NP  A,<  '73  !GX0  6.@  $[[  !(_P
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M.-A<BSS36I0_T%B<0LY7HT3+5:Q&R56U1\=4P$G%5-!)PE/F2<!6]46^6?]
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M08]Q_T&/<?]!CW'_08]Q_T'_6Q0!_V@/ /]U#P#_@!$ _XD3 /*0%P#EEAP
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M65^-PUI>C>!88H_U4F20_TUFD/](9H__1V:/_T=FC_]'9H__1V:/_T?_; @
M_GP  -Z*  #0E@( R)\$ ,"G! "YK@, LK(4 *JQ* .AKS<,F:Q#%Y&H32&)
MI54J@J-<,GR@8SEWGFH^<IQQ1&V:>4AHF8%,9)>+4&"6E5-=EJ)56I6P5UF5
MP5=8E=Y66Y;S4%V7_TQ?E_]'8);_1F"6_T9@EO]&8);_1F"6_T;_< , ZX$
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M0TJU_T%+M?\^2[3_/4NT_SU+M/\]2[3_/4NT_SWB@P  S9(  ,&?  "TIP
MJJ\  *"X  "6P , C,H' (;-% "!S28">LPU"'/+00]LRDH79LE3'6'(6R-<
MQV(H6,9J+%3&<C!0Q7PS3<6&-DK$DCE'Q)\[1<2N/$3%P3Q#Q=\\1,3S.T3#
M_SE%PO\W1<'_-T7!_S=%P?\W1<'_-T7!_S?5BP  Q9H  +>D  "KK   H+0
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M&3'Q_QDQ\?\9,?'_&3'Q_QFRI   I:L  )BV  "+P   ?LH  ''5  !EW@
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M_Q#_-BT"_SLL O] + /_0R\#_T,U!/]"/@;_0$H(_SY7"_\\90W_.G,/_SB
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M4&YWQ%!M=^!/<'GU2')[_T-T?/\^=7W_.W5]_SMU??\[=7W_.W5]_SO_80H
M_V\" .A\  #9A@$ SXX$ ,B5!@##F@8 NYP6 +.<*@.JF3D+HI5%%)N13AV4
MCE<FCHM?+8F(9C.$AFTX@(1T/7N">T%W@(1%='^-2'!]ETMM?*-.:GRP3VA\
MP5!G?-U0:G[S26V _T-N@?\_;X'_/&^!_SQO@?\\;X'_/&^!_SS_9 @ _W(
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M1UJ2_4)<D_\^79/_.UV3_SM=D_\[79/_.UV3_SO_;@  X'X  ,Z+  #$E0
MNIT  +&C  "IJ0  H:X+ )NO'0&4KBX$C*P[#(6J1A5^J$X<>*96(W*D72IM
MHF0O::%K-&2?<SA@GGL\7)V%/UF<CT)5FYQ%4YNJ1U&;ND=0F]%'49ON1%.;
M_$!5F_\\5IO_.E:;_SI6F_\Z5IO_.E:;_SKQ=   V8,  ,B0  "^F@  LZ$
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M+4&\_RU!O/\M0;S_+4&\_RW.B@  OY@  +&@  "FJ   F[   )"X  "%OP
M>L<$ &_/"0!KT14 9]$F 6/1- 1>T$ (6=!*#%7/4Q!1SUL43L]C&$O.:QM(
MSG4>1<Y_($+.C") SIDD/LZH)CS.NB8\S]0F/,WO)3O,^R4[R_\E.\K_)3O*
M_R4[RO\E.\K_)3O*_R7#DP  M9X  *BF  "=K@  D;8  (6_  !YQP  ;\X$
M &36"0!>WA$ 6]X@ %?>+0)3WSH$4-]$!DS?3@E)WU<,1M]?#T/?:!%!WW$3
M/M]\%3S?B1<ZX)89.."E&C?@MQHVX<T:-M_L&C7>^1HTW?\;--S_&S3<_QLT
MW/\;--S_&S3<_QNYG   JJ0  )ZK  "2M0  A;X  'G'  !MSP  8M8# %CA
M" !5ZA, 4>L@ $WK*P%)ZS4"1>P^!$+L1P4_[$\'/>U8"3KM8 HX[6H,-NYT
M#3/N@ XR[HX/,.^=$"[OK1$M\, 1+?#>$2SN\1$L[/X1+.O_$"SK_Q LZ_\0
M+.O_$"SK_Q"MH@  H*D  ).S  "&O0  ><8  &S/  !@V   5=X  $[S"@!*
M]Q, 1O@= $/X)P$_^# "._DX CCY0 ,U^D<$,_I/!3#[5P4N^U\&*_QI!RG\
M= @G_(())?V0"23]H HC_K *(O[$"R'_X LA_?(*(/S\"B#\_ H@_/P*(/S\
M"B#\_ JBIP  E;$  (>[  !YQ@  ;,\  %_9  !2WP  2.@  $/_"  __Q
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M$JUU51JH<5XAHVYF)I]L;BN;:G4OF&A],Y5GA#:298PYCV25/(QCGSZ)8JI
MAV&W0H5AR4*$8N1!A63W.X9F_S6'9_\QAVC_+H=I_RV':?\MAVG_+8=I_RW_
M5PP _V$$ /YL P#D=0$ VWL% -. " #0@PH QX4: +Z$+0.V@3P)KWU($JAY
M4AFB=EL@G7-C)IEP:RN5;G(OD6UY,XYK@3:+:8DZB&B2/(5GG#^"9J=!@&:T
M0WYFQ41\9N%#?FCU/']J_S> :_\S@6S_+X%L_R^!;/\O@6S_+X%L_R__60L
M_V,! /1O  #?>   U'\$ ,Z#!@#*AP@ PH@8 +F'*P*QA3H(JH%&$:-^4!B=
M>ED?F'=A)9-U:"J/<V\OBW%W,XAO?C:%;H8Z@FR//7]KF4!\:J5">6JQ1'=J
MPD1V:MU$>&SS/GEN_SAZ;_\T>W#_,'QP_S!\</\P?'#_,'QP_S#_6P@ _V8
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M0&A[_3IJ>_\V:WS_,FM\_S)K?/\R:WS_,FM\_S+_80  ZF\  -EZ  #,A
MPXL  +N1 0"TE0$ K)<. *67(0&>EC$%EY,^#)"02!2*CE$;A(M9(7^)8"=[
MAV<K=X5N,'.$=31O@GTW:X&'.VB D3YE?YQ!8GZI0V!^N41??L]$8'_L0&*
M_#ID@/\V98'_,V:!_S)F@?\R9H'_,F:!_S+_9   Y7(  --^  #'AP  OH\
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M,%*6_S!2EO\P4I;_,%*6_S#F<@  T(   ,*,  "XE@  K9P  *.A  "9I@
MCJT  (BN$0"#KB(!?:TQ!'>L/0IRJD<0;*E/%F>H5QMCIUX?7Z9E)%ND;2=8
MI'4K5*-_+E&BB3%.H98T2Z&D-DFAM#9(H<@W2*#G-4F@^3)*G_\P2Y__+DN?
M_RU+G_\M2Y__+4N?_RW=>0  R88  +R2  "QF@  IJ   )RF  "1K   AK(
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M'#;$_QR^D0  L)L  *2C  "8J@  C+(  ("Y  !TP   :,<  %W-!0!3TPH
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M!![YF@4<^:L%&_K !1KZW@4:^?(%&O?]!1GV_P49]O\%&?;_!1GV_P6>I@
MD:\  (.Y  !UP@  9\L  %K3  !-V@  0M\  #CE   U^P< ,?\/ "[_%@ K
M_Q\ *?\F "7_+0 C_S0 (/\[ 1[_0P$;_TL!&?]3 1;_70(4_VH"$O]X A'_
MB (0_YH"$/^K P[_O@,._]4##O_M P[_\ ,.__ ##O_P P[_\ .3K@  A+@
M ';"  !GS   6M4  $S<   _X0  ->8  "WT   J_P( )O\+ "/_$0 @_Q<
M'?\= !G_(P 6_RD %/\O !+_-0 0_ST #O]% 0S_3@$*_U@!!_]E 07_= $#
M_X4! O^6 0'_I@$ _[4! /_& 0#_R@$ _\H! /_* 0#_R@&&MP  =\$  &C,
M  !:UP  2]X  #[D   RZ0  )^T  "/_   ?_P  &_\% !?_#  4_Q  $?\4
M  __&  -_QT "_\B  C_*  %_RX  O\U  #_/0  _T<  /]2  #_7@  _VT
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M,Y-5RC.15>4SD5?W+9%9_RF16O\ED5O_(Y%;_R&16_\AD5O_(9%;_R'_3PL
M_U<" /]A @#J: $ WFT$ -AP" #5< L RW(; ,)Q+@*Z;ST&M&Q)#:YI5!.I
M9UT9I&1E':%B;2&=870EFE]\*)A>@RN578LMDEN4,)!;GC*-6J@TBUFU-8I9
MQC:(6>$VB%ST,(A=_RN)7O\HB5__)8E?_R.)7_\CB5__(XE?_R/_40D _UH
M /5D  #@;   UW$# -!T!@#-=0D Q'87 +QV*@&T=#H%KG%&#*=N41*B:UH8
MGFEB'9IG:2&697$EDV1X*)!B@"N-88@NBV"1,8A?FC.&7J4U@UZR-X)>PC>
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M-G1I_3!U:O\L=FO_*7=K_R=W:_\G=VO_)W=K_R?_5P  ]F,  -]M  #1=0
MR'L  ,%_ @"[@ , M($0 *R"(P&E@3($GGX_"9A[2A"2>5,6C79;&XET8B"%
M<FDD@7%P)WYO=RM[;G\N>&V(,75LDC1S:YXW<&JJ.6YJN3IM:LXZ;6OK-V]M
M_#%P;O\M<6[_*G%O_RAQ;_\H<6__*'%O_RC_60  ZV4  -MP  #->   Q'X
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M*V%\_REA?/\I87S_*6%\_RGU8@  WF\  ,QZ  # @P  MXD  *^.  "FD0
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M)$>:_R34=P  PH0  +:/  "KE@  H9P  ):@  "+I0  ?ZH  '2N!0!OKQ0
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M$C7#JQ,SP\ 3,\/@$S/!]1,RP/\4,K__%#&^_Q0QOO\4,;[_%#&^_Q2XD
MJYD  )^@  "3IP  AZX  'NT  !NNP  8\   %C% 0!-R@4 1,\, $/0%P!"
MT"4 0- R #_1/0$]T4<!.]%0 CG260,VTF,$--)N!3+2>@<PTH@(+M*8"2W3
MJ0DLT[X*+-/?"2O1\PHJS_X+*<[_#"G-_PTIS?\-*<W_#2G-_PVNF   HI\
M ):F  ")K@  ?+8  &^]  !CPP  5\@  $S-  !"T@, .=D) #7?$  TWQL
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M 0C_N@$'_]0!!__K 0;_]@$&__8!!O_V 0;_]@&/K   @+8  '*_  !CR0
M5M$  $C8   [W0  ,.(  ";F   ?\   '/\  !G_"0 6_PX %/\3 !'_&0 /
M_QX #?\D  O_*P )_S( !O\[  /_1   _T\  /]<  #_:P  _WT  /^0  #_
MHP  _[0  /_&  #_U@  _]8  /_6  #_U@""M0  <[\  &3)  !6TP  1]L
M #K@   NY0  (^D  !KM   5_0  $O\  !#_ @ ._PD "_\-  C_$  $_Q,
M ?\8  #_'@  _R0  /\K  #_,P  _ST  /])  #_5@  _V8  /]X  #_B@
M_YL  /^H  #_L0  _[$  /^Q  #_L0#_)2L!_R@I ?\I*0'_*"P!_R,R ?\>
M.P+_&D<"_Q=5 _\58@/_$W #_Q)\ _\2AP/_$I$#_Q*9 _\2H /_$J<#_Q*M
M _\1M /_$;L#_Q'$ _\1S@/_$=\#_Q'K O\2]@+_$OX"_Q+_ O\2_P+_$O\"
M_Q+_ O\2_P+_$O\"_Q+_ O\2_P+_*"D!_RLF ?\L)@'_*RD!_R@O ?\B. +_
M($0"_QU2 _\;7P/_&&P#_Q=Y!/\7A 3_%XX$_Q>6!/\6G03_%J0$_Q:J!/\6
ML03_%K@$_Q;  _\6R@/_%ML#_Q;H _\7] /_%_T#_!?_ OL7_P/[%_\#^A?_
M _H7_P/Z%_\#^A?_ _H7_P/_*B8!_RXC ?\O(@'_+R4!_RPK ?\J-0+_)T$"
M_R1. _\B6P/_(&@$_QYT!/\=@ 3_'8H$_QV2!?\=F@7_':$%_QVG!?\=K07_
M';0$_QV]!/\=QP3_'=0$_AWF!/L=\@3W'OL#]1[_!/0>_P3S'O\$\Q[_!/(>
M_P3R'O\$\A[_!/(>_P3_+B(!_S(? ?\T'@'_,R !_S(F ?\R,@'_+SX"_RQ*
M _\J5P/_)V0$_R9P!?\E>P7_)(4%_R2.!O\DE@;_))T&_R2C!O\DJ@;])+$&
M_"2Y!OLDPP;Y),\&]B3C!O(D\ 7N)?H%[27_!NLE_P;J)?\&Z27_!NDE_P;I
M)?\&Z27_!NDE_P;_,AX!_S8; /\X&0#_.!L!_SHC ?\Y+0'_.#H"_S5& _\R
M4@3_,%\$_RYK!?\M=@;]+( '^BR)!_DKD0?W*YD(]2N?"/0KI@CS*ZT(\2NU
M"/ KOPCN*\L(ZRO?".<L[@CD+/H(XBS_"> L_PG>+/\(WBS_"-TL_PC=+/\(
MW2S_"-TL_PC_-1H _SH6 /\]% #_/Q< _T$? /]!*0'_0#0!_SU! O\Z30/\
M.%H%^#9E!O0U<0?Q-'L([S.$">TSC0GK,I0*Z3*;"N@RH@OF,JH+Y#*R#.,R
MNPSA,L@,WS+<#-HR[ W5,_@-TC/_#= S_PS.,_\,S33_"\PT_PO,-/\+S#3_
M"\PT_PO_.18 _SX2 /]!$ #_11, _T@; /]() #_1R\!_D0[ O="1P/Q/U0%
M[#Y@!N@\:PCE.W8)XCM_"^ ZB S=.9 -VSF7#MDXG@_6.*80U#BN$=(XMQ'0
M.,,2SCC3$LHXZ!+'.?<2Q#G_$<(Z_Q#!.O\/P#K_#K\Z_PZ_.O\.OSK_#K\Z
M_P[_/1, _T(/ /]&#0#_2Q  _TX6 /]/'P#]3BD!]$PT >Q(00+F1TX$X$5;
M!MM$9@G60G ,TD%Y#L] @A#-0(H1RC^1$\D_F13'/J 5Q3ZH%L,^L1?!/KP7
MP#[+&+T^XABZ/O(7MS__%K5 _Q2T0/\3LT'_$;-!_Q"S0?\0LT'_$+-!_Q#_
M0!  _T8, /]+"@#_40T _U,1 /]4& #S5"( Z5(M >%0.P':3TD#TDU5!\Q+
M8 O(26H.Q4AS$<)'>Q._1H,5O46+%[M%DQBY1)H9MT.B&K5#JQNT0[8<LD/$
M';!#V1ZM0^T=JT7\&JE%_QBH1O\6J$;_%:='_Q.G1_\3IT?_$Z='_Q/_1 X
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M*8-8_B2#6?\@A%K_'H1:_QR$6O\<A%K_'(1:_QS_3@$ _U<  .5?  #89@
MSFH  ,=L P##:P4 O&P2 +1M)0"M;#4#IVI"!Z%G30R<9581F&->%91B91B1
M8&P;CE]T'HQ>>R&)78,DAER,)H1;E2B!6J J?UJL+'U:NRU\6L\N>UOL*WQ<
M_"9\7?\B?5[_'WU>_QU]7O\=?5[_'7U>_QW_4   ]5D  .%C  #2:@  R6X
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M(FQJ_R!L:O\@;&K_(&QJ_R#_5P  Y&(  -)L  #&<P  O7@  +5[  "M?
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M(%=\_R#E9   SW   ,%Z  "V@P  K8D  *.,  "9C@  C8\  (:0#@"!D1T
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M($.7J"%"E[HB09?3(D&6[R!"E?X>0I7_'4.4_QQ#E/\<0Y3_'$.4_QS,=0
MO($  +&,  "FD@  FY<  )&;  "%GP  >:,  &JG  !EIPX 8Z@< &"H*P%=
MJ#8"6:= !%:G2093IE$)4*99#$VE8 Y*I6D11Z1R%$2D?19"HXD8/Z.7&CVC
MIQL\H[D<.Z/2&SNB[QL[H/X:.Y__&3R?_Q@\G_\8/)__&#R?_QC$?   MHD
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M!"7+[@0DR?P&(\C_!R/'_P<CQ_\'(\?_!R/'_P>IE@  GIT  )*C  "%JP
M>+(  &NX  !?O@  4L(  $?&   ]R@  -,\$ "O4"0 FV0\ )=D9 "7:)0 D
MVC  (]L[ "/;10 BW%  (=U; "#=:  >WG8 '=Z' 1S?F0$:WZP!&=_$ 1C>
MYP$8W/@!&-O_ A?:_P(7VO\"%]K_ A?:_P*@G   E*,  (>K  !YLP  ;+H
M %_!  !2Q@  1LH  #O.   QTP  *=D  "'>!0 >Z X '>@5 !OI'@ 9Z2<
M&.HP !;J.0 5ZT, %.Q. !+L6@ 1[6< $.YW !#NB@ .[YX #O"S  WPS0 ,
M[^P #.W\  SK_P ,Z_\ #.O_  SK_P"7HP  B:L  'NT  !MO   7\0  %+*
M  !%S@  .=,  "_8   EW0  '>$  !CL @ 6]PL %/<1 !'X%P 0^!X #ODE
M  WY+0 +^C4 "?L_  ?[2@ $_%<  _UF  +^=P  _8L  /V?  #\M0  _-$
M /SM  #\_   _/T  /S]  #\_0"+JP  ?;0  &Z]  !@Q@  4LT  $32   W
MV   +-T  "+A   9Y0  $^H  !#Z   ._P8 #?\,  K_$  '_Q0 !/\:  '_
M(   _R<  /\P  #_.@  _T4  /]3  #_8@  _W4  /^*  #_GP  _[,  /_'
M  #_Y0  _^4  /_E  #_Y0!_M   <+T  &''  !3T   0]8  #;=   JX@
M'^8  !;J   0[0  #/H   G_   &_P   O\$  #_"0  _PT  /\0  #_%
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M!M4KYP;0*_4'S2S_!\LL_P?)+/\'R"S_!\<L_P;'+/\&QRS_!L<L_P;_-1(
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M%YE%_Q681O\3F$;_$9A&_Q"71O\0ET;_$)=&_Q#_0@4 _T<  /=/  #E4P
MW54! -=5!@#54@L RU,9 ,-4*P"\5#L!ME)(!+%14@>M4%P*J4YD#:9-; ^D
M3'01H4M[$Y]*@A6=2HH7FTF3&)E)G!J72*8;E4BR')1(P1V22-@=D$GO&X]*
M_AB/2_\6CDO_%(Y,_Q*.3/\2CDS_$HY,_Q+_10  _TL  .E3  #>6   TUL
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M&7=9_Q=W6?\6=UG_%G=9_Q;_3   Z58  -E?  #+90  P6@  +II  "T:
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M&6)H_QGL5P  V6(  ,=K  "\<@  LW<  *IY  "A>0  EW<! )!X$0"+>"$
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M(5%WIB)0=[<C3W?.(T]W["%0=_T>47?_&U)W_QE2=_\94G?_&5)W_QG>8@
MR&X  +MW  "P?P  IX0  )V'  "2AP  A(<  'V'"0!XB!8 =(@F '"(,@)L
MAST$:(9&!F6%3@EAA54,7H1<#UN#8Q)9@FL55H%T%U. ?AI0@(D<3G^6'DQ_
MI2!*?[8A27_,(4E^ZQ]*?OP<2W[_&DM^_QE,?O\83'[_&$Q^_QC59P  PW,
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M$S>=Z!(VF_H2-IK_$C:9_Q$WF?\1-YG_$3>9_Q&^>P  L8<  *6/  ";E
MD)@  (2<  !WH   :Z0  %^G  !2J@  3:L. $NK&@!*JR< 2*LS $:K/0%$
MJT8!0JM. D"K5@,^JU\%.ZMH!CFJ<P@WJH )-*J/"S*JGPPQJK ,,*K'##"I
MYPPOI_H-+Z;_#2^E_PTOI?\-+Z7_#2^E_PVVA   JHX  )Z4  "4F0  AYX
M 'NC  !OJ   8ZP  %>O  !+L@  0;4& #ZV$0 ]MAX .[8I #JW-  YMSX
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M !#2_P$0T?\!$-'_ 1#1_P&<F@  D:$  (.H  !UL   :+<  %N]  !.P0
M0L4  #?(   MS   )-   !S5   5V@4 $.(+ !#C$0 .Y!H #N0C  WE+0 ,
MY3< "^9"  KF3P )YUT ".=M  ;F@  %YI4 !.:K  +FQ  !YN8  .?Y  #G
M_P  YO\  .;_  #F_P"3H0  A:D  '>Q  !IN0  6\   $[&  !!R@  -<X
M "K2   AU@  &=L  !+?   -XP  "_$(  GS#@ '\Q, !/(:  +R(@  \BH
M /(T  #R/P  \DP  /)<  #R;0  \H(  /*8  #SK0  \\8  /3E  #T]@
M]/L  /3[  #T^P"'J0  >;(  &JZ  !<P@  3LD  $#.   STP  *-@  ![=
M   5X0  #^0   KH   %\P   _T!  #\"   ^PT  /L1  #[%@  _!X  /PF
M  #\,   _3P  /Y)  #^6@  _FT  /^"  #_F   _ZP  /_   #_V   _^0
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M ,T _P#? /\ [ #_ /@ _P#_ /T _P#] /\ _0#_ /T _P#] /\ _0#_ /T
M_P#_'R, _Q\A /\>(0#_&2, _Q,I /\.,@#_#$  _PE- ?\'6@'_!&<!_P-S
M ?\#?0'_ X<!_P./ /\"E@#_ IP _P*B /\"J #_ J\ _P&V /\!O@#_ <D
M_P'; /\ Z@#\ /8 ^ #_ /<"_P#W _\ ]@3_ /8$_P#V!?\ ]@7_ /8%_P#_
M(A\ _R(< /\A' #_'A\ _Q@D /\5+P#_$CP _Q!) /\.5@'_#&(!_PMN ?\+
M>0'_"X(!_PN+ ?\+D@'_"ID!_PJ? /\*I0#_"JL _PJR /\*NP#]"L8 ^PK4
M /<*YP#S"O0 \ K_ .\+_P#N#/\ [0S_ >T,_P'M#/\![0S_ >T,_P'_)1L
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M!K@L_P:V+/\%M2S_!;0L_P6T+/\%M"S_!;0L_P7_- P _S8% /\Y P#_/ @
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M#HA&_PV(1O\-B$;_#8A&_PW_0   \D<  .-/  #44P  RU4  ,14  # 4 0
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M$6Q8_Q'Q2P  WU8  ,Q>  # 9   MV<  *YH  "G9@  GV(& )AC% "29"0
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M&EUBIAQ;8K8=6F+,'5IBZAQ;8_P87&/_%EQC_Q1=8_\376/_$UUC_Q/F50
MSU\  ,%H  "V;@  K'(  *1T  ":<P  CF\  (=O#0"";QL ?7 I 'EO-0%U
M;C\#<FU(!6YL4 =K;%<*:6M>#&9J90YD:6P186EU$U]H?Q9<:(H86F>6&EAG
MI!Q69[0=56?*'55GZ!M69_L85V?_%E=H_Q189_\36&?_$UAG_Q/A6   RV,
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M&$1ZY!A%>?@61GG_%$9X_Q)'>/\11WC_$4=X_Q'-90  O7   +%Y  "G@
MG(0  )*&  "&A@  =X8  &N&  !FAPT 8X<9 &"()P!>B#,!6X@\ EB'10-6
MATT$4X94!E"&6PA.A6,*2X1L#$F$=@]&@X$11(./$T*#G11 @JX5/X/"%3Z"
MXA4_@?<3/X'_$D" _Q% @/\00(#_$$" _Q#&:P  MW8  *Q_  "BA0  EXD
M (R+  "!C0  <XX  &6/  !=CPD 6I 4 %B0(0!6D2T 4Y X 5&000).D$D#
M3)!0!$J/6 5'CV '18YI"4*.<PM C7\-/HV-#SR-G! ZC:P1.8W!$3B-X1 X
MB_80.(K_#SF)_P\YB?\..8G_#CF)_PZ_<@  LGT  *>&  "<B@  D8X  (:1
M  !ZDP  ;94  %^7  !4F0$ 3YD/ $Z:&@!,FB< 2IHR $B:/ %&FD0!1)I,
M D*:5 - F5P$/IEF!3N9< <YF'P(-YB*"C68F@LSF*L+,IB_##*8WPLQEO4+
M,97_"S&4_PLQD_\+,9/_"S&3_PNX>@  K(4  *&+  "6D   BY0  '^7  !R
MFP  9IT  %J@  !.H@  1:0) $*D$P! I!\ /Z0J #ZE-  \I3X .Z5' 3FE
M3P$WI5@"-:5A C.E; ,QI7D$+Z2'!2VDEP8LI*D&*Z2]!BJDW@8JHO4'*:'_
M!RF@_P@IG_\(*9__""F?_PBQ@@  I8L  )J1  "0E@  @YH  ':?  !JH@
M7J8  %*I  !&JP  /*T  #6O#  SL!4 ,K A #&P*P OL#4 +K$^ "VQ2  L
ML5$ *[%; "FQ9P$GL70!)K&# 22QE (CL:8"(K*[ B&RVP(AK_,#(*[_ R"M
M_P0?K/\$'ZS_!!^L_P2JBP  G9$  ).7  "'G   >J(  &VG  !@JP  5:\
M $FQ   ^M   ,[<  "JZ P DO T (KT5 "&](  AO2H (+TS !^^/0 >OD<
M';Y2 !R_7@ :OVP &;]\ !B_C@ 7P*$ %L"V !3 TP 5OO$ %;S_ 16[_P$4
MNO\"%+K_ A2Z_P*AD@  EI@  (J>  !]I   ;ZH  &*O  !6M   2K<  #ZZ
M   SO0  *L   "'$   9QP4 $\L+ !',$@ 1S!L $,PE  _-+P .S3H #LU&
M  W-4@ -SF  #,YP  O.@P *SI< "<ZL  C.Q@ (SN@ ",W[  G+_P )R_\
M"<O_  G+_P"8F   C9X  '^E  !QK   9+,  %>Y  !*O0  /L   #+#   H
MQ@  '\H  !?-   1T0  #-8%  C9#  &V1( !=H;  3:)  #VRX  =LY  #<
M10  W5(  -YB  #><P  WH@  -^=  #?LP  W\X  .#N  #?^@  W_\  -__
M  #?_P"/GP  @:8  '.N  !EM0  6+T  $K"   ]Q0  ,<D  ";,   =T
M%-0   [9   )W0   ^$   #C!P  XPT  .02  #E&0  YB(  .<K  #I-@
MZT,  .Q2  #L8@  [78  .Z,  #NH0  [[<  ._1  #OZP  \/8  /#V  #P
M]@"$IP  =:\  &>W  !9OP  2\8  #S*   OS@  )-(  !K8   2W   #.
M  7C    YP   .L   #K    [04  .X+  #P$   \14  /,>  #T)P  ]S,
M /E   #Z40  ^V,  /QW  #]C0  _:,  /ZV  #^R0  _]\  /_?  #_WP!W
ML   :+D  %K!  !,R@  /,\  "[4   BV@  %]X  !#B   )Y@   .D   #L
M    \    /8   #V    ]P   /@   #Z!P  ^PT  /T1  #_&0  _R,  /\O
M  #_/@  _T\  /]B  #_=P  _XT  /^?  #_K@  _[H  /^Z  #_N@#_%B,
M_Q4A /\2(0#_#B0 _P8J /\ ,P#_ $$ _P!. /\ 7 #_ &@ _P!T /\ ?@#_
M (< _P"/ /\ E@#_ )P _P"B /\ J #_ *X _P"U /\ O0#_ ,< _P#6 /\
MYP#^ /, _@#^ /T _P#\ /\ ^P#_ /L _P#[ /\ ^P#_ /L _P#_&B  _QD>
M /\6'@#_$"  _PHE /\$, #_ #T _P!+ /\ 6 #_ &0 _P!P /\ >@#_ (,
M_P"+ /\ D@#_ )@ _P"> /\ I #_ *H _P"Q /T N0#[ ,, ^@#0 /@ XP#W
M /$ ]@#\ /0 _P#T /\ \P#_ /, _P#S /\ \P#_ /, _P#_'1P _QP9 /\9
M&0#_%!L _P[_XO_B24-#7U!23T9)3$4 " DA /\,+ #_"3D _P5& /\"4P#_
M %\ _P!K /\ =0#_ 'X _P"& /\ C@#_ )0 _@"; /P H0#Z *< ^ "N /4
MM0#S +\ \0#+ /  WP#N .X [ #Y .L _P#J /\ Z@'_ .D!_P#I ?\ Z0'_
M .D!_P#_(!< _Q\4 /\<$P#_%Q4 _Q8= /\3* #_$#0 _PU! /\,3@#_"5H
M_PAF /\(< #^!WD _ >! /H'B0#X!Y  ]@:6 /,&G0#Q!J, [P:J .T&L@#J
M!KL Z ;( .8&W #D!NP X@CZ . *_P#>"_\ W0O_ -T,_P#<#/\ W S_ -P,
M_P#_(Q( _R,0 /\A#@#_'A  _QX8 /\<(P#_&"\ _Q0[ /\220#\$%4 ^ ]@
M /0/:@#Q#W0 [PY\ .T.A #K#HL Z0Z2 .<.F0#F#J  Y ZG .(.KP#@#K@
MW@[% -P.V@#6$.P TA'Z ,\2_P#-$O\!S!+_ <L3_P'*$_\!RA+_ <H2_P'_
M)P\ _R<, /\E"0#_)@T _R43 /\C' #_("@ ^QPU /4:0@#O&$\ ZA=: .86
M90#C%FX X!9W -X6?P#<%H< V1:. -86E0#4%IP TA>C - 7JP#.&+4 S!C!
M ,L8T@#'&N@!PQOX < ;_P&^'/\!O1S_ KP<_P*\&_\"O!O_ KP;_P+_*PP
M_RL% /\K P#_+0D _RP. /\I%0#W)B  [B,M .<A.@#A'T@ VQ]4 -4@7P#1
M(&@ SB!Q ,PA>0#*(8$!R"&( <8ACP'$(98!PR&> <$BI@&_(J\!O2*[ KPC
MR@*Y(^,"M23T K,D_P.Q)/\#KR3_ Z\D_P.N)/\#KB3_ ZXD_P/_+P8 _R\
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M"X\Z]PJ-.O\)C#O_"(P[_P>,._\'C#O_!XP[_P?_.   \3X  .-%  #420
MRTH  ,5'  #!000 NC\1 +-!(0"M0C$ J$,^ *1#20&@0E,"G4%; YM!8@28
M0&H%ED!Q!I0_> >2/W\(D#^("H\^D0N-/IL,BSZF#8D^LPV(/L0.AC_@#H0_
M] V#0/\+@T#_"H) _PF"0?\(@D'_"()!_PC_/   ZT,  -Q*  #,3P  PU
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M#FQ/_PQL3_\+;$__"VQ/_PON10  W%   ,E7  "]7   M%X  *Q>  "D6P
MG%8$ )56$@"05R$ BU@O (=7.P&#5D0"?U9- WQ55 5Z5%L&=U1B"'53: ES
M4W +<5)X#6]2@@]M48T1:U&9$FE1IA1G4;859E'+%652Z11E4OL19E/_#V93
M_PUF4_\,9E/_#&93_PSJ20  U5,  ,5:  "Z7P  L&(  *AB  "?7P  EEH
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M#5=>_PW>4P  R%T  +MD  "P:@  IFT  )UN  "3;0  A6<  'YG"0!X9Q4
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M$$ENFQ%';:L21FZ^$T5NW!)&;?011FW_#T=M_PY';/\-1VS_#4=L_PW,7P
MO&D  +!Q  "E=P  G'L  )%\  "&>P  =7@  &MW  !E=PP 87@7 %]X) !=
M>3  6GDZ 5AY0@)6>$H"4WA1!%%W6 5/=V '3'9H"$IV<@I(=7T,176*#D-U
MF0]"=:D00'6\$$!UV1! =/,/0'3_#D%S_PU!<_\,07/_#$%S_PS&9   MVX
M *MV  "B?   EW\  (R!  "!@0  <H   &5_  !=?P@ 67\3 %> ( !5@"L
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M!BR2T08LD>\&*X__!BN._P8KC?\'*XW_!RN-_P>S>   IX(  )R(  "1C
MAY   'J3  !ME0  89<  %69  !)FP  /YP! #F=#@ WG1< -IXB #2>+  S
MGC4 ,IX^ #&>1P PGU  +I]: "V?9 $KGW$!*9Y_ B>>D (FGJ$"))ZU B.>
MS@(CG>X#(YO^ R*:_P0BF?\$(IG_!"*9_P2L@0  H(@  )6.  "+D@  ?Y8
M '*:  !EG0  6:   $ZC  !"I   -Z8  "ZH!0 IJ0\ **D8 ">J(@ FJBP
M):HU "2J/P CJD@ (JM3 "&K7@ @JVH 'JMY !VKBP ;JYT &JNQ !FKR@ 9
MJNP!&:C] 1BG_P(8IO\"&*;_ ABF_P*EB0  F8\  (^4  "#F0  =9X  &BB
M  !<I@  4*D  $2L   YK@  +[   ":S   >M08 &;</ !BW%P 7MR$ %K<J
M !6W-  4N#X $[A) !*X5  2N6( $;EQ !"Y@P /N9< #KFL  VYQ  -N.<
M#K;[  ZU_P .M/\ #K3_  ZT_P"<D   DI4  (:;  !YH   :Z8  %ZK  !2
MKP  1K(  #JU   OMP  );H  !V]   5P   $,,&  O&#@ *Q14 "<4>  C%
M*  'Q3( !L8]  7&20 %QE<  \9F  +&=P !QHL  ,:@  #%M@  QM(  ,7O
M  #%_   Q?\  ,7_  #%_P"5E@  B9P  'NC  !MJ0  8*\  %.T  !&N
M.KL  "Z^   DP0  &\0  !/'   .R@  ",X!  '0"@  T!   - 6  #1'@
MTB<  -,Q  #4/   U4D  -98  #6:0  UGP  -:2  #6IP  UK\  -;@  #6
M\P  UOX  -;_  #6_P",G0  ?J0  &^K  !AL@  5+D  $:]   YP0  +<0
M "+'   9RP  $<X   S2   %U0   -L   #< P  W0H  -X/  #?%   X1P
M .(D  #D+@  YCH  .=)  #H60  Z&L  .F!  #IF   Z:T  .G%  #IX@
MZ?(  .GU  #I]0" I0  <:T  &.U  !5O   1\(  #G&   LR@  (,X  !;2
M   /U@  "-L   #?    XP   .4   #G    Z $  .H'  #K#0  [1$  .\8
M  #Q(0  \RL  /8X  #W2   ^%H  /EM  #ZA   ^IL  /JO  #ZP@  ^MH
M /K?  #ZWP!TK@  9;8  %:^  !(Q@  .<L  "O0   ?U   %-H   W?   %
MXP   .8   #I    [0   .\   #Q    \P   /4   #V @  ^ D  /H.  #]
M$P  _QP  /\H  #_-@  _T<  /]:  #_;@  _X4  /^:  #_JP  _[D  /^\
M  #_O #_$2  _Q > /\,'@#_!"$ _P G /\ , #_ #X _P!, /\ 60#_ &4
M_P!P /\ >@#_ (, _P"+ /\ D@#_ )@ _P"> /\ I #_ *H _P"P /\ N #_
M ,( _P#. /\ X@#^ /  _0#[ /L _P#[ /\ ^P#_ /H _P#Z /\ ^@#_ /H
M_P#_%!P _Q(: /\.&@#_"!P _P A /\ +0#_ #H _P!( /\ 50#_ &$ _P!L
M /\ =@#_ '\ _P"' /\ C@#_ )0 _P": /X H #] *8 _ "L /L M #Y +T
M^ #) /< W #U .P \P#X /, _P#R /\ \0#_ /  _P#P /\ \ #_ /  _P#_
M%Q@ _Q46 /\1%0#_#!< _P4= /\ * #_ #8 _P!# /\ 4 #_ %P _P!G /\
M<0#_ 'H _ "" /H B0#X )  ]P"6 /4 G #T *( \P"H /$ L #P +@ [@##
M .P TP#J .< Z0#U .< _P#F /\ Y0#_ .4 _P#E /\ Y0#_ .4 _P#_&A,
M_Q@1 /\4$ #_#Q$ _PT9 /\*) #_!3  _P$^ /\ 2P#_ %< _@!B /H ; #U
M '4 \@!] /  A #N (L [ "1 .L EP#I )X YP"D .8 K #D +0 X@"_ .
MS0#> ., W #R -H _0#8 /\ U@#_ -4!_P#5 ?\ U0+_ -4"_P#_'A  _QP-
M /\7"P#_%0X _Q05 /\1'P#_#BH _PLX /T(10#X!E$ ] 1< .X$9@#J!&\
MY@-W .0$?P#B!(8 X 2, -X$DP#=!9H VP6@ -@%J #5!;$ T@6[ - &R0#.
M!^  S CQ ,D*_P#'"_\ Q@S_ ,4,_P#%#/\ Q0S_ ,4,_P#_(0P _R & /\<
M P#_'0H _QL0 /\8& #_%", ]A$P .\./@#J#DH Y0U6 .$-8 #=#6D V0UQ
M -4->0#3#8$ T0V( ,\-CP#-#I8 RPZ= ,H.I0#(#JX Q@^Y ,00R #"$-\
MOA'R +L2_P"Y$_\ MQ/_ ;83_P&V$_\!MA/_ ;83_P'_)08 _R,  /\C  #_
M) , _R$* /T=$0#Q&AL Z!8G .$4-0#:$T, TQ1/ ,X560#+%6, R!9K ,46
M<P##%WL P1>" , 8B0"^&)  O!B8 +L9H "Y&:D MQFT +4:P@"T&M8 L!OM
M :T<_ &K'?\!J1W_ :D=_P&H'?\!J!W_ :@=_P'_*   _R<  /XJ  #O*@
MYR<! .<B"0#D'1  V1L= ,\=+0#)'CP Q"!) +\@4P"\(5T N2%E +<B;0"U
M(G0 LR)\ +$B@P&P(HH!KB*2 :PCFP&K(Z0!J2.O :<CO &F),X!HR3H J E
M^0*>)?\"G27_ IPE_P*;)?\"FR7_ ILE_P+_+   _RT  .TR  #B-   VC,
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M!GP[_P5\._\%?#O_!7P[_P7T-P  Y4   -)'  #%2@  O$L  +5)  "O0P
MJ3X+ *(_%P"=0"8 F$$T )1!/P"104D!CD%1 8M 60*)0& #AT!G X4_;02#
M/W4%@3]]!G\^AP=]/I$(>SZ<"7H^J0EX/K@*=S_-"G4_Z@IT0/P(=$#_!W1
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M"&!._PCC1P  S5   +Y7  "S6P  JET  *%=  "86@  C5,  (92# " 4Q@
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M"U19F@U26:H.45F\#E!9V Y06?(-45G_"U%9_PI16?\)45G_"%%9_PC440
MPEH  +1A  "J9@  H&@  )=I  ",9P  ?6   '5? P!O7Q  :U\< &A@* !F
M8#, 8V \ 6%@1 %?7TP"7%]3 UM?6@197V$%5UYI!E5><PA37GX)45V*"T]=
MF0Q-7:@-3%ZZ#DM>U Y+7O$,3%[_"TQ=_PI,7?\)3%W_"$Q=_PC/5   OEX
M +%E  "G:@  G6T  )1M  ");   >&4  &]D  !I9 X 9609 &)D)0!@93
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M"CMPS0HZ;^P).V[^"#MN_P@[;?\'.VW_!SMM_P>_8@  L6L  *9S  "=>0
MDGL  (=\  ![?   ;7H  &!X  !6=P$ 4'<. $YX& !,>"0 2WDN $EY-P!(
M>4  1GE( 41Y3P%">5<"07E@ C]X:0,\>'0$.GB"!3AXD08W>*$'-7BS!S1X
MRP<T=^L'-';]!S1U_P<U=?\&-73_!C5T_P:Y:   K7$  *)Y  "8?@  C8
M (*!  !V@@  :8$  %N!  !1@0  2( * $6!$P!#@1X 0H(I $&",@! @CL
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M 1N4_P$;D_\"&Y/_ AN3_P*G?P  G(8  )&+  "'CP  >I(  &V5  !AF
M59L  $F=   ]G@  ,Y\  "JA   AHPH 'Z,1 !ZC&@ =I"0 '*0M !ND-@ :
MI#\ &:1* !BD50 6I6$ %:5P !2E@0 3I90 $J6H !&EOP 0I.( $:+X !&A
M_P 1H/\!$:#_ 1&@_P&@A@  E8P  (R1  !_E0  <9H  &2>  !8H0  3*0
M $"F   UIP  *JD  "*L   9K@  $K ) !"Q$  0L1@ #K$B  ZQ*P -L34
M#;%   RQ2P +L5@ "K%G  BQ>  'L8L !;&@  2PM0 $L-  !+#O  6O_@ &
MKO\ !J[_  :N_P"8C@  CY,  (*8  !UG0  9Z(  %JG  !.JP  0:T  #6O
M   KL0  (;0  !BV   1N0  #;P#  >^#  #O1(  ;T9  "^(@  OBL  +XV
M  "^00  OTX  +]<  "_;0  OX   +Z5  "^J@  OL(  +WD  "]]@  O?\
M +W_  "]_P"2E   A9H  'B@  !JI@  7*L  $^P  !"LP  -;8  "JX   @
MNP  %[X  !#!   +Q   !,<   #)!P  R0T  ,D2  #*&0  RR(  ,LK  #-
M-0  SD$  ,Y0  #/8   SW(  ,^'  #/G0  S[,  ,_.  #/ZP  SO@  ,[^
M  #._@"(FP  >J(  &RH  !>KP  4+4  $*Y   UO   *;\  !["   5Q@
M#LD   C,    T    -,   #5    U@8  -@,  #9$0  VQ8  -P?  #>*
MX#0  .)!  #B40  XV,  .-W  #DC@  Y*0  .2Z  #EU   Y>H  .7S  #E
M\P!\HP  ;JH  &"R  !1N0  0[X  #7"   HQ@  ',D  !/-   ,T0  !-4
M  #:    W@   .$   #B    Y    .4#  #G"0  Z0X  .L2  #M&@  [R0
M /(Q  #T00  ]%,  /5F  #U?   ]I,  /:I  #WO   ]\X  /??  #WWP!P
MK   8;0  %.[  !%PP  -L<  "?,   ;T   $=4   K;    WP   .(   #E
M    Z0   .P   #M    \    /$   #S    ]00  /<*  #Z$   _!8  /\A
M  #_+@  _T   /]3  #_:   _X   /^6  #_J   _[8  /^_  #_OP#_#1P
M_PH; /\"&P#_ !X _P D /\ +@#_ #P _P!* /\ 5@#_ &, _P!M /\ =P#_
M '\ _P"' /\ C@#_ )0 _P": /\ H #_ *8 _P"L /\ M #_ +T _P#) /X
MW0#] .T _ #Z /L _P#Z /\ ^0#_ /H _P#Z /\ ^@#_ /H _P#_$!D _PT7
M /\&%@#_ !@ _P > /\ *@#_ #< _P!% /\ 4@#_ %X _P!I /\ <@#_ 'L
M_P"" /\ B0#_ )  _@"6 /T G #\ *$ ^P"H /D KP#X +@ ]@## /0 T@#S
M .< \@#V /  _P#O /\ \ #_ .\ _P#O /\ [@#_ .X _P#_$A0 _P\2 /\+
M$@#_ !( _P : /\ )0#_ #, _P!  /\ 30#_ %D _P!D /T ;0#[ '8 ^0!]
M /< A #U (L ] "1 /, EP#Q )T \ "C .X J@#L +, Z@"] .@ RP#G .$
MY0#Q ., _0#C /\ X@#_ .$ _P#A /\ X #_ .  _P#_%!  _Q$. /\-#0#_
M!P\ _P(5 /\ ( #_ "T _P Z /\ 1P#Y %, ]0!> /( : #P '  [0!X .L
M?P#I (4 Z ", .8 D@#E )@ XP"? .$ I@#? *X W "X -H Q0#6 -D U #L
M -( ^0#1 /\ SP#_ ,X _P#. /\ S@#_ ,X _P#_%PP _Q0( /\/!0#_#@L
M_PP1 /\'&@#_ 28 _  T /0 00#M $T Z0!8 .8 8@#C &H X !R -X >0#;
M (  V0"& -8 C0#3 ), T0": ,\ H0#- *H RP"S ,D OP#& -  Q0#H ,,
M]@#! /\ P +_ +\#_P"_ _\ OP/_ +\#_P#_&P8 _Q<  /\4  #_$P4 _Q$-
M /\.% #Y"A\ \ 8L .8#.0#@ T8 W -1 -8$6P#2!&0 SP5L ,P%<P#*!7H
MR 6! ,8%AP#%!HX PP:6 ,$&G0"_!J8 O0:P +L'O "Y",T N KE +4+]P"S
M#?\ L0W_ + -_P"P#O\ KP[_ *\._P#_'@  _QL  /\;  #Z&@  ]18% /81
M#0#K#A4 X@LB -@+,0#0##X RPU* ,<-50#$#EX P0YF +\.;0"]#G0 NP][
M +D/@@"W$(H MA"1 +00F@"R$*, L!&M *\1N@"M$<H JA+E *<4]P"E%?\
MHQ7_ *(5_P"B%?\ HA7_ *(5_P#_(@  _R   / C  #F)   X"$  -P9!0#;
M$ P T!$9 ,@3*0#"%3< O19$ +D73@"U%U< LQA@ + 89P"N&&X K!EU *L9
M? "I&80 J!J, *8:E "D&IX HQNH *$;M "?',4 GAS? )H=\P&8'O\!EQ[_
M 98?_P&5'_\!E1__ 94?_P'_)@  ]"<  .8M  #:+P  SRT  ,HG  #''P@
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M VTZ_P/J.0  U4(  ,1(  "Y2P  KTL  *=)  "?1   F#X! )$\$ ",/1T
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M!EY'F@=<1ZD(6TB["%I(U A:2/$'6DG_!EI)_P5:2/\%6DC_!%I(_P3;1
MQDT  +A3  "M5P  HUD  )I8  "15   ADX  'U+" !W2Q( <TP? '!,*P!M
M3#4 :TP^ &A,1@!F3$T!9$Q3 6),6@)A3&("7TQJ UY,<P1<2WX%6DN*!EA+
MF =73*<(5DRY"55,T0E43.\(5$W_!E5,_P953/\%54S_!55,_P752   PE$
M +57  "J6P  H%P  )=<  "-60  @5,  '=/! !Q3Q  ;E < &I0* !H4#(
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M"$99R@A%6>H(1EG]!D98_P9&6/\%1UC_!4=8_P7'4@  N%L  *MA  "A9@
MF&@  (YI  "#9P  <F   &A>  !A70D 7%T3 %I='@!772D 5EXS %1>.P!2
M7D, 45Y* 4]>4@%.7ED"3%YA DI>:@-(7G4$1EZ"!41=D 9#7J '05ZQ!T!>
MR = 7N@'0%W\!D%=_P5!7?\%05S_!4%<_P7#5@  M%\  *AF  ">:@  E6T
M (IM  !_;   ;V<  &1D  !;8@4 5F(0 %1B&P!28R4 4&,O $YD. !-9$
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M RYP_P,N;_\#+F__ RYO_P.S9@  IV\  )UV  "3>@  B'P  'Y]  !R?0
M9'P  %=[  !,>@  0GD# #QY#@ Z>A< .7HA #AZ*@ W>S, -GL[ #1[1  S
M>TP ,GM5 #![7P O>VH!+7MW 2M[AP$J>Y@"*'NJ B=[OP(F>^$")GKW B9X
M_P(F>/\")W?_ B=W_P*N;   HW8  )E\  ".?P  A((  'B#  !LA   7X0
M %&$  !'A   /(0  #.$"0 PA!$ +X0: "V$)  LA2T *X4U "J%/@ IA4<
M*(90 ">&6@ FAF8 )(9S ".&@P AAI4 ((:G 1Z&O $>AMX 'H3U 1Z"_P$>
M@O\!'H'_ 1Z!_P&H=   GGT  )."  ")A0  ?H@  '&*  !EBP  6(P  $R-
M  ! C@  -HX  "R/   ED P (Y 3 "*0'  AD"4 ()$N !^1-@ >D4  '9%)
M !R15  :D6  &9%N !B1?@ 6DI  %9*D !21N0 3D=@ $X_T !2._P 4C?\
M%(S_ 12,_P&C?0  F(,  (Z(  "$C   =X\  &F1  !=DP  4)4  $67   Y
MF   +ID  "6:   =FP( %IT, !6=$P 4G1L $YTD !*=+0 1GC< $9Y! !">
M3  /GE@ #IYG  V>=P ,GHH "YV>  J=L@ )G<P "9SL  J;_@ +FO\ "YG_
M  N9_P"<A   D8H  (B.  ![D@  ;98  &"9  !4G   2)\  #R@   PH0
M)J,  !VE   5IP  $*D%  NK#0 (JA, !ZH;  :J)  %JBX !*HX  *J1  !
MJE   *I>  "J;@  JH$  *J5  "IJ@  J<$  *CD  "H]@  I_\  *?_  "G
M_P"5BP  C)   '^5  !QF@  8YX  %:B  !*I@  /:@  #&J   FJP  ':T
M !2P   .L@  ";4!  *V"@  M@\  +85  "W'0  MR4  +<O  "X.0  N$8
M +A4  "X9   N'8  +B+  "WH   M[8  +?3  "V[P  MOP  +;_  "V_P"/
MD@  @I<  '2=  !FH@  6*<  $NL   ^KP  ,;$  ":S   <M@  $[@   V[
M   &O@   ,$   #"!   P@L  ,,0  #$%0  Q!P  ,4D  #&+@  R#H  ,E'
M  #)5P  R6D  ,E]  #)E   R*H  ,C#  #(Y   R/0  ,C]  #(_0"%F0
M=Y\  &BF  !:JP  3;$  #^U   QN   );H  !J]   1P   "\,   /'
MR@   ,T   #.    SP,  - )  #1#@  TQ(  -49  #7(@  VBT  -TY  #>
M20  WEH  -]N  #?A0  WYP  -^R  #>RP  WN8  -_T  #?] !YH0  :Z@
M %RO  !.M0  0+L  #&^   DP0  &<4  !#(   )S    ,\   #3    V0
M -P   #=    WP   .$   #B!0  Y L  .80  #H%@  ZB   .TK  #P.@
M\4L  /%>  #R<P  \XL  /.B  #SM@  \\D  //A  #SX0!MJ@  7K$  %"Y
M  !!OP  ,L0  "3(   7S   #M    ;5    V@   -X   #B    Y@   .D
M  #J    [    .X   #P    \@   /0&  #V#   ^1(  /P<  #_*0  _SH
M /]-  #_8@  _W@  /^0  #_HP  _[,  /_!  #_P0#_!QD _P$7 /\ %P#_
M !H _P A /\ *P#_ #D _P!' /\ 5 #_ %\ _P!J /\ <P#_ 'L _P"# /\
MB@#_ )  _P"6 /\ FP#_ *$ _P"H /\ KP#_ +@ _P#$ /X U0#\ .H ^P#X
M /H _P#Y /\ ^ #_ /@ _P#V /\ \P#_ /$ _P#_"Q4 _P43 /\ $P#_ !0
M_P : /\ )P#_ #0 _P!" /\ 3P#_ %L _P!E /\ ;@#_ '8 _P!^ /\ A0#^
M (L _0"1 /L EP#Z )T ^ "C /< JP#V +, ] "^ /, S #Q ., [P#S .X
M_P#M /\ [ #_ .L _P#L /\ [ #_ .L _P#_#1$ _PD0 /\ #P#_ !  _P 6
M /\ (@#_ "\ _P ] /\ 2@#_ %4 _0!@ /H :0#X '$ ]@!Y /0 ?P#S (8
M\0", .\ D@#N )@ [ "? .L I@#I *X YP"X .4 Q0#C -H X0#M -\ ^P#>
M /\ W0#_ -T _P#= /\ W0#_ -T _P#_#PT _PP+ /\#"0#_  P _P 2 /\
M'0#_ "D ^P W /@ 1 #U %  \@!: .X 8P#L &L Z0!S .< >@#E (  XP"&
M .$ C #? ), W0"9 -L H0#9 *D U0"R -( O@#0 ,X S@#F ,P ]@#* /\
MR@#_ ,D _P#( /\ R #_ ,@ _P#_$0@ _PT" /\'  #_!0@ _P . /\ %@#W
M "( [P P .L /0#H $D Y !4 .  70#= &4 V0!M -4 <P#2 'H T "  ,X
MAP#, (T R@"4 ,@ FP#& *0 Q "M ,( N #  ,< O0#? +P \0"[ /X N0#_
M +@ _P"X /\ N #_ +@ _P#_%   _P\  /\-  #_#   _P<) /@!$ #H !H
MXP H -T -@#8 $( T@!- ,X 5P#* %\ QP!F ,4 ;0## '0 P0!Z +\ @0"]
M (@ NP"/ +D EP"W )\ M0"H +, LP"Q ,( KP#8 *X"[0"L _L JP7_ *H&
M_P"I!O\ J0;_ *D&_P#_%@  _Q(  /<2  #L$0  Y@X  .4&" #= Q( U ,@
M ,T$+0#(!#H PP5& +\%4 "\!E@ N09@ +<'9P"U!VX LP=U +$(>P"O"((
MK@F* *P)D@"J"9L J JE *8*L "E"[\ HPS4 *$-[0"?#OX G0[_ )P/_P";
M#_\ FP__ )L/_P#_&@  ]QD  .H>  #?'@  U1H  - 3 @#.# L QPL6 , -
M)0"Z#C( M@X_ +(/20"O$%( K!!: *H080"H$6@ IA%O *01=@"B$7T H1&%
M )\2C@"=$I< G!*B )H3K0"8$[P EQ30 )05[ "2%OT D!?_ (\7_P".%_\
MCA?_ (X7_P#Z'0  [B,  -\H  #0*@  QR<  ,$A  "]&04 N1(0 +(5'@"M
M%BP J!<X *080P"A&4P GQE4 )P:7 ":&F( F1II )<;< "5&W< E!M_ )(<
MB "0')( CQR= (T=J0"+';< BA[* (@?YP"&(/H A"#_ 8,@_P&#(/\!@B#_
M 8(@_P'U)   Y2P  -,Q  #&,P  O#$  +8M  "P)0  K!T, *8>& "A("8
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M FTSG0)L,ZL":C2\ FDTU0-H-?$"9S7_ F<U_P)F-?\"9C7_ F8T_P+B-@
MS#\  +U$  "R1P  J$<  *!$  "8/P  D#D  (@T#0"#-1< ?S8D 'PW+P!Y
M-SD =SA" '0X20!R.%  <3A7 &\X7@!M.&4!;#AM 6HX=0%H.( "9SB, F4X
MF0-D.:@#8CFY V$ZT -@.NX#8#K_ U\Z_P)?.O\"7SK_ E\Z_P+=.P  QT,
M +E)  "N2P  I$P  )M*  "210  B3\  ($Z"0![.A0 =SL@ '0\*P!R/#4
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M!$]'QP1.1^<$3D?[!$Y'_P-.1_\#3T?_ T]'_P/,1@  NTX  *]4  "D5P
MFE@  )%7  "&5   >TX  '!*  !I2 T 94@6 &))(0!?22L 74DT %M)/ !9
M24, 5TE* %9)4@!52ED!5$IA 5)*:@%12G4"3TJ! TY*CP-,2Y\$2TNP!$I+
MQ01)2^8$24OZ!$E+_P-*2_\#2DO_ TI+_P/(20  N%$  *Q7  "A6P  F%P
M (Y<  "#60  =E,  &M.  !D30H 7TP3 %Q-'@!:32@ 6$TQ %9-.@!434$
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M SI8_P,[5_\#.U?_ SM7_P.\5   KEP  *-C  "99P  D&D  (5I  !Y9P
M:V(  &!@  !570  3EL, $M;% !)7!\ 1UPH $9=,0!%73D 0UU! $)=2 !!
M7E  0%Y8 #Y>80$\7FP!.UYX CE>AP(W7I<"-EZI S5>O0,T7]T#-%[U S5=
M_P(U7?\"-5S_ C5<_P*X60  JF$  *!G  "6;   C&X  (%N  !V;   9VD
M %QF  !19   2&() $1B$0!"8AL 06,D #]C+0 ^8S4 /60] #QD10 [9$T
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M 2!Q_P&I:P  GG,  )1Y  "*?   @'X  '1_  !G?P  6G\  $U^  !#?@
M.'T  "]] @ H?0T )GT4 "1]'  C?B4 (GXM "%^-@ A?C\ 'W]( !Y_4@ =
M?UX '']K !I_>@ 9?XP %W^? !9_LP 5?\X %7[O !9\_P 6>_\ %GO_ !=[
M_P"D<@  FGH  (]_  "%@@  >X0  &V&  !@AP  5(<  $B(   \B   ,H@
M "B(   @B 4 &HD. !F)%0 8B1T %XHF !:*+@ 5BC< %(I! !.*3  2BU@
M$8ME !"+=0 /BX< #HJ;  V*KP ,BL@ #(GJ  V'_  .A_\ #H;_  Z&_P"?
M>P  E($  (J%  " B   <XL  &6-  !9CP  3)   $&2   TD@  *I(  "&3
M   9E   $I8&  Z7#@ -EQ4 #)<=  R7)@ +ER\ "I<Y  F71  (EU  !I=>
M  67;@ #EH   9:4  "5J   E;X  )3@  "4]   D_\  9+_  &2_P"8@@
MCH@  (6,  !WCP  :I(  %V5  !0F   1)H  #B;   LG   (IT  !F>   2
MH   #:("  >C"P !HQ   *,7  "C'P  HR<  *,Q  "D/   I$@  *16  "D
M90  HW<  *.+  "CH   HK8  *'2  "A\   H/L  *#_  "@_P"1B@  B8X
M 'N2  !MEP  8)L  %.>  !&H0  .:,  "VD   CI@  &:@  !&J   ,K
M!:X   "O!P  KPT  *\1  "P&   L"   +$H  "Q,@  LCX  +),  "R6P
MLFP  +*!  "QEP  L:P  +#&  "PZ   K_<  *__  "O_P",D   ?Y4  '&:
M  !CGP  5:0  $>H   ZJ@  +:P  "*N   8L   $+,   JU   "N    +L
M  "[    O <  +P-  "]$0  OA8  +\>  # )P  P3(  ,)   ##3P  PV
M ,-T  ##BP  PZ$  ,.X  #"UP  PN\  ,+Z  #!_@"!EP  <YT  &6C  !7
MJ   2:T  #NQ   MLP  (;8  !:Y   .NP  ![X   #!    Q0   ,<   #(
M    R0   ,H%  #+"P  S0\  ,X4  #0'   TR8  -8R  #800  V%,  -EF
M  #9?   V90  -FK  #9PP  V>$  -GP  #9] !VGP  9Z8  %FL  !+L@
M/+<  "ZZ   AO0  %<    W$   %QP   ,H   #.    T@   -4   #6
MV0   -L   #=    WP<  .$,  #C$0  YAD  .DD  #L,@  [4,  .Y6  #O
M:P  [X0  .^<  #OL@  [\8  ._=  #OY !JJ   6Z\  $RV   ^O   +\
M "#$   4R   #,P   +0    U    -D   #>    X@   .4   #F    Z
M .D   #L    [@   / "  #R"0  ]0\  /@7  #\(P  _S,  /]&  #_6@
M_W$  /^)  #_GP  _[$  /_   #_Q@#_ !4 _P 4 /\ % #_ !< _P = /\
M* #_ #< _P!$ /\ 40#_ %P _P!F /\ ;P#_ '< _P!^ /\ A0#_ (L _P"1
M /\ EP#_ )T _P"D /\ JP#_ +0 _@"_ /T S@#[ .8 ^0#V /@ _P#W /\
M]P#_ /< _P#P /\ [ #_ .D _P#_ Q( _P 0 /\ $ #_ !$ _P 7 /\ ) #_
M #( _P _ /\ 3 #_ %< _P!A /\ :@#_ '( _P!Y /T @ #\ (8 ^@", /D
MD@#X )@ ]@"? /4 I@#T *X \@"Y /  Q@#N -X [0#P .L _@#J /\ Z0#_
M .D _P#G /\ XP#_ .  _P#_!PX _P - /\ "P#_  P _P 3 /\ 'P#_ "P
M_P Z /\ 1@#^ %( ^P!< /@ 90#U &P \P!T /$ >@#O ($ [@"' .P C0#J
M ), Z0": .< H0#F *D XP"S .$ OP#? -  W0#I -H ^0#9 /\ UP#_ -4
M_P#5 /\ U0#_ -0 _P#_"0H _P$% /\  P#_  D _P 0 /\ &0#[ "8 ]P T
M /0 0 #R $P [@!6 .H 7P#G &< Y !N .( = #@ 'L W@"! -P AP#: (T
MU@"4 -0 FP#1 *, SP"M ,P N #* ,< R #@ ,8 \P#% /\ PP#_ ,, _P##
M /\ PP#_ ,, _P#_"P$ _P,  /\   #_  , _P + /, $@#N !\ Z@ M .8
M.@#B $4 W@!/ -D 6 #4 &  T0!H ,X ;@#, '0 R@![ ,@ @0#& (< Q ".
M ,( E@#  )X O@"G +L L@"Y ,  MP#4 +4 [ "S /L LP#_ +( _P"R /\
ML0#_ +$ _P#_#0  _P8  /\#  #W    ]  # .< #0#@ !@ V@ E -, ,@#.
M #X R@!) ,8 4@## %H P !A +X : "\ &X N@!T +@ >P"V ($ M "( +(
MD "P )D K@"B *P K0"J +H J #+ *8 Y@"E /< I #_ *, _P"B /\ H@#_
M *( _P#_$   ^PP  .\.  #F#0  WPD  -H !@#0 !$ R0 = ,0 *@"_ #<
MNP!" +< 2P"T %0 L@!; *\ 8@"M &@ JP!N *D =0"H 'L I@"# *0 BP"B
M )0 H "> )X!J "< K4 FP/& )D%X@"8!O0 E@C_ )4)_P"4"?\ E G_ )0)
M_P#\$0  \14  .,9  #6&0  S!4  ,<0  #$!PH O0,4 +<$(0"R!BX K@@Z
M *H)1 "G"4T I I5 *(*7 "@"F( G@MI )P+;P";"W8 F0Q^ )<,A@"6#)
ME R: )(-I@"1#;, CPW% (T.X@"+$/8 B1#_ (@1_P"'$?\ AQ'_ (<1_P#V
M&0  YR   -8D  #()0  OR(  +D<  "T% $ L0T. *H.&0"E#R< H1 S )T1
M/@":$4< F!)/ )425@"3$EP D1)C ) 3:0".$W  C!-X (L3@0")%(L AQ26
M (85H@"$%;  @Q;! ($7W0!_&/0 ?1G_ 'P9_P!\&?\ >QG_ 'L9_P#O(0
MW2D  ,HM  "^+P  M2P  *XG  "H(   HQ<( )X6$P"9%R$ E!DM )$:. ".
M&D$ BQM) (D;4 "'&U< A1Q> (0<9 ""'&L @!QS '\=? !]'88 ?!Z1 'H>
MG@!X'ZL =Q^\ '8@U !T(?  <B'_ '$B_P!Q(?\ <2'_ '$A_P#H*   TC
M ,(U  "W-P  K34  *4Q  ">*P  F"," )(>$ "-(!L B2$G (8B,@"#(SP
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M 5LTQ@%:-.8!637[ 5DU_P%9-/\!633_ 5DT_P'2.   P$   +-%  "H2
MGD@  )5&  "+0   @CL  'DU! !S,Q  ;S0: &PT)0!I-2\ 9S4W &4V/P!C
M-D8 8C9- & V5 !?-EL 73=C %PW:P!;-W8!63>" 5@XCP%6.)X!53BO E0Y
MPP)3.>0"4SKY 5,Y_P%2.?\!4SG_ 5,Y_P'-/   O$0  *])  "D3   FDP
M )%+  "'1@  ?4   ',[  !L. T :#D7 &4Y(@!C.BL 8#HT %XZ/ !=.D,
M6SI* %H[4 !8.U@ 5SM@ %8[: !5/',!4SQ_ 5(\C0%0/9P!3SVL DX^P0)-
M/N$"33[X DT^_P%-/O\!33W_ 4T]_P')0   N$@  *Q-  "A4   EU$  (Y/
M  "$2P  >44  &Y   !F/0L 8CT4 %\]'@!</B@ 6CXQ %@^. !7/D  53]&
M %0_30!3/U4 4D!= %! 9@!/0' !3D!\ 4Q!B@%+09H"2D&K DE"O@)(0MX"
M2$+V DA"_P)(0O\!2$'_ 4A!_P'%1   M4L  *E0  ">5   E50  (M3  "
M4   =4H  &I&  !A0@@ 7$$1 %E"&P!70B4 54(N %-"-0!10CT 3T)# $]#
M2P!.0U( 341: $M$8P!*1&X!245Z 4=%B %&19@"14:I D1&O0)#1MP"0T;U
M D-&_P)#1O\!0T7_ 4-%_P'!1P  LD\  *94  "<5P  DE@  (A8  !^50
M<4\  &9*  !<1@4 5T8/ %1&& !11B( 3T8K $Y&,P!,1SH 2T=! $I'20!)
M2%  2$A8 $=(80!%26P 1$EX 4))A@%!298!0$JG C]*NP(^2]@"/DKS CY*
M_P(^2?\!/TG_ 3])_P&]2@  KU(  *-8  "96P  D%T  (9<  ![60  ;5,
M &)/  !73 $ 44H- $Y*%0!,2Q\ 2DLH $E+, !'2S@ 1DP_ $5,1@!$3$X
M0TU6 $)-7P! 36H /TUV 3U.A $\3I0!.TZE 3E/N0(Y3]0".4_R 3E._P$Y
M3O\!.4W_ 3I-_P&Z3@  K%8  *%;  "77P  C6$  (-A  !X7@  :5@  %]6
M  !44@  3$\+ $E/$@!'4!P 15 E $-0+0!"4#4 05$\ $!11  _44P /E)4
M #Q270 [4F< .E)S #A3@@$W4Y(!-5.D 313MP$S5-$!,U/Q 313_P$T4O\!
M-%+_ 312_P&V4@  J5H  )Y@  "49   BV8  (!E  !T8P  9EX  %Q<  !1
M6   1U4' $)5$ ! 51@ /U8A #U6*@ \5C( .U8Y #I700 Y5TD .%=1 #=8
M6@ U6&4 -%AQ #)8@ $Q6) !+UFB 2Y9M0$M6<\!+5GO 2Y8_P$N5_\!+E?_
M 2Y6_P&R5P  I5\  )ME  "1:0  AVH  'QJ  !Q:   8V4  %AB  !-7P
M0UT" #Q;#0 Z7!0 .%P= #=<)@ U72X -%TV #-=/@ R748 ,5Y. #!>5P O
M7F( +5YN "Q??0 J7XX *5^@ "A?LP$G7\P )U_M 2=>_P$G7?\!*%W_ 2A<
M_P&M7   HF0  )AJ  ".;@  @V\  'EO  !N;@  8&L  %1I  !)9P  /V4
M #5C"0 R8Q$ ,&,9 "]D(0 N9"D +60Q "QD.0 K94( *F5* "AE5  G95\
M)F9K "1F>@ C9HL (F:= "!FL0 ?9LD 'V;K "!E_@ @9/\ (&/_ 2%C_P&I
M8@  GFH  )5P  "*<P  @'4  '5U  !I=   7'(  $]Q  !$;P  .FX  #!M
M P I; T )VP4 "9L'  E;20 )&TL "-M-  B;3T (6Y& "!N4  >;EL '6YG
M !QN=@ :;H< &6^: !AOK@ 6;\8 %F[I !=M_  8;/\ &&O_ !AK_P"D:0
MFG$  )!V  "&>0  ?'L  '%[  !D>P  5WH  $IY   _>   -7@  "MW   B
M=@< '78/ !QW%@ ;=QX &G<F !EW+@ 8=S< %WA  !5X2@ 4>%8 $WAC !)X
M<@ 1>(, $'B7  ]XJP .>,, #G?F  YV^@ /=?\ $'7_ !!T_P"?<0  E7@
M (M\  ""?P  =X$  &J"  !=@@  4((  $2"   X@@  +H(  "2"   <@@
M%(() !&#$  0@Q8 $(,>  Z#)P .@S  #8,Y  V#1  ,@U  "X-=  F#;  (
M@WX !H.1  6"I0 #@KL !(';  2!\@ %@/\ !G__  9__P":>0  D'X  (:#
M  !]A0  ;X<  &*)  !5B@  28L  #V,   QC   )HP  !V-   5C@  #X\#
M  J0#  &D!$ !(\8  ./(  !CRD  (\R  "0/0  D$D  (]6  "/90  CW8
M (^*  ".GP  CK0  (W/  ",[@  C/L  (O_  "+_P"4@   BX4  (*)  !T
MC   9H\  %F1  !,DP  0)4  #26   HE@  'I<  !68   /F@  "IL   *<
M"0  G X  )P3  "<&@  G"(  )TK  "=-0  G4   )U.  "=7   G6X  )R!
M  "<EP  G*P  )O&  ":Z   F?D  )G_  "8_P".B   AHP  'B0  !JE
M7)<  $^:  !"G0  -IX  "F?   ?H0  %:(   ZD   (I@   *@   "I!
MJ0H  *D.  "I$P  JAH  *HB  "K*P  K#8  *Q$  "L4P  K&,  *QW  "K
MC@  JZ0  *N\  "JW@  J?0  *G]  "I_P")C@  >Y,  &V7  !?G   4:
M $2D   VI@  *J@  !ZI   4JP  #:X   :P    L@   +4   "U    M0,
M +8)  "W#@  N!(  +@9  "Z(0  NRL  +PX  "]1P  O5@  +UK  "]@0
MO9D  +VP  "]S   O.H  +SW  "[_@!^E0  <)L  &*@  !3I0  1JH  #BM
M   JKP  'K$  !.T   ,MP   [D   "\    OP   ,(   #"    PP   ,0
M  #&!@  QPP  ,@0  #*%@  S"   ,\K  #0.@  T4L  -%>  #2<P  THL
M -*D  #3NP  T]@  -/M  #3]@!SG0  9*,  %:I  !'KP  .;,  "JV   =
MN0  $KP   J_    PP   ,8   #)    S0   ,\   #0    T@   -0   #6
M    V0(  -L(  #>#@  X1,  .0=  #H*@  Z#P  .E/  #I9   ZGP  .N5
M  #KK   Z\(  .S5  #LY0!FI@  6*P  $FS   [N0  *[P  !W    1Q
M"<@   #,    SP   -,   #9    W0   .    #A    XP   .4   #G
MZ@   .P   #N!   \0L  /42  #X'   ^RL  /T^  #^4P  _FH  /^#  #_
MFP  _ZX  /^^  #_R@#_ !( _P 0 /\ $0#_ !, _P 9 /\ )@#_ #0 _P!!
M /\ 30#_ %@ _P!B /\ :P#_ ', _P!Z /\ @0#_ (< _P"- /\ DP#_ )D
M_P"@ /\ IP#^ *\ _ "Z /H R0#Y .$ ^ #S /< _P#V /\ ]0#_ /$ _P#I
M /\ Y #_ .$ _P#_  \ _P - /\ #0#_  X _P 4 /\ (0#_ "X _P \ /\
M2 #_ %, _P!= /\ 9@#^ &T _ !U /L >P#Y (( ^ "( /< C@#V )0 ] ";
M /, H@#Q *H [P"T .T P0#K -4 Z@#L .@ _ #G /\ Y0#_ .8 _P#@ /\
MV0#_ -0 _P#_  L _P ( /\ !@#_  D _P 0 /\ ' #_ "D _P V /\ 0@#[
M $X ]P!7 /0 8 #R &@ [P!O .T =@#L 'P Z@"" .@ B #G (X Y0"5 .,
MG #A *0 WP"N -T N0#: ,H UP#D -0 ]@#1 /\ T #_ -  _P#/ /\ RP#_
M ,< _P#_  , _P   /\   #_  0 _P - /H %@#V ", \P P /  / #M $<
MZ0!1 .4 6@#B &( WP!I -T ;P#: '8 V !\ -0 @@#2 (@ T "/ ,T E@#+
M )X R0"H ,< LP#% ,$ P@#8 ,  [P"_ /X O@#_ +T _P"\ /\ O #_ +P
M_P#_ @  _P   /\   #_    ]  ' .T $0#H !P XP I -\ -0#; $$ U@!+
M -$ 5 #- %P R@!C ,@ :0#& &\ PP!U ,$ >P"_ (( O@"( +P D "Z )@
MN "B +4 K "S +D L0#+ *\ YP"N /@ K #_ *L _P"L /\ K #_ *L _P#_
M!   _P   /8   #N    YP   -\ # #6 !4 SP B ,H +@#' #H PP!$ ,
M30"\ %4 N0!< +< 8P"U &D LP!O +$ =0"O 'L K0"" *L B@"I )( IP"<
M *4 I@"C +, H0## )\ W@"> /( G0#_ )P _P"< /\ FP#_ )L _P#_!P
M]@D  .D+  #?"@  U00  ,X !0#& !  P  : +L )P"W #( LP ] +  1@"M
M $\ J@!6 *@ 7 "F &, I !H *( ;P"A '4 GP!\ )T A "; (T F0"7 )<
MH@"5 *X DP"] )$ TP"0 .T CP#\ (X _P"- ?\ C0'_ (T!_P#Y#@  ZA(
M -P5  #-%0  Q!$  +X,  "Z @H M  2 *X '@"J "H I@ U *( /P"@ $@
MG0%0 )L"5@"9 EP EP-C )4#:0"3 V\ D01V ) $?P".!8@ C 62 (H&G@"(
M!JH A@>Z (4(SP"$"NL @@O\ ($,_P" #/\ @ S_ ( ,_P#Q%0  X!T  ,T@
M  #!(0  N!T  +$7  "L$   J D- *('%@"="2, F0HN )4+. "3#$$ D Q)
M (X-4 ",#5< B@U= (@-8P"'#6H A0YQ (,.>@""#H0 @ Z/ 'X/FP!\#Z@
M>Q"X 'H0S@!X$>P =A+_ '42_P!T$_\ =!/_ '03_P#H'@  TR8  ,,J  "X
M*@  KB@  *<C  "@'   FQ,# )8/$ "0$!L C!$G (D2,@"&$SL A!-# ((4
M2P" %%$ ?A17 'P47@![%64 >15L '<5= !V%GX =!:* '(7E@!Q%Z0 ;QBT
M &X8R0!M&>@ :QK\ &H;_P!J&_\ :AO_ &H;_P#@)@  RBT  +PQ  "P,P
MIS$  )\L  "7)@  D!\  (H7# "%&!8 @1DB 'X:+ ![&S8 >1L^ '<<10!U
M'$P <QQ3 '$=60!P'6  ;AUG &T>< !K'GH :AZ% &@?D@!G'Z  92"P &0A
MQ0!C(>0 8B+Z &$B_P!A(O\ 82+_ &$B_P#7+   PS0  +8X  "J.0  H3@
M )@U  "0+P  B"@  ( A" ![(!( =R$= '0B)P!Q(C$ ;R,Y &TC00!K(T@
M:2-. &@D50!F)%L 921C &,E:P!B)74 826! %\FC@!>)IT 72>M %LHP0!;
M*.  6BGW %DI_P!9*?\ 62G_ %DH_P#/,@  OCD  +$]  "F/P  G#\  ),\
M  "*-@  @3   'DJ P!R)@\ ;B<9 &LH(P!I*"P 9BDU &4I/ !C*4, 82I*
M & J40!>*E< 72I? %PK: !:*W( 62Q] %@LBP!6+9H 52VJ %0NO0!3+MP
M4B_U %(O_P!2+O\ 4B[_ %(N_P#*-@  NCT  *U"  "B1   F$0  (]!  "%
M/   >S<  '(Q  !K+ P 9RT5 &0M'P!A+B@ 7RXQ %TN.0!<+T  6B]& %@O
M30!7+U0 5C!< %4P9 !3,6X 4C%Z %$QB !0,I< 3C*H $TSNP!---@ 3#3S
M $PT_P!,-/\ 3#/_ $PS_P#&.@  MD(  *E&  ">20  E4D  (M'  "!0@
M=ST  &TW  !D,@D 8#(2 %TR' !:,B4 6#,M %8S-0!5,SP 4S1# %(T2@!1
M-%$ 4#19 $\U80!--6P 3#9W $LVA0!*-Y4 2#>F $<XN %'.-,!1CCQ 48X
M_P%&./\ 1CC_ $8W_P#!/@  LD4  *9*  "<30  DDT  (A+  !^1P  <T(
M &D]  !?-P8 6C80 %<W& !4-R( 4C<J % W,@!/.#D 33A  $PX1P!+.$X
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M 3A#_P"W20  J5   )Y5  "46   BUD  (!8  !V5@  :%   %U,  !32
M2D4) $9$$0!$1!D 0D0B $%%*0 _13$ /D4X #U%/P \1D< .T9/ #I'6  Y
M1V( .$AN #9(?  U2(T -$F> #-)L0 R2<D ,4GK #))_@ R2/\ ,DC_ #-(
M_P"T3   IU0  )Q9  "27   B%T  'Y=  !S6@  954  %M2  !03@  1DH%
M $!)#@ ^218 /4D> #M*)@ Z2BX .4HU #A+/0 W2T0 -DM- #1,5@ S3&
M,DQL #%->@ P38L +DV< "U.KP L3L< +$[I "Q-_0 M3?\ +4S_ "U,_P"P
M4   I%@  )E=  "/80  AF(  'MA  !P7P  8EL  %A8  !.50  0U$! #M/
M#  X3Q, -D\; #5/(P T4"L ,U R #)0.@ Q4$( ,%%* "Y14P M4ET +%)I
M "M2>  I4H@ *%.: "=3K0 F4\4 )E/G "93_  G4O\ )U'_ "=1_P"L50
MH%P  )9B  "-9@  @V<  'AF  !M90  8&$  %5>  !*6P  /U@  #56"  Q
M51  ,%87 "Y6'P M5B< +%8O "M7-@ J5SX *5=' "A74  F6%H )5AG "18
M=0 C688 (5F8 "!9JP ?6<( 'UGE !]8^@ @6/\ (%?_ "%7_P"H6@  G6(
M )-G  "*:P  ?VP  '5L  !J:P  76@  %%E  !&8P  .V   #%> P J70T
M*%T3 "9=&P E7B, )%XJ "->,@ B7CH (5Y# "!?3  ?7U< 'E]C !Q@<0 ;
M8(( &6"5 !A@J0 78,  %F#B !=?^0 87O\ &5[_ !E=_P"D8   F6@  )!N
M  "&<   ?'(  ')R  !F<0  6&X  $QL  !!:P  -FD  "UG   C9@@ 'V8/
M !UF%0 <9AT &V8E !IF+0 99S4 &&<^ !=G2  69U, %6A? !-H;@ 2:'\
M$6B2 !!HI@ /:+T #FC@ !!G]P 09O\ $67_ !%E_P"?9P  EF\  (QS  ""
M=@  >'@  &UX  !@=P  4W8  $9T   [<P  ,7(  "=Q   ><0  %G * !-P
M$  3<!< $G ? !%Q)P 0<2\ $'$X  YQ0@ .<4X #7%;  QQ:0 +<7H "G&-
M  AQH0 &<;8 !G#2  =P[P (;_\ "6[_  EN_P";;P  D74  (=Y  !^?
M='X  &9^  !9?@  37X  $!]   U?0  *GP  "%\   8?   $7P$  Q\#  *
M?!$ "7P9  A\(0 '?"D !GPR  1\/0 #?$@  7Q5  !\8P  ?'0  'R'  ![
MG   >[$  'K+  !YZP  >?H  'G_  !X_P"6=P  C'P  (.   !Y@P  ;(0
M %Z%  !1A@  18<  #F'   MAP  (X<  !J'   2AP  #8@!  :)"@ !B0\
M (D4  "(&P  B",  (DL  ")-@  B4(  (A.  "(70  B&T  (B!  "'E0
MAZL  (;$  "%Y@  A/@  (3_  "$_P"0?@  AX,  'Z'  !QB0  8XL  %:-
M  !)CP  /)$  #"1   DD0  &I(  !*3   -E   !I4   "6!@  E@P  )40
M  "6%0  EAT  )8D  "6+@  ECD  )9&  "650  EF4  )9X  "5C@  E:0
M )2\  "3WP  D_4  )+_  "2_P"+A@  @XH  '6-  !GD   690  $R7   _
MF0  ,IH  ":;   ;G   $IT   R?   $H    *(   "C 0  HP<  *,,  "C
M$   I!4  *0<  "E)0  IB\  *8\  "F2P  IEL  *9N  "EA   I9L  *2S
M  "CT   H^\  *+\  "B_P"&C0  >)$  &J5  !<F0  3IT  $&@   SH@
M)J,  !NE   1IP  "JD   &K    K0   *\   "P    L    + %  "Q"P
ML@\  +,4  "T&P  M20  +<P  "W/P  MU   +=B  "W>   MY   +:I  "V
MP@  MN0  +;U  "U_@![DP  ;9@  %^=  !0H@  0J8  #2I   FJP  &JT
M !"O   )L@   +0   "W    N@   +P   "]    O@   +X   #  @  P0@
M ,(-  #$$@  QAD  ,DD  #*,@  RT,  ,M5  #,:@  S(,  ,R<  #+M0
MS,X  ,SI  #,]@!PFP  8:$  %*F  !$JP  -K   ">R   :M0  $+@   >[
M    O@   ,$   #$    R    ,L   #+    S0   ,X   #0    T@   -4#
M  #8"@  VQ   -X8  #B)   XS4  .1(  #E7   YG,  .:-  #FI0  YKP
M .;3  #GYP!CI   5:H  $:P   XM0  *+D  !J\   /P   !<0   #'
MRP   ,\   #4    V    -P   #=    WP   .$   #C    Y0   .@   #J
M    [08  /$.  #U%@  ^"4  /DX  #Y30  ^F,  /M\  #\E0  _*H  /R[
M  #]RP#_  \ _P . /\ #@#_ !  _P 6 /\ (P#_ #  _P ] /\ 20#_ %0
M_P!> /\ 9@#_ &X _P!V /\ ? #_ (( _P") /\ CP#_ )4 _@"; /T HP#[
M *L ^@"U /D PP#W -L ]@#P /0 _P#S /\ \@#_ .P _P#B /\ W #_ -8
M_P#_  P _P ) /\ " #_  H _P 2 /\ '@#_ "L _P X /\ 1 #_ $\ _P!9
M /X 80#\ &D ^@!P /@ =P#W 'T ]@"# /0 B0#R (\ \0"6 .\ G0#M *4
M[ "O .H O #H ,T Y@#H .0 ^@#C /\ X@#_ .  _P#5 /\ S@#_ ,L _P#_
M  8 _P ! /\   #_  0 _P . /\ &0#_ "4 _0 R /L /@#W $D \P!3 /
M7 #N &, [ !J .H <0#H '< Y@!] .0 @P#B (D X "0 -X EP#< )\ V0"I
M -8 M #3 ,0 T #> ,X \P#, /\ RP#_ ,H _P#( /\ P@#_ +X _P#_
M_P   /\   #_    ^P + /8 $P#Q "  [0 L .H . #G $, XP!- .  5@#<
M %T V0!D -4 :P#2 '$ T !V ,X ? #, (, R@") ,@ D0#& )D Q "C ,$
MK0"_ +L O0#/ +L ZP"Y /P MP#_ +< _P"V /\ M #_ +$ _P#_    _P
M /\   #V    [@ % .< #P#A !D VP E -4 ,0#2 #P S@!& ,H 3P#' %<
MQ !> ,$ 9 "_ &H O0!P +L =@"Y 'P N "# +8 B@"S ), L0"< *\ IP"M
M +, JP#% *D X0"G /4 I@#_ *4 _P"D /\ I #_ *0 _P#_    _    /$
M  #H    X    -0 "P#, !, QP ? ,( *@"_ #4 O  _ +@ 2 "U %  LP!7
M +  7@"N &0 K !I *L ;P"I '4 IP!\ *4 A "C (P H0"6 )\ H0"= *T
MF@"\ )@ T@"7 .X E0#^ )0 _P"5 /\ E0#_ )4 _P#\ 0  \ 4  .,'  #5
M!0  S    ,4 ! "^  X N  7 +, (P"O "X JP X *D 00"F $H HP!1 *$
M5P"? %T G0!C )L :0": &\ F !V )8 ?0"4 (8 D@"0 )  FP". *< C "V
M (H R0"( .< AP#Y (< _P"& /\ A@#_ (8 _P#T#   Y!   -$2  #%$0
MO0X  +8(  "Q  @ JP 1 *8 &P"A "8 G@ Q )H .@"8 $, E0!* ), 40"1
M %< CP!= (X 8P", &D B@!P (@ =P"& (  A "+ (( E@"  *, ?@"Q 'T
MQ ![ N$ >@/U 'H%_P!Y!?\ > ;_ '@&_P#J$P  UAH  ,8=  "Z'   L1D
M *H3  "D#0  GP4, )D % "5 !\ D0(I (T#,P"+!#P B 5$ (8&2P"$!E$
M@@=7 ($'70!_!V, ?0AJ 'L(<@!Z"'P > F& '8)D@!T"J  <PJO '$+P0!P
M#-\ ;PWV &X._P!M#O\ ;0[_ &T._P#A'   RR,  +PF  "Q)@  J"0  * >
M  "9&   DQ " (X+#@"("Q< A PB ($-+ !^#34 ? X] 'H.10!X#DL =PY1
M '4/6 !S#UX <1!E ' 0;@!N$'< ;!"" &L0CP!I$9T :!&M &82P !E$M\
M9!/V &,4_P!C%/\ 8A3_ &(4_P#6)   PRH  +4N  "J+P  H"T  )@H  "0
M(@  B1L  ((3" !]$1( >1(< '83)P!S%#  <10X &\5/P!M%48 ;!5, &H6
M4P!H%ED 9Q9A &46:0!D%W( 8A=^ &$8BP!?&)D 7AFI %P9O !<&M@ 6AOS
M %H<_P!9'/\ 61S_ %D<_P#-*@  O3$  *\U  "D-@  FS0  )(Q  ")*P
M@24  'D= P!S& X ;QD8 &P:(@!I&RL 9QLS &4<.P!D'$$ 8AU( & =3@!?
M'54 71U< %P>9 !;'FX 61]Y %@?AP!6()8 52"F %0AN !3(=( 4B+Q %(C
M_P!2(_\ 4B+_ %(B_P#(+P  N#8  *LZ  "@/   ECL  (TX  "#,@  >BT
M '(F  !J( P 9B 3 &,A'0!A(28 7R(O %TB-@!;(CT 6B-$ %@C2@!7(U$
M52-8 %0D80!3)&H 425V % E@P!/)I, 3B>C $PGM0!,*,X 2RCN $LI_P!+
M*/\ 2RC_ $LH_P##-   LSL  *<_  "<00  DD   (D^  !_.0  =3,  &PM
M  !C)P@ 7B81 %PF&0!9)R( 5R<K %4H,@!4*#D 4BA  %$H1@!0*4T 3BE5
M $TI70!,*F< 2RIS $DK@ !(*Y  1RRA $8MLP!%+<L 12[L $0N_P!$+O\
M12W_ $4M_P"^.   L#\  *1#  "910  CT4  (5#  ![/@  <3D  &<T  !>
M+@0 6"L. %4K%@!2+!\ 4"PG $\L+P!-+38 3"T\ $HM0P!)+4H 2"Y2 $<N
M6@!&+V0 12]P $,P?@!",(T 03&> $ RL0 _,L@ /S/J #\S_@ _,O\ /S+_
M #\R_P"[/   K4,  *%'  "620  C$D  (-(  !X1   ;3X  &,Y  !:-
M4C , $\P$P!,,!P 2C D $DQ*P!',3( 1C$Y $0Q0 !#,D< 0C)/ $$S6 !
M,V( /S1M #XT>P ]-8L /#:< #LVKP Z-\8 .3?H #DW_  Z-_\ .C;_ #HV
M_P"W0   JD8  )Y+  "430  BDX  (!,  !U2   :D,  & ^  !6.0  334)
M $DT$0!'-1D 134A $,U* !!-2\ 0#4V #\V/0 ^-D4 /3=- #PW50 [.&
M.CAK #DY>0 X.8D -SJ; #4ZK0 U.\0 -#OF #0[^P U._\ -3K_ #4Z_P"T
M0P  ITH  )Q.  "240  B%(  'Y0  !S30  9T@  %Q$  !2/P  2#H& $0Y
M#P!!.18 /SD> #XY)@ \.2T .SHT #HZ.P Y.T( .#M* #<\4P V/%T -3UI
M #0]=P S/H< ,3Z9 # _JP O/\( +S_D "\_^@ P/_\ ,#[_ # ^_P"Q1P
MI$T  )E2  "/50  AE8  'Q5  !Q4@  9$P  %E)  !/10  14 # #\^#0 \
M/A, .CX; #D^(P W/BH -C\Q #4_.  T/T  ,T!( #) 40 Q05L ,$%G "Y"
M=0 M0H4 +$.7 "M#J@ J0\  *43B "I#^0 J0_\ *T+_ "M"_P"N2@  H5$
M )=6  "-60  @UH  'E:  !N5P  85(  %=.  !-2P  0T<  #I#"@ V0Q$
M-$,8 #-#(  R1"< ,40O #!$-@ O13T +45& "Q%3P K1ED *D9D "E'<@ H
M1X, )D>5 "5(J  D2+X (TC@ "1(]P E1_\ )4?_ "9'_P"J3P  GU4  )1:
M  "+7@  @5\  '=>  !K7   7U@  %55  !+40  0$T  #5*!P P20X +DD5
M "U)'0 L220 *THK "I*,P H2CL )TM# "9+3  E2U8 )$QB "-,<  A3(
M($V3 !]-I@ >3;L '4[= !Y-]@ >3/\ 'TS_ "!+_P"G4P  G%H  ))?  "(
M8P  ?F0  '1C  !I80  7%X  %);  !'6   /%4  #)2 @ J4 P )T\2 "90
M&0 E4"  )% H "-0+P B43< (5%  "!120 >4E, '5)? !Q2;0 :4WT &5.0
M !A3I  64[D %5/9 !93]  74O\ &%'_ !E1_P"C60  F&   (]E  "%:
M>VD  '%I  !F9P  660  $UA  !"7P  .%P  "Y:   E6 @ (%<. !Y7%  =
M5QP '%@C !M8*P :6#, &5@\ !A810 665  %5E; !19:0 36GH $EJ- !%:
MH0 06K< #EK5 !!9\P 06?\ $5C_ !%8_P"?7P  E68  (QK  "";0  >&X
M &YO  !B;0  56H  $AH   ^9@  ,V4  "EC   @80$ && + !5@$  48!<
M$V > !)@)@ 28"X $6$W !!A0  /84L #F%8  UA9@ ,8G8 "V*)  IAG0 )
M8;( "&'+  AAZP )8/T "E__  M?_P";9@  DFT  (AQ  !^<P  =74  &IT
M  !<<P  3W(  $-P   X;P  +6X  "1L   ;:P  $VL$  YJ#  -:A( #&H9
M  MJ(0 *:BD "6HR  AJ/  ':T< !6M3  1K80 ":W$  &J$  !JF   :JT
M &G&  !IYP  :?@  &C_  !H_P"7;0  C7,  (1W  ![>@  <'L  &-[  !6
M>@  27H  #UY   Q>   )W<  !UV   5=@  #W8"  EV"@ $=@\  '85  !V
M'   =B0  '4L  !U-@  =4$  '5.  !U7   =6P  '5^  !TDP  =*@  '/
M  !SXP  <O<  '+_  !Q_P"2=0  B7H  (!^  !V@   :8$  %N"  !.@@
M08(  #6#   I@@  'X$  !:!   0@@  "H(   *#!P  @@T  ((1  ""%P
M@AX  ((F  ""+P  @CL  ()'  ""50  @64  (%X  "!C0  @*(  '^Z  !_
MW0  ?O0  'W_  !]_P"-?   A($  'N$  !NA@  8(@  %**  !%BP  .8P
M "R,   AC   %XP  !"-   )C@   H\   "0 P  CPD  (\.  "/$@  D!@
M ) ?  "0*   D#(  ) _  "030  D%T  (]P  "/A0  CIP  (ZS  "-T
MC/   (O^  "+_P"(A   @(@  '*+  !DC0  5I   $B3   [E0  +I8  "*6
M   7EP  #Y@   B9    FP   )T   "=    G0,  )T)  "=#0  GA$  )X7
M  "?'P  GRD  * U  "@0P  H%0  *!F  "?>P  GI,  )ZK  "=Q@  G>D
M )SY  "<_P"#BP  =8X  &>2  !9E@  2YD  #V<   PG@  (Y\  !>@   .
MH@  !Z0   "F    J    *H   "J    J@   *L!  "K!P  K P  *T0  "N
M%@  KQX  +$I  "Q.   L4@  +%:  "Q;P  L8@  +&@  "PN@  K]T  *_R
M  "O_0!XD0  :I8  %R:  !-GP  /Z,  #&F   CIP  %ZD   ZK   %K@
M +    "R    M0   +<   "W    N    +D   "Z    O ,  +T)  "^#@
MP!0  ,,>  #%*P  Q3P  ,9.  #&8@  QGH  ,:4  #&K0  QL@  ,7E  #%
M\P!LF0  7IX  $^D  !!J   ,JP  "2O   6L0  #;0   .W    N@   +T
M  #     Q    ,8   #&    R    ,D   #+    S    ,X   #0!@  TPT
M -@3  #<'@  WBT  -]   #@5   X6L  .&%  #AGP  X;<  .'/  #AY@!@
MH0  4J<  $.M   TL@  );4  !>Y   -O    ;\   ##    QP   ,H   #/
M    TP   -8   #7    V@   -P   #?    X0   .,   #F    Z0$  .P+
M  #P$@  \Q\  /0Q  #V1@  ]UP  /AT  #XCP  ^:8  /FX  #XR0#_  T
M_P + /\ "P#_  X _P 3 /\ 'P#_ "P _P Y /\ 10#_ %  _P!9 /\ 8@#_
M &H _P!Q /\ =P#_ 'X _P"$ /X B@#] )  _ "7 /H G@#Y *< ]P"Q /8
MO@#U -( \P#L /$ _@#P /\ \ #_ .8 _P#< /\ T@#_ ,T _P#_  < _P $
M /\  @#_  8 _P 0 /\ &P#_ "< _P S /\ /P#_ $H _@!4 /L 70#Y &0
M]P!K /4 <@#S '@ \@!^ /  A #O (H [0"1 .P F0#J *$ Z "K .8 M@#D
M ,< X@#C .  ]P#> /\ W0#_ -D _P#, /\ Q0#_ ,$ _P#_    _P   /\
M  #_  $ _P - /\ %@#\ "( ^0 N /8 .0#S $4 [P!. .P 5P#I %X Y@!E
M .0 ; #B '( X !W -\ ?@#= (0 VP"+ -@ D@#5 )L T@"D ,\ KP#- +X
MRP#5 ,D [P#' /\ Q0#_ ,0 _P"^ /\ N #_ +4 _P#_    _P   /\   #^
M    ]P ) /$ $0#K !P YP H .0 ,P#A #X W0!( -@ 40#3 %@ T !? ,X
M90#, &L R@!Q ,@ =P#& 'T Q "$ ,( C #  )0 O@"> +L J "Y +8 MP#(
M +4 Y@"S /H L0#_ +  _P"P /\ K #_ *D _P#_    _P   /H   #Q
MZ  # .  #0#8 !8 T0 B ,T +0#* #< Q@!! ,( 2@"_ %( O0!9 +H 7P"X
M &4 MP!J +4 < "S '8 L0!] *\ A0"M (T JP"7 *D H0"G *X I0"^ *(
MV "@ /( GP#_ )X _P"> /\ G@#_ )P _P#_    ]P   .L   #A    U@
M ,L "0#% !$ OP ; +L )@"W #$ M  Z +$ 0P"N $L JP!2 *D 6 "G %X
MI@!D *0 :0"B '  H !V )X ?@"< (8 F@"0 )@ FP"6 *< E "V )( R@"0
M .D CP#\ (X _P"- /\ C #_ (T _P#X    Z0(  -L#  #, 0  Q    +T
M @"V  T L  5 *L ( "G "H I  T *$ / "> $0 G !+ )H 4@"8 %@ E@!=
M )4 8P"3 &D D0!P (\ =P"- (  BP"* (D E0"' *$ A0"O (, P0"! .
M@ #U '\ _P!_ /\ ?P#_ '\ _P#N"@  W X  ,H0  "^#@  M0L  *\#  "I
M  < HP 0 )X & "9 ", E@ L ), -0"0 #X C@!% (P 2P"* %$ B !7 (8
M70"% &, @P!J ($ <0!_ 'H ?0"$ 'L CP!Y )P =P"J '4 NP!T -0 <@#P
M '( _P!R /\ <0#_ '$ _P#C$0  S1<  +\9  "S&0  JA4  *,0  "="@
MEP$* )$ $@"- !L B0 E (4 +P"# #< @  ^ 'X 10!] $L >P!1 'D 5P!X
M %T =@!D '0!:P!R 70 < )_ &X"BP!L Y@ :P.F &D$MP!H!<X 9P?L &8(
M_0!F"?\ 90G_ &4)_P#6&@  Q"   +8C  "K(P  H2   )D;  "2%   C X!
M (8'#0" !!0 ? 8> 'D'* !V"#  = @X '()/P!P"44 ;PI, &T*4@!L"E@
M:@M? &@+9P!G"W  90QZ &,,AP!B#)4 8 VD %\-M@!>#<X 7 [M %P/_P!;
M$/\ 6Q#_ %L0_P#-(0  O"@  *\K  "D*P  FBD  )(D  ")'P  @A@  'L1
M!0!U#0\ <0T7 &X.(0!K#BH :0\R &<0.0!E$$  9!!& &,030!A$%, 7Q%:
M %X18@!<$6L 6Q%V %D2@P!8$I( 5A.B %43M !4$\L 4Q3L %(5_P!2%O\
M4A7_ %(5_P#&*   MBX  *DR  "?,@  E3$  (PM  "#)P  >B$  '(:  !K
M$PL 9Q,3 &04' !A%"4 7Q4M %T5- !<%3L 6Q9" %D62 !8%D\ 5A=6 %47
M7@!3%V< 4AAR % 8?P!/&8X 3AJ? $P:L !+&\< 2QOI $H<_0!*'/\ 2AS_
M $H<_P#!+0  L30  *4W  ":.   D#<  (<T  !]+P  ="D  &PC  !D' <
M7AD0 %L:& !9&R$ 5QLI %4;, !4'#< 4AP] %$<1 !/'4L 3AU2 $T=6@!+
M'F, 2AYN $D?? !''XL 1B"< $4AK@!$(<0 0R+F $,B_ !#(O\ 0R+_ $,B
M_P"\,@  K3@  *$\  "7/@  C3T  (,Z  !Y-0  ;S   &8J  !>) ( 5R -
M %0@% !1(!T 3R$E $XA+ !,(3, 2R(Z $DB0 !((D< 1R). $8C5P!$(V
M0R1K $(D>0!!)8@ /R:9 #XFJP ])\$ /2?C #TH^@ ]*/\ /2?_ #TG_P"X
M-@  JCT  )Y   "40@  BD(  ( _  !V.P  ;#8  &(P  !9*@  424+ $TE
M$0!+)1D 224A $<F* !%)B\ 1"8V $,F/0!")T0 02=+ #\H5  ^*%T /2EI
M #PI=@ [*H8 .2N7 #@KJ0 W++\ -RS@ #<L^  W+/\ -RS_ #@L_P"U.@
MIT   )Q$  "11@  AT8  'U$  !S0   :#L  %\V  !5,0  3"L' $<I#P!%
M*A8 0RH> $$J)0 _*BP /BLS #TK.0 \*T$ .RQ( #HL40 Y+5L ."YF #8N
M<P U+X, -"^5 #,PIP R,+T ,3'> #$Q]P R,?\ ,C#_ #,P_P"Q/@  I$0
M )E(  "/2@  A4H  'M)  !P10  94   %L[  !2-@  2#$$ $(N#0 _+A,
M/2X; #LN(@ Y+RD ."\O #<O-@ V,#X -3!& #0Q3P S,5D ,C)D #$R<0 P
M,X$ +S23 "XTI@ L-;L +#7; "PU]0 M-?\ +33_ "XT_P"N00  HD@  )=,
M  "-3@  @TX  'E-  !N2@  8D4  %A   !./   13<  #TS"P Y,Q$ -S,8
M #8S'P T,R8 ,S,M #(T-  Q-#P ,#5$ "\U3  N-E8 +39B "PW;P K-W\
M*CB1 "@XI  G.;D )CG8 "<Y]  H.?\ *#C_ "DX_P"K10  GTL  )1/  "+
M4@  @5,  '=2  !L3P  7TD  %9&  !,0@  0CT  #@X"  T. \ ,C@5 #$X
M'0 O."0 +C@K "TY,@ L.3D *SI! "HZ2@ I.U0 *#M? "<\;0 E/'T )#V/
M ",]H@ B/;< (3[4 "$^\P B/?\ (SW_ ",\_P"H20  G4\  ))3  ")5@
M?U<  '56  !J4P  74\  %-,  !*2   0$0  #9 !0 O/0T +3T3 "L]&@ J
M/B$ *3XH "@^+P G/C< )C\_ "0_2  C0%( (D!= "%!:@ @07H 'D&- !U"
MH  <0K4 &T+1 !M"\0 <0O\ '4'_ !Y!_P"E30  FE,  )!8  "&6P  ?5P
M ');  !G6   6U0  %%2  !(3@  /4H  #-'   J0PL )D,0 "5#%@ D0QX
M(T0E ")$+  A1#0 ($4\ !Y%10 =14\ '$9: !M&:  91G@ &$>* !='G@ 6
M1[, %$C. !5'[P 61_\ %T;_ !=&_P"B4@  EU@  (U=  "$8   >F$  '!@
M  !E7@  65H  $]8  !$5   .5$  "].   F2P8 ($H. !Y*$P =2AH '$HA
M !M+*  :2S  &4LX !=+0@ 63$P %4Q7 !1,90 3374 $DV( !%-G  03;$
M#D[,  ]-[@ 03?\ $4S_ !%,_P">5P  E%T  (MB  "!90  =V8  &UF  !C
M9   5F$  $I>   _6P  -5@  "M6   B5 $ &E(* !92$  54A8 %%(= !-2
M)  24BP $5(T !%2/@ 04T@ #U-4  Y38@ -5'( #%2$  M4F  )5*T "%3%
M  E4YP *4_L "U+_  M2_P";70  D60  (AH  !^:P  =&P  &ML  !?:@
M4F<  $5D   Z8@  ,&   "9>   =70  %5L% !!:#  .6A$ #EH8  U;(  ,
M6R< "ULP  I;.@ )6T4 !UM1  9;7@ $6VT  UN   %;E   6Z@  %O   !:
MX@  6O8  5K_  )9_P"79   CFL  (1N  ![<   <G(  &=Q  !9<   3&X
M $!L   U:P  *FD  "%G   89@  $68!  QE"@ '90\ !&44  -D&P "9",
M &0L  !D-0  9$   &1,  !D6@  9&D  &1[  !DCP  8Z0  &.[  !BW0
M8O0  &+_  !A_P"3;   B7$  (!U  !X=P  ;7@  &!W  !2=@  1G4  #ET
M   N=   (W(  !IQ   2<0  #7$   9Q"   < T  ' 2  !P%P  ;Q\  &\F
M  !O,   ;SL  &]'  !O5   ;V0  &]U  !NB@  ;:   &VV  !LU@  :_(
M &O_  !K_P".<P  A7@  'U[  !S?0  97X  %A^  !+?@  /GX  #)^   F
M?0  ''P  !-\   -?   !GT   !]!0  ? L  'P/  !\$P  ?!D  'PA  !\
M*0  ?#0  'M   ![3@  >UX  'MO  !ZA   >IH  'FQ  !XS@  =^\  ';^
M  !V_P")>@  @7\  'B"  !K@P  784  $^&  !"AP  -8@  "F'   =AP
M%(<   V(   &B0   (H   "*    B08  (D,  ")#P  B1,  (D:  "*(@
MBBP  (HX  "*1@  B58  (EH  ")?   B)0  (>K  "&Q@  A>H  (7[  "$
M_P"%@@  ?88  &^(  !ABP  4XT  $6/   XD0  *Y$  !^2   4D@  #9,
M  24    E@   )<   "8    EP   )<%  "7"P  F X  )@3  "9&@  F2(
M )HN  ":/0  F4T  )E>  "9<P  F(L  )BC  "7O   EN(  );W  "5_P"
MB0  <HP  &2/  !6DP  2)8  #J9   LF@  'YL  !2<   ,G@   Y\   "A
M    HP   *4   "E    I0   *4   "F @  IP@  *<-  "H$0  J1D  *LC
M  "K,0  JT$  *Q3  "L9P  JX   *J:  "JLP  JM   *GO  "I^P!UCP
M9Y0  %F8  !*G   /)\  "VB   @HP  $Z4   NG   !J0   *L   "N
ML0   +(   "R    LP   +0   "U    M@   +@$  "Y"P  NQ   +T8  "_
M)   OS4  ,!'  # 6P  P'(  ,"-  #!I@  P,$  +_C  "^\P!JEP  6YP
M $VA   ^I0  +ZD  "&K   3K0  "[    "S    M0   +@   "\    OP
M ,$   #!    PP   ,0   #&    QP   ,D   #+    S@@  -$/  #5&
MV"<  -DY  #:30  VV0  -M^  #<F0  W+   -S)  #<XP!=GP  3Z4  $"J
M   RKP  (K(  !2U   *N    +L   "_    PP   ,8   #+    S@   -$
M  #1    U    -8   #9    VP   -X   #@    Y    .<&  #K#@  [QD
M / J  #R/P  \U4  /1M  #TB   ]*$  /2V  #TQP#_  D _P & /\ !P#_
M  P _P 1 /\ ' #_ "@ _P T /\ 00#_ $P _P!5 /\ 70#_ &4 _P!L /\
M<@#^ '@ _ !^ /L A #Z (L ^0"2 /< F0#V *( ] "L /, N0#Q ,L \ #H
M .X ^P#M /\ [ #_ .$ _P#2 /\ R0#_ ,0 _P#_  $ _P   /\   #_  0
M_P . /\ %P#_ ", _P O /\ .P#] $8 ^@!0 /< 6 #T %\ \@!F /  ; #O
M '( [0!X .P ?@#J (4 Z0", .< DP#E )P XP"F .$ L0#? ,$ W0#= -L
M] #9 /\ U@#_ ,\ _P#$ /\ O0#_ +D _P#_    _P   /\   #_    _P +
M /P $P#W !X ]  J /( -0#N $  Z0!* .8 4@#C %D X !@ -X 9@#< &P
MV@!R -< > #4 'X T@"% -  C0#. )4 S "? ,D J@#' +@ Q0#- ,, ZP#
M /X OP#_ +X _P"V /\ L #_ *T _P#_    _P   /\   #Y    \@ & .L
M#P#F !D X0 D -X +P#: #D TP!# ,\ 3 #, %, R0!: ,< 8 #% &8 PP!K
M ,$ <0"_ '< O0!^ +L A@"Y (X MP"8 +4 HP"S +  L0#" *X X "L /<
MJP#_ *H _P"H /\ HP#_ *  _P#_    _P   /4   #K    X0   -8 # #/
M !, R@ > ,8 *0#" #, OP ] +L 10"X $T M@!4 +, 6@"Q %\ L !E *X
M:@"L '  JP!W *D ?P"G (< I0"1 *, G "@ *D G@"X )P S@": .X F0#_
M )< _P"6 /\ E@#_ ), _P#]    \0   .4   #9    S0   ,0 !@"]  \
MMP 8 +, (@"P "P K0 V *D /@"G $8 I !- *( 4P"@ %D GP!> )T 9 ";
M &H F@!P )@ =P"6 (  E "* )$ E0"/ *( C0"P (L PP") ., B #Y (8
M_P"& /\ A@#_ (8 _P#S    XP   -$   #%    O0   +8   "N  L J  2
M *0 ' "@ "8 G  O )H -P"7 #\ E0!& )( 3 "1 %( CP!8 (T 70"+ &,
MB@!J (@ <0"& 'D A "# (( CP!_ )L ?@"I 'P NP!Z -4 > #R '@ _P!W
M /\ =P#_ '< _P#G!P  T0P  ,,-  "X#   K@@  *@   "B  4 FP . )8
M%0"2 !\ C@ H (L ,0"( #D A@!  (0 1@"" $P @ !2 '\ 5P!] %T >P!C
M 'H :P!X ', =@!] '0 B !Q )4 < "D &X M !L ,H :P#J &H _ !J /\
M:@#_ &H _P#:$   QA0  +@6  "M%0  I!(  )P.  "6!P  D  ) (H $ "%
M !@ @0 A 'X *@![ #( >0 Y '< 0 !U $8 <P!, '( 40!P %< ;@!> &T
M90!K &X :0!W &< @P!E )$ 8P"? &( KP!@ ,0 7P#D %\!^ !> O\ 7@+_
M %X"_P#.&   O1T  + @  "E'P  FQP  ),7  "+$0  A P  'X$"P!Y !(
M=0 ; '( (P!O "L ;0$S &L!.@!I D  9P-& &8#3 !D!%( 8P19 &$$8 !?
M!6D 7@5S %P&?P!:!HT 60>< %<(K0!6",$ 50GA %0+]@!4"_\ 5 O_ %0+
M_P#&'P  MB4  *DH  ">*   E"4  (LA  "#&P  >Q0  '0. P!N"0T :0@4
M &8)'0!D"B4 8@HM & +- !>"SH 70M  %L,1P!:#$T 6 Q4 %<-7 !5#60
M5 UO %(->P!0#HH 3PZ: $X.K !,#\( 3!#C $L0^0!+$/\ 2Q'_ $L0_P"_
M)@  L"L  *0O  "9+P  CRT  (8I  !])   =!X  &P7  !E$0< 7PX0 %P/
M%P!:$!\ 6! G %80+@!4$#4 4Q [ %(10@!0$4@ 3Q%0 $X15P!,$F  2Q)K
M $D2> !($X< 1A.7 $44J0!$%+X 0Q7? $,6^ !#%O\ 0Q;_ $,6_P"Z*P
MJS$  * T  "5-0  BS0  ($Q  !X*P  ;R8  &8@  !>&0$ 5Q0- %04$P!1
M%!L 3Q4C $X5*@!,%3$ 2Q8W $D6/@!(%D0 1Q=, $475 !$%UT 0QAG $$8
M= ! &8, /QJ4 #T:I@ \&[L .QO; #L<]@ \'/\ /!S_ #P<_P"U,   J#8
M )PY  "1.P  ASH  'XW  !S,@  :BT  &$G  !9(0  41L) $P9$ !*&A<
M2!H? $8:)@!%&RT 0QLS $(;.@!!'$$ 0!Q( #X<4  ]'5D /!YD #L><0 Y
M'X  .!^2 #<@I  V(+@ -2'6 #4A]  U(O\ -2'_ #8A_P"R-   I#H  )D^
M  "//P  A3\  'L\  !P.   9S(  %TM  !4*   3"(% $8?#@!#'Q0 01\;
M #\?(@ ^("D /2 P #L@-@ Z(3T .2%% #@B30 W(E< -B-B #0C;@ S)'X
M,B2/ #$EH@ O);8 +R;2 "\F\@ O)O\ ,";_ # F_P"O.   HCX  )9"  ",
M0P  @D,  'A!  !N/0  8S@  %HS  !1+@  2"@! $ D#  ](Q$ .R08 #DD
M'P X)"8 -B0L #4E,P T)3H ,R9" #(F2@ Q)U0 ,"=? "\H;  N*'L +"F-
M "LJH  J*K0 *2K/ "DK\  J*_\ *BK_ "LJ_P"L/   GT(  )1&  "*1P
M@$<  '9%  !L0@  83T  %<X  !.,P  1"X  #PI"0 W*!  -2@5 #,H'  R
M*", ,"@I "\I,  O*C< +BH_ "TK2  L*U( *RQ= "HL:@ H+7D )RV+ "8N
MG@ E+K, )"_- "0O[@ E+_\ )2__ "8N_P"I/P  G44  )))  "(2P  ?DP
M '1*  !J1P  7D(  %0]  !+.0  030  #@O!@ R+0T ,"T3 "XM&0 M+2
M*RTG "HN+@ I+C4 *2\] "@O1@ G,$\ )3!; "0Q:  C,7< (C*) "$RG0 ?
M,[$ 'C/+ !XS[0 ?,_\ (#/_ "$R_P"F0P  FDD  )!-  "&3P  ?%   '-/
M  !H3   7$8  %)#  !)/P  /SL  #8V @ N,@P *S(1 "DR%P H,AX )C(D
M "4S*P D,S( (S0Z "(T0P A-4T (#58 !\V90 >-G4 '#>' !LWFP :-Z\
M&3C( !DXZP :./\ &S?_ !LW_P"C1P  F$T  (Y1  "$4P  >U0  '%3  !F
M4   6DP  %!)  !'10  /4$  #,]   J.0D )3<. ",W%  B.!L (3@B " X
M*  ?.#  'CDX !TY00 <.DL &CI6 !D[8P 8.W( %CN% !4\F0 4/*T $SW&
M !,]Z0 4//T %3S_ !8[_P"@2P  E5$  (M5  ""6   >5D  &Y8  !D5@
M6%$  $Y/  !%2P  .D<  #!#   G0 4 (#X- !T^$0 </A< &SX> !H^)0 9
M/BT &#\U !8_/@ 5/T@ %$!3 !- 8  207  $4&" !!!EP /0:P #D+$  Y"
MYP /0?P $$'_ !! _P"=4   DU8  (E:  " 70  =EX  &Q=  !B6P  5E<
M $Q5  !!40  -DX  "Q+   C2   &T4) !=$#P 51!0 %$4; !-%(@ 212D
M$44Q !%%.P 01D4 #T90  Y'7@ -1VT #$=_  M'DP )1Z< "$>^  A'X  )
M1_8 "D;_  M&_P":50  D%L  (=@  !]8@  <V,  &IB  !@80  4UX  $=:
M   \5P  ,E4  "A2   ?4   %TX$ !%,#  /3!$ #DP7  Y,'@ -324 #$TN
M  M--P *34( "4U-  =.6@ &3FD !$Y[  ).CP !3J0  $VZ  !-VP !3?(
M 4W_  ),_P"66P  C6(  (1F  !Z:   <6D  &AI  !<9P  3V0  $)A   W
M7P  +5P  "-:   :6   $E<!  U6"0 )50X !U43  95&@ $52(  U4J  )5
M-   53X  %5*  !65P  5F4  %5W  !5BP  5:   %6V  !4U   5/$  %/]
M  !3_P"38@  BF@  (!L  !W;@  ;V\  &-N  !6;   26H  #UH   R9@
M)V4  !UC   58@  #F$   E@"  #8 T  %\1  !?%P  7QX  %\F  !?+P
M7SH  %]%  !?4P  7V$  %YR  !>AP  79P  %VR  !<SP  7.\  %O]  !;
M_P"0:@  AF\  'UR  !U=   :G4  %UT  !/<P  0G(  #9P   K;P  (&X
M !=M   0;   "FP   )K!@  :PL  &H/  !J%   :AH  &HA  !I*@  :30
M &E   !I3@  :5P  &EM  !H@@  :)@  &>N  !FR@  9>T  &7\  !D_P"+
M<0  @G8  'IY  !P>P  8GL  %5[  !(>@  .WH  "]Z   C>0  &7@  !%W
M   *=P   W<   !W @  =P@  '8-  !V$   =A4  '8;  !V(P  =BX  '4Z
M  !U1P  =58  '5H  !T?   =)(  '.J  !RQ   <>D  '#[  !P_P"&>0
M?WT  '9_  !H@0  6H(  $R"   _@P  ,H0  "6#   :@P  $8,   J#   "
M@P   (0   "%    A ,  (,(  "##0  @Q   (,5  "$'   A"8  (0R  "$
M/P  @T\  (-@  ""=0  @HP  (&D  " O0  ?^,  '[Y  !^_P""@   >H0
M &R&  !>B   4(H  $*+   UC0  )XT  !N-   1C@  "HX   "/    D0
M )(   "2    D@   )(!  "2!P  D@P  )(0  "3%0  DQT  )0H  "4-@
ME$4  )-7  "3:P  DX(  )*<  "1M@  D-@  (_S  "/_P!^AP  <(H  &&-
M  !3D   19,  #>5   IE@  ')<  !&8   )F0   )L   "<    G@   *
M  "@    H    *    "A    H00  *()  "C#@  I!0  *4=  "F*@  ICH
M *9,  "E8   I7@  *62  "DK   I,D  */K  "B^@!SC@  9)$  %:5  !'
MF0  .9P  "J>   =H   $:$   BC    I0   *<   "I    K    *X   "N
M    K@   *\   "P    L0   +(   "S!@  M0T  +<3  "Y'@  N2X  +I
M  "Z5   NVH  +J%  "YH0  N;L  +K>  "Y\@!GE0  6)D  $J>   [H@
M+*8  !VH   1J@  !ZP   "O    L0   +0   "X    NP   +P   "\
MO@   +\   #     P@   ,0   #&    R ,  ,L+  #/$@  T2   -$R  #2
M1@  TUT  -1V  #4D@  U:L  -7$  #4X@!;G0  3*(  #VG   OK   'Z\
M !&Q   'M0   +@   "[    O@   ,(   #'    R@   ,P   #,    S@
M -    #2    U0   -@   #;    WP   .(   #F"P  ZQ,  .PD  #M.
M[DX  .]G  #P@@  \)P  /"R  #QQ0#_  , _P ! /\ ! #_  D _P / /\
M& #_ "0 _P P /\ / #_ $< _P!1 /\ 60#_ &  _0!G /P ;0#Z ', ^0!Y
M /@ ?P#V (4 ]0", /, E #R )T \ "G .X LP#L ,0 ZP#A .H ^ #I /\
MYP#_ -D _P#+ /\ P@#_ +T _P#_    _P   /\   #_    _P , /\ % #_
M "  _P K /X -P#Z $( ]@!+ /( 4P#P %L [@!A .P 9P#J &T Z !S .<
M>0#E '\ XP"& .$ C@#? )8 W0"@ -L K #8 +L U #1 -, \ #0 /\ S@#_
M ,@ _P"] /\ M@#_ +( _P#_    _P   /\   #_    _0 ( /< $ #S !H
M[P F .T ,0#H #L XP!% .  30#< %4 V0!; -8 80#3 &< T0!L ,\ <@#-
M '@ RP!_ ,D AP#' )  Q0": ,, I0#  +( O@#% +P Y0"Z /L N #_ +<
M_P"P /\ J0#_ *4 _P#_    _P   /X   #U    [  # .4 #0#? !4 V@ @
M -0 *@#0 #4 RP ^ ,@ 1P#% $X P@!5 ,  6P"^ &$ O !F +H ; "X '(
MM@!X +4 @ "S (@ L0"2 *X G@"L *H J0"[ *@ U0"F /, I #_ *, _P"A
M /\ FP#_ )@ _P#_    ^P   /    #E    V    ,X "0#' !$ P@ : +X
M) "[ "X MP X +0 0 "Q $@ K@!. *P 5 "J %H J0!? *< 90"E &L I !Q
M *( > "@ ($ G@"+ )P E@"9 *, EP"R )8 QP"3 .@ D@#^ )$ _P"0 /\
MC0#_ (L _P#Y    ZP   -T   #/    Q@   +P ! "U  T L  5 *P '@"H
M "@ I0 Q *( .0"? $$ G0!( )L 3@"9 %, EP!9 )8 7@"4 &0 D@!J )
M<0". 'H C "# (H CP"( )P A@"J (0 O "" -P @0#V (  _P!_ /\ ?P#_
M 'X _P#L    V@   ,D   "^    M@   *X   "G  D H0 0 )P & "8 "(
ME0 J )( ,@"0 #H C0!! (L 1P") $T AP!2 (8 6 "$ %T @@!D ($ :P!_
M ', ?0!] 'L B !X )4 =@"C '4 M !S ,P <0#M '  _P!P /\ < #_ '
M_P#?!0  R@H  +P+  "Q"0  J 0  *$   ";  , E  , (\ $P"* !L AP D
M (0 + "! #, ?P Z 'T 00![ $< >0!, '< 4@!V %< = != '( 9 !P &T
M;P!V &P @@!J (\ :0"= &< K@!E ,, 9 #D &, ^@!C /\ 8@#_ &, _P#0
M#@  OQ(  +(3  "G$@  G1   )4+  "/ P  B0 ' (( #@!^ !4 >@ > '8
M)0!T "T <0 T &\ .@!N $  ; !& &H 3 !I %( 9P!8 &8 7P!D &< 8@!Q
M &  ? !> (D 7 "8 %L J0!9 +P 6 #< %@ ] !8 /\ 5P#_ %< _P#&%@
MMAH  *H=  "?'   E1D  (T4  "%#P  ?@D  '<!"@!R !  ;@ 7 &H 'P!H
M "< 90 N &0 - !B #L 8 !  %\ 1@!= $P 7 !3 %H 6@!8 &( 5P!L %4
M=P!3 (4 4@"4 % !I0!/ ;@ 3@+2 $T$\ !-!?\ 307_ $T%_P"_'0  L"(
M *,E  "9)0  CR(  (4=  !]&   =1(  &X- @!G!@P 8P,1 %\"&0!= R$
M6P0H %D$+P!7!34 5@4[ %0&00!3!D< 409. % '50!.!UX 30AG $L(<P!)
M"8$ 2 F2 $<*HP!%"K8 1 O0 $0,[P!##?\ 0PW_ $0-_P"Y)   JBD  )XL
M  "4+   BBH  ( F  !W(0  ;AL  &84  !?#P4 60L- %4*$P!3"QL 40LB
M $\,*0!-#"\ 3 PV $L-/ !)#4( 2 U) $8-40!%#EH 1 YD $(.< ! #G\
M/P^0 #X0H@ \$+8 .Q#1 #L1\0 [$?\ .Q'_ #P1_P"T*0  IB\  )HR  "0
M,@  AC$  'PM  !R*   :2,  &$=  !9%@  41$( $P/$ !*$!8 2! = $80
M) !%$"L 0Q$Q $(1-P!!$3X 0!%% #X230 ]$E8 /!)A #H3;0 Y$WP -Q2-
M #84GP U%;, -!7- #,6[@ T%O\ -!;_ #06_P"O+@  HC0  )<W  ",.
M@C8  '@T  !N+@  92H  %PD  !4'@  3!@$ $84#0!"%!( 0!09 #\4(  ]
M%2< /!4M #L5-  Y%CH .!9" #<62@ V%U, -1=> #,8:@ R&7D ,!F* "\:
MG0 N&K$ +1O* "T;[  M'/\ +AO_ "X;_P"L,@  GS@  )0[  "*/   @#P
M '8Y  !K-   8B\  %DJ  !0)0  1Q\  $ :"@ \&1  .AD6 #@9'0 V&B,
M-1HI #0:,  S&C< ,AL^ #$;1P O'%  +AU; "T=9P L'G8 *AZ( "D?FP H
M'ZX )R#' "8@Z@ G(/X *"#_ "@@_P"I-@  G3P  )(_  "'00  ?4   '0^
M  !I.@  7S4  %8P  !-*P  1"4  #L@!P V'@X ,QX3 #(>&0 P'B  +QXF
M "X?+0 M'S0 +" [ "L@1  J(4X *2%8 "<B90 F(G0 )2.% ",CF0 B)*T
M(23% "$EZ  B)?T (B3_ ",D_P"F.@  FC\  (]#  "%10  >T0  ')#  !G
M/P  73H  %,V  !*,0  02P  #@F P Q(PP +B(1 "PB%@ J(AT *2(C "@C
M*@ G(S$ )B0Y "4E00 D)4L (R96 "(F8P A)W( 'R># !XHEP =**L &RG#
M !LIY@ <*?L '2G_ !XH_P"C/@  F$,  (U'  "#20  >DD  '!'  !F1
M6C\  %$[  !'-P  /C(  #4M   L* D *"</ "<G%  E)QH )"<A ",H)P B
M*"X (2DV " I/P ?*DD 'BI4 !TK8  ;*V\ &BR! !DLE0 7+:D %BW! !8M
MY  7+?H &"W_ !DM_P"A00  E4<  (M+  ""30  >$T  &Y,  !D20  6$0
M $]   !&/0  /3@  #,T   J+P8 )"P- "$L$@ @+!@ 'RT> !XM)0 =+2P
M'"XT !LN/  :+T8 &"]1 !<P7@ 6,&T %3%_ !,QDP 2,:@ $3*_ !$RX@ 2
M,OD $S'_ !,Q_P">10  DTL  (E/  " 40  =E(  &U0  !B3@  5DD  $U&
M  !$0P  .S\  #$Z   G-@, 'S(+ !PR$  ;,A4 &3(; !@R(@ 7,RD %C,Q
M !4T.@ 4-$0 $S1/ !(U7  1-6L $#9]  \VD0 .-J8 #3>\  TWW0 --O8
M#C;_  \V_P";20  D4\  (=3  !^5@  =58  &I5  !@4P  54\  $Q,  !"
M20  .$4  "Y!   D/0  '#H( !8X#@ 5.!( %#@8 !,Y'P 2.28 $3DN ! Y
M-P /.D$ #CI,  T[60 -.V@ "SMZ  H[C0 )/*( !SRX  <\U0 (//  "3O_
M  H[_P"83@  CE0  (58  !\6P  <EL  &A:  !>6   4U4  $E2   ^3@
M-$L  "I'   A1   &$(# !) "P 0/Q  #C\5  X_'  -0", #$ K  M -  *
M0#X "4%*  =!5@ &064 !$%V  -!B@ !09\  $&T  !!T  !0>X  4'\  )
M_P"55   C%D  (->  !Y8   <&   &9@  !=7@  45L  $57   Z5   +U$
M "5/   <3   %$H   Y("  +1PX "$<2  ='&0 &1R  !4@H  -(,0 "2#L
M $A'  !(4P  2&(  $AS  !(A@  2)L  $BQ  !'S   1^T  $?[  !'_P"2
M6@  B6   (!C  !W90  ;F8  &5F  !99   3&   $!=   U6P  *ED  "!7
M   750  $%,   M2!P %40T  5 1  !0%@  4!T  % E  !0+@  4#@  %!#
M  !04   4%X  %!O  !0@P  3Y@  $^N  !.R0  3NL  $W[  !-_P"/80
MAF8  'UI  !T;   ;&T  &%K  !3:0  1F<  #ID   O8P  )&$  !I?   2
M7@  #%P   9<!@  6PL  %H/  !:$P  6AD  %DA  !9*0  63,  %D_  !9
M3   65H  %EK  !8?@  6)0  %>K  !7Q0  5ND  %7[  !5_P",:   @FT
M 'IP  !R<@  9W(  %IQ  !,<   /VX  #-M   H:P  '6H  !1H   -9P
M!V<   !F P  9@D  &4-  !E$0  9!4  &0<  !D)   9"X  &0Z  !C1P
M8U4  &-F  !C>@  8I   &&G  !@P0  7^8  %_Z  !>_P"';P  ?W0  'AW
M  !N>   8'@  %)W  !%=P  .'8  "MV   @=   %G,   YS   '<@   '(
M  !R    <04  '$*  !Q#@  <!$  ' 7  !P'@  <"<  ' S  !O0   ;U
M &]@  !N=   ;HL  &VB  !LO   :^(  &KX  !I_P"#=P  ?'L  '-]  !E
M?@  5W\  $E_   \?P  +X   ")_   7?@  #WX   =^    ?P   '\   !_
M    ?@   'X%  !^"@  ?@T  'X1  !^%P  ?B   'XK  !].0  ?4@  'U9
M  !\;0  ?(0  'N<  !ZM@  >=H  'CU  !W_P" ?P  =X(  &F#  !;A0
M388  #^(   RB0  )(D  !B)   /B0  !XH   "+    C    (T   "-
MC    (P   ", P  C @  (T-  "-$0  C1<  (XB  ".+P  CC\  (U0  "-
M9   C'L  (R5  "+K@  BLT  (GO  ")_P![A0  ;8@  %Z*  !0C0  0H\
M #21   FD@  &9,   Z4   &E0   )8   "8    F@   )L   ";    FP
M )L   ";    G    )T%  "="P  GA   )\7  "@)   H#0  *!&  "@60
MGW   )^*  ">I0  GL(  )WH  "<^0!PC   88\  %.2  !$E@  -ID  ">;
M   9G   #YT   6?    H0   *,   "E    J    *D   "I    J0   *H
M  "K    K    *T   "N 0  L D  +(/  "S&   M"<  +0Y  "U30  M&0
M +1^  "SF@  L[0  +/5  "S\ !DDP  59<  $>;   XGP  *:(  !JD   .
MI@  !*@   "K    K0   +    "T    M@   +@   "X    N0   +H   "\
M    O0   +\   #     PP   ,4'  #)#P  RAH  ,LL  #,0   S58  ,YO
M  #-BP  S*@  ,S"  #,X@!8FP  2:   #JE   LJ0  '*L   ^N   $L0
M +0   "W    N@   +X   ##    Q@   ,@   #(    R@   ,L   #-
MSP   -(   #5    V0   -T   #A!0  Y@\  .<>  #H,@  Z4@  .I@  #K
M>P  ZY<  .RN  #LP@#_    _P   /\   #_  8 _P - /\ %0#_ "$ _P L
M /\ . #_ $, _P!, /X 5 #[ %L ^@!B /@ : #V &X ]0!T /0 >@#R (
M\0"' .\ CP#M )< ZP"A .D K0#G +T Y0#8 .0 \P#B /\ X #_ -  _P#$
M /\ O #_ +8 _P#_    _P   /\   #_    _P ) /\ $0#_ !P _0 G /D
M,@#U #T \0!& .T 3P#K %8 Z !< .8 8@#D &@ XP!N .$ <P#? 'D W0"
M -H B #8 )$ U "; -( I@#/ +0 S #) ,D Z0#( /\ QP#_ ,$ _P"W /\
MKP#_ *L _P#_    _P   /\   #_    ^  % /( #@#N !< Z@ B .8 + #A
M #< W0!  -@ 20#3 %  T !6 ,X 7 #, &( R@!G ,@ ;0#& ', Q !Y ,(
M@0#  (H O@"4 +P GP"Y *P M@"^ +0 W0"S /< L0#_ +  _P"H /\ H@#_
M )X _P#_    _P   /D   #O    Y@   -\ "P#6 !( T  < ,P )@#( #
MQ  Z ,  0@"] $H NP!0 +@ 5@"V %L M0!A +, 9@"Q &P L !R *X >@"L
M (( J0", *< F "E *4 HP"T *  RP"? .X G0#_ )P _P"9 /\ E #_ )$
M_P#_    ]@   .H   #=    SP   ,< !@#   \ NP 7 +< ( "S "H L  S
M *T .P"J $, IP!) *4 3P"C %4 H@!: *  7P"> &4 G0!K )L <@"9 'L
MEP"% )0 D "2 )T D "L (X OP", .( BP#Z (D _P") /\ A@#_ (, _P#T
M    Y    -0   #(    OP   +4  0"N  L J0 2 *4 &P"A ", G@ L )L
M- "8 #P E@!# )0 20"2 $X D !3 (X 60"- %X BP!D (D :P"' ', A0!]
M (, B "! )4 ?P"D 'T M0![ ,\ >0#Q '@ _P!W /\ =P#_ '4 _P#E
MT0   ,,   "X    KP   *@   "@  8 F@ . )4 %0"1 !X C@ F (L +0"(
M #4 A@ \ (0 0@"" $< @ !- '\ 4@!] %@ >P!> 'D 90!X &T =@!V ',
M@0!Q (X ;P"= &T K@!L ,0 :@#G &D _0!H /\ : #_ &D _P#5 P  PP<
M +8(  "K!@  H@   )L   "4    C0 * (@ $ "# !@ ?P @ 'P )P!Z "X
M=P U '4 .P!T $$ <@!' '  3 !O %( ;0!8 &L 7P!I &8 9P!P &4 >P!C
M (@ 8@"7 &  IP!> +L 70#< %P ]@!< /\ 6P#_ %L _P#)#0  N1   *P1
M  "A$   EPT  (\(  "(    @@ % 'L #0!W !( <P : &\ (0!L "@ :@ O
M &@ -0!G #L 90!! &, 1@!B $P 8 !2 %\ 60!= &$ 6P!J %D =0!7 ((
M50"1 %0 H@!3 +4 40#/ %  [P!0 /\ 4 #_ %  _P"_%   L!@  *0:  "9
M&0  CQ8  (<1  !_#0  =P8  '$ " !K  X 9P 4 &0 &P!A "( 7@ I %T
M+P!; #4 60 [ %@ 00!6 $8 50!- %, 5 !2 %P 4 !E $X < !, 'T 2P"-
M $D G@!( +  1P#' $8 Z0!& /L 1@#_ $4 _P"X&P  JB   )XB  "3(@
MB1\  ( :  !W%0  ;Q   &@+  !A! H 70 0 %D %@!6 !T 5  C %( *@!0
M #  3P U $X .P!, $$ 2P!( $D 3P!' 5< 1@%A $0"; !# GD 00.) $ #
MF@ ^!*T /03$ #P%Y0 \!_@ / ?_ #P'_P"R(@  I2<  )DI  ".*0  A"<
M 'LC  !Q'@  :1@  &$2  !:#0, 4P@, $\%$0!,!1< 2@8> $@&) !'!BH
M10<P $0'-@!#"#T 00A# $ (2P ^"5, /0E= #L*:  Z"G8 . N' #<+F0 U
M"ZP - S" #,,Y  S#?D ,PW_ #0-_P"M)P  H"P  )4O  "++P  @"X  '<J
M  !M)0  9"   %P:  !4%   3 \& $8,#0!##!( 00P8 #\,'P ^#"4 / TK
M #L-,@ Z#3@ . T_ #<.1P V#E  - Y: #,.9@ Q#W0 , ^% "X0F  M$*L
M+!## "L1Y0 L$?H +!'_ "T1_P"J+   G3$  )(T  "'-0  ?30  '0Q  !J
M*P  8"<  %@A  !/&P  1Q8  $ 1"0 [$ \ .1 4 #<0&P V$"$ -! G #,1
M+0 R$30 ,1$[ # 10P N$DT +1)7 "P28P J$W$ *1." "<4E0 F%*D )17
M "05XP E%OH )A;_ "85_P"F,0  FC8  (\Y  "%.@  >SD  '$V  !G,0
M72T  %0H  !,(@  0QT  #L7!0 U% T ,A,1 #$4%P O%!T +A0D "P4*@ K
M%3$ *A4X "D60  H%DH )Q=4 "878  D&&\ (QB  "$9DP @&:< 'QF^ !X:
MX  ?&O@ (!K_ " :_P"C-   F#H  (T]  "#/@  >3T  &\[  !E-P  6S(
M %(M  !)*   0",  #@> 0 P&0H +!@/ "H8%  I&!H )Q@@ "89)P E&2T
M)!HU ",:/@ B&T< (1M2 " <7@ ?'6P '1U^ !P=D0 :'J4 &1Z\ !@?W0 9
M'_8 &A__ !L>_P"A.   E3T  (M!  "!0@  =T(  &U   !C/   63<  $\S
M  !&+@  /2D  #4D   M( < )QT- "4=$@ C'1< (1T= "$=)  @'BL 'QXR
M !X?.P ='T4 '"!/ !HA7  9(6H &")[ !8BCP 5(J, %".Z !,CV@ 4(_4
M%2/_ !8C_P">/   DT$  (E$  !_1@  =48  &Q$  !B00  5SP  $TX  !$
M-   /#   #,K   J)@, (R(+ " A$  >(14 '"(; !LB(0 :(B@ &B,P !DC
M.  8)$( %B5- !4E60 4)F@ $R9Y !(FC0 1)Z( $">X  XGU@ 0*/0 $2?_
M !$G_P"<0   D44  (=(  !]2@  =$H  &I)  !@1@  54$  $P^  !#.@
M.C8  #$R   H+0  ("D) !LG#@ 9)Q( &"<8 !8G'P 5*"4 %"@M !,H-@ 2
M*4  $BE+ !$J5P 0*F8 #BMW  XKBP -+)\ #"RU  LLSP ,+.\ #2S_  TK
M_P"91   CTD  (5,  !\3@  <T\  &E.  !>2P  4T<  $I$  !"0   .3T
M "\X   E-   '3 % !8M#  4+!  $RT5 !(M'  1+2, $"TJ  \N,P .+CT
M#2](  TO50 ,,&, "C!T  DPB  (,9P !C&Q  8QRP &,>L !S#\  @P_P"7
M2   C4T  (-1  !Z4P  <50  &=2  !=4   4DP  $E*  ! 1@  -4(  "L^
M   B.@  &C<! !(T"0 /,PX #C,3  TS&0 -,R  ##0H  LT,0 *-3L "#5&
M  <U4@ %-F  !#9Q  (VA   -ID  #:O   VR   -N@  #;Y  $U_P"430
MBE(  (%6  !X6   ;UD  &58  !;50  45(  $=/   \3   ,4@  "=$   >
M00  %C\  ! \!P +.@T "3H1  @[%P &.QX !3LF  0[+@ ".S@  3Q#   \
M3P  /%X  #QN   \@0  /)<  #RL   [Q0  .^<  #OX   [_P"14@  B%@
M ']<  !V70  ;5X  &-=  !:7   3E@  $)4   W40  +4X  "-+   :20
M$D8   U$!@ '0PP  T,0  !#%0  0QL  $,C  !#*P  0S4  $-   !#30
M0UL  $-K  !#?@  0Y0  $*J  !"PP  0>8  $'Y  !!_P".6   AEX  'UA
M  !S8P  :V0  &)C  !780  25T  #U:   R6   )U4  !Y3   540  #D\
M  E-!0 "30L  $P.  !,$P  2Q@  $L?  !+*   2S(  $L]  !+20  2U<
M $MG  !*>P  2I   $FG  !)P   2.0  $CX  !'_P"+7P  @V0  'IG  !Q
M:0  :6H  %YI  !09@  0V0  #=A   L7P  (5T  !A;   060  "E@   -7
M P  5PD  %8-  !5$   514  %0;  !4(P  5"T  %0Y  !410  5%,  %1D
M  !3=P  4XT  %*D  !1O0  4.(  %#X  !/_P"(9P  ?VL  '=N  !O<
M97   %=N  !*;   /6L  #!I   E:   &F8  !%D   +8P  !&(   !B 0
M808  & +  !@#@  7Q(  %\7  !?'@  7B@  %XS  !>0   7D\  %Y?  !=
M<@  78@  %R@  !;N0  6M\  %GW  !8_P"$;@  ?'(  '5U  !K=@  774
M $]T  !"<P  -7,  "AR   =<   $V\   QN   $;@   &X   !N    ; (
M &P'  !K"P  :PX  &L2  !J&0  :B(  &HM  !J.@  :4D  &E:  !I;
M:(,  &>;  !FM0  9=@  &3U  !D_P" =0  >GD  '![  !B>P  5'P  $9\
M   Y?   +'P  !][   4>@  #7H   1Z    >@   'H   !Z    >0   'D!
M  !X!@  > L  '@.  !X$P  >!H  '@E  !X,@  =T$  '=2  !W90  =GP
M '65  !TKP  <\X  '+Q  !Q_P!^?0  =8   &>!  !8@@  2H,  #R$   N
MA0  (84  !6%   -A0   X4   "&    AP   (@   "(    AP   (<   "'
M    AP0  (<)  "'#@  B!,  (@<  "(*0  B#@  (=*  "'70  AG,  (:-
M  "%IP  A,4  (/L  ""_@!XA   :H8  %R(  !-B@  /XP  #&.   CCP
M%H\   V0   "D0   )(   "3    E0   )8   "6    E@   )8   "6
MEP   )<   "7!P  F T  )D3  ":'P  FBT  )H_  ":4@  FF@  )F#  "9
MGP  F+H  )?B  "6^ !MB@  7XT  %"0  !!DP  ,Y8  "27   6F   #9D
M  &;    G0   )\   "A    I    *4   "D    I0   *4   "F    IP
M *@   "I    J@0  *P,  "N$P  KB$  *XS  "N1P  KET  *YV  "NDP
MKJX  *W-  "L[P!AD0  4Y4  $28   UG   )I\  !>A   -HP   *4   "G
M    J@   *P   "P    L@   +0   "S    M    +4   "W    N    +D
M  "[    O0   +\!  ##"P  Q14  ,4E  #&.0  QT\  ,=H  #&A0  QJ(
M ,:\  #&W@!5F0  1YT  #BB   II@  &:@   VK    K0   +$   "T
MMP   +H   "_    P0   ,0   ##    Q0   ,8   #(    R@   ,T   #/
M    T@   -8   #;    X P  .$8  #C*P  Y$$  .5:  #F=   YI$  .6L
M  #EQ #_    _P   /\   #_  $ _P * /\ $@#_ !T _P H /\ - #_ #X
M_0!( /H 4 #W %< ]0!= /0 8P#R &D \ !O .\ = #M 'L ZP"! .D B0#H
M )( Y@"< .0 J #B +< WP#- -P [@#9 /\ V0#_ ,H _P"^ /\ M0#_ +
M_P#_    _P   /\   #_    _P & /\ #P#\ !@ ^  C /0 +@#P #@ ZP!"
M .@ 2@#E %$ X@!8 .  70#> &, W !H -D ;@#6 '0 U ![ -$ @@#/ (L
MS0"5 ,H H0#( *\ Q0#! ,( XP#  /L P #_ +L _P"P /\ J #_ *0 _P#_
M    _P   /\   #[    \P ! .T # #H !, XP > .  * #: #( TP \ ,\
M1 #, $L R0!1 ,8 5P#$ %T P@!B ,$ 9P"_ &T O0!T +L >P"Y (0 MP".
M +0 F0"R *< KP"W *T T "K /( J@#_ *D _P"A /\ FP#_ )< _P#_
M_P   /0   #I    X    -4 " #. !  R0 8 ,4 (@#! "L O  U +D /0"V
M $4 LP!+ +$ 40"O %8 K@!; *P 80"J &8 J0!M *8 = "D 'P H@"& *
MD@"> )\ G "N )D PP"7 .< E@#_ )4 _P"2 /\ C0#_ (H _P#\    \
M .,   #4    R    +\  P"Y  T LP 3 *\ ' "L "4 J0 N *4 -@"C #X
MH !$ )X 2@"= %  FP!5 )D 6@"7 %\ E@!F )0 ; "2 '4 D !^ (X B@"+
M )< B0"F (< N "% -8 A #V (( _P"! /\ ?@#_ 'P _P#M    W0   ,P
M  #!    N    *X   "G  D H@ 0 )X %P": !\ EP G )0 +P"1 #< CP ]
M (T 0P"+ $D B0!. (@ 4P"& %D A !? (( 90"  &T ?@!W 'P @@!Z (\
M> "> '4 KP!S ,< <@#L '$ _P!P /\ < #_ &X _P#=    R0   +P   "Q
M    J0   *$   "9  , DP , (X $@"* !D AP A (0 *0"! #  ?P W 'T
M/0![ $( >0!( '@ 30!V %( = !8 '( 7P!Q &< ;P!P &P >P!J (@ : "7
M &8 J !E +P 8P#A &( ^@!A /\ 80#_ &$ _P#- 0  O 4  *\%  "E @
MG    )0   "-    A@ ( ($ #@!\ !0 >  ; '4 (P!R "D <  P &X -@!M
M #P :P!! &D 1P!H $P 9@!2 &0 60!C &  80!I %\ = != ($ 6P"0 %D
MH0!7 +0 5@#0 %4 \@!5 /\ 5 #_ %4 _P#!#   L@X  *8/  ";#@  D@L
M (D%  ""    >P " '4 "P!P !  ;  6 &@ '0!F ", 8P J &$ , !@ #8
M7@ [ %T 00!; $8 6@!, %@ 4P!6 %L 5 !D %( ;@!1 'L 3P"* $T FP!,
M *X 2P#& $H Z@!) /X 20#_ $D _P"Y$@  JA8  )X7  "4%@  BA,  ($0
M  !Y"P  <0,  &L !@!E  T 80 1 %T & !: !X 6  D %8 *@!4 #  4P V
M %$ .P!0 $$ 3@!' $T 3@!+ %8 20!? $< :0!& '8 1 "% $, EP!! *D
M0 "_ #\ X@ _ /@ /@#_ #\ _P"R&0  I!X  )@?  ".'P  A!P  'H8  !R
M$@  :@X  &((  !< 0@ 5P . %, $P!0 !D 3@ ? $P )0!* "L 2  P $<
M-@!& #P 1 !" $, 20!! %$ /P!: #X 90 \ '( .@"! #D DP X *4 -@"Z
M #8 VP U /0 -0#_ #4 _P"L(   GR0  )0F  "))@  ?R0  '4@  !L&P
M9!4  %P0  !4# $ 3@8* $H"#P!' !0 1  : $( ( !  "4 /P K #X!,0 \
M 3< .P(^ #D"10 X TT -@-6 #4$80 S!&X ,05^ # %D  O!:, +0:X "P&
MU  L!_  + C_ "P(_P"H)0  FRH  ) L  "&+0  >RL  '(G  !H(@  7QT
M %<7  !/$@  2 X$ $$*"P ^!Q  .P85 #D'&P X!R$ -@@F #4(+  S"#(
M,@DY #$)00 O"4D +@I3 "P*7@ K"VP *0M\ "@,CP F#*( )0RW "0,TP C
M#?  ) W_ "4-_P"D*@  F"\  (TR  "#,@  >3$  &\N  !E*0  7"0  %,?
M  !+&0  0Q,  #P0!@ U#0P ,PP1 #$,%@ O#!P +@TB "T-*  K#2X *@TU
M "D-/0 G#D8 )@Y0 "0.7  C#VH (@][ " 0C@ ?$*( '1"W !P0U  =$?(
M'1'_ !X1_P"A+P  E3,  (HV  " -P  =C8  &TS  !C+P  62H  % E  !(
M(   /QH  #@5   P$0@ +! . "H0$@ H$!@ )Q > "40)  D$"H (Q$R "(1
M.@ A$4, (!). !X26@ =$V@ &Q-X !H3BP 8%*  %Q2U !84T0 6%?$ %Q7_
M !@4_P">,P  DS<  (@Z  !^.P  =#L  &LX  !A-   5R\  $XK  !%)@
M/2$  #0<   M%P4 )A,, ",3$  B$Q4 (!,: !\3(0 >%"< '10O !P5-P ;
M%4$ &A9+ !D65P 7%V4 %A=V !08B0 3&)X $ABS !$9S@ 1&>\ $AG_ !,9
M_P"<-@  D3L  (8^  !\/P  <S\  &D]  !?.0  534  $PP  !#+   .B<
M #(B   J'@$ (AD) !X7#@ <%Q( &A<7 !D8'@ 9&"0 &!DL !<9-  6&CX
M%1I) !,;50 2&V, $1QT ! <AP /'9P #AVQ  T=RP -'>P #AW_  \=_P"9
M.@  CS\  (1"  ![1   <4,  &A"  !>/@  4SH  $HV  !!,@  .2T  #$I
M   H)0  (" & !H=#  7'!  %1P5 !0=&P 4'2( $QTI !(>,@ 1'SP $!]&
M ! @4P .(&$ #2%Q  PAA0 +(ID "B*N  DBQP )(N< "B+[  LA_P"7/@
MC$,  (-&  !Y2   <$@  &=&  !<1   4C\  $D[  ! .   .#0  "\P   G
M+   'B<# !8C"@ 2(0X $2$3 ! B&0 0(B  #R(G  XC+P -)#D #"1$  LE
M4  *)5X "29O  <F@@ &)I8 !":L  ,FQ  $)N4 !";W  8F_P"50@  BD<
M (%*  !X3   ;TP  &5+  !;2   4$0  $=!   _/@  -SL  "TV   D,0
M&RT  !,J!P /* T #2<1  TH%@ ,*!T "R@E  HI+0 )*3< !RI"  8J3@ $
M*UP  RML  $K?P  *Y0  "NI   KP0  *^,  "OV   J_P"21@  B$L  ']/
M  !V40  ;5$  &-0  !:30  3TH  $='   ^1   ,T   "D\   @.   %S0
M !$Q!0 ,+PP "2X0  <N%0 &+QL !2\C  ,O*P ",#4  # _   P3   ,5D
M #%I   Q?   ,9$  #&G   POP  ,.$  ##U   O_P"02P  AE   'U4  !U
M5@  :U8  &)5  !84P  3E   $5-   Z20  +T4  "5"   </@  %#L   XY
M!0 )-PL !#8/  $V$P  -AD  #8@   V*0  -C(  #<]   W20  -U<  #=G
M   W>0  -X\  #:E   VO0  -N   #7U   U_P"-4   A%8  'Q:  !R6P
M:5L  &!;  !760  3%8  $!2   U3@  *DL  "!(   71@  $$,   M!!  $
M0 H  #\.   ^$0  /A8  #X=   ^)@  /B\  #XZ   ^1@  /E0  #YD   ^
M=@  /8P  #VC   \NP  /-X  #OU   [_P"*5P  @EP  'E?  !P80  :&$
M %]A  !47@  1UL  #I7   O50  )5(  !M0   230  #$L   9* P  20D
M $@-  !'$   1Q0  $8:  !&(@  1BP  $8W  !&0P  1E$  $9@  !%<P
M18D  $2@  !$N   0]P  $+U  !"_P"(70  ?V(  '=E  !N9P  9V@  %MF
M  !.8P  06$  #1>   I7   'UH  !57   .5@  !U0   !3 0  4@8  %$+
M  !1#@  4!$  $\6  !/'@  3R<  $\R  !//P  3TT  $Y=  !.;P  3H4
M $V=  !,M0  2]@  $KU  !*_P"%90  ?&D  '1L  !M;@  8FT  %1K  !'
M:0  .F<  "UE   B9   &&(  !!@   )7P   %X   !>    70,  %P(  !;
M#   6@\  %H3  !9&0  62(  %DM  !9.@  64@  %A8  !8:P  5X$  %>9
M  !6L@  5=(  %3T  !3_P"!;   >7   '-S  !H<P  6G(  $QQ   _<
M,F\  "5N   :;   $6L   EJ    :@   &D   !I    :    &<#  !F"
M9@P  &8/  !E%   91P  &4G  !D-   9$,  &13  !D90  8WL  &*4  !A
MK0  8,T  %_Q  !>_P!]=   =W<  &YY  !?>0  47D  $-Y   V>   *7@
M !QW   1=@  "G4   !U    =0   '8   !U    =    '0   !S @  <P<
M ',,  !R$   <A4  '(@  !R+   <CL  '%,  !Q7P  <70  '".  !OJ
M;L8  &SM  !K_P![>P  <GX  &1^  !5?P  1X   #F!   K@@  'H$  !*!
M   *@0   ($   ""    @P   (,   "#    @@   ((   ""    @@   ((%
M  """@  @@\  ((7  ""(P  @C(  ()#  "!5@  @6P  ("&  !_H0  ?KT
M 'WF  !\_ !V@@  :(,  %F%  !+AP  /(D  "Z*   @BP  $XL   J+
MC    (T   "/    D0   )(   "1    D0   )$   "1    D0   )(   "2
M @  DPD  )0/  "4&0  E"<  )0X  "43   DV(  )-\  "3F   DK,  )'8
M  "0]@!JB   7(H  $V-   _D   ,)(  "&4   4E0  "I8   "7    F0
M )L   "=    GP   *    "@    H    *    "A    H@   *,   "D
MI0   *8'  "H$   J!P  *@M  "I0   J58  *EO  "IBP  J*@  *?'  "F
M[ !?CP  4)(  $&6   SF0  (YP  !2=   *GP   *$   "C    I@   *@
M  "L    K@   *\   "O    L    +    "R    LP   +0   "V    MP
M +H   "]!P  OQ   +\?  # ,P  P$D  ,!B  # ?@  P)L  ,"W  "_V !3
MEP  1)L  #6?   FHP  %J4   NG    J@   *T   "P    LP   +8   "[
M    O0   ,    "_    P0   ,(   #$    Q@   ,@   #*    S    ,\
M  #3    V@<  -L3  #=)0  WCL  -]3  #@;@  WXP  -VI  #=P@#_
M_P   /\   #_    _P ' /\ $ #_ !D _P D /\ +P#\ #H ^0!# /4 2P#S
M %( \0!9 .\ 7@#M &0 ZP!I .D ;P#G '4 Y@!\ .0 A #B (T X "7 -T
MH@#: +$ U0#% -( Z #0 /\ SP#_ ,0 _P"X /\ KP#_ *D _P#_    _P
M /\   #_    _P " /L #0#W !4 \P ? .\ *0#J #0 Y@ ] .( 10#> $P
MVP!3 -@ 6 #4 %X T@!C -  :0#. &X S !U ,H ?0#( (4 Q@"0 ,( FP#
M *D O@"Z +L V0"Y /< N #_ +0 _P"I /\ H@#_ )T _P#_    _P   /\
M  #V    [@   .< "@#A !$ W  : -< (P#0 "X RP W ,< /P#$ $8 P0!-
M +\ 4@"] %@ NP!= +D 8@"X &@ M@!N +0 =0"Q 'X KP"( *T DP"J *$
MJ "Q *8 R "D .T H@#_ *( _P"; /\ E0#_ )$ _P#_    _    .X   #C
M    V    ,T !0#&  X P0 5 +T '@"Y "< M0 P +( . "O $  K !& *H
M3 "H %$ IP!6 *4 6P"C &$ H0!G )\ ;@"> '8 FP"  )D C "7 )D E "H
M )( O "0 -\ C@#[ (X _P"+ /\ A@#_ (, _P#X    Z0   -P   #,
MP0   +@   "R  H K  1 *@ & "E "$ H@ I )X ,@"< #D F0 _ )< 10"5
M $H E !0 )( 50"0 %H CP!@ (T 9P"+ &\ B0!X (8 A "$ )$ @@"@ (
ML@!] ,P ? #Q 'L _P!Z /\ =P#_ '4 _P#F    TP   ,8   "[    L0
M *<   "A  4 FP - )< $P"3 !L D  C (P *P"* #( B  X (8 /@"$ $0
M@@!) ($ 3@!_ %, ?0!9 'L 8 !Y &@ =P!Q '4 ? !S (D < "8 &\ J0!M
M +\ :P#F &H _P!I /\ :0#_ &< _P#3    PP   +4   "K    HP   )L
M  "2    C  * (< $ "# !8 ?P = 'T ) !Z "L >  R '8 . !T #T <@!"
M '$ 2 !O $T ;0!3 &P 60!J &$ : !J &8 = !D ($ 80"1 %\ H@!> +8
M7 #5 %L ]P!; /\ 6@#_ %H _P#%    M@(  *D"  "?    E@   (X   "'
M    @  % 'H # !U !$ <0 8 &X '@!K "4 :0 K &< ,0!F #< 9  \ &,
M00!A $< 7P!- %X 4P!< %L 6@!D %@ ;@!6 'L 5 "* %( FP!1 *X 4 #(
M $\ [@!. /\ 3@#_ $T _P"["@  K T  * -  "5#   C @  (,"  !\
M=0   &X " !I  X 90 3 &( &0!? !\ 70 E %L *P!9 #$ 6  V %8 .P!5
M $$ 4P!' %$ 3@!0 %4 3@!> $P : !* '4 2 "$ $< E0!% *@ 1 "_ $,
MY !" /P 0@#_ $( _P"R$0  I10  )D5  ".$P  A!$  'L-  !S"   ;
M &4  P!?  L 6P / %< % !4 !H 40 ? $\ )0!. "L 3  P $L -@!) #P
M2 !" $8 2 !% %  0P!9 $$ 8P _ &\ /@!^ #P D  [ *, .@"X #D V0 X
M /4 . #_ #@ _P"L%P  GQL  ),=  ")'   ?QD  '45  !L$   9 P  %T&
M  !6  8 40 , $T $ !* !4 1P : $4 ( !$ "8 0@ K $$ ,0 _ #8 /@ ]
M #P 1  [ $L .0!4 #< 7P V &L - !Z #( C  Q )X , "S "\ S@ O .\
M+@#_ "X _P"G'@  FB(  (\D  "$)   >B$  '$=  !G&   7Q,  %<.  !0
M"@  20,( $4 #0!! !$ /@ 6 #P &P Z "$ .0 F #< +  V #( -  X #,
M/P Q $< , !0 "X 6P M &< *P!V "H B  H )P )P"P "8 R0 E .H )0'[
M "4!_P"B(P  EB@  (LJ  "!*@  =R@  &TE  !D(   6QL  %(5  !+$
M0PP" #T'"0 Y PX -@$2 #,!%P Q 1P , $B "\")P M BT + ,T "H#.P I
M!$, * 1- "8%6  E!64 (P9T "(&A@ @!IH 'P>N !X'Q@ =!^< '0CX !T)
M_P"?*   DRT  (@O  !^+P  ="X  &HK  !A)@  6"$  $\<  !'%P  /Q(
M #@.!  Q"PH +@@. "L'$@ I!Q< * @= "<((P E""D ) DP ",)-P A"D
M( I* !\+50 ="V( &PQR !H,A0 8#)D %PRM !8,Q@ 5#>8 %0WY !8-_P"<
M+0  D#$  (8T  !\-   <C,  &@Q  !?+   52<  $PC  !$'0  /!@  #03
M   M$ 8 )@T+ "0,#P B#!, (0P9 !\,'P >#24 '0TL !L--  :#CT &0Y'
M !<.4P 6#F$ % ]Q !,0A  2$)@ $1"N ! 0Q@ 0$.@ $!#[ !$0_P"9,0
MCC4  (0X  !Z.0  <#@  &<V  !=,@  4RT  $HH  !")   .1\  #$:   J
M%0$ (Q$' !T0#0 ;#Q  &0\5 !@0&P 7$"$ %A I !40,0 4$3H $Q%% !(2
M40 1$E\ $!)O  X3@@ .$Y8 #1.K  L3P@ +%., #!3Z  T3_P"7-0  C#D
M ((\  !X/0  ;ST  &4Z  !;-P  4C(  $DN  ! *@  -R4  "\A   H'
M(!@# !D4"@ 5$@X %!(2 !,3&  2$Q\ $10F !$4+@ 0%#@ #Q5"  X63P -
M%EP #!=L  L7?P )&), "!BH  88OP '&.  !QCU  D8_P"5.   BCT  (!
M  !W00  ;4$  &0_  !:/   4#@  $<S   ^,   -BL  "XG   G(P  'Q\
M !<:"  2%PT $!<1  \7%@ .&!P #A@C  T9+  ,&C4 "QI   H;3  )&UH
M!QQI  4<?  $'9$  AVF  $=O  "'-T  ASR  ,<_P"3/   B$$  ']$  !U
M10  ;$4  &-$  !900  3ST  $8Y   ^-@  -3(  "XN   E*@  '24  !0A
M!  /'0L #1T0  P=%  +'1H "AXB  @>*@ ''S, !B ^  0@2@ #(5<  2%G
M   A>0  (8X  "&D   AN@  (=L  "'R   @_@"00   AD4  'U(  !T2@
M:TH  &))  !81@  3D(  $4_   ]/   -3D  "LT   B+P  &2L  !(H!  -
M) H "2,.  8C$@ %(QD !"0@  (D*  !)3$  "4\   E2   )E4  "9E   F
M=P  )HP  ":B   FN0  )MD  "7R   E_@".10  A$D  'M-  !S3P  :D\
M &!.  !72P  34@  $1%   \0@  ,3T  "<Y   >-0  %3(   \N P *+ H
M!2L.  $J$0  *A8  "H>   J)@  *R\  "LY   K10  +%,  "QB   L=0
M+(H  "N@   KMP  *]8  "KR   J_P",20  @DX  'I2  !Q5   :%0  %]3
M  !640  3$X  $-+   W1P  +4,  ",_   :/   $C@   PV P &,PD  #(-
M   R$   ,10  #$;   Q(P  ,2P  #(W   R0P  ,E   #)@   R<@  ,H<
M #&>   QM0  ,-0  ##R   O_P")3P  @%0  'A7  !O60  9ED  %Y9  !5
M5P  25,  #Y/   R3   *$@  !Y%   50@  #D    @] @ !/ @  #L,   Z
M#P  .1(  #D8   Y(   .2D  #DT   Y0   .4X  #E=   Y;P  .(4  #B<
M   WLP  -](  #;R   U_P"'50  ?UH  '9=  !M7P  95\  %U?  !27
M1%@  #A5   M4@  (D\  !A,   02@  "D@   -& 0  108  $0*  !##0
M0A   $$5  !!'0  028  $$Q  !!/0  04H  $%:  !!;   0($  #^9   _
ML0  /M   #WR   \_P"$7   ?&   '-C  !L90  9&8  %ED  !+80  /EX
M #);   F60  '%8  !)4   ,4@  !%$   !/    3@,  $T(  !,#   2PX
M $L2  !*&0  2B(  $HL  !*.0  2D<  $I6  !):   27X  $B6  !'KP
M1LT  $7Q  !$_P"!8P  >6<  ')J  !K;   8&L  %)I  !$9@  -V0  "IB
M   ?8   %5X   U=   &6P   %H   !9    6    %<$  !6"   5@P  %40
M  !4%   5!T  %0G  !4-   5$(  %-2  !39   4GD  %*2  !1JP  4,H
M $_O  !._P!^:@  =VX  '!Q  !F<0  6'   $IO   \;0  +VP  ")J   7
M:0  #F<   9F    90   &4   !E    8P   &(   !B!   80@  &$-  !@
M$   8!<  & A  !?+@  7SP  %]-  !>7@  7G0  %V-  !<IP  6\4  %KM
M  !9_P![<@  =78  &MW  !==@  3W8  $%U   S=0  )G0  !ES   0<@
M!W$   !Q    <0   '$   !Q    ;P   &\   !N    ;@(  &X(  !M#
M;1$  &T:  !M)@  ;#4  &Q&  !K6   :VT  &J&  !IH0  :+X  &?H  !F
M_@!Y>@  <'P  &%\  !3?0  1'T  #9^   H?@  &WT  !!]   '?0   'T
M  !]    ?@   '\   !^    ?0   'T   !\    ?    'P   !\!@  ? P
M 'P2  !\'0  ?"P  'P\  !\3P  >V4  'M^  !ZF@  >;8  'C?  !W^@!S
M@   98$  %:#  !(A   .88  "N'   =AP  $8<   >(    B    (D   "*
M    C    (T   "-    C    (P   ",    C    (P   "-    C00  (X,
M  ".$P  CR$  (XR  ".1@  CEL  (UT  "-D   C*T  (O.  "*\P!HA@
M6H@  $N+   \C0  +8\  !Z0   1D0  !Y(   "3    E0   )<   "9
MFP   )P   ";    FP   )P   "<    G0   )X   ">    GP   *$#  "B
M#   HA8  *,F  "C.@  HT\  *-H  "BA@  HJ(  *+   "AZ !<C0  39
M #^3   PE@  (9D  !*:   'FP   )T   "@    H@   *0   "H    J@
M *L   "J    JP   *P   "M    K@   *\   "Q    L@   +0   "W 0
MN0T  +D:  "Z+0  ND,  +I;  "Z=P  NY0  +NQ  "YT@!0E0  09@  #*<
M   CH   $Z(   BD    IP   *H   "L    KP   +(   "W    N0   +L
M  "Z    O    +T   "_    P    ,(   #$    Q@   ,D   #-    T@$
M -0/  #5'P  US4  -A-  #8:0  UX8  ->C  #6O0#_    _P   /\   #_
M    _P # /\ #0#_ !4 _P @ /P *P#X #4 ]  _ /  1P#N $X ZP!4 .D
M6@#G %\ Y0!D ., :@#A '  WP!V -T ?@#; (< V "1 -, G0#/ *L S0"]
M ,L X #) /L QP#_ +T _P"Q /\ J0#_ *, _P#_    _P   /\   #_
M_    /8 "P#Q !$ [0 ; .D )0#D #  WP Y -H 00#5 $@ T0!. ,\ 5 #-
M %D RP!> ,D 8P#' &D Q0!O ,, =P#  '\ O@"* +L E0"X *, M@"T +0
MS0"R /( L #_ *P _P"C /\ G #_ )< _P#_    _P   /H   #Q    Z
M .  !@#9  X T@ 6 ,X 'P#( "D Q  R ,  .@"] $$ N@!( +@ 30"V %,
MM !8 +( 70"P &( K@!I *P ;P"J '@ J "" *8 C@"D )L H0"K )\ P "=
M .8 FP#_ )H _P"4 /\ C@#_ (H _P#_    ]@   .@   #<    S@   ,8
M 0"_  L N@ 1 +8 &@"R "( K@ K *H - "H #L I0!! *, 1P"A $P GP!1
M )X 5@"< %P F@!B )D : "7 '  E0!Z )( A@"0 ), C0"B (L M0") -,
MAP#W (8 _P"$ /\ ?P#_ 'P _P#R    XP   -(   #%    N@   +$   "K
M  < I0 . *$ % "> !P F@ E )< +0"4 #0 D@ Z )  0 ". $4 C0!* (L
M4 ") %4 B !; (8 80"$ &D @@!R '\ ?0!] (L >P": '@ JP!V ,0 = #K
M ', _P!S /\ < #_ &X _P#?    S    +\   "T    JP   *$   ":  (
ME  + )  $ ", !< B  > (4 )@"# "T @0 S '\ .0!] #\ >P!$ 'D 20!X
M $X =@!4 '0 6@!S &( < !K &X =0!L (, :@"2 &@ HP!F +@ 9 #> &,
M^P!B /\ 8@#_ &  _P#,    O    *\   "E    G0   )0   ",    A@ '
M ($ #0!\ !( >  9 '4 'P!S "8 <0 M &\ ,@!M #@ :P ] &H 0@!H $@
M9P!. &4 5 !C %L 80!D %\ ;@!= 'L 6P"* %D FP!7 *\ 5@#+ %4 \@!4
M /\ 5 #_ %0 _P"^    L    *0   "9    D    (@   "!    >0 " ',
M"@!O  \ :P 4 &< &@!E "  8P F &$ + !? #( 7@ W %P / !; $( 60!'
M %< 3@!6 %4 5 !> %( : !0 '0 3@"# $P E0!* *@ 20#  $@ Z !' /\
M1P#_ $< _P"T"0  I@L  )L,  "0"@  A@4  'X   !V    ;P   &@ !0!C
M  P 7P 0 %L %0!8 !H 5@ A %0 )@!3 "P 40 Q %  -@!. #P 30!" $L
M2 !) %  2 !8 $8 8@!$ &X 0@!] $  C@ _ *( /0"X #T W0 \ /@ / #_
M #P _P"L$   GQ(  )02  ")$0  ?P\  '8,  !N!0  9@   &   0!9  @
M50 - %$ $0!. !8 2P ; $D (0!( "8 1@ K $4 ,0!# #8 0@ \ $  0P ^
M $L /0!3 #L 70 Y &D -P!X #8 B0 T )P ,P"Q #( S@ R /$ ,0#_ #$
M_P"F%@  FAD  (X:  "$&@  >A8  ' 2  !H#@  7PH  %@#  !1  0 3  *
M $@ #@!$ !( 00 6 #\ &P ] "$ /  F #H +  Y #$ -P W #8 /@ T $8
M,P!/ #$ 60 O &4 +@!S "P A0 K )@ *@"M "D Q@ H .H * #^ "@ _P"A
M'   E2   (HA  !_(0  =1\  &P:  !C%@  6A$  %(-  !+!P  1  & $
M"P \  \ .  2 #8 %P T !P ,P A #$ )P P "P +@ S "T .@ K $( *@!+
M "@ 50 F &$ )0!P "0 @0 B )4 (0"I "  P0 @ .0 'P#Y !\ _P"=(@
MD28  (8H  !\)P  <B4  &DB  !?'0  5Q@  $X3  !&#@  /PL  #@%!P T
M  P ,0 0 "X $P L !@ *@ = "D (@ G "@ )@ N "0 -@ C #X (@!' "
M4@ ? %X '0!M !P ?@ : )( &0"G !@ O0 7 -\ %P'U !<"_P":)P  CBL
M (0M  !Y+0  <"L  &8H  !=)   5!\  $L:  !#%   .Q   #0- @ M"0D
M*04- "8#$  D 1, (@(9 "$"'@ @ B0 '@,J !T#,@ ;!#H &@5$ !D%3P 7
M!EP %@9J !0'?  3!Y  $@>E !$'NP 0!]L $ CR ! )_P"7*P  C"\  ($Q
M  !W,@  ;C$  &0N  !;*@  424  $D@  ! &P  .!8  #$2   I#@0 (PP)
M !\)#0 =!Q  &P<5 !D(&@ 8""  %PDG !8)+@ 5"C< $PI! !(+30 1"UH
M$ MI  X,>P .#)  #0RE  P-NP +#=D "PWQ  P-_P"5+P  BC,  '\V  !V
M-@  ;#4  &,S  !9+P  4"L  $<F   ^(0  -AT  "X8   G$P  (! % !D.
M"@ 5# X % P1 !,,%@ 2#!P $0TC ! -*P /#30 #@X_  T.2@ ,#U@ "P]G
M  H0>0 ($(T !Q"B  80N  %$-0 !1#O  80_P"2,P  B#<  'XZ  !T.P
M:SH  &$X  !8-0  3C   $4L   ])P  -2,  "T?   F&@  'A8! !<3!@ 1
M$ L #@X.  X/$P -$!D #1 @  P0*  +$3( "A$\  @22  '$E4 !A-E  03
M=@ #$XL  12@   3M@  $]$  !/N   3^P"0-@  ACL  'P^  !S/P  :C\
M & ]  !7.0  338  $0Q   \+@  -"H  "PF   E(@  'AX  !8: @ 0%0D
M#!,.  H3$@ )%!< "!0?  <5)@ &%2\ !!8Z  ,61@ !%U,  !=B   8=
M&(D  !B?   8M0  %]   !?M   7^P"..@  A#\  'M"  !R0P  :$,  %]"
M  !6/P  3#L  $,W   [-   ,S   "PL   D*0  &R0  !,? @ -&PD "1D-
M  89$0 $&18  AD=  $:)   &BT  !LX   ;1   '%$  !Q@   =<@  '8<
M !R=   <LP  ',X  !OM   ;_ ",/@  @D,  'E&  !P2   :$@  %Y&  !5
M1   2T   $,]   [.@  ,S<  "HR   @+0  %RD  ! E @ +(@D !2 -  $?
M$   'Q0  !\;   @(@  ("L  "$V   A00  (4\  "%>   B<   (H4  "&;
M   AL@  (<T  "#M   ?_ "*0P  @$@  'A+  !O3   9DT  %U+  !420
M2D8  $)#   Z0   +SL  "4W   <,P  $R\   TL @ '*0@  2<,   F#@
M)1(  "89   F(0  )BD  "8S   G/P  )TT  "=<   G;0  )X(  ">9   F
ML   )<P  "7N   D_0"(2   ?TP  '90  !N40  95(  %Q1  !33P  2DP
M $%)   U1   *T   "$\   7.0  $#8   HR 0 #, <  "\+   N#@  +1$
M "T6   M'@  +2<  "TQ   M/0  +4H  "U9   M:P  +8   "R7   LKP
M*\L  "KN   J_@"%30  ?5(  '55  !L5P  8U<  %M6  !350  1U$  #M-
M   P20  )48  !Q#   3/P  #3T   8Z    . 4  #<)   V#0  -0\  #04
M   T&P  -"0  #0N   T.@  -$<  #17   T:   -'T  #.5   RK0  ,<H
M #'N   P_P"#4P  >U@  '-;  !J70  8ET  %M=  !/6@  0E8  #92   J
M3P  ($P  !9)   .1P  "$0   !"    00,  #\'   ^"P  /0X  #T1   \
M&   /"$  #PK   \-P  /$0  #Q3   \90  .WH  #J2   ZJP  .<@  #CM
M   W_P"!6@  >5X  '%A  !I8P  8F0  %=B  !)7@  /%L  "]8   D50
M&5,  !!1   *3P   4T   !,    2@   $D$  !("   1PP  $8/  !&%
M11P  $4G  !%,P  14   $50  !$80  1'8  $./  !"J   0<8  $#L   _
M_P!^80  =F4  &]H  !H:@  76D  $]F  !"9   -&$  "A?   =70  $EL
M  M9   "6    %8   !6    5    %,   !2!   40D  % -  !0$   3Q@
M $\B  !/+@  3SP  $]+  !.70  3G(  $V+  !,I0  2\(  $GJ  !(_P![
M:0  =&P  &YO  !D;P  56T  $=L   Y:@  +&D  "!G   490  #60   -B
M    8@   &$   !@    7P   %X   !=    7 0  %P)  !;#0  6Q(  %L<
M  !:*   6C8  %I&  !96   66T  %B%  !7H   5KT  %7H  !3_@!Y<
M<W0  &EU  !;=   3',  #YS   P<@  (W$  !9O   -;@  !&T   !M
M;0   &T   !L    :P   &H   !I    :0   &D#  !H"0  : X  &@5  !G
M(0  9R\  &<_  !F4@  9F8  &5_  !DF@  8[<  &+A  !A_ !W>   ;7H
M %]Z  !0>@  0GH  #-[   E>P  &'H   YY   $>0   'D   !Y    >@
M 'H   !Z    >    '@   !W    =P   '<   !W 0  =P@  '<.  !W&
M=R8  '8V  !V20  =5\  '5W  !TDP  <Z\  '+3  !Q]P!Q?@  8W\  %2
M  !%@@  -H,  "B$   :A   #H,   2$    A    (4   "&    B    (D
M  "(    AP   (<   "'    AP   (<   "(    B    (@'  ")$   B1P
M (DL  "(/P  B%4  (AM  "'B0  AJ<  (7'  "$[P!FA   5X8  $B(   Y
MB@  *HP  !N-   /C0  !(X   "0    D0   ),   "5    EP   )@   "6
M    EP   )<   "7    F    )@   "9    F@   )L   "=!P  G1$  )TA
M  "=,P  G4D  )QB  "<?P  G)P  )RY  ";X@!:BP  2XX  #R1   MDP
M'I4  !"6   $F    )H   "<    G@   *$   "D    I@   *<   "F
MIP   *<   "H    J0   *H   "L    K0   *\   "Q    LPD  +,5  "T
M)P  M#T  +55  "U<   M(X  +2L  "TS !-D@  /Y8  "^:   @G0  $9\
M  6A    HP   *8   "I    K    *\   "S    M0   +<   "V    MP
M +@   "Z    NP   +T   "_    P0   ,0   #'    RP   ,T,  #.&@
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M_____________________________________________________P
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M]/7V]_CY^OO\_?[_;69T,0     # 2$   $                    !
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M________^X Q        "6',____________________________TEH"
M     %W,____________________________J#4          %S3________
M____________________?0T          %36________________________
M___N?44          $34___________________________\JF0O @  !"(W
M25C.____________________________Z:1K02@_8W^5I[K:____________
M___________________5LJRRS.3Z________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___ENY=W8LC_________________________________VYYG-@H  HS_____
M___________________________(?S\%     %[/____________________
M_________]F!.0       #RJ_____________________________YY,
M     ".0____________________________W&\:         !!]^?______
M____________________KT@           !O[O______________________
M____A!,           !DYO_________________________L40
M  !7WO________________________^X%0            !(UO__________
M______________]T%              XS_________________________FB
M6A,            CQ?_________________________?FUPL           -
MNO__________________________[[%]53DB$0<! A$BLO______________
M________________W[^EF9B:H*R]VO______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________X[Z=@'S[____________________
M____________\K>$5S . !VL_______________________________2BDP5
M      !R\____________________________]9_-@        !+R?______
M____________________^I$^           OJ_______________________
M____P%H            :E?__________________________C20
M   (A/_________________________G7@              =___________
M______________^T)0              :O________________________]]
M                6_3_______________________TK
M3.O______________________Z4                 /.'_____________
M_________S ,                +=G_____________________F8IA)P
M            )]?______________________^V^B54G            )=S_
M_________________________LJ==EU*/#(M+# Y1][_________________
M______________WFW=;2T-/9Y/__________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___OU+O6_________________________________^>XCVI++Q5O________
M_______________________DH6<T!P     \R?______________________
M_____]:".P         2E___________________________[84Q
M    ;___________________________ID(             4.'_________
M_______________L:0              -\G_______________________^S
M+P              (K;_______________________]Y
M$*?_______________________(T                 )G_____________
M_________ZD                  (S______________________T8
M             '______________________WP                   '3_
M____________________EP                   &K_________________
M____S@                   &/______________________RDB 0
M         &'______________________[FC@%<W%P           &C_____
M______________________K3KI2&?'5Q<')W@93_____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________V[J=@FEIT_______________________________R)-E/1D
M   =GO___________________________]N.3!,         ;O__________
M________________VWPL            1=?_________________________
MBRH             (K3________________________"1
M Y?_______________________]] 0               '______________
M_________^<V                 &K______________________YT
M             %C______________________T8                  $?X
M____________________Z0                   #7I________________
M____E@                   "7;____________________O
M         !C.____________________ZP                    _"____
M_________________P                    JY____________________
M_R<                   JU_____________________W
M      VY_____________________^"<C'!50C,F&Q0/#0X2&B:_________
M____________________^>38TL[,R\S/UN#\________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________Z].\X___________
M_____________________]*IA65(+!(!A?__________________________
M__&K<3P/        3^#_________________________U7\U
M'[+________________________C=1T              (G_____________
M__________^0(P               &?______________________]5#
M             $CV_____________________XH                  "[=
M_____________________S@                  !?(________________
M____O@                    2V____________________G
M          "E____________________N@                    "3____
M________________W                     ""____________________
M_P                    !T_____________________Q,
M      !H_____________________T(                   !@________
M_____________WH                   !=_____________________]$
M                  !A______________________\D
M  !F_______________________)K)F)?79Q;&EG9F=K<'J,____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________XL6JD7EA
M=______________________________=IG=0+ P     ,<3_____________
M____________X)).$P           (_________________________2<!T
M             &#______________________^YO#P               #?B
M_____________________Y8<                 !3 ________________
M_____T                    "C____________________K@
M          ")____________________G@                    !R____
M________________O                     !?____________________
MV@                    !-____________________^@
M       [_____________________PX                    J^?______
M_____________S,                    ;Z?___________________UX
M                   /V____________________X\
M   &T/___________________]                      RO__________
M__________\K                    R/____________________^
M                R______________________W%@$%!0,!       !!@T8
MR________________________.OAV,_,S<_0TM37W.+J________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________':QO______________________________
M\<:CA&A-,A@ %:O__________________________[E\1A@          ''_
M_______________________7?"\              #OC________________
M_____]]D"0                RU_____________________W0#
M          "-____________________Q14                   !J____
M________________F0                    !+____________________
MM@                     P_?__________________UP
M       9Y___________________]@                     %T_______
M_____________PX                     P?___________________R\
M                    K____________________U(
M    GO___________________WD                     CO__________
M_________Z4                     @/___________________]@
M                =/____________________\V
M;?____________________]\                    :?______________
M_______7#0                  :/______________________<
M            8?_______________________U \1DY465UA9&AL<'9^B?__
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________[]6[HXMS6I7_________________
M__________B_CF1!(04      %+\_______________________WG588
M         !?!_____________________^5L%@                "-____
M_________________V,                   !>____________________
MG0                     U_/__________________H0
M       1V?__________________R@                      N_______
M____________[@                      H?___________________PP
M                    BO___________________RT
M    =O___________________TT                     9/__________
M_________V\                     4O___________________Y0
M                0/___________________[P
M,/___________________^H.                    (O______________
M______]$                    %?____________________^!
M            "_7____________________("P                   NS_
M____________________7@                   .7_________________
M____R1P                  -K______________________YT!
M      <.%\7________________________5N;S!Q\[5V^'F[?3[________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______XW\______________________________[,:EB&U4.R$' #+>____
M____________________UY)9*0            "@____________________
M__^)-@                !G_____________________V8
M       R]O__________________E0                     #R/______
M____________IP                      H/__________________UP
M                    ?/___________________P
M    7O___________________R4                     0___________
M_________T@                     +/___________________VH
M                &/___________________XL
M!?/__________________Z\                      .'_____________
M_____]4                      ,____________________\D
M             +[___________________]4                     *[_
M__________________^+                     )__________________
M___+#@                   )+_____________________5P
M         (;_____________________J@H                  'G_____
M_________________VT                  &;_____________________
M__=5                 $7_________________________:B,K-3]*56!J
M=7Z'D9S_____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________^C/MIV#:4ZY_________________________^RR@UPZ'0(
M      ![_______________________%;2D               ! ________
M_____________X,;                   'R___________________D@
M                    F/__________________I
M    :O__________________W0                      0?__________
M_________PX                     '?___________________SD
M                 .C__________________V
M ,[__________________X4                      +?_____________
M_____Z@                      */__________________\L
M             )#__________________^\6                     'W_
M__________________\^                     &S_________________
M__]I                     %K___________________^9
M         $G____________________2%@                   #G_____
M________________6                    "G_____________________
MH@                   !G_____________________]58
M      3______________________[LO                  #X________
M______________^K*0                #/________________________
MR4<     !Q,@+CY2:(3M________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________]-7)________
M____________________^M*PDG==0B@,  !*________________________
MQ7U%%P             1V/___________________\10
M    G___________________H@P                     :/__________
M________E                       -O__________________V@
M                !^S__________________Q4
M ,3__________________T@                      *+_____________
M_____W4                      (/__________________YT
M             &G__________________\,                      %+_
M_________________^</                     #[_________________
M__\S                     "O___________________]8
M         !C___________________^!                      7_____
M______________^L                      #____________________>
M(@                    #R____________________7
M      #?____________________GP                    #,________
M____________Z$H                   "W_____________________Z 6
M                  "<______________________]Z @
M  !W________________________>@L               5,____________
M_____________Z)7:'2 C9RKO-#G________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_^WC___________________________2HWI8.BDC'!8.!@  G___________
M__________^L4@X                 :?__________________Y$,
M                -/__________________>0
M ./_________________S0                       ++_____________
M_____Q,                      (7__________________T\
M             %W__________________X,                      #K_
M_________________[(                      !S_________________
M_]L#                      +___________________\J
M          #[__________________]/                      #G____
M______________]T                      #4__________________^;
M                      # ___________________$!P
M      "M___________________P,P                    ":________
M____________9P                    "&____________________HP
M                  !R____________________XT0
M  !<_____________________Y$&                  !!____________
M_________^M?                   =_______________________*2P
M                ________________________RU<   P8)#$_3F!TBZ?'
M___________________________7Y_+_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________KU,W'PKZZM[.PK:FH
MI?___________________]U^4S\P(QD1"0(          -O_____________
M____=@                       *?_________________N@
M             '7__________________P<                      $;_
M_________________TX                      !K_________________
M_XP                       #]_________________\$
M          #;__________________$9                      "^____
M______________]$                      "D__________________]K
M                      "-__________________^1
M      !Y__________________^W                      !F________
M___________>(0                    !3____________________2@
M                   _____________________=P
M   K____________________K H                    6____________
M________YT4                     _____________________XH
M                _____________________]9-
M_?____________________^G+@                  U?______________
M________F"H           88+45@X/_______________________ZAC=(&/
MG*N[S>+Z____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________GR[>IG96.B82 ?'AT<&QH99#_
M________________O&I(+1D*                 #'_________________
M_P                        /__________________T(
M          #<_________________XX                       "R____
M_____________\X                       "-__________________\I
M                      !K__________________]:
M      !.__________________^&                       T________
M__________^N                       >___________________4%P
M                   *___________________Z/0
M    ____________________90                      ____________
M________C@                      ____________________O!D
M                [___________________\4X
MV/___________________XL                     O_______________
M_____\Q#                    H?____________________^1&0
M            >O_____________________R= H                17___
M____________________Z'03'RPX15-B<H6;M-+U____________________
M_______7Z/3_________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________________________________OW
M\_'N[.OK[/'__________________]FRF8=Y;61=5E%+1D$\.#(M*"/$____
M_____________TLE"P                    "2_________________X@
M                      !F_________________]<
M       ]__________________\S                       8________
M__________]L                        __________________^=
M                    ___________________)#
M    ]O_________________Q-0                      W___________
M________6P                      R___________________@@
M                M___________________J08
MH___________________TR\                     C?______________
M_____UX                     =____________________Y,'
M            7O___________________\U#                    0/__
M__________________^'$                   '/__________________
M___87@                   /______________________OTX       X<
M+#Y2:H:ER/_______________________\)\C)JGML76Z/W_____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________________^[AU\_)P[ZZMK&M
MJ:>FIJ>N_________________[Z&;5M,0#<O*"(<%A +!      4________
M_________]<%                        __________________\T
M                    ]O________________]V
M    TO________________^P                        LO__________
M_______A)                       EO__________________40
M                ?/__________________>0
M9O__________________H                       4?______________
M____QR,                     //__________________[DL
M            )____________________W0                     $/__
M_________________Z,6                     /__________________
M_]A,                     /____________________^(#P
M         /_____________________+4P                   /______
M________________I3@           D=-$YKC/______________________
M_YDY0U%?;GV.H+7+Y?_____________________________K^?__________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________KS+FLH9F1BX:!?'AT<&MH
M9F9H\?________________]A13(C& X&                GO__________
M______]^                        =?_________________#
M                4O_________________[-P
M,O__________________:@                      %O______________
M____E@                       /__________________OQL
M             /__________________YD(                      /__
M_________________VD                      /__________________
M_Y "                     /___________________[DL
M         /3__________________^A<                     -G_____
M______________^1&                    +S____________________*
M4P                   )W_____________________F"X
M$"E&9L3_____________________[G\=#!HH-T97:7Z5K\SN____________
M_____________^>@JKG(V.G\____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________________?7P
MZ^;BW]O8U-+1T-+7X/_________________.GHI\<6EA6U913$A#/CHV,B\N
M,?_________________2)1$#                     /______________
M____0@                       /__________________?0
M             /__________________L L                      /;_
M________________W3D                      -S_________________
M_V(                      ,7__________________XD
M         *___________________Z\B                     )G_____
M_____________]9(                     (+___________________]R
M                     &G___________________^A*
M     $[____________________37                    #/_________
M____________EBX              !4R4G?_____________________X'(3
M   !#Q\O0EAPBZC([/_______________________\IO;GZ.GK##V.______
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________^>#2R,"ZM;"L
MJ*6BGYV;FYR@I___________________@F162T,\-C K)R(=&!,."00  -3_
M________________D@                       *W_________________
MS!X                      (O_________________^U(
M         &W__________________X                       %'_____
M_____________ZD;                     #K__________________]!"
M                     "/___________________5H
M      S___________________^/%                     #_________
M__________^X/@                    #____________________E;0,
M                  #_____________________GS<              ! O
M4'3_____________________W7(4      87*D%:=92VVO______________
M_________[Q81%1D=8::K\CC_______________________________2S>'Q
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________\^_K[_?______________________[KFHG9:/BH:"?WMX
M=G1R<W5X?Y#_________________ZT\Z,"@A&Q40"P<"         "/_____
M_____________VD                       #__________________YL*
M                      #__________________\@Y
M      #___________________!C                      #_________
M__________^*#@                    #___________________^P-
M                  #____________________56P
M  #_____________________A1H                   /L____________
M________L4D              !@Y78'_____________________Y7L>
M   ,(3A2;X^SV?_______________________[M8*3E)6FR E[#-[?______
M______________________^SGK3%U^O_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________________________Z
M[^?AW-G6U-+0T-#1T]G@Z_?__________________[B*?G=Q;&AD85Y;65A7
M5UE>97'__________________[\Q'Q80"@4               #_________
M_________^U6                      #H__________________^"!
M                  #,__________________^K+P
M  "S___________________25P                    ";____________
M_______W?!                    "%____________________HC<
M            !2N4____________________RV$"            #"Q0=I[1
M____________________]8TP       -(SM7=IF^Y?__________________
M_____\-C&"H[3%]TC:?&Y_____________________________^H?Y:HN]#G
M_____________________________________?______________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________________=SL6_
MO+FVM+.QLK*UN<#)U>/___________________^7;&1>65513TQ*2$=&2$M0
M66:A__________________^G)@X' @                !6____________
M_______.4                      Z___________________T>0L
M               A____________________GS(                    .
M____________________Q%@                (,5J$________________
M____Z7\?           &)TMQFL+I_____________________Z=)      (7
M+TIHBJ[5_/_______________________]-U'B8X2EYUCZO+[___________
M__________________^N<H68K,+;]O______________________________
M____W^______________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________O[*JIJ.A
MH)^?H:.FK+3 S=WL____________________BEI33TM(1D1#0D%"0T=.66E]
M____________________GBX&                    ________________
M____PU8                  !5!____________________YWL:
M      DT8(NT_____________________Y\_          0E2G&9PNO_____
M_________________\9F#P   !,J1&*#I\WU________________________
M_^N.-2L^46B!G;S>______________________________^^=G^4J<'<^?__
M________________________________TMCS________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______V\O#O[^_Q\_C]____________________________^+"?FI>6EI:8
MFY^DK+;"T>'N_____________________HY02D=%1$1$149'2U%::(.I____
M_________________Z9! 0          !S9CC[KA____________________
M_\9E"@      !"=,<YS$[/_______________________^6(+P  $RI$8H*F
MS/3___________________________^K4#9*87N6M-;Z________________
M_______________2AWR8L<OI____________________________________
MU,[M________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___MY>/CY.;H[?'Y______________________________VQE)*2E9F=HZFR
MO-#M__________________________^=4T=)35%68'.*K];\____________
M______________^R5@ :-5!MBZ[2]______________________________-
M;SY?>YFWU_G________________________________NGX.FPN'_________
M____________________________X\[K____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________
M
M
M              #_____________________________________________
M____________________________________________________________
M____________________________________________________________
M_____P   /_N "%!9&]B90!D0     (# ! # @0(                _]L
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M0W,%4Y.S-*!T8R05D/_:  X$ 0$"$0,1!     #\_P"??P
M
M
M
M
M
M
M
M
M
M
M
M         G33YV/G:RR;"S=;9K]>QZ2;,>;3:O5.$XN==-8X&VOMGM7JD
M
M
M"NKMRNJO0^1U_P!>^E\9KC>^W\]BDZ:/6OL+8WS L387JPV<BLEQ,;I<M4^:
M96#:=DYVLL-PKHI-<8.TO')OG?8;#XY\Q[;9>%XN=<P
M
M                                          -M[+38[]'?;\RTIT/N
M_,XAS'H/4[#Y.\[Z[96DM5O,MEQ/H     SW,P++U-Z#R>NNNO2>.UE9[63Z
M^>/B^D[EY(\W[+8L
M
M             &SL_56+ZJ]#Y%S_ );D8--\]?&=&W?SUI?19N         !
MGF9@6;OSV//=+;YV^@PCY@^!ZOO7DOSGL=B
M
M                             !454^/I;[KENCNN_2^+U_\ ,3P/4NA-
M%ZG?9@            &59&+;OI5[KF.@\EOX]G^0G->S]'8!A[&[@
M
M                                            !LG.U=D^SO4>'\R\
MG><];L_@[R'O]R^"(;XMY/*NPJ+NH>1;^#]"  /:9>PJ+NHLMBO7^+31G6MJ
M[.YP      WOM]!AOU+Z!RGG3Y>^!ZSO7C[S/M-D
M
M                               '2>]\OA'URZ1QKGCY.\ZZYTKIW6;G
M*0 /N=KO1_EPSFFYJWX,;+S?ZM=J47M#9'37AMMFF][VMY/*_0]K*X_X4R-=
M]3<*JM[-OL58KD,58AB=5&?:AKL=#=DV,_YQ<ZW<7L.2BJS*FYKC8%-W4?'U
M_ ^B0!>+EFE^LG1N1<U\^Z7TN4?,3P75M[
M
M                        =>^E\9KCZ9^\Y5I+X\<S[-U)B^/E7  #85-W
M47U_P-[^=[FV]B=H:\JM;@[MQ]C\K>',C7_4/Z/XFU^,_!>3K?JWT7:RN.=
MW<;K/7=5K<'T9Q=K\<> <G6?6CLNQG_-[35S'Z0LLTY-UM8SOGYQI?P/I#E4
M5X%ORUD\G_'_ #M'^B+3MS'Z+ (CZ3>YYEH2[7*+7\A.;=GZ.\1,0
M
M                                        .M?1^.UW],O><JTG\;^8
M]IZGM-N[4@ !](,3;?&;LFQG_.+!:K6T\@BO$:Q-M^(NP\]^G7[JZ[T?Y9/F
MAEZC[7[RMY/+E(BX8C-O87;^/L?F%\E,[2?H$^KF%NO@?A]5O8VK:[.];E%5
MDLDT9/S[=QNN>O+&=\\OGOE:OZ\Z(N8W5   ?07V?.])9SEX>.?(#FG:.D
M
M                                             #H#<^<P_P"N_2>,
M<\?&'E_;.K;/:O50  !]*,3;?%O@/)UOUFQ.JWGWU2P]S\(+'-.3_-[*U7V;
M^DN)MOB]P=DZWZK_ $[Q-O\ #_C^_@_1'7E5K;_>F-LOE);)B^;BMW^<_DOG
M:3] 'TEQ-M\7^>+N+V!A-5O9FM:K.ZM[6\GE?EJ]A]UZTKL[I   /I)[GF>A
M<:Q\WU\O_ ]7WP
M                                                           !
MFV5@6O[H=;X#RI\;.8]IZJPW%S+J          'I/CZVX6[_ #\YO1<UAPMD
MZWZF\A7\'Z%@       1'UUZ3Q[F/A/R/0MH<:>7]OLP
M
M                            /2(?<OK7 ^5/G=XKHN^=":?T&9@
M                 %TN6J?[5]3XAR7\2^5=WZ?UG@;6^@
M
M                             ?0KVG-]-[2V&EMOSD\1TK>P  ?5S"W7
MP0V!3=U)/*;Y&YND_0=AU5O8H        5::'N;&V/RWYFO8G;/0]K*Y X@R
M-=]/       W)L]+BOTQ]YS'GGX5<C^@.L(
M
M                  ,ZR]?:?N)UC@?+7Q+Y7W+KBFIJ]@ !]T-=Z/\ +7\:
M\_0_I ^CV)M?C/HB[C=5=&V<OC>CF+AH.YC=8=AV,[YU?/C*UGUVZ+M97'>]
M;>3ROPGD:WZH2"J[\QME\F>+,C ^EEIFF_\ 1MK*XWVK;OZ%XMR-?]*_K?A;
MO\^WQRSM%^C/*8KP;8M%W3F<4W-84Y5_-/+U'VK^NF%O/SW8-5;VCRS>PN[.
M0K^#]#   ^DWN>9:$T/J/29#PAY#H.V@
M
M              ^Q_3N)\T\>>9]AMSG32>DSH   ^Z&N]'^6O&IHS6W3%Y^3
M>;I?OS]\=;Z3\GOYW=IY?]A'Z*M5ZG\=O%&1K_IATA:R^,];UV=S4Q6\'Y.M
M^JOU1PMS\(.7;V'W/V78S_F]PODZ[ZE:EKL= =76,W@?@W)UOU9^FN)M_B-\
MO,S3_<WM?'V'S,WO;R>5OC#GZ#])OW$UWH?R^?.K*U?V*S>FYK'#*K>R,^IN
MZG^:.7J/M:  %QKMR/MGU7AW(_P3X_\ 0W6UFM7ZD
M
M                      VYLM-COUYZ5Q?GCXU\P[3U2   !]T-=Z/\M?QK
MS]#^D# ZK6U*M-!]\=9Z7\GOP#V?F?UH_=37>C_+-R5>POH%KFNSN/H^UE\:
M6J:;]M.B_HFG15Z&N8W5ECFG*,PBYKO1-S&ZHZ\L9WSRX1R=;]4_L/@;W\ZG
MRYS-/]S^DK67Q?O>WD\K?$78>>_3K]U==Z/\LGR<S=)]^/I]A[CX>8S-&:Z"
MNXW6?S1R]1]K   #M;U/B-37F[;LWS/\)U/>0
M
M                 !]D>G<2YIXE\K[?<NB=1OLQ    WI;R>6M-5V.D*":;
MK[3+WY:R>3] 7<7K2_Q7BF][63RKH&[B]:7>*L>W7;R.9^?;N+US3E7T-:RN
M0-(7<;I[**:\'L,TY5E]-S7FO:[6WMOV[_/.$56]FW--DOT58II&YC]/;UM9
M/+%BFG*/I9B;;XK2Y3.=;N)V-P!DZSZT@  $^8\?;SJ_"^1/@;Q[Z(ZWMMN[
M/
M                                         R_)PK=]ONK\%Y=^*?+.
MW]9@                    $U,GKZQG?/"OB;5QU?P/HQ13%R    [Z]CS[
M2^NL';5G!/C^A[<
M                                                       ^C_N.
M8Z3H*%VXP\O[;:P          !5)HL]HNZGUS79W) B 7**K->XJQFM3;,*J
MM[,E(G          9!>QZ+[!]+XWRO\ !OD/T)UJ
M
M                   !]Z^P?//)'QIYAVGJ^UV[M0          &Q:+VG?L
MY@;[\VV@KN-UEM&B]HSXE;#SWZ;,TIN:VQV:<PWW;R>4>U\?8?,S=EO(YE^*
M&P\_^F;'IHRX          /L'TOC7+WR+YOV?H/5^OVU^
M
M                       #8^=K++]@>E\4YV^/',^S=1@          'T?
MQ-M\:,9JHS;@;)UGUAR&*\1ZGLYG"/=^-LOE9E5->!_+W,T_W*[%L9_SFW9;
MR.9?BAL//_IFQZ:,N          #L#TOC=7Y'?M6+YM^&Z?NT
M
M                           /H%[+G.GKS=Q9W$OE?<;;           /
MH%C;3Y(W^FK$_F_EZG[,_1?%VOQRV71>TKF5->N+#-.5\JWL/O'I>UE\4;LM
MY',OQ0V'G_TS8]-&7          !?;UBC^N_2./\N?"KDG?^KP
M
M                            ^U/4^&<P?-?PO2^A-?X>PO8
M !>8JQWZ[8.\_/7D45X=S;=Q.T.7[V'W)]/\3<?#C%9MYY\[LK5_83K6QG?/
M[;U%_GGY#9VC_0S8IHR@           ^V?5>'<D_!3C_ -#=94U-<P
M
M                               #[Y]A^=^1OB;RON'7(
M                   !]3N@\HYT^=/B.G;>T-J/0Y:
M
M                    7J[8I?N1UG@/+GQ>Y=VWJT               "KJ
MIDW:Y:I*ZNB1/FF6$B*IE#17/M-N[5TE-4X         [=]7X;4>*XV>X+\A
MT+;@
M                                        !OG;^>Q+Z(^VYEJ/Y;<_
MZMT2             !554RLKR,6TY+?Q[7<[ENF    "V6[E3C5C(NF*8^5=
MJ6FJ:       ;_W/GL*Z9WOFM9_*;GG7N@0
M
M           #LGT_B-9[WW'G+#P!XWH6Z@            F2\YIE8=DS')Q+
M-,F/(      !+B?6'8V7><+Q<R]RX>@     ,URL*T_3/WG,>=OBMRSN?3X
M
M                                   !]!/9\XT].FU6\;>8]IM0
M       "XUT4VRL_78S<J[=,         !;:+E3K7 V.36ZBNI     )DQY^
MS/3^+<G?"'D7T%UF
M                                                     ?2_W?+=
M&ZSP-AE_+N@]5L,           NMRW2;0S]9BU15$L           IZ9F:OP
M-GE-JMW*L     ^TO4N)\E?!GD'T)UJ
M
M        ?4'W_*-#Z/U.ZSSF_1^ESP          *RJF3M;8ZO$JNJF4
M        %)35-U3KMIEM'35.    #[4=2XER5\%N0?0O6H
M
M                      !]0??\HT/H_4[K/.;]'Z7/           V=GZ[
M%[_>L6\             "P6;]PUC@;'*     ^U'4N)<E?!;D'T+UJ
M
M                               ?2_W?+=&ZSP-AE_+N@]5L,
M  "_7K-!L_/UN+               &L,#9938;-ZO    ^TO4N)\E?!GD'T)
MUJ
M                                       ?03V?.-/3IM5O&WF/:;4
M         V9GZ[&,AO6+<               8]9OW'6>!L<G   )DQY^S/3^
M+<G?"'D7T%UF
M                                                 =D^G\1K/>^X
M\Y8> /&]"W4         3)>=R[/3X7,EY               )</6FM9N,TEP
M]  !FN5A6GZ9^\YCSM\5N6=SZ?
M
M   -\[?SV)?1'VW,M1_+;G_5NB0        "ZW+=)MC8ZO$@
M    U/KMIEMJMW*L  -_[GSV%=,[WS6L_E-SSKW0(
M
M                 !>KMBE^Y'6> \N?%[EW;>K0        "_WK%OV=GZ[%
MP                UC@;'*+!9OW   .W?5^&U'BN-GN"_(="VX
M
M                            !]\^P_._(WQ-Y7W#KD         OUZS0
M;/S];BP                :PP-EE-ALWJ\  /J=T'E'.GSI\1T[;VAM1Z'+
M0
M                                      /M3U/AG,'S7\+TOH37^'L+
MV        %QKHIMN;+58@                &H];M<OMU%=2  'VSZKP[DG
MX*<?^ANLJ:FN8
M                                                  !] O9<YT]>
M;N+.XE\K[C;8        1&Y-GJ,+J*HE@              %/3,S3>LV^:0
M %]O6*/Z[](X_P N?"KDG?\ J\
M
M    -CYVLLOV!Z7Q3G;X\<S[-U&         ;!S<#'<LR,:T@
M   &)X^3=M?86?D0  =@>E\;J_([]JQ?-OPW3]V@
M         !$ D0 $ $0    $ $0   0 1     )(0
M                         !]Z^P?//)'QIYAVGJ^UV[M0        %RKM
MTVV=EJ\1]$              /)'4VMVF76VBY4@ !]@^E\:Y>^1?-^S]!ZOU
M^VOP                              >QF>+E2LYU^;+G1'@"0B(*D "$
M"81@) AZ!* @0A($8DAZ"$O,*D(P) @**JB;J_::^HM=5$?*
M                                 ?1_W',=)T%"[<8>7]MM8
M  SS,PK!F.3B68             ##L;+O.!X>;?P  R"]CT7V#Z7QOE?X-\A
M^A.M0                              #9NOSZ6MM79FM\_$G>9A&)0DB
M@2@$$9((121""22* 0 1$$D021$!$$B!4($JRB6X]7GT&E-SJJZU5VHI$
M                                        !E^3A6[[?=7X+R[\4^6=
MOZS         /<O.T<_68K>;MJC            "S6KM9J[ V>5>(>@  [Z]
MCS[2^NL';5G!/C^A[<                              "9%3>NGV]%I?
M:8%;DT+-D-55/0PAA,49%.A"HF)>>1<Q;7=5O+(CW$H$-B17C.NZJ,F\PC!+
MW*$M$:F)A(F/6R8KPW6<T9E4Q/BCF)E?%4N7-,:='J\4URJ*NF.;T58I@TLK
MH9IFU5-<-F8.12Z8VNKJX20@
M        ^R/3N)<T\2^5]ON71.HWV8@        %1,2]G;#6XO=[EJC
M      +1;NUFL=?LLHIXF8  $^8\?;SJ_"^1/@;Q[Z(ZWMMN[/
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MCG)J9<TT%Q34:WB,OME,S=H8&13:5VVKJH
M                    ^Q_3N)\T\>>9]AMSG32>DSH          +[>LT&=
M9>%8;M<M4@      !:;=VKP7$S;]8K-ZO    N-=N1]L^J\.Y'^"?'_H;K:S
M6K]2                               !M7 V%'3Q<]X'E8M3YF%9$><C
MBNUXC5%VA,(Q ()99%5KQ2JBZ( @$@1@RRFNT8G51=P" BD 0 1$) JJ*VW]
M=FV_46SUE;9;MGW
M &=9>OM/W$ZQP/EKXE\K[EUQ34U>P          B+S=M462W\:UWZ]8H*^NB
MGB  ("@HKJ+#9OU^-6,FZ6:U=K8     /I-[GF6A-#ZCTF0\(>0Z#MH
M                           /<RV)@9<C,,3+\4M;RF2F(PJF$::8PJF
M1B28@A&"20"( 3%#U$A"4(Q$8THPJF$!$  @$!54TM3[/ J[%=L1@
M                                        ^A7M.;Z;VEL-+;?G)XCI
M6]@            "=,>*ZNB1/FF6$B*IE#17/DQ/L      -R;/2XK],?><Q
MYY^%7(_H#K"                               21@
M             @                                           #TB
M'W+ZUP/E3YW>*Z+OG0FG]!F8                      !=+EJG^U?4^(<E
M_$OE7=^G]9X&UOH                            !&1 D)(
M               !,$$1Y
M     &;96!:_NAUO@/*GQLYCVGJK#<7,NH                     $1]=>
MD\>YCX3\CT+:'&GE_;[,                        "(@    )B69:_(54
M5D@)"0                      $ 1*,4L=RK:P7[
M                           .@-SYS#_KOTGC'/'QAY?VSJVSVKU4
M                 ?23W/,]"XUCYOKY?^!ZOO@         B"HFE-IJ5U-;
MT"0  1! ()  !$$ @/ H*J'B8$(   +Q8O,[MWDG(LHH0220JJ
M            1B  0A54CJ[C6FSPWF1
M               !UKZ/QVN_IE[SE6D_C?S'M/4]IMW:D
M    #Z"^SYWI+.<O#QSY <T[1T@         !$7*FYYVMJ]C3*JO-(CT/12
M ""8",8$P   (",2A)Z3YKHGS;Z[+56QP*V1-*   OEB\S6FXEY% A&" A,@
M                     (@ 3"-L8N0UEG8*$B
M                       .O?2^,UQ],_><JTE\>.9]FZDQ?'RK@
M          !$?2;W/,M"7:Y1:_D)S;L_1WB)B         1%QHN>=V:K9T,C
M+QL3TSDVL\V?$X-K&8SE![$J2=!*DFQ+)XFQ6F8O=HEZG02T/<DN)3%+-Z;F
M-X-51DD9+]1-!C]<5^48]Z5G>)>I-'[;67"7-*  +YCWF:KJ7D64:))D   0
M! (I!!"*4$(I    ! $(I  !! (I   $ ! E'!OM9;#!0D0
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M@  #,C6MRA:<(EM/*3 ,6,]N!8Q-EGNS&1P  ! E4%/7ELRB)Q+ )IV1%*
MAD:<6LIDE,38@    A!*.#?:RV&"A(@
M                 V3G:NR?9WJ/#^9>3O.>MV?P=Y#W^Y?!$
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M,;_M9<P   A!*.#?:RV&"A(@
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M@SC(37>MIC==B,A   "$$HX-]K+88*$B
M                    #9V?JK%]5>A\BY_RW(P:;YZ^,Z-N_GK2^BS<
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M]0)4HF9!#$[!++LAAA]AEETLJ<DA@N 2VU2%6   $()1P;[66PP4)$
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M32:4VFLK @ OF/>9JNI=^VC$$2   (2  $"1 D$1 9##%K<7BWRN(    1$
M! E$(   !5"$$</(:RSL%"1
M              %=7;E=5>A\CK_KWTOC-<;WV_GL4G31ZU]A;&^8%B;"]6&S
MD5DN)C=+EJGS3*P;3LG.UEAN%=%)KC!VEXY-\[[#8?'/F/;;+PO%SKF$1 10
M52W!K+EJ^IW.[^O=F<QU&T=D^=Q'QJ^E=E'E'V%V;  'W.Z9\1N8M+TM\_\
MRO>GWQZE\)/D5X'ZR<I:/J0  /4F9XF7*R[$S)6K=A@U48A"0D ; HJQ.W54
MW29+QFENK&+;=72@HB?5Q-'EDU8_KRNC/LAMU6!4GV2E.U_51DX1!!,IDRW'
MJ<^CT_M=966>]9(E! +YCWF:U7DJ];>J8                          0
M4HTC$R&LL_"0D0
M       $Z:?.Q\[66386;K;-?KV/239CS:;5ZIPG%SKIK' VU]L]J]4@
M$V:7T.YM;I_IEP7!F8#['VE'C678D9AY;R5?\"_J?95%AR*@!6567W2Z9\1.
M@=MX)\8N=_8CCWS_ %P  "0(Q+8>%F4^78F9XP',QI]FNT3/,PC $0 $/:4L
M1'N9>(A[@\2!  'N)9';N2,[U^1XU?M==-Q7(QYH0@ +Q9O,ZLW4G*H>J*4)
M                         !,E9# R&M<_ >9$
M                                            $1G>#5#]#OR'I:;
M??>_M6H<'W=ZN>99I^;O=\LE_-7J=BXVI2 ,QR-0^^/4OA);+>4XA\WVE\SO
M&_2(   "(25--;8^OS)%VMW),52,4Q"!!,@@0]T1[O%=F595_P!0JDIB/J!(
MB !"9AX1'&LBQ48)FXLV7-*$   3(EF^%DJJ*D4  D
M     !"(*JF.7K+'<BP
M                        +Y=PEFM9K[$<#L2.PO#WZ/"]SU2GY3]KI[MR
MUT?3V[<NJW<KYM>S\#>Z>8!]]>I?"+YF>-^DG).AZL^YG2_B5\^O*]\<6><[
M(     (@    (@EO2_Y:AT98]/7>4@      @   !)$( 2
M           'N#,Z:['A55N^>4@
M                               [*]#Q]]P>E?%3\^O*?OAJ+0>ZA]/.
M4Q2?/CJ>PJNL]%ZFQ=A^(];+Z*\9Z>=\?^V<FK^)_4>0KH(7JYAK+;S 5E5E
MZ0H:;X     B 20@  #T WK>\O0Z*L^HKO("("  (R( @     B/8\"
M                     /0Z!IN:>T-5;W!2D0     /42V!KMPV=JM^SW7;
MAEN'L5[L9:LHN)4TK5=QV-9>"PG.U+6^TTC5VV\^MEVP
M                                 -MY_E'Z0>O_ )V-;8?HWYR>1?H<
MLUO-=C^?]-:_LGPOL]'S![WR4OH+R.\4$U>_A!W?B=]U9F:V8'V:LYWY[J4K
M-8S1N7/XJU=J2JC>V*HS7.(JUOU)3=XLXYKL=_R"I^>ES&^K(  !$!"2(!!&
M);UR/*T>BK'J:SR(B B( (@ @      -ZTW=5Z:JM[2MZ/0
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M<>^VWI-^W5HO2-YZ#TS#<W5N2O9<Y<L>MYZM5VP
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MG.OV+C#W/+W(7M.:J&NT)00B(
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M8ZTY%*,0           (0>JY;;TF\=C^'Z"R'&R'S\Z/QIH#T7CD)$$
M                                     !UAO>5ON1TOXG;)S/.*6FXY
MITW2'YZ.4??SS%Y]>N9]/L_;W,?;^.0^E>7E=;\]]*YA]9YV9\2>S\>ODBF
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M^^NQ4       +K=OPZF]IT.EZ!])[*FY8\1S:?H_G/*< UM;Q\VQ::;M
M !TWHO<2^G-%[B7B>1K_ %<*+T/G)[7C,\ #I?1^V\=)Z3VLOYJ^WXI/"(20
M@",D(          +C;OOI+R_N38^LWCA_P!_RY8-MH\2D7J9&$VLC-/-VLHA
M$                0'NDZW\=[UU%Y'V;YE=6X*TWN_,O,
M                 >TO<2\J20D@ES /<P3**'B)9KD:5^C'KGYZOF;XWZ1?
M,WQGTD\) &=Y6C?I%Z_^=:TV\I^:/CGZ0*5>5%-Q]D?)^RX[^07J?&]?]8:_
M<8315(\?[/29U"(;Y]/[63] .J=NH]5Z;S7KE/Q7.:K%<;$G>*8*A3(@!(
M  A"9;.Q>?VG661[Z[)J       " AL':;J7VC[_ *G1R,'78[\[.7<4R_7>
MIT7OR     B-MZ[T/FNHNPTYL_-^Y$T@ ,ILYT,GQ\^&LL[0^O*4Q)$/"$9(
MU03+Q1*         N=J^^G?*>]+M9RG"_O\ E[!MIBH1;;IG7Z<TI&SW&0@E
M$                ! 1DZ%\SZQV]X'H[YG=4X0T=OO)H
M               G2=(W/*4&;7M/YVI?\]+N%R:;*[>+9_E3KNVYMX2F5&Y^
ML;J'1?5]O(N^;>\<L\1\[5:8Y?J8U]6,MM&2   .K][RQ;*,ES'I>E #:=C,
ML7T<\WO.=/DKZOS'5'U0\Y['37SMWWF-K]&](Z=,ZT]YTZFY0\1S*;HCS_EJ
MRW46_4:0       !$,IM^>H]G4<^H,$J]E58'D^QN*W!,@     (J4$@V!8L
M:UZ2]]U/,-M^A]5/^?O*^(UFB?,>,G^0000D      "<-K1IY6=W-7(V)7HI
M>]MAYVS\GZ[WETYEM^NNGA+-/5YS?_6]M*RO;Y<OF+BOGZG7GB]>\I
M1DJ[=Q].>5=Z7FUEN#N@<O8GFXR$D!G4XN%2HF?A;(RZ$RC
M      &^/.>F=U\_Z:^7W6>!-0;GS*$'F0
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M\P     $4OHOS/MC;&F]$^?O2.4L2S\9YF4:8![BF&XKNOT_INC8[A\Q*(
M                5$$NC/*^K=F^'Z$^478/G=@V?J7D
M          !$1B6Q[&OE_I:TGSYH*NZES"%_\UUKY?3..>UZKF<?Z'U'\^^K
MV\F^<'T5[O+^P/KGTE6RZ*+9GPALM4;J\]ZJV\H?2_C,H^1_$^7;CH[$
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MBDF0                 0@J=A>*]\W3H-Z^4W7_ )Y6ZY9
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MSO/.N/?<^&>**'FNI&(  )(H;%M8F!V._<OF*49&0*B-( 0  $0
M    !&(9'CY;Z><F[2^:?4^$-&;[R8(                           /4
M@>Q]2N=M0]?Z7O4G1.V]7L?E#T7-;SPSZ;DDSS!['F3S         '1GKO>2
M.]>H=IH^'^<\?J-7ZS35?B) "        J8IIU,0GU1*MZJN5U(3*OMVZ*73
M$REN5U,(J1JA[IB%;3106ZJNX7BBBTV>NY=D@1@!)MG4ZO2&IMOM-WJ8 F1
MD0Z-]5[FGZ0]3[BF^7'$_G*X8YBZ^,(      (CT)E1]Z>'Y6D>?_7?3VY,K
MMZ^CX*]1\UV_EW>T9-"80@\P      =D^)Z<ZP\?T5\V>H\?6N]02!&   $$
MR:?.YHUVI=*5;/;D:8)EZB5PHJ5M%:MM2FP1%-44%VE0U4J2JA"J!*$R4PC6
M*0        D0Z-\QZYU;X_VKY(]D^<%)5;0
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M"  0*BEKA9K]MCF5;>*X1B$)J*8        $@C!])^6]@<L^NYRX^]KS5"(
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M^>AWN8?-+V7S_48!D^>>(       "(ZD]KT>G['Z%U6DX,YOQRMQ/"PIT9D
M      !%!) 9CCX^!6&Y7EM+-R=<8M6RIMK=**FJ44-!5=NW@J+K3;QJUS5?
MZJY-!3Q-1.HHF03(FPD^:J8TJNML^1>OL;<,BLV<4N=-FQX3DYNQU4HTP
M 2;6W7HI7:_ONJT7RGX?\U7''</ C        &S-9$O[8\/S<4X#Z5Z#).%O
M;^=J[7.(ES(    (B\V<E]BN)_33YV]+Y&U;M].!,@  00KJ1BE[B648=U?<
M:XS*_KM9V.C)RZUVLB_0 0F0     $4+%D4,5S;+R@I@D3(       @/5,/H
MYS+K[EWU?.G(WL^;(20@                            BE] ^:X])D%E
M)^?_ $K9W&P7\-+B4$       B+QD9</K#W/Z8MW)_B>83="Z#S%;YH
M    3""55%$FZVK=DL%Z_D,::4*ZD:8$H(!,B(>*IC!+U,O:$(E"3P(Q!327
M*BB&U-=JM&:OV&UWC+EZ@E$    $$':_0NK46$ZK3>N$N8<6JX20@
M/H/ZO@C4>#ZMRUH>GI4R@     ])=>^,Z0Z@\GT)\XNH<D>4"0   $)E-IJ9
MMK[JX8]2%PFS33YUDZK46O\ &V^Y?5N$*Y02      0>D+5D4,+SK*$P4P3(
M       A)&#>?G_2NQ?$>]?(KLWS:\B
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M<5OJCR'MSYI]3X0TSNO+O,P                              C)"
M    "]9&7#ZT]V^G+;Q;S[DM3IS3Z"J\R(AZI      $D)(TPW]H='R)9KM[
M+=/[?:]%RJY]Y%CV,8V'A8FK+9>7B73-3<+E=FN,*>%5^,+D4]3:MT<VU9M<
MF_?N/NE+IKU5XC0DTV1?OV/['9;8(A$ADNFT^B-9Y^?OVPVK-1XF2((D
MDA('8/N>FT=HPL!P5RWBE9YD       /U2]O_+UPCYCN+XD<W^T0     &Q]
M9NGU@X_]%OE+V'AJBKH     &9X60NV-4A,@C$(Q";=BGSB[J]38#C;;<,*I
M(       "(C%+#\^TLM^T)        !"9=G>%Z&I*M>^?W1^.(1
M   [A\KU&5P]ZKETT              .[_)]6DZIV&@]<S;SQ$P    ,DL9L
M.F='[?QR%Z/G<P   Z[][U"FZ0]A[VFX6YUR2X6FFWZ!$/5(      0A7*ZV
M:+5NK3:;E?!LW+W#@.?G[6D3,Z]V[-DSO%Q-7X[<R,TRJ_>Q[U7=G^T*BW:L
ME%DY&0S[-J@JK%G'*3)R,GKL;&Q2BR+N1>Z%/+N55%ASMCM/T*NS9QZYXF'@
M=@V>RV[(MTL7Q\>HL]JU,0     J RK,V/GZ(]/[7;ODSPKYEN..8F!Z
M   /U2]O_+UPCYCN+XD<W^T0     ':'A^H-T:'V#@?I'+B)    0&18UUD^
M#=1J()!ZB'FJ7JBEF^3J]3XI1L=AT5NY=8)       "#U,)-4-?[''2ZH
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M)OH!H'T/FG.?JO*HQ    1"?%;/M9D/<"9 $4$$*I5-=NDS')UNI<'P-KN6
MC402Z7O8W!WU$S]7^?C%*:]C6^)O/Q\UVW_3388JS   (@ACF3;4V9CXO]KK
MF!^9SYO4Y?V:Z36>+_F%3F?<$    ( (CU-3ZP\;[D^4G8/G=K?9:,
M     ?<'EGU#2?$+J7R_5_;GEOT_2?,CW7#ZCZ.^*[/(X2]9RF=TCI/:R_F=
M[GB,_P"X/*_J&D^4_0."5/9_F>E2OEO[WA-1]D^:?2-+\[?9\<G_ $*\;V"1
M\=.E?.-5]E^9_25+\\/9\>G_ $:\5V:1\D.B?/=3VIYCIDK56PT'JW5V6^]1
MZSQ;J[,<"S-3'3VR\YZ[N\EU:3P1Z[DT[8V%N8=L>7Z=)^>_L>03_J3X+NU/
M\I>@<#J)T5.VO+].E?+#WW!Z@ ",FW]]ZF5]'.N]ZH?GER_B%=CMBQ-C3 D
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M_P#/-\M:<S[J=4+/"/R5IS?T!       DZY\3[M<:*'SUZ/Q<
M?5OGW?:?E/T'@9F2V<V&^M1ZSQB]_!C\[/9\<G_3[PO<J?&;V%'JK0>]E_#/
MJORS5_1_Q7:)%_LY<--[/S?KG;<^-F?4[P/>*?2.U\QZQN]A1XX]+S>;W7Y3
MJLGYB^ZX=4= :?UWCNWR?59.&96MC@>7J?5!7:;:UWH/-WMY,.'_ %/+IVV]
M=Z'SO35>I\7"B]#BWT_-)W?GD.M2/CMTGYRJLRQME#ZC>"[K3_.?VG&Y^G]E
MYST 1'U?[G],6[F#R'.YVC//^7J\^Q<;6591:MV/WK^=9?BX>L]3Y^RWA$
M  7ZU9Q_.<+#U!@&9F[DSS'Q=46*NYG&#9F9G4)E?;]Z5E61DR/4
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M<S[SQ$SK[SG19?QUZ3\XU( &VM=Z#S]#?&]AD?)CH?S]4@
M 9AG[7S]7NY_2UM^<?*>%5^-6<6;LG68.IJ6[-99[MZ^YO@8.LZ2[>N$3U
M !%$*VFU9,TUN#I7'<S+V5B5_,VQ6UV[+JS.V&Z*VY=\YUEY5)ZF8@@
M   #)=3J-+6+:;+:=/5<NJ9B@  !(DQW'L3<9QL>>    F'0/I_:4^U]OOY/
MS=XYP*NA,/" 1'H38AXFH2B(H>4DPC3#U)V-XFF@S'!II\3RE3QK[JNND3)2
M>IJ=J^%ZDV1K/3.'O>\U0J(P   DRW"OKYC5H)    1@]4TH25==JUY1FX6M
ML+UNSVZKENN[8Y3[]S,#XV!A-%S:OSHP]A]OK'%66!VODX7RHZ&O8_%/#.+G
M?6_'*:LX^@.9@?&;3=J[U!PS:S/K%WKLM7\2^,(R/I+NF;?-7#M.1]00
M  2;!UFT?0_FG6'QP[9\R((              !GV)MH9OB;3SJ/8^>]6:[C1
M  NUO(;$PMQYU+L?/^@               .C?6^\D=D]#ZM1\"<WX[<J&W;C
M?+5K'LIQ[.,X5EW\VO%NW:,7OY.4((B$D4()!&"XV[=ON-%NS8Y>OY3>K=FR
MJ9F6>_=NV<9>925UVY (U"B($Q0     "0B$VBBCR'5:O3V,;G<;NC$01,0
M !((>8A@^+BU=%:M>H)$"0$$RS//V?COWI79J#Y\?/'S5:O$4"0>HIC&;L?J
MGS?J5-GWGLVZ>XI\R;MND35.FS4I\F[+DV,"/PC[5R')/O?\R6;?FVELJS7:
M[U\(/J_;U>DMU'N$2]CZ <Z[*H:KSD;V7@D+E2-,   A)G^NRE99/,R    "
M,0@/:&=Y>KTWAF/LMMTE-RI        C FEKK9XZ55"(        O-B^^L''
M>Z/B9W?Y729H                                     ';G1^OTFP=Q
MNY?&/A>9U\(I7:U;LU_M6<1PK+RMCDE,$RA)&(02C D2*80"2NIII,UQL756
M*[+9;=R_(R:2=31256-;LB:?-!E9.4DQ0     $)0C,0R+4:S3]FS\[8U-?N
MWI"),0   $P@0MUNW[PG$Q:I 0) 0@EZD^G?7>^VSF3YZX!@.*ZK6/-2 3E?
MO;#-H>V>:]$R7+M1L;E"F?3*L6[WCU5?FY6\4US:&YBTWRJZIRC(/I/P;HGF
MHG$CLOSO'JKY?_06?;=*;Y#U+THK=?\ A.UUFG=OK)_*'K_'>_*40  $9EL7
M5Y*9;/-4@     (H7&;%HR'+Q=>89A;';29       $8@@P+:8ZCKI
M  !&3Z]<5[X^,G;_ )A8_DX(
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M*I1BE];>,]Y?(/L_S8P[-U0                 ",B $B)$   @     "(
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M9DPL%.VKR6![*PH;M!        02K+=3ZZ<9[T^*7=/EM;;N,
M      (B*6^=+MZ/3&TP:SQ,,^HJQ?#:HR6GF/?E+V$0O<**^U5VG!E&1WU7
M16-36RT)@EB8A?XKH[!--9*$U*4A.IEM[6YE'HS<ZFL@)]5;[)_0GU=:^%N.
M_)E)@%K877&KN]JKM8MV;([=K!,%S<S:D::0!!)!&8>Z8A-E*IJIG1"DA<E6
MV+='MN*=-V#:;7<B   $D9((A"9BB(!/M46WW3$FFNW;R$) 21F(03&-%'BM
MLZZU4M[-N-U\_%O6;%/?L#08]9?07;K/OZZ12ZCV5YC1%-,R-=)H]Y158%3M
M<EL6+CS4R  #I?UWO*:ZS7XX&Y;Q.L@    /I+[#YT;5SO+/D-X'ZT=T^FX@
M[,]%QY\2>;_:    #T.Z/ =;9+B[EQA[GG94(   @,YP,E<,>HJ B@D4D8(2
M 2]4TH20JE&(7>Q;\Y31K+?*KI\4UO/KO%>)3V/853+7C[2KA<DH(Q"(NEBW
MYMUZOU+JJ00U]LL53W",       !"J67X6>^G')^ROB[W'Y=2YH
M         5,5-QZ?;4VI=IKZD-Q45X79JTV67*LB;9?RDH(I\)F3<TTMAED%
M5*STU,7>>FC]HC[F::BI7">I]5<54%/51YO\54.OYC(-?HS#=NJR:29Z'PWE
M,1G57(_1+OOVK3<B<:^&+=-Q]/4ZFJZ358O5ZV3DEJQ@>"9V;M132G4Q+S#&
MQL#MMZY?J954U]NW:DS&O6\?DS578C7D9[XKGU"HN-$6[:U-.H;!L]GN-
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M,H"(0$ LV32P[.L$0B        .F_*^S;7TNV?,WJ?!@
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M]>AYF0     "(8CG6EDR;8A&        (=R\_P"F-<[/SKB'WG)D
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M:87#*UE')LWYOBUES\DQ;$J=E:FWQV.JIK+B;VX6:C;UT:80NU%,%,H2
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M&!;7'25(         Z9\I[)N_0^@?+KK'S\\(
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ML=2"(   (5%^Q+S*\*XBE"0          (P!"2%,,5V-E8;UM$        0
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MMHSW%7O.=$B   (",D$LEP[K),:X]6SS7(         #U3 (26+(H8GFV"0
M       A":F:8&P?3GE'9GQU[9\T,?R->\@
M            #W,OKMWKZBMO$O/.25>KM5HI\*JE133*S'%Q<!P;+RMAQB4
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M!%"Q9=#$\NR@A"91B        "(=J>%Z,FQ:?.GIG#T(/(
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M?K&2^IG(>VOE3U_Y\:MVOG1"
M   B.@O5>XD]Q]+[#1?//F'%KEL/5:?2%CR,O,=C8.!IC16XW'4LM,0    A
M,-CZ_ U#8\B]F=QHFU3:+%-;LS.R6[[+87CVCSYF?4:'GU9I\0JGTJ(7)]HD
M@      "$GK7TK+B<_J*S7[3S6>J];("OLX^*^[<2(S2H,C(R;$]?@4DNBCW
M[F?=HKN7F1-4P$FQ]KO)?<W0NM4/R5X5\S7*WV<5               1 ;HT
M?J7TYY3WI\M^N<567(Q2)     $![F5_QKC(,2XJ*)!$0DA5)0!$>HAY$($E
MNO4,8R;2W9,(Q           AVAX7HK(,:X^:/4^$/,0
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MNNTE4H#U$$         !FV!LGTTY3V1\H.Q?/#6NRT"
M                        #N;I?8Z38>XWDKC/GW*Y\N(C&(A1UW*D
M 3#W3$+Y9M62V7;EUKJ*+;05UW&GN7*C.<O*HZR:O%5Y3#A2>,P:JJN52&]O
M^:;H&S]H$       *HA'71&UZGQ5158>PA4^P]-3*B%4^D1"RV+4W$<;'J(J
M0(D !<KM^'THZSW:V_-CCO *[3^@\I-@                 SS7[=];..?1
MKYV],Y*U3NM*0(      A!** $IM,JBF4Q(E)F%/-*75"*$)D@C$$D)E&
M     "$R]Q2^B_,>NM-;SRK@WH7'4!"
M            ,XV6X\?5/M_TE;OGIR_B5?AF#KIL0!(     ($B"0$RGU5PS
MC,R:6X:NBFK_ "6#)DYUV/G87%#Z3+K4"       "($*[R>/;8WTFW^GR;Q&
M2$%BLVI^*XN/.((   #ICUOO*;;VY]#3_,7C7SU<:6W:
M $1V/XGIKKKQG2GS3ZIQY:,FTC1           D$1!       (H02     (#
MJ+RGMG3ODO7ODOV+YS6N[CO*
M     !$?0CJW<:*YY&1YXS\+S*O\P$@       @"2$RB)\S#;/F*+!;?49M7
M+OU3+_XK!L^/^WS[W"N?2       $Q!,0RG3:G1T^U9LV';O>=%>2.+6;-39
M,?'F02"$D8 !)7W+T/I!U7N5NX0Y?Q:IYS\EX.I\@                 B)
MD2^H7)^_+?=I<&=$YHEJ$*I1@         E$0!       ,GOZCSCMG9^I47
M  0$1 ;-U>Y?1OE_7'RXZUP-J'<^6$H(0
M              1&=[+<^/J=V_Z0M_ O-.,5FO-9JI\:Q0   0","8$H! "1
M,H(55IYS[F&&\^WSZ.LVMVEH.7ZF\5_4MQ;*7;WIZF(1B8@     0D(A7XV/
MC=1;MVC$\G)S_&,7%GTE,>@   ""3JGV'0J7:.VWM/\ ,CC7SY<K?:QT
M               &3XV>^LG'?HIS7ZGQKDSVGB4J81I@2
M "IJLPSG*\]XL-K8^L;L;;T   $,FQLY]+>5=B<3>[Y6Y(]ES1X
M                                  1!+N+I78:3</H/4R>$N=\BN%-3
M3%$@  A41IA>+=%BH9FYW>FU:KU8MXC27*[O9;MR]W.W;H[C31B]BKNY9;)N
MY#GW+\*-A]AE>:397/&1\[PIU?T_;6ZDW5^;&F$4@     0(>91I<3&MU'BX
MEJP_(O9DMTBH    0RW,V7CZ'=2[9;_GCR7A-7H;S'BZ@/(
M     "(VEJ?0/J=R3Z"<<^VYRYH]5Y1*KA&                 +M<PH9)?
MU7FVT93%\?;^R0 $(+W;R7T?Y;UYH/T7C7 W1.-O"$
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M5Z69Y                      &[=%ZI]-.5]X<M>M\*Y1]AXA07B,0
M            RO(TOG&+&W]2XK! 10S/ V3Z(<TZPT=Z#R3YZ](XNIYM@
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MHW>G.NH./_:\U<2>\Y0\*4
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M^?,H/4;*K[\Z9V:@TQYOQSA?F?':^P8V%Z"
M"8EU[XOI+N7P'66EM]Y7SR![3PGK!=AA)54$D8            AE>1IO.,X^
MW];X\[ZUVGX3HC5>V\X^>G2N,,.S-6
M                     ,HS=CY^FG9?H6@UYJ]'ZXZ\/S2NE4VXP5 1 D 1
MJAO'#Y)9=49'1KG9)VL^%4HP   JAG?F+5#AV'YNJQC+PYFZ)R-)>41P>*<_
MG(H\G7+!9%%SII7*\U5V=3;MV"0V;FL-<XW53F29C=Z:[#E2NU8E--Y]*9>!
M+6P-EY'H9/?W:_H6WZCU?FIO"/,>.5V)8&J]^0
M   !$>Y.I_-[K$M[>4ZMEO1'F?:M'^B\33\F>Q\C48'L->I:H $!$)$  $!$
M D0 $!-B71^CV\.G_#]+C6VZG!_0^1.<_2^(>4(
M                               #*<W8>?I5V'Z"H<:Q<"/%_A.6UUNM
MVXA&((D$8AE-'G:/>-KD=!A;U7O3&1U2\1D@D  $$-B>+PJ'3VP\Q73J3:=5
M[3>"TV=E[%G(US<S%*.(RNSHE0A?LQFK5^%FT\Y5:IM,Q?(4T5MDF;A73734
MT43JB9\2J+?BQ[S?;E^@/8?H.AUEX7Q]/PAY3E-WPK6:CWYD0
M               !LG#KL,(>M<9U%\W1I/02>Z/ ]2H=NZ+VMTU/N//- >C\
MHTOO/.,<S+*CK@4B1"%52--(  D0A,O5$MCZ[;-_^;]2Z+\QZ]2Y&##B;V_,
M(\M>L\ I:J
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M@E7V;J_8V6RW$V#/]=M&S-1N6VM/ODVDYU]+XER]ZWP"S;OS?G6=5KU2H
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MTH    #:E-WSK.JWZIT
M                "(O&1E0[2Z+UNEZ=]GT2GYU\QXFIYG\CX*IL^/BQV78\
M);=<7O<7*7-P     )(2((P(A&3S(@C!"J0 0V;MM]*ZO]ET*DSK-R)','C_
M  \WF7Q?@:S7>LT<Z732@ @                          /4F]=%=M?1'
MCKM5&#']I%NON),+7<B;Q][?'NF+Y4>XC8<5XCF<58M92^7<M>!33EVRHKP/
M7\T9KGD58;HVJWMBD1Z      #:E-WSK.JWZIT
M                                     B-@[7>>.T.B=:I=[^H]I)T'
MYOQT_7?D>)R-#8>]N?F:D$HR("")   D $0""2H *BJMN;?>HD]'^I]S39UL
M-K)T_P"+XM;]5^-X'<.;-9[:OP.UDS@@(B                       B(
M "(",G6/C[]JV7YZJL7YI+)G1+OFMFMA4\<Q^ULM/;:W7!OFF]JO3M5K96YJ
M;NL-33;V5LJ*M94Z;ADL3:,"FG++!-.08?--W      #:E-WSK.JWZIT
M                                                       #U DS
M[:[SQU?[GIE/TI[#WU/B>'@>])>?\G/T_HO,S<$U^HF>4(P(      (27"[>
MAM3<^AE;FWOJ).Z_0>KDV7&PH:1\YXWWSKY'PT_!M)Y6=EEOS5#IZSZ"X^0
M                 $0D"$ 1 0$9 "$ 1"0$%\LSXWAH+M,K2]X^9KE1M34V
M7,ID\2^_Q[E2U@;MHN:LOBJS2"N]E!BR,OV9%6J\.F,_OL,:T%7:WE9T3@
M    VI3=\ZSJM^J=
M                C F1#T-]YOGZ:Y>BZ[[Z ]3[B1O#TGKY/JNN.NM5HYF!
MZW3^\/P=;[QK$P/5FL8OJAM68RXA45UPN=W(A?LG,AE.;L/&:Y^U\;!VFZEY
MUL=O+Q+ U4=9Z?SD=)>9\?-T]H?,S\,UVJFVK&Q(W2<9LO(T]!IW']#7P
M               $R*E\M7E9$^8$8P  @ "( "4 "$D2,:3T-]>>NT>U=)-#
MHWTE%9I_<45R00HYCU9KMEXFD$!$0'L2A       !M2F[YUG5;]4Z
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MN^=9U6_5.@
M          $0&]+_ )FGT?8])42U0(Q(A"93*JE;=OKQ>O\ FJFKQ,JJCZF8
M2XIC)IB-MM6O5KLXT:>BT@"1!)"  NTXS9ES3T&G;7H:\
M#T)DRWIH]M2:RV./462Y9]D  (#-8KQR]1/BPJ:RDJ55GE6T1[]H0%^BJFL-
M5-3Z'J"4)@SJBK',$N49'*BI&*0  02R&U<E[#PLJET?M]572II
M&U*;OG6=5OU3H
M       1 0     1 ;UR?,TVCL;TM3+5 (1$  ! 1$!$!   1 !"1 %VG&;-
MNZ>@T[9]#7P               !&3:6LV,BQ7J?>-WK,P@D  0;25:_K",Q,
MJO*>DIFMPR8S'+3$KY$VK&ZXOM=3%HNZJBHXFY8A51DVQ8JP>PS$V93-=I6N
MC8DM"(  @DB65V+TFOBGSK7.PJB"         ;4IN^=9U6_5.@
M                                       !$ D0 $) C     "0-Z7O
M,T^C['I:B7,D  DA        !&2,!**075C-EW]/;M08_H;C"0 0   D AY"
M80@      #U)O/1[BFTWML"IB@   (ELA7A^/*;UFT58U;JJ:XKF7,I92*6^
M4K9C5<7^GIB/FN?4BF:N^%HNLK=:D5<VF?6"33EN,(N,4   "$2W%K,^FT=N
M=/4^0        &U*;OG6=5OU3H
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M&?TU8W@%5&2>00""2!)N35Y]#HS<ZBN\H        !M2F[YUG5;]4Z
M                                           7.BY#<.IVE+IW:8%7
ML&*[!;R=AJW>0"XJI-2F%J4SY2!*$PC %R52+;,3R""(A)?J:Y-@JIG9K378
M\*JHOA#,,7+EU<VO&M<[!GP    'H9EAY4O);&9*UOG8-3!4VY35@^!33DUS
M&7JL>DJ::V2NLFF:N97$B\45VBUS%PKICQ"E38C5&49G3.&VF8R*X0L'N9K,
M8B*W#JHR2^VK\O-<6N5I[::RI\@    /4FZ-1M*/66=8K*.NTB"2(0&U5>%Z
M]F,MW=-6G[!3&85L3:J6N;G.HBAJ+BFM=*\X>IOUZIJI\[IKPK#JZ,FE3$FZ
M0I;G$V^1$UF(5TY3LJF=8XY-.0S*9]Z9KIV+X 0"(7&F[#8.'D4NG=KJJN$
M        ;4IN^=9U6_5.@
M         &Q,+,DT,5S:'(M4>71..X]*^Y=#'TH7$I:^)H[!,7BCE65L*:DE
M&YTJ6D1/IYFOS%.%8E-.3W.)II9XID5=7$R+5*Z3"BRM.-X[%.06B5UP"5_V
M[K<RFTCM]34@   !Z&[]/MZ/4.SPZSS%*$FX**L$M!7W6J:7,)8;AL1E\:H\
M8K3&1Y3558Z%-+>X+XFSXS$7WR3[^8AJZJC:VQZ;FL<&49]=Z9QW6%49\F&X
M]7GT6D=SJJV2H    !$7>W<\[BU>THM-;'"KY=5*(0!LN:L/J:9\S*E%,HBY
M5=55DI"[XY%%5?:IDTTH7>B:*5"-2B-OF)EV56K'5-\\0G4]5?N]S%JR&8LN
M/T+Q./&GIIS_ ,S E"":J;EUF9;]+;;6U]MKM1         -J4W?.LZK?JG0
M                                                #.,7*DUEF_'&
MLO'ALRBO#;5*[WPM'F8E4I6TE,SJRY-NJ93\:IHN]_JJLDVF)5M+YDT58[9$
M5=WB;932O=KFE.A(F$J>FHDHE5LU4EF4WV\4S:=-33GNV=;ETVD]QJJF
M B-XZ?;T^GMG@5$0B5:2[A"GM]4U%S3(MD14S)2_1"0F;"F"J8W)%':T5=ZB
MJCMR*JAF)E;$^*67J9"%)-/HELW7YE+K;88%5:;MD     1&38]_QM#7;"GP
M_(LS\:R*)DJ8 'N#RAZ'D1$ $9/0\B(\CU! 0$0$4O,GH>$(P34LELW9&7XU
MV3JG9:^JQ^]8]P         !M2F[YUG5;]4Z
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MQ9GA"           VI3=\ZSJM^J=
M                 (BOHKAN'5[.FG4W(*42"44!, C$12A )D(!%" $4(B
M "4$GN:?.M,["J<2RL69Y     >ANK4[:DU;G8E73U4B$$LX58S?I4-\MK/2
MW'NHMHXK6R#+4X?;H7BS51>,]58#AU-.:54*6>4E/5-?XIB;J2NG,XQ"$R#=
M.JV%%HG=:>MEH      !$ $ $0 )(01   ! !$ $  1 0 1$9(00D0
M    ;4IN^=9U6_5.@ 1$
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MI2@
M             (@+I:NMB8.7(KHK(F((!&(2 $((B "(@ 2A(KIEX-E8M1C.
M1C^H                            R**E8J6B:4L(@    !(@      DB
ME7Q*YI8;-M+
M                      1D1**!" @D"0 0 $0  "1 $
M             3DLLBMA\VV8Q7)ED<4FB;Z$!<XGQ*/5%,1B)0F#P)@N<3XM
M$Q[]B @/8JTJ%#*XJDXK-,X*E*^Q4Q2:
M                                            $1     1  $   "1
M                            !>%2 HD,LBJEQ6::K-J:J2:F$\E"-"CW
M"9F^" A71/BDF)GJ$;RFEM2)UTA"BE*IBIG3,NC1/F1%/=T^+83J&4S"9MS\
MOBY##YMQ
M                                  "*4$
M   K4KW%3&IH9[%RFI3W,B/$V9A0H4J)EQ3*])F4J/<],NH/-E1/R:)I[9,3
M?</%OF)\Z%/[F?=6GQ3DSVB56Q,,?FFHOT5R-?U6JO*XN,/FV
M
M               "(@                         B,TBY#'YIC;%(("(@
M B "  (B B @ B( (@)@S.+D,1FB-(@
M
M                        >AD$5KHF$1 B           !$@$@CC,T*9"
M
M
M
M
M
M
M
M
M
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M.7F;FKOPA%J&XX(M/%,M0Y'!EIX<%? ]FK?%&_!/"$:R,M5K)^#0V:PALD?
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M@1<(T(ST))ZZGIHK@XCT))F7F1$$((PDM#3Z)/S(B"?1*",B21A'D:$Z$2=
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M9^=V933J2JDMDV3/J#[3+4<L@9#E$$I(NPDZ&I)&$IT[SA:E /0^_H-.W0:
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MDJDM"B&EIR$O'\,?L!,NH],BJS)$]PNVDC1X<>\O%3U(6:#H;XII9+"9C/?
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MGCT#W#I?R^(N01"0[J2DFH: _(>HT&@(QJ-1J?:1Z!#QI"'^(%VZ^-H+VO\
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M'G.YKH.$(<#R>)*2U)7EX\=SB^!RZ+HK#)G X9?!R,AXE_#Y')<:7C[RG6?
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M<1F$*U&9Q>!W$9.A^O>T!>0,M0ZCA-((] K^8)220HN(%Y$:=1H. @1Z$1:
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M]FO87;KVEVZC7MU&HU&HU&O@&""?R_<VUH(MF5KMHZV$6-E1G!W$28AY-#E
MC(R\&7:QX@G9_&:$S,ILXZ_!)U@=1@T. "+3M(] DR>2I/"?$1#FZ]Z3GM='
ML>R]O8U)&Q_(8U]&[A@@1\U)@R&HU[B1Q>?%H#+4S7H:CT"C'H#,*"@OND-0
MVDUG(7PI[C'YG?4B^#+X8P0+R3]SW6DNE88' EB;MBZD*QRUK3+*;*&;6X<E
M(1N."W&;![C-!6XZ0[N*\8=SB<\91[>R$/;>8\(&VT1D0JQB$7>:6:3?X5B2
M^&G%)-MSB[N[VUSU"]M!N^5B5[>QJ2-FF:3L]G;5[>?I&+WHTCEF^WQ#U!^0
MU&HU&H29#^)Z U$1FC4UJ(S7H1F6H7Y!1:D>@69#4:C4:@BU!%Q&DB9)YWC/
MN,?F<]2^R_\ ^?NFI)*)ZBB/!S#:]85@E:8+ JX@G"*Y(9QJ"T&8S;)>"9Z!
M3Q((FW)1TV-FI-U3<@H;_FE6O<D1T2$;M;6*Q=RURBSRH]KMKFL4:[Y'H(\K
MA"FTN!3!D.48Y9CEF.68Y9@VCT)H]":,<M0Y1CEF"09 VS!-GH39C@,<LQRS
M'+,$T80P9@B2T3SYK/NL?F=]?LG0:#3^7[R%H)25&YCL=!#R(/M)>1/AE'=[
ME[>QJ2-FF:3L]G9KM)/Q:/M!N^5B7@I6:0B<9 IY#WY#WY#WY#WY#WY#WY I
MY#WY:N7#:5?,$CY@D>_(>_(>_(>_(>_(>_(>^('/(.334%*-0U[Q'H$K)0XD
MC5 U0-4#5 U0-4#5 U0-4#5 U0-4#5 U0-4#5 U0-4#5 U0-4#5 U0-4#5 U
M0-4#5 U0-4#5 U0-4#5 U0-4#5 U0-4#5 XDCB2%NZ_>1ZR89=$I)*34V2HJ
MH%DAQ-G?(0(=,[9G88KRF=.W<^YMLDMMKMKFL4:D1T2$;K[4.8TYLKD]A=U_
MP6HL#TE?;RDZ?>3=C<MS$6I&2S9$S;K.&LL@K02@AE CR'"#>(K=1CCQ,I4D
MEEE-,<59EV+KF5O=DB.B0B-&1&1\#J#$_P#NOA"^RB/4'Y>&1&8BX[,DB/M]
M.<#.V3AAO;-D@G;:&0+;F$#VXA&%[:QC#NV0?VWEH$G#9[ ?BN1S^Y>:8DQD
M\*ZIGZ>3@&:NXI.K;%JQ9]!C/*0ZDR45M"4TJOFIE-SX:9*+.N5"<["(F2)Y
M+@B^ONA(;(A';U.06JE.$V;J.%<K\WB:BP+_ ,KN:? )+0&>OV2@] LO AUS
MTPZ_;J2\(6W\)@1:YB(3\QI@.Y+%;#F8LD%YH%9FX/UF\"S-T(S10;S-LPUE
MD589N(SP4A+I3<1@RA/VT(Q8XK,@ S^Y.]6W/S^,-C=QOE3P;7P'C-S[I#S1
M.IU.L>:62RR:L]VA;1M&))<1--&L1BT49:FZ7\JFC#J?YI"3-3Y_S2OS=^+3
M2I0CX'8.AG;.08;VQ20;VUBD$[=0B#^U5<\X>W4(+VXBF'=M$A_;>0D2,'FM
M"13OL&MA2.S4:^$1:A1]C#"GUR,%3 A_#XQ317H5N@D2? Q['7;E>7T+5.KN
M$>I&6G=J<0EV(J\ BQ0AMN.F7DT9@2<Q=4)-P^^.,@IT<9@U#4<0XAJ-1QCF
M&&)SC)Q<LDM")F+2Q%G-22L\9B6(M=NGF1)C.1U?<??';GY0^-E]QOU#&%?-
M5$<K+%,INSBDZFHF.(62",LKH^ &&WS0%RC,-.\L_=AQPUFD]#=<XS3*,B-P
MS/W8=?XR[(58_-.!MQ*>$+;N&R(E/&B!V0AHGLBB-!W-(R YG:""L[6#SEX3
MMU)4>2G.G0G.S#>=,F&LPB+#%S&>!DEPI>.Q)(F;>L+$[ Y+(D5CC)J2:?!0
M6@4>IC!*!JP58P4SF<OQ]JG=Q_;U+B"Q.HEC)\5<IE556Y9/1\$KX;<S!(DP
MLCPB-6Q(,%R:Y V^BQ4?HZJGIR/&G:9>+U#=I)G[<(XX>)5*QE6%'6IQ>H;M
M),G;AKFY%B5?"B46"19T6SC)BR,0Q-BX9RNF;J9.)_V!X?$9=F8#!E-V->Y
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M%Y#30*/4_#1Z']V_4:Z=F@L93D>16;A2HY5^X,20(MBS*$B$U($C$8;H>P1
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M-0)A"!S4#FH'-0)9I<;I(I1!S4F.:@<U YJ!SD#G('.0.<@<Y YJ!S4#FH'
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MS 'SF /G, ?.8 ^<P!\Y@#YS 'SF /G, ?.8 ^<P!\Y@#YS 'SF /G, ?.8
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MP..,Y1GN^M5DU[B..; [KXM:;T8XWE>#]%5$RF'UDY;+E7_33ELO&,ZZG?\
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MNYL+<+;>YVVL/M(T]A$#+P-IMI,BWHO^GKI1Q386..H_K,QO95.XFY62;JW
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MN7B^==4U&U<;>[6[NYIA*+;8_=/=RXV/VXG[6XWU0MI;W)Q+_8\WWVS"^O\
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M%;@6!C]?V@_7]J8_7UJ$[@V)")N&ZV[;;AUTN260XU-!P\>GG(PPW"D8_8Q
MI*D&-1A6&3<XL<?H8.*5V\&YS=@<Z8Y.>/[%U&*9?;858;2[]U&XR,RP"JS5
MG/\ :>SQ=V1">B*TT!'\-1_V[W]0A5U<R[E;:].L>M/(\FJ,*K]W]_[/<%7$
M-?N47D*"_G8S8;8;E0-R:O=O:U-TV\TN.LP7@18#LQ'@EJ8JL4>DE*N,>HQ)
MS>VE'-GSWCT(:EJY62V63!),S6A2#!]GF/(:&$-*=$>PE1#A9Q:11&R"BN$V
MF)K;+%\3L,ML<-PZ#A-=NQN6UP7URY;R ?V.VXII6U75!+IBJK>LRJ#GVQ\>
M[/)<(G4,EUE;)@_3X.D_MW"XG<#Z?KS*3Q#!*7!HVZ/4+1X&699W=9[.,]?N
M=B&7V.$6>W>XE9N-6;J[1MW:7H[D5P_+OD1J/&J5$.!?UQUDWOF,:KF(D6\R
MF7=N$1K5,>CX)6U-O'R^)18A(O%Y%A3]''OSUQ2FV^?LHR,?E8[=W>/2+^[+
M;)XD1:25*FSMMWXT>NQAVPKJ#&G+]FFP1ZXC4E(_1)J,&>N8U[@CU1%XM1MM
M!O[ZUQS&(.,L;G;F)C(R3(G+5P_LDB!)-0J\DF;,XSMSU.T.4%955=D<6]V"
MK%HR/;VPH'Y$5Z/\&RTX^O;_ &,R&X8PO:/',(/.=S\=V\9W*ZD+_- 9Z@_N
MAA^7V>$6.VVYU7N3 W-VDCY8BSKI-2_V:]I#$:GYE,X>$LSITSHOJ"/R[IF'
MHZ[/&]!'5P.[E-&N/1T,R]*CBFQ1NN0'L<DI0Y0[DS9$5^':V=B\R?\ [FJ9
M\AS*JIIM-K665'7RXSS$BHVW,CA175L8GMZXMV!%>7&Q/#WW)&.[?;;V>X$O
M$L0K,)@;@[E-(BY+DZ[%1_9>V.-%D%MN;DIY#;#:;<K+,9L6]^\8AV)' OHF
M1[&4%P62]/MU .RQ&77..U\AH'JDQZ=G\>SR'D-1Z@] A"G#Q[:7*\E&-=+K
M*1C."4.'HR3<6@Q4MP>J2^NE2YC\Y[[I$,?R&PQ>=M/O37;BLYYMO6YRQEN&
M66'2O+NQ+*5 &+V<J9!DY!8.'Y$??H[YVH<L<9K\A1944^J54YG'<B2\Q@0(
ME'ET1$&3F5.FOL,G8D4S.7U=K&L<S1*FM9M#3<P+QF-=IS14>Y/*,>C+QW+V
M8 CYE25C*<IC)H\4R6/11DY1'.BV9VVF7%77UT#'(6XVX:);689NJY,QZ_92
M4\1PTEMUB3BS<40VLJ6J>#>VSUY.Q?.;_"WL1ZNYL<8OOCA>6"5"B6K5MLUB
MUJ+;IJC/BRZ;[V.)VRN30BD[?7D4W<;FL@Z.60*CF*-G$+>0(NU.53! Z?,P
MFBKZ6YSAU'39BT$4>#T&-C(,QH\4;ROJSQZL&8]0.99@6&*-<&7_ %S^ZFHB
MRG8;NTW4:U.*ZHZ_)X>X.RL_& 9&D%Y]I:D,-/6O>_J>#%E/0E1\R6XA</'K
ME+FWR'BEX9:1S=J)S)J8=;,]4GJ-1Q$#/4>0+4S)AQ014SGA4X%>7+VW6P,*
M@5>Y! QJ-GN[+MFG(\JE7R]1J-1K]CD0Q?;VSRAFAVGL6KG<.WKLIL[#'9<,
MZFK=MYNYT]K&ZX:C4:Z#'L[R'%#H>J[,*P4W6#3OBKZD< LB@;F8E9B+819I
M VD&"220M:6RFYC05HLM]<#JA;]66'P1>=8-J^,AWUSC) Z\M]>HU&%?V$L_
M]?[K:C;#?.WP \0S>FSJ'GFRM7E0R?#K;$)';AO^W._U/#,-2'6#BY5.BDWG
M<A(3FD5P+MZ24%(QMX'"QDQ[#&04/&2!)QIL-VM'%$+)X[S]%@%U</4]%#HF
MLRW2@X^,QS]R2_:6KUJ]V']DU=>[:2J2J;I()'Q#<W!HTR-2Q\@JAM]%B*3D
MEPN]L3\$O(,V\^."R>X(.9#:.AU]Q\]? PK^PE_U_NQ19!8XU+VZZFH5F3\>
MOR*'F?3XV^+O'[+')&HPW_;G?ZGA>O9J->S^.@T&@T&@T&(;37^7#"=I:7#1
M<7T*B:S;=F;;HO\ ,2<2XXIU1GK]ED-FL=-YX>@O"*<XVDD(MZ9BVKLIQB5B
MTLP0PS"SO$N8?CF0-85AD6:X[AV.7R*W"9\VU+#\7F+K,#ER[A["\=MD38CD
M%_P\*_L)?]?[LZC"=SLAP%W!.H_'\E*; @7\7*>GBOFB%@=WB,)T]7-/@XL1
M^<YC&P^071XKM!CN+"XOZ^@:M]W4RE7N71*Y[.[*/-GZC7LU^RB&U%@Q(HC(
M+6E*:%"GT^ID1J/>.X;GVI@A)/VN"TUK+J)6WTYZR;Q]YQBZW*M9-';[>TBF
MEX;;?.I6W+BU9'G9$F]\/"O["7_7^[>HP_<[(\'5AO5'66(IL@K,C8R':K&<
ME.]Z<)#8NML<GH0I*D'IXFHKJJ=;+I-B\HMA0=/%/"%-CM9CS=[N!1X^,CWJ
MGR4Y%G9&Y'R29;66[VA3-?L/0:>$0HLAFX[)I=Y6G4VFZ#-S*01)(M=<CN44
M-7,E+FO AA%M!N:FIQ2DQ%W"+F+:286+8YCC\25#SK(<BJJ_(&:(Z_#+BLQV
MEQ>7?6'S6?X>%?V$O^O]W"[-JI;T*JQWJ5R>D7CG4QB]N*G):J]3:8[57966
MQN)V L.FV*L3.G.^:$G8S+V ]M+ES 5MME*#+;K*##>V.5.!C9O,9 B[ Y5(
M$+IMGK%=TZ44<5>U.*5 ;:8@-6NXF/U M][_ "RO=6?+$[/#TG7DRP/B%$?_
M *CN_P#WFOQJ&U+./C%E*!X3<$/T5<#]$W _1-P/T3<#]$W _1-P/T3<#]$W
M _1-P/T3<#]$W _1-P/T3<#]$W _15P/T5<$/T5<!.&7+9XADMHPRU_K)W05
M8WR_T3<#]$W +";@2,<LH8<4Z8)9I"E*4"4:1SE@U&H&\M1>)A7]A+_K_=PN
MS;/_ &5_^H1Z!BRE1CH=Z<IH2J.J2X9.LZG*>04+?;%)A1]T<6E!O-J!T)RB
MF6#R6H(+RVC0'<]QYD2-UL:8*7O=3,E/W\616N^EF^+K<SWIOY\\HI>0SI1N
M.K<!]M%_N.[_ /=_%$(T5V6Y5[?PJUI[-J6K-S<^<8_<ZT'[G68_<ZS'[G68
M_<^T(?N?:#]SK0?N?:#]S[0?N?:#]S[0?N?:#]S[,?N?:$/W.M!^YUH/W.M!
M^YUH/W/M >YMF8_=*VT_<ZT'[G68_<ZS'[G681N?.#&94EJ=KM['FLR8[D5?
MP&%?V$O^O]W"[-L_]E?_ *G9J#/L2ZM 9M)3!MY=9-G^NK(%G<\@>>3P>=V)
MAS-;)PI&1SY)+E/.@S,^S7L].Y1?[CN__=_%,M*>735,+ 85]?2;^1WL(QV-
MD<OY5A\AV9C;=!;Q:'YU:3ZUZOD\*B/DN&:4*6=1&K5L$VLR=C/,!<9]I*4J
M6;L=]@5=#$E8RY'>9+OX]DDK'G\@IHF;PG&S;5X^%?V$O^O]S=/'+LVS+_T5
M[^IW->S4:]FO9J->\?=HO]QW?+_S-/B=!MI2I?DY7>*OIX\^]M27%.C[<)DS
M'+IB_P MQVY5"R9NX5=Y?9)2G*<EMF\=RM5/ Q5>&N)GP<8L$T^)XWDR;RKQ
M?)U98,,E_+'V6Y]U5X98E3XMC]Z6;QG6S:7W=.S#[]5!/W(HR@3/7Q\*_L)?
M]?[FZ_ [9G_Z*_\ U.S4>OP!$-#,<"AP*%&A7S'=U!^]-"AP*' H<"AP*' H
M<"AP*' H<"AP*'"9>.9?),,+P-M);$6917:Z2X?9@5V65\^.QF+R"Q_*)V-)
M=OLCC1+_ "E>25N2N8@XS6PH<QA.&X?,8CTNV\MF).PV8PJOQJ$=-%Q;VLK&
M\<@-87'/'W'ZGU[YB:1WF''X^%?V$O\ K_<L@AM2S:H+&07Z8M!^F;0?IFT'
MZ9M!^F;0?IFT'Z9M!^F;0?IFT'Z9M!^F;0?IFT'Z9M!^F;0?IFT'Z:M!B3\V
M@KW<:M%*_3-H/TQ:#],6@/&K-)/1'HY^)ZC'\*L+T%08GCJ%95B\<_UO0#];
MX^&LYHDJG[@4TI7ZVH!^MJ$?K>@'ZVH#'ZUH!^M: ?K6@'ZUH!^MJ ?K?'Q^
MM\?'ZPQQ\(/"KL7^VTF*3B%-J/P\T/@QOP#/0>@U\R!F:@:U:<1@C(:GKJ/3
ML(]#,S4>H4HUE(R"5(K]? Q4^/$3\?"O["7_ %_N5H,0Q!S)'K'(J;% K<^R
M,?N=:D/W.M1^YUJ/W.M1^YUJ/W.M1^YMJ/W-M1^YMJ/W-M1^YMJ/W-M1^YMJ
M/W-M1^YMJ"W.M2![G6IG^Y]J/W.M1^YMJ0_<VU!;G6A"-N*U,5DN#PY<1232
M9^"1#!\-8>8R3.7YQJ6IP\9Q*1D2K/;KD1-#&HIL7:M*8&+C'T5D/N^0:;)U
MS):%&/R-2'H*+*IU$[:5$#.J]UI3*M/"O2*QQ'7O8IBC5XW78]CN0KQ.@0Y?
M6\,X\RBCPY4R4VA+W*7PXYCSN1.N-+0L<"M3:6.$]"2:APJ,EM*:"FEH+34+
M;6@55-$DXLIM:"+MU[#/05ZBK<+,_'PK^PE_U_N550564O,;=.-1#U,0<&2B
M/>X>Y61]2(B/4&9$*RIDW#E'5LVDM]LF7-2/LU(QZ#74(J)3D'T!'J-07F-=
M165+$Z'J,;QJ/=5VI C(QB&2O4,S<:A;K99^#A&._J&PSS)CENF-=!D[BJK&
M<?R&3CDJF5439$"DK<DB8IJG%:VEK*>FFQJ2XJ<BHXD.!E,+'\3>RO&(K:K6
M!28J[.P^!&NKVL8A7MABU<QD^2II(<F^QN!%R*U1CE%:YQ0,8]8C'KY_'Y>X
M-*S,8\'4;>2T75?807*V3V%V'Z35'&PJD<4S8*02<W<S^0Q;1*.+4YCB##!6
MN,9<[D,_![%R%-Q.S7D&18ZVA6275Z[C-^>2/5M'5-MR,1P!EMVOQV:FHQ2E
MR']2U>,Y(YF)8:LXLER%9V]9B$\ZG%:*\//&'$<I?:8J:YRVE[DS45S'CX5_
M82_Z_P!R2&V<9+]YE\E<NVH(Z)=INA*<=N8.3R8%9$JJO%ZJ355635+,*CIZ
M+ +2LD2<?BU>2Y!C^-PI#T69C.0C'**MBU\"-2YJSAN.Q'H=F_13H<6WJOTM
MC&/0WX2J:#DU=5P*6NH*BKJIK-8W0YH6/8_&=J:"IK:NFHI];84>+4D%NER!
M=%,A$9D,H4=CBA^ 7IB!)H<:6XIU0,M0;'ZTQW'L%=YF$083Z<>>O9+&+EIB
MZHJ\JQF5ALBMK,L,OE>ZQ_\ J-]+1 A9'+NW'Y5C9L7E[B5G*R*V_P":Y#H>
M09,9'EV8G_[EW6/_ -4&FIX8^5[1O(-M?@:BDM7J:7=4\;.8;S*V%@NW'+2%
M:U%9AT>ADT62-6N5JP^/+M(N21+3+L7GQFK#;^0U'O<6L(S.14/+Q'(:_%&Z
MNY8KZZ\RC)\<D9%)Q8X\NGH:AC%Z^-+8+#</EL,4>V\IF)/P><Q[6J2]6QL5
M]K+QNFKF,$CN+-Q?;'CN2G:RNB[?0;2Q>M9/CX5_82_Z_P!RL G)@W6>5JZZ
MVK9AU\S-J)_(9"\6C4]):Q5Y?0U,1>)X]DAI_2FV*DG88%!?J\BQMYJ>S78)
M,<53LHO<<PJFD8TO&H]@^S8(<MJ.EB/66'878R#H7;/*?93E\>%XOPWF.810
M2L?E8[*3+IH;"LGQ3%ZB73T6-1;:%6Y,TF?1-MJ>7G2DU-"?@VW_ (V'%VP;
M&36.6&3VEJB#92:QUW+;=]QFRE,M5UO,J%V5U-N%/V4J2B;82+%<BPD2VZ_*
M+6L;ES9$YW]87)LN7,YV2Z^X\Z];3'WY$MZ6[-L)%BOLVM696%TT3,[P?08Y
MDTK')#D:BSQ%G@-M7+<J)[0^7RQ\OECY?*(+ASE@J^60*'-2DJ^8DRKY@*OE
MD90)A&J!,69Q)RA[":0]E.!0)B3.%-6?L)FGL)9$5?+(% F),X<U1^PED%0I
MJP5=*(?+Y8:IY[PK,!M9ZF_D> HR#()60R3^ PK^PE_U_N4RZIEQ9QMQJJPK
MI-8Y#LY5><B2[*7%FOPERYC\Y:GW%H9?<CN.V4EYXG%)5*M9<Y+3RV%S+*5/
M-B0[%<F6,JP5#L)$$T27&G)EK+G@WW#0T\MA<VTE3B0^XVF++>A./V4J0J),
M?@KDS)%DYB6+?+AE^0'D,\_!F?\ G89W*6K3;R7V^2YJ0HL91<UR3U$&H3-A
M*QE":#74?*$_+%UDIN(",@1D/X>1]W:YE1R[9[GR_!U&H0M2#J=P;2H0C=V6
M/W?='[P.C]X'1^\#I MX'2'[PNZ?O"Z/W@=![P.F/W@=U_>%T?O"Z8_>%TQ^
M\+H_>!T'O Z8_>!T?O Z/W@='[P.C]X71^\#H_>!T'O Z8_=]T.;NRS%QGMI
M<H4M2C,_@<*_L)?]?[E:BOLI%6]"SVGMH_*PF2?L<*!P<+'LL+'LL+'L<*'L
M<*'LL*'LL*'L<*!0L+'L<+'L<+'LL*'LL*!0L*'LL*'L<*!0L+'LL+'LL+'L
ML*'LL*2&\BQ"D&29?,R!S7P2&WDENUJY<9<-[7MV_K(UM:8A25DQ^K5C.4#
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MQ^EI_@+ZQ7^2NE2M>N.F?I%WJK>G#=7J'WIJ>H/I&^C7_P H^IG_ /(C;_\
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MU$3565)9O0*BIP^ _&Q%?Z=HJFRQNT@X)82K&M"?ZWW%RNA1DE7MC?KQRY^
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M@R$ZI8/1?COV+,=9W<=)Q[!J4OXJZKDVT#;&<Y!+LZS]B[[J*VQ_^G[>0?\
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M/B-0($6I]W70,EHGO+/539:)VF=C'U\[F76*X[BW61FN'Y[TL_3J_P#COO\
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MFV^W]' MW)=7$JJS"\)KLCQW#LCD<6$WE+5.T3D>RRSP=",<"1RTCEI'+2.
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MC)I-<LG#B1N0?$0XB'$7PJ@7W??_ #=JV4K'MB!QU$#:60X%$-.S0:&-!H.
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M8YIVA V/&X_<HXV,.TA0L:.T]O5)*749J?113C\IVCO^Y3$.0;RG9+O\HZI
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M)1114.6?/B4YY^PY\N^EM&5O_"=A"('A=-O:-&Z'HD-;,DP&=1/NC]3S[99
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M=J@XM/SB'\PAM46@9VN/88+A<X:CV!2Q-;?^)2>-1[UXQJ*GB?M_XEQ/<<P
M[U%P)SN[H*G#!&9SNUR@P.=H@-L]BAA@,_<=9E^U1Q7%V<[A0.>6.$8A.P?.
M.X03].LG\( V=@@HM)9AU-%.D]E&>E#%$>\5CUH0!/$!I([Q0>:,%\ X" J#
M@+,MHTC(<;!'#[S?ARC)NS4##PQ$GUU(DD1A%SCZT;U(0:VBTY3W<_**%<?3
MT1'+-3Y((\^:^FVBLJZ/20S_ &4B%PXCQ^8]ZEB'2 =X7C_:WN7C_:WN7_,V
M-[E/$=H)&Z"BXDYS'HHE'#P(.Q-@S]U.9'%>2][CJR 5#(%?\SQ.,VL[_7N5
M_#:&N;[MA]OMA0AGU&C4:"FX@K$>9$2(7T\3Q@:'"W/:-61V(T!L9DV#L&17
M6R8*!;E/8*NAB*5!X)RJ,52%2J0J0J0J0J0J52%2J52J52%2%2%2%2%2J0J8
MJ BT90H#G'T:/M*^X(F!E:B3$SKW'*F8GE1$OIQ#[NBW)DF30KQ,7&DTDJ(_
M-E";YHQ(,RVH^OK1, 2 D.8,/#$2?74B21&$7./K1O1PQ(U1]X=^2S2CC8(X
M?>;\.49-V:CH9J(5*I5*I5*I5*I5*I5*I4RJ52J52J52J5'H>%4^B:5,J)^T
MA> 8"DU"/(//8 X7&&(![KC0_,Z@_B^9' QIX>)^UYH.2,LQ@;4</%$")@P\
M330?6@Q%2&-YD'#9&(;[SQEL&>9J%!0PS( 2 L5TR!D._F?5:08B+G]F2%E,
M5=;)@H%N4]@J41(A?3Q)/'[O;:-(R?XC3,M^'^-E6:'5'?=&2XP#:0/$>X95
M](-%V$(>N^E7*C-IM'>*T</$$6N$""B<1T6 R%9%4>U-):"6>$FGUEK7TC,D
MPTH>8I8[]ILS'?*L(%M2#3X@-8]G+<B8$QA5'EB)$(N<8DTGJCOL9Q/;KB=0
MB5*\[,/[H+APR<Y ["N%@&<D]RDUFH_W*AFH]ZH9J/\ <IM;M':5Q8>IWL7$
MUPU'M[%)X&<$;Q!180<Q!W?8P8C=(M%8]:T,1AB"BPTTM-A[K46.$"# \A^B
M8'LKAEL1#Z:0;4?*X\P1#V^M%*.$^J8/Q-J/8<J#A:AB-KIYDN6"AR1Z@[[$
M1Q'!N<J&&"\_I&V>Q<,&C((G68[(+_(XNSDE<#2<P*\,,Y"F0-9[E-^SVKQ'
M4J7;.Y4NV=RDXZO:I.U@CO4@#F/?!3:=4=RB(@ZE)Y.1W%OGM4,9FEO<?[E!
MK@#8>$[:=$?L5])YX'?M=;F->OD^OACB;3E;WC=F') KZC!(G4>YV]!XI"%V
M'U&3:=[3D-&HU*Z1_&PKZ>(<WKD41SB>2'(>AX&..@PUT*;0W.1V1*XWM&:)
M[EQ8AT-AVE3<XZAV*E^L=R][6.Y4NUCN4G'UU+A?K'M7"YIU]R\,<T]R@X$:
M"ICJ!<: (ZDW#8(-)F32>[K#@US@(T GO32?A&[H071)- 3G.@(&0'1P)O.L
M;/6:!OR*&'P#)-VON 43%Q.DE1(NC+W4KC)=FD.TK@:!E,SK*FIA4=#Q '/-
M</#F/?%180[8>Y0>TC.N!QA89CV:(*&,+IM$V]XVJ\P@BT&/V(^B\\3:/Q-[
MQNT\GU&#@=^TV9K-57(6.$8^O\$?6(J/?E0>3P.V+_:PJX7H5?B[':[59!7'
M4CHH<V&$TNS#>: HXA#/W'9+]RB^+SE,!J$#M7^-C1E $==*BX@9S!3<-$3N
M4@XZ!VE28=?L*DP:UX6[>]0NMV]ZFT;5-G[O8N)I&:![E,D9QW17"]NN&]6A
M<3!HX=T$?IF&>>Z"B!$9)[*=B@0I](&- @X$&,<TIY4'MI%J+G@"!A*/:2BS
M!A+WCV=Z#GQA^)L =@WJ%#A2.T(O?0-N10PY6 "\=H.Q7<=LX2)$#&J(E+-!
M##<&P,: 8R!-J+WF "AA"%DHN[MB_P FIS8;@%*1%([LBOMA&(I]0G'$ R 1
M$3EB3)7S%H^66LCM7T\23JK#W%7VPC$4^H3BX",KL(Z8S,@@PD$$SD)"NB%2
M<QH; &L'O37FD@'6(H-8 8B,XVY"%?? &)$M&4I^=##\NT\( )A>-%E "AB3
MM!$#LAM"#VT%?3PP":R:![5?$86W!#7!!N+"!K$H9\B)%0*'U V%< 8T5346
MD 60!]JNO %TFB/:38B& &,YQ["$#:.@@3>=\([35OR*$;K;&]II.[(H,$=V
MNA1QC'(WO]@SJ&&T-T=M*FI#J$'"*BSA.2C5W0487A:.Y7L-Q:?6D4'2KOF!
M _$*-(I&B.A7F$$&L3^PP^@#>!B(59\EL4+T(PG"B-<$<-\P?78CANT&T5'U
MKY('Q"CM&8HX>)1$PR9$?+8TQ1.L>NQ1]TS9E%ARMVB!0>TR0>*:^C@)DJ+^
M 9?%^GO@HN%\VNH_31KBJ@!H 5-XY.^A<#0,\^Y3<=$MRB><='.BQQ&8P4R'
M9QVB!4,1I&43V2[5P.$;*#J*@]H/K;2HX9AD,2-=.]1(E:)C6ICHG_*[<4S.
MG$4PAKD@[%H$Z"9U4(L<Z1$*'=R:1;#09)K*H$]B.)63#0$2:6S';L3=/\I3
M<.JD[AVHXII)@,P[T6&NC(:BFD6P.8R1SA1=[HCIJ[T6NF"C"EKMQ4<H0:Z@
M D^N=7FM .0 )^?L3/E;N";\O:5^8]B?G30*P"<Y3<04Q@=X3F60.NG<%?Q#
M=B8TTZXJ#8G,(;X(N$HDF%D2CF.Y!HK(&M !HE7 1UTIGYNQ.SC=S[^*8#:<
MPK1;A<#?W'35HUJZP1/K25>QN(V"CO.Q<( %@Y(=4FHP@;1VVJ,+S;1VBK<H
MX9SCW3G'J4&NX7V&@YCV4Y_L)>\+/BM^6W<KF&(6FLYRHE!S3$&@A2\0FT]F
MG>H&1'(<=GYNQW8[7:@:'--*^B\\0H/PN%'K6#!.9BB8,",O<:1D7TVS;N&7
MH;K0230!,J]CFX+!-W<-N90PF@&VEQTT]BXC.P3/KG4,,0RTGNWJ+B3GZ(Z.
MBX71%AF/7,H8HNY1,=XVJ+"",DU$"Z<E&KN@B81%HF/9I4^@?\KMQ3,Z="J!
MU&)V*X\D1!A"%.F*+BYT!.D?VH7,0QJ$0-[0FNR$:OXHMK!V'U*=&L0&E-T_
MRE-?DAJGVHLK!V%%YJ$4UHM&R91SA0/O C3(]BB42WWG&&DJ%A"=\O:.1^?L
M"9\HV! "IHWE?F/8GYTTBP#2)%-97&.H0[4]^8:HD]BB:28#)8,RXR2<DAW[
M4X-HB89HR1S'<F?,-_(S\W8G9QNYUQG$_8W/W:X*_B$D^L@*E>Q8@65Z;-^9
M08  IJ ZQ J]A<+MASBK0KN(('?F09C\3;?>'>-NY![#$&L?8" F2AB>8T-_
MN[M=B@%?Q# ;3F"NCA99;\W=1O7^OB&1\)L-FFK+GY/]C#'S#^KOUV\A#JUP
MCA,VG)9G&Y![*#XDW'?$&$X>\*M52#F#A,CWJ(F#SP_$X&Y?$<P[3M4,)LZR
M9N.<]E&10)B;!VV* -T6#O\ X=+I'27F$@Y%=QA'\0[1W:E>801ZTJ+1=.S5
MW:E,=QS%3YQ::Q!1:TF!D6B.[M3O]@&<(1$)0G)7L&8J@>(>N17'!\/EAK,!
MM*^IBTU"S*<JN'0;"HL!C:T7@?7*$<7') :(B,OVBC*FZ?Y2BQW\#:KV'$Y6
M]U.Q77AVD71V!7G3<=F0=Z.<(AI@0(C/$+Z;PXC(/Z@)ZT,7%I% [3W(AH),
M1("*)>TCAK!%8MY/JX<[1VA7,,. RB6MPEH0<07.=$F +H44FU0>"#$TB%B<
M6M<1&D ]R)P8D&R>MLYZ%%X.4NEZZ$&-JVFU%V&(M,Q"D9(4KZ?$!E%W;"\=
MJ+0TN K ,"HD$$MHKC"A,)8X .'NFW-R"Y2TQA;:BW#:X1IX9:R(:4+U,!'/
MRQ-".%Y<P%;JS\M@RTV*ZP1.[*2HGB?;9F';2HN4E/K=W$$1ZT*^SB;M&?OW
M*+)@TM-![CE5]ASBL>MOI[Z>'3L M*C2ZMQ[+-_)<;Q/LJ'S=U.97\0Q.[(+
M.6Z_QMIRCXN_+G4"N'PNFW)^'1NY+AT&PVKZS#%S3$"K-W:LJ!$C6+"B'S7^
MOB4>Z>SU[N;<PA$UV#.:D'OXWVF@?*.TSS*+SHK*@WA&TYSW=/I'37F$@Y%=
MQI'XA1ILW9E P<#I"OX,Q96,UN_.H=&'X1(NTPL->6"_RDN&B([]:+,,&=),
M.PE?5- $!E)[AS3G"=\O:.L%[S "DJXR3-KLIR6#7DL;6>ZTH-PQ 5VG.A%0
M'7H(XF!I;_;W:K%?88$>L"%8\4M[1:-WIJ"GR#$92/6&E?6C 5Q]TU@HX?EY
M"MU9S69Z<W-&(RD;<ASH8C*#L-8*+,20IC\)MT(B,85BOD@5]0>!TG=_KVH.
M$P5$2(F"H.DX2([>6^_A9;6[Y>^C.KF& T#UB37G*NX4S;5HMW9U$DF/4-(Z
MAPF(^$T>PKA,#6TT^T95>'"ZVW/WTYU=<.CBYHT1&Z"B&#3$[R5 <VZ\1%D>
MY7L,0)E23O/00'3E[S "DJ DP4"W*<NY7G2;OS=Z A "I0Y!M] 7\*3]CO;E
MUJ\V+7-.D%0,GBD6Y1DW>CYJ !.6':B+IE"<H35X#.#3!3X86UH/#I5RD;".
M8,3S8.%AD1GXR#1+W=,Q6$7._P KXR<X4 4 ">DVHA[0QYBX%@ <'FO*#[PK
MSP*&(TC$$#?A*Y"V-1%=1D;3!78F%,*H\\QB6FD9:B/6A0,FU-';:?4<PM<O
M];$H]T]GKW<G^RRKQ"T>OK)!S)@H8WF1E#/[O[==BO., /6 5T2;9;G[NH10
M@HE04NG!82#412$&8\G5.H!SV'9F5QX[QF41,&@^M!ZC*>:E1@9Y"H%IM"G
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MCQ2:G#*+;#H-4"UT"XTG(IKZA ! I7TL-U-8,(0]9A%LA$@ FM$.F1ZCDI4
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M-'$>8 3)L 7UL,BZ?>M]?8@YAF-4U]2)R#/7T@\NVKB=GJ';I"O&AN^KOU*
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MQ+"(YJ#LZF', ,3"<;,A"O6&*<'@" %$>TE7&B+M@S]ROB-W(T7=<.U##Q8
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MUVQWMCU,?,-Z@KKY0,#KFJ7:QW(M.(008&)%/Z4&LF&P.CU*+36)9Q/=%1-
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M2H.*I5(5(5(5(5(5(5(4E-0"FKPZH2OJV]3N_"8:#/O3<85BZ<XF-^SGP<X
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M2&HD(AQ +@TTY(=BI&M4C6J1K7B TJ(<-86(,-\ *(!IJR@J/U#^EO\ :O\
MF']+/[5'ZAU-_M0/U#^EG]J_YA_2S^U$?4,Q#PL_M3&/<71< 9-K.98E]I(+
M"",X1A$#,>Y8;A'QM-!J(R+%#ISA#0%A_P"/W;76G*A_CVN[U$LAI=WH$,$L
MKN]%F&(" E_%%QIO'<.K00:H=?.<[TSY6[AZ:PQ^$'7/M3M V#DDB33!1/+
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M8L,_,-W30*=C"5XQ,S3K56MW>@]PC @TNI&E0',_*.U.'XCN'6+ILIY*)%&
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MOFX9_"!J$.Q.SQU@'E.8H<V:@.@.9'H8O;$BN?842!,Y3WH#X:$'N/>B\>,
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M9A"\XT 3/KEH0Q/,P<[X?=;G^([,]*O/,-YS!?Y' 8=3!'6XUG8*K5P"'HP
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MY_70IUQ!1!J5X"6<*(D,JB:+0K\)(71&$4?IZ:.U<=.CL411:5$SS*+A+.%
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MHAU7>KI7TYPVT10(C.U!QCZZ%_D,S5&"+F55*Z*UQSRDP46F60[D(1G;SO\
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MDC^KJ!ZV.=B&T0_40WM6-B?*W7>)W#[E'89]X$:Q!!A]X.;JXOZ?2(9\3QJ
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MLN22GSASY*/V(=@&DB+38X>$]AR$HX&)(/-T@^Z\4;>$Y\G48%1'48E0'/\
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M7F$.!LFH@7#DHTM[H(NAPVB)'>-*F.@PO^XS^8+%^7M"PR:"2W2X$#;!''P
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M!!$B")@@U$&A0Q"!CX4&XH^+X<0"Q]?PNB*+L5?JK%H]:%<;$=J+GF5(0#!
M+Z[*:^_F_3P6Q-9J:+7&KU@AB8G'B6GPM^4?U&=D%>Q#"P5G,/4*ZS@;D\1S
MGL&WI\/YF[QTU_#):<G;;I09YD73\0\.D5;LR@X!S3I!];47X$Q\/O#-;OSJ
M!Z-V!YEK3? NW@/$(R!J+HU4P@H^5#<-X-=ZZ197#. FX^.]INF(#8F)JB2&
MPAF*'E6F+G$%PL:)B.<PAD!YH^5VY,_[@_E=U@8>&"7&0 K0Q<6#L4UU,R-R
MVNT"5,YN-#>TV#?4OJ8AB=@R *-BAUZ2&%YDYG_W=^NU'#Q0'-/J"#4<JCXL
M,^%W8ZQV^D5@>G'^3\R(L>(96GW7-L<TS&7(C_XTL+\2,&703]5I\+F"PC])
M!!F"F^;_ /+ /?2W!IPV?]PT8COP^ 5WZH#F/\GYD1:\0C6UWNO;8YIF-1D2
M$_R?F!Q-,C4]I\+VY'#48M,P5A^8\F"Y\;MP1/U6NIPX")-ZJ1@Z#A,)KRTM
M) -UT+S8B-UT"1$4&!(CR!PI"NFG<?:BTTA774%7F^$T<HQ,2+,.WWG?+_<9
M617T\%H:T>L2:SE*+,"9^*H9K=V=%SB236>H8?S-WCJ' 8MK::-%ARC3%<!@
MZMII'>,HV*^.%]M1^8=M.>A77 ^M8-G1P9BNA1.#_P"<.5UV*= :TZV@%7G&
M)-),SS?JX)@Z8C &G(X$(,QWW@#$"ZT3@1[H%O+'J@P\,$N)@ %>=Q8A'$ZS
M\+<EIKU 7&3>=3<I[ BYY))I)4%!9^O1Y!A8LV;6YLF35E+7@.8X:"/6@J\V
M)PW>%UGX79<M>L#T>0_%!(D0#$TP.JNQ$%SH6W3ZRIRBB*:S!87LCQNH,/P"
MLUSD:)1B WR[?J,())FUP-4 =J</,$-8:!98T9;3[(<L7R!43/.K#:%$3Y!C
M%K;X!:'0%X-,RT.I@3.%'/;],M9CX9X'F@M)XF/@";OO"1@X2DYRO,'U,8CB
MQ7">4,$[C<W$?><90Y8BBM?6937E%NBOD.%BTU>OKM5QR&/YP96X?:_^W]5B
MO/( 'K !76\++*S\W=1GZB' &>;M3<8@\)!JJ,5<@<M'8I=.'89(=&1%(0P_
M,P#JG4!V>P[#D7T\41%1K&8J\)M-!%?<<FI0/4"7XC1 P/$)'+Z]J,<5ME-!
M]?6*+'$@ 1#K2/=-ALJ-%D7M;AD$>$QD<]AV'(OJ.A')VBH[QR240)6KB,0H
M-D5><);NE#&"))@ *22K[YXCA,_"/A'::SD@OIX<WG]HM.6P:3E))B32>9F4
M#4H=?^GB38?VY1DM&D3I+'@.8X:"/6@J%+'>%W])_$-M(L'HT/\ +N+1&#B*
M9Y=BG,TJB: =$F-2, 14FXC&.D;P(!F-QRY%?A=<)%L;*\Q];4S#^)P!A3E7
MTL-C8$4=L:3O78A&NI"XH(AM';TWTW4&A7F^$[,B%R),8 "DY$W'QV@X@$J[
MO87"VJJU1=,FAM9[AE5[$.85#-U)S2)P,*:89%<(7U'";LZSJ'3&- Y!A8\V
M5&MO>W:*K% P<UPT$>M:.+A3:=F0]]:@>F>[RI@\"(!KR VV:D<3%C>-*X0H
MT* ;% XK'!KQ(P@T^T:PKPK7UW-%XUFH6#UGH"X9"Q040(J#]*(91&72#S&,
M/\CA('W&G^HUV"5J@V;S0+/Q'LMUHN<8DTGG9U'T!]'%/ :#\)[C793:CA8H
MBT[#41E'K)'!Q/RFIS:B.VP^C78.().$/X95]7RD7 "8]XFL@=FJ=/ TD"DP
MWV",HY4,7S+2&SA5&JSW31W4OQ'$'#(@&$1#R:'.!'"1DI,Y4)H@!;"A.Q<,
M 7J0*S:O]D" ;1E]B^HZ)*!:FG$;>PW#2TC)N*): 8"7K7ZUI^,2! 1G7W=Z
MCTT0OHNF3++&HA?5Q8.Q#J8+!EM.@2C&%+S0.TY-Z+WF)/KJZH'M\,1&FV:#
M15T]VLR4*^6X^;#2/ARM[17G41!S7#00CC84V'6W(>PZ*:>E+7B1$#F*+_*N
MNX@F(^%P^%QML=H,IB[<N@2)H@ZS3JRIQ\U&%%TR)TU0M3F !X)B"0+T11'+
MZVJZ]HAVH8;)!#RT8@49K#Z[$!,IF,T"1B015WHNPFS[4<9QA6?9W:ND_P!O
M&'"#P ^\X>]F;5:[-,O=34+3ZTHO>8D\^]Z"'EL4_(?Z?[=5BN&3A-CK#9F-
M!UU(X>((.:8$9?1D5=-!1&&QHO4P GGM4 $)*[5FG_!!F&TP-)J 1\EA"AL(
MB4"?7:HDT">1?1Q)1H<1+,;,Z$*E?Q)!HB<R^C@29*)H+LF:VW-3TT OKXP_
MR.$A\ L^8UV4"N,!-YH':<F]%[S$FD^A(E1LYL'38:19E&7?J41!S7#005]3
M#FPT9,A]9Z^EC)%I&<5*Z! !%HK4&&E7X2[4<=\WFBQL:!WU543)?C5TP40
M6RSH'$( .6:-QS3"J-.7*@SPL!C=M-IS5>L.B&'0T3>;&V9S0-=2@(-:T:
MB\T"318.\UJ//(4#0?0,0KKO&VG*/B[\N=?[>$.)HXQ\31[V=M?X<WHV*CRG
M&QF@M<(".V(*A  &0@O]EKO$9MRPI;W552HY XO(@("!A"%$((Q<Z<C,SS]0
M'G,<3IPVFK\9R_#939"\9N/A%OL%:+WF)/H6 K43SKCYL-/X3:.T=J+'0<UP
MV6CL*(I:9M-H[Q7TTN1N&91-*&$T2:/6.5%CA!HE$UIS6T D<DU'HPUHB28
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M.Q+!+/0-OH<E%YKZB&&AXNZ:6]VE8F&)D"\WYFSVT:>EQ/G=_,5B_P#Z[O\
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M-RQ?G=O/IK"'X ?U<7:GZ!J Y)(N-*BZ:AR$9$":T2%XAL1B8R*:AS3F1/+
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M=G&52N/:YAJO2ZF!D"Q#^-V_K\%)4JE4JE4JE4JE4JE4JE4JE4\E*I5*G/G
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MB-CK["HX;8:3VGK+&_B;O"<ZQI.H(]=&=#F1Y(*7)#DCR04>6"'++D,4Z[3
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M"'?;&YLI#D%N87B/D<#]SR/;=HMY;J[E-(X8(VDD8\RJH)/B&$N+K;H]DM'
M(EW67LFH>/V*!Y0>AD7PX6;OYW@O+Z3(F*PB2V3Z)>3M68=("'P8$V^;?L\#
M9$R;U="8L?HW+E?$JCP8-AL5];*$%!#M5B^BG,&2-8_XV"FT[3NUR1RR+!$I
M\'VCGRC!7;NZ9*\C2[C0_56 _G8^P[LVBC\J[D;XD&.OW;LR.BYD'^:<#TSN
MG&XY>SW$K\<#8'ZX[O[A!S]A+#-^=V6.PW:XN[%'R*7MD[CQ]CVHP8UA[LWE
MU.,^R[&VNF^IV<V&F[K76X[+*1U%CE%S"*\I64%S_P!*,/<]SKVQWZ!1U8PQ
MM+AOX$A,?_K<>A=]MHO-LD)*J;F%D1R/Q'IH<=*DC]S81=Q]IFN+8-IDO)/L
MK6/GU2O121^*NI^93B/</6ON<FYW H6LK M#;@\JM*?M7'2HB.'V;:FV[;[A
M!I>SVR(373L.24I5M73,X\.'MO5WL:0IP6YW-R[4_H8B #_SC#HPR[MW@NXH
M&K]C9L+6.AY"(0I8?2+8::=F>1B2S,222>4D\?<E_P )[W?V,:&HBBG?LCX8
MB2A\:G"0=[[2SWN ><^GT6<_PXP8_P#U6/U)WK/ZK><:)+?=HE>V>O$=H-4>
MGIDT>#'Z[[ETV6XG!>*YVIUDM'KP/8DF/3T1&/PXEW"QM1O^SI4^D[:&>15Y
MY(#]H.<Z0ZCE;!5@0P-"#Q!_<Q_5/<3;I+K20)KANI;P@\LDIZHRSTYNWS5.
M$W_UHS)OVYQ+VC1/6.PAH*FJ&AE Y3)1".,8P>[_ '%B3>KRW7LXXK'3%914
MR [4 J0.01*PY*KB2VW#<6L-L>H]"V^L$1!Y'8$NX/*'8KS >\?3>Y.ZW-@Q
M.IHXWK$Y_+B:J/\ PE.(]L];.W]D<E_6&WJ2OAD@))'248]$>&[S[:;>2\E&
M6[;4RI.'IPF6E&/.LJ:P,AIQ+O%I'^O.[L=6-]9H=<2CEGAS9.E@70<KCA^Y
M='8V$3SW,SK''%$I=W9C0*JBI))R &(.]/KM+VEH:/'L\+4F<<1Z1(OW8/*B
M=?G9"",#N;W:MX)MPM5TP[1MH5$B/'[9P"L=>)J&D-=6DUKAX=_O#;;06JFW
M6A,<  .6L5K(1SN30^:%X>]5WSN=N$^WWJTZ\+4##\5U-5=?R6!'1B+8/6Y"
MFWW;41=R@4FV<\/M4S:,GE8:DY3H7#=\/5S+;[1O=PO;)/:T:QN]689T2H&K
M_21\Y9E<X?NWWYL)+*Z%3&QZT4R ^?%(.JZ^ U'!@&J/W*T[L]R+0SS9-/,]
M5@MT)IKE>A"CF&;-P56.6).^/>.Y@FW>*.MUO-X HCJ*%+=370#P 6LDE:5-
M0HF[L^JLR[7LYJCWYZMW..'4I]RIZ/M#EFF:X,DA+.Q)))J23Q)/L[A_A"2R
MMH=M$7;37TDL:%I=6E4,<<A+44DY"@IGF,7O?G>;K:;NQL C31V4UP\H5G":
M@LD$8(4M5NMD*GD]JL42EG8A5514DG@ ,;5N7?2R:P_7$<LUM!*:3!(RH)D3
MBE=0HK4;G QN%GW0N;"V?;4BDF-])*@(E+!=/9Q25\TUK3$O<CO--:SWT,44
MK/9N[Q:95U"AD2-JTX]7W14V6;TO96;5-MMPQ,+5.90\8W/XR\3YRM2F)-BW
M.".X<+KGVZYHMU:O2G:1,,\JY21FF>EJ5*XD[Q[$9-V[H%LKI5^VM@3DMPJY
M <@D4:">(0D*?W*.T@U6/=FV<"\W)UJ*\3%"#Y\A'\%!FQS56BVG;X5A!!-O
M9Q$-=WLP%#)(QS/)JD;JJ**H\U,?K#O+-V=A$Q-I81$B" '+(?.>G%VS/)1:
M*/:6_>'?*0/?13;Y>N1YL+)JCK7F@56IR$GPX-_O,:JNYQ7FW7\"CS#5HR,^
M4QE7'TAPQN'=7=E*WFW74UK**4ZT3E21T&E1SC$/?/NCLOI>SS]KV<_IEI'7
MLG*/U))5<492,USY,L+W@V6VM[#:916&[W*5HDEIRQJB22$?E:-)Y&-#3]<=
MY[6&YVC6L9O["0RPJS< ^I4=*DZ0615+9 DD5L_6C<;:DO=B!+N!;MY(&T7*
MJ *1ENT!%<F"4'/C8+[N!MGI\&WV]X+EO2+>'07:,KE-(A-0I\VN-U__ (>O
MTGLX/UA^@^95^S_3,N.KS,^?DQ/_ /.S_P 4]C!VOZ-]WI^S_1?LO-YL^?!W
M3NM:1P;2&*>GWTAA@+ T(2@9WH002B, <B0<L#>MRM[;<=M!59;C;9FD6(N:
M#M%D2-P*\6TZ!\YAB7O9WTV7T+:H&C22;TRTEH9&"J-,4KL:D@9#PX@V'N]:
MRWNXW3Z(;>!"[NW'(#F ))X  DY#"WEY-L^WRL,[>YNY&D7(',P12Q]&3G,<
MU#B*U[][<UM%<5["X1EE@D(%2%D4D:ARJ:-RTI0XO(_5YMOZP:P$1N1Z1!#H
M$NK1]](E:Z&\VM*9\F+[N+:;3V.X;6T:W\DTT?H]N9$$B!ID9U8LK A4+MGP
MR-)-ZBBL=XBA1I)8]KFDDE55S)$<L<3/T! S='M(-^[O74MGN%L^N*>%BKJ?
M".0C(@Y$9&HQ'W%]98@M.\$J]BDC "VOM0IIH<DD;@4/5?YG'0+GUA^IBW9[
M,:I;S9HP2T8XL]L.)7E,7%?YNJT1:']R8;_OPDLNYMK)2:X'5>Y=>,,%?X[\
M%X"K9"V[F]T;6W.[)!HV_:X<HX4Y)9J9A:U.9URM7/SG6?O1WLNWO-QN#5I'
M.0'(JJ,E5>110#VNS=QX*TW&\CCE9>*PCK3,/HQJS>+$W=W:RL$V\/%M=O&F
M6F #5+0?B]FF@_3&-\]6EV]$N8TW.U4F@[2.D<P Y2RF,\]$/'DM^^EHFFT[
MP6P=R.'I-M2.3RH8CTDMC8T<55GW $=!O)<7>U>KJ:UVONYM5U):6ULMK#()
MHH'T R%U)4-IR6,QZ5.FI(U8GWK<H$6/>^[;W,D/%4DEM2Y"GCU'\T\<@>.(
M/4J(+/\ 4CK>7QFT2>D]II!IJ[31IRX:*].-GVWNG:[=<1;K!=-,;Z*9V4QE
M%&CLY8P,F-:@\F.]?]VL?SY<6W=.-BK;FVT66I>*]OI2N>65:YX?<^Z]G$#9
MI!MVV6Q%(E=AI0L!0E44%B :M2E16HL>[_K,N8-TV'>+F.RD1K:&$V_;MH5U
M,2+J52PU!]=4KRYXW7^\V/\ K"8W+UH7<:ON=Y<O86SD5,=O$JL^D\G:.:-T
M1KSG%[9>K3N_N]KW=V^Y>W@,>QR7"W:Q-I,K220O59""5[,IU",R>M@;?W^V
ME]JW7=;*026MU#)$]K>1ED254D = '4.E<S&0"6!)/?&*0%75-M!!Y"&N*X3
MN!ZL#!M]T\$=]?WQ@CEE:24T50LBLGF(NIF5B054:=.<N[][S&^[[?>O92S1
MH$$RB-)%D*K158ZR"% 7JU %:8[T;7MZ".W3=+ED1<@HD;70#D U4 ]I49$8
MM_5]ZV[G5%U8K+=I6S7D6.Y8\1R"4\/YS+KBY]9_JFMU3>J--?[;" %N^5I8
M0,A-RLHREXC[3[QHI5*NI*LK"A!'$$<_[DGZWWL26W<ZPD NYQ56N'&?81'G
M(\]AYBG\8KBW[E=RK>W&^>CB.PL(U BM8AD)9%')^*O%VS.53BXW_?[B2[W"
MZD,DT\IJSL>?X@!D!D* >VWCUEWB?8[?"MA:L>!FGZTI'2B #P28;N=ZWIMN
MN]TVT@^CWNU37PA,R*_5802H"RZ2=)KPKPPFZ=V'V?;MP4%$N+789[>10XH1
MVB6JD C(YTIQQ>;G9H)+[8W3<X2HJ3&@*S"O-V;%SSE!C8OZ2_\ ]<EQN?\
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M\YB6-0%]UJ,?_+'OW*)=_M82L$DU#Z;;**$-7SI$7SJYNG6S(<X'>?NQ$?\
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MTDBMMZD>^0H 6)A:9P#3SJQ4%> RQ!?6,[W_ '8OW*6MTX DCD U=C-IH-5
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MS;)9]T+F_N4W**YDF-])$Y!B9 NGLXHZ><:UK[9_4UWAF^SDUW&TNYX-FTL
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M^,8[S_W:'_6(_87NANDP>\BVT[-NUN& E4=EV0E'+21*,K4IJJ.*G AW+?K
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MY[PV-L;;<(9<_3+5AH$U.6H.F6G!^MD'48?:P'EV.\+3;;<M\Z.N<;'AKCJ
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M50*\..6#%MUJQD S 0CXP,7.[6,8-LS_ &D;4!ZH%:#C6F'@,1%P!UNJRD>
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MS=+]3M)L-#W6M=QWJ4#J-'$+:$TY"TI#C_HCA[;N=96.PP,.K(%-W<+_  Y
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M0GG Y?Q$X(.=B3B'=-KFDM[RWD66&:)BCQNAJK*PS!!S!&$[A=_7B@[YP1$
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MT>":4M;,BO5!49NKBG/EC;;+N=>7BP322&_N+QXI!%$@%-"I'&2[$T )IRY
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MPP4W&X!G'\S'UW\8&0_A$8:WV2-;9>21QVDGB%-(\C>'':WT\DK<AD8FG@'
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MV4:6MT0<@OV;$\X&:^%?(<,+F B(U*L#56 _%/+\?.,:7!4CD.(K* 5>5U0
M<[&F(N[MH=$LR:2!^+R^7VEMNMM3MK6:.=*\-4;!A\(P]MN^Y6,%O=PA+JRW
M"=('76.LG7*ZJ4\Y">0@C+&U+ZGYK<"W24SM:3/-ID60,C=JS-J.9H0QI0=&
M$V7UE.EEN79&*=IHB]M<BE"<@P74/.5@%KDI-:8/>S9[K9(KV,ZE=+\3E"QI
M6.+M'"G/BBB@YAANY7<0R?JJ1@;N[=2AG"FJHBFC!*BK%@&;A0"NJ+O)MZ]M
M"08KJW+:1+"Q!*UY"" 5/(1RBHP;'O%?V#6C49K;<I5M98VS'5+LI##,:HV/
MTJ'%CW!]54$$]YNEXD$TMLSR(JZC5GN'+&2F>A59AG6H''>P3Q]# _[7%B#O
M1L)!EC!22)_,EB:FI&Z#09\A /)@;+WOD@M>UIVMGN8T*K#YRS>9EG1@RMSA
M:TQ)NW=R[VR*>16!>UN&OIR,JJI#2NH)IE55/$\"0FU;5&]IW>M7+QQ.?M)G
MX"22F0H/-45I4DDDY6_]TNOS<6&Y[S:^E;9>W@LKI0 66-XG8L%.34TYJ>()
MPO??N]<;/;78K*C3711XS2M4MYGZC#DTQ@UR&>)NXOJ_D::VN.I>WVDJK(.,
M<0(!(8^<V0(R6H:N(-QWV[M[*T%K<*9KF5(D!*Y#4Y J>3/&WV?=W=K"_N$W
M-)&CM;J*9E40RC451B0*D"O3[ [A=]Y3:V\,CO9W94M&%D.IHWI4KUB2&I3K
M&NFE2O>OO;>;/=W:!:R0WM9' X:XX'K)0"G65LNKPRQ?;/MUQ9;-LFV);PV1
MNY8K7MM6O68XW*T1=*@<N=6 J!A+_8+RWOK4;? G:VLJ2IJ#O4:D)%1498V/
M;MTWW:[:[BM0LD,U[ CH=1R968$'PC$,'K(2UMMUMBT=+J1X!D3G'<HR@QMQ
M"LXZ1RD;;W9N[.:*)2T%EM;K.78U\YU+*"2.LSM7PY5NN]>\T6:<@)$OFQ1J
M*(B] '$\IJW$XMML[Y7L6W;W#&L4QNCHAF*BG:+(>H-7$JQ!!K2HSP>]\*[;
M<[B#VL<5C*UWUZU&B%7:%""*@D(%Y",6^^W^Z;?M=Q,9-=G=WL*2QZ791J#,
MIS ##+@<-:P7,$UE;[H-%S%(KQ-$LU5<."5TE<ZURY<;]86&_P"U3W,VV7<<
M445] [NS1, JJ')))R 'L7 [R,8MLW*%87F +")T;4C,!4E<V!H"14'A7%KO
M'?'<MGO3:+KA)O@L@#4.DQQN'8<*HRFF=5XXO4V=@]@+F86[ $ Q!SH(!SS6
MG'V4MK9&DED8*B("S,Q-  !F23P&(N\_K&B66ZR>';VS2/E!FY&;\CS1\ZIR
M!W#=Y5AA4411YS$#)47E/^1H,3PV5;:S%1V(/6:F8+D<?!P\/'#6T 92#I8G
MC\.*DU)Y_8I[XK[";IL%R]O.O'2>JP_%93DP/,<)M.ZZ;+>J =F32.8_\F3R
M_DG/F+8]%WB/LKV-2+>\C [6,\WY2UXJ<N:ASP=KW^*L3U,%RE3%,HY5/..5
M3F/ 03^S5/9C[F=R(4DNV0RRR2N$BAA4@-)(V9T@L,E!8DT4$X3<(%&Y]Z72
MD^Z3H-2U%"D"9]DG/0EV^<Q%%&)N[7=SL]Y[X@%?14:L%JW/<.O*./9*=9^<
M4!#8E[U=^K^2^OY,EU&D<25J$B0=5$',HZ34DGV%EB8JZD%6!H01P(./\.]Y
M9@>^.S1JEUJ/6NH/-2Y Y3P66G!Z-D'48EL+Z-)K:=&CECD4,CHPHRL#D00:
M$'C@OM*.W=/=6>;;934]F:U>W<_C1UZI/G(5-2VJF>/3A&]SM\G5GMPU-:'B
M >0\W,:'DIC_ .6^X[?)M]ENUL]O'>32=997!%.2E>3/QZM*XW*7OWN*6_=)
M)&EM[YB.TN(SFJHM*!N0\E?-5A3%E'ZI;4;;LUG(#-D.VNUJ-6MC4BM,B:GA
MP'4Q:_\ $;ZLT5KD0J=SAC%&( IK('*M*-T#\AJE6R/*/:#:N[ELTTN1=^$<
M:GYSL<@/A/  G$>Y[N%W'>11NU=?LHC_ ,FAY1^,V?*-/#'I&[3!&8=2-<Y'
M^BOX>'.</:V+^A6I! 1#]HX_*<<*\PITDXTL=*]'X<58Y^ZW?T)/S<>/W5=Q
MV6YDMIU^=&>(YF' CH(IA-N[Y(MM/D!=1@]DWTUS*GI%5^B,=E<+%=6<R@C@
MZ,#P((^ C$FZ=V%:10">Q'W@Y<OQA_&^EB?<]XC,?HU=&O(5 S/BQ+=DUC4Z
M(Z<-(QG[C>]T^_MG:7/ZRBC%F]U&II+&Q)1'.:,X/(1JTA>) */ZO8+?:-V1
MP6+M*894TD:2 6"&M#J52>-0:Y6G>SO;?VDBV+F6*"S,CZWI12S.B4 )K0 U
MH,0^KZTE5]QO)HY[A%-3'#'UEU<Q=])4<RD\WM;?^Z77YN-M_P!ZI_42^S3W
MK#M.T0O<7EPP2**,59B?\LSP S.6$WS? EUWB=<WXI;@C-8Z\6Y&?Q+05U?:
MTGW!UK#;J<SS,W,OQ\G+0[EOD^N8UT1@=5!^*HY!_P"DU./1YFI#/U*<@/)@
M7D2TCG4,3R:O\J8KR^_0\9(8&H(.8(Q%W;[^RUC-$@OFXCD EYQ^7Q'SJ^<)
M-EWZ%+JQG4,#RJ:=5T8<&'(1\1QJ;5<[-.Q%M=@>/1)3S7 \3#->4#]D.GV,
ML4]CJ^TIY,4/L6'?GNI+V6X6$H=0:Z)$.3QN!Q1U)5AS'*AH<0^MB"\ALMH[
M(M>FYE51:2H!VD<K&@!4G(Y:@589,,7'<OU(O+8[4=4<V\$%+F<<"( <XD/X
MY^U/)V?*9926=B2S$U))XDGVEAWZ[JR]G?6,@;2:Z)8SD\3@<4=:@^44(!Q8
M]_.Z[UMKM*21$@O!,N4D3T^<A^L*,.JP.-S[L=^I8K3;NR,ZWTI519RQ@E)P
MS$ :/G5(#*64FC'%Q80SQW4<$LD2SPU,<H1B Z:@#I:E14 T.8&.G$=Y:.T<
MT3AXW4T964U!!&8(/+B3N#OLJIZP.[L9>U8FG:,JT5J?BN!0T\T@Y'0M;KNY
MOD+V]]9RO%+&XHRLIH01T'![H=Y6$O=C>&$,T<E"D;OEJH<J'@:Y<*T&JH[R
M=VU,O=?=ZSVLJYJA8U,9/17*O$4XG53V$W?=M=CL5:]J1]I,.:('D_+.7,&S
M&%VG8;=+6TC%33B33-G8YL><DXDL.[!669:AKELXU^@/G'I\WZ6'N'E:6=SU
MY7)8GRXUR$ECC+W:[^A)^;CQ^[5P!8/VUB35[64DH><K^*>D>,'':;9)V=VH
MK+;2$"1><C\9>D>.ARQ,D-+>\E1E,BC)ZBE' ^/B.GAA[>^B94&8/$$5X@\H
MP?<:CCA;;;-]N>R1="K.$N %Y .V5Z4X#F&0RP;6ZWZ=$-<[>.&!LQ3SXD1O
MARX\</=7DCRSR$L\DC%F8GB23F3[5>\'=:Y]%OU1HQ)V<<E%<4(TR*RY^#$>
MU=[]P],M(I1.B=A!'1PI6M8T4\&.1-,5'CQ08RQG[%3PQEC/W>'9MFA>XO;A
MPD4:"I)/Q <23D!F<L"[NM%SO]P@$]Q2H0'^;BKP4<IXL<SE0 [9MNF?>)%R
M3BL0/SGZ>9?&<N,EW<RF>]E.IY&-37':R-5S@2IDX-0>D<,,[YW$:D#GU**_
M#@J_$$CWY3%/8C[O]Y6:;9&(5'\Y[<GE'*4YUY.*\Q>RO4BOMKO8A45U(Z-F
M""/*",P<QGCTJUUW&PW#D6]P1FAX]G)3@P' \&&8SJ!^QP"BK'(#%O;0;%-;
MQ7*=JEQ<%4A"T)!9@32H&0I4\@S%5F_5]LK,3]FUW%J&503G3/P\F?)B\N^\
M>Z6UCO79@V5M']K&7%21*XI0$4 TAB*UIU=+>E]\=T.T[YVQ'HXC2:/LP10Z
ME>I)SYJ'DIGB#>^YUA<MNVW+&)YHU9NW0^?+**F@'$$9<!QXUQEBJBN>/3-]
MK96.@.":&1M5* +R<:YTY>7+$=SN\8OKF9@W;NO5C0F@4)G0@9DGQ<*F6#;U
M6'2_V=U&JBAIF6I34#\/1R)<0:+U"',A@KU-/ ]:A((SJ/\ TD<V)-ACNIUV
MR659Y+42,(6E4%5<I726 ) )%0/;W W1)KSNKN*'TRTAH765%/9S1!B%UUZK
M5(#(<\U6C6E\YV[NS&^JWVJ!SHR.3S-D97Z2 J_,5<R?9LN^W=V1EEMW EC!
MH)8B1J0^&F5># &AI3%I_P 4GJGC1G:$'=X(AULA0R$"M"M*-QH!G30U:BH(
M/D.+K_AX]9<@:_CCKML[YO5?,8$\64FA_&K^6U+ON9O\3)=6\A5<JAU/FLO.
M""".<$<^(N\_K!BYG@V]AY&F'^9]?E7!O=QD6"VC 51SY9*JCB>8##6\9:WV
M[YL(/6DYBY'YHR'3QQ2NA#\T8H.'NU.3#Q.]'4U&)=L#5$JL*\U13!NFEJPK
MI&>.MGCI]V.]1,T;6YZC*2"#2M0<'8N\16WN-6B*X.4<AYF_%;I\T]' MMN\
MQ"2,@Z6RU(3RJ>3XCRX:[MAVM@U2DJ\#3.A'(:<GDKBAX\WN^HXMXM@V2]G6
MZSBD[)EC*BI)U'*@H<Z\PXD Q2)W>N/M795!*@C2:9U.0/(>!X\"";;=X(H)
MKVXD"/9K(-<88T#,QHM.4\H%#QU!=OO-_P!ZU0,(WN[1(0DV8JT:L690:Y5Z
MU..>/U39-++MMPO:0R2+0BI\TGA4?^CF%:XIRXC?:[9FA:309#DJ\I+'F_RY
ML-NF_P _;;>F06(=8L.->8'AEPSZ*K)W6=8[D(K*Y8Z"3\QZ\,^!XCE%,1W>
MY6Y,,B:F:/K!#S,1EX^%<N:N7#W2+;]OC::YG=8XXT%69F-  !RDX_6.YJLW
M>&Z0=O)Q$*G/LD/-^,?G'H P=JVDK)O$BU'*L*GYS=/XJ^,Y4K(=;23R$M)*
MQ)8D\<SC6YJ>?V,L"QE-89R*#F;ACTB 4AG&H <AY<5Y_?V>%V;?':;896X<
M6@8GSU_)_&7QC/(O87R1WFUWT0J*ZE=&%0RD>(@C,',9X['K3[1<DM9W)'$<
MJ/3(.O+^,.L.4#/]C;[;^_%I;WM^ML)-O@N:,C,K5D(0Y,RBA%:Y5-,JB..&
MBN .L<QY,&-N(S:G+@4RX,& YNC#/(:JH)HO+7Y,2V-PHGC:%X'23K(8RI&8
M/(<2;/NOV]A<@S6MTD;+&ZL:Z:D :EY0.&7(1BVV_2[B:5$*QBK$$T-..>!8
M2;1$;J:0R!I2#1 H.HD];57A0_OI<6 C8F9Y%C92)'51D:<"!D?\AB]_62B=
M9(6>U*1T$;OD=1KS<!IY\^0W%O<H4"$&E0.UKF2HK7HPTMRI"2 HJDT*TXCG
MSQ=66P%C:QOIZQKUOG4/-7W9NX7?!A-W0WUA!-'+0I%(_5#4;*C<#7*M#D-5
M?UYW=4S=T]YK<V4R@E4U&IC)Z*Y5XK3,G52RWGNN9!ND,RF 1@EF8FFG2,SJ
MK0CE!IC8^^'>79H8.\=C9HDLK$._:D5-:=4E#6ASS+,*5 ';WIUW#@]E IZS
MG\ YSY*G+!O-SDUR9]G$M0D8/(!\9.9Y<&24U/P>\",13H>KJ ;P5P)T/5(J
M,>A0G[*/C2F9QD>&*^Z4PD,>;.P4>/ M(<II%('/4Y5QJ/%N.(]B[TLTVV9+
M',:M)".0'E9!S<5Y*C+!BF$=W87* \C(ZG@01\!&&WK85:;;7/)F4/XK?@/+
MT'!#"A'NM6X8V;;O6!!Z3M%S.(66E5#ODA8?BZJ5IG3, FF+?:]FCCA@A51&
MBY(B**  <@ % .088/3JFN399X8.-5 10Y@CIP9X&TSJP9:5'#P\^'L=JFCC
MW2VE-S;,XU%G5:-'7B W.O*!4$98N=BWF%H+VTE>*:)Z55E-",LO&,N;#]]>
M]VUF[5.V%9GTQ$4HFGCGJJ.>N8S44E79;:&"WBB)$5244O0 5&6HY<.'"H%,
M6^RW+0K L3HUFI"ROH JP!H=()&HC@#4UU5Q+!<CLH78NJJ.JP)K1>BF6>)K
M2_#F.=65EY50#,%?\CBX3; PM1(RQAR": _Y<I\)Q4</<J#CA.^?>:+_ .-W
M*5@B<9VT3#E')(PX\JKU<B6QZ/:E7W:X4]C&<P@X=HPYAR#YQZ <2R-*TL\S
M%I92:DL>.>*UKBOLB2,T=2&!'.,\&9,[F)30<NH"M/'@J^3*:4]_TY,)W9[P
MR$[).U(Y&-?1W8\?H$^<.0]8?.K-W?WM!+:7"U5EIJ1OFNAY&'$'Q&H)&)N[
MV[C4%Z\$P%%FB)ZKK\1'(:C]B\_8V??K"2XBDMKN)V-JFN4H&ZP5#DU17(Y'
MERQ#N\<4EO'+ LYCN08Y5!4$:D.8/..*G(X!2H51UFID!_EPP.QMR(&%%8"G
MC!Y>G"->!76;24B(J0&RJ>@#//\ ]*VR1EK-3U)T.1)S('@QM,_JVMX]RV>R
M[>_NR9E6<-%%P5&(J "W5%6+4 %:U_\ F':">VL=IFCEBD2/49G5CJ11S"E&
MR(SIRT+&36T@%6CTU/, !S#%M!N!2WDLXZ1ADK1&Y&'&M#X<3#NLHN-GW?9C
M/-(&96AGM%)R4G02[.*4STDF@\TV*[]%#")K@H&:(%@*:FJ1P&7BSZ<;GO6S
M7%N\D"AAVKAD!<T(15/'F)Y2!QQ)=W&;R,78]+&I]VJ,7_\ P[^MVY1-RL+<
MR[;>S, P6,$J^IB,TX-4C4#F3K:DN[;BZ7N[EG6.50=$4=:#14 ZF'%B :=4
M "NKLTI+N,BUBAKP_*?F7X3P'*1)>7DIFO)<V8\G, .  Y ,&20U8\OO$>Q)
M!*?MD5@G#E&6&F?,L:^[5Q^L9A]E;FN>68SPW9G[*,:5'3RXI[ L+W5/LTC5
M>*M6C)XM'7X5X'H.>%N+=H[JPNH\CQ5U/$$'R$','IP^_P#=Y&DVN0DL*U,1
MYCT<Q\1SXT.1]TJ,;=-MFL7:W4+1F.FH,'!!%2!Y<N?%I>]YK-]LW#T5)#!*
M0SDD>:2.J&Y^8Y&G(;A8C*T;TT$$DUX5Y!X\#M8UMV4U)IPZ".G#;1(VL15&
MH"H+UJJCFXG/*@Z<73]^=&VE(3)#.[Z(:@9-JK2E.7CXZXV_<+#=X=XM>]LL
M]\MY%$PB2,OJ#:Q52K(05S&K@FOCA>Z^U2O^KXZDZI%+:V&9('P \ 1QP]RK
M=G8WDVE<PSL4KGER5ID>/&G X[D][-F=#N$4TR7;R K6%T.HMR]  '\) *XM
M]O[Y7\:1I,3I K2//@23R"I&KIJ:&NX]X>Z=] K2%8D&;ZV/$J&X C.G 4H?
MQ<&1CF:GW-/6%WDBKM]N_P#88G&4LJG.0@\50\.=_HYONEY1I358(JT,CTR'
M@'$GD'308FO[R7M+JX-9'YAP"CF &0&#SXK[0 8;;9FI'.1IK^,<L%U4]C*-
M2GDKRC]@*<F(^X/>.7/);"9S_P"I)/\ $^K^*,/MLFF/<H*R64Y'F24\TGCH
M>E&\3<5&)]IW.)H;NWD:*6-N*LIH1_EQ_8NF-G[V7J-+;[?>PW$B)2I5&!-*
MY5YL6N];#<P/MTL&3H 6-5!SIRC@1A+-&MT6[<)JN&5-1TU*J&H"2 30<@QO
M/JSWF);.T0&#9^H-326Y82EV!(!H 4% * BM:#"=Y=VO+2#:+92+F[>9%1 *
M@AF)R/"@.9R %<7%UMVX>GZ)9;6&TAMV[630#I;K4 1C2C]/#$O_ !->L.9W
MWGO*KP6=B9"D5G8,X00B-RJNSZ.TU::D<*XWSU+^KK:/U9''&L=M=VEP4[%I
MB)9" !6N96NKE/-0V/?"?<K2'<H(U:]C,E&C9,B=-2:&E1Q^ XN-M[XP46Z9
M%CW"<_9R-2G7&G[,<!4UZ:#%Y-N$%JRW4<;6\JR5"PL1U00/!7+\&-V[U)N$
M,]C;K(>RJ X3201IY"!YIY:>+'ZMVPN-I1PZF04D<TRU9\!7(<GQ^[".,%G8
M@  5))X #"]Y^\25WR=.I&?_ *M&P\WZ9'G'D'5'SJ]G%27<I1]E%S#\=N@?
M"<N<B6>YD::[F)9Y"<\_BIR#DQJ8U/*?>5?8I7W=8D%2QTBG3@PU FD4CPL1
M3%3QK7Q^T%O<%IMGF;[:'B5/XZ<Q'*/G#IH0)HC'=;?=Q^%71N0_A'$'IP=X
MVI6DV><G2U*F-N.AOP'E'37!]SRQ;[K:DB6VF29"#0AE((S%#Q'(:\QQ:;O9
M3=O?1(L<\*L 59 -1*C, 'GZ.0@F2W[T;G;[=<3QNXB?KZM"$Z3IJ:-T MS"
MI%=[M_7;=QKML\YN;*XT'5&I) @""HTTH%SJ,];.*LOZR[G ;YN6\()(3&3&
ML4=:$R#B#S*:&O, <;;M6_;5)MOJTMZW=W)/,&-RL>21.^6I#("615&JA#'2
MK5N(>X)L4N[,QVEFP05JPI(44C( 4H ?" .%]WG[_3S7$=];K"\<("J&C $;
M!.%5'+YQJ<R3G:W?=JU[?;(#]M%>4)F##.E!U"!DK"M?G!@=.-L[][;O*6US
M>VLJ361AU/ 5--)TUTDGK?E4^<&0F^WV#>)!N8@[:VC?609(Q314Y"OB'Y7*
M3<[A2.&NI8D/5!Y\='N4>TKJ3;X:2WLP^9$#YH/XS^:OC:E%. B!+7;;&$
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M"1]K&\CL!7(T9:4\(-L_>6\W*/=3&OI*V\\'9"3YVC5 3IKPJ:TXX"("6)H
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M:L-H/1H^;4/./UJCP 8+<IS/O#7"Q5N<8U2,6/.37VE<":ZJ$Y .7 @@0"G
M\N#))R^S3%!PQ3%,9>Q7%,5]BIPUW(.L17#2,:DXKC/V.TBZLE.3A@Q2BC#W
M('FPNW3M6YVUNP:O'LSG&?)51]'%EWSMEZETOHMP1_I(Q5">EEJ/ GNNV?W*
MV_JUQL__ )AM_P#5+GW.QD==,M^TEX__ #ATH?J*N(]F1JQV%LBD<TDO7/\
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MMUA&TMS/(L44:YEG<T4#I).+'9V.HVEM# 2.7LT"U^#%M!<MI%_;3VBD\-1
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MCR6=V5+1J)#J:-]-2.L2RM2F9U4H*_XN[UW>SW5XH4M)#>DR/I&6N*W>LA
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M^\+?^7C_ ,2;/_WA;_R\?^)-G_[PM_Y>/_$FS_\ >%O_ "\?^(]G_P"\+?\
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MV\UW>2DB.&"-I)&H"3I502: $Y#ABGLV]]>VTT-M>*SVTLD;*DJHQ1C&Q%&
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MO(Q .+9+9F6.@\W%I!=Q-V E6DA!SS'+AG< D0K3RMAYM<AGK0J6)^##SP9
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M1BP[\]P+F2][G[HXB7M7$KP2LI=!VB@!XY%!*-QR().1-KW3@U1;5#2YW.Y
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M!#9"E333F.M7&X=X^YJ17=_%8R7=FDBLT<I5-:BBE6.H< ",R,\!5VW8R3D
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MMFD5B[<H X>7!EC! !IGAH9$<@U4Y#Y<9</;0[)LD1FNIC15' #E9CR #,G
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M9X!4O#TKRL@\J](S%7S3D(]]GZ9^(8?Z1^/VF>!MFR1]44,T[5[.)3RL>?F
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ML=@K3LP:23@<LI')^0,N?5D13]ID&^;+*8;RW<,C#X01R@C(CE&!N%K2*_A
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MT905N;A3YHY44\_.>3@,^!AB.BW3(*.7&7[%!5S)RIB&YV20)N=Z_:,CYJ>
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MI1''P5>+.>91RG_(X;M#Z-9+4I#JZSTX%N<_ /AQI=M, X*/8S_8IKRT"QP
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M<N5F04[2,Y21D\CIQ!^ \A(PVX;218[CF:J/LG/Y2C@>E?&#@VN^6[1@GJ2
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M\^@_S,742G,0O'QUP4L(P#^,V>";F4D'D&0QQQ:?T\?YPQ:_T(^,^_@J DG
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MP#'75E'$5!&+S=I$K=1RD(V=0-*_+@&166O."/CQG[:Y=LFG+TKT@#!]W?\
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M7_!CK[A(?!$!^$XROY?^C7Y<?9;DP\, /^>,?V6]@?Z:LGQ:L:K:..8CEBE
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MRDZ:D\IS]J^]]V8Z-FTMLHX\[1C_ #?J\V$V+O$Y-KDL4[<8^96_)YC\WP<
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M!'!$H5$7@!_EQY_;[GZR]NWCNS!LS106>V6]W=WJS16T"9!PEFZ@M(9)" S
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MFC&^]\MRB:*UWW=QZ$6!':Q6D?9M(O.O:,Z5_&1N;V[12 ,C A@<P0>(.-<
M.BWE$D?Y<+\E?HDJ>G$=W;MJBE171ARJPJ#Y/W&)]TN?NX(V<CG(&0\).6!?
M7_72-VNYR>!.JH'C8C+FK^P3VMTBRP2JR21NH965A0JP.1!&1!Q)N=A9[GW=
MEED[5TV6[6.(G.H6*XCG1%)-=**H% %H*@C<MT7>]_565EM]TOD$(*UXBTAM
MV8$D$AF(.D"E-0:VV+8;:&RVVSB2"WMK=%CBBC045$10 J@9  >X1;_"OVMJ
MW9R$<L;G+R-^<</M$S5FLFHM>6-ZD>0U'@I^XQ;[%$W7N6[20#\1. /A;/\
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M&56*ZHI5;267-^]/>K8Y.VVW<]HV^]MI!\^&>YMY(V\:L#COO_NVP_KGQO\
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M)/,/8H.#K7QCW?8ZBO5MN2O\^V)MNO%#Q3(R,#S,*8W?N](Q*6LVI <Z5JI
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M<2!#(0**&( /6RY>7$6[7%PVXVS,IEBC57H*YY 5 Z5Q:[KLY,,D\L=0Z D
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M2E>;IZ<7$EZRBRX0H*5\)/'&S=^-BGGM;F&Z$+2Q)VXT,&ZC1,"M&K74:%2
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MAC]6F9/2BH<1UZQ4\H\F([2YE5)I?,0G-O ,-V]] I4T(+BODXX?=8[F-K1
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M+%66,>9U 26ISTQ<7T&ZV^VPQN5AA/9EFH.+:JFA.6-W_6'9FZMTEB<QD%6
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M(*F2-@AYFIU3XCB7NSN#?VJQ(4 T!TGX?:Y_ ,(35FD.E HK4X2(6Y)8YT/
M<YPQBJ"IH0>CV,B,NG]EJ,XKY<9O\!QY_P !^3'G_ ?DQY_P'Y,>?\!^3'G_
M  'Y,>?\!^3'G_ ?DQY_P'Y,>?\  ?DQY_P'Y,>?\!^3'G_ ?DQY_P !^3'G
M_ ?DQY_P'Y,>?\!^3'G_  'Y,>?\!^3%(W!/-[8GIP3[-\3_ /99OS#@U_\
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MVN"YB9FDD*$.9KB8$4&5 /#CN[LWJ^L-FO(=WM+FXG.Z07$K*T4BJH0PW$(
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MEN-MV>XW>#;MTE@=(YK97F$4C:G5T7LR:L2K  '(X+OOO>U545)-[MX  _\
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M616=F85 R&0.9Q'MV[P,UO*">V*$Q*PY&8>:>8FF+6WV"XDN=OE#^D19211
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M3%?-J>1>4X07]XFXV,BT>L21/&W.--*CHX^U$(S" ,>@\G[EY1N!%,&VF)U
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9"E&KE4URRYQ^Y=7]TGCCC[UX_P#YS#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img117130267_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117130267_1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )*!>H# 2(  A$! Q$!_\0
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MAX?_ .1#DG_8HRW_ -0J)_,N?_\ (]SK_L;9C_ZF5@HHHKUSR0HHHH ****
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MMH>*M+U;7!I?PA\2P-;>)=8\(V O[[0XAJ9M[F_NM,_![X\>"?\ @G'_ ,%
M?VM_V./V=O\ @DE^S=\;_P!G*/XG>+G\ _%C_A;>IZKXIO+J77M>T&2#QMI-
MOK/[0/QK/]D?#[P99^,?$/B""'5?"XEL[0EH+]T2:UG"<24<5B,3AYY9FV#6
M"C*6-KXRAA84,(EAOK<?;RI8RM.+G1<90Y:<KN44^75JL5PY6PV'PV(AF658
MMXR2C@Z&$K8J=?%-XCZK+V,:N#HP:A6O&?-4C;EE;F:2?XB45_9Y_P %L?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O\ 9>\"_P#(
MD>#?^Q5\/?\ IHLZ_P :&O\ 9>\"_P#(D>#?^Q5\/?\ IHLZ_(_%/_F1?]U3
M_P!YQ^L>%_\ S//^Z9_[T#_,9_X+S?\ *6S]LC_L:OAW_P"J6^&M?D/7Z\?\
M%YO^4MG[9'_8U?#O_P!4M\-:_(>OT7A__D0Y)_V*,M_]0J)^>Y__ ,CW.O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTG6JNA&4*+J3=&,GS2C2<FZ<92ZR4+)OJTV?NM_P7G_Y*C_P3L_[1&_L3?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML?3Y\*W>348'\C]%%%?9GQX4444 %%%% !1110 4444 %%%% !1110 4444
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ME5583I5TY*+JT*N+>.K4G)1T57%2G6DTKJI)R\C]N?\ @M)^UW'\:]9_8_\
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MZ*=U1<IQE)TZD8?B;1117IGFA1110 4444 ?H!_P2C_Y2;?L ?\ 9X'[/?\
MZM#PU7*_\%*?^4C'[?G_ &>M^U1_ZO3QW75?\$H_^4FW[ '_ &>!^SW_ .K0
M\-5RO_!2G_E(Q^WY_P!GK?M4?^KT\=UXZ_Y'\O\ L3Q_]39GKO\ Y$,?^QO4
M_P#4*F?%-%%%>P>0%%%% !1110 45^]7_!'RW^'/A;]ES_@K%\??%GP$_9Z^
M.WC3]G[X"_!OQE\+[#]HKX-^#/C-X5\/ZYJ7Q \0:1J=Q;:)XOTZ[^R#4[!T
M@U!M+NM.N+I;:T$MPPMH@OM7P+\:>"O^"D?[&_\ P4<U?XW?L$_L@? O1/V:
M?V8]>^-WPC_:C_97_9_\-?LXW'AWXY>"M3T>3P[\&?$.JZ%++H_CE?BI8:S)
M;MX=NHY+FQL+*Y\N(:UK?A+4M)\.OG+H5\7!X24\/@L5A,+7Q"KTHR]IC*>%
MJ0=.A-)U%%8N"E%3YY<LE3A.7+%^U0R=5Z&%FL7&.(QF&Q>)H4'0J./)A)XB
M$U4KQ;5-R^K5'%N#A&\>>4(MRC_-717[\?\ !0+_ ()Z_'/QYX+_ ."9_C;]
MD/\ 8=^+'C/PEXL_X)7_ +*OB'XF^+OV;_V:/&'B+P[XE^-.KZK\4+[Q;KGC
MO7_ACX*O-,UGXH:GHDWA2\\1ZGX@N[GQ7>Z7+X>N-3GEM)--<^7_ /!07]F2
M[_9R_P"":W_!)#_A/_V>[CX$?M!>,=8_X*"_\+B_X3#X3R?"_P",?BJT\/?&
M'X5_\*W_ .%E_P!M:!H?C;7+?0_"NN'_ (0C_A*?M4>F>']8/]@^1INH'SM*
M.=86N\!"$H.KCL37PWL56IRJT'0P^,Q$IU()N7*U@W"UE:56%_.*V38J@L=.
M:DJ6"PU#$^UE2J1IUU7KX.A&%*;7*Y)XQ3W:<:4[=#\5Z*_K"_:6_8N_9HM/
MV&_B]^P5X)^%WPNT3]OK_@G?^R=\ OVW_C)\3](TOPS#\4?B+KOBB;QGXI_:
M[^%/BKQO!H<6O:_X/^!WP[^)?PRUCPUI\VN7D$MU9Z+IT5AI/]CL;OYB_P""
M/7[.6B?$S]E;]K;XJ_ /]FK]GW]M?_@H-X%\<?#G0?A_^SW^TFGA[Q1X/\*_
M '58#<^-OBSX6^$OB_6_"WA+XB>*IM?$>@2R:[J]VWANVTVSDTJ&WN-7N- \
M=\ZXAPTL%B,:J-2,*.*H8>*J3ITH3I8MT7A,;*M.2I4L'6I5X576F[0BIQM*
MI'D?0^'\0L;A\'[:G*5?#5J[E3A4JRA4PRJK%8.-&$75JXRC5HSHJC"-YR<)
M7C3GSK^=JBOVQ_X*)^,/">K_  $\+^$OVD?^";<W[ /[?_A?XN:H-*UWX0?L
MV#]GG]GOXR? :WT7['K=EJGA6]\5:7;R>.-"\67>C7^E>,/!/A+Q5X?U/0DB
M0:S:1>)4DM_V*_X*06'[77P+_;5^.7PI_9%_X(1_LJ?%7]G;PEJ7A"'X;>/M
M,_X) Q?%"P\06>J?#KPAKNOR6_COPAX&C\.>(%T_Q9JFOZ2TNFJ%LI+!],N2
MU[97+$EGKB\+#ZK"-3%0QM1.MCL-2H<F#JX2DYT<2G.G7C6^N0E2Y>65H5%.
M,91:1'(U+ZU+ZU.4,-/!TVJ.!Q%6OSXRGBJBC5P_N5*$J/U2<:BES)N=-PE*
M,TW_ !B45] ?M3>(O'OBKX__ !*UGXH_!#P?^S=\09-7LK#Q7\#_  '\(?\
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MBO0_&OAR&"UTK3])\.^.=-\)6&G1?\(K<LWYE_\ !33]IK]H_P#8?_X)(?\
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ME_0J'_@W&_X+-7$,4\7[&^^*:-)HG_X:%_957='(H=&VM\<59=RL#A@&&<$
MY%?IGHWQP^,O[;G_  ;+?MD^-OVR/%NK?%3Q!^S=^T=\--._9_\ C#\2+ ^*
M/'C72>+_ ((Z9<6,GBW4$F\0>(]9%I\4/&/@V7QM?WMWK\6B>,M0TO6-8O\
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MTMYH98Y&<?IOX?\ ^#G#X?\ BV3X;_$G]K#_ ()-?LL?M)?M5?#:UTFVT?\
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M^&_C6Q@NM<\2^(;W3M%TFVFOKNULXI[^]MXI+JYM[=&,TT:-\J_\,/?MJ?\
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M=I9WVD?SD?\ ##W[:G_1H'[47_A@/BQ_\R5'_##W[:G_ $:!^U%_X8#XL?\
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MJ\,^-])\ >*8[+0_B1I&E-X<A\0:+KUO:^)[#3SHD>HVT5L;!:^\/V>_BE\
M?VC_ (??\$&M3_:S_:S^&-^/V7O%W_!1CX_?M,3?%[]H#PM/\1].M/!7Q9^&
M'C+X*>"O%%MXR\5OXIN==^*>J>&?#>D>!_".HM%J_BWP39Z[=>%[6_TO0KKR
M/YY/^&'OVU/^C0/VHO\ PP'Q8_\ F2H_X8>_;4_Z- _:B_\ # ?%C_YDJY*N
M!RF>%P^'IYGA:%2A/%3CBJ=3"JO)XO"X["2][G33A''RG"5W[].FVFKHZZ6.
MS6&)KUZF6XJM3KT\)3>&J4\4Z,5A,5@<5&T>3:<L#"G-67[NI-)IV9^YG[.'
M_!P-XPUS]NGPK\2?C'^RO^PAX1\$?&OXEVO@7X\_%'0/@)X9\+_&V/X,?$C5
M[+PQXKE\4?'E7&O^(8O#GAF:RU'Q!-K%I!9>*;3PT+*ZAT6&XBN=-\?T/]D_
M]A5M;_:B_9P^#/[9_P !?@%^V1\!OVM-1^(O[*?[97B7]H?Q!IWP#^.7[).M
M^%8+?PQ\,=.^.G@KQ->_#'P+\5O!UUJ5EXD\1>)TT*+5;G7;B\\#6&JZGI^F
M>)M2\,?DG_PP]^VI_P!&@?M1?^& ^+'_ ,R5'_##W[:G_1H'[47_ (8#XL?_
M #)4?4,HHSE/+\SH9<IT*%&4*&)H3IU'AJG-0=6G5J2C5IJG4K4*E&2Y:E*L
MM8SITY1/KV;5H1AC\MKY@X5JU6,Z^'KQJ06(IQA65*=*G"5.HZE.C7IU8OFI
MU:6TH5*D9?MU^V)\>-2^'?\ P2R\=?LF?M>_MX_!'_@HG^T7X[^.GPW\8?LU
M?\*E^+;?M37W[-'@_P &F[O/B/XL\6_M$WL3R1W7CC3]2;P%H/@ :OJM]H^D
M7L\NESSZ-=ZWI_A3ZJ_X*9^!/CI^T?\ MQ_'KXU?LO?\%G?V'_ /P)\<ZIX.
MN? 'A+_AZIX>^'W]D6VD?#?P;X=UP?\ "'^&O%=SHFC?;?%&D:WJ.RRF?[7]
ML_M"XV7=W.B_S-_\,/?MJ?\ 1H'[47_A@/BQ_P#,E1_PP]^VI_T:!^U%_P"&
M ^+'_P R58PR[+J4Z=:CFV C54L;*HI4L#/#RECG@'4=+#*I"G0Y5E]&W*Y2
MG.I6J3E*=63>T\PS"K"I2JY3CI4G'!1I\E3&PKQC@5CO9JKB73G4K\SQ]6_,
MHJ$84:=-1A3BED_M6?"_Q=\)?C7XF\,^//CC\)_VC/%M[#IWB77/BY\&?C-8
M?'WP=XGOO$%JM],TGQ-L)[@:UX@M68V^NQ7<SWUI?(T5PSG:[?KQ^S'^S-\.
MQX3_ &9OC]^PE_P5S^%7[&WB?5O"O@U/VP?"'[2/[2=C\#_B5\/OC-X+UR:Z
MUW6O /@K1=(\.6_QI^$=Y:W7]I^ /"FH?\)!,"MQI?B3Q3=MKVJVOAK\G?\
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MJ*&%K1@IUJDJDE"/(^6*E)J*N[*RN?+M%?47_##W[:G_ $:!^U%_X8#XL?\
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MX(_X3[_A9'_"(_\ "L?LWA3QOX8_M/\ X17_ (0+Q/\ \)IO_P"$R^W?8O\
MA(_">W^S?LWVMOMGVBU^3_\ AA[]M3_HT#]J+_PP'Q8_^9*C_AA[]M3_ *-
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MEJUR9)[B 2V5S^2O_##W[:G_ $:!^U%_X8#XL?\ S)4?\,/?MJ?]&@?M1?\
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MT4Z5X?TG@?\ AA[]M3_HT#]J+_PP'Q8_^9*C_AA[]M3_ *- _:B_\,!\6/\
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M_##W[:G_ $:!^U%_X8#XL?\ S)4?VA@/^@[!_P#A31_^3\U]X?4,=_T!8O\
M\)JW_P @?+M%?47_  P]^VI_T:!^U%_X8#XL?_,E1_PP]^VI_P!&@?M1?^&
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M_P!&@?M1?^& ^+'_ ,R5']H8#_H.P?\ X4T?_D_-?>'U#'?] 6+_ /":M_\
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MJITE%17NRD?UZ_\ "I?A;_T3KP3_ .$QHW_R'1_PJ7X6_P#1.O!/_A,:-_\
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MR_H$_P"%2_"W_HG7@G_PF-&_^0Z/^%2_"W_HG7@G_P )C1O_ )#K\+OVFO\
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MWPF^$^E^)M:^&NN^#/!GB7XGW.MZ-YZ>*KW1U\6?LY^.[*Z_M)[FP.GVU_\
M$FPM%$,W^CZ=G$WYN1_M%?\ !>/P+_P3K\;?\%&OB#^VY\&-<^$>M_!7P?XM
M^''A[0OA?\)O^%GZ!XA\;?%_X;^%-)U#6-!D_9:T3P?+]GT34_$=EJ%H_C+6
M[&(:A#=6UM=WD%O/:=.7\$8C,L#@<?0S[AR$<?C,-E]'#U<5F$<3',,4J;IX
M*I"&63I+$1C4C*<859Q44^6<G9/FS'CO#99C\?E^(X?XEG++\'BLRK8BCA,N
MEA99=A'-5,=2G/-:=66'E*FXPE*C";DTI0BKM?UY_P#"I?A;_P!$Z\$_^$QH
MW_R'1_PJ7X6_]$Z\$_\ A,:-_P#(=?SW?M,?\%,OVS)/A=_P3F_9-_8YTG1/
M&W[?W[;'[+OPD^-7B[XF^*='\,IH?P]\->(OAU'?^(?B'!X;>SM?!%GJFI^)
M-'\9^(9KK5M OO!OAK1/">J:;8>!O$6H:[HMGH_DWB/]K;_@L[_P2J\>?"GX
MA_\ !2CQQ\$/VM?V1/BGX[T+X<>.O&OPDT;P[X?UGX*7NJ#43::Q:7FC_"3X
M&W*WUQ;BYUZ2U\3^&?%WA77K#PK-X6M_$W@#Q!KEAJ\T4.!\TK4J;^NY/2QN
M)6)EEV55\;*EF>9T\+5JT95<%1=!TN2M5H5H858JOAIXETY*E"5X\U5N/,JH
MU9KZCG57!8;ZJLQS>A@8U<KRJIBZ-&O&ECJZQ'M>>C2Q%">*>%H8J&&56+JS
MBE)Q_IJ_X5+\+?\ HG7@G_PF-&_^0Z/^%2_"W_HG7@G_ ,)C1O\ Y#K^87]K
MO_@LC\?OV,O^"U&H_!?X@>,Y=7_84T+3/A9:?$'P1;^!/!DEQX TSXD?#SPI
M'/\ $Z/QM8>&$\>^1X7\>^)--UW4['4_$>IZ=J.CSZAX;TS38]2U#0I;#]#O
M!7[8'QW\1?\ !<;X@?LCK\2;?5/V8M-_8STKXO\ ASP-:>&_ LMI_P )E?W_
M ,/EC\3VOC>S\.CQM?V]U9Z]J#0V4GBNYT*2.\66*Q/E6SQ95^"\XP^&P^,J
M2PGU;$\.RXDHUE4K.,\)3^K^UPG^[IK,*4<7AYU*+M04*L91Q,KF]#C?)L1B
ML1@J<<7]:PO$<.&:]%TZ"G#%U%B/98NWUAWRZK+"8B%.LOW[G2G&6&C9GZV?
M\*E^%O\ T3KP3_X3&C?_ "'1_P *E^%O_1.O!/\ X3&C?_(=>A45\B?8'GO_
M  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7
MX6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]
M$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$
M_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A
M,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_
M\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?
M\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^
M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
M'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_
M  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7
MX6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]
M$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$
M_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A
M,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_
M\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?
M\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^
M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
M'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_
M  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7
MX6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]
M$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$
M_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A
M,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_
M\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?
M\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^
M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
M'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_
M  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7
MX6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]
M$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$
M_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A
M,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_
M\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?
M\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^
M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
M'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_
M  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7
MX6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]
M$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$
M_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A
M,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_
M\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?
M\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^
M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7R[X%_Y$CP;_V*OA[_ --%G7U%7R[X%_Y$
MCP;_ -BKX>_]-%G0!Z'\,?[>_P"$4;[$-(^S?\)5\0?*^U&]\_\ Y'_Q/O\
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M]- _/4?\*/\ BJ?30/SU'_"M^B@# _XJGTT#\]1_PH_XJGTT#\]1_P *WZ*
M,#_BJ?30/SU'_"C_ (JGTT#\]1_PK?HH P/^*I]- _/4?\*/^*I]- _/4?\
M"M^B@# _XJGTT#\]1_PH_P"*I]- _/4?\*WZ* .9NI_%%M;7%R4T!Q;P33E
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MH_XJGTT#\]1_PK?HH P/^*I]- _/4?\ "C_BJ?30/SU'_"M^B@# _P"*I]-
M_/4?\*/^*I]- _/4?\*WZ* ,#_BJ?30/SU'_  H_XJGTT#\]1_PK?HH P/\
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M&R_Z]+;_ -$I4>J_\@O4O^O"\_\ 2>2I+#_CQLO^O2V_]$I0!;HHHH ****
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MWQH\:^!-,UWXC_#W_A8'_!*KP3_PB7B:Z:<7NC_\(GXU_94U/Q7H/V=4C/\
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MOAGH'A'PEI5CIS:SXSU769?%\7A-Y^WQ^TL= \(:KXFUGPYX5\4_LF_\%,/
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MEX//CEOA5H>C6GA[]H63PKXEU'Q5\0M?\1?\)SX&T3QMKWAJWU*\^OOVH?\
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M1:S^+]W^T9HW@OQCXXTP>&?#?C#Q#\!](T*\DU30_$,]W:^#-9L/$LU7XI_
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M>((;#QMXC^'_ ,!?%NC6$&E^(=;TV\U;P]H&J:O;5?B7_P % O G@;Q]\8_
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MPLZ%?^T<5"AAZ%7$4Z<L91GA%";J*==4W3C.-2%'$T:-/V:BBBOECZL****
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M2_%'CRX\*Z0GA_PO/XSU^QLH-6\43>&]!CCT309=<N[Y]'TA$TW3VM[-5A'
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MX]67AK2-:LA,1=:9J_@Q["SU;2[B2:TO[&XN=/ODN;2>>*7^N/XH_ /X%?'
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M>H>+$\0>#KR[NJO@WXS_ ++5KX@_X(>^._A<= ^!'P!^%OB+]J'X$^(?#_Q
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M,C_YZ)_WTO\ C1YD?_/1/^^E_P : 'T4SS(_^>B?]]+_ (T>9'_ST3_OI?\
M&@!]%,\R/_GHG_?2_P"-'F1_\]$_[Z7_ !H ?13/,C_YZ)_WTO\ C1YD?_/1
M/^^E_P : 'T4SS(_^>B?]]+_ (T>9'_ST3_OI?\ &@!]%,\R/_GHG_?2_P"-
M'F1_\]$_[Z7_ !H ?13/,C_YZ)_WTO\ C1YD?_/1/^^E_P : 'T4SS(_^>B?
M]]+_ (T>9'_ST3_OI?\ &@!]%,\R/_GHG_?2_P"-'F1_\]$_[Z7_ !H ?13/
M,C_YZ)_WTO\ C1YD?_/1/^^E_P : 'T4SS(_^>B?]]+_ (T>9'_ST3_OI?\
M&@!]%,\R/_GHG_?2_P"-'F1_\]$_[Z7_ !H ?13/,C_YZ)_WTO\ C1YD?_/1
M/^^E_P : 'T4SS(_^>B?]]+_ (T>9'_ST3_OI?\ &@!]%,\R/_GHG_?2_P"-
M'F1_\]$_[Z7_ !H ?13/,C_YZ)_WTO\ C1YD?_/1/^^E_P : 'T4SS(_^>B?
M]]+_ (T>9'_ST3_OI?\ &@#\@O\ @M!_R;E\-_\ LMFD_P#J">/:_FGK^SK]
MICX0?#;XY:=\./!7Q0\/KXI\,#X@6>J'31K&N:+B]CTS4=.2<WOAW5-)U !;
M/4[Z'RS=^2?/\PQF6.%X_)/^'9'[#'_1%$_\.9\7?_G@5_6?@_X\<(>'_!E#
MAW.<NXDQ.-I9AC\7*KEF#RRMA73Q52$J<5/%9Q@JW/%1?.G044[<LI;G^7GT
MKOH3^*GCIXNXSC[A+B#P^R[)\1D6297##<1YKQ'A,S6(RVA5IUYSHY9PIF^%
M5&<IITI+&2G))\].F[)_R045_6__ ,.R/V&/^B*)_P"',^+O_P \"C_AV1^P
MQ_T11/\ PYGQ=_\ G@5^H_\ $UWAW_T)N-/_  W9'_\ 1&?S9_Q3$\>_^BN\
M(?\ P_\ &?\ ] !_)!17];__  [(_88_Z(HG_AS/B[_\\"C_ (=D?L,?]$43
M_P .9\7?_G@4?\37>'?_ $)N-/\ PW9'_P#1&'_%,3Q[_P"BN\(?_#_QG_\
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M_P"'9'[#'_1%$_\ #F?%W_YX%'_$UWAW_P!";C3_ ,-V1_\ T1A_Q3$\>_\
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M .'_ (S_ /H /Y(**_K?_P"'9'[#'_1%$_\ #F?%W_YX%'_#LC]AC_HBB?\
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M  YGQ=_^>!1_Q-=X=_\ 0FXT_P##=D?_ -$8?\4Q/'O_ **[PA_\/_&?_P!
M!_)!17];_P#P[(_88_Z(HG_AS/B[_P#/ H_X=D?L,?\ 1%$_\.9\7?\ YX%'
M_$UWAW_T)N-/_#=D?_T1A_Q3$\>_^BN\(?\ P_\ &?\ ] !_)!17];__  [(
M_88_Z(HG_AS/B[_\\"C_ (=D?L,?]$43_P .9\7?_G@4?\37>'?_ $)N-/\
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M+;+_ .,UKT4 9'_"/Z#_ - 32/\ P6V7_P 9H_X1_0?^@)I'_@MLO_C-:]%
M&1_PC^@_] 32/_!;9?\ QFC_ (1_0?\ H":1_P""VR_^,UKT4 9'_"/Z#_T!
M-(_\%ME_\9H_X1_0?^@)I'_@MLO_ (S6O10!D?\ "/Z#_P! 32/_  6V7_QF
MC_A']!_Z FD?^"VR_P#C-:]% &1_PC^@_P#0$TC_ ,%ME_\ &:/^$?T'_H":
M1_X+;+_XS6O10!D?\(_H/_0$TC_P6V7_ ,9H_P"$?T'_ * FD?\ @MLO_C-:
M]% &1_PC^@_] 32/_!;9?_&:/^$?T'_H":1_X+;+_P",UKT4 9'_  C^@_\
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M#(_X1_0?^@)I'_@MLO\ XS1_PC^@_P#0$TC_ ,%ME_\ &:UZ* ,C_A']!_Z
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M%4:N&I*]ZF(I5*,+U(2BO4?^$?T'_H":1_X+;+_XS1_PC^@_] 32/_!;9?\
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M+_A']!_Z FD?^"VR_P#C-'_"/Z#_ - 32/\ P6V7_P 9KR?XS_M%_"7X!?\
M"(0?$C6_$"ZY\0=4U/2/ O@KP%\._B1\8?B3XQN]#TJ;7/$$WACX7_"#PEXZ
M^(FN:7X:TB'^T/$^MZ;X8N=%\-6UQ8OKNH:?_:.GBY\+\0_\%(OV,/"GP_\
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MG^TA^T=X8\)?%WQ1\$?VH]:_9!^!GA/Q]86/B_1/@S\,/A+X4\,ZK=ZAX/\
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M#_T(?P$_\)?XA_\ STJ_(ZBOVK_B#'A;_P!$3DO_ (*K?_+C^0/^)NOI*?\
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M@_XFZ^DI_P!'BXO_ /"G"?\ S(?KC_P^<_:A_P"A#^ G_A+_ !#_ /GI4?\
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M/_"7^(?_ ,]*OR.HH_X@QX6_]$3DO_@JM_\ +@_XFZ^DI_T>+B__ ,*<)_\
M,A^N/_#YS]J'_H0_@)_X2_Q#_P#GI4?\/G/VH?\ H0_@)_X2_P 0_P#YZ5?D
M=11_Q!CPM_Z(G)?_  56_P#EP?\ $W7TE/\ H\7%_P#X4X3_ .9#]<?^'SG[
M4/\ T(?P$_\ "7^(?_STJ/\ A\Y^U#_T(?P$_P#"7^(?_P ]*OR.HH_X@QX6
M_P#1$Y+_ ."JW_RX/^)NOI*?]'BXO_\ "G"?_,A^L]K_ ,%D?VG;19UC\"_
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M !#_ /GI5^1U%'_$&/"W_HB<E_\ !5;_ .7!_P 3=?24_P"CQ<7_ /A3A/\
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M=3\43Z3XMCL/%T&NZ78_EKK7P"^-US\9?%NI'X*_%2XTJX_X.'_@G\;[6_\
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MGCVOYIZ_I8_X+0?\FY?#?_LMFD_^H)X]K^:>O]'OHR_\FMPG_8ZSC_T]3/\
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M3PIX@^%-WJUKX^M=7M$\.KHJ2SWM[>SRI&FG&TBS]NM[XD07-G(K13Q,P<
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MHH **** "L;6.NE?]AFR_E-6S6-K'72O^PS9?RFH V:**\#_ &HO@;_PTI\
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M5J5*TZ%ZKA64:--P^H?VA_VK?^%"_&_]CSX-_P#"!?\ "5_\-8_%#QC\-O\
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M4:*HP_H=\"?M1?LS?%+PMXU\<_#']HGX%?$;P3\-K&;4_B+XQ\"?%SP!XO\
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M<+_\@T?;-<_Z EM_X.%_^0: /SF_X*D_![XC?'#X.?#?P5\+O#O_  D_B?\
MX6]IFI_V9_:^A:+_ *%'X2\7Z<\_VWQ%J>DZ?\MYJ=C#Y?VOSCY_F",Q1S/'
M^*/_  [$_;C_ .B(?^9*^$/_ ,W]?U!>.9]1DU;P USI\5O)'XLMWM42^6X%
MS.(FQ"[BVB^SJ1SYQ67'3RS7HOVS7/\ H"6W_@X7_P"0:_:^!?'CB_P_R"GP
M[DV7<-XG!4L5B<7&KF>#S.MBG4Q4HRJ1<\+G&"H\D7%<B5!22OS2EN?Q[XT?
M0G\*_'3CBOQ]Q;Q!X@Y=G&(RW+\KGAN',UX<PF6+#Y;3G3H3C1S/A3-\4JTX
MS;K2>,E"32Y*=-73_DX_X=B?MQ_]$0_\R5\(?_F_H_X=B?MQ_P#1$/\ S)7P
MA_\ F_K^L?[9KG_0$MO_  <+_P#(-'VS7/\ H"6W_@X7_P"0:^Q_XFN\1/\
MH3<%_P#ANSS_ .B,_)_^*8G@)_T5WB]_X?\ @S_Z #^3C_AV)^W'_P!$0_\
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MN\1/^A-P7_X;L\_^B,/^*8G@)_T5WB]_X?\ @S_Z #^3C_AV)^W'_P!$0_\
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M;_P<+_\ (-'_ !-=XB?]";@O_P -V>?_ $1A_P 4Q/ 3_HKO%[_P_P#!G_T
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M(A_YDKX0_P#S?T?\.Q/VX_\ HB'_ )DKX0__ #?U_6/]LUS_ * EM_X.%_\
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MUS_H"6W_ (.%_P#D&@#;HK$^V:Y_T!+;_P '"_\ R#1]LUS_ * EM_X.%_\
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M_D&C[9KG_0$MO_!PO_R#0!MT5B?;-<_Z EM_X.%_^0:/MFN?] 2V_P#!PO\
M\@T ;=%8GVS7/^@);?\ @X7_ .0:/MFN?] 2V_\ !PO_ ,@T ;=%8GVS7/\
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M-"+N95:%&M*A.K3C.6&J^WH2EO2K>RJT/:1[2]E6JT^ONSDC;HK$^V:Y_P!
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M ,B8O_8U?$/_ -6%XIKTB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)I-PDX<LDKQ;/>Z*\$_X:K_9>_Z.1^ G_AX?AY_\T5'_  U7^R]_T<C\!/\
MP\/P\_\ FBKH_P!6^(O^A!G7_AKQW_R@X/\ B(/ 7_1;\(?^)+DW_P VGO=%
M>"?\-5_LO?\ 1R/P$_\ #P_#S_YHJ/\ AJO]E[_HY'X"?^'A^'G_ ,T5'^K?
M$7_0@SK_ ,->._\ E ?\1!X"_P"BWX0_\27)O_FT][HKP3_AJO\ 9>_Z.1^
MG_AX?AY_\T5'_#5?[+W_ $<C\!/_  \/P\_^:*C_ %;XB_Z$&=?^&O'?_* _
MXB#P%_T6_"'_ (DN3?\ S:>]T5X)_P -5_LO?]'(_ 3_ ,/#\//_ )HJ/^&J
M_P!E[_HY'X"?^'A^'G_S14?ZM\1?]"#.O_#7CO\ Y0'_ !$'@+_HM^$/_$ER
M;_YM/>Z*\$_X:K_9>_Z.1^ G_AX?AY_\T5'_  U7^R]_T<C\!/\ P\/P\_\
MFBH_U;XB_P"A!G7_ (:\=_\ * _XB#P%_P!%OPA_XDN3?_-I[W17@G_#5?[+
MW_1R/P$_\/#\//\ YHJ/^&J_V7O^CD?@)_X>'X>?_-%1_JWQ%_T(,Z_\->._
M^4!_Q$'@+_HM^$/_ !)<F_\ FT][HKP3_AJO]E[_ *.1^ G_ (>'X>?_ #14
M?\-5_LO?]'(_ 3_P\/P\_P#FBH_U;XB_Z$&=?^&O'?\ R@/^(@\!?]%OPA_X
MDN3?_-I[W17@G_#5?[+W_1R/P$_\/#\//_FBH_X:K_9>_P"CD?@)_P"'A^'G
M_P T5'^K?$7_ $(,Z_\ #7CO_E ?\1!X"_Z+?A#_ ,27)O\ YM/>Z*H:5JNE
MZYIUEK&B:E8:QI.HV\=WI^J:5>6^H:=?VLHW17-E?6DDUM=6\B\QS02R1N.5
M8BK]>/*,H2E"<90G"3C.$DXRC*+:E&46DXRBTTTTFFFFKGUE.I3K4Z=6E4A5
MI581J4JM.49TZE.<5*%2G.+<9PG%J491;C*+33::84445)84444 %8J?\C%=
M?]@6Q_\ 2[4:VJQ4_P"1BNO^P+8_^EVHT ;5%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 8NB?ZO4?^PUJO_I6];58N
MB?ZO4?\ L-:K_P"E;UM4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!0U7_ )!>I?\ 7A>?^D\E26'_ !XV7_7I;?\ HE*C
MU7_D%ZE_UX7G_I/)4EA_QXV7_7I;?^B4H MT444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !6-K'72O^PS9?RFK9K&UCKI7_89
MLOY34 ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU?[.RK,<7*670P]"/MJ>#E&M+%PE*&'I4JE0_K;HK^2CP=X*\7?M3'_@A?\
M!_\ ;!U4?$.UUWQM_P %"_ ?C'4?#?QT\%_%"3XG_#GX7?#+6-6\$:3XU^+'
MP,\:>)_"_BNYO]+\%^&_"OQ3L],\67,OB"73/$.E^)4MKS4M4LHOZGOAG\-/
M OP<\ >$_A=\,O#=CX0\ >!M&M?#_A3PSISW4EEHVCV0(M[."6]GNKR8)N9G
MFNKFXN)I'>6::21V8^+G>2TLE6'I2QWUO%5WC).-"A#ZFJ&$S3,<K56GC%BI
MRK2K5,NE6C!86$8TJL;U7*+4O<R+/*V=O$U8X#ZIA*"P45*O7G]=>(QF599F
MSI5<$\+"-&-&EF4:,IO%3G*K2E:DHRO'N:***\ ^A"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#\?_\ @M!_R;E\-_\ LMFD_P#J
M">/:_FGK^EC_ (+0?\FY?#?_ ++9I/\ Z@GCVOYIZ_T>^C+_ ,FMPG_8ZSC_
M -/4S_GZ_:+?\I*9I_V2'"?_ *B5PHHHK^@C^% HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _4?]@']O[5OV>=6L_AI\2[R\U?X,ZO>+'!/(SW-YX"O+
MEPIU#3PQ+R:)([!M0T]3B$9N;8!@RG^G[1=:TGQ'I.G:]H.HV>KZ-J]G!?Z9
MJ=A.ES9WMG<H)(;BWFC)22.1"""#D'*L P('\'5?J/\ L _M_:M^SSJUG\-/
MB7>7FK_!G5[Q8X)Y&>YO/ 5Y<N%.H:>&)>31)'8-J&GJ<0C-S; ,&4_RIXZ>
M!<.(88KC#@_"QAGT(RK9ME-"*C#.H15YXK"PBDHYK%)NI!66/2O_ +VD\1_I
MM]"[Z:-7@*KEOA1XKYE4K<$5JE/!\+\48RI*I5X0JU)*-++<RJS;G/AJ<VHT
M:TFY9')V=\L;6!_J1HK,T76M)\1Z3IVO:#J-GJ^C:O9P7^F:G83I<V=[9W*"
M2&XMYHR4DCD0@@@Y!RK ,"!IU_!DX3ISE3J1E"<)2A.$XN,X3BW&491DDXRB
MTU*+2::::NC_ &VI5:5>E3KT*E.M1K4X5:-:E.-2E5I5(J=.I3J0;A.G.#4H
M3BW&46I1;33"BBBI- K%3_D8KK_L"V/_ *7:C6U6*G_(Q77_ &!;'_TNU&@#
M:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#%T3_5ZC_P!AK5?_ $K>MJL71/\ 5ZC_ -AK5?\ TK>MJ@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *&J_P#(+U+_
M *\+S_TGDJ2P_P"/&R_Z]+;_ -$I4>J_\@O4O^O"\_\ 2>2I+#_CQLO^O2V_
M]$I0!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "L;6.NE?]AFR_E-6S6-K'72O^PS9?RFH V:*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OEWP+_R)
M'@W_ +%7P]_Z:+.OJ*OEWP+_ ,B1X-_[%7P]_P"FBSH ]:^$_P#R)B_]C5\0
M_P#U87BFO2*\W^$__(F+_P!C5\0__5A>*:](H **** "BBB@ HHHH **** /
MS]^+7_!+G]B/XW_%OQW\=?B'\+_&=U\4_B:_AF3QYXF\*_M"_M)?#:/Q))X.
M\+:3X*\-27OA_P"&WQ=\)>&(WTGPQH>F:7 UIHUNTBP27=P9KZ[O+JX]"^'?
M[!G[+/PLU+X)ZSX.^'VO1:Q^SKXB^)WBOX.ZMXC^+7QE\=:GX0UWXR>$_P#A
M!OB-=O?^.OB#XDN_$<.O^%?^)5#IWBR77=-T%2;SPY9Z1J!-W7V!17I2SG.)
MT88:>:YE/#TJ7L*>'ECL5*C3H?5Y83V,*3JNG"E]4G/"^SC%0^KSE1Y?9R<7
MYD<DR:%>IB891ED,35K?6*N(C@,+&O4K_688SV]2JJ2J3K?6Z=/%>TE)S^LP
MA7YO:Q4EX+_PS!\!/^&C_P#AKG_A6VC?\-%?\*Q_X4[_ ,+,^TZQ_:'_  K[
M^V?[=_LK^Q?[2_X1?^T_MO\ HW_"6?V'_P )A_8?_%-?V]_PCG_$JKQKX_\
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M J2I:*QB8W%P1A58_8L_8L\9?M6^,EDD6[T#X6:!=PMXO\7M"0) "'.A:$7
M2[UB[0%25+16,3&XN",*K?U@_#GX<^#?A/X-T3P%X"T2TT#PQH%HEK8V-J@!
M8@#SKN[FP'N[^[<&:[NYBTLTK$DA0JK_ #;XW^-]#@JA6X:X:K4L1Q9B*7+B
M,1'EJT<@HU8Z5*BUA4S*I!J6&PTDXT(N.(Q$7%TJ5?\ T'^AO]#?&^,&-P?B
M'XAX3$X#POP&)53 8"HJF'Q?'.+PU2TL-AY)PJT.'J-2+IYAF%-QGC)QG@,!
M-36*Q6#F^'W@'PK\+O!?AWX?^"=+BT;PMX6T]--T?3HF9Q# )))YI))'):6Y
MN[J:>\NYF^::ZGFE(!? [&BBO\]J]>MBJ];$XFK4KXC$5:E>O7K3E4JUJU:;
MJ5:M6I-N52I4G*4YSDW*4I.3;;;/]W\%@L'EN#PF79?A</@<!@,+A\%@<%A:
M4*&%PF#PM*%##87#4*48TZ.'P]&G"E1I4XQA3IPC"$5&*04445D=05BI_P C
M%=?]@6Q_]+M1K:K%3_D8KK_L"V/_ *7:C0!M4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!BZ)_J]1_[#6J_P#I6];5
M8NB?ZO4?^PUJO_I6];5 !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 4-5_Y!>I?]>%Y_P"D\E26'_'C9?\ 7I;?^B4J/5?^
M07J7_7A>?^D\E26'_'C9?]>EM_Z)2@"W1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %8VL==*_[#-E_*:MFL;6.NE?\ 89LO
MY34 ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7R[X%_P"1(\&_]BKX>_\ 319U]15\N^!?^1(\&_\
M8J^'O_319T >M?"?_D3%_P"QJ^(?_JPO%->D5\L^$/@;\//&.E7GB/7;#5)M
M5U'Q5XZ^U2V^O:O90M]D\;>(;"#9;6MW%!%MMK6%6V(N]PTC9=V)ZC_AF;X3
M?] O6O\ PJ->_P#D^@#WZBO ?^&9OA-_T"]:_P#"HU[_ .3Z/^&9OA-_T"]:
M_P#"HU[_ .3Z /?J*\!_X9F^$W_0+UK_ ,*C7O\ Y/H_X9F^$W_0+UK_ ,*C
M7O\ Y/H ]^HKP'_AF;X3?] O6O\ PJ->_P#D^C_AF;X3?] O6O\ PJ->_P#D
M^@#WZBO ?^&9OA-_T"]:_P#"HU[_ .3Z/^&9OA-_T"]:_P#"HU[_ .3Z /?J
M*\!_X9F^$W_0+UK_ ,*C7O\ Y/H_X9F^$W_0+UK_ ,*C7O\ Y/H ]^HKP'_A
MF;X3?] O6O\ PJ->_P#D^C_AF;X3?] O6O\ PJ->_P#D^@#WZBO ?^&9OA-_
MT"]:_P#"HU[_ .3Z/^&9OA-_T"]:_P#"HU[_ .3Z /?J*\!_X9F^$W_0+UK_
M ,*C7O\ Y/H_X9F^$W_0+UK_ ,*C7O\ Y/H ]^HKP'_AF;X3?] O6O\ PJ->
M_P#D^C_AF;X3?] O6O\ PJ->_P#D^@#WZBO ?^&9OA-_T"]:_P#"HU[_ .3Z
M/^&9OA-_T"]:_P#"HU[_ .3Z /?J*\!_X9F^$W_0+UK_ ,*C7O\ Y/H_X9F^
M$W_0+UK_ ,*C7O\ Y/H ]^HKP'_AF;X3?] O6O\ PJ->_P#D^C_AF;X3?] O
M6O\ PJ->_P#D^@#WZBO ?^&9OA-_T"]:_P#"HU[_ .3Z/^&9OA-_T"]:_P#"
MHU[_ .3Z /?J*\!_X9F^$W_0+UK_ ,*C7O\ Y/H_X9F^$W_0+UK_ ,*C7O\
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M*<\_^;@_XE]\!/\ HR'A#_XK7@S_ .<IX/\ \.Q/V'/^B(?^9*^+W_S?T?\
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M^R3\/= M_B#\?O&_[;"Z%J'P*\-_ ;2?"GB.]U'PCXEFTZ#0_B#XEG\9>-/
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MF$Z>%Q3G@85*.)AB*E\+5A.6'<GK\U> /^#F/]A'XC:9\3M5T3X3?M;6MO\
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MTITLKP><X/FY\5#-LYPV)JT_JU2[C]5P%:&!I5Y.5YQS&,US*E)Q_I<^$O\
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M+$)7]C&)Y>6<<9UC<SP638CZOAL3C^),XPF#Q*PRG3Q62X2GGF'A.,.=)8K
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MTT/0=8U_6]-@M))_$NG:%#?Z')JWR'_P4K_Y3@_\$;?^ZC_^C[JN-_X-^_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_A*="_Y_6_\  .^_^1J .@HKG_\ A*="_P"?UO\ P#OO_D:C_A*="_Y_6_\
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M_P C4 =!17/_ /"4Z%_S^M_X!WW_ ,C4?\)3H7_/ZW_@'??_ "-0!T%%<_\
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M'Y-Q34 X5VC8I:WK;70X=&Q;'#J>&4X*G@@&G?\ "4Z%_P _K?\ @'??_(U
M'045S_\ PE.A?\_K?^ =]_\ (U'_  E.A?\ /ZW_ (!WW_R-0!T%%<__ ,)3
MH7_/ZW_@'??_ "-1_P )3H7_ #^M_P" =]_\C4 =!17/_P#"4Z%_S^M_X!WW
M_P C4?\ "4Z%_P _K?\ @'??_(U '045S_\ PE.A?\_K?^ =]_\ (U'_  E.
MA?\ /ZW_ (!WW_R-0!T%%<__ ,)3H7_/ZW_@'??_ "-1_P )3H7_ #^M_P"
M=]_\C4 =!17/_P#"4Z%_S^M_X!WW_P C4?\ "4Z%_P _K?\ @'??_(U '045
MS_\ PE.A?\_K?^ =]_\ (U'_  E.A?\ /ZW_ (!WW_R-0!T%%<__ ,)3H7_/
MZW_@'??_ "-1_P )3H7_ #^M_P" =]_\C4 =!17/_P#"4Z%_S^M_X!WW_P C
M4?\ "4Z%_P _K?\ @'??_(U '045S_\ PE.A?\_K?^ =]_\ (U'_  E.A?\
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MT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\
MD:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*
M="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\
MY&H_X2G0O^?UO_ .^_\ D:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_
M\ [[_P"1J .@HKG_ /A*="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"B
MN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\ D:@#H**Y_P#X2G0O^?UO
M_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*="_Y_6_\ [[_ .1J/^$I
MT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\
MD:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*
M="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\
MY&H_X2G0O^?UO_ .^_\ D:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_
M\ [[_P"1J .@HKG_ /A*="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"B
MN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\ D:@#H**Y_P#X2G0O^?UO
M_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*="_Y_6_\ [[_ .1J/^$I
MT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\
MD:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*
M="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\
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M* "BBB@ HHHH **** "BBB@ K%3_ )&*Z_[ MC_Z7:C6U6*G_(Q77_8%L?\
MTNU&@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8UJ\:LJ5-WYIQHJ#JN.EK052'-=KXD>[T445D:A1110 4444 %%%% !1110
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M"JW_ ,N#_B;KZ2G_ $>+B_\ \*<)_P#,A^N/_#YS]J'_ *$/X"?^$O\ $/\
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M=PQ+E2H4!002?R8HH_X@QX6_]$3DO_@JM_\ +@_XFZ^DI_T>+B__ ,*<)_\
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M@ HHHH Q=$_U>H_]AK5?_2MZVJQ=$_U>H_\ 8:U7_P!*WK:H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"AJO_ ""]2_Z\
M+S_TGDJ2P_X\;+_KTMO_ $2E1ZK_ ,@O4O\ KPO/_2>2I+#_ (\;+_KTMO\
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M+Z;1+[XC_$"\L+;3-*LHM^L^([BT@L;&!7ABMXE]!\?_  \\ ?%?PCK'P_\
MBEX&\'?$KP'XA2TCU_P3X_\ #.B^,?".N1Z?J%IJUA'K'AOQ%9:CHVII9:K8
M6.IVBWME.MMJ%E:7D(2YMH9$^FCQ-7I8^CBY87ER^IAL/0=-8>C1K5:F$RIY
M7#%1QM"%#$UYX+$2EC</#ZW!QKTZ/[VC5ITZM+YZ7"^'JY?6P<<7S9C2Q.(K
M^T>(KUZ-*GC,VCFL\)+!5ZE?#4*>.P\(8+$2^J24\/4K/V5:G4J4JO\ *?\
MM->'?$OPY_9@_P""L_PFT3_A1WPD^'/AS6/V&M9L_P!G']E_XG?&7X@^#_V:
M/BOXC^/W@2\\82>$/&'B+]G+]G_X<> KSXBZ>WAOQM??#?X:?;-2\'>(;/\
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M"WA#]GG]G>'X9?$;0O"%MK_ASPW\)OAK'X$\=^&?"\TVL^ K?6-(TS0!X?\
M$^A>';C4)]5\(17MO?:?I$U]-?:,MN]R\K\V3\18;+J.!G6PV)J5<%]7P\?9
M^S5"I2H<29?Q#.;J3?,JS6&J8545!Q]^G6=6W-3.K.>',3F-;,(4<5A:=+'O
M$XF?M%4=>G5K\-8_AR$(TX>ZZ,7B:6*E6<U)\E2@J5^6J_Q]_:0^$^F_LB_M
MD>!;#]AKX;:9\+_'?Q,_X)U_MZ75YX;^%^A>3=_&/XH_"31/A]KGP1UKQOI-
ML))/B;\2M,\:>)=2>Q\:>*!K'CS7+SQ#J-MJFOZ@-2N$D\&U+X4_L9Z9\"_^
M"+'QX^&-OX)'QQ^-O[7'[(WBK7?BKI^N17_Q?_:%\4^)8;_Q/\=]:^-'B87=
MUXF^+7B71_B+=WFH^+]1\>7&KZC\.?',LGAZUN/#,VIW.@W_ /2S?^!?!&J>
M+O#_ ,0-3\'>%=1\>>$]+US1/"OC:_\ #VD7?B[PUHOB9M/?Q)I'A_Q)<6<F
MLZ-I?B!])TI]<L-.O;:TU9M,T]K^*X-G;&/R:S_9*_94T[QYJ7Q3T_\ 9E_9
M\L?B=K/BB+QOJ_Q&L_@Q\.+7QYJOC2#6?^$B@\7ZEXO@\-IX@OO%$/B#_B>Q
M:_=:A+JT>L_\3-+M;W]_6F&XKC"AA(U_K[Q&'H<F(Q%*NG4S*269TX4<;.I)
M3J4*=+&T%3E-U90C0JT52Y:U.K0SQ/"<IU\7/#_V>L-B,0IX;#5:#5/+8_\
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M<)_^HE<****_H(_A0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK\1R/\ /'L#6FC7GQ*\9_#WP/!<0Q2R7LC>(?&>@VAMK:=(;J6\:VM+CZY\
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M5PW_ (@^+/BCX!>)/B+\:/$GQ8\$0V?A#P9I/AWX%?%+XWZ O@7X5ZKX4'Q
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M[?L+^#OVE?B5\./#?P__ &#/ 7[47Q+^-^G>!_V?]5^-_P 1+_QYXOU?X>^
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M"2?_ .75'V;7_P#H+Z;_ ."2?_Y=4 ;5%8OV;7_^@OIO_@DG_P#EU1]FU_\
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M .=;1_PYC_:A_P"A\^ G_A4?$/\ ^=;7])OV;7_^@OIO_@DG_P#EU1]FU_\
MZ"^F_P#@DG_^75'_ !,UXI?]!>2_^&>C_P#+ _XIT_1K_P"A9Q?_ .)9B_\
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M1_Q,UXI?]!>2_P#AGH__ "P/^*=/T:_^A9Q?_P")9B__ )0?S9?\.8_VH?\
MH?/@)_X5'Q#_ /G6T?\ #F/]J'_H?/@)_P"%1\0__G6U_2;]FU__ *"^F_\
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MLJ5.E5=*JER5%3JTZCA*7)4A*TEQOPB^$7@/X'> ]$^'7PZT2#1/#NBP!%5
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M!?3?_!)/_P#+J@#:KY=\"_\ (D>#?^Q5\/?^FBSKZ(^S:_\ ]!?3?_!)/_\
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M\7O_ )@*/^'G?[#G_1;_ /S&OQ>_^8"C_B&_B)_T07&G_B+9Y_\ ,(?\3!>
MG_1[_"'_ ,65P9_\^C[VHKX)_P"'G?[#G_1;_P#S&OQ>_P#F H_X>=_L.?\
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M (1[X@?M0^.OV@/VR?CG\*/^"?5U\5/$^H^"=3^*/['7@6XB\3>&?VA_C/\
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M%'P1K#OJVGZ/XZO)--MI]4^1_CK^UM^UE\0['_@G;\0(?@EJ_P"S]\$OC_\
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M>,_&MS\(/AEXN^$GQ4T;Q1I&E:7JV@:U\*]>33M,U^#6&N)[FU.BW'I?PO\
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M444 %%%% !1110 4444 %?+O@7_D2/!O_8J^'O\ TT6=?45?+O@7_D2/!O\
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MJ2<J-7]KJ***_.#]+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M *5O6U6+HG^KU'_L-:K_ .E;UM4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!0U7_D%ZE_UX7G_I/)4EA_QXV7_7I;?^B4
MJ/5?^07J7_7A>?\ I/)4EA_QXV7_ %Z6W_HE* +=%%% !1110 4444 %%%%
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M@^C^7XF@>^N?^$7C\8[-"*W47G:@3I:_4/AC]N/]E[Q/H/Q:\02?$JY\"0?
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MC#XFZ9X4TS0/AGXD\>0ZEI7A3P?\6O@W=7]_<76@K82K>>+([=;>Y:5(_,B
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M_AI^RO\ $WX3>*9=0>,#3[F#QAXI_;&^-.DV]G:S9>\L9/ US-?1D10:CIS
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M\ > ?^$2\7:IOO/[9\$Z5_PFNC:#Y%M]A\?^(_M4OV/Y-^%G[-/CKP/^W?\
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M^*M,TKP)H/B+3_$7Q4\5^"+/7=;\!>$=+TZUTG3]=Y[]M/1?B=^U;IL_QF^
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M ,51_P +H^$__10O"O\ X-K;_P"*K>_X5YX _P"A&\'_ /A,Z+_\A4?\*\\
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M'PG_ .BA>%?_  ;6W_Q5'_"Z/A/_ -%"\*_^#:V_^*K>_P"%>> /^A&\'_\
MA,Z+_P#(5'_"O/ '_0C>#_\ PF=%_P#D*@#!_P"%T?"?_HH7A7_P;6W_ ,51
M_P +H^$__10O"O\ X-K;_P"*K>_X5YX _P"A&\'_ /A,Z+_\A4?\*\\ ?]"-
MX/\ _"9T7_Y"H P?^%T?"?\ Z*%X5_\ !M;?_%4?\+H^$_\ T4+PK_X-K;_X
MJM[_ (5YX _Z$;P?_P"$SHO_ ,A4?\*\\ ?]"-X/_P#"9T7_ .0J ,'_ (71
M\)_^BA>%?_!M;?\ Q5'_  NCX3_]%"\*_P#@VMO_ (JM[_A7G@#_ *$;P?\
M^$SHO_R%1_PKSP!_T(W@_P#\)G1?_D*@#!_X71\)_P#HH7A7_P &UM_\51_P
MNCX3_P#10O"O_@VMO_BJWO\ A7G@#_H1O!__ (3.B_\ R%1_PKSP!_T(W@__
M ,)G1?\ Y"H P?\ A='PG_Z*%X5_\&UM_P#%4?\ "Z/A/_T4+PK_ .#:V_\
MBJWO^%>> /\ H1O!_P#X3.B__(5'_"O/ '_0C>#_ /PF=%_^0J ,'_A='PG_
M .BA>%?_  ;6W_Q5'_"Z/A/_ -%"\*_^#:V_^*K>_P"%>> /^A&\'_\ A,Z+
M_P#(5'_"O/ '_0C>#_\ PF=%_P#D*@#!_P"%T?"?_HH7A7_P;6W_ ,51_P +
MH^$__10O"O\ X-K;_P"*K>_X5YX _P"A&\'_ /A,Z+_\A4?\*\\ ?]"-X/\
M_"9T7_Y"H P?^%T?"?\ Z*%X5_\ !M;?_%4?\+H^$_\ T4+PK_X-K;_XJM[_
M (5YX _Z$;P?_P"$SHO_ ,A4?\*\\ ?]"-X/_P#"9T7_ .0J ,'_ (71\)_^
MBA>%?_!M;?\ Q5'_  NCX3_]%"\*_P#@VMO_ (JM[_A7G@#_ *$;P?\ ^$SH
MO_R%1_PKSP!_T(W@_P#\)G1?_D*@#!_X71\)_P#HH7A7_P &UM_\51_PNCX3
M_P#10O"O_@VMO_BJWO\ A7G@#_H1O!__ (3.B_\ R%1_PKSP!_T(W@__ ,)G
M1?\ Y"H P?\ A='PG_Z*%X5_\&UM_P#%4?\ "Z/A/_T4+PK_ .#:V_\ BJWO
M^%>> /\ H1O!_P#X3.B__(5'_"O/ '_0C>#_ /PF=%_^0J ,'_A='PG_ .BA
M>%?_  ;6W_Q5'_"Z/A/_ -%"\*_^#:V_^*K>_P"%>> /^A&\'_\ A,Z+_P#(
M5'_"O/ '_0C>#_\ PF=%_P#D*@#YX^,?B+X"?$L^ ]'\6W7PV\>^']/\8VVJ
MWNE>)K/0_$VD6OEV=U:_;Y[#5K:]LXW2"[N;87#0[UAN9X0P2:16S?\ A7O[
M W_1,/V6O_#:?#/_ .9^OI@_#KX?-C=X%\'':=RY\,:(=K#H1FQX/N.:7_A7
MG@#_ *$;P?\ ^$SHO_R%7I87.<WP5)4,%FN982@I2DJ.%QV*P])2EK*2ITJL
M(*4GK)VN^K/G\QX2X5SC$O&YOPSP_FF,E"%.6+S')<MQV)E3IJU.#KXG#5:K
MA!-J$7/EBG:*1\S?\*]_8&_Z)A^RU_X;3X9__,_1_P *]_8&_P"B8?LM?^&T
M^&?_ ,S]?3/_  KSP!_T(W@__P )G1?_ )"H_P"%>> /^A&\'_\ A,Z+_P#(
M5='^LG$7_0_SK_PZ8[_Y><'_ !#[@+_HB.$/_$:R;_YB/F;_ (5[^P-_T3#]
MEK_PVGPS_P#F?H_X5[^P-_T3#]EK_P -I\,__F?KZ9_X5YX _P"A&\'_ /A,
MZ+_\A4?\*\\ ?]"-X/\ _"9T7_Y"H_UDXB_Z'^=?^'3'?_+P_P"(?<!?]$1P
MA_XC63?_ #$?,W_"O?V!O^B8?LM?^&T^&?\ \S]'_"O?V!O^B8?LM?\ AM/A
MG_\ ,_7TS_PKSP!_T(W@_P#\)G1?_D*C_A7G@#_H1O!__A,Z+_\ (5'^LG$7
M_0_SK_PZ8[_Y>'_$/N O^B(X0_\ $:R;_P"8CYF_X5[^P-_T3#]EK_PVGPS_
M /F?H_X5[^P-_P!$P_9:_P##:?#/_P"9^OIG_A7G@#_H1O!__A,Z+_\ (5'_
M  KSP!_T(W@__P )G1?_ )"H_P!9.(O^A_G7_ATQW_R\/^(?<!?]$1PA_P"(
MUDW_ ,Q'S-_PKW]@;_HF'[+7_AM/AG_\S]'_  KW]@;_ *)A^RU_X;3X9_\
MS/U],_\ "O/ '_0C>#__  F=%_\ D*C_ (5YX _Z$;P?_P"$SHO_ ,A4?ZR<
M1?\ 0_SK_P .F._^7A_Q#[@+_HB.$/\ Q&LF_P#F(^9O^%>_L#?]$P_9:_\
M#:?#/_YGZ/\ A7O[ W_1,/V6O_#:?#/_ .9^OIG_ (5YX _Z$;P?_P"$SHO_
M ,A4?\*\\ ?]"-X/_P#"9T7_ .0J/]9.(O\ H?YU_P"'3'?_ "\/^(?<!?\
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M8?LM?^&T^&?_ ,S]?3/_  KSP!_T(W@__P )G1?_ )"H_P"%>> /^A&\'_\
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M_HH7A7_P;6W_ ,56]_PKSP!_T(W@_P#\)G1?_D*C_A7G@#_H1O!__A,Z+_\
M(5 &#_PNCX3_ /10O"O_ (-K;_XJC_A='PG_ .BA>%?_  ;6W_Q5;W_"O/ '
M_0C>#_\ PF=%_P#D*C_A7G@#_H1O!_\ X3.B_P#R%0!@_P#"Z/A/_P!%"\*_
M^#:V_P#BJ/\ A='PG_Z*%X5_\&UM_P#%5O?\*\\ ?]"-X/\ _"9T7_Y"H_X5
MYX _Z$;P?_X3.B__ "%0!@_\+H^$_P#T4+PK_P"#:V_^*H_X71\)_P#HH7A7
M_P &UM_\56]_PKSP!_T(W@__ ,)G1?\ Y"H_X5YX _Z$;P?_ .$SHO\ \A4
M<7I'QC^%D,=\)?'WA>,R:MJ4R!M5MANBEN6:.1<MRKJ0RGH1R*UO^%T?"?\
MZ*%X5_\ !M;?_%5O?\*\\ #IX&\'CO\ \BSHO7U_X\J/^%>> /\ H1O!_P#X
M3.B__(5 &#_PNCX3_P#10O"O_@VMO_BJ/^%T?"?_ **%X5_\&UM_\56]_P *
M\\ ?]"-X/_\ "9T7_P"0J/\ A7G@#_H1O!__ (3.B_\ R%0!@_\ "Z/A/_T4
M+PK_ .#:V_\ BJ/^%T?"?_HH7A7_ ,&UM_\ %5O?\*\\ ?\ 0C>#_P#PF=%_
M^0J/^%>> /\ H1O!_P#X3.B__(5 &#_PNCX3_P#10O"O_@VMO_BJ/^%T?"?_
M **%X5_\&UM_\56]_P *\\ ?]"-X/_\ "9T7_P"0J/\ A7G@#_H1O!__ (3.
MB_\ R%0!@_\ "Z/A/_T4+PK_ .#:V_\ BJ/^%T?"?_HH7A7_ ,&UM_\ %5O?
M\*\\ ?\ 0C>#_P#PF=%_^0J/^%>> /\ H1O!_P#X3.B__(5 &#_PNCX3_P#1
M0O"O_@VMO_BJ/^%T?"?_ **%X5_\&UM_\56]_P *\\ ?]"-X/_\ "9T7_P"0
MJ/\ A7G@#_H1O!__ (3.B_\ R%0!@_\ "Z/A/_T4+PK_ .#:V_\ BJ/^%T?"
M?_HH7A7_ ,&UM_\ %5O?\*\\ ?\ 0C>#_P#PF=%_^0J/^%>> /\ H1O!_P#X
M3.B__(5 &#_PNCX3_P#10O"O_@VMO_BJ/^%T?"?_ **%X5_\&UM_\56]_P *
M\\ ?]"-X/_\ "9T7_P"0J/\ A7G@#_H1O!__ (3.B_\ R%0!@_\ "Z/A/_T4
M+PK_ .#:V_\ BJ/^%T?"?_HH7A7_ ,&UM_\ %5O?\*\\ ?\ 0C>#_P#PF=%_
M^0J/^%>> /\ H1O!_P#X3.B__(5 &#_PNCX3_P#10O"O_@VMO_BJ/^%T?"?_
M **%X5_\&UM_\56]_P *\\ ?]"-X/_\ "9T7_P"0J/\ A7G@#_H1O!__ (3.
MB_\ R%0!@_\ "Z/A/_T4+PK_ .#:V_\ BJ/^%T?"?_HH7A7_ ,&UM_\ %5O?
M\*\\ ?\ 0C>#_P#PF=%_^0J/^%>> /\ H1O!_P#X3.B__(5 &#_PNCX3_P#1
M0O"O_@VMO_BJ/^%T?"?_ **%X5_\&UM_\56]_P *\\ ?]"-X/_\ "9T7_P"0
MJ/\ A7G@#_H1O!__ (3.B_\ R%0!RFI?&7X52:??QQ_$#PL\DEE=(B+JML6=
MW@D554!LDLQ  [DXJ2R^,WPI2SM$?X@>%E=+:!64ZM; JRQ(&4C=P0001ZUT
M_P#PKSP >O@;P?\ ^$SHO_R%1_PKSP!_T(W@_P#\)G1?_D*@#!_X71\)_P#H
MH7A7_P &UM_\51_PNCX3_P#10O"O_@VMO_BJWO\ A7G@#_H1O!__ (3.B_\
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MA4?\*\\ ?]"-X/\ _"9T7_Y"H P?^%T?"?\ Z*%X5_\ !M;?_%4?\+H^$_\
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MQ;'5O"NI:'X@N-.,6KPQ1\Q_P=&?\HV/#O\ V<]\+_\ U#OBC7X6_P#!<KX
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MWT61+;Q(UUIUOX/^%O@2^AU07V@V<0FN=1O+3[))<QFR,SQ3P_D9_P $,O\
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M'>:-XDM)K];.^GM(;G46\-Z5+%=VL^F7<>M,S12S6OV2\^U/V*_A-8?LW_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,;>9;QY=&*;XRCMZ!_;6H?\ 0J>(/^__ (8_^:2@#H**Y_\ MK4/^A4\0?\
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M:I9Z;XCTVSU34[2PUNSAAU.SMM1OX+>ZCBO+A).D_MK4/^A4\0?]_P#PQ_\
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M;S6E[97<,=S:7=I<QM#<6MU;S*\-Q;W$+O%-#*CQRQNT<BLK$'XY_P"'</\
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MTE']M:A_T*GB#_O_ .&/_FDH Z"BN?\ [:U#_H5/$'_?_P ,?_-)1_;6H?\
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M_MK4/^A4\0?]_P#PQ_\ -)0!T%%<_P#VUJ'_ $*GB#_O_P"&/_FDH_MK4/\
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M $*GB#_O_P"&/_FDH_MK4/\ H5/$'_?_ ,,?_-)0!T%%<_\ VUJ'_0J>(/\
MO_X8_P#FDH_MK4/^A4\0?]__  Q_\TE '045S_\ ;6H?]"IX@_[_ /AC_P":
M2C^VM0_Z%3Q!_P!__#'_ ,TE '045S_]M:A_T*GB#_O_ .&/_FDH_MK4/^A4
M\0?]_P#PQ_\ -)0!T%%<_P#VUJ'_ $*GB#_O_P"&/_FDH_MK4/\ H5/$'_?_
M ,,?_-)0!T%%<_\ VUJ'_0J>(/\ O_X8_P#FDH_MK4/^A4\0?]__  Q_\TE
M'045S_\ ;6H?]"IX@_[_ /AC_P":2C^VM0_Z%3Q!_P!__#'_ ,TE '045S_]
MM:A_T*GB#_O_ .&/_FDH_MK4/^A4\0?]_P#PQ_\ -)0!T%?+O@7_ )$CP;_V
M*OA[_P!-%G7T%_;6H?\ 0J>(/^__ (8_^:2OGWP+_P B1X-_[%7P]_Z:+.@#
MUKX3_P#(F+_V-7Q#_P#5A>*:](KS?X3_ /(F+_V-7Q#_ /5A>*:](H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH \O^(7_(:^&_\ V.5M_P"B7KU"O+_B
M%_R&OAO_ -CE;?\ HEZ]0H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K%3_D8KK_L"V/_ *7:C6U6*G_(Q77_ &!;'_TN
MU&@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#%T3_5ZC_P!AK5?_ $K>MJL71/\ 5ZC_ -AK5?\ TK>MJ@ HHHH
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M/Z9 5$VHZWK^M75CI.E6$)91+>7]W;V\990\@R,_SR^+/VB_V[[G]@_X ?\
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MOVL_V;/AK\2/"/Q T+]H#6?V2_V5[3XE?&KP+\?O#_C74_#GA2?Q?\"_CO\
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M#PO\$/VL?CUH?[/6I7^B?'[XK? 7X-VGC3X5?"#7=$LHM3\3:'XG\1ZMXO\
M#&H:OJ_A'3)3?^++#P+H?B^?P_!!=)J2P7-K/ GZ+^"?&GA?XC^#O"OQ \$:
MQ;>(?!WC?P[HWBSPKKMFLZ6NL>'_ !!I]OJND:E#%=16]U"EY874$X@NK>"Z
M@+F*Y@AG22-?P>^#/Q,_:"_X)T:9^UW^S\?V-/VF/CQX^\:_M*?'CXY?LT_$
M/X1_#&_\>?!WXIV?QPUH>(_"5M\3_B#INHV&F_"O4O"VL7,>E_$$>,[_ $D)
MIEE-?:#?:BBP%_W&^$D_Q.NOA;\.[KXU6OA.P^+]WX*\,W?Q/T[P'%?Q>"]+
M\>W.CVD_BO2O"O\ :NK:[J,V@:9K4EY8:7=WNK7MQ>V=O%>22(T_E1_,Y]EV
M#P5*@\'2BJ+G&%#&_P!HTL1/,J3PU*K+$_4X0OAXJK-JZG"-)S>$J0J8BA6J
M1^IR#,L;CJM>.-K2=90E/$8'^S:N&AEE98BK3CA?KLY\N(DZ45+E<*DJJC]<
MIU*>&KT:3^ _^",7C_QY\4O^"9/[*/C[XF^-O%WQ%\=>(_"OC*X\0^-/'?B3
M6?%WBS7;BU^*?CO3K:?6?$?B"]U#6-4FM]/L[2Q@EOKR=X;.UM[:-EA@B1>\
M^-?_  4.\#?"?XN>+_@;X+_9_P#VK?VG?B1\-O#_ (6\2_%/1_V:/A/I7C2S
M^&>G^-[*^U3PA;>+-:\7>-/ .D-K7B32M/N=4T?P_P"'KW7M;O;%'EBL"T%T
MD'YF?\$O?VP=3_9/_8-_9W_9Z^+G[$W_  4DMOB+\-?#WB?3?$\'A_\ 84^/
M6MZ/'=:M\0?%WB2T%EJB>&K=+M#INLV1D=84"3F6+!\O<;7Q^^+_ .V'XM_:
M>^,'A_XG:5_P5+\!?L_SZ%\.=8_96\,?L$_ ?P0L'C72?$'@_3M1\6)\:OC/
MXB\(>*=?^'GC^U\5"]T34/"GB3Q#\.K3PS B30WEN1-<ZE[V)R!5^)\_J8G#
M4(X&6-S7%8%3Q3PU'$4O[4A&F\+#"TZM3$QCA\0JD:-.>%A"E_M,\1&C0E2J
M_/X7B!T.%N':>&Q5>6/6"RC"X^4,*L36P]7^RI3J+%SQ56E3PLI8BA[.5>K#
M%SG6:PL,/*OB(5:7I7[4?_!7.\@^%_[ _P 7_P!DSX;?&OQ]X(_:2_:N\(_#
M_P <R:3\-/!]]XD7PYH&H>.M)^(/[.ZZ+XQ\::-)X9_:%\4:_P"%C;>&]-N8
M5TF3PYH/BO48?&.BSS>';^^^NOBA_P %./AK\/\ XB:G\)?"7[/?[6_[0'Q*
M\&>!O"WCWXQ>$/V?_A'HOCB_^ ^G^,M'77M T'XL7NI^._#.BZ;XVO=(\V^A
M\&>&-4\5^(;J"WFEL;&[C$;2?BQ\+O@K^T1\+?\ @GA^PY>>+/V;_P!HVZ\7
M_LP_\%A)?CS\7OA9IOP^\9?$3XRVOPTTKQ9\=4OO%6A:58Z7_:GQ8LG'CCP_
M=P^-/"BZGH?BBWNKC6].U.XMUG:/N?&WP:^+GP4_:L_:O^)WB6Y_X*X>$_AS
M^U5XS\)_'KX4ZQ_P3V\#^$/%]C?0ZWX$TK3]7^'OQV\$Z]\*O'GC?X=?%#P5
MJFG-I-A)K%W9^#KC1KF,2W6B7UK=K>^E4R'AZ=26%I0H2C@:F=4L-46+;JYG
M.EF^'I8>&(J8;GG6='+:SQ%..&C%U8I5XMT(58R\REQ!Q'"$,55GB(RQ]/(Z
MF*IO!Q5/*Z=;)JU;$5*%/$\L*$:^9T?JU5XF4U2FY4''ZQ.E*/ZW>/\ _@JG
M^S+X-^&W[+GQ5\-Z9\7/C-X6_;#U3Q1X=^"4/P<\!Q^*/$>K^+O"VBZG?7'@
MW5O"^JZYX=UW2_$U]XATJY^'\=@;&XBT7QH);?QA<^&= T_5_$.G5?$W_!3K
MP9H6L>%O NC_ +*G[:WQ ^-.M?#BQ^*OBSX"^ O@_P"$]6^)_P (?!^KZ[JW
MA[0Y_BP^H_$[1_A_X<U37;S1+^?2=$T[QYKNJ76GK;7OV5(;VT,WYC_!C]DW
MXL_#:;_@D5<V_P #/VB/#45A^V7^U%\;_BMH_P 3O$FD?&WQG\*[#XF^ ?&*
M:?K_ ,7/&WPN^%'PT\">!_\ A,;^2TUG^Q)M!@M=!UKQ&_AVXU_5=:CN8XOH
M#]M'XD?M>VW[8OC7P'XK;_@HAX0_9+A^'/P_U7X':C_P3I^!_@?XAZO\1/&<
MT.I_\+)T[XN?$[6/!_CC7/AKJEGK7]GZ9X9TR67P=H%]H$4^JWVIZ9(UKJVH
M^<\BR/ZW2P>%C2Q25#-,5*OB,T<?:QPN<8O 8?#PA@:5>.*JK#1I5YQPTZ*K
MPA+%0K4,-"HJGIQS_/?J=7&8N57"MU\IPD*&&RI2]E/%Y+@LPQ.(G4Q]6A+#
M4OK,ZU"#Q,*SH3G'"2HU\3.FZ>Q^TK^W3I7[0?P3_8/^+O[.'B_XM_#.T\0?
M\%;/V5OV?_BWX2U3^W_A9\1='DL_B3JV@_%#X)_%KPYINJ!FM;R-+.+Q3X/O
MK[5M"U6PN;*/4(KD;H(OW1K^2_X(_L]?M'6'[./PE\/^(O@)^TKI/B[3?^#B
M3X6?'[Q#HGQ,\-^*?''Q'TOX/WWB_P />)KSXK>//'>F:1/HOCC1-*L+EV\?
M_&C1;R]\"W/B*VUJ[N-<A=9TC_K0KR>*<)@<!'"83 3IU*-'&9M&$XU:5:HZ
M,JF%G1YZU+2K%1E)4JFJG%.46[MGK<)XS'9@\7C,?"=.M7P>42G!TJM&"K1H
MXF%?DHU=:4G**=2G92A)\LDFDD4445\@?9!1110 4444 ?GO_P %&O\ DDW@
MO_LHEM_ZC7B.OQOK]D/^"C7_ "2;P7_V42V_]1KQ'7XWUC/XG\OR1UT?@7JP
MHHHJ34**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** +FGZA?:3?6FIZ9=SV&H6%Q%=6=Y:R-#<6UQ"P>*:*1"&1T8 @@^QR
M"17[6_LI?M66/Q8L;;P5XTN8+'XB6$ 2"=RL-OXJMX4 -S; D*NJ(HW7=JO^
MMYFA!RRU^(U7=.U&^TB_M-3TR[N+#4+"XCNK.\M9&AN+:XA8/'+%(A#*ZL 0
M0<$9!!!(+3:?YKN1."FNS6S_ *Z']/FJ_P#(+U+_ *\+S_TGDJ2P_P"/&R_Z
M]+;_ -$I7P[^S/\ M66'Q9\.7/@SQG<V]A\1-/TBZ2*9V6&W\56\-JX-U:@X
M5-350#=VBG,IS-"""RC[BL/^/&R_Z]+;_P!$I6R::NCCDG%M-6:+=%%%,044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8VL==*_[
M#-E_*:MFL;6.NE?]AFR_E-0!LT444 %%%% 'SQ\%/V:/ GP(\<?M$>/O"&K>
M+=1UC]I?XK1_&#QW;>)+_1[S3-)\31^$] \'+8^$H=,T'1[JPT(Z9X=LIS;:
MQ>:]J'V^6ZE&IBW>&U@^9%_X);_L[V_A[X[>"],\3?&+0? WQE^+UE^T/X2\
M'>'?&.BZ#IG[+_[0=A++J,'QF_9:U/2O"5KXI^&GBL^)GC\5OHVJ^(?%_P /
M_P"U(YM*3P6G@_5==\,:K^D5%>C3S?,J52I5IXRM"I5CA8U)J2O)8%4UA'MI
M/#QI0A3G&TXPYX<W)4J1EYM3)\LJTZ=&I@J$Z=)XMTX.+M'Z][1XQ;W<,1*K
M.=6$FX2GR3Y>>G3E'X9T7]@+X2WVK_%KQ1\=O%_Q-_:O\9_&?X3WWP$\6>+?
MCU=?#^"\L/@=JDL5]J_PL\'^'_@E\._@SX%\'^']:UR&+Q-K.JZ%X2M/&6K>
M([;3=4O_ !1<2Z'H"Z7SWA__ ()R?"UM1\(S?&?XK?'3]J7P_P##;X7>-_@[
M\+_!'[0.M?#75O"W@+P1\2?!)^&7CF.(?#GX6?#3Q#X^\2^)?AG)=_#_ %/Q
MQ\8?$'Q(\:3^'-5U]?[>&J>)/$.IZI^@]%7_ &UFB4U'&5(*45"*IJG35&"I
M.@XX50A%8.,J#="HL)[%5*+=*IS4VXD?V)E3Y'+!4IN$N>3J.I4E7G[98A3Q
M<JDY/&RAB$J].6+=9TZZ56#C42D?G[\/O^"=_P /O!VN?!N?Q;\;/VB_CAX!
M_9PU2?Q!^SS\&OC+XL\ :U\.OA'XGMT.G^$/%-E=^%/AAX,^)/Q'\0?#+PU/
MJ?A/X9W_ ,<?B'\5#X0TC5[R_L8V\56^E>(]-@O_ /@FI\ =3_92^,/[']_K
MWQ0N/AS\9OBAXW^,.K^)?[>\,0?$7PGX\\;?$N+XL_VQX$UZV\&0:3HDWA7Q
MC;VMUX2FO?#VKWEC;6T4&IW>KNTTTOZ$T4WGF:N<*GUVK&=.M0Q--P4*:AB,
M/5JXBE7C&G",(U57KUJTZBCS5:M6=2JYSDY-1R+*8PG3^HT91J4*^&J*HYU'
M/#XFC1P]:A*52<I2I2H8>A0C3<G&E2I4Z=)0A%(^-_&O[#7P6\5?"+X ?"?0
M[GQE\+[C]E6X\"W_ .SG\4?AGJFBZ+\3_A+JG@+0X/"UG=Z)J&K^'?$'A+7=
M/\3>%5O/#/Q \'^-_!OBGP#X]T75+ZU\4>$]29;&6RY&W_X)T? ?6?"GQ]T/
MXQ:M\1OVA?%?[35MX4T_XO?%GXL:YX>L_B/JFD_#NXM=1^&.C^%IOA/X3^%_
M@WX;:9\--=L[?Q5X.M_AQX,\*&U\8J?%VI2:IXB=]2/WM140SC-*<.2&.Q$+
M5?;*I&=JT9_6(8SW<0E[>,'C*=/%NE&HJ3Q4(XEP]LE,N>3954ES5,#AY_NO
M8NG*%Z$H?5IX.\\.W["=18.<\(JTJ;JK"SEAE-49.#^"_AY^P/H'A#]H+X;_
M +3?C;]HW]IKX\?%;X5?#7Q?\(_"-]\7O$'PC_L*#P+XQ?19[VROO#?PO^#/
MPRTB]UVUOM(DOCXV>W3QOXCEU)[7QUXB\6Z9H/@RP\+^Z_M'?LW?#[]I[P3H
MO@_QW=^*M U#P;XVT#XG_#3X@> =<'ASX@?"SXH^%(M1M_#'Q#\$:M/9ZII<
M/B#1K?5]5LUM/$&B>(/#6K:;J>HZ1XAT#6-(O[NPF]_HJ)YGCJF(P^*EB)1K
MX6"IX:=.-.BJ%.,ZE14Z=.E"%.-/GJU6X*'+)3E%IQ;1=/*\!3P^(PD<-&5#
M%S=3$PJRJ5G7J.G2I.I5J5IU*DZG)1I)5'-S3IPDFI),^/O ?['>BZ#\7O#G
MQW^*WQJ^-G[37Q0^'^A:QX>^$NN_&N3X0:5IOP@LO%=O=V/CN\\">#_@+\(/
M@AX*/B/Q[IDUAHWB/Q=XL\.^*O%<6@Z-9Z#X=UK0='OO$-CK>[\5?V4/"/QV
M^$FM_"3XT>/_ (J>/XKGQQ_PL;P7\1(M=\-_#;XJ_"#QAI.JMK?P^UWX4^,/
M@QX1^&Q\.:O\*M1\J7P3KE_I^M:]=0PM9^.M5\:65]JEO?\ U)12>9XYUJ5=
M5W"M0]DL/.C3I47A51E.I3CA%1A".%A[2I4JSAAU3A4JU)U:D9U)RDW'*\#&
MC5P[H*I1Q'M?K,*U2K7^MNM"%.I+%NM4J2Q<_94J=*%3$NK.G2IPI4Y0IQC%
M?&'AK]C#2E^*WP_^,?QF^/?Q[_:=\7?"&36[[X06GQEF^"NA>$OAMXB\2:3=
M>']<\8Z-X,_9_P#@K\#?#7B#QA=>'KV\T/3_ !!\0=.\97WA?3[R_P#^$/?P
M_=:GJ5S>?3_@OPSK7A;3M1LM<^(7C#XDW-[X@UK6;;6/&MEX!L-1TC3M4NVN
M;'PGIT7PZ\#^ =)E\/\ AR$BPT6YU;2]4\4SVBJ_B'Q+KU^6O6["BL\1C<1B
ME%5IPE&$(TZ<(T:%.G1IQG4J>SP].E3A##PE4JU*M2%"-.-6K.=2JISDY&F'
MP.&PKDZ$)QE.<JE6<J]>K4KU)0IT_:8FI5J3GB:D:5&E2ISKRJ2I4J<:=-P@
ME$\ ^'/[./@?X8_'+]HW]H#0-5\5W?C+]IZY^$UUX^TS5[[2+CPSI$GP<\#-
M\/\ PPOA"SLM#T_5;!+[1F-SKPUK6=?:ZU/$VGMI=K_H5<7^T;^R1H?[0_CS
MX!_%-/BY\7O@O\2?V;=;^(.O?#+QC\)/^%2W5Y;WGQ.\$W'P\\61ZUHWQD^$
MWQ>\*:M;7'A2]U"PLTD\/Q2V4M_->PS?;8;*>T^LZ*J&88RGB(8N-9NO##QP
MBG.%.HGA8X-9>L/.G4A*G4I/!+ZM*$X2C*E>,D[N\SR[!U,-/"2H16'GB98Q
MPA*I3:Q4L:\Q>(A4ISC4IUECG]:C4A.,H5K3BTTK?"5G^P9X7O/$GC7XC?$;
MX]_M%?&+XT>(_@_XU^!_@OXT>.]:^$^D^+O@5X)^(%B;;Q1=? [PK\+/@_\
M#?X-^#O&FIW<6FZI>>/]0^%WB#QCJ,VB:1H^KZSJ/A2U;P]+]%_!'X$_#OX
M? WX=?L\> M+=OAM\,_ 6D?#O1K#7/L>I76J:)I>FIIUQ=>(WCL[2QU35?$#
M?:=1\17"Z?;6NI:EJ%_/]BACN/(7V*BJKYECL335*MB)RHQE3G"C%0I4:;HP
MG"BJ5&E&%.E&E&K5]G"G&,(2K5I1BI5:CDL/EF!PM1UJ.'A&M*%2$ZTI3JUJ
MD:TZ<ZSJUJLIU*LZLJ5'VE2I*4YQHT8RDXTJ<8_._P"RM^S7X._9$^"7A;X
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M:+=7U[XBT/4O$$;>'+35YKQ)Y8/B?]A7]L[5_@!_P3N_X)C_  +^#_P4U?\
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M$E?K8^FPF*HXW"X;&X>7/A\7AZ.*H3:LY4<13C5I2:>JYH3B[/:]@HHHK Z
MHHHH **** "BBB@ HHHH _/?_@HU_P DF\%_]E$MO_4:\1U^-]?LA_P4:_Y)
M-X+_ .RB6W_J->(Z_&^L9_$_E^2.NC\"]6%%%%2:A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* "BBB@ HHHH **** "L;6.NE?\ 89LOY35LUC:QUTK_ +#-E_*:@#9KP/\
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MGQ;^,_Q%_9._:$\!?#'PG^T'XQ;XJ?$SX0?&K]G_ %7XY^#+'XPWNCZ'X?\
M$GQ$^&VI>"/CK^SQXN\*7'CG3?#NDW7C/0?$>O\ CS1;S7X)M9T&#PW]LNK.
M7SJU_P""9UCX2\*?!_Q'\,_CAX@T3]K#X/\ QU^*_P"T?%^TGXT\$Z'XRTWX
MC?$C]HNYNT_:1T7XD_!C0M3^'_AJ?X6?%+0+]?#NF^#_  #X@^'WB/X>V_A?
MP!JOA?QY'KGAW5]1\4_:PS7)*]#!TLQQ,:\*$,)&G0H+,:6&<\/D^(PV&J9C
M@<1A\9AJ$\)C5AUB*V55:U+%4IUW++<2JCC'X^>4YYAZ^,JY;A94)UYXR52O
M7>6U<3R8C.<+B<33R['8?$8/$XB&,P'UEX>EFU.A6PM6&'C',\,Z:E+Y4NO^
M"S.E?#_X8_M=#Q!XV_99_:%^)'[.VK_ S3?AQ\3O@%X_A\-_L[_&*V_:4\3S
M^$? VH>(+Z^\;_%N'X/R_"[5[35)OC-8:G\4/%UO:>']&.OZ3K%N=9MM+L,K
MQ7_P42N/%=K\5OV8?&7[1/[$7[5,WQI_8F_:;\8>$_B!^Q7K7V2/X<_$+X8?
M#+5]4\9_#CXD^![WXY_'R^O- \1^%=5.O_#KXF1^)?!\VI7?A3Q3H%_\/$(A
MUBT^X/%W_!/_ ,2_&_X<_&K0?VF?VE_'7Q&^(7Q7\2_#OQ=X3\2?#_2=2^&?
MPP_9Y\0_!O5;?Q#\*]7^ WP1\1^.?BSI7AO5=-\26L6N^.M9\3^*O&&M?$F=
MY=-UO4K;08M-TG3MRX_9(_:*^),?C"7]HO\ :^'CB2__ &??B)\#/!/A3X.?
M";Q)\!OA'9:M\4]#FT+Q9\9/BY\.9?CM\3Y?C9\1;6S@TJT\%V.H^*?"GP_\
M"6;^*I_#/@NQ\2>*%\2Z.H8WA.FG.%&E&JJKG4:EB6Y58X'+UAZ^":RB'+2I
MYG#&XJM03RJ,J=2=%4J]#ZM0I$L#Q?-QA4KUIT715.FG'"I1I2S#,)8FACD\
MYGSU:N5SP6$H8AK-I1J0A7=6AB/K-:K\+_\ !-#]M;Q1^TY\(?A5\,?V<)?A
M0WP(_8Y_9%^!'@W]I'QA\1M%UWQ-XV^)?QBG^#^CV?\ PK+X0^"])\9>#7\(
M^!/!;^$_%NF^-/C7\0;+Q)HOC3Q9:R^#_AAX'\0:/H?B+Q]:<W^R;^V[^TO\
M4-+_ ."=/P/^!'P^_9!^!&E_M(_L>_%+XX>(I-/^#OCJ;X=?!V]^'7Q!TO1K
M/3_AM\'_  C\8/ ,.J>&=9AU!M#F\)W'CKPW=:9J7B$^.X_%M_;^%YO 'C'[
MB\+_ /!.E_AQKO[)WC+X6?%ZT\%^,_@1^S#H/[(7QIO_ /A6TFH:!^TW\&/#
MG@O0/#WAZTU[PW:_$'1QX'\4^"?$>BW/B[X=>);?5/%<WAH:_K?AG5[3Q5H5
MQ##!A?LL?\$S/^&:/%W['7BK_A=G_":_\,F_LN?$K]FS[!_PK?\ X1S_ (3_
M /X6'XVT/QC_ ,)I]J_X3W7O^$5_L?\ L;^SO^$<^S^)/[0^T_;/[=LO)^RR
MZ8G,N&)+,JU!4;UY2KX'"XC#8FO4IXF&!SRFZN*J2P\</BJE;,:N"QE*52*I
M0HXBCAYT*5&AB*$,L+EG%4/[+H8CVW^SQC0Q^*P^*PM"E4PL\?P_45+"4XXB
M6)PE.CEE',,%6C2DZM2OAJV)A7JUL1AJ\_+/#'_!0S]H?Q=I'@7X%:9X1^#<
M?[7OC']N;XV_L7R^-)-,\:2_L_Z=I/[.OA^^^*7Q1^.D'P^D\86/CR_2/X36
M.SPW\()OBKIUYJOCJY2VF^)MKHUN\\WOW[*O[1/[47BC]K[]JO\ 95_:/A^!
M>JQ_ /X?_ [QOX,^(/P8\(^._! \>6'Q>O\ XDROJ.N>%?&GQ*^);^%7TVQ\
M*Z9HO_".6WB#77BU73]8UL>)M0T[7=-TK0_FOX[_ +'L'P$T^U^*&D:[\:?$
M'Q)N/^"B7Q%_;(^''Q:^#W[-&I_'NQ^ ][\6]!M_#_B?P%\7_@+X*\?O\7_B
M_P#"'Q?X4M=5\!^)M:^#MII_C6SO]=T;Q/#_ ,(%::#/K3]G_P $\?AE\==1
M_:N_;6_:L^+NN>*_$V@?&+PW^S[X \">*/%GP"\:_LLKXED^&EM\1=0\2KX)
M_9X^*VI:K\8OAI\/?!T7C'PWX/TZY^*6IZQXB^('C'3O'?C;2]2?PCJ'ATS9
M8NCDM3*<RQ>#IX*%*6"<J7/A\1'$/-IYQ@5+ZG7G2]G3HPRZ=6G'+W6A5C&.
M)Q2P<L/[+%1VPE;/*>;Y9@\94QLZT<<HU5#$X:6'63PR7&2_VW#PJ^UJ5I9E
M"E4>8QH3I.4\+A'C(UW5PLO7OB_^T+^U+??M]^'?V,O@1<_ 7PAX=U/]D:^_
M:2U[XF_%KP!\0/B3JN@ZCI7Q@7X;/HFE^#?!_P 6_A/;^)K;68[_ $E(+6Y\
M3>%WT0C5]?GUS6C:Z?X1U/YZ\!_\%'_CQ\4?!O[.7PD\,>"OA-HW[7GQP_:7
M_:1_9QU[Q/J5CXOUWX >"]+_ &/=4UQOCA\:M-\$0^+/#?Q \4:?K&BZ1HUK
MX!^%MW\1?#%['K_C.W76_B3+:>&F7Q1^@K_LR[_VWK;]LG_A-L?9OV5;[]F7
M_A7'_"-YW_;?BYIWQ3_X3;_A+_[?&WROL']A?\(W_P (NV_S?[4_M]/+_LY_
MDG2O^"8EUX2\.>$=8\!_'EO#7Q]^$_[8/Q]_:Q^#_P 6;GX8KK'AC1[;]H[Q
M/K]W\3/@I\0_AD?B!87/CSX?>)/!/B.Z\):UJ&@?$#X<^+9=4TS0/%F@:UX8
M:PO-#U3CPN*X<>'H4L1#"QJTL+A7"J\)B)6S%X3-8U:N,E"E*>(PM+&3RJIB
M:-JM.="E)8>A5E+$1J]N+PO$JQ&(JX:>)E2JXO%*=)8O#1OEJQ>3RITL)&I5
MC##XJK@X9O3PU9NE4IUZL7B*]*,</.EXI\>_^"DO[1W[-GPS_;F\(>,?"WP3
M\;?M-?LAV?[-/C?PEXA\.^'_ !UX4^#/QF^%_P"T?\5]'\"Z7>7/@?4?'_BO
MQ=\-_%WA>(Z]H6N:7<_%#Q;I[ZN= \5Z3>ZMI$^J^&M/^D-)_:L^.'P._:IT
M/X$?MB>+_P!FR7P#X]_9E^(O[0NF?%7X>>&_%WP9T7X0WGP>\4>%]-^('AGX
MD:C\4?BY\0]%\4>#/^$?\:Z;JFD?%*WNOAI+;77A_5$UOX?6=EK$%UHG(?$G
M_@F'K7QH^%?[6>F_%3]H*TUO]H#]K_4?@3'XW^+V@_")_#_@'P5X(_9V^(6E
M>-_AS\//AQ\&[KXGZ_JVDZ'##;ZY;:UJ&N_%WQ'KVN>(/$EUXDU'4KBUTW2?
M#EI]A>+?V9_^$I_;#^#7[6'_  FWV'_A4GP8^+GPB_X0'_A&_M7_  D'_"T]
M?\!ZY_PD/_"4_P!O6_\ 97]A?\(3]E_LG_A'-2_M3^T_/_M/3OL7DW=5\5PW
M[!484\-.52GF#Q=6EA:].4\5#),H^ISP52IA^;"T*V>4\SE2A"G3C"%1K$T*
M6$E2HQFAA.)E6=6=3$PC3JY='!TJN*P]2,,+//<W^NQQM.GB.7%XBAD-3+(U
M:DZM24YTXO#5ZN,C6K2^/?VK?^"K'P$^'_A+X76O[-W[1'[(7Q \6_&+XQ:7
M\(X?B;XG^./@C6_@+\#K0^'=:\9>)?B%\8=7\(>-]-#6FE>'=!GM_#O@H^,/
M!FI^-?$6J:5I=AXATX-+,?"G_P""P=K\/?#_ .UWI6L^+_V9_P!KOQ7^S_\
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M^$/A[]K3XS_M)?M)_LZ^(O%^LV/C/7/V>_!=A^Q[J'B&7XS_ !?TKP1:>*-
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MQE;+J>75OK.'K49PJQHPHNOA)*KI6QF(YZ2=&A-_S4_&/_@F_P#M ?"?P/\
M\%0_V4OV1O@5#??LJ?M5_!#P#\1?@#HVE^/_ (>:%HW@7]HO3+K0O!WQ'^&%
MEIGC3QKHVO:?;^-?#^AZ9XW3Q#JUL?"=F-)M](7Q(FH3'3H_T=^"_P"T9^W)
M#+\)_AUXR_X)@_%#P3X:BD\">"O%7Q'O/VH?V2M<TSPEH<;:5H6N>-[OPYX=
M^)^I>)-8L-!L!=:]/HFA6=_KFH6]H]AIEM=7\T$4GZ<T56*XFKX_#QH9AEV7
M8Z<9*K]:KRS2.*EB/J."R^6)J3P^9T*=6O4HX##3JSJTIJI64ZLHN52=XPG"
M]#+\2\1EV99E@(.#I?5*$<JEA8X?Z_C<PCA:<,1E=>I1P]*MC\3"E"C5@Z="
M4*,)*-*GR_C5X'OO^"F'[)6H_$_X177[.&J_\%#_ (1:Q\0/'OC#X/?&.3]I
MWP!X1^)>B^"_'>OW^NV?PJ^,&D?'K5;.?5(/!?\ :-SHFE:]X1U'5M,B\,P:
M;IECX;C@@2RL>B_8[^&.O_\ !/#]E+]KW]H']H?1O OPVOO'/Q+^-O[9?C'X
M*_#+7%NOAK\&='F\*:7+:?#+PGJK6-AINIZY+8>$(#K.KZ-I-IIFK^)=62PT
M33I;2SL#<_KG7F_Q6^$?P\^-WA+_ (0/XI>'AXL\&OX@\*>)[OPY<:IK6G:7
MJNJ>"?$FE^+O#L6NVVBZEIH\0:);>(-&TR^O_#&MF_\ #6NI:K8Z]I.IZ=)-
M:21+/EB8RP^)P6%PV'QN(P=3-Z^7PQ$<5CJ>&J<\G[&MC98"C5FW*HWA</A%
M*K:[C3<XRN/#[PTHXC#8[%XG$8'#XRGD]#,)X:6$P%3%4^2*]M0P4,?6I0BH
MTTL7B<8U2O92FH3C\@_\$J/@WXN^ O\ P3T_9;^''C^RETSQS%\/[KQMXQTJ
MXC,-WH_B;XL^*?$/Q8US1KZW)*VVH:1J7C:YTW4+6+]Q:WMK/;VX$$48K]!J
M**\C'XNIF&.QF/JJ,:N-Q>(Q=6,=(JIB:TZTU'^ZI3:7E8]G 8.GE^!P6 HN
M4J6!PF&P=*4]9RIX:C"C!R:WDXP3EYW"BBBN0ZPHHHH **** "BBB@ HHHH
M^:OVD_AEH/Q;T[X?>#_$=WJ]EIEQXYMKAY]$N+*VO@_]FW]EA);^PU*W"^5>
MRM@VK'S%C.[:&1_&_P#AW3\$O^AH^*?_ (._"7_S$5]4_$+_ )#7PW_['*V_
M]$O7J%)I/=(I3E%64FD? W_#NGX)?]#1\4__  =^$O\ YB*/^'=/P2_Z&CXI
M_P#@[\)?_,17WS12Y8]E_7_#?GW8_:3_ )F? W_#NGX)?]#1\4__  =^$O\
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M^'=/P2_Z&CXI_P#@[\)?_,17WS11RQ[+^O\ AOS[L/:3_F9\#?\ #NGX)?\
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M- %55 ^K'+,2Q)-ZBFDELA.4I6NV[;7*&J_\@O4O^O"\_P#2>2I+#_CQLO\
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M/!OQJ^,7[+6F0?''0OVG/@;^SM\?XOV=OB?XRN?&'@O2;+X5>(+KQ%>?&O\
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MZ+HWQN:&P7P]XACU7PI%XJL])M[W[_\ B%^VC\%/AUXS^ 7@Z_N]<U]/VA_
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MG\%>(TUG]GWXO7?[27_!+GQ];^$?,\)?LZ?!G]HCPG\9=6_M_P ,)_PAVO\
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M/_/_ 'O_ (%3_P#QRC^TM1_Y_P"]_P# J?\ ^.4 ?NG17X6?VEJ/_/\ WO\
MX%3_ /QRC^TM1_Y_[W_P*G_^.4 ?NG17X6?VEJ/_ #_WO_@5/_\ '*/[2U'_
M )_[W_P*G_\ CE '[IT5^%G]I:C_ ,_][_X%3_\ QRC^TM1_Y_[W_P "I_\
MXY0!^Z=%?A9_:6H_\_\ >_\ @5/_ /'*/[2U'_G_ +W_ ,"I_P#XY0!^Z=%?
MA9_:6H_\_P#>_P#@5/\ _'*/[2U'_G_O?_ J?_XY0!^Z=%?A9_:6H_\ /_>_
M^!4__P <H_M+4?\ G_O?_ J?_P".4 ?NG17X6?VEJ/\ S_WO_@5/_P#'*/[2
MU'_G_O?_  *G_P#CE '[IT5^%G]I:C_S_P![_P"!4_\ \<H_M+4?^?\ O?\
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M?VEJ/_/_ 'O_ (%3_P#QR@#]TZ*_"S^TM1_Y_P"]_P# J?\ ^.4?VEJ/_/\
MWO\ X%3_ /QR@#]TZ*_"S^TM1_Y_[W_P*G_^.4?VEJ/_ #_WO_@5/_\ '* /
MW3HK\+/[2U'_ )_[W_P*G_\ CE']I:C_ ,_][_X%3_\ QR@#]TZ*_"S^TM1_
MY_[W_P "I_\ XY1_:6H_\_\ >_\ @5/_ /'* /W3HK\+/[2U'_G_ +W_ ,"I
M_P#XY1_:6H_\_P#>_P#@5/\ _'* /W3HK\+/[2U'_G_O?_ J?_XY1_:6H_\
M/_>_^!4__P <H _=.BOPL_M+4?\ G_O?_ J?_P".4?VEJ/\ S_WO_@5/_P#'
M* /W3HK\+/[2U'_G_O?_  *G_P#CE']I:C_S_P![_P"!4_\ \<H _=.L5/\
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M?^?^]_\  J?_ ..4 ?NG17X6?VEJ/_/_ 'O_ (%3_P#QRC^TM1_Y_P"]_P#
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M?VEJ/_/_ 'O_ (%3_P#QRC^TM1_Y_P"]_P# J?\ ^.4 ?NG17X6?VEJ/_/\
MWO\ X%3_ /QRC^TM1_Y_[W_P*G_^.4 ?NG17X6?VEJ/_ #_WO_@5/_\ '*/[
M2U'_ )_[W_P*G_\ CE '[IUC:QUTK_L,V7\IJ_$7^TM1_P"?^]_\"I__ (Y2
M'4=0.,WUX<'(S=3G!'0CY^"/6@#]U**_"S^TM1_Y_P"]_P# J?\ ^.4?VEJ/
M_/\ WO\ X%3_ /QR@#]TZ*_"S^TM1_Y_[W_P*G_^.4?VEJ/_ #_WO_@5/_\
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M_G_O?_ J?_XY1_:6H_\ /_>_^!4__P <K(U/W3HK\+/[2U'_ )_[W_P*G_\
MCE']I:C_ ,_][_X%3_\ QR@#]TZ*_"S^TM1_Y_[W_P "I_\ XY1_:6H_\_\
M>_\ @5/_ /'* /W3HK\+/[2U'_G_ +W_ ,"I_P#XY1_:6H_\_P#>_P#@5/\
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+OA[_ --%G0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img117130267_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117130267_2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1A"08# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%U^>?_!)+_CQ^)'_ %TLOY35^AE<N84H4<3*G35DK?DCJR^K.OAH5*CNW?\
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M&7[PM;A)2/KM)IV=KBNKV-*N&^-_Q)?X0?"GQ)XQCT]=4?2+;[0+-I?*$OS
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MO.OP*\3>//$L7B/5$7Q#JJJMU* /MLG W'_:K]]:_GM\4_\ (S:M_P!?<O\
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M*2_%_P# ,;O'9G9?#%_@O\V?;U%%%?&GV@4444 ?DO\ \%0?^3C8/^P/;_\
MH3UZ+_P21_Y#_P 2O^O6Q_\ 0YJ\Z_X*@_\ )QL'_8'M_P#T)Z]%_P""2/\
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MR%=E'&\%2"1UR#US7Q?_ ,% ?CGX#^.?C[0+_P $R2WK:?:26MY?O;-"L_S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "ORN_X*J?\EN\/?]@5
M?_1KU^J-?E=_P56('QO\.#.<Z(I^G[UZ]O)_][7HSPLZ_P!T?JCT3_@DI_QZ
M?$7_ '[/^4M>K_\ !0[]G,?%GX8MXKT>S\WQ3X;C:4",?-<6G61/<KRX^C#O
M7E'_  22(:S^(_8K)9C'KQ*:_0QE#*00"#P0>]5C:TL/F$JD-U;\D+ T(XC+
MHTI[._YL_G]\!^/-7^&_B$:QHTPAN_(FM75QE9(I8VC=&'<%6/Z5SP.7!]Z^
ME/V[?V<7^!7Q7FO]*M9%\(:^S75C(%)2"4\RVY;ID'+*/[I'H:^:&?RU+XSM
M&<5]I1J0K056'7^OP/B*]*I1FZ,^G]?B?T'>"_\ D3M"_P"O"#_T6M?D;_P4
M<_Y.O\3?]>UE_P"DT=?KEX,X\'Z%SG_0(.?^V:U^1G_!1QL_M9>)U]+2Q/\
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M/@YJVI^*_"6G:YJ$6KR0I<7:%G"".,A>O3)/YU]51_L??!>-PP^'&AD@Y&Z
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M +#-W_Z-:OWOK\$/C@?^+R^. .<:U=C/_;5J^HR+XZGHCY7/_P"'3]6??W[
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M.*WK_P!I+$.%-^ZWH[+1?\ QH?V8\.IU5[R6JN]7_P $;_PZ/U#_ **;;?\
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M%!XSSSC%?EUI6G?$7]H_QR;6U_M7QGXCNMTK>9*9&5<\L2QVHH+>P&:^P_\
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M SQ=3FEB5;LOS.+'PPE/ECA7?N_R/W#_ &3/^3:?AK_V [;_ - K\KOVZ_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTJ-HX[JZ51(X9V?D* /XL<>E=K116$I.<G*6[-XQ4(J,=D>!_M._L?\ AO\
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MSTW9FM6E"M'DJ*Z/G;]F;]B_0?V8_$>KZQI/B/4]:EU*U6U>*^CB54 ?=D;
M#FO?]3TRUUK3;K3[ZW2ZLKJ)H)X)1E9$8$,I'H02*M44ZE:=:?/-W8J5&G1A
MR4U9'P%\1O\ @E#I&J:Q+=>"_&4NA64LC.;#4K7[2L()X5&5E.!_M9^M=S^S
M'_P3UMO@+\0+'QGJ/C&?6]5LHY4AMK6V%O;G>I4ELLS' /3.,U]B45V2S'%3
MI^SE/3Y'''+L+"I[6,-?F%%%%>:>D%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1137;8C-Z#- #
MJ*^</V5?VL[G]H[QA\2-$G\.QZ(OA+438K,EP93<?,PW$8&/N_K7T?0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)D.$9:M7$    & .PI:**@L**** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME?H=7YX_\$O?^2M_M$_]C W_ *,DK]#J "BBB@ HHHH **** "BBB@ HHHH
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MF*T*S] _Y MG_P!<Q6A7M4/X,/1?D>56_B2]6%%%%;F04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<;A_9_:5W]Q[+SC$YSP]CZF*M>+LK*VET?9=%%%?<'X:%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4R;_4R?[II],F_P!3)_NF@#\]/^"7O_)6_P!HG_L8&_\ 1DE?H=7YX_\
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MGXW)8X;#/$TZRFD[:?YW9[>4\73S#,(Y?7PLJ4I)M7?;79I/OJ>_5YO\1?\
MD-Q?]<!_,UZ17F_Q%_Y#<7_7 ?S-?FV>_P"YOU1^OY1_O2]&'Q1_Y(7KW_8-
M;^5?/?[%+K'XUUDLP4?84ZG'\5?3'BGP]<>*_A5J&D6C*MU>6#11%S@;B.,U
M\6V_P!^)VFNPM] O8' VEX)U7=CW#=*X,7[6G6P]>$')1CT/T/ASZKB<JQN
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4R;_ %,G^Z:?3)O]3)_NF@#\]/\ @E[_ ,E;_:)_[&!O
M_1DE?H=7YX_\$O?^2M_M$_\ 8P-_Z,DK]#J "BBB@ HHHH **** "BBB@ HH
MHH *_#+_ (*]?\G<7'_8(M?_ &:OW-K\,O\ @KU_R=Q<?]@BU_\ 9J /U9_9
M6_Y$'PU_V ;+_P!%)7NE>%_LK?\ (@^&O^P#9?\ HI*]TH **** /&/VM/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *9-_J9/]TT^F3?ZF3_=- 'YZ?\$O?^2M_M$_]C W_HR2
MOT.K\\?^"7O_ "5O]HG_ +&!O_1DE?H=0 4444 %%%% !1110 4444 %%%%
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MG K[#^''_(@^'?\ KPA_] %?(7[3?_(]V'_8,@_K7U[\./\ D0?#O_7A#_Z
M*_2,>V\FP3?9?DC\;X?BH\39JHJRYO\ VYG1T445\F?J84444 %%%% !1110
M 4444 %%%% 'RO\ MOVTWE^%KD1.8%:5&D ^4-@8!/:O)?!G[1_B_P ">';7
M1=+DLA8VP(C$T.YN3GDU]\WVG6NJ0&&\MHKJ$\[)D##\C69_P@_A[_H"V'_@
M.O\ A7SN(RRM4Q$L11J\K9^DY;Q3@L/EM/+L;A/:J#;U:MJV]FM];'QI_P -
M?^/_ /GIIW_@-1_PU_X__P">FG?^ U?9?_"#^'O^@+8?^ Z_X4?\(/X>_P"@
M+8?^ Z_X5G_9V._Z"7^/^9T_ZR9!_P!"Q?A_D?&G_#7_ (__ .>FG?\ @-3H
M_P!L'Q]$ZR,=-E13ED-OC</3.:^R?^$'\/?] 6P_\!U_PKXZ_;!TNSTGXBV4
M-E:Q6D1TX,4A0*"=QYP*X<;1QN"H^V>(;/>R/'9%G>,6#CE\8W3=]'M\D?9?
MA/7/^$E\,Z7JIC\DWENDQCSG:2,D5K5RGPI_Y)MX;_Z\8O\ T&NKKZ^E)RIQ
MD^J1^,XN$:>(J0CLI-+Y,****U.4**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?ZF3_=-. "@ # ' %5KB]MD61&N(E< @JS@$<4 ?GW_P2]_Y*W^T3_V,#?\
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M %]K_P"@U](UZF62<L'3;?0^3XJA"GG6)C!65^GH@HHHKU#Y0**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !3)O]3)_NFGTR;_ %,G^Z:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% ",P12QZ 9-?GS\2_\ @I_KVM>-=4\$?!3X6:IX
MQU^RNI;-[VZ1O)WH2K%43G@C^(@5]C>(?C]\-O#&IWFE:OXXT'3=2M24FL[R
M_CCDC..C*3D5\\?LF?MD_#?Q9IWCG^TW\'?#W^SO$-Q9VT=K/%;_ &^(<BY/
M3<6)/S=Z /([+]E;]JW]I^1;KXO_ !-/@+P]/C?HFB'$C(1G[B$*I[?,37N'
M@3_@E_\  ?PAX=N].O\ PY+XIO;R/9<:IJ\[//N[NA& A^E>S?\ #3OPD_Z*
M1X8_\&D7_P 57A7@O]N1_B3^W&?A)X6?2-;\#Q:7)<OK-FS22/.L(=E5@=NU
M6.T\4 >/?LT^ M>_99_;ZUKX6^$I]8U/X7:EIIO&@NB\D-DY&Y"7(QN!!7CD
MAN:_22FA%#%L#<>^.:=0 4444 %%%% !1110 4444 %,F_U,G^Z:?3)O]3)_
MNF@#\]/^"7O_ "5O]HG_ +&!O_1DE?H=7YX_\$O?^2M_M$_]C W_ *,DK]#J
M "BBB@ HHHH **** "BBB@ HHHH *_-?_@MQ_P DN^'/_85N?_1:5^E%?FO_
M ,%N/^27?#G_ +"MS_Z+2@"__P $U?\ DS#2_P#L8;[^2U]X?#7_ )%:'_KH
M_P#.O@__ ()J_P#)F&E_]C#??R6OO#X:_P#(K0_]='_G0!U-%%% !1110 5R
M7Q'_ .01!_UU%=;7)?$?_D$0?]=17EYI_N53T/0P'^]4_4=\.O\ D#R_]=37
M5URGPZ_Y \O_ %U-=73RS_<Z7H+'_P"\S]0HHHKTS@"BBB@ HHHH **** "B
MBB@#X>_:I_Y*S>_]>T7\C7VAX<_Y%[2_^O6+_P! %?%_[5/_ "5F]_Z]HOY&
MOM#PY_R+VE_]>L7_ * *^QSC_D7X/T_1'Y5PM_R/<T_Q+\Y&C1117QQ^JA11
M10 4444 %%%% !1110 4444 %%%% !1110 U_N-]*_/OP7_R<5IG_8>_]G-?
MH*PRI'M7YZ>-/ OC'PQ\1=3GM]'U-+J*]>>"ZM+=W'+95E90:^8SOF7L9I72
M?^1^J<"NG/ZY0E-1<X65WZK\+GZ&45^=K?%[XB>&]3C:ZUS5K>ZA82&WO2PR
M.N&5NQK] ]!O9-2T/3KN4 2W%M'*P'3+*"?YUZ6!S"&.<E&+37<^9SWAROD4
M:<ZE2,XSO9J_2W^9?HHHKU3Y$**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_(CRS_#_ .VQ-:BBBOIS\K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVQM'0^] 'V51110 4444 %%%% !1110 4444 %,F_P!3)_NFGTR;_4R?[IH
M_/3_ ()>_P#)6_VB?^Q@;_T9)7Z'5^>/_!+W_DK?[1/_ &,#?^C)*_0Z@ HH
MHH **** "BBB@ HHHH **** "OS7_P""W'_)+OAS_P!A6Y_]%I7Z45^:_P#P
M6X_Y)=\.?^PK<_\ HM* +_\ P35_Y,PTO_L8;[^2U]X?#7_D5H?^NC_SKX/_
M .":O_)F&E_]C#??R6OO#X:_\BM#_P!='_G0!U-%%% !1110 5R7Q'_Y!$'_
M %U%=;7)?$?_ )!$'_745Y>:?[E4]#T,!_O5/U'?#K_D#R_]=375URGPZ_Y
M\O\ UU-=73RS_<Z7H+'_ .\S]0HHHKTS@"BBB@ HHHH **** "BBB@ HHHH
M**** /DO]L__ )&GP[_UYO\ ^AU[E\ /^20^&_\ KW_]F->&_MG_ /(T^'?^
MO-__ $.O<O@!_P DA\-_]>__ +,:^RQW_(DPWK_F?E&3_P#)7X__  K_ -L/
M0J***^-/U<**** "BBB@ HHHH **** "BBB@ HHHH ^#?VL?^2Q:C_U[Q?\
MH-?;GA'_ )%31?\ KRA_]%K7Q'^UC_R6+4?^O>+_ -!K[<\(_P#(J:+_ ->4
M/_HM:^8RS_?<3Z_JS]4XI_Y$>6?X?_;8FM1117TY^5A1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M** "BBB@ K\U_P#@MQ_R2[X<_P#85N?_ $6E?I17YK_\%N/^27?#G_L*W/\
MZ+2@#0_X)J(S?L6Z:X4E5\17NXCMPM?5ND>,M1T:S6UM9$$*DL 5!ZUX1_P2
M B2;]D&-9$5U.N7G##(ZI7TY\5+:&WCT_P J)(\LV=B@9H [#PMJ\FN:);W<
MJA)'!#!>F16M7,_#K_D5;7ZM_.NFH **** "N2^(_P#R"(/^NHKK:Y+XC_\
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M[E^'^9\U_J!C/^@BG][_ ,C] Z*_/S_A;WQ9_P"@WK?_ 'X_^QH_X6]\6?\
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M1F#%1G''>@#7^'7_ "*MK]6_G735Y7\/?$-Y!JMMII??:2;@$(^Z<$Y%>J4
M%%%% !7)?$?_ )!$'_745UM<O\0K>6?1HS&C/LD!;:,X%>9F:;P=1+L=^ :6
M)@WW&?#K_D#R_P#74UU=>06&L:GID)BM99(HR=VT)GG\JV?#OBO4Y=9MH+B?
MSHY6V,K*!BO"R_-Z-.G3P\HN^BOT_,];&9;5J3G6BU;<]&HHHK[ ^:"BBB@
MHHHH **** "BBB@ HHHH **** /DO]L__D:?#O\ UYO_ .AU[E\ /^20^&_^
MO?\ ]F->&_MG_P#(T^'?^O-__0Z]R^ '_)(?#?\ U[_^S&OLL=_R),-Z_P"9
M^49/_P E?C_\*_\ ;#T*BBBOC3]7"BBB@ HHHH **** "BBB@ HHHH ****
M&/$DH =%<#^\,TW[+!_SQC_[Y%2T4K#NT1?98/\ GC'_ -\BC[+!_P \8_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH @O[;[;8W%OG'FQM'GTR,5^?W_!,OQWX;^'6N_%OX2:SJ,.F>+X/&%W<
MV]E>L(Y+J$A44IG[Q^3.!V8'O7Z$5X3\2/V3/A3XF^*^B_%K5[&+1_%.C7,=
MV^J1SB".X*#"B<'Y6[<]>!S0!\W_ ++GBJQ^#W_!0'X]^ =9N(M&A\231ZMI
M2W3A!<E><+GJ=KN1_NFM.]\6:-J/_!6308O"US!>7'_"*3VVNFTD!4R!2R;R
M."RKLZ]*Z_\ :F_9B^!W[8>K6-]<>.M+TCQA9)Y$>HZ3J-N\LJ<[8Y$W?, 3
MQCD<UUO[(W["/@C]DQM0U+2;NZU_Q)J$8BFU:^"ADCZ[(U'"@GDGJ: /I>BB
MB@ HHHH **** "BBB@ HHHH *9-_J9/]TT^F3?ZF3_=- 'YZ?\$O?^2M_M$_
M]C W_HR2OT.K\\?^"7O_ "5O]HG_ +&!O_1DE?H=0 4444 %%%% !1110 44
M44 %%%% !7SO_P %"/\ DS3XI_\ 8*/_ *,2OHBOG?\ X*$?\F:?%/\ [!1_
M]&)0!\$?\$2?^2H_$#_L$Q_^C5K]>KE0UO(" 1M/!^E?D+_P1)_Y*C\0/^P3
M'_Z-6OU[N/\ 42?[I_E0!X]X*_Y'"S_WW_\ 037LM>->"O\ D<+/_??_ -!-
M>RT %%%% !2$ C!&1Z&EHH C,$>#^[3_ +Y%>6:7_P C?#_U\G^=>K'H:\IT
MO_D<(?\ KY/\S7RV=)*IA[?S?JCZ#*W>%;T_S/5Z***^I/GPHHHH **** "B
MBB@ HHHH **** "BBB@#Y+_;/_Y&GP[_ ->;_P#H=>Y? #_DD/AO_KW_ /9C
M7AO[9_\ R-/AW_KS?_T.O<O@!_R2'PW_ ->__LQK[+'?\B3#>O\ F?E&3_\
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M_?AJ/KV%_P"?B^]!_8.:_P#0-/\ \!?^1ZY17D?_  U1\._^@M+_ -^&KM/
MOQ*\/?$>TGGT&_6\$#!94P5=,],@^M7#%4*LN6$TWZG/B,JQ^%INK7H2C%=7
M%I'44445U'E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >-:A^Q
MQ\$]5O[B]N_AKH-Q=7$C2RRO;Y9W)R2>>I->&_M%:9^Q_P#LPV<1\9>"O#PU
M2==\&CV-KYUW(O\ >V!OE7W8@5]HWEP+2TGG(+")&<@=\#-?FY^PY\%O#O[4
MGQ6^*OQM^(]LOBG4H/$DVF:98:BN^*U2(*5;8>,A610#P-I]: //K/\ ;&_8
MHGU 13?!*6VMBP N#I\;8'J5#Y_G7W1^S-X3_9]\465M\0O@]H>@K)L>V-_I
MT6R>#</GB=2<H>G!%>H:U\&? 7B'2)=+U'P;H=U82H8W@>PB *G@CA<U\,?!
M;X?V_P"R;_P4BO/A]X0FDB\#^,M%?4O[*W;A:R*"0!Z ,&QWVD#M0!^C-%%%
M !1110 4444 %%%% !1110 4R;_4R?[II],F_P!3)_NF@#\]/^"7O_)6_P!H
MG_L8&_\ 1DE?H=7YX_\ !+W_ )*W^T3_ -C W_HR2OT.H **** "BBB@ HHH
MH **** "BBB@ KYW_P""A'_)FGQ3_P"P4?\ T8E?1%?._P#P4(_Y,T^*?_8*
M/_HQ* /@C_@B3_R5'X@?]@F/_P!&K7Z_U^0'_!$G_DJ/Q _[!,?_ *-6OU_H
M \:\;?\ (X7?^^G\A7L%K_QZP_[@_E7C_C;_ )'"[_WT_D*]@M?^/6'_ '!_
M*@"6BBB@ HHHH 0]#7E.E_\ (X0_]?)_F:]6/0UY3I?_ ".$/_7R?YFOE\Z_
MB8?_ !?JCZ#*_@K>G^9ZO1117U!\^%%%% !1110 4444 %%%% !1110 4444
M ?)?[9__ "-/AW_KS?\ ]#KW+X ?\DA\-_\ 7O\ ^S&O'?VQ] U&[U70-2@L
MY9[*.!X7EB0L%?=D X]J\DT;XI>/O#VF6^G:=J&H6UE NV.)(3A1^5?HD,#+
M,LIH4J4DFFWK\S\)JYQ3R#B?&8C$TY-222LO*.NMM-#[_HKX-_X77\2_^@QJ
M7_?D_P"%'_"Z_B7_ -!C4O\ OR?\*\W_ %8Q/_/R/X_Y'T'_ !$3+_\ GQ4^
MY?YGWE17P;_PNOXE_P#08U+_ +\G_"NJ^$7QW\9W?Q%T73M2U1]0L[ZX%M+#
M<+]W.>1Z$8K*KPWB:=.53GB[*_7I\CHP_'^75ZT*/LIKF:5VEU=NY]D4445\
MD?IP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4UT$B,C#
M*L,$4ZB@#YAUK]B:VO=6N[BQ\32VEK+(TB026PD*9.<;LC-4O^&'6_Z&X_\
M@$/_ (JOJNBO'>48)N_)^+_S/M(\99Y"*BJ^W]V/^1\J?\,.M_T-Q_\  (?_
M !5'_##K?]#<?_ (?_%5]5T5/]CX+^3\7_F5_KGGG_/_ /\ )8__ ")\J?\
M##K?]#<?_ (?_%4?\,.M_P!#<?\ P"'_ ,57U711_8^"_D_%_P"8?ZYYY_S_
M /\ R6/_ ,B?*G_##K?]#<?_  "'_P 51_PPZW_0W'_P"'_Q5?5=%']CX+^3
M\7_F'^N>>?\ /_\ \EC_ /(GQA\1/V33X!\&:IKY\2F\^Q1>9Y!M N_GIG/%
M:W[$/&N^)_>"+^9KW#]HS_DC'B?_ *]OZBO#_P!B+_D/>)_^N$7_ *$:\F6&
MI87,Z,**LFO\S[&GFF+S;A;&5L9/FDI);):7CV2/KFBBBOL#\8"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#_4BC_T,*?X?_)'Z$45^>_\ PB/Q8_Y]/$?_ '\D_P :/^$1^+'_ #Z>(_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQW,,BY*MT- 'O%%(O*CZ4M !1110 AZ&O*=+_P"1PA_Z^3_,UZL>AKRG2_\
MD<(?^OD_S-?+YU_$P_\ B_5'T&5_!6]/\SU>BBBOJ#Y\**** "BBB@ HHHH
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MO_74_:,US'A7.JRQ.*J3YK):)K]'W-__ (;!\">M_P#^ YH_X;!\">M__P"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /F7]MW_D!>&?\ KZD_
M]!KL_P!DC_DC=C_U\3?^AFN,_;=_Y 7AG_KZD_\ 0:[/]DC_ )(W8_\ 7Q-_
MZ&:^:I?\C>I_A_R/U+%?\D90_P"OGZR/9Z***^E/RT**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KY5^.__  4H^#7P"\87'A;5+[4=<UVT;9=VVB6PF%J^ =KNS*-V". 3
MCOBOJ#4Y)(M-NWAYF6%V3']X*<?K7YV_\$Q?@WX6\=CXL^/O%NA6>N>+)/%M
MW8/)J42S>2B[78!6! ):0Y/L* .E/_!9KX)XS_8GBW_P"A_^.UWO[/'_  46
M\,_M-_%VS\'>$/".N16+VD]S<ZQJ"*D<#1@%4PI8$MGN1^->2?L(_#?PC'\6
M?VB/A1XA\.Z5K%OH^N?:+2*]LXY'CAD+AU#$9"\IC'2NB^!/A&S_ &1_VZM7
M^$_AP*G@7QQI+>(+&SE(+6%Q'D.BMC)4[2 ">!B@#[SHHHH **** "BBB@ H
MHHH **** "F3?ZF3_=-/IDW^ID_W30!^>G_!+W_DK?[1/_8P-_Z,DK]#J_/'
M_@E[_P E;_:)_P"Q@;_T9)7Z'4 %%%% !1110 4444 %%%% !1110 5\[_\
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M7Z_(:^X:^'OV8/\ DMNG_P#7&Y_] -?<-=/$_P#OL?\ "OS9Y_AW_P BB?\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D/\
M;;_Y&/PY_P!>TG_H5>Z?LZ?\D4\)_P#7H/\ T(UX7^VW_P C'X<_Z]I/_0J]
MU_9T_P"2*>$_^O0?^A&OF<+_ ,C6MZ?Y'ZEFW_))8'_%_P#)GH]%%%?3'Y:%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_/R?^^:/KV%_P"?L?O0?5,1_P ^W]QO45@_\)OI'_/R?^^:/^$WTC_GY/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR%>GV_\ J(_]T?RKSLFA&G7Q$([)V_%G;F<G.C1E+=K]$24445]6?/!1110
M4444 %%%% !1110!XW^UA_R2"Z_Z^X/_ $*N6_8R_P"1>\0?]?2?^@UU/[6'
M_)(+K_K[@_\ 0JY;]C+_ )%[Q!_U])_Z#7V-+_D05/\ '_\ (GY5B?\ DM:/
M_7O])'T;1117QQ^JA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X;^V%_P DE/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#8P-_Z,DK]#J "BBB@ HHHH **** "BBB@ HHHH *^=_\ @H1_R9I\4_\
ML%'_ -&)7T17SO\ \%"/^3-/BG_V"C_Z,2@#X(_X(D_\E1^('_8)C_\ 1JU^
MO]?D!_P1)_Y*C\0/^P3'_P"C5K]?Z "BBB@"KJG_ "#+O_KD_P#(UX[X.U>#
M0]82ZN=WE!"/D&37M,L:S1/&XRK@J1[&N"U3X965K:W5S'=S*(T:18\ C@9Q
MF@#IM"\7:?X@F>*U=A*@W%)%P2/45M5Y+\,N?$B_]<6_I7K5 !1110 4444
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M'PK_ ->2_P S7=U\ABH1IUZD([)M?B?J6759U\%1JU'>4HQ;]6DV%%%%<QZ
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M, _]#K] ZG(ERPJQOM(TX^:G6PM6R3E"[MZA1117TY^5A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6%?&4J-.52Z=NB:/0P&38O'8F&&Y''F>[B[+U/H^BN,L_BUX,%G!O\5Z1O\
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M_P#&C_A;?@G_ *&O1_\ P-C_ ,:T]O2_G7WHYOJ&+_Y\R_\  7_D=;17)?\
M"V_!/_0UZ/\ ^!L?^-'_  MOP3_T->C_ /@;'_C1[>E_.OO0?4,7_P ^9?\
M@+_R.MHKDO\ A;?@G_H:]'_\#8_\:/\ A;?@G_H:]'_\#8_\:/;TOYU]Z#ZA
MB_\ GS+_ ,!?^1UM%<E_PMOP3_T->C_^!L?^-'_"V_!/_0UZ/_X&Q_XT>WI?
MSK[T'U#%_P#/F7_@+_R.MHKDO^%M^"?^AKT?_P #8_\ &C_A;?@G_H:]'_\
M V/_ !H]O2_G7WH/J&+_ .?,O_ 7_D=;17)?\+;\$_\ 0UZ/_P"!L?\ C1_P
MMOP3_P!#7H__ (&Q_P"-'MZ7\Z^]!]0Q?_/F7_@+_P CK:*Y+_A;?@G_ *&O
M1_\ P-C_ ,:/^%M^"?\ H:]'_P# V/\ QH]O2_G7WH/J&+_Y\R_\!?\ D=;1
M7)?\+;\$_P#0UZ/_ .!L?^-36?Q/\(:A=1VUMXFTJ>XE;:D:7B%F/H!FFJU)
MZ*2^]">!Q25W2E_X"_\ (Z>BBBMCB"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J@VOZ6C%6U*T5E."#.H(/YU===Z,N<9&,U\!>*O\
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M*** "OD?]LK_ )''0_\ KR/_ *&:^N*XOXB_"/P]\3TM?[9@D\ZVSY4\#['
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/[&WC">))!=Z9AU##+GO^%._X8Q\8_\ /YIG_?9_PK[4MXOL]O%%G.Q0N?7
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M\TS_ +[/^%?;%%=']AX/L_O/-_U\SK^:/_@)\3_\,8^,?^?S3/\ OL_X4?\
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M2?\ KTB_] %:=?:P^%'X76_B2]6%%%%69!1110 4444 %%%% !1110 4444
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M_P!C W_HR2OT.K\\?^"7O_)6_P!HG_L8&_\ 1DE?H=0 4444 %%%% !1110
M4444 %%%% !7SO\ \%"/^3-/BG_V"C_Z,2OHBOG?_@H1_P F:?%/_L%'_P!&
M)0!\$?\ !$G_ )*C\0/^P3'_ .C5K]?Z_(#_ ((D_P#)4?B!_P!@F/\ ]&K7
MZ_T %%%% !1110!XOJ'_ "/,W_7[_6O9QTKQC4/^1YF_Z_?ZU[..E "T444
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MTA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 4444 >6>+_\ D:;C_>3^0KT^W_U$?^Z/Y5YAXO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7P
M1^U7_P EBU7_ *Y1?R%?>]?!'[5?_)8M5_ZY1?R%?-Y]_NJ]5^I^G>'W_(VG
M_@?YQ/N3PS_R+>D_]>D7_H K3K,\,_\ (MZ3_P!>D7_H K3KZ&'PH_-ZW\27
MJPHHHJS$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;=_Y"'A?_<D_G7UC7R=^V[_R$/"_^Y)_.O%SC_<I_+\T?<<%_P#(\H_]O?\
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M#^E;$W^ID_W33Z9-_J9/]TT ?GI_P2]_Y*W^T3_V,#?^C)*_0ZOSQ_X)>_\
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M\FV_S"BBBN0](**** "BBB@#SK]H0D?!SQ-@X_T?_P!F%>+_ +&/_(;\1?\
M7&/^=>T?M"_\D<\3?]>__LPKQ?\ 8Q_Y#?B+_KC'_.OLL%_R),1Z_P#R)^4Y
MM_R6&!_P/_V\^K:***^-/U8**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OD[]MW_ )"'A?\ W)/YU]8U\G?MN_\ (0\+_P"Y)_.O%SC_ '*?R_-'
MW'!?_(\H_P#;W_I+/7_V8_\ DB'AG_KD_P#Z,:O4J\M_9C_Y(AX9_P"N3_\
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MA4N(#N#!>Y*,X_"OV \?^/-#^&'@S6/%7B2^33M#TFW:YNKEP3M1?0#DDG
M')) K\/O^"3%M-<?MF:"T43R+#IM[)(5&0B^7C)]!D@?B*]?_P""K7[5%Q\3
M_B1:? [PS?1V>BZ5>Q+K%U<RB"&:^)PJ.[$ 11!@2QXR2?X: /GGXNZOXY_;
ME\5_%;XPW8>P\+^$[!9T1PS0VT/F)';VJ<\2/N9V([ACCI7TA_P1!_Y*+\3?
M^P5:_P#HYJ] ^(%[\"?@E_P3F\9?#'P9\2_!_B'Q-<Z=')>/IVJP27&IWIFB
M,CJBL6( 7"CLJCW->*_\$?\ XK^"_A5X[^(=SXS\5Z-X5M[O3;:.WEUB]CME
MF82L2%+D9('84 >J_P#!;WQW=P6?PS\&Q[EL[AKK59B#@.R;(T&.^-[G\17N
M_P#P26^&NE>%_P!D/2=<2Q0:IXEO;R[O)Y8QO=%E:"-,GG9LB# =,NQ[U\I?
M\%LD:Z^(_P +]3AE6?3KO1;C[/+&VY'Q*K$@],$.AR/45]Q_\$SYHY_V)_AN
MT;K(!#<J2IS@BZE!'X$8H _*#]L#P_!^S5^WKKLGA9(].@TS6+/6K.&U78D'
MF+'<>6H&, %R,#MQ7ZQ?M]Z@-7_88^(%\!M%UI$,^!VW/&?ZU^5O_!5)A=?M
MP^-EA82'R-.3"G/S?8H1C\Z_3W]L^%[;_@G?XFAD7;)'X;LT9?0CR010!\._
M\$3?^2\^.?\ L7?_ &YBK]E*_&O_ ((F_P#)>?'/_8N_^W,5?LI0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4R;_4R?[II],F_U,G^Z: /ST_X)>_\ )6_VB?\ L8&_
M]&25^AU?GC_P2]_Y*W^T3_V,#?\ HR2OT.H **** "BBB@ HHHH **** "BB
MB@ KYW_X*$?\F:?%/_L%'_T8E?1%>+?MF^!M9^)/[+WQ%\-^'[0WVL7VF,EM
M;*<&1@RMM'O@&@#\Z?\ @B3_ ,E0^('_ &"8_P#T:M?K_7X(?\$SOB7XD^%W
M[6WA_0K)_(M=>F?2M5LYD^\H#''JK*Z@_ABOWOH **** "BBB@#C?BE_R 8O
M^NP_E4?PJ_Y MU_UW/\ (5)\4O\ D Q?]=A_*H_A5_R!;K_KN?Y"@#MJ***
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\G?
MMN_\A#PO_N2?SKZQKY._;=_Y"'A?_<D_G7BYQ_N4_E^:/N."_P#D>4?^WO\
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MZ#\'/A%X?^!?P[TKP5X76Y31--#B!;N8RR#<Q8Y;C/+&@#\</^"Q'_)W"_\
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MTWX[?#74OA]\/-#U/2M*U-D6^U?4V2.6: $,8EB4MM#$ $ECP.G-?6G_  Z
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MNH964C!!!Z@BODWQW_P2U_9\\=ZY<:J_AB[T.>X<R21:+?/;PECU(CY5<D]
M /3% 'Y;>#+'Q!^WS^W(-7MM,GMK;6-834+SREWC3[")EP7;IPBJN3U8C'6O
MUM_X*)1K%^Q;\3$4!573D  [#S4KTCX(_LY?#S]G;1;C3? 7ANWT2.Z*FZN
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MD=:]_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7R=^V[_ ,A#PO\ [DG\Z^L:^3OVW?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]_TKV'2[EKS3K:=P \D:L<=,D4 6J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,;QA_R+5_\ [@_F*YKX:_\ 'W>_[@_G72^,/^1:
MO_\ <'\Q7-?#7_C[O?\ <'\Z^7Q7_(VH^G^9[^'_ .1;5]?\COJ***^H/ "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BNO^/6;_</\J^&/@W_R
M7[3/^PA/_P"SU]SW7_'K-_N'^5?#'P;_ .2_:9_V$)__ &>OL<B_W;%_X?T9
M^5<9_P"_Y9_U\_\ ;H'W91117QQ^JA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\]^A[&6\7T,1*JI82$+0D]UK9?#LMSYN'BWXM$_\?'BC_OS-_A2_\)5\6_\
MGX\4?]^9O\*_0:BNO^QI_P#/^7]?,\?_ %WH_P#0!3_#_P"1/SY_X2KXM_\
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M445TGF!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4R;_ %,G^Z:?3)O]3)_NF@#\]/\ @E[_ ,E;_:)_[&!O_1DE?H=7YX_\
M$O?^2M_M$_\ 8P-_Z,DK]#J "BBB@ HHHH **** "BBB@ HHHH *1ONGZ4M(
MWW3]* /P#_9._P"4AN@?]C3>?^ARU^_M?@%^R=_RD-T#_L:;S_T.6OW]H **
M** "BBB@ I-H/84M% 'DGQ.X\2?]L5_K7IF@?\@2Q_ZXI_*O-/B=_P C)_VQ
M7^M>EZ#_ ,@2Q_ZXI_*@"_1110 45S%Y\4?!FGW4MM=>+M"MKF)BDD,VI0HZ
M,.H(+9!]JA_X6[X%_P"AU\._^#6#_P"+H ZVBN2_X6[X%_Z'7P[_ .#6#_XN
MM[1M>TSQ'9"\TG4;35+0L4^T64ZS1[AU&Y21D4 7Z*** "BBB@ HHHH ****
M "BBB@ HHHH **** ,;QA_R+5_\ [@_F*YKX:_\ 'W>_[@_G72^,/^1:O_\
M<'\Q7-?#7_C[O?\ <'\Z^7Q7_(VH^G^9[^'_ .1;5]?\COJ***^H/ "BBB@
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M#_7_ "3^:7_@)]DT5\;?\-@>,O\ GRTK_OT__P 51_PV!XR_Y\M*_P"_3_\
MQ5'^K6/[+[P_U_R3^:7_ ("?9-%?,GPJ_:BUSQ5XWTW1=8T^S\B_D\E)+565
MD<]"<DY%?3=>-C<#6P$U3KK5JY];E.<X3.J+KX-MI.SNK.^X4445YY[84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !3)O\ 4R?[II],F_U,G^Z: /ST
M_P""7O\ R5O]HG_L8&_]&25^AU?GC_P2]_Y*W^T3_P!C W_HR2OT.H ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M -TT^B@&?GCI_B3_ (0[XI?VW]G^U'3]2>;R-VW?ACQGM7MG_#:C_P#0I_\
MDZ/_ (FO7=<_9_\  _B#5;C4;K1E%S<-OE,3E S=S@=S5'_AF;X?_P#0(;_O
M\U?>5\URK&<LL32DVE;^K-'XQA.&N)<K=2& Q,(PE)OO?[XOH>8?\-J/_P!"
MF/\ P-'_ ,31_P -J/\ ]"F/_ T?_$UZ?_PS-\/_ /H$-_W^:C_AF;X?_P#0
M(;_O\U<OUG(?^?$OO?\ \D>A_9W&?_09#[E_\@>8?\-J/_T*8_\  T?_ !-'
M_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\ 0(;_ +_-1]9R
M'_GQ+[W_ /)!_9W&?_09#[E_\@>8?\-J/_T*8_\  T?_ !-'_#:C_P#0IC_P
M-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\ 0(;_ +_-1]9R'_GQ+[W_ /)!
M_9W&?_09#[E_\@>8?\-J/_T*8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,
MWP__ .@0W_?YJ/\ AF;X?_\ 0(;_ +_-1]9R'_GQ+[W_ /)!_9W&?_09#[E_
M\@>8?\-J/_T*8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?Y
MJ/\ AF;X?_\ 0(;_ +_-1]9R'_GQ+[W_ /)!_9W&?_09#[E_\@>8?\-J/_T*
M8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\
M0(;_ +_-1]9R'_GQ+[W_ /)!_9W&?_09#[E_\@>8?\-J/_T*8_\  T?_ !-'
M_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\ 0(;_ +_-1]9R
M'_GQ+[W_ /)!_9W&?_09#[E_\@>8?\-J/_T*8_\  T?_ !-'_#:C_P#0IC_P
M-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\ 0(;_ +_-1]9R'_GQ+[W_ /)!
M_9W&?_09#[E_\@>8?\-J/_T*8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,
MWP__ .@0W_?YJ/\ AF;X?_\ 0(;_ +_-1]9R'_GQ+[W_ /)!_9W&?_09#[E_
M\@>8?\-J/_T*8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?Y
MJ/\ AF;X?_\ 0(;_ +_-1]9R'_GQ+[W_ /)!_9W&?_09#[E_\@>8?\-J/_T*
M8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\
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MC/O:BBBO@#]M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 4C?=/TI:* /YX_@3XZT;X:_MR:;XC\0W7V+1[+Q1=-<7.TL(U:61=Q
M[ D9K^A>UN8KVVAN()!+!,@DC=>C*1D$?A7\_O\ P4-^$^@?![]K37M(\.12
MP:==F+4C#*^_9),2[A3_ '=Q.!VS7[P_#+_DG'A;_L%VW_HI: .FHHHH ***
M* "BBB@!",BO*=7^'VKMJ5R\,:2Q.Y96#8X)KU>B@#QW_A7NN?\ /NO_ 'W1
M_P *]US_ )]U_P"^Z]BHH \=_P"%>ZY_S[K_ -]T?\*]US_GW7_ONO8J* /'
M?^%>ZY_S[K_WW1_PKW7/^?=?^^Z]BHH \=_X5[KG_/NO_?='_"O=<_Y]U_[[
MKV*B@#QW_A7NN?\ /NO_ 'W1_P *]US_ )]U_P"^Z]BHH \.N/#&H6NI06$D
M0%S,,HN[K^/X5?\ ^%>ZY_S[K_WW7H.I>')KWQ38:HLJ+%;KAD(Y/7_&NAH
M\=_X5[KG_/NO_?='_"O=<_Y]U_[[KV*B@#QW_A7NN?\ /NO_ 'W1_P *]US_
M )]U_P"^Z]BHH \=_P"%>ZY_S[K_ -]T?\*]US_GW7_ONO8J* /'?^%>ZY_S
M[K_WW1_PKW7/^?=?^^Z]BHH \6O?!.K:?:R7$\*K%&,L0^:K:9X<O]8=UM8P
MY09;+8KUGQA_R+5__N#^8KFOAK_Q]WO^X/YUXU?&5*>.IX9)<LE?SZ_Y'J4L
M+">$G7>Z?^7^9S?_  KW7/\ GW7_ +[H_P"%>ZY_S[K_ -]U[%17LGEGCO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]#J_/'_@E[_R5O\ :)_[&!O_ $9)7Z'4 %%%% !1110 4444 %%%% !1110
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M&MO]I;]J3P/^ROX)'B#Q?=N\TY,=CI-IAKJ]D Y5%)  '=C@#/7D5X?^RO\
M\$S/#_[+GQ&M/&FG>/\ 7]6U2&"2WDMQ#%;VUPCC!61/F)7.& ##E0<\<_F_
M_P %._B#>>/?VSO%&G:G>2+I.@-;Z5;* 2(8A&CR,%]2[N?? ]J /I:;_@N)
M,-740_"=#I>_EWUDB;;GLHAVYQ[U]Q?LJ?MC^!/VM?#=U>^&99=/UFP(%_H5
M^5%S;@]'&#AXST##N,'!KY;\.?MH_L3>'/A1!\.X;!YO#"6GV26VG\.2LTX(
MPSN^W)D8_,7SG/(-?!W[&OCZR^%W[<?A:Z\(ZE<#PQ=ZZ^E0S7*!9+BPF<QH
M)%/0D%#Z@B@#]=OVO?VY_#'['E_X8M?$/AW5]<?7HKB6%M,:(",1&,,&WL.O
MF#&/0UY-\5?^"M_PY\#?#?P[K.C:/>:[XIURS6]3P^TR1_848D+]IE7<%) R
M%4,<$$XKP?\ X+C_ /(R?"'_ *]-3_\ 0[:O8/\ @DA^SIX1TS]GZV^)5]I-
MGJGBCQ'<7,:WEU$)6MK:*5H1$@887+1LQ(ZY4'I0!E_ G_@LMX2\=^*;71?'
M_A23P1'>3"&'5;>\^U6L6< &;*(RC)Y8 @#DU]=_M._M)Z'^S)\)SX[U;3;S
M7=,:YAM5BTQX][>;G:P+$ CCU[U^9_\ P60^ WACX=>.?!GC7PWID.D3>)8[
MF#4X+55CA>:'RRDH0#AF61@Q'!V*>I)/V7^P;)I?[2O[#O@ZS^(>BV/BRVT]
MY; P:Q MS')]FD9(7(8'+!-HSUX- 'X[_!KXRZ?\-OVF=!^)E_8W=[INGZXV
MJR6D++Y[H69@H+'&[YAU-?O3^RQ^TUHO[5GPXF\8Z%I%_HUE'>R6)M]1*&0L
M@4EOD)&/FK\/OV:?".B>(_VW?"7AW5=)L]1T&X\4O:RZ9<PJ]O)%YC@(4/!7
M ''M7] 7@3X<>%?A?HS:1X0\/:;X9TMI3,;/2K5+>(N<9;:H R<#GVH Z.BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KQCQ-^RMX4\1Z[>:F)[RR>ZD,LD4+_)O)R2/3)KV>BNO#XNOA).5"
M;BWV/-QV6X/,H*&,I*:6JOT/BWX__!72/A5IVDW&FW-S</=S-&XG((  SQ7N
M7[*G_)(+'_KXF_\ 0C7'_MG_ /(#\-_]?3_^@UV'[*G_ "2"Q_Z^)O\ T(U]
M;C*]3$9)3J597DY;_>?F.58.A@>+Z]##048*GHEY\A[!1117PY^P!7X]?\%.
M_P!KSQ_:?M+1^!OASXRUSP_9Z#:16EQ#H%_+ ;J]E.]@WED%BH:- #G!#8ZF
MOUB^(WCK3OAEX"\0>+-68KINBV,M]/CJ512V![G&/QK\,_V-/"]_^UA^WCI^
MNZQ&US"VJS^*-3,F6 2-_,56(]7,:?C0!WG[ '[:'Q"T+]J?0]!^)/C?Q+KV
MBZT9-#EM-:U":Y6UNG8")]DC':PD54)XPKM]*_;.OP4_X*4_"*[^ W[76J:Q
M8-Y=GXAE7Q)I[HI C=I#YB\ #*RJQP.Q7UK]J?V??BE;?&GX+>#O&EM(LG]K
M:=%--MXVS ;95QVPX88H ]"HKX0_X*H_M.?$?]FS0_AU<?#S7UT*75[B^CO6
M:R@N/-$:PE!^]1L8WMTQG->!?#O]KW]JK]K'X>:7X5^%%L\FO:;$S^)/&4L-
MM;*\CNWEPQL5$<>$Q]T;SMR,#J ?K92,P523T S7X0WO[67[4_['OQ>DT7QM
MXJUC4-0LV1[G1_$=T=0MKJ$G@H[$X5@#AXV!_45^G?[2OQ6^*'B[]E3PWXW_
M &?K>[N?$FMR65W'%:6D-U*EI+$S2 I*I7Y3M4G&010!XEI7_!4&Y^+G[5_@
MGX8^!-$_LWPQ=:Q]BU'5=37==72JK96./I$-R]3DG_9K[._:&MO$MY\#O'$'
M@[[;_P )5)I,ZZ9_9TGEW'VC:=GEMD8;/0Y%?SO_  EU+XA:=\<=&O? \-Q+
M\1X]1=[&*&WCEE-U\VX"-@5)^]P1BOV6^%WQ-^/.A?L/?$?Q=\4S=:1\2]*%
M_/82WNGV\+)"D$;1/Y2+L8;S)U'.#GM0!Y5_P3M\+?M/Z)\:]0F^,LGC9_##
M:3*L7_"0ZD]Q;BXWIMPK2-\V-V#CUK](J_+_ /X)G?MI?&#]H7XZZGX=\>>*
MDUK1X='ENDMQIUM;D2AT ;=%&IZ,>,XK]0* "OC[_@H+^W;;?LG^&K?0] AC
MU#XB:S 9;**9=T-E#DK]HE'\7((5.Y!)X'/V#7\\O[9'B6Y^,G[;?C475QYD
M<WB$:-;LA^Y!&ZP1@9R/NJ#Z9R: .M\$_"K]JG]N==1\2V^I:WK>ER3%FO=5
MU,VEB[@GY(4)"84Y&$7"^U4O$L7[4/[ 'B+3Y]0U77/#MI<R@0.MZ;S2[UD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%>4_'+]J'X;?LZ6MK)XY\11:
M;=78)MM/A1IKJ< X)2)<L1GC-5O@A^UC\+_VAIKBU\%^)8KW4[=/,FTRYC:W
MNXU]3$X!Q0!Z_112$X% "T5\V>._^"B'P*^'GBZ?PYJ/B\W=_;.8[J33;22Z
M@M6!P1)(@*K@]>:]R\!?$'PY\4/"]GXB\*ZQ:ZYHMVNZ*[LY ZGU!]".X/-
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M+^3%(5C4GOA<#/M7SI_P6Z_Y$KX<_P#7_/\ ^BZ]M_X)(_\ )F&@_P#84O\
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M2_;Q_:#\,R?$;PUK_B)M%DWR6XM[Z"PCN F<^3;DKO&00,*<D8YH _::BOS
M_8'_ ."DGBOQ%\1;;X3?&9FGU:[G-EIVM2P"&>.Y7(^SW*@ $D@@/@'=PV<Y
M'VC^U[^T_I'[)WP@NO&&H6;ZIJ$\PL=+TY#M%Q=,K,H=OX4 4ECZ# Y(H ]N
MK\^/^"OGQ@\<?"+P;\-[GP3XLU;PK/>W]Y'<R:3=O 9E6.,J&*D9 )./K7R-
M\/?CE^V;^V3XPU*^\ ^(M71+##31Z5/'IVG6V22L9+$*S'T8LQ YKC/VWOC1
M\:_$>C>&?AM\<] ^P^*/#EU/>0:L42,WL$BJ@QY8\MP#&<2(>>_/- 'Z:_\
M!+3XB^*/BC^RZ-;\7^(-0\2ZN=<NX/MNIW#32^6JQ[5W-S@9/'O7U]7P_P#\
M$>?^3/U_[&"^_P#08J^X* ,;QA_R+5__ +@_F*YKX:_\?=[_ +@_G72^,/\
MD6K_ /W!_,5S7PU_X^[W_<'\Z^7Q7_(VH^G^9[^'_P"1;5]?\COJ_#/_ (+
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M0@CK@@]Z_97X!?L^^#/V;/ -OX3\%:>;2R5O-N+F9M]Q=S$ &65\#<QP!Q@
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M>/(#JWG.""K$$8[+SQS'^V1_P3V\(?M>:KINOW6LWGA;Q38VXLQJ-K$LT<\
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MB9+^^^WO/=0+"L;F-$940$X4[,\D]: /?**** "BBB@ HHHH **** "BBB@
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M2>2: /G73?VM_P!F;X5_L8:_\(O!7B/4;O5;O1+F!KB31[B,WU]+'AY'8J
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M5?[K'>P'Y,#^-?L'^SII<^B_ /X=V-R-L\.@62NN",'R5..:_$GP#X7\>?\
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M8_\ H35X]_P0]_Y$?XJ_]A&Q_P#14M 'R[_P5R_Y/.UK_L$V'_HJOVC^!O\
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M@I5,;3Q2>D5:WW_YGI4\5&&%GAVM9/\ R_R+-%%%>N>:%%%% !1110 4444
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M]W81M(><\MC)Y]ZM_#WX#?#KX4/O\'^"=#\.RX(\ZPLDCDP>HWXW8/UKO**
M"O-?B-^S7\+?B[KD>L^,_ FB^)=4CA%NEWJ%L))%C!)"Y] 2?SKTJB@#PO\
MX87_ &?_ /HDGA;_ , 5KL/ 7[.WPP^%UXMWX3\!:!H%V@(6XLK"-)%R<G#8
MR/SKT2B@ HHHH SO$/A[3?%FA7^C:S90ZEI5_"UO=6=PNZ.:-AAE8=P17$?#
M?]G#X8?!_69]6\%>!M&\,ZG/";:2ZTZV$<CQDABA/IE0?P%>D44 %>:^/_V:
MOA5\4M1&H>+/A_X?UZ_SDW5W8HTK'U+8R?QKTJB@#GO!'P\\,?#71TTKPIX?
MT[P]IR  6VFVR0J<9QG:!GJ>OK70T44 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSQ_X)>_\E;_:)_[&!O\ T9)7Z'4 %%%% !1110 4444 %%%% !1110 4444
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M.L+==D-K:1+%%&OHJJ  /I69XT\ ^&_B-HSZ3XIT+3_$&FOG-MJ-NLR D8R
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M]3)_NF@#\]/^"7O_ "5O]HG_ +&!O_1DE?H=7YX_\$ON/BU^T23P/^$A//\
MVTDK]#-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBD# ]"#2T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %(P#*0>AXI:* /A#XG_\ !*?1
M?&'Q(UWQ1X6^)6O> K?6)!//IFF1ED\W'SMN\Q2=S9;!'&:YK_AT9?\ _1P7
MC#_OTW_Q^OT4HH _.O\ X=&7_P#T<%XP_P"_3?\ Q^C_ (=&7_\ T<%XP_[]
M-_\ 'Z_12B@#\Z_^'1E__P!'!>,/^_3?_'Z/^'1E_P#]'!>,/^_3?_'Z_12B
M@#\Z_P#AT9?_ /1P7C#_ +]-_P#'Z/\ AT9?_P#1P7C#_OTW_P ?K]%** /S
MK_X=&7__ $<%XP_[]-_\?H_X=&7_ /T<%XP_[]-_\?K]%** /SK_ .'1E_\
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M_P!'!>,/^_3?_'Z_12B@#\Z_^'1E_P#]'!>,/^_3?_'Z/^'1E_\ ]'!>,/\
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M@O&'_?IO_C]'_#HR_P#^C@O&'_?IO_C]?HI10!^=?_#HR_\ ^C@O&'_?IO\
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M,$Q1,E@WS#OR!0!\D'_@D9?YX_:"\8X_ZY-_\?H_X=&7_P#T<%XP_P"_3?\
MQ^OT4HH _.O_ (=&7_\ T<%XP_[]-_\ 'Z/^'1E__P!'!>,/^_3?_'Z_12B@
M#\Z_^'1E_P#]'!>,/^_3?_'Z/^'1E_\ ]'!>,/\ OTW_ ,?K]%** /SK_P"'
M1E__ -'!>,/^_3?_ !^C_AT9?_\ 1P7C#_OTW_Q^OT4HH _.O_AT9?\ _1P7
MC#_OTW_Q^C_AT9?_ /1P7C#_ +]-_P#'Z_12B@#\Z_\ AT9?_P#1P7C#_OTW
M_P ?H_X=&7__ $<%XP_[]-_\?K]%** /SK_X=&7_ /T<%XP_[]-_\?H_X=&7
M_P#T<%XP_P"_3?\ Q^OT4HH _.O_ (=&7_\ T<%XP_[]-_\ 'Z/^'1E__P!'
M!>,/^_3?_'Z_12B@#\Z_^'1E_P#]'!>,/^_3?_'Z/^'1E_\ ]'!>,/\ OTW_
M ,?K]%** /SK_P"'1E__ -'!>,/^_3?_ !^C_AT9?_\ 1P7C#_OTW_Q^OT4H
MH _.O_AT9?\ _1P7C#_OTW_Q^C_AT9?_ /1P7C#_ +]-_P#'Z_12B@#\Z_\
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M (_7Z*44 ?G7_P .C+__ *."\8?]^F_^/T?\.C+_ /Z."\8?]^F_^/U^BE%
M'YU_\.C+_P#Z."\8?]^F_P#C]'_#HR__ .C@O&'_ 'Z;_P"/U^BE% 'YU_\
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MPZ,O_P#HX+QA_P!^F_\ C]?HI10!^=?_  Z,O_\ HX+QA_WZ;_X_1_PZ,O\
M_HX+QA_WZ;_X_7Z*44 ?G7_PZ,O_ /HX+QA_WZ;_ ./T?\.C+_\ Z."\8?\
M?IO_ (_7Z*44 ?G7_P .C+__ *."\8?]^F_^/U\T_&O]D37?A/\ M2_"WX30
M_%_Q1J-IXRV>;J<DLB26N963Y4$I#?=SR1UK]JJ\A^(7[,'@[XF?&;P;\3=7
M%X?$?A3;_9_E3%8N'+C<O?DF@#Y)_P"'1E__ -'!>,/^_3?_ !^C_AT9?_\
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M)'J7B"VT:*[U:*U=\VT*_:;C:I(C#8R2<  $]Z_+G]J#XZ>(OVA/&_@/P?\
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M%;/A7?6S,CZKH4MO<A3PZK#,!G]#^% 'Z!4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7SU^V/^U*W[-GA#2(=$TD>(_'?B6[&G:%I&<"28\;WQ
MSM4D<#J2!D5]"U^:/[<'Q>T[X??M_?"?4-<TJ\U^TT#2)9[+2K"/S)KB[E+"
M)$'J75.>U ':^)O"?[:G@WP9<_$.3XBZ!JNJ6,!O;CP3#IJ_9VB4;G17P&+@
M9XSVX-?1/P'_ &H=(^+7[-T'Q6U*V;1+>VM)I=4MFS^XDA!,@7/4'&1]17SW
MXT^-?[9/@;0YO'^J_#?PM-X3MX?M-YX:L[KSKV"#JQ8CDD+G(&<8Z5=_:1_:
M T#XT_\ !-KQ=XY\$C^S;6_MH[:>T155[64S(LL3A>,X/7N"#WH P/AUXQ_:
M@_;*L[[X@>#/&&F?"GP+]HD30K"6P%Q-?(C8#3%@3M)')&.^!Q7K7[(O[37C
M'QEXY\6_"'XN:?9Z9\3O"VV8SV)VP:E;-]V6-?8%2<<$,.AR*]#_ &+])BT/
M]E/X6V<.-B:#;'/J2N2?S)KYK^)K_P#"-?\ !6GX>3V8\M]7\,&*Y*C[XW2C
MG_OA?RH [W]J7]I;Q\?C+X?^!/P6ALO^$\U2 WFHZQJ"%X=+M<$[L=-V 3DY
M[#&37GWC7XG?M&?L27>A^)?B3XET_P"+'PTN[M+35;J&S6UO-/:0X5AM !4'
M..#G&#CBF?LQ>9KO_!3W]H34;N0S2:=9K96X?_EG'NAX'Y?J:][_ ."A.E0:
MK^QQ\3Q.BO\ 9]+:X3<.CJPP: /?],U*VUG3;34+*9;BSNX4G@F0Y61& 96'
ML00:M5X9^P]K%QKW[)GPPN[EF>4Z-#'ENN$RH_0"O<Z "BBB@ HHHH ****
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MM/5X98&&8Q+(06!9<8.>^3C->5_M.>(KO5/^"9_P'M+F5Y5U6738[@N<[PG
MS7Z?^%["+2O#6DV4"A(+:TBA15Z!50 #\A0!X7^QE^TW?_M#>#]:L_%&E+H/
MC_PM>'3-=TY,A/-'21 >0K8/'.#WKZ(KX!_9MC.A?\%._C[86[L+:_L([N2,
M'Y?,+1G./7D_G7W]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0\-Q:RQ.K="K(01^M?$__!(O499/@=XQTLD_9=.\3W4<"]E#8)Q0!]U4444
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M^V)!=ZY(IZMDYQCGT7/<\C] ?AW;> O ?A[2_"?A"XT:PTVT00VFGV-S&?R
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M"R#MGG!KSCX;_P#!.'X4> O%]EXFU!M;\;:M8G-HWB:_:[B@;((94/&1@=:
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M]7O=<T&VO=6\37BF.;7-;N3<W6PXRJL1\H.!GO[U[Q0 4444 %%%% !1110
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M219(=!U#5GDLE(/ *8Y7VXKZ]TW3;71M/MK"QMX[2RMHUBA@A4*D:*,!0!T
M% %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @OII+:QN)H8?M$
MT<;.D0.-[ 9"Y[9/%?/7[)?[8EA^TO-XMTF_T9?"'B[P[J#VESH,]T)9C&./
M-'RKD;@RG XQ[U]&5\W_ !J_8&^%WQJ\8R>+KB+4_#'BF52)]5\.WAM)+C(
MS)C[QP!SQ0!\_P#_  5)U2R^)_BOX-?";P[<+?>-[CQ(E\8+4AY+6$(5+/C[
MOWMW/9":L?MU69^$'[3?[.?Q<U.21/#^E3IHVIW2C*Q+N)W,>P(D;\C7TG\
M_P!C#X:_L[ZO>:WX?L;S4_$EVNR76];N3=W87'*J[#Y0<<XKU#XB_#CPY\6/
M"%_X8\5Z5!K.B7R;)K:X7(]F![,#R".10!@_&+XN^'?AO\&]>\:WVK6B:3#I
MTD]O<"92EPQ0^6L9S\Q8D8Q7PM^SK\"-:\6?\$R?B)%]@E36O&*W^LV-J_!D
M .Z$_P# MI_,5[/I/_!+'X.V&J64E[=^)]<T:R=9(-"U/5GEL@1T!3'*^W%?
M7FGZ=:Z3I]O8V5O':V=O&L,,$2A4C11@* .@ % 'S1_P3F^+.E?$K]EGPE;6
M]Y"=6T"W_LS4+(N/-MWC) W+U *X(/\ A7B^B7EO\?/^"JW]N>'[I-2\/?#[
M0V@N;RW^:+[2R/&4#C@_-)V_NFO7_B3_ ,$X/A1\0/&.H>)K.37/!VI:DP:^
M7PWJ#6D-P<DDL@&,G)S_ "KV#X$_L]>"/V<O"1\/^"=*^PV\C^;<W,S>9<73
M_P!^60\L: /2:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\YOV
M_K&U^%?[87P(^+FM6H?PI'<"PU"\D7,=JZME&;Z*S-_P$U^C-<U\0_AQX;^*
M_A.^\->*](MM:T6\7;+;7*;AGLRGJK#L1S0!E_$KXB^&/#7PDUWQ5JFK62^&
MUTV6;[89E,4R&,X"G.&+= !US7YV?LQ_!C6_B!_P3-^+-E#9RVT?B+4+S5M'
MM-O+1QB-EVCODQ%1_NU]!V7_  2K^#UO?6HN;_Q5J6A6TBRQZ#>:P[V>0<@%
M,<K[?K7UUH>A:?X:T:STG2K.'3]-LXE@M[6W0+'$@& H Z"@#YT_X)V_%/2/
MB'^REX*@M;^.74]!L5TS4[=F E@EBROSKU ( ()KQ;PKJ5M\?_\ @J7J&O:%
M(NH^'? /A\6%QJ-NP>+[2Q.$##@_,SCC^X:]8^(W_!-SX3^//%^H^)+*37?!
MU_J;[[Z+PYJ#6D%P226)C QDY.>W/2O8_@5^SYX(_9S\(?\ ".^"=*%A:R/Y
MMS<2MYEQ=28QOE<\L<4 ?'GA&\L_V?\ _@J?XSC\0W0T[3/B-I"S:==7!V0R
M7&4.P,>,_NV'U8>M>H_\%//B?IO@W]F#7?#9N$DU_P 5E-*L-.1AYT^]AN95
MZD#'7WKVGX]_LV^!/VDO#D&D>--+-R;63S;._M7\JZM']8Y!RN<=.E>7?"O_
M ()V?"OX9>-[/Q9,^M>+]:L#FQD\27YNTM2#D,BD=1ZG\J /6?V;? <_PR^
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M]G#4;_5_#UK>:EXCOUV7&N:S<&YNV7C*AS]T' Z5[I0 4444 %%%% !1110
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M &IX]_:T_;#\"^&I?B1J?PDT?3? T.)I--E;?<PPDC#2 -O7@C)QQFNIM?\
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MP#I&HQ-9:RR2*\17R&42.<Y.66/MVH _4&BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img117130267_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117130267_3.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" )-!>0# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Y&_X(&_\
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M .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\
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M (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\
MB:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")
MH_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC
M_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^
M((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@
MBOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*
M_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]
MD_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3
M_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_
M .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\
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M (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\
MB:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")
MK]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FO
MVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;
MJB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ
M* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH
M _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#
M\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q
M%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7
M_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^
M((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@
MBOV3_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*
M_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]
MD_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3
M_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_
M .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\
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M (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\
MB:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")
MH_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC
M_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^
M((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@
MBOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*
M_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]
MD_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3
M_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_
M .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\
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M (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\
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M!(GFLSA7B8'DGD, >*^UJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-K=;=ES;,1_%%.DL1]T- 'K5%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ."K_P"S9\-=+M]+\':;X7;Q!I&B6,8CM[&?4?#9N+A(HU&V-3(Q(5< #
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M3PAX\\$_$#3&UKP!XRTG7+-93&UYH^H17,2N!DJ6C8C/(XSGFOSW_P"(4?\
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M89C(E13E<$@8Z4 ?2E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YJ_\ !1OX[?\
M!2?XQ_\ !4[P5_P3I_X)U?M;Z?\ "3R?A+=>,?'&O7W@G3]:C*M=^1;(RW<$
MA1B48 (5R&).<"O7?V'/V6/^"Q'PB^-R^+_VWO\ @J'H7Q;\$C2YXF\)Z?\
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M7WAG5_%O[.K6NHV<MK<B.S"L8Y$*-@]C@FO)_P!A7_@GU_P<Z_\ !.SX&?\
M#/'[./B3X#P^'/[;NM5V:U)]JF^T7!4R'>5'R_*,#'% '[A45^47]D?\'>/_
M $-_[./_ ( BC^R/^#O'_H;_ -G'_P  10!^KM%?E%_9'_!WC_T-_P"SC_X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *_.O]M#]ESX<_#;_ (*X_LN?M#:!
MK/B>;7/&?Q(UF+5K74O%%U<Z?$J:#<8^SVDCF*W/RC)103SGK7Z*5\3?\%!?
M$?A_4?\ @HE^QOH=AKMG-?6GQ,UPW5G#=(TL(.@W6-Z Y7\10!]LT444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?F9^UC^PK_P4L_9$_;Y\8?\%$O^"1VA^"/&7_"U
MM+MH/B=\*?'&H&SBGOX%6.._MI3)$O*@,RF5"&#GYP^U=;]B_P#8,_X*&_M$
M_MP:+_P4I_X*XW7@W0]=\!Z'/IGPJ^$_@6X-Q::(US_Q\WEQ/O=3*1A0JR2[
ML*2RA K?H[10!^8O[7W[%7_!5C]E+_@H3XN_X*#?\$EM'\"^,K'XK:/8VWQ.
M^&?C3419K<7UHOEPW<;N\2\1G[PF1A\PVL"*ZG_@F9^PE^W_ *U^V?XF_P""
MGW_!5+5/"MG\1-1\))X6\$^!/!]P+BT\.Z49!-*&D!9/,9^/E>0G+$OR!7Z(
MT8[8H _)/4_V._\ @M]_P3$_:.^*FI?\$L/ GPW^*'PB^*OBRX\4P>$?%^LI
M9W'AW5;E +AU$DUN""40?+(X8*A**0:^C/\ @C[^P!^TM^S1JWQ2_:R_;L\<
MZ+KGQN^-NM6UYXJ7P[\UCI-E:HZ6ME"Y5<A1(Q.T;1\HRV-Q^X** /R2_P""
M@7Q?^%_P*_X.;_V9_B7\9?'^E^&?#]C\'_$"7FLZU>+;V\+26VH1H&=B -SL
MJCU) K]&O@Q^VO\ LD?M'^)9O!OP%_:-\'^,-5MK4W5QI_A_7(KF:.$,%,A5
M"2%!91GU(K\S/^"H7[,GP(_; _X.1_V;_@%^TC\.[?Q5X0U?X0:Y)J6BW=Q-
M%'.T,-_-$2T+HXVR(K<,.G.1Q7WU^R5_P2<_X)Y?L+_$&\^*?[)O[,VE^#/$
M%_IC:?>:E8ZE>S-);,ZN8R)YW7!9%.0,\=: /HRBBB@ HHHH **** "BBB@
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MA<Z7#.WBRZ^.NG>'6%TS.)+?[)<6DKD( A\S=AM^ !M.0#Z:HKX9_P"&YO\
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MTY_X.J?V7=O_ $1OQ)_Z1ZE7ZE$XZT (H(&#2T9STHH **** "BBB@ HHHH
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M?V'/^"RUU^RG^UM_P47^(GQ2CU?X7W6N?#NWUFXD.G:S;B6..X\^&2:0V]W
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M8L[6>%6FB.)$VSQH^03_ '<>E 'I5%%% !1110 4444 %%%% !1110 4444
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M<_!]O9:E-X$_L^\G\36B176S3;T/Y;F3#[20#M)P2,T ?H)17 _\-6_LN_\
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MXUZ/\3-?^#OBS0_@IXEL=%\:7OAF_M_".L:I"9+:QU1[=UM9Y5"L6C28QLP
M)*J1@]*ZJO)_VZ/C9XH_9K_8P^*W[0G@G2([[6/!/P[UC6]*M9HRT;W-M9RR
MQ[P.2@906_V0: /S3^*5G_P7Q^".L1>'?C%_P6Y_95\+ZA,H:.PUZW6UG*GH
M=DEJ&P?7&*]N_P""8O\ P35_: M/VJ+C_@IY^W%^W-X=^-WCRY\*R^'O!TO@
M.W4:'I-A)(&D:&1=HE=@,<(H7>^2^01XW_P2>_X(7_\ !/S]K[]C;PK^VW^V
M_P"$KOXW?$WXMZ:VO>)O%7B3Q5?;8I;B1F:"*.VGC1"F I)!92"%*K\M;7[$
MW[/_ (8_X)0_\%RV_8+_ &6?%.L/\(OBQ\);SQ5-X%U+6)+Q?#.I6DRJLL32
M%G$<B[D^8[CN7+-M% 'ZP4444 %>7_MEZA^TAI7[+GCB]_9 T:UU#XH+H,J^
M![6^\GR6U!B%B,GG,L>Q2=QWD+A>:]0K\-?VJ_\ @M-_P5'_ ."3?_!5[4/#
M_P"WYH.K>)_V<;F:Y_X1UO"_A&QC6\TZ5]T%W%<[%,ES!GRW@>:,$CD#<KD
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M@/X#^,K.WT_6)+GQ!J7BBRC6.QN)U2-YY#;R2*EM;Q>8[2,RL^<! < _9?\
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MF+X/CLM-NK?^U5F%U]J)^T7$V[RS%;_=VX\WG.1CZ<_:-^(-G\)OV?\ QO\
M$[4)_*A\/^$]0U"2;^Z(;9WS^E?,O_!(3_@GM^VK^P38^/K7]L3_ (*'^*OC
M[)XHFTQ_#\GB;5-2N3HBVXNA,(_MUU/M\[SHL[-N?(7.<#'N'[?6NOX6_8K^
M*/B ?!B'XC16?@G4)KSP'<3-&NNVPA;SK3<H)R\6]0 .3@=Z /Y0?^"?WQ*_
MX(CR>&/$7B#_ (*K?#;XN^(O&GB+QQ)+I<WP[F1+33-.=(F::Y9KN%G)FDF.
M(TD<+'T)8"OZ=O\ @CO\/?V"/A[^P_X?M_\ @FUK]QJ7PNU2^N=1T^:^U*6Y
MGCN96S-'*9?GC=6&#&V"IK\R/V&?^"G?_!#+Q3_P1T^+G@#XC_ CX7_!W4/L
M>O6^K?"2.1KK4-=EFBD:SGM);K=<W<I,BQH^XFU>,8,4:1D>N_\ !F/X#^*W
MA7_@G-XT\2^-+2ZM_#WB'XF377A&&X4XDB2SMXIYH\_\LVE3:/\ :B<]\D _
M8*BBB@ HHHH *** 0>E !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %?&?_  42_P"3_P#]B_\ [*=KO_IANJ^S*_.3]LO]HK7O'W_!7[]F
M'X&7_P"SE\0- L?"?Q&UF2U\=:YI,<6BZZ7T&XRME,)"TC+NYRJXVF@#]&ZI
MZUI&F>(=(NO#^N:?'=6=];O!>6LR[DEB=2K(P[@@D'V-7*^;?^"OWB;Q1X*_
MX)?_ !W\6>"O$VHZ-JVG_#/5)M/U72;Z2VNK640G;)%+&0T;@\AE((- %/\
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MU\WPTTTFQ!P-TLCN?4L37Z'5\-?L _\ *9?]O_\ ["OPQ_\ 44% 'W+1110
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MR^(G_92M7_\ 1BT4 ?L5_P &1?\ R:=\:O\ LHEG_P"D"U^W5?B+_P &1?\
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MTG3X[:+=Z[8U S^%7M0TVRU:QFTW5;.&YMYHS'-;W$8=)%(P593P0?0U:HH
MYWP7\)OA?\-S.WP[^&N@:"US_P ?#:+H\%KYO^]Y2KN_&N@*;AL8<4ZB@#E_
M#_P9^$7A/Q%)XP\+?"OPWIFK3;C-JFGZ';PW,A;[V9$0,<YYYYKP7_@M7//:
M?\$DOVC)X+5IF/P?UQ-B]E:T=2W_  $$M^%?45?,O_!9\?\ &I?]H\_]49\0
M?^D,M 'YC?\ !)G_ (*P?\%(?@?_ ,$Z?A1\)OA#_P $3_B)\1O#6A^'#!I/
MC;2=>\JWU>/[1*WG(OV5L#)*_>/*FOVG^'NK:O\ %GX+Z'K_ ,0_ UUX>OO$
MOA>UGUSPW<W#>?IDUQ;*TUHSJ%.^-G:,L IRN1BOF#_@WM);_@C!^S]_V);?
M^EEQ7V70!YK^RK^R=\!OV*/@S8_L^_LT^!O^$=\)Z?>75U:Z?)J5S>/YUS.\
M\TC37,DDLC-(['YG.!@#   A_9M_8]_9Z_9&M?%EM\ ? ;:+_P )UXPNO%'B
MJ2;5KJ\DO]5N=OG7!>YED9<[5PBD(N/E45ZA10 4444 %,EB2:-HI$5E8896
M&01Z4^B@#XI^)_\ P;R?\$<OC#\5I_C5XX_8HT637;JZ-Q=_V=K&HV5I<2EB
MS.]I;W"6[EB23F,[N^:^O/ /P^\#_"KP;I_P[^&OA+3]"T/2;5;;3-(TJU6"
MWM8E'"(B !0/85M44 %%%% !4%]<)96<U[(/EAC9VV]< 9J>J?B/_D7K[_KS
ME_\ 0#0!^79_X.QOV(KK5=4TOP]^S?\ &;6%TG5)M/NKK2?":W$(FB;#+N20
MC/0X/.&![UX7_P %#?\ @Z/\?>*O@(NF?\$Y/@5\5/"_Q _MJW=]2\6?#=;B
MU^PX?S4VNKC>3LP<=CS76?\ !K:"?V-OC$V?^;EO$7_I!I5?IA5<I/,?@'^R
M5_P<P?\ !8_0_P!HWPGJ_P"U_H^O:W\-(-2+>+M*T'X1P0WES;>6^%B=8%*M
MOV'AAP#7Z,?\17/[(O\ T:)\>?\ PA6_^*K[DI"N3FCE#F.,_P""9/\ P5)^
M!O\ P50^&_B?XF_ KPIXDT>U\)^)/[$U2T\362P3BY\E)3A59N ' .<$$$8K
MZ<K\J?\ @UU_X\OVOO\ LZC7?Y+7ZK5)04444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5\9_P#!1+_D_P#_ &+_ /LIVN_^F&ZK[,K\Y/VROB?^TQXD_P""
MO_[,/P_^(G[+EKX;\ Z-\1]9;P?\1(_'UO?2>(G.@W&]&TY(5DLMN6Y>1\[>
MV: /T;KYB_X+1?\ *)_]H/\ [);JO_H@U].U\Q?\%HO^43_[0?\ V2W5?_1!
MH ]J_9R_Y-Z\!_\ 8F:7_P"DD5=G7&?LY?\ )O7@/_L3-+_])(J[.@ KYM_X
M+%_\HI?VBO\ LCGB#_TAEKZ2KYM_X+%_\HI?VBO^R.>(/_2&6@#T#]AW_DRS
MX/\ _9+?#_\ Z;8*]2KRW]AW_DRSX/\ _9+?#_\ Z;8*]2H **** "BBB@ H
MHHH **** "BBB@ KXS_8@_Y2H_MF?]AKP;_Z8(*^S*^,_P!B#_E*C^V9_P!A
MKP;_ .F""@#[,HHHH *^&OV ?^4R_P"W_P#]A7X8_P#J*"ON6OAK]@'_ )3+
M_M__ /85^&/_ *B@H ^Y:*** "BBB@ KX9_X.3O^4)GQR_Z\=%_]/VG5]S5\
M,_\ !R=_RA,^.7_7CHO_ *?M.H ^YJ*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH ***1_NT ?F%\=1_P4'_ &/?^"OOQ,_:@_9!_P""97B#
MXI^#?B9X3T2R\::K#XRTNR%Y?65I''#=6?G2K(FR,+;R12+M8PAU89(KVCX-
M_P#!0?\ X*2>/_BIH/@OXB_\$9/&_@W0]3U..#5/%-]\1M%N(=+A8_-.\<4I
M=PHYVJ"37EOQP^+O_!3;]M#_ (*I?$[]AK]D[]J70_@3X)^#?AG1+W4O$%UX
M'37-0\07&HVB7(DBADFA'DH9/))#J T3?>)P/4/@S^P?_P %7O WQ6T'QA\5
M?^"SZ^,O#FGZG'/K7A4? 6TL/[4MU/S0?:%U.0P[AQO",1Z&@#[8HHHH *0K
MDYS2T4 <%>?LO_LU:G=2ZCJ/[/'@6XN+B1I)YIO"-FSR.3DLQ,622>23R:^1
M/^"37_!,'QC^QM^T9^T=\6/B_P##+P;#;^/OB@NM?#6ZTN.":>QT_9,I48C!
MM3\Z_(IQ7WQ10!^:?[8'_!/O_@I[\"O^"@GB/_@HA_P20\<^ )[KXC:+9V/Q
M+^&_Q(65=/U2XM1LANMT;(VY4Z%)(W!##)5R#T__  3._P""=W[<FB?M@>+/
M^"E?_!43XH>&=<^*FN^%X_#7AGPWX-A(TSPUI7F"62&(D<Y<#NS'YF9V+5^@
MM% 'Y1ZW_P $_/\ @M)_P3S_ &FOBIXV_P""2_C#X4^)OAC\6O$TWB.Z\!_$
M_P ]%T'5)UQ-/ 8GC.XE5&0Y5E";T)0&OH;_ ()$?\$Z?CS^R!+\3/VC/VSO
MBU8^-OC9\:-=@U'QKJVDVXCL[6"W1TMK.$;5&Q!(_1549  (7-?:U% 'Y)_\
M% OC!\)?@7_P<W?LS_$KXW?$_P .^#?#=C\'_$"7GB#Q5K4&GV-NTEMJ"1AY
M[ATC0L[*JY899@!DD5^C?P:_;7_8V_:.\23>#?V>?VMOACX\UBVM3=7&D^#?
M'NG:I<Q0!@IE:*VF=E0,RC<1C+ 9YK\R/^"I'[+WP/\ VQ?^#D']F_X ?M&^
M!(?$GA'6/A#KDFH:1<3/&LS0PW\T1)C96^61%;@]J^]_V0_^"2O_  3^_8/^
M(-Y\4_V5?V>;'PGKVH:6VG7>H6M]<2-);,ZN8\22,,;D4],\4 ?2-% &!BB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OR>_X-:/]1^UM_V<
M=JG_ *,FK]8:_)[_ (-:/]1^UM_V<=JG_HR:@#]8:*** "BBB@ SSC%>-?$3
M_@HA^P!\'_&VH?#?XM_MS?!WPOXBTJ18]4\/^(OB;I5C>V3E0X66":X62,E6
M5@&4$A@>A%>R,N[O7R3^T!_P0S_X)<_M1?&'7/CW\<_V5],U[Q7XDN$GUK5I
MM1ND:YD6-(E8A)0HPB*. .E 'R5_P:NZ]H?BA/VMO$GAC6K74=.O_P!H:ZN+
M'4+&X6:&YA>(LDD;H2KJP((8$@@Y%?K97Y%_\&HG@SPY\.]%_:N\!>#].6ST
MG1?C]<66FV:L6$,$4)1$!)).% '-?KI0 4444 %%%% !1110 4444 %%%% !
M1110 5'<?ZB3_=/\JDJ.X_U$G^Z?Y4 ?Q?\ @C_D<OB)_P!E*U?_ -&+11X(
M_P"1R^(G_92M7_\ 1BT4 ?L5_P &1?\ R:=\:O\ LHEG_P"D"U^W5?B+_P &
M1?\ R:=\:O\ LHEG_P"D"U^W5 !1110 4444 %%%% !1110 4C*&&#2G..*^
M#OVI?^"NW[5'[/GQ\\1_![P%_P $=/CU\1M)T.[6&S\:>%=&:33]34QJQ>%O
M+.5!8KU/*F@!/VDO^#;?_@D]^TU\4-0^,'B+X'ZEX:US6+HW.M/X'\13Z9;W
MTS$EI'MT)B5F)RQ15+'DY))/T!^P_P#\$YOV._\ @G7X%NO '[)?P:L_#<&H
MS++K&I/-)=7^I2#.&GN9F:20#)PN0BY.U1DU\@_\/WOVV/\ I /^TU_X(&_^
M-5['^PO_ ,%/_P!I#]K3XY?\*E^*?_!*WXT?!_2SH]Q>_P#"8>.]+,-B)(R@
M6WW%!\[[CM&?X30!]FT444 %%%% !1110 4444 %?+O_  6LO38_\$DOVC)U
M@:3=\']<CVQ]1OM'7=]!NR?85]15\S?\%G?^42_[1W_9&O$'_I#+0!^6'_!*
M?_@O_P",OV6O^">/PK_9^T__ ();?&SQK#X7\.FTC\5>'-.9['4A]HE?S(2(
M6ROS;>IY!K]PO@[X_N/BM\)/"WQ1NO#-[H<GB3P[8ZJ^BZDNVYT\W$"3&WE&
M!B2/?L;@<J>!7RW_ ,&]W_*&+]G_ /[$MO\ TLN*^RJ "BBB@ HHHH ****
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MCG_^4] 'V57S;_P6+_Y12_M%?]D<\0?^D,M</_PTE_P6]_Z1>_"/_P 2.?\
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M/6$T_P #:*S"XOEE2^BD9=JL?W<;M(>.B&OLS_@G#_P43_;]_:T^,VI?#_\
M:G_X)>^+O@GH-GH,E[:^)M>DE,-S<"6-1;#?&HW%69NO1#7B?[5HV_\ !U3^
MR[M'_-&_$G_I'J5?J50  DC-%%% !1110 4444 %%%% !1110 4444 %%%%
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M7_V9OA9X@\9_&7]EGXE:;J'[27[36O>)M.\/V_AM9;CP?I]W9V\<$^M*)?\
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M;XBO(Y[7P7X7NF6PTM5ACC,<(%PO!*%S\HY<U^@U?#O[3?\ P<1_\$J/V/\
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M/B33TO=&U:R?='<0MW'H0<J0>000<$&OE[_@K+_R5_\ 8U_[.VTK_P!,&N4
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MV^%>N?&SXS^+K?0?"_ANS-WK6L7BMY=K"&"[VV@G&6 X'>OE?_B(B_X(T_\
M1]GA/_OW<?\ QN@#[4K\GO\ @UH_U'[6W_9QVJ?^C)J^C3_P<1?\$:<_\GU^
M%/\ OW<?_&Z_.?\ X-]/^"L/_!/G]DN+]H\?M#_M+Z)X7_X3+XX:AK7AG[<D
MW^GV+R2[9TVH?E.1UQ0!^]E%?%?_ !$1?\$:?^C[/"?_ '[N/_C=>A_LO_\
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M&X?_  1>^)/C/5OB%XY_8MBU#6M<U&:^U6_E\>>(%:XN)7+R2$+?A1EB3@
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M.7_T T ?CG_P:V_\F:?&+_LY;Q%_Z;]*K],*_,__ (-;?^3-/C%_V<MXB_\
M3?I5?IA51)D%%%%42?"/_!KK_P >7[7W_9U&N_R6OU6K\J?^#77_ (\OVOO^
MSJ-=_DM?JM69H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 (PRM?"/_!*_XC^/?VD[OXY?&_X[_M1ZHVK:AX^UKPBO
MPOAOHK2U\"V>GW<\$#PPX!6YGA9+AKA@2XDCR3L&/N^OQO\ VAH/V7/^"@G[
M07C;XL?!/_@A9\1OB_!H_B2XT#7/BGX3^)"^$(-?O[-VAG&(]0M6O5C93&7<
M/R"#C % 'UG_ ,$@?'OQ'LO%?QR_93\0_M#ZQ\7/"_PA\;VFE>#_ (@^(;[[
M9?SPS623RV%S=CBZEMW.TR$EL, W(K[= P,5\O\ _!+;3=1\'_ Z^^&<7_!.
M2^_9MT?0]2VZ3X9O-<L+\ZGYB[Y+KS+.:7+;N&:5B['GFO9OV@?'/Q<\ ?#J
M75O@9\'O^$X\37%U';:;HLVL1V%NC/G,]Q.X.R%,9;8KN<@*I)H [JBOA/7_
M /@GW_P51_:"U2;QE\?/^"O&N?#_ .T?-:^"_@;X-M+&PTT==GVR[\RYNCZM
M)CIQ@' T/ WP,_X*]?L<7O\ :7A[]K+1_P!IGPA&V;SPK\0=!@T7Q%%'_P!.
M>HVI\F:3 ^[<IACP&3J #[<HJGHM[<:EI%KJ=WILUG-<6Z226=QCS(&902C;
M21D'@X)&1Q5R@ HHHH **** "OC/_@HE_P G_P#[%_\ V4[7?_3#=5]F5^=?
M[:/[*/P2^&'_  5Q_9;_ &D/!NAZM#XN\;?$C68O$5Y=>*M1N;:94T&XV^7:
M33O;6Q^4<PQH3WSDY /T4KYC_P""T1_XU/\ [07_ &2W5?\ T0:^G*Y?XR?!
M[X=?M!?"KQ!\$_B]X936/"_BG2YM.U[29+B2);JUE7:\9>)E=<CNK CL: ,G
M]G/7-%7]GOP&K:S:@CP;I>1]H7_GTB]Z[+^W]"_Z#5K_ .!"_P"-?(]O_P $
M%O\ @EC;PK!;_L[:K''&H6.-?B7XB"JH'  ^W\"O#/\ @IS_ ,$=_P#@GS\!
M_P#@GU\8/C)\)O@[K6D>)?#?@._O]#U2/XD:_(UK<1QY20+)?,C8/9@1[4 ?
MI6=?T0CC6[/_ ,"%_P :_([_ (..HK']F:_U?]L/PO/&-+^+7P-\2_"?XB?9
MY@5>5K.XO-&N' .-PG$T&[J?-B7HO'TI\$_^"'7_  3-\5?!KPCXFU_X#:Q<
M7VH^&;"ZO;AOB5XA4RS26\;NV!?@#+$G@ 5R'[;_ /P;G?L#_&']DWQYX$^!
MOP8OM+\<W/ARYD\%ZC>>/-9NHX-4C0O;;H[F\DB*M(H1BRG"NQ'(!H ^QOV'
M2?\ ABOX/_\ 9+?#_P#Z;8*]2KYW_P""4W[0'AW]I?\ X)[?"GXE>'=&CTMX
M_"-II.K:+'N']F7UE&+2XML,2R[)(6 #$L%QDDU]$4 %%%% !1110 4444 %
M%%% !1110 445\[?M/?MJ?&WX!?$M? WP_\ ^">OQ6^)]@VFQ7/_  DG@UM.
M%F)'+@P?Z1<1OO7:"?EQAQ@]: /HG-?%_P"PJ<?\%7/VU,_\]O /_ILOJD/_
M  5!_:G_ .D-7[07_?S1O_DRO ?V<_VDOVV/@[^VE^T!^TEKO_!(GXY7&D_%
MB3PRVBV=M)I'GVO]G6=Q!+YN;O'S-,I7!/ .<4 ?J517QF/^"H7[4HX/_!&K
M]H+_ +^:-_\ )E>[_LI_'[XA_M#^"]0\5?$?]E[QI\*;JSU0VD.B^-VM3<7<
M?EH_VA/LTLB^7EBG)!RC<8Q0!ZK45Q#%<0M!<1J\;J5=&7(8'J".XJ6B@#\X
M?BCX%\9_\$.OBQJO[3_P,T/7M>_9=\9:TU[\6OAWI<37<GP_O9F'F:]IL(RW
MV-CS<6Z9V_>4< #NO^"D'Q$\$?%GQ)^Q!\2_AIXIL]:\/ZY^U1HMYI.K:=.)
M(;J"3P]KC)(C#J"#_C7VYJ%A9ZI93:;J%I'<6]Q"T5Q!-&&21&&&5E/!!!((
M/45^+/\ P46^"4O_  1N_:7^ /Q-A^)0M?V29OVC]/\ $+>%;Q6GF\!:Y_9N
MJ1R16.,M_9\T4\TQCY\IH % #'< ?M=15#P_X@T/Q;H-CXJ\,:S:ZCIFI6<=
MWI^H6-PLL-S!(H>.6-U)5T92&# D$$$5?H *XW]HO_DWSQW_ -B;JG_I)+79
M5QO[1?\ R;YX[_[$W5/_ $DEH \9_P"",G_*)?\ 9P_[(QX>_P#2"*OIBOF?
M_@C)_P HE_V</^R,>'O_ $@BKZ8H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "@Y["B@G'6@#\\?VQ/^"57_!03XI_\%#KK]O7]CG]OWPW\)+R3PW:Z
M)_9__"N1?2WUG'&NZ&^9IA'>+YN]XV>/?$'VJP &/-_BI_P1S_X+(?&WX]^"
M_P!HGXL_\%:? ^NZM\.;J6[\%Z7>?!E?[,TR[D38UTMJER%DG"\+))O9?X<5
M^C7B3]I3X"^$OC?HO[-WB+XK:/:>//$6DW&J:-X5DNO],N;*#_6W 0?=C7!^
M9L [6QG:<>"?L]?\%NO^"<'[4'[3MU^R3\'OCJM]XNCNKFUT_P"T:;+!9:M-
M;_ZZ*TN' 2=E'. >1RN10!Z+^Q3\+/VX_A;X<URR_;=_:C\._%#4KJ^C?0[[
MP[X)714LH F'C=!*_F$MSNR,#BO<J** "BBB@#\[/VL/^"7/[</PW_;A\2?\
M%$/^"2'QR\"^$_&'Q!TNWLOB5X(^)5C<2:'K4L*+''>!K9'DBE"*I(51N<%B
M?G;.C^Q7_P $MOVNK_\ ;2M_^"D7_!5']H/PWXZ^)FA>'6T7P'X7\":?+!H'
MAFWDW&5XO.57ED8N_P [*&^;DG:@7] J* /SE_; _P""9/\ P4/\$?MWZ]_P
M4+_X).?M%>!_"WB+QYH=IIOQ&\#_ !)L[A](UIK;"PW):".1Q(J]"%5A\P#A
M7<'I_P#@FU_P3-_:T^%W[57BS_@H=_P4D_:$T'X@?&+Q)X<B\.Z3:^$;.2'2
M?#NDJXD:VMO,2-F!< Y**3RS;F8FOO.B@#\M_$__  2Y_P""N'[&?[2WQ.^*
M/_!(G]I_X6V/@7XM>(9/$&M_#WXL65V;?2M4E7$MS:M;PR_,V!S\H90@</Y:
MD?07_!)[_@FU\4/V((OB-\:?VGOC;#\1OC-\8O$$.J?$#Q59VGD6V(%=;>U@
M3"XBC$CX^50 V H  K[&HH _*+]MOQIX1^'W_!T1^S'XI\=>*=/T;3;?X.^(
MEFU#5+Q+>&,M:ZBJ@NY"C)( R>2<5^E_@GXZ_!;XFZG)HGPX^+GAG7[R&$S2
M6NC:Y!<R)&"!O*QN2!D@9Z<U^3G_  5:_9,^ 7[;W_!QK^SC^S?^TYX$/B3P
M;K7PAUN74]'&J75GY[017\\1\VUECE7;)&C?*XSC!R"17W;^Q9_P1J_X)P?\
M$\OB5??%_P#9 _9W;PEXBU+2FTR\U!O%VKZAYEJSI(8_+O;N5!\T:G<%#<=<
M$T ?4:?=I:1<#@&EH **** "BBB@ HHHH **** "BBB@ HHHH **,T9H ^._
M^#@''_#FG]H3'_0AO_Z40U\H_L$_\$_OV#?&/[%?PL\5>+OV)?A'JFJ:AX%T
MVXU#4M2^&^ESW%S*T"EI))'@+.Q/)8DDFI/^#F3_ (*]_LA?"G]D3XE?\$]-
M$\5_\)5\4O&6A#3[K0]!D69= 0R1RM)>N"1$PC0L(N7P5)"J0:^;/V/_ -M[
M_@LKX4_9:^'_ (;^&/\ P25L_$7AVQ\)V,.BZ\WQ(LX#?VRPJ$F\MGRFY<':
M>1FJB*1]U_\ #MC_ ()U?]&#_!7_ ,-7I'_R/1_P[8_X)U?]&#_!7_PU>D?_
M "/7RW_P\ _X+F_](7['_P .E9?_ !='_#P#_@N;_P!(7['_ ,.E9?\ Q=42
M?4G_  [8_P""=7_1@_P5_P##5Z1_\CU\Q_L=_!OX0_ W_@Z#T_P9\%/A3X;\
M'Z.W[/MY.=)\+Z';Z?;&5GCW2>5 B+N.!EL9.*K_ /#P#_@N;_TA?L?_  Z5
ME_\ %UQ__!+WXK?M/?&3_@Y*L?%?[67[.47PO\4#X$ZA"OAN'7(M04VZO%LF
M\V,D?-D_+G(Q4R'$_>JBBBI*$?[M</XF_:5_9Y\&:[<>&/&'QT\'Z5J5FP6Z
MT_4/$=M#-"Q (#([AE."#R.AKN&Z9S7QE^T=_P &_G_!)7]K;XV:_P#M%?M!
M?LJR:]XR\3W27&N:P/'FNVOVF1(DB5O*M[V.),)&@PB*.,]230!\S?\ !K1J
M%AJ]Q^UUJNEWL5Q;7'[1-Y);W$$@=)$,;$,I'!!'<=:_6>OR'_X-/_ WAGX:
M>'_VJOAUX*TW['H^A_'N>PTNT\YY/)MXH2D:;Y"S-A0!EB2<<DU^O% !1110
M 4444 %%%% !1110 4444 %%%% !4=Q_J)/]T_RJ2H[C_42?[I_E0!_%_P""
M/^1R^(G_ &4K5_\ T8M%'@C_ )'+XB?]E*U?_P!&+10!^Q7_  9%_P#)IWQJ
M_P"RB6?_ *0+7[=5^(O_  9%_P#)IWQJ_P"RB6?_ *0+7[=4 %%%% !1110
M4444 %%%% !7BO[=?BC]NKPA\%TU7_@GK\-? _BKQW_:T*2:;\0+Z6WL19D-
MYC[HIHFW@[<#=CKQ7M5?-O[<?_!6C]@+_@G-JNDZ!^UK\?+?P_K&N0^=INAV
M.E7>HWTEN&*F=H+2*1XX@0?G< $JP7)!% 'Y&^!OBG_P7AC_ ."]OC#Q1HW[
M,GP+D^.TG[.ZP:OX9FURZ&AQ>'_[2TXBXCE^U[S<^<+==ID(VN_R\ C]I_V*
M?$G[9'BOX!V.L?MY?#[PCX7^(S7URNHZ3X&O))].2W$A\AD>265MQ3!;+<'L
M*^%/V@/^"BO_  1S_9%_; TG_@JIIGQF\7?$;Q]\6/A/_P ([X=\(_#/3QJC
MWFAK=V\S77D,(A;L)K5$_?RHQ(D 0E6V_6W_  3V_P""JW[(7_!3'PSJFK_L
MX^*=4@UC0&5?$G@WQ1I9L-8TG=]TS0;F4JW9XW=<\9SQ0!])4444 %%%% !1
M110 4444 %?,/_!::Z@M/^"2?[1TMS*(U;X.Z\FX_P!YK.15'XD@?C7T]7S#
M_P %H;:&Z_X)*_M'1W,2R*/@YKSA67.&6RD93]00#]10!\=_\$4?^"QG_!,+
M]G__ ()8?!7X-_&C]M7P3X=\4:!X4:WUK1-1O76>TE^TS-L<!#@[6!Z]Z_4W
MP5XR\,?$/P=I/Q \%:S#J6BZ[IL&H:3J%JV8[JUFC62*53_=9&5A[&OS,_X(
M@?\ !*__ ()N_&[_ ()1?!'XK?%W]A[X8^)?$FM>$VGUC7-:\'VMQ=7DOVJ=
M=\DCH6<X4#)/05^FWA/PKX;\"^%=-\$>#]#M=,T?1]/AL=*TVQA$<-I;1((X
MH8U'"HJ*JA1P  * -*BBB@ HHHH **** "BBB@ HHHH *I^(_P#D7K[_ *\Y
M?_0#5RJ/B++:#?*!_P N<OX_(: /QU_X-;?^3-/C%_V<MXB_]-^E5^F%?@[_
M ,$D?^"M7@S_ ()C?"7XE? ?XS_LG?&37-2UKXU:UXAM;SPOX166W%M-!9VZ
MJ3-+&V_=:N> 1AEY/('U9_Q% _LV_P#1CO[1'_A$V_\ \E529,C]-J*_+GP]
M_P '5O[)'BVWDO/"W[(/QXU.&&4Q32Z?X5LYE20=5)2[(!]CS6A_Q%!?LWGI
M^PY^T1_X1-O_ /)-4'*>D?\ !KK_ ,>7[7W_ &=1KO\ ):_5:OR;_P"#4C4]
M8\4_"K]I3XDZEX*UK0;?Q=^T)J&M:;9:]I[6]P+>Y@CE3<IXR V#M)&0<$U^
MLE9E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% "-]WI7Y9?"SX<?\ !<O]C[Q=X^\"_LSO^R/-\.]8^(&KZ[X9T/Q=
MXFU87&E+>733R)F':07D9Y65F8*\KA2!@#]3J_*?XU?LD_\ !J#KOQ9\3:Q\
M:?B/\'8?&%UKEU)XFCOOV@+^UN$OVE8SAX1JBK$XDW90*H4\8'2@#[:_8.\9
M?M\^+_">O77[>^G_  ;M]6AU*-=!7X.ZE?7-L;?R\N;@W;,PDW] O&VNN_:H
M\<?M+?#?X:P^,_V6_@SHOQ UJQU2*36/">K>(#IDU]IFR3SA9S^6\8NP_E%%
ME C8!U+*2IKXL_X-^_!_[*GP^\0_M'>!OV&K%=2^$VG_ !*M!X5\;1:G<WD6
ML,U@C3PQSS2,D\=O)E%DC #!ADN1N/TA_P %1OCS\8OV>?V<;#QG\(-;D\/Q
MWWC;2]+\7>.(?#;ZPWA+1)W876K"T0,9?+PB\JRIYOF,K*A! /F?]K_]KOP7
M^W5:>"?A3X4^'/C"^U+PSXH%[\8?V:-5U8>&O%.KZ<UK*B"!99HH]0BCGVN8
MXIO+E5<[QMP?3_\ @E_\"/'/PU^-'CKQKX$_9H\8?!/X.:IX>TZU\/\ PU\<
M>(H[R\DUB.:=KG48[>.YN4L(C$\4>Q9F,K+O*K@9\2^%WAWX3_\ !0;]HFQ_
M9L\??M-M^U9X#3PO>:U?>/)O!,.BZE\/=5BE@%DUGJ^F06P26?,O[I#YJ^1E
MCM(!^U?V4?@)^T_^SQX@U+P1\1_VH;KXG> 8]/4>%[KQ=9[O$EC,).8KF\3"
MWT?E])742[A\Q;.0 >Z 8&!10/I10 4444 %%%% !7PW^W[\0? FN_\ !2+]
MCWP7HOC72;S6=+^)FN-J6DVNI1275H#H-S@RQ*Q:,'(^\!UK[DK\_?VX?V</
M@)\/O^"JO[*/QW\$?!_P_I/C3Q;\2=:C\3>*+#2XX[[5%30;G:L\H&Z0#:N,
MDXP* /T"HHHH *^9O^"R_P#RBK^/O_9,=3_]%&OIFOF;_@LO_P HJ_C[_P!D
MQU/_ -%&@#V?]G/_ )-[\!_]B;I?_I)%79,,BN-_9S_Y-[\!_P#8FZ7_ .DD
M5=D1D8- 'PI^POJ5M^R/_P %./CS^P+J[-:Z/X^*?%OX6QLN(I([N3R-;MTR
M< I>>5*%&2?/E/ 49^ZP<C(KX9_X+,^&I/@K=?![_@IYX6M635O@)XZC'BB>
M'@S^$M5VV>JQOC[RQY@G&<[5BEP,MS]NZ9J-GJUA;ZKIUPLUO<PK-;S1GY71
M@"K#V(- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I-OS;LTM% !11
M10 5\2_\%B_"_A[QKX[_ &1?"/BO1K;4M+U3]JK3K34M/O(1)#<PR>'M=5XW
M4\,K*2"#U!K[:KXU_P""LO\ R5_]C7_L[;2O_3!KE 'D^B7WB[_@@]\7H?!V
MLVVM:U^Q[XRU%8]$U9IGNI/A+JDTG_'M-G+?V1*[81\GR&;!R#7Z,:7J>GZU
M86^KZ3?0W5K=0K-:W%O('CEC895U8<$$'((ZBL_X@_#[P9\5O!&J_#;XC>&K
M/6M!US3Y;'6-)U& 2PW=O(I5XW4\$$&O@/X/^)OB;_P15^-V@_LJ_%O6]5\3
M_LO^.M>CTWX2^.+^1KBY^'FH7#A8M!U"0Y9K)Y#MM[AB1'N\MBJJ, 'Z+5QO
M[1?_ ";YX[_[$W5/_226NRKC?VB_^3?/'?\ V)NJ?^DDM 'C/_!&3_E$O^SA
M_P!D8\/?^D$5?3%?,_\ P1D_Y1+_ +.'_9&/#W_I!%7TQ0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'XG_P#!2+XX:U^P1_P44_:V^,/C/X4>
M)-6\9?%[X*Z1HG[,^O:7X9GOA'=-IJ6%Q:0S1HP@D2[,ERRY4LOJ6 -/PC\!
MY_A?X._8'_X);_#;X:ZS)\7/AWXTTGXE?$:^AT*1+?PWILT=U)=M/=;0@>9W
M,7E[B28SNY"@_4?[07[5'_!3+]J+_@I7\0OV$O\ @G[XE^'/@'1?@SX=T>\\
M9>,/'WAZ74IK^^U&U2[BBM8D90$6*6,%CCYE;GH*[WX+_ +_ (+FZ#\7= U[
MXX?MQ?!G7/"EOJ,3>)-+T;X8SVMY>68/SQ1S&8[&(Z,00* /MRBBB@ HHHH
M**** "BBB@ HHHH _%?_ (+(_M)?$#]DG_@X1_9Y^.GPQ_9TUWXK:UI/PCUB
M.U\#^&[CRKR^$R7T+LC>7)@1JYD/R'(0].M?:'_!.?\ X*G?M)?MN_&/4OAA
M\8/^"87Q"^"VG6.@R7\/B;Q9JAFM[F59(T%LH^RQ?.0Y;.X\(>*\-_:M_P"5
MJG]EO_LCGB3_ -(]2K]26Y&* !?NTM%% !1110 4444 %%%% !1110 4444
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MWP/X9\<?$+QAK=K8^!_#5UX>_M&\LVN[A84ED91FU@9\$EV 8(3@XH ^!?\
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MY1+_ +.'_9&/#W_I!%7TQ0 4444 %%%% !1110 4444 %%%% !1110 4444
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MT?LD_MQ_MD?&_P"-_P 5=6TWP[\8_'FE:KX#NK?PI>W+WEM!)JID9XXHRT)
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M%*_5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCXI?$3P)XZMK:?4KK3[:ULHM-FM%FLY+6.!%"^8A8R*PR'4CD8)^X* /R?\
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M@5LY)KXU_P""B8_XS_\ V+_^RG:[_P"F&ZH ^S**** "BBB@ HHHH *^2O\
M@M%^SIXI^.W[$&J>-OA5$Z_$/X0ZQ9_$3X=W$*GS1J>DR?:?)3'.9H!-"!TW
M2*3]W(^M:AN[6WOK:2SNX%DBFC9)8W7*LI&""/0B@#A_V8OCSX5_:?\ V=O!
M?[0O@JY633?&/ANTU6VV-G9YT09D^JL2OU%=]7PC_P $A]7OOV;_ (R?';_@
MEAXK,B?\*K\8-XE^&K3<?:O"6M,UU"L?]X6]TUQ$QZ*75!]RONZ@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "OC'_ (*UP0W/Q:_8W@N(EDC;
M]K32@R.N0?\ B0:YVK[.KXU_X*R_\E?_ &-?^SMM*_\ 3!KE 'U]_P (YX>_
MZ -G_P" J?X4?\(YX>_Z -G_ . J?X5<HH I_P#".>'O^@#9_P#@*G^%<9^T
M5X>T%/V?O'3#0[,?\4?J9W?94X_T23VKOZXW]HO_ )-\\=_]B;JG_I)+0!XS
M_P $9/\ E$O^SA_V1CP]_P"D$5?3%?,__!&3_E$O^SA_V1CP]_Z015],4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !2-@CDTM% 'YN_M4_#/\ 8A_X
M*:?\%%/'W[$G[<WP#T_0]2^%/AW2-2^&?Q$C\42Z5K.M6][;I+<&T="OF00S
MLT9&7 EC)V@\UZ_^Q+_P2)_X)G?L,_$Z3XO? KPQ'JGCJZ@-M#XL\6>+'U?4
M88VX*0-,Y$18<%D4,1P21Q7RM_P5:\)?\$D-<_;?US5_VL_^"7?[1/Q0\>6V
MGZ>)O&GP_L?%,FFR1_98O*2!M/O8H%9$VJ^Q =ZG=ELFO,/V.O%/_!":V_;@
M\ _#3X/_ /!-']I+PG\3O[6M[[P^WBJ[\6JFGXDVK>W$%UJ;K]G5L9>2-H_6
M@#]NZ*** "BBB@#\R?VG?A+_ ,%2_P#@I7_P4 \>?L^^#_V@/B=^S3\ ?AO9
MV<.G>+O".GW&G:CXWU"2-))9;:]_=DPQONCQ&Y4JF2#OP.7_ &3?'7[>G_!,
MW_@K-X/_ .":/[0_[76O?'GX:?%KP?>:SX+\2>-)S/KNC7-MN$D<T[LTDB'R
MQ]YV4^8"H4AP?N+]OW_@HS^S/_P3C^$X^)/Q_P#%;"^U)VMO"?A+3(_/U3Q#
M>\!;:U@7YG))4%SA5R,G) /SA_P30_8P_:2^,G[5>N?\%@O^"BF@?V+\1/$6
MAC1/A?\ #/:=O@3P^69PDI/)NY-[;Q@;-\F<L^(P#R[XWS?MQ?\ !73_ (*7
M_%S]D7X!_MQ^+O@5\'_@);Z;8>(]6^'%PUMJ^NZW=(9BBW,;)(BQA"K .%&
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M\!^,FFCTVQC@5V_L351DA ,FO7/^(H;_ ((G_P#1V\G_ (1^J?\ R/7YN_\
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M2'3O)D/F1?9[F!O-\T1#EB-I;C."/CW_ (7U_P ';O\ T9[^R7_X%:M_\MJ
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ML9?L??%#_@D%\)?'/Q+_ &4?AMXBUJ^M=0-YK&O>!=/O+JX(OYU&^66%G;
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M* "BBB@ HHHH **** "BBB@ HHHH *CN/]1)_NG^525'<?ZB3_=/\J /XO\
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M3_$?Q7L_'FH0> ]'COO'&GZA]K@\13+91!]1CGR?.2X8&99,G<) <G-?&_\
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MOMRW)=LX]Z_1.OC/_@HD?^,__P!B_P#[*=KO_IANJ /LRBBB@ HHHH ****
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M@^''B#X3>/M+%]H/BC1+O2-:L6D*_:+.YA:&:/*D$;HW89!!&:^)5_X-E?\
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MJ.RQJ#SFOMC_ (2/P]_T';/_ ,"D_P :_,C_ (*7?L9?LMR_\%?/@O\ &O\
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MM+?1=)NM0BBU+5A\7-/G^QP,X#S>6J9?:N6VCDXQ0!]<T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !0QVC-%-<]L4 ?*G[4/_!$O_@E]^VC\9K_
M /:$_:8_99MO%'C#5(;>&^UJ3Q1JUJTJ0Q+#$/+MKN.-=J(J\*"<9.3S6)\'
M_P#@@'_P2,^ WQ.T/XS?"7]D"UT?Q-X;U"._T74U\8:W,;:X0Y5PDMZR-@]F
M4CVKS;QQ_P %EOAW^R%_P5B^*G[*_P"W5^TOX/\ "OP_;PSH=[\+8VA1GM)I
M+2)KV._EB#202-*S/&LP"&)D*MU%>[_#C_@LA_P2X^+WCS2?A?\ ##]N7X?Z
MYX@UR^CL]'TC3]8$D]W.YPL:+CEB: /IJBBB@ HHHH ***16W=J %HI,Y'RT
MH(/2@ HI"Q!QBC.1\IH _%S_ (+&? SXX?M&?\'"O[._PE_9U_:0U+X2^+-1
M^$>L/I_CG2;7SI[%8H[Z2153<N?,C5HSSP'K[3_X)W_\$_/V_?V5/B_J7CO]
MJ;_@J3XH^-N@W>AO9VGAG7-(^SQVMR9(V%R&\U\L%5EQC^.OD;_@J5^U/\!O
MV,_^#D#]F_\ :$_:8^(47A?P=H_PAUR+4M:FL;BX6!IX;^&(>7;QR2'=)(B\
M*<9R<#)K[T_8^_X*\_\ !.G]OGXB7GPG_9'_ &E;3QCX@T_2VU&\TZWT#4K4
MQVJNB&3==6T2'YG48!)YZ=: /I8# P**12<<TM !1110 5^3?_!OE_RD]_X*
M,_\ 95M!_P#1NNU]G_\ !2C_ (*/:)_P3@^'OA_X@:W^SWX\^(B^(-6DL8]/
M\!Z6;J>U*Q[_ #) !PAZ ^M?C-_P3'_X*ZZI^Q'^U[^U/^T-X[_X)]_'35--
M^.WC+3=8\/V>E^#9O.L(K=]19DGWH!N/VQ,;21\K>U ']%U%97@KQ+'XS\':
M3XRBTZXLUU;3;>\6UNEVRP"6-7V..S#=@CU%:M !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 (P)'%?GQ^UQ_P2V_X*@_'/]HSQ1\5_@=_P6@\:
M?#7PKK5Y'+H_@?3="\V#28UAC1HT?SER"ZL_0<N:_09F(Z5\B_M!?\%V_P#@
MD[^RM\8]=_9_^/O[7ECX=\8>&[E(-<T6;POJ\[6LC1I*JEX+1XVRCHWRL1SZ
MY% 'Q]_P:6>&?$?@[P?^U)X4\8>+)M>U;3?CM+:ZEKEPNV2_G2#:\[#)P78%
MB,GK7Z^U^17_  :B>-?#7Q%T7]JSQ]X*U1;W1];^/L]]I=XL3()[>6$NC[7
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MB#QW5W)"WES2QS#<IP8@1@@$ 'ZG4444 %%%% !1110 4444 %%%% !1110
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M HHHH **** "BBB@ HHHH **** "BBB@ J.X_P!1)_NG^525'<?ZB3_=/\J
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MH **** "BBB@ HHHH ,XZU7DU+3XG,<U_"K+]Y6D (_6K!YKX"_:P_X-LO\
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M_P! G]D__OJ^_P#BZ /U.HK\L?MO_!WA_P! G]D__OJ^_P#BZ/MO_!WA_P!
MG]D__OJ^_P#BZ /U.HK\L?MO_!WA_P! G]D__OJ^_P#BZ#>_\'=P'_()_9/_
M .^K[_XN@#]3J*_#[]B#_@HO_P '-G_!0+2_&FK_  "TC]FOR? ?B^X\-Z]_
M;FGWEL?ML)^?RP)FWIZ-QGTKW/[;_P '>'_0)_9/_P"^K[_XN@#]3J*_+'[;
M_P '>'_0)_9/_P"^K[_XNC[;_P '>'_0)_9/_P"^K[_XN@#]3J*_+'[;_P '
M>'_0)_9/_P"^K[_XNC[;_P '>'_0)_9/_P"^K[_XN@#Z!_X*]_\ !/7XV_\
M!1:X^!/@7P-XG\+V'@OP+\8K'QA\0K?7KRXCN+RVM8VCCCM$BMY5EDVSW'RR
M/$N=O)ZKJ?\ !:K]B#X_?\%%?V&-0_9)_9[\7>&=#NO$7B/2Y/$%YXHOKF"W
M.F6]P)Y(T^SP3,\A>.(JI55.WEAQ7S5]L_X.[O\ H%?LG_\ ?5]_\72_;?\
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ME_$S7&U/1[74HI+JS!T&YP98E8O&#D8W =: /N6BBB@ HHHH **** "BBB@
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M^._$FOZY%I]K\0_V=-:6^L;20G'FS1/&_DE2,L%G8KSP,<@'['T444 %%%%
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M(OB]_P %1$T"XM=2C^",/PV^&-FT;)]BU1].%UK3PAN5/]H/';JV <0/R0U
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M9%_\FG?&K_LHEG_Z0+7[=5^(O_!D7_R:=\:O^RB6?_I M?MU0 4444 %%%%
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M*^$]5U**TUSQ=HOQ,L93IMLQPT\B1Z9')<!1SM,@)]17Z<T4 %%%% !1110
M4444 %%%% !11D8S10!^*O\ P67^$?[3'QQ_X.#_ -GGX;?LB?'^/X8^/+[X
M1ZP^D^,IK$W"V21I?/,OECKOB5X_;?FOM#_@G%^Q;_P58_9T^,NI^,?VXO\
M@I%:_&#PO=:#):V/AV'0&M3;WAEC9;C<>N$5UQ_M5\O_ /!2;]H'X*_LP?\
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M+!>^=:$HHF7Y_+/SIT;F@#V_4=1T_2K";4]4O8;:WMXR\]Q<2!(XU R69CP
M!W/%31R)(BRQNK*W*LIX(]:_,'_@XQ\8_M>>+KCX'_L-_ &Q\#-I7QL^(EA9
M,VN:Y?VU]<75A<+>/#*MO ZIIQ5(1+*K-+E]HCV\G]&?@\GQ3B^%N@0_&VT\
M.V_BY-+A'B&W\)SSS:;%=;?G6V>X5)7B!X5G56(&2JYP #J,\XHR,9S7Y-_
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MQC'4]:^X:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "F22)&IDD;:JKEF/0"GU2U^*6?0[R"'[[VLBK]2IH _('P)X=_X*<_\
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M?&#QIX='AWP]X1NEOKO0X+?4+>[N+R_2++:<L443J_GB-E5F)&U6(\@_;-^
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M*XF4OL4,QR>]):_#;_@Y6L+75+*Q_P""7/[&L,.N3)+K4,.CZ>JZ@ZR"57G
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MT&59-#UK5H[6XNM.=6#AH)9+\O"0P# H001GK5/XB^'?^#GOXOZG::Y\6O\
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M@ HHHH **** "BBB@ HHHH *CN/]1)_NG^525'<?ZB3_ '3_ "H _B_\$?\
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M -N'5_@9J7A+QWINAK\)OC5IOC;4EU*WDD-_;VT4R-;Q[/NNQE!!;CBOJ*@
MI'SCBEH(R,&@#\]_@]JTOQ7_ .#D#XQ3>(4;_BU/P!T#1_#L;+\J#4)_MES*
MONQD1">,B)1V%>R?$S_@LE_P3\^$/Q5U3X)^//B=XNM_$>CZI_9^H6MK\'_%
M%W"EQD#:MS;Z:\$BY(^='9?>O,/C%X>/[*/_  7*\ _M+7S?9O"G[07P];X>
MZQ>,V(HO$%A(]WI_F$\*9X=\*\C+Q(H!+5]YCIQ0!\#_ /!QYI:Z7_P3DA^/
M.FS-#KGPI^+'@_Q/X;NH_P#60W?]L6]@2I]3#?3#Z&ODO]MK]EG_ (;[_P""
MGO[4WP6M;55UW6/V1O#>K>%9&X^SZS;3F[LR#_#F:-$)_NNWK7U=_P %J8-2
M_:I\<_ S_@EUX$CEN=0^)/Q$L_$_CS[.I(TOPGHL@NI[F4XP@DNEMHD)X9QM
M'S%<^N?#[]@;Q3X*_P""J/CC]OT^-=+?P_XI^%>E^$[/PU';R?:;:2TE+&5G
M/R%"#@ <^M 'R;XM_:FA_P""I?[.G[&/[.,=VUS??&#6H/$7Q6L'4[X]-\.!
M)-1BG7DJ);]88B#@,#(,Y%<?^R'G_AV;_P %&0!_S6KXH?\ HR>OI[_@GK_P
M1V@_8A_;E^,7[6%]\1[?7-)\9&2V^&OAV.U=3X5L;J^FU"_ARWRYEN9%8% .
M V>N*M?!3_@EA\0_A;^RE^T]^SYJ/Q3T:ZO?CUX\\7:_H^H0V<JQ:7'J[R-%
M',#R[1[_ )BO!QQ0!\&_ /Q1_P './P%_P""4GPU^./[..J? #Q=\/='^$NB
M7GA?PGI.DWUSXF71181-$9(Y88H9IXX-ID2.5F8AA&)#@'Z>_P"#??X"6_Q%
ML_&?_!63XG_M:Z?\8/BA\:+6VTS7-3T;2WLK3P_!:;0=+$,BI(DB,L2L'5,"
M*/ P=S?;G[$OP#UC]EK]CGX6_LS>)-=M=6OO /P_TGP]?:E9QLL-W):6<<#2
MHK<A6*$@'G!YKY^_92_X)@?$;]B+_@HA\2/C_P#L[?%32K'X)_%B%=0\3?"J
MZMYO,L-?Y+7UFP_=HK'.Y>,B0@Y\N,@ \B_X+T?!3X2?![]F_P"%]Q\+?AMH
MOA^7Q-^V%X6UGQ%-I.GQPR:GJ%Q+>2375PR@-+*[,268D]A@ "OTRQCH*^9_
M^"GO[#?BW]O3X4> ?A_X.\<Z?H,WA'XO:'XPNKC4K>21;B"Q,V^!0G(=O-&"
M>!@YKZ7 ([T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<I\8
M/C7\(_V?? EY\4OCE\2]#\)>&]/V_;-<\1:E':VL)8X :20A03V'4UU=?G?_
M ,%Z]0\(^'/%/[)_CKXV7%C;_"W1?VDM+G\?7FMKG3+1?*D^S37A;]VD2R9)
M:3"*,EB #0!]V?"[XL_#/XW^!=/^*'P=\>:3XH\.ZK'YFFZWH=^EU:W*@D$I
M(A*M@@C@]:Y/P-^V?^R7\3OC#J?[/OP[_:3\%:YXXT7S/[4\)Z7XDMYM0M"A
MPX>%7+ KSD8XP<U\;_\ !"WXK_"7P3\#?BMJLOQ"\/Z7X/\ 'W[5WBQ/@?#-
MJUO!#KMB;>T(ATM691<AIX+YU2'=G:[#@$CY!^!_C']@C5O^"K_[+?Q5_8 F
MM]4TF^\3>*='O/@;=:>]IK_@"]G0MJ.O7S":2Y<.ZMB*\8QJF?*4;3M /W6!
MR,BOC/\ X*) #]O_ /8OP/\ FIVN_P#IANJ^C_VC_C!X@^!'PEU#XF>%_@MX
MI^(5Y8S0)'X5\&VJ3:A=>9*L9:-795(0,7;)X537Y]?%O]L?XA_M,?\ !2']
MD;0?&?[$_P 5/A7%IOQ UJ>'4/B!IL$$-ZQT2Z7RHC'*Y+@?,00.* /U"HHH
MH **** "BBB@ HHHH **** "BBB@#XU_X):?\G+?MI?]G,-_ZCFC5]E5\:_\
M$M/^3EOVTO\ LYAO_4<T:OLJ@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *#S110!^7/C+_ ()2_P#!67]DC]I;XF?%?_@D
M/^US\,=$\%?%GQ!)K_B#X>_%BQO#:Z9JDJXENK5K:WGR[87G"9 4-O\ +4CZ
M%_X)0_\ !-?XA_L,6OQ$^+W[2?QQ7XE?&3XOZ]#JGQ \76]D8+=_)5DM[:!"
M 1%&KOCA0-V J@ 5]@T4 %%%% !1110 4444 %?E7_P:R'_B@/VK/^SJO$'_
M **@K]5""1@5A^$/A]X%^'\=Y%X%\%Z7HZ:A>-=:@FEZ?' +F=OO2OL WN<#
M+').* -RBBB@ HHHH **** "BBB@ HHHH **** .7^-W_)&/%V?^A8U#_P!)
MI*_.G_@T=_Y1+?\ =5/$'_H<-?IQ<V\-Y;O:W$*R1R*4DCD7*LI&"".X(K-\
M%^ O!'PYT;_A&_ '@_3=#T_SFE^PZ38QV\/F-]Y]D8 R<<G'- &Q1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'<?ZB3_=/\JDJ.
MX_U$G^Z?Y4 ?Q?\ @C_D<OB)_P!E*U?_ -&+11X(_P"1R^(G_92M7_\ 1BT4
M ?L5_P &1?\ R:=\:O\ LHEG_P"D"U^W5?B+_P &1?\ R:=\:O\ LHEG_P"D
M"U^W5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_AL_]CS_ *.O^&O_ (76G_\ QZOC#_B%2_X(P?\ 1O\ K?\ X65[_P#%T?\
M$*E_P1@_Z-_UO_PLKW_XN@#[/_X;/_8\_P"CK_AK_P"%UI__ ,>H_P"&S_V/
M/^CK_AK_ .%UI_\ \>KXP_XA4O\ @C!_T;_K?_A97O\ \71_Q"I?\$8/^C?]
M;_\ "RO?_BZ /L__ (;/_8\_Z.O^&O\ X76G_P#QZC_AL_\ 8\_Z.O\ AK_X
M76G_ /QZOC#_ (A4O^",'_1O^M_^%E>__%T?\0J7_!&#_HW_ %O_ ,+*]_\
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MW"!V+;1@$\G.!CJ/^&S_ -CS_HZ_X:_^%UI__P >KXP_XA4O^",'_1O^M_\
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MO_!&;3X_B]^U_P#MG?MJW*"0>)OC1'X-T6=LEA8Z';>6=IR1M,URZ\=XO84
M?H71110 4444 %%%% !1110 4444 %%%% 'Q?^Q?^U+^T%K'_!47]IS]BKX]
M_$=M:T[PLNB^)_A;;3:/:6SVFAWT;++ 'MX8VG6*<! \I=\,N6/-?-GQE_X*
MU_M8^%/^"W%C\/O#GCN ?LR^'_B5H7PH\8::NC6>)?$^J:?+-'<_:WA-PGE7
M3PPNJRJ@$)ROS$GO_P#@HEXOM?V&_P#@LA^S]^W-J<D=GX5\?^!?$OP\\<73
M2;5:2&V;4[!6[;GGMT5?9&_'Y]T;]BOQC\:_^#;CXF?M!WMI+'\3OB)XDU;X
M^6]Y;H?M!NH;]KZS*$_-N?3K==N,%6N#C)Z@'VS_ ,%&?VJ_C]X"_;0_97_9
M!_9K^(#:'J7Q,\=7^I>.FATFTO'D\,Z;;*]S"PN(I/)662:-1(FR3]VVUQ@U
M\4_\%#=$_P"#D[]@3]EGQ=^UQXC_ ."P_@W6M'\,W-D&T33?@[H:3R+=W\%H
M@5Y--Q\IN%8YZA3WKU7_ ()K_%.3_@I=_P %>?$'[=@F$WA_X5_LZ>%O#FC^
M7S"FM:S&VH7VPX'S1CS87XR08^@P*]D_X.33_P :9_BWG_GZ\.?^I#IU %/]
M@#]G+_@N/X3^,?AOXI_MI_\ !3SPG\2/AS<:3)-J7@S2_AEINFW$\DUN3 PN
M(+*)UV.RL<. =N.1Q7WM6!\+?^28^&_^P#9_^B4K?H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KXS_X*)?\ )_\ ^Q?_
M -E.UW_TPW5?9E?G'^V4G[:"_P#!8+]F%OB[<?"]OA3_ ,+'UC_A7R>&X=1'
MB%9/[!N/,_M S,;8K]_;Y(!^[GO0!^CE%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#XH?M0?L2?M7?%?2_'7BWX%:19:IX:^)6G^&[?39=7L[^TNI83<VD($"31/
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MGX,^%OQ@N]&\/^)X_AGI.K:JJ!<Q:;%%+$L'D(J[WFF669C,H5E"G.[\9/\
M@EZO_!/7_@HM\ /VQO\ @EW^RA'9^&9M0NO"?QI\*^#HU1&T:\"@:@Z22#=Y
M#XEX.285&#FO5_\ @CG^S9\=/@!\7_VLM>^,GPUU#P_9^.OV@+S7/"=Q?;-N
MIZ>UNBK<1[6/RD@CG!]J /'/ W[1W[;/[87_  3%_:T^ 'QD^.>GZ)\4/@CK
MFM>%-6^(_ASPG:R1^(+*UM5N7<V<P,,+W-N7A<HJ^7YF^,*RBO!/A_\ '/\
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M'[2WP8\1?!3XQ>&K#5?#^OZ3<6=];ZA;K(B*\97S!N^ZRYW!A@@@$$5^3?\
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MO;EYY7<1 +U;:..B@5[A10 4444 %%%% !1110 4444 %%%% !1110!\X_\
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M52H^8]J=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %1W'^HD_P!T_P JDJ.X_P!1)_NG^5 '\7_@C_D<OB)_V4K5
M_P#T8M%'@C_D<OB)_P!E*U?_ -&+10!^Q7_!D7_R:=\:O^RB6?\ Z0+7[=5^
M(O\ P9%_\FG?&K_LHEG_ .D"U^W5 !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX'_!O^U+BR74+G4=3U;7K[[3J&K:A<R&6XO+F7:HDFD<EF(51V   %>K444
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MPTT'XP_"_P 11ZMX;\4:1;ZIH.J0QNJW=G/&)(I5#@, R,&&0#@T =%1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'<?ZB3_ '3_
M "J2H[C_ %$G^Z?Y4 ?Q?^"/^1R^(G_92M7_ /1BT4>"/^1R^(G_ &4K5_\
MT8M% '[%?\&1?_)IWQJ_[*)9_P#I M?MU7XB_P#!D7_R:=\:O^RB6?\ Z0+7
M[=4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ&L4$T%S=3R<[(1.Z,1EW6%!D,Y8=5\,/^"R/_!0#X/_ /!2OX=_\$\/V]_
M7P+U*\^*VDI)H^K?!K4=0:3PS>,)A]GU&&[N)?-97C"LJF'C+*S@X !^JE%?
MG1^P%_P65^*WQ-^$W[4#?MV>$/"/A7QY^S'K6J)XBL?"UI=6]G/I]M%*T4X2
MYN)I#O:!\,' <,FT#//C$O\ P7]_;0\!_P#!.+X-_M+?&/X0_"O1OB!^T/\
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M^R'\:M%TWP7X!\4?'SX-ZG)I%NVAZPL?AWQ)*_G+:7L<Z.R^1(]O,=T;;'5
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M@DZ+#)+HWB29&FEU%KAHO,EB,<L$8B9BG[DG8"Q)^>OCU\#OBU\<O^"46C_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0>>***  KNZ
MTW8*=10 W9W4T;.>M.HH 3:>[4GE^].HH ;Y?O2[?EVFEHH 0KQ@4,NZEHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+4_]'C77_A-Z=_\ &*/^(FK_ (+4_P#1XUU_X3>G?_&* /[!J*_CY_XB:O\
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M-=?^$WIW_P 8H_XB:O\ @M3_ -'C77_A-Z=_\8H _L&HK^/G_B)J_P""U/\
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M?_&*/^(FK_@M3_T>-=?^$WIW_P 8H _L&HK^/G_B)J_X+4_]'C77_A-Z=_\
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M^"U/_1XUU_X3>G?_ !B@#^P:BOX^?^(FK_@M3_T>-=?^$WIW_P 8H_XB:O\
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M'C77_A-Z=_\ &* /[!J*_CY_XB:O^"U/_1XUU_X3>G?_ !BC_B)J_P""U/\
MT>-=?^$WIW_QB@#^P:BOX^?^(FK_ (+4_P#1XUU_X3>G?_&*/^(FK_@M3_T>
M-=?^$WIW_P 8H _L&HK^/G_B)J_X+4_]'C77_A-Z=_\ &*/^(FK_ (+4_P#1
MXUU_X3>G?_&* /[!J*_CY_XB:O\ @M3_ -'C77_A-Z=_\8H_XB:O^"U/_1XU
MU_X3>G?_ !B@#^P:BOX^?^(FK_@M3_T>-=?^$WIW_P 8H_XB:O\ @M3_ -'C
M77_A-Z=_\8H _L&HK^/G_B)J_P""U/\ T>-=?^$WIW_QBC_B)J_X+4_]'C77
M_A-Z=_\ &* /[!J*_CY_XB:O^"U/_1XUU_X3>G?_ !BC_B)J_P""U/\ T>-=
M?^$WIW_QB@#^P:BOX^?^(FK_ (+4_P#1XUU_X3>G?_&*/^(FK_@M3_T>-=?^
M$WIW_P 8H _L&HK^/G_B)J_X+4_]'C77_A-Z=_\ &*/^(FK_ (+4_P#1XUU_
MX3>G?_&* /[!J*_CY_XB:O\ @M3_ -'C77_A-Z=_\8H_XB:O^"U/_1XUU_X3
M>G?_ !B@#^P:BOX^?^(FK_@M3_T>-=?^$WIW_P 8H_XB:O\ @M3_ -'C77_A
M-Z=_\8H _L&HK^/G_B)J_P""U/\ T>-=?^$WIW_QBC_B)J_X+4_]'C77_A-Z
M=_\ &* /[!J*_CY_XB:O^"U/_1XUU_X3>G?_ !BC_B)J_P""U/\ T>-=?^$W
MIW_QB@#^P:BOX^?^(FK_ (+4_P#1XUU_X3>G?_&*/^(FK_@M3_T>-=?^$WIW
M_P 8H _L&HK^/G_B)J_X+4_]'C77_A-Z=_\ &*/^(FK_ (+4_P#1XUU_X3>G
M?_&* /[!J*_CY_XB:O\ @M3_ -'C77_A-Z=_\8H_XB:O^"U/_1XUU_X3>G?_
M !B@#^P:BOX^?^(FK_@M3_T>-=?^$WIW_P 8H_XB:O\ @M3_ -'C77_A-Z=_
M\8H _L&HK^/G_B)J_P""U/\ T>-=?^$WIW_QBC_B)J_X+4_]'C77_A-Z=_\
M&* /[!J*_CY_XB:O^"U/_1XUU_X3>G?_ !BC_B)J_P""U/\ T>-=?^$WIW_Q
MB@#^P:BOX^?^(FK_ (+4_P#1XUU_X3>G?_&*/^(FK_@M3_T>-=?^$WIW_P 8
MH _L&HK^/G_B)J_X+4_]'C77_A-Z=_\ &*/^(FK_ (+4_P#1XUU_X3>G?_&*
M /[!J*_CY_XB:O\ @M3_ -'C77_A-Z=_\8H_XB:O^"U/_1XUU_X3>G?_ !B@
M#^P:BOX^?^(FK_@M3_T>-=?^$WIW_P 8H_XB:O\ @M3_ -'C77_A-Z=_\8H
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M^5?Q^_\ $35_P6I_Z/&NO_";T[_XQ2M_P<S_ /!:AUVM^V+<8;C_ )%K3O\
MXQ0!P'@C_D<OB)_V4K5__1BT5SW[-&N:EXE\+:UXCURX::]U#Q-<7-W-G;YD
-LD<3,V!QR2310!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>eldn-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-08-14T16:27:17.5258+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.eledon.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:eldn="http://www.eledon.com/20241231" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" namespace="http://xbrl.sec.gov/ecd/2025"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2024-01-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" namespace="http://xbrl.sec.gov/stpr/2025"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" namespace="http://fasb.org/srt/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd" namespace="http://xbrl.sec.gov/cyd/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>75000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>75010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>75020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>75030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit" id="StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit">
        <link:definition>75040 - Statement - Consolidated Statements of Convertible Stock and Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>75050 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" id="DisclosureCybersecurityRiskManagementStrategyAndGovernance">
        <link:definition>995457 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1" id="DisclosureDescriptionOfBusiness1">
        <link:definition>995467 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>995477 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments" id="DisclosureShorttermInvestments">
        <link:definition>995487 - Disclosure - Short-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>995497 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1" id="DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1">
        <link:definition>995507 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>995517 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>995527 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
        <link:definition>995537 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>995547 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting" id="DisclosureSegmentReporting">
        <link:definition>995557 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>995567 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatements1" id="DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatements1">
        <link:definition>995577 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995587 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995597 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables" id="DisclosureShorttermInvestmentsTables">
        <link:definition>995607 - Disclosure - Short-Term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>995617 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables" id="DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables">
        <link:definition>995627 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>995637 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>995647 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
        <link:definition>995657 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>995667 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" id="DisclosureSegmentReportingTables">
        <link:definition>995677 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsTables" id="DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsTables">
        <link:definition>995687 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" id="DisclosureDescriptionOfBusinessAdditionalInformationDetail">
        <link:definition>995697 - Disclosure - Description of Business - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>995707 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail">
        <link:definition>995717 - Disclosure - Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails">
        <link:definition>995727 - Disclosure - Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail" id="DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail">
        <link:definition>995737 - Disclosure - Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2">
        <link:definition>995747 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail" id="DisclosureShorttermInvestmentsAdditionalInformationDetail">
        <link:definition>995757 - Disclosure - Short-Term Investments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail" id="DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail">
        <link:definition>995767 - Disclosure - Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" id="DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails">
        <link:definition>995777 - Disclosure - Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails" id="DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails">
        <link:definition>995787 - Disclosure - Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" id="DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>995797 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail" id="DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail">
        <link:definition>995807 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail" id="DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail">
        <link:definition>995817 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail" id="DisclosureGoodwillAdditionalInformationDetail">
        <link:definition>995827 - Disclosure - Goodwill - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>995837 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail" id="DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail">
        <link:definition>995847 - Disclosure - Commitments and Contingencies - Components of Operating Lease Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail" id="DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail">
        <link:definition>995857 - Disclosure - Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail">
        <link:definition>995867 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail" id="Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail">
        <link:definition>995877 - Disclosure - Income Taxes - Summary of Loss Before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail" id="DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail">
        <link:definition>995887 - Disclosure - Income Taxes - Summary of Provision for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" id="Role_DisclosureIncomeTaxesAdditionalInformationDetail">
        <link:definition>995897 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail" id="Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail">
        <link:definition>995907 - Disclosure - Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail" id="Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail">
        <link:definition>995917 - Disclosure - Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail" id="Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail">
        <link:definition>995927 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail" id="Role_DisclosureStockholdersEquityAdditionalInformationDetail">
        <link:definition>995937 - Disclosure - Stockholders' Equity - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent" id="DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent">
        <link:definition>995947 - Disclosure - Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail" id="Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail">
        <link:definition>995957 - Disclosure - Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail" id="DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail">
        <link:definition>995967 - Disclosure - Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail" id="DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail">
        <link:definition>995977 - Disclosure - Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail" id="DisclosureStockbasedCompensationAdditionalInformationDetail">
        <link:definition>995987 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail" id="DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail">
        <link:definition>995997 - Disclosure - Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail" id="Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail">
        <link:definition>996007 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail" id="DisclosureStockbasedCompensationSummaryOfRsuActivityDetail">
        <link:definition>996017 - Disclosure - Stock-Based Compensation - Summary of RSU Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail" id="Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail">
        <link:definition>996027 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail" id="DisclosureSegmentReportingScheduleOfSegmentReportingDetail">
        <link:definition>996037 - Disclosure - Segment Reporting - Schedule of Segment Reporting (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails" id="DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails">
        <link:definition>996047 - Disclosure - Segment Reporting - Schedule of significant segment expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails" id="DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails">
        <link:definition>996057 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails" id="DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails">
        <link:definition>996067 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails" id="DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails">
        <link:definition>996077 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Parenthetical) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails" id="DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails">
        <link:definition>996087 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Corrected EPS Calculations under Two-class Method (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="eldn-20241231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:href="eldn-20241231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="eldn-20241231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit" xlink:href="eldn-20241231.xsd#StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:href="eldn-20241231.xsd#DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables" xlink:href="eldn-20241231.xsd#Role_DisclosureStockholdersEquityTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails" xlink:href="eldn-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail" xlink:href="eldn-20241231.xsd#DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#DisclosureGoodwillAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureStockholdersEquityAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent" xlink:href="eldn-20241231.xsd#DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail" xlink:href="eldn-20241231.xsd#DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail" xlink:href="eldn-20241231.xsd#DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#DisclosureStockbasedCompensationAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail" xlink:href="eldn-20241231.xsd#DisclosureStockbasedCompensationSummaryOfRsuActivityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails" xlink:href="eldn-20241231.xsd#DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails" xlink:href="eldn-20241231.xsd#DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails" xlink:href="eldn-20241231.xsd#DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails" xlink:href="eldn-20241231.xsd#DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails" xlink:href="eldn-20241231.xsd#DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd#eedm1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="eldn-20241231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2" xlink:href="eldn-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:href="eldn-20241231.xsd#DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail" xlink:href="eldn-20241231.xsd#DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail" xlink:href="eldn-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail" xlink:href="eldn-20241231.xsd#DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="eldn-20241231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1" xlink:href="eldn-20241231.xsd#DisclosureDescriptionOfBusiness1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments" xlink:href="eldn-20241231.xsd#DisclosureShorttermInvestments" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1" xlink:href="eldn-20241231.xsd#DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="eldn-20241231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:href="eldn-20241231.xsd#Role_DisclosureStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:href="eldn-20241231.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting" xlink:href="eldn-20241231.xsd#DisclosureSegmentReporting" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:href="eldn-20241231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatements1" xlink:href="eldn-20241231.xsd#DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatements1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables" xlink:href="eldn-20241231.xsd#DisclosureShorttermInvestmentsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables" xlink:href="eldn-20241231.xsd#DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" xlink:href="eldn-20241231.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="eldn-20241231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:href="eldn-20241231.xsd#DisclosureSegmentReportingTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsTables" xlink:href="eldn-20241231.xsd#DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#DisclosureShorttermInvestmentsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail" xlink:href="eldn-20241231.xsd#DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail" xlink:href="eldn-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail" xlink:href="eldn-20241231.xsd#DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail" xlink:href="eldn-20241231.xsd#DisclosureSegmentReportingScheduleOfSegmentReportingDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_MA" xlink:label="stpr_MA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationDescription" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessTable" xlink:label="eldn_DescriptionOfBusinessTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessLineItems" xlink:label="eldn_DescriptionOfBusinessLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NOLTrueUp" xlink:label="eldn_NOLTrueUp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidClinicalExpense" xlink:label="eldn_PrepaidClinicalExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1ExchangeAgreementMember" xlink:label="eldn_SeriesX1ExchangeAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnderwritingAgreementMember" xlink:label="eldn_UnderwritingAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionAgreementMember" xlink:label="eldn_ConversionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EffectiveFederalAndStateIncomeTaxRate" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXOneNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ManufacturingExpensesOffset" xlink:label="eldn_ManufacturingExpensesOffset"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RegulatoryMilestonePaymentsObligation" xlink:label="eldn_RegulatoryMilestonePaymentsObligation"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationPeriod" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfWarrantActivityTableTextBlock" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AreaOfOfficeSpace" xlink:label="eldn_AreaOfOfficeSpace"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ArmisticeCapitalMasterFundLtdMember" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WorkersCompensationLiabilityCurrent" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FeeDueForMilestonesAchieved" xlink:label="eldn_FeeDueForMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementInitialClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA" xlink:label="stpr_CA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnnualLicenseMaintenanceFee" xlink:label="eldn_AnnualLicenseMaintenanceFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccreditedInvestorMember" xlink:label="eldn_AccreditedInvestorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementThirdClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsRightOfUseAsset" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AggregateNetSalesAchievement" xlink:label="eldn_AggregateNetSalesAchievement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationPermanentItems" xlink:label="eldn_IncomeTaxReconciliationPermanentItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnrealizedGainOnAvailableForSaleSecurities" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccretionOnInvestmentDiscounts" xlink:label="eldn_AccretionOnInvestmentDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LesseeOperatingLeaseRemainingTermOfContract" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementSecondClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LeerinkPartnersLlcMember" xlink:label="eldn_LeerinkPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXOnePreferredStockMember" xlink:label="eldn_SeriesXOnePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EquityDistributionAgreementMember" xlink:label="eldn_EquityDistributionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PerformanceBasedVestingRequirementsMember" xlink:label="eldn_PerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NetOperatingLossCarryforwardsExpirationPeriod" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NoncashActivitiesAbstract" xlink:label="eldn_NoncashActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RisksAndUncertaintiesPolicyTextBlock" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_GuggenheimSecuritiesLlcMember" xlink:label="eldn_GuggenheimSecuritiesLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCumulativeChangeInOwnership" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonAndPreferredWarrantsOutstandingMember" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandTwentyLongTermIncentivePlanMember" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_StateIncomeTaxesNetOfFederalTaxBenefits" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TableTextBlockSupplementAbstract" xlink:label="us-gaap_TableTextBlockSupplementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="us-gaap_EarningsPerShareBasicLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FactorsUsedToIdentifyEntitysReportableSegments" xlink:label="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaLtdMember" xlink:label="eldn_OticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationStateTaxRateDifferential" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiability" xlink:label="eldn_SettlementOfWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_InProcessResearchAndDevelopment" xlink:label="eldn_InProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOffering" xlink:label="eldn_ProceedsFromIssuanceOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsLeaseLiability" xlink:label="eldn_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaIncMember" xlink:label="eldn_OticPharmaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionOfPreferredStockConversionBlockerPercent" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RemainingMilestonePaymentsForFirstLicensedProduct" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalPreferredStock" xlink:label="us-gaap_AdditionalPaidInCapitalPreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenStockIncentivePlanMember" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FiveHundredMillionAggregateNetSalesMember" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Personnel-RelatedExpenses" xlink:label="eldn_Personnel-RelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AmortizationOfOperatingLeaseAsset" xlink:label="eldn_AmortizationOfOperatingLeaseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CormorantGlobalHealthcareMasterFundLpMember" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonWarrantsMember" xlink:label="eldn_CommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OneBillionAggregateNetSalesMember" xlink:label="eldn_OneBillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccruedClinicalCurrent" xlink:label="eldn_AccruedClinicalCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="us-gaap_ErrorCorrectionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ContingentLiability" xlink:label="eldn_ContingentLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfMilestonesAchieved" xlink:label="eldn_NumberOfMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EGenesisIncCollaborationAgreementMember" xlink:label="eldn_EGenesisIncCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited / Canceled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award total number of shares authorized.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Total Number Of Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New aggregate share limit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-U.S.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre-funded warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-Funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance as of December 31, 2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X1 non-voting convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X1 Non Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X1 Non-voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series X1 Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RestatementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revision of Prior Period [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of non-cash investing and financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Agencies Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">California Franchise Tax Board [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MASSACHUSETTS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Burlington, Massachusetts [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Anelixis Therapeutics, LLC and Otic Pharma, Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Anelixis Therapeutics, LLC and Otic Pharma, Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anelixis Therapeutics, LLC and Otic Pharma, Ltd.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Convertible Preferred Stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Convertible Preferred Stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants or rights cancelled or exchanged.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Cancelled Or Exchanged</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled/Exchanged</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X and Series X1 Non Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X and Series X1 non voting convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities, in-process research and development.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities In Process Research And Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Acquired IPR&amp;D</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions from tax positions taken in the current year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounts payable, accrued expenses and other liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts payable, accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable, accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration description.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credit carryforwards expiration description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Purchase Commitment, Category of Item Purchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares weighted average grant date fair value of stock options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition, Acquiree</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Liabilities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common and Preferred Warrants Outstanding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Issuable Under RSUs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities, convertible preferred stock and stockholders' equity (deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Aggregate Fair Values of Warrant Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net valuation allowance Increased (decreased)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of business.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Business [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description Of Business [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of business.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Business [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description Of Business [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand fourteen employee stock purchase plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Fourteen Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2014 Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Percent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options Outstanding and Other Equity Awards [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManufacturingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManufacturingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryforwards, not to expiration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NOLTrueUp_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">NOL True Up.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NOLTrueUp_lbl" xlink:role="http://www.xbrl.org/2003/role/label">N O L True Up</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NOLTrueUp_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NOL true-up</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Impact of Correction of the Misstatements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement .</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with conversion of x non-voting convertible preferred stock shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock In Connection With Conversion Of X Non-voting Convertible Preferred Stock Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidClinicalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid clinical expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidClinicalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Clinical Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidClinicalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid clinical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock And PreFunded Warrants In Connection With Two Thousand Twenty FourUnderwritten Offering, Net Of Issuance Costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Outstanding and Other Equity Awards [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Earnings per share, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic earnings per share of common stock (As Restated)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1ExchangeAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X1 Exchange Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1ExchangeAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X1 Exchange Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1ExchangeAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X1 Exchange Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of options outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, forfeited and canceled in period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Canceled In Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited / Canceled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issued in lieu of making a cash payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Warrant Liabilities Measured at Fair Value on a Recurring Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Domestic Tax Authority [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty Common Warrants One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty Common Warrants One Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturities of available-for-sale short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants or rights cancelled or expired.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Cancelled Or Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercisable for exchange</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cancelled/Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled/Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions from tax positions taken in prior years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnderwritingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting Agreement[Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnderwritingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Agreement[Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnderwritingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stockholders' equity (deficit):</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity (deficit):</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Retained earnings / (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Commitments [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value of options exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective federal and state income tax rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Federal And State Income Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal Income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X one non-voting convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X One Non Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X One Non Voting Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ManufacturingExpensesOffset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Expenses, Offset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ManufacturingExpensesOffset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing expenses offset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ManufacturingExpensesOffset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing expenses offset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RegulatoryMilestonePaymentsObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory milestone payments obligation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RegulatoryMilestonePaymentsObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Milestone Payments Obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RegulatoryMilestonePaymentsObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development and regulatory milestone payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash cash equivalents and restricted cash maturity period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents And Restricted Cash Maturity Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, cash equivalents and restricted cash, maturity period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statutory federal income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock warrants exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock warrants to purchase common stock shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share (As Restated)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Securities Purchase Agreement Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Three Securities Purchase Agreement Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand And Twenty Three Securities Purchase Agreement Common Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credit carryforwards expiration period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax cuts and jobs act of 2017 change in tax rate income taxes expense benefit.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Cuts and Jobs Act of 2017 Change in Tax Rate Income Taxes Expense Benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant subject to specified beneficial ownership limitations percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with exercise of pre-funded warrants, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock in Connection With Exercise of Pre-funded Warrants, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with exercise of pre-funded warrants, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Liabilities, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options, Common Warrants and Subsequent Closing Warrants Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X non-voting convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X Non Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series X Non-Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X Non-Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of warrant activity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Warrant Activity Table [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Warrants to Purchase Common Stock Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">ROU assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use asset, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AreaOfOfficeSpace_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Area of office space.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AreaOfOfficeSpace_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Area Of Office Space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AreaOfOfficeSpace_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Area of office space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Guarantor Obligations, Current Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indemnification obligations amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of available-for-sale short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, forfeited and canceled in period, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Canceled In Period Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited / Canceled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Short-term Investments Classified as Available-for-sale Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments, Debt and Equity Securities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net change in cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Armistice Capital Master Fund Ltd.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Armistice Capital Master Fund Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Armistice Capital Master Fund Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common warrants issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of operating lease right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding, balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected stock price volatility, maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Workers' Compensation Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation and related expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-Sale, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Losses before income taxes:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnTerminationOfLease_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on lease termination</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnTerminationOfLease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Termination of Lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Option Exercise, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Prepaid Expense, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FeeDueForMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fee due for milestones achieved.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FeeDueForMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fee Due For Milestones Achieved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FeeDueForMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fee due for milestones achieved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement initial closing.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement Initial Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement Initial Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CALIFORNIA</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Irvine, California [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants or rights issued.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnnualLicenseMaintenanceFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual license maintenance fee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnnualLicenseMaintenanceFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Annual License Maintenance Fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnnualLicenseMaintenanceFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual License Maintenance Fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, number of shares reserved for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, number of shares initially reserved for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of common stock and pre funded warrants net.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock And Pre Funded Warrants Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of common stock and pre-funded warrants, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds after deducting offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of stock, shares converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Option Exercise, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Significant Components Deferred Tax Assets and Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increased number of shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and development tax credit carryforwards for federal and state</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccreditedInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accredited Investor.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccreditedInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accredited Investor [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccreditedInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accredited Investor [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants or rights assumed and replaced.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Assumed And Replaced</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated fair value, assumed and replaced</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Assumed and replaced</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Goodwill impairment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment charge</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Impairments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill, Impairment Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Commitments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Asset Instruments Measured At Fair Value On A Recurring Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement third closing.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement Third Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement Third Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets right-of-use asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Right Of Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Time-based and performance-based vesting requirements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Time-based and Performance-based Vesting Requirements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AggregateNetSalesAchievement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Aggregate net sales achievement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AggregateNetSalesAchievement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate Net Sales Achievement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AggregateNetSalesAchievement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reaching of aggregate net sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 6)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Present value of lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock exchanged for X and X1 non-voting convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Exchanged For X And X One Non-voting Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock exchanged for X and X1 non-voting convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalent, and Short-Term Investment [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Category of Item Purchased [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Category of Item Purchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax reconciliation permanent items.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Permanent Items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Guarantees, Commitments, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of one-time milestone payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TextBlockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Text Block [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Fair Value Of Warrant Liabilities And Fair Value Of Financial Instruments Issued In Excess Of Proceeds Includes Reversal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic weighted average shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average number of common shares, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares outstanding, basic (As Restated)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">September Two Thousand And Twenty Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">September Two Thousand And Twenty Common Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">September 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (In years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of accrued expenses and other liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Expenses And Other Liabilities Table [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of U.S. Federal Statutory Income Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gain on Available-for-Sale Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrealized gain on available-for-sale securities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain on available-for-sale securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccretionOnInvestmentDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accretion on Investment Discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccretionOnInvestmentDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion on Investment Discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccretionOnInvestmentDiscounts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accretion on investment discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccretionOnInvestmentDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion on investment discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease remaining term of contract.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Remaining Term Of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining term of office lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Asset, In-Process Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research expenditures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tegoprubart - Other Development Programs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tegoprubart - other development programs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tegoprubart - other development programs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement second closing.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement Second Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement Second Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity (deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LeerinkPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leerink Partners LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LeerinkPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Leerink partners LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LeerinkPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leerink Partners LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXOnePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X One Preferred Stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXOnePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X One Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXOnePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X1 Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt, Long-Term and Short-Term, Combined Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt, Long-Term and Short-Term, Combined Amount, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty Common Warrants Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty Common Warrants Two Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EquityDistributionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity distribution agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EquityDistributionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Distribution Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EquityDistributionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Distribution Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Issuable Under Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Effective Date of Acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Business acquisition, date of acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets depreciation and amortization.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Depreciation And Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PerformanceBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance-based Vesting Requirements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PerformanceBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance-based vesting requirements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment, Long-Lived Asset, Held-for-Use</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairments of long-lived assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Impairment, Long-Lived Asset, Held-for-Use, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax examination likelihood of favorable settlement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination Likelihood Of Favorable Settlement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax examination, likelihood of settlement, percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current State and Local Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Description and Basis of Presentation [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty Common Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants available for exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of Shares of Common Stock Issuable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Country [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carryforwards expiration period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carryforwards Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforward expiration period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Basis of presentation and principles of consolidation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Presentation And Principles Of Consolidation Policy [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Principles of Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reportable segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Anelixis Therapeutics, Incorporation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Anelixis Therapeutics Incorporation [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anelixis [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Anelixis [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock in Connection with Private Investment in Public Equity Transaction, Net of Issuance Costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash paid for amounts included in measurement of lease liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for amounts included in the measurement of lease liability:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant exercise price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock With The Completion Of The Second And Third Closing In Connection With Two Thousand Twenty Three Securities Purchase Agreement Net Of Issuance Costs , value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NoncashActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncash activities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NoncashActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NoncashActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSU [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Net deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Liabilities, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">In Process Research and Development, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-Process Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Current income tax expense (benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Agencies Short-Term Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Agency Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Risks and uncertainties.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Risks and Uncertainties [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risks and Uncertainties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accruals and reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_GuggenheimSecuritiesLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Guggenheim Securities LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_GuggenheimSecuritiesLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Guggenheim Securities LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_GuggenheimSecuritiesLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Guggenheim Securities LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average number of common shares, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares outstanding, diluted (As Restated)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock in Connection with Private Investment in Public Equity Transaction, Net of Issuance Costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202307Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2023-07 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, vested in period, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSUs Vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected stock price volatility, minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of cumulative change in ownership.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Cumulative Change In Ownership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of cumulative change in ownership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common and preferred warrants outstanding.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common And Preferred Warrants Outstanding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common and Preferred Warrants Outstanding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasuries [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating business segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">General and administrative expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty Common Warrants Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty Common Warrants Three Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of RSU Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited / Canceled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty long term incentive plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Long Term Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2020 Long Term Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rental expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of pre-funded warrants exercised for common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Pre-funded Warrants Exercised for Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of pre-funded warrants exercised for common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements Issued But Not Adopted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Payments Under Noncancelable Operating Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Vesting period of stock options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest or penalties recorded during the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, term of contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less current portion of operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Four Securities Purchase Agreement Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand And Twenty Four Securities Purchase Agreement Pre-funded Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Securities Purchase Agreement Pre-funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-Term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds after deducting offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Private Placement, Net of Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of private placement, net of offering costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">State income taxes, net of Federal tax benefits.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State Income Taxes Net Of Federal Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income taxes, net of federal tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Provision for Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Supplemental Cash Flow Information Related to Leases [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other supplemental cash flow information related to leases.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Other Supplemental Cash Flow Information Related to Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty One Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty One Pre-funded Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2021 Pre-funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TableTextBlockSupplementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Table Text Block Supplement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss and comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss used in the calculation of basic and diluted loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Changes and Error Corrections [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Net Of Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of net of offering costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds after deducting offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows from operating lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Loss Before Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Factors Used to Identify Entity's Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term, Simplified Method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Expected life assumption using simplified method, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Otic Pharma, Ltd.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Otic Pharma Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Otic Pharma [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock In Connection With Conversion Of X1 Non-voting Convertible Preferred Stock Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RestatementDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revision of Prior Period [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid expenses, other assets, accrued expenses and other liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Tax Credit, Amount, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss) Available to Common Stockholders, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss attributable to common shares - basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets measured at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total financial assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Time-based vesting requirements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Time-based Vesting Requirements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Time Based Vesting Requirements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax reconciliation state tax rate differential.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation State Tax Rate Differential</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State rate differential</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options assumed in period weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Assumed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Range of exercise prices</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Gross unrecognized tax benefits at the end of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Gross unrecognized tax benefits at the beginning of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments other than options, nonvested, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant subject to specified beneficial ownership limitations permitted percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RestatementAdjustmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revision of Prior Period, Adjustment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RestatementAdjustmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restatement Impact [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Expected life of option (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Recurring Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with exercise of pre-funded warrants, shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock in Connection With Exercise of Pre-funded Warrants, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with exercise of pre-funded warrants, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid expenses, other assets, accrued expenses and other liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock In Connection With Conversion Of X Non Voting Convertible Preferred Stock Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in operating right-of-use lease asset and liability due to new lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease in Right-Of-Use Operating Lease Asset and Liability Due To New Lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in operating right-of-use lease asset and liability due to new lease.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Settlement of Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Settlement of warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Settlement of warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with vesting of restricted stock units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_InProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">In-process research and development.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_InProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">In Process Research And Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_InProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-process research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities measured at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets lease liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value, 200,000,000 shares authorized at December 31, 2024 and 2023; 59,789,275 and 24,213,130 shares issued and outstanding at December 31, 2024 and 2023, respectively</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Fair Value of Warrant Liabilities and Fair Value of Financial Instruments Issued in Excess of Proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss) Available to Common Stockholders, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss attributable to common shares - diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Three Securities Purchase Agreement Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand And Twenty Three Securities Purchase Agreement Pre-funded Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Securities Purchase Agreement Pre-funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warranty liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Otic Pharma, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Otic Pharma Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Otic Pharma, Inc. [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of preferred stock, conversion blocker, percent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Preferred Stock, Conversion Blocker, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock, conversion blocker, percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Remaining milestone payments for first licensed product.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remaining Milestone Payments For First Licensed Product</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining milestone payments for first licensed product</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected stock price volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalPreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalPreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand fourteen stock incentive plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Fourteen Stock Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2014 Stock Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Five hundred million aggregate net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Five Hundred Million Aggregate Net Sales [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Achievement of 500 Million Aggregate Sales [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest and penalties associated with uncertain tax positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants exercised.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State and Local Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Income tax benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IsraelTaxAuthorityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Israel Tax Authority [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IsraelTaxAuthorityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Israeli Tax Authority [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of common stockholders receive cash and other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Common Stockholders Receive Cash and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of common stockholders receive cash and other assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Biotechnology Value Fund LP, Biotechnology Value Fund II LP, Biotechnology Value Trading Fund OS LP, MSI BVF SPV LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Biotechnology Value Fund L P Biotechnology Value Fund I I L P Biotechnology Value Trading Fund O S L P M S I B V F S P V L L C [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">BVF Exchanging Stockholders [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accumulated other comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Personnel-RelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Personnel-Related Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Personnel-RelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Personnel-related expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Personnel-RelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Personnel-related</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock With The Completion Of The Second And Third Closing In Connection With Two Thousand Twenty Three Securities Purchase Agreement Net Of Issuance Costs , Shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Settlement Of Warrant Liability Into Common Stock Due To Exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Settlement of warrant liability into common stock due to exercise.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlement of warrant liability into common stock due to exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax provision</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred income tax provision</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred income tax provision</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">RSUs Vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Earnings per share, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted earnings per share of common stock (As Restated)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Segment Reporting</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Error Correction [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock In Connection With Conversion Of X1 Non-voting Convertible Preferred Stock Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AmortizationOfOperatingLeaseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of operating lease asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AmortizationOfOperatingLeaseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Operating Lease Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AmortizationOfOperatingLeaseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of operating lease asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Foreign Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Period For Which Cumulative Change In Ownership Annual Use Net Operating Loss And Research And Development Credit Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership interest percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cormorant global healthcare master fund lp.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cormorant Global Healthcare Master Fund LP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cormorant Global Healthcare Master Fund LP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Noncash Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tegoprubart - Kidney Transplantation Programs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tegoprubart kidney transplantation programs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tegoprubart - kidney transplantation programs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average discount rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-current operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-current operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, grants in period, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Operating Lease Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Liabilities, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Investments, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Goodwill [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Likelihood of Unfavorable Settlement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax examination, likelihood of settlement, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Corporations and Agencies Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Agency Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OneBillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">One billion aggregate net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OneBillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">One Billion Aggregate Net Sales [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OneBillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Achievement of 1 Billion Aggregate Sales [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign operating losses carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares of common stock issued upon conversion of each share of preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares of common stock issued upon conversion of each share of preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ALS therapy development foundation, Inc. license agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">A L S Therapy Development Foundation Inc License Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ALS Therapy Development Foundation, Inc. License Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccruedClinicalCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued clinical current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccruedClinicalCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccruedClinicalCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued clinical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restatement of Previously Issued Consolidated Financial Statements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Error Correction [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Four Underwritten Offering Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand And Twenty Four Underwritten Offering Pre-funded Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Underwritten Offering Pre-funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stock Options Roll Forward [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ContingentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ContingentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ContingentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Board of Directors Chairman [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Board of Directors [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Opinion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, nonvested, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of milestones achieved.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Milestones Achieved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Milestones Achieved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Previously Reported [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">As Previously Reported [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EGenesisIncCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">eGenesis, Inc. Collaboration Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EGenesisIncCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">eGenesis, Inc. Collaboration Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock And PreFunded Warrants In Connection With Two Thousand Twenty Four Underwritten Offering, Net Of Issuance Costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock-based compensation expense, recognized over estimated weighted average period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock, Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vested and expected to vest</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PreFundedWarrantsMember" xlink:to="eldn_PreFundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_MA" xlink:to="stpr_MA_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" xlink:to="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" xlink:to="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" xlink:to="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" xlink:to="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TaxCreditCarryforwardExpirationDescription" xlink:to="eldn_TaxCreditCarryforwardExpirationDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:to="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="eldn_DescriptionOfBusinessTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="eldn_DescriptionOfBusinessLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" xlink:to="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManufacturingCosts" xlink:to="us-gaap_ManufacturingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NOLTrueUp" xlink:to="eldn_NOLTrueUp_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SecuritiesPurchaseAgreementMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PrepaidClinicalExpense" xlink:to="eldn_PrepaidClinicalExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockCompensationPlanMember" xlink:to="us-gaap_StockCompensationPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesX1ExchangeAgreementMember" xlink:to="eldn_SeriesX1ExchangeAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_UnderwritingAgreementMember" xlink:to="eldn_UnderwritingAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ConversionAgreementMember" xlink:to="eldn_ConversionAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_EffectiveFederalAndStateIncomeTaxRate" xlink:to="eldn_EffectiveFederalAndStateIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember" xlink:to="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ManufacturingExpensesOffset" xlink:to="eldn_ManufacturingExpensesOffset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_RegulatoryMilestonePaymentsObligation" xlink:to="eldn_RegulatoryMilestonePaymentsObligation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" xlink:to="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TaxCreditCarryforwardExpirationPeriod" xlink:to="eldn_TaxCreditCarryforwardExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" xlink:to="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ScheduleOfWarrantActivityTableTextBlock" xlink:to="eldn_ScheduleOfWarrantActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:to="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AreaOfOfficeSpace" xlink:to="eldn_AreaOfOfficeSpace_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="us-gaap_GuaranteeObligationsCurrentCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ArmisticeCapitalMasterFundLtdMember" xlink:to="eldn_ArmisticeCapitalMasterFundLtdMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="us-gaap_WorkersCompensationLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnTerminationOfLease" xlink:to="us-gaap_GainLossOnTerminationOfLease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_FeeDueForMilestonesAchieved" xlink:to="eldn_FeeDueForMilestonesAchieved_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SecuritiesPurchaseAgreementInitialClosingMember" xlink:to="eldn_SecuritiesPurchaseAgreementInitialClosingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AnnualLicenseMaintenanceFee" xlink:to="eldn_AnnualLicenseMaintenanceFee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AccreditedInvestorMember" xlink:to="eldn_AccreditedInvestorMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SecuritiesPurchaseAgreementThirdClosingMember" xlink:to="eldn_SecuritiesPurchaseAgreementThirdClosingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DeferredTaxAssetsRightOfUseAsset" xlink:to="eldn_DeferredTaxAssetsRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" xlink:to="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PreferredStockWarrantsMember" xlink:to="eldn_PreferredStockWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AggregateNetSalesAchievement" xlink:to="eldn_AggregateNetSalesAchievement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" xlink:to="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncomeTaxReconciliationPermanentItems" xlink:to="eldn_IncomeTaxReconciliationPermanentItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_TextBlockAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" xlink:to="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" xlink:to="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_UnrealizedGainOnAvailableForSaleSecurities" xlink:to="eldn_UnrealizedGainOnAvailableForSaleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AccretionOnInvestmentDiscounts" xlink:to="eldn_AccretionOnInvestmentDiscounts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_LesseeOperatingLeaseRemainingTermOfContract" xlink:to="eldn_LesseeOperatingLeaseRemainingTermOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:to="eldn_Tegoprubart-OtherDevelopmentPrograms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SecuritiesPurchaseAgreementSecondClosingMember" xlink:to="eldn_SecuritiesPurchaseAgreementSecondClosingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_LeerinkPartnersLlcMember" xlink:to="eldn_LeerinkPartnersLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesXOnePreferredStockMember" xlink:to="eldn_SeriesXOnePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_EquityDistributionAgreementMember" xlink:to="eldn_EquityDistributionAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="eldn_DeferredTaxAssetsDepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PerformanceBasedVestingRequirementsMember" xlink:to="eldn_PerformanceBasedVestingRequirementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" xlink:to="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NetOperatingLossCarryforwardsExpirationPeriod" xlink:to="eldn_NetOperatingLossCarryforwardsExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:to="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AnelixisTherapeuticsIncorporationMember" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:to="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_NoncashActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_RisksAndUncertaintiesPolicyTextBlock" xlink:to="eldn_RisksAndUncertaintiesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_GuggenheimSecuritiesLlcMember" xlink:to="eldn_GuggenheimSecuritiesLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate202307Member" xlink:to="us-gaap_AccountingStandardsUpdate202307Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PercentageOfCumulativeChangeInOwnership" xlink:to="eldn_PercentageOfCumulativeChangeInOwnership_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CommonAndPreferredWarrantsOutstandingMember" xlink:to="eldn_CommonAndPreferredWarrantsOutstandingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandTwentyLongTermIncentivePlanMember" xlink:to="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" xlink:to="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:to="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" xlink:to="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_StateIncomeTaxesNetOfFederalTaxBenefits" xlink:to="eldn_StateIncomeTaxesNetOfFederalTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_TableTextBlockSupplementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CommonStockWarrantsMember" xlink:to="eldn_CommonStockWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareBasicLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" xlink:to="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments" xlink:to="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_OticPharmaLtdMember" xlink:to="eldn_OticPharmaLtdMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" xlink:to="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TimeBasedVestingRequirementsMember" xlink:to="eldn_TimeBasedVestingRequirementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncomeTaxReconciliationStateTaxRateDifferential" xlink:to="eldn_IncomeTaxReconciliationStateTaxRateDifferential_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:to="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" xlink:to="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SettlementOfWarrantLiability" xlink:to="eldn_SettlementOfWarrantLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_InProcessResearchAndDevelopment" xlink:to="eldn_InProcessResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ProceedsFromIssuanceOffering" xlink:to="eldn_ProceedsFromIssuanceOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DeferredTaxAssetsLeaseLiability" xlink:to="eldn_DeferredTaxAssetsLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_OticPharmaIncMember" xlink:to="eldn_OticPharmaIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ConversionOfPreferredStockConversionBlockerPercent" xlink:to="eldn_ConversionOfPreferredStockConversionBlockerPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_RemainingMilestonePaymentsForFirstLicensedProduct" xlink:to="eldn_RemainingMilestonePaymentsForFirstLicensedProduct_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalPreferredStock" xlink:to="us-gaap_AdditionalPaidInCapitalPreferredStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandFourteenStockIncentivePlanMember" xlink:to="eldn_TwoThousandFourteenStockIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_FiveHundredMillionAggregateNetSalesMember" xlink:to="eldn_FiveHundredMillionAggregateNetSalesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IsraelTaxAuthorityMember" xlink:to="us-gaap_IsraelTaxAuthorityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" xlink:to="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" xlink:to="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_Personnel-RelatedExpenses" xlink:to="eldn_Personnel-RelatedExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" xlink:to="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AmortizationOfOperatingLeaseAsset" xlink:to="eldn_AmortizationOfOperatingLeaseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" xlink:to="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CormorantGlobalHealthcareMasterFundLpMember" xlink:to="eldn_CormorantGlobalHealthcareMasterFundLpMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CommonWarrantsMember" xlink:to="eldn_CommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:to="eldn_Tegoprubart-KidneyTransplantationPrograms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_ScheduleOfGoodwillTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_OneBillionAggregateNetSalesMember" xlink:to="eldn_OneBillionAggregateNetSalesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" xlink:to="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AccruedClinicalCurrent" xlink:to="eldn_AccruedClinicalCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" xlink:to="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ContingentLiability" xlink:to="eldn_ContingentLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NumberOfMilestonesAchieved" xlink:to="eldn_NumberOfMilestonesAchieved_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_EGenesisIncCollaborationAgreementMember" xlink:to="eldn_EGenesisIncCollaborationAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="80.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="81.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="82.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="83.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="84.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="85.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="86.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="87.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorOpinionTextBlock" order="88.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="89.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentDescription" order="90.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_InProcessResearchAndDevelopment" xlink:label="eldn_InProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="eldn_InProcessResearchAndDevelopment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_22"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_23"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_24"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_25"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_22" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_23" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_24" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_25" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NoncashActivitiesAbstract" xlink:label="eldn_NoncashActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnrealizedGainOnAvailableForSaleSecurities" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AmortizationOfOperatingLeaseAsset" xlink:label="eldn_AmortizationOfOperatingLeaseAsset"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccretionOnInvestmentDiscounts" xlink:label="eldn_AccretionOnInvestmentDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="eldn_NoncashActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnTerminationOfLease" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_UnrealizedGainOnAvailableForSaleSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="eldn_AmortizationOfOperatingLeaseAsset" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="eldn_AccretionOnInvestmentDiscounts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:to="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatements1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="us-gaap_ErrorCorrectionTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ErrorCorrectionTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RisksAndUncertaintiesPolicyTextBlock" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eldn_RisksAndUncertaintiesPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TableTextBlockSupplementAbstract" xlink:label="us-gaap_TableTextBlockSupplementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:to="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfWarrantActivityTableTextBlock" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_CommonStockWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_PreferredStockWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ScheduleOfWarrantActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessTable" xlink:label="eldn_DescriptionOfBusinessTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessLineItems" xlink:label="eldn_DescriptionOfBusinessLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXOneNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="eldn_DescriptionOfBusinessTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="eldn_DescriptionOfBusinessLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaLtdMember" xlink:label="eldn_OticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaIncMember" xlink:label="eldn_OticPharmaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202307Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="eldn_PreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="eldn_OticPharmaLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="eldn_OticPharmaIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="us-gaap_EarningsPerShareBasicLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_EarningsPerShareBasicLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonAndPreferredWarrantsOutstandingMember" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="eldn_CommonAndPreferredWarrantsOutstandingMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ShortTermInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiability" xlink:label="eldn_SettlementOfWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="eldn_SettlementOfWarrantLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidClinicalExpense" xlink:label="eldn_PrepaidClinicalExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="eldn_PrepaidClinicalExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidInsurance" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccruedClinicalCurrent" xlink:label="eldn_AccruedClinicalCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WorkersCompensationLiabilityCurrent" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="eldn_AccruedClinicalCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_WorkersCompensationLiabilityCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_GoodwillLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FiveHundredMillionAggregateNetSalesMember" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA" xlink:label="stpr_CA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OneBillionAggregateNetSalesMember" xlink:label="eldn_OneBillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_MA" xlink:label="stpr_MA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EGenesisIncCollaborationAgreementMember" xlink:label="eldn_EGenesisIncCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AreaOfOfficeSpace" xlink:label="eldn_AreaOfOfficeSpace"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LesseeOperatingLeaseRemainingTermOfContract" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FeeDueForMilestonesAchieved" xlink:label="eldn_FeeDueForMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfMilestonesAchieved" xlink:label="eldn_NumberOfMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RemainingMilestonePaymentsForFirstLicensedProduct" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RegulatoryMilestonePaymentsObligation" xlink:label="eldn_RegulatoryMilestonePaymentsObligation"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnnualLicenseMaintenanceFee" xlink:label="eldn_AnnualLicenseMaintenanceFee"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AggregateNetSalesAchievement" xlink:label="eldn_AggregateNetSalesAchievement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ManufacturingExpensesOffset" xlink:label="eldn_ManufacturingExpensesOffset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ContingentLiability" xlink:label="eldn_ContingentLiability"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="eldn_FiveHundredMillionAggregateNetSalesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OtherCommitmentsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="eldn_OneBillionAggregateNetSalesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_EGenesisIncCollaborationAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AreaOfOfficeSpace" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_LesseeOperatingLeaseRemainingTermOfContract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_FeeDueForMilestonesAchieved" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_StockIssued1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_NumberOfMilestonesAchieved" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_RemainingMilestonePaymentsForFirstLicensedProduct" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_RegulatoryMilestonePaymentsObligation" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AnnualLicenseMaintenanceFee" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AggregateNetSalesAchievement" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_ManufacturingExpensesOffset" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_GuaranteeObligationsCurrentCarryingValue" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_ContingentLiability" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EffectiveFederalAndStateIncomeTaxRate" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NetOperatingLossCarryforwardsExpirationPeriod" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationPeriod" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationDescription" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCumulativeChangeInOwnership" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_TaxCreditCarryforwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IsraelTaxAuthorityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_EffectiveFederalAndStateIncomeTaxRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_NetOperatingLossCarryforwardsExpirationPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="7.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_TaxCreditCarryforwardExpirationPeriod" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_TaxCreditCarryforwardExpirationDescription" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_PercentageOfCumulativeChangeInOwnership" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_StateIncomeTaxesNetOfFederalTaxBenefits" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationPermanentItems" xlink:label="eldn_IncomeTaxReconciliationPermanentItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationStateTaxRateDifferential" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NOLTrueUp" xlink:label="eldn_NOLTrueUp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_StateIncomeTaxesNetOfFederalTaxBenefits" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_IncomeTaxReconciliationPermanentItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_IncomeTaxReconciliationStateTaxRateDifferential" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_NOLTrueUp" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsLeaseLiability" xlink:label="eldn_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsRightOfUseAsset" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_DeferredTaxAssetsDepreciationAndAmortization" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_DeferredTaxAssetsLeaseLiability" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_DeferredTaxAssetsRightOfUseAsset" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_3"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LeerinkPartnersLlcMember" xlink:label="eldn_LeerinkPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1ExchangeAgreementMember" xlink:label="eldn_SeriesX1ExchangeAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ArmisticeCapitalMasterFundLtdMember" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccreditedInvestorMember" xlink:label="eldn_AccreditedInvestorMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXOnePreferredStockMember" xlink:label="eldn_SeriesXOnePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionAgreementMember" xlink:label="eldn_ConversionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CormorantGlobalHealthcareMasterFundLpMember" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_GuggenheimSecuritiesLlcMember" xlink:label="eldn_GuggenheimSecuritiesLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementInitialClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionOfPreferredStockConversionBlockerPercent" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementSecondClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementThirdClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EquityDistributionAgreementMember" xlink:label="eldn_EquityDistributionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnderwritingAgreementMember" xlink:label="eldn_UnderwritingAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOffering" xlink:label="eldn_ProceedsFromIssuanceOffering"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_LeerinkPartnersLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SeriesX1ExchangeAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="eldn_ArmisticeCapitalMasterFundLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="eldn_AccreditedInvestorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXOnePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_ConversionAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreferredStockWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_CormorantGlobalHealthcareMasterFundLpMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_PreFundedWarrantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_GuggenheimSecuritiesLlcMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementInitialClosingMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ConversionOfPreferredStockConversionBlockerPercent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementSecondClosingMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementThirdClosingMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_EquityDistributionAgreementMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_UnderwritingAgreementMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="7.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_TitleOfIndividualAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOffering" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="7.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonWarrantsMember" xlink:label="eldn_CommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_6"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_CommonWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreFundedWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_4"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreferredStockWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenStockIncentivePlanMember" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PerformanceBasedVestingRequirementsMember" xlink:label="eldn_PerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandTwentyLongTermIncentivePlanMember" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_TimeBasedVestingRequirementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandFourteenStockIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_PerformanceBasedVestingRequirementsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandTwentyLongTermIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="7.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_4"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FactorsUsedToIdentifyEntitysReportableSegments" xlink:label="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Personnel-RelatedExpenses" xlink:label="eldn_Personnel-RelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Tegoprubart-KidneyTransplantationPrograms" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Tegoprubart-OtherDevelopmentPrograms" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ManufacturingCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Personnel-RelatedExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingExpenses" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalPreferredStock" xlink:label="us-gaap_AdditionalPaidInCapitalPreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="srt_RestatementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalPreferredStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="srt_RestatementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_InProcessResearchAndDevelopment" xlink:label="eldn_InProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="eldn_InProcessResearchAndDevelopment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfWarrantActivityTableTextBlock" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_CommonStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_PreferredStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ScheduleOfWarrantActivityTableTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessLineItems" xlink:label="eldn_DescriptionOfBusinessLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessTable" xlink:label="eldn_DescriptionOfBusinessTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXOneNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="eldn_DescriptionOfBusinessTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaLtdMember" xlink:label="eldn_OticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaIncMember" xlink:label="eldn_OticPharmaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202307Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="eldn_PreFundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="eldn_OticPharmaLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="eldn_OticPharmaIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="us-gaap_EarningsPerShareBasicLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonAndPreferredWarrantsOutstandingMember" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="eldn_CommonAndPreferredWarrantsOutstandingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiability" xlink:label="eldn_SettlementOfWarrantLiability"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="eldn_SettlementOfWarrantLiability" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_ScheduleOfGoodwillTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FiveHundredMillionAggregateNetSalesMember" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA" xlink:label="stpr_CA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OneBillionAggregateNetSalesMember" xlink:label="eldn_OneBillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_MA" xlink:label="stpr_MA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EGenesisIncCollaborationAgreementMember" xlink:label="eldn_EGenesisIncCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AreaOfOfficeSpace" xlink:label="eldn_AreaOfOfficeSpace"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LesseeOperatingLeaseRemainingTermOfContract" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FeeDueForMilestonesAchieved" xlink:label="eldn_FeeDueForMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfMilestonesAchieved" xlink:label="eldn_NumberOfMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RemainingMilestonePaymentsForFirstLicensedProduct" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RegulatoryMilestonePaymentsObligation" xlink:label="eldn_RegulatoryMilestonePaymentsObligation"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnnualLicenseMaintenanceFee" xlink:label="eldn_AnnualLicenseMaintenanceFee"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AggregateNetSalesAchievement" xlink:label="eldn_AggregateNetSalesAchievement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ManufacturingExpensesOffset" xlink:label="eldn_ManufacturingExpensesOffset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ContingentLiability" xlink:label="eldn_ContingentLiability"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="eldn_FiveHundredMillionAggregateNetSalesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="eldn_OneBillionAggregateNetSalesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_EGenesisIncCollaborationAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AreaOfOfficeSpace" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_LesseeOperatingLeaseRemainingTermOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_FeeDueForMilestonesAchieved" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_StockIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_NumberOfMilestonesAchieved" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_RemainingMilestonePaymentsForFirstLicensedProduct" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_RegulatoryMilestonePaymentsObligation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AnnualLicenseMaintenanceFee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AggregateNetSalesAchievement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_ManufacturingExpensesOffset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_GuaranteeObligationsCurrentCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_ContingentLiability" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EffectiveFederalAndStateIncomeTaxRate" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NetOperatingLossCarryforwardsExpirationPeriod" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationPeriod" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationDescription" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCumulativeChangeInOwnership" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IsraelTaxAuthorityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_EffectiveFederalAndStateIncomeTaxRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_NetOperatingLossCarryforwardsExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_TaxCreditCarryforwardExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_TaxCreditCarryforwardExpirationDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_PercentageOfCumulativeChangeInOwnership" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LeerinkPartnersLlcMember" xlink:label="eldn_LeerinkPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1ExchangeAgreementMember" xlink:label="eldn_SeriesX1ExchangeAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ArmisticeCapitalMasterFundLtdMember" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccreditedInvestorMember" xlink:label="eldn_AccreditedInvestorMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXOnePreferredStockMember" xlink:label="eldn_SeriesXOnePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionAgreementMember" xlink:label="eldn_ConversionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CormorantGlobalHealthcareMasterFundLpMember" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_GuggenheimSecuritiesLlcMember" xlink:label="eldn_GuggenheimSecuritiesLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementInitialClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionOfPreferredStockConversionBlockerPercent" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementSecondClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementThirdClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EquityDistributionAgreementMember" xlink:label="eldn_EquityDistributionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnderwritingAgreementMember" xlink:label="eldn_UnderwritingAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOffering" xlink:label="eldn_ProceedsFromIssuanceOffering"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_LeerinkPartnersLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SeriesX1ExchangeAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="eldn_ArmisticeCapitalMasterFundLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="eldn_AccreditedInvestorMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXOnePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_ConversionAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreferredStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_CormorantGlobalHealthcareMasterFundLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_PreFundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_GuggenheimSecuritiesLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementInitialClosingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ConversionOfPreferredStockConversionBlockerPercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementSecondClosingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementThirdClosingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_EquityDistributionAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_UnderwritingAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonWarrantsMember" xlink:label="eldn_CommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_CommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreFundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreferredStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenStockIncentivePlanMember" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PerformanceBasedVestingRequirementsMember" xlink:label="eldn_PerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandTwentyLongTermIncentivePlanMember" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_TimeBasedVestingRequirementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandFourteenStockIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_PerformanceBasedVestingRequirementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandTwentyLongTermIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Personnel-RelatedExpenses" xlink:label="eldn_Personnel-RelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Tegoprubart-KidneyTransplantationPrograms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Tegoprubart-OtherDevelopmentPrograms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ManufacturingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Personnel-RelatedExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ShareBasedCompensation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" xlink:label="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalPreferredStock" xlink:label="us-gaap_AdditionalPaidInCapitalPreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="srt_RestatementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalPreferredStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="srt_RestatementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="eldn_InProcessResearchAndDevelopment" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_InProcessResearchAndDevelopment" xlink:label="eldn_InProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="2" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnTerminationOfLease" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="eldn_AccretionOnInvestmentDiscounts" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="eldn_AmortizationOfOperatingLeaseAsset" order="10" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="12" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" order="14" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="15" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="17" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccretionOnInvestmentDiscounts" xlink:label="eldn_AccretionOnInvestmentDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AmortizationOfOperatingLeaseAsset" xlink:label="eldn_AmortizationOfOperatingLeaseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="eldn_PrepaidClinicalExpense" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="4" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidClinicalExpense" xlink:label="eldn_PrepaidClinicalExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_WorkersCompensationLiabilityCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="eldn_AccruedClinicalCurrent" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WorkersCompensationLiabilityCurrent" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccruedClinicalCurrent" xlink:label="eldn_AccruedClinicalCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="2" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_StateIncomeTaxesNetOfFederalTaxBenefits" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="2" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="4" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_IncomeTaxReconciliationPermanentItems" order="7" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_IncomeTaxReconciliationStateTaxRateDifferential" order="9" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_NOLTrueUp" order="10" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="11" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="12" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_StateIncomeTaxesNetOfFederalTaxBenefits" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationPermanentItems" xlink:label="eldn_IncomeTaxReconciliationPermanentItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationStateTaxRateDifferential" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NOLTrueUp" xlink:label="eldn_NOLTrueUp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="eldn_DeferredTaxAssetsRightOfUseAsset" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="eldn_DeferredTaxAssetsDepreciationAndAmortization" order="5" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="eldn_DeferredTaxAssetsLeaseLiability" order="6" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsRightOfUseAsset" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsLeaseLiability" xlink:label="eldn_DeferredTaxAssetsLeaseLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="eldn_Tegoprubart-KidneyTransplantationPrograms" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="eldn_Tegoprubart-OtherDevelopmentPrograms" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ManufacturingCosts" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="eldn_Personnel-RelatedExpenses" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ShareBasedCompensation" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Personnel-RelatedExpenses" xlink:label="eldn_Personnel-RelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" name="AccountsPayableAccruedExpensesAndOtherLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_TwoThousandTwentyLongTermIncentivePlanMember" name="TwoThousandTwentyLongTermIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SeriesXOneNonVotingConvertiblePreferredStockMember" name="SeriesXOneNonVotingConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" name="SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_CommonWarrantsMember" name="CommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ArmisticeCapitalMasterFundLtdMember" name="ArmisticeCapitalMasterFundLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SeriesXNonVotingConvertiblePreferredStockMember" name="SeriesXNonVotingConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" name="BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_AccreditedInvestorMember" name="AccreditedInvestorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" name="TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ScheduleOfWarrantActivityTableTextBlock" name="ScheduleOfWarrantActivityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_NoncashActivitiesAbstract" name="NoncashActivitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_DescriptionOfBusinessTable" name="DescriptionOfBusinessTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" name="ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" name="PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_AggregateNetSalesAchievement" name="AggregateNetSalesAchievement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_DeferredTaxAssetsLeaseLiability" name="DeferredTaxAssetsLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" name="IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" name="TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_EGenesisIncCollaborationAgreementMember" name="EGenesisIncCollaborationAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_GuggenheimSecuritiesLlcMember" name="GuggenheimSecuritiesLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_PerformanceBasedVestingRequirementsMember" name="PerformanceBasedVestingRequirementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" name="IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_ProceedsFromIssuanceOffering" name="ProceedsFromIssuanceOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_SeriesXOnePreferredStockMember" name="SeriesXOnePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_AreaOfOfficeSpace" name="AreaOfOfficeSpace" type="dtr-types:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" name="JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SecuritiesPurchaseAgreementInitialClosingMember" name="SecuritiesPurchaseAgreementInitialClosingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" name="ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_IncomeTaxReconciliationStateTaxRateDifferential" name="IncomeTaxReconciliationStateTaxRateDifferential" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" name="NumberOfPreFundedWarrantsExercisedForCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="eldn_SecuritiesPurchaseAgreementSecondClosingMember" name="SecuritiesPurchaseAgreementSecondClosingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_PercentageOfCumulativeChangeInOwnership" name="PercentageOfCumulativeChangeInOwnership" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_DescriptionOfBusinessLineItems" name="DescriptionOfBusinessLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" name="ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_StateIncomeTaxesNetOfFederalTaxBenefits" name="StateIncomeTaxesNetOfFederalTaxBenefits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_TwoThousandFourteenStockIncentivePlanMember" name="TwoThousandFourteenStockIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" name="IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets" name="PercentageOfCommonStockholdersReceiveCashAndOtherAssets" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" name="IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" name="IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_SeriesX1ExchangeAgreementMember" name="SeriesX1ExchangeAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" name="BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" name="DeferredTaxLiabilitiesInProcessResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_LesseeOperatingLeaseRemainingTermOfContract" name="LesseeOperatingLeaseRemainingTermOfContract" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" name="ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_OticPharmaIncMember" name="OticPharmaIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" name="JanuaryTwoThousandAndTwentyCommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" name="ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" name="JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_EffectiveFederalAndStateIncomeTaxRate" name="EffectiveFederalAndStateIncomeTaxRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_DeferredTaxAssetsDepreciationAndAmortization" name="DeferredTaxAssetsDepreciationAndAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_SettlementOfWarrantLiability" name="SettlementOfWarrantLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_AccruedClinicalCurrent" name="AccruedClinicalCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_PrepaidClinicalExpense" name="PrepaidClinicalExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" name="TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" name="CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_PreferredStockWarrantsMember" name="PreferredStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" name="IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_Tegoprubart-OtherDevelopmentPrograms" name="Tegoprubart-OtherDevelopmentPrograms" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" name="IncomeTaxExaminationLikelihoodOfFavorableSettlement" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="eldn_PreFundedWarrantsMember" name="PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_OticPharmaLtdMember" name="OticPharmaLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" name="IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" name="IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ManufacturingExpensesOffset" name="ManufacturingExpensesOffset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" name="ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" name="CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" name="IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" name="SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_AnelixisTherapeuticsIncorporationMember" name="AnelixisTherapeuticsIncorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" name="AnelixisTherapeuticsLlcAndOticPharmaLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" name="SeriesX1NonVotingConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" name="IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" name="ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" name="IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" name="JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_UnderwritingAgreementMember" name="UnderwritingAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_CommonStockWarrantsMember" name="CommonStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_Tegoprubart-KidneyTransplantationPrograms" name="Tegoprubart-KidneyTransplantationPrograms" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_AmortizationOfOperatingLeaseAsset" name="AmortizationOfOperatingLeaseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_TaxCreditCarryforwardExpirationPeriod" name="TaxCreditCarryforwardExpirationPeriod" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_TimeBasedVestingRequirementsMember" name="TimeBasedVestingRequirementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_InProcessResearchAndDevelopment" name="InProcessResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_IncomeTaxReconciliationPermanentItems" name="IncomeTaxReconciliationPermanentItems" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" name="IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ContingentLiability" name="ContingentLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_OneBillionAggregateNetSalesMember" name="OneBillionAggregateNetSalesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_UnrealizedGainOnAvailableForSaleSecurities" name="UnrealizedGainOnAvailableForSaleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" name="ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_AnnualLicenseMaintenanceFee" name="AnnualLicenseMaintenanceFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_SecuritiesPurchaseAgreementThirdClosingMember" name="SecuritiesPurchaseAgreementThirdClosingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_FeeDueForMilestonesAchieved" name="FeeDueForMilestonesAchieved" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ConversionAgreementMember" name="ConversionAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" name="TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_NOLTrueUp" name="NOLTrueUp" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" name="TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_AccretionOnInvestmentDiscounts" name="AccretionOnInvestmentDiscounts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_RemainingMilestonePaymentsForFirstLicensedProduct" name="RemainingMilestonePaymentsForFirstLicensedProduct" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" name="TwoThousandFourteenEmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" name="IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_NetOperatingLossCarryforwardsExpirationPeriod" name="NetOperatingLossCarryforwardsExpirationPeriod" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" name="OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" name="PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_TaxCreditCarryforwardExpirationDescription" name="TaxCreditCarryforwardExpirationDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" name="TimeBasedAndPerformanceBasedVestingRequirementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_CommonAndPreferredWarrantsOutstandingMember" name="CommonAndPreferredWarrantsOutstandingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_FiveHundredMillionAggregateNetSalesMember" name="FiveHundredMillionAggregateNetSalesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" name="IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_RisksAndUncertaintiesPolicyTextBlock" name="RisksAndUncertaintiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="eldn_DeferredTaxAssetsRightOfUseAsset" name="DeferredTaxAssetsRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_Personnel-RelatedExpenses" name="Personnel-RelatedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" name="ProceedsFromIssuanceOfNetOfOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_ConversionOfPreferredStockConversionBlockerPercent" name="ConversionOfPreferredStockConversionBlockerPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_EquityDistributionAgreementMember" name="EquityDistributionAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" name="JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_NumberOfMilestonesAchieved" name="NumberOfMilestonesAchieved" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" name="PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_LeerinkPartnersLlcMember" name="LeerinkPartnersLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" name="CashCashEquivalentsAndRestrictedCashMaturityPeriod" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_CormorantGlobalHealthcareMasterFundLpMember" name="CormorantGlobalHealthcareMasterFundLpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_RegulatoryMilestonePaymentsObligation" name="RegulatoryMilestonePaymentsObligation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" name="SeptemberTwoThousandAndTwentyCommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Aug. 13, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ELDN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ELEDON PHARMACEUTICALS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001404281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag', window );">Document Financial Statement Restatement Recovery Analysis [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1000967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">19800 MacArthur Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(949) <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">238-8090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,881,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,885,717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">173<span></span>
</td>
<td class="text">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Crowe LLP<span></span>
</td>
<td class="text">KMJ Corbin & Company LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Los Angeles, CA<span></span>
</td>
<td class="text">Glendora, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of Eledon Pharmaceuticals, Inc. (the "Company") as of December 31, 2024, and the related consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders&#8217; equity (deficit), and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Explanatory Paragraph &#8211; Restatement</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 12 to the financial statements, the 2024 financial statements have been restated to correct a misstatement.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Audit Matter</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.  The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#ff0000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Classification and Valuation of Pre-Funded Warrants</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in Note 2, Summary of Significant Accounting Policies, and Note 8, Stockholder&#8217;s Equity, to the consolidated financial statements, the Company accounts for issued pre-funded warrants either as a liability or equity in accordance with ASC 815-40, Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period with any change in the fair value of the warrants recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. The Common Warrants and the Subsequent Closing Warrants (as defined in Note 8) issued in the 2023 Private Placement are liability classified and recorded at fair value</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">using the Black-Scholes option-pricing model at issuance, with any subsequent changes in fair value recognized in the consolidated statements of operations. Determining the proper classification of pre-funded warrants as either a derivative liability or as equity instruments requires significant management judgment in assessing the specific terms and conditions. The valuation of the derivative liability for liability classified pre-funded warrants also requires management judgment in determining the fair value.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The classification and valuation of warrants was determined to be a critical audit matter because of the complexity and significant judgment involved in determining the accounting for the pre-funded warrants and the significant audit effort, including the use of specialists, in assessing management&#8217;s conclusions and inputs to its calculation of fair value.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit procedures to evaluate the classification and fair market value of the pre-funded warrants included:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining and inspecting the securities purchase agreements to evaluate the contractual terms of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluating management's technical accounting analysis on the classification of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consulting with specialists on the classification and valuation of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Developing an independent expectation of the valuation of the liability-classified warrants to compare to management&#8217;s valuation.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of Eledon Pharmaceuticals, Inc. (the &#8220;Company&#8221;) as of December 31, 2023, the related consolidated statements of operations and comprehensive loss, convertible stock and stockholders&#8217; equity (deficit) and cash flows for the year then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive proxy statement for its 2025 Annual Meeting of Stockholders, that was filed with the Securities and Exchange Commission on April 29, 2025, are incorporated by reference into Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">In this Amendment No. 1 on Form 10-K/A (&#8220;Amendment No. 1&#8221;), unless the context requires otherwise, &#8220;Eledon&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221;, and &#8220;us&#8221; means Eledon Pharmaceuticals, Inc. (formerly Novus Therapeutics, Inc.) and all of its wholly-owned subsidiaries.This Amendment No. 1 amends the Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc. for the fiscal year ended December 31, 2024, as filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 20, 2025 (the &#8220;Original Report&#8221;) to restate for the effects of material errors in the previously issued financial statements as of and for the years ended December 31, 2024 and 2023.   See Note 1. Description of Business (As Restated) and Note 12. Restatement of Previously Issued Consolidated Financial Statements of the Notes to Financial Statements included in this Amendment No. 1 for additional information and reconciliation of the previously reported amounts to the restated amounts.The Company has not filed, and does not intend to file, amendments to the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024, June 30, 2024 or September 30, 2024 (the &#8220;Impacted 2024 Quarterly Reports&#8221;), which will be restated prospectively with the corresponding 2025 quarterly filings. Accordingly, investors should rely only on the financial information and other disclosures regarding these restated periods in this Amendment No. 1 or in future filings with the SEC (as applicable), and not on any previously issued or filed reports, earnings releases or similar communications relating to these periods. The financial information that has been previously filed or otherwise reported for the periods covered by the Original Report and the Impacted 2024 Quarterly Reports is superseded by the information in this Amendment No. 1 (as to the fiscal years ended December 31, 2024 and December 31, 2023 included in the Original Report, and, solely with respect to the information included under the caption &#8220;Restatement of Interim Financial Information&#8221; in Note 12 of the Notes to Consolidated Financial Statements included in this Amendment No. 1, as to the information included in the Impacted 2024 Quarterly Reports) as well as by the restated financial information related to the quarters ended March 31, 2024, June 30, 2024 and September 30, 2024 that will be included prospectively in the corresponding 2025 quarterly filings.  The Company also expects to file an amendment to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the &#8220;2025 Form 10-Q&#8221; and, together with the Original Report and the Impacted 2024 Quarterly Reports, the &#8220;Impacted Reports&#8221;) to restate the unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2025 and March 31, 2024 included in the 2025 Form 10-Q with respect to the material errors described in Note 1 and Note 12 under the caption &#8220;Restatement of Previously Issued Consolidated Financial Statements.&#8221; The errors did not result in any impact on the Company&#8217;s cash and short-term investment position, liquidity, or results of operations.This Amendment No. 1 presents the Original Report, as amended and restated to date, with further modifications as necessary to reflect the restatement described herein. The following items have been amended to reflect the restatement:&#8226;Item 1A. Risk Factors&#8226;Item 8. Financial Statements and Supplementary Data&#8226;Item 9A. Controls and ProceduresThe information required by Items 10, 11, 12, 13 and 14 of Part III of this Report is incorporated by reference to the Company&#8217;s definitive proxy statement, which was filed with the SEC on April 29, 2025 (the &#8220;2025 Proxy Statement&#8221;). The information contained in the 2025 Proxy Statement is not impacted by the restatement described herein. In addition, in accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), Item 15 of Part IV of the Original Report is being amended and restated solely to include as exhibits the certifications of our principal executive officer and principal financial officer required by Rule 13a-14(a) under the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350). Except as otherwise expressly noted herein, this Amendment No. 1 does not amend, modify or update any other information set forth in the Original Report. Furthermore, this Amendment No. 1 does not change any previously reported financial results, except as necessary to reflect the restatement described herein, nor does it reflect events occurring after the filing date of the Original Report. Information not affected by this Amendment No. 1 remains unchanged and reflects the disclosures made at the time the Original Report was filed. Accordingly, this Amendment No. 1 should be read in conjunction with our filings made with the SEC subsequent to the filing of the Original Report, including any amendment to those filings.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtRestatementRecoveryAnalysisFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 20,549<span></span>
</td>
<td class="nump">$ 4,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,552<span></span>
</td>
<td class="nump">5,027<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">143,730<span></span>
</td>
<td class="nump">56,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset, net</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_InProcessResearchAndDevelopment', window );">In-process research and development</a></td>
<td class="nump">32,386<span></span>
</td>
<td class="nump">32,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">363<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">177,405<span></span>
</td>
<td class="nump">89,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">5,833<span></span>
</td>
<td class="nump">967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liability</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">5,430<span></span>
</td>
<td class="nump">2,545<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,577<span></span>
</td>
<td class="nump">3,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">2,183<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liability</a></td>
<td class="nump">640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">44,865<span></span>
</td>
<td class="nump">76,211<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">59,265<span></span>
</td>
<td class="nump">81,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 200,000,000 shares authorized at December 31, 2024 and 2023; 59,789,275 and 24,213,130 shares issued and outstanding at December 31, 2024 and 2023, respectively</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">417,946<span></span>
</td>
<td class="nump">270,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(355,586)<span></span>
</td>
<td class="num">(319,402)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">62,446<span></span>
</td>
<td class="num">(48,486)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock and stockholders' equity (deficit)</a></td>
<td class="nump">177,405<span></span>
</td>
<td class="nump">89,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, value</a></td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">53,543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember', window );">Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, value</a></td>
<td class="nump">$ 2,151<span></span>
</td>
<td class="nump">$ 2,151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_InProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In-process research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_InProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479772/718-30-S55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">59,789,275<span></span>
</td>
<td class="nump">24,213,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">59,789,275<span></span>
</td>
<td class="nump">24,213,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember', window );">Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 51,964<span></span>
</td>
<td class="nump">$ 30,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">18,613<span></span>
</td>
<td class="nump">12,688<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">70,577<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">3,924<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="nump">30,900<span></span>
</td>
<td class="num">(76,211)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(35,753)<span></span>
</td>
<td class="num">(116,537)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(431)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">(36,184)<span></span>
</td>
<td class="num">(116,537)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (31,992)<span></span>
</td>
<td class="num">$ (91,987)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share of common stock (As Restated)</a></td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (3.74)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share of common stock (As Restated)</a></td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (3.74)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (As Restated)</a></td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (As Restated)</a></td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X and Series X1 Non Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (4,192)<span></span>
</td>
<td class="num">$ (24,550)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share of common stock (As Restated)</a></td>
<td class="num">$ (36.61)<span></span>
</td>
<td class="num">$ (207.58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share of common stock (As Restated)</a></td>
<td class="num">$ (36.61)<span></span>
</td>
<td class="num">$ (207.58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (As Restated)</a></td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">118,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (As Restated)</a></td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">118,268<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Convertible Stock and Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Series X1 Non-voting Convertible Preferred Stock [Member]</div></th>
<th class="th"><div>Series X Non-Voting Convertible Preferred Stock [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning Balance, Convertible Preferred Stock at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,378<span></span>
</td>
<td class="nump">$ 3,017<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning Balance, Convertible Preferred Stock, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,970<span></span>
</td>
<td class="nump">6,204<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 23,788<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 226,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (202,865)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,776,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue', window );">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value</a></td>
<td class="nump">33,017<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">33,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares', window );">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,730,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue', window );">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock, Value</a></td>
<td class="nump">866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares', window );">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,782)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue', window );">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Value</a></td>
<td class="nump">3,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,835)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares', window );">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,884)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares', window );">Issuance of common stock in connection with exercise of pre-funded warrants, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,154,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue', window );">Issuance of common stock in connection with exercise of pre-funded warrants, Value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in connection with vesting of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(116,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending Balance, Convertible Preferred Stock at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,543<span></span>
</td>
<td class="nump">$ 2,151<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending Balance, Convertible Preferred Stock, Shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2023</a></td>
<td class="num">(48,486)<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">270,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(319,402)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,213,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue', window );">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value</a></td>
<td class="nump">48,064<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">48,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares', window );">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,110,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares', window );">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,636,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue', window );">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Value</a></td>
<td class="nump">6,155<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares', window );">Issuance of common stock in connection with exercise of pre-funded warrants, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,423,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue', window );">Issuance of common stock in connection with exercise of pre-funded warrants, Value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares', window );">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,356,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue', window );">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value</a></td>
<td class="nump">$ 79,533<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">79,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock Option Exercise, Shares</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Option Exercise, Value</a></td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">13,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(36,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending Balance, Convertible Preferred Stock at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,543<span></span>
</td>
<td class="nump">$ 2,151<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending Balance, Convertible Preferred Stock, Shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 62,446<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 417,946<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="num">$ (355,586)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,789,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with conversion of X non-voting convertible preferred stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with conversion of x non-voting convertible preferred stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with conversion of X non-voting convertible preferred stock value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with exercise of pre-funded warrants, shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with exercise of pre-funded warrants, value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479772/718-30-S55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (36,184)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Gain on lease termination</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use asset</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AccretionOnInvestmentDiscounts', window );">Accretion on investment discounts</a></td>
<td class="num">(2,799)<span></span>
</td>
<td class="num">(1,203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">13,122<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="num">(30,900)<span></span>
</td>
<td class="nump">76,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax provision</a></td>
<td class="nump">431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">1,298<span></span>
</td>
<td class="num">(1,954)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AccountsPayableAccruedExpensesAndOtherLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="nump">7,751<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(339)<span></span>
</td>
<td class="num">(363)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(47,271)<span></span>
</td>
<td class="num">(39,527)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of available-for-sale short-term investments</a></td>
<td class="num">(156,131)<span></span>
</td>
<td class="num">(78,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturities of available-for-sale short-term investments</a></td>
<td class="nump">85,817<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(70,314)<span></span>
</td>
<td class="num">(45,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet', window );">Proceeds from issuances of common stock and pre-funded warrants, net</a></td>
<td class="nump">133,307<span></span>
</td>
<td class="nump">33,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">133,522<span></span>
</td>
<td class="nump">33,017<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">15,937<span></span>
</td>
<td class="num">(51,797)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">4,612<span></span>
</td>
<td class="nump">56,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">20,549<span></span>
</td>
<td class="nump">4,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NoncashActivitiesAbstract', window );"><strong>Non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock', window );">Common stock exchanged for X and X1 non-voting convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_UnrealizedGainOnAvailableForSaleSecurities', window );">Unrealized gain on available-for-sale securities</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease', window );">Increase in operating right-of-use lease asset and liability due to new lease</a></td>
<td class="nump">920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise', window );">Settlement of warrant liability into common stock due to exercise</a></td>
<td class="nump">$ 446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AccountsPayableAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts payable, accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AccountsPayableAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AccretionOnInvestmentDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion on Investment Discounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AccretionOnInvestmentDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock exchanged for X and X1 non-voting convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in operating right-of-use lease asset and liability due to new lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NoncashActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NoncashActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock and pre funded warrants net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement of warrant liability into common stock due to exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_UnrealizedGainOnAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized gain on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_UnrealizedGainOnAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479092/842-20-40-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (36,184)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management, Strategy and Governance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strategy and Oversight</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and data related to our clinical studies and employees, or our information systems and the data contained therein.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We retain a Chief Information Consultant to collaborate with the company, including the Chief Financial Officer, and Executive Leadership Team, to help identify, assess and manage the company&#8217;s cybersecurity threats and risks. This group identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example, automated tools, subscribing to reports and services that identify cybersecurity threats, analyzing reports of threats and actors, and evaluating threats reported to us. We also use a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> security management vendor to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending on the environment, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our information systems, including, for example, incident detection and response policy, route risk assessments, data encryption, network security controls, data segregation, access controls, physical security, asset management, tracking and disposal, systems monitoring, penetration testing, and cybersecurity insurance. As part of our information security program, we provide mandatory periodic training for all employees on how to identify potential cybersecurity risks and protect our resources and information. This training is supplemented by firmwide testing initiatives, including periodic phishing tests.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assessment and management of material risks from cybersecurity threats are </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into our overall risk management processes.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> For example, the Chief Information Consultant works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. In addition, our </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.</span></span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we do not believe that known risks from cybersecurity threats, including as a result of any previous cybersecurity incidents that we are aware of, have </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">materially affected</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. However, we can give no assurance that we have detected or protected against all such cybersecurity incidents or threats. For a description of the risks from cybersecurity threats that may materially affect us and how they may do so, see our risk factors under Part I. Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K, including the risk factor titled &#8220;</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We depend on our information systems and those of our third-party collaborators, service providers, contractors or consultants</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which may fail or suffer cybersecurity incidents that could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.&#8221;</span></p><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board addresses our cybersecurity risk management as part of its general oversight function. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of </span></span><span style=""></span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">risks </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.</span></p><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span></span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.</span></p></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assessment and management of material risks from cybersecurity threats are </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into our overall risk management processes.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board addresses our cybersecurity risk management as part of its general oversight function. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of </span></span><span style=""></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">risks </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.</span></p><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span></span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.</span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">risks </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from cybersecurity threats.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 1. Description of Business (As Restated)</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 Ligand (&#8220;CD40L&#8221;) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (&#8220;ALS&#8221;). The Company&#8217;s lead compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that we believe has broad therapeutic potential. Unless otherwise indicated, references to the terms &#8220;Eledon,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;we,&#8221; or the &#8220;Company&#8221; refer to Eledon Pharmaceuticals, Inc. and its wholly owned subsidiaries, on a consolidated basis.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 14, 2020</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, Eledon acquired Anelixis Therapeutics, Inc. (&#8220;Anelixis&#8221;), a privately held clinical stage biotechnology company developing a next generation anti-CD40L antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases. The Company maintains its corporate headquarters in Irvine, California and has research and development facilities in Burlington, Massachusetts.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restatement of Previously Issued Consolidated Financial Statements</span></p><p style="text-indent:5.393%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.111%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the course of preparing the Company&#8217;s Condensed Consolidated Financial Statements as of and for the three and six months ended June 30, 2025, the Company reassessed the rights and preferences of its Series X and Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> non-voting convertible preferred stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value (&#8220;Preferred Stock&#8221;), and concluded that, because they are substantially identical to those of its common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value, the Preferred Stock should be treated as a separate class of common stock for purposes of calculating earnings per share in accordance with </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounting Standards Codification (&#8220;ASC&#8221;) 260-10, &#8220;Earnings Per Share.&#8221; As a result, the Company determined that it should have presented earnings per share under the two-class method in prior reporting periods.</span></p><p style="text-indent:5.391%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, in connection with this reassessment, the Company concluded that it had incorrectly classified the Preferred Stock as permanent equity in the consolidated balance sheets. The Preferred Stock includes a provision that, upon the occurrence of a fundamental transaction (which includes a third-party tender or exchange offer) in which more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> percent of the common stockholders receive cash or other assets, the holders of Preferred Stock, upon any subsequent conversion, are entitled to receive the same form of consideration, even if they did not participate in the original transaction. Because this feature may result in settlement in cash or other non-equity consideration upon an event outside the Company&#8217;s control, the Preferred Stock does not meet the criteria for permanent equity classification and is instead classified as temporary equity under ASC 480-10-S99-3A. Although a tender offer is not considered probable as of the current reporting date and redemption is not deemed probable, the existence of this provision requires classification as temporary equity. The Preferred Stock is not subsequently remeasured to its redemption value because redemption is not considered probable.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain consolidated financial statements and financial information are presented herein as restated. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">See Note 12</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restatement of Previously Issued Consolidated Financial Statements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for further information.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#8220;Otic&#8221;). Otic owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#8217;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#8217;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#8220;ROU&#8221;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments with original maturities of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months or less</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> when purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds, U.S. government securities and U.S. government agency securities. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all of the Company&#8217;s long-lived assets were located in the United States. The Company&#8217;s products will require approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#8217;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reportable Segments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#8217;s Chief Executive Officer and the Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Long-Lived Assets</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairments of long-lived assets have been identified during the years presented.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-Process Research and Development</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts allocated to in-process research and development (&#8220;IPR&amp;D&#8221;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#8217;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;D was impaired for any of the periods presented.</span></p></div><div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#8217;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share (As Restated)</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net loss per share are calculated using the two-class method in accordance with ASC Topic 260, Earnings Per Share. The two-class method allocates undistributed losses to the Company&#8217;s outstanding common stock, and the Preferred Stock, based on each class&#8217;s proportionate share of the total weighted-average shares outstanding. Since the Company has never declared dividends, net loss and undistributed losses are equivalent.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. The process is used for both common stock and Preferred Stock. As the rights and preferences of the Preferred Stock are substantially identical to each other, they are considered a single class of common stock for earnings per share purposes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#8217;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023 includ</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,443,755</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,776,270</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> respectively, shares underlying pre-funded warrants to purchase common shares. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), these shares are deemed to be issued for purposes of basic earnings per share.</span></span></p><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The calculation of basic and diluted earnings per share for our common stock and Preferred Stock is as follows:</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:60.06%;box-sizing:content-box;"></td>
           <td style="width:1.86%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:16.279999999999998%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.86%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:15.940000000000001%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(As Restated)</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,543,787</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,619,197</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,268</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss used in the calculation of basic and diluted loss per share</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss available to common stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,992</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91,987</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, common stock, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.66</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.74</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss available to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,192</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,550</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.61</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207.58</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
         </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;">
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:57.76%;box-sizing:content-box;"></td>
           <td style="width:1.72%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:17.4%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.72%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:17.4%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options outstanding and other equity awards</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,007,789</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,909,155</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common and preferred warrants outstanding</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,567,751</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,577,332</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,575,540</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,486,487</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div></div><div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#8220;not more likely than not&#8221; that a tax benefit will be sustained, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. </span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">second step is to measure the tax benefit as the largest amount that is </span></span><span style=""></span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">more </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% likely of being realized upon settlement.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Notes to Financial Statements.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for issued warrants either as a liability or equity in accordance with ASC 815-40 Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (&#8220;ASC 815-40&#8221;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Adopted Accounting Pronouncements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">early adoptions</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> permitted. The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ASU 2023-07, effective </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t impact the consolidated financial statements. See Note 10, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for disclosures related to the adoption of ASU 2023-07.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements Issued But Not Adopted</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#8217;s present or future financial position, results of operations or cash flows.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 3. Short-Term Investments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The objectives of the Company&#8217;s investment policy are to preserve principal, meet the Company's liquidity requirements and safeguard invested funds. Short-term investments consist of U.S. government securities and U.S. government agency securities. The Company has classified these investments as available-for-sale securities, as the sale of such investments may be required prior to maturity to implement management strategies, and therefore has classified all</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">investments with maturity dates beyond three months at the date of purchase as current assets in the accompanying consolidated balance sheets. Any premium or discount arising at purchase is amortized and/or accreted to interest income as an adjustment to yield using the straight-line method over the life of the instrument. The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts to maturity. Investments are reported at their estimated fair value. Unrealized gains and losses are included in accumulated other comprehensive loss as a component of stockholders' equity until realized.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of short-term investments, which were classified as available-for-sale securities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:32.294%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.577%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.577%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.577%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.577%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,603</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,603</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All of the Company's available-for-sale securities have a stated maturity of less than one year.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalent, and short-term investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4. Fair Value Measurements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities are recorded at fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies fair value measurements using a three-level hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1&#8212;Quoted market prices (unadjusted) in active markets for identical assets and liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2&#8212;Observable inputs other than quoted market prices included in Level 1, such as quoted market prices for markets that are not active or other inputs that are observable or can be corroborated by observable market data.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, including certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. These fair values are obtained from independent pricing services which utilize Level 1 and Level 2 inputs.</span></div></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.387%;box-sizing:content-box;"></td>
         <td style="width:1.78%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.12%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.12%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasuries</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,679</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">137,093</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">138,308</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.387%;box-sizing:content-box;"></td>
         <td style="width:1.78%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.12%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.12%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,736</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's warrant liabilities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:27.514%;box-sizing:content-box;"></td>
         <td style="width:6.879%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.199%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.46%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.439%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:27.514%;box-sizing:content-box;"></td>
         <td style="width:6.879%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.199%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.46%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.439%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.2%;box-sizing:content-box;"></td>
         <td style="width:6.48%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:28.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Settlement of warrant liability</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">446</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes the reversal of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in warrant liabilities associated with the Subsequent Closing Warrants (as defined in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), which expired and or settled as of year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract', window );"><strong>Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock', window );">Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 5. Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:56.709%;box-sizing:content-box;"></td>
         <td style="width:2.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.697%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.956%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,915</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,128</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid insurance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">693</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">624</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">185</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">729</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,552</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,027</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other liabilities consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.08%;box-sizing:content-box;"></td>
         <td style="width:2.34%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.119999999999997%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.34%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.119999999999997%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,642</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">451</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and related expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,601</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,003</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,430</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,545</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses, other assets, accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses, other assets, accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases office space under various operating leases. Total rent expense for all operating leases in the consolidated statements of operations and comprehensive loss was approximately</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for each of the years ended December 31, 2024 and 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 19, 2024, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38-month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,817</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Irvine, California, that expires on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2027</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Irvine Lease Agreement&#8221;). On April 19, 2024, in conjunction with the Irvine Lease Agreement, the Company terminated an existing operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,197</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Irvine, California, that was set to expire on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On April 19, 2024, the effective date of the Irvine Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 4, 2024, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36-month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,138</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Burlington, Massachusetts, that expires on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 21, 2027</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Burlington Lease Agreement&#8221;). The existing lease expired on November 20, 2024. On November 21, 2024, the effective date of the Burlington Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determines if a contract contains a lease at inception. Our office leases have a remaining term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and do not include options to extend the leases for additional periods.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities as adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, we estimate incremental secured borrowing rates corresponding to the maturities of the leases. As we have </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding debt nor committed credit facilities, secured or otherwise, we estimate this rate based on prevailing financial market conditions, comparable company and credit analysis, and management&#8217;s judgment.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our leases contain rent escalations over the lease term. We recognize expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we do not currently have any lease agreement with lease and non-lease components, we elected to account for lease and non-lease components as separate components.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term disclosures include only those leases with a term greater than one month and 12 months or less, and expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less, that do not include an option to purchase the underlying asset that we are reasonably certain to exercise, are not recorded on the consolidated balance sheet.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total operating lease expense were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.833%;box-sizing:content-box;"></td>
         <td style="width:1.88%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.203000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.88%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.203000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">407</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">400</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a) </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Includes variable operating lease expenses, which are immaterial.</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other supplemental cash flow information related to leases were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64%;box-sizing:content-box;"></td>
         <td style="width:2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.299999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.84%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.860000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of lease liability:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.433%;box-sizing:content-box;"></td>
         <td style="width:1.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.403%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.403%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.46</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.49</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:70.514%;box-sizing:content-box;"></td>
         <td style="width:2.941%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:24.544999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">391</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">403</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">293</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,087</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less imputed interest</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">133</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of lease liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">954</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less current portion of operating lease liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">314</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-current operating lease liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">640</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Grants and Licenses</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ALS Therapy Development Foundation, Inc. License Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2015, Anelixis executed a License Agreement (the &#8220;Agreement&#8221;), which is an exclusive patent rights agreement with ALS Therapy Development Foundation, Inc. (&#8220;ALS TDI&#8221;) for certain patents and &#8220;know-how&#8221; of ALS TDI. This agreement continues until the licensee terminates the agreement with ninety days written notice. The Agreement requires license fees payable to ALS TDI, subject to the achievement of certain milestones and other conditions.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The first and second milestones of the Agreement are the dosing of the first subjects in a first toxicity study in non-human primates and the dosing of the first patient in a Phase I Clinical Trial, respectively. Both of these milestones were achieved as of December 31, 2018 and 2017. The fee due for the achievement of these milestones was</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million each. During 2018 and 2017, Anelixis issued $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million wort</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">h of its common stock in lieu of making a cash payment. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> milestones achieved during </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 or 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Agreement was amended and restated in February 2020, and a first amendment to the restated license agreement was executed in September 2020. As amended in September 2020, the remaining milestone payments for a first licensed product total</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In the event that the Company develops a second licensed product, the Company is obligated to pay up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional milestone payments.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the milestone payments, the Company is required to pay ALS TDI an amended annual license maintenance fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million beginning on the earlier of January 1, 2022, the Company&#8217;s first sublicense, or change in control, as defined in the Agreement. The Company has made a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million annual license maintenance fee in each year since 2022.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, the Company is required to pay ALS TDI fees based on reaching certain levels of annual net sales of any product produced with t</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he patent rights. A royalty in the low single digits will be due on aggregate net sales. Upon the first calendar year of reaching $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in aggregate net sales, the Company will be required to pay ALS TDI a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Upon the first calendar year of reaching $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion in aggregate net sales, the Company is obligated to pay ALS TDI a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lonza Sales AG Inc. License Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2018, Anelixis executed a License Agreement (the &#8220;Lonza Agreement&#8221;), which is a manufacturing know-how rights agreement with Lonza Sales AG Inc. (&#8220;Lonza&#8221;) for the use of certain processes and know-how related to the manufacture of tegoprubart. The Lonza Agreement continues until the later of the last Valid Claim (as defined therein) or ten years from the First Commercial Sale of tegoprubart, as defined and subject to the conditions therein. A royalty in the low single digits will be due on aggregate net sales of tegoprubart that is manufactured by Lonza or any other third-party or licensee.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">eGenesis, Inc. Collaboration Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2022, and subsequently amended in January 2023, Eledon executed a non-exclusive collaborative research agreement with eGenesis, Inc. (the &#8220;eGenesis Agreement&#8221;), under which eGenesis will gain access to tegoprubart for eGenesis&#8217; ongoing preclinical research and development xenotransplant studies of human-compatible organs and cells for the treatment of organ failure. eGenesis will pay Eledon for supplies of tegoprubart based on the number of study days per animal needed for the eGenesis preclinical xenotransplant studies to offset manufacturing expenses. As of year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company offset $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of manufacturing expenses. The eGenesis agreement continues until September 2025, unless terminated earlier by either party.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Matters</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and its subsidiaries are not a party to or the subject of any claim or lawsuit that individually or in the aggregate is anticipated to have a material effect on the Company&#8217;s results of operations, financial condition or cash flows.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnifications</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnification. The Company&#8217;s exposure under these agreements is unknown because it involves future claims that may be made against the Company but have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future because of these indemnification obligations. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amounts associated with such indemnifications have been recorded to date.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> contingent liabilities requiring accrual at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss before income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.72%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses before income taxes:</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S.</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,951</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,736</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-U.S.</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">198</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">199</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,753</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision for income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.88%;box-sizing:content-box;"></td>
         <td style="width:3.4%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.4%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.68%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current income tax provision</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred income tax provision</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on its review, the Company concluded that it was more likely than not that they would not realize the benefit of a portion of its deferred tax assets in the future. This conclusion was based on historical and projected operating performance, as well as the Company&#8217;s expectation that its operations will not generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets within the statutory carryover periods. Therefore, the Company has a valuation allowance on its deferred tax assets as of December 31, 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.913%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.783000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.422%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Statutory federal income tax rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,473</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal tax benefits</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">908</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,170</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,358</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,819</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent items</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,273</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,078</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State rate differential</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NOL true-up</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">566</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,137</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,200</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.72%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,740</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,089</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,560</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,202</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">366</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">475</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research expenditures</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,809</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,567</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,281</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,085</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,056</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,319</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,037</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,828</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquired IPR&amp;D</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,623</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,682</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,841</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,769</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,379</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,811</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax liabilities</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,183</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,752</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:61.448%;box-sizing:content-box;"></td>
         <td style="width:2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.277000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.277000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the beginning of the year</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,636</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,664</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in the current year</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,596</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in prior years</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the end of the year</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,232</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,636</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The deferred income tax assets have been offset by a valuation allowance, as realization is dependent on future earnings, if any, the timing and amount of which are uncertain. The net valuatio</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023 to December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The net valuation allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2022 to December 31, 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s accounting for deferred taxes involves the evaluation of a number of factors concerning the realizability of its net deferred tax assets. The Company primarily considered such factors as its history of operating losses, the nature of the Company&#8217;s deferred tax assets, and the timing, likelihood, and amount, if any, of future taxable income during the periods in which those temporary differences and carryforwards become deductible. At present, the Company does not believe that it is more likely than not that the deferred tax assets will be realized; accordingly, a valuation allowance has been established.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, available to reduce future taxable income. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company also has state net operating loss carryforwards of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Both the federal and state net operating loss carryforwards incurred before 2018 begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2035</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if not utilized. The federal net operating losses incurred since 2018 of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million do not expire. The state net operating losses begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2035</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal research and development tax credit carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. If not utilized, the carryforwards will begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2036</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has state research and development credit carryforwards or approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, which will begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2030</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> if not utilized</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Internal Revenue Code (IRC) Sections 382 and 383, annual use of the Company&#8217;s net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% occurs within a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has not completed an IRC Section 382/383 analysis regarding the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limitation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of net operating loss and research and development credit carryforwards. Due to the existence of the valuation allowance, future changes in the Company&#8217;s unrecognized tax benefits will not impact the Company&#8217;s effective tax rate.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s ability to use its remaining net operating loss and tax credit carryforwards may be further limited if the Company experiences a Section 382 ownership change in connection with future changes in our stock ownership.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the Company files income tax returns in the U.S. Federal jurisdiction, California and Massachusetts. The Company&#8217;s tax years for 2018 and forward are subject to examination by the Federal and California tax authorities due to the carryforward of unutilized net operating losses and research and development credits.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s policy is to recognize interest expense and penalties related to income tax matters as a component of income tax expense. There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued interest and penalties associated with uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any interest or penalties in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 or 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 8. Stockholders&#8217; Equity (As Restated)</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> authorized shares of preferred stock with a par value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> non-voting convertible preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares designated; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued and outstand</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ing at December 31, 2024 and 2023, and </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares designated; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding at December 31, 2024 and 2023.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each share of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or X non-voting convertible preferred stock (the &#8220;Preferred Stock&#8221;) is convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55.5556</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, at the option of the holder at any time, subject to certain limitations, including, that the holder will be prohibited from converting the Preferred Stock into common stock if, as a result of such conversion, the holder, together with its affiliates, would beneficially own a number of shares of common stock above a conversion blocker, which is initially set at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total common stock then issued and outstanding immediately following the conversion of such shares of Series X Preferred Stock or Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Stock, respectively. The holder of the Preferred Stock is entitled to receive dividends on shares of the Preferred Stock equal (on an as-if-converted-to-common-stock basis and without regard to any beneficial ownership limitations) to and in the same form as dividends actually paid on shares of the common stock. No other dividends will be paid on shares of the Preferred Stock. In the event of any liquidation, dissolution or winding up, the holder of the Preferred Stock will be entitled to receive out of the assets, whether capital or surplus, the same amount that a holder of common stock would receive if the Preferred Stock were fully converted to common stock, which amounts shall be paid pari passu with all holders of common stock. Shares of the Preferred Stock will generally have no voting rights, except as required by law and except that the consent of a majority of the holders of either series of outstanding Preferred Stock will be required to amend the terms of such series.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Preferred Stock includes a provision that, in the event of a tender or exchange offer by a third party in which more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the common stockholders receive cash or other assets, allows holders of Preferred Stock, upon any subsequent conversion, to redeem their shares for the same form of consideration. Because this redemption right may be triggered by an event outside the Company&#8217;s control and could result in settlement in cash, the Preferred Stock is classified as temporary equity. As of the current reporting date, a tender offer is not probable, and the preferred stock is not deemed probable of becoming redeemable. Because redemption is not considered probable, the Preferred Stock is not subsequently remeasured to its redemption value.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2022 Exchange Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 11, 2022, the Company entered into an exchange agreement (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange Agreement&#8221;) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., MSI BVF SPV, L.L.C. (collectively, the &#8220;BVF Exchanging Stockholders&#8221;), pursuant to which the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchanging Stockholders exchanged (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">550,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,899.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Ser</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ies X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, the Company entered into a Securities Purchase Agreement (the &#8220;2023 Securities Purchase Agreement&#8221;) with certain investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#8220;2023 Private Placement&#8221;) (i) in an initial closing, (a) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,151,518</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share, or pre-funded warrants in lieu thereof (the &#8220;Pre-Funded Warrants&#8221;), and (b) common stock warrants exercisable into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,151,518</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants in lieu thereof) (the &#8220;Common Warrants&#8221; and, together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;); (ii) in a second closing (the &#8220;Second Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,202,024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants); and (iii) in a third closing (the &#8220;Third Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,252,530</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants), in each case subject to customary adjustments as provided in the 2023 Securities Purchase Agreement, Pre-Funded Warrant or Common Warrant, as applicable. Each Common Warrant has an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expires five years after issuance. The Pre-Funded Warrants are exercisable immediately and until exercised in full, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pre-Funded Warrants and Common Warrants are subject to specified beneficial ownership limitations, which are generally set at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% unless otherwise permitted. The Shares, the Warrants, and the shares of common stock issuable upon the exercise of the Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 5, 2023, the initial closing occurred, and the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,730,168</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock and Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,421,350</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 8, 2024, the Second Closing occurred, and the Company received gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">909,088</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 30, 2024, and October 1, 2024, the Third Closing occurred, and the Company received gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,727,400</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2023 Private Placement, the Company filed on May 18, 2023, a registration statement on Form S-3 (the &#8220;2023 Registration Statement&#8221;) with the SEC to register for resale the Shares and the shares of common stock issuable upon the exercise of the Warrants. The 2023 Registration Statement became effective on June 2, 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company concluded that the Common Warrants, and the potential issuance of Pre-Funded Warrants in lieu of additional shares of common stock in the Second Closing and Third Closing (the &#8220;Subsequent Closing Warrants&#8221;) do not meet the conditions to be classified as equity instruments under ASC 815-40 and must instead be recorded as liabilities on the Company&#8217;s consolidated balance sheets at their fair value and remeasured at fair value for each subsequent reporting period.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The valuation of the Common Warrants and the Subsequent Closing Warrants is adjusted to fair value (Level 3) at each balance sheet date until the Common Warrants and the Subsequent Closing Warrants are settled or expired.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, and as of the issuance date:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:47.149%;box-sizing:content-box;"></td>
         <td style="width:1.48%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.823999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.481%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:23.064999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.9</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share price</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.14</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.80</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Conversion Agreement of Non-Voting Convertible Preferred Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">O</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n May 16, 2023, Cormorant Global Healthcare Master Fund LP provided notice to convert (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,782</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series X Non-Voting Convertible Preferred Stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X Non-Voting Convertible Preferred Stock, and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,883.586</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">437,977</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock. The conversion was completed on May 23, 2023.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 6, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;2024 Securities Purchase Agreement&#8221;) with certain institutional and accredited investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#8220;2024 Private Placement&#8221;) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,110,484</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the &#8220;2024 Shares&#8221;) of the Company&#8217;s common stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.37</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and pre-funded warrants (the &#8220;2024 Pre-Funded Warrants&#8221;) at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.369</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per underlying share, which are exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,989,516</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The 2024 Pre-Funded Warrants were issued in lieu of shares of common stock and are exercisable immediately and until exercised in full. The 2024 Pre-Funded Warrants are subject to specified beneficial ownership limitations (equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% as determined by holder of each such warrant) of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% unless otherwise permitted. The 2024 Shares, the 2024 Pre-Funded Warrants, and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Pre-Funded Warrants were classified as a component of permanent stockholders&#8217; equity within additional paid-in-capital. The 2024 Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In addition, the 2024 Pre-Funded Warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Private Placement resulted in gross proceeds to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Private Placement, the Company filed on May 24, 2024, a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC to register for resale the 2024 Shares and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants. The 2024 Registration Statement became effective on June 5, 2024.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Equity Distribution Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 20, 2024, the Company entered into an Open Market Sale Agreement (the &#8220;Sales Agreement&#8221;) with Guggenheim Securities, LLC (&#8220;Guggenheim Securities&#8221;) to sell shares of the Company&#8217;s common stock, having aggregate sales proceeds of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, from time to time, through an &#8220;at the market&#8221; equity offering program under which Guggenheim Securities will act as sales agent. In connection with the Sales Agreement, the Company filed on September 20, 2024 a registration statement on Form S-3 containing a prospectus and prospectus supplement (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement became effective on October 2, 2024. As of the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024, the Company has not sold any shares under the Sales Agreement.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 29, 2024, the Company entered into an underwriting agreement with Leerink Partners, LLC, as representative of the several underwriters named therein (the &#8220;Underwriters&#8221;) in connection with the underwritten offering, issuance and sale by the Company (the &#8220;2024 Underwritten Offering&#8221;) of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,356,173</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock, at an offering price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.65</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and pre-funded warrants at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.649</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per pre-funded warrant, which are exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,931,507</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;Offering Pre-Funded Warrants&#8221;).</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Offering Pre-Funded Warrants were classified as a component of permanent stockholders&#8217; equity within additional paid-in-capital. The Offering Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In addition, the Offering Pre-Funded Warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Underwritten Offering closed on October 30, 2024 and resulted in gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting underwriting discounts and commissions and offering expenses. The 2024 Underwritten Offering was made pursuant to the Shelf Registration Statement and a prospectus supplement relating to the 2024 Underwritten Offering dated October 29, 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A holder of the Offering Pre-Funded Warrants (together with its affiliates) may not exercise any portion of an Offering Pre-Funded Warrant to the extent that the that, after giving effect to such exercise, the holder (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates) would beneficially own in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (or, at the holder&#8217;s option upon issuance, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%) of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of such Offering Pre-Funded Warrant.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Pre-Funded Warrants from 2023 Securities Purchase Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, Armistice Capital Master Fund Ltd. (the &#8220;Exercising Stockholder&#8221;) exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">501,197</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 14, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">501,197</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 2, 2023, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">653,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On November 6, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">653,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 30, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">600,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On January 30, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">600,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 7, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">583,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On May 9, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">583,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 11, 2024, the Exercising Stockholder exercised their remaining Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">240,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 11, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">240,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants were exercisable into common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the warrants to purchase common stock activity:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:40.5%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Warrant Activity</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,788,032</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,776,270</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,564,302</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,921,023</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,921,023</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
         <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,423,000</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,423,000</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,581</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,581</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,778,451</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,274,293</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:40.492%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.297%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.837%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.2%;box-sizing:content-box;"></td>
         <td style="width:17.836%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date Issued</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Shares of Common Stock Issuable</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration Date</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,586</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,591</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">247,264</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.96</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,800</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.96</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">298,692</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.08</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 14, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,151,518</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 5, 2028</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2021 pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">509,117</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,844,153</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,989,516</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,931,507</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred Stock Warrants</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants exercisable into Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Stock which are convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,789,301</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:54.52%;box-sizing:content-box;"></td>
         <td style="width:2.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:41.04%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Series X</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Convertible Preferred Warrant Activity</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed and replaced</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
         <td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Warrants were issued on September 14, 2020, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.96</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and an expiration date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 14, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 9. Stock-Based Compensation</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Option Plans</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For stock options granted to the Company&#8217;s board of directors (the &#8220;Board&#8221;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months that vested stock options granted to Board members may be exercised upon termination. </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2024, the Company held its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;). At the Annual Meeting, the Company&#8217;s stockholders approved an amendment to the Company's 2020 Long Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan, as amended, (i) reflects an increase in the limit on the aggregate number of shares of the Company&#8217;s common stock that may be delivered pursuant to all awards granted under the 2020 Incentive Plan by an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares so that the new aggregate share limit under the 2020 Plan is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,960,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, and (ii) extends the date through which the Company may grant new awards under the 2020 Plan from November 15, 2030 to April 28, 2034.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 1, 2023, the Company issued stock option awards to its employees with both time-based and performance-based vesting requirements, totaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,381,857</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options, with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,476,372</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the granted stock options subject to the Company&#8217;s customary time-based vesting schedule. The remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,905,485</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options granted are subject to both customary time-based vesting requirements and performance-based vesting requirements that are based on the same clinical development milestones applicable to the Second Closing and Third Closing of the 2023 Private Placement as specified in the 2023 Securities Purchase Agreement.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the Company amended the performance-based vesting requirements with its named executive officers and other employees that upon the Second Closing and Third Closing, a full or prorated amount of each closing installment shall vest based on the percentage of funding received relative to the total funding opportunity represented by the investors&#8217; Second Closing and Third Closing subscription amounts. On June 13, 2024 and November 20, 2024, the performance-based vesting requirement based on the milestones applicable to the Second Closing and Third Closing were satisfied and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,763,085</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options were issued.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2014 Stock Incentive Plan (the &#8220;2014 Plan&#8221;) was closed to new grants following the approval of the 2020 Plan, and therefore, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares reserved for issuance under the 2014 Plan as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The number of shares reserved for issuance under the 2020 Plan and Employee Stock Purchase Plan was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,373,242</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,077</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, respectively, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:40.708%;box-sizing:content-box;"></td>
         <td style="width:1.06%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.762%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.54%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.282%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.06%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.762%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.54%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.282%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under Options</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,218,033</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.69</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.1</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,026,451</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.10</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">862,631</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.07</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,381,853</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.9</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">235</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">622,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.22</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.30</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316,465</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.29</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,637,388</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.02</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,628</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options vested and expected to vest as of<br/>&#160;&#160;&#160;December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,637,388</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.02</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,628</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options exercisable as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,667,177</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.37</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.8</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,898</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that had exercise prices that were lower than the fair value per share of the common stock on the date of exercise. The aggregate intrinsic value of options exercised during the year ended December 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:42.72%;box-sizing:content-box;"></td>
         <td style="width:2.54%;box-sizing:content-box;"></td>
         <td style="width:26.1%;box-sizing:content-box;"></td>
         <td style="width:2.54%;box-sizing:content-box;"></td>
         <td style="width:26.1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90.5</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Estimated dividend yield</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The per share weighted average grant date fair value of stock options granted during the years ended December 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.93</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.60</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Units</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the RSU activity, as follows:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.72%;box-sizing:content-box;"></td>
         <td style="width:1.26%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under RSUs</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Grant Date Fair Value</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,000</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.97</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,000</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.97</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation Expense</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total compensation expense related to all of the Company&#8217;s stock-based awards for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 was comprised of the following (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.47%;box-sizing:content-box;"></td>
         <td style="width:2.46%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.304%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.46%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.304%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation classified as:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,491</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,845</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,054</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,122</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,545</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested equity awards wa</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over an estimated weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.4</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. Segment Reporting</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company currently operates and manages its business as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment, to develop therapies to protect transplanted organs and prevent rejection. The Company's chief operating decision maker (the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;CODM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;), is the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_51220781-3cc8-4cb6-858a-6cda531d29d7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.</span></span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_49cee393-18e3-4648-b5d8-3eb7be1b8087;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment entity, </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant segment expenses, as provided to the CODM, are presented as the following:</span></span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:70.026%;box-sizing:content-box;"></td>
         <td style="width:1.66%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.078000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.078000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - kidney transplantation programs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,452</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,940</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - other development programs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,186</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manufacturing</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,448</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,048</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,706</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,351</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,122</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,545</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,930</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,924</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,674</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment and net loss</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 11. Subsequent Events</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has evaluated events subsequent to December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through the filing date of this Annual Report on Form 10-K. Any material subsequent events that occurred during this time have been properly recognized or disclosed in the consolidated financial statements and accompanying notes.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Consolidated Financial Statements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionTextBlock', window );">Restatement of Previously Issued Consolidated Financial Statements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 12. Restatement of Previously Issued Consolidated Financial Statements</span></p><p style="text-indent:5.391%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the course of preparing the Company&#8217;s Condensed Consolidated Financial Statements as of and for the three and six months ended June 30, 2025, the Company reassessed the rights and preferences of its Preferred Stock, and concluded</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">that, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">because they are substantially identical to those of its common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value, the Preferred Stock should be treated as a separate class of common stock for purposes of calculating earnings per share in accordance with ASC 260-10, &#8220;Earnings Per Share.&#8221; As a result, the Company determined that it should have presented earnings per share under the two-class method in prior reporting periods.</span></p><p style="text-indent:5.393%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.111%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, in connection with this reassessment, the Company concluded that it had incorrectly classified the Preferred Stock as permanent equity in the consolidated balance sheets. The Preferred Stock includes a provision that, upon the occurrence of a fundamental transaction (which includes a third-party tender or exchange offer) in which more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> percent of the common stockholders receive cash or other assets, entitles holders of Preferred Stock, upon any subsequent conversion, are entitled to receive the same form of consideration, even if they did not participate in the original transaction. Because this feature may result in settlement in cash or other non-equity consideration upon an event outside the Company&#8217;s control, the Preferred Stock does not meet the criteria for permanent equity classification and is instead classified as temporary equity under ASC 480-10-S99-3A. Although a tender offer is not considered probable as of the current reporting date and redemption is not deemed probable, the existence of this provision requires classification as temporary equity. The Preferred Stock is not subsequently remeasured to its redemption value because redemption is not considered probable.</span></p><p style="text-indent:5.405%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;margin-right:1.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of these conclusions, the Company determined that a correction was necessary with respect to the classification of Preferred Stock as temporary equity and the presentation of earnings per share under the two-class method.</span></p><p style="text-indent:5.405%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accordingly, the accompanying financial statements as of and for the year ended December 31, 2024 and December 31, 2023, and related notes hereto, have been restated to correct the classification of the Preferred Stock as temporary equity and to include EPS calculations under the two-class method.</span></p><p style="text-indent:5.405%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.333%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The impact of the correction of the misstatements is summarized below (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2023 and 2022:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">117,970</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,204</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2023 and 2022:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">117,970</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_5853a7a4-cb72-4798-821a-733264c3ef61;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c28ce8de-197a-4f3f-9904-8e00f34bd0bf;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_87be77a3-13bd-421e-9cd7-c93000cef4f1;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,204</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_159afcc3-d066-4b5b-b4ad-7e01474c1944;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_216519ab-59aa-4af1-9fab-606834bbb418;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_0af8023e-7ef3-4515-a7a7-678b84c987ec;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">326,586</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">270,892</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,208</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,486</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_6bb67e40-7995-438a-8c0a-20c0a769173d;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c377af31-8b8b-42b5-9eae-9f9fb6815960;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c6895469-f099-4775-83e9-d61a31e2f6fe;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_7a49ba59-b1e6-4d93-bc53-ad26ea9e9103;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_3ecf4669-c43c-48e7-8139-38d3d48178bf;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_b7cc2b0b-bf5a-4561-9ed3-8272893f1903;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">473,640</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">417,946</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,140</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,446</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.44%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended<br/>&#160;December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.73</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.74</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207.58</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,268</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended<br/>&#160;December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.66</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.61</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restatement of Interim Financial Information</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The misstatements described above were also material to the Company's unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2024, as of and for the three and six months ended June 30, 2024 and as of and for the three and nine months ended September 30, 2024. The Company has restated its unaudited Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations and Comprehensive Loss, and Condensed</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) for the quarterly and year to date periods ended March 31, 2024, June 30, 2024 and September 30, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The restated impact of the correction of the misstatements is summarized below (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>March 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at March 31, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at March 31, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_2a99917e-c2e2-45cf-b60a-d41b5d89eba1;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f2ebfc2b-8b13-4228-bc2d-fad05f7d9efa;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_1303f048-cd42-4ee1-9b21-e85795fc53bb;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_6bc77dc0-e7bb-4f64-9a27-5fac7e301766;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_0dada35c-b9ab-4d7c-908e-93714dd5302f;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c911075b-c1e4-44d9-bc77-3ee81c355044;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">328,280</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">272,586</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,728</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,422</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.44%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Three Months<br/>Ended March 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.79</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.65</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.12</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at June 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at June 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_340180a0-3a27-4a0d-8de8-cd273d95f58c;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_cd553f55-0d93-4b97-8756-5443f53b6f9b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_aac64cdf-40ce-4e29-82c3-c243c042d20f;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_987f1dac-17cd-48c8-99fd-7394ead1371b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f28eec08-2fa6-4243-b694-0b4d71ef0a06;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_a65f2652-7b7d-4f58-9664-7b9d2fb6a05a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">379,400</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">323,706</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,501</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,195</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:46.359%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.641%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Three Months<br/>Ended June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Six Months<br/>Ended June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.06</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.92</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.61</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51.29</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.60</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>September 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at September 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at September 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_3435e4db-2763-4d2f-8c7a-737f3a13270a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_2951b263-900f-4b8d-a786-60aa356956ac;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_53bb6073-43e0-4db5-9b19-9926bcc63d4a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_0bb67f5b-fcbc-4b89-907c-5702aef7f8c6;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_586405c0-5bfb-4612-b423-2372508e93d4;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_bb70f791-1438-45ad-a7f7-20802b5dd599;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">386,884</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">331,190</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,058</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,364</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:46.359%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.641%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Three Months<br/>Ended September 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Nine Months<br/>Ended September 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss attributable to common shares - diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,504</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,703</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61,086</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,230</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.32</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.28</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.42</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.23</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stocks - basic</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,666</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">852</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58.21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.44</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss attributable to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stocks - diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,801</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,856</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.73</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68.60</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#8220;Otic&#8221;). Otic owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#8217;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#8217;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#8220;ROU&#8221;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments with original maturities of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months or less</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> when purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds, U.S. government securities and U.S. government agency securities. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_RisksAndUncertaintiesPolicyTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all of the Company&#8217;s long-lived assets were located in the United States. The Company&#8217;s products will require approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#8217;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Reportable Segments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reportable Segments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#8217;s Chief Executive Officer and the Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Long-Lived Assets</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairments of long-lived assets have been identified during the years presented.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InProcessResearchAndDevelopmentPolicy', window );">In-Process Research and Development</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-Process Research and Development</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts allocated to in-process research and development (&#8220;IPR&amp;D&#8221;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#8217;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;D was impaired for any of the periods presented.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#8217;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share (As Restated)</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share (As Restated)</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net loss per share are calculated using the two-class method in accordance with ASC Topic 260, Earnings Per Share. The two-class method allocates undistributed losses to the Company&#8217;s outstanding common stock, and the Preferred Stock, based on each class&#8217;s proportionate share of the total weighted-average shares outstanding. Since the Company has never declared dividends, net loss and undistributed losses are equivalent.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. The process is used for both common stock and Preferred Stock. As the rights and preferences of the Preferred Stock are substantially identical to each other, they are considered a single class of common stock for earnings per share purposes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#8217;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023 includ</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,443,755</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,776,270</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> respectively, shares underlying pre-funded warrants to purchase common shares. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), these shares are deemed to be issued for purposes of basic earnings per share.</span></span></p><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The calculation of basic and diluted earnings per share for our common stock and Preferred Stock is as follows:</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:60.06%;box-sizing:content-box;"></td>
           <td style="width:1.86%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:16.279999999999998%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.86%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:15.940000000000001%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(As Restated)</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,543,787</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,619,197</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,268</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss used in the calculation of basic and diluted loss per share</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss available to common stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,992</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91,987</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, common stock, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.66</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.74</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss available to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,192</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,550</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.61</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207.58</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
         </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;">
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:57.76%;box-sizing:content-box;"></td>
           <td style="width:1.72%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:17.4%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.72%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:17.4%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options outstanding and other equity awards</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,007,789</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,909,155</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common and preferred warrants outstanding</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,567,751</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,577,332</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,575,540</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,486,487</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#8220;not more likely than not&#8221; that a tax benefit will be sustained, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. </span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">second step is to measure the tax benefit as the largest amount that is </span></span><span style=""></span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">more </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% likely of being realized upon settlement.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Notes to Financial Statements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Warrant Liabilities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for issued warrants either as a liability or equity in accordance with ASC 815-40 Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (&#8220;ASC 815-40&#8221;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements Issued But Not Adopted</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Adopted Accounting Pronouncements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">early adoptions</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> permitted. The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ASU 2023-07, effective </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t impact the consolidated financial statements. See Note 10, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for disclosures related to the adoption of ASU 2023-07.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements Issued But Not Adopted</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#8217;s present or future financial position, results of operations or cash flows.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation and principles of consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_RisksAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risks and uncertainties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_RisksAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InProcessResearchAndDevelopmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InProcessResearchAndDevelopmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), these shares are deemed to be issued for purposes of basic earnings per share.</span><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The calculation of basic and diluted earnings per share for our common stock and Preferred Stock is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:60.06%;box-sizing:content-box;"></td>
           <td style="width:1.86%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:16.279999999999998%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.86%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:15.940000000000001%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(As Restated)</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,543,787</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,619,197</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,268</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss used in the calculation of basic and diluted loss per share</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss available to common stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,992</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91,987</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, common stock, basic and diluted</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.66</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.74</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss available to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,192</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,550</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.61</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207.58</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
         </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.</span>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:57.76%;box-sizing:content-box;"></td>
           <td style="width:1.72%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:17.4%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.72%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:17.4%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options outstanding and other equity awards</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,007,789</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,909,155</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common and preferred warrants outstanding</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,567,751</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,577,332</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,575,540</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,486,487</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Short-term Investments Classified as Available-for-sale Securities</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of short-term investments, which were classified as available-for-sale securities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:32.294%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.577%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.577%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.577%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.577%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,603</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,603</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Table Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Financial Asset Instruments Measured At Fair Value On A Recurring Basis</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.387%;box-sizing:content-box;"></td>
         <td style="width:1.78%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.12%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.12%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasuries</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,679</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">137,093</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">138,308</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.387%;box-sizing:content-box;"></td>
         <td style="width:1.78%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.12%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.12%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.323%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,736</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of Warrant Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's warrant liabilities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:27.514%;box-sizing:content-box;"></td>
         <td style="width:6.879%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.199%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.46%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.439%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:27.514%;box-sizing:content-box;"></td>
         <td style="width:6.879%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.199%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.46%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.439%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of Aggregate Fair Values of Warrant Liabilities</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.2%;box-sizing:content-box;"></td>
         <td style="width:6.48%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:28.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Settlement of warrant liability</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">446</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract', window );"><strong>Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:56.709%;box-sizing:content-box;"></td>
         <td style="width:2.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.697%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.956%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,915</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,128</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid insurance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">693</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">624</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">215</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">185</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">729</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,552</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,027</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Liabilities</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other liabilities consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.08%;box-sizing:content-box;"></td>
         <td style="width:2.34%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.119999999999997%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.34%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.119999999999997%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,642</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">451</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and related expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,601</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,003</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,430</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,545</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses, other assets, accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Operating Lease Expense</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total operating lease expense were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.833%;box-sizing:content-box;"></td>
         <td style="width:1.88%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.203000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.88%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.203000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">407</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">400</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a) </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Includes variable operating lease expenses, which are immaterial.</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Schedule of Other Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other supplemental cash flow information related to leases were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64%;box-sizing:content-box;"></td>
         <td style="width:2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.299999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.84%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.860000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of lease liability:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.433%;box-sizing:content-box;"></td>
         <td style="width:1.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.403%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.403%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.46</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.49</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Payments Under Noncancelable Operating Leases</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:70.514%;box-sizing:content-box;"></td>
         <td style="width:2.941%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:24.544999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">391</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">403</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">293</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,087</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less imputed interest</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">133</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of lease liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">954</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less current portion of operating lease liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">314</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-current operating lease liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">640</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other supplemental cash flow information related to leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Summary of Loss Before Income Taxes</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss before income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.72%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses before income taxes:</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S.</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,951</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,736</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-U.S.</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">198</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">199</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,753</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Provision for Income Taxes</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision for income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.88%;box-sizing:content-box;"></td>
         <td style="width:3.4%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.4%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.68%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current income tax provision</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred income tax provision</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of U.S. Federal Statutory Income Tax Rate</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.913%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.783000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.422%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Statutory federal income tax rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,473</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal tax benefits</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">908</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,170</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,358</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,819</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent items</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,273</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,078</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State rate differential</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">490</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NOL true-up</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">566</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,137</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,200</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Significant Components Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.72%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,740</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,089</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,560</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,202</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">366</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">475</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research expenditures</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,809</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,567</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,281</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,085</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,056</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,319</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,037</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,828</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquired IPR&amp;D</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,623</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,682</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,841</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,769</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,379</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,811</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax liabilities</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,183</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,752</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:61.448%;box-sizing:content-box;"></td>
         <td style="width:2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.277000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.277000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the beginning of the year</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,636</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,664</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in the current year</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,596</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in prior years</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the end of the year</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,232</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,636</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options, Common Warrants and Subsequent Closing Warrants Granted</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:42.72%;box-sizing:content-box;"></td>
         <td style="width:2.54%;box-sizing:content-box;"></td>
         <td style="width:26.1%;box-sizing:content-box;"></td>
         <td style="width:2.54%;box-sizing:content-box;"></td>
         <td style="width:26.1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90.5</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Estimated dividend yield</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:40.492%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.297%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.837%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.2%;box-sizing:content-box;"></td>
         <td style="width:17.836%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date Issued</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Shares of Common Stock Issuable</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration Date</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,586</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,591</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">247,264</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.96</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,800</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.96</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 2020 common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">298,692</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.08</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 14, 2025</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement common warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,151,518</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 5, 2028</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2021 pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">509,117</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,844,153</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,989,516</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering pre-funded warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,931,507</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_CommonStockWarrantsMember', window );">Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ScheduleOfWarrantActivityTableTextBlock', window );">Schedule of Warrants to Purchase Common Stock Activity</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the warrants to purchase common stock activity:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:40.5%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Warrant Activity</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,788,032</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,776,270</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,564,302</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,921,023</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,921,023</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
         <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,423,000</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,423,000</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,581</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,581</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,778,451</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,274,293</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_PreferredStockWarrantsMember', window );">Preferred Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ScheduleOfWarrantActivityTableTextBlock', window );">Schedule of Warrants to Purchase Common Stock Activity</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants exercisable into Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Stock which are convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,789,301</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:54.52%;box-sizing:content-box;"></td>
         <td style="width:2.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:41.04%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Series X</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Convertible Preferred Warrant Activity</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed and replaced</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
         <td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options, Common Warrants and Subsequent Closing Warrants Granted</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, and as of the issuance date:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:47.149%;box-sizing:content-box;"></td>
         <td style="width:1.48%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.823999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:3.481%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:23.064999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.9</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share price</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.14</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.80</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ScheduleOfWarrantActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of warrant activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ScheduleOfWarrantActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_PreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_PreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:40.708%;box-sizing:content-box;"></td>
         <td style="width:1.06%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.762%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.54%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.282%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.06%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.762%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.54%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.282%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under Options</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,218,033</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.69</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.1</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,026,451</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.10</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">862,631</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.07</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,381,853</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.9</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">235</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">622,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.22</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.30</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316,465</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.29</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,637,388</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.02</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,628</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options vested and expected to vest as of<br/>&#160;&#160;&#160;December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,637,388</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.02</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,628</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options exercisable as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,667,177</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.37</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.8</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,898</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:42.72%;box-sizing:content-box;"></td>
         <td style="width:2.54%;box-sizing:content-box;"></td>
         <td style="width:26.1%;box-sizing:content-box;"></td>
         <td style="width:2.54%;box-sizing:content-box;"></td>
         <td style="width:26.1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90.5</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Estimated dividend yield</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock', window );">Summary of RSU Activity</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the RSU activity, as follows:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.72%;box-sizing:content-box;"></td>
         <td style="width:1.26%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.92%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under RSUs</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Grant Date Fair Value</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,000</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.97</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,000</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.97</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total compensation expense related to all of the Company&#8217;s stock-based awards for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 was comprised of the following (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.47%;box-sizing:content-box;"></td>
         <td style="width:2.46%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.304%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.46%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.304%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation classified as:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,491</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,845</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,054</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,122</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,545</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant segment expenses, as provided to the CODM, are presented as the following:</span><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:70.026%;box-sizing:content-box;"></td>
         <td style="width:1.66%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.078000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.078000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - kidney transplantation programs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,452</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,940</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - other development programs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,186</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manufacturing</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,448</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,048</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,706</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,351</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,122</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,545</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,930</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,924</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,674</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment and net loss</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Consolidated Financial Statements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Summary of Impact of Correction of the Misstatements</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The impact of the correction of the misstatements is summarized below (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2023 and 2022:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">117,970</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,204</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2023 and 2022:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">117,970</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_5853a7a4-cb72-4798-821a-733264c3ef61;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c28ce8de-197a-4f3f-9904-8e00f34bd0bf;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_87be77a3-13bd-421e-9cd7-c93000cef4f1;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,204</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2023 and 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_159afcc3-d066-4b5b-b4ad-7e01474c1944;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_216519ab-59aa-4af1-9fab-606834bbb418;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_0af8023e-7ef3-4515-a7a7-678b84c987ec;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">326,586</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">270,892</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,208</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,486</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_6bb67e40-7995-438a-8c0a-20c0a769173d;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c377af31-8b8b-42b5-9eae-9f9fb6815960;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c6895469-f099-4775-83e9-d61a31e2f6fe;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_7a49ba59-b1e6-4d93-bc53-ad26ea9e9103;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_3ecf4669-c43c-48e7-8139-38d3d48178bf;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_b7cc2b0b-bf5a-4561-9ed3-8272893f1903;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">473,640</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">417,946</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,140</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,446</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.44%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended<br/>&#160;December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.73</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.74</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207.58</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,268</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended<br/>&#160;December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.66</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.61</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The restated impact of the correction of the misstatements is summarized below (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>March 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at March 31, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at March 31, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_2a99917e-c2e2-45cf-b60a-d41b5d89eba1;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f2ebfc2b-8b13-4228-bc2d-fad05f7d9efa;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_1303f048-cd42-4ee1-9b21-e85795fc53bb;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_6bc77dc0-e7bb-4f64-9a27-5fac7e301766;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_0dada35c-b9ab-4d7c-908e-93714dd5302f;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c911075b-c1e4-44d9-bc77-3ee81c355044;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">328,280</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">272,586</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,728</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,422</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.44%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.9%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Three Months<br/>Ended March 31, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.79</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.65</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.12</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at June 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at June 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_340180a0-3a27-4a0d-8de8-cd273d95f58c;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_cd553f55-0d93-4b97-8756-5443f53b6f9b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_aac64cdf-40ce-4e29-82c3-c243c042d20f;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_987f1dac-17cd-48c8-99fd-7394ead1371b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f28eec08-2fa6-4243-b694-0b4d71ef0a06;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_a65f2652-7b7d-4f58-9664-7b9d2fb6a05a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">379,400</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">323,706</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,501</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,195</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:46.359%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.641%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Three Months<br/>Ended June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Six Months<br/>Ended June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.06</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.92</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.61</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51.29</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.60</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic and diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:52.669%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.138%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of <br/>September 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Restatement Impact</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at September 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,543</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,151</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at September 30, 2024 and December 31, 2023:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_3435e4db-2763-4d2f-8c7a-737f3a13270a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_2951b263-900f-4b8d-a786-60aa356956ac;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_53bb6073-43e0-4db5-9b19-9926bcc63d4a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_0bb67f5b-fcbc-4b89-907c-5702aef7f8c6;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_586405c0-5bfb-4612-b423-2372508e93d4;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_bb70f791-1438-45ad-a7f7-20802b5dd599;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">386,884</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">331,190</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,058</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,694</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,364</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:46.359%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.641%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.381%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.964%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Three Months<br/>Ended September 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Nine Months<br/>Ended September 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Previously Reported</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As Restated</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss attributable to common shares - diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,504</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,703</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61,086</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,230</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted earnings per share of common stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.32</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.28</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.42</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.23</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stocks - basic</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,666</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">852</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58.21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.44</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, basic</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss attributable to Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stocks - diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,801</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,856</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diluted earnings per share of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.73</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68.60</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding of Series X and Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Business - Additional Information (Detail) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 14, 2020</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets', window );">Percentage of common stockholders receive cash and other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember', window );">Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXOneNonVotingConvertiblePreferredStockMember', window );">Series X One Non Voting Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsIncorporationMember', window );">Anelixis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1', window );">Date of acquisition</a></td>
<td class="text">Sep. 14,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DescriptionOfBusinessLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DescriptionOfBusinessLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stockholders receive cash and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when acquirer obtains control of acquiree in business combination, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-38<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-7<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXOneNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXOneNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod', window );">Cash, cash equivalents and restricted cash, maturity period</a></td>
<td class="text">three months or less<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating business segments | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairments of long-lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit', window );">Tax benefit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement', window );">Income tax examination, likelihood of settlement, description</a></td>
<td class="text">The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement', window );">Income tax examination, likelihood of settlement, percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eldn_PreFundedWarrantsMember', window );">Pre-Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding | shares</a></td>
<td class="nump">12,443,755<span></span>
</td>
<td class="nump">5,776,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member', window );">Accounting Standards Update 2023-07 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in Accounting Principle, Accounting Standards Update, Adoption Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption', window );">Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember', window );">Anelixis Therapeutics, LLC and Otic Pharma, Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership interest percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=eldn_OticPharmaIncMember', window );">Otic Pharma, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership interest percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash cash equivalents and restricted cash maturity period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax examination likelihood of favorable settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax cuts and jobs act of 2017 change in tax rate income taxes expense benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476151/220-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476151/220-40-65-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was early adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476151/220-40-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eldn_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eldn_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=eldn_OticPharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=eldn_OticPharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss used in the calculation of basic and diluted loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (36,184)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (As Restated)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (As Restated)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss used in the calculation of basic and diluted loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31,992)<span></span>
</td>
<td class="num">$ (91,987)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share of common stock (As Restated)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (1.61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (3.74)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share of common stock (As Restated)</a></td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (1.61)<span></span>
</td>
<td class="num">$ (1.23)<span></span>
</td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (3.74)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X and Series X1 Non Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (As Restated)</a></td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">118,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (As Restated)</a></td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">118,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss used in the calculation of basic and diluted loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,192)<span></span>
</td>
<td class="num">$ (24,550)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share of common stock (As Restated)</a></td>
<td class="nump">$ 58.21<span></span>
</td>
<td class="num">$ (51.29)<span></span>
</td>
<td class="num">$ (36.12)<span></span>
</td>
<td class="num">$ (89.6)<span></span>
</td>
<td class="nump">$ 7.44<span></span>
</td>
<td class="num">$ (36.61)<span></span>
</td>
<td class="num">$ (207.58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share of common stock (As Restated)</a></td>
<td class="num">$ (15.73)<span></span>
</td>
<td class="num">$ (51.29)<span></span>
</td>
<td class="num">$ (36.12)<span></span>
</td>
<td class="num">$ (89.6)<span></span>
</td>
<td class="num">$ (68.6)<span></span>
</td>
<td class="num">$ (36.61)<span></span>
</td>
<td class="num">$ (207.58)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">24,575,540<span></span>
</td>
<td class="nump">33,486,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Stock Options Outstanding and Other Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">6,007,789<span></span>
</td>
<td class="nump">14,909,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=eldn_CommonAndPreferredWarrantsOutstandingMember', window );">Common and Preferred Warrants Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">18,567,751<span></span>
</td>
<td class="nump">18,577,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=eldn_CommonAndPreferredWarrantsOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=eldn_CommonAndPreferredWarrantsOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 119,603<span></span>
</td>
<td class="nump">$ 46,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">119,603<span></span>
</td>
<td class="nump">33,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 119,629<span></span>
</td>
<td class="nump">33,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember', window );">U.S. Government Agency Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">$ 119,629<span></span>
</td>
<td class="nump">$ 46,490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">$ 18,679<span></span>
</td>
<td class="nump">$ 4,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">138,308<span></span>
</td>
<td class="nump">50,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Treasuries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">17,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">33,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Government Agency Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">17,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">137,093<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member] | U.S. Treasuries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">17,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member] | U.S. Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">$ 119,629<span></span>
</td>
<td class="nump">33,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member] | U.S. Government Agency Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details) - Fair Value, Recurring [Member] - Warrant Liabilities [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value</a></td>
<td class="nump">$ 44,865<span></span>
</td>
<td class="nump">$ 76,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value</a></td>
<td class="nump">$ 44,865<span></span>
</td>
<td class="nump">$ 76,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="num">$ (30,900)<span></span>
</td>
<td class="nump">$ 76,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance as of December 31, 2023</a></td>
<td class="nump">76,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="num">(30,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SettlementOfWarrantLiability', window );">Settlement of warrant liability</a></td>
<td class="num">(446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance as of December 31, 2024</a></td>
<td class="nump">$ 44,865<span></span>
</td>
<td class="nump">$ 76,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_SettlementOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_SettlementOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal</a></td>
<td class="nump">$ 59.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PrepaidClinicalExpense', window );">Prepaid clinical</a></td>
<td class="nump">$ 1,915<span></span>
</td>
<td class="nump">$ 4,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">693<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Prepaid other</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">729<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 3,552<span></span>
</td>
<td class="nump">$ 5,027<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PrepaidClinicalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid clinical expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PrepaidClinicalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract', window );"><strong>Accrued Liabilities and Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AccruedClinicalCurrent', window );">Accrued clinical</a></td>
<td class="nump">$ 3,642<span></span>
</td>
<td class="nump">$ 451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Accrued compensation and related expenses</a></td>
<td class="nump">1,601<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued expenses and other liabilities</a></td>
<td class="nump">$ 5,430<span></span>
</td>
<td class="nump">$ 2,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AccruedClinicalCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued clinical current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AccruedClinicalCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 04, 2024 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 19, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th"><div>Aug. 12, 2022</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Milestone</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Milestone</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 21, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926,000<span></span>
</td>
<td class="nump">365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 954,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_LesseeOperatingLeaseRemainingTermOfContract', window );">Remaining term of office lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Indemnification obligations amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ContingentLiability', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember', window );">ALS Therapy Development Foundation, Inc. License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_FeeDueForMilestonesAchieved', window );">Fee due for milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued in lieu of making a cash payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NumberOfMilestonesAchieved', window );">Number of Milestones Achieved | Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_RemainingMilestonePaymentsForFirstLicensedProduct', window );">Remaining milestone payments for first licensed product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AnnualLicenseMaintenanceFee', window );">Annual License Maintenance Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember', window );">ALS Therapy Development Foundation, Inc. License Agreement [Member] | Achievement of 500 Million Aggregate Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AggregateNetSalesAchievement', window );">Reaching of aggregate net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount', window );">Amount of one-time milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember', window );">ALS Therapy Development Foundation, Inc. License Agreement [Member] | Achievement of 1 Billion Aggregate Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AggregateNetSalesAchievement', window );">Reaching of aggregate net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount', window );">Amount of one-time milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_EGenesisIncCollaborationAgreementMember', window );">eGenesis, Inc. Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ManufacturingExpensesOffset', window );">Manufacturing expenses offset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | ALS Therapy Development Foundation, Inc. License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_RegulatoryMilestonePaymentsObligation', window );">Development and regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">Irvine, California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">38 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AreaOfOfficeSpace', window );">Area of office space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2027<span></span>
</td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MA', window );">Burlington, Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AreaOfOfficeSpace', window );">Area of office space | ft&#178;</a></td>
<td class="nump">6,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Nov. 21,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AggregateNetSalesAchievement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net sales achievement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AggregateNetSalesAchievement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AnnualLicenseMaintenanceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual license maintenance fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AnnualLicenseMaintenanceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AreaOfOfficeSpace">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of office space.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AreaOfOfficeSpace</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_FeeDueForMilestonesAchieved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fee due for milestones achieved.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_FeeDueForMilestonesAchieved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_LesseeOperatingLeaseRemainingTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease remaining term of contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_LesseeOperatingLeaseRemainingTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ManufacturingExpensesOffset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Manufacturing expenses offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ManufacturingExpensesOffset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NumberOfMilestonesAchieved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of milestones achieved.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NumberOfMilestonesAchieved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_RegulatoryMilestonePaymentsObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory milestone payments obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_RegulatoryMilestonePaymentsObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_RemainingMilestonePaymentsForFirstLicensedProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining milestone payments for first licensed product.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_RemainingMilestonePaymentsForFirstLicensedProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the entity has committed to make for future royalty guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477866/928-440-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyGuaranteesCommitmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=eldn_FiveHundredMillionAggregateNetSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=eldn_FiveHundredMillionAggregateNetSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=eldn_OneBillionAggregateNetSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=eldn_OneBillionAggregateNetSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_EGenesisIncCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_EGenesisIncCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Components of Operating Lease Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liability:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating lease</a></td>
<td class="nump">$ 378<span></span>
</td>
<td class="nump">$ 378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">9.46%<span></span>
</td>
<td class="nump">2.49%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for amounts included in measurement of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">1,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less current portion of operating lease liabilities</a></td>
<td class="num">(314)<span></span>
</td>
<td class="num">$ (383)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">$ 640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Loss Before Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Losses before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="num">$ (35,951)<span></span>
</td>
<td class="num">$ (116,736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non-U.S.</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (35,753)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Provision for Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax provision</a></td>
<td class="nump">431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net valuation allowance Increased (decreased)</a></td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards for federal and state</a></td>
<td class="nump">$ 5,560,000<span></span>
</td>
<td class="nump">3,202,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards', window );">Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties associated with uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest or penalties recorded during the year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PercentageOfCumulativeChangeInOwnership', window );">Percentage of cumulative change in ownership</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">$ 88,700,000<span></span>
</td>
<td class="nump">68,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NetOperatingLossCarryforwardsExpirationPeriod', window );">Net operating loss carryforward expiration period</a></td>
<td class="text">2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Federal net operating loss carryforwards, not to expiration</a></td>
<td class="nump">$ 87,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards for federal and state</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_TaxCreditCarryforwardExpirationPeriod', window );">Research and development tax credit carryforwards expiration period</a></td>
<td class="text">2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State net operating loss carryforwards</a></td>
<td class="nump">$ 37,700,000<span></span>
</td>
<td class="nump">30,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards for federal and state</a></td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_TaxCreditCarryforwardExpirationPeriod', window );">Research and development tax credit carryforwards expiration period</a></td>
<td class="text">2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_TaxCreditCarryforwardExpirationDescription', window );">Research and development tax credit carryforwards expiration description</a></td>
<td class="text">As of December 31, 2024 and 2023, the Company has state research and development credit carryforwards or approximately $2.6 million and $1.5 million, respectively, which will begin expiring in 2030 if not utilized<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember', window );">California [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NetOperatingLossCarryforwardsExpirationPeriod', window );">Net operating loss carryforward expiration period</a></td>
<td class="text">2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NetOperatingLossCarryforwardsExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards expiration period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NetOperatingLossCarryforwardsExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PercentageOfCumulativeChangeInOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of cumulative change in ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PercentageOfCumulativeChangeInOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_TaxCreditCarryforwardExpirationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_TaxCreditCarryforwardExpirationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_TaxCreditCarryforwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_TaxCreditCarryforwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate</a></td>
<td class="num">$ (7,508)<span></span>
</td>
<td class="num">$ (24,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_StateIncomeTaxesNetOfFederalTaxBenefits', window );">State income taxes, net of federal tax benefits</a></td>
<td class="num">(908)<span></span>
</td>
<td class="num">(3,170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="num">(2,358)<span></span>
</td>
<td class="num">(972)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">2,819<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncomeTaxReconciliationPermanentItems', window );">Permanent items</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="num">(7,273)<span></span>
</td>
<td class="nump">18,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncomeTaxReconciliationStateTaxRateDifferential', window );">State rate differential</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NOLTrueUp', window );">NOL true-up</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">15,137<span></span>
</td>
<td class="nump">9,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncomeTaxReconciliationPermanentItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation permanent items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncomeTaxReconciliationPermanentItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncomeTaxReconciliationStateTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation state tax rate differential.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncomeTaxReconciliationStateTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NOLTrueUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>NOL True Up.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NOLTrueUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_StateIncomeTaxesNetOfFederalTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>State income taxes, net of Federal tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_StateIncomeTaxesNetOfFederalTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 22,740<span></span>
</td>
<td class="nump">$ 18,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credits</a></td>
<td class="nump">5,560<span></span>
</td>
<td class="nump">3,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals and reserves</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research expenditures</a></td>
<td class="nump">18,809<span></span>
</td>
<td class="nump">10,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">3,281<span></span>
</td>
<td class="nump">3,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DeferredTaxAssetsDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">52,037<span></span>
</td>
<td class="nump">36,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DeferredTaxAssetsRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="num">(218)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment', window );">Acquired IPR&amp;D</a></td>
<td class="num">(7,623)<span></span>
</td>
<td class="num">(7,682)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(7,841)<span></span>
</td>
<td class="num">(7,769)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(46,379)<span></span>
</td>
<td class="num">(30,811)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (2,183)<span></span>
</td>
<td class="num">$ (1,752)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DeferredTaxAssetsDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DeferredTaxAssetsDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DeferredTaxAssetsRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DeferredTaxAssetsRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities, in-process research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits at the beginning of the year</a></td>
<td class="nump">$ 3,636<span></span>
</td>
<td class="nump">$ 2,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions from tax positions taken in the current year</a></td>
<td class="nump">2,596<span></span>
</td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions from tax positions taken in prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits at the end of the year</a></td>
<td class="nump">$ 6,232<span></span>
</td>
<td class="nump">$ 3,636<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2024</div></th>
<th class="th"><div>Oct. 29, 2024</div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 20, 2024</div></th>
<th class="th"><div>Jul. 08, 2024</div></th>
<th class="th"><div>May 06, 2024</div></th>
<th class="th"><div>May 16, 2023</div></th>
<th class="th"><div>May 05, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
<th class="th"><div>Jan. 11, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jul. 11, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>May 09, 2024</div></th>
<th class="th"><div>May 07, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jan. 30, 2024</div></th>
<th class="th"><div>Nov. 06, 2023</div></th>
<th class="th"><div>Nov. 02, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Jul. 10, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets', window );">Percentage of common stockholders receive cash and other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,789,275<span></span>
</td>
<td class="nump">24,213,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,307<span></span>
</td>
<td class="nump">$ 33,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=eldn_ArmisticeCapitalMasterFundLtdMember', window );">Armistice Capital Master Fund Ltd [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">583,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NumberOfPreFundedWarrantsExercisedForCommonStock', window );">Number of pre-funded warrants exercised for common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">583,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXOnePreferredStockMember', window );">Series X1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares of common stock issued upon conversion of each share of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,789,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants available for exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,207.419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember', window );">Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eldn_LeerinkPartnersLlcMember', window );">Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOffering', window );">Proceeds from issuance offering</a></td>
<td class="nump">$ 85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfNetOfOfferingCosts', window );">Net proceeds after deducting offering costs</a></td>
<td class="nump">$ 79,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants available for exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,052,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares of common stock issued upon conversion of each share of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares of common stock issued upon conversion of each share of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,356,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,931,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member] | Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_PreFundedWarrantsMember', window );">Pre-Funded Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants available for exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,052,744<span></span>
</td>
<td class="nump">21,564,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">Common Stock Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,110,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Initial Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Common warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Initial Closing [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,151,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,151,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Second Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">909,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Second Closing [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,202,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Third Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,727,400<span></span>
</td>
<td class="nump">1,727,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Third Closing [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,252,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Common Stock [Member] | Securities Purchase Agreement Initial Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,730,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Pre-Funded Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Pre-Funded Warrants [Member] | Securities Purchase Agreement [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,989,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Pre-Funded Warrants [Member] | Securities Purchase Agreement Initial Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,421,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember', window );">Preferred Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants available for exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,207.419<span></span>
</td>
<td class="nump">50,207.419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 14,  2025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Common Stock [Member] | Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ConversionOfPreferredStockConversionBlockerPercent', window );">Conversion of preferred stock, conversion blocker, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Common Stock [Member] | Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ConversionOfPreferredStockConversionBlockerPercent', window );">Conversion of preferred stock, conversion blocker, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Pre-Funded Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Pre-Funded Warrants [Member] | Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Common Stock Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Common Stock [Member] | Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ConversionOfPreferredStockConversionBlockerPercent', window );">Conversion of preferred stock, conversion blocker, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Common Stock [Member] | Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ConversionOfPreferredStockConversionBlockerPercent', window );">Conversion of preferred stock, conversion blocker, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Pre-Funded Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Pre-Funded Warrants [Member] | Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember', window );">BVF Exchanging Stockholders [Member] | Series X1 Non-voting Convertible Preferred Stock [Member] | Series X1 Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,899.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember', window );">BVF Exchanging Stockholders [Member] | Common Stock [Member] | Series X1 Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember', window );">Cormorant Global Healthcare Master Fund LP [Member] | Series X Non-Voting Convertible Preferred Stock [Member] | Conversion Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember', window );">Cormorant Global Healthcare Master Fund LP [Member] | Series X1 Non-voting Convertible Preferred Stock [Member] | Conversion Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,883.586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember', window );">Cormorant Global Healthcare Master Fund LP [Member] | Common Stock [Member] | Series X Non-Voting Convertible Preferred Stock [Member] | Conversion Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember', window );">Cormorant Global Healthcare Master Fund LP [Member] | Common Stock [Member] | Series X1 Non-voting Convertible Preferred Stock [Member] | Conversion Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_GuggenheimSecuritiesLlcMember', window );">Guggenheim Securities LLC [Member] | Maximum [Member] | Equity Distribution Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant subject to specified beneficial ownership limitations percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant subject to specified beneficial ownership limitations permitted percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ConversionOfPreferredStockConversionBlockerPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of preferred stock, conversion blocker, percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ConversionOfPreferredStockConversionBlockerPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NumberOfPreFundedWarrantsExercisedForCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pre-funded warrants exercised for common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NumberOfPreFundedWarrantsExercisedForCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stockholders receive cash and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock and pre funded warrants net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOfNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of net of offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOfNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of private placement, net of offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=eldn_ArmisticeCapitalMasterFundLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=eldn_ArmisticeCapitalMasterFundLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=eldn_LeerinkPartnersLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=eldn_LeerinkPartnersLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_UnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_UnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eldn_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eldn_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=eldn_AccreditedInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=eldn_AccreditedInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementInitialClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementInitialClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementSecondClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementSecondClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementThirdClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementThirdClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SeriesX1ExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SeriesX1ExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_ConversionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_ConversionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eldn_GuggenheimSecuritiesLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eldn_GuggenheimSecuritiesLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_EquityDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_EquityDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">101.30%<span></span>
</td>
<td class="nump">90.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">96.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected stock price volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected stock price volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail) - Common Stock Warrants [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning Balance</a></td>
<td class="nump">21,564,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued', window );">Issued</a></td>
<td class="nump">12,921,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised', window );">Exercised</a></td>
<td class="num">(1,423,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired', window );">Cancelled/Expired</a></td>
<td class="num">(9,581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending Balance</a></td>
<td class="nump">33,052,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning Balance</a></td>
<td class="nump">15,788,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued', window );">Issued</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised', window );">Exercised</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired', window );">Cancelled/Expired</a></td>
<td class="num">(9,581)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending Balance</a></td>
<td class="nump">15,778,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">Pre-Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning Balance</a></td>
<td class="nump">5,776,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued', window );">Issued</a></td>
<td class="nump">12,921,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised', window );">Exercised</a></td>
<td class="num">(1,423,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired', window );">Cancelled/Expired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending Balance</a></td>
<td class="nump">17,274,293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants or rights cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants or rights issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail) - Common Stock Warrants [Member] - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">33,052,744<span></span>
</td>
<td class="nump">21,564,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">5,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 18.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 14,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">3,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 18.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 17,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">247,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 12.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 14,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">71,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 12.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 17,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">September 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">298,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 3.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Sep. 14,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">2023 Securities Purchase Agreement Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">15,151,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">May  05,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2021 Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">509,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Dec. 31,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">2023 Securities Purchase Agreement Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">3,844,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">2024 Securities Purchase Agreement Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">7,989,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">2024 Underwritten Offering Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">4,931,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail) - Preferred Stock Warrants [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning Balance</a></td>
<td class="nump">50,207.419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced', window );">Assumed and replaced</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised', window );">Exercised</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired', window );">Cancelled/Expired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending Balance</a></td>
<td class="nump">50,207.419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants or rights assumed and replaced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants or rights cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2024</div></th>
<th class="th"><div>Jul. 10, 2024</div></th>
<th class="th"><div>Jun. 13, 2024</div></th>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">622,000<span></span>
</td>
<td class="nump">11,026,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Shares weighted average grant date fair value of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.93<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation expense, recognized over estimated weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod', window );">Expected life assumption using simplified method, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">For stock options granted to the Company&#8217;s board of directors (the &#8220;Board&#8221;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of 12 to 18 months that vested stock options granted to Board members may be exercised upon termination. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Employee Stock Option [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Employee Stock Option [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=eldn_TimeBasedVestingRequirementsMember', window );">Time Based Vesting Requirements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,476,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=eldn_PerformanceBasedVestingRequirementsMember', window );">Performance-based Vesting Requirements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options issued</a></td>
<td class="nump">5,763,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,763,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember', window );">Time-based and Performance-based Vesting Requirements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,381,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,905,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eldn_TwoThousandFourteenStockIncentivePlanMember', window );">2014 Stock Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eldn_TwoThousandTwentyLongTermIncentivePlanMember', window );">2020 Long Term Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,373,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increased number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized', window );">New aggregate share limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,960,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember', window );">2014 Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award total number of shares authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses use of the simplified method to calculate the expected term that stock option awards under the specified plan will exist before being exercised or terminated, the reason and justification for its use, and the periods for which the method was used if it was not used in all periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=eldn_TimeBasedVestingRequirementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=eldn_TimeBasedVestingRequirementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=eldn_PerformanceBasedVestingRequirementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=eldn_PerformanceBasedVestingRequirementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eldn_TwoThousandFourteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eldn_TwoThousandFourteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eldn_TwoThousandTwentyLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eldn_TwoThousandTwentyLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares Issuable Under Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance</a></td>
<td class="nump">15,381,853<span></span>
</td>
<td class="nump">5,218,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">622,000<span></span>
</td>
<td class="nump">11,026,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited / Canceled</a></td>
<td class="num">(316,465)<span></span>
</td>
<td class="num">(862,631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance</a></td>
<td class="nump">15,637,388<span></span>
</td>
<td class="nump">15,381,853<span></span>
</td>
<td class="nump">5,218,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest</a></td>
<td class="nump">15,637,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable</a></td>
<td class="nump">8,667,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 4.21<span></span>
</td>
<td class="nump">$ 8.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">2.22<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited / Canceled</a></td>
<td class="nump">7.29<span></span>
</td>
<td class="nump">8.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance</a></td>
<td class="nump">4.02<span></span>
</td>
<td class="nump">$ 4.21<span></span>
</td>
<td class="nump">$ 8.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest</a></td>
<td class="nump">4.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable</a></td>
<td class="nump">$ 5.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term (In years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, balance</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options vested and expected to vest</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, Outstanding</a></td>
<td class="nump">$ 20,628<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options vested and expected to vest</a></td>
<td class="nump">20,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable</a></td>
<td class="nump">$ 7,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">101.30%<span></span>
</td>
<td class="nump">90.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of option (in years)</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Estimated dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of RSU Activity (Detail) - RSU [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares Issuable Under RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">46,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending balance</a></td>
<td class="nump">46,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">1.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice', window );">RSUs Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.47<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice', window );">Outstanding, ending balance</a></td>
<td class="nump">$ 1.97<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2.47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award, equity instruments other than options, grants in period, weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award, equity instruments other than options, nonvested, weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options, nonvested, weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award, equity instruments other than options, vested in period, weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 13,122<span></span>
</td>
<td class="nump">$ 6,545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">4,277<span></span>
</td>
<td class="nump">1,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 8,845<span></span>
</td>
<td class="nump">$ 5,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of Segment Reporting (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">srt:ChiefExecutiveOfficerMember<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FactorsUsedToIdentifyEntitysReportableSegments', window );">Segment Reporting, Factors Used to Identify Entity's Reportable Segments</a></td>
<td class="text">The financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</a></td>
<td class="text">the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. Significant segment expenses, as provided to the CODM, are presented as the following:<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FactorsUsedToIdentifyEntitysReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the factors used to identify reportable segments, including the basis of organization (for example, whether management has chosen to organize the enterprise around differences in products and services, geographic areas, regulatory environments, or a combination of factors and whether operating segments have been aggregated to reportable segments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FactorsUsedToIdentifyEntitysReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of significant segment expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">$ 18,613<span></span>
</td>
<td class="nump">$ 12,688<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">70,577<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">3,924<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="nump">30,900<span></span>
</td>
<td class="num">(76,211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(431)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">(36,184)<span></span>
</td>
<td class="num">(116,537)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_Tegoprubart-KidneyTransplantationPrograms', window );">Tegoprubart - kidney transplantation programs</a></td>
<td class="nump">27,452<span></span>
</td>
<td class="nump">11,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_Tegoprubart-OtherDevelopmentPrograms', window );">Tegoprubart - other development programs</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">3,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManufacturingCosts', window );">Manufacturing</a></td>
<td class="nump">12,448<span></span>
</td>
<td class="nump">8,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_Personnel-RelatedExpenses', window );">Personnel-related</a></td>
<td class="nump">10,706<span></span>
</td>
<td class="nump">8,351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">13,122<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">6,543<span></span>
</td>
<td class="nump">4,930<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">70,577<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(70,577)<span></span>
</td>
<td class="num">(43,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">3,924<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="nump">30,900<span></span>
</td>
<td class="num">(76,211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (36,184)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_Personnel-RelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Personnel-related expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_Personnel-RelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_Tegoprubart-KidneyTransplantationPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tegoprubart kidney transplantation programs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_Tegoprubart-KidneyTransplantationPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_Tegoprubart-OtherDevelopmentPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tegoprubart - other development programs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_Tegoprubart-OtherDevelopmentPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManufacturingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred in the production of goods for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManufacturingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restatement of Previously Issued Consolidated Financial Statements - Additional Information (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets', window );">Percentage of common stockholders receive cash and other assets</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stockholders receive cash and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalPreferredStock', window );">Additional paid-in capital</a></td>
<td class="nump">$ 417,946<span></span>
</td>
<td class="nump">$ 331,190<span></span>
</td>
<td class="nump">$ 323,706<span></span>
</td>
<td class="nump">$ 272,586<span></span>
</td>
<td class="nump">$ 270,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">62,446<span></span>
</td>
<td class="nump">20,364<span></span>
</td>
<td class="num">(64,195)<span></span>
</td>
<td class="num">(70,422)<span></span>
</td>
<td class="num">(48,486)<span></span>
</td>
<td class="nump">$ 23,788<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, value</a></td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">57,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember', window );">Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, value</a></td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">$ 3,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalPreferredStock', window );">Additional paid-in capital</a></td>
<td class="nump">473,640<span></span>
</td>
<td class="nump">386,884<span></span>
</td>
<td class="nump">379,400<span></span>
</td>
<td class="nump">328,280<span></span>
</td>
<td class="nump">326,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">118,140<span></span>
</td>
<td class="nump">76,058<span></span>
</td>
<td class="num">(8,501)<span></span>
</td>
<td class="num">(14,728)<span></span>
</td>
<td class="nump">7,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member] | Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member] | Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Restatement Impact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalPreferredStock', window );">Additional paid-in capital</a></td>
<td class="num">(55,694)<span></span>
</td>
<td class="num">(55,694)<span></span>
</td>
<td class="num">(55,694)<span></span>
</td>
<td class="num">(55,694)<span></span>
</td>
<td class="num">(55,694)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="num">(55,694)<span></span>
</td>
<td class="num">(55,694)<span></span>
</td>
<td class="num">(55,694)<span></span>
</td>
<td class="num">(55,694)<span></span>
</td>
<td class="num">(55,694)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Restatement Impact [Member] | Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, value</a></td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">53,543<span></span>
</td>
<td class="nump">53,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Restatement Impact [Member] | Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, value</a></td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">2,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholder in nonredeemable preferred stock-related transaction in excess of par value, value contributed to entity and value received from other stock-related transaction. Includes, but is not limited to, preferred stock redeemable solely at option of issuer. Excludes common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479772/718-30-S55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Parenthetical) (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">117,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">117,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">117,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">117,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember', window );">Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">6,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">6,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">6,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">6,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Consolidated Financial Statements - Corrected EPS Calculations under Two-class Method (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (1.61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (3.74)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, diluted</a></td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">(0.92)<span></span>
</td>
<td class="num">(0.65)<span></span>
</td>
<td class="num">(1.61)<span></span>
</td>
<td class="num">$ (1.23)<span></span>
</td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (3.74)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares, basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (As Restated)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to common shares - diluted</a></td>
<td class="num">$ (15,703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (53,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X and Series X1 Non Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, basic</a></td>
<td class="nump">$ 58.21<span></span>
</td>
<td class="num">(51.29)<span></span>
</td>
<td class="num">(36.12)<span></span>
</td>
<td class="num">(89.6)<span></span>
</td>
<td class="nump">$ 7.44<span></span>
</td>
<td class="num">$ (36.61)<span></span>
</td>
<td class="num">$ (207.58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, diluted</a></td>
<td class="num">$ (15.73)<span></span>
</td>
<td class="num">$ (51.29)<span></span>
</td>
<td class="num">$ (36.12)<span></span>
</td>
<td class="num">$ (89.6)<span></span>
</td>
<td class="num">$ (68.6)<span></span>
</td>
<td class="num">$ (36.61)<span></span>
</td>
<td class="num">$ (207.58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares, basic</a></td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">118,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (As Restated)</a></td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">114,508<span></span>
</td>
<td class="nump">118,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common shares - basic</a></td>
<td class="nump">$ 6,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to common shares - diluted</a></td>
<td class="num">$ (1,801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,856)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.06)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
<td class="num">$ (1.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.75)<span></span>
</td>
<td class="num">$ (4.73)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, diluted</a></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (1.06)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
<td class="num">$ (1.9)<span></span>
</td>
<td class="num">$ (1.42)<span></span>
</td>
<td class="num">$ (0.75)<span></span>
</td>
<td class="num">$ (4.73)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to common shares - diluted</a></td>
<td class="num">$ (17,504)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (61,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>274</ContextCount>
  <ElementCount>377</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>87</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>75000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>75010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>75020 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>75030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>75040 - Statement - Consolidated Statements of Convertible Stock and Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Convertible Stock and Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>75050 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995457 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance</Role>
      <ShortName>Cybersecurity Risk Management, Strategy and Governance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995467 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995477 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995487 - Disclosure - Short-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments</Role>
      <ShortName>Short-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995497 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995507 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1</Role>
      <ShortName>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995517 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995527 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995537 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995547 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995557 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995567 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995577 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatements1</Role>
      <ShortName>Restatement of Previously Issued Consolidated Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995587 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995597 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995607 - Disclosure - Short-Term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables</Role>
      <ShortName>Short-Term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995617 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995627 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables</Role>
      <ShortName>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995637 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995647 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995657 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995667 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995677 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995687 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsTables</Role>
      <ShortName>Restatement of Previously Issued Consolidated Financial Statements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatements1</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995697 - Disclosure - Description of Business - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail</Role>
      <ShortName>Description of Business - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995707 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995717 - Disclosure - Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995727 - Disclosure - Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995737 - Disclosure - Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail</Role>
      <ShortName>Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995757 - Disclosure - Short-Term Investments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail</Role>
      <ShortName>Short-Term Investments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995767 - Disclosure - Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995777 - Disclosure - Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995787 - Disclosure - Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995797 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995807 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail</Role>
      <ShortName>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995817 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail</Role>
      <ShortName>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995837 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995847 - Disclosure - Commitments and Contingencies - Components of Operating Lease Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail</Role>
      <ShortName>Commitments and Contingencies - Components of Operating Lease Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995857 - Disclosure - Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995867 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995877 - Disclosure - Income Taxes - Summary of Loss Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Summary of Loss Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995887 - Disclosure - Income Taxes - Summary of Provision for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Summary of Provision for Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995897 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995907 - Disclosure - Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail</Role>
      <ShortName>Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995917 - Disclosure - Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995927 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995937 - Disclosure - Stockholders' Equity - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995947 - Disclosure - Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent</Role>
      <ShortName>Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995957 - Disclosure - Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail</Role>
      <ShortName>Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995967 - Disclosure - Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail</Role>
      <ShortName>Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995977 - Disclosure - Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail</Role>
      <ShortName>Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995987 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995997 - Disclosure - Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail</Role>
      <ShortName>Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Stock-Based Compensation - Summary of RSU Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of RSU Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996037 - Disclosure - Segment Reporting - Schedule of Segment Reporting (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail</Role>
      <ShortName>Segment Reporting - Schedule of Segment Reporting (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996047 - Disclosure - Segment Reporting - Schedule of significant segment expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails</Role>
      <ShortName>Segment Reporting - Schedule of significant segment expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996057 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails</Role>
      <ShortName>Restatement of Previously Issued Consolidated Financial Statements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996067 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails</Role>
      <ShortName>Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996077 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Parenthetical) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails</Role>
      <ShortName>Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Parenthetical) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996087 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Corrected EPS Calculations under Two-class Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails</Role>
      <ShortName>Restatement of Previously Issued Consolidated Financial Statements - Corrected EPS Calculations under Two-class Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K/A" isDefinitelyFs="true" isUsgaap="true" original="eldn-20241231.htm">eldn-20241231.htm</File>
    <File>eldn-20241231.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img117130267_0.jpg</File>
    <File>img117130267_1.jpg</File>
    <File>img117130267_2.jpg</File>
    <File>img117130267_3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="955">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="45">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>91
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "eldn-20241231.htm": {
   "nsprefix": "eldn",
   "nsuri": "http://www.eledon.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "eldn-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "eldn-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 300,
   "keyCustom": 77,
   "axisStandard": 27,
   "axisCustom": 0,
   "memberStandard": 33,
   "memberCustom": 47,
   "hidden": {
    "total": 37,
    "http://fasb.org/us-gaap/2025": 34,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 274,
   "entityCount": 1,
   "segmentCount": 87,
   "elementCount": 715,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 955,
    "http://xbrl.sec.gov/dei/2025": 45,
    "http://xbrl.sec.gov/cyd/2025": 15,
    "http://xbrl.sec.gov/ecd/2025": 5
   },
   "report": {
    "R1": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "75000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
     "longName": "75010 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
     "longName": "75020 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "longName": "75030 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit",
     "longName": "75040 - Statement - Consolidated Statements of Convertible Stock and Stockholders' Equity (Deficit)",
     "shortName": "Consolidated Statements of Convertible Stock and Stockholders' Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_903fb9de-3a55-4a71-b923-06cf285c9991",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_625d824a-477d-49cd-8fc7-67814f7675af",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
     "longName": "75050 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:GainLossOnTerminationOfLease",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance",
     "longName": "995457 - Disclosure - Cybersecurity Risk Management, Strategy and Governance",
     "shortName": "Cybersecurity Risk Management, Strategy and Governance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1",
     "longName": "995467 - Disclosure - Description of Business",
     "shortName": "Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "longName": "995477 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments",
     "longName": "995487 - Disclosure - Short-Term Investments",
     "shortName": "Short-Term Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements",
     "longName": "995497 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1",
     "longName": "995507 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities",
     "shortName": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "longName": "995517 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes",
     "longName": "995527 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity",
     "longName": "995537 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation",
     "longName": "995547 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting",
     "longName": "995557 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents",
     "longName": "995567 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatements1",
     "longName": "995577 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements",
     "shortName": "Restatement of Previously Issued Consolidated Financial Statements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995587 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "longName": "995597 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables",
     "longName": "995607 - Disclosure - Short-Term Investments (Tables)",
     "shortName": "Short-Term Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables",
     "longName": "995617 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables",
     "longName": "995627 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)",
     "shortName": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables",
     "longName": "995637 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables",
     "longName": "995647 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables",
     "longName": "995657 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
     "longName": "995667 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables",
     "longName": "995677 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsTables",
     "longName": "995687 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements (Tables)",
     "shortName": "Restatement of Previously Issued Consolidated Financial Statements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
     "longName": "995697 - Disclosure - Description of Business - Additional Information (Detail)",
     "shortName": "Description of Business - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8bba3766-4964-4ab7-92aa-e8434203d2c8",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "longName": "995707 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
     "longName": "995717 - Disclosure - Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R37": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails",
     "longName": "995727 - Disclosure - Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)",
     "shortName": "Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail",
     "longName": "995737 - Disclosure - Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)",
     "shortName": "Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail",
     "longName": "995757 - Disclosure - Short-Term Investments - Additional Information (Detail)",
     "shortName": "Short-Term Investments - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:ShortTermInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R40": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
     "longName": "995767 - Disclosure - Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)",
     "shortName": "Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_a02b7bbf-5219-43e5-a35f-53b985449b45",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a02b7bbf-5219-43e5-a35f-53b985449b45",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
     "longName": "995777 - Disclosure - Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_30f84d62-e30b-473f-9c61-8ef1e1832085",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_30f84d62-e30b-473f-9c61-8ef1e1832085",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
     "longName": "995787 - Disclosure - Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)",
     "shortName": "Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_834dcb4b-a7e6-4a63-a26e-6cacde80edc9",
      "name": "eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
     "longName": "995797 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail",
     "longName": "995807 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)",
     "shortName": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "eldn:PrepaidClinicalExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "eldn:PrepaidClinicalExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail",
     "longName": "995817 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)",
     "shortName": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "eldn:AccruedClinicalCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock",
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "eldn:AccruedClinicalCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock",
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
     "longName": "995837 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail",
     "longName": "995847 - Disclosure - Commitments and Contingencies - Components of Operating Lease Expense (Detail)",
     "shortName": "Commitments and Contingencies - Components of Operating Lease Expense (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail",
     "longName": "995857 - Disclosure - Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)",
     "shortName": "Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail",
     "longName": "995867 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)",
     "shortName": "Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail",
     "longName": "995877 - Disclosure - Income Taxes - Summary of Loss Before Income Taxes (Detail)",
     "shortName": "Income Taxes - Summary of Loss Before Income Taxes (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail",
     "longName": "995887 - Disclosure - Income Taxes - Summary of Provision for Income Taxes (Detail)",
     "shortName": "Income Taxes - Summary of Provision for Income Taxes (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
     "longName": "995897 - Disclosure - Income Taxes - Additional Information (Detail)",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail",
     "longName": "995907 - Disclosure - Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)",
     "shortName": "Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail",
     "longName": "995917 - Disclosure - Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)",
     "shortName": "Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail",
     "longName": "995927 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)",
     "shortName": "Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_1eef9a49-60fd-482b-a231-9fc95faabb9b",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_703721ac-e233-4584-a2ed-617913379b0c",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
     "longName": "995937 - Disclosure - Stockholders' Equity - Additional Information (Detail)",
     "shortName": "Stockholders' Equity - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c9c85a29-4958-462d-81cd-61348312f2ed",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
     "longName": "995947 - Disclosure - Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)",
     "shortName": "Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9843be81-0c96-414e-9e7e-97d93fc8b5f9",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
     "longName": "995957 - Disclosure - Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)",
     "shortName": "Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_f6739b83-64c1-4196-bfa3-188e64be71c2",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_d73e41e0-eaac-4f7a-8f85-cc17e8daac55",
      "name": "eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
     "longName": "995967 - Disclosure - Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)",
     "shortName": "Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_c0e69edb-7d74-4a88-a331-7063c41b32d0",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_47180cae-052a-4fcf-aff0-dd86481a6ea5",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
     "longName": "995977 - Disclosure - Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)",
     "shortName": "Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_5dc4d3d6-be01-4bf6-aebf-77b1734fcf32",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f268d5e-cf5e-403a-87e4-658902565516",
      "name": "eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
     "longName": "995987 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail",
     "longName": "995997 - Disclosure - Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)",
     "shortName": "Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_1eef9a49-60fd-482b-a231-9fc95faabb9b",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail",
     "longName": "996007 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)",
     "shortName": "Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
     "longName": "996017 - Disclosure - Stock-Based Compensation - Summary of RSU Activity (Detail)",
     "shortName": "Stock-Based Compensation - Summary of RSU Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_4e5c52f4-44ed-4d03-b98e-acba67aad85d",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1eb7071c-d34e-4235-bcb4-1e3102fea0ef",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail",
     "longName": "996027 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)",
     "shortName": "Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5b4148f0-d4f9-403c-af32-f52bc3bd07f6",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail",
     "longName": "996037 - Disclosure - Segment Reporting - Schedule of Segment Reporting (Detail)",
     "shortName": "Segment Reporting - Schedule of Segment Reporting (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:FactorsUsedToIdentifyEntitysReportableSegments",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:FactorsUsedToIdentifyEntitysReportableSegments",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
     "longName": "996047 - Disclosure - Segment Reporting - Schedule of significant segment expenses (Details)",
     "shortName": "Segment Reporting - Schedule of significant segment expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4",
      "name": "eldn:Tegoprubart-KidneyTransplantationPrograms",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails",
     "longName": "996057 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Additional Information (Details)",
     "shortName": "Restatement of Previously Issued Consolidated Financial Statements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R69": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
     "longName": "996067 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Details)",
     "shortName": "Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:AdditionalPaidInCapitalPreferredStock",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:AdditionalPaidInCapitalPreferredStock",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
     "longName": "996077 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Parenthetical) (Details)",
     "shortName": "Restatement of Previously Issued Consolidated Financial Statements - Corrected Condensed Consolidated Balance Sheet (Parenthetical) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_b693d0f0-a45f-453e-a2bb-f555ee43c70f",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2091d266-9d3c-4b0a-b436-3f24223bba88",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:TemporaryEquitySharesAuthorized",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails",
     "longName": "996087 - Disclosure - Restatement of Previously Issued Consolidated Financial Statements - Corrected EPS Calculations under Two-class Method (Details)",
     "shortName": "Restatement of Previously Issued Consolidated Financial Statements - Corrected EPS Calculations under Two-class Method (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_8a2e70e3-2ed3-407e-a0af-d1a1cd2c2189",
      "name": "us-gaap:EarningsPerShareBasic",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_d2875a70-0df4-4171-877a-c58e658fdb69",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ALSTherapyDevelopmentFoundationIncLicenseAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ALS therapy development foundation, Inc. license agreement.",
        "label": "A L S Therapy Development Foundation Inc License Agreement [Member]",
        "terseLabel": "ALS Therapy Development Foundation, Inc. License Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate202307Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingStandardsUpdate202307Member",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update 2023-07 [Member]",
        "documentation": "Accounting Standards Update 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235"
     ]
    },
    "eldn_AccountsPayableAccruedExpensesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AccountsPayableAccruedExpensesAndOtherLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts payable, accrued expenses and other liabilities.",
        "label": "Accounts payable, accrued expenses and other liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r959"
     ]
    },
    "eldn_AccreditedInvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AccreditedInvestorMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accredited Investor.",
        "label": "Accredited Investor [Member]",
        "terseLabel": "Accredited Investor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AccretionOnInvestmentDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AccretionOnInvestmentDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion on Investment Discounts",
        "label": "Accretion on Investment Discounts",
        "negatedLabel": "Accretion on investment discounts",
        "terseLabel": "Accretion on investment discounts"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AccruedClinicalCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AccruedClinicalCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued clinical current.",
        "label": "Accrued Clinical Current",
        "terseLabel": "Accrued clinical"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities",
        "terseLabel": "Accrued expenses and other liabilities",
        "totalLabel": "Total accrued expenses and other liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional services",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total",
        "terseLabel": "Accumulated other comprehensive income",
        "verboseLabel": "Accumulated other comprehensive loss",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r57",
      "r115",
      "r741",
      "r762",
      "r766",
      "r1240"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r7",
      "r15",
      "r563",
      "r566",
      "r646",
      "r757",
      "r758",
      "r1129",
      "r1130",
      "r1131",
      "r1142",
      "r1143",
      "r1144",
      "r1147"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r779",
      "r1142",
      "r1143",
      "r1144",
      "r1147",
      "r1241",
      "r1306"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalPreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Preferred Stock",
        "documentation": "Value received from shareholder in nonredeemable preferred stock-related transaction in excess of par value, value contributed to entity and value received from other stock-related transaction. Includes, but is not limited to, preferred stock redeemable solely at option of issuer. Excludes common stock."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r131",
      "r132",
      "r133",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r174",
      "r234",
      "r235",
      "r269",
      "r271",
      "r272",
      "r273",
      "r302",
      "r303",
      "r306",
      "r329",
      "r330",
      "r331",
      "r332",
      "r416",
      "r417",
      "r418",
      "r419",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r524",
      "r525",
      "r526",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r609",
      "r610",
      "r629",
      "r630",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AggregateNetSalesAchievement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AggregateNetSalesAchievement",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net sales achievement.",
        "label": "Aggregate Net Sales Achievement",
        "terseLabel": "Reaching of aggregate net sales"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1015",
      "r1025",
      "r1058"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1018",
      "r1028",
      "r1061"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1092"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1053",
      "r1062",
      "r1066",
      "r1074"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation",
        "verboseLabel": "Stock-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r420",
      "r430"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AmortizationOfOperatingLeaseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AmortizationOfOperatingLeaseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of operating lease asset.",
        "label": "Amortization Of Operating Lease Asset",
        "terseLabel": "Amortization of operating lease asset"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AnelixisTherapeuticsIncorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AnelixisTherapeuticsIncorporationMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anelixis Therapeutics, Incorporation.",
        "label": "Anelixis Therapeutics Incorporation [Member]",
        "terseLabel": "Anelixis [Member]",
        "verboseLabel": "Anelixis [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AnelixisTherapeuticsLlcAndOticPharmaLtdMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anelixis Therapeutics, LLC and Otic Pharma, Ltd [Member]",
        "label": "Anelixis Therapeutics, LLC and Otic Pharma, Ltd [Member]",
        "terseLabel": "Anelixis Therapeutics, LLC and Otic Pharma, Ltd."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AnnualLicenseMaintenanceFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AnnualLicenseMaintenanceFee",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual license maintenance fee.",
        "label": "Annual License Maintenance Fee",
        "terseLabel": "Annual License Maintenance Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "eldn_AreaOfOfficeSpace": {
     "xbrltype": "areaItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AreaOfOfficeSpace",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of office space.",
        "label": "Area Of Office Space",
        "terseLabel": "Area of office space"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ArmisticeCapitalMasterFundLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ArmisticeCapitalMasterFundLtdMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Armistice Capital Master Fund Ltd.",
        "label": "Armistice Capital Master Fund Ltd [Member]",
        "terseLabel": "Armistice Capital Master Fund Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r87",
      "r111",
      "r141",
      "r143",
      "r144",
      "r192",
      "r206",
      "r221",
      "r225",
      "r268",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r550",
      "r552",
      "r618",
      "r725",
      "r726",
      "r734",
      "r817",
      "r908",
      "r909",
      "r922",
      "r959",
      "r971",
      "r972",
      "r982",
      "r1184",
      "r1185",
      "r1264"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r117",
      "r141",
      "r143",
      "r144",
      "r268",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r550",
      "r552",
      "r618",
      "r959",
      "r1184",
      "r1185",
      "r1264"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value",
        "totalLabel": "Total financial assets",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r588",
      "r945"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r987",
      "r988",
      "r1011"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r987",
      "r988",
      "r1011"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r987",
      "r988",
      "r1011"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Opinion",
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r242"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Unrealized Losses",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r243"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Amortized Cost",
        "totalLabel": "Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r279",
      "r733"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Debt Securities, Available-for-Sale, Total",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r279",
      "r587",
      "r611",
      "r612",
      "r613",
      "r614",
      "r722",
      "r883",
      "r945",
      "r950",
      "r957",
      "r1160",
      "r1246",
      "r1247",
      "r1248"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r383",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation and principles of consolidation.",
        "label": "Basis Of Presentation And Principles Of Consolidation Policy [Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biotechnology Value Fund LP, Biotechnology Value Fund II LP, Biotechnology Value Trading Fund OS LP, MSI BVF SPV LLC.",
        "label": "Biotechnology Value Fund L P Biotechnology Value Fund I I L P Biotechnology Value Trading Fund O S L P M S I B V F S P V L L C [Member]",
        "terseLabel": "BVF Exchanging Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "terseLabel": "Board of Directors [Member]"
       }
      }
     },
     "auth_ref": [
      "r1158"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Domain]",
        "terseLabel": "Business Acquisition, Acquiree",
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r769",
      "r931",
      "r932",
      "r1232",
      "r1234",
      "r1235"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Axis]",
        "terseLabel": "Business Acquisition",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r769",
      "r931",
      "r932",
      "r1232",
      "r1234",
      "r1235"
     ]
    },
    "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Effective Date of Acquisition",
        "terseLabel": "Date of acquisition",
        "verboseLabel": "Business acquisition, date of acquisition",
        "documentation": "Date when acquirer obtains control of acquiree in business combination, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r937",
      "r938",
      "r1229",
      "r1230"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1134"
     ]
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "CA",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "Irvine, California [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "California Franchise Tax Board [Member]",
        "terseLabel": "California [Member]",
        "documentation": "Designated tax department of the government of the state of California."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalent",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r109",
      "r885"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Total cash equivalents",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r613",
      "r614",
      "r1244",
      "r1245"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CashCashEquivalentsAndRestrictedCashMaturityPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash cash equivalents and restricted cash maturity period.",
        "label": "Cash Cash Equivalents And Restricted Cash Maturity Period",
        "terseLabel": "Cash, cash equivalents and restricted cash, maturity period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsAndShortTermInvestmentsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalent, and Short-Term Investment [Text Block]",
        "terseLabel": "Short-Term Investments",
        "documentation": "The entire disclosure of cash, cash equivalent, and short-term investment."
       }
      }
     },
     "auth_ref": [
      "r1159"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "periodStartLabel": "Cash and cash equivalents at beginning of year",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r63",
      "r138"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "totalLabel": "Net change in cash and cash equivalents",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r63"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for amounts included in measurement of lease liabilities.",
        "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liability:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "documentation": "Indicates (true false) whether accounting standards update was adopted."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r104",
      "r131",
      "r156",
      "r234",
      "r302",
      "r306",
      "r329",
      "r416",
      "r471",
      "r479",
      "r480",
      "r524",
      "r525",
      "r544",
      "r559",
      "r575",
      "r576",
      "r609",
      "r610",
      "r629",
      "r641",
      "r642",
      "r755",
      "r756"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r131",
      "r234",
      "r302",
      "r306",
      "r329",
      "r330",
      "r416",
      "r417",
      "r471",
      "r479",
      "r480",
      "r524",
      "r525",
      "r526",
      "r544",
      "r545",
      "r559",
      "r560",
      "r575",
      "r576",
      "r577",
      "r580",
      "r609",
      "r610",
      "r629",
      "r641",
      "r642",
      "r755",
      "r756",
      "r1115",
      "r1146"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]",
        "documentation": "Indicates (true false) whether accounting standards update was early adopted."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r104",
      "r131",
      "r156",
      "r234",
      "r302",
      "r306",
      "r330",
      "r417",
      "r472",
      "r481",
      "r526",
      "r545",
      "r560",
      "r577",
      "r580",
      "r609",
      "r610",
      "r755",
      "r756"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]",
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r157",
      "r173",
      "r270"
     ]
    },
    "eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds",
        "negatedLabel": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds",
        "label": "Change in Fair Value of Warrant Liabilities and Fair Value of Financial Instruments Issued in Excess of Proceeds",
        "documentation": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value Of Warrant Liabilities And Fair Value Of Financial Instruments Issued In Excess Of Proceeds Includes Reversal",
        "documentation": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal.",
        "terseLabel": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r112",
      "r113",
      "r114",
      "r141",
      "r144",
      "r178",
      "r179",
      "r186",
      "r188",
      "r194",
      "r195",
      "r268",
      "r315",
      "r318",
      "r319",
      "r320",
      "r324",
      "r325",
      "r333",
      "r334",
      "r336",
      "r337",
      "r339",
      "r343",
      "r346",
      "r347",
      "r350",
      "r353",
      "r361",
      "r618",
      "r773",
      "r774",
      "r775",
      "r776",
      "r779",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r805",
      "r825",
      "r843",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r1097",
      "r1137",
      "r1138",
      "r1148"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r194",
      "r336",
      "r346",
      "r347",
      "r348",
      "r350",
      "r353",
      "r359",
      "r361",
      "r558",
      "r773",
      "r774",
      "r775",
      "r776",
      "r923",
      "r1097",
      "r1135",
      "r1137"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r1187"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price per share",
        "verboseLabel": "Warrants exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r147",
      "r362"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class Of Warrant Or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Common stock warrants exercisable",
        "terseLabel": "Common stock warrants to purchase common stock shares",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants or rights assumed and replaced.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Assumed And Replaced",
        "terseLabel": "Estimated fair value, assumed and replaced",
        "verboseLabel": "Assumed and replaced"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants or rights cancelled or exchanged.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Cancelled Or Exchanged",
        "negatedLabel": "Cancelled/Exchanged"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants or rights cancelled or expired.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Cancelled Or Expired",
        "terseLabel": "Warrants exercisable for exchange",
        "verboseLabel": "Cancelled/Expired",
        "negatedLabel": "Cancelled/Expired"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants exercised.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Exercised",
        "terseLabel": "Number of shares exercised",
        "negatedLabel": "Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants or rights issued.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Issued",
        "terseLabel": "Warrants issued",
        "verboseLabel": "Issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Outstanding",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Warrants available for exercise",
        "verboseLabel": "Number of Shares of Common Stock Issuable",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class Of Warrant Or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r1187"
     ]
    },
    "eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage",
        "documentation": "Class of warrant subject to specified beneficial ownership limitations percentage.",
        "terseLabel": "Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage",
        "documentation": "Class of warrant subject to specified beneficial ownership limitations permitted percentage.",
        "terseLabel": "Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 6)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r79",
      "r737",
      "r804"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r308",
      "r309",
      "r870",
      "r1181",
      "r1183"
     ]
    },
    "eldn_CommonAndPreferredWarrantsOutstandingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CommonAndPreferredWarrantsOutstandingMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common and preferred warrants outstanding.",
        "label": "Common And Preferred Warrants Outstanding [Member]",
        "terseLabel": "Common and Preferred Warrants Outstanding [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock, number of shares reserved for issuance",
        "verboseLabel": "Common stock, number of shares initially reserved for issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock exchanged for X and X1 non-voting convertible preferred stock.",
        "label": "Common Stock Exchanged For X And X One Non-voting Convertible Preferred Stock",
        "terseLabel": "Common stock exchanged for X and X1 non-voting convertible preferred stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]",
        "verboseLabel": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r973",
      "r974",
      "r975",
      "r977",
      "r978",
      "r979",
      "r980",
      "r1142",
      "r1143",
      "r1147",
      "r1241",
      "r1304",
      "r1306"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value",
        "verboseLabel": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r805"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r805",
      "r823",
      "r1306",
      "r1307"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value, 200,000,000 shares authorized at December 31, 2024 and 2023; 59,789,275 and 24,213,130 shares issued and outstanding at December 31, 2024 and 2023, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r334",
      "r342",
      "r739",
      "r959"
     ]
    },
    "eldn_CommonStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CommonStockWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock warrants.",
        "label": "Common Stock Warrants [Member]",
        "terseLabel": "Common Stock Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CommonWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Warrants [Member]",
        "documentation": "Common warrants."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r615",
      "r616"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r141",
      "r142",
      "r149",
      "r152",
      "r192",
      "r207",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r225",
      "r226",
      "r227",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r729",
      "r908",
      "r909",
      "r1184",
      "r1185"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r141",
      "r142",
      "r149",
      "r152",
      "r192",
      "r207",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r225",
      "r226",
      "r227",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r729",
      "r908",
      "r909",
      "r1184",
      "r1185"
     ]
    },
    "eldn_ContingentLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ContingentLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent liability.",
        "label": "Contingent Liability",
        "terseLabel": "Contingent liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ConversionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ConversionAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion agreement.",
        "label": "Conversion Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ConversionOfPreferredStockConversionBlockerPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ConversionOfPreferredStockConversionBlockerPercent",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of preferred stock, conversion blocker, percent.",
        "label": "Conversion of Preferred Stock, Conversion Blocker, Percent",
        "terseLabel": "Conversion of preferred stock, conversion blocker, percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Conversion of stock, shares converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r21"
     ]
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockSharesIssued1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Conversion of stock, shares issued",
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r21"
     ]
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r347",
      "r350",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Shares of common stock issued upon conversion of each share of preferred stock",
        "verboseLabel": "Shares of common stock issued upon conversion of each share of preferred stock",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r33",
      "r50",
      "r72",
      "r356"
     ]
    },
    "eldn_CormorantGlobalHealthcareMasterFundLpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CormorantGlobalHealthcareMasterFundLpMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cormorant global healthcare master fund lp.",
        "label": "Cormorant Global Healthcare Master Fund LP [Member]",
        "terseLabel": "Cormorant Global Healthcare Master Fund LP [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "auth_ref": [
      "r141",
      "r150",
      "r151",
      "r326",
      "r348",
      "r649",
      "r668",
      "r732",
      "r887",
      "r888",
      "r889",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1236",
      "r1237",
      "r1238",
      "r1239"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1107",
      "r1135",
      "r1140",
      "r1228"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1107",
      "r1135",
      "r1140"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Current income tax expense (benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r1135",
      "r1140"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1107",
      "r1135",
      "r1140",
      "r1228"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1085"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1085"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r998",
      "r1087"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r998",
      "r1087"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1089"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r998",
      "r1087"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r991",
      "r1080"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r992",
      "r1081"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r992",
      "r1081"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r990",
      "r1079"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r990",
      "r1079"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r990",
      "r1079"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r993",
      "r1082"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r995",
      "r1084"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r995",
      "r1084"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1085"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1088"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1086"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r994",
      "r1083"
     ]
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "terseLabel": "Debt outstanding",
        "totalLabel": "Debt, Long-Term and Short-Term, Combined Amount, Total",
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Summary of Short-term Investments Classified as Available-for-sale Securities",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1135",
      "r1140",
      "r1227",
      "r1228"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1135",
      "r1140",
      "r1227"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred tax provision",
        "totalLabel": "Total deferred income tax provision",
        "negatedTotalLabel": "Total deferred income tax provision",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r91",
      "r1135",
      "r1140"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "totalLabel": "Deferred Tax Liabilities, Gross, Total",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r78",
      "r460"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r735"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State",
        "negatedLabel": "State",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1135",
      "r1140",
      "r1227",
      "r1228"
     ]
    },
    "eldn_DeferredTaxAssetsDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DeferredTaxAssetsDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets depreciation and amortization.",
        "label": "Deferred Tax Assets Depreciation And Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "terseLabel": "Research expenditures",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "eldn_DeferredTaxAssetsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DeferredTaxAssetsLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets lease liability.",
        "label": "Deferred Tax Assets Lease Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Foreign operating losses carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Federal net operating loss carryforwards, not to expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "eldn_DeferredTaxAssetsRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DeferredTaxAssetsRightOfUseAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets right-of-use asset.",
        "label": "Deferred Tax Assets Right Of Use Asset",
        "negatedLabel": "Right-of-use asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credits",
        "verboseLabel": "Research and development tax credit carryforwards for federal and state",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Accruals and reserves",
        "totalLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities",
        "totalLabel": "Deferred Tax Liabilities, Net, Total",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1223"
     ]
    },
    "eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DeferredTaxLiabilitiesInProcessResearchAndDevelopment",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities, in-process research and development.",
        "label": "Deferred Tax Liabilities In Process Research And Development",
        "negatedLabel": "Acquired IPR&amp;D"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_DescriptionOfBusinessLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DescriptionOfBusinessLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of business.",
        "label": "Description Of Business [Line Items]",
        "terseLabel": "Description Of Business [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_DescriptionOfBusinessTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DescriptionOfBusinessTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of business.",
        "label": "Description Of Business [Table]",
        "terseLabel": "Description Of Business [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r381",
      "r412",
      "r413",
      "r415",
      "r934"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r987",
      "r988",
      "r1011"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r987",
      "r988",
      "r1011",
      "r1054"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r987",
      "r988",
      "r1011",
      "r1054"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "terseLabel": "Domestic Tax Authority [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "eldn_EGenesisIncCollaborationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "EGenesisIncCollaborationAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "eGenesis, Inc. Collaboration Agreement [Member]",
        "documentation": "eGenesis, Inc. Collaboration Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Basic, Total",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Earnings per share, basic",
        "terseLabel": "Basic earnings per share of common stock (As Restated)",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r127",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r169",
      "r175",
      "r178",
      "r186",
      "r187",
      "r188",
      "r191",
      "r332",
      "r418",
      "r486",
      "r548",
      "r584",
      "r585",
      "r724",
      "r749",
      "r897"
     ]
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasicLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r186",
      "r188"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Earnings per share, diluted",
        "terseLabel": "Diluted earnings per share of common stock (As Restated)",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r127",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r169",
      "r178",
      "r186",
      "r187",
      "r188",
      "r191",
      "r332",
      "r418",
      "r486",
      "r548",
      "r584",
      "r585",
      "r724",
      "r749",
      "r897"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share (As Restated)",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r190"
     ]
    },
    "eldn_EffectiveFederalAndStateIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "EffectiveFederalAndStateIncomeTaxRate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective federal and state income tax rate.",
        "label": "Effective Federal And State Income Tax Rate",
        "terseLabel": "Federal Income tax rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax rate",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r936"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1217"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense",
        "totalLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized stock-based compensation expense, recognized over estimated weighted average period",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Stock Options Outstanding and Other Equity Awards [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1191",
      "r1192",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "terseLabel": "Entity",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1096"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1090"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r1090"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1090"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r96",
      "r103",
      "r104",
      "r123",
      "r124",
      "r125",
      "r153",
      "r154",
      "r155",
      "r158",
      "r167",
      "r170",
      "r172",
      "r193",
      "r269",
      "r273",
      "r303",
      "r331",
      "r363",
      "r418",
      "r469",
      "r470",
      "r482",
      "r483",
      "r484",
      "r487",
      "r547",
      "r548",
      "r561",
      "r563",
      "r564",
      "r565",
      "r566",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r583",
      "r622",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r631",
      "r646",
      "r747",
      "r757",
      "r758",
      "r759",
      "r779",
      "r843"
     ]
    },
    "eldn_EquityDistributionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "EquityDistributionAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity distribution agreement.",
        "label": "Equity Distribution Agreement [Member]",
        "terseLabel": "Equity Distribution Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1015",
      "r1025",
      "r1058"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1012",
      "r1022",
      "r1055"
     ]
    },
    "us-gaap_ErrorCorrectionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ErrorCorrectionTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatements1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement of Previously Issued Consolidated Financial Statements",
        "label": "Error Correction [Text Block]",
        "documentation": "The entire disclosure for reporting error correction."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r169",
      "r170",
      "r171",
      "r172",
      "r191"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "us-gaap_FactorsUsedToIdentifyEntitysReportableSegments": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FactorsUsedToIdentifyEntitysReportableSegments",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Factors Used to Identify Entity's Reportable Segments",
        "documentation": "Description of the factors used to identify reportable segments, including the basis of organization (for example, whether management has chosen to organize the enterprise around differences in products and services, geographic areas, regulatory environments, or a combination of factors and whether operating segments have been aggregated to reportable segments)."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r906",
      "r914"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r588",
      "r601",
      "r945"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r588",
      "r601",
      "r945"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Asset Instruments Measured At Fair Value On A Recurring Basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1244",
      "r1245"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r586",
      "r588",
      "r589",
      "r590",
      "r591",
      "r600",
      "r601",
      "r603",
      "r612",
      "r655",
      "r656",
      "r657",
      "r883",
      "r920",
      "r921",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r945",
      "r950",
      "r957"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r588",
      "r589",
      "r591",
      "r945",
      "r1247",
      "r1250"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r596",
      "r598",
      "r599",
      "r600",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r721",
      "r945",
      "r951"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r365",
      "r370",
      "r372",
      "r588",
      "r601",
      "r612",
      "r655",
      "r883",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r945",
      "r957"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r365",
      "r370",
      "r372",
      "r374",
      "r588",
      "r589",
      "r601",
      "r612",
      "r656",
      "r883",
      "r920",
      "r921",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r945",
      "r957"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r588",
      "r589",
      "r590",
      "r591",
      "r601",
      "r612",
      "r657",
      "r883",
      "r920",
      "r921",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r945",
      "r950",
      "r957"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Aggregate Fair Values of Warrant Liabilities",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset."
       }
      }
     },
     "auth_ref": [
      "r1244",
      "r1245"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r602"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Warrant Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r597",
      "r602"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r588",
      "r589",
      "r591",
      "r945",
      "r1247",
      "r1250"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodStartLabel": "Balance as of December 31, 2023",
        "periodEndLabel": "Balance as of December 31, 2024",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r602"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r586",
      "r588",
      "r589",
      "r590",
      "r591",
      "r600",
      "r601",
      "r603",
      "r612",
      "r655",
      "r656",
      "r657",
      "r883",
      "r920",
      "r921",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r945",
      "r950",
      "r957"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring Member",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r945",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1250"
     ]
    },
    "eldn_FeeDueForMilestonesAchieved": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "FeeDueForMilestonesAchieved",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee due for milestones achieved.",
        "label": "Fee Due For Milestones Achieved",
        "terseLabel": "Fee due for milestones achieved"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r281",
      "r282",
      "r328",
      "r359",
      "r558",
      "r573",
      "r608",
      "r617",
      "r620",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r731",
      "r748",
      "r917",
      "r945",
      "r948",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r960",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1243",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252"
     ]
    },
    "eldn_FiveHundredMillionAggregateNetSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "FiveHundredMillionAggregateNetSalesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five hundred million aggregate net sales.",
        "label": "Five Hundred Million Aggregate Net Sales [Member]",
        "terseLabel": "Achievement of 500 Million Aggregate Sales [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Tax Jurisdiction [Member]",
        "terseLabel": "Foreign Country [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r444"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1062"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1062"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1062"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1062"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1062"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnTerminationOfLease",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on lease termination",
        "label": "Gain (Loss) on Termination of Lease",
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total",
        "verboseLabel": "General and administrative expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r827"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill impairment",
        "terseLabel": "Impairment charge",
        "negatedLabel": "Impairments",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r283",
      "r289",
      "r294",
      "r296",
      "r543",
      "r919",
      "r947"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r919"
     ]
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Indemnification obligations amount",
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "eldn_GuggenheimSecuritiesLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "GuggenheimSecuritiesLlcMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guggenheim Securities LLC [Member]",
        "label": "Guggenheim Securities LLC [Member]",
        "documentation": "Guggenheim Securities LLC."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r987",
      "r988",
      "r1011"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairments of long-lived assets",
        "totalLabel": "Impairment, Long-Lived Asset, Held-for-Use, Total",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r30",
      "r67",
      "r129",
      "r890",
      "r946"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r68"
     ]
    },
    "eldn_InProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "InProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-process research and development.",
        "label": "In Process Research And Development",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InProcessResearchAndDevelopmentPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InProcessResearchAndDevelopmentPolicy",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "In Process Research and Development, Policy [Policy Text Block]",
        "terseLabel": "In-Process Research and Development",
        "documentation": "Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S.",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r145",
      "r442"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r83",
      "r86",
      "r725",
      "r727",
      "r745",
      "r891",
      "r893",
      "r894",
      "r901",
      "r908",
      "r1151",
      "r1153",
      "r1154",
      "r1155",
      "r1156"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Non-U.S.",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r145",
      "r442"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Losses before income taxes:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "terseLabel": "Income Statement Location",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r307",
      "r554",
      "r555",
      "r556",
      "r557",
      "r593",
      "r597",
      "r602",
      "r619",
      "r620",
      "r621",
      "r752",
      "r754",
      "r828",
      "r882",
      "r883",
      "r937",
      "r939",
      "r943",
      "r944",
      "r949",
      "r957",
      "r1231",
      "r1233",
      "r1276"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "terseLabel": "Income Statement Location",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r307",
      "r554",
      "r555",
      "r556",
      "r557",
      "r593",
      "r597",
      "r602",
      "r619",
      "r620",
      "r621",
      "r752",
      "r754",
      "r828",
      "r882",
      "r883",
      "r937",
      "r939",
      "r943",
      "r944",
      "r949",
      "r957",
      "r1231",
      "r1233",
      "r1276"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "terseLabel": "Income Tax Authority",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r443",
      "r444",
      "r453",
      "r465",
      "r936",
      "r1224"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Domain]",
        "terseLabel": "Income Tax Authority",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r443",
      "r444",
      "r453",
      "r465",
      "r936",
      "r1224"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r1224"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r1224"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r146",
      "r435",
      "r443",
      "r449",
      "r450",
      "r451",
      "r457",
      "r464",
      "r474",
      "r476",
      "r477",
      "r478",
      "r730",
      "r768",
      "r778",
      "r936"
     ]
    },
    "eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncomeTaxExaminationLikelihoodOfFavorableSettlement",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax examination likelihood of favorable settlement.",
        "label": "Income Tax Examination Likelihood Of Favorable Settlement",
        "terseLabel": "Income tax examination, likelihood of settlement, percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Examination, Likelihood of Unfavorable Settlement",
        "terseLabel": "Income tax examination, likelihood of settlement, description",
        "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority."
       }
      }
     },
     "auth_ref": [
      "r1222"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit",
        "totalLabel": "Total provision for income taxes",
        "terseLabel": "Income taxes",
        "negatedTerseLabel": "Provision for income taxes",
        "negatedTotalLabel": "Total provision for income taxes",
        "verboseLabel": "Provision for income taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r92",
      "r141",
      "r171",
      "r172",
      "r192",
      "r208",
      "r225",
      "r441",
      "r443",
      "r475",
      "r750",
      "r891",
      "r893",
      "r894",
      "r936"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r437",
      "r438",
      "r457",
      "r458",
      "r463",
      "r467",
      "r772"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r936",
      "r1219"
     ]
    },
    "eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds",
        "label": "Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds",
        "documentation": "Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Statutory federal income tax rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r936"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r936",
      "r1219",
      "r1221"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r936",
      "r1219",
      "r1220"
     ]
    },
    "eldn_IncomeTaxReconciliationPermanentItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncomeTaxReconciliationPermanentItems",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation permanent items.",
        "label": "Income Tax Reconciliation Permanent Items",
        "terseLabel": "Permanent items"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IncomeTaxReconciliationStateTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncomeTaxReconciliationStateTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation state tax rate differential.",
        "label": "Income Tax Reconciliation State Tax Rate Differential",
        "terseLabel": "State rate differential"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationTaxCredits",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount, Total",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r446",
      "r448",
      "r1219"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1102",
      "r1132"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in operating right-of-use lease asset and liability due to new lease",
        "label": "Increase Decrease in Right-Of-Use Operating Lease Asset and Liability Due To New Lease",
        "documentation": "Increase (decrease) in operating right-of-use lease asset and liability due to new lease."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1053",
      "r1062",
      "r1066",
      "r1074"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r989",
      "r1078"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r989",
      "r1078"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r989",
      "r1078"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Investments, Fair Value Disclosure, Total",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Total short-term investments",
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method."
       }
      }
     },
     "auth_ref": [
      "r1244",
      "r1245",
      "r1249",
      "r1251",
      "r1252",
      "r1253",
      "r1254"
     ]
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IsraelTaxAuthorityMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel Tax Authority [Member]",
        "terseLabel": "Israeli Tax Authority [Member]",
        "documentation": "Designated tax department of the government of Israel."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Common Stock And PreFunded Warrants In Connection With Two Thousand Twenty Four Underwritten Offering, Net Of Issuance Costs, Shares",
        "documentation": "Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares",
        "terseLabel": "Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value",
        "label": "Issuance Of Common Stock And PreFunded Warrants In Connection With Two Thousand Twenty FourUnderwritten Offering, Net Of Issuance Costs, Value",
        "documentation": "Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with conversion of X non-voting convertible preferred stock shares.",
        "label": "Issuance Of Common Stock In Connection With Conversion Of X1 Non-voting Convertible Preferred Stock Shares",
        "terseLabel": "Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock value.",
        "label": "Issuance Of Common Stock In Connection With Conversion Of X1 Non-voting Convertible Preferred Stock Value",
        "terseLabel": "Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with conversion of x non-voting convertible preferred stock shares.",
        "label": "Issuance Of Common Stock In Connection With Conversion Of X Non-voting Convertible Preferred Stock Shares",
        "terseLabel": "Issuance of common stock in connection with conversion of X non-voting convertible preferred stock, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with conversion of X non-voting convertible preferred stock, Value",
        "label": "Issuance Of Common Stock In Connection With Conversion Of X Non Voting Convertible Preferred Stock Value",
        "documentation": "Issuance of common stock in connection with conversion of X non-voting convertible preferred stock value."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with exercise of pre-funded warrants, shares.",
        "label": "Issuance of Common Stock in Connection With Exercise of Pre-funded Warrants, Shares",
        "terseLabel": "Issuance of common stock in connection with exercise of pre-funded warrants, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with exercise of pre-funded warrants, value",
        "label": "Issuance of Common Stock in Connection With Exercise of Pre-funded Warrants, Value",
        "terseLabel": "Issuance of common stock in connection with exercise of pre-funded warrants, Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Shares",
        "documentation": "Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, shares.",
        "label": "Issuance of Common Stock in Connection with Private Investment in Public Equity Transaction, Net of Issuance Costs, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value",
        "documentation": "Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, value.",
        "label": "Issuance of Common Stock in Connection with Private Investment in Public Equity Transaction, Net of Issuance Costs, Value",
        "terseLabel": "Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Common Stock With The Completion Of The Second And Third Closing In Connection With Two Thousand Twenty Three Securities Purchase Agreement Net Of Issuance Costs , Shares.",
        "documentation": "Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , shares.",
        "verboseLabel": "Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Common Stock With The Completion Of The Second And Third Closing In Connection With Two Thousand Twenty Three Securities Purchase Agreement Net Of Issuance Costs , value",
        "documentation": "Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , value.",
        "verboseLabel": "Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyCommonWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty Common Warrants [Member]",
        "terseLabel": "January 2020 Common Warrants",
        "documentation": "January Two Thousand And Twenty Common Warrants Member."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyCommonWarrantsOneMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty Common Warrants One [Member]",
        "documentation": "January Two Thousand And Twenty Common Warrants One Member.",
        "terseLabel": "January 2020 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty Common Warrants Three [Member]",
        "documentation": "January Two Thousand And Twenty Common Warrants Three Member.",
        "terseLabel": "January 2020 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty Common Warrants Two [Member]",
        "documentation": "January Two Thousand And Twenty Common Warrants Two Member.",
        "terseLabel": "January 2020 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty One Pre-funded Warrants [Member]",
        "documentation": "January Two Thousand And Twenty One Pre-funded Warrants Member.",
        "terseLabel": "January 2021 Pre-funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Operating Lease Expense",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1258"
     ]
    },
    "us-gaap_LeaseExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseExpirationDate1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expiration date",
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_LeerinkPartnersLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "LeerinkPartnersLlcMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leerink Partners LLC [Member]",
        "documentation": "Leerink partners LLC.",
        "terseLabel": "Leerink Partners LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Payments Under Noncancelable Operating Leases",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1259"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r1136",
      "r1141",
      "r1273"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r1136",
      "r1141",
      "r1273"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r1136",
      "r1141",
      "r1273"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r1136",
      "r1141",
      "r1273"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "eldn_LesseeOperatingLeaseRemainingTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "LesseeOperatingLeaseRemainingTermOfContract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease remaining term of contract.",
        "label": "Lessee Operating Lease Remaining Term Of Contract",
        "terseLabel": "Remaining term of office lease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1257"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r48",
      "r141",
      "r143",
      "r144",
      "r268",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r551",
      "r552",
      "r553",
      "r618",
      "r803",
      "r900",
      "r922",
      "r982",
      "r1184",
      "r1264",
      "r1265"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, convertible preferred stock and stockholders' equity (deficit)",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r80",
      "r743",
      "r959",
      "r971",
      "r972",
      "r1135",
      "r1139",
      "r1177",
      "r1255"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "verboseLabel": "LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r108",
      "r141",
      "r143",
      "r144",
      "r268",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r551",
      "r552",
      "r553",
      "r618",
      "r959",
      "r1184",
      "r1264",
      "r1265"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities measured at fair value",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Liabilities, Fair Value Disclosure, Total",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r588",
      "r1244"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Category of Item Purchased [Axis]",
        "terseLabel": "Category of Item Purchased",
        "documentation": "Information by category of items purchased under a long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Purchase Commitment, Category of Item Purchased [Domain]",
        "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased",
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "stpr_MA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "MA",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "terseLabel": "Burlington, Massachusetts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManufacturingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ManufacturingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing Costs",
        "terseLabel": "Manufacturing",
        "documentation": "The aggregate costs incurred in the production of goods for sale."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "eldn_ManufacturingExpensesOffset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ManufacturingExpensesOffset",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing Expenses, Offset",
        "documentation": "Manufacturing expenses offset.",
        "terseLabel": "Manufacturing expenses offset"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r200",
      "r310",
      "r311",
      "r312",
      "r313",
      "r376",
      "r407",
      "r408",
      "r409",
      "r432",
      "r591",
      "r684",
      "r751",
      "r753",
      "r767",
      "r795",
      "r796",
      "r850",
      "r852",
      "r854",
      "r855",
      "r857",
      "r865",
      "r866",
      "r868",
      "r869",
      "r880",
      "r881",
      "r916",
      "r923",
      "r933",
      "r937",
      "r940",
      "r941",
      "r950",
      "r951",
      "r955",
      "r956",
      "r969",
      "r1186",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r200",
      "r310",
      "r311",
      "r312",
      "r313",
      "r376",
      "r407",
      "r408",
      "r409",
      "r432",
      "r591",
      "r684",
      "r751",
      "r753",
      "r767",
      "r795",
      "r796",
      "r850",
      "r852",
      "r854",
      "r855",
      "r857",
      "r865",
      "r866",
      "r868",
      "r869",
      "r880",
      "r881",
      "r916",
      "r923",
      "r933",
      "r937",
      "r940",
      "r941",
      "r950",
      "r951",
      "r955",
      "r969",
      "r1186",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1188",
      "r1189"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "eldn_NOLTrueUp": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NOLTrueUp",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOL True Up.",
        "label": "N O L True Up",
        "terseLabel": "NOL true-up"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "totalLabel": "Net cash used in investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "totalLabel": "Net cash used in operating activities",
        "verboseLabel": "Cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r65"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]",
        "terseLabel": "Cash flows used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "totalLabel": "Net loss and comprehensive loss",
        "verboseLabel": "Net loss used in the calculation of basic and diluted loss per share",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r65",
      "r84",
      "r104",
      "r106",
      "r118",
      "r120",
      "r125",
      "r141",
      "r143",
      "r144",
      "r149",
      "r157",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r171",
      "r172",
      "r184",
      "r268",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r332",
      "r335",
      "r338",
      "r344",
      "r418",
      "r486",
      "r548",
      "r585",
      "r618",
      "r746",
      "r824",
      "r841",
      "r842",
      "r891",
      "r893",
      "r894",
      "r981",
      "r1184"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net Income (Loss) Available to Common Stockholders, Basic, Total",
        "terseLabel": "Net loss attributable to common shares - basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r128",
      "r162",
      "r163",
      "r165",
      "r166",
      "r175",
      "r176",
      "r185",
      "r188",
      "r335",
      "r338",
      "r344",
      "r548"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net Income (Loss) Available to Common Stockholders, Diluted, Total",
        "terseLabel": "Net loss attributable to common shares - diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r177",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r188"
     ]
    },
    "eldn_NetOperatingLossCarryforwardsExpirationPeriod": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NetOperatingLossCarryforwardsExpirationPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards expiration period.",
        "label": "Net Operating Loss Carryforwards Expiration Period",
        "terseLabel": "Net operating loss carryforward expiration period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements Issued But Not Adopted",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1053",
      "r1062"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "eldn_NoncashActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NoncashActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash activities.",
        "label": "Noncash Activities [Abstract]",
        "terseLabel": "Non-cash activities:"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_NumberOfMilestonesAchieved": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NumberOfMilestonesAchieved",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of milestones achieved.",
        "label": "Number Of Milestones Achieved",
        "terseLabel": "Number of Milestones Achieved"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating business segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r909",
      "r1152"
     ]
    },
    "eldn_NumberOfPreFundedWarrantsExercisedForCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NumberOfPreFundedWarrantsExercisedForCommonStock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pre-funded warrants exercised for common stock.",
        "label": "Number of Pre-funded Warrants Exercised for Common Stock",
        "terseLabel": "Number of pre-funded warrants exercised for common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r902",
      "r914",
      "r1152"
     ]
    },
    "eldn_OneBillionAggregateNetSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "OneBillionAggregateNetSalesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One billion aggregate net sales.",
        "label": "One Billion Aggregate Net Sales [Member]",
        "terseLabel": "Achievement of 1 Billion Aggregate Sales [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 0.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r891",
      "r894",
      "r901",
      "r1151",
      "r1153",
      "r1154",
      "r1155",
      "r1156"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r636",
      "r958"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Expense",
        "terseLabel": "Rental expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of lease liabilities",
        "terseLabel": "Lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liability",
        "negatedLabel": "Less current portion of operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Non-current operating lease liability",
        "terseLabel": "Non-current operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating lease",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r635",
      "r637"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "ROU assets",
        "terseLabel": "Operating lease right-of-use asset, net",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Amortization of operating lease right-of-use asset",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r639",
      "r958"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r638",
      "r958"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r226",
      "r908",
      "r909"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Accrued other",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r959"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Net of Tax, Total",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r11",
      "r119",
      "r121",
      "r126",
      "r167",
      "r622",
      "r623",
      "r628",
      "r723",
      "r747",
      "r1129",
      "r1130"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net",
        "totalLabel": "Other Nonoperating Income (Expense), Total",
        "verboseLabel": "Other income, net",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r942"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Prepaid other",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1117",
      "r1180"
     ]
    },
    "eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Supplemental Cash Flow Information Related to Leases [Table Text Block]",
        "documentation": "Other supplemental cash flow information related to leases.",
        "terseLabel": "Schedule of Other Supplemental Cash Flow Information Related to Leases"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_OticPharmaIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "OticPharmaIncMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Otic Pharma, Inc.",
        "label": "Otic Pharma Inc [Member]",
        "terseLabel": "Otic Pharma, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_OticPharmaLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "OticPharmaLtdMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Otic Pharma, Ltd.",
        "label": "Otic Pharma Ltd [Member]",
        "terseLabel": "Otic Pharma [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1006",
      "r1017",
      "r1027",
      "r1060"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1020",
      "r1030",
      "r1063"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1020",
      "r1030",
      "r1063"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedLabel": "Purchase of available-for-sale short-term investments",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r134",
      "r237"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "eldn_PercentageOfCommonStockholdersReceiveCashAndOtherAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PercentageOfCommonStockholdersReceiveCashAndOtherAssets",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of common stockholders receive cash and other assets",
        "label": "Percentage of Common Stockholders Receive Cash and Other Assets",
        "documentation": "Percentage of common stockholders receive cash and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PercentageOfCumulativeChangeInOwnership": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PercentageOfCumulativeChangeInOwnership",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of cumulative change in ownership.",
        "label": "Percentage Of Cumulative Change In Ownership",
        "terseLabel": "Percentage of cumulative change in ownership"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PerformanceBasedVestingRequirementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PerformanceBasedVestingRequirementsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance-based Vesting Requirements [Member]",
        "documentation": "Performance-based vesting requirements."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards.",
        "label": "Period For Which Cumulative Change In Ownership Annual Use Net Operating Loss And Research And Development Credit Carryforwards",
        "terseLabel": "Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_Personnel-RelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "Personnel-RelatedExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Personnel-Related Expenses",
        "documentation": "Personnel-related expenses.",
        "terseLabel": "Personnel-related"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1191",
      "r1192",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1191",
      "r1192",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "eldn_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded warrants.",
        "label": "Pre-funded Warrants [Member]",
        "terseLabel": "Pre-Funded Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r346"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r805"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r346"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r805",
      "r823",
      "r1306",
      "r1307"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, value",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r334",
      "r341",
      "r738",
      "r959"
     ]
    },
    "eldn_PreferredStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PreferredStockWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock warrants.",
        "label": "Preferred Stock Warrants [Member]",
        "terseLabel": "Preferred Stock Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PrepaidClinicalExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PrepaidClinicalExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid clinical expense.",
        "label": "Prepaid Clinical Expense",
        "terseLabel": "Prepaid clinical"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1119"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses, other assets, accrued expenses and other liabilities.",
        "label": "Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses, other assets, accrued expenses and other liabilities.",
        "label": "Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Text Block]",
        "terseLabel": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r886",
      "r918",
      "r1180"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement Warrants [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of common stock and pre funded warrants net.",
        "label": "Proceeds from Issuance of Common Stock And Pre Funded Warrants Net",
        "terseLabel": "Proceeds from issuances of common stock and pre-funded warrants, net",
        "verboseLabel": "Net proceeds after deducting offering costs"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ProceedsFromIssuanceOfNetOfOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ProceedsFromIssuanceOfNetOfOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Issuance Of Net Of Offering Costs",
        "documentation": "Proceeds from issuance of net of offering costs.",
        "terseLabel": "Net proceeds after deducting offering costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds after deducting offering costs",
        "label": "Proceeds from Issuance of Private Placement, Net of Offering Costs",
        "documentation": "Proceeds from issuance of private placement, net of offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Warrants",
        "verboseLabel": "Common warrants issued",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "eldn_ProceedsFromIssuanceOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ProceedsFromIssuanceOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Issuance Offering",
        "documentation": "Proceeds from issuance offering",
        "terseLabel": "Proceeds from issuance offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from maturities of available-for-sale short-term investments",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r1161"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r9"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "auth_ref": [
      "r200",
      "r310",
      "r311",
      "r312",
      "r313",
      "r364",
      "r376",
      "r407",
      "r408",
      "r409",
      "r415",
      "r432",
      "r591",
      "r658",
      "r667",
      "r684",
      "r751",
      "r753",
      "r767",
      "r795",
      "r796",
      "r850",
      "r852",
      "r854",
      "r855",
      "r857",
      "r865",
      "r866",
      "r868",
      "r869",
      "r880",
      "r881",
      "r916",
      "r923",
      "r933",
      "r937",
      "r940",
      "r941",
      "r950",
      "r951",
      "r955",
      "r956",
      "r969",
      "r975",
      "r1182",
      "r1186",
      "r1247",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "auth_ref": [
      "r200",
      "r310",
      "r311",
      "r312",
      "r313",
      "r364",
      "r376",
      "r407",
      "r408",
      "r409",
      "r415",
      "r432",
      "r591",
      "r658",
      "r667",
      "r684",
      "r751",
      "r753",
      "r767",
      "r795",
      "r796",
      "r850",
      "r852",
      "r854",
      "r855",
      "r857",
      "r865",
      "r866",
      "r868",
      "r869",
      "r880",
      "r881",
      "r916",
      "r923",
      "r933",
      "r937",
      "r940",
      "r941",
      "r950",
      "r951",
      "r955",
      "r956",
      "r969",
      "r975",
      "r1182",
      "r1186",
      "r1247",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1012",
      "r1022",
      "r1055"
     ]
    },
    "eldn_RegulatoryMilestonePaymentsObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "RegulatoryMilestonePaymentsObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory milestone payments obligation.",
        "label": "Regulatory Milestone Payments Obligation",
        "terseLabel": "Development and regulatory milestone payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r148",
      "r149",
      "r236",
      "r371",
      "r375",
      "r647",
      "r648",
      "r736",
      "r744",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r822",
      "r849",
      "r1305"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r148",
      "r149",
      "r236",
      "r371",
      "r375",
      "r647",
      "r648",
      "r736",
      "r744",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r822",
      "r849",
      "r1263",
      "r1305"
     ]
    },
    "eldn_RemainingMilestonePaymentsForFirstLicensedProduct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "RemainingMilestonePaymentsForFirstLicensedProduct",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining milestone payments for first licensed product.",
        "label": "Remaining Milestone Payments For First Licensed Product",
        "terseLabel": "Remaining milestone payments for first licensed product"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "auth_ref": [
      "r141",
      "r150",
      "r151",
      "r326",
      "r348",
      "r649",
      "r668",
      "r732",
      "r887",
      "r888",
      "r889",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1236",
      "r1237",
      "r1238",
      "r1239"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r882",
      "r891",
      "r892",
      "r908",
      "r1272"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "Research and Development [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Restatement Impact [Member]"
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r169",
      "r170",
      "r191",
      "r583",
      "r584",
      "r630",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1105",
      "r1106",
      "r1146",
      "r1157"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r103",
      "r104",
      "r105",
      "r130",
      "r153",
      "r154",
      "r155",
      "r157",
      "r158",
      "r162",
      "r163",
      "r164",
      "r165",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r174",
      "r191",
      "r271",
      "r272",
      "r331",
      "r332",
      "r418",
      "r483",
      "r484",
      "r486",
      "r487",
      "r547",
      "r548",
      "r579",
      "r583",
      "r584",
      "r585",
      "r630",
      "r645",
      "r646",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r770",
      "r1157"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r1002",
      "r1013",
      "r1023",
      "r1056"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1014",
      "r1024",
      "r1057"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1021",
      "r1031",
      "r1064"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r103",
      "r104",
      "r105",
      "r130",
      "r153",
      "r154",
      "r155",
      "r157",
      "r158",
      "r162",
      "r163",
      "r164",
      "r165",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r174",
      "r191",
      "r271",
      "r272",
      "r331",
      "r332",
      "r418",
      "r483",
      "r484",
      "r486",
      "r487",
      "r547",
      "r548",
      "r579",
      "r583",
      "r584",
      "r585",
      "r630",
      "r645",
      "r646",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r770",
      "r1157"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSU [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1191",
      "r1192",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Retained earnings / (Accumulated Deficit)",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r74",
      "r742",
      "r761",
      "r766",
      "r777",
      "r806",
      "r959"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r103",
      "r104",
      "r153",
      "r154",
      "r155",
      "r158",
      "r167",
      "r170",
      "r172",
      "r269",
      "r273",
      "r303",
      "r331",
      "r418",
      "r469",
      "r470",
      "r482",
      "r483",
      "r484",
      "r487",
      "r547",
      "r548",
      "r561",
      "r564",
      "r565",
      "r568",
      "r583",
      "r629",
      "r631",
      "r757",
      "r759",
      "r779",
      "r1306"
     ]
    },
    "eldn_RisksAndUncertaintiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "RisksAndUncertaintiesPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks and uncertainties.",
        "label": "Risks and Uncertainties [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyGuaranteesCommitmentsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RoyaltyGuaranteesCommitmentsAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Guarantees, Commitments, Amount",
        "terseLabel": "Amount of one-time milestone payment",
        "documentation": "The amount the entity has committed to make for future royalty guarantees."
       }
      }
     },
     "auth_ref": [
      "r686"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Stock price per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "As Previously Reported [Member]"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r103",
      "r104",
      "r153",
      "r155",
      "r157",
      "r158",
      "r162",
      "r163",
      "r172",
      "r191",
      "r331",
      "r332",
      "r418",
      "r483",
      "r486",
      "r487",
      "r547",
      "r548",
      "r579",
      "r583",
      "r584",
      "r630",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r770",
      "r1103",
      "r1104",
      "r1105",
      "r1145",
      "r1146",
      "r1157",
      "r1178",
      "r1179",
      "r1242",
      "r1260",
      "r1261"
     ]
    },
    "eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of accrued expenses and other liabilities.",
        "label": "Schedule Of Accrued Expenses And Other Liabilities Table [Text Block]",
        "terseLabel": "Schedule of Accrued Expenses and Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249"
     ]
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Summary of Provision for Income Taxes",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1226"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Significant Components Deferred Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1223"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1149"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]",
        "documentation": "Disclosure of information about basic earnings per share by class of stock. Includes, but is not limited to, two-class method."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r186",
      "r188"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of U.S. Federal Statutory Income Tax Rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r936",
      "r1219"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Error Correction [Table]",
        "documentation": "Disclosure of information about prior period adjustment to correct error in previously issued financial statement. Includes, but is not limited to, effect of correction on financial statement line item, affected per-share amount, cumulative effect of change on retained earnings and other appropriate component of equity or net assets in statement of financial position, and effect of prior period adjustment on net income of each prior period presented."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r169",
      "r170",
      "r171",
      "r172",
      "r191"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Impact of Correction of the Misstatements",
        "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]",
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Table]",
        "terseLabel": "Schedule Of Goodwill [Table]",
        "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r919"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Summary of Loss Before Income Taxes",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1135",
      "r1140"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r378",
      "r380",
      "r382",
      "r383",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r415"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options, Common Warrants and Subsequent Closing Warrants Granted",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock, Class of Stock [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r71",
      "r73",
      "r74",
      "r112",
      "r113",
      "r114",
      "r194",
      "r346",
      "r347",
      "r348",
      "r350",
      "r353",
      "r359",
      "r361",
      "r558",
      "r773",
      "r774",
      "r775",
      "r776",
      "r923",
      "r1097",
      "r1135",
      "r1137"
     ]
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock Options Roll Forward [Table Text Block]",
        "terseLabel": "Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants",
        "documentation": "Tabular disclosure of the change in stock options."
       }
      }
     },
     "auth_ref": [
      "r1193"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r1187"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r935"
     ]
    },
    "eldn_ScheduleOfWarrantActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ScheduleOfWarrantActivityTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of warrant activity.",
        "label": "Schedule Of Warrant Activity Table [Text Block]",
        "terseLabel": "Schedule of Warrants to Purchase Common Stock Activity"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SecuritiesPurchaseAgreementInitialClosingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SecuritiesPurchaseAgreementInitialClosingMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities purchase agreement initial closing.",
        "label": "Securities Purchase Agreement Initial Closing [Member]",
        "terseLabel": "Securities Purchase Agreement Initial Closing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities purchase agreement .",
        "label": "Securities Purchase Agreement [Member]",
        "terseLabel": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SecuritiesPurchaseAgreementSecondClosingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SecuritiesPurchaseAgreementSecondClosingMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities purchase agreement second closing.",
        "label": "Securities Purchase Agreement Second Closing [Member]",
        "terseLabel": "Securities Purchase Agreement Second Closing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SecuritiesPurchaseAgreementThirdClosingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SecuritiesPurchaseAgreementThirdClosingMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities purchase agreement third closing.",
        "label": "Securities Purchase Agreement Third Closing [Member]",
        "terseLabel": "Securities Purchase Agreement Third Closing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "auth_ref": [
      "r197",
      "r231",
      "r232",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r725",
      "r726",
      "r727",
      "r728",
      "r792",
      "r793",
      "r794",
      "r851",
      "r853",
      "r856",
      "r858",
      "r865",
      "r867",
      "r868",
      "r869",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r884",
      "r898",
      "r924",
      "r925",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r970",
      "r975",
      "r1275",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r907",
      "r915"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r904",
      "r912"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r192",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r209",
      "r210",
      "r211",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r233",
      "r902",
      "r905",
      "r906",
      "r908",
      "r910",
      "r913",
      "r914"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Reportable Segments",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r228",
      "r231",
      "r903",
      "r904",
      "r911"
     ]
    },
    "eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeptemberTwoThousandAndTwentyCommonWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September Two Thousand And Twenty Common Warrants [Member]",
        "documentation": "September Two Thousand And Twenty Common Warrants Member.",
        "terseLabel": "September 2020 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesX1ExchangeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesX1ExchangeAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X1 Exchange Agreement.",
        "label": "Series X1 Exchange Agreement [Member]",
        "terseLabel": "Series X1 Exchange Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesX1NonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesX1NonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X1 non-voting convertible preferred stock.",
        "label": "Series X1 Non Voting Convertible Preferred Stock [Member]",
        "terseLabel": "Series X1 Non-voting Convertible Preferred Stock [Member]",
        "verboseLabel": "Series X1 Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series X and Series X1 Non Voting Convertible Preferred Stock [Member]",
        "documentation": "Series X and Series X1 non voting convertible preferred stock."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesXNonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesXNonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X non-voting convertible preferred stock.",
        "label": "Series X Non Voting Convertible Preferred Stock [Member]",
        "verboseLabel": "Series X Non-Voting Convertible Preferred Stock [Member]",
        "terseLabel": "Series X Non-Voting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesXOneNonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesXOneNonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X one non-voting convertible preferred stock.",
        "label": "Series X One Non Voting Convertible Preferred Stock [Member]",
        "terseLabel": "Series X One Non Voting Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesXOnePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesXOnePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X One Preferred Stock.",
        "label": "Series X One Preferred Stock [Member]",
        "terseLabel": "Series X1 Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SettlementOfWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SettlementOfWarrantLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement of Warrant Liability",
        "documentation": "Settlement of warrant liability.",
        "negatedLabel": "Settlement of warrant liability"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SettlementOfWarrantLiabilityIntoCommonStockDueToExercise",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement Of Warrant Liability Into Common Stock Due To Exercise",
        "documentation": "Settlement of warrant liability into common stock due to exercise.",
        "terseLabel": "Settlement of warrant liability into common stock due to exercise"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vesting period of stock options granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, forfeited and canceled in period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Canceled In Period",
        "negatedLabel": "Forfeited / Canceled"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, forfeited and canceled in period, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Canceled In Period Weighted Average Exercise Price",
        "terseLabel": "Forfeited / Canceled"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, grants in period, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares Issuable Under RSUs",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, nonvested, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options, nonvested, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs Vested",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, vested in period, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Exercise Price",
        "terseLabel": "RSUs Vested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Estimated dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term, Simplified Method",
        "verboseLabel": "Expected life assumption using simplified method, description",
        "documentation": "Discloses use of the simplified method to calculate the expected term that stock option awards under the specified plan will exist before being exercised or terminated, the reason and justification for its use, and the periods for which the method was used if it was not used in all periods presented."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r424",
      "r427"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected stock price volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected stock price volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r378",
      "r380",
      "r382",
      "r383",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r415"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Increased number of shares",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1218"
     ]
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options assumed in period weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period Weighted Average Exercise Price",
        "terseLabel": "Options Assumed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Options exercisable",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Options exercisable",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited / Canceled",
        "totalLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r1197"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited / Canceled",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r1197"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Stock options issued",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r1198"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted",
        "verboseLabel": "Stock options granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares weighted average grant date fair value of stock options granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Outstanding",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance",
        "terseLabel": "Number of options outstanding",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares Issuable Under Options",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance",
        "verboseLabel": "Range of exercise prices",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options vested and expected to vest",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "periodEndLabel": "Options vested and expected to vest",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options vested and expected to vest",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (In years)"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award total number of shares authorized.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Total Number Of Shares Authorized",
        "terseLabel": "New aggregate share limit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r383",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r385",
      "r404",
      "r405",
      "r406",
      "r407",
      "r410",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428"
     ]
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]",
        "terseLabel": "Summary of RSU Activity",
        "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life of option (in years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options exercisable",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, balance",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options vested and expected to vest",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Short-Term Investments, Total",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments",
        "verboseLabel": "Short-term investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r1118"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r140"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction [Member]",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "eldn_StateIncomeTaxesNetOfFederalTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "StateIncomeTaxesNetOfFederalTaxBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State income taxes, net of Federal tax benefits.",
        "label": "State Income Taxes Net Of Federal Tax Benefits",
        "terseLabel": "State income taxes, net of federal tax benefits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsAdditionalInformationDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r112",
      "r113",
      "r114",
      "r141",
      "r144",
      "r178",
      "r179",
      "r186",
      "r188",
      "r194",
      "r195",
      "r268",
      "r315",
      "r318",
      "r319",
      "r320",
      "r324",
      "r325",
      "r333",
      "r334",
      "r336",
      "r337",
      "r339",
      "r343",
      "r346",
      "r347",
      "r350",
      "r353",
      "r361",
      "r618",
      "r773",
      "r774",
      "r775",
      "r776",
      "r779",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r805",
      "r825",
      "r843",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r1097",
      "r1137",
      "r1138",
      "r1148"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r54",
      "r55",
      "r96",
      "r103",
      "r104",
      "r123",
      "r124",
      "r125",
      "r153",
      "r154",
      "r155",
      "r158",
      "r167",
      "r170",
      "r172",
      "r193",
      "r269",
      "r273",
      "r303",
      "r331",
      "r363",
      "r418",
      "r469",
      "r470",
      "r482",
      "r483",
      "r484",
      "r487",
      "r547",
      "r548",
      "r561",
      "r563",
      "r564",
      "r565",
      "r566",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r583",
      "r622",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r631",
      "r646",
      "r747",
      "r757",
      "r758",
      "r759",
      "r779",
      "r843"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "auth_ref": [
      "r197",
      "r231",
      "r232",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r725",
      "r726",
      "r727",
      "r728",
      "r792",
      "r793",
      "r794",
      "r851",
      "r853",
      "r856",
      "r858",
      "r865",
      "r867",
      "r868",
      "r869",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r884",
      "r898",
      "r924",
      "r925",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r970",
      "r975",
      "r1275",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r193",
      "r333",
      "r334",
      "r336",
      "r339",
      "r631",
      "r685",
      "r771",
      "r780",
      "r791",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r805",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r826",
      "r827",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r843",
      "r893",
      "r894",
      "r976",
      "r1305"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r193",
      "r236",
      "r333",
      "r334",
      "r336",
      "r339",
      "r631",
      "r685",
      "r771",
      "r780",
      "r791",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r805",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r826",
      "r827",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r843",
      "r893",
      "r894",
      "r976",
      "r1305"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1016",
      "r1026",
      "r1059"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1191",
      "r1192",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216"
     ]
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Stock Options Outstanding and Other Equity Awards [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r1150"
     ]
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued",
        "terseLabel": "Common stock issued in lieu of making a cash payment",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r21"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of common stock in connection with vesting of restricted stock units",
        "verboseLabel": "Number of shares vested",
        "totalLabel": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r74"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Stock Option Exercise, Shares",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r74",
      "r391"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock Option Exercise, Value",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r54",
      "r55",
      "r74"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' equity (deficit)",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r54",
      "r55",
      "r66",
      "r807",
      "r823",
      "r844",
      "r845",
      "r959",
      "r982",
      "r1135",
      "r1138",
      "r1139",
      "r1177",
      "r1255",
      "r1306"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity (deficit):",
        "terseLabel": "Stockholders' equity (deficit):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "Stockholders' Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r345",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r360",
      "r363",
      "r558",
      "r574",
      "r846",
      "r848",
      "r864"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liabilities",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r847"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r650",
      "r651"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions",
        "terseLabel": "Ownership interest percentage",
        "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TableTextBlockSupplementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TableTextBlockSupplementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Table Text Block Supplement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r1052"
     ]
    },
    "eldn_TaxCreditCarryforwardExpirationDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TaxCreditCarryforwardExpirationDescription",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration description.",
        "label": "Tax Credit Carryforward Expiration Description",
        "terseLabel": "Research and development tax credit carryforwards expiration description"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TaxCreditCarryforwardExpirationPeriod": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TaxCreditCarryforwardExpirationPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration period.",
        "label": "Tax Credit Carryforward Expiration Period",
        "terseLabel": "Research and development tax credit carryforwards expiration period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxCreditCarryforwardLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Tax Credit Carryforward [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxCreditCarryforwardTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Tax Credit Carryforward [Table]",
        "documentation": "Disclosure of information about tax credit carryforward available to reduce future taxable income. Includes, but is not limited to, description, amount, expiration date, limitation on use, and related deferred tax asset and valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax cuts and jobs act of 2017 change in tax rate income taxes expense benefit.",
        "label": "Tax Cuts and Jobs Act of 2017 Change in Tax Rate Income Taxes Expense Benefit",
        "terseLabel": "Tax benefit"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_Tegoprubart-KidneyTransplantationPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "Tegoprubart-KidneyTransplantationPrograms",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tegoprubart - Kidney Transplantation Programs",
        "documentation": "Tegoprubart kidney transplantation programs.",
        "terseLabel": "Tegoprubart - kidney transplantation programs"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_Tegoprubart-OtherDevelopmentPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "Tegoprubart-OtherDevelopmentPrograms",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tegoprubart - Other Development Programs",
        "documentation": "Tegoprubart - other development programs.",
        "terseLabel": "Tegoprubart - other development programs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Temporary equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "terseLabel": "Temporary equity, value",
        "verboseLabel": "Convertible preferred stock",
        "periodStartLabel": "Beginning Balance, Convertible Preferred Stock",
        "periodEndLabel": "Ending Balance, Convertible Preferred Stock",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r318",
      "r319",
      "r320",
      "r324",
      "r325",
      "r333",
      "r334",
      "r336",
      "r340",
      "r429",
      "r431",
      "r740"
     ]
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Temporary equity, par value",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Temporary equity, shares authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r336"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary equity, shares issued",
        "label": "Temporary Equity, Shares Issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r336"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedCondensedConsolidatedBalanceSheetParentheticalDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertibleStockAndStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Outstanding",
        "terseLabel": "Temporary equity, shares outstanding",
        "periodStartLabel": "Beginning Balance, Convertible Preferred Stock, Shares",
        "periodEndLabel": "Ending Balance, Convertible Preferred Stock, Shares",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r336"
     ]
    },
    "us-gaap_TextBlockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TextBlockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TimeBasedAndPerformanceBasedVestingRequirementsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time-based and performance-based vesting requirements.",
        "label": "Time-based and Performance-based Vesting Requirements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TimeBasedVestingRequirementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TimeBasedVestingRequirementsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time-based vesting requirements.",
        "label": "Time-based Vesting Requirements [Member]",
        "terseLabel": "Time Based Vesting Requirements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "auth_ref": [
      "r1158",
      "r1262"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r328",
      "r359",
      "r558",
      "r573",
      "r608",
      "r617",
      "r620",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r731",
      "r748",
      "r945",
      "r948",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r960",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1243",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1075"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r1077"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1075"
     ]
    },
    "eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand And Twenty Four Securities Purchase Agreement Pre-funded Warrants [Member]",
        "documentation": "Two Thousand And Twenty Four Securities Purchase Agreement Pre-funded Warrants Member.",
        "terseLabel": "2024 Securities Purchase Agreement Pre-funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand And Twenty Four Underwritten Offering Pre-funded Warrants [Member]",
        "documentation": "Two Thousand And Twenty Four Underwritten Offering Pre-funded Warrants Member.",
        "terseLabel": "2024 Underwritten Offering Pre-funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Securities Purchase Agreement Common Warrants",
        "label": "Two Thousand And Twenty Three Securities Purchase Agreement Common Warrants [Member]",
        "documentation": "Two Thousand And Twenty Three Securities Purchase Agreement Common Warrants Member."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand And Twenty Three Securities Purchase Agreement Pre-funded Warrants [Member]",
        "documentation": "Two Thousand And Twenty Three Securities Purchase Agreement Pre-funded Warrants Member.",
        "terseLabel": "2023 Securities Purchase Agreement Pre-funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandFourteenEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand fourteen employee stock purchase plan.",
        "label": "Two Thousand Fourteen Employee Stock Purchase Plan [Member]",
        "terseLabel": "2014 Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandFourteenStockIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandFourteenStockIncentivePlanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand fourteen stock incentive plan.",
        "label": "Two Thousand Fourteen Stock Incentive Plan [Member]",
        "terseLabel": "2014 Stock Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandTwentyLongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandTwentyLongTermIncentivePlanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty long term incentive plan.",
        "label": "Two Thousand Twenty Long Term Incentive Plan [Member]",
        "terseLabel": "2020 Plan [Member]",
        "verboseLabel": "2020 Long Term Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r131",
      "r132",
      "r133",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r174",
      "r234",
      "r235",
      "r269",
      "r271",
      "r272",
      "r273",
      "r302",
      "r303",
      "r306",
      "r329",
      "r330",
      "r331",
      "r332",
      "r416",
      "r417",
      "r418",
      "r419",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r524",
      "r525",
      "r526",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r609",
      "r610",
      "r629",
      "r630",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. Government Securities [Member]",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r926",
      "r928",
      "r1274"
     ]
    },
    "us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "USGovernmentAgenciesShorttermDebtSecuritiesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Agencies Short-Term Debt Securities [Member]",
        "terseLabel": "U.S. Government Agency Securities [Member]",
        "documentation": "Debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae) which have maturities of one year or less. Excludes US Treasury securities and debt issued by Government-sponsored Enterprises (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae)."
       }
      }
     },
     "auth_ref": [
      "r977",
      "r978",
      "r979",
      "r980",
      "r1274"
     ]
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "U.S. Government Agency Securities [Member]",
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r1274"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasuries [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r896",
      "r926",
      "r928",
      "r930",
      "r945",
      "r1274"
     ]
    },
    "eldn_UnderwritingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "UnderwritingAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting Agreement[Member]",
        "label": "Underwriting Agreement[Member]",
        "documentation": "Underwriting agreement."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "eldn_UnrealizedGainOnAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "UnrealizedGainOnAvailableForSaleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Gain on Available-for-Sale Securities",
        "documentation": "Unrealized gain on available-for-sale securities.",
        "terseLabel": "Unrealized gain on available-for-sale securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Gross unrecognized tax benefits at the end of the year",
        "periodStartLabel": "Gross unrecognized tax benefits at the beginning of the year",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r454",
      "r935"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties associated with uncertain tax positions",
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r935"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest or penalties recorded during the year",
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r935"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions from tax positions taken in the current year",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r935"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions from tax positions taken in prior years",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r935"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90",
      "r196",
      "r198",
      "r199",
      "r200",
      "r725",
      "r727",
      "r899"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Net valuation allowance Increased (decreased)",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1191",
      "r1192",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1191",
      "r1192",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liabilities [Member]",
        "verboseLabel": "Common and Preferred Warrants Outstanding [Member]",
        "label": "Warrants [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r973",
      "r974",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "verboseLabel": "Warranty liabilities",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1246",
      "r1247",
      "r1248"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Warrants and Rights Outstanding, Maturity Date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r1246",
      "r1247",
      "r1248"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total",
        "label": "Weighted-average number of common shares, diluted",
        "terseLabel": "Weighted-average common shares outstanding, diluted (As Restated)",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r188"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureRestatementOfPreviouslyIssuedConsolidatedFinancialStatementsCorrectedEpsCalculationsUnderTwoclassMethodDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "verboseLabel": "Basic weighted average shares outstanding",
        "label": "Weighted-average number of common shares, basic",
        "terseLabel": "Weighted-average common shares outstanding, basic (As Restated)",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r188"
     ]
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WorkersCompensationLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Workers' Compensation Liability, Current",
        "terseLabel": "Accrued compensation and related expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-23"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-3"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-6"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-4"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "S55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479772/718-30-S55-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479092/842-20-40-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477866/928-440-50-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-38"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-6"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-7"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>92
<FILENAME>0001193125-25-180865-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-180865-xbrl.zip
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M0T5@S=JK:.>DP1=.SQSJYM):,/"T/+0Y'C+Q!Z'QP0!&A@S*)!8K4-)DJ[!
M.(P$N",8DXWB\BH2R2!A*T%B057;70NB(5\!7_;$YB7X(.5@>B$%(D]'^#0)
MU$R38F!U7PC;H"<-9 R_$E+URA0/VK#B!-EUA+T(:I!8LBX*NF,F:3>8=E::
M"\^!,U7)1P,G]9.QLH8D=$3<8/Q58!X9!5IJVE=/JH5VP7,R?!.A1VZ\)+Y.
MW@P',#*)ZF(,XU4QZQA<%>"6&:WI8Q5M"5=A9T(FVF=#LMIIK%8;@3!#Y$K
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M)$W[3I(V2ZDW-DT9C1&2J\0LK],7.7H6I30LZVB\T(4G;#)UK1'N'# ?&*W
M5-MMVUJ JI,R+ 2>F3&.%VMS1-$L=Q*"F7X4NSO758!,@VZ!N.1,L@[J_=Y5
MU+.&#+PU<8E%<""1"<RNM@U!YC7]!HDKH4. TJY[^<Z2V_SP!KH,H'QAW"22
MTC$$!L8"D\DH;[AJ,:GS3G.O65^$VEDJU8[;6=8IY223G"1]H54NRAA?VD5S
M:^UF<49XM-/U.G3W_D+KT3@-M.]#4 34@%"#BZ2>#$;F51%,%IO1A-I0O]G1
M+I\V7S\#$J?A3YB,RXQH )X0BZ:]\;Q^H2]1&$I,?*T'?"_%MJ>Y=OR?_!O1
MVSR/TW=;1("0,G+,!$/KB ;' PNR2)8%>.N*TU$W&Q^\\R*L6>] )ET3!+/*
M0QTK "P&3,P32"[:9J=%DQ9C<WF&M]WG^"[9[QQ1QZB\,YY!$)YI2(5Y(-&G
MI)>HK)!"-9F?0OLSGTW&Q^8:T=5'&.@E+0)4*MI=7G;=YM$MX9\,1@C!:>-*
MJ5E\COE<*R]R1!6,*EHT%Q5;S76R[,9X8BROV7?R:3ZF6#6)_?RIU]K)8E$+
M'AEP6Y/8Z8>'3%=W3AMOHA2P]F2&;].LAG'/A!I"LQ8NK5+2,:Y)G^KJE24K
MWS 5I-"Y3NUIEXSOR@>_I?'W4.G+1:JD+7*6?!5\.1/CI, 9W41)CEJ%=M.R
M_L!M@#[NELA7KA:Z<.KU*$<G0T*6.8>U$39@%;2&Q>2*AT!8WC>'XM=6J=-,
MG*%HHWSAM1K0D 8(M#]!)V181/$B"0$;V0>DX9J3VQ#:VF=5>P,4KLC6,+HP
MB F809.]<F1%NXVO^<ZYEZLP>07C_'1ZDOJ\(2FUQ:!R'@-#T)EX45L&*EOF
MK5'*R8(\-%L5M /S/>*Q^D_=HW<P^71[GM.>'3V'[A^XJ+Z-P6(M3V#<_0TF
MA_CKT7.$^>&RW?"3#O]YB-/TD4?U].1SI\Y?5U]^MY82W?5XPXHIDDS-P +)
MYSJ,+3*OG:\]Q;G)RG*;VI?8;4;FOC">X.6T*@JVF2DWQ3H5HE?,ZAK,%<&R
M6$#5M'"T.J(3:5.AUZV,AQF2FVW,FG:$A9AK#W&-Q,@ELXB1HPP)"8RUMC5?
M\6W_.IXM,.U-9Y/9VZ->WO;N[%>7?_[TZ65'WG10F__7$U[N/GOU?/?IKW][
MLOOJ;\^>[=R$$_H$+S[^D/;ZUF%#6X0W%C*Z+F"5%;"*E0#K1Z=>"[ Z$93(
M-=.[* *L] -LI-^*D=SJ(@@<M<85+=F*#01TBU,R2)L9^%1ABM-D[@M@JOK)
M4Y$:='."[2L-_:K_KQNGQ3'G_3X=$WS<_?V[#' 4XC=3"&6F+$DOU1QN[[QD
MUCOP7.3,L=F"B^_>+Z &VV07C0#+L*_M*K8PCVB8%")R#8C9K;UT8T.D6?02
M4Q5?Q@:29FA9*)XSD3!!C-Z)]<]JO[(T.TWXF#^9=2_P_79*%;T1N;_J9E/Z
M=5D+]FD7O>.S=NLH)I*(\]\/,BU@%33<;8SM0_LC%)>U'LF2[:,<&<[6,H6:
M0(:37&"SB46->%9.?_TKO0UT:>_H6<W=_HQSY>GTX' Q[\\0=VZ>:]!M\5;8
MR&12U2,H" *;A,RDVMDDU^3+9B7.'>W<,NUDJ6SAD059^SP*S"PD65CQWD7@
M7$G85!?AND+[5VGF/S0@W2P4.ARVRB:Z8&P=HT?82J7,HDZ&15$R.D.4JYHK
M(+Z]#@-7K":G0[/IBMU(5Z?K[[?A0*G9Z!84<]+5^CNB3)\-*>*"G <?0HK-
MJM_60J8MR!@DPRT)P=!4KR(&LM]JTI]4Q2:71 ZJV;2ES71GZ-7=&7:H- <L
MJD!0#%6-C*I2IRUK03MM<HG&1 W-^JQ6,?5^W_UM1MLY[6EAUAW,NCX)>T[?
MVWY+6);V_DP#W,'G*\M^SC$IIVJ'PE*':GB"SUP9QI/V,6>KR !KE8X:C[!?
M%EJOQ?JGZ9<+G+XLI29$OMW<>#MMK"M$+2Q+29!!Z<P@^L3(+C,:;;+&-QN^
MNJ5FES<Y4:V!\ H7*<0Z)"D70?!2]JWS76$R%Z,RH16IFZO^N97V#M?<7N%6
MWEXZ=;CME4J1%BE,18(C&F0A$%("2RHD19^AU,U6RC?LK%A/DRK:K#H7);"@
MZQ@+78M@D@Q,)>N<#46FV%PM^_?5X7  &7[>[O]*!>?Y4Z_%Y%89CX$SHX6M
MTW2(@IPP#(*)*9L8P&VB37GK'> 'XVLG%3@0+.6^@[3F# Q=O8"VCOZ'*36+
MPF[.ZEJ;A7IBDC["N%C9+&W'!G0*-%$0DZ7.QXV%LUC[4<A$'V>?@\W-$D_C
M-N#RUIN6J,L=6(_HF9? F3:VL&BS8B$X5Z0$J=K+ +E%E' WK>T&@A3<6Q<@
M6I:2)@UG2V10LF!>)1,%0$RNV=R6(7($Y!_-R3FDCRIR,GN"9>A]K.A(,5^$
M)^+T1G 0RNN[FL -<BAE$@'6(8L&8LV8SRQ&>I!HP96H,\AVTX66G=!.-[4V
M/#LKD3^7?(U5-A $/>=:>ORA]MI;]SC?6]M2U(ZDNU7)D717@46@!RF."^EE
M%MHW&\Y:D4./0>!-J/[OO,'#127!F1QDO#S/!:PA*\@5D&0%863!>LND"#99
MJ:3)S98EWW7EN]R]$H9RKZ#*P*-CTJI8*T1,#7)5VN Y!N>AF$T73^L?T-6
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M(XGH 'P,0KG!F*A/0>O]_]\9FM2;B2;?O-Y^L?NTAXUWB'*=B')Q2OBC96;
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ML'3W04^+I?MQL'2#I;NMI9M<-GEIJB*[,LEE5<>SV27ZQ@!9N\M]_M7=-+K
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MR>T9\_(,2RCCVD0_%;2S@($.R,_!.NYH_O%DL)/W0<N+G1P/=G*PD[>UD^/
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MHJS P_)>E>W2S^?LBU',P^"TC(,X[_/99,RHFXUA$-N2"\,N+/)>H!OLU=_
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MV7R<(B"$RIQC1#<P0!3^![..# 5#Q=KH7R#L-85UTWID?\/9]:*60M-O#8D
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M/=9@+]7"A=Y:*1H'<0V-DWOK7 I-ER%[K*LLEF$ALZ47.I:&1.05SV\69'E
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MT3B Z[D4)FBEF("#KBM_=UEHC4ID@J9VVHO H^T!O^8N"#^41K4*L/'I1SM
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M+LC>+^@7=)D119$?TVG1\XJA!?\_$\OUWC55A0O9]WY!6Q&39C/M-_[[7O4
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MJKEFQ>V[RR40%0Y&Q\PCWLCIZN3C,D#$,A3"@NE&4;@-2D#,N/F9D#0IM@,
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MW(DM.UN(EPQWYVVN.MOC"@R!EA.KL=TL;=,S^]'Y3  H:2:@7]JMM5-EZ'!
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M+UZEKI7O@E7&?.VJ>N]>O+IP!3WFRD R5WY@;->"%/K:P_0DX..+SAL8^U$
MB\;1:7+[.2Y;B>K)].5Y[Y+52E,%13LZ1_0>&?L3CK-#U].B (3/UMU\'V?@
MJS 4$<CVI86LU461!>X";^(V%'+>WT<\7<3YG)UB:[=VP71$ R#IW@.2'@V
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MGF"6.9;2>"2R7Z7:@$J:ZN9-R>2J[1+7W]+\*GRXE2!4(-ZE<9_LJAZAW0I
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M/#@-(.\[;M\A9^SJ]95S3PH3OJ[V]4!VRSDCK MC0HE?5<(]:-6W24D[% 3
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M:"$J:DPD#TV, 'BA6V4;^5JLH<HMU^A4'^@=A9!@1,@N@"@F+U1_&_%XUR!
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M]4]J-T@-Z!&Z2^BE<*0<.@H$.!<8C<>R.!)@:F%C2Y>Y+7N)N5G% E#_62[
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MI%N9=.OG[P[>DI_2(?_H/^O-FW6Y><,.P\12C9:9NJ[7]7B).JCJ!^2].$.
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MK?O&F@:XQV9"VDN;;M)9GQF^]-&46QKI -N_&^MPUDDDJT2TXR\;?@:2?Y1
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M8UMY_'F!#$1(C*H$UE*:5T9F@$]EE>"GLOK@0"[8&Q'D&CS9)M*:&E8? T:
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M$BR1U#32.]C%*\S"IHLA4VR)8) ESTL@K1RJ"W,@W5/;+HHDN7:P!7 A&C9
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MV3V^5/I>KM',B#@<'"^%,\_!><4[8$V3VE)?;:J:&8\S'B^OB =>$5K"$[<
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MEU6[$C[: /JIME>K9P'J-[7@C22O"X7G1\:8F!B$:?G&XV6\[MD[,C<+@[H
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M*\W2//^A"'.K;=8)&TI:Z!U @^6(66)<*_L$&)^,'6M(1Z+7;ZM]-]8A%*<
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MW../_?75QT^6,R%!NE.9?;*3S&K]7NK!,__58H0LPVC=#]=<T6<+>/Z_85W
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MJUVQ&V1;$?#.:P\9:W5*1/8!;'83L!E"F,C7HP:#7D,!KX\ T?)TC8"9BL7
MAL^1S5*@LEO1&]OI7)"XA"C/2T;EZF8%:]XXI76^I+R[#W?299D4$.J[N(:)
M%H&X'AP&+/&:VR6MKZ(, #=7.KP&%'P4M1) ]-=KLG 0.J+%-1)' @8@(LA!
M)JWK"6?8M);,EG6HANXF4[@B<^,?IG<5:&G"&Z^&[[KM+AT@)0)*8-+/X52"
M.6D98T(C%<@ZFX-XF1">R-?">/A@9[.@::]\.9IE29[AM)RKI&C/6?I5R>U#
M6<-F1/,;ZP-P(8RZ D 3Y!7?GE*@R.IE#]-$2M$L1^:OA7Y_KT68P\P5FX62
M2\VV-'$@>QPN!X+(I/6% 5::NJE:BQL3 XUK0Y<%[3X=U:4FJRM+JM;@N%>!
MY'0S9/LM#9W5>6;XJ[4.\\<.QD)7MNXH$*H9J9(.;6JH5E27>+9Z92>N?M-&
MO],^%ZX%^67DN?MW.(V[NM3P[;R\@"?B,())[JJAFI;/-:_,6=.B/>AU%[_6
M@;;Z)*,0*C[G]Y(D\[1EH#WC:7(PS^<)*I<4S%C*8$VJKEUQ>!'5/E( ,+1R
M,1>5,X,3$'?IR]].R0Z"_Z4G9HJ*'FBC)5S8=(GNGJBAQ'NH433TF9*.<;0
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M% 41 X.PP9AC0A(F1#&+:LT&@%V+M&49TU7\9S4J5K>/M4B<;C)C@"A>YL,
M0W&%38;727F7GG%L9U$O;X=ZAN9@5M5+&*O$MA07X!I/)^E %_R%[#TR+\:<
MYIX4A=BT3I9R((/HHE<:U;86XS]DDC+V&HOXP66U,650SOR+_6(++6H8"SN8
MN]2H!CY0YO@72E!J2!PO*9V$M#Y#5>I;T1N02;AN1EC,B:@H@1>X-!?25]=!
MJCK6$'=,*I73,.DJET<L&4+P.]VIW!-QY5%EO@15) AKWG"*$$=64,/X0(5S
MBZ"*;B"MY<W6CPPMY7(I@+2$=$369PYTJSF&_WZ%,1W"*WK%3CP/B)+RV,-\
M13S+VLX>TB>V)<2(@ZAQJQ- U6#UQ(WP*F#Z_'YOC=]L[[,Y\ZYQ3R76ORL*
MJI?LS26Z++\YCD$78/[1@@NNY40.<<Y<)7VQSKP:2]WH(;3'T7.2,J2%8ZMK
M0 AY? 2!7^'UD:=XY357C_'& PRJ\B_28^AH<]^]<L*8GF?56Z0^EYLIU[GT
M5R]HOP&HFRZ!=,-ZJ'U<.V*8M,%QSLF'(<//=!+UU\LJT*XTFDPS@L?]%QB<
MR##3^%*2?V#MV?5Y_^K$X])U#$ R3,GR@L<)P.4EE6XMW+.5*7")B$S0G.:L
M1G5CD=$WE6&WH%%."2FJNO2P?8P5=<!M N#P/3,Z0!C@T9Y[AJZT>4L-0N8V
M!.[K2GBUBM4,4LA/G&FD(8V>!X81]]?DB3$%'!GUUH/#8S@OJ 2N,(8H'W?]
M*$SB#0X-8--G.+Y&)7)K&0'Q7A!(D(,\)0Q(SR]E+!5ZG41KFTOW[)74RZ37
M"LW=EG.+TJ[4_^&J.E\6WDY=8(X?1N+BJ0KGO$@N.>YF.'S(&],TG:T%I[ ]
MGS@QD-B>\+JSNX$?ZI <HZHH_U&Q?PN^\HRIT?#8[+"@ET&*<)WGYB*#FA>T
M=/T-P7$:4MGN^I]L)0%E[09?NTHSK#T5 BCG08)R]@,H)X!R B@G@'(>J%-D
MF_\Y!0LZZCD=[,7C'YAT%!.1<1VIV;RH%M('79NT<_AO## &A(V9]-\<\T/F
M3 *_AG-:4YO@B8]I'[)+T%C"8A<P/^0VS)^2.S#%VGU;)6%XARE]:EM[L'_C
M8U4PK+."2,+GZ6TYK 1&;J=YD9>_P Y9$@DFC#1L_>/KM3M&G\UEY S@R&OJ
MV"!!*3=?M2RM.NU3Z;H<.Z[*G4DR03LQ\*V-=V7\K9=AK:_R%:NI30/HH9C4
MCC,B\[?>)MJ*WMD\RE*8CM!44Z1-UBDP_FB>#*^4"::2+V5HA0Q)I_1RWR&?
M)PN\;#F)[U8>87G\&G"4+>2R>[_?^-,"[WKCDZ_QQN@DE)::OSAY#B1@8B%$
M)Y&[@">I_C+8H@EG=0)-[U^AZ06]#M(!;B=89P]6H_^8DQ8C!,*[T>#T80(Q
MU>[F!8(!\D+94(&IJ,M3)[%&L\^W4SX:=AUFFNG1*KN3H/ C.68_7V<.;6K5
MGBANH=&TZ%)=[KT5_>8\3N),*NUJ[N@ CX=#MUB@FX<<M]ZA&N.IV_^3#3D6
M^518@U+A96(F)SJMSD&35;40^1#O$D7?TJ[ UQG)V8I.)71*V$?=E$##(SD_
M?"W!0A"(?+?2G+*A27+HF'A'&]-P'+5,\: QR]2.QW!PF,X&0VS==8((*DL@
MCDT=4"63Z'9R?56>5?1< \L+O6N#,-^Q, ]3F \TIF@,K_XPQG05FT,LS6.P
M#R%A49FSJ''>QJD:_9X@Y$'([UC(G1Z>3NQB2%9SW0X3,0L(VTS/B4EJN:(H
MB&D0TSL64T*X4O#([\!(.EJDTH4AD33'3J&#(\I!/(-XWD.G<,TWI]TNKPWF
M0E?[V>YPB/3JM^8-4AJD]'ZE%/[%A#A2E.IVM9_&U(?910;9*/E7Y39/TEPL
MSL5!8(/ WH/ @KIL<RN@AH/0P3^C71 SB6))-9F<SG22"Y3<$LZ!VN17K+U[
M5;IC.2-SQ2TZW14V1=@4=[PID)<=XVPL^9,AK=QH1E%=J@CR6,*KW"N-K6PL
M$O@3*/.FL02#"4:,L2((=YX;.]?M0*E#A7DFXS.JLCG/Y_P4';O#B_(V'!-A
M1]S?,=&R1&LLBRFP9XH.VVV'BFF(ZAT&E-M"/ =+2A9YU4J5F]XJ07*#Y-Z#
MY&K"9S2P#;(ER%J0M3N6M=3IP0&?-=/9B5K1$6[ 9&!1.*GOI$R*1>/&U"[/
M*ZDA[V>7@] &H;UCH95^5])KEPDY1LAN11V80'++:@;_,!EE!Q4AW>Z)P5>#
M)CG?9@MGJ;('[L2L6Y#>(+WWIW*Y$TO=I=(O+#I72=&>ITEMNUDTH&AAQ5]$
M01*#)-ZM)()PY%4&"S[B?WGH-\UX9!$ZDLMX@0HS"&,0QCO&'' J3/?;(^^G
M.4]J_I=K46X-"=_39BQS2KSI2&&X,,(^:1]K@XG@I6C>U(0\S3P\O>!*"=B$
MYA)V >46EH1![4J'NI]*FTU3+?@'54*4C"]%4KZ+/.O\TA+N[C*IJ\1T,_#4
MC:%T$I:IPAAKQ$I5)TR+L@K$&NCKC#"\U>V"FS:.IA4V/955RJ77J;/48H7T
M,<*)+)UE!K7N7\PSCCPV2E?8L*#DNI=0Q@=!)/48CNOHY%]LXJ02LCT1E5._
MKRQYF?;1\36K0D (87@2^;/E($A!J4H#-$66KZ[FOLX.A:,3UW99''6W&=OQ
MLU;SCGM3AOKNAU_??1#JNT-]=ZCO#O7=#[3JS&]IIQKDFL$NQUZ?+-/.V;0V
MTZV@A/!JN%VJBWJG"]1:"C-S'#Z0J8N^NP&)8KFA)N1K+/IVV76I\1X32FO^
M)2,\-D) 8I(29R]SP+)4:3(O:MW*D2\X&5(\*,P+D&68<ZK8"Q/,17R%?7*#
MM$>VEQ;Q+6%U7-+D#3.3HN%7+ ;(F%#>*VPTC&]"YLQ&2C!A!A75-J.].D4J
M0N+ZX4[LCL&84Q^T.;:)T*SG9F=9_GK>7/3?2S/D=7MV RK(Y8BW8)_ELY)]
M*VI6FRF7,1!4)TP(NE>V>DHZO^9.&XZA)^OJ4I"7>5(;5H?!F:4O^R9CGG<U
M=MRDU<(UK3/;CI<;^;)3B7-.K<V4M_;@2<#SYP4\0#<'_O7DY*/N#3PTR47^
M51%3MF:%C'FM83)K&)1>;JHST O'?&9:H3$KNR93T!2SJ^102F\K2UO&G&R"
M);L$JPT?J)GKD>':AFXU0.QZZRL.-3*]6VYXW< MUH229L47-!>%M)GKW1!+
MM;Q\U!TXOGN/P^\]<7O.?\2NN6_?1F]!N*/CDRVR#8T0?+3*B,E,F^BD+#%B
M\8G6# 7O305.WWA[]-^V22]S[4USXH9;$I0;BT6/!.XN'LFM4Z1]H9"'L%][
MF30"F_1Y[RC*$_U7!W;[[G8<[6SO['$_=[VIB+P4J?:8$X\N?Z52-9O $';'
M? MV8Q@8/2KF3''19LJE%Q19F%AXL?T]Y^X1U__86+<825J/H]HJ3F91=8):
MSAS/\L;HON&01\(BH8G(\]FPVJ2S4<@*A>!.Z$94RQT:EXXLS=CATY.::1:6
M1FF"LSRO7E^!:]AU:V:06!SIO$W-X2DM-?K1?W./+M!U6 UBS5G2C]ZAR%A*
M1Z_7I1EXO]L[C8G[H^.E_!KUC;5O5,BTR"E!:]#O,YQ0&P)IN)1$!2@P5>OU
MC8U!(Q<X7 "GPHR^M[WW;/)<%]>?)O4D@9D???A6J$5T@DJ8=Y4,HM'-(31E
M8)1T&:,L\7R13O72SJ9I!_>TB9$FYE.\;R1A82O'+H%Y#?6=8/5D.[NZ6RL$
M2*V7!.)&<ZHI<O2Y+KVQEE:&J3>$8(:#WUB)CM%/4I66>FCJ\KO&6%B!OMAR
M@!+%O\IPK; 1GNUWA>>2,3E:;'3M(FQ1A9A>Y:!<M,3H\0MK:AR=ZSY)$^6I
M!<].I6U&MFJJF5X'/KW_2:9T26I$W8W,*E8>J<'W#1O6\&C'@[REJ:]COV!;
MUM27Q[JJ-O!+T5IJTF9Z[O2:@%Q@ _+:]""B_B1S!RERG9E@-O;2&/L$CV9?
M9HET^E9>#3=PET]Q"63\<016\)MX^1_1N6K<_#9X-O.*U@5V$?H91EU+$T(,
M:X+!4R271+J;7)HN3U_18X!U!1TME*_]S<*'A)Q\$_!/4!\S;84Y0"6/$G.'
M%,,P+&[EPG#F8MYB-F=T?_]FMA[8J2;TWJRZ4%[%X55\6$^1,>@ZPD#\8@ML
M6:H/ :1IAJF,F:.!JXEEA:*90D,C]F5"<SV(_<(M6-@L\S4*]U5QEU7:M%-_
M2M"X%U6MFPLY/'5EPVFVQC9:6)*/&3$P6Z.Q5M21"1FQ05CRCD@=A8./L^[Z
M;)G;26*YIR1M 59B*X$%(K7"H1O%*J^;J,AEI$Y,ME%R_42H9%+\_8RN[: '
M5A66H.@SZRH^HYZZ-ZURX+)?JJ3.A@(Z8&Y6>=F:5Y!W8X;EQ"E:E<QB38IN
MIP87:EHC$E'. B,3>%(X._?J74O$[DN[%N\%C4--DMJ^JJ")7/'@WJ?0#("Y
M#+-U)G+98A2K6?ZH0 $5P#UWI&F=3 1+$0=1>#M:)YXZJH!?YL@L[@:^#$]?
M:O<E-*BE(GLI('2#M-YU,25"9M@]LAT4RXX"7DM4O9Q+X+,=(SUHOR^X>5RG
M;4*C>(.P!F&]8V&UEAC<5U(W%S$"/8L \VMB8%C9)3;O()Q!.+_#N9]=4( 7
MCO@\57Y@LV>^$G%"U2 1#E?A<@/:Q(32/2<)C 5J',[>.E;^E((H%2<[R':0
M[?N0;=W5M>^U1]H;G\'7V@ L6ZU)E'4%DO,6!<*OE\58YZC/\PFH=?VHH9 /
M_.VRSA',RE%6&%00\B#D]V%=8'4O<TH7Q:#N#9(7).^NG3#M>CF!.SC1N:LY
MO'JJZEJK4$H;5UU/#0M!K@_LGT@W$'R4+BD K2P0I7F5-]C'/"\*02I)4H?N
MI>8DA!<J.DG2\^NK2^37.<_GC".P+"'G58-4[1P/KC$R[,(J)$9(6M\&C!L'
M+<2H M#PALY23@(V:E95XH7J@P=9?7 8J@]"]4&H/MC4ZH-@SP1[YB[<165,
M$YW@T"X=6@]M5*@$',?#_9_TSQ=5JQG)T !?\@1-HUDT)MJ"K9L4'X*,[,CB
MP^G%N4(XB_2<<Y*7?AK:P!]U"ASNY0SX719>/QW(R3^5[HTG#:$D%T[ LZ0Y
MCZA:&A;)4(),*^2F472N<*H\8#:6^VI1CMOT9A=(@4KH&8UI#(/SZ9+[8'CE
MK*XND=!OZA4P;44GC!YNJ+^W9JG$O:K2W%8B,X?\0!LE@92R7U A<)4JB_%:
MK'2V-Q/@H.QA 01_<>W%O\^]%>49GW%?QI,O6/@/GP/.QQ?0O=/I%V8&:YL?
ML 6O!^]$R/_XEZWH=SWR'U6*=JWA4D_W*75092QSV.LR,^\1#F!PX%L].,I_
M_'O^#>]_W\U4G:<DLV^^'(Z/M@^.#HY'Q],#-=H;;V^/C@[3H]%>-MV;'NVG
M1^GAT=\(@ 7?_ F]DI=?ILGA9'^<'(S4)-L>[4T/IJ,CI?9'.^/Q9'LO42H[
M3/\6E7"2PEPLLI]?+A"=P)P&"^R:^)N!Z7S4 -XW57V"_XNHI;>"RX9_GI09
M70S__ Q.4=(VGV$<OZ!W\K=(-:!T<*WK3O$8\[)3V4E[W0_[,KZF0WV7&B+]
MDKKSL=E:X>56Y*W>377K VQ@>:W9.27@VAF7@'P@X@QX8=!$UNK@ C!=.2!E
M+0;Y?I'46&WEM3K6,N:@^MTZ3UVM@=4JJ"CD@:A);,E/33U9*4_O[3(P%4A[
MZ"1GBO0JNIESAU9[J5J,5Q*N+Z\S8@%?4$ 2HZ:JOLB)] 0/\PZIOCGT*&QS
M,2+/,P(\XZB::MKB?]BZ$_.^+&D3%X^ZHK$R3.64/YB(E^TD,7"T<1LK([\,
M22,H=8>R7"H8R@1M(NF2!B^/'%HB&IEF+F]:&)'J56A040+7>#@+Q1]M:F7I
ML3H\D#$,-2]# 8V['<3T3J*7Y[F:1F^=Z7R)E==%2P4K6*M2%,F$0=6FNLM4
M8CE 9O1 Z5EO3'W$!ZZRX<5^_0UDGZ3@G4HRB;=_9CAN%9VK8KYV2SFOM1[N
MX)8B6A_<=PB!!M$$=Z&;V]I/*0>F%V _RZMV* )WJQ*KM'1Z5XJ7=:LJOA"<
M]XN\KDKR4CH".VNE,E/M>47NH4Q6+*7:":JC&%%JU4SV )$X8+T1UL$*\II+
M]WC<>N?+QC,58T-#CYGH]T^NMN-G4*S SA-WG8W[GZ4OX;MX<W8PGR X!!]'
M/'82#9GE-Y#7OPU;@.KX,#W>.SX<'>SMI6 H93NCH\GNT2B9[NQ.TLGT<"\Y
MOD<+\#-J6ZP^7KPNS^!OV9LB.?M;Q-L#;*9O+6RF;RH;D96W&?N93H@1G1!&
MR7E3^Q]_Q8.ZZ]':@]6!QU^H,D,/NL*=F3>XA7A3ZIHY_;]]'1'?ZMP-AX%9
MCE=4\TK*C,-7CB*C4EMC- V;3-24@1MDS\\7C=,JNSY+ROS/1&IA9RIIF+;!
MV%-H*<"58*H(MT-58+VK;V?)TM*[F5/N%O;5@+D0K]3'R'Q!1<!< .Y0S6'-
MB>)A@@#"N0)CP2&(+$I_+;(_5)G6BSE'G<26LX)O^7KHVD:=(3&(T A0NTWG
M$CVKYG86?;>Z),8ZHO2K/J P@HX O-B81O8$@^<I&(]0B6 ULZD)]V<P+X6T
MA )KJ%QL8Z5A(_FLQL/\4AD*E!DN+G759?)"T/'P8JY>I2!:4;C%MR76O;I[
MW,G$^V/C91>H5>LP@C,7H#"+FU&*(6#>#?]NNKEU!>"(G^;U[!+'+#-B6E1=
M**]CFOF0^;G0Q^ -FZA/[N(D/LK2O>QX='RP<P G\?'^*-E)CD8[V;$Z.IIL
M3X^W#[Y'+.8MO. ,#=!L5;!E,S0I4N)81>"<2YJBXOIJ"SVW^S&O#HZSG?'V
MGAKM[N\EH[V#_:/1Y&":C/:GV4&2;:ML.YE^WT5]  96;@;[$.PK; 3)1' 7
MQ/#$1Y0CBN8 WGH(G_/&/9NMF[G"9:6@"7NJ;MDGUO'G%48]!)&V<DY\2V.%
M54&Y7-BC5,AIR9X*\&S)AK5;':RGA+-=?K+*JW'%G^YGNV?C[>/IT=[^*$-%
MOK>;'8PF.[LI[/G]_?TCM;V33=([W^ZRR6'A>)%@C0GP]I(ZQK5*?:A/NTFJ
M_^N3+>:%6TST<K.5_8I8AV$V:VZB[<N,.&\(5P!R"C?&QF,7NNX39(J)S SZ
MM95(Z:2K@C1>T@[$504$IX-7-&RX7J4 -L><^5'K_+E"&UV172LX@(DJ<G4A
ME0-?R^JRO'*)71,RL6EJ0HR4"\/VM62"LR/2>-0D3&2!W1LIIGU/>B-5.[O;
MX]W1^/AP#W1 LCV:I$>[H]W=2;JW?7"@]H[NP_;37'DG4G/QH?YD2/7>D9K]
M7/6O^J3.B-JG;%=9$M.D:#9%;PP0"#Z$0_A&%(=1YPF\1S,KN0%TGYW>ZDP#
M))T<+<&.:0&U%?VGID02LM&SG/#5#K>FWB.T*RQW6ZU]1&5[_5(=!+$PKMAO
M56TB161_)$)-.'=I8JX./NBV54,SQ%Q'7*B\8'*2*FHJ\-F58Z%,.4(K-#;,
MBKC%K(CCDZW!S7\/,G)+Z!3NZ>@-?\%&23,!M:X@C?13&\YB1 +2DYJ#^]&_
MR<%^LCV9HK4VR49[D]WIZ/CX>'>430ZW=XX2E4SV]N]<_]K8MS'"3LI,X ^2
M8[0(B<UWVQ"Z1]%-7-KU64.DCY7PEA--=[)?9%E)]D4'N&I*P'+7Y$HW:-:>
M2/, U+K+<$6LXUC)VX&&JM=;(OT.'HZ_D^5-W<U=Y@07OB=10IHJW2.50J!,
M_$:,1N91PD4I-3=Z#6W'CMB<*O'0F<&@V8$S9DMJ@ZX%2%*[>SO;69:,TFVE
M1GO'>SNCY #VY<%NEAXE.Y/Q].CN'2BRZC],C4U_I4_41QM=9]3?#VVTH:"9
M7]$I0K%1 2CCA#"%KB?+:HZ'$"IC*?SNM>2Q^0&DP]3MJBHMM0CE3=F,NY_3
M<@>VV][!P>'H,$W3T5ZZDXPF>\G.*#N<'B7I\>[N].#N<\9W&-+H;]_K? ]M
MWTV0F<_G]^6$[F=JG&4[^Z/CR70\VMM/]T;)\30='8(^FVSOILGXZ/ ^8]52
M1=1\J,TR-^[*;KX%U(L:/0"3!)-SFS2>/M,@*36EM%^[7C$ZF6[''39JT8DT
MB[UT@P7ZFQ>D6[J!2WR&_QK*BQ]B>?%1*"\.Y<6AO'B#RXO)BA%3CE7Z]8M:
MR)QS1.#&UM/ >^_2"[QC!^<N/N]!6<D<+-XDR^8ZZ,C>Q&^6I?AAV/Y:#<%Q
M<OSUZF(0R]*R*L>+?$IB!S84'29TG[11[M\^C%.X7C7<CLJ.#[;5=#0YWC\<
M[27;^Z,D2<:C9&<Z.3@\.#@^FMXK6.<*!VAUAOYIYXP_K)&= ?+R\YQ+"VSV
MWPTCQU0;(:4 !H@T)/B::3[1;/)7P( :MVC,*22"5WU5"P.84<)'7J@+!-B
MF#=56:J">\"MK/D@" ["+#&U8IA*U^V)> 6S.P;;84R3+CM3[GQP3SR^;$6X
M.G;N]R]Q7#,&]U[DBOILFRL<3"_CF8EM7?\\TG5+@M/8NMH;6[G-P2K8AYV\
M/YINIW!.'^WOC9(],!=VCY.#PVPOF1Y/DN\!TK$[/VSX#0F!'1Z/U73_8&=T
M=)!F"-=,1\?;1^/19+*SNY,<[4S2O=T[%XU/5:$^3)V:F(U&8O614=(;H[%8
M;0VEZFFA9>4,#TWYE<S2XO1NNJ+6S&G4J6V,RX&B4\0&<F =+YY1DXXE:!>5
M6)FOT'46\A%8'3:#;8%JF?M4('6HJ'RGEG(%#(DM)"_NQ(.X)[0Q>#:3';!=
MMB?I>+0WV3L8'4^RX]&^&B?'T\GX\&AZ]VGLZQLPG/C_7%$H_P&$<U?([4,(
MZY)0P^:8S;'-+R?BI4/3/$M:,:0E]S1!,D@$Q@V6FO22T=1D"?/W[G8E.1?[
M9ZG3UFJLXPT/;H1A'"9[(-G9&-QYE8"E/CV>CG;2[30='X\S=7CWVMF*]^MO
M6)Z=-YZR#L?UM8[K54? .79(Q7:;.]O10B5U'Y^&$EO8 F8D,ZJQ1:/7U<G^
ME1NB.O7R6"T'GWVV\,UOQ=716ANOA;@/#M%YY4P82J1@.)56X/;-,* Z@==W
MZ1(_T>H\0B\.L/;OWYG#9.>+,!7 H;BI8 ."[.UL11_KOZ*6[WV8>AH#BY'K
MS"O#7<"-0SF !)J5K"W8XF]K<#%!!;R$\<.>+?.$BN4+:G))+NBW''%-</3M
MQT?CPZC!KNC@NBK%997TV(B^1[">\.6V.R8_B(X[V.C<L;;TNCX?]GOH:O-S
MX#G&KS:#.HC'NT=K!P4?^4N'*92S%I%7OX%WG*3G7:/:ECA*_)&]!_U$_79V
MQC*Z'TB"MONE4&=)\85,<X4*>K.UQ.Y6] X'O-&*@GNP\VP&96$HSU1.4:)+
MQ*8S2Z"@()'3(\]R=MRHSSDC3-LJELXGI2[JR0FW.)>NOYJ$!V\B:D+I=HT%
M(/A\ Y<D(8^LD,//!=*JGYWKRA%#J !3/B)"!3V&I9M-C1M6"@FO957#+TF-
MJ-BNMGA94]/V [?XWA=8$?6E2::J77S!+I]%16P#&[W1][:BWS G?9I,-WJO
MPYQ&K^R<ANU^#8;# +)YD"";XP"R"2"; ++95)#-?4ZMJ"FV*M P^I+GFVH^
M?#SY]'FC38;H[=L?: [N?^$FXU_ T_U2F_K@Y@L3?G]1?W2;NK)D&.Z#8<A=
MTM%5MP7.AOGP)1.7O_ZC(SZH3Y+W.07MOM%BH9L[_88]U6N.IK[%EE!U]+&K
MT_.$"DZF\F'1*8>]5\:C-L[ O/<)%+%P(L/!&'<"=1ZA/U-^9=QU%!W8]TF3
M)7]$+Z4U@,PEA]O(M5[,8.5T8>_K=Z_>2Z7@!M)[_;!L.^U/F+KT/!H?4G!O
M/V:.W>@2_Y\?6-P[\MLDP+TU6HS94 N&[Q]!V-!=_DJW% F;N\?@72()1 1.
M1Y'4PNZ0Y)G023,]"YR3>9K/$23'UQ&< R]<,+'?BCX=\5!+%RDZ]J0T>L/-
M2I!CHM;]BK$(4JAZ^*V)(8Z$%VL&./-@VTU$MQU)N LXQJYJM=1YGAY$E]J*
M=KB\C-2WG D+3=WS$O>&#?]+.?1@N;0M94=*!+BRK?-4GJ>;J;AMGVWU-88-
M*5SIXN0T<06%$>UG$,^% A-'XPE_9-3PX O*0'VALDU5!&0-'FQ%_]^GC3;K
M9!:W_O\0 7OH$;#][1 !"Q&P$ %[BA&P_OEX^,56"S245>L:;#GXA?H*-'GS
M9;K1!^<AAE'T!YC8R2OS'62NG,BWN.77&_E)%JOVTE#<X =\LAPW'RS'S5/P
M'&Y)2W8SF;C1M&/, 6MTRHQ1V-36A/C#"#+(L08BO9>_#E'@X:^#?$9>GT\&
M"M[GMS3GNC$ICAX=)QC+OX3*A>M[T+!/$+ZN,BH_PE./(I%V_/"UK;)5-*4T
M0U7@Y%2F:R+"&".>M5<J9>C0+D.']CRN7)I4\'BJFBCQ'6AE?!6EFVX)1+T:
M+\$9&15519SYSA#QJ\1#G*F$*P&F&(>DE^\<GNA5L*')Z(30&-'X>'>7:5QG
M]"7LE)I;QZ\';GW]+3U/RC/E/&//?P83=%&]HB-7$RP1 T^8BPTI=I5,T46N
M)^ATI8CVUZV/)B JITKIL-;I7-&ZO(>%P-!R4I.C^$;FY)W,R:F9$XF!78,T
MCRO"K =),J5EO<UG,IO@PN-4,XE8EA/=F,.0R"@58F23(X<Q=M0F=/7*]6A5
M9^C,3W5_&Y?,CZ#B'%H'";;1/R97C"VYHDM?B#A:LUU4T:A+BGCI.>'B#%JY
M2P5.>D+O%%?8[=^356DGDJ9@DQ1.4R5'++A?DH@&52[P?E[JB+*%EZDY43")
M<TX24227A "DKVN3KT2564T*336"_7P(=D\QCS6S2I5_4VP(II<-B^WR&KX"
MU1A"(:L4QLT5C&C?ZQ9<@F9:+S AX"=,F:]?OG[_.7KU^A^OWWWX^!O\^_3Q
M)SQN>7PCFQ86:SX%"^?:B8\E?EW*?L">GZ/>_5/ZI^G>>KK@5]5T%"!3.&]7
M=5;-ZVZ"FA"OF8!K.T-.QK.BFL"%D[R:PQDS@V_J;+]"5"&DQ1+0)*"O45UC
M,3$7&TR1G1?4 .BJS\[C6YA;U3*D\>6KO>T(=1.\\AD5"C&K-B@U_.G=\ZV(
MREA0Q] ?J 1BHE2)-LIER971Y_DD;Z,9Z/]\7N#YV,"G=P4WH,%RNCDI<GL4
MT&OQG2]?C<'6P)IG_!R8ZI)M(63GI2^!IX%6;YPB:=';"-I,2E+S2V.D#X&W
M(6<R5B-6&(K^TU ]%8O9_+Q*%V@.4:GVYUJ=835RU/ )#:N6(=IS7LWQ*^2V
MSS(4AF=R9P&LLJ::0AFL[E2T]5?\F3M'!(0<FI/,L!SR*%L8=P>+J9(0#HD/
M5K,EA60LF%*QY:KW"B9L6B2SF19M7FWL./ 5A0GW;I2T%,M'!'$*,DYFN3:W
MX<-H_Y))6>.Q3J0JI2Y@U5VO4"/ [L485LE<VK!%W5)7I>_UKH01_8N?X!I$
MT:S*2([QBWPY;8A#MFLK^3N8?;AG8NGC%)6JJROSS50D9?8:#H2^,_%\))K"
M>=*>7R:+ 6W1%+"UY35,2JNLQX2WZ4(I_$BC-N$+P/0CTGX]6"(*0+<&AY@I
MO4[TZ67&?4=HEF"07<MMS(H*8VX*;""P=Y$/=]H.SAZ^WJ@S\$5FZ$VA;K@3
M".XCVDR:/3,BCQ).()WP=ZF'>\>;]CQ](;9SCXML5N=9OJ6V8F>1N+J.-X24
ME8/<GG<P=*KQYB/A.2WW-U5>_S&X<WFEJ8T,/?&YN_%(^[.CI;T"/NEAG<XC
M6"(ENU-SKF)E0#Y5PYM9N"^R#NM\L/V9YEJ>1FC4X[SQ4:Z/&-0G+7J7[!X0
MB3[LKJ]Y5BHL)/B6IX1(.@>S,)J 0Y%1B7IC>O["S;.J#O)K(_>.4.:HIZB
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MY<_I*3CDG)(L2+Y'I([/DN>$$CD[PP.>8=;C_7B\/X[WQT?:WO)L7_J3>?:
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MB[42<VS.WKYR,6KK-MC.UO@F^VOGNVVOX^WC>/MHU>8*^R+L"]X7IVK>"N_
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MXG:ZNFNH#/*"*C3-J+4.L(<!A>3L?F8?Q)TQ9PS3*NT:CD#AN[ZJA53.QUZ
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MO6B\=;2_^Y,WH.TU+%H_)!ISW9Y9@VT';K.';K4:3U[;7V\^R^J1S*8OO3?
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M@Q(-@AJ4:)#-IR2;=TMP%N_LAU3@8Q/4X+L_\-E\+(+X"#7F!C#3;(J4_O"
M=:#5W\00]\OSI#Q345Y&TR2OHXNDZ%143:/+I*Z3LHV*/)GD1=[F,&*DWO>O
MFN9E4J9Y4L #FK;NL MM$^5-TZD,GZF^I:II\,IY7:5*90$4_MA.X8=3B/(
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M-* ;([DUS8]5/16*9!=2PH)*%TVG=&%U-L=7W4;Y+)K/J9S%FV0-[.'*GV$
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MNOXH77KO.UZ0*MPA'=>CC*?%[5:&6JX,J/^CRZ#+[-YE_N>Y \'@*#CZW&'
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M8 @,M>K44.T=HE,*P "8#O:SK@L_@! 0 D) B,$#G-,30G .G .$@! 0 D)
M"-6>SFMB7;.KFZ-4'_"@VMM9M6<W4[7GSISP4AA^*-5XE<?^YQ]&MC4\28S0
MF0LN W]A=T[N>I7\V3J!Y*\F:SD $Y*__<,);D+RAU!2LVB(?34PB'HP$9(_
MD+1>X29@" RUZM20_!VB4PK  )@.]K.NJT: $! "0D"(P0.<TQ-"< Z< X2
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M;:5D\"(.B(4:9AD#_PZ(?WRTIE*1=76'%>,S( 2$@! *,HSY  R  3  !L
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MA5!U@7_[Y-\G-XTF(C:Z'4B[:D9&  ;  !BD735M$  &P  8  -@  R  3
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ML%F(P\U!0*BZP$, !L  &%1=A]$@  R  3  !L  &  #8  ,@ $P  ;  !@
M V!Z 095EWZJKD'14KN\1%9W1+5]^"O_2[>NI$5KY6\[C7TG> 281N/!?);#
M)WOC3F^@3]ZP]U$\-Z*I\2'TQ#STIP2_%)N5*C,CC8R),.2:I? ,/Z3/UWXZ
M,X3CSOC.="8,SX^%FT9Q8CBA1U_28P1]H%_?!<*+PCJ<5UFG]=T]]K7F@5F#
MDROK!">X>0AZMA?U5&H^36H>#75,4Z:%KPR+^-I4/!>+5,PG(C;LFIQ862=T
M#YVJ&'F H0X8OD*GAG[N$'U3  ; =+"?.(,:$ )"0-AL"#%X@'/@G.: @7.
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M,SX[66!\]-,T$'50#=9MM:8!53A &CSS$*A_FF=P4GL,#R//,URE0Z(ASPY
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M!PV<U W#PQ"6P3TY)!JRBVR#@J#@_BBH\J#9/>6''CBR8"<P!(; $$(U#/T
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M!6K7W!;40=\VOK#V*V^[5Y#V(4Q\3\3&U]AAQ(W/4>"[2VC*&M Y !@  V
M#( !,  &P #804A@H"D#&8!A+3"$INP0#0,  V  #( !,  &P  8  -@  R
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MM0XL_5M35HGJ+/*SM17YO?=#A_ZDOR#RTW])!7WYX,T@> @>'BAT-9_H@&R
M#M#5"#H,M0 3(K_FL@$8ZHSA?9'306,"IUCA V  #( !,  &P  8  -@  R
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M+\WOFDV$#CP$#P\4ND9.4T V0 ?HM(0.0RW Q,GJS64#,-090PCI#M$P #
M!L  &  #8  ,@ $P  ;  !@  V  #(!!2%?7A9RN;982GEU>(JL[*DZ8?M K
MH=O;!F3^MM/8=X)ZK!W56<EG:ZODNS\K'91\]5F);'[7;")TX"%X>*#0-7*>
M!+(!.D"G)708:@$FE'S-90,PU!E#*/D.T3  ,  &P  8  -@  R  3  !L
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MX<DV=OJT;&9"?BUUY9IE:;-CS.JEDI;PZ<^F^NFO!T/ORE'R[DQ7YZ%]DR:
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M[G0]!W4_O:;RV7SVT0+A02_F?[VNDH,0 [B?3?737Q</:-NLGW?X#3W/$>)
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M/@N2U&U2(4()F;&@*%060DZNK4,ZEQQE67BD=UBGGCTE5O5#-]J=0N3AZ$V
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M*SEH,KC)R]<^+VPQ?E2I_5:^I/6-CTTHSV4+]DY/]88TML5V5Y20MHH1>L@
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M"SN=L3VM]*B>-OW(CX_S^3WWX\S-R6PY_!-7R*N!9'A TA;.Z,)H[[CE@'3
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M(> E.&HG'!7PLM/&[(L; EZ"H\)AAENQAJZ9<T5&U][%-707?E3K.#4*R^&
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MXDISI)6VR%J;,N=-+O+L*>?R04H#QCJ<W->[58='?IP,R[I.]&BZ[+#R9V'
M%I]\\V=8?-@CH3$K2)O_Y8Z*M):8NX-2Y)&VA> .G+U7SCZE>,S:8EU ;G!F
M0&Y ;G!V0&YPYJUQ9D!N</:M<79 ;G#FWC@S('<KEY?": !H!V@'9P9H!U$.
MS@[(#<Z\3<X,R W.OC7.#L@-SMP;9P;D!F??&F<'Y 9G[HTS W*#LV^-LP-R
M@S/WQIE7@=SK79WV4.B^>O$/?T$OY^]FZ?UN<C6<\2;GA!/D':>(<VR0=AE#
MC'O)O39>6[JTP8]G3F,C$4V905QQ@;11*:($.Y-)I7,A;Z^&._+CPY$MS_W;
MLJX?OG2M#F\F_'3/&C9"TH%@LGVKV#J#*S<][>%.]6.[ 0;8<JN]&M@2V'*E
M;"D5$R['&!F9*\2E\$CC5""FL.0RIYG&8A5KQX$M6XTKJV7+9SF4MH=KCQ\Z
M_C]/36O*H?N.=_>K'NJ1]8FNDS)/7GOKSXVO$D8&"<64)2_WZN2]K\=Z[-WF
M5%&[WT@?Y0[=H1&77#DQ0]\V8.J\X/D.Z[9#\FQ<@@@KF=#:($55D!/4<I01
M*9'U69XZFZ:Y2)<DB,3ADA#D:VE9D"!&H;@+#L),I5I;EWMA;TN04W]^45:Z
MNCSXSZ087S8[U=3'DW% N%%\&3=42=U\NBA'#H_>W"M#\ "KM.TR!,;[!L<[
MQ.M;[M"/5=9_;KMG Y,M,1G'7N8A;$:!?@*3N12'8%KFR&>9Y\SE:0BTU\!D
M^[JJ+D.3]\Y#2#7>&X^KPDS&.KRET_)=H+'1>$4[JPDV$)P!OP&_ ;^!0_?3
MH8'6EFDM\%I*B H1F<"(9TP@(P.MI5:G5-I4FES>IC5IC#0RUXAY0A GSB/C
M)4.&6>N5QS25?N,!&A]P2H&^8+0#?8%#0WBV;3Q&A+>4\QP93N(^V=X@X[)
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MH-.122)8%&*^1QX70DB9R\>7H3R;<%\;/2(1^OU-6IRDNU>3%CO#LM(PL!=
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M5A;7_0SLO<14^N5%W9;VX8V9BEEY:6#3?D%R(0D6^_?++07!-_GKVPO<7>'
MIO^K X>QK/Y;LLT6>ZK1I%L9ZFS1F*JC85E-RPI&-!/-[(68S^J7JU\ -[B/
M+\1GXYI4$5' DKP0TRMQW;[\X6\]ISX.KHG@K$')^&\@-G_'0>V@>Y1]#<C-
MNA&6Z^>PTQJ<ODO^7^RMCB9R"A+[85;M$PH(;$SURGW4+E91W P-JP(;-_82
M+#8W_6[W]OW6\WNV]5,*L16JJZEH6]Q <'MWD_T)?YOFAW6\CK<0_(%)>S^A
MN-%6;=<\_N;]F]<G'X*/_W7\R\_'K][\^NG=J^/WIY/@W8=71_=!T <?>/"=
M>LV]%]!:(O!^;:K6Z-^'2L3O2]7A=R7:L]^+L2[WJY,/IR?OW[T^_O3F=7 Z
MZ@7^!&/\^<V'3Z?!R=O@U?'I?P5OWY_\-NXQ/SI3CI0.?WE7!;.S>MZ*2K=_
M]4LV0EO0VL#6!%Y30JW\MUIFIW_@\/#Y,!N\G(#R5<^[2]RK0DJ/Z(_]];"T
M4W'1FA>MN1"@Q)E57<+>]\-&;];+LBUE.2UGUR_Z![S<TG75O3 -CR+VXU!7
MZF6_59;^=M-]X1'/[G+;7>ZA1UE"!__=Z2%^CD.?S99>OMGW]_+=NNENU^#W
M[GZV;SES>W38@D#9@\J,)PM;[)B6#TN[)PCX "OC5__WA^2'!Z'B_7OB/QG/
M/FQ3ZO\UH@G>@)ZO_RZ;O_UCV)7Z<?E\CU?HX?:&%P9[N6Q>&.Q&&# O#!Y5
M&. Q!![U#Q<^=GS,E8>80^3K!X>8:#1,/_:E>&3%TFN3HUPKKTV.&NH]1WI:
M[@TM_>[V'#DNCCQL6G[-@6>#K9LZEP(SK%"/KW/-[GTTXX-&CQ_6+'DEVK.@
MF-97;3!OC0[**J@O#";E59\#3%^_+&>E:5^,8,,\ >T/',.?L+;D %'<4]-O
M<;_%#X\I#YV:=U#5]O<4[5&H:K=:L0]F%DSKMKW+#GBZ ['W&:L?J1AS+-3<
MY\KJ$0/U3D%@:Z^1QVC%)6B8)%%.C D5X5F<$EF(C(@TI4(6143IQC%LA4AE
M'(J$&*DIX452D,R8F+ PE)0+@XU*UBNQ >3>5:H^-^\!Z7;>6"29A!D?7S7V
MO@/ &)J&C(6&7B2-@2.]2#I\D21DIM-"&A+G242XU@7)I8Q)06F6I#S+F6;K
M(HEG@N8@>HC*THQP51@BXQCD$I69H9R;T&PT!WE0D12&R22.4B^3'D<F^2C$
M*$W;8XUM,&PE+7;J: Q\I<JI":K.YL5/\7<LL_5Q">^T/ 0WFW=:[B\U_1;W
M3#DZICQT:CY-7,+.%_O(5-U;'C50,:S.#X^R./IQ94!TO3O"7JA[_RE0>ZN"
MJ1&M"8!1X4+;]6FL5OOAP?TSLR(?FW#>?31Z]Y$I6)X7:41REN'9CCPFTD2"
MJ"QA.8\+SI*-WK)WB6@@V*'GZ*3ZM 2ZD^(]8M^.NLR&(SSE<2P[W\<TO"P:
M%S6]+!JM+/J/?\M8R#RK[I15=^US]V;;4WGISVL@SK^L H/]<9?^=V?(66J0
MNB!S^$.TK9F-%;J\#-US:GH9.EH9>L/I5-PH14-#(I5RPEF>$5D832B+(J4S
MGM-\(UA_%VOKI,<D:U_]@K,]*7YMS3'"T1# WGRYP(Z^.[+ HCCW)MBA;U8O
M-?:<FH?"B,]&:H0Q#8L$#V^2/"$\9I2((M;$I"RC190P&6:[2/%Z*JF1^F3D
MT=F>/F0X2MM3J<;TAF=971J7+A;HLE6P>C-?%>65AA'CT @8\0"5AJ<*'?((
M3% :9P0$>$QXFL5$)C$>FQQ&89KE5&3%?8Q9,]75BP7BG53O%GCWNH>[7>>A
MLTF:>Q/61Q&]6-H3:GJQY,72^FG)&>=)IA6)!(\(YRHC4C).J))2QWG(E+R7
MM?P$8BF<,!IYL;2?Q5'>6'XB8]D>9TZDP#HI/ G95*U/K_7*B%=&GJ$R<D,X
MUBC%3*%)DA1@P<I4$A$;&YW-$Y&)I$@W5(6[A&./I]-:X5FIIV>B,3\A(KT:
M -)NW>EA- D9\]K"H>]2+R[VG)J'PHC/1EP8#89D!/9DGL5@)4H6$L'3D"A.
M=9SF!:=ALHLX[*.*BV02\]A+"Q]_]2;E+=J"GXGJL\&N&X4HF^!23.<&0[%7
MHFE$-0NFI;#'.)<P8E'IM:N*LA*5*L44'M#.FKGK]%&V[=QU\C!?E&E;O/*B
MJ15HDCZ<ZW6/$</:"!CQ '6/)ZL$E4:$!JQ?5AA)>)PSDNF4$\H4+>!_-(SO
ME9ML_>8.0-]5;P$8_QMQ\:3XS6'G^R5T'E=Z\/W;'C7?+4'SG<7,=Z *(6*>
M%!\[O-QYJTPZR:DO*_4!82_8]H2:7K"-5K#=$*Y-=9*%:4X*DX6$YQG8.WD(
MEG4>41!'4DJC[QVN'8W8^:JT29,)"$XO;<9FB_OP[AAM\=>F,$T#EO-,?$&#
M^;)L?7#7*Q:C!I\1,.*S42P,E2RGDI-$Z8+P2(4D$PDG@D9Y;G).8W.O].3>
M6]_CD.N._4E\Z?SS/YG*P#AWI!OPR"L&![\WO9#8<VH>"B,>H)#P38W&84Q]
M-;#I#Q+889BR73L= *NX75AR$*;T)P7X-N)[TOC:MQ'?7VKZ+>Z9<G1,>>C4
M]*[N W%U?VS,A2AU8)QGR2EQ]>S,-)U6-U8[\O!@WUN)WJ$Q#H?&=J\W2W-E
MLE@0740)X3G+,(LK)CD72:CSN& RWX77^UVE&NP2]MJXG^^J#J1Z=WCG!3^N
M] D"E>TA]A"%T7GF_>*'OGN]&-ES:AX*(QZ@&'FJ=..8@2A*#26I3$/"XTP0
M&=.4:)%D@J9)Q@JZBV*JAQ94WY!/>>R;6XZW<8>OLAJCN7NL7!N=X$)<"SDU
MDT HU6"1U!8#>!#+&*O4\.K+GE/3JR^C55]N4"XT2[,\2TA2V-:444%RS7,2
MFBQ,31P!GMS+"NY[@%F8^NA0ZMAA5*=.M+T^,4@PWU6:^"2-?3+8P6]6+S7V
MG)J'PH@'*#6>K&6R2"-A:(&]I@S\$TF214:21(B(QXK1*%*[Z$WY4'+IMEV4
M$U\T.V*KUP=YQVCUGJR=(^@-V\-5423L--,L/CF*+V9!6T]+'?3,-!9Z[Z$2
M<T?B>C5G9VI.%N=*:I83'B:,\(ASDFG)2*0U37+!4-%YF"#TZA%6O8YSO?.^
M(-$(3XG8'U#9Y[8A7Z&RBR;0:#1T]L+2"TLO+$<N+//"*+#^$T)5K@E/4D&R
M4!H2BC#/BB()51(_3"#\L81E,L*S*_8'5)[<7;#C(#E[4G=!=)32]!#<!1_,
M+%"B/0OFK>L>.JCT@SUVZ1T'7A?RNI#7A?9*%\K R >]1Q"=89 D5(;D)N.$
MZRAD61(F\,LN' < GJ\ .S]BURAM]$_7O[;8P&6A$!TO$'37RA!/)RP=8?1^
M?X#%.P^\P#Q$OO8"TPO,[Q:8*N<RE,:05&8IX;F)B*!I0:B.HI1E,@NIV87S
MX.D$9I1/8I9Z@3D6@;GK? /?\N=;\'#EB"OKJ?Z>'D#H&RBF]54;%$U]'I3V
MF-I5]X!O_N,[@^Q)+PO?&61_J>FWN&?*T3'EH5/S:0(]CQK7&9F>=KM6/O-&
MG6%Z9UT$XE*44TS1)F !D1:LI* ]JYL9 6[L%39[[L0(3/VQ+,9A>*7&0LT]
M]#F-&,P/PJ-D3*Y#+5(2A503'IN$9"+C)&*<*1&G+ GO=0Q<[U'Z**XMMGVJ
MC]4_YV5CCGLT?%LWIX"%IT;-&VNFOC9R5VWTPSB9A+Z5_F%&5\9"0R^CO(SR
M,NH!910341Q'64ITRB/"69P1D:<@J$(6T2)+A!8[29E\&AF59A.6C3#B,19
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M_W-<Z?\YJ<R'NOIOJ_B]6NI]'WNUS]ZUJQX\X\OY&,L.'F48P!N@.]GYOU9
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M/EM)N=W^"ID(#9YQ22/*"6=<D3PM! E94F@I*!7R_J&N)7"=%+\YV%J85^\
MM 89,];:>M/AU:X:H' ?^?+6EI<AXZ:FER'CER'>VGI(:PM^P?R/,0&9>S>#
M=W_M=?<APRWF^JW7?V6VRXUWESVQ',UN9G]J3" 46&@PEFN,HU7U#!YEK;;*
M-AH7,[-H)R6F,%[X /6F]N@^=6F[GD>PPL>ZO$3V_3O\[ ?V+U)6VGQYP5X6
M4_.%Z+(Q5NUZ 2.>GU<O==E>3,7U"_QV8W\?Q;"9\=6=QX$>I?C)'_-V5A;7
M_3#LO<14>DNYGZR_X)QQ'HLN<U]NB0_?9/9O<UMWA8.U_J\.JL;"BF_)F!@J
MV\I09PO?4T?#LIJ6%8QH)IK9"S&?U2]7OP!N<!]?B,_&N:&(*&!)7HCIE;AN
M7_[PMYY3'P=D17#6H/7R;V#:_(Z#VD$C._L:L&UJ#%H!U\]AIS4X?7=4P6)O
M=3214["J'F;5/J&T0E?4*_?1,I5:W P-JZH!;NPE6&QN^MWN[?NMY_=LZZ>4
MJ"M45U/1MKB!X/;N)OL3_C;-#^MX'6\A^ .3]GX2>J/#XZYY_,W[-Z]//@0?
M_^OXEY^/7[WY]=.[5\?O3R?!NP^O[B62'WS@P7<J6?=>0.M0L@K-[[/Z=QB(
M-E5K].]#U>;W7K49ZW)_./GTYC3X=!*\.OEP>O+^W>M1K_'QIS>O@[?O/AQ_
M>/7N^'UP^@D^^/G-AT^GP[4?8.]W#&+A+_PP/S=-J3IW84'#7*8ZQ#HX03C5
M"<E-7)"PT#R1151H;79QZ/U/\Q8 JFU?FU8UY04BTG&E?Q)MV9X4'QO38G=6
M_/03O.>GJ2V:@TO%!3QCULS-+76][.ZZWD[[TNZ<C6$;!N%1," ?RNF>JL%?
MCML VT[CGOSK5J"P,T6A )IV?!1%T8_K(QW0,7D:,NX<ZZ=& Z$^GHGF'-XV
MM[Z(%K"^4D=!V08"I&E9X8=HF'TV@2R!SNJL@O%^O@XZNRY (G\.RED;E.?G
M\^Y+\^4"G1LND1+TU\_&)E+.SDSPZC6GP?OR,^9._@4]+(R^Q,_>V]_#EW\-
M+L3L#/17-!2UN333^@)O!#J4SGJ\:' <LV#6B J5OPJMR+J!)[8V(Q/(=HE1
MP\;\X>RPB?T8[IR!CCP+Q/EU/6OJBS/8YR#UX<DP0S4U#2@#[6),(/?Z$1T%
MGW#@;L+6*92^;#''4ULJ8& 8Y]D-UD8LX4$S\[F^:.82M'<<0/#N\W^&^,NL
M)':^]E=9Z^O@JIR=!6>P20)1@,C X"8VD%FC%MP;7)GIE%R*WG2&%0%RVR5R
M1(9[8()7L%9F6L)P@C/1!K*I8:2.A':9@XL:>0!,[J/@UVJ*6Z3&KZ_<@FEX
M(#Q]$M@R75,I1W8<#A#KO TZ"CD&FG14ZC^MY\WZ1_-V_9,KL_BDFVC/"4LB
MXY=V!/CRKS(KKBXRX-59/9U>!_55A1UEYK(M=2D:X)J)+8M<=3M(1->C^Z/!
M?2SH,<'!215LD_X[$**9C!0>UA='0H) 5!')F&2$@F!E@LHDH?&Z$,V2)!6Q
M!DF;2$-X&N=$)CPED4R5$4QD61;?)$2/U3_GI5/KWQ0%(L"E>0U+?E(,O@E7
M@VC($N0<AG"&SR1:7!,\<PQ,[)&LSJFYF)ES"9LAY). 4<RH[#AWA>;_&).?
M8])O6X&$QS9/QQ7@TA< QT]+-.IW\0)XNVMZ]$7<NVC*2U@BV-QG9JIO)Y@Z
M.$:Y(X(*>"OX;"KCW A;85B@S%M HQ,6%LP1C*U\<>?4 0;/IZ(9R!_129GY
MK+9"T& C?4R@;9WHJ<R\J;7IWW^Y_'Y%M 1HMZ*MVEHX4W5S@6X/0'$0-?^<
M@R Q38N2YEUS":P^"5X!C,#@JE+8UR#8H[(H&N6.U!M*I$(HC$"C#(4G_#1'
M)\KG&0[[9["9A3J;MV8VNP$1#TNIM*]Z4<Y@%.H[V+E3(?N,)-#++\MZW@)3
MOFO;.7#WJZ%\>;MP:Y\NW-JWD3;Y3G7/%;]->!2&X8]C%4#O*JL(*% @6NMG
M@]==@/CN]<8U]>M5;W)_F^RXL^%Y]NR*3MV8G348G8!/VO)+8)&_Q=,FX0G_
M#_=O1"W*QI/ANP-,IX=-BR_%CRU5%SKG0E>"5^'V/36H>G1M /L_[@C/:Z'"
M=@[J]6 57"/ W2S#O5H"[MRM<[O&@9/@W^^INSQ"[E$J:<*8CDD:9P7AB=)$
M&IF0/%0R2W->Q%QLZ$%2BBA-$L+SA!,N9$IR)@0Q&8\XHY%F*EO7@U:[ZWP4
MS4ECMX+^;S&=FX^F.04E>BW9"'[%Z^&J%M0DJTF(UZ!,BZ;MKNY2D>@P%>E;
MF4C;Z2!DGH69H83&&G2[*&=$4* (BU*6&\9U)++-KD1,<YU*PDPN".=%0?("
M[E9Q&B=%K%3,T_'2@1Y1NJT]T0U)6J/8>("\P242:J&7+>@96((.U#-4BNI*
M3>?: J, >U<:);!:$F 2%*O&6'-L)JQF!0*S1&GG[%8T+&L'^$[I62;T[L6V
M5AHVJ0$KA<44S)N0AB03.@)KAQ:XJ\,B#]?96;",JYQIDF:* A2PA&0*[C%%
MIIEAL9+)QK8>9 V.D9?'R+I.>*_Q;=">U7.P(:1Q&CY\;A7_%I4-5+9M# G9
M<26W'!6'BSDHY*V3\$ Z-9^Z^F!0N'%8;0!2&1Z/[%Y6-O6AT:",&.?@&1.-
MCF%L\\H.'CBDTJ+1J%'ILD#?#S+WPAH[?;5PS+&$DA 4H][_TT\;^"^P+'74
M^VV.D:)@BLRGLU4-2AMT(955!Q2PY?OU.!.75JZCKQN^W4)3&_IUVMM53=PR
MG1M #^M] Q,1E@A4QKJQ\X+[REK?SL.3ASOU\*PIW32)1ZMT'VMM_2&(RA,D
M(WQ5.:^IX]K96=DN]%[4IE?7<Q7W<3G/!"X'L#XFP0#4VW4"ONITYO7=*.P*
MPZ#1JL+3WVUE1V<)K+CKIG8KM6?&S#JS>?U9I1N+->.;^K)L<19.'LTO:O?0
M6JEY8Q5U:Q($!7"5Z$Z_LP9]!^Y_@3509\-' B4:30 D8(0S8WD1&*[O^0U/
M@['\%<?N[CRO&Q1_XMYNM4>083K*9)R%H(UEF2*@7<5$A$*31"91D9DT"EET
M'QEFT^(!)3!X*CZ;DV(@S,[ @C=-^XM1IKPTW2&A)^B.MK7)J^V@ (&7<HNP
MH>!BWQ!<\<TUR&/8B+@+5.=9<,R_%#X=B6 ;6AH%]M@?]$DAE5PKBM9MR_Y*
MYYX8;HYN"^">154,=AJ^S-E4K?-> ;^B5C:;&ALLZ=^&SVUA&2UYG5RL6E#@
MFL[KA<&6H"R<JJ=+C6E^*(-!ORLO4*!VV[D&/ 3C?&6;'04_+11%P)D"Y#&>
M/7DNKCOI@3>WRT(P!*B5R:-]V*'&RK#ZV08N%%3/9_C=5D<"KD%33[<K"[J&
M]<0)G1L;70'B-\ 232F<1K .73W:J=[-J#$45%;MS$:+EE@H,$!TCOZ]YKJ_
MV0DXD+@!SU#2DM,\)]'Q47 \!2DWQ_C0 GD0;?#1.+9^Y@;]$+6T>4K.Y6$'
M;/%N-A"-B*AV:' 'C,$!@7N4-D#HY6,<4<R7$L;?0:9=J"6\-L:Z=MN-F6_.
M[P;0=B]>,N44U_X<),Z\<8R(9L%@I,XJZ0V,S2ELH88/\RQPYI5IT,/\[13<
MX5&O\$59.72U:]L,-378AJ:T"]YT,?:CQ])U[^C(Q<1DES/ 1B4"QDVU^[N_
M1V4"(7P7\\9*D0%SKT#%1FS-IM+Z%'"? G[?T>0^!=RG@/L4\+&F@-O]LBV9
M)1-)K!*P>H4 %9WG2A 1FYS$A9$I3;(B27:2$7H*BV"5Z6JV]-5]!'97I6EO
MR@*U[RTKD,7'L]L.]O?0)X^:@!T%I_/S<[158'</B!\,/*4]^4>=)!T\6#)T
MRHWFL0Z)2$(-; R,E.=<$D-E9#(:AT9NG";RW;T3MN0\'U?Z8U."+GDQQ4C&
M4LN$[^R27-\K*_J)LGF?('_%TK93W1?4M6;>DKZ=<%M2V*=+][)_W2.]W6AV
MIO&%0/?#EB#0?QX??SSJTN(PL>TU")TKO*E/]K(NM?JJVFXLC<MM'*<T%491
MDF'\GL<Q)7G" !%D*C+-8(<;M8X(B8E25N241)3EA/.(DXQI3936N6&"FS36
M&\*P3^6]/FG>6%?2SS;L\ZZZ!)O4F%?S\[F3W0,?\Q6(^_:LO#A&=?AX.OVT
M]#K>VJ?\[L/;'_X1TG%[CG_L'7VE,\-Q0Z._$^-Z+F]F$,9<.$[KGC[81\N@
MYP;9]8;\S/?O7ZTPZ[0\Q^#RH!E7EW3ID@%.,,?<I6K#O3-]-$CA7-S;IVG:
MQ$I[?LTRO@>O6;@OK?L _WC7-L),%X%)?,DR0=^^<D^V#<NT@@UC2,X%;)N<
MQD1$44Y,4="XH!%\HC>B+1$S.LL2 O?9Y"$!FZ[@A!F6ZBABBD4;"3!^VSS6
MMD$/]:]'IT?+H@/8"2N[P&8XHP@IYI5R =?.,:^N^X&L!R:*N@$EH1H\U):5
MP)7V72Z7XV5P5E^92]-, M6Y=K'XIG*YQS8TM-*F'+,0<0OW01B<N0ML@ (U
M&)0=;6N&P9K!C5,G 9OZ?,NMKC/?8(PMOF(1*,4DBS;0<YO9"83M7F^0_HX0
MZT%\1SD<Q*6;P.T)AB.VX86!2M_5LGR["44 _+]RIUWS'KB$LPP<>5?)!(SS
MN9O4S(W89C=(8V!U$  K^](5-_SM?(\[U>AU2*-8JH0PJ2+":2P!5"(*LC@R
M0D4FXGRC,N,NQBQVG2[>M#. AQF>[_,\2A?OJ*7_ZG+A%N3R"OA  7>JM>@K
M/&\(YWY#1W?;#CW^J+DLU/)E*!/&!:+0!CH *\[%GZ:+$&!>4K\N=ML#P,Y=
M]+%U"3#"5AP-4 SQ]=SA!.:;=+'Z%32&Y_20[;#DS-:'J&F-(= NXHYPB .Z
M =*[&/OW$\/.8J-)CT/<\[I=1<[EY._\/NMELVU:K60E4K2=,@@$< O;$6.R
MT?/55O+A:PM1]MFI0)V5XSEZ]?"7DU\7>6O;:3;!>3=ST%AL*'_EFQ*F539]
MJ&M:8]LNT)/T8@&MMF U J"'+<M97_[;D=Z10P_6&VC_\Y+_D#RN&FA)>R#1
M60G4:VP"K2VU+6UTW@X* ^0-!N86XVO^-+ ;+T ]@V7LWVHNA>.F5?X=L'Y7
M0FIK/Z6Q.6"@MJ #?*FHJ[)1\W/4F10._%C-@)Y=Z@9R R;VZ=+F*N#8&Y?]
MV^D-F/6[G)5[J+O8K T-E@<[+)2=>%WLD6)1<X$9(](L7G)[&?_((I>E,F)%
M!M)64,RTRO%(WLB03!<J9:EBS*2[$+FOZ@HU>@>5OY3MGZ\: _3#W[S\_7J"
MQ)!RUAUF*1<@Z;PL[H.I@[R0%MC( 9I+?%Q44$YMJMD?/2#V*:,(_0.9HM;I
MK1R]&Z"WR^5I9UW&=7LV<>E?**@!_A<HVIZ!I"6860SC0>.VT]^WUU9J8V,^
M5H@5!C/&;$E"Y1*.<$+E;.Z@QEI3RKA\\,UKK2_##<&]U]ZQ?31].BTJ,:6+
M-%C:8(H=/+PUYD];ZE:[U)K&9D-;MZR8HJ@ZL_7\TQ*FKE%OZ;25I2AI16$^
MST73CP41#T 5R/#;LA^ !?GA:G1)4R!%ZM:E6ZTLSF MNN[J5OXNEK^/GO7:
M6$?;NKD>$G*9%>M0?[$":)[9BMX>TRN; #CI\F[[VK]^&#;='JOY"S#5F^_A
MA4D@Y[8Q@C7$[(R7=ABLZ7"FCRT31*0T3R6@N@@!WRD@?4:9($ELPE0F7*7%
M1F'8G62"RZW%'V^61-M!".4Y20=D.60S^\N C$\5%+SC/+;WRWJ.HFPH(_K4
MT=9" G9D ;!WD+L)Y8M\YG/$K(5CZF&::$11+D01%D06<0C*HQ9$LB0EF0I3
MGB1I9HI[Z8TV^(H\O88.@!>8]P<# :#$[WYVD[W^:#US(UE#5\W=57&C+0<2
M>P_Z8X!,-!56E:DST0E?:3:DVE&P )T-@=>5I[@O2LS&%AK&%(C^=.U G1EE
M%8O>73E!.IGKSBYT*L+$>6L_UY<P;&O\M8OCN.V+U[\&&Q$=O<NK'BWE]_M0
M>E-# (7#.@ZLVUO5[6S2:2;BXJ*IOW3&*"@=93-T,PR4GX&"L;KS9]9A/E1
M;Z5(W.";3</4T!Q4@01V,-<A;E[&2%+D>9K$7,81O_>&1YL&M_BO51<[P*E\
M72%8SS&ZS3@/.<?HKLG42'FWM8:T]U*YKTNT.^JU4:[I413:=AS<4@Q^B296
M0M_@ M[PUX'BW[@H51=VL4$T6R#MXLOM]A9O@ AZKJS GTY[B\LA!<#",OYE
MX?%M73L[YG4S_QP<:Y@:F*[-:CGMV]?'2[>DZT=B0U8-F&Y38>TFBZT(*=+@
MMS80B0?$H-]*8(H.6&;N0^ <.VZ\"#Z3:-A8OUEC$TZZBLS-:;BZ+AM\[U&K
MFYM>3*ZC"# =OAADJC9386]HYSU:XF76\X;NTE4K?T%"V3=A[*A>S-' .PK>
M58'H:D]A+3'8;+]>T%9>V[^!7M;EBR75+3 E3@"F"@M<E_9D9C!,T:^NL8S-
MN&JOSI79EZ+!(XUH^H"C,\ M/98O@Q]HY/LRH:U:,1*^]^/4EN2+-@WN!#:X
M:A"#N%CIT8?]!.>P#:X'-KTSQG%M^F2063VQYV8OVGAUMU:P/-83,UGV_!HV
MM<+!3-")#+I.V9[U#GN[L!=-:<OYE]L'BQ*[\#T\L&LCV3DOW UFAHZ993.Q
MB9W>M%PF< V5( S<5)=E4U== 7&WB]V YPM@M]NFT[= #3,7UE_>O=7NS,F"
M)Q<I-2[2<5GC\VR*3=<@PR4DP%@[A[_UFABG/=;2)@"(15%W[ZFI/GO>7N'M
M46FK;I_]GW;8H\TR%V#RA:NY'_K#NFXI [3]/[A#+X!/K>D*=P(,ZKI!7=_%
M15Q<"LOHKYV+S6$ZC).<"VW#C:+%,-:*'(3'BH$8LX[* OD.$,'%[6[N13=;
M<;UB4.E>+I*'/=-C>YF7+_[RQ5\/,IJ0^NHO7_WEJ[_&7OW5N3K$('?WEB55
M=ZK$8C_<+["T9;@[]<X<B/J'CH,Q20/7WN*&KKV#I-?966-[@-@^1*[!BNG3
MC@;>C>ZR>N[L\:NZF>K52#BV"9Z)/]'UW& 7C2[]IQY&D&=#972RU$1=B/4:
M=,7S=JB5VH@X6C43;%8\G9TM0M)@N:"E50-Y^[RIH@ B@FF&.4SB<Y?A=GXQ
M1R> %C-Q%/Q7G].\JN2NZ<>+<8C6=L:W34>&S02'+9N^KB!?SJ?8FQD!'D\0
MASO._CD'&L$518D!:1SK.9AI<S T53]'4*%;L&"Q&;0!+;%SW,!5,/P&5J3%
M?#4S-6B#SJNN-0I.HYQBIA=<>';=6J/63J<N9K:\PDGR$HW(Q6=@9L[[!,'%
M.R\':1<NV<HU11DT6W1^F[;/4J\ON@8Y\&PMSBWUT;<#&GY][?+,%DM=-]:9
M7:%7JNORV/=T'"9S !/,FZ'-N9+,Z-Q&M^#O-9>0S<SOF0HF!]R @YUMS>C
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MP["I5:=F(+8[:G2R?U9C%QO'W0:T^J[HSEZS,@[,X^OC*,,J$I='"6;MU!Z
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M";]$BX9;CL__.2\OP>1;,.N567*_#J118MX:/%RU;' O3.<M;IZK>C[5P9F
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M^_X5+,_D3%+5T  $0 +MO:?*<9(Y/I5)YHV3,W4^3>'JYD0M]8B2[9Y?_RZ
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MQP@5U E2%-MA@B/Q6:N..\YAJEGE*7#6&G8O0?,PG,6Q,(XQT3 5$YXBR;E
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MPUX$SQET5)?LG>^<<=<:?'(*WGV.<Q9-</@'S;X&UP)\AED-G]3?#+)W\X#
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M)#Q)>'+:>-*M$L*$)R^/)Z=^[)@ )14()D!)@)( Y=0!I7OE?^<.)ZD ,!4
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MRFM9,6;:+I4F;%@UMG5"@&4,8,-'6S4G5@R)8+FOVB'3)9%##C(8+29:+M'
M 4S8N.OJK28.WJ@.WPVWF/_[HQK.HF747'"C;IN4Y[#3MV#JW*C*;M^W7>WR
MEF, HQ@T"^PP"]\8-0G:P]MP5?Q^?+GP0AIN8;/9S;BQDC;=U;7WA_^WX9
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MJ7]Z(&,?#1:WVT')FX(I$R1%9N"_FUHZ2T>WW>FZ59^OEK]M3!28UJRF\Q-
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M[YSOG(9?W1NK)_QZ;U1ZIV7YGY2<\F-*3OFSG7VWYM8],H\?ZOKL5RX&8W#
MBS<8@UT8 S(8@T<R!JL9B8/6/SK%<0.M&X-1T$&Y/&.>WKMRH?UA^%XOQ--"
MRFL:Y3K0#]$] ::$ZQX"@WK1[?9^(I,"OV%KZ/=53S'GH?>UW:M=N%'9/&'K
MU$/$,@,M!^$>A/O9,.1SH.4]<=F-L;X[0K![M1(_!EQVIW7[V^F'TWM)P(X[
MM/>"LD^G3W;:8KP7M%SGTKL3\4_]Y,9^*.F=BO[+A^2)/2"/F C+K0\.>48P
M8MX)9+@UJ/"$%9Q:3^).\K2:C*SD9Z94]"8;=P%C?K\\:W@E<RO47>[6M<>>
MZ=JQ9_A4PUK!7[>5X.,GFE]_!'I0%?=2%=_V4U4,ANN@:3D8KL%P77-J1$7*
M->?(8!<1T\PC);Q$!7&:D4)Z$S=RYIDRA08#A9R2"C$7 [*<@_4JK H%8P&'
MC7.6/3)<&(L32<5@N1[+<NUC V-PE'>@$GZI)FAPEH\/<]QG'_4)J/WHA-T!
MFSYPB_I8X,IV,.%8E!$;CK2WX 4[JY"6RB!?"  )S$L<-]H%/I(7W!Y;NCN6
MN!E":-5#^#"(_5.(_5>G8@T6;&#E?K+R8,$D^+76Z@(5.EFPZ,$:>:Y0X)1;
M543P'3>;/#V.._RU%@R,E!Z,U)-+]A/N$J^>O<ZO>3QO>/7X+CY5G'ZS-IKB
MAD/@_767?Z_F9MP'%=X+"3E*I$%.25)(OEJDL^B]TD@''<._'Y6/$'8\59S?
M*Q.-" JIR"UBQ!)D->&("<ZPI 1'[)_(-?_QRWQFN@)H[^;AO/ZEFN0*I=5X
M#+>^2RL?ZNOK=M]_ UMRVGN(=(0JJ1>;W#=2>7#J![X>3.U@:N]E:HM(K L,
M\6#!;.I0(*6]04PY;KFP3%/W1#&$IS*U:<N=4SG8VC[9VK7(!'Q(];26U3?;
M,G1=S<7^6+Q=%VO;8ARW4F!H>3FTO'SH:$@QM+P<6EX.+2][W/+RNO:5=RS<
M>Z]ZO^3:;IOWK!K+6<&,(!'1=!"!809O]=XAK%2P+!>4Y;NM&IMJTL/J@6QT
M%60!;[9MU[X/DP!KN9>*L4^R6;"/IE>Y=TY=MJT2AZJQSZ=J+#U5ZI[U2>DI
M>_QJJN*QW_DTL[SOF@PU8^]4D&=G>NEXRGWU(LPP5(T]QEI>0]78?BN4P1P,
MYN#9FX.AM.-0-[9W"W&(FF.H&SLHEZ%N[ $L1"_KDPUU8_>=1][VEQYJPAZ@
MSN]KYM0AXI2!EH-P#\+];!CR.=!R..UW-*?]?@K@4PSG_7J@A(8:6[TZ8-!7
MS;Y3Z?_?_Z$()@._KKSFP.I<]()P@](<E.:@-)\GOSZU4[&+^IF#4[%;"?DP
M-_/03WTT6,>#IN5Q0+3!* YL>@!L.NC*@Z;E<3#AH"L'-AUV)9Z9 ]%6 >VG
M1AK,XF-FL!VR1AKJ'3];TSJP^E"E?M#: RL/6GO0VOUE]:%G64\=H%R$?>2:
M%/J50BF7%53ZH+YZ0??!RAZDZAFL[&!E!U8??*-!:P^L/&CM06OWCM7WL9W4
MEW(UA^X>_1!B -?(#X>+A_.'!W)F;CA_>'BT'(1[8,A>,>1SH.4]<9<G(4;3
MAS2>^VJ8X\SD&<X7]T0/#9F#_63"?NCTXXQ9#&QZR(0;=.7 A(.N'-BT+]';
MP8MX*B]B.% \V,6>*YS!+CY&UV$=O&%>8A1L)(AA'9'%EB 5 [=,,18#V47/
MMVZ#*2N>-Q/_<P4+<TW+M[NW$;ZQ>S"CN(>=@P<A/63"#99B8,*CMQ2#!]4G
M#VK8A^FE!S6<J#Y*R_C<DO*&_--G:UT'5A].#0Q:>V#E06L/6KN_K/Z$^T['
M"-/W<*C:MZ'=X53U8&F/3OT,EK8?^U34",^-=0@S21 3+B"K?$0R,N^PP49[
MMLM]JN>X-37(]N 0#F9J8.7!3 T.87]9_0FWT8[1+]F#0[AT_A((6O$*0]T'
M_=4+JA^EF26G)"D?7RWL./1+^QQT$[#[4?D(;>YVUY!;P@WG&.F"8<2TB<@$
M1U (A>#@X@4F]"Y<P\$E[+& 'SZ2OD+<P2U\SNP\V*MCL%<]]1%[S/?[\1+A
M@X&I_J4SL+\LSL.L=/#9EY]6)KF:E<A/*:7?W)":B E\?@)'['(P-[W\*XZ"
MP8#*"&PTF8_^N? ?SW.!Y'HT"_]:E,VV'N 8D$=X #QL-#\+H[?5.8S\(O.W
M?%W?X/&=7&X/IGU!4]=A7H_,Q(_&I;'EN)R7H?F<GOO)C!<F0SLS'E>?S<0%
M&(=+W.M'YJ,I)_5\- GS;0\]'?UPES?-PG(V<.6B[J84)@"ZVGMG9@Z7PKQ#
MC,'-\Z32-1?!S/+WL#KN#+ZJZK#V,GAX '#8/*@:V31Z6/%_!W\Z>K-U=D#H
M4"?N+.LSN.GS60!8F^E_7L'3QN4?87P!;P(^F53S/(JXF"]FW9.;YU4Q/7($
MPZP3Y>%CNG ;Y3^7<%UZ$HS-N+,R?$IC^ST1X')X[?T3@,%Y[N:ZH4_#+(%:
MN"S] NPS*VM?9O"*[ 5:_3RRIBZ!'=*" (.,%SZM!LSB4PE,VT[ ?#+E.(GJ
M:%K5L&"?0KY^$CZ:_ $N!N%TX73T$ZQ6-:O;^\/RF8D5_QGR&^OTU"0[:?JV
MJO[H&+-;3OAOJ$/([VN(>K+DC24AW.)\,6[>ONU9)L+UB0X@=$EP? DL,TMC
MA+D"NR21J4=G90VCO6AF/PL=0UZD%Z11.%//X<+3577VO+72]Z9NN*J<=XM\
MLJIZDC^7%SPI#C-/,O/97"LT)DO.Q>ASM1C[_%TKE_F1MG'D,A,"X\VZI4^O
MWB9#H  NY3 )#TA",YRL M,X;#?\9N63D<YKWW)G^@UXQJ1%[X0HR10P"(AH
M2))0;U6TC79IF+.==]T]*G'\4KP_PIR2&AO5BPC*O4R\"5/(O-ZR+DRC525P
M?UGY.JFL5;ID7F]H4Z>Y5ZXT:>B?R_G9#0IF?M82"/3:?)'X?N3,;'91?6HD
M);TJJYQ92+R_OJQGIKY&W;2\L-6<9%'_(;AP;N$=%)^,2$'8($Z7@=D5$F<>
M23^5DT5(:YZH6-=W4?DWK(&]6%H0X&F@Q]DM.KSAWW,#]WT!(0$#"6,S_I^+
M>IXA" RL&=$V:[]U=(UTVQ7(L,*((3\4V&1%6CI#T##E4D^LCJ*L5^%"9],;
M9+3&7X DMV#EV]AG&=-J(6D;TG*!,$X51=IP@QB#?Y27$5%+"QIY-"S(782T
M/C@ '8MQ>!]_S$@'UF<9Y?H-:/9;2'H-3%4FV.])>_P.;_Q^7+D_7@!P<6::
M)&JV""^>NX2]R5QW2:P.1/WM],/I*#9%VU8TXDJN7%;3+;=OZ/MN639N*+/:
MBU7B_GKT,G-ZM:A!U.IO7VU5?$\>*KJ;2#S !5SZ>]G=VW;\S #U.V\X#3&]
M V:4+D=C<U$MVDN:U^&B."V^Z:X'SAJ;:1U>U6%JTAITE&D\YGS?BZT[D\DW
M:@#?J^XAUVTY-B\6_%1CFM[\)5$MC;*=-BS#E]<OOKOI9GRJV7UOO>]][%0J
M6ES^[]X/.J YXU-&R%Y?>MM6MWK$@NFG!2YW6'NU>=P65;)%7:D=::O+L&(/
M0MM[H>=^Z??4Y97%]O+*#Z7D5R?0](=W[PIV/C?ZPE9C_Q6+\S_!S$8_ H[S
M?[:S[_ZRZE\]/K\?\"H];7GGP4CT?@D'(['W&OS/6/WLUTBD0-M@#8Y?E=SC
M!,.@;IXC?^]=W=!>,7_?EZ.7O44>W.^ZH>\>6U[?I+L.)Q__PS+>W$6@KX21
M[RM*^\W)?S+B/ZEMWF?IO)ZP\UX3&1^/,X\P5?%E1^]'3M['A:1:% H9$B1B
M/!!DI-(($TD#,Y(+37>:O+^^I7E-3O^;>=MF::E U[9%[Y[R7\/JP5^WY/[+
M$UZH'63_#WID@^N^[;,>&2S<$5!TL'"#A;O)PDFGB7+<(Z4P1DQPC2SE'!DL
M':<A$,DWCJ<Q90H-E@PY)15B+@9D.0<S5U@5"L8"#O&@+!QA)TS2P<0]KHE[
MJMII@W=^]R8\5TY+I'3'E!3>NNNK*;A]MA<#DCD"BCX%\08 TWL @ZT@THL"
M*2<<8C@ZI%E0B&)LB&4>$_J@%D%A[">OLBY<0I!0_Q+F[V,+4>"+%K74N\8E
M>O"[![][L%:'2-'!6@W6:HNU(L);43!PMQFAB/'(D0T&_HI.62LI9IO6ZFO<
M[:>T5O0$RV*P5P?A1 ];W(]4<@X\9#<+?G"0!\@Q0(X!<CP!Y'#,^: D  W)
M!&*&.60=%8 [*,.",B/(3FJ37Q/AAR_>-@IP1Z7HR GE@UL\N,6#C3I B@XV
M:K!1VX*X*M*@(I@:[@)B1"BDN/6(R8*#EZL*Q=P>=Z%W;J.T)(.%.@A'>-A-
M?JS=Y,K]@9K"4R"#*=DCBUZ?%?R .(Z H@/BZ#7BN X/.!I"ZJ=E @44H!0R
M0A;(.XF9Y,%A@??HL_Y2I;(""QB1'8<V,^W#F9F%7/?O[8KZ>EO5NRJQ3DX4
MU@-J>"ZR/!B7(Z#H,3'DLS$NA27$2D<0#LXAIAQ&%A/P. N-'>&,2+81$-VA
ML_DDQD62(63:ZP9@PX;LX_BAORYK8<-CSH=-V0$A'(A>Z0%#/AN$($41@M$"
M.:K E=34(N.L05A$(;PE8/0?GE-\#3Q8*JAW23_MR/SC(1S];*1T,!M'0-%C
M8LAG8S:$UEX$$9#7$DQ 0<$$R! 0H302[+SC3CTXN?<QS<80CNRUSSCL73Z.
MS_CVS$P^-AUI3#G+S3UR%ZO/9C9+?<FN]@I;ORJ6$P-RFJM;U?/9(C7NJ$=E
M72^:%B#ABTO]37(WJ,H!3AR<T@%='(CBZ@%#'B&Z>*HL+%$090BQ*&0L8J5!
M.A*-"EU@X9DE@L=]N;V-CGTW^0ETY]^3ZGP?_[M1KS]?:M<W$[_R^T^=8GUW
MJ5??9;7Z;O)C5JKOXZ^M2MU]32PR% P9DI '\W>(%!W,7Z_-WW;CI"-5E#N.
M"B8T.-=IUU9'C. K2S2+A(L'%:HZ".-T<Y!7G11RV.;MM<L^;/,^9O&JW(JP
MZWD\!V'LLR8?H,414'2 %@<(+1SGA97,(.]I!!]61F1#@'_@+R>-($+:??F]
M65&U92U_6-%4.\($3 \5.9Z-P X6Y @H>DP,^6PLB*<LJJ@E<H*25-:)(,/2
MR948-&$2;(0,^W).]VQ!Z) ZU&N/<M@$?AR/\I?W/X_FLT5 BVF?5>Z  8Z
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MN3\\['[OO[957;\:?3+C15O_>#RN/IN)"_U4Y@.B./)0W"%BCB&Z_Z2HA,G
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M_JI>KJ*YLI(KNF'=("7)OM06FU*_6^%^V'I^C5S?)CNW:9D'Z>]5JN=RW4F
MX/:N]F/Z+WP.LQ=7%3;?0O 7?VGDY8K^[Y(+.:<NI85A'#!BW*3>%\J!4VY(
M!+^]8%3\H_7=X=;@W\SO?!N]H\I63], ;*.JR%?(5W[5JW(.HW!?69(D21O
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MZ$*34(DS<RBV=\S>[VELK[9@6LMWN='<3:YO:G3.AM1$GU4(40#1/)8M&VC
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MS/ NPB,$^^LDY329I-A[.QN'/WK_9TM9 HKM'IE][JY>;6]JPS2QQN@ AID
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MT3]76IA,>^TO>.P,O^]="1^@"882,L;WQ3_TLAM,>A_<<)ZV]PH[5^'?RJ7
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M??W3OR1%*6A#@8=0\AI>@9'&@0K124XCLU%WQ2&V*I8^I3!O*HO'.2.5F]P
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MZTIF-R/)7]-D.AZ-TA 6\^JZ[)$K13@!B5:*<(04P0;%5&I*9Y-#BF I&/P
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M;%XK?!-LC$%)!\9+M#PF93#6.'!1.1.=453$OBS[L#TJ;TH15KT=I-Y60S(
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M?%61!P!EA:_"5Q5Y %!6^ :^5%4+$581KV3;#R@K?!6^JL@#@++"5^&KBCP
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M1]14CY+7H^3U*/F3'B6_BBO,4H#1%S@>Q9A.#M[\H;Q7.@FT@!@_@^!H_$Q
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M&90KGLLWI#=BU"Y(8I"2*J=$,@.GLX8HO8I,9J\]_X.M2>^]+N,_/#0^^<[
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MRZP/_"KIY]&7%.$?:3JYU(NS-AB[77NW07W5G%1S4LW)(,U))FA.DC. SG;
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M(#?BHFJ\:"L03D$2653R+ 6"8 Z,$,6$2K*1K74[34QKG7F$R%L$KTR!Z$(
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MP@?FUM8].ASI6?B_-N 'CI5S=:"9VY,8GZ!J$.(C[B2%?%+<2?''L%66,'0
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MMCL4G$)R(C B,"(P(K ])C"*/0BZ";H)N@FZ]PZZ;^@0ZUCRVB,X8SG4@*)
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MKS+#$$J=DZ,P^7OX,G_Q['G]X!^?QVG^\M/_^O'YA\7'R4__ U!+ P04
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M__2G/[UEOW[SG_^-$/;&N)MM$,:$OSA7@<WDKAA]_.M83L$Q?G7\_@.LXS=
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ME3:38:]:T*'>EC/WNC#[0:_JU\GT+R6;4]OG:Y9-@<<B!]>:O6OFX%Q?E\!
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MI'!'QMR:RO(>O4@9O99HC/$SO]R'U/"A*34?'.^0XV?"6<D18O%3N=I3^L3
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M%\RDAX\\+8_7("](R4TR]&380D>IL5N"_1X1T3-173/SKNJ<)+V3I'L8'<'
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MA2]LA#+)0CK4S4M!TM07)GTIS(^2/0Z2>HLI(--HU-) 94"MP\2 %V'HFH\
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MUR/-:F\"G\ T0,6,P"E,(5/,$)5B+-$SYXXV L=?R0@4@G+,1'ZY;]W3S3:
M(VW/4TI8M E&;+,\5;T6Q'W *T%T=5G*?E0)$-F5R(DMJSQQ\ .0\DFJ4:!B
M%$8UB!J3,1MT6KJ9'[RD//()KLUA+*0]H6O7]WFE; ^MF4=3(.T8'H!S7Q;!
M@T]3RUX8+_9)6#&\_8*9,;#JWRV#GP;I]U?N;]3;WP?95K<PF:@&]P)$*P@M
M2_HADAV6XJT8(IPCW/=R;4G"%?DG\C7RJ:BNJ\+6('.J^MU#LUJ@=A&57GB1
MR+,?6>4;1[ZLJ4(KD"H[(-ST8"*H<$Q)R\QDRC2%A[>,B4[YP63_X[JUBM$O
MI$%6V0?4J*3S;+7?%:3KI0^O'UN]$4.N=R[]\\\VQ: ,64RY5VR%,MBNT-2@
M$+#E>^%E\J[3K58*>-9-V"0NXQ-I4L8I]YMQ7E^'/V\\(&$:S^5U3HS/23;P
MX(N?&P5SG8KI8= BR]5#1%D1G*[PU=GH'4;V.%@=/V"F2C0B!-\H8F6JDRT?
MB,5*!!V4$%5IKZ&<GQW\P60[(O[XDY2KN<2<I$/6H#+J*>\G1ESM'!]WQ;&=
M>A%2:[E:KE:N3>^V5OM4@<PFBO18,0U&D41(<ESUNK<$8BTQSD&)YI0((S5O
MQE,(TP7C;O3^>Q)8H</K8\64+L.[W:,M_[JET3;P(Y?'3RX90#YL/B.D5#$N
MB&(#[[PZ(T3CA*S@1\6+T<RKCSN+N2EI@B@:B8HITH#2)RQ0D$?Q$OI'1!:&
M4890(R6!QI(U[;ARZ,9W8>6+ZAA)5\0R@H"HJI\$"_O?.S>DY0'#&/#;<6(5
M%BY<>$4_I$'\\*$*GPXD$W.M+OJPV5DI42,,E8Z>@C ^QF@!4*V?:12/"J-;
M">O7(P*@%-!Q9/<_AFJ>B0/]'AIV5<L$"8(TYLIK"I/9!,/*9 Z-EBLMS[//
M0@D\^!2@8O],4Y6B&(B ]C<O8!G#39:D'S(34#*(T&FTE+Z2CVL*[5H)C_M1
M-&L'8_\>N!<A3K"GKJB+B;Z^<XH^$ ]M(</G &?MYRQJ)U^;EECI4H61UDZ@
MF!.+A\N)<O&Z%21(YB:0870K*2";25N(B):2K4C<?I&)VY9(W%;!^JRTY,CF
M_(.?6>DY8#-54WSR1"37DX( 2(G'J8DD7C842H7D*;$8J(D4#)X2B?A3Y>%_
M(;.9J8THAOJM&NBQ=W8=L !$O0Y\;4>XAT^1Q=)J^H$*#7'0G04;R_5'/^I&
M'I##. 23I)]3Z#Y$^[U#/_^==D4J%+D^@AAAU B0FSW_!0E+QH1(C)6/<7('
MR][.!G%#-TIC-1X)/Z;@*:_T;K/!*"N6+J NH)?)!92P&QW/6;>BS."PBVO"
MYOBAPXHM'!_8HOA9I@U4OVAOK8,C;I_0P+LU'+/Q0\ ++97,71CA^7SIP_!O
M7'\]#^.E8(P9)A5K!V+2+"@BDZX@DRLIH[7D2E$>_%4 *I]_YA@\"-W2+U&-
M597)%. YRA;?.6++-?-EZ@&AMQ:@Y^HPT))M#HDCDMN0]#3XT/.>H1S&M'*Y
M,[1I?A-,UPP:V3FS<:,8U/%3:^L":Y^L"/9TS$>_BIU!TA)4#T1T07@?!#LA
MT,O8;K/!!52.M!K!S 3;CR!@VN$VM93JO@%;B>-Z.U3GD],57DEX-ZES$08;
MO-KN9.7R7&H7<Y!TG6NM;_UHE[V3%71/M/Y112HJSV*F4-4D0Y4*R#>2"IZ@
M:]Q8(6@SK!@,\[))208 V3["A FFC3#R(F%13>D!"EE6+>F(;*W03.;$"%*5
M5\ R*)<P_SO<R-OO>"E'$S!FXI$1A[AC)*@V,AZYJW=7$.5[IHY5,S9J^#AB
M%2X\57B,QS].&DT'VWD8N__%-GN! SE>\*.\-;@V7"V<G6U"Y1];^G2)^X0<
M"T2J#3<</?(D")P7U_.N>B*T23I&8-@&8SX%X3N%!.RP>JSWK#R6H!LO=W&$
M^SLLH8R[Y);B)L_S9YG]:&=Y]S3<?!@19KHIRK3&=0' M.*<:*P3Y/UU-M+!
MROHP/O)<O\GQN,M<@2I=00,XP1T5[2@_!1Z001!+M(U\LCZ[F]UFNG6J08MH
MS!X1R2Y)^!45A 7+7^_@IQPX<I@X;""+-B#/JA>L6&UDM+*>C(R?@Q_%.)11
M# /6.;JH@5.'W=QY;P2[.W3)"U2:+T4RS<)J5K*?@_ W&%;]Q5;0OB(4N.,"
M%91_E]X.-=Q@0?X )4PM1-L.=[FX*]\A(?68[474(!C]@E@=V)O\U0].L<&F
M8\2.-I:TS7?70Y4P%9.D5 XSF%A8U)!;<IF+#31(Y6*+3BB,K%[^X9/K!R&+
MXP*6:83.\#05[K7^1.,G='\IOW9O#SE+-14%&(6-7+*;N 0C\L@8EKYSS@9)
M^==UT*XC1/M!UR+TY2$E*99QM+593T*J^C9T0=4XZX5=_CSZ%1^N3=C]TK]G
MX(;"Z<!L-?UR)) R@2."6U[BA/I!B)2QOJ LXD4!D32Z:&5BE$UD&%RX_EV\
MB<_#, A/ SC1F0&O!VB+2CE0&>[<D<*^8]V0I)^185C4)8P!LC/#[!GL_/Z:
MFRS9Q2O244-EP&KSBG"%ZU21.6#!QC,E25ZTFF6'/TZIJ#D-N55)>\3'9OP\
M>PR(O0GIUG(=8?[N=Q?A$;:"HBQZ9>P&,IPX^@Q):5B:QJC1&A>4GNU0#?WD
M>G"^!SY<>>TGESZW7V*9.!N@3)P=CXW;*.+$$M3'C;(94"RQS% <((E9%20A
M2B350Y$F=4.HGJ'1L8XW6R_88[7?\!E3\8LMD9X7V$*=05";M8_F$[X]H@VE
M=QV@PA,A.32.Y(["LZ)$S!'R(&-GC#IW)AZSE$U6L$($+Z0\KTGQ@S@/"4<R
MGI/Q9*[84D5UZ4L?OK<\@<$_$ JR"L[:RA1J2]6/=GF'Q.8]CHV!/*K@\H6J
M+)@M.E)E#@SA_XXJ>!K_=T[2XTU*J",7;F1;'M9P._>=,[@,](K2$I 6G"BO
M#'>.$=9 ]Q!D\:83(XJWX:^GBZX<+ZXN+Y:WUY>+F?&7@@6!\\!'%1P.2M M
M?-<RLM!3M:[8G7X)FGD O'1.U<U6NF)4,?92TCT4>:K*=QD3JK?/N3;W]SI@
M5DKJ7._ZG&#]C0FE&=JQEJ'-S,:<7_C(./YJASX+-YT*1*$<>WKN\2AFQDC'
M)$^'ZRB \I$'JJ!6L8#>X7(EH:OB:X$<.G0Q9]BR6'0C\5FWVD^1^DT&O)HL
MW#S*8$@%@ V"ACF]E A%O#OMITC]%I'+4:-^38V!?HK];":@V91HZ:#M<:<K
M"3O7:Y]P\Z^VHW0.IT\5 Y!V93U"\\ $RUAF]3H71QQW!_:;@Y4N?ZHTF,$C
MDBN'<9!B)PI'(Z'313#&3:/T_9WE7;DV&A\_6:X?4_17THOV]=ZS";",,O$X
M:;)):),5'1LT=CBIQ'8CI!$DB4:37(Q7J7YH85)19Y-(U# <TH:EM&/!;PQX
M^<$/*3>'8[P CS"YMSZ/&O>:L, AITG"!$$NCF14"3#R18Z6OE@RLH_NOKVE
M$<7"F O?.<-RF\$6=Q;A(^$U$3M.OJ3,H1H2VHE+=[JJCR-(K4]BG>CCXZ@F
MZ:_"P\5//V0L?*8.K.Z+7;P+J<Q.'"2/62;PBY-6=L;\D;P[E8UY\ -0GN.<
M7%Z%*AGJX^!^*0-0E0Z=&P+A%O/V9@>#G>K%R;C:^, F ,HBPDU01U[^KMO7
MB,AH9>DL9%?+0K:UL6([Q!9>C!7K/K%W^#0>5W,S-2SJ%EF6E)TN- 7# ;T2
MWFUB^;@>+\W5Z&BDKYY%*R0J6R+'F24R:I41HX.2WDH0M4@6\"'6"J%@')[H
M#3>U8 67.EYX.)H(CIQ#(PP/2#XRY$(4QK^JP-B/-%B'UO;)M:T^!=9U,B/C
M7P_*?BJG6Z,U_J'L,U Y#.31K!ZB]"9UWG=6PR1=AIR8LG<HX@<G7%K%TB5,
MF^IL4Q*61/6RG)Q!@Y_9ML\[(KPG$5IUQ!. CH@>\AN1J>._AQN!!F'-1E*@
MD@J<N0)5<.AI5?:&K3T*:[N@%!?3 +0^)P" -30>915*[]PU+TN#97>"S3;P
MF0N^P5C-UKDLW4T+QW'Q$7E!6^SBIR!$ ]!TT0[7ZOZ6<"?/DX2_KVAHTT62
M.&BGD[OF&J^5!Q].X6^75X""&S5*'TGKTY"U /$S[XJD^F*@KZRW Q>^U'SG
M:.8[K"5HLSX/?:XS53GK!2:VWBVSWJRH0Q%^'1^*XA%#+%.Y.7PT,#]W@"PC
MN;P3<@<A0PKAAPEBIJ9J3]C/DWTQ@1XWT#+<5#/%F#J?4$)-_HD%CR%PO,##
MN0_P*\U%O5BO0Y;J>>G'H&]'KMVGH.&0696<=XY(+]%\XH!]G4'O4C(0)80A
M)?Y0IB==7IC?Z9Z3\:7:^.+7XSK!;;[A4X$0$(3#H'0KLD32'3DR82 YY$:3
MY]\0_/9 <F1Q<$P+DY@0X'7!.V-@6][?8+^.'-?N#F:;-AC@)L,N@$B<Z-0/
M53YO!J*UCYED&')LZ[RE6\^RIXH5MC@? N.)<S*CR.'^PY1R*[2.(A;],Z^;
MY.!+&IU4EDP4NQL69+1"(*5G;D<M6B!?T@BD[WD+@]+F+8>Z$H8IPAABE5._
M])IO6MISL2K'$HU/]C? VS!VV+K<<>P0%63L<5(K[(S'LM2&B^;\HLN'"(J"
M'8@' 8*6J[=E&OGX5]LDM(_=J)'#D#X!8W"SY"A:??5'%>7(K^RI'B3\F"DM
M12)97VZVL!OB$D%DJ'Z[BT+'=A71PQ C9=U5E+!T4K@>_9+:4X1"/*B$UNCO
MS3 SX*57T!'1I@'I&8@'31?PRI3M*OZV7R%668XK4Q4M,E9\0^YS&Y?# +)M
MOY<Y52,F3L?#$")O3YU DG0^3!\S7R[U100-3)&%UML>EDO0,E)G1[I?%+JF
M4%).J$]7;EP$Q]D3RE2YW1(@4J49?2NZ_>ZH!-[4'"RIP8'15X'L=C0P48PO
M^^3Z"#K?:UL7-$97Y'KSJX^N*:;E(E)0G4EN?0\?4 +\F9 SY #BCCP!.]-S
M Y"^2 EB8^Z='D2*(C@A[I4<'0!8E:ZX]+>[.+I"!_;WO=[B!&L;@:&1Z!%A
M9,GWY@S)=(TK^99NL<: O^ZYO 0YHN@97&!Z;1&*>K,5[6 S7_JWZ+'%.$)6
MB6$0DT.R&[#.4I MLF.RB/4*+DN?+(ABA3!>#GU("A:R")!3@Q#X6:$G,&EI
MH7K#;*,:P2GVTN'D*=I0O83Z:+MJ'<+>_9,;.N80%6/L;G(\Q?Y"JVVX"D^0
M=3,;+,7^0C='4C0K>2I"9 ",%$[GR"0FRN" &6DL#%/PX2/ G>203,:6A;U'
MN8#-3)G0GIND,@]@2";7JPM*@8Z[/PXM8M;RH47Q<^?U<D54W=?#D*S0''^;
MFZ=1A;EW-]R]A^F9-%P%X0;? O85QJ_!FW%+_[US0^X:'.0,QSZ/6<U+GJZ:
M="N^?>8=DU#K>=S5:F08Q!+.B'^3$U]T2/0>S9SO:7.LC# 89-(SIED5@#-V
MXOIP A4;S)-0F8.;H6++N6&I5+'ZHI2%/EZFDBP44QZ:X>31IVDBH7APJ8Q?
MOJ8QPAW),A2;#DD)V8!?%?7MTYA$2%Q6HL!6(P?_#BB7-,\J>1"@@!$E&M6#
M$2>=Z(0SPF 5X,:=FR\3&#7"R8K.=>8Z6E/?[EX*4G?;,M^Z3O. Q,FB"^DR
MV3IA\NUU %/VA^]&C_.@/B9[@6 +9^/Z+MJT,.E&N/]Z';^"-I,N35UY0(W%
M18TA9AINHE164S(*SZR_9D7_5'W=KI$?DAJO(7B45 T^$#GTFKDW"$_EQSS&
M '=%7OG1,Y=//I10>FE.TS)DBCM&#";(#4(.%K%P_K43A4<Q[$I NESU+/N4
MK?3(]TK6K2Q+I'5,M)Z-%"K"^@^+'>AX07CAAIO+KH'^@@9!(N3R;+;LIK*-
MS/#,P^L3<*KSS_83QC\CU-TOL 1_6?KT.O!_"O#M$J@T+FC8Z>M7WSP5';B+
M2@Y8NO0O;$7^\I[X@7_\S+B0T#7(!D)\Z;?ID=-43(^3IJ IL#?5,RO"]PM+
M0_F%0/>8CRV'2.. 9&ZT7]8(E2%*]EM&HRN]5O24"8N%$;I["L(82PQK5:;[
MNK*QEZ-LM.P1&PW6W3'VI]7TA@NT.3>V@6%(^=**!![]7+\*_#7V*=UWR<WD
M9'\*I^DZ"/?+%1ZDLH73(ZQ+4D0U#&DJKZ%C*+C+D+BI][Y4YE'W.A7,B;4<
MX5X)NB(>9Z W;2Q$6NJDF&5.QDM5$IZ$J5[06<"[(2[V,^[!-XJH8L5JD;MI
MZD21YVKFX4F8LBNGYVOTW(Q@;WGQ_N/.0NLU143!Q,["*K9V!2CGA$E"^4B/
M^Y?U8 ]/OI3RS6O:PGX2^/0X=F%]JM+ 9,L3!4>WF\LCKV=H5W*>&PCHXDH@
M4[PN?16MIW)TM3@O..BUWPMBFT4)H4L?%$F*V;\26!=>543.@7LP@EM:7M>3
MDG$)FD JJ#%)!M>A U''3K<J"I^6!::0)F<:6RK 8LDWD8Q_S9.0O0'RR7!]
M+<]<!R[0[#!,=TVW6JG)<+7)X"6QD";EDP$M%42R*R<C% *,?'.<]VRDM*G)
MIV(2CV1?4UJI0]* G6P<P1JY6PU(9^^=7T_WC\@-BX7<W[K1;Y\LW^)9^C=!
MQ/ JHZ7(:$1MX)9&6_C*'0#>(-4UP;Y)TCE1O9- YC]B_T1CP.B5^F>*85-P
MIX)7"7B4&!FY@$&,7+?[&/UE1T3TI,&?%A9*P_Z.R#U2..@Q2&?O,Q+D18Z%
M)<;"?#F\467VTE-^+,5,4(1DZ041T?N(O1RTR*DBFUFY4]+JLRPD)]\NE+/$
M&<W)+ +1MS%S@-Z_!/=/P2X"1D"/N'^!S6G/#:*#!'NI?@AT1&1/3#'F?<F*
M)&:CP$87/Y=UT788>+=CIV",/ KIC 0Y!!_>?7B7E7?\6_%F&X16N.=EIGO?
MC04U6:K<7,K30(*DE#0E#64T1T\A95OM8SU4Z&,)5*@H3X 1>VDHT*XE/8:$
M:M68.YH$@W46 UL$LDH3ZN-N:SV1:#,*PBU%@!CN?&3OVL[RT%/1]=7+'@W(
M"JE9>R=B[9&"M:<*D^14:\4YT5@GS)%ER*0W\ZG07__7*9AD"HH4YB:C]^VE
M3_;4"J.1]60% H@POCOJR**BH"<Q\*+!JK%DMP4-S,_B73-H:NR;V<\"!IVD
M6=5&UA6-#81\*>4 +%=$=*DJNC+%F6-'Z>9VGD]OPFQB>$C*4!YSXV(5C8LY
MH,SSU0H# B6&([I%X2J;=HT.7L-)=:J#.6&_6;_PE!"BXX],.M4@)3@,TL.;
MNS?D0M0007SK78R1#YD1,S<>M:=25'8L]4EI2B&D-M#YHTJEWU0FU&2C5KCM
M+%>DB;X452M,)O*MT@7CEWZVW'R"D=!Q.67*QR/&B^KC>!6$Q]B+5BCE0*7-
M:"::U&LAM962&M.92*2Z&U<O&4]L??6WE7GNQ58^,J/;I<^#]?OX<X8TG7"N
MT-TK"W!B]A_LU3"7*^IB ?7(D"]HV@$>P2S59&R_[$'-5SL-Q*W='16JM= /
MS2(PH@@&_])'] ($_5'>87,>:<$&BW57C.A^ZGEXIXMKH]^$[C,HK3=86:%O
M<N[',(!AD+$EARF/F.9TI7M)'E]UT0%1/8Q?2XD50?"3L/DS-[(Q1K*O$J*(
MXU&LI2$H^@<DFIBW+T*D0DB>E&1N(IES2)*55?::0BYUH.X>(_KO'?1Y_CQ$
MUD]"CW""1G?YP:1)G?19D4;']TT27^^#I"CRC>4ZE_ZIM75C42$YYZ=C<$61
M&\.=)7QV;<K5'+3EK'U&I0],_>+F\O2H6%/4:^[(>LM,(V %>+3^O[:ARVF,
M E_*UGK^ZL9$N_L-L:9&OL^Q$^ *5%Q*T\G^RK6$WB0L\>0/X<SE/<'%0L(T
M<$B#4/FQ8O1=L< WWM^XQI$1!1?;BA X@TNA.>Z8LVZY4@Z\0Y4W;5[/3F>P
M6L$;QF?;5%$(!9\(%V)^C;L5E<47OG.6U!4?#"@2W^1C>6.\U:N8:[T=NO2%
MI>F9X]4Q8R0IR2B4F2 Y^7$7YW84SPM>\*K7%=2CH1_MB"2I'D5HHHHAHC@R
ME=UG?NR*,V">U1!8DO"XZ)MT'6S#W:,5QL?,_:N] /!VK$.K>WY*0IH<"]^R
M1IU(\@<G7Q93-24G#ZYP-#FWHIN1851'$#0=ZME,RJE T._PO36(=Q^Q_B8'
MO!] ;'F#K\1]Y_W,!O)^ +&;8]X;ECVI4 [WQJ? <X!1'K+=]7AF#\-)&L>A
M^[B+62Q+',"5*S2@=O47HQH!_U#XKX2^G[\0^NV=W;LY;I&@^3N1 $"^=2C<
M9]QX=*#+-(@3+.5E>,>RGYAMXH;R.LM#568$^NC0XCV(G'SH@ULP#E/4RN*-
M6RLT4\#Q3L+[+5?Y-=HW.%M!!\JRUFJU&DN^$<8%V %\G+G8A^ZO/+O722W(
M$4F/7%V=FCF1AQ(D9_OB FTU@<8V;PTC2!J_<X)IR=4ITZ)WRXJ5/?C!8T3#
M9YZLL]W%Z3OO54]< KV6F1YC75'0[(CH//%2?KD8W*OQ$_^%VAD"NP@>F-YX
M![I4('$!GY@Y9L:^1 PIEKHTE(MCZI(PI%CI2P&7[;UQP1*+Y6.,Z'9H*Y8P
MA?CY--@\PLO@](+50N+P@@)Y#E"8!FAD$%NL$T,&N'%D3=<F?HQ- B2,))&F
MA[><0D,!D \19BU$L;L!]:MS@'3$,S0D&5#! \^U0643_QJ,+N@G4"H8."/5
MJ#OCWRQ_9X7[^@Q]:-'K$! =-08HP'9&SH;Q1R!SNG<9"1-P#>,/A+[*Y2B8
M1&M )/1S/\9+H^- FTC\@TKCAZYV,T:/"$I'\@-ABBB,U$'(HD_,5 +E+BD8
M0^<%>!L8J)AT@I0H;AE&@)8'E2=W>R(:57.IJ=PR<H;E3M!6C!Y.:0@?9(L4
MEA='ZR#QJHR["PXN6LJ^3G3"FO? R$DWN&BI;6-2^89* ='PN6X#S[O@>((S
MR*_1&"/_1-:(X.TK&=(T8#X#.&.I!V@)>O =&LJA&KVF#SJU>7B'*.3>M=82
M\XYS2JJX_?RY3R'O,!%L4<^>%S(>/6"58Q*D\6FS< @]4B00[^ J@R5K'/)@
M%"&SJ07UD!^'*6;.!]D,WV1L84]V$6C0H*?;/&[Z_['W[LV-(T>^Z%=!^-Z(
M'4>H[>FVO=[=>_<//=NRU:)"I'KL,W\X(* HP@8!&@"EIC_]R:P7JH ""!)
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M0+7]Q<I/-*C 6UY5J"(.:PG[/1\SAA5B2,KU]22H7&FWX4E0/DN"XL]8I/A
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M54PW^ZRD5'4KG2*AFGC:O+!+P\*.;[0&V3(KHN>82"PU:F7NB4LG>U4@VC@
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MKV?4\)A_F3*@ --?[/B/-(1Z@$2C6GZ""H-/D7A$"Q:U;0^_0+_][M.$0Z7
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M$X5-:]C<>OKS7K/Y,&MY[< VM'-B-21.[Q?B(T@O7A9HKGI*TF=4H5 V9U6
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MG%!AJQ,MU6_&N;@&N+=.X-H*@NUZ&Z,%AQ9WPE#@C*Q(DD>OA!U@+$)-RVK
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M;3 'UJO1%G%%MY DP_T+U,6CTJGU"N7&V'?3DF=??7-B+Z?/^RC> 3_-+DE
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M93@?%K4Q4JE?P)NA(EK;6)#MH/ZE[HX:W5_$/:,BXGO.<(]R^ZB(\KX 6V.
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M-N!:B^#W]C,ZZ:>"EKW@%^'HDE]T!U](J9F]1J;J8B!< :JR/J,?L#6@TXJ
MSLGCBM=P)WNM'VL9&M44JD!.;>\*2ZQ;PYZ&^I]^68K36765%'SYYX50I&@H
MF32I=.Y4N\8[F7$[K5%Y:V"9Q43*J$,WVWB(B3D 3^S);%W,DV(M5=]8IANT
M*02VW\=YH;+&Z8GQC=KI]US]9<OREZUE4H98A'_WT\,%NTRZ_#)Y[:VD6/LY
M'TO A#S^6ZLC:XF.K+7$BC&ND-4C-T./'.E1[X,3[B&3ILJ&\%"T?L<)" ])
MD@'O(;S[[H($"A$O<>0"X/4)<Y)/2D;H#:10%$:?O)CG&;<\:GNCR-(JL>#+
M+Z;HP:NST=S(:JJ74=$94+$O)P"'\MY2)TY-<@C-P,EF),6OI1I,9":K4VAU
M7:X>-7.QDRTG3*,0+2N77@G[7;R[4PGETQ7=A;R?8V%ZY_P]SE8IA%]^4>-Q
M+E3"N_#RN)CF>J:\CV2;?]D0-XL>X^U#Z :9!R"U?T#YP@EZ*]8R!<,X$T-Q
MU[-+BWC7Z24&)\?W[KZ?0)B 9),>0%S>$ZX;0Z2J7R"R^8\ML'M]JQ8WD*<C
M63(?Q<:WG;KKJI95K*=:')U[B8P@F9F5G[Z!+7W7"<HIX'@.H:4VWTHY'WA6
M,WBJ79);Y**9M@GGF]K=ZG)S"5.G=-"[B YETB;?;:B;5&CG:_C)-.1R',"%
MZKN2Q 06D6XS$#@R&UJ$J6DD:C1>N(BB=S+PZS&P110"DW-:Z3=!">3?U!<%
MM%22;T6Y,]O:*-&7J^HJBOV%,61ZL3$D2_7EQZL+'2_CT%KJBP:.XJ^0Y]Q$
M1T11)8&4ACZZJ,;34]]3207,+W&T TF2<Y![ !C")Z.39AW@@KYY] %B)]T[
M0S^G8\ZX(1?G()Y6:P@DAK((#6$P=$),;1%JPV@H68QT$<K#:!19''P1JH0L
M6F1='8M0)SY%D??-#P**%](N'> Z2_P0LI@K]X_,3_(UY7^, :"FR;#[R9;U
M0Q#XW_UD"^G..8$L]5WDG6K*AV.S7X2Z:A/.*JIZ9&217K;3/N6'(U2O8^1#
M?(P2UKQ[C;5/'O*Q!W@TP[W_'I1Q(,U19RB^8F-H6VICPZ@F3$MH)+76-GT<
MFR&G))):FW$1<[/:1AWAY7F+T$^(7+(MK)#XD@J$/D#\'IF)D1!G:^-'Y!>+
M(#$&NVD#Q7&:%P$9XX)A0:8LF\5FH#"<;CJSR>3:U2O\SY>&.]U$QZ-?/!>(
M'A6*PM0/RU>!9J-U/4;A?@OBXTL6NP<G::WYQDG!/D(OS*"-KW[WJ+K8T-$D
M:VCW_@?X5Q9ZD/R>(/&BDU45AWH&Z9L3-(\Y7>IH_)WERJ))G+8V#/ZMV2SX
MER]O8(]P_ 2B/93 #L@HC-T*>ELI4TZ ^\,^^O@Q24]Q,67TI]9TX=^^W%SU
M)U;^JUXO2NM,LW1<<GM]2S@!)&Z'^T< 3P\^=I#>5E\1,#CV9G>% H+W@%'!
M#-]6G\>JF4A2)%\XS;_DN>)0A$7Y$M2R)Z*CR+9:/;X5RMOY%A5SC$YY4F4$
M&5U^-4%E[M%W\Q@-R.SR.5',6$/'FI9CPDL7]/D@ANKH;8UA5S1K";ZMON>+
MB&+ ]9D@"%"XP=#1M"V?(C=R&_7$QI#,*S8AN!:6F]B=IA,^GK#"QY-&X>,1
M:IL =.]D1-2;'=I;"B%P=)2\^W>? -2-?63?NXD".)W2Q,=Q,?!VG?0>>$67
M+('O-[_)OFYCX&QVF]T.7H1O)^<B6X+0:'I@L)O9_U7CL2ED5[^@HUO(5'XB
M'A1,4T,D]5=_?T@WN\])80'EDMC[?0Q9"JDH'*NUY/.%8XNO .FX?B$M$!FK
M</=)S^23\]T_9D?BJ>S^KHTF;L%[BN2R%$*%BF0=HCA%?X9BRSM4D[VK(]0&
M2'3.V5FV40B VPS<1_&3#T62-((7U95[\*$"X^$HA-9<GP\UC=RO188LB0UV
MFDB&\#E#5+?9\2%(:2UY7O7)K3_UXIR+=Z6B^-Z/D[341U$8FY?A68+X(-)7
ML<\"U/I\,8/->^#O\VL-/W.>CM*C8,+,"4I(GB!R*4#)W ">&WSD"[FY[)GU
MU8^2[(ZDB'Q:>VU'_34Z.T%Z_I0Y*(4>15RV-$(:=^7H*!GP)R?,=O"FS%"I
MD#J_9;>[E'28S?4%XE1P-2>FBLZ\<>+X#*=*JP7+W5UV:8S*,$ OUHMK9H8O
M<J3_J0Y0$7#YS-K'R^4J0JC53II9P\'M^^D$:^.]+(L BNJFZ<1BBSI%%@'?
M0%=1$V<WV$LS:WBYW#DY5Z.SOUF#Q.4XJD$BH[D(D$:ZJ#JO.@\5818!]"!G
MV$7JU"4Y+P(\6=(QAT-OUMF08E+QT]7,X1@D%?-X,!>!VE@9C]N_.O<ZSUR"
M2LM[NPCJXCJ3)!?S(I*QF63#T&5G#1(VX*%SEGK<Y><?YBU""=YQN'"#123G
M<Y^JP9K3(F$4,#1>!(FHJ&-@8*8@-^51L%52\F%&M'7YPL7?5ZC$ XE*[/Y[
MEM@10@(KX:$7F51!L8H/PH%-%7;_6)%C1V:56/USQ0H?!%;B\^N*#S-$K;(?
MK!QK:,1;#>%J@Q$)O:MAFZ?-88#IBA8\6(&U*HH<\8DU6JOJ(Q(!6<.VJD'L
MH,P:K'GJ/8-HC#]>M )OE?;)L:@U2!.(^1IK=E)B(5"I8B@\(+EAAXT_M+&X
MC#V)T)*3Y&ZBA"_)+V]HQ@D>'ZB#@6 1;_11D&M*;>4,\BT[G8JWAYW@QDD.
M]T'TK55 ZA4$Z*'@;90CJ.,E#U*: 9SKB^-[4"\L!*CJ.4;O(6P]B;K9=8S-
MY#<[) UJR&FO-#ZN$U\W7LM33+U/OP/D80/>U0?\UWUCY:]#F4@YE<+#F+E@
MM#/HG+U")O,"8A>0WPX1'4;O%2:71Y'OM.:@+R+Z=+!$(&L_5I3%Y2X>)K>(
M0#JUN&)YZ7219:9+N_=9"IL^0<H[9L>*;7Z&DFG\'(4N,O4&*,JC"[&53]<M
M2)K"A4K4-IQJDV\S\ PW9?L-!!_@"2[E0*SK-G0XXP'XO\")M]^BD>NN1K%C
MN?";I.1X\7&,7_+(E1JZ0,B@RVL-O3#JH@+IM$H3P\8R1#>:NHZ5JNDS'H&D
M=S)M,4@X&+*>5K^9")_#[]I5:9*);WV5KSJ3=%@+D6'6Z3B3 ZLHS0+[^N%L
M\23+05+S#'XMP WSX!YO5O!.FWTP.^IDR7I2\Q"61X9M,7.Z6'S=SQFA]_J.
M8.M\!\E;=CPZ*$T//4EW#791YU<;S7#%]-%R[B$)%:22P8TO*2 *+Y?YY(?Y
M?C] -@\7E^8OU;5'N?LC@S\_@?00P5\^8)."%.G&/!TST:;'#5CL+?Q#DOJN
M//CJ$37# "?#;?*E];!I-^_A7_T]Z3VP$0/:!,+==[AQ\"+Q0\A4\ZA'=,.@
MK,$H@%/;5^=:'DK<7S3C(M?(G=OBP"ANM0B["@<C&PGH^'U=T$;8>&+J&V$1
M%C-[]XG_TE)BH</J[!K#&G#:T4L<??@)_ BD:<OUH]MR<^IEE&D%UR $.S_%
M40Q#@ATSHL9W2XI)WP-(TNCQ7NS<&2MF=-87V%O8-.1M\8@!=8-0[A'OUK)Z
MK9JEG'.7EQV&%]XC_,K T\<UA&[RZTQ2D @9?;7O82G@#>2=],ZZ]ZV<GBC;
M(/72OE?#-LG4W1%;#:.3?I;.M0J!Z6M0?R2(E=T"2GSBV2), ./%N3:T3+EH
M$9@*VK?&;,$B\%1T_OG$Q$48F)1P 99XN@AD!7G!*%)?!*"JA &&OK&, $(E
MP@!1VUD$IHKHE46H,X_,5$&HRX94,IVRP)1;2<X,/P\Y%.[*\_QB::U"+#9Z
M>.HU767I(=^]]A,0)*M"M[%^FT@]G^[;3,SIE\VU+0#.Y0:>";^H_@8)Z9L3
M>YU*]KTE4#H8M O/SA$(D5'=P:R=>.R7H^/9C::3ML7<[7; 3?V/AF.A@@,X
MCD]8F,  AI&=( -H==&_$+N==:5:<(-27N)S]S6 WORQ3?7AG\0."-I409T\
ML;GD1]KK,U@:7]'3 ,@ TSF2O3D*=-3G9"IC(WD(!=]6GT/)"7S(Y4/?N8^=
M$,K>"8+S.H)<G[H,=C^Y2TKBM+4<^+=F*=B7OLKI=G_3AC*J@%LH2D$0?4-5
M7RI5!ATZ],C1S0'-\B&DUAD0'F;Z/< 23?]7;?O0,??^;Q;[B>?G3U12:9W5
M2[MSN]K]I$GSBI*D+<&QDDV&C&3#LCM;-W[MW>%L (">EC)@(,DBP3-(R=]L
M'B!\ ;$?>3C10&R 21EB6?6+R!*[O]M 3<]1^I:]_P?*8MNHP78\<1'&G7:W
MNL]Z7>Y6YW=S=@NKL2>O( %.[!YX]X8QBN13C_T:SVGGZSCM;&]!XL;^"7,2
M1'M+GG=9CM'9@\WN)CNB]WF@"E6)B)MO(8B3@W_"39JWJ_P9P_V#5\WO!]\]
M4#Y<O)OS.0%]]@\OYXIHX1]OP0<(HA/*&L%0-V'A4\Y &QOY',; C?:A_V?.
M!$K71U(KU"\@=(*\""U*RBGS<UPWSD#_7,H8T2H82F^11!BJ$<WPLM'])U@'
MVH6S8A$Q7VQ7!QVLQJ>P7+@N_!%MR$2,_HN D.V78E/<HHZH8&@;[40O"R^"
M^[D-%MX[LE"8+AUUG9-(],<L JZQ%V7GDIQWZ"C_)2GB45L$="*\B^"Q6RA.
M=.;%X2)<!&Y\7*SGC5Q$_+"X9"_N$)TUD%@7=H>:>B?MYQ_F+3&(\'*F4W?6
MI#-,QF*=6"7AY%9 1F5;@QSN*Y9CL>QY\96$YR\*T'YILGD__BZH4PF&)$@M
M06T:A(2XKDHTZ44X5%#,7#A1>C1)(1;3E><VD,RZH1D5%"N9L<B,%1M2(OE/
MF3A^@/@]LA5)D>B4$KQ?5R+DAJX3*E,9C=93W *0.V:G0F^!-C<J>I/&#U6;
ML$#3 O4B&A5=5(&Z*LSC0:UCE2I0)U":#<II?X6 A:X?^/E7-KO/;Z6?#%D4
MLC2*SQU'F=79[G:G6C;[T-DR0HF&JY2ZCZR%2_F&Y-#7KML6).ABVC5%ZJK3
MCHM9Y>UJVN;6+)"954_L9]J2GB/$##(W]=\#4-+3VP%>!M=. KR;Z(C^)6]Y
M$S&>01D[MF3Z)$P*2EQ')T25:3!%!00Z3C/;2@Z\=_P8N2"AD/T[O'Z=,*V>
M1"NNS];O]W[HP %0513(([/\ 8*'),E0%9KB2<2\/+X+ #Z@7--,IL$SYSS5
MY>GOH.@ )^5?9-H-&D)VHMGF<0OER\_8=(?F1],8RB8]@/C*^T]6OGTAQC(N
M>INVO.H87%BN+@,$Q%8N,K!^4&90 'G0@TG2Y+U%A%%R0BPF3BXB=$L.<;;E
M5:DQ)>8^/"L'.%&I>!$1$R*GF5/X7D1@A 3<E*L!BPBKD+ 19/UAUE$50Q!L
MZ2^S#@60>_-<JD\J7-XS!4](.5N$-WPHKJ1G!>3J*Z97&'YS#U *#.!M^N;O
M0W_GN_#&1=)?A&28Y(+,4,1G<Q^OSAES:LZ0P]<(RQ(9P9QELL*G^);*&,6H
MY5;_5C(L-,GX(Y>%<_>\$W!O,-]@YBS^(<S%]R3!AW_P+ILUC#D+OMR@MB(.
MIUW9B(3]5TH^)=D=<#''6P#O$M>O9G1UC.+4_Q-7WTR\O^JY/P((6755GKFF
MV^MB#EE^BN&%P$M816/5\+[Z^T.ZV7U.0/YW+GS[?=3-L24BB?&P$0-I)Y=:
M3&I-FD$TV"[:%R+N\#+:HX4G)_9*&'MBOJHG)"*OWBH. #ES%U;'%0-$'I%^
M$1G28[%DWJZKVVH010Y0.U9'5\\[(*;.K.XI%GQ]C6IU1W$<[5)U4^*>,NTI
MPE'4=:%02G5*61]-,D;#E>J&LAY)/K59KC>J"]K6TH,KI*?+S<6<'=61Z$U%
M\!R>W@QR@O93TJ[!W@]#/]Q#3G87>N@/><6S!-X/^(2_U1%J6KEXPA)(K4V;
M/H0Z1O(NNE2S -FL[N&Q+U^<+E*J8>N7*,G?!Q9<K>C@=H#S@OB6&FA(0YL&
MC-A:O_QBYQU&7+P*&^XIW_6WU(E3BZ]]65QF-?".Q);(I%9S+S>RD&\IL>L6
M1QT*?,;)JF]IY'X]1 %<<W+W1X;*KWN>7ZSR(=Q%\;$LY6.?%%HNARYX]AKI
M>ZNTB99$.W)]O@F<).E4=.W-G-9#VS*NL\0/09)<N1#7@@/E?XP!_6%S=C_)
M(16/ ![)\.L+O'Q1D:#'P,4^!4AOJPWF+1Q[L[M"22Q[@$QAF,>0Z6VU3;TU
M$>25?(:,IOF7+?Q3XN3EG!/J([VBH\@NWP$) B3__NGNNYM'S5_M(:&B3Y.)
MB-5%VX:\@@"94A!UG]O(79_;OU (3&  (Q9)9428AI.^2YH_40'B$_I^_[6G
M<JK$9M.^_PU.60Q).6DHN3\I+-!B?2==TA:)-9O=0^CY'[Z7.0$!?'P[O5/]
MW4\/.>VBDW?P3]OH+DPO"NG3%L$809]DY-0R#B*,S:[%8ZA'F:.CMD5!9>T#
M\IF7P'')]P:CL;X=R=X3W_.=^-R"F')!D-M+OI:OXJ./JO"#&^?DIT[PY"20
MI]QG4.]*/?+5S---']@H:1;M>J&I- E4-,"I?;0MI3<;ZN'%M]4V=3B1(TI@
MAH1+/:J7[8Q2Q<@D0VHM^X2Z;A[EB9S3'R"!W2C'DM16\IRN_2@%[B&,@FA_
MS@L Y$?_!?_O#P^X7^#5@IQYJ,'F[?'EZ>WA^K?[MY??'A]OR N<YL/ZS@RR
M1Y3<_K%?ZK1_;K!M-1YW2'%QDKML\SGEX8E)\<^0('\B'G]6/R-V@\IY,0W5
M:,^;$+Q45E0R9^7I(7E^S2YRZ/7DQI)GU5UY6<$$;R5AM]=&AN4\J)=HMXWT
MS8V/$1K^4Q"].\&_@!.D!Q>>TI;4=Z)M-W]WT]A74<%&D'=5G=3P@.<H_"U"
M'JR21:*248),@7N(:<TC_??]VN:/^C?IH+I9G(==O?3M*S0869WTZS[M.XE'
M[[EH+Y\7HY,./"XVC&TZ/35BY]C_53)0G[+]'H0'X!\;,J/Z6N@=-'-4#&]I
M,\G/)Y2Q4G%1*IL5&TF1]T("\^4?8SI6]Q#ZJ*K831!!E78_B/%AAY NB-2F
M C87(3=6)ONB"G?M?6Q^N88#?@5Q^7@-72CF'F4Z^GA#,;G>&/+ C2#[AFF_
M#-1L?AFI\0I<@!ZZ<1*4$E&4/<OCU;$WT,"AIMN1[<&/1VT(9@ 33(5MELXV
M&'9:2P:_,*?>^DD:^^]9RJ?:LCM-*L3TW@6\$&.ZOYNP_R].O(ESH=3+C77P
M).:;S*8%8D_)=/$92J;Q-W2JPCT'1=":3TL+W:=(+VFA\[MNHUMY96_B/!7P
M.4.3@MI)S<]NG"  WO6YNMK+A@QCZ>!1S8+C[CN\G_P$2HV^VY3FK6=+-%<,
M&DNCP_=2UB]?N_^3>#DP.AFR&$$NQ]G9D,5Q7.&4#D8M8I.E2>KD26<"*VGW
MDJUK=(YP_0[RVPFX_LX'96T(5(:[?LGQT3_Z1<!QTHBU6 U$UMBFK1G^&<6G
MJ5W\Q4<T$G)191UE.*!#A5)P.VH,D919_:2;!'$?[(?NY ]S;%#I\]QDDA T
MMJ%CF1"DE=^]C#N V-PP.NM#+D1L%YTGH;B"'/BIJFP_R=S&4+])U(Z5/=G7
M*[.;8=1?B<]"5%]WFH2B6@S]*O0N?"W/^/J=@\>2_4I=J;-=?*O28]#CUN2[
M;M@8NEW_^:/;N3K6(OTG)T5:Z_F6_)XK=W<S$A+QV6?M'$1JRM<BBD9R9XO5
M=8+(:5N+ (R:]]6F+>$LJT7 -S#WK'EFCY7VM0@4Q1/&VI2)R\12 5M@ &*L
MA"Z$BV NU:PIC)F$50$FG/XT5PH33Y)JGT52%M*LB8P[BZDCJW'@.W<:(^?0
MUA<D5P+6,JB+)VVK36&$Y*A%@$5-#&N#A$G#4@'0!XC?([,@8F1SM4'BT*KF
MRJI&I$8W/(R8HC;KLS@HI[\&;:(<NEGO %?>7)<;,K/4%@<8@3Y9*6>+P(FC
MQE2E8.&UUD6@--9(1,D>5%'CT(1K=Y@6RI'5.'? N 7?7MKD7'$9)X0(I78N
MHM[H6%&BSAA='%IT.8(_<TH%< :JIP*B12LS=A%4-=[IQ$SJ742%7V8R<(>?
M88YRA=(/\Y9?F3(%/8-YUK2$S<SO,*8^##,EEG&"%B.K>]8D-%"T$DP=7QR$
M='E+(%5]$<AQBEL<KDX5<)F@24X@?>'K#"SB65@^&8-2X6 1*#&OB,$5%Q8!
MGRB3HWO<%P&90FZ'K9JQB)>9^8[QX((=B\!0\"P3HQU4@+40<0579&413X,+
M:&J$RBV+@&GH=7MICEL$7&-/*D=%GED_0T\H2U@9XWK%?BHHY)KC#'2D#&%6
MY (<LZ:@@8Q+)'U%!7YS$C>HY:-*\/XQ2^)CL:]N?:H*BIEZ$\29U]BZ6"IH
MR\#;0)"U$=)#9WT0Y= >NPA9">(_9PVB0!@'(4]/!4PFW9C<9,8J^%8"]>M*
M3TQP%P'50,)BROX_K2('LZQ?!=6\ ]%&0=6I;E3A-6\G.Z?[3EH1PPK5>;NH
M)D+ULDQB!>^\'2T"AYQ96+%";-Z&7$[WWN#RCA6*\S;"<=,=N5)D!=2JIPI5
MI*Q@F[=F.N:45B4Q*Z06KD@(%NBL(@17/8*S]F<%V*I-<-46K>"2JDP8:,L=
M<RYYRIQ6.$I5'ZS%4;RT:H7?JA\(5FNM@)M 3?@_/U[@!A?QM=4 ^WNYO L0
M00"\*/S!C8X_5L5Y?TR=[U$8'<_%-&[]Q VB)(M!.YJOB-UHC)M7\* >\X4F
MGQ-4-^8:BF=?$Q<V!\DF_P')N@BYR /!-KH%*5)10[ ]@'O'CW/3777,6\BC
MP'WP1P::RN,I,KO_SW_U5_A?'=H!WU. :/Z_=)7ZQ1>_#8J-)S325[N^,5(C
M1>3:@5N(HH=!F)0GLW&27Y^;-B_..?>Q?7-BKV/2[JU3WOC:(*+6G>TM%]]6
MV]0'ACCT%B4ZRA(?]M7Z(O)X+L ZFZ2C>7&+]H__^('M Z6^U%I7XZN??+V'
M!/B 4DQ!DKZ2:[VK_^Y\(2U#CW0A6WU^9N];6[#O1<2LMGTO/S\/@.^^GX"+
M?.H1JAL90#EU*FY%^/*<89V08]$G,&N0IV,/] FL[\02]O^=#?^["/Q;$!])
MKZ<J_.#Z)C1A?W-W)VT_B@9FV F%GB\::S:9:SEJ+O.)<<_VF(3<=,73YNW>
ME&[C)%?SFRTMRK,0==BH>A/+2N%#*9POL69V97@MI_A:GUQ$?5&EA"^# F9=
MD4UW1<F57<@SG,Z:4"W:))+Q=1$EO*S=G_ZM.^\X*GNWJ<?MYIG<,:@\@^3J
M,L: ,0'-*K)=S[I^S: *2',O(:*01DO[NXIJ&!=2^.2!JJ_P/U_XHE6K^-)M
M5-E$V^'E;NI_H-!>D#I^L$:=*ILL-H^$%D9*Z:#/K\7SRFW?U47MHV\IW&^7
M]=?#[B@Y&K0;)DX. ,6VTP<PZ[WM/J[$]F:=V8N+A^?</NJ/[60GLO$OI]U-
MVX*H1>FQMT"_K9)SBJU_3SJLN,:29W61$46>$ZFI;)QHU>#ZI;BJFBT8! <,
MHW,EN=H#/)1@!4XHGWO\JC!#ZEQAG6LW>F'-2#K7<X.R,5%)PDT,%54_EK P
MS)#&K!#J!E#IDKS&:M"YW7M?_ML0#9H=N453/181*\#6O<0?%IDW8@->=L9K
M*;,/$F)I.81:.$14%T%>?(K5H#(<4H$[ 3B4!QE"G)H$'Y<9IHT>055:!*W)
M>KMLWB@)7I',!P9G'H,E?CT2U?!% ,;/\(=;"!;R]+K8264!OX@8*)74A[/J
MJ #5%DJ4!&O+E"0U#.S7 LT0[%$)[:6@B3-D20W;6F%MK&=2 ZWF *R 24U)
M!%"AQ=V%E_ 96E\,*2M.>&Z78+L,XBCKM+=K!:Y!'#ILR6L0QQK$P7;+_*\3
M9E!?WGZ+MH<H2^"IAB+C]AO$\,P;WR$ZQ!KZL89^K*$?"P[]X&88FQ!?36OH
M*&91.ONQ-W[R9XZE:PMA"PE;V(RB;0OY"Q%C=XV[N[:-@L/(.&WM<:27'SVE
M^<!CI!7Q022O O?='#1*D1#>Q4D;>SHJA-SY)09_X8T%'#B2 7LHLDJIXT^P
M]OLHBQ4N?>CP$ZV\?GXZ!6'U:HF,)0N-:X;US;RH+Y.B<HP/^#()K '.;&%C
MQB)B**R(!3.)\FP) S/0]VIR")A))+9&?UD?_642.:F\*UM&N#4FC)_[LZU[
M:V 8+Y:/:@/#EG*26[;8-;Y.TFMSLP90*3&V[<W+**DFCN8 B_<RRIZ)0RG/
M[#[KBF5JCC[5R#_KZEH34RP3Y7F_:B\)Y<'NC!+D?ZX@\X$LYCDIT?UUL0_\
MOD& 0/+OGVZB$"IZJ0]UJ)=JM6TKT5H];0V\7518I$4!M]@#2R]^1&YO%N%?
MJ-9K'*I,REFK.I%2\48N;*WJ9.\A^_(W0Z1B\R)?C%,<9+OSYHW6L&(.%-EB
M&:C9$.QB'&JV1+P86OA(B8MS];(KJ'VQ2&>[)%@O:U_(\7[.H9: U-H7:TD1
MT=L&:@%*')_FEFBX?.G&\_QBD0_A+HJ/^3_:: !^"9P026,4"V2GB3:-MIH%
MU<#8:Z1MLK^!)(4'A3K7;AO9R3/^L7@MI_S**X *<UR\!TI)C6'WTF=TEOWB
M:=\V+6U\=7E0R(F7 E#$*#_ &RU,_0^ B)XKW8G97>[F)G':VECXMV93T5-7
M6\0?-[L'>*5\^%[F!!@61&ZG=ZJ_^^GA%00Y820'_[2-[B"6Z1E[X(>,H)MS
M4:Z#=@MMTVSNYZ)04G5*<TC1P4W2Y.(!NH3AYQPYJ#[6*.WYM#Y/'#^P/@MX
MD\UQXYS\U F*6EFO4!R+/P!DAO%]EL*]1I5#D79 ,HD+CS,I:[J.(-R;W2V\
MIETX8G)S<'PHCN(O!(X.LOVO(,[%8XB+N#C"WUG=E5M$SSQ&X1Z]3BE^Y[+[
MV\<V6&]XOOG'4^#O?. ]@?00]3UKTW]?E7!]%7JC"'S80-H(II!QX0<HTD&W
MC;FT393AFP7 />'1.95\:M([Y!7-E"!]-[^I5VONX+&-SJ PN51QH,+:#6N4
MZ:$EWL7M7\T]*E3R+=G42VZZ(Q71DOH)??7FVH2UR:\=[,ZRV]NWUY5=O;%[
M%E+P508OV-C_\R)\9HHORBYX-72JVPAJ!=5\&;BH_))]9%6<BN13[JMY"(LC
M_BF.$ND:*>5+DUX(3W[8?N#]XDKH_CZ3'9UD,R?>1^<[?1\[O\]D'W\'R!,(
MU94/$#M[D/^($G1KA6R2C6;/PEJX*Z=_O=:<X3^$:>R'B>^JQ)CKT_IE+Q!_
M^"[ +_89)>HDB#+0NI)\ >W?D0'W.4K_+TA?@1OM0XK8HNY[\X.P()?[*"[_
M";4C:0(33\*," R<C[T=;]$W,RPB"!+K(F]2&#G\UXN 2;K;&T=X"XKSQIOT
M<*FS;&?[K %CNN@19H.<XW.O-H=QH;</78_QS1T-.9[Z3AZ!/)8XZQ,L/SR@
M$R0J[E^?-=HCXH0J3LKRY<\:/SZY4,#=.OLJE"HEP\X=-G<D^65"CFB0A:2^
MJ+E4)@Q)6<@^<:K98I$L<R\+B@UT$:+30>$E%:P_S%894')G]4)8%E$K5-R,
MP0RNF35NV#"G#O'T89!["(T!PM#[&QM+I((B#;RB5<8J=AY_(,<O5:FPZ\TS
M2%OJR0LJZBL;A:59O(,G-FT9):]525<$/X"*'/#YTKG2&,-EU"%7R<-E;/8R
M:I6;Q?UI(:0J]L,@ 9*08%!Q[5ZH:57X?55LM)/GS*OPL^BR&SI;E<I?Z5([
M77+$]R[C80,C]XHO.'@9CR(HV2"%0<;3/::P[LK(N.7*,3C!=61<6;.W['AT
MXO-F=Q4$!=>I'K?(WP[Y^:\__0W9&>'H?T7_?Q5Z#Z&7N?GF%E>)C370QC+F
M5FF\W@W:>9;R-0J"712CCHIR. 9,Q-I4&<ZUZD7:F!35<MJ]N;X"Y"N :[B)
MPCS<,G,"%"U!J).D90IZ"?2"0UXN]%V81$AK_IE&K!//9 Y\ ?&Y^ZD8;OMC
M<P"OL#6KQZW\SEI)3D(E.46WQM5^'^=UC;NZILI;@O7).9RP2=)ZR=\S%T*B
M\X;':"5%^I,X VOEE]\*?3KTZCC:"/V3N#!!K0IDQ@3-/0L+JIPR(6QLTB%<
M0(K '3X?TT2%XC&0 ;QY\L];RYC+9:! !LT<>,A,],&>YW%# @'>;1;7<:9%
M+$TK)I+XU.&(@>9 :UW&,P%)]3]H[FW#$A<O/'<Z9%:Q29@+-F.9]U&\ SY*
M/$Z*^]2/B_1;Q<7(V-^=+Z0:#/#CYF3M5F@ST.%??K4.-'-=15_^;B_ ;/5%
M*;%R?W[& &L@[)&3LG8S6B*J4K*^_,X<(-- J+Q?MSR*:G0TBLQ@16[6M("'
MBW6&;ESLZ=01#8LH6J0V:$'1N:PNKP6<0+G.?D7[T=GY61^;*:,2%&T6(>Q^
MGOMEF6@B,WY 19DH8_9U+H*)S%"%66^X??(*+:]WWGMDM*S"S;YGO56VRC$C
MPE]FO9]FR#G3!^+,NO3;7(2<06$_L]Y9#=+,@!@BJ5OP:[$%8<Z;/9,V09ZX
MHN? SOJD:!54%(6?S7K#S)!$= 7 +:-:GS4Z.$=(G=0=6R\Y61QY/4CF\$BU
M09;+* !I#<O$Q4\JV:/"T7H7&L4FYW$B^0,WE12:G/O.*CZ!_#&IZ^99=2S'
MQL*J*+TY]^U6?%8Q$;7K+EEU*+D#?%74#R7OZ^0%]B#,X$NORMX%K$T=\]9K
M99\3Y*VY#ASW*_P=#I,4T"+<X-X^11X(MM$M@$+YT0^;DJR;7=ONG+O+@6=C
M%3ZN.H]70?YQ^*?-KE_),=>^'_NE)'NQY+*_8E](/NVIO-\B]%9I $_EJY-*
M#\<7^+(^6.NS*8=2.N\-](%4\JVUDI:$2EIF'<]7/_EZ'P-DY@.0B:=3'4[L
M=^VK9<!Z'%1Z+0/V!^=!E]6:;M&S0%!ZF/K2Z'S7#'%>D12C_)'<_LV_C'AV
ME9>]< US$:I8Q/8HB(!5L^&+V W;.!M>:%I$_.I46Z5(&%O(NZ^V'2B\M#==
MB(&YKV6\)EGU3H:-EK?!5'+W1P:7_!#""S?+[]Y->@#Q]N"$I3FR?I9%82GV
M89.P3P'C7Z>:JB3"WS? AC<\<)'/;C=V?&T0%7.H7ZS&+K/;9C4K&EB@G_],
MTKQR2@KY2Y[:O! W$&D+;T26KT_"P/:!PJ2&_E.T$TL)O<];<ZX'/SIASKQF
M2,Q%,)@V8NY]WER B7)H(^2%'GK2\=DY@ML()<L-!7/(IZSA MT--X<+",S+
M&JS+C(@\UO/&"5UDL"&<=)TST7;H7^&>PQV%T\K-4Y]#/TU>WSYW'UWOG5YZ
MGUF0ACF'<O LS;U'YF*<&E'.?-4H.:>$Q]BF$.M1]FTI?ACQ<[6@:I[2[;SM
M+>M92!?AXE<9<#%ZBV:] R;P:_EIZK*NMB7Q-&G&T(GOG^54+UZ"6-$W$B\B
M;$JI/"'C8,]Z%TRX:C1<@6LQ:J4WH%E4M6Z@Y?=BW]^TD.*.V' A.17B: ZH
M"MT?YBE(FL6;)N.9(CZTM<BC4H:IU8.WD)J!*GWS;1;,< =6:*^\=$Z\=+@C
M="T-:;DH>NG1G'^!P86><EYWZ\0$8'IU)?SO*(TM3$#IT]I&3:M\,Q*[,[C:
M<L4VVKS#M82?HLA#167+1$-6;L3 P0Q(]UE+]JPUMY1F315S!!Y^"25G(:53
M\776MKB'$')>R%/A%-&!?RQW@Y(@1NMAVC*H,<WT/CH#/ &4B0Z0V]Z"#Q!$
M)S2[DE!889[,GMJ6]0F$4'H)X-RNO*,?^NC^2/T/P+,POKZF*1]#+N6U;(DU
M519XKP45>!M8UV*RJDK4&VL1Q,UQ9W, UG.W+!(RJEV5?0NO1UONT595,&W>
MGG=AVN84Q:8#3V>-'[!'H+V"4Q2G?KAOV9%ZOUAI(>JM@64#(C77IC445FYT
MT-&4$-\HYTC23BD=])FJ>K#>1-[Q(?1002WT("6B).3KBQ(_YVKQISC*3IL8
M,KVCGZ8 ( _@'2*EQ(?KN0NS(RA>B>+<1GG?TP;A/:3"*,[+Y6^C!P^NSM^=
M[^!_TW/"31N"@QA%+R]QM/,A;T^2)^ @QO6OZ!M:R"U(W-@_"5(#SVAF7&XL
M#M:^UVC,8A%2K@A8"IF2"L$AL!1F4<:E(O3)5NP&\T$540X7()HIM/I0'=KY
MKA.F9:-2J"\=G(D!\FL2IZU;$/ZMN0'A7[[<1&$2!;Z7SRG7X[!6?&I3;5?W
MYI1S0;@EY8FFVK5)K8V1/*S3%\CJVT.XB^)C3BG7Y_)'SG*/W"/)7;;P.<$X
M[2@-C2&R%IX7!G<&P6&[2B[QL 7[Z!1G[P[<@/_?]T)PWL9.F)P"I^2;\$K:
MQ\[%G 4[*YQU'EC4LF+R3IC83QOI/#EAMH,,)HMS<2 AJGJ8AI(!?H'"?Q2&
M(/A+&5-47;0X5,F-#2OZP@P.ZC0VU9D\S(UL@-1 H"%R._U3+JS/2"!G3;K5
M4M^T$4M[AD)U=U)TNF%TDLQ8;@XH:N A;+WU^+N#0@G21]]Y1X_U^/EC\:W?
M[_W0"5W?"5K1I ])DJ&H\+OO+DB2S0XR;Q< #\N>5']2<UC0UOE>[M4UY !0
M?:0&!%VVUF?]!BGS>'7;Z%7R>=2WMH)/U)96:UW?%#)$KU&!HE&VI.'*'L*6
MID3-%3JVXDA&1F7 B G8#-%/ZS00 2UQ&<QMW-D4VXNE.1R$*9)L 5A$A(PH
M?C1SPS)RTX<0',4BLHRTTX%41K+$J$CKFPUH3 M0B=[?YQZ;.1 _C,FI1.R_
MI=);E#K!K/!J*^0E8O]8$<,AQC"UE>#]<SV@EU>I<AM@"?ZO<Z_",I!VB7;#
M2ER6H[QU@=O.Y6[NF2TKS.3J&%@VJ3$F!Q7B*2/PT4$#'WZ4)<&Y.(*-,05X
M]4&M(_:3*\_S"QA:$)L3L"-@L;Z+XRB^B> VNFB&B$>]H#TOTC.NO/]D29HO
MN077!2WU$\E'C:G->(\B):,PKS/QXL2;.-]N+^?6<.:YT$]8,$]/?=GPKAME
M81Z.EU]2:#LN=H@>-B0TA &A1+P$V*(_SFH20P?6!THUCYO 01)%3J248@'D
M]O+#,5S$%_?%(P;5^3E$ ;Q\(&=P 50.;YP$)?3EDNE5DH"+\)%10^GC-"UL
MJ14/, W-D#2D7!MM$82+^2["$#^$7Q.J$ QF@[/W&$F[*CK(DWGMW &5Q@_&
MW0W+<(XH(=Z1.SA[CQY+CNI<9IC[74V1;).27,8HU"7AY>T\9,#I=+AV E0T
M]>T 0&J.ELT(]V_!08CS[[>8-!NA]7%BNLYE&XUZ3',!%(4X6:DNY [:%O%2
MG>U\<KEP2Y@]KJ6V:7=-V,([P=U=VP*WX'B*8B<^<ZV'U%I?><C5AD?8FQLG
MCL\H4O.(5*JK-(W]]RQ/X-U&+_F=S[?''..L]KW5OC?1U?T&E2,'3JB1L0J/
M#_"PR:M<7>9B"QOU-C3<99#\^Z?G*/PM*O+7PP\0IZA>0O="QN(\; Q]?*/V
M8;TXOO<0WC@G/X5_Z4R2Q#"X^NJ29YMS2CP/M-:KK9YP,"2<"_./Q:5\RJU@
M&) J0% ZJQP!C-(W=\LD6UUI6VZP&MHBW ZB2EX;-:+^M CDI/O"^+=B(?5,
M&?HYA11Y%,!%$.GJ59SLXKU,G^53VA9!AW*=5UB19ZYDQM:8FS>NA#7991"?
MD%3#J2 OPN<\1CKD$&"D@F>0 ,-U,U M%XN@+EWA.+.-5N"_(H1OB)E3XDC.
MIBC=V+@4,TNB86;'T^1$::DM5CS[$*3"<'  J>\Z@3GQ2&O$@(2(@3S2/+G*
MT@,\'G\"C[!85J\U&D"YGV8QT0!6>1#7> !;XP%Z+$TP!9*W]^J9EGM3%:*-
MR"U5]M"89BNR1;R]S-J539;"*R'T(#F);$V[FR%!RISR$*.3(8L1Y&F<G0U9
M' <_H'0P:A'LX\/J988-0'ID %-9680;9_5EVVJ^6G"&[.JU-96+,NL-S-SE
M8;"A>G70K0XZ'2)5)44OHW;PZLP;=URY+1MS?RMTFL/9T0X74:A:.JXL&\\B
M*EDK1I4I5DJM=+TT=+'WM-Q*V(M$%,=<Y9;+QL)J>\S(W2FY<0(W"_*I)9]#
M"-SV6^0BN>$)0,;JF1,GLM:MF="\O4;:-% X<0C92E)=A-=.XKND)6+;KE$U
MJA>ZG*B:M<8&9I<DQM3(+,?-B SHMS.&P]WZ0982O;&DU@N.'J-'^:#,(WDA
M64-&T[8UOP-_?X#$<06GY^S!<X:F Q'OR^RT.U5L#-.66IX.W@ !T5',>#+X
MZ@/J"$5V^F7=6]K>BHYBP7+IS%-\'*,R =?B+&I,&@0=8R%U,M; F,D.\%KD
M82WR8(+'\4)'6@2!*;\W:N%CY@4*=(?[K0$^P[3:N<,G_8 +*M!SC]188WZL
MCHN<+5U.=>[)UJ0UH&@(S,)6K#7"2"W,?0%V@F CSA@.#^S\T.]%</3B'8;'
M=;S"_[1N-T(%CT1;Y8TWXCZ3G"N/^CWW;]AKC33AM0;"Z'"#_#D[5D!!MY%!
M!=,M?)FIQ4!ISS)=-%O?9)I@@3=9C&Y:_B7U.V@^R'SSQ[?5=R**YS71_R&2
M^' ")*A<I55%;>HQX>JK.YHK>7'.Z*HJ(:?';?4;FU)OPK:WRA;X0)>=T5?#
M)_T%2OA.%@Q'?"W'Y!"K3[<D$!+#8G?4MJC;$N%"B=TZWUN7-M1M"2MB]=(G
M^AZB.-V"^/@ B:A4Y4E"+ZZIMHEO3B!V$/D_ @=J\B6<9_I-R.ADR&)>D;UO
ML_N<@%R@XEI+O\]:I&R,;)4=41H,*%YFAVSG%(,#"!/_ S2V*WAL-SMXDLE"
ME] HAM!>?2;@/KE#SE*KG\Z"3"=X<=Q]/Z$BN%",SW>@HYT0%L734R=AQAGP
MNHIO/L'6/Y')D:.O9*[Q$+[$D0L29!P&3NPBC>H6?( @.ATO]X"KBS;P7U'R
M6PB\*LRB=;[AY>Z[/HFD.#KJ"U2&.H>#]-K0RR\0GJAD6A<SK!0\U@F3K$+<
MUB"-ET3#!MD7 [:M0<9=;J.N$43"I@[=QXYZWO0:Q/U"34&6O"B/*@:A2\:4
MUL,$4L#:N0>:QW$+:OR:6.]R$[&%%N.E_Q]*/P?>__Q7&N=VU/(?(6S@>WH7
MY!ZI__FO!.S;EWW?.5W[9OTP_='SC[5OV@D"1N#/(\W/W'?X45S'@Y'XZP42
M.R=(@/!2#W#DV,W>P5_@OR(-(0H92Q\2KV@R EYN=OO+L:,]#MGVOM_1^D6+
M/.9SZ0*T?/ECWFRC>=\LAX7JD^L0!)\'S'(XV'[6#H<@N,XL!T'M \-&@U/=
MF7_Q.EX>R>'"ED!0.JY48%![Q<S&@I=_4ID$GL-:OFXE!9Q58'*I8F@6*_D%
M$>OAD/"^<,?#:SD@8T10IJ_8<FRXY5"\E]GRU8N)G2Q_M>5@L*]4AH_;\O6K
MJ(:N I*?C;U*1+WNEJ,SYE[A<-E;C@[WS<+EZK<<#&'[!D^4@.68D.\;OL@#
M%<O_Q53>RA.[8#D@8]@I/0K"<F"X.>D$/%,//7"L'1>383D ' (Y/J9#Q;K_
M9BIGQ+G3+0= DL_,>AQXC;QJ%OIW.S:<&B.C I?_M@,7HC=-!2;_L .3J:W>
M_[0#%G9\%A\X9>V);FT)(RM/%$[A TA]%RY!>Y&$"\?-6H9B+4.!Y^."KZ?S
M]K8QQ55G7*Y([AAO+U-([/(E.A[2NNBU)A[+WI+JH37^[2A[K*F4<C>"G6/$
M[&9"D1W!NX2GIPG+XN1?M![F+(-ZYDFMS9D^^Z10NZP9'L8$YZT9'M)"\;A%
M>J/16&.61P?5<.L3EH<6#3H6E]>XY2A8$[L\:8358,JH)"/+$; E[&[2T)#!
M1*$\[F%2/S /#%SZG.7^06$DIKD[)O0$#D1 )8^<T.<W</4#F('1+JSFR?O-
MK@R@+>K9=R*-48SQZM*:K4NKCIPN X99%<K)[346HL)%M);S(RR#WD<_Z=CK
M8+34 V?=N^2?0 A/8@ )^,H[POL#G<(4\FLZW;-ZZ:VG!562J.(O188+?36,
M3FK\5 M^L?R"^?->$K*WHG@*]R&\=_PXUTTVNS)FO1M\U/K]W@^=T/6=X"&$
M1)_E<D\ASSZ$=]]19L1FEZ=( *^_K$D^J6U3FU2R>R@E%Q&/&=R[1B2\!KLH
M!G7.+DCNOD.V >5VN+[XG$M;*%X:]H029Y ?PQ1 @9DD0ZC\HF88X61+FK^&
MG'9'K(%):JUM^IU7J B3[K;1-E7">^#8*>/;&C/U^D4OKLE37KV?J#JJV(.;
MV$6)C6':4LEO#(HLECC*ZJ"VR1O'U)V[*8=4+=5D*%9?O32C(H5DC%[_ZIV7
MZ)V_L#58[HD6XH-,NX7E8'#R 8:YPW(0^+W0@ZPIEOOHA<X+QN9B^?+I)V0:
M^\XB0AJ46G86$0U!-.HL(@*B9Q-:1,P#P;BTB(@'HG7*\F1FOM4+&K=48/*K
M)9B0K6#6A,4P(V):0FBAQ^)2V:MB4=KC!2YV<8V/62,R\)&MZ_/,A@:AU*13
MXAM!N,.\$ T'N6'[Z/-S=6=#W0)\6WNG/OJI; NCF=8D^SGF=A.*V5-IBMYG
MK1PPXG:P\-5&CAK6=&KB[J]O7SB/N4'GNE_]EKH%A,:23S*RU*)Z6DCOJB\E
MR#VB, 0NXB>_^^GA)?8_("DT3R8\A"_9>^"[!9EO8R=,G+QU7A2]&O,F2M*D
M?-CKD@%,]&7;\"K(50M@Y:=U(%9P?^3HWNPX[H1Q1#7H8Q:@,I)TAGU-.RX<
M JI$<N'^F@VXR"08_L]-@0R:WO8 D-@2@#2?(?SK&W"CT+L*O>W!C[V;($IR
MSUIW5=MOT?8090D4%K;?( ,];^'G4=<LSKV?+UGL'IP$7.WA/R,..YJ'&S'9
M^>^*&!<P8:XZ>,C==Q"[?@*0TQ[<9\C:7[U*,))=L$<V;+WCK@WFP'HUVB)$
MXQ:29+A_@;IX5'J57J'<&/MN6O+LJV].[.7T>1_%.^"GV24)R!MW"@* A_=B
M0Y@G^#[*XL^P1_P-'N$40&8 [S6XPM&\?YK9S !7L<,XR63,/,#YCYO<^9M4
M/(B4Z#)@(-,6G6^%A#53QM%H!_Y/5KY1N8T(!MY\K]ZA-)%7CP!0NT>-7@%4
M]Q,_A5)'_.&[H%CC*Y1>]H5K'W><)ONLWF1GYGM^6%"XNMJ=1;AF/*UI/L;F
M> PJ)L83<F$T+FOZCR $M!".3L@E/MK $B3*0 >%4-3!%&9#PN8;U+ 2#>EA
MQJ3%&52H5%:"E(J+%'^*3$;!\LJ<$\+ S1L8 3F6PV!+Z5IC4N5HH4&6+YS_
M2/!'&"TBYV\B[CCANKE)@136-.M,Q4FCIV:=]3AM7-6LDRE5!US-.AM3>5S6
MK+,YE4=OS3KO4WV,EQ(=Q1C[KZEQ/$K1-\9@8"KZ"CG'3\8HHU)#NY1 98RN
M)C,J3 E2QF@W$D/%E !E@?(R49R9$G@M4&BF"3=3@JXQ&L^8>#(ER!BCS8P(
M.E,"C#&*RG2A:4H,Z<8H+&(1:4JP,$9]( 2Q65/2Z-9/$()0W+DY0PB20D4Y
MO_K)UR<G=/;YRM]0N56P/\-[ZU,$5754-!%(J5\$O_?#/OKXT3U[1:@@_$,3
M(0C_\D5T6H2GJ$8-)24T4OY2<:60AH^C:Y'7$12]47FP& H_49QL<A/1_I!N
M(7E?PT]^Y5DBQRA:%XBD/R2V@4W\EKV[U=^@&G*"5S R?4'%8\32AXYO*&E?
M\-H1Y/THMWK9J,7FQ623!"1P-Z[0_^?6(P_^XN_R8,_0RQO#/R*3D0,E%!%2
MD/,A@V!"I6/W:$^]^\#I5\D8.(BNY97S@1OR$.ZB^(C*0BIF#;(_:21EC#TA
MN)%T+10]O+K9-9,46ANYL_Y]RZWE+TZ<GN_"/?RW ><9/X3^I;U$22Z>)YNX
M/E=)^RB)<RZ>$74MO-F&FD' RZ2\6GPWUY.;VX=S[>*#FK_O0_D2][#Z($A!
M[#M!<+[:[0"RH6_B5^ D4+U]#\Z/_E<0G+=1O]4KV.?O=H0I_X&0\!W]=(+*
MP,=I[I!I_G$\G? /:RN=" (CZV,&R8?-QLK@,>,^H/\@L3CC*SA%<;J-<A%7
M_JU[.;QU>:@R#&K(ZCG"6F5I7M)(TQ41M'$:X)S %+4(<=#A*&O+/+&58( 2
M ;YOO[$TVT@GWVP1_IS0D\ [I1O4YH2O-';*LU'S!$X;KU2,[ 3AGZJ./,4^
M.B>DIJ9!@G76TB1 5<0G:O*=$WS34.0 V[*EB9KZ:50QZ]2%X52L4X8)W-+4
M6/6T*V RGQ.&=M"N8O GB-^?4"$5L>!;FJ&L_RK#&/ZM"<!%&LV7)@KWLBQ+
M;C=/M+T6VBZP<V$TH#R,^"@WZFY0U5WW +P,*8SYC*[/^?RH#XA2>NA[(@Z.
MO=E=H32AXCA0GG;$M]57!+B92 *OK&=X_II_:96\H+\F)3K*LI8[^NE(XCMY
MQ&QEVLMXK$[Z7TJU]U%>.U^H;7@JRJFZ1CE5+\XY9TXHZ[:=BH;2IW(E'\J\
MV;'XMYS[DN(<%'U$\E%J%Q4HTSW)1XC<V(0MO!!/GJ,45/.$>@02\8@QZ^/'
MD[PQW7(C[+VAMI?-?VN0RN]<0:[_40F$)(B%NEH7O\(EE'9R8&DBH-$>?J[2
MT531L)/R*BJ96((-K9BT*G!F4UYZH+C:*JS*E!"-1F@M4"]88)>7U4J1\V:$
M&Z$P,44L-'GQ_)7*V?:73LEN/+^V-+9DK*@B(F3/""+"4:$+ZB:O7]5IF?BU
MG E+QC%/C)AZ9(TGH'$"W(+$C?U347/P.DL@"$G2%*HIG$OY_7F+RE<'0YT#
M!,T3^WF2[9^GAV3-&/LUG%F?U5J;0:7>4[>H)X0.'_HCE)ZI=CUV/\E07X4@
M\"%3V1Y [)Q EOIN@NK<Q.AQ#?1YLJV$MZM1FT V!Y-:FS3]N]Q3[W^ 6W@W
M0%&J^>4G_E71!EF-]PLSWBMC5.J\5H*/O>!\6&)#:-N<[FQ>G'@3YW1?E/A[
M 7&NB!-VB+.SFNW9A$#"#HF,HN_8-TJ^X [Q]#1A651G]F4[V2X<J%U!/N_L
MNR562_7Y%;@ 7F4W3G*X"HO'?E X78J58H<.99T;14#*K_4MFM!MLK6*0^'D
MON1J,+C%8I.185HF.)6MME6"*%.;# 2%1 1/RE#9W&AT5C<)'P0,?9)U3'H<
MQQ(\: Y8F8#,QNEJRX.5D]F_!]PR$]N^)W"%#+QG>#5 2U$1/S-"BJ6E?I*!
MM,*EB%H*"1^A4'172U-UARAR@Q5F:QQI_92:['ATXC,D"W\?YFG$R%GH1EF(
MN,1+%/@N9!W3N=?XYG.Q@1T#F. 0LJUX7)\G>N1$NL_/\KVZZ 02:IJ76NZC
M^!E\:Y%)#$]\%KIE^"+9%20VANXL+Z_@J52;*K:IK1,?[0B2Y9@KPTC*\"H*
M09';F[4$'B<CML<\EJ&?L!I& V7MT'-B+_E\\J#4#5O^\M=_T), N?K*3X?I
M/DI'S83!-I5:)=8#?H$S_$,#+_S+ESL(37K&DL;%SY)!VL!;\@5J2T?G,?7(
M .&:Z0N?R-X3W_.1T!47$:5/(#U$7O$:/0 WV3$+'&2=;FD'WT*H#QS\T]4N
MA4I $+0S DAA%]*_,Q$]/8*]$Q14@^'\N!;F$;I^AE?;Y8J]1T_#12%#/*/W
MT;:4WFRHEQ"^K;:IEQR9>KUTVQBE9$T7@B>@4#T&;FX.X6+]8@,HNYZ@)L=S
M/37-9&<].\D!_0\=CP\G*+/,FH>7T6]/3IK7>RD>TL1-=, HVLCY.4,X;G:;
M$T#Z,Y3=BH@-$D&3VVM;PL/QY/AQ7J]H]QB%^T=X5WN%!?!?<#^@!OTY(04L
M\?75QQ<!4@[@C#X@VGM0@5^\%+S)T@0)VJB&L)/X+HEO"HUAEB)5O?/[ @].
MDS91YQ.10H2'C269EVR=[S=9?O+_-WJ'%P"DL)__^M,_;@XH5^PAA#^_0C&B
M>($5_@4DJ()<F(!K$(*=WW\,5,J0^HYH-:6[[\[1#YW"C/X5WCF'*/(VN\_A
MSOF(8F0^?0-I6D2/D8[LH+$D;RYK$O?,Y0P>1M\)+<FL;8ST0]<_!8"H^N>&
M,]"_)66,:!\,R#D#_RP;BVI8JP"Y<^+@7$U?(B+=<:V"Y.%X+.M7%G%W$E&Y
M&-K.\-^!7L@FX$+$!VAYS-9" X3YPAX'^>@P>?\]!Y(EP-#B'Y4@8TD@)!?I
M,#UOF*!AO'/($BQHU"(+#$L(A,UU:8[E3ODF/C>;Y6AP^$;;U3+P?CQ+,2 Y
M0NH%8PVSEBYVK'2FT.=G-*+4&X?BXT.871*8)4O%72B":[7CON!+(Q@0F%A!
M<H&8R6@(YF31W+%MED%P>AJ-!/OFI+IRV\OO.4Z-7O9,,M(F3"*1H\13',&6
MXB,@7+4\RI8N5HKI:XACVV2\E-ZM6C+#I\K"DB"F4V(&3$9F$IH1-*#9G,0E
M@9(X0S=,1FD2JF*(Q98^ABB+B@2C9$Q&:Q)JHIAM+7V:4!8E#0Q"LO1-02F2
MY>@P)TN?$)1V!0X+C5*!VC_-1VUX\)4*P'XU'S IP5M*-$&+_!+C0[Z4(&B!
M\4%BC)@2""W2NN7$E,V[(D938;\L$X)4@);-"]X<00;G=0]W!BE16>H4-4B>
M0?H8)4E5569<$8WQF5Q.',)5U=/)%9<+XNBG=-$[&? 2'W:&U^=BJP0>NN4=
M1W]2X5KZ>TV7F4LQ8U6[<^L'&?S7"X#%]H<XBIIJX%#=+?_TDX2JX$-&TY<Q
M"-)" 4,7)F&3NFWT943C+@J1Z].<J9?TS3GYJK5U<?YB$A#^+3)N,</^:(EY
MES#FB),1)A,#? 4:'S44E, U%K UIKPQ1> R.4!BRL-#EN L1XB_B.\@>=#D
M8 DE]-,3'4UVZRM9/T$>-=DA/0D.M7!KC752V#!9M<+;)7\'\*_?"]OD-7 =
MN/3M >362G2M/R17<#0/H81>X\B-DXDVZV1[+LU[ZM7T+TRK_<UFV3&E#6^
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M2'>.8.&CV8I,AG$@C1$,$<PKX,(P8S0VH@(%RUS(@N<"54O0X90A),-CB=C
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MWACRP(V@LD!6L_EE9-4K< $*;702%*F8/U]1Q%9C6?W H:;;D>W!CT=M"&8
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M:IOZ0,=<;U&BH\S[Z3L#7PH>/B7BXZ+M7V?XZJF^RZ2^)%M7[:N??+V'U/F
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M>04"EG=X;QP://11GCL$JL0=\,4HD3&<X?-17I!E&OB/P._W'NR\#:GP)Y1
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M2S0JGV5KMBVKYN*X9UJ9^Z_&O:H)^@=02P,$%     @ RH4.6[NK\-,-"0
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MLN5)OVU>TSIZTF_;%[S^ U!+ P04    " #+A0Y;OM^:!0@&   W)0  #P
M &5L9&XM97@S,E\T+FAT;>U:;5/;.!#^WE^AH],.S,2)G1#:VBDS.0ASS'6
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MJJ6;\$]BC? \-Z0(W)WLAH"8:ZW>.1/1V?5/R+FXDBHZ[ GV76F7FS?6JZC
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M(';T_BA[@61VDA-FH"2MT7Z%J)]UJV9]1)D%2Z\LH,Z"#QQ\1)V#.-G^D>J
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MV2\%X88;4O 9^#4U?@5L?*<)'L,B+#?$KF42LG2(&:V$4]P-IQ]BD?O>#3W
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M^YXT_X_2[1-/VYW&9PF)G>_P:?Q;;8%E\;RD)EF:G&M9K]IRF3.E]O-:#CO
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M%]G.O?/,T0F)G?TF4KBFM=+HXONLR;H2XMQ3K]*MF)-6SQ3.! "TN_]39Q)
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MGX%"(V#L 30&J8//PB!1^S(KL'#TW0@,+AOST#T /Q4KL_Q$S,3-WW, YD4
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MY5QZ=468X7GYP*"MZ #(?=D0<3V$WYT#/%MYL*,L[2-\?]O$T .(92V/YIZ
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MY9#3KGW+VA_?I?5GYX6@--WLH^[FFF7L'U-MM87LAM^*(T<P?NHA/FOO"]X
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MRT2?4(U 2U(D9@M84U&).U3Y.#V?L +I&+J!9(E^Y72%*,..^;W$-^T'P=-
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M$\$C>T'S'?GKE@MUX=)LU0WM&=$W1*&B"P[5SI,7\,[FJ25;.$\3BX1>Z/?
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MW7\ "L&6,SG@(N;3H;G,/F:(V9Y9"!SDOF Z 658$W,JX)=;"_P&%D?CF N
ME9[WF5E S+UD9J@@]-1!X :O<D )@)S=QJ-  CN8TPNXLM[5R@$'9/\V$> -
M<Z.&@0(HPW,K, I.OC,*V*N.GK1E')=_[!_+H$K#ZG(82:(];"PC3E!9@S)R
M>!XY0PP&^U'4/,91%M;C#N %M=\.9X190H_WT1_647JU=)/VDF$R'5#%HJ%T
M4':GFD-O%<NRW]+O"U9%4AA^G H/+&,8<;_YG2YNWW\,2_=HGM"SD_:F/D/W
MB/9/W5%6$.V>-AI31Y^AN)#M1]\J\8GX2#_$#_!8RDAF"6\\IX\;\CQ:3FOH
MH7?GT'+;CFL?TS8UKD9R:5DF2=53FE3[/JN.]D"Q*())SQ%>=+] _X8>OC&3
MICJH/J*D^0\_[&)0_^U?J)U$/=N1 $NHSQIU57XT%^.UK"4T5'TX8C5]BL3)
M74;O8I^[7D2+/?WF\!OJFR-VG4>IZA%O33BUJC\ ND]EMV=4-E*O-.1EMM,"
M]//#_Z&=D 6Y[Z1C.1V7WO)?X6^,2GE40GK;/JX+X8YJ._LWD0JVH$])FRHN
MLNZ2O3+_1NY2(L,I\']4LWL6O(1>=A''DP,']Q=PO8' UGKV1\9%919ZA<%B
M=K$N,0K+GR./&+LR-L*_&)1-9V!GQK#;&Z@2<+RPCKN%NV??0LY$CG<+A)Y$
M3RF\6*,L&:!#+B!0V7_P-UB27@$[0Y9-3A !''43@)>9E\Z=XX3)K7O[T:_2
M#<VS6>=$#V4OD-."/@8>_L3K+_T.K^<<VMH*4='#80;P%M+EY@?&0=O.,MDE
M=?!P,;I&Y]5XDC5&]5W:BTR2WZ 7P!Z2<Z4+(41X,^T[>)=W)&PEF,0FN?['
M_ <^=B8;W=]<LB>>16[PL?8CZ::IDG8X7_<OC00I5/=*HL 7LG-IV\ M(GUH
M+_,Z;Y%K'[.<-?UT$;J^-WQW+O*^PZ[A.'RNZ8_X)'33<H_:"RTRG"IN &O5
MIBTWF'=D0:'IS!H!W15@+D3M3IE8QT?^&M(CW,&Q#6/@G5U7Q!.@TA8SY2?8
M6D\HG@[.-WAN*6&B2FOH=.8*49/K5N <>\FI:2S<T;-#XY' _0?J,^'90S11
M)C2WVY:2#R8W7]XE8!XP%V^9Q S1=&\\"CR0L%V]  7[\>&]BJ^XNSVG9+WX
M&F.51$R8S9>+)(23I!Q!"[&U\#?O-&EWRFG.*_++D"/LF=0REQ*6#3WO$%5^
MD.'5?4$*T:_7P>(*NHPW*"33:X@(WT(G%7IS;]"M*?,Y?]&?A02@48QL%R<$
M"\PXF"FSL!E=%DD5NM% $66QYG*[! 1D*4')ZX;#"PHY/R%N<C$[$KP6?) E
M!WV</\+7F(8#$5*9Y'HG55PN&M;'"0L%K9PF/HUW'%_'/<.=N5/"<6#G)QU"
M4597<!+R%G[O?!2.@V:/VDGVZ]9U8$5JM8<N4*!2)+-YO -2#JZ9.TMT+?\H
M&Q!X)SFP_N7B@_Y%"E"QLQZZ!.?OMY,L;:AMQPN_FMJT8?RO^N>HF6>K\<9>
MXQ 5O/RYZ#/)[<V-K'SAK" -_(KSVYD$E2'"?8EB=4=GFU5(;)FIJ>7C&_)8
M-[D-QD&L/?NW;NX.!*U59FSV0UY(RH/28)#O[9P#+6!)1XQBC\$;K=^%\WK2
MU8?YL]L&6"Y<O\;)M6RVTI25]P==I)4GWD+D_Q_^I;"ST-4Y CR'8D86B^Z-
M?FFM$1S;PU*[\@[TWD*4G"?MBVK'LD.MJ7DRUK$Z;"(+V:Q*"WP ?1#=<_8$
M%6R[@5G&()QGPTZ]/>Z<+%^S 4]F_J<L)$1@G&7U1/_<2/$#4FZ\03B'W!S@
MPW.FACMVL%?0M_1/KG.@_:ROU\VG#4D[U78T(3-<D4WC5M&E#;3>;?6B]_2Q
M\=,$GO12_\O</,9T1P-:R'C3M]RPB#5BZ=#.1$R2BZI5L DHD.=#%RM[)7L@
MAYP/HL6@,8[.+P%7^M,X+<R]CB+60699KX/>091O;M78"ACB0\I0W@B#(J-S
MYU?<$3]FZW,BA,FH2^PO7@\RXN_!F0#'.D(L#_!$3[PN3KW2=%2=K,"*KBGP
MTH=TD72O.+]BD7B^X$>V22#G66,1WGB.K]]K=CFKUY&$],/CN[':-M--TR15
MMZ%0M%Q^2?.==DZZ6&DNSQ<!LI3L:?R?HC^Q2[D$OL2O&WW+?N^(06*1O[OV
M:EU;2,9DE;?57U@B3S-]H-E*#/K>LG.BJ6I<EHS/D:^+.<KY)6KW U&8^\VQ
M!'[/FM*U6G.NYW?=/N7E]E>"R[+W3?NI,HF/A5T6+6PP;,E:RW=53XXA<ZQ2
MU"\;=>(?<=P)M[(N=;9JF,/XND@ENY\IV"*K[\RDSA4_:EY6>DV89'Z0>9IW
M1R>,\>'L4$SS<V>]%\8XYL(8E-@TMGD8>U!%;[B-RT9WFU?@9Q!T!AS^X2X_
MS3G"TZU'E(M)RR+-T@@RT>>^,)SJ:._&^4V/;O1L.D*;IOQ0?Y]Z'O4Q+:<.
M$9;H:ZDGBP;4%VG3M\8H[&C$R V27/I8GV9!!?V$?1S'EW'1RF@<18*4ZRV/
M87^6P+@"RL"7ZJA@>]%\U2/0,>V@/(IY*N*BF,\D^Q#Y;<QX^P(VEQG0<,QZ
M7I"M*#+_Y-4A/77!W#&X5JV&+2S<I9J%1J9MD-%8LR.J11?@6S[QO#]0EST9
M?0\B#1.L<Q2E\D9SB/0K_,: B*W89YI'PNJ"$\I8?NR6/=(3W("(Y2);]M\^
M]KP"Y*6] ,5 ;?4[&W8:1/+))K4V#]ZLOZO:A$W4!,K]"@(5C9(-6V*EBX6^
MX9>%$,_.9PKW!OK)7H^.A=LMY^N?6)4RKFF1N0&ZK-]JZ*\]K^[2G-MY3+%&
M\3[U7XE1.C5<)1PG'./]EKN+<]Z^A=6(<"R)]>P.LFR.<:CY +1-][[^4^TV
M=:31:>=V^;!V5ZI:$JH0A^<)FL1*[UO<Z;Q*^WY6-BO,_+P^9"!:VFDL[=H-
M?M:96_[4?%6];PC>.55>6(>FIHO?J$?#UPNV2Z]Y'^&<YY^R'V&M9-W0M/>6
M8TMX@1W'L=^IAA9_7$?%_H8^/#^WV[2$8-ALT>41'V[\K<23-WO>EH13Y]M^
MY@W1 S5+>GC40.Z3]MO4L=38YC#*QXJ2^A[JW[E;C8NH-9N3M3NI/S:.*@!:
MO>=%<3:=ORZ0^X@QJ#9W<Z"7W&UM#\'/E$M-8:!C^7-+/].P[4'=*F9PX@<-
M@3EI(R@W @\]CXNXP+-U9*X#<[9Z39>21^&<;/W(N45Q;<QBYY=GFH^C2[?E
M&T)8XQ.E:C,R=F.4[#(\R7-4> E:N:Z+PP:C5.K.<[+QG,!6-_$P66]5"55E
MQ\V3^,J<?_4X;D^BO^HQ^\'&>;+5Z&3/W4)7Q&W=;?9O*%LUN]-;RV+O;Y&I
MQ.2U#5_D_65IID+)QQQ4=UD4EO!.Y<V7A+R4TCC7/?L$=>ALNW%L+ARG;.NP
MFM^QLUHFU460#C64:IM+OQFOJY;G^.IB99J$W<I.\?20LY*G_%+/;L$R]K#=
M:K8CLD@9U1'9LH&]I-G4<(;$JO]DRBP=,";K_LO^I#VDTB30E?XRWY V"20\
MZ-G%W\OUM M ;R.'%!_;?W;O0"\T)[0YD(+J]=;+I=5UGTRL[%%MH2XY(4MQ
M5SD_1"WQ$A__/T7BE=MM1@VL>,&<D13L,H9E\!'65+.P!\8E%Q2T+\)OV*IO
M9!"V1+\R=1+; D:T:K*CF[M\+76<S5A!#-V=/[J72 $9M,&QE+#J=]T"2D"!
M7]M,2M76"FLYY5[T,:.!B@2T:7BT>+<4V5IZNDTEOX!1QX>'*\%>AFO_'^;Q
MZI8NF#ECYXO6<8!VZ[J&G<"V:'F='D@(4*L5P!8WC#0$X-N<Y1F %_S0/>6<
M_?0K_6/9WM4AG5S6S9W"EG'(<-JU^DKX0O1V0R\\-@!1#4$A;EP)#M3;KN3^
M!\[AO=VM$.^G@WV.0C7F64<OW[33L]F)>RE-;A%S[*,]](]0=0!>^9$UR<TB
M/@9#M@7<[= "GFKH/]5NNE<O0_X.8^X8*XW+_]!$%)U,RS;?%>1&S]([</\$
ME"JCV'JW0;$+*]#6R'D,?>9%#&'J^+0//5]T2S$E[56J_?FCC??EC#1W<[QD
M:]1'G5[H%%"HZ.)^<3LA:D8/VY[C,.!^WNS!SU9/VM$>JODO3$C;?_K/^;K&
M[>H/:;--9Q7CHV[J'"0S W(4@8+9;C=$WIQYMI\X+D@*]_)@8]L^6D_/BL9_
M,!YM3//-?,1Z2_\];9PI1+TIZH;6+!,'E,K_$=YU>R=\Q75;-Y_]"KG(G'FL
MH/8SEGO "UNPZ_?P1-ST[)*^=MR'Q-L=DPE+PL#&Z42&S^&Z?O(LIU/*)Y1/
M:R*$@W1;YN2C#/(WK&9T,[FI>,*>2>2Z[%V]$O*MQ.MMMRFY8;R&V]3E/H\,
M*&V,\Q+%2;KCFFN" PR4.?M('K,;B^X/  [N>C?T&IB9'=M3P>A)/-PZR!"'
M<>KW,ZP^O_58QE7G//E9(&!M&O\E<)3YU^%P]@8L9M\JUO"N8X.7$&RV0W<2
MC$UL;[% _6&(90A:L&&AC@9RG>MD[T#;M0?XZYGW@!^'4H5=V.P11W[]KNZ!
M:]SSV3.ZMG)<$DW-C>B>,([Y+*MP@YNV ?G;^:K,'7IJLXRG!J\"MP_*%2NQ
M<7OSI/1=K0,3Q%.S9W8R!8<234U7>>HPN>DG!]H0JWF*XEPF2_D(Q::8MQ!J
M!?8=^*;+QVX<'E:OW=7:GZJ8F#VOXYQT=F)+DY/(.ZS!E,4OV%"HV<11N:R7
MCF7=L6GBML,Y@/$ W5R#]1M>;^#OZNH[I-F;O:S#6SDKL:]1)66&]1JO";]O
MH*I/\4@N&1(Q>Y;-36X:_!9 #RQN2L+Z[CE@Z=LUW!=>MR+;I;U7TY]XLG&!
MHB;LO'&;)&B#5KU3,,^%* GB3+$=QYV#%#X=PO?4%E],(\C^[XU%Q."\K/ZD
M:+RCT$RV(?@1WE+^(A;NV$S]B]0:>YX61+'WZJ+OI?YY/("]1J\]WX=[0'<:
M_@M_G_:]_E_"+=HS 89XB_81?Y/TDKXD+Y4RBQX;\X6ZG:[TFD3[0?_Y\$EM
M H=[]C]L"7O);@3'8!VQT/ *I)GO1.B#NW"CQ(?0Z>T%Y'7@PQ@OBH+Y:3V&
M%@\\?F!?_5,N.+.^=JUTRN!E;*3(:OJ%JQ:4<:_CVWFE6!/A"Z<VET9*1TNB
M ?(#)-#S-;4+[+TGQSPWDD\UULS3?1B(JPU5LXU\+%$1QA'ACD@7U?((CJ)I
MVRQ$"^]*U"WR)O9V3S+5!LZ]&XJ9UYIV,K,ZQ'JM?UQ-I7E'76)MNV$2&X.;
MH#Y0@^()<FK.->(D\=]1D:01WE;/Q90.Y-$=IZJ*@<4G8C'J+FOOV^I#K:L,
MH;7C&EI0!K;0&%6]%_=4<R7'CL"4VT:>(,4*%WB<I$2A ;=3*C^,#A_'8Y;N
M2>B=4QW<.ZC/J2&U+V8UU#ZP"JO'XS!U[[.UA+_58R)SB*_$<@\6^0.[Z%9?
MI?74VF,WJXX=ZNW9@;FS=YQ.7S.K+P!Y68MKHV/R<-/JF[+GX??I"!%?B'KI
M,8]D<A=GQ[55C 4U2PYK&8MK_;H ACTV47N2L1%7C+0R"O J3#Y#27B2O9YQ
MG908N0(()G_RH -WJ;^NU-.*J)I#-30>5=M93.NCUFMVTQY2#\)U]!74'U4E
M] K:YJQD^D5:;T018QM]@\<88#7]\>6UE _H_ /7J/:L">W_4O.0<>H4:@ML
M#Q72QD)EE3DT#'@HLYKV'_AW^&ZZFHEQES!P0/^E.G*O!#L:3GXK*FG+HW@+
M*I6?*'P>'W2ECN5<KDBC<MBV&4::+:LH?#GM&<QS=Z/?!G==="4UZX[MNT-Z
MJ3[;\IOLI[BCL) -TI_,B93E8I?R;,H! 3;]#K66J]HDIL6C3+>;]#3HR_EO
MQ!N-<T?:2<LM[LV72!5U87*(=%V;!8PC%RAI903*;*D^W85R0UBW:1[U!#?&
M34I[B.PX]XOHW1V_MX](;J,U72,>;^3+A"0OLYQA1SJM;RP]2(95UJUJRE9I
M15@;-9U_PRV=QF09S_D11H:+A]\2Q_2W-DTA1G5V2D>(7<TZ^@Y2G$58NI@\
M3U^Q]6_R?\H)82F4[R('MW4T=[3G;!>A]$CN< ZA?5]CXW;"\T&Y= HQHBN+
MMH=XO]FFA$/J,EU-:R!K-8&A?RC=$E?7/]2W;,6)J>BEZHF#_JSG-9'U0ZR5
MM7@Q'JG"-OT_L7.X=\7WX !"3IHMU$-\&8I"F\@CKA3P&_7;L=NL*/*3 2^$
M3EEI:8)/4K)$6-B!8J6<A734:<5CH=54WI;M8#]MU<8W8!'MMJL=Z$\_?;0/
M?@"?ZA\#N\#CS!:("84)L\!/8!WY*$@"E^Q:"BYBMJ<:F:>8X1MW, W 4Y>[
M3"$ '<F"K$)AKP;\R']L6@-F\@(%,YBW.4TD(Y/!]BFR8_JRSJ4\9(Y'<D/N
M F^@ZRX&X#.XXO LL$&]L2>1^5FQO^X^LU#FP[L%O!=W$Q5 G="G, ZHYOV3
M$@ D<U)"*H!4ELFE"*B&% <_,6^9/W4',#WK=(9+@$5GP[T%>*D:"-V,%W*'
M C;C@+@SN84Q)%@:,I5QCN/OLH'Q!WY\<"XSJ$W7E0FHF_+U_P(3+)\YWQBJ
MNFK\,T:ZYOW.)PQ_16&R*V.]N"-XB)'+,[C,9IA84P\4 ,<&'#L; =ONF7H7
M!J_5S/%A++1.Q7O2;QB).Z/H9S37DG;3+\G'!&,8XP2'G-\QDM$)H_\"V/WF
MSA6,*[O5.B[#HW<)FT/O:MN.4]*K&KKR3]%+#.^3LNDTY<]@3_I>D<'Y&F,N
M>F4/0=R)B6R9*WQ:+55]%<377&"MX%W&SJF]R"W!5>[(XDS&O]^\&+42=4'C
M64EDD5,C,IGZ83==%$Y2-#L+]*27JHG\^>1-R 9N$[FSY@LGEN*3IT!_4NXD
MEK.ZJ=I #H*CL9WH\"9Z[Q!9\ T\W32!OQ,,4?S@/F .PLX<A!E7,YT= 'S;
M?A:= .Q/.(-< /B!R^%.H-0I"Y(!6P:+^4?Y8ZRW>'Y<@_PPYP3'!UK'QJ O
MJI>@0:S![9-82Q!1@A?\!\X/V M]@YR=_,%OS&L#B;PSBG4-U[B;I)]E>]DW
MQ ?!N:A(*,(XLPKXQ;G!2#9W<[P)3F$O#]@!Y2(GG%:!M9!/?Q9O9EU,_7T.
M1Y<@/<%>I?9CNK!N*995Y2&#TK';Y'"'\$&\#33$:PE8 -Y@>SE-!<? %7U2
M+KXIK?YO]I=Z5/('Y1OY0"DK4D>M[$4<5*7;IL(.LLBX4<A3^-W_.EC$+7;\
MS#0CU-[/W''=T18"F]W6(-F"+F[<PSB G#$W5LZ'>_22'  ZH-H5MPV\))WN
M;P&G\',=GS%36/F];$[GGM7F[VS?/J/X$.M01Q_# 2EO$E4(X41S:<Y":(?.
M/6XJR)0?\2]C'A%.=[S)G(>N;,O2'*C:JU^K<JJ>QD^4'Z])IER2,FLMI:_$
MFW!S,N\)Q^%;8I;P!HE%OEI. ;G681(ZGOJZ5:9F$)FZ:N58XC.>2-9$RJ L
MD122[I;ZB]S(<&8H_S<E+EK./41U]HUFP[0PA\DL;[JFY;!J$]-9RY!?!_9S
M>Z4@D$OV%V\&EI34"!T8'S(T_.F,)]%S.8\8#S?\1H<9WQRF( S KOF*THG3
MKP%D1]DHQRHAHX6D;%$T:W-QD\ 'R4S_PG.$RZ+J. LAVH91=#PH=)@*WV/*
MFCXKG*1Q:IWT@G@;>Y]8)*PF8H5%?'C76_YF;F-Z'C>3?27*FYW!>K^!S=H&
M?W.8!J>!MYL<Y37:>ZHGTB5J#_9TT34%AC DZ):V[ KDU8L>;[W Z1 LCSR/
MCG!#-R0CEU%?AVG0?>AW(T/VH#Y5Y2,1&1^A6:(8?0QAEF"5VE#4Q%LL?[,U
M@^,@\8BDH]Z"E WV2"XGV&$ZQ("_6+_(L&U69:O$MJF<=5QXR_(>3^.WU6TI
M6L5MU/2F/6$?E/^,=&-=$J_:,!'^Q9OR?\H-.655R-;VW54&BJ]U7F7%"-&6
M4MQ/?F+]J<(N;GB=79J G:^NC7C%8DHU/K?@/7R>PW3P+8M@.%L_O2I;9#4.
M8.J!;WI>]9OJ0YK:VMA\+V4J]GB*1+86C]D4*[I.#/8JYE>3MZ^SL!]0'QM\
MS!\)]2*[NE;B+ "CHQ$%U8'J/)+=CCY%&.EIRDKI,O+IL+?".Y0S7J$\%FW2
MNM/L*71 KS&=9!P1EAJ$C!+&<6T>8PU&J(IGC-FQ6.Y/_Y-LD=@PEH0I!)\9
MD5[+N;T,Z;IW:#3CA^ZAL1<])C#HZ:PA^DM--K*[ZHHR!KZ<5RN+AF<EKQ)O
M@C+"@@7KP(;U/SB?F#_L_F*9F5MT:^K.B_KY#W1U@F]T9S7 CZZ:KZCEUF^_
M)RWC3$AJ$Q%18NA'?@ER=_U]3CSL9^?(F@-RM$C=%%4//TS[4!%.$ZB.2<]5
MTN5#XBW;TR6]@CM)T<+=O.+0 =XP^]GZD^P!5K3=1D0-J30_#22CB'=&NU5?
M25NH\M0X5/R1+U-<SKTC62&%-K\0NHH<0JD\9][N]?UL/_9:NU1D/4S7\ US
MFL)Y69JW]254H_*H,:F")VO4+<ZM%3<K'V\6"@Y)+:&AW*/"J/46]#+GB%T^
M_ #9J/'5'^F\R?VC,;8&4OV4E=:-%3:R:-/BW"7B2.VGS;&"'8ICH;.YU6)P
M/0\5\E;;5<(FY)[X3;NP:B(TU$S'A.%7- BJA<5+3=J:CYDW]5PL(TZM3L?[
M!9V2?2,N<8=$A>1$&R970[TE1MIT^)M0>1.'L EWJAXEG-YUTH@0B9E<734I
M*2Y=%4Y."3)(WU)JW-G"4NH%FPN<'GJQ>&DKB4X"GS;6T!UP:98RVN=="77E
MM ^9*[5Y] 5Q$Y6A]*R@"LEW>J\[3\!FK+==P'[*^$>D;<E#WH%)UESX![;+
MO!U>7G3$L ,JR&C4%(+G8]L56\"$H #)<N85=RY_E%EMF\SV82X5_=6,%V0P
M#S60>(>Q2TT,;DB1AQYBG\W8H(;0ZMA,.<2R#9HESH0O_Y^:]7\!HT8P2"AL
M.BS?PXRJ/RF%:AN,I\5QA?MT9X5+TR^HSO+>QRZ4'>*<"7PM:D3KW?F\&J3<
MMA-=#?D+79IL=#^ A_7NFA6UP48/I5-AMLY3YIE.57F+_6/NR%P$@8'71!.X
MZ]U%W&?H,MM+K-WP',&UQGWUBX$.RW&CI'92W6[=I<)%6HOJ1_H&I4GN&F.0
MMHNW!W8)%7R6NYA+9:MMW[!VPD<%LL::UKE J:7&>J5F?UVF.:3@G#9(CV[]
MKMR@NA=3+0V7;0A4"OV%7'<^UX-S>=U$UDHD'=X[&%G92MS1 U7=+#O6?J)Z
M7>Z+IK<URN17EGM8CX@)!AGNCV^3>@;AD_-'J2\Y:(V%;T>]!#,'*O$+B;'=
M&CRQK*UM/V%*[MG&LX3CR1?,?<3=X9_T9:0;ONW*5Y2E+K82.ZIA[0*>.ST5
MCN]/H 40OG?1J/^5%;=JJ>=R$:N5^CQ9;A+3W,(OZ-)H=;Z-BH?T=2Z)XO7T
M6VN)W Q&%SR^SQYV)>@Z<Z"$TF\M=%"0Z]+ 8_Y,CC5"3'6X1;N5F>"KDW]D
MSG&I$F4#[]>>Y=0!SZ"._U=E#F%31S&GKE3?+&!';CM3KT4G)4^I$R//PO$:
M+'S75RQ?]?^WQA?6@?=M%K+_,'] F3TXR6O\E_8VT=/2U*93@B?;6);+O ])
MIPVGN?/"4]4M[(V^;%D!J\JE0? 5-MNDL,G@<^BO[B?J.OQP^T+EF-(E34ZR
MI&V)%C>Q)4EE<!2.#_=1S^05^Z+24?89EV%!"<O-!F;/A'K!N]TEQA5X?IM:
M]Z#D56.3FKIME;E1,3.I4F^2M(;/48F%D;YD:1CWJ<MY_EL4M>E ^^%,L+-[
MF17$(VT!9E/)_49O0\FV\>:EFL5)&?JI\E?A,Y2_Q*=\(<EY_H#+0[Z.W6AS
M%JV 'Y"6''"O+*R@#9^N G:<&XC%'-\ZK0NH"8J-:LFI?1J\V_( =W+]*?TB
MPF6'9OF_9(]5WP42ZDG2K-$27%6%:L]CW,$=S_K7XY.WKNF,(JR(W=X\GV@7
M?,NL(^WR&JN]3C[M.$EVB%J]6L!GTX-)L_<'4U=4,'?OH9S?<;7W#V5@ZXR.
MJ907L6F-UZDIP4]-I=377O:: 5J]8YIT#YVW9@:OGB$DC=\W'A17Y PQF7MV
MF'M.,O]*>]9V#;#$!EI[@(K@)\84(,,K0MT-9#JJ)><!^AH2]QZPA_AL[R?V
MOQ4A@[6H8@?0/<S:D3;:>A))CG5IL,)EP4_K,J%&KSS52?"EXR7).#!ZS56N
M+W.4>&SO.E%XA<N 1K!K![;K.D^3UM_RA/,H=DW]4794\&L#B778BZS\A<0Y
M312G0$_6KN6T@R9B\S"B**^PZ7\AF[0#T[5,K$SK;K$5>L:NJI_)>Q+\47^*
MT^@E4R:BU4Z>HGU(\MI\CC^TC2@<GJG;4;&F?YNZ=$=M)U.1E-;3#$E]8I=9
M*D5>P9_T ?P0KP;%24ZFTU91&(NS5L&^ WTG4O;TF]=5V/6]-$AV4#M^:PZD
M#39]53R/M3$_DKJ%3-3M%G*\^A69W"].%<+G*&?M?K8,)MVT5K^K<#S66)M<
M>:37"=N 23>LPKVL?H'V$]QK.37KB @N+&> ](&P(*J"(B>M]>R@<2FRZX-5
MMXB+CRZJ+B-RNH_5/")-U#W&;B9)67+<?K)7]1I"$/E5]AGB94I79 >YCBKW
MM*7NH35<?5OY-S3Q<';5*)C<%5Z]A=FII=3<97HCZ=@JX!IF+GX^P,UZ2;@(
M!$7\(HTR/GIT4'XP#%>\RD6"\P<-E1'\F1W2JM?<G9HQU1+V57AJ[2845_D#
M-XVU+.LO_ MX,"*+^!7R]0BG)#/)_UC*HM2T W,KIBB.MD^KW"=;JN)C:L0(
M>*(F0#BQXE_L:IX^,P2_@C,__"@QEI7A_H(\ GE>RBB-J?][__GROXSXUA,5
M)W4GE%NJV.JUS+;J[7)^^<?:K>+/&0"N2A 5'D(8X,2ZZ\D!\,&+227,#M6^
MTV4Q+3-;1BO&-60H$BJ/&@W ?DRK]DVY2TVOTC/]#O:F9-.F\P0?_@3W;-)Y
MUIH+[.*W0Z_W32H=["4TORHO;M\CKZZT:[S+>(&9;YY91JQQTKFDIV$+%%,V
M5>'/"2GN=B0<FGK^=['XT/@1:FGJ7GES=-F7_B.RO14='<<9OE7JQK.E=ZMW
M&T>W7JK]I=ZUZ2\\7FQQ^T5R9J>>/D)>7&ZS1T6NJWC?N(]B7]4L<Z8,5F]A
MK*'&U\XH?4G]#WMOZU5:&_Y"V NZB#3&3<L8HJA/Y1'=\+S=-.)]0J"U@\0F
MO)#:D=V)!KH]^2&IH'02I84<MG46E4/Q#$NDJ:@Q;G[T9S39B>=X$+@S^(00
M S ;_(B3 4?Q<>(9QDOJ9Y*1,5HRGLQC-*;Y4P0,<6@O=80!N3ZB.S%JCQ?@
M9O*F#Z3B'G!&+&WX;C9&A"%P4'?*42*--;MX @F%/V_!DEN@?T+74;Z!!E<U
M#69Z'_U6^X_"KN\=MEOZWAR'$XH'A2OP!"&-W$B@\#?OFD]LX'JD[B,]0+]L
M;*$D(&+7#.I[\-*1<S6WC7Z]QVM']3:F=5BS^C_!!)Q<,4AJPC=)Z47^A#NB
M3:E_D[QY[S;ZDX?9::ZKJ3@X\O"=FB4MGCW7:L=8_8WK:Q^8I_,78J_KCQ,O
MXKZJX4(.(5CNGB(D6D2=(7?)P=S[+A^ITQ'!8;MJ3M_$GN4U59WV=66U<<U?
M>?'8D'HC<3:NJ"ZRX E^G_IFRGRBA\PC1$2Z+G!T.4?I9S4>ZJQV'+%V*VMF
M#-XPG*VYW:WGFFN/M=H1JK#_UG<6;,/'&U8G6PCGE*DA021$9./20ZE$Q?OR
M0$I92OL=<$5%B([#O%TUG9/+[,2<P'<P^37RG2>81"PC>0ZS!L\+1ID"XAWG
M/N9UBFXD!AC$+6T[":#X,=J=P';\378<$$D8Q/4" 41+_AL@G-24E UL(Q\,
MG@!HJ1.<2<Q)-&#O.L8B^HU6/F,2_9@F@_X?O1OUH;^EUV/WT'_0V_*7,5;1
MCV[N9V31GP:)&2.,^<Z10 PC9L\_M XVML6'9D41U5-: XN+?*'U(Y): ^T!
MW+7#G6X+74[\0Z> 'X.6T+^#$YP7,RS ^]U2*D/RL^DSE2'V4[91><(\^ RU
ME4^IL5 ?<_5YN;0(]HG$?-H ZV[@('TS?,;I/6,.B!]B460Z9N-KBE;]4M%(
M:5':09<H%V2;JP]2%XIKM]=3 8$TX3IM&E<7N(TV@NYTND170!<&N\C7&]XT
MSB4_-C/D)\GO#6?!'Y2EFB_58RB5RN7;)U&>2CT2"JE$X8K !;2-G$-.0W07
M^/?@#')<IZ^UB)S5\J]\#KG &@YN(K--19A4\@,=F(NAE"FY\9^ITR1Y 5>I
MMWCWG4RT:ZRQ V;2ZZ'TAJ>DG[V.,C+I>SN-V4">W\BO.D0N,\FW?2/_T++C
ME916>62 C,H3]#B):#+6M:XB7D!IKRF1\[&\69S)OE])9T#H&TQ4I0,ZN69M
MCHGE@%T;EXXDXV/\-\)BXEZ'']!KBKZ3RY'6OC26LAG8%Z)M*(R[39>SC/C+
M%9N1$X0'V8^0,:2IL7O@4'*LWPW(0-GK\ R:1ZOHD+&G4?_41:/S:&N%V2Q;
M6C!-@FREY9=7P7*:)ML9>DI[$NL"A=,#_$!PE-[@<!5,8:QJ!UE6UG2#/3*,
MY D<X >PF:J&5T#/RI10-12>!8.WP):8'C #G.GGS?S,+'$XQFP&>MIV(@SA
M;[TSK!7(^6[06?YT"A]:R*TN[0#)[-N9H^!X-"UF+5.)C/@^9<;"$QSV,!>"
MRUKQL$'UG\X/.J XP L!/\ERR5W@)O&=DN?,'F%&YAIF,.^?Z#[@!2?(MP$8
M9%4Y= )J:'O+(/32=%R+AQ88SG(I8+262WK#5*D6E_@Q9\GJ,]1 DWA-=":P
MA0_Y5@&^;(N#%7"'"2VV4$$+H+D%*JR[.9>9A\U<4C1SJF%9L1& U*T9,P!7
MN7W4!\8+$<LWE'&)JW*H8]Q""IN/0)-Z%VD*P, .&B>"F=><1NP#U);;Q2N
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M5Y"CPR+A%#!W]3MV-+,)H^HCB?**IG?R!">R@UN*^%.3LAMF<T,C6NI4;'Y
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M[ ;%"L7,XK\4WQ5[$G<!IP%^R&'P++C,]00\#G+8$".18XE=YZ73L#&F'ND
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M3[ RK$.UT[BE%5)T&H8W![$?Z'P:R/)=FA)+;1:IVF!JC0643OJ>T'E$KV;
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MKKB%HR9%@VTRNAZD2\>@MM(.EA'Y+J-4M"''Y;-SHY$Z^=[$&PA3P8K(1IB
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M3I-?36G@5;*;&>*<=G)%22>^HK(;6U'7C2_1=A$+=1WS#93]QR"VW $4%N9
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M<?.^UND7>*XG(F*R-0[:JT\A-ZDR^+525+&L@B"I$-(4186\VMS\ ATOM\S
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MKO'\[MB _>YP%O?-H1/_Q?XVX9/= &',?I@PXOB*\ S]FM#O,DJXY_+&ZU>
M@#1X[)P,E .S@'/D3Q :KP"1]280HG<#'ZL)3*H>T'BF0)99 R'" ;#Q:'#/
MP  FW_V'2YGG=^<:W#>G!OQ7QQ;"5X<NK\\.O<3W]L^(KQU?$(?0KXB/7%X3
M[[J.DFY@1LF_ H1U$\$3::#MGP5\[3]!;+@"))8;P=]Q%PC=#P&7I <,EBE0
M_:V!&.H .)4+>*2Y_7#+\_SN6HK[YE)#^(IN]/KBU$K\['B9]-'A(?FMXR!Y
M&/V"_-CU%;D7\XIRS>TU]9+[Z"^!%]* W3$9?/;.!*'F_]R+"33?  'VNT#B
MI@%"+SU@,TR!(;0!BMP1O*)=O^.2W;]YY&"_N)40/KD>)7YT.4%^[]Q">8?N
MIKYQ>D =03_W?N+ZDMKK-N+=X_Z*UNGQBM[N^6M 7#L1\-LG WO/3/!']D60
M[C((-EL/P78[(,CU($CPNB#P-@4VS^8K(\#I$S4"\X$8[SF&S\"_P1801STJ
MR*_<ZJ@O,4VT8=<.^I#K'?J ZQ"]U^T%XZK'B,]%SY?,-NQ+YAG<2]:O  EI
M(&Z=#+Q=,T%V8#Z$Z"R%"--U$&&S'4*=#X#<\\@W"=GXDX!M_8[C[S3J$X(9
M\8[!#I-2O(8(.>1GN!+O)Y[5]$<>)QG][N=]'KK?8-[U>,:\XOF"=0$[S#F+
M'^:<(CSGGO#Z-2 C#93-DT&X8P;(]\^#B"-+(-ID#41;;X4HI[W?PMVU/RB(
M1F\D#*N70J'C$#<(,\",Q#VB)1 ?D#.HO<0"^FU")?,&KI[=@SW+N8*]S.W&
M/N:=QP_QF@E#_ ;B(/\8:9!?3?XUH*R9"+2-DT#\S_[?-Q>B#_\%<4:K(-YJ
MT_<XA]T?8C":HQ%X_6&%M\53&=^A7R3%]/)"<3>9L>0>>@KM$C6'V4DNX700
MJWGGO4[ZMA$N"%H(O<)3Q&?".M)3X5'R4V$Y]:FPE/KLEWXV^&R8!-(MTR%B
MWQR(TUX$2<BUD6*QX5.R_8XWB2X'AE6>.@.1%-,'P1S;6U(_S%61'-_%BZ1<
M8,4SVACI[+.T?%X3M5QPDG)<=(+<XG><W".NI3P15U"?B$MH3\0%] &_O'$
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MPT-Y<2$QHBAYLB0\,"<P.*!<'A30H @,N!@<$/A $1#P,"@@H"\P4-8?\"O
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M[)L"!*W90#%<"-Y6*X&"W@A>N)V H^\'=Z$6N,AUP2G:$!R23< VQPQLBBW
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MV>,^$S[@N2UL"VLJ=,9[(O2PSUCH)=^1T$>^PV'O?3>%@>] ./BLCP"?OB5
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M%5&%_:(J<!Z[\HOU,P@UXSM0<0:AK*MX_FV$@F81\EWD09X@B.@@@6B@0*"
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M8(O#3O:,XPS[$&V[_T7:%'O6:8(][[0EX+O3:  X;0X$ITU+ %]I H3BWDO
MW;T*[T6N$N%3H0;Q5;$!Z6&Q%>\_A4XKKN6P)"ZLXBB<3HG6.):0HG<H+L=X
M7W2)^>[(:O*.\";;[:$=E*TA?=2)X&':&&?*>92SUV5ST!G7(<X=UT'.&]>!
MX&^N_<'@VA<"+NN6 /YX#R)P[_WX?F^V)()".<)<F0KA284V\4ZE*=?O90X"
M%PH]Q$_FLA4.9T2H[TM+T-N9G&$RG5!@,157;CT>4V\W&K7687-$-VU3^$;G
M@; QU_ZPG6Y]H<<9O:%_,+K#7C*ZPK^Z=8:#6WL$T-LBP/5G$(B[.QKW7IHH
M@CQQM% JA5Y5R:,'=:J$/^H,2!>K[):?*G,3.U3D*[\G-U1])BM6;RH]U60L
M-<=R)*G89E-"M?U 7!-U?6R'4V_T>M?NJ!&WCJCM[FV1ASU:(J]XK(UZZM$<
M_=E]330PFF+ K7$)P%E)@#C<NQFXNPM%T:=*,?2T3A+=;I1#5QKU2&?J;98=
MJ79=N;?,6VZZB*,VF1>E.YJ=9#R4D6DQD%Y@TY=:3NE)KG?L3&QQ;DOHI:^-
MV\1HBIOR:(C=[UD?>Y%9%_>861O_T:,V'MQK$L"].@$8/X,0? X)N'FS\3I*
MA-%\C3!ZV"B"_E@KB2XTZQ"/-UGQ[Z]W$MU1S9*=+ M4'2V.T!W,3S#NSTFW
MZ,W*M>G,**&TI=<X-J>N<6Y,Z:+7)V]TKTD:]ZQ*W,.L2#S+*D^:994GOV>6
M)8,'YKX4",/-FXR;,U<0+92O0,_K<7NO%4!7VL31F39-XN&U%GR[FQQ%MM9[
MRFRI9JML*@_365\2:]1=F&+>GI=EO3:GR+XIJ]*Q/K/1I695NUME>K]'6=H6
M9DG:+E91ZFFOPK1[7@7I<\R"].^>!>G@@;G_#"+P'J2N0% @@%Y7+4>W&OG1
M]=9EZ&+G2G2\4YVXK]V,=WHM57B\R5UZJ-Y/N;\Z1+N[(MJPK33)O+DX@]Q0
MF&]7FU_N6)5;[UR6T^I6G-7G49 YPLS-W.&5DWG"*ROSME=VUEM6=M:B9W86
M>"P%HO >X.[]5K0,W:GE03>:^=#E#MS^/2+H<(\J85>7"<]4.T5HI,5-:J#)
M1ZEG-4>KO3;2H+DJP6QU13JYIBS7KJ*DE%I25.M<6+#6+3>_UR,K;YB9D3?M
ME9Y[S"LM[R_L#2LM[QLS+0\\T_/ XV<0@_<@<QEZ6\J#_J[G1E=:>-'Y;CYT
MO$\8[>M3)DRO,^(9Z[83'.QPE5S7ZJ78L290L[DQ7']U?9QI=6VJ57EUMEU1
M91$UO[S:.;ML#3VCI-L]M7@3,[EX&RNQZ+!70O$-[!4KL7B!F5@,GDE%X/$S
MB%N&((</W:\@HNN-W.A".P\ZN8X''=H@B'8-*!(F-QAP#_?9"/3W.(MW=3(5
MUK:SU5>WA.I5-\>8E#4F6Q8V9-KFUA<X9-96.*77-+@F5W4R$BHW>L963#*C
M*PZRHBJN8B_PUU\\HRO (Z8<W'\&B7QH(9\+_5--0)?7<J'3W=SH2#\WVC,H
M@+8-R:'137I< QO)RWLVT,1:^SSD&GK\5*N[0G3*.J*,"ML2S7-:5EEG-.?9
MIZXI<TQLK'>);6ASBUJ]P3V\?MPSK'X_,Z3^$C.T_IEG:-UGC] Z< ^K_16D
M<J/GQ0C=J$?H?!L)'5M'0OLVDM#T"#\:&Y5&FT:U2>LV6_"W#5%%&P<9,M4#
M/LJE_1RM@KX(@^S>>-/T[C2KY*X<V_B.$H?H]EI:1&N+2TCK>C=.RYA[8,M>
MCX"6B]@3]X"UGQ@!S< (; :WGT$& =TK1^AR$T(GNXCHP 8BFAE&:&R<&VV:
M%$=]DQK$C@DSWJ9QBE#-%KIDZ8B70OYPH'K6IC#=M,%8HZ2!%+/8#5GDR/XB
MV["^:@?.NF9:0.\Z9[_>45>?WMUT[][S=.^>QW3O[@\8N'IW_>IC'D(W:Q Z
MUXK0D3X"VHG[=V(+[G_<G^MF1%#'#A7"FADC[III6X'2;2YB^5N9LIF3;.74
MB1#-A+%HO9@M2481HQEF(2,%5H&;*VW\AYOLO8=Z'%A#FQT]AW;2/(;.8@]I
M[H/O:>X;P6DILR5X#QH1.H[[>P_NWZD1W-\_^G,70BW[!%'C?@5"]7Y]4LD^
M,G_>7IIPQFX/R>1=OO)Q.SDJ43LB-<)F$G0YT^D&[.UY)K[;*\Q9VQJM/+9U
M6S.V#MO2M^ZP<]UZ!INU=9F:MW.9^&[O/ &4G_U=A= 9O <'UN/^QV>P>>+'
M\^/Y^PFH]A@_JC@NA8J.:Q%SCIOSI!]S$$@\ZB8:<\1;,OQPH%SPX7"E@$-Q
M:GX'TS2]#^;J>!XHTV<<:#"B'^@R<3XP9$8[,&/F>."4.>W  S/'??/FU+V+
ME@Y[X!>7\!X<Z4%H9A"AT3&$UN,S:-V+4.U1(BHZRXNR+XBB51=5",D7C$AQ
M%VQY(R\X"X2<9XH$GF>+^YT/E?8^%R/'/)>BZ'XN6X5^ME3-^6R])NULIQ;U
M["8=RMEI7?MS)['[.O9GYG3M3G_3MST%!C\[V8[0;GP&8_@,^K<BU+8'S\<-
M7G2&A%9=YD7Q?ZQ ,7_*H(B;.H20FQ:DP)M4'K^;C&5>-WU6>-[D"#/^C%KI
M^F>BA/.?F5*.?Q;+.-RLD[.[V:Y@>W-0T?JO[4KDOTY@=Y7(?[Y1LKKQ1<7R
M.JC^;!\^@PE\!@.3"+7C.U!W&,\_C="J2R04^P<O"IT51)Q96<2>U23X/#0A
M,A_:<C$>.O&X/O+D<W[DO\SQ48B PZ,80?O'*<(VCW-%R8_+Q2R?-(F;/^F5
M,'NR1=+DZ5XIDZ<7I8R?/I(R?OQ>ROC1MU]LQ9^#P7&$[S]"]8?^G9]^":'H
M/P@H\ XW\GLMC+S?R"+/-QH$M[>&1.>W5B3J.PJ7_3M7;MLY)H_UG#^OY5P(
MG_E\#+_I?.HRX_=Y H;O*U?HOU\KJ/NA7TCGXX2P]L>#PEH?+XEH?GHLHOGA
MW2^&\.>P"]_!^@-X_JE_YT?]B1#[#D+,M[R(\548N2Q((\<%%0+EFP[!9M&$
M:+5()II_IY!,OKN0C,"#RP!\N76!PZT-43R:D,RC!KF\JE#)IPPM?$K0SZ\(
M$_P*L)]?'L[QR\'M7_3@.]BP'Z'BDWC^;WC^383\\7RWAP@Y+7 C"@@B&Q!'
M5B"'S$"-8 RZ!'TP)NB !1''+E$='(FJ0"<J 9.D /XD.0@E24,\ER1D<HE#
M&9<8-'&OA'7<HC#"+0(SV,%?-.'/0,EQ//_BO_/][B+D^@@A^W<(D8& YRY'
M1B",]$ ":>-U:( *4@%-@B+H$>3P6F3 @B %M@1QH!)6XK6( (LH# '$%1!)
M%( 4XC(H(/)#+8D/VDB\T$_B@<V_ &-C(E@8$/_S#L#&A 0V9"ZPH7$#F<4+
M5B'+P")A!9AE"X-)N2@8-XJ!48<$&/5)@N$F;(L4&&R3!H-=V$'LE P87,;N
M82^P]]@WF6^&(+U@"#)?#4 6D_L9F.+99#TBV.D3P=Z(!!0++J!0N<'.DQ=L
M@Y:!=:P@6&6*@$7)2C"O%P>S5DDP[94"TXW28#*"3<J \0YLORP8'\<N8K>Q
M9[*+QO.R7TT69#^;@.PG$Y#[: SR'XQ!X6=@CN?;XO[_\0[@Q\_&T'Z\#Z)P
M@R.#%ZCL94")$@2[-!&P*10#<K4$6#5+@667-%CTXV,8E@7S<3DPWX[MD0?S
M(]@Y^6_F-^6_FC^1_V3^3OZ]^5?Y.7-0>&<.BF_-0>F-&2C_#*SP; KN?QKN
M3!=M(KCA\W"SY0:Z*R^X^"X'IW A<$P2!8=<<; OQT??( VV;;)@LTYNT7JC
M_#?K4?D%\I3"5_).Q2_D@XJ?R:<5/Y)_5YPC/U1\0WZK^-+ZJ^)S,B@_(X/J
M4S*H/?F7^G\#VQ_S58E Q\WM@=?!,B2!%YD;F#1>\& M!T:P$-#C5H)SAL0W
M6K'T5\=:V<_49KF/#ET*'RC]BO.4(:4Y^W&E=_;3RF_M]RF_MC^A_,K^LO)S
M^P?*CREOE&?MOZC>MP/UNW:@><<.M/Y9 E!4">"J1  /!0)XJQ'!7X\$;',N
M\*?P@"]CV7<OMM!79M3*C^ZIDO-N>3)O72OD7KLT*+QT;E-ZX=2K_(RV4>4I
M;53U,6VKZB/'W6H/'8^J/:!=5+M+NZ=VB_9*_0_'SUJ_.X+.54?0O4P%W4M4
MT/L9T/!\!FYO+UD"!"@3(%B+""'X/()M>+X%N?!_9'L+OO,+7?G*.T'R&2M3
MYK%GL?Q#]QJE!XQFY7MNG:IWZ.O5_G$=TOC;=4+SILL.K1LN![5^=SFK?=7E
M'YW?7%_JG'/YI'?&!?^^Y *&)[#CV+&?@ ON?2;N?C86@O<B0IT(4?JD;U&6
MW.\CJ'RO0SU6/.4$BLX&1DO>]4^3O>63IWC3JUSE.FNUVE7/%LW+'MU:OWEL
MT+G@/J)[CC&E=X:Q1_\TX[C!2<95PV/N3PP/,=X;'V" R5YLCSN8[EX",'#O
M^^#NY>#VC\1[$:=,^)Z@37R?8$)Z&6_+\RB&OOQNI)_P7V%ADM>"$^4N!68J
M76 7J9WUJ](\Y=.H<\*[3>^85Z_!$=:@X2'6%N,#S&F3?<R#IGN8Y\UV,>^;
MS3#?F6]C+5I,L<!B$IM8 GCB]O?'S1DNAB!."D&R/.%SJAKA59H>\5&J!=?M
M9!K?]7B6\&\Q',FS$3'R)T-358X%YVH<"BK5/A!0H[>7O<9PMW^'\4Z_]:8S
MOL-FVWVF+*9\]EA.^IRR&O?YVVK4YQ5YL^]7\I OD#=A@WY@]3-@B1$@"/=N
M-&[_)+R.=&DTEZF('F=K$&YG&Q-_SZ#P74AU%SJ5R)8\&A<A?R Z465/1(;F
MSK "W>F0<H.MP?7&DT%K3<<#N\U' P8L-P=L(0^Q=U@/LH_:#+"OV?:SG]GV
M!7RV71< MKV!8-/S+^O_!CYX#T)P[_WH_U01]#5+#+W(DT+W"A31]0)]XH5<
M6]Z3F73!P^F^$GN30^1W),2J;(M-U9R,SM$=BRPV' FO-AD*:S0?#&VWW!#2
M1UX?/&S3R]EFU\TY8-_%N4CIX#RBM 5_L&\-!ON6$+##;-?^!/Q%$(3CWDO$
MZ\@01!_RA-'C(A'T5XD4NE2B0SQ51.8YG.<LN"?;2WQZ59#<5&J4RI:D1,W-
M"1EZ@W'YAAMBRDW[HNHL>B+76G5%]-BTAP_:M89-4-:&[758$W:6VAAVG]H0
M/N^P.APHJR/ OOY?=O\- G!W1PD@2!% G[,%T+-" 72G5 !=JQ!'9RLT"4?+
M+'CV%CNNF,GW%)_,8<N.9H:K;$J/T]R0DJ;7EY1CU)U0;-H17VW1&MM$;H[I
MM&V*WF"_.FJ+0UW4+L>:J%..U5%W:%71[QPKHQ>IE3'@@%%^!D'X^6.6(TA;
MAI[G\:%;)7SH>B5N_VI1=*)&C7"@RHQ[1[F#P%2QN]A(@9_L8&Z(\OJL&(V>
MC&3=CO1,P];4 M/FY J+QJ35Y/J$-MN:^#Y*9=P(M3QNAE8:=\RI).XOI^+X
M-[3B^&_4X@1P^'^4_P;!> _B^=&G#%YTIY ;72_G19=J</O7X?:O5R'LKC/F
MVE9MOWQ+A=O*324^,NL+.4K=>9$:[3D)NFNST@T;,_),Z]-++6K2:JTK4]?:
ME27W4HJ3AQP+DK;3\I....4F77?.37Y%RTU><,Q-!FIN"OZ=YR<0BKL[D1>]
MS":AOXNYT)4J'G2NGA>=:!!"^QN5"#,-AEP3];;+AFM<1?LKO*1[2@,5VXO#
MU9L+XG0:\E(-:G.R32JSBRW*,JO)Q1EK[ I6=3GDI@\Z9J=M=<I,.^2\*NVJ
M\ZKT%TZKTK_2,M*!BCEDK/I?$,Z'_YO A>[G(G2]C(0NU'*C4XT\Z/":%6C7
M6@6TM5F?--)DS3^PVEFDMY8IU5[%5F@N#U5;71JC75.<K%]1F&E2DE]@7IA7
M2<[+;;3-RNFD9&0/.*9E33JE9!UP3LZZA#US2L[Z3$O. L>4+*!B#O\-(KG1
MUS0"NEV T)5*(CJSF@L=;>9"^UH%T'2;+!IKTR5M:K'BZUM#$^IH\)!LKO>3
M7UT3K%I=%:557I&H7URVRCB_-,\\I[C,*J.HWC:ML(V27-!/3<@?I\7E[W6*
MS;_H')O_!/_Z"?\S.&)4S.&_00P)O<[ W8O[_T(-$9UH(J$#K22THX,?379)
MH<U=6L3^#@O>KC:J8,M:AGC#&A^YZD:.2MGJ",VBNGB]O)HTHZRJ'+/TRA++
ME(I:F\2R%ONXTCYJ=.D66F3);J>(DG-.X26/:!$E'QTC2H :60(./X-XA&:S
M$;I6AKNSGH .KR6BW9T$M+6'!XVL$T<#ZS2(/;VF/*W=%('&3KI83;N73%EK
MH%+AVG#UW#6Q.IF-*09I#5DF2?5%%G%UU>3HVF;;B)I>2FCU"#6X>J<CI_H,
MC5,]Z\BI>D\-K@*'_T?Y;Y"$T)U\A'[#[7N\":%]N/VVX_X<[2>BC0.BJ'=
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M7KU)16Z[>5E.[\3B[$&K@JQ5-GE9VVUSLT[8YF3=M<W-?FN3FTVL$:L?(=$
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M"R:+%@]X<//G^PNRYH7)IO7'*B;W):O$S\G2B)E=I!W96ZT7.JO%,&A6CTE
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M]HINL1Q@CUHN96^R7".VP7(+9[WE0<Z(Y27.:JO'XBNL_N0.6^$*LB:\93]
MK$6 V-& .-+AE3,3'CFSX=X4'OPZ60;..NK",2<K^,G)E=KKY$_;Z1A)WS8E
MD;%E<B9KDT.AR :'"M'U]O7L$?M6L35V79S5=GWB*^T6<H?M5G"7VV[D+;/;
M(['$[HS$(KO[_ 7V;R4'[(GD?&3>#Q!;"O,!7KBA\TU%_Y_*A)_=V7#:30"'
M/31@[U1SV#%U"C7JX47;Z!["&'&+9:YQ31%9Z9(C.NQ<++;<N8JSU&F:^!*G
M=NXBQQZ)0<=Y_ ''I9+S'$<$_8X[!'V.QX6S'6\+9SF]ENIQ(E(SD6YG(AS/
MV-'R!U> N^C?O^(C_JP_#4[XLN"0MP3L]E6&K7[&L,'/EEKKZTY;Z>//&/*.
M8"WU2A!=Y)G.'IR:QQGP*.7.<Z_AS75ODICCUBG9ZS9'T..V4-CMMDIJAML6
MZ4ZWPS(=;M=DVMW_D&EU_X(0F18/(CT>,@5?7=C_Z^B^YX(!CJ+['0BFP^Y
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M^=, X*,EP!?<K'X-^ON[(&5_?R=E ,%)1S;^ Y'1!"*-GBN)<+6 L-%W6=9
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M(+Z_!#C[6T%LWWP0W3<"(OM^0F[B_1\@NO<C\ODO9F._V^;C\P"S<[#/"6L
M@C< >(P"V&_#?,S51557W0<@>Q! \C %XL=%0?0$#T1.2 'KA!(P3V@!XZ01
MT$]: >VD([X$<4-R"E]"IW#1G<(%=QH+?0H#3N&'GD+?/_T[\@)Y^1<=V/<:
MK'G^2H"D=;@.\*]-'?L.#N::8:X.YBH?!I#&7Y4X!2!V%H!QD8:;#G3^GR4
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MFB4)DUK%"5>UBQ)>(U^1/[2*$N2:1.,1[T;3^]/_7Z;^"99?^[(5YR^L,5.
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M*,[-.H<SLY[!:9TW<$+W2TSJ_8ZC>G(<F2W'X2>8>KQL'B\;\B4O[P?ZRGC
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M0KY ^\KI^W!RU_-:'.=U,*%X#@I8>!BPG*0^-77/3I^_2"Y3^QJY,</3RBR
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M,K-,#)KEH]^L!'UFU5AJWH0EYIWH-A] E\4:=%AL09OE ;1:GL%BJ]MHL?H
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MR.8 ^6U!XVY!XVXE\=I*TG-\(L'-1+LMU[L5<AO!OIU*W48AMB'LMR'FMUT
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MMBJU\C2E5%ZBY,J;E53Y"'B%YQ]P[=]*J5C0Z=C>ZJ8_E-$.Y6A.T -:>=T
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M[ZF@1_3=R1@&/O:M0?P!S?T*=?%SQ5*=#KCRJ%XW'+5H\U9L=^/_@!ZD/AY
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MNQ2=-**HI%G9DS?+EGR*K,D7@YL5F?R(+,DORY+T=T4F_<MS%LYB^ 9(MSI
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MA,(=%H4Z[ I.CU-0>HH"TS/E[W3)SVG\T;Z9@B!4,A H&8B##&:%##(#YZV
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MPS.&9PS/&)Y6G<!POW[@PB_J@*%Z8&ZP?+8B8-D #,<=(089.:@7DYHTI<#
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M57WM&S#T!W_,K!^]HX%A0F*-\FUE0+$-&$Y9G;+K+IL\%8L'U6I$I&8Y,(C
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M:_OMF$.>NT/3E'4S627N#0J6Y6@9PW2IO-"8Z"C0XUQ8#@+X_UC^00510Z[
M:2BA'((4-=V?I,[V)ZCS_?$:IJ^G0LNBGT<M(X:B91-G_.*:\.ZMSB$K? ]C
MCNGNCDKC-<XM8 0VEN:Y#ZMRRB\:<BP)EFQS>GFFD>"@&8@NLI[D)NHI[B>Y
M!ZDZNB=9E^5-U.5Z$W0%GI[J1UO4\[^7Q\3\43[VM<\:![U>]>6@-<;OAQ\7
M?#PIJ;!] 3VK?D-11M5!'M5W3DSUQ,I)KB05WIFJ3;.GZU+*\8:D<H(QP48R
MQ5LIIC@KS7S=2C=?LV257;'D]5BWG'V?^]D=/>2;JNA)P9M1,\T_#UDK^N?X
MPXPO7KM*O[LXC=2QD89K.9";WG"&D5)WF9T8O,Z)JX[G7:]*XE^M3"F]'$@7
M7O+C11?\1-%Y'UE\SD>5G*V@2TY79$M[JAONOKUN!OI'!ULBAUN^&/"Z&!V^
MINCQU#WT[Q:<)'RY\DK*IUL2$N\>2(N]=8)PI>LLY4+'1=JY]JOT,VVQ6:=:
M$[)/MB3G'&])S3W6C,L[VDS(/])$RC_<2"TXU)A9V%,U>?OVJ@M&]+%U]1LM
M_2-Z#A,=OSP3G;6)\/B=/<D_KCL2]]V.4Y>_VG_^[(/#ET_>/WGM^&?GXHY^
M>BGA\"?7D@Y]')=\X*/$E/WWDE/WW4U+VWL7E[[G#A&W^S8%O^LVG=!3!7U]
MD?*FOOUD]_N.8:%#IV>BDQ<2T/DKDM$5Z^+03=LN_KI]]^E'>P\<_?'0D4/?
MGSB^_[NSI_9^>_',[J^OGMWU=>SYG5\E7-CQ,/GB]@=IESY\@+^T[4O2Y:U?
M4J]L^2+S:D]EK^Z#*&[VZL]"HT9DH:-?(J#39R2C"Q?$HBN77D#7OW\2W;KN
M$+IK\[X_#GZXZ[=C.W?\>GKWME\N[-WZ\Y5]FQ_%[M_T*.' QI^2#V[X9]JA
M#?_$'U[_(^G(NA]I1]?^D'VLIT)YHYY'!:\-1GEO34&+5[^-,K9O^3GWR/&O
MLL_$?9QUE=*9F<QHHI,$M1ET>24U1^<CYYLK"(46+XYI]::QK9X4KLV3Q"_W
M) C+W?&2<G><W.Z.5=O=UXWE]MB>Z1G#,X;_8N #0^ET8%@$#*N X<,M/^<=
M/O%5[LGXCW(N4SNR$HL:,_'"FLP,58">;?11\\HJB 46+[[(ZDECVSPIG')W
M$L_N3A#:@<'ACE,ZW+%:AR/68+?T4&&&5P>C_(534,ZJQ6C1MJV/\@^>?)A_
M+.%>[OF,]IQ85GUVNK@JBZ+U9669*V@Y95YROM6#9]C<Z2R[.X7C<"7QG*X$
MH=,9+W4Y8U4N1ZS.:8G5.XUQ!D=/A J 0?@*,+P)#.\O1IG 4+COY,."PPGW
M\L_0VW*O%M?EI$@K<TAZ7TZFN8*>;?%0\FQN8J'=E<YTN%**G<XDGLN1('([
MXN1N1ZS6;8G3NHUQ.I<F7N_HB=#2;@8!,'!7 L/6;8\8>TX^9!Q(O%MXDMZ6
M=XE3FYLH]^<2C+[<#+,W*\OJH>66NTD%#B>NR.5(+78[DG@>>X+(:X]3>*UQ
M&J\Q3N/1QFO=R@2]LR<"AN=0T<O L& *6@(,K"W;'C%WG7S(W)=XEW$TL[7@
M/">8'Z?PYZ4;??G4,F].IM6=D1V*23GP##<6CRI/XE64)XA]MGB5WQBO]FGB
M-5YE@M8M3=2Y>B)4V,U0.A\8W@LSL+:??,C>G7B7>2BSE7&:&RRXIO3GIQHK
M"LAEGCRZS9V9A<6DW'9"@1>+1UF3> %K@K32&*^HU"2H_(H$=84D4>,1)NE<
M/5&(03PMS,!;L1AE;_[P4?&VDP^+=R3>9>_+;&4>Y]8P+BO]A8G&"@:AS%-(
M*W?ET)U83*J<F._#\H+*DGG5YD19C3I!7B5/5 ;$22I?:;+&PTO6N7HB5(0Q
M3!V$"M\(,Q1O^O 1=\O)A]QM"7>YN^BM["/<&N9YI;\HSEC!3 _E"#GS,USV
MS,P**SFWL@R+!27SZS2)DCI9DJQ&E*RH%*2H?"4I&B\G5>?JB5 Q,$B>,"Q?
M@G(V;GM4LNG$0]Z6A'N\[?16[GYN#?NTTL^^:JQ@)UO<;)+=P:"Z;3D9_C)J
M=HT1SVC0IY8V2U-$#:6ITB O55')25/YV6D:+S-=Y^J)P@Q3!J&B>5-0/C!P
MUV_[F;_^Q%>"C?'W2C=GM/%W<X+<8\H YZ*Q@AMO<7/Q=CN;[+464"M-='J]
MEEC8*DOGM?/3A8V<=&F0A9-7,7$J/P.O\1;BM>Z>Z+\9EBU!2]9N^UFP]OA7
MHG5Q'XG7T]J$'Q;7\@_* _PSA@K!M3*W(-5AYY$JRECD&GT>M5E)R[_)(Y5T
ML(C")@914EM E%?EDY3^/)*Z(I>D=?=$J 08I),'H>*Y4U !,/#6;/U%N.;8
MUY(UL1_+/J"V2S>QZL2[996BHWJ?Y(+9+8FWV\6X"K. %-1PR.TB1L'GC"QN
M5QZ]M#F')JG+ILFKLZG*0!9570%+JZ<G^F^&=Y>@@E5;?Q&_?^P;^?O7/U&]
M3^Y4?5#4H-PJKE+NTP0T)PQ>W66K4Y_DULM)09& V)9?3+N3Q>)TT0L$+1FY
MXGI:MJR&EJFHI-%5OHP,C:<G0J7 ( ,&R>M3T%)@$*[<\EBVXLBWJN57/]4M
M(]PTKLAO-JWA!\NV*&J<^U6.LG,6O3;1B]V%4(S=.\@C=1!YC$X25]!"*A(U
MD JD05*>O(J<H_*3LS7>GBC,\%(WP](EJ'CYYE\5[Q[^3O?.Y?MEB]/O.-_*
M:O>]PZKUKQ';[7OU.M/Y<KDVJ:)4@:\NE.#JL=R#-.S,@ZBD.9TO:D@OEM;B
MF/)J?*$R0,A75_1$J P8Y, @G3,%%;ZS!)4NW?2;YNV#/Y@77GC@6I#T2<T;
MI-:F!05.[P<RK?6 26J\X"C5)GLY*GQEKAP?)$N(]:EB>F.2I*@Q22JL3Q9*
M@RDE\NI4MB*05J3R]42H?"0P3 *&V5-0T9(EJ.*M#:AQP=Z?''-//:R9<_56
MUROIOOHWF7K/!H7$<KB,;[QLY^I2/$4:O \[?X#Y_JFRC-I$65XM^/S!.(6X
M)EXBKTH4*"J3N"I?3X3*1SR'*EZ,1F4SIZ"2MY>@VOEK?[/-WOEMU6N'[G1.
M.QN\-95HKGV;+?5L5918CYG9IBMV[!Z" BW>2]<0?.#[!]+ [T]29H//7P0^
M?TGE=96D\KI<&8@3J7P]$:H8_ARJG!B-*F9,1A7SWT+-LU;]X'MYT[WVJ1_6
M?CKI8GG7RV1Y[;OLDHKM,J;]I+ZP[)HUWYCJR-$3W#0=T8.=.\#\_F1U5K?/
MS_+%:GB^JQJ)[XI*7=$3H<IASZ&J"=&H<OID5#MKP6/7E'<_;9KX7OVGXW<[
MOIQT1=7U&J6D_CTF([!+F.<^I<HIOV;(MJ24T<WX<HJ1Z"#HR2[,[T_197HP
MGS]>5^B)T[$]L7J^^XI.XNF)4'5,+U0S?B"J?GDR:ID\YT%PS!N-'X]<[OIN
M_#[-%U.N\F[.(14VK<K/KMG#I?M/B6B>:W**,TE#L*?JTVTX8[*5:$ZT4,KB
MRC(LU\NRK-?,>;:K9H;MBIECNUPFM/9$J'9P+U0W9B"JF_+2#[Z1TUKO#I[N
M^7;D*NVCB0?X#Z9?+KB[,)U^8RV=W+2W@%A[BHVOOL)+#<0)DWQ)XGAOJNRZ
M!R>_ZB8J+[NHJHLNNOJ\,UMSSIFO.>-D:DX[>3T2:HCNA1I'#/C-/G),>WO4
MB(JO!\_6_S9ZC>"7*?L*OYY[+N.S=^,)=S;@TCKW45/:3F7%-U_(N]9PE7&Y
M/HYYL3:)?3Z8RCE;@^>>KB:5G*RF\DY49?*/5^8*CE86"HY4%I?V1#^:(WNA
MEIBHMMK(*-_-R-'ZWX;,+47'KRK\[;4=&3^\=13_U>KSR?>W78O_Y$#BU;O'
MTR[>/HL_>_,2Z53G-<J)CGC:L1M)]"/M:9F'V_!9!UO)V0=::#G[6[)R]S7G
MY^YI9N;U1+?*>R,=%?UZ^YKZ]S-\$3FN%!TVIQ"=O#P#G;<1_^NR74D_;3@4
M^X]=)RY^L__LZ8='+A[_\N25(_?/73OT^>78 Y]=C]O_:7S"WD^2$_=\G):T
M^V-"\JZ/R"D[[]%2M]_+3OWP;D%:3]3JZ(/XJOHAQLX^D:5_#!Q7B(YYC89.
M7X1#%ZU(1%>MNXINWG+N]^T[CC_>N^?PHT/[#_QT_-#>'T\?V?W#^:,[O[]\
M?/L_KI_X\!_Q)[=]EW1JZ[>II[=\BS^]^1O2F8W?T,YN^#K[7$\4</=!C(V]
M>Y5^\EQD(3IX% V=.#D=G3TK'GUGP25TU9)3Z/KE1]"MJ_:A.]?N1O=OV($>
MV;P-/;EU"WIVV^8_+F[?^/N5'1M^B]VY_M>$7>M^3=F]]C%NSP>_$/>N_H6V
M;]7/V?M[(E/E<XBP"^E5B/;M1T6'#4E#)X^)0^=.NH"^]>H)=-F<@^B:^7O0
M36]M1[>_LP7=NVPC>FC%>O3XRK7HF55KT NK5Z-7UJQ"KW^P$DU8^QZ:LFX%
MBEN_'"6M7X;2-KR+YFSLB= <6!\*ID6A!6^-0_,^F(5F[5R.9AS9^FO&Z</?
M4R]=?$!.3/J$B"?=2:=F=:5D%;8GY;-;XHM*FF*+!8W72X3U5P7BNBMB:=TE
MF:SVHDI>>T&O"%XP*X+G[8JJ"VZ%[Z);_F=ZQO"_B"$7& JG1:*%P)#_P6PT
M&QBR#F]]G'GRR#_H%RY]28M/_IB23KE%H.1VI&<R6U/RN$U)#$%# EM<%\>5
MUEX7R(/71,J:*S)5]665NOJ27E-]L4Q3==&N\5YVJ)U7')H_$YH'# Q@* *&
M F#(V;D"S3FP[7'VL2/?99V]_ 7]>NI'&:FTFV12?AN!7MR<GL-O2"D4UR8Q
M9<$$CK(ZCJ^NNB[25EZ3Z0)75?K %;TA<-EJ\%ZU&>P@R[4_%YH_I!=:! Q,
M8"@$AEQ@R-VW[7'ND:/?Y9RZ<C_K<MJ]S*2,3AJAL)5,XS82LH5UZ?FRFI0B
M5552L;8R@:>'1YC1'RLU^:ZIS;ZK1K/G6IG9?KW,7 8RQ/ZYT )@8'8S,-;,
M1O-VK$#S]VQ[G'_PZ'=YQZ_<S[F0?C<K/K.#CBMJIE%Y]:0L21"?IZQ*8V@#
M*6R#+ZG$5)$@+//&R:S>ZQJK]YK):H\U6RP@0ZRY3!M7]J=""X&!!0RL$,,<
M-'_;"K1PY[;'A?N.?E=PY,K]O#/I=W*N979DI3";Z&1!'3535DW*50?PA09?
M&LOL32ZQ>A.$-D^<W.:YKK,Y8DVVLEB3U1!GLFKBS!9EO+GLSX0R@($]-1)E
M T/1ZCEHX985:-'V;8^+=A_]CG'PROW"$^EW\BYEM><DL!JS\*5!>H8B%)\C
M%I@K<$Q+*"Z'Q>3B%';7]5",JUP?9RQ7QYELBGB359I@MOR9_L50O"C,4+1I
M!<K:NO4Q>\>1[UA[K]PO.IQ^I_!L5GO>=59C3JJP)HNB#-"S#!64_#(OOLCF
M3N':70DBIRM.[;3&ZIWZ.+U#%6^PRQ*,-G&"R2I,-%O^3&@1,!1C# O'H<Q5
M<U#FAA5H\>:MOW*V'?X'9]?E^^S]:7>8)[/:"R^Q&O(2134Y!)4_FVZLH.5:
M/(3"<E<JQ^E($'G*XS0>?2@&I7-*$PP.4:*Q7)!DLO*2S)8_$\H$!@XP<#"&
M]^>@['7+4>Z&+;^6;#[\#]Z'E[XHV9UZEW,D\P;K+*N1<5U8DY^F\N=23=[,
M;*N+5.!PI!9[RA,D/D.\RJ=(T'C%B3I7:9+>P4LVEG-33-;B%+/ESQ1BX&(,
M;XY#6<!0_,$RE+=N\V^"C8>^+]UR\<O2[2GW^/LR.KC'BQK9%TMKBA)4_@*"
MT9M+MSFIN2Y;&MM?EBBK5B0J*H5)Z@I>LM;-2=$[V*F&<F::R5:49K;\F5!6
M-P,78UCY.LI=O0P5K-GTNW#=@1_$&\\_D&Q-^DB\@]HE/%38S#_-#W*N*@*L
M5(.WB&JS9V9YS3AF4)DDKA>DR*LYJ2H?*TWK+DK7.QDX@[T 9[+EX\R6/U.(
MH01C6# .90-#R?OOHL)5&_^0K-G_HVSMV8>*C0F?*+>2;BGVY+7*CG+JQ><E
M5:7QVHH2O*6\D.;39C#K>3AA$Q,OJRF$H9)/T'CR"#IG+L%@SR$8;3D$D_7/
MA+*[&4HPAO=>1_GO+47%*S>@\O?W_J1:??IK[=K8SPT;<'>-VS([3?L9+::3
MO'K3-8E'D6C6EA!\_(+<^OS,TN9LFC28154&,JD:;R9%Y\JDZ!V99&-Y)MED
M_3.%&'@8P_QQ:/&*.6CI\G=0Z?+UJ&K%[I]U[YWXSKSJRI?E:Y,_<6\BW0WL
MSFRO.IT?<%P4FPRQ)I$TK2*_A%Y'*18TD_(EM>0<124E2UU!R=2Z*72]DYIA
ML%-I1MN?"2T&'X</##Q@X"Z;@XJ6@N^]="VJ6[KS<=F[1WYPK#C_C7_U]<_J
M-R?>;C^44EM_(M?N/R=4E%\SLL#_ILJIP10)IR&U1%J;SE14X@I4/GR>QD/(
MT;F(608'*=-8_F=".< @P!C>&(?RWIF-2A8O1M5OKT%-;V][[%A\X+O LN.?
M-ZTY<^?.^FMU7=M)SL9#A6K_.1'?'J<O,.(<1!4YD"#/KXE52*L3P-]/+E;Y
M4ID:;UJAUIV>KW?B<@WV/Q/*[6;@SQN'"MZ>B<H7O87JWWS_M_(%F[[W+]KQ
M>=.[>V[>67:R[N.5B<X;FS+4M?O9_(JSTB)@R#'ARPDZBC=1G>./59?XKZJ4
M_EB1VA?/TW@3B[7N9*;.F5*H=_R90@RE4R)0 3"(%LY U6^\B5KF+ONQ8NZ:
M^XUOKN^\LW!7\//%YYSWEJ6J6S=F\X/[.47 D..(T]$L. O.2'8DZ;+!UV9Y
MKNI$GDL:C?>J5..Y7JIUQY7H7 G%>L>?">4!@W!R!%KZ^CA4.F\Z:I@U[Q?7
MC+>_K)NUM//.K#4U]^?M=SQ8=%ESYUT<OV53#B-X@)/M.R?.<,6KB.5IAA0+
MR1)OII=?-Q78KYI*[)>,4L<Y@]YY4:EW7I'HG==*]8X_$\H'!M%+$:APSCA4
M-7,::GUEUC=54^=VW9JZH.;^:QL<W[]^6//%PJO\V\OPA:U;LK/J#K&HE1<$
MQ(IX::HK597@(.BNE=.,EZVYIHM6EOF"M=1TUJHPG[(8+:?U9LLYY9\++04&
MR:0(5#1K+&J8-NE'[XM3;W>,GQR\_]+;CN]?W:+YX?5C_/MO72NXLQ)';_^0
M3FH\4H@/7BQ.J8KEQ_N31=BY@TL>BN*\*TMUQE6H/NWDJ$^YQ.H3+K7ZJ,.B
M/6HM_U.A(F"03NR/*J>._*U\_)A/FH:.KOUL]"N.[R>]J_G]U6W\'^8=*_SR
MG2L9'WV00KBYDYS:=BPKL>E\_O7Z:\S+P<3B"]5I)6>K2/Q3E1G_%SOW%=34
M^C[P?@&*V'O?]MX+(BK2>Z^A)Z$D(2$)@1 2$D)(Z"7TWGL1D")%FB@"B@4;
MZK8A @H*"(B]/F?I_S?G"MRWY^*,\QG'J_>;E<!ZGW=6S"=?B2L@=:86$CIS
M4"6%SE?.%3AT-!?]%RA9@D#I1AFHV;!T[-JBQ;<&%ZULG5ISH/+75O5<.(!)
M^G"2(![39 2^,N4*7M@+N<]<@EF/W<+='[*B:#W<6,H]OWB7.X&)A-OAR4ZW
MHE,<NA-3\=T9:;CNO'1L=UFZ?7=MVG^!LL4(G%TW9^K20IE;/?.D6R<7K:O\
MM?9P+CK_)\)1LX@ORKB =_IDWS%+=\YK//OW]R!H_30!I8\I(O5Z!SH_\PUV
M?.H?BG\2$H9]+(ZP>Q0GMODW)=+Z85:DU</"*,L'Y?\)*A<BOY^)Z;XF(]'Z
M:.[<BI]+_LF%?PXEPA[E") W\/^E:<G_:H+S^F!#<'N'IY#'"73"J*N[XXB[
M)_ZUEQ=VF,>Q&_+SMGD5R+5^&?;G>P^8@7A?BX$4@5E_EL"TO]#OO[RKE4%N
M79)&+MR:(U'Q8L[\'%CV3P)LWA<.ATZ(0%&=![KZGF!F2OME947\CK5S_.J,
MPWTF.]A]I#M9?V 2+-]S2)@I'Q?S=T*RZ60@Q60RS-5X(HIJ-!Y/,QA/I>N_
MS7;[+W<;I9"6SMG(V8=2$ME?YL^/AU5KPF#[=B$<.\0%57EWT%$B@[&Z$V"T
ML6"K;P,.AI9 -#$'5U-3<#,W!J:%$; Q!K]\+/5_^EGI_@RTUOD1:J/]/=)6
MZWN\G>:W%/O_<N&"%'*V6P+)ZD,DXF"A3 BL72: />N]0&X;#4[O)8#Z(1SH
M';,&$WD+L#QE"G:GC<!!21\(*GI 5M4!FIH6N*MK DM# [PUU<!72Q5$VBH0
MK*,,8EU%B-7[+Q6=")+U+X)$?T0D@F'Q+#ZLG^\!VY>ZP/[5>)#[QP84MUB
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M<V_YI!7]/AN\SBJKZ&(V5%YBM52>]VJIJF*W5)5Q6BI+O"]4%G);S^;_!XA
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MFEM);*VO)-4V5U/+FJO="INK/7):JCPS+U2RTBY4_ TDH TI&V=#YI%E<.;
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MQK%.\-KA@M]K?*?P->Z.: #_1/C4\;GPGE.?\(9SG^@Z86;@O4(2O- &-MK
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M55(?A972'X<6N3T)R7=[$IS#>!HTDS\-[F@#<_<<=/9>"%'H[)VHL@E2=?9
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MD]+SZ/J="!+1@R"^ PCB!;,1"BR0P,-222M8+64"FV;KPLXY&G!PKC(<GZ\
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M2TZ#1I42J#<H@WJ;*JC=5 75YVJ@.JH.*A]1/]4!_?-%"]0F=4!]1!<T!O5
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MF"*5.4V1"@E3Q%SB>T(V\8-S!NFCTW3 [O?9(/H[@H)>#R_TLR'8+@4A!V5
M?&+1]RBU55-1>AM'(\QVO0RQ.]PK(IWJX;EK=GOQC+K< S#MM$B[5DJ20Q,I
MAW">4.92Z]Q J7:Z[EKA/.1:0IAPS2--4#)=)LEIY'<N*90I4A+E/6$Z8(?.
MFGAT;1HZ[W'1CH M4B#>+PVQQ^=_3%!>-I:HO?9EO/'69U'6!^Z%.)VZ+J)I
MMOMX&;6R_2P;F*'86K=8ITIJ.JF,4N1:XE)#*W1I=\MS>>&617E+3W4=IR51
M)USC:9.4.-H[EQC:%&DZ8(_.F$[HM7!'YST^VA.,7I.8/;.^)<G.G4P[O6@X
M76-E7YK^AIX$S/[KD?B3ET,HFLTB#^,ZOH]5I7<@KI05Z5SHD4S.=<NC9=(J
M&&FT5O<4VF./1/HH(]9MS"V:\986R9AP%3,F*1&,=R[3 2S:0$#7_OULCM\:
M"0C?@,Z=.Z4^I1^6'LT^,6\@3WG)HVSM?[I3S?9UQ&%/-HM)&K4A;D9G_3E6
MQ;Y"7!XWC)#)CJ>D>&;1$SQ*/6(\FIA1'G<]Q<P1CW#/44:HYUMZB.<X-<1S
MPC68.4F>#N#0=5U62_QY'B0 G7FCUDG\2MDF^2Y[_ZSA0MDYO24G%]S-UUQ_
M-=-D;VNR[8FZ.&>-LV*:45$(RRHG@(]+\PLF)/*C76.X:6X1G")F*+N>%<2^
MR0KDO&$&<$;<_3EC;O[LMS1_]H2KB#U)F<Z?AM]G,;^?00A&KT7L&HEO&9LD
MWA;LDAPHW3_K8?FQ^3>*U=>UY1GM:<BP/EZ9[*A>'$LQS(GTL$P-Y>+B@_P)
MD2*Q:ZA?,B/ MX#IQZ]A^?*[O/B^KSWY_!$/OL\8PY?WEN[+':?Z<B<ITP$\
MVD#]W]P;AL[=B2N1CSGK)%Z?V2S16[5=XD[5T7E7RE77M!09[*K)M90KS<"K
MYB6[&*3%,3#Q41RL.$)(" X-IXB"$MWX ;E,CG\5R\N_TXL5,.SI)1KQ8/N-
M,CB"MW1OWW&J-W^2,AUP0-\'-_0:"-"Y6[P4@=2ER+N"Y<A@Q2KD8?T_$C=J
M#\NT52FO/E^FO^-LD85L02Y6)2.3J)>00C,7)[+L@F-]G?RB0LA<<1R=%9[E
MX1YZED4/;6/1PUYZ,D)&/-P#QQC,@+=T3]$XE26<I$P''-$&C]_?"UJ$0,PB
MY&/F0F3PS +D<=T"Y';C.J2SX>"<YEK%E=55NMN*R\R.9!7;*27E.^M$9;N:
M!J<S;?Q2> [>B8$D9GPTC1Z;P:#$E#)),:V>Q-A^)CEJU-TU?,R-%OJ61@^>
MH+H%3E*F \[H9\$+G?V#%R)?$N8CS_)DD/MGT?F_81YR[<)JY&++/NFZ1H7E
M9?7:6W*K30ZEG+51B"YUU HI(AO[Y;M;>>=XXYA9(@(U74PAI:72G5)+&/C4
M%G=<:A_#(6G,S3GV+9T4-4YUB9API81-DJ<#+NC[P%V 0/@\I"]M%M)3- >Y
M62V#7&V60=HN+T<:+N^>57'QQ)+"%HV-Z0U&^V/KK$Z$5N/4A!4D?>\RNKG'
M&;8MM=C/@5@83G#(3R;;Y1=1;?*;:-;YSZ@V.>-4^[0)5WS2),4Q[AW9.?H=
M:3I 1=\'P5SD7<PLY&&6%'*S5!KIJ)5&6EMG(PU=2Y"JKNU2Q5?D%F:VJZV/
MOV2P._R"A:RHR5Z)>YZ@Y5%'-:+6L"S^'[;M,B[*]'T#_CG!T-W=W<Q00PW=
MW=TAJ2 @@B *B(2""B8JH*"HV-W=J^ZJZZJ[JZ[MVIWG<_+;Y_\\RNZ+[V?&
M%W)<]WE=]\P<(^9LKD]*WS0[/6EC;U;<Z.K<Z-'=>5$;;^1&K7N5%[OJ55["
MBE=Y24M?YZ8L?)WS7W"B)& 3&WZG_O_3( N.C;)A[TXV;#LB!*/G)6#X)QWF
M\O.V8CUGW97:3P7JSS@1937U:))3^>$L0=&A0O^< Q6A:?OKHA/WM<;'[.U)
MCMB[.C5L[^ZTT'TW4H-WOT\/V_PN(W+D74;TZG<9L?W_C6H(/.D ^&4IP(DU
M3-B[F0E;]C)AY"0'!GX1@[ZK:HR>JQ:<CLM\V9D_^VE.O1AN7/Y3@FWA^0RG
MG+,%'FEGRGT3SM0%QIQN#0T_W1,9<GIU=-#IW3&!9VY&^Y]Z'QMPZ$M"T*[/
MB2%;/B>%;?CTG[ !X.9\@#,# /O6,V S=;\UAUBPXBP'>G\3A^Y;ZHRV/RTX
M,_YTEJKYPUMYTN^A.H4WXTRR;Z1;IU[/MT_X;1(_^K=:]_#?6KV"?^OU#?AM
MR-_O^IX WQLW_'VNO0GT^@5#?4YCN.\1C/#?BU'_Y7X;P 6:P<%A@"V; (;W
M BP[P8+YESC0_E@*FA]J,^L?6G*J'CI)E3[T5,I[$*29_B!*/_%!LFGL@QS+
MB <EMB$/IM@'/FAR\GO8S?=^N-)5\&B+N\?CL^[N#Y^[N]U'#[=;Z.7Q*_H(
M?D*__W*59G!L$&#;>LK? ;#T,$#7.2:T_,:!Z:_DH.:5-G/2*W-.X2L'B>S7
M'G*IK_U5XE^':T:]CM<-?9-A$/AF@HG?FPHSK[?UEAYOVZU=WRVVY;];RW5Z
M?X#G\.&VO</;C_;VKY'G^#<Z.-]#I_]R:CG CK4T_RV4OQ]@[BF F9<!:AX*
M0\47.4;15TUFSE=C=MHW6Y&$;RZ2T>@M2Y5!,1"C57SI0Y@G9FNZ8[&V"U;I
M.N(,?1YV&=KA"F,;W&1BA:=,+?&QF07B_UA__&^[AP!&1FG^NP'F' =HO 10
M^0= R2=1R*7NGX9JS'C49T6AA5 (\H0#T%7,&WTD/#!$RA6C99PP6<X>LQ7L
ML%C)&JN5+;!)U13GJQGC@(8A;M,TP'-:^OA42P^_:NLA_J?UZP#Z: _F'@&8
M_A- Q4V _$< Z<B!!)2"2%1D!*,FTP^-6)YHR7:ESN^$KAP>>@G;8J"(%4:(
MFF.\F FFBQGB! E]G"RI0R_\FCA/6AT'9-1PBZPJGI)3P7ORROA)X;^LV$K[
M?Y#RSP&47P?(N0N0\!8HFP%!* X^*,-P1V6&,VHQ>6C(M$$+E@7:L4W0B6V(
M[D)ZZ".DC4%"&AC)4<-$CC)F"RM@J; <UHG(8(>(-"X3D<+UHE*X5U02?_E/
MW?MH_J<I_]=_\F.>C'W_ 90-X(9L<$0)L*5U6* 2PP0U& :HQ]1!8Z8&6C!5
MT9:EA XL>71ER:(72QH#V9(8R1;')+8HYK$Y6"'$PD8A^G HQ,!E9-U_0A\#
M)GI8L=#5@8T")S9ZNG'0TU<$/2,E49 JCQZ%*NA:K8'\)AUT[-9'AZ6&:+_*
M&'GK39"WW0RY!\S1[A2Y8H&V]RS1]B7Y;(DV^ \N<4"+;TYH^9&/5N]<_@U]
M]?]9@SN/A5ZT#A\7#OIXBZ!ON"3Z),NC9X$J>E1JHNL,7>3/-4"G)<;H.&B*
M#NO-T&&;!=KOMT3>*2OD7;5"[GUKY+ZR1KLO-FA'*^"B->5;HS-:?W1!FS=N
MM,+_@'ZT!H$E"SWM6.C'96. $P<#!"(8&"*% 0D*Z)NKAE[EVBAHT$>W#B-T
M662*_'YS=!ZQ1*>M5NBXGW).VJ##%5MTN&^']B_)9T*K<"!\M/WDAMS7[LA[
M*D#>8\]_0W\])GI:L-#7FH6!-FP,L?_G^Z"P "D,C5'$X$QU#"C50=]:0_1J
M-4&/!>;HOMP*W8:MT76C+;KNLD.7HUSD7^ A_[8]\I^1#P3_Y[,[VK_R1,<G
M7NATSP>=;OO^&P;0&KQI#0$DS)*-D;9"&.TL@K&^4A@=J8B1J1H85JB+P=5&
M&##3''WG6J'/8AOT&N"BYSH>>FYS0,%^1_0X[80>-\AC9_1X2]#YLP"=7GHC
M_Z$ONM[V1]?K >AV)?#?,)"ZIH\9"T--6!AMRL9X2R%,=!#!%"\I3 Y3Q(1$
M#8S-U<.H<A,,K[?$D#8;#%K Q8#E#N@_Y(1^&YW1=Y<+^AYS19^?7;_XW'/[
MX//*[:WO-]>7ONA^/P %-X/0\^=@]#P7BIZG_P,&Z3 QP)B)D=3_$TBJ&1LS
MN,*8[2&%64&*F!&K@2F9^IA88HJQ-588U<3%B+D.7\,6.W\.&7#Y%#SB]B%H
MF\?[H ."MX'G!"\#;WL^#7KA^3CHB]?=(/2Y%H*^Y\+1[T0$^AV*1+\#_P%#
M: TA='_&TCQ2Q_Y_DC$;\VTY6.@J@87^"I@?I8[9*?J87F#V.66RS?O$!ONW
M<6W.KV(6N+Z(ZO-X%CGD^7?$1N_'X7M\'H:=]+D?_KOO[?!GOK^'?0ZX'(Z!
MIR(QZ% T!NV)P: =L1BT+>[?,)3Z903E)VDQ,8M,H%F4T'Y,<A;'23YR6!:F
M]KDH0>]M7K;IR^PRFZ<94QT>I32[W$^:ZW$W89'7[;@!GS]CU_G=C-X1<#WJ
M:-#5J&M!EZ+_#CX7_2GT> R&[8O#\.WQ&+XI </6)V+H2-*_81CECGTW-_9[
M4OFD5(^%%;0?U?:B.$4@\[$Z2.5518S.WV5I)@^*"FWNY%<Z_)$]W?6W]#;/
MRZGS_2XE]P7^E#@4<C9A4]BI^'T1)^+.1QZ-OQ]Y(/Y]U*X$C-Z4A-'K4C!J
M.!6C!E,Q<B 5(\;#<,J/I^PLZAG%U'TGT][4&+.PWD[XXW17R9<-?HJ/:R,T
M[U8G&_U>D6=UI62BX\4)4]W/YC;YG,R:$W@L8V'HH;25$?M31Z+W)N^(W95\
M/&Y[\I]Q6U)>QZ]/_1H_E/8UKC_C6^SR#(Q9EHG12_X#1FC2/E#WSJ6>,9'6
M,85Z=X,!\VN3E=#K%B>QQRU>LG\U!:O>:(C7OU2397UV<K'3\;(JP:'B!K]]
M!:W!N_*Z([9G+XW>G+DZ;C1C4^*Z](-):],O)P]E/$\>R/R4U)?].7%QSI>$
MWIRO\3VYWV(7_(?_K2&5LB>,_?\#6L<T-08VZ3+>SS9C/>WD"=_M=).\V1Z@
M=*DY1O]T0YK5D:D%3OLJ)PEV3IKJOZ6T*72TJ#-JI* W;CAO9>)@[KJ4E3F[
MTY;GG$];FO,X;5'>A]0%^1]3YA5\3NHJ^)(XI^!K/(D;#Z,T&)A.?;MX[/?N
MJ?LVTGI:-1FOYAHR'\RW9O_1XR3Z2Y>OXIGV2+TCS<E6>Z?G.FVK+?7<6%T=
M,#*Y(6SUQ-;H_M)Y\7U%RY(7%PZG]4[8GK&@X%3FO GW,^86OD_O+/J0VE[T
M,65V\>>DUN(O":U%_X8Q=-U9E%U&7:=6#K!9 3YUJL+3^=J,.XM-F-<6<T7.
M]7@I'.L*T]W7GFBYK3G+<;2Q2+"FKB)@H*8NK*^J.69QQ9R$GDF+4KK+5F5T
MEF[.:B\YFCV[]$[6K+)WF2UE[].;RSZF-I5]2IY9]CEQ9MF7A/$PCKI_#LV@
MG#KO6/=NE86WW0KP<)$J_+Y<AW%IN:WPR24"^0,](3H[NN(L1MLS'(=;"@3]
M,R8&+*NO">NMG1$S;TI[8F=53^KLR2LSFRM&LV>4'\R97O%'SO3);[,:)K_+
M:*CXD%9?\3&EOOQ34GWYY\3Q,(%FGR\SUGL!&TF'%+SLD8&_^F3AZJ ZG.VW
MYAQ9[BZW>W&0UJ8%,>9KNU(=!MKS/);.*O7O::H*ZYK>$-->WYK84CLOM;%F
M>>:T*>MRID[9EULSY;?<*35OLFJFO,NHJ?Z05E/U,:6F\E-23>7G?\&DL=^'
MH>PIU'N;).!YESC\OD0,?AL0AXM#*G!BM870_@%7F6W+ S37+8XR'>Q)YBWK
MSG;OZ2SRFSN[(G1V2UUT4U-S0D-C5^K4AJ695?5K<BJF[<Z=5/\+>95=/NU=
M1D7M^[3)4S^F3*[YE%Q9\SEI/$RELU!,G;-6'-ZUBE+GXL"5/E&XM%H,SHPH
MPN&U9NR=0WSIT0$_]:'E$2;+ER1R>WLS7>?.G^ S>^ZDD)F=-5'3VF;&3VGM
M3*EH69Q1UC247=RT,Z>PZ0)YD54\XUU&R?3W:64-'U/*IGU*GECW.6D\3*>S
M4"9&9T$$_NI@P=6%0G!AI3"<62-"_5<>]FXP9FU9YRBY=MA'=>6J,*-%*^-M
MNY>E\]L6YWO/["T+FC:_.J*Z>WI<^=RVI)+.WK2"]L',W/9MV=GMY\BSS-S9
M[]/S6SZD36CZF%(XXU-24>/G?\$L.H?EPO!A!@MNS&7"A25"<'J0 T?7<V#_
M%AG8OL6 N7Z3O?C@!B_EI2,A^O.&8JW:!E.=9J[,%4SK*_:O6CHY=.+B:=%%
MO:T)>3T+4K(6]*>GS]^2D3K_-'F:GM;U(2VSXV-*=MNGY)Q9GY-R6SXGCH=Y
MM _5+/AK%G7O^0PXLYP-1X:I_V]DP_8=DC"Z4Y>Y>H>=:-]6#\4%FX)T.C9$
MFS>-)/.FK<EVK5I=Z#UQL#RHL+\V/'=E2TS&\NZ$Y+X5R0E]FU+C^DZ2)RGQ
M2SXE)_5\2DKI_IR8-N=+0GKGE_CQL)#VH8ZZ-_7_\XL C@ZR8,\($[9N9<#Z
M?6(PM%^3L7R?-:=WCZMLYRY_C>;M$<;3MB;:5&W.<"K;6. Q8<-$W^QU-4%I
M(TWA26N[HF+7+(^-&MX8'[GF1'S$\./XB-5?XJ-7?(V/7?(U+K[W6UQ"S[?8
M\;",#?=G /S<#7"B#V#O$ .V4/<;V<F @2-"L.R8"O0<-6-W'G&6;#[DHS+M
M0)ANY;XXL](]:78%N_.<LG:6NJ?NF.*=L'V&?\RVN<$1V_K"0K>.1@1O.QX1
MO/5Q1-!FC Q9AU%AJS$JHA^C(I=CY'A8!?#[;( S"P$.# !L'0%82]UKY3XF
M+#K!@>YS<M!^SI#9=)8G6G=:(%=Y*DB]Y&2T?O[Q%+/,8SDV*4=+'.*/5/&C
MCS1ZA!^>XQ5\N,\WX/"HG__AX^2QG\\!#/3=C4'^6S$X< .&!*W[MT<- )>Z
M (Y0_]X^3->_D?)W ?0>9D+'66%HNB()TZ]H,6JN6 F57W:5*/[%7R'WYPCU
M]$N)NDF7LHQC+Q991%ZLM F]T,@+O##'T>]"G[//Q5$7KXLG7+PO/N8+SG]U
M=S^+ L%1]/+<C]Y>N]%GO-]; 4[2.=@U"+".^N_*;0 ]!P#:3[%@^B5AF');
M$B;?UF24WC9G%=QR%,F\Y265<BM4(?Y6G&KTK73-\%L3]()O51CZWZHW\;G5
M;NYU:XFEQ^UUUNYW#I-[UJY_?K)U_@-YSK^A _\B.KF<0^?QSL\#V+<28,,:
M@/[-E+\78/9Q@/H+3)A\G0.E3V2AX(D6(^N)&2OU;WM._-\>XE%_!TB'_ATI
M'_0T2<GO:;:J]],2#<'3*5INSYIU^<_FZSL]'S1P>+'#R/[EST:\YZ^->'^C
MD=T3-+%[@.;<NV@QWN%E )N&  ;I'/;2'LP^"C#M/,"D:P#Y]SF0]4X64MYK
M,N+?&S.CWMNR0S_P.0$?O41]/@:+>WZ*D7+_E"+C\CE7SNESF8+]YUHENR^S
M56R^+E*U^CJB;O'MH(8Y_J5I]N63IMDGU#1[CQI$<[RMM >K: \6[J#\PP"U
M9P'*K@)D_PF0_)8#L2@#$:C*"$9]IA_U?B_DL=W158B/WAQ'#!;F8;2(+2:+
M6F&.F#F629A@G:01MDL9X#(9/1R5U<7C<CKX2%X;O\AK(?ZGH;4 B^@^:#M(
M^6< 2J\ 9%!^S . ,.K^@2@%WJ@ 'JC)X*,ADRHTTPZY+&ODL\S1DVV" 6Q#
M#!?2PW@A'<S@:&*QL!K6"*M@FX@2+A51Q VB"GA45![_(A\(BHVWA,Y ^WZ
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MU0I6%C?Y]!5V!BPN6!C2D]\?/B]O0V17[OZH.;F7HSOR7D2VYV-$:SZ&S2K
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M^1=5HF]Q)7J75*!G23EZC(>)=!9R >[0/ERJ SC91)VGC0F[YS)AZSP)6+]
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M$FK$H(1J,3"Q6C@D5HD!C_DLN:\G^31S<(SQ[VGA/)C%&M '=Y+V-AW,;+=
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MDTO-,+ZT",:7MT%S^1SY"$87_X#1!0'C<T)Z$NU>I)6,O9-Q3]_*&M"'9QT
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M;F!2#^.G-_>B976E/Q^P28+E%@.8;S4E=C#;Z@K3K=XPV3:63('QMF@8;<N
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M(+FH=XKR^YR4VS];.?T!REH0H<P%B<I8D*GT@4*E#50I=:!9R0,]2AH84<+
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MN$C^@^LT=W"?_ ;/RW?P07D/_EP^ _^0;S\1:Y]9?@9ZS;H)>7S NCMH"5@
M.D ][Y?!G3M?2D,F)0R@/9".\Q;-5."HLP)&9\M_-$!SQ\(U9RQ>?F,9\ATK
ME,_B:GDO;M?LQ4/R7#PA]\6[Y;;XC%P7WRN7Q2_)9>PCN2XRRVW$BF&S3E._
M76!5-WT1S <MH KNPGZTYR#Z'XD4-0K_$FGN<I-FK[27QX2+W">\Y#81*-=5
M$7)9E0BRY+RJ5+-6-<II5:\<5RV5PZIMLE]U7':K[M2,B6<U<^)=V:W\5O;C
M9CD86(XZ66"YI6<Y& 2=H([W2H9H@Q$I:3'\R^!?(<U9+<U>AP;<.$6.6QQD
MO\55=EN\-7-+D&9LB=2T+<F:NB5/4[94R69+NTQ;,'X+?[#E$+C P$.T;D*H
M;?J2!9$H=H,%>_G:6C"&G_M!,\\KC!P0=4X91_^O@I]BYFR4/+>B 7>@P7?;
M:-I>.YGVHG'WNC.H? $!T'X6X?TL-/N96/;76[8_[3>.0*&Y]Z,S]R&@]Z(S
MK_D4P+_'@NUPK:2N(\;.')[74N?"E8P!9'+L!O0WO'-V2A[7P'\ #7Y8FH)\
MUG4$P\<= ,'@";3V20*>4P0<IUAH3[,(GS:2\'3JTSCS]";+3R*?0LR?1#R?
M^#N _[@%&R:8F^'L!TWXNG0]XW +8P#>4'CG')3<X70Z@09'HYNH#G).!-),
M;MAQ,W;<8NQ2<;?\L]A%[+B=H.AV%KX[T/UWT+'NH"%OWPMN!D_PG7>8G(GF
M;S-/[E)90UU'0,=F^N%VQL$>^B"\8?#..0D_G$YP3C?R+[<#JD*0ST('[C-V
MJ2 ('B0X?XC@_!*:_V':Y5'LN$Q@<IG%[S*3S.-TKL?QQ64*O'P_0,A?ICT>
M,T]B&>W;2W,U[&<N.,(\P-<BSUEVQ7A<E!SODJ8:7 ]9<R]7<B'&29VGK#F1
M9TW2CQ$$SQ&,OX!(>,G;<G3]YP0?K[  OLI@?Q7=_PL<^RJ5>94_^L5?P#^!
M6<.T;QM-57&&-L"_L? &WDW_H_LX/2I->\+*]:PU[V+D07YFS4M<.:GS:VM^
MXK>(MM_-E/Y 7_T3@?E?L.-=@J3W6'S^2O_\VUKI?<C>QXGOORQ]@*K[X OU
MGF<^PK1"?)S\ 'W@,<F;>CH]0]\S\B\O63E_<57.Y?\YH:/O=XK\W=@E8OR*
M#3[Y"K'R30A"DC[ZG7%"AD%GIL'-.-I\"5 A\Y^M^8=95AC/KYP*B9/EEI R
MT&C-/QB[0XR;2E?*<DIF*]@MX];4[U!SW^HTNO$F_0LU^$\:[TL4\1>H_\_1
MW,9IF"NW<1@[0HP=&:_)>BO%9.[#WIJ#L+?:8=Q88MP28NQ0,7ZUIGHR%V,Y
MG;)07Z%SOT3G?HX=GV'')]CQL0[J(UVG#U&!'Z SC=,I?T4AOXL3W^'9G_G+
M/UV5>S%R'\:)D!<G;3#R'L9.")/UT;#)V"DSCWK%\Y=9\)5B?ST<'93?1_G#
ME+V4)IB@[/64NY5Z[:'L0RC;X]3\/-WC=KK)@W ]JU=HO)]CK<'Y4RN>L^8B
M)D^%R.8_\@_,Y'"ZX;VYU"D2OA3X\N&IU.]ID]?1_;]!]_\2.U[%'S^G75[&
MCI>PXT7L>!XE_6,4]S.TR5.ZFR'T.#ROXI$/]1B>?!06 \;O^SPHRV_]7,W_
MU627FHKOG*B3%^T5#%<L]<C ]B*]0)O\6,T,QR[JT$_9PS LH>R5E+E>E[2-
M7K!7#Z#R[Z--[M5%=/M#3"G/3^Z9N4@O^>]=&;=<98-Q <[?9-F$]2I]XT5T
M_S/TBR<5#D\2/#EPE%)^#>6W4,,NRN_7G=AQ.W9<Q(Y;L>,6;=?-]-$;=4(W
MX(MS](NSE'*:&IW$N\:^)@,GK\(5_G=-EF'^D\GI8 K^<L)7GM0ED'I$PY.*
M_7FZP#BY2764WT+Y793?KS/8<8K^<5*KZ V;Z)F[\<2U.C*9#;D#BQ[5?OKF
M7@;O-;2V\;M#5^,KXX>Q'"R74S_+XR-,,??9&%/R3#B=J9,//2P$KGAX,JA#
M 1P5<-3#T0I'-R-B 1R+M$_+*7,MO6*;=L&\D[_8CG>VTAZ;\>PFT[O::/.5
M-MBR3DWY'O^ ^TV6O>? 0RP[=S#5WL1[YUD"SMHZ4#<W1OY<'3%%Z*!-DO;9
M9NN:*47:/;5*NZ8U:,>T-FV?/E];IP]JRXS%VC1C0AMG;-;ZF7NU=N8)K;&[
MH%5V#VJE_0M:X? 7+7?\&K!&7(7WF,I>G<O2,0=^EKUS/BRGO'>$Y>>PDZT.
MV3EIK_UL[78(U@['&&UU3-5FIUQM="K5!J<:K9O5I+7.G5KMW*]5SB-:Z3RN
M<9<-6NZR1TM=KM-BEYLUYOJ %KF^H!&W=[70[5L-N9LM<+/@#W,M.9C[P(V$
M(=<%$F[XH[E8_G8PY6]WG:$M+J[:Z#I'Z]S#M=H]01,>F5KA6:!QSW(MFUVG
MI;-;M7AVC\:\!K7(:XE&O-=HH?<.#7H?T8#/#>KWN5=]/C_6?-\_J\?O:W7[
MF=7M^SV,TTD_C&19CB#$  ?"X>:]34'H/FQ9ZVNKU=ZSM,+'2\O\@K5D3HS&
MYJ1HT=P<C<PMUD+_*@WY-VH@H$,+ OK5'[!(O8$KU1.X1=V!!]49=+TZ@NY2
M6]!3:@U^6RW!7ZDYV*SFH._QLRB6?$*?F\%1L,N:^UB-+2M"B6_PS9) !XT&
M>6@XV%]#\R(T,"]!"T(RU!=:H-[0<O6$UJD[K%5=83WJ"%NH]O#E:@W?J.;P
M?6J*.*V&B#M5'_&DZB+>5&W$EZJ),%L0;E8M>#'><C/+]>  V$KHL9KWEF/+
M&+:,X)N%X3,U$.ZBO@@_S8\,47=4K+JB4M41G:/VZ&*UQ52K):9)S3%=:HH9
M4$/L4M7'KE=M[#6JCCNIJKC;51'WN,KCW@!?J"R.E3 6Q)A5#GZ<S#A,(<P#
M>\ &L(+WQK!G(2$9$D:],5/5'>NLSC@OM<<'J34^2BT)26I*R%1C8J$:$BM4
MGUBOVJ1VU23UJRII3)5):U2>O$MER<=5DGR;BI(?4V'R_X#/@%F%22#1 N.?
MG2Z"8V '6 .6$!HO)/3H)PSJP9:.1!NU)3FJ.=E#C2G^:D@)5UUJO&I3TU6=
MEJ>JM%)5IM6J(KU59>F]*DU?I.+T52I*WZ&"C&/*S[A%N1F/*B?C5\K.^%39
MZ6;EI%F1:M;C6?0%<!AL 2N-_$NFD7N!'UO:L:69QX9T>]5EN*DFPT]5F2&J
MS(Q1>5:*RK*R59I=K)+L*A5G-ZDPNUL%.</*RUFIW)QMRLZY5IDY%Y21\[#2
M<WZAM)Q/E)9M5GJ6%9EF/4SX>][8'00V&OM?P$+>FP_:L:<)>^IXK,Z>H8H<
M%Y7E>JLT+TC%>9$JRDM487ZF"O(+E)]?H=R"!N44="J[8%"9!<N57K!%:06'
ME5)XDY(+'U)BX<^56/"Q$O/-2C*09U9RKEGW$_J> 7O V@)I,5C \R[0G(?>
M )4\+RV8JN)")Q46>2J_R%]YQ6'*+8Y3=G&:LDIRE5E2JHR26J67MBNU=(%2
M2I<JJ72C$DH/*K[T!L66/JB8TI?!1XHI,2NV&!19<!>2Z 38 2; ".@%;: >
ME(/B$O1_J4FY90[*+G=39KF?,BKF*;TB6JD5R4JIS%)R99&2*JN56-FB^*I>
MQ56-*:9JO:*K]BNRZIS"J^Y76-5+X$.%59H57@'*S8HH,^MBJ70MV *6@R$C
M!P2:0352J;@<W5=)S%V%_JZ>J90:9R75>BFQ-D )=>&*KXM77%VZ8NOR%5U?
MKJCZ1D76=RN\?D1A]6L44G^-YM6?55 ]*W#]BPJH?U^!=42LM:#&K&!P$V'W
M ; >+(:K'[176G) %?#F(Y6R:M&>R,>$QBF*:7)4=+.[(IO]%-$R3^$MT0IK
M25)H2[9"6DLTK[560:T="FP=DG_KA.:V[I)?ZRGYMMXE[];GP%_ETV*6;S-H
M,LNOT:RS-:P--9:]0".@!S2#&GA+",>S&] ]3?"WH+^1*J&=,Q7<Y:R@KMD*
M[/970'>8_+MC-:<[37X]^?+MJ91/3XN\>OHUNV>Y/'JVR;WGN-QZ[I1+SS/@
M7;EV?2>W3O,DW#O,N@Z.K6 Y& 0=H %4(-$*X&;(*[$#_B[T+]+1O]]6/@,.
M\AITT>Q!;WD.!LIC,$+N0PER&\J4ZU"Q7(;JY3S4HUE#8W(:VB3'H6OE,'2K
M[ :? &_)?N K.2PPR['?@H/4;ST8 [V@%=2"XC9\ '=R-_H?B12Z 'YDHS<R
MVFULJIR7.,IIJ:L<E_K(86D0B)+]TF39+<W5C*65FKZT3=.6#FG*TM6R6;J/
MB>\&\# -CB!;_*E,8T33HV;9@EV=C >P$'3#V03*>9[70QOTH?T&X$<>^8_"
MOP3^<338A*WLUMAIZAIGF=80_*PA\%C#XK^6168M$]I:!M-:.M!:'+=V&4#$
MKS6N?4"XKD:TK?H8$$5.6+"9.BX%"_AZ!ZCA>2%USJ#.\=0Y;#'\RR6O"<EU
M#1H8C4Z8))NM,Z1MZ+EM!%[;"31V$(CL8*'=R8*WDTEM9[GE*J2=%+)S(SC&
MYW?R703D-D3AMN_H!.9)K(%KD7%##_5MY+&,.F>/T0<Q/WRE% "O%T6X;)$<
MT.C3]A#TXEH=L 4$GP<)_ YAQV'L.((=UX81!!A;4YG<CAK78U&IHQ1T%&%_
M+6+^6D3TD7?X_C?\G7D2X_ M-&[H,4YGX>L\?)V\&OU/?0.V2K-W2<Y[)?N#
M:.!KX3X.3@%<JS/8<19_7(\_SF/'#02!-V+'S00?-[, 7T#W7Z!S73!^*HS"
M;D;<WX2@OQ'Q?.,7?-\\B:5P]JY@+*RB'ZYC'L+/T31?('6=?1A^I+J=D7\Y
M9\V_7-F+8N1#[@"X5W<1G-]M+]WK3#!"_W@ .QXB\'B(A>^A2NM)'7QQZ1#@
M#Q]Z7GKP0[YGGL3"]<S+FQB+2/)L_!S'UX+A]<)D9[KRS%NL7'=;\RY7<B&/
M@L>L.1$C1_$D@N I?/(,;?-CX]82['@Q&L'"XO<2_?.EA8 &?>DLX(]?^CU
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M@!CG<HR](?=>E0\Q\@6/HODOTS8_9+P\91Q<9U%^BO[Y(QKZ1U3P29SWY.V
M]OCA1](3WZF6.N<;=]%0YY ]DC?U=3X.__76_(O!>9<U]W)E3\@35D%DY"8F
MS^/\=RX$8? J;?,;[/@?QLK_TB:O,<&]3N?^+1WIMU3J#0I[XW7PB4JW,Q?@
MZRCJ/ <?N]Y(_[MHS;\\9.5\TIIWN7(OR<_U_=TD_SZ+\U^Y$.-\C/'3%A_1
M+A\3''["PO,I@_ S.MIG$'Y^*Z 2GQO9B&G6/1!3K?D08P^&<4NI<1[&N(\C
M Q3+LA>D!?3(<B9F5,;=(-\R4+YFD'R%PON2CFJYD^.L/D99&_=QO(]"-TZA
MO,LWKOQ"K)&#,&[D_)'^KSLH;*QV&+D8XSR,<1]'TF0NYAN5H4WK])G:] _L
M^#O*Z0-TW=]0<N^A@OZ"'7_&CC\R6/Z ,OT='>AU.LUO8/DESGI%G_S[EU&,
M,RB7K3F(_SX#8L$T+)Y%?693GR#X8M"D:=:S*!647X]R;=/_8L>OL>,7J+I7
MF+1>QHZ7L.-%]-USJ-1G&#Q/Z1:ZS0-8\3Q-^IX>Q6M&WL78_V'<A6'LO[CP
M7S88YS#>EXGZ..A-N5$//_P6"D\\')F47XAG*RF[GK);*;N;LOLI=YCNN@3/
M3S!$-C)4=L%QA.%SO6[G_[?QS5OI,!=@,#AOEF4?QAE]?P;$V /RD;4[&7LP
M7M!TNOLLNO]L. +@B(0C";]E4781'JZ8W(=Q&_WC%G3_!93K39/[,)8P74S
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ML/SC5FM.W#7RBSLKG[C[Y!7WDKQB/Y1WK%F^,18<B+)LDS?V G49.2!0 8I
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M<#%%Q8DQ*DT,43GB'E5#W*(:B$L4(VU4;W&(&BMV40LP)L%A),%@)#%UQ$]
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MMG5 R2"6SQ'H$LIW0>CAQRLN)V:NF_C>$&TOKK%.XA3/ )?  )9DLG7D%+6
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M&R".#5\,B!;"T"&42%(]PSO0MAXI.\2V!RL&A/$Y"%W\T</'WUXLP!Q@)\9
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M1H#9;@A>.PP OU,? G;I 0DI>+<NA.S6@; ]VA"!Q/FC@(.<'R*V3(.P W.
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MTPNOC9S;=.&9MG+S<WW]TL=F]AD/[;SB[[N2>;>QC+#K/GS2);]8?!])BKU
M37+K#$MUZF"GV[5%9UBW23(M6],S+=N*)AR(ERA"XII)4+AI\J>F75,>7=H_
M[?J]XXNZGY[;TOA&2[G\M9Y.]BM3*]D+.[3@J1N>.8(C4X9]Z?XWB1'>_P1S
M/:[1HURO, 5.E[FQ=OT"D?5%B=CB8JK$O"\W?J)!/&*0KU*"RO5*+[HW*=T8
MWCJE^XGRDH:WJEM+/VD>R_JHJY'TP<0DYKV=/>LU&AWRW,N;^-C/S_<A*1!W
MGQJ,N1L6XG*'17<<XH79W18R;&Y)F)8W4UCF@UD3#A+^4H3\OQ4_-*]4N'5S
MH4+WXZW3Z]\J+ROY?G9+Q@_U0PG?=<X*OYOHLK_;F=(^8VP"WWL[XM_XNWF.
MD=W=7])P;L\97L[/.#X.3_F^=D]B"#:/)7Z6H\D!YH\RB!,-4A<K0.5BU$#_
M3-2%T86*=6^WSBS^KKPL'4YODL"Y?7S0/LX$8U4JV&D3 6/@ ][&V._^YIBO
M9$O7+S1KIT\,6X>/'#N[#U$.MA]B':W?QSM9ODMV-G\K=YEHD#\/=:-U&JKK
MZ@Q4[;O%2H6P;78:'%X:!R?6<>#L#AIH'2"!T3$\V)[R!/19#'BINX*?IA,$
M:3L 3<<.PO5L@*UO#7P#2Q :6H#8R P2SYM"FO%$&ZR9C&KOG(JJ'IR&RH,E
MDU-A^^Q8V/\7"XZNHL#IC7Z@L1T'!GO<P/* $[@<M@?<45O *UL#\80E!)\T
M!_HI,V"<-@7.:1/@GS&&&)7S$'_6$)(F7$?#9%1EWV14SH-I"DFP;$H,;)G%
MA%T+@^#@,A\XL0H#Y]8[@NXF*S#=:@YV.TP!O=,8/'>?!_P>(R#N-03R7@,(
MV:</8?OU(&*_+G /Z(#@@#:(#DZTRC8E5/8U153"YYF*0OA[<CBLGQ$(6^=Z
MPMY%+G!TJ0V<^=L,M%:=!Z,U!F"Q3A?LUVN#ZP8M\-BH"5X;-0"_21T"-JE!
MT.9S0$&B;U$%YI:SP-DZT2 4V3@AFZ="$'*M8!R9#[S3RT"HN0YB37:"T.$H
M1.'. 8>H#XPPBV]TGL/'8!'Z'5'F^9J0AG_IDQWPW+. ]!1;&OS$O9HZBFZB
M/7+K#!UQZ0\?<AI@7+6_R9Q(_S/\S_#_:0C>-PLB#L^'J%-+(18QQ!GO!)'=
M41!ZG ->@"%$T*V^A'&=WU-C/%Z3I+XO_5,#GOEF!CWQRJ>.8DOH#]VKPAY@
M&IGWT9VLNZ[][!M.-[C]C@/LB01AR,ZB(8:0O;. <V@^"$\N!8GZ.D@PV@GQ
M-L= C%$'(>'\#Q[%[F,$"_.:'NW[(E@<^(281'U(2 \;\<Z)N(LKX@Y[5/*'
MW!NC;V&ZA-==^V-[G"\+.URN\282A",&.K)QZ'MF 0_9%R+D;)^@MA:2#79"
MDI4R)+AJ@-C']*N0[/@NDH%[R>0%/ Z)#7E 2F#>]4O]^3U,]$VOPM@!7*7D
MND=3PA5,=V*W2W=BBUN?N %S63B1@($80A%#^.Z9$(7L"\F))9"$&-+T=T*:
MI3(D.VN"S,O\BSC0Y;4@U.<IATM^$"I@W F6\&X2DV-O$#+CKWH7)%W&5:3U
M>S3).UU;,IO0':FU[CW22NQ%T43ZCX&Y:R8($8,4V1<IY]9 INY.R#!7AG1'
MK6\I6(N/"?[H5Z(0OU$^BW:7&<6]&2**O4Y*E%WVDZ?U>>=E]>#*\SH]&O+K
MT8UY51ZM&:6XKJ0BKU[)1 (FLB_"D+,]:^=,B-T_%V3(ODA770,Y.CLAQTSY
M1Y:]]B>YN^7;%(+[BP1*X ,A@W&;$RFX'AJ3T$^6RGL"TG(Z";GY;?CRPD;O
MNJ)RC[JB(L_F[#SOCM1LWPL)$^D_!@ZR<>(00Y+R7Y"ANAKRM'= @8GRUSP[
M[?<Y:.N7&3[8T602^4X<G7V=%R'N"^>G=(;$9;8$)>;5$S,+:_R+BBO]:DKR
MO6M*LGT:\^2$MO0TO^[$B001B"$<,7"1C2/>-P=2E!=#]MG54(@8BHV5/Q7;
M:+\N=+5^FNOE>2_-GWI=$LSOC0Z3M+.YJ0UAPJQJ:GQ^&3FMJ(B46YH?6%&6
M0:@N2_6K+TP*:,V0!78F3Z3_&'@_?Z6#&-*.+89<E550K+7]>_EYY0_EUMHO
M2YUM'A9@O6[)\;2+,A*_/98F:>!%I%9&1&47A\45Y(4D%6=1LLKDP27E2:2J
M"FE@;;$DJ#E+3.Y(G4C 0@R,C5,@ZN<O9/;.!OFQ19"/&,JTMG^M,CKVMMI2
M^VF5H^V]8G?OJ]G>M*[D 'ZCA"*I%(2G%G&YV3D1,07RL(229'IZN8Q64"&A
M5E;&!->4"JE-.0)J>]I$ A:RLQ@;ID#TUND@0PR91Q=!H<I*J-#<]JG.X-A8
MO87V:)V#[>UR-Y^+>5ZTUG0_7G4"65(LHJ?F1+.ST[C1!8DL28F$D5(N"L^M
M%(975/)HU66\T,;<R- V^43Z96 B!B%B2$(,V4<70O&9%5"MN?5#D_[1%RUF
M6@\:[6QN5+MZ=Q?A0AJR\+RR9)(D-SXD-3V6F2V+YA7$\40E DY2.9^=7<EE
MEU5%,*K*(Y@->1',UHR)!.Q_&V(00PKR69E[= &4G5GQK59CR[M6O2//.DVU
M[K;:VERN<_%J*_4(J<[UB2Q,#Q!G)%)2$N/#LN)$W()H84P)-SJA/(*?41G.
M+ZZB<RLKZ-R&_%!N:\9$^F6(0 RB+=,@#3'D'UD %:?__M*@L?EUI][AT5X3
MC=N=UM:]C4Y>C948:EF1-S<[VR\N.2TH69Q$SXJ6LO+9$D%)N"B^G!:;7DF)
M+:P,$E16!$?7%P1'M61.). @!A9B$",&.?)Y781<OZM/+_O4HK[I98_NP0>7
MC-6N]UA9=;8Z>M;4HBD%99Z<M *\*#Z;E"20AV2P4YAY84G\8HI,7$9*2*D@
M2O,J_.(K*P+$]05$44OF1 (NLGG9R.Z.1ZZ=F;MG0.GAN=_J3RU]VZ&V_NDE
MG7UWKQN=Z^^WL&SNLL>6-;F2LVJP;%F9;VQ,$3&1DT>1AV:%YP1G< N)Z;$E
MA+2D,I^TG'*O].HR[^2&?%]92^9$^F7@KIL",L20LVLZ5!R:\['YY%\O>M76
M/!C0WC5XVT"U^YJY>6V?K4=!APLIM<D](J[66Q!9Z2<-*R6G!A>'9OD7LO-\
M\H6%N'Q9L7M^=@DFO[+8/;LQSR.C-6,B0>121>"OF0S)FZ9 P<YIWVL/SGK=
M>6+APZNJ*X;N:NR\=$]?I>66J6G951MT9I\3,;X+'<YO]>2'-Q'$P?6D1/\:
M6KIW-2O+HTJ0XU:9D.=2E97O5%61[US>G.U2U)X^D8"'[&[AZDF0OG$RE.Z8
M\K%Y__3'%X_/O3U\>MFEAQJ[.A_JJE3?-3'.NV7EDG3=@2"XY$IC]F$YE N^
M0O^N0(E7!RW1O9V5ZM(N2'=LDV78M65FVK259=JVMJ7;U7<E3R2(0@SBE9,@
M>_TDJ-XZZ677WBE#-P_,N/3@S-\=S]1WU3W5.5/TZ+Q1VHBE0]Q=!T_N$#J0
M?LN33AKT8_E>)_,]KM"%+OT1<?9]_'CKWK@$RYYDF7E/KLRLIT9FT=LKF4@@
M0+:_##E3%JY1_-"T4?'^U0U*ET;VS6I_?GIES6OUW46OM$_)7QCJQ3^SM.0_
M=70)?^SN&3SJZ^<W0@SRNDL)P0R%A3G?8C/M!Z-9-@-BCN6-Y$CS&UD\T^ME
M/./KS1,*8A8K0OHR1:A<H?"DYR^%R_=6*K8_WSNGYOWI504?S^U*>Z]U//Z=
M@4;46\OSC+=.5I0W6,> UWBTSTL2#OLLQ-OM"0/O-,KUMW\D(-H\$),L1Q*#
MS$?DP:;W"RG&]ZHF%(@7*D#^(H6WK7-15P9FHMJ>KYI4]6'O_/SO)U>E?C^[
M/>Z;QF'>-_TSX=\L-(._.1D$?,.9>G\E6'I\)MFB/](<G-\SG1S>1KK8O1&Z
MV;R6H"W'$C'FK^0>IJ_RL<8ORW 3"=+FH5Y7ST)=[)Z.:KLS$U7Q<?64/-BW
M(!F45\; F<UL4-]+ [VC)# _A0?'<YZ U<0 7L<52/I.$&)H#XSSML UM@:!
MB>4/L9G%=YFYV;=T"Y.ON9;&7XNM)M)8X3147^-45%/?-%39RSF*V;!V6A+L
MG2^ P\N9<')=,)S;Z@>Z>SS!Y" &[(^Z@/MQ!_ Y:0<!IZV!HF()86<M@*5J
M!OQSIA"C9@+QZN<A6<,(,C4-(5]K(O5734(UM$Y&E5R;@LKX,4\I =9/BX*=
M<\-@_U^!H+S"&\ZNPX#69D<PVF8#UCLMP66/.>#VF@)^OS$$'C@/E(-&$';(
M %B']8%W1 ^$1W1!<E0'DH]I0\:$:JQ30A5=4$*EW592D, ")3ZLFT:'+;/]
M8?<"'!Q>X@*G_K8%]57FH+?6&,S6&X+=1CUPV:0+V,W:X+-%"_RW:D+0-@T(
MV:8.X=O5@+4=&68[5"%FQUF(WSF1BEL44&E74*C89TH*7%BH% (KIA!@_0P,
M;)MCC[PN+.#8XO.@LD0/-)=I@^%R#3!?H08V*U7!:>59<%MU!K"K3X/WZE-
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MF%<49Y=7#+3#*YZ[[4L1SNI%HI?Y,[FWZ;,"'^.G5;Y&3SOQAD^N_S80SU.
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M\K,KOV9K;WV;8WSD>9:M^DB*F]E-B9=;?S01W\D."6X.BPBOI?(YY:2XJ.*
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MD!00&B.EL'EB1A0SEA=+%\1)@J.2$TC\W$0BOSHI(/J"+#"J/S:0=X,;&#G
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M@P; .F$$S(O&P/C3!+SNFX+G,S.@OS;[09LRG_.8,9^ESEE\I/ZPF**"V>^
MSSH2,/ :V!J"$* M#"%&BR'<>BE$4%9 !&LUA(4I0G#*)@@H5 /_6BWP:]<#
MSDX#\!TV I_])L ^:@;>Y\R!==T2F'>MP.NI]0_/5S9S]"F;&=J,[0?:5]MW
MM'F;-S2P^AWPQ6M@XC5PU 0@2$L8(@P60;2E!$0[KX!8KS40%;P>PA-5("1/
M P*K="&@U1#\>TR .V@&G#%+\#UD!3Z3-L"^8@>L?^SGF4_(7[U>.<QX3CE.
MT6<=W]*_.K[TG+=_[@FVO_/O&E3XP5]5 ,(TA"!:;Q'$64A @N-*2*2O@;B
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ML!*X"&\ JH@B>(G(@X^H'/!$UT"XJ"S$+UH%&8M60L&B%5"U>!DT_A90UY/
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MBSU9L>2AM%1*;W*.1T]"":,SMH;=%MW":8GL]F^,& JHCS@85!M^/J@F\DE
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M]V)<=07 S4P(* Z+P-ES"3@&+ 5RW#*PSUX)=N728-LD S:=LF#3NQJLA]>
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M=(+)>$2&Y5AH@=U(<(7#4&"#<S^OW76G_P[W[7XC'MNXA^E=W,OT#NXS6D?
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MP!XE4O>(_J+6(>L5M7TNZTIWT)7S>MA:&5T\P^2.,+.X]EB;R"VIY)#67.>
MYG(W;E.CAT_3-CJK<;<7L_&$%Z/QGJ=WTT<WGV9PYC2#/;<)['X%,23T.A=?
M ]S_%[80<'N2T,$!(MHS2D #XQ*H9UR1V+9/1Z1^U$*J;,1Q3?XNCXT9@RRU
MI#X_W9C>$./P'=$6P3W)-O[;LLF^W:7.K*X&5Z_.+G=:Y["'1^=Q#VKG72J]
M\R/%JPL<F5U@Q^P$VU]!(D(/BA"Z6H_09"<!3?02T![<?OW[$>H^LABU'9$C
M-!S6%"R?,!7/'R>ORMCG)I\XQE".'N5HA.T.T@L<B33F[DHT9P]E63,&B^WI
M _6.[@.=SJX#PRXN \>Q?UPH ],.;@/S=M1^L,:L?C6-]^$_%0B=:\7]_[._
M<?OUX_;J.D1$S9/"J.ZT#"J?W,R7?])H4?H)FV4)QRBKHXYX*H8<]E'F'0K0
MX$Q$Z+ .)AAZ'L@P\1@O-G<=K[-RWM]IX[A_EQUY_W$[\OA=6X?]T]:.^\#2
M:1^8.>T%TU\]RD?H<AWN?]S?>WL1&AC!\P_\? ^<A"HN"**BRU(H]_(&8MHE
M7:'XBY9+(BXXK@@Z[[':[YRW ONLOQ+C3-AFVIDX#;?3&=HNIXOT'"?K#.TG
M.XUM)X=-;$Z?,+$^?=_$9O*CL<TI,+0]"?JV)_[7G^4(G=Z"T/AVA :'\/R?
M[\'C_BP_RX=RKPFAE-MBN(/E"-%_J?.%_F4BS+ME)^Y[RVT9\T_&*OI-[EKW
MFR'RE)NQ&YQNI&\BWRA4L;U1IV9ULU/=\N:(AOF?)S7-_WRH87YC6L/\^@]U
M\S] S?S:_[K0@-"A;H1V]2.T;0^>C_NS?!*AG,LDE/B7$(I^(H'"GL@1 IZH
MDGR?& @RGUB*TI\X+7%_0EOJ\L1GN>.3P)7V3Z)D;)\DK[9ZDK?6XDG5.K.G
M;0HF3P<4C9\=5C1Z=D/1\.D[1</'7Q4,'X'B0HYU(#2R$Z$>? Z;\1Z4G40H
MZQ)"\;>(*/2I, IX+X4X4W($YI0*B3:ER^\Z92;H],%.Q/X#99'-!R\QJP\<
M<?/IX*6FTS%21M/IRPP^%B_7^]BP4O?3-FGM3WNDM69.K]*<>;1*\],':<T/
M\QC\CU&\!SOP.6S!WP?EQ_'\"PC%_HE0X#V$?&=$$/.[)/+XOH9 ^;Z1Z/A#
M@V3[PY#?\H>%@-D\6=!XWE78 +Q$],!75!N"%VE"S&(UR!#;#*5+5*!)?!-L
M%U>"O1(;X2SV4&(#3&.S_Z,7[T'K&)Z/ST#6>81B;B 4@.<SGB-$!6'D A+(
M'J0)UB!/, -EHA%N?GTP)&F#.9\&V/&K@@N_"M $E,!;< /P!!4@4F@=I JO
MA6+A-= HLAIZ1&1ACX@,'!==!;>P^_^C#9^!RL-X_ED\_SI"/#R?_@0AIQF$
M[( ?68 8,@8II \R!&U0(*C#)J(*:!"50)>X'HQ)\F!)PO%)6@T4TBJ@\ZT$
M7[YE$,(O"0G\$I#'+PXU N*P56 )] N(P3YLXG]432"4?1K/_P,A?SR?]A3/
M?HV0^3Q"AH"0#KX6ZG@=*G@=&V$500'6$=;">H(L*!.D09VP''2(4F!$E  +
MHCC8$<6 0EP$GD1AX)($(8+$!RDD$A21B%!+(L!6K/M_@)XJ$0S5B&"F1@(+
M+<R #\PL!<#$60B,6")@$+((])+$0#=_">A4BX-VJP1H=V/]2T%K-S:.'</.
M28+6#>PQ]A:;70K:\QC\_R3^/^+_X^<:C#<3P6(S":S5,5T^L#(3  M'(3#S
M$@63P,5@%+\$#'+$0;]" O2;EH)>IR3H]6+#4J"W#SLL!;JGEX'N->S!,M![
MC7W"?N!_!O\UKP^2\WH@^4,/EOX*]/%\LY_W03 [51+8:_&!G8D V)*%P)HN
M"I;^B\$\1AQ,,R7 I%02C.NEP+A]&1AM7PY&@]CH"C ZN (,3V*7L+LKP? E
M]G$E&'U;^=T(5GS%YHQ@^9=_+?L5&*H0P?+GS\1@CIM(X*3.!\Z& N!D*P1D
M=U&P\Q4#FP@)L$J5!,O"96!1O0(L6E:">1?6*PUFPZO ;#]V5 ;,SLF Z2W9
M>=-GLM_,/LA^,?LJ.V,&LA_-8-6T.4A_^-?*7X&I$A%L%8G_[6_*^G_OQ5#U
M!,#=4@A<71:!,VL). 8O!7+",K#/6?'O_: &&;!IEP7K[:OGK0?7_+ :7?O=
M:D+NJ]6DW)S5M76SEH_635N]DW]O-2?_U@KD7EO#VE?6L/JE#<B^L &97X'%
M>B*0UQ'!%?>W!_[JA:\%4YL?&&9"X.FP"*AT<7#G28%K](IYE_15WYR*5L\Y
M5J_][-"R;I;<*?_)?J?B1_OA]1_L]F^8LCNV\;WM1:4WMO<VO;!]L^FIW1>E
M1_:PX2$9%.\[@/P]!Y"[ZP!K?P76N+.=UQ# 0Y8(3-S@/AM(P-'@ XZ1(/C8
MB@++3?P'PW?9%WJ8](Q'TNII]YQU[UW+%-^ZU&]X[;QETTNG;2K/'?LW/W78
MH_:$?$C]$?FLY@/R;<U_R*\T_W*85;OI!"K7G6'3-1?8<)4"ZZ]00.%78+^6
M &ZK"."U$O<W[ET>WI,@O!]!>#\"+$6^^CLO^<1A+GO/#I1YS8R1>^Z9OOX)
MK6#30_=*U7MNC1K_N&[5NDW9H7W+99?N#9=QO3^<3^I?=?[#X)+S,X/S+I]T
MS[J"YFEW4)ND@LHI#]ATT@,V_@H<\5P:[EXV[DX>;O!0O"<1>#\BM?CG(DR%
MIT/MQ5X'T98]Y7%E'W#"Y?]F)RK=8F:K7O<JT;A*K]&^1&O1N^#197"6VFMT
MVGVW\2FW0R8GW,Z;'G.[;WK8?<IXPN.[_D$Z:!_P O5Q!JAB*K\"EY_7 #<G
M%S=?R,_WOE?C_EU/_!:O1IJ.-Q!\&6N]^%&4F]3?H6S9&X%!BE?\8Y3/<]+4
MS[#SM$]YE^D=9]89'F%L,3[DN<WL 'W0?#]]G^5>VDFK4=I-J]WT5Y;#7G,F
MPTS0W^4-VKO8H+'+!]1^!6YX+@O/#\#='2F%(!ZO*7D=X5/J)N*K-&W^1RGF
M(K<3G"6OQC!DSX?[*TZ&1*@<"TS4..2?J7N 6VBPS[?29)3=:#;BO=5R%VNG
M]2!SQ*:?>=BVEW');COCJ=UV[UF+'E\P[N& ?@\7M'O\0/-7X('WP ?/_]G>
M,;C]DY>C;QFRA'?9BH0G.:JD.]G&0E?3'):>3:3)G(CE*!Z*#%'9'Q:C.1J<
MJC<2F&,TR"LQ[?.KL=C);;'N\>VV[?(=M._P&2>W^YQQV,*^[["%,VVSQ1_,
MMO# L"T0]##M7P%=$N\#;NZ?[9V UY*^%,WDKD O"M:@>\4;"7\4Z N>R[:3
M.)[N+G,PR5MA;UR@RDATI.9 1*)>;UB&44](@5E74(7EUH &FRV\K?;-_KT.
MC7ZC3O5^)YQK_?YRKN6]MZ\+_&%9%PPF]:%@4!\&NK\"+]S=/-Q[4;B]DW^^
MY[L$315*H,>ER]&M<@7"Q1)=@9,%UN(3.:ZKQM*9"KN2_97[$L(T>V)C]3JC
M4HW;(W+-6\)*K!I#:VWK@K>0JX-Z'"L#1YS+ H^XE ;^02D-?N-8%OK-NCP<
MS"HBP:@B"O^M\PM@XL<>B'LO%DL311_R%J$7I8O1W2HQ=+5:CG"F4DO@2*GE
MDGT%+M+#.9[RO1D<Y6TIP1I;$Z/U6N.3C!IC,\WKH@NMJB*K[,HCFAQ*PKJ<
M"L.&7/)#)UQS0R^YYH:]<,Z/G+,MB ;SPA@P+HH%@U^!-SX'P4+X+ JACYE"
MZ%Z1(+I=(8S^K!5%%^K6H!,U&OP'*LW%=I<XKNPOH*W;EN.S:6MFH$9+6H1N
M?7*\475BNEE%?)Y525RY76%,@T->=(=S=E0_)2-RW#4]\KQ;6M0SEXS8+W99
M\6"9G0"F.8E@]"OPP=<_3 !!D@!ZDD-"MTL%T/5J(72U002=;I)!AQO4^,9J
M31</5I)7;"^ARG44>BNUY/+4Z[/"=*LR8@W+TE),BU)RK/*32FRS$VL=,N+;
MG%/C>BE)<?O<$N+.8(]=DQ)G[5.2P2HM!<S24\'H5\#!YR""#\VD$M&]?"*Z
M4<Z/FT<0G6\60L=;I=%XRV;22*/QHMY:^^6=E6YK6TN9&^N+_-2J\D-T2G.C
M#0NSDTQS,[,L,].+;%/3JAV24EJ=XY-W4&*21]VBDB?=(I,?N,:DSI#CTL$Z
M(0/,$C/!^%?@)X(@FHA>X.:[741 5ZOXT+E& 71JBP ZU+X<C;4KDP9:#46W
M-=I*M=525C=4>6VH*N>HEI8$:1<411KD%"28IN>E6R;G%-@F9%>28S*;G2(S
M>BAA&;M=0S).N/T?0NXZKLITZQOXNG?0(-W=W8V$= M(=W<W@I2D" HH6(@8
MB&('=G>..6=TQAQ[[.[U+F;./(?Q/._[_O'];&<\X^^ZUW7=[/V[9Y_)J+D1
ME%W[QB>O'MWR&]"YH $G_PA3Z2P4 ]RI [C<SM 98,.1!1S8MY0#8\LD8,,R
M'=:J 6O^@45N$GW] 8IS>L,TV[OC#)JZ4LWJ9N?83)]5[%#>5N52W-+HGM_<
MX94]<[YO1N-00&KCAJG)C0>F)C5>GYK:]-HGO1G=,EO0.;L%)_\(,SCPOAS@
MMT: \YW4^^:S8/\2-NP88L'&E6(PLE*3M6RY)=^"01>Q[B6^\K,63E-OZH_1
MJYV?;%K5DV55-K?0OG!.A5-N9YUKYNQVS[19O3Y)[8-^\>WK N+:]P7&MO\<
M$#_KI7=BQW>WY YT3IF-DW^$V0 /I@-<I?Y_JAOH##"P<Y"!3:L 1M:(P/(U
M:LRB$3.>WE5.DSI6>,LV+0M6K5T:I5.Y)-&H9%&&><&"?)OLOK+)Z?-G."?/
M:W5+Z.GVC.D9\(GJ'O6-Z-[C%]Y]V2^BYX57=,\WU]A>=(KK18<?83[ [5J:
M 77?H_,!=@\ ;%Y!_9^ZS] &05B\48F9M\&8,WN=@U#S6D^IVI% Q<KA<(WB
ME7'Z><M33;*&<BQ3!TML$Y=63XX=:':.6C+'-6SQ$H]IB]=Z!2_>[16T^"*]
M/G>?MOBK2]ABG!R^&.U_]*J4SB+U_Y-S ?93_]Y*_7?MZO%\ZI_;>:!G3!9F
M;]=G-V^SX:_=XBI6L<E?MFA#J$KN^ABMC-%D_>2U62;Q:XHLHD>FVX2OGFD_
M;;C+,6AXL4O JC53_%;M=O4;ONCJM^J9<\"JKY,#5Z+=U)5H\Z-[M \_M0,<
MIAF,#0*LHSU8OH[Z)_6_KCTL:-LG#C/W:3$U>RUXRO<X"Q?L]I',WADLG[8C
M2B5Q+%$S=GN&7N2V L/0K96FP5L;+0*V=%K[;EEDZ[UYQ-YSRRY[CRT7[3TW
M/[/SVO35VFL36GIO1(L?_4IG\03-8,\2@ VT!RO74O^D_C=G%T#30394'Q>&
MRN/*4'+<F)UWS)XOXZB'2/*10(FX(^&R48?CE<(.I:L%'\K7##Q8H>MWL,'
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M<^2PGBN#<[C2.,@CA1MY)/$@^9E' A__E_Z- &V[Z?P=^RL__CI T&T ]P<
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M)67S70I+E[GFE:QWSRG9YY%=<M4CM_2%2W[Y=_N""K0NJD1S8C81)K#@0R[
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M4U%K(IPVO@_4_3, ?J7>>:&4!:<KN7"\BA?V3Y>"L>FZS,9*&^Y(N;O@\I)
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MIC![K5U^]B[[O.SS]GDY?]@4Y'TU*\Q'HZ)\U"\J0-V), K@CS3:AT+JO94
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ME;K!D9NPWI,_9MU4X<AUX6*AH_&2P6O390+7YLO[K:E4\EXS4]5C9(ZZV\B
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MCMK]<QS5>T\YJG>_<%3N(%?E]C^MI/MO 9V_C@WCS^  "O=3_G& \#/4P2\
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M9:(X$08R,-Z][U/G^X7>XLYG4]_)9<.1'"[LS16';7E:L#[7BKTZVY5W*"-
M:$E:N-B"E'BI><EILMV)N0I=":7*L^.KU=KC9FJVQ,[6;HJ9K]L0O4R_+GJ=
MX8SH/48UT3\95\<\-:B)_:I=$X?J,^)1A2A--+X/[ZA[WZ'^?XGR3^739_U"
M!O85LF&L4!0V%*G#2*$Y:RC?F6=)KJ]@?_8TT9[,&,FN]&39CK0LA;:40N7F
MY$JUQJ1ZS?K$=NT9"3UZU?$#!I7Q:XS*XW<:E\6?-2F-?VQ4EOA9ISP)-2J2
M494H3S3^KSK&]^&W\1GD4?<O!MA72IVKE(%-I2*PIDP%EI>:L)84.W+["[T$
MNO.#)W7F1DFV9R?*-&=E*#1FYBO7I9>IS4B;H3D]M46G(F6N7EG*8L/BY-7&
MA<EC)@7)ITSRDQ\8%Z1^TBU,0\VB=%0C*A-A*, CVH=_90&<ILYUL Q@%WWD
MV$)&*X5A9942+*TT8OHK[+D]91X"LXL#1=H*PR6:"N)EZO-2Y6?DYBA-SRE1
MK<BNUBC-FJE=G-FI5Y"QT# W?95Q=OI6DZSTXZ:9Z?=,LC,_Z.5DH59N%JKG
M9J/J1.-GX1Z=Q4O4_X]3]]U'V=NKJ7?6 *RJ$8#!&?*PL$:?Z:VVY716N?&W
M5?B+S"P+%:\KB9&N+DZ6JRS,4BHK*%0MSJ_4*,AKT,[-[=#+SNTWS,A989R6
ML\4D->>H:7+.'9/4W/?ZZ7FH330R\E%UHO=T%FZGT3Y0_S]<3C.@[,UUU+WK
MJ7O7\\+"!AF8UZ#+=-5;L=MJI_#-K/$5KIT>(C:],DJJO")1KJ0\0[&P-%\E
MKZ1<([NX3CNCJ%TOM6B^07+AD%%BX2:3^,+#)G&%MTP2BM[I)Q:A=E(Q:B07
MH^I$+\;/PO@^T#G8/YUF0-GKJ7^N;*;NW<R&><V2T-6BQ;0W6;!GSG3BK6WP
M%JRJ"Q(MJXV0+)H1+YM?G::0,SU7.;.J5#VM<H96<D6K;D)YKWYL^:!A=-D&
MXZBR@\:193>,H\K?Z,>4HW9L!6H0U8F>) )<I7TX1C/83=US,^6/M%'OHAX^
MCSZ&=LX2@[8.-9@YRY15V^[ K6KU$"AM"10I; H3SYT9*YW5F"*?WI"ME%Q?
MK)I05ZT16]NL'36C6R^B9JE!6,TZPVDU^XU":JX;3:MYK1=6@UKA-:@>48.J
M$]U/!?B)SN(AFL'83)H!9:^83=VWB_*IB[?,%8&&;B68,=>0J9QCRRGI<N7+
M[_03RIX]331C5K1D2GN23&);ID)<:Z%R=$N56GCS3,W0YCG:P4U+=*<VK=4/
M:-I+_J4?,/.5SM29J!DT$]6)RD0W:1].T;VPE_9@"UW_2"? 0#=U3^K!S7T
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M:;7IHJ35AA>2ENN_2UJN0TG+T7_:0WNPD>K@"LI?,$![0-=>3W6LE'IPYA:
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M-[!,W'9@BX3-TI,2-@./Q*T7?Q:W7H3BU@M1S&:"_70?;*9]7T7YB^<!S%U
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M/3@*S ,J\@\_$2KO#_ZCE_*;U_SU/:0LNO88NN[ X[3_IP&LS@/H7P)0^QE
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M0S*=P2BY0#)@"^FSA70R(&F7D%K\H]6*O[0ZV2EZ\+M6'WY5;L7/REWX47D
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MQ%\5,N;)5]1/1E'_%F#/^DZBK@5U#=]DW=6Z'ZHS,N2SD>S(EP(7Y%I<D!H
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M-N ;]%-G-W4&J7,"GS(6]W ='^%%?,!._!Z_\0XC]=9(WNH-8011PW#>P]J
M\=!C/.C[S1@/XXELFUF0]-SPMW8P?E?&XX$\"]_+2_"U? $^ES7C4WD'[LF[
M\9%\+3Z0;\+[BNUX5[$7;RF.X W%$%Y57,;+RN=P5^LCW-'^$<_I2GA63\(M
M?0DW_PO)1A_2)/I_:QFD\;J0QK%,5FP?L\GXU7@.[JM\\+4J I\9I.!C@SR\
M;U".MPWJ\(9!*UXSZ,0K!JOPDL%ZO*C:BA=4N_"\ZB!NJT[BEN$E/&-T&T\;
M?8AKQC_ALHF$2Z82+IA*POG_0IJJU"08U4QA.6QT\?=X8_PX=AR^M)B.C\U<
M\8YI(%XSB\5=\W2\8%Z(VQ:5N&G1@!N6[7C*L@M/6O7@FE4?KE@-X/*8O;@T
MYB@NC'D<Y\8^C<?'OHG3X[X3'K/^2S@^7A*.CG#D$89O8PZS_\SB;4^^F"[@
M"UL=?#K>"&^/&X^7QCO@N0E>>&92.*Y/2L05FVQ<LBG&!=MJG+-MQ%G;11BR
M72:<METMG+3=*)R8O$,X/GE0.#KYE'!X\A7AT)2[PH$I7XI[I_XA[IXJB;O(
M3K+C$21[EL&!0X\3AUH7X!UG#ON.,KPZ51?/3;7$4].GX_+,>3@_*Q!G[&)P
MRBX5)^SR<,RN5#ABMT X9+=0&+1;+!RP6R[NL^L5]]AM$7?;[1%WVAV3;;<[
M+]MF_ZRLW_Z>;+/#+_*-#I)L ^ES) [_HG[X\"?J?LHA_DUO^G]..<^Z S?F
M*G#5T1CGYMC@M-,<''?VQF'G< PZ)V"?<X:PQ[E V.E<+FYWKA6W.3>+_4X=
MLBU.*V6;G/KD&YVVR_N<#BK6.0TI>IV?5JYQ?D_9X_*3<J6+I.C6(%_Q"']1
M_QOJO^=/OQ5$;7*5YQ<]!9R9K\)Q-VL<=+?#/@\W[/(,PG;/:*'?(T78[)$M
M;O0H$OL\*F7KW.ME:]W;Y*O=NQ0][FL4*]VW*%>X[]5:YOZ85I?[%>U.]]>T
M.SR^UU[L\8_6(D])212/\F ^IR _3KT<UF]&<)T?"9SCE'<JD'[#1P_[?2VQ
MRV\:!OQ=L-G?%QO\PX5U_O'"&K]TL<<O3[;2KU2VPK=:OLRW2='INUC9X;-2
M:['/!NUVGYTZ;3Y'=5I\+NHV^[ZHV^3[M6ZCWU_:C7Z2%E$V/,*/GIP.Z?_O
MT/M>I_<\'P><Y/$PR[,W2 O;@\VP)<06?2%SL#;4"STAP4)W2(RP+"19[ S.
MDBT)+I0O"JJ0MP75*5J#6I7-05W:38&].@V!VW3K @_IU0:>TZ\)>DZ_.N@+
M_>K@A[I5P9(VT7J4;WV!MUCO9ZE].0D82F;]>=S'G[=%B-@8;HS>B(GHB;3'
MBB@W=$4&"!V1$<*BB 2Q-2)-UAR1*V\*+U$TA%<KZ\(7:BT(Z]"N#ENM4Q6V
M5:\B[(!^6=@9@]*PFP8EX9^2W_5*PB6=D@A)FT>M4;YDS%^-!IZF][W I<]C
M7'8,\KB39=D40[\3H\+*V''HBIV)CCA7M,?Y"BVQH<+"V%BQ(2995A>3)5\0
M7:BHCJY05D;7:Y5'+](NC5JI6QRU2:\P:J]!0=0I57[TTZJ\Z(_)K_IY,9(N
MT2':HWS"?O BZWPME9XS$SA&#[Z/#'#*[V6YNA/TL331"HL2IZ(U:2Z:DKS0
MD!@DU"9&B=4)B6)E0KJL/"%/7AI?IBR.K]4JC&_5SH]?KIL7MT$_)VZW05;<
M8ZK,^"=5&?$?&&;$_Z*?D2#I9B9(.IGQDO8H'[+=GZ/6974>BM[S4#[]%MF<
M ZQBN9:FZ*(MU1P+4VW1D.:(VE1W5*?Z"Q6IX6)92IQ8DI(J*TK)D1<D%ROR
MDJNU<I*;M;.2NW0SDM?IIR?O-$A-/JY*2;YFF)S\+OG9(#E9TDM)EG1&T%;S
M+MOA)K4N4O.Q GK_8GI_TE?(M7X6U[J92C1EFJ N<R)JLNQ0F34/99F^0G%F
MJ%"8&2/F9R3+<C.RY-D9A8K,C$IE>GJ3=FKZ4MWD]+5Z2>G;#1+2CZGBTZ^H
MXM+?(C\9Q*=+>D27Z!!M-:_'LR\P!H^S[L=*>"^4T?-Q.;RV%%B<1[^1*\."
M7"-4YEJC+&\&2O*<49CG)>3G!0FYN5%B5FZB+#,W0YZ>FZ](S2E7)N<T:"?F
M+-&)SUZM%YN]33\Z^XA!5,X3JLB<U\F/^E$YDEY4MJ1+=(BVFI=X#UQC#(98
M]\,5; <N/S>3GBJ@A9\MH"\O+U*AN&@,"HJF(J]X#G**/9!5'"!D%$>(:47Q
M8DI1FBRI*%>>4%2JB"NLTXHI;->)*ERE&U'8KQ=6>$@_M/"B04CA*^2^?DB!
MI!M:(.F,H*WF>=X#3[ -3K+N![CLW%['=J@'EO/8R&5Y.3\O+-=#;KDYLBIL
MD%'A@+3*>4BI]!62*T.%Q(H8,;XB619;D2V/KBA61)37*,/*6[5"RKMU@LJW
MZ :6'=3S+[^@[U?^DKY?V?=Z_F62KG^II$.T T:XR7O@/-O@&.N^MP'8NI"^
MLYE]D<=:EJ689<FJU4):K3%2:L<CJ6X&$NJ<$5?GA=CZ("&Z+E*(K$L4P^LR
M9*%U!?+@VBI%8&VSTK]VN99O[29M[P4'=#QKS^EZUKZHZ['@6QW/FG^T/6LD
M;<]J26N4ZXS!$.M[B/J[6NG[VNF]:8W:274;?1=]>4JS@+AF%6):K!#5,@61
MK8X(;YV/L%8_A+2&"4&ML4) :ZKHWYHG^K:4R[Q:&N4>+5T*MY8-RODM^[1<
M6\YJN;2\H.72_(V6R\*_M5R:)"W7)DGIVJCADOI)/?53:M0?6,(Q82G015NT
ML(OMP&,FB2=A2W41W&F*P,X)".B:"?\N)_AU><*G*Q#>79'P[$H4W+NRA/E=
M):)K5YW,N:M#-K=SG7Q.YQZY8^>0PJ'S-OE*[M#QE\)AB:1P6/PO9]D'CK"N
MNSH8@V4<$[K53R>Q'5:Q']"3)Z\&(HG_:A&>:U1P7V,)M[6VF+_6'O/6NL)E
MK3><UX; J3<6<WO3,+NW0'!86R/8K6T79JU=(\Y8NU.<MO:4.'7M+7'JFB_%
MJ:O_E$U=)6E8J>$QMOL!UKV?%JB7FEUK&8-UC ']>!:M:MPF^O_-]+_TYG.W
M:L.AWQCV_6-AUS\%L_H=,+-_'F8,^&+Z0!BF#21@ZD 6)@^4P7:@&9,&5F+B
MP#9A_, )P7K@AF#=_YE@O>6A,&ZS)(S;)(FC'&;]=[+N&VC15ZX'VC:.Y&!H
M49-I#\/IB;UW \Y[@%G[ )L#NIAXP!@3#HS%^,$IL!YTP+C!>1@[Z(LQ@Q&P
M&DR&Q<%\F!^LA=G!3I@>W R3@T=@?/ ZC ;OP7C_[S#>)\%XKR2,LI?Z6UCW
MM1N #FK7T0X643.->E'TXWZ' %?:]EE'Z<%/T(/3GYJ<UH'1D!&Q@FK(EMC!
M8,B5^$%_*!)Z0VG0'2J%]E +M(;60#&T%_+3Y\C+Y#X4I_Z!\J3T'P88]_6,
M=Q?KW<0ZE^X',J@90UOJ/[PKAAYXB/5_'+"B-S:F536X(H/6-7W(KII N#J&
M@YPMH=>^1H][C8NPZYQPKZNWB/*&O\Z&OL;*73M&Z+>O?DI^)=)_V,BV7L&Z
MM^P%*ECG+&K'G@8"SE*?FK,N I,N Y;TY49/ 7K/ /)GZ;6?H^=_CI[_.1/@
M>9;C!9;C!9;C15?@+LMQEY/Q2QSL7^(@\Q([^4NLX$N\Z$MWR3?\_>_DGV%6
M[=#LS*DZ N2PSG'GJ,^ZNM*6S[P.3&#1S6\!JN< [3O4?IF\1M2YD#>57 #I
M V\; ^]:<%$Z$?B 9N$C+M#OL1SW.!E]PLGO$PYZGS+@G[)Q/WV"B\?7R=?D
MYV$6'0!J&*:\,QP'J!W(^KH^K=D58TU=TQ<!_5=8=[7F.^0#HMZ=<H]\JLZ'
MR&A*=("O5%P<,R;?C:51F<+%^ES@ <OQ@ N#7S@0_\)![U<V^J_L6+^Q@K\Q
M'K]].$PM^UD^VSJ1\0Z^ <QCG*>SON-87V/JZH[F7^Z-Y%]&=XA\-[)+Y#^Y
M$#FOIPL\- +^LAAY2L9QY$TAZC>6E(T\(;-UY$VI;&CI^C"2@35]]CCP3J4C
MGD#HN>%(O$@$22&%I)HT_\_\P_]]2N;QD=TAS]&KOT^W_1W^HF,?S7W\\;]R
M($;T^@:6D)06_,EJI!SJ'2KS23!)(#FDG-23=M)%>D@?=;929^?P/HP_<80:
MI_ [+N)7W, #O,H0?4'G_^MPKN/^2,[C_@C?CR"9F$$R-*'/)U SEDR%9I>,
M'XD>R0<54:N:.@NILQB_83E^P1KJ;*!./YMD%Z]_@-<\QJ8ZBZ\9BR_Q DOP
M,9OP1WS";W\RG!V2^(F&CT88SGT8JQ@+ TA:AFP3<WXZZ9%\4"@U$ZF7P_J4
M4:>6T6W!-VR3K["".FOQ.3929X :>WCM0^P^)_$>8_$.;N)-O(W76:I7>957
M>+671C)5CR)9ZK,<VHR% I)*#Y*^,<O"6 C3&%\7UM.?FM'42Z-6 74J6/9Z
MWAZM>!=+J=!-G5[>KINHL9T:^_ B8_$"8_$<KN,6;^:;+.D-ML=3U'M2E'!=
M]G^1QBE9CI&7WYBR',:,A\H,?^A.Q ]*>WPN<\='LA"\)XO'F_),O"HOPDN*
M*MQ1-.!Y11MN*SIQ2[$2-Y7K<$.Y%4\I=^&Z\A"N*D_CLM857-)^$1=U/\,Y
MO=]PUD#"$#FM1B7AU C#+Q\>I^$A;^U?+!3XE>7X1F6.>WJV>$MO+E[6]\$+
M!A%XUB 9SZAR\)2J!-=5U;BJ:L1EPW9<,NS"!:/5.&^T 8\;;<<9HP,X;?P8
M3AD_@<>,G\<QD\]PV.PW'#27<(#L_R\D#K'JEQ#],!GXG$/+1[RMWQNCP+M&
M^GC9> QNF\[$T^;S<=4B")<L8W#.,A5GK?)PVJH4)ZUJ<&),$XZ/682C8Y;C
MR-BU.#1V,P;'[L:!<4>P;]SCV&-]$[NM/\3V\3\+ Q,DH9]LG2@)6QY!FJ;9
M]/:Y X?!V1S*>7R>/S\[41M/69OBB0FV>'SB7)R:Y(WC-F$X8IN 0[89.#"Y
M /LFEV/OY 78/;D9.R<OP8[)W=@V9;W0/V6;L'7* 6'SE-/"QJG7A0U3WQ36
M3;LOK)TNB6O(:M*C05#S<":'O3G ^YSR7G0#GIG/Z<V):VT[$>>FJG!R^G@<
MF6F'P5ENV#LK$+OLHK#=+AD#=EG8:E>(S785PD:[.J'/OD58;]\I]-JO%M;8
M;Q97V^\15]D?%[OMGQ!7.-R5+7/\6M;I^)=LJ:,D=HRP9(0''$X_I>ZKWO1;
M]."7R>->P"E.?T=GZ^' ;$OLGCL-VYR<L=7)!QN=P]#G'(=>YS2L<<X1>IR+
MA97.54*W<X.PW'F1V.6\0ESJO%[6X;Q=MMCYL&R1\SEYF_-S\E:7S^7-KG_(
M%[I*LJ;_X@=GQH#ZS]-_7PL&SH5PC<OS0_QL[SPEMLTSQ68W&_2Y.V*MNSMZ
MW .QTCT*R]T3A2[W#&&I>[ZPQ+U,7.2^0&QS;Q9;W9?*FMW7R)O<M\H;W0\H
MZMV'%'7NSR@7>-Q3UGC\IJCQE.35&F35'AJ^=M?LPWDF#+@4R?J3P^' GB"N
MLWT$;/ RPEKO\5CE,PO+?5W1Z>N+);YA6.0;*[3YI@@MOMG"0I\BL=&G4JSW
M:9#5^BR2+?!9*:_VV:2H]-FKK/ YJ2SW?5*KU/<#\HNRQ$]2$/DPOAH^8WU?
M8MVO1[$-8NEUN/38'ZO.?W"-R7*L]C? \H Q6!HX#8N#G- 6Y(7FH" T!44)
M]4&)0FU@NK @,$^L#BP5*P,7R,H#6^5E@<L4)8'KE46!N[0* X]KY0=>U<X+
M>IO\K)47)"ES@R0%D>>-\!&G^.>I=YG:ISG%'DX&=O.XA>58PW@L"]7#XE!S
MM(;:8F&8(QK"W% 7YH^:L'"A*BQ.J A+$<K"LL62T"*Q.+1*5ABZ4)X?NE21
M%]JKS G=KI45>E0[,^RR=D;8Z^1'K8QP24D4&6'#R-6\R[K>HO^_2-W'4KG.
M3Z?GI ?=0"_<S67AXDAM-$>:H"%J(FJC[% =Y8K**!^4186@)"I:*(I*% JB
M,L3\J (Q-ZI"EA/5(,^*7*+(B%RM3(L<T$J-.JR=$G5))SGJ%9VDJ/O:2=&2
M,CEJ&,4H;[ ?/,TEUSGJ'\MD/^12M)_TLBR=+%=SK!QUL4:HB;-&1=P,E,4Y
MH3C.$X5Q@<B/BQ!RX^*%[+@T,2LN5\R(*Y6EQ=7)4^/:%<EQJY2)<5NU$N(.
M:L?%7=")B[NK$QOW'<\E+:(DBE%>9A^\SCJ?R6 [Y-!O<1FZF?30"R]BN>KY
MNZI$%<J2QJ X:0H*DF8C+\D-.4E^R$H*$S*28H7TI!0A-2E;3$XJEB4EU<@3
MDEH5<4G=RIBDS5K128/:D4GGR!V=B*1O>/Q'*S))4A+%*'<8[\O4.JG>"T3_
MN[V([4"Z>=[,N%2S74K2]%&09H'<-%MDI]LC,WT>TM-]D)H>@I3T:"$I/4E(
M2,\4X],+9;'I5;+H]&9Y9-IR17C:1JVPM/U:H>EGM4/2G]<.3O^:Q[^5(6F2
M&D7H",\FL"]0ZW@^L(]+3]HTK"MG7RQE#!B/,I8M/UL'6=FFR,B>@-3LF4C)
M<492CB<2<@(1GQ,AQ.8D"#$YZ6)43KX8D5,A"\MIDH?D="F"LON4@3E[M?QS
MAK3\<FZ3+[7\LO]2^F=+BF&R--Q(X3V92]]+_=T5O!]H2U:3CBI@ <M1Q)AD
M%BB04F"$I()Q2"B<BKC"V8@I<D-TD1\BB\(0410KA!6E"B%%N6)P49D86-0@
M\R_LD/L6KE-X%^Y6>A6>5GH6W2*?*ST+'RH\"Z1AO/(EN9IKC,%I6H"#U-^Q
M@.U 2])-VNO8#UB6O$KZ3L8EMLP T>66B"RW07B%'<(J7!!:X8W@RB $548A
MH#))\*_,$GPKBD7OBEK1LV*QS+UBK7Q^Q4[YO(J3"M>*9\AG"M?R/^2NY9+<
MM>Q?+C'>)ZBQKY;MT,3[@7:DBS23\D;ZK@;Z#I8GK%87P;4F"*P;CX"ZZ?"K
MGP/?>C?XU/O!NSX,GO5Q\*A/%]SJ"X5Y]=6B2WV;Z%S?(YM;OUTVN_Z$S+'^
M*?*)S+'N=YECK21S7/ OZCU1AUG_70N!36W *EJ1)8O9%T@1SU/;Z7WY>4"K
M#%ZM*GBT6<*]S09N;;,PO]T9\]H]X=(>!.?V*#BU)V-.>RYFMU<(#NW-@EW[
M2F%6^X XH_V8.+W]NCBM_6-Q6MMOXK06:9CIS1I.LMT/4'\;]=9U ,N[Z#V7
ML1V6 [DDGH02+^*\7 =SEAMC]O*Q<%@^!?8K'&"WPA6S5OA@YHI0S.B.P_3N
M#$SK+L&4[@9,[EX&F^XMF-1]6)C0?85\@ G+?Q$F=$D:.C4<8;QWL\Z;J-VS
M@C%81?^_&BA>0_^_EC'HI?^G59Q'[-<#4_OT,;G/%+9]UK#IFXI)&QPQ<<,\
M3-C@A_$;PF'- 7;LACR,V5 #JPU+8+&Q#^8;!V&VX1),-[P%T_4/8+9.@EDO
M62L):@XLUKPE9QVUEU.SF3KE&X!L6L,X6O;@?L!] '#<1GWZ\_$[1%CLTH?Y
M+E.8[1H'TUU38+++ <:[YQ-_&.V.@N'N-*AVE\)@=S/T=Z^&WJ[=T-UU!CJ[
M[D!GY[?0W?$/]+9+T-NF0?V$U@;6>Q7KV:[.P= .YE$O:2?[X1ZVP5Y@SCY@
M&KWQ^(/TX(<!HZ,*Z!TW@/8Q4V@=&P?EL2E0''.$_)@;Q&-!$-23[S$.+,=J
M2"=A98[26!]]BH, C?*17]D)I?^PA3%?V_=O#J9P-Y"R'X@X!'C3FL[E5Z<=
MI_YC@-EI0$5_KG-.@'B>_O:\(3$'+HPG4PD7I!>Y(+G(Q<!%#O(7BS2O1KI(
MD0NLS 7ZW NO\3OWR5]$&F8]Z][%>#?NXIA,[336,Y)>W.<4]8<T>V"L^573
MBX !O;GR&CTVJX.GZ;.?U@-NT&<_PW(\8\W%(!?FM[@XO.T!/!>JV1CZ7+GF
M3S0]MYF?LT*W:>YO,Q:W'Y"_AUG!N#<SYF6L=P;K&TU=WW/4OZC9 S/V*F#\
M)*#'K\K4^9?GR8OD+GE)!KRL [RB EXSX8)L#/#_:!;>X>+\??5&;?4CW)P,
M/V2;?,@._R$;^$,&\H,7R.<\?S!,*]NZDC'/8KUCJ.W'NLX=V0,SYB;;_C9C
MK\Z_O#22?WE;O0^%O#^2EQC.ARBX,&9,/F=,OK0 OJ9A^<Z.IH7Q4#^^^R/[
MQD\<['YFF_S,8/_,P/[\'/EXF&J&)X=UC[L$^%\'G)ZA/G4MJ:MZF;%_-/]R
M[Y'](%^/Y$*^'\F%_*1^@X@2^%4?^(,Q^<MZY(VIZD?[HT>>D%'_Q9C1OURC
M?DO(4\-(6F/H;RWI1BU'?+]Z#X8=<1_VW!*2H'D&I((TC.0?U'M!5@_G'S1/
MR>P@^Z!Y2N84-'M!GL$_>(.^^6O\B=__D__X?81?H7DJ1;TG0]*CUU>8\DR-
MV4@YU/M17$@ B269T.Q'J8%F+XCZ6905U%B#O[&!&OW4V,5K'\!O.,[KGZ5?
MOT:-.\.9A_L\4^<ZOH/FO27?C!Q'SR4#>GT=(YX9$O51G8^Q);.A>4I'G0]*
MIE8>=<JI4T>-5FIT\,K=U%A+C8W4&. U]_":A]A4)_$%8_$97?\G;,B/J?XA
M2_H!K_3^_T RI-?7UX,DT^%/^B.Y&/5^E)G\UGQJ!N$7Q+&Y,ZA32)U*:C10
MHXT:2ZG138VUU-C$ZVW#NVR3MW&4K7 &KS(6+_,&NLM.=(<E?YY7?7XX4R7A
M]B-(QMJ,A<A^P>ZAX#E4P['XC;&XCSFLES>^1#@^9;_X"-G4*:9&-34:J-%&
MC:746$F-7EY_,Z^Y [<PR-[P&)YF+)[$L[C*$EYAQ"ZS]2Z-])9'&<Y]<+@;
M?A$PN[2DI8/?!2/JCF4=9U!S'MYBOW@5T=1*I4XNKUK"*%?C!AHY7+7A.CJI
MLXH:ZZG1CPMLDW/LGV?YWQ!+<HI7."E^AQ.R/W%<(>&84L+11Y L-"_>^8U\
M:\Q;C\/-9TIMO"\SP>NR27A1[H#;<@_<4(3@NB(.5Y1IN*3,PP6M4IS3JL%9
MK28,:;?CE'873NJLQ@F=C3BFLP-'= _BD.YI'-2[C@/ZKV.?P7?8H_H'NU2<
MHPQY)SV"^N7'OW%X^WH"AQSR!G]^V53$7?:19_4L\*3!5#RA<L)YE2_.&(;C
ME%$"3AAEX)A1/HX8E^&0\0(,&B_$?N/%V&>\ GM,UF&723]VFNS'=M/',&!Z
M!?UF+V.S^;?8:/$W^BPY/Y!UC_"0T\WWDZD_@]JS@&>G<SJP :Z.4>"2B1'.
MF$_ 8Q;V.&+IAD&K0.P;$X4]8Y*P<VP6MH\MP+:QY>@?5XLMXYJQ>5P'-EJO
M0I_U1JRWWH7>\4>Q9OP%K)[P/%9-_ +=DQYB^21)6#9"UPB_<)KYS%ZS[?"6
M,W"%Q_,<[D]S&CPQ7A^')EAAWZ1IV&GCA&VVWMAB&XI-DV.Q87(*UD_.1N^4
M(JR94HF>*?58-:4-W5.68?G47BR;.B!T3AT4EDX[(RR9=E-8//V>T#[]-Z%U
MAB2T_!?W.:R_3^WG.<5<\^0ZGT/K8_. 0YR&]\W0PH[IIM@Z8Q(VS'3 NEEN
M6&,7@%5V$>BV2\!RNS1TV>=BJ7T).NRKL=B^">WV2X0V^U5"B_UF8:'#7J')
MX:38Z/"D6._XOECG^$"LG2V)"S0(-2-\R7J_1MT;OIS:Z<%/DD,^7-^YT7?.
M%;#!T0AK9UMCU9P96#[7&9U.WNAP"L%BIVBT.R6AU2D3S4[Y:'(J%QJ=:H5Z
MIU:AUGFYL,"Y3ZQVWB56.1\7*URNB.4N;\C*7'\42UVE84I&<9'$>ZSS'>I?
MI?\^PRG_2*AZ_P?7=_RLC[%9Y6* 9:Z6Z)@W!8OFST;K?'<TNP6@T2T<]6YQ
MJ'-+Q0*W'%2[%0M5;M5"A5N34.:V5"QU6RL6NVV3%;D?D16X7Y+E>[PLR_/X
MGDBR7 ])?)3W&?]G X%+G.I/<IH=C*+7B0 V!G.-RW)T>NB@W<,,S9Z3T.AE
MAWHO5RSP]D&U=P@JO:-1[IV(,N\,E'CG"T7>Y4*A=[V0[[U8S//N$7.\M\JR
M?0[*,GW.RS-\[L@S?+^5I_O^(TOWE=2(P_A(XIO4N<&ZGXO2Y&#VDOY8KG%9
MGN4L1YN?$DV^QJCSLT:UWPQ4^CNAW-\3I?X!*/8/1Z%_'/+]4Y'GGR/D^)<(
MV0$+Q,R -C$CH%N6%K!9EAIP0)X<>%:>%/@<^4J>&/BW+#%0DB5I$-6\'$#O
MSWJ?H?;A1'H=+@,W\[B:/W?P\Z9@$36!*E0&C4%I\!04!SNB('@^\H-]D1L<
M@NS@:&0&)R$C)%-(#RD44D.JQ)209C$I9)DL,62#+#YDGSPN=$@>&_JL/";T
M"_(GD61J8D>XP^7G9?K_4]0>3!W)P?#8S9_;^7DMRU$>9H#B, L4A-L@-]P.
MV>$NR SW0GIX(%+#(Y 2GH#DB'0A*2)?2(BH$.(CFL38B$Y93,1Z653D'GED
MY&EY1.1->7CDY^0AD601CW";_>!B/,<"ZNZC_QW(8CN09>G 0L:CDN4HBM9%
M;I0ILJ(G("-Z!M*BYR(EV@-)T?Y(C E#0DPLXF)2A=B87"$ZIDR(BFD0(V([
MQ/#87EEH["YY2.Q)>7#L#7E0W*?RH-@_>"[)AHG1\ S[P3GU?B3J[^&R;PL]
M\!JRE.?U+%<IRY$3KX7T>&.DQH]#4OQ4)"3,1GS"?,0F^"(F(031B=&(2DQ&
M1&*V$)Y8(H0FUHK!B8O%H,0ULH#$'3+_I!-ROZ2GY+Y)]\CO,K]$Z5\2)-F3
M;/<SC/\A:N[DDF]C,>]'LICG-8Q'(>.1GB)#4HH*\2E6B$VQ172J/:)271"1
MZH7PM""$I44B-"T1P6F90E!:D1"05B/XI;6+OFD]HG?:-IE7VC&99_IUF4?Z
M1S*/M-^()/-,_9<K;/>3U#I0J'Y##,<$VH$5I)7GE2Q''F.2G,TU=Z8^(C/-
M$)XU$:%9,Q"2/1?!V>X(S/9'0'88_'/BX)>3!I^<?,$KITKPS&D1W7-6BO-S
M^L5Y.4=EKCE792ZY[\M<<GZ1N69+XC!9&BZRGL?R>4]2<RL]^%I:@4ZRD.>E
M+$M6";TW[5)8@0Z""HP14# ._H53X%OH )]"5W@7><.K*!B>1=%P+TJ&6U$N
MYA65"ZY%"P7GHA7"W.(MXISBP^+LXLNB8_$[HF/1 ]&Q4!)GJRG0<#9'\Z:>
MG=7TWG6:-[0L)O7U[(NU]%TL3S3+$U A@U>Y"AX5%G"OF 2WBAF85SD7KI7N
M<*GTAW-5.)RJ$C"W*@NSJTK@6-4 ^ZHN85;5)F%FU4%A1M4E87KUF\+TRI^$
MZ172,#/*)5'-2=;Q #6VJ=]20VNXG!:@M97>E\>\9B"1GX4UT?OQ]R[UNIC;
M8(PY#6,QNV$R'!OLX-#H OM&+]@U!F%F8S1F-*5B>E,AIC8MP)2F#M@V]<&F
M:3\F-5W Q*97,;'Q1TQLD(2)]9(PJ4[#T4K.3[S^YE;U6WIY/RRA]^Q@.Y ,
M$LV? XD;+>/LQ2)F+#; M,5FF++8&I.73(7M$@?8+)E'?#&Q(PP3.A(POB,'
MUAV5&-O1AC$=:V'9L0<6'6=AWG$7YDONPV(15ZSM&BS)(&.^O0U83[T571R7
MEC,&W9IG@9)(V"KZ?^)$9I!)JQ08VZ/"F!YS6/6,A^7J:;!8[0CSU?-AMMH?
MIJNC8+(F#<9KBF&TI@F&:U9"M7H'#%:?@O[JV]#O^1H&*_^":B57S]T:]K0S
M!IV, 2WI4FHTT!(6]_)^7 ]$T9;YTY>[D%G$9A,]*.VSR58E5/TJ&/2;0[]_
M/)D&O?[9T.UWATY_$+3[XZ#LSX&BOP:RK4LA;.67MM#4;J&1W?P1H=?=)$'8
MJ&&@2Y.#63&2@ZF@5O86^L\!(&@[VV '8$^[;+N+^KNIOQ<PV"]"ZX >A /T
MN <LR43"1> !+D8&O4@822$<: ZP4QU@Q0[PB_OI=?>]2FA0]_Y)I&'4.9B>
MT1Q,/]N FHG4"J$?=Z<U=1@$)A^B/JMA3'^L?P)0G*2_/45#<HJ&X!07XZ>M
M"+WV$!>E0TX<]+@(.L,!^ P'WS/L\&?4?YJ(%Q_BET_?(E_R>[\1:9C_DX/9
MP_&(FJ'4\Z"> []B2SVKTX 1;;+N.4"\2/W+(UQA.:ZP'%=9CFLT"=>Y,']2
MO2AF.9[VXZ) _9 R![D;C82QN,&*W> %GOY_Y#YYR'_[#SI9O ;&N9AU3J5V
M^&. YQ#UJ6G#T%E< E34TQK-O]PDZES(;?5^%'5.1 &\H >\2*-TEX;I97K^
MUZ8!;[(<;W%A^!8GG+<Y +W-F^YM]HNWCY,;Y&/"-GG[P? ;:DH9Z_03FC?T
M>ET ')^@_L@S2 ;/,/:C^1=U[N75T7TH(_F0=T?S(8S)QS1JGZB-$@W+5URP
M?\MR?,=%VO?L&_<Y"-SG37>?G>L^A>ZS3>[SB_<_107KGGF*]P#K['.%8P!U
M)U'7C/74O\/8J_>_O#ZB-YH'^6PD%_+E(_M"AG,A(O"3#O +8_([^^I?DS4/
M\@^_+57]/ P'8JEGY"TA0R-O;;U%QVD^DG<P&\F#C#X#HMZ#$43BH7D&I(0L
M@&8OB";_H'DF9@/I)[N@>2;F.-1[0?ZA"_V;@?N3A?UC]"VEC_##2/[A*[7G
ME9F,Y!W4&(^40[T?Q8GX0O-,3BHTS\.H<S'JO2"MO/Y2_$7?_Y"^_P]LI,8
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M+/I&7!9](M\2?2)^)I+H$RX)OB-<I<:I!(Y'U-W&I7@??7ZW^CD<^O%JQJ.
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MO9H_]H2&QU[2O'$/:N[XES3']B,-VGVG07N39EMAS,'\(DRZ%LG0 V[F]<E
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MZ#!7!0XCRG/<J5S'D\IVO$M93C]3IM,[RG3^"IB4!>Y&YWF&M:.D&WM3C>?
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M2CRD98B;!(>XB*N23A):I*.$/G&4-"$.DA;$3M*6V$IU(C92'L1*JA?I(!U
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MCB?+X$%;T'I%&&F>P7KUR W<O!?ASR9,^:LPW2[ <#8=_T^!/HG0!;,<9(M
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M"<\QAP>;H3>U0\\VQ01D0B[ BJ^)L5 =,L8LA!G+VQ$R%SQ_"O*$=K_V@(3
M/OU@$V_F%::L,.DL(44ZB<@31R$E8B>D3FR$VA)K(0-B)6Q*+(4MB86(/3$3
M<2'M1;N2=J*^Q$1L(#$6&TX,Q<<1 _$91$]\-=&5V$ET),X1;8D71%OR*]&6
M:B YD+D$T_LL4()TYB[6#KP](!$FC7M T#X]T%[N2N"<\J+$1D::=)"4)^82
M2J2]A#II)ZE-3"4-B;%D>V(D94T,I9R(OG07HB?=F^C*!!)MF:%$2S:!M)']
M@VC(KB+JLCN(FNPYHBI7@?R-J,F!^T/^0G#(&?:\J^D2,,U'X_]A" 4#$0+Y
MP$[=T#:N:!M[M(TE1YR8R,D0(UD%8B"K3/1E-8FNK"[1D3,FVG(61$O.GK21
M[TPTY7L0=?D HB8?0504QA)ESG2BQ%E)%#D["8=S#ODE<AW^#^X/>0M #Z<C
MW)K4J?$N$G#;(0@# Z!?;]C)$W[2"6&(#2B,F:H0,524(-H<.:*EP"&:"JI$
M@Z-%U#GZ1(W3GJAR;(B*HC-15O0B2DI]B:)2&.$HQ1-YY:G(RXF<<CZ143Y%
M9%2>$EF56OP?W!_RYT'V5/#9B<P^%.3AH 4AH$G]H$<OM$T7^(D3?,0*;=,.
M;:.G(4(T5:2)JI(\45%2(LK*&D1)69<HJI@@=R <E8Y$0=63R*OY$SFUP416
M/9;(J&<0*8TE1%)C"Q'7*"(2&H^0/^%GF#^9*_D@=W(7WJO(..1(T*-@5][6
M_1YH&S=KQ/KPD0YH&U.TC2YLHMY&DBBIRQ&.NB)14%<C\AIMD0V)G*8%D6WC
M0&3:="'26CY$2BN82+0=2<3:IA)1[45$6#N/"&D?(\)MRY%KB$C;!N[WH6=!
M;@;X_7CF/A3D8?CW(/S,'[IUAXW<T#8.L$D'V,08-M&&353T18F"M@R1T^80
M66T5(J/=ADCK&!!)'3,BH6M'Q/7<B*A>;R*B'T2$F$LC]4%:]#$+Z"/HU4>P
MJ7\/N09&_4$6HOXSO'A;TIE]*#',G;#,61Q09C]P?2_8I#/T=( NYO!9 _0=
M3=A$J9THD3.2)E*&\D3<4(F(&6H242,](FS4C@@9P\F,\4O&*-0$A-D$',L$
M9,D$,:0)\S')P\AW\!PZ&/\@"R!_.F2F^/+VH8Q"#@?7#P*W]D41W?#<%;K8
MP":FT$,'_J,*FRAT$"'2%M)$S%R>")EA@#=38Q;,F$T[4!:*FC-*XY<M$,-:
M():VP.QC 1)A#C)@CGC:O!38&NXZ#/-]I*F0.:D?;Q]*='_>U1$#0-E]\/.N
MT,6I!_HDJ)(A;-(&U5."G\@ZBA!Q.W 96TPNMAC$;##IV&!0LX'#V*!CV\*I
M;?%+MGV0PY%!9&TQ&]NL14:D8'T3N8:[#L,]C\1\GSF(MP\E"CD4.1#_[P5=
MW/#<%A2I'6RB@VK!W8D\VD^RLS 1<L7$YH))Q1F<JA,&L4X81#IA@.W4'AD-
MUPG 3JA()W#_3N V'4'F.H+ .($L.(%W.]9PUV%FHKDR@AOWH8"6#F>V*B#W
M&XQV &7OB.>6L)$!=-& +ASXBS3T$>DN!&?!A-8-DTE7V,(3MO# P.Z! <T#
M[>'!'&Y# WK@%SP@P .S<)<IO ^<NB-:<[L.1X,.K@UD.F2EAO/VH<3"=2(;
MS^)X1P 6"AN$P'U@E[:@:4JPERST$44[8?*&TX+W^\(6/K"%-R8W;]BB-R;>
MWI@$>Z,]>L,G>C,;G/#+O:*1TWD77/8 2>L.[N\%[M^M@4R![&1TG811O#MA
MPV-@@Y%X!%V<H(L9W$D7.JI"'SG82APZ(4B"HLBP$PD2A?- CP&RO#TIS$;'
M_K!%?PPF_=$>_=%X 5 \ (7U0__LARBQ+Z+&/B!D_N]0CP:2/HJW#V7,V,9O
M$X^!VF@ZUSBX"W0RP'-UZ"0//<6CN$'-KPS]"7=?"O2(@!X1:)-PZ!&.22X<
M@VH8!I0P.'$8.ETH*A$Z#@T-<CT847,(HLC@*M2E@:0P^U"28 -TWR'XVQ_9
M ]W(#MD$OZ*9"!\ 1@+Z$3K'-V;NWA0$@*.A1QSL$8>^&H?))0Y^$8O.'(O!
M)@9&BXGC;;88"3(=78B)Z24J_H,D,]_E0? 8@1R0AC9 =D2SM4/6PK\YR!+<
MNV ;<].9G/1F/TMMGN&GJ= C%;Z1BC9)A5^DPA:I<* 4&"\EO?&.6)#HB0_1
M"+4D<3+,"G<=, WN,AU="&J:-]X'JX@LT;3OI.E.6('G<9IE[C.TS0)97H":
MB399@$%M 6RQ@+F4!\:=OQ!8D/JY5U'F!Q(-F<&0X3T7/H#?M\S$. "(XB+(
M;[[_I/E:R!K"?PZ'>Q:'\.XK83)W[0)])A=ZY&+\W( VV8#)> -LL0'](Q="
M<S%FYYX [B49#+F^D.D.6=;H-OJ0HP13232MNV!HY:ZQ,.LK3=_&R2<"SN&0
M7W>'-.T5*< 8<IC91 [?.()@Y C&S2.PQ1$XW]&ER  ?+B9]4$>/E1@'4!=#
MR%.&/,F-A'\/RJ[&<IGUE:;])H+.X31?#V%>8#/[0HJAQTWFCE9,^&7PS]OH
M([?1T<I@BS*PNM+C M8?F/M!FL[#Z(&)F(,7,V\CW<E[Q,L,0ZI$W/X*@\0+
MQ.[/P:>>@M<]!JM\B/BY',YZ#RR-.8M2 D->@[&N0-%+Y!'4JN.>0V&D[FE<
M@]@@8 V$60?X#$[#?!.E"O'[*T3ASQ"I/T04?Q>1_2UPF!O0XQKTN(*!ZA+X
MU 4,%.?!QLZBHYX&VSV!CE,(!SX*1SH$*0?1,/N!WDMJ?GX'A9&]AMJ#\>M[
M*,P^#'$P(7E2#!YQ%9SJ3_#^,^ /)\ HCD./(]"#=R=H ,H>B+*'H.RA<(F1
M*#\>33@1KC.5Y(&Y;H3CKH<M<O#;V>#<S-K':L([@[*@<0]&T_H+(YM9@[C*
M;4XA-+$,9"E"3AO(,$#YYBC;'F6[D$W08P/:93V87@X8V%HPL35@NJNAQRKN
M3H,QL, D</<98'A+T%USR5PP^]EHG9G@W,S:QW3"NP>#V8.!F8N[_L)L)SK;
MZ&I[N"XO 5GRD*,"&6U1OC'*MH3^]BC;&65WX7Z39#[8WUQPJMG@N;/ JV:
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MTIE?"59@3J\.Q+*+X >PUS@HP 766@[A?UM4[< "/.0O(H0%H-:3I[( U.K
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MBV]<+R[C7_*ZNG9.ZMB1$2$#^OKT[.KF[&AKU8%_':786)'U$H2_? 'K*/R
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M(C1DT,"@H$&APZECOT4VNFH<:;[U6GY %;5_FK"VLT\5I0'4'LM\UCN0??R
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MG.*=S):8!*4-]]H^;4S,095)+O&;MT]?.-EJXI=5>U^'^FZ,FXV.&7<HL?#
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M?%&R#.)F/=\3^L,G^;7YFJ/T(GK,P%N=IKAXKQP"WMF&L#KO6*;N@2B^H#1
M=H=BO7NB'@M!2E^FR2RB0)QZ*HW25;"S,3K81T5:IWN4_6$:7:"60BDOM (@
M)54&6^\-BQI9!AD0?DPB>V.8C9/)T<KGF>IZGT^+?8GQY[SES&:*$RANA&.
M<[&.,29R_M@R#XPLS.$G5*0,8-$(UM'0$G)G43U3^+:<N+^UA\&A52OI&9\&
M^ .DHG&E27'>M]RII@@#P\ZNX9 "\(EDS_ZY\C2 M*73]L'Z_Q$C (Z!0:W!
M&;]%-B/GE!<$V_>G,.O/7 >01B9VCDEW6+ZA32JB];A9A)43"E$JQ=1J77VC
MSQUN#RC"'KHG1JJBFEI,MON3]J9XKK7UU0;(XC_5YOI:7&N#3>_;0LXD][I1
M*YAAIA7:2W/=-9;H3-SM  33F\G;U$F?&[E0IX#N_?PYVMQ?L8NZK[%=W2^
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M3QQ2#U66V;SEB@'!%Y/H70-WNM25P9KJ(93BA_\9&IU.[2D G(_)WSCX>*3
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MX!FGK$<)#BR93(BN+!_4JTL*'#>3%V#ISL1[F&JOYX:][RF@O\?/YYL-,.7
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M#=&LLAN-AAU+Q')P1W'^U5KF_H<^M&:HWW>Z6L+V8\3&"MQ3@'0(<=\<7:3
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M0^.SA04^HYAE%CJ%BV&I0:M/\9?^M_S.-S@D=/:B"FV;P[M@JS.A3D@F!;9
M9+Y\]+AG_Q9S."D-[Q)DH11LJ0Y>69T^-V%BT&$@GI:F<TV,0QE@UN?B]L*#
MI&7<WD9NLE.VKNJ$]1_"@9_ <A^Z>L>A^F>D?T7TA#Y[6#IZSD;7-J/IDYV@
M4=I<=,IQ]:I""1\OT-&-Z\@HXXC_[(86]^FR;OW;5'[/@;T6:Y(/_;BL>P\+
M1\@M WR5AE*QE]DT@?)[J(ST85KU,:"V6W^&___82U2;+%/]YZ[XCR[ ,WL)
MN24R8'[DMBKY:-C_CW.R23X&.YI$[YAF'1W_.<,*)\ER WQLN.FG#/)UVLFX
M;12AUY9:[I8DFI*P/JJW.=NT?$ IVA>S@0Q0/Y.0I+*<UI5F<,$:45V:WIZ)
MY_%'\#*003UW<=^X0^A4(ABAYZ65D??RMQ,.[_[PFD!EF'7YI"M:OR[OI3\
MAU'%@[9UVI*:UO-,!IM\!V9.:FY FD[4X;,B7Z!9#W_YRWJ3OZ1ER6(+SEIB
M_B;0,IP>,6_]H?>5=7[K3KRX[284%LWWS#LE'?K3.];,5H(_J'%+4";[(0#
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M$[S]ATHP29O6/ALON7_F][Y%E $_ B+!=W0C=QOJ1P_3.Y;RZ[)<*O]CZ (
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MA6@8G"3.4N\PO*/@_'KBI"E(GN6*",6(P_!"BD>DJJV[K86VFU>4UFO_7HB
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M@G%G'Q1C7(:_1X SM)1TWG I#8_3;;EG&,MS%@8'YA)7L-JP,\'F0HJM-EA
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M)XVBK.6\HWP8"*.9I*4@E\63CO_(CTDC$BLFBB=[)7WF?<PD&=#I3QFH;OH
M0QS0,/#S6?] 0.;G!ZV694&HSFGIT;.7^?CZA?[A<3R<2#.8&#H@Q,OG^_Y#
M*+>Q874/'9_]PS.#!D5FLV6#RP+P1&0]P;5(9Y2>0%AY<=E4*OC;%TRO7U8
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M:PS5X6Y>TWV5=7U)F_HU'[3:HFY2Q-P)A=A=>9;=*)*-*[VQ$P5-<'MA4LX
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MB L?@V."=F14\B-PRK@<&V,0GR[76BADA$EY@'(@X"[5<KJ78@(O_O8 Y1%
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MS!=8;>6Y('1<Z;OGW%606E&+ZD0_(V&?<'*.;A>71[+@P6K(]\N9";0S#('
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MK55!.GGR($=)1L>S8](:U7NQNTG!*=H1\&?IG0+/*;%=NE_$?C@2&'FA_T\
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M^27[Y;;@L!35K;1OXHD/\!\TWK?NUB=B[Q0NIJ2PGK(R/+%1^_B68?!-L^:
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M+70B/U@)7^E>G>?A$H6G4PQ_)CM<(R7C\0ZT;W,G;939. NRP:]A:&P==:;
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MO>X:4_HM 3U(O9N K8&$JT0)!2:'E'M68(Q*8@RJ;.@]_06A(F%[Y,/=,54
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M/?ETJ>+8\&5!=Y]]U.8Q4Z<%]<->/+7AY">@(H>?K08Y7K@4BT(![*15)=D
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M-G@."^8L6^<M^.^:D70:;U^^$3R.F__KO0%(5\-0Z4?$ Y5_,A7>N>8H\H*
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M%N15G3GW?W,K9<TP:Z52&90I"@]GVQB<K+6GW1)7DM=;T_T[-5IL9M-Q>[T
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MN6OPQ:NT &_%]ZG9^I">/C8;)2&)$(L:%YH)(DASKH+F.,Z@K46YL$%0ZJC
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M5HP4>%\E+[1_/>!]%9."8?_F?W6A_/^B2!MA_]9]_=R\7D]CRZ5*7/HX:GK
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MPEUNV7%K8+8RI6"FJ N/_X[M#>3W_X;'_H;=_H\P_;]@M'T[%"Z?,9(-R4[
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M7XZCBC33SB)/-+9LJ06VMHR5+&U'^R]3?X#ZII5VMQ$;;5!3GS9C?[B1]B0
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M#/O #Z:_GY!\-+(<-=V%<& F2;? FOW@E^2V.ZX_,>-OC==2,CIOG%16-9U
M'/7DR'#17ZL!"@T^/G$/A[(S799\AD@'#%X? \YAN9GG3#Y72@_H3TBYG7]?
MSD+G^ZY#Y ]#D_8?09>4X^)L&;F9P>)%MDVOS@XUK26UTR5]D6]I6V*NAZ@:
MT"XDE)()<ZFI-<2+991Q$L R7^(+4!34) 0D_U/2WI*HJA7,M&@ER8"]R'1Q
MTU73QZJMAO/,FIUU9!FJM[1FV'?HC<MF['E)8F4*U5-&73%E>-OV'756/W=9
M$#1$AXAIRAO3S]?-"Z"OL;,NE80W$XPO01Y%-M]^_;TNIQ(54\O1P(^&WI3Z
MCK[)@K)A/^WQY:VVS?7 \I'-PX_%NDOY?6ZTE='CPAT.,_UFBTK,]C1PF_C%
MU8I00-R*\=[*O;/UQ\#$QR*?+C7BXYE=IY)UX=TI3")5*!R4E3-[K)3ED35'
MGXXHS0\ZGY_EN$>^ #PAI3U$%7!3&T3<%.$:R<),"X.R-G3\F3#2SJ)+\;#Y
MQC:WJG)1K9B7TCZ6)WBDI\(L21YAJT!HUNF=6Z"8D_,@?.SZH;6+LIEHD^I7
M[8=YJD)W"V]"B3,7_T3>;&8L0T%;C4BZG:!7K:G,#8&I=> (Z35;8M-@*J'B
MX-^!P@C60?WE0?G!G_8:C\S[K7R3? -N\8H-50_1G?LLCD&W@2OB?__ =8;9
M<"MD7..)'CP%J!%;G'TS=4RZ(EP!+!S?%V$IIHAUP4H^ ,?O96'O^Y$-B\:U
M)1':*(LIV.>T@$=8R-M*]MKV$L#"(JTY-H?&5^J&%I,,TL2#"E==%B1R@VP?
M(J+!5F6T./Y:P;]I<0W>#=659="PKW.7U&EJ4Z2RM/2J+%\3-HU!I7[TVM?U
M13.C025+[3M2):-FC?-^ 4W? <='[%D* 1?<7?54]WX[V)IO=7&\8.RT1=>J
MER"A+^=&[N$'_NZ!S8,2;D8^XOJYHM\H!J0+!UR;U)4XN?R'E+FVAIGH(.HM
M;M<YGO;)!%1SQEK-$=LT*WT.$;]/]0]Y?R]))L/F N'R8GS1FH=#@ 19XV9B
MBPP>#L+><?:Q)Z1F-@/"<CG? 19J%3/-]YK;D\Z4;#PG'2B9L>/-KA*G(V%[
M7YZ0<"]/,"XP64+N7[%A@&Q0OU*,?!FAK/?^^)#4'>S'&<+CPL?R.J;/ -^B
MJOS&5GTX54)=3]&>I"0?M)*NH'@6Z\F8PJ,"4(B8-;*67U#&C6E).M^?H=QG
M_J$[&T5GJO,A?SS6?"E' GO=V?ZWVRM'0+9$(%S4MT;0 =J605TLWW,\&[.8
M+]48S"4O#QL*>>1-EAQY3P0*532U2T_QT-#N,QY^5 <Y/#3USBS;<= (]UNK
MM_6%E-KO&U95F6MJ:)C@1$Y-OQ3%P=07&0"_8O/GH#F4:(GN/-Y-2)S583R/
M\:&Y7!$2,][,%QP0;:B&&5D/".M@&P=+'=$H3>'2ZO794ZEZ%!4XXT+S^@',
M(\6XEJ3Q63^C]A1^Q@5S\12H4"J+3/SFD2'I*\]07 AEV:LH"Y7KV01M/))R
MA[4[[?"$*#H<C996;")88Z;]FC[U;0A[ZSLRV[+/]1)O[;+\^9A9PL*T.+BA
MH1*<N+"U5J];_TF3D8V3OHO!=?!..5>=OF$&QY:AVWHL.\V9=DZ5&<6D[$=/
MJ<7T&<O<Z9_T1X!A @LD!M@PW=':')?D7<W,6-GX0;HT:+Y969B8B^:X,U%A
M=WVF^2AW?J-$S*%._,XX"@4Q2F0[#WI?WQ]@F8E<[3HLL]7+5#T>#U71XXEC
MLN.GR/S&6BKT)=:!2R%X?YLKUCN0@ZY,&FZ]9-@Z=,1DF< U5F;G.JY!%B[8
M6H1J)]:4PE1$//XE'$(#3)>E_!@G:D;FWR-P$^)R_G9S!V?P_P$>Q!RQFSZJ
MA"QPL$,B+BH6G[,N.Z2D7-=#8,<+K0!3NSC.!&R@9/V"%ZN\2I=!O!+?^<R+
M-:AIB0%CP[-ER0CU'$7"D9 UL[S7@8EV>P):1XK5V="$K61.7-S7(E4M T;<
M1NHYN+$/-9Y@X,1?O/9%I"6VG2F.\\>5Q)"B?X2BR=\[*>O3D'=*M$POG,4R
M\B;967.T9R;2,?6):*W+2:5.3<O)&_ H2D_;^\&)C!29MBOL^*8,V=[:2DJ0
MO)L,"^&ARL?\ORCH5EBXD4/BZ QX2V; T<6$)Z3&PR>D.R*'R85X._D/.1&]
MNR.RJ/5+2<MUC_.V8OE+5F73XOEI-C_./T@E4UB%<["P<E/^_.'\ 5)@X30+
MDP;;-$S:E<U+S#?/^+[BHA9DC4\0B2BS88@Y"-D@E_?%G0H(WY$3I3Z6Q^D(
M'.=)_#ZG7#P<-\[MZ\@_[3V2D_#EN[:2,X"\CTG"42R @@:WDM2E/"D[&OE=
M/$SRBM)VWZEK,=D*8Y,5M&$BZXH<XR=35VD#@+XSB3\3KB./W[LR$-5<#E_H
M"X]$6.4?06(NRO^9I=MD.7I:7B;R4;PI]HF;NC6<C(R7*+DT#:61]LML9 KT
M?KS3#9-?$S"]Y0<UIK3=B-'L$%OX5RTS9_IVVO[#+]0F"XLS011)O H\?6LN
MQ"]H.7U':^J#1E>2]DC/ [(+)_4^/#196/=Q\91EU\3=Q72;"]U5L%/?*? [
MHD#!H-XM-C8C_/<8ZS]+!V,9#ZA8T.MU%/5!EZQSNNN\Q6SM=JJ<S%&/BEJ\
M[G%*D:8VPMLMVZXU3)5L#/Z5&%'GLPN'>[CH[\+I5W(3CZ28P0X&E;8"TOO'
M!R$UU*A*.0*6F+2>DMO5]E^;HL*G?+!S=":>D.H\/YW1@#I&B^3;DN<:Z,<?
MR17G%INLI$(LU;A(QIJ2(4IV'2/%+G(&1JI6/;'O^()&Q/ZREI+_+57 #:>>
M;I8D^2/VD?=KL:;6R<]<5\*(/J>?Y=JC]F,9$08=M]22].8GG[KUZC>CG(;I
M0X<\#39UDU\0MF)W#E]MW<K<KYISL\YRM-O\\-QA402:]\7[NL!&>61K'9>
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MS/^6)D<UO$X+1L:%K^"^EA@/L=V+FK<ZOG,:?T)R6-/[I,B@M>T^Y3U%JPI
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M+0SDQ[%.]X=?:RM'A/B.W+GZW7,2*[Q5/]\^BST'30WP"U<Z)3UTP6[V0OS
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MX"=<RTGA )Q@6,4Q'ST6/ZMNG+IDR0N%6X,DOI2BUA(Y"D\;GM"G_D!R4Y8
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M]#VKLU9(&"ZX&$CS*[R05W;^_OM4#VWWJWV\63+$/'('/YS,VXK%K%SG0[A
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MZDXT\K9A$)M[RR(PBSA#&*8K,)E'>5@;6EFRG=[7S5G )Q>.G<3T1)FQ_-;
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MGK@\&XUR;?*^)&X:J((DFC8C'3%PR@L[]Q>J;EQI,[NHPLL3!?+#*QV>CCS
M%WZCK4L4_L[@G_<59Q7ZA*$QI*R.@;M, (?OF5-'NZ%*S#'//K68"%!12E:5
M%>+8RKAP&P'TUP9=DB&8_B:D7&NLB)5Q](?TPTO^C87#8[7D/?N*_<#+^85!
M>_ !F)I%NR2S,$(#PKH'96"&U99V:U'L1U'^%PKSST"W3MUB8%A\B6Y3EXZ*
M2T,V*;JL3WVL6C_4)L)1G<+YV3:I$H,U?CA3IU34"51BDS+2CI#ER((7O)#2
M]"=K.;<H(!X@FTP%MM]JZYRD, &VRF']9HF'+)*AY+MMB,,-:62#FIE=>30S
M1/.T"#8"J(ZG65 1;/B17WDS?K:7^9CG=7/SCQH)3D@,G9""*9&6)I6=DV<I
M%:K:-(15!OB=\-:D:":R%4QY?XQ/0K!DLNTI2'9>8:S,XTIN C=6#W]7/]H9
M>!H8&"488:ZUO! ]RKT\A\&VUIZ77[1>RCP<<5G3IQ%\3%E<,C>F6I4DHIQY
M3NS]G1^OA<RLH93R?@8L4R +FJ3_A0R6N19A)?+'R7SP]H-0&>$GA4D;B;]@
MD+)>[7N_"F^;L=6%%*P46ZEJ12H2NH<<_0I@2QXSG>T@Y9^1O1+"&@BD?,X3
MY:Z7"-]6#0*[*.DN9:E&\ KH<]W/'#PE<Y@2CO6O  %Q.T(14251)X;FM0C9
MMH(_O@C) VNJS_-XM% 2-3B*YLE*/H[2A)X8<-[D[_;-[DYR/LAAEBQQ:OH*
M),,)%:&$V4\0NU&B4<-3>IP/6+)QW$TI..$ ;=X8Y+.C"N6\CT_43NK5CL5R
MJIR6%JOCY7PCHEM5GAQGN_A5D-SI6<77PK;T)3C2'.CK68X1D![*W0&W';":
M5OZB;A[N&OM1$HO+"U0+7U$,1/'.\B$;"B6P-]F>FB5S6.K'/[*\QW^>B&8O
MSBJVZ6PNF(Z1.^ *HJ]CQ2LPKY70?6BAD3_<.I8:TMK'J]'?_H)[QJU-)%&R
MM)5I19(:Y-JQ29,+1#B:I&O-8WHJNYW5"<I/,&Q4DZ[8PB1"KL7/+B,'^=EX
M$N*>":,U:3?P9!OT>Z@WDN<[D=BZ1M99<*Q3SJ)_;))>5./V^U&9@A*BOA^M
MKJXRDX\N_P3CROA+2QCOM#0%DFIAJQP"6;"=C,8^ #%ZC,#-K<9M#?2@><V-
M4:0]D!V6$T7L_<QU\I9Y6$9".Y! 0!E%XE&#$P*ZFX]A*6"=8)ZP#N%=Y>Z8
MMVEX8?VS,'NVN0C+$6X"/JST/CE%1W/%YL%F'HWVI=WBR5P0PGY0P_M&N4)Z
MF'_)<=)ND#M?J:C0R>C1K+-9487SP1)GK6R<OAFXIS*>ZZ@RD4S(0"(9IC+(
M(#*JTH4Y7>I%K<IU$ZFT'!-W^R%6:0#"@YD'N?08:#\F T[RT[_NNG?RF:*,
MN<Y2=9_H_.CDRW)*E 9X"#+HQ_?(B$KTU[-C3(C.*OVSFEUX=F(Z"378[]I$
MA7(7P?C]%Q(TV%]>AYCZ/$S<K9?&FT9ZT^5<"@,?*ANI<&^T6(O#@A4B?P;:
M"95H:?,D!"PX(?17AA%:%M!M8(J9KPAK/\@0Z5/5D54?4(95US_@'K8FT? $
M56*&@P:S(6,Z:Z@&R0W$HT!N?)S"A*W?_]868D**B++#Z:"0LB"45#];>#A@
M,6T339%ZKN (%3EX4^UZ1W$P&2J TE^A0#+J;8R,'0EWOZ\&#>7Y%IAPTT>J
MIB)-F*C!&J)V']IGA!422#\QFZ]H<3+84"-:\+_[IE5=THH,@DS4H?$NO[0&
MHJ$_YH /J3+<Z'!FS U*^GT_C^H"Y8,D)X]?OKO+*0S# ;>P110NG]&+7]P"
M(I\=/$A]WJA!L=*(IU6?Z6(F)X%Y6W"(>/@B[3]62?+%@:0ZK[3F+Q36"ETO
M4R"<[\T>9@L?GHS(:E5P]4IIT8Q4):B"JU_2_!0"<*5I]N2\13]ANCWE%"PN
M)(/B$NX@,/4QQ]+Y,N/IA/Z>I/;,DO%2+ROA&IC2:'#4Z1^O%!]'1!U7@2IX
M&T.BMK ":V/LC:090#&A[O!0$TJSKK5A^O;H<#\XLD MM7!J)C2UW)RR!\+9
M?1SG*D_^DD[F/:0*8Q$A<$=S<#*)9C K\<E;>*]Z($E.2!M51+\2"UDCR@N8
M#NU)T^.2<77Z-[$^,F0,B[-66.:JF=Q=HJA;]F:V%?E'O:*H02"FH?T)OS(@
M([NKN:*Q'6SM<#];4?8??Y#&T6#G3?',+&_\QKO<5A0IJ8[0 G!(AU?&F2
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M5!ZJ*A3VDU'^59; F?%[;H,B'^*I&7Q'W@8[=^IRQ:HM:S"T? ;ZLK=5.N2
MH]3KE"F7?+&3E;E[R=8-.T\U5KER1<"2/S3EMI1;?H*_8%>H25<S+I:HP&WX
MR13>+(UT6"R7J4E7]2MHNLTF^QN8^8-F]KGOWTNC;--/K4Y(>3^X;*BARKZD
MC]V$@N#<^AC-#]Y3Z1.)+66.H@GMIB.7D$=3"(DW1W?SASQ2B+[@_%.F9D(R
M5EPF)Q1_@06U4&\:IP[E<HFII6WUHD*&#M+T".83CQ&-3Z@V<HTMIRHB_L18
MQ\6J0R:.EA..$NK&;V^YD]'D0+A]BK/'[IZ HP1.7=Q+5*A9S;\G&)BR]0+7
M"*6CQ"Y%#YPG)PW"\--YSGWXL'U8,P9 K@&/-"<#=\Q(5^>H)V70TID,[&]6
MQN_LDW$2C]$?-?7<Q!AQE;<9MW)UQW9>U)8^J;PVGY-<9[B#\5[D*QG;[BDN
MXHEJ>)=@R<NG-^1#X00Z#%X9VKV!Z8!P(WSIEV@Z\81>LC8X7*[>QI?4@PQ
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M+(#!Y+O9 /W5'\'X7;=:-'\DJH>L-"V:63@,:KYQHGX48F+M JISV;]MM+0
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M6BOFM"P19L\$-\JB725$$,>_F]R"N;F8%.,5H$K9$E*]E4Z455=]BN;=BCF
MPM<=%<*,Q(N':SU!O:Q$7YUFP+"%3A8M-8X6,1 5W8<B!7C/05TW35PQG<-=
MS8I-<$U?*ZP,L1=1DD756--"MDM_;Y ^\;7 E%M080;DS, Z[$75LE[,IX @
M9?"=%XJ_^63Y.S=A^.S,(%#R)C7F&FLDUY@"9[7?<%MI";$^I7N6,2N>,%+)
M@8M:+-/ <*N2[]3-5'%,[3)NM3E*1*@$;BE>@E=6N8L6@(2#%9,-&.69"  K
MHI#UCW*!X&6$I?G0[0R^?/Y-FG'5[*K6;T.[0N/<6,T.ES<JHZ SF!JA6OVB
M3WLMV)S=;>=",K["WP8GBMO#=H/5%4E/E/D(,\_?/L\T6O]J81[UB5-P_U]$
MR/]08J@\78\@IL84*1\J8]?B/T4WM8E#"LF51#,M+8H<-5$1QI!/-$53L%A9
M8$OXY,/"V&_(?B5)5C0*XOM/1*3E;HMD=<G^*24CFN\)IF_.(D6C82\HI(<?
MEYRYN) %M6"RNW:@.L8JF#WLXT0IXA$CM]X'X]  BW&X:?O0BCN[=GJ$830B
M6U7(?'+) ':&L#7)\#P''"E*WVKG3,6K?-@T67S4;Z4PK[YD;*PKKJ@X_2A/
MH%T/IM[4J9;"/YJ)?3^.$+E'/60FEJ[B&;?T4F"R$D%K)U1,4F!>9V%K>]V<
MC/^1X9PYOAD32PWJYW'L"/PFA]Q79O[G%3"CQSDNR&"IL[\^,^./NE(;ZN#J
M-DPVL(SXR][-4:$6"A\A!#9(C*H&?"++U/SACGB*B0S$@S<ER?PY)5>9?:1(
M-J[R^=,2*D:>X&,-F_K(GSB5WRA7\2ILYR^*_VKD%<!E[];&*V#[5K)1$%7/
M!=PKVZS/+BXF4M6=)P)S+<)1"%N3E@T266# R1.AW8/B+)E/O@*T1V-YQN*@
M9,JQ)L3C0F\M"E%N1)_FB27S-S=*>YZ!+[<*V(?0^X)[K6W(#Q7MCLD4+ X/
M#*Q?QAQ)BQH8MH3A_[XNYPJ4_=ZI&?I(_GP<2SEU<:%^_>X]GW!+M5D+AOS4
MH)#29S4._FO7K(?@9S&3J(NZHJ.PIEN9.0.'_6Z63D_FTBN\$?@"D)14:1A0
M3AA;.2HR/2[OCL'B T=$)/ NOGAAN[/*]3V80E8N#!.C2'J23%LQB;W3/_HD
M9E>^SK4XSY-Z[\^<<P)&4-RT95 V&PU#J70 -)MF1[CK5'W;Z2<P;0(LR>0B
M!(-'))WP3-3 ;8)11\^B(. XQG'K<X\9;%/M?^]V"A;C$B"9%X$,]F!Y'&,R
MXBQ*QV2.-RA+J?;SQ$@OT(1FFDDCDJ'FU93L/YB@XJ'6K12B+J!&&'Y>M.^%
M?8F_X>6Y!,3&)0E1:''Q>!RFFA=D+*C0,^G5=IG%BW&:L,.&C>%F^5^Z'\WG
M>GZT(EP)10P*P(-ZKB*NLZF,Q=B1TPU/J*E5+*AJ<Z\ 0!!=-^9N23TV*)ZN
M":[&7H):@WM74HL^ 2""'\+D;2 W)!$F4?]K#;'?Q*O/\1VO7M;>AZJ%VO[6
M@_ "+*YMS[5M*9#(B(HS(2V%[ YRBU#O46TJC/O= NX6Q@^LV/(HM!?]\;36
M)'9H5(1>DZ QIFT#ODG('VY2Y[:G^#?&9_A4Q-012^O(21]IEUAFOB]<(Q\B
MIK7EDZ2E:PJ'RHV;=76)UJXY86?\6"!N5Q)@-*]MQJH,<MI>0$%[D X#1$S+
M/+:H._9E,BRB2,43$^-I(/&!C876X(E6;3XJ6/8**M$9LBY56VQS-<R 3R)6
MQHQYP[$9,3[+@VAX8R?XU;,BPPWL&/>A>$TI)RBHTVI+5R::Z*G]?B3,5V2C
MM.6XFOW-96M\M8EYX][%OL$7&"6B-ORA=8HY@2@8H+-'%9 C>(N"60Z>Z!5@
M2O8*L/^[/__^^+#YI/Y/%N7BX%\V\*[FI4OP9?85T!AX>_G][LMSQ2N@)NX5
MT/ *.#-]_N#R7/(OG.+)3N"9Y)/^_[L=V+BW<.1)1\\9.]>CCW9H$%=BKIK3
M17B\R,^-F6QV*J?XK7G904\PZS[Q4AGI%'R1.C6Z PO.VWD$MA2.N&@MV4\W
M>1^D$HY/#3( W@6BM O$?UPQ:/M1.ZCD:*2+0?%A'Y-)9Q0Q,E7@^$B(A3BO
MQ(.;8@:FQJ7(-+ES5BL)DE&Q=+*SUSC3V53.7KQO*\58LK? TS%-\L+[>6KY
M!'@0;K&@/;E0>GZ<_XT>VF&$/^[)0E- !_-+)=>L<K)!DOJ[$?NGO/%IM!M^
M;:0W>5BI1]&_)Y7CK;#I4 0)7@%,BSYWB LKA\<HW\L_:5JGN/_CK7^)@[9,
MRKT?HD6H"U\D$U.</P(HF=GZTH_<ZEVI8#B$%5G9AP*:P._E=CGB)MD3F0-R
MGIFMD!$$$@P,SD!N280+_UU*D150N&&*&"3WF>8@KX)0$->4_8G^9,N,9RYY
M?\E')JSZ)6P>Q%*F^ AP'8N)2K*&(LZ4.9RMCN4K (<4,[[W2_@E7YP%:KI&
MH>?Q.[PR'[6O##EOG$0^"2K4;Q1Z.EV\ S5WJ@8=B1\+(F_<_B3S7PQRNI"+
MB.:Y+U@(56&56X<>B8_25\_Y?X+QL-"FH9TW_II#\>MS&8="O<RVWD_1UC0N
M")&7AAK2]!U5&ALI&Y7B!J8S\,RHY0-GQRBR"PI'WA0Y:AV%(KFSD&LQUSP$
MB?3K,>!9(<32Z])D1Q,U ??4>M;*ED0_!?^]04MX$!J+J3+2(;^BC_G_P*2(
M3G'_PSBB)U9"2XBC^#+E82+X*7*@\&ATL:+"U-U3NU,5EZWX;_YM=20$?8>H
M)3%@Z*.=Z+9'3M/%3=XJ64/RZ5Y;2 *=+CI.80H!A;UB&M6(M%R99UC!CES^
M?.U$"&51XE),)JT/WRG6J8Y&J0XUR!!&P #3X"E'GI=:W2B>KKPO18[K/.D5
MJ$%=W<@&X"'J6[2!0=RH/PK*JF23>8)!JNPX4>[V_%R!O&TMKIHG9^.";*8Y
MJY/%M9$_46[=O$L.2?]&#QQ\I6T.X# KJ<QI:I^(?@M+FLQ(OGVYJ^Y\=()Y
ME12=-M:0!A0]FB%0+<5\Q#ZQ?!.ZH;K?I>VG<YU3\M&<T%944;-S;5$4=Q"5
M+14GWC](NPS_(.VJ/LMVRES_+Q9W$1W+HO\=Y@Z!9\<Q^2C2(*GH)UA1O*-'
MNQ\EU<9YM<RC3;6G&:16*]9UDRUW@%E(:Q:C3Z@B*;=\K<]]X/=ZQ^UO+_MK
MUU5+4GX^-MF']>\I^V*]04R%ONW3;=0T611NXPD\'VI9J%W+RDJO:RAJ8*NH
M(D-U9NVLD5<WM;LQ(85^,/!TX@^R! ?[/PB_<Q8X^4@R>N15I2'O6'&2"9O.
MUK73OY)INV5PEOZD<$=(D]&3?H>R4J!$JET=<HCM[9;Z9F=EG[1&N2SXT[]?
MK^F!_&>BNCK]7R;[=[<!O-L?Q4#F<1WA7P?9 Q3Q"NA [EW8D<4V#RHL.V0F
M1L4(W1(.\XYUXI^RC!"8A.FQ@<U03N'R5+:*/G*#U@'.0G2Q2MCO>$LP1KJ4
M*R+NC)R4:Y$<,6Q>(ORL'N?,T3^9_%.<XNJ""^DG8L1:!:L&4&Y(PIQ;O\N6
MW;FQ66U"0J1?OZ7J0T/$>G PU7(J_"L 5%Q0 +*LY!+ 95;M9?M(1=#X;0UF
MYTW&YF'?5#V'('?"F_G8$L)G4JRA<4QE*+7K447W2&.<=*"< ]+YK?!19B$=
M-@A/N*]-7<(,)T=<F)4#U!X!FH\G*/-SA%S'(NL"[OYJN04,M #N(1[@TJ$5
M=T<PT*J02MOS:>LPYUM**#Q9J\12=X(Q[8+/AR*$"WGR\"'Y\GG;5K:@I1@,
M9=2R*11=%N,_*GV^*K^'KMKSG24_NT$_]^4RX,GU?;\UN6Q "_SSD4FJI?'[
MP^:?K!:K-39]2JQTG\BMLAH)4O(^^+D/)2G4&]9]0CTH&U[R!VNV^YYYX, K
M8A</U\(7:!<'\71&7\;VAYW EVQ+DHCVO 'K\!*3K:7:=7-: _)U0^-/C<*#
MKHA]7*H^^-%L.AJ%L*634Q8AIXCD%;\QLH>L#D:1P>12VD4%3^'$W9#/=,*T
M(T@4!M1C'++X)PW=YUK>/6L=1BCN8-WH2"AM5UU45#8UTSY&&*X[O/YO8^<E
M(V"_5)UZ&KT\4#O].MXB01XT'<:5^1,@9KG]_JM=FM66>R)S>R>*V> AMX>L
M)<B$JA<R";/,,P/+6:)!S,VW+HF(Q9I<<4%<>>HTSN3!MJK]O<FU(UZ(R6C=
MUDE]C@\F(+\;)'\!VN!@G+Y>$XR)X&+7,0> ]MOLZ4'7*#J9#%EUZ:AT%^8O
M]RA_11NL]@H8"=PQ>I$DY,!Y!90X+DG>O# \I<1C(W3 0M< Q ;5W-YXCHC^
M]X%'0WTF^T%S'X;2.8BIIP<&>+UI8\>(53DEKHO)B-.3X%P^7YUA6B*23DN1
M%\U ,GAY#]^-O:6<4?35?# &7J[.2@*>:L/Q8&6*:<9U_$Q SI20?!RL,-AQ
M=!Q7>L@K@"P4@D@X2@>2PT,(PQ39X9$[1FG\[]Q"OS]^Q-?F(T#I,0X3\'#!
MU1; +D?!DX.P#W(F%LF]#U%%08_5I,;1+ @'A,UA,X\GR)P4(Q^MY40\&J&-
MNB5 .<F"?DAMY"WR[5-=S<3C<:T]Z"W')9HJ@ZIM]*6P:K6XD1M4Z0OHT)T,
M6B+B2<AIZR#$"P7[:DOMG8I8M<*3]MI[77=RJW@;U5LPQ[/=S](P=\''9)2=
M4W'0E812I&\DD%;9%:YRS@WU5U,-WE? J;ID:-B!N?E#SI^!@L\F7^\M/56*
M7P$[DE>(F$Q]&+@)Q9"XH1=XE2_G> -] G*>0MXB[ N8 CT6@K^&;BZ]/9?4
M\3M_XKWOO@T)THSW7*BK#CB2KT=@-E4]]4DG@@6!*G?1V;E)\.&)G5\!97W5
M)F5?\^ QC[97<J(!2',DPWUB^!*E07]H6P.,;5$PJ+%&R=TFZVJ?%9<T7?JE
M-OQ%GF<*1"I3C/.$8[VJ[!?@??XX;_BJ68X':VD(,*T4S%D417(O1XMCS1K'
MIY#V *X0'4K8G%0[WR:YW@=Q@4 ,N  ];=-X5%XJXA!^Z0 7SEX%#W (M_2@
M&@65.;FNO"I_RN>L6B0Y5+P<%)$LVR7=::):C86F.*[X>4RP8&V;&GU=*EYB
M"-W$CZ(? >J@A;0XS0L#U8:6X_;-J036/>G'I2HZL7A, 0WC&:N#)0:R;2^I
M+[S[RA$ 3U/8!X/J6&4#5;JGBWOW-DB7*5Q^K%FH(2* HB$3DI$)?5%^!1!O
MH+43H17V.#,0/[!ZH$2D_>KG__*0(.A[!@5B='-X2"+D\T9:?C]:[/EY2!+S
MJ[5Z3EJC-"Z<D%2:5O\--YD:V'@:K5]%EBV9#(:!*J:?1\,W72>)@4H6H1G$
MGI[=?2;=-D=&8XU_P1K]@:M-!>#I "IQ0&XF9C!+>'1!/.7W0UKZ@I>?7]B1
M&AF>,^2Z%@ '7_S_A'Q6I/]OAID)Z(SV!XNR2+9.S#J^%MN%>=QW5H,<H1[?
MCZ3L(1S976 F_'X#*\ML!5A]^S*4X>J%B(ICJ&#'K!/T8;;.M<>#'+6Q@ M^
M5JRLZ(V'?9BYA5 U(G<183_Y[;A"(_S7$5!)N?!"QRF<^;?!Y,J^1S_*VS\[
MG +<B) )@<8YV)03+G,+,=:_WDH%N)V%[ U<?]3'%,3#'Y^;-G(=:EFD8(2#
M# /(@83T4"GAU5[OL!-R%"R^LP19H-.I0HACQBG+.9D9WUVN$NLVW$ZO+:U.
MJ6IGK)"*(NJY(FC6]U($=E@XQ>:LE'V^?:9FEU_K7.Z=?-2$'=;R<1N*4^@H
MO2$JK&8YF2!EZ"@'>I.@3("ANSUR /5KFX:;S- ZQAS#J\P=9OV.82C8WB@W
ME4<PD^>ONS^5AQ/2L0>20<GP'0N7*H661N/C?R9PT&'\2>DU39(MNN)5;(E9
M)3KD\I4L\A('Z'!'<RTK+0*(]J:N3*Z9]4D/Q A^EJ&<2?^SXT;>462E<11:
M*2L2R?6I_';FOZC CSC,(@Q?G0E0MCI'/$:*/%*I_Y'I8X:W.P2U(!I6E!>"
MZ@&?E"D\I8&?J<%$%:J*C=1F[SR-Q7R*WTLKE+LBSG2J+2N'#/6GK1)"-^D5
M]596+Z&,"-AWLB</*[@("WT6[ZC7T$ 7IT;)@2\E34N5FLL3MN;G*L"?)]-I
M10=W1XW-U@,7X0IXEV(F +B>J"5""Q9Y=IKHEYKBY2=V.J4(.2;N0?F \WF.
M#:-J8Q9ZQ4XIC3(-? YZ.HH50VF2_EYG7CM7%!-#)C5K3=BX#;_FD<#@9S=R
MOO<AS@ >NURHNJ>X<-ACC8GPEUYHB?D*ZJS>/(45?-K>Z;N!_R )W\GQ\')Z
MUVXFW )'%MP%_*I=)@]XX2$V^,S,6(5&W +T#'3 M<L'JAS&,)>E.JR"PUFU
MX=O/OK9:?:"K]M;I9VE!8O]OPG%DT$=(BQ>>6*^M!:=GJ+0(O#?S?6R ,$Y&
MK/A^:%%4'#+D; R4,4OV._&X1)(+7R9*#@F^3*(-/Z&Z6B:2BS;;?0-?'AZ/
M=T(7?,B=.F+,[XXP\4\+R#9/D+F,$-:8^*UG$^OTDEX?DZNV'"WOL%-!C2UL
MYVA-RS+$T,(91O*-FZQT[<IS4_EBEY(]\@.WF\L>OJWVNW:84T=6-"N16E3\
MNG&RIL;A?BD+2TB!\!SI^WVITKAHM[6\&D&M=G&3\NL4>&X<&7@6E)2_G>D0
M\90V+N-"'^V(9=&/LT84KNRM51?.6,7_R>3R3V1[F[=(P2:!E[4N(E<?$B%J
MQ^/M)CTCZ"=E+I!DON&)EC<XS"<K=9OI,0 ORU7X7;(D%(LXJ/E::^-B/'M:
M:9MDR <V.TSM0#47/!HIAZR+0 _079E"R9$H /T05J[25(U38$'-\Z4>M^,#
MTF9T[L-)XC_EY? [R0]V-6 D(+28I$]=C'K+BV+-@<K[\@J&M#"Q"R?373.2
M/?0\I_-6NI+5\;9Y!3H]'35O?OE;_8^]\!=*)WFP%-F(S]FI_HAE51WUX_I9
MHH+?H\GR!KQ,@ZV!>@ ^\D0AGMF!NVKN.)=%U#K*GL.JFU^42)ZD ,.-;GK>
M@:>K FM7BD[GR?')"?V$S*.9&087UWAJPJM( 0BMHKCEI&P(BZ9+*+[Z),U1
MWYDO'3Q? 3S$O6G#?TI:+C3YF?-)2P]_%L!GYBMG4D6+2Q&&>!*@Z/E^.R2+
M6#&6DH[++R!-SF:JX/IT<1(WZ*3E^I!I3U[(AN/ADWE9B1/#PFL_LL$D$1?3
MX9PQ8NFIGQI8WL<K:%/66:*X1&B)#K<].LOX/GT,"4&@Q1&1T;PM[<M/SZA;
M;3+\]_HI?F%O.D2T]\FEMIP](%/T105('#"2SIUR0TVHR2M '7]D*&CI>/5W
M^1]3GO8+M(:]<_Z3,L(6J2C0X?<[;A347WM>K1%_AK?;,DG9Q7N3XFG'(=Q/
M2"_M"83@"#U22?5(JK;(=+OTY'H=3Q)[<BTF0%%Q_AP5P>P,IH!*,B K;(64
M/_-',I^L.NJG">?D;^1^-)^J.UX!B;F<_2P^DR:10J:FF&[8. U&V4XDG0!
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M7,P?ERE%NW,M+&_+320!<KQU@OY%S#/QT0\=5#E(D/AG>A_S[/B':L'@=*)
MAQT.[W2LY)7O@]T\O7[C<VZY"P<T(DB,,A$(RA,EX>T^W^WDB(R=8K=6MT6V
M$M5/6SQ44--IY/"Y/FP%YUGH?/3'WBY8TG+>!DC?PIB^8T=E*;BM\/7EA+!T
M"(:)O'77\&(!?E44"9>>*Q5)'>>"\$MCFO*C=!4_Q4U>DF<<Z5]B(NEE!W'0
M(J.3D5<WG)+ID"D6YH\!71[>[>\B]NF2X7,CF&:;B*S"/>G_=EW;3(ET:>N
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MOA#P+6"DAR6-[*9^C4F+1>YC(M58<#G8T(4,J[^Y<WF-O"#JH,0)<93?VYT
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M9_T%1#W4&;?2EIG.LS:)8H/?-;R7%&A*#\3^_B-I[)"+] ^P,N^+A%_6P4F
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MEKD5N_LW(QE5UX]-_CI04:=I/66<FKP"2[8&QSAZ^!5SRYZ?#[PSN.QWOB*
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M=6FPI4WM(7A;86X.24S/E4E7!R.<Q/=W#+B"R$I]'W,V.F&"9M[:\'J)'[T
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M?/''P<F+7UX^K\%=RLG5KV-!DZ\-1'*#6C#EK3YYQ;=\>[[#T6Z%)8@:F&<
M%XSY:J>52#QKBY[J;RJF.=3V;D>8],F\'(?+Q&+GN_N,91%D81DBE0#[.T][
M^]>T+N_?W=@A&I4[?MM(D>..1P>QBAZH9E4LSZ20:C3N7=7UY;1;=WWAMS+!
M<7EPDU!J"UM[@1QR+,I8$(J]9=7G*'&.]]CM-R+VQAL3'!=*C()HEN@$D"N
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MV)IXYL;+_<I?ZSVW^(MS5K+8I%R+BDD_,8U/S?RSE^+JSHUILUO';0DEY"H
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M^I'OI<4VN^E)V>:1LH+ES4P$G@DIS3FERS[3+$GKW[E6_74*N^01KQ HJW0
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MSU.5<:CQ;CB/8N]+--MF2QS&K20CD!Y60<W%>2HRP8IA'=V%R@/(R.IX$$?
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M7%>I6IXH#D:XKP.RP2,\L@F[>&;+EF[^8;&#@"A]7M]G[[!/AR7^R=':J(R
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MW^3N Y@1$K\^1)#W*&3W^M?EV3F>IXR[6? Z>,3*&>S9P]ORLBSQ5:($[SO
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M9=4E"TDMJJXF@2H;;P ]+,;BC<JX8Q<KVTE95\M(%6)D$EXNY%0XMZ6XBS>
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M1,^F^2@B%#E1+O:LRZU?D@9HR&'E;(W&QAN*S.S+!04'MC)<:@W$8&(#O1"
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MG %#[=R WS6W(%1>IV6Z$G/VJB@BU&%&A+-5"OGNE_Z]7936.J) ?E?YA<'
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M776..;QF;RP6->?8"W K#QB%B->=8,XJ-"7AS:>)[0FXYBH8B0Y%G J[%[\
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M67>8EHI5@ZO(,(E.&T\NN)C*Y<JO$C1NV_#MWB;H:K#A]3J0PBG8H^VOU6_
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M\]W\]NLD:&T\VNNI(RRA:=]X?9B_G7^#6<RG3JK1ITOR M 4I:;Y6ECU^2V
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M^PR9-5V6N&(ZX0T.YS6?8OT\S:V\4U&R(HYF&=_%%BMOM<L *HZMFPVD<G-
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M^'S5MDB"M>*9Z\:&Z4N"U@3Q57)@\LZ;I9^<WV*/"/$BT*F,MQ\ZS[_[2?1
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M@N*OZ&E#W/C+ _[Q<BX74<L;";3H;?\U/=X=_N%[0\*0_=J] 3:"QA""S10
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M""=73],JIC[&8A#55"'>'.Z6>F +\O G&#[S1G1,Q>Y+)M998)'Q#^%AMRM
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MO?"T^R2F,K37*5C^'5#>,CPSW]KET-YW,HD_5YN\B1V6V9'AAFO<E]+@[$@
M+:HTO7 11,^:5N+&C9M!R!Y!K.)3BFB(QW#>^"GP<CWTU!?WNY(CK>*\(W,C
MV4 X$BA_HL&?R;+R>D#1\76@E4B7MB6E^"H<O,2^(IZB(F_-IF0+NE_N)/[
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MA@P3SEV#G6DYO]NH#U6]RR9E<]C?Z<ZQJ\T[NU*;.?.&"*;Z4<)''>E4]/Y
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M< N\2H.?UG=1;GY3A1&=S*TJ@+S%0U5".M" J0:.]U+6)S,JTM6+E)M71<\
MG)RK2'C/>,O&>C_DU%FXI*O19&RV:WXJN2W=LE2Q:MF172B[^C0#O33.K-DC
M,V4,0R)/(^$PZ=PB:$ZY+'3J(6C+54:B=,^A"NTU7\/XCH0!P,U&WR"NP^P
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MN?:1^KT); #F:&04MS*9$[W88M+B'H,5MDA&%E:1"CTCA/S3@+GR.%]?>_V
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MR=95.@8$RK91*B=/Z<>KMN<"F(ER:AWGA@0?>=."2:C7C,^^,"5@?)S\>ZA
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M'QW<-S;\6P.MK>-ALHV>!MG*N./3<37P##\V7_X@$P,6^?(@MM+\%+:XA,F
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M0SP *U)W@'!D=R6Q%K>=/C 85:+3RYA. 9#%HIL'N'-6!]0P5S5]TAOW".S
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MF2:)=,%9B1BYA)4ZR#IP/Z$HAMR$.>]L=3'YG3K&;-+)9'K(X[NCZM1 >[$
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M#.66BZY%7<*@3+#+N"Y^>2[0) U'*@")JPVZ\WKDZ+4U^O,Y8O?4MGU+WDV
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M)=9-/6UO3H6A6Q[J_ (U:E>[1X[S^ =/HV<4;7JNALF&)*\E7Q4-T$%G]ZU
MC[8M3I+KMDCNI8M>S"O2]BV)$7+$(W@2>SZ+SMX$WX3"&<%VJHG!UB#FANV1
M\AD8Y09_ I-Z/(;+EHB&4I@D?HZ5=^[HD8&\U54S5E.2&-&"%2C/B*3=^=Y
MSUX:2HSH<0!811*MT:Q%0\RVYR4)P:L,0-V2?#OQD.CH:#P%8%S#9-:'W1I
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M_KY^;\98[V3?ZY8(M\N5B[V6E^[_R98><'8=MHS:/7+C,U4"I;P_)::]+(%
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MFOMYW3_[^+TW7<J0NNS.GI*4X*QQ)'/J-#3?XRZ#QW#$B.5P3H"VK'^,# &
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MF.4UT(N3GD+3P^*_L:5RNM2N4YDPV?^6-^S#'I)S=$GG-<!#M8LV=F5)T(Z
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M=0YHG$^/8N=8]0-J-%U\)P>3(4%0.3_LXC4*.;T^0<*E-B9K<&7,B,+)QIH
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M)E  RSEH)L .$>P'T_OHZG D^Q/);B9$OD!"^Z7)R=^#(H881$-^\,.8F*I
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M0^W?W97QE_FND\TU#<TS,\-VG #9=SI))IUU3GY_/\NWFH10 ^Y9<Q9P'GH
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MKVBB8:.1930TSPE?[N:C!'*P&KC*PF:A(\6(#*PJ$#*204-"5<L _]@%;./
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M;P)T")N:0[2&\]BW40FPYD4S]HL$;CFNU+#]6?ZV>/+V19N!UC"%RMWH_O!
M)])0++[V\$6S[:<NP?7Y]W&7?1*6O 9'7T5P0J2-WZ:WMLHH,NS<?(R<W%0"
M,DG3_W99WWCUY%G$NVP?@D4=NRGS;LV(T^D*KRT8LXJT^^/5+YUSH*9\@_G.
M[+-L&^<#'T6__2W,$"-PG:1IFV\\;CJ[5%+?7&8,RH)SJYQTP5Y 8>HE5#['
M7!@J!WIWBDRPM^^>__J5B5S9)=BS<?J;+8.PVTD;[: K1MR*I;.:,#OZ;;&-
M-+@R9Z]D5'89$.8SJY6IK1E)B/4->OF<?2.D>(>\ W'I/][N/7LT422]($F6
M,L+'Z/-R7AZ=4]\5I(ESA<%MH 2N>E&M>"H;R++U8+O&]6@,_!VU<C'*K?W7
M@G@+M(JLR9$H.Y3J!>:R3?SY7A,<\A,=MK;BS0@;@?, ;)C8(Y3E$80UP 6%
M6\1=S<(\FCP\)MHQD@ZH"N+8P*9Y^&^" ]RDM3'0QCJ*"KC5,Z?[;-SL>Y3Q
M((8D 7G-ZY&GGK2,KEV(B?^</_FDK.]J RXX1ZOB0^"#[. 8&17(>W]<"OA,
MQB\JT+:P(K/*<**ZL8G7\+XNW\CK5G9[*Y4Q'>QWO#MPXGPN_N)>#YOQ2RW@
M7\6Q9S8>IMK^X5676J/F7-3#F#;YEC0:_7@LB_0M#YP12;_@1Q+\A-5=&+XJ
M?)!E<+N(1P:/5K94XZO8!IDM(UL%1R;C*4=^;QVC4A/4)FBZ<$'OW*Z.L8;X
M8:S39+S9\<' CB:)_]<N=*RF54TT)_$#IB5E_0WR$^S*=?YIPD7(:AD"95F8
M+-I> @8\06WX7&HU:F'4;$BP9F6)$?(N]3,16+"0X#AA>1W-IJ;4GZ.]L70U
M<9SHLN>L6#E!.DTJK5GLI5DOG_'XF2/T[YJPW]ZJG[_9=I'8D"BLH.V!KTS]
M+GQD9P?T&-#T%NE:H]JJ[G*!"HK3<!(K,3ML](O ZO(COL-UY7ZRLFUBN#R9
M.))8U?OB\<OG"YV8KY$#V)UV>T0#9/"X&#&SA4M:OD>)U-D$=T)4D4P0M-0K
M1FC03/!'3N_'3_78:7?#_9SYS?9)Y4M_28W;*N*9R'1;%39%\_18Y9.)9LUY
M[5FX@%'0@;UMF>3J<Z"B?SI-=ZS<138Y5T]9JU/.OM2G1 ,O\#V(3*%Z-G/M
M(AZ<M-U>=:+D\/'F=JZ41WL0#I.Z;Z>*<TOLX1<AX.BK_9;"8ISQVK[#@7NQ
M665N]_6E-/#M]800_PHGMVSK,$M7PV8QHF!^1DHDG<=/(/;8Q*0FS#,9/#QD
MU4N7@T=_?"?+PT^/ L]%=F#"7&OK>D$&>X:^BW  <L\6["_'%WYAN(VOF:$9
M_I.4JDAF:4'%8F$EN2H(MQ&U\DH%.*< [QU9:>%?6\#N6!N9MF+YUD"1)V&?
MO5E2N0F["%APJ2>_,&C^=E1+TK"!^Y,"CD&68#=-?\*@Y2WJ$]D9I/->EX>H
M/XDZ/CD>J>$X0\N! ('*%I%,')0DDE[B2H)^D -D="5!=;R@*3L4/M8V%N)S
MVE(([E!X?ZL_G-H5P%Y-+J#K=$6+=H]99+D,1SHTP>EE"W%."GU++B1YQQ@V
M665A[E>;J;0UA:4ID32:?Y3XCMQH)5".$4F_1Y\?N7%E7E%2=3@3Q_R1*^K\
M"\-6.00D.Q&D+L] *,;ZAG;J2A=641#"EIU955F@;P]@6]TVLT6Q9TW.)(_]
M'^R]6513V1HN&LL& 2%*WTE*4>F$V!!!Q&0K!10@1'JD2R&%$! 0 8D2LDKI
M^U($2A!2"#$T0D Z121""&RE$.D[)211D4Y65,+2--S%N4]GG'W'W6>,>][N
M WE8(V.2^<___YIDSG_Z@:N9RUZ._@2O5L'I"4IXV<=[MI[T3&F?=*PVMU!]
MUUA8PPOGNX8=O]2,YX0U+P;.+P<9.=QM/-Y"?%-TRD,5PRYX?^]2Q+TO@0"L
MF9H,YRHR>PQ=:%:Q1LZ55P0T6W>B.SU =SRZ>L535V$X)?C?I>8PNR.83?3E
M)4&^\#'4/\><6A<"8+Q8GZ/>N<^^WGH.-B&P<3G#C9+;0(2_Y#(5PK%'QHM$
M";WM\VE61^F2+%89:FQ-9[%X[,[;Q/SEPM2$I2S?"TP/'$\'!1U>EV@RI)=Q
MRS!I#+ZJ![K"L3O)O\ $$@E#HX_T""D++IB.$/!&5'I\/F68L+TC'.2P?ZS?
M$@=QWVWE^Y#R\0)::Q(/O>MMZ'1?6IT).4J=C=[FZT-L$P6#!1V>ZLK]VS^,
M-4C.2BJ9E_.FU^&22KJ,FZ.B]L;BIVN%?PYUFI-&A#U0&C=/0QPTW&DA=AZ1
M&I&:6)X!^R0-/S\&US,Z]_F0'J#4PZ?W5F(UP;<GVIVK:]]Y^[*Y$D6+NB&S
MDBU1#\TM!L+<7AZ]?NXQ._EU2$JY!C_T8JTGC:!LK9QQ]6IY9CDRQ+E4U>'\
M>V$FXU3DN,O@]KO!L8LAWN>F3U+'OZ1?#'\YMQ1(=*D]FT(^L=?&ME.K0U(Y
M[S_F-O\^]JE2'F9&&@>$P9D_L4(7:9+DNP%E)A&?A +KQ$@^58M$Y:ZFM# A
M;Z:<5:"DFH_<\6YQ''M@&-=$WLYGJ"P*"5-M/KK5ZL+4BD B;3:Q*#%E931F
MIH-C3]X\6*, =/E2CHLM-CTP\).T-^ 8=I? )F><7L[,%L>!"=SX3+39DF]M
MK4UG/G>=C4R'.20I.+Q*VZ[C#9T)/G]$V3^L/[(VL+W%1-M]!/UY U%=AV.U
M(U=41<> KN9K3-0J [OO#)\Y+8?6@69<!)TM,;6+NI:"5BHXTL?<?3E23*@-
M]U+WHAAT"/!YL0.63A23BSPAH#8(Q =6E?2-7;H *##G&E&@.Q,RQ+$8D!&P
M@OP;P@OO0RN@.:RIMG0:3)*\N/'=JS^1.#VZ2"@.E40^:$)/)ZO7P]$92QE@
M)DGUVO+JXC2L@NK?B6V&K+Q0F;%1NWV@D/.BD)N/S'!(HIAT6&3U3TW?UF1Z
M@5OO2&Z@[QY?Y5V$,7^=0T%N:)J<BB%O;U3XR9'Y6M<XOWW:/@HO;>(N?K$J
M,J4?CC1]2'23<?GP[<JW*R/=CQSJ,OL7@I;<ZWQHR*!EKM;]N]6]=TKM ]:4
MDDO$L= ^T3;IQ :BV6Y%IE;ZBB#?N9WTF"_, J5%C\*Q/T-V_-K2K7!59<7*
M[_U)7KO4>ZF5J8&A_N3[:;VP\$=I,HQ1Q04#K?1HA5%7GZE_DAM*7J :T"OQ
M@E/"NG'@(E*&K#EFNH$((R 79X\.88#D'X,95DBN]I*3]8L;$<(F'ES1LN@L
M,;Z<9)1P*A'E_'2L><!UIJ>)2#DPHO5Z \&*+W[^L(+>'R=-PBH,?>Z :6T[
M$4X4/\H0=8_5P> Y8-J-WR=68O(P@RLRW%(LI@7VQ<XW@\#:'MS4R+3=X:&6
MV0Q>5'K927"8T(\9>-ONF48CWO$?(%9,'L!0=HHU(;SH(@!+GV F9 PLSP?3
MII8ZU<8!(GI*7<@%"XM4[\?_D&'CT@B[R-?G5G=!_3VZOWQTNZ8T^"]PU,LR
M"?]H<0.!%/N#MI"/CP\K\</UK_S[[JH^=[H#%X:D?67["^Q6C+K+PC6# IU3
MPOZLW3G:?3'D9JV64C)QX.5(5M6[7_@<15F6TS!=QW,_+6KE1JS1B.2=X>@K
MNLZV12^:L_O'!1[XIF^D@/3:8Y]&=0M^/<(14I64 G/%U#;UE6!!.&^B"SFU
M.B>3CM4C_P(I U4+./7+*U9V<TXR+-VM8]_> 2X@Z]./^1Z"*E1[%KI:W%OQ
MZ-/TLN[>X8@.K^@J4LT$2[I_S.IX1"TQ #4>=?DZ?EHDE)?4,W]CJ$)!7=06
M>A=N-WG?.#F\XMU2Y^XG'6,=QKQ!!5(9R_E)ZH1GWED!XX^X#80JZ;C[F-G)
MR&]?>0IR@X0B7U!LV9L24T<</S'].<]D?>V@2(\RBE6 3H-I4KD^4%Y8.+Z!
MB(B:3)B+ZD7-]/$)/5%I*- -/37"[6/W4^4AH&\<I1([J/B6;/@,*@*77E#V
MCY)QU=@6\.O9/Q9^*/3T\P$%4CX/=RLN:C?Y5*>6TT0FV4XJ-U!!&<-:PEGB
M3%8:MS(7$2D#'- =/YG'->]A;@V?+EH)#J*1SX 3*_ES^,P ]'"'=SO^EA1#
M+%[M):3?L"J^=(^+RRR3&\(DGNJ]0@1T8B.">F:UALGQ<TZ[/RGP<GPG*GHT
MLYO"+,*^78F]@FDTN])PE9;M5F?TQ"?N=)U.E^6]F*I&92$>7?TRT[[7R+7D
MZ0>/?U]=*_#H&:K-JLVEI=9E5FN,=3UQR3GL7BVRG-Q1_I=1%!(5UOCM.U@W
MZV0K\P5GH^(U1=7][XPT87AUY;K(E>0KU(5@$[1M%$H *X2[-[O?0!*I*=!U
ME!E,S2VS$!!Z\R:;N%$]@^F=AE )/X&3'J ]L1;AR/92*Z;0:M^&O2&9__KL
M29&+[XKSJN>3T:C(J/H#'?*H'<<UW13<Y&US44N8:->:"G4?LR!56VKS?=I)
M6W\S>Q.">_P<&"M0$6!J+V(9C@I:SJ[NP3ZN<34)%E6]QW('/6=F?I\2#[D0
M9@:[\J;DA>$"\Y6%_W'@*H^'GIR? VYA#U!& =")F</1ZC27LM=A^L#5BP]L
M\@!A)RGLX\P+BN4;[!;2J\$>I[DGXH38-K=/4JVRJ?%A0/'[B;*0#)[@1 7
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M9]&E.[]B!K5!IB(PUXAJ'F0!ZB3]'K79+9(R<B W3U[*QNZ0W!3CP7P>DC4
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M82V->ZR6)[*4]G)^PFXA^XUWZD(,-Q"_O 8&^4!A9;J"-CA42GF[J=J?BN_
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M*X4<#%,@IP\G3[:)TR-*39))M6S=PT,K%:D)2'FHR&7L<*19)J/4C9Z3JUB
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M@C_-8_SF[7]RI:((<J @)+M3=T$K?OF#R(;L+/E;' @R>W\$"@*HUV-,*[B
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MNP:YI'Z$*L>&[=&1W"]4QWZ="B:QB3>;*-O[$=I3\%WS(Y0]'#AC_N,;S6?
MTYS[X0IXK4+]73;]BQFQ@8I'H* Z='&8X_']V[Q;N U4007R/"'%/*3=; 4Y
M_@M<R0]W15"*LPD"GAS&((.)&>YX^73&J!J2@_/;Y670&A3%FD=#*ZI8E1S$
MN#'L8J2[O1SF%?1' T_%6GD?X_C!A+IG<H*R),]SPZ=TL9YZ1G2K-ZT-TQFY
M[ 8[6XU2"ERVR'\F_[49XCRUGF,H%X+:G;\/([OM5)EW_[#=Z>F<X89WL<1:
MO+B*M<J(()L6Q)?BC^]A;A3NQ%[F&@M(%"W\2(D1>(MG*QP62H'/[V,5N'<
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M"S7"4;^UULC6J+$/"'WSW1>QW=&E=GF2 <.PKS7FQG6>"P$/OLV^U.I^>M#
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MJ^>TC[M7 E_L/R_R[2??^6ZT&S6^OO$H&,B&+^X4020V"[M%D"<$.@'4(G9
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MX4=NR8#XS^N![R['F;?R2_KR5=YSA.*9!9%!]1@Z%=2NJ!23T]\Y[XFRK6'
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M-["JQ.?.GF=/A<9)5B:70+U':AZ7R[W]WZM&$[7>1^3M]SI7'NXG?2LK9Z2
M\QP:<!8[/2D. >#+&J N'\U&&LG_H1DPK0CUV RY!K2UGE < ,;<),;S$S2/
MF_M# @ K,JZ[4U1$OMVZ_?/2ZH#=WV^?M]__AVJH[W)85H..I\^\%/M-?']9
M]I/43.(6SS*L@*PE/RDB5@V [F49$;;P(Z%[@+VPOA547NPJX"DSHG! OX!\
MD[ESL8VT%_A01-I'\&!S$2I\\)?K2>/?.@L#AC9AC2M[)4[B.[*<GV6/R?S'
MK&8Z%YG-^H%D3(Q1X+B2Y @Q#DC.1@@SLP!>GXO^B.)'J+W,;6-2PYT //??
ML23/=Q[AYMZ3%2V3JSRU\&E<[$'KSTF>%GC33-$363/YW(KJJ4W83V)9'3H&
M,]4O3H5"^1A-8CCT!WTV%JLNUX1\!>W=[S2YI79CUJLO]2ZNZ;92N^=V>06D
MHKU:FU(5Z:B-6Y%7U])>J[ISS\9#TE'3<A>3LJSR&QPW)N('3T.#!U9--I?6
M*DK?5%P(L#]\K\#BC=Z!..U+:^7></BQ ZTFQJ\?21^QMY9.4G8%L@/^.?2%
M+;R\=NE(U9T!XPNN>O]JE;FKW.Q_7)[^;ZGCDRI/30]_<R,O!XE!O$;<_8U-
MV U>>\0]< N7M\5EE]0=<@!7^.MY+DY$"P9$ =*X/&V& S#![B$;6J/,!<M;
M(L +3,,< 8]#-X2H7?*?O93"6L$< D*XGL;4)K3U_5*0DL)3PW5,T%++9JXZ
M*I3'BN!@1;G4 ;K/4B+'.F&F:4(>1X84V+-9,[V+OT ^/"64NQ"A =7Z @HT
M(4.NS^3(=_+A(OM;TBA1WB%"#)MT"(1WI9J>8-SS&Y*>='Y'3[,MAN\:4'AP
M%SRO]&=9&9I?[(("J)0$T0@Y9H5":ZG, 2TYA=?[,@>J;A+=1;P;)B9 X,VB
MQ5.T0*] SL0Z$]E0]!JO:,IV*J&\/;[$=?F"6?8'3!_+4-Z%;:WBT&^A=]2A
MDB4&4@^H6')1Z@(]!"@<M!XZ'G&'UAK(IF7/V&<I!/:LF#+*<*^;DO]=,(>$
M9"(U7T&5=-_U?;7(7#K1\#(P*8X$GD5L&2;Z"A87\Z)Z"^2J0'+6G)*5@''A
MXSC]=L]OHFR_W0&%XKSMSPRKJ6\:UN)ZCCTZKW/F,ONW+U+/:L<'SX<+S-!+
M,V.'$\TR'I%B.)">?P6%+03O]G1\K0B4V#%*#_MT_4[(]JM"V<&U];\*&U\4
MZ/MF6!G5]JE.BDM4W=0[N*1_^R7)'P,5*G. <E-!.XB9'"&+3<M$Z\WRW3G(
M/)H*0QN0<$EJP"3'V3YBB(@46?Y*,C;G.F%FL-P-))N^DW#+4"$?J()-6!=6
MY^/$3AQI]\3J[$ H>V9;=>VL/U2X"=OZ(V!^DY$*4KM(JI"EY(24I-!HEX=;
M4F/$MT%\-T*5Z#+.L  (BR$HIGG.B?'0/JRF' %1^^2'&@ B3C@0U4W>2G0
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MX/?;S5JOY!ZL^ 3='H06Z8A\E&?$BF7E,'4 BE2+(CXK>V;CC);O6):@I+X
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MD9%$ZG9N,CK'-MRSKRBB,4D0JF;/WCF%]1):+M8%6(;K6%J^L+5(N#MWCC:
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M205GTRI4 \=3&.9!8U*0#U>'*(,KP7E^1&_"6P%BD4Y0#Q+J@L4A,N]G"+*
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MWLB=$L%:PG+%2O3AL3_LB7E_*PFR6D*L_A",@'1K1#">_A^NJKIQ8/T^H8Q
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MOSN@VSU+9CM.+;[,,\_=8XMQ2I>:6<EP-?[DX6CP7G(DZ;[V@=8R)=B6H3^
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M[),9A_L)NZ&*UCRLN!%X$X#:]FH?5Z(%04)L0UT#ALY"3R/.!0-#3F #"XG
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ME//NXBW*X6);F-+\@&C GY>3#$1SJ2E-1]6>ZA7?QVM X$.\81]#DN\ZH/<
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M?5QF:ATBEKRS*1KHXW0G?5IZ2[=!;H+ZN!V_F*M Q9S<1-1U(C;B')8*2;B
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M6FU O($/]C@MH_>DNG"[1[NIPBW^YQ=6#X9N2GRN[WC]_&JM!S8H>?LKJD*
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MR^-[E_@P&B9=$[3P23J 4'=!$5\B6M'+WB"&252"WG"7 _DK2T] $QYG>;<
M5W ""[BSO1#'@=,4OI%#6.OPDMBR/L9EVS!A=ZTG#ZL]IW!*,[#EL7YZ& C
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M79?^@K?E9HE-?ZRP:=#^EW4_#P!?;&>\>2*#M=GO:71?TM^5)[E3+X/]/A>
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M\(]'*S&!CG?"[*C'^-4>JCX#"1:%OW2=R,W<>6^'6E!\'48HVBNO"AEB#:A
MA!&K2RJE:_$=O*A^FIHX!#"5:Q/M6/E#U!1'RL52$G85#KNVE,=>YDK<#P,$
M8Y/FI^.H R= [1'Q+<K&Z/,ISM6-K;.>XYO&-Y=,#\M@T>@ILG2C>Q_\C2;/
M7?PK!R@FL?S$(: I<VA9[KI###DWXZWYN0^:Q\GNNBAY(BF6P=8)FV4P)?<I
M.2"B'Y):T*V$/4)2FX0AVA=OLI1(/#TM3I)<D[J0>H(9X?$;B2]FK*%D$'ET
MA/$'<HJR'SS/1F>,S'?.9HXR/2\"6=Y0#/#R<V^PIM>]$'Q>=Q$66CD^1M1[
MZX7CQ\."\#+8P;'D=SH>;6![[C>Z?% *]JV= )9,XE(8K1_D?,R427I#$S;>
M8B,,VI;11\:2MT#)P$H_14F<RLVAFT'%2:*0CE&Q(O>=W%&'7'9._(DQV3?Z
M]6 ;;E2M.*86>RS!TZS'=<<SH*B;?V;%X-J)>HQ*?D40GWJ#XU1]V<=;:.U7
MBX5?R5!.FA\IB']7ZWVVWL=VJ3"AL#*TG,\K9/(#%)T':EQUKF28AV\J>?2G
M?Z*B#O+4TW*SB(116D"UQ^B=E":MZ]&C9WYD";,D]23>/G&\A.PB9YU,!;D;
ML6)[<B]<5[Q+[F2R5(.RA(1^(_$T 36J@+Q,6R)![LEDR(/1BFYA//QY(ET;
M:K<0NV>9<?KQ)^G?)8'+H2+/:.Q#!K.>E*U?FMF&-<23>XV=(;EC>:1+206N
M'J^HX% O)4^NW\5Z7+AJ&$1CVT[A<3TI"GT=M0=2^61=Z,K\*=1NWA.C$)^.
MAY/VT4E#<+FK*K!Z+EO$5I(V].DAR-2'.$#20&F*?HM&M&#9B#R&'GT/Q.%R
M<ENQV708Y,MK/,^#YX@-N"H(?6B1J>,TF_$%JT78"Z:\C9%N ")?WJ-OF[2R
MPVC@MK\.F>NT_EBOR"#.D#:BH[#9B(=];8D"9$:8CJ05'3E-R0L.9&&F,ER,
MH")_L(&QIDOE7JQ^!HV-S3L4#F2Y@HR"KP@-@N+DJ2\5KKV5QD Z70_L3_O2
MT@#=MS[O_ACH*NFXP;*H6N^N.MQXB?V\.L7C0KN^C1]H;^IKWS]ZYQ!+/3@]
M>H+]>[1W4(IRDW;0C<ZSU8YC-/VAN\>>IMP@FC:Z;F?V51JW9&)RRS(.6VW"
MF W415C4W4BQ?Q^6B4"$/6%'&%D=/]/B;Q*@0=T['-8C1YE"3NO,+;"HFZ0L
M14F?EZ$S[> Y4Z1<! NKPXABY-&1DCM20[Q[&%!"3N:K/%411*[DDJ)^'O/A
M!QV#9W]Y<LQ:K,+?1,536=(MX*\8Y:&+58N!G5[T:F$DR06QUCY>28R4/$3+
MJ]U:.5MT(IVFY"+:Y)\X.5+SB249+ 8A;RL( B-%?Q T);?D*+&'Q\DA\=:!
MR#2ZY=NW^!:V/'R>C72%;J/P.' \AHW51'Z%YR<NZ!,KK=ORL%D "R=B<!G9
M8:N@(FJL4S^+9HA']T\=N<I7Q3%3VFNY#,UHNOEH*V,C=':Y >7*:W3[YOJ4
MT?X07)M&;(QLC)[<V5LS?SYV8G+BU6%E-=0WFT*U^]I)9F[%RJ^=DJMUA_N/
MUA_Q84?$()O"F\<3M+87WY][OCU]1U"N5NUH08H]Z8)3DFCG^N=!4T$U$3LT
M&L,*=U;K/O=_H)N;;&*X2[OE1Z7E*D]53[U]QC,[*P[QSGR=&ZNUT*HE?M2R
M$&]GM/4O&PD84VG"VW+BOEKZDK2FRQ\GLO$"(J;9= ?HL<@'O\)S[L]I<K$5
M[^J <NZKPIET5<DUHH/[&B>KD]\.,4ID,/:P,ZL'=R%^7<BSQH9 @>)R@LA-
MO VD+F4 P=@WH]S*)^"L\ &(Z:.I34=?E8X1]XS2U2%]>!H'WA:?JTI"LS](
MKM$(D7QS@BO/:S-_4R2BIT++CK;AF5I9?+*U'?T1Q8+PJX0B5@);I,J)<C +
M?0R6/ 4[W(I84Z5+!Q2NB$TDU7)87KFD_4VIECCH?>C,U'MJ-RF7H[I,P-C%
M1:U[\ BT<FKKNTY.UKYI77Y^LC:A310/D7G8I?>BDZ0>PV12-D(]B9;%4"$:
M0P/")\,KTDV$4Q#U@OW]FS$.2V0^276N"#_*[^^E:6(7IMKKZV,G?YR\WKF2
MW^5?@TN1=M0$]R;68!=*YV=3O;LC;5]LOZ&\.X5V#%A*U+]^(6%^LL]%M21N
M3=WH8*1%7=/O//_AJG3FM,?V(JJ<19>$E[LB>P6+)VTR$%^OOF^M-X]</MI#
M:GKPW#3%?F>V6U%UJ5OUUN!VI,X3FG=J !6SN*(HG2"IV\&G3+NQ+:;+!P L
MDZ/8%0_6,\/,0?=NDA[!$GK<*#X+84 #7R@U+J%.O!^*N<C':(@-(2W^D*+X
M*#"489+57])Y0 :[%"_>RD?*$R0F-,;%L0@[G(Q4._"!HBTGL_>"W9F<Z<1N
MSL-3)&4D <,M<#T&[>"B\TC&2^)(U4P*$,_G+&^- _=A+I'4VI"KO7AY.6+7
M!,$T.6O7AN.+1_&T@ZVO^@O%9HRHL96F24S13[F.$5Z&K$4>Q G20QTV\@I%
MO0L!NG*CEG1T^CE3 F&MY#;1*#: Z QY _U,??>>BE0671]PA/)X]7D<A049
M3)T0>KXF5G]PZ-(7AOIQ?-4^("L+2<#6S2O=[_^]0P;;34!),F4PG PV;2"$
M0P+!4T^YPH2ODO\ ',7J+R#:3Q&UP/BE6<'*!KGD,F:XW+F-)POC /IE\"5B
MJHH9C,ZRD@,_Y1?QSE&"O3VG1P2)=:)J<.?.MX=MNR;P?SKAP/KSC;-C>//C
M7J<+H89'X/ ,6F:]5:^5\8G\?H$92TLY(1F,>?5\.V7*4S6W9N[Y4\*6A;:T
MWN&[WYMWSR3[X,NU/0/NQX6H%K(C'D!UW@,&?>]O6#U9'7Q?(_F/!]"V9KT^
M6]$._IG6XFC>7 3/#:F7WAB&'E4EQD,XX0@D$/WFP*9I$GOEZ(2Y3-Q),(+B
MFR!R]P1VHW0[<3@XJ]LS/I^DCM*J7>QT+T@B72[3R:*O(221-"!7U@]Z41SO
M'I0#KO:'0N[@Z.:/QZQ1:+5JWJ#V;&]B*G)ID\ASFC@I9RD]C,*=[D*$-CZ-
M"493-G:AMYP)"<-["N!I]TN9#"W4CE0J\_T7&6R)83#O]/?1WSLS7WZ8W7?K
MT%A9W\@>Z [V)0TRI2ZK WND2M]%YC&DYI7EF^">'E*+>R_C39HW=/-^Z!3A
M)&A#X=YPL87@?M!5N9[0Q?L*$#T&,M@&50M$OHLA6%)ZP>E=B-C%92NX-H,O
M"G5E5FX9/84Z*&P/K+31M"C6C=JX\#.L]-I#"WNX)2$$OT8/WWYWHUR_!_YR
MT5ZGF[\+KERM7_G<TFC0\?'S_*J/ MOHB=HB_^J;I*A(O9+5>@47RH(.?O;/
M/Z/1'>[<Y%1HHN*YJ$L(<-@HL"!.858/*)FYM4;^V 30A/.2<N)6@LF8RPY<
MI<,H73&ZTA JDOO#V.45*=HHGHE>CSH$< 0ZE[S$E390N& ; [2?S>"#Y\C4
M^8Y@0<A<F.EDZ^(*W&RR==#CFZ=&Z+9BSK) I!84/4$WH4M:T)$&2'C8_8JM
M)4_/B_:+-[4/-PDF3$&CIJM;FVH=\C7Z>/:>-$5\Y_21:&HRG<*<,<E\/; M
MJ[:1QC7-)ZKAF[MLN?%Y'"VZT:)TG5R4+:?)8(K*TB&T;I<64,]WS_S8Y<S'
MQ:<S/V+60KY^4!HW]+19&U(5G]6?@ ];P4Z(C?B6Z^Q5O':N>+5-+*.F\VX%
M2>F/H5Z1,6&5G%)W$:>)UI)J\3%@DD>D)HM^E0YVGK^"B@'M6YU7,XOPB3YC
M4JL%DC9!,Y+O=<XQ:9JB"_'YB+4+$\:PYL>WY-5T@QU']=]6#0TGUZ"0#<].
M+ 7R&CIN:5HAA84V?G,1"4>9W$B/UE$6_^';K<>U=EO84P/\<"<6^O#I]ZHP
M2N8BIZ8X5M\=]O>R0FU':@EODZ]Z!A.C4U@0O .GF?&B.:EYW&2YAGD=]ZK;
M]_KVP=[G]W=N%[;Z[\%\,15>D72ZZ$N'$#KH/X;60,S/\GQ1D</>(J9 OW&V
MGZQ!\'Z%0G"16?IP)CGS'%;=[AWQ@YQK/*"P9C:-H$XEJUCK]TFQVOC8E^QW
M4PO:WYR&IC8WQU<1[,%I+BE?JA>+U1<CP")>8*Y4=:XS/KNMX@1_,I.^"7(/
MA2+OS1NKYWXD:<=VEI+MGD8L,MOUXS,W/:#?8@=.!C<$=%H%!)Z-]9G>VM6+
MOK7RALPC=MPCN,M=;HA/Y9^_1",XWW$%JZ3*!: F=Y9%-IZ;5,>1X$0M#OY\
MG[$CI'BB9B[EZUW.W ]RIGAW,F]E ^2.&0\(Q?8(*4#!7MWA-F>U::_A/Z%9
M?BB<Q\EE<.\K>@,ZE]O(OW2(M:*$JF-=AV@$]U'"Q3J",J1MS\B2@Y\G'SV%
M%" N$?7QH[Q[4F>@-#.YT672;Y)@S\<8R.GPC#F86<T;X!@OZ!?>BG.IJ D-
MTQI8\&=RSWRM[_)".<L%B-_3"@_\:QN;_C]VE)L=J3_*OAAZM*Q _U.UJ>L;
MW^K@ML#@"R/\%WT55@%[--W2SWQ-V#A_E#GA;XY9[=#SAD@R\V/ONY;(DD0$
M93M@X?K#_N/!Q37>=VM8/XP >>43V1)\@(X"0B+0+\R!M$"#'K1JP\DQZ6:H
MOYNB@UK%E\%4\(I>[:.TY+P"US[Z)GE.9-NKFC(G=OTX4E$36Q2Z6'I.&XR9
MT.D8.=@^T3*@#\&%=R0WI>;0A(C7P4),F7"Q[/CLSI/%VY[4XA6[2=KBGXWJ
MS__88HK1Q.G,:/T?+9X;]<A>F#I:=+22N>?@2RHU\\;%A],OI"=1QP0BC YQ
MA-(Q<1>-\](4LI^ "/&&;\(V_?Z^^%\@.(]ZF:B\X+)IA/AK;.=X*0MYI90"
MCVMS%)^X33 %2'EVTUX!%Q/Y5+EHW3B74OF81(7(?+UQP1C!@3?4.LTB(@!2
M.H/[SI?GI>D)_%D6GTTPK7[M=3=H.J94N^Q\ 3J<8Q@&/7^N<NL@O\*Z"YMR
M]UNOM](N?.YG"3)(IV/-WQ-ZS]S75-4:S.Y-Y)L%-&8>OY8?DVI8I7X3C?M:
M;J.I'F!;FR54QZBFE65@<6:U/D+_=B9XSE:#8V.@\BR+'3X7@45%6M YCLSW
ME,?XXV&VJAY'JW/]WP_D]O6,W9WK.VU_L1$QAI@^+ZR9D,'^H&0:*X",3*)!
M#%8+Y0YJ"CIZY!1$B@!>/A$L,C++MNAS^A ;W7E>EL<G4(%42(4?*KE?? _[
M-N1MK/HQO*OODY)7+R:&NX:WV)YQ^K9\'JSB1I%=U.8H;9QN="9G/=V <!:4
ME/8,*1/"(1/17OPM 2.+@ !3V7]K9:B)D6"B*TA96A8Y0VE,8R.H-!E7 T4Q
MI4[ > ?9+G1/7WU5--$AC^ET/COIW84N2ZF*<]-<I8Z$@H[":.)O!8UT[>$-
MJ<DEQ&_H$ZKGV<:_3B:K>)GL?]7J9<)_EWFG;E&_K[[&*S[\?DQP9,;3WH]W
M:L+>[HV)C%DSZ6![8/V1Q5ET1VD?)8W2<2Y-Y$)\+F= O?&9B%:YO->3CB$4
MY%C1?Q2RYR_#^1V91"7")F@K7X+FNY/I9F)?$'L9F<Q9+W8>?9%RI%2NGQ1C
MZ%832<XXOD-NEW<\;VCU,5SIN:E)89A>@'\&FWNVK/CAQQ3'%T?B/'<.[FZN
M7] ]96]E=R?G0^9F1PNL7X;'H[S *L?Q]W_64+6O#I=]>-VU*[S<Y\[-LX$]
MO+.YCT_Z#UPF8=G\6+X)"FU]&-7<1NQP2GKP[4Z86BG:WD$IM7^^Y+$H0OKW
M&3UP&XW+T2".R>D(.4N,Y4$H_T0:WO<XQ $&#H';<N*X?F-_@FU]M#L<J)+C
M-_H[D)1BTV*:6]W5EHF&;RNJ;6^:P(4G17Q]+#4A.+>-HU3NO(4^]Y3\F.Q=
MUZ8GU9O7A*I<L_R@G+7DNR2F9_T@-]3%\_T3,"D8FX7FDVJ>W7:MV5J8(X-I
MAI3D]G_[*A;B<3RU:G"/\.?")1$4WVVL0NE%:!)PHI/2=V7$#&JTOJFP/T_L
MW1"#51&O1:%YR_HS:^(P/F.G%3Y2[T<['<BZE;#UPU/2VIN1":D-QWM2Z8Q6
M1@]CRD!X7=ZB+90JC(<87$HVW1+XQF1,[9OU'B<@:ESY<3J\;]E?R:]O^30#
M'_,$ XL&H4=8S)D=>3XMCQ\SH(M\W0BPY%;,_3"O!GS$#,+<QA#"PN69%OOH
M<<-6*V;0U+5T4V6DRM^L!/" *JJ*/+MPGWF;ZW;OKK,W/7(Z;O1*EE;$KW.2
MV$(-I%Z@=:%R>913LJ55U :K6^H>9;7>70<(]HKK_Y!<RTUK/%)QL :)\Q5&
M^4F:27_$P?LZ)UEQ."%54IY$RJ;KC\79D=7QBGX0#QC @$V7Z^7")BSM1/5B
MF-83$.7TL;AF9K'S0][=J6/8H+V)B?4X_;"*]9@+-<&N=MAVQ+*J#+:^0K2=
M$">YA^9MD,'21=*-LY?M?U[:P=23,&2P=33Q%M*;QE_^[5CA Y(</GJ)O.?E
MT#3I01L&>=KEV3:\-$(<#]H*HT89W&+20\6E0?XNH)JZ? N@RB'X5C^;E/9M
MPO,"V,\C]2W+V0$@*>TCR^=8HW7W)I(6/F"ZSQOG]#ZCOQ>M?@"1*8Y/!159
M/X6W=6S\QKF\9)$<5Q2R9+#KX<1IK'!?%T8&JSI55W_F@XYBV1]^%JYZ3KI+
MTO; ,-V:.N]>WH,;7?2\7A[5_1H.7IAI<_I6QJ'.V%W4[/KG=<^C$VR0!L51
M4.[9GE':9=Z"7J,2;\NBIU).W^\MRG)^T+NO V5LNMI7:=V8+U7!^\D8:^1)
MM;Z+DZ2-)->DG/6MR"F$L$!22M2:H[1<H65\1>00[2!UD1<T),"PL1DN<#!]
M.^L$" ^&0@3(-[Y<?UIVEP&O(L1[V)>O#E#(]O%:^$369$IISI=X9>CAI"N]
M!?V[V%M20SI)N@Q")^,+T*V8;D:Z.G[B^:(/<(JQD6@-K>Y6ASJ./ S1?LH
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M<F6%_J, (_20UR!KZ=",MK%JF^2^B[)TBO+ [:J D1;0&83)Q[9\8Y-5Q.%
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M!(649R114MA(L*V>GS%JNR6$2ZB$3=;M&2?B[NU%IHOM0037?R4+A=SB1 @
MY:H.?6%+:<JVW.=)[RS>SZ2J1&\]F?B#A47<##?CT:L#X1;T?J,KF3LW-/ L
MKE,F=C@>\RT^Z%8>&X8_YI=?[!AL;[+V'G<6V3*04-R,#:O.+M@:LJJP1"WQ
M+E7?G_3FP:-'8_FFYB\K[N05[#XP5O'^B.\1BUAUL[NYGS&'+?^+V]5SZ:$
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M#NR @O??45G3$6\E9O' .*YNDRV;^@S!,H0+P[\6%/[QU2LPQES(V;U+O %
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MW:87MAA!PU,0W[%D ;XHCB3F!/ V-<IPVVR S"2%(PX,Y&S:./M.G_[Y\,S
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MYC>_23#)E,DIR9<J,Y<*%S]VIO>3EN](\?Y\*Q%C<6NGA_\LV86F_B^VB[>
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M76GH5[+0VYC]_2V5<X'A(?S(W?!+L$@J'^XJ;%IX@SY*LF; NY&R.-]6 2N
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M4KL^];\R 0.-(G$KF0AQF.@083\4 VH_F0[/C ^*D:JUE55*BON*DNC"0F%
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M&SO1]"#MFNK'6L_Z; ("(<:RE<@<7RR\-$D*P;[N_;C"0K<@4]$XY!NT8&4
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M6.CPJ?/RH'[AT C;)/5H;@5U ^G\$(4)MU,5*TZT,-]0!AX,BBS$6'!V65U
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MT".'!T*!QL=L&[<68TF@JI-?A=714GQ4'?[,>,F]1PN72&AFN]^5[JW2MU3
M@_)*1NS<62^2O:<(B8 Q6W?/.#,Z&OW[6.N;: 5'R>U.="W!')KB43.I*M\2
M+=XD*]SLWBT^"<2PLL1Z]^:G;[3'X)+YMN[QK?=%OTNOU-RMW/_\0W[O!_R^
MWBK4(9^,VJ,WC"9]/MB\ROEF;ETG'JG\_9CW;8%;F5F C?>^$9I1:YBF=]F'
M'R<O^#=,Z1P>J\]Y\2!N<;+,Z$"%A@>+-\^[_S!>T[?Q_?Q1Y5I/!LKGY+&D
M;Z'.-\[6LF7 \\SVU/]*![J,8$D5?E^#Z7\ .-+!LS+256- P?V@,>9#__WG
M7Y/G!F4?MV]9@X4V"-9@[E[HV45A+NF9\UFJ\,\+5.E=/QD*,>]0>+_]G^B2
M9TQ2H3V=G!9GPIDN"J_N!U,.^PRM7CE5,D\PT=OV<.S>:,G^-ZBX3B7SAO%F
M_Q]/Z^LC^\VQ!L1_J$T&%#0.KJN?>_?>*O)J2\#R!W"@8&\[,KPRX!%<0J6M
MK#.6L5 L6\/??Y.Q/+5M9JGU-WUIJ]UVPFX \63EESGJUFZ=B+\BRG5&3FVN
MNV+[L1+/U>X*]'W\JPNI#OM,<2KATHZ7[-T;,O3RT;>(?Y4;OC^LZTCAYEB?
M4TLLG]7 AN7V\O6TH./%2CZ&8WW\NU1QWO7WC*+AO$K/C#_'!GPNI$?8*TMS
M)!N(^:CH_MMAU_ #.<\O%2AQ&U6>=S<7G?67O]YS]K:LYE09^>?5F]Z^.\;[
M+GJ+V"8(E[])"-/D'SAI$359FT\O3@I3\<#./I4N9_QL3?M_'1H=!JM=CE(6
MAB$M[(KV-<N6,CS68/<GZ]=@53&!WO^Y;^J_.GZQ_Z^&S5=.D-ZKUY*F,F:E
MUY]Z^I,&\HLE28&DN1MW%.(\CL%4_A</U?_Q7!R]I'_29AXKU&R2>IW8].+_
M^4.(Y\7+\W400C@AJ?GYZ#P9(RT$.=[ [%*^R'H1O='N%QQI\QKL[-"TEX!#
M-D5'<[(!?#+_997@\8MD+K9G* N#SHBGID7RW--LMHRU=N$<)HL$?E.TL0^'
MQDXZA7RCI))BX+G,5JM>!J1/2Y5J0W?=KU)EA?A<[DKV=,S &BRKK5P%^/A8
M0$DKH2[5<Q>7700#5\5PKGN6C7XK3T>9KYXKU9O?CW=Q&I?J0?9]-HZIG9HI
M](7/>$3@5!BP-(FMIC8CET:X,:^Q/&D[%[UA,?@@>$YJ"A6"VOSO!9T)H+;/
MZ#>&+K3RLW]-!8NGLLOU0 ?:W0BBULBG\P*1:]'5ZEPE.;<_4>B*.>&4<2))
M::8J^4OA@%C9BGO;9H6-5,=[R2S5DB+P4WV<EIE*43!>KS]8 42DGOO&N;(&
MVXGRX7T$J&Q).&_W @=N6:9/4A"' \O]M"IQ()0,AKI -*Z[AF,#]NT0;Q'W
M?JRQP6YY-D GR@)0-?05:GHG7BQYE66O2HZO.V7$7>0;I,8ITURVWW)1*N/O
MFRHR=PVI"YDP3#YVE+2N";6:'_5P-;Y&$GJHI#S6$7Z8%RN?CTK9>18!5[S(
M=O*NSQP,S?D'^%;CN$GPK0Y/QN@^G:*DBX/![\L] +H/NY$4EB_3_9EB]Q21
M%W'<$Y+CJ2][)7,9&P9!9@]S?1PB0W</]!@TX@R@MUHPR'9JT/I8D.P\3D F
M<]&9=J:C*-5:2-T3F*P*X6.U"3;8;?-6ETMF;4480I2DF70ZA@SGI> $\=0^
M;?=I=6$II">R([[$(AA2132;,6W,NWP=1/?.6$UVF^.D^R$Y8#T/D=ZY$0SM
M1RA9K/P2A1EZX@+? &GQ$9JXI(E,"GBPY_MT KE1NX_C^I;48R%5C.I 9JT0
M7$!E 2G'S@9_72:PTKN//!7Y+1#W KY4T6\13!4[1,1W.W6(U("_2%(DV,KH
M;:\MXC<@(77EF_N&><[69>D.1&8'-=.R[.(@6PJ?:K1\@?D,QF,A_>(>A$8$
M5O4]5"&@YJW!5*3[Q1A0G<74"":.V>F!R'24*?CF2; 9A*Q^$0J@V=@MEHCT
M[G50#+#(H\_V:@]VN;-U-9J!*59RD';P5"MGQPS!<50<+Y<MMH^LG74\\(^>
MUQ:3/_871GJ^]U^(NWC<PBC4'+?]*"F0Y1SI"$_+T'BV@_6TORSAJ-,'[Z*0
M %X<O2AVPSQ_4M>_PZ?>L'/#8OC#DAOW_='U/K1O)L=#S,ZYV50E)O_)#WWA
MM;6^W^50O4E'3I\XHY(X0FK?#5&$V9"'R(:VK"ERDS0+(R:D^Z1#)#42COGJ
M31^U:;**YTY)0F:CT+PC*ZF8E2R"/6 L/ 8=D=&T;5"RWW6^(VN^46S+&ZQW
M]7($]:_RF:H+26AAXH-A2%WD1<!,D7AGH7#>P#(<_,+'+A^I)_XS8P05 \7"
MO6NPU'SBTV U25&W":-O>8? NQUHSXHC[<3#>8REUUQW%;'5N"6>Q%,#.>DM
M1U:RS0/?59?6OR:<!W2I(8PR^V53I' +<&F!HRJ3J2L%S);V/L1_N$03GI8+
M?@^ KOYD"FI$3;$%Q;,)5+13A8[4$%\2UT%Z/#3Y\@N!D@VKWZ95>IVW:4(<
MT!@0P!*XVK-+E,H:<Q5/$'LPF]H%C^P,"*<DE:0H1 %SFP4G,]@2\@"^]!&-
M00J+DI'$[.' "7^FV(J3ZPDF5&& ;"EM\]?WSQAJ&9!/,<&V.R53V='GQ$?N
M^<_;9):%ZXRKG_EBAHA;M'\5XE,[4MQ"*SX17\_?Y9#GO;M</M_P5)5GB8^T
M\2%)[6Z]7QZH&KOUVHE!ZPSO"G1,+F&L7MVY.BS+^P(4.5EK<-B2PO#5F/.L
M-0R9W 6J;1]\Q9O=:6MB0T<6HT\CIUW8,_I0#\#A3?51IMN%M\E\1IX4#C$P
M('*I5!1+' C> BF!<B= =%I\B@TK$"Q^PLQ>@REV[Q KRQBJ*]PY;#Q>Q[ZW
M0[=+](=[+?[@B>:IW9,H<P,RRO$B3:RR!F-C!F3B*!(+[45DM<!_@1C\RXPJ
MZ01GV\<' .(J Z5$@QCLB^@G<-TGDR66LVR&IM@60*EOZS,I;K+*(H3?F=;&
M18YJU\9H38\*%JDP(KLCG$PT%9M#$R!:F/5S(&DD5HNP ^#DH@X#"5+ULY5
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M?W6(3=TDM@#U2_DQF<%:T OP$BOX5X"3WAK0*G,[C1>>3G C7*+/(>#,YC-
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ME[$5%/8G@'OL1X.+PDC@$.,_)^/87V[B7Z;#\0IQ#HP5C6A ;'"+(3X*[":
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MQP@_DZO^[O.)$].4V6\H@6(X8\7S6Z/W?_KXX^BJ VK_\K56T4N\[V*^B!@
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MV3N%IS11NF9D5(X:!QR:X ]RYJ?)FO;<?K!0;+!U@U\YM7N,D3HD702&.)5
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ME5V[<N4478Z8'V::5PUHV-;ZSKVRA-QR,<;=O44;^<;;N9>HAHM/PMUNKLQ
M^L=<W3*CU?L3W<C]Z!=AAGM^,SJ5GFC@);M^@-VZ]B*15ME_EBVP1K_]XE:I
M1?ZCEY#C20 ]QOPM/$0/,3*\Q55")*3)CAHQ7'*%*0(/_U IATI9\*>22/ E
MGCPRD<KR#<DDJQ$Y7<VX]=B-Q*=<0_81';:V0V[Y[.BZ1I 6<&3OX>')(6U>
M_%VWDK<7"5+%/S;%(S?S&2.JA^!>@54H0Y:,(K\-0$%ZB^U22A;'OP93^)'R
MK!8\<XR08:N9C+448H'$\;5]& VZ.0Q$\8Z_V^L#&K((&1O";,59@??@[/Y#
M.3Z17LY5!=8%?9E3;K+KM[OE^D??,@^_R4VXD/AAO[S*5.J'3D-?I\1PR]+M
M5@N;)ROR54\VEKNHU9^[6^EJ><,;<S;+]D97-SK1Y"7WYHY7Q&<.F>1Z8R<7
MI["6R,,BVQ(&!3^V9>F3J(QL+NX0[Q'=HR.$/P]B4>178A/X+EC*E.X?0"A!
M7OQZ-">%C.-P=0BC*.YB<A1Y^UOAIM>8551?.([KE8,VC5V4&3M4)HP;$EZ(
MXZ*4PP(V02AF#:YSM#EU6#I*#/QT:1SNJ"$*EOX E^=[!&AOTCF0,)\;&\7E
M9.I;0HY=3;#C)5Y4VAFB9T\WW1!V U',/X1&<$X0A.P*0(+D>NZ,524FCL=(
M&->5(!+S6;8!5R)ISN'#VN^U.<GG;(Y2/;H5*B"M%W877;LF?ZN[WM':I.)=
M]875E2377W/;M?B;;^.FM$2N^<5#5K]SV1O]YE[=#$Z+$=,26(&SS-4Y]Z%K
M7:;/RX(3BQ5,Z[72=Q3G#=*^55G.!E)=HM]7C3X2;2YA6%E2X.U^$[JMA\!S
M'83ZE,XV>7Y<&M9(S"'KBBJM"IUYS>R]C"L!:^ 0,*/+:WD%F?@S%,#@,I(!
M/=*Q:,B$A=W>]RU2>ZQ]!7>99CI?_+KQG9<GY$ )BZ2:USB*97V@O;P4-BT1
MU^"53C='Z;V!JW!CCY;:>B?!.!9>[25/%,]-2?FZF)[?4RPT;A[$-33Z[S;3
MY'XKJ.:V;<&#'\:( :_ZGGDQ_VPY?CQOJN8:O^X-QL%"4RNP2%]*QYGNU8YS
M<2R.\OJ66Z$#Q'1E/')W8?A1-Y=="=$WCT^74G[;Z?UV-U+6B.>YK6A;6;3[
MC.=*B7=H('5[/^OY=2;/P"#]:GB23\O93+YEN:P#CFIY[ "QN^$?.MY\7KP"
MO#\(1HG2Z5)6V7^@\-(!@CFL*?XU9YT$\:::NRBR]'DM4T/ZAU//U3]*$+(2
MQ/O#!($V?9,$,=L)';GXC_\3)L>17S#TR,:D_:*G4NY3 :PC!?XX#3V9\6@J
M#7?R+C)17T?, C]2)(CU6536XLBP"S21O5G\IN]KAED\03P&^7V>I8>D?3L2
M[F\-O(E)Z?\Z>-SJ,HD,YT=*Z;4?9#@_!?"US.BKPU"@"Z!((D?)^<U@-S8W
M/83SXP0'B?WM+=3,TQBO;3>+C [BN(J]\PTC,7=S-DCEJT647G7XH?(#]Y_9
M?:7\1,*)4J62!C4Z)9;+E0X=Q1"5B65@"]ZWJ2NM>('R".S$9Q\+QV]+BJ"1
MGQ5IW?5._O--N,;/!L(6SX(O:;^FQ);%RPG'Z/$P6Z!,1',=%\H%9\FO4'4,
MIB*2ZT*#\.+UEWC')Y!$YXY\KQ9W\B8XBY<S*M]=I!FM^$WTK6<T7&S89ZFG
MTPF^/107$;+1V0(S=$WV4_[7T.#;!K_[^RHUW#]A?*9VGVN9<?"M@\&PT^."
MZDVY)%)TA/ZL[3#-3=6WM+VO8';PP0?/S[D^XDA,OUUQ8KG_T>PMBO@,BY68
M*6=+-F=GEVOGQ^_2(3]WM+:YNOL6X^6=KG</)AJYEA0[]69M)[\D[9"2^C)R
M!V$CV7!Z8CU61]RKC4S%1/ BHUQ!3F( 05;H\+I5DP\HSV"CQAI0JTC'(%1"
M0TZRONV0^KT[>R]9=^KO&**A*[(FZY(__N9*(\5(![PM9J$> 3E6B\D$3:QU
M=QEQJM/3EES.MULM160DUI3D<K>]R;8F/?S.I>&<TV)-HFK7Q;@K)2U]'U(\
M['EC+[6RS$.M#.6#,&Z,+[_0]SZ%N0(LN8?Q4!=H;AQ.(P5R)[3(KVR]DG%!
M$XDHT+FZ$+7T![R:STC6'DZIK3&WNA3$ AJL$RPGUO@(T2U]M)@)7:'+TX&:
M!H%T^F>U$V'2?4$Y8IU\SF.L$?FM>+-4E.X3!),,\_F:'3FPX4=I):0W:V_+
M!R<Z@;KF=#*6/(1K<BC"&);YP"&\H4+22E[^)$WO")]=Y+^E(QKHU./UM%D<
MJ7O4 !DP0_,U5AZT61%-T,EF^V^>LQW@VZN[UFX<Z.IC=:E%$S%V"B?#\4GT
M1U[(-.\[]>\[@[6>6X8?/5<49.S:>B$4H@=A="H]??RU;[ "C7I9]W\+YU)M
M8<RI;70Y=RX;\"Q/8V*L]ISC?<G4"Q^8^\PT]RCN08],I!' H](:[N&BKM*5
M2 [01#<!.3.^7G2OP2Z$A5N'.5 6&F !7<IAV>'V]<<4>AU-^46*UM9,7^'G
MB"-14C$P&I5<&]@$Z3<_"$"G?/4W.3I\@G(DXWW.50KHQ4G Z0%1\A,CA(ZS
MX?DH9"PA45\9PC,IVA-26B$5=Q*$,MS,<TR-5?1=//8ZUIF@3L*]?M"ZD:MG
MW>GK.ZL-I&..!56$!OP\L+BNL!S./N(P\K62803\MM=$AX.4"MS&.YZED<'Q
MYAFU0(=SI)6\_/V%3Z_R>3@%$@:F65^+C?KYIF^$[;HG5.:.0^IHRS;7YT;N
M^V)/9U(J\L@X,*63 IM368HHWK9&9.(WY*CJTB9X+S?J:GWX^>42="I]"TAC
MT5)]<](L\4C_CDBK@M&\-.J('R%\=[[J6$]DZ*;'UWZUWLVQQFY)>4AJ\:F0
MY7Y18.K@MW.BB1<G?$M="@SRH&U[MU-=BU2TY'(-; +/?C\!J1#3]KGE;7Y=
M<3/"=9H9O2WVMKUQMZF+?_YO55-[UJDJ.\[F5KD7G'/9V!ZB'C; 'NCNIVIQ
M-&]URZ1DGNFE-&3K?ZDT-+8"(GZ<.CHI,OU7S_84 M(*>PT\>T*REB >CI1)
MT5B6/RH.FUOQ_B_^(-)?V25!/*OI!-[,V4AQ?X#S?454,O'Y^FVJZ+JN%.SO
MYW:F;Z=-;X&/_JM._%>7\<'RO'%OZE6?344;5;Q/I8WN.9&W&ZE;?S I8,^6
M6*7LQ%UU"F4;%!T/*&Z[$SXSW3]2^R*LH?](Q9TPZJD[@Y9#E=2JB*"5;=)
MS@,=O_*@,E_K=EIVRXLS<(L6M[\5R<]R",Y&J["U4Q>^VIWE[:_4;]8V[@Z.
MW[)V0&U]^>;)GR::/(3J;-.FSVR,RC,%\,_K3$N7WAZU^CKBA_1?C:%G.O=C
M8C;E7@[^^7+$?TQS[C\>@7#WBCNEHOVINP21WB_2.00B,VDHL0/MZ5I*2F,:
M4M@M?F][J5>"^(/2(R]!E"V\$Q[@-U\AN*Y,Z9P)4!5E+-]ZL+R%R13U7QAZ
M\7#VV(2<:/;6BZV: NNV@$0R;6&3O2AG14UDA6O"/23I0X"5!)$4]3:X5;7K
M0E+4=VV295V!'4OK3H[8@;!6M]JR&@T?7=[A_4P4_V:HBSQ\[("ZD @\^.MS
MTW5_Z;#GD5$"5 \ \U95$L3,\:'!?[D1WH_KZ'_54^_^-\+WM;.$;]P+TK@_
MN^>A('ZP!!&0-[%BL/VG=W]I ?A/KZ (O1B:0&$$,*H^5=^8W>(E2OZ=<7-@
MU2-O:7E.I) "B\.+-*'S5TI@*M/W0]D=<B-W0GG&TW8\Z8'WD2M6>95EX6?\
MPU:2RNXA=XU^&@\EK#ZKZSFH?K1@YI65T?.C!08;.\_<R.3:-&Y_OBO#95?&
MH:Y#%7>.["TQ[J/Z%CI957;6:-<5&C=4=5H9#5)=S2VHKBHN%HF\MR&RAAL/
M2-=@J4RG6!UD7+54M.@LD@?'$[A(^>DZ'7\=)EFS]ZMH]2]]D7=\#",N63CV
M12Y8SJW7OE!^BQD1J7;*Y^0?M<LGXNZ7I+V*-;3--33.-79RJW0]>ZY@:O<'
MHU>NIUUOEHW=O!O9-!99[UKNE&0<L]V-ZI"E?:;<(6N[0Z&Q>R5[?Z%MS.1-
MHW[JFM+U![9W&3D8;;TFY>-W!9;$Q4E']L181O<X>K#5X/ZT!-' 6-B$[$+^
M=)QX6H+P;AWX2E'H!H<[BI0B4!K,RFE;NYKDEEB<TO@KLX;XE_%XP9JFAX6'
M_3!#=6<FFCGS]J@%MUHI45&W!-:3D' Q'QBA=(T;#SX@*Y#[+_XT)T$@Z#M@
M&5YV2A 7GQ: A&(@(K[[8LI5H5=02,5T@ 4<#&ESVL?MFD%.)L8D++B:J!G0
M%SOVM-#P&3!92FD>[N*,1'6-JX-Q\U_ +QV "@TC#P)=E$;*@GTD3V3(UDX4
MJXORR7K$YDZZSO!ITJ8X+D>%2!X["$VEUM!(<?=A7P'KZ-R=[824T9:WH<UA
M'Y]%+0^S<*-QDX1.3K*^(LSFH_3'#DSBTC3%LGW8C>_@<[]"N.S6 Y"]'YRS
M)JY(!EQF(E<1-7^%#'/H6^!\5DN$\X,9N@Z(3XY]=_[(.J;G<%D_O[<ATG>E
M9X;!C4>F/O\R>N8CZY1E>6)'MZ*F[: 1%SS38["_7 Y'+S?UE/-K>*MK/$3=
MX\E\9>%TYGNNF,;;\5W*S4BW2$T/=A*?G3A9V4OU4LXL"E,X@#D0]7;0VR_F
M0I6145^IIW)Q:N*][X;?K?@ ;-#-^M$H\26C<>J*<.<D[LV-I3-0]X)JE7#=
M(U"SDS BX$XD"PW N]SN1+*BT!M,R?EVB!0$<3H9CR:8$YDH38P7_V!#UBG!
MZ:>3TITU0(-AZY+"Y2!''*-IQ(H?KTGRH^;[^:BTB29@WDM@']8L1A*D'/X1
M+8$1@5,D[7O=^+3F*/&&7SY_(@FK-:VO05"8^2/4-CFM\LT(9_*E'UP0<7$\
M>6@I?[>,2X+WA=K QO&,)4ATLPSVJA4&47@W[Q 2A1;0.E3BQ:4,&BS/"TG!
MFH91-#XMULQ;<I(T<:L:%]?-,'0=6:+SSCTF%$6A'3XEBH]4F?$:TAZ_4AKN
M:_6M7/BJ\8<\"-Y(UB2YP\Q*H5=.Q[@BO.7^MBSH5#\/?U6\F60&)TW:7?R"
M?S3P%:TH790RXBVP<^>$IIGP&-_DB/-A*8!>X-X2(LT9T.8I][YYS%HJ,5O@
M6M_TN.7Q*X,:@ST?X+*9@6[NEM\9JI\\7CY\H7^(H&CDM.O'82PQ=3=G!#X<
M=>,O6>$WJGT?W>1ERR=O[^C<F*Q<=?/A_$G:+6[;BH]#2"9G!YR[_KDE-R5[
M5X5Q#3Y(CNC]NF+:+<E836W3=_Z/'O?SHDH<]\:D=!\)"=??"BL:SI^3R=0\
M*/5NJ<@ OA(K<#@DL/4E]HLU<O,[%^%CS0PE'6Z5<-^ETSI $@WR)&0W^YI1
M+_<0!\F:$\0J=7!>/"<SOP<Z98<4RTU46*>2]6Y+$%'_\70._WBPU?D]'"6(
M7_J] =X;(D'(&^4D)DR+"6GWXN<H\ $^E/UR?<U P/E[+GF,HW#0$E^4WXJ_
M)_2%UE!4:DFR,NV%VF,LAN970A86 =\&9;K&$6#;4I&5'9I]48)@<K*EM17/
M?T,RK#F>%O@:XX9,GGIM)7(:$CCT-NHL!'0N=:TCRB]]$-TF_SP[;OZZIO4<
M#X>8TU\+!\5!CUBC0#<C$=@(G(J_BTZX$_FBZ>(P^_BOHA(RBF0N'H7CN$_O
MYR'588Z];7Y*JY'!^!V,X_TP8+0E9/13;3"KSSO?E-YF(PA.[_K\H9&OF<4Z
M<?9M9\6NIS=1#VLR*Z_V4&VH>*69^_%R:GQ?EPM]/<0 M%SIK=?W!V42V[^<
MBMG*O\KDGM-MR4,JE5HMA$[.!)W3<CCK$:T_Y*&_N<WG6'I*EJ-@$\D)CP(Z
MT!C76,YJ($3,&E\/7^'2TNNRG F"D%1TJY? :A\8Y9+/_1K"W*SHV8=2[1I>
M?DC,YG?><+QW+7:-IFUR3#VTS.; 6Z>RZ(81$WK83>$O!3AXC&W-:*X4U9'E
MA;;PH[)9L0ULP6>L#Q J@UZ=*&7A=EA4/(M5;!&S@0W=)>'#0[;+R3%1J:L[
M+R91D[_-1=B=/@:4H&<(G<BQJ*5S,)]OAN(N7A$Z\VNLNXJV@2<EB U"Z6_2
M*3^),4(9.C1UU6QK/Y\.X9@,.("@(-:SA^0/]B?7E',JWQ&-_2_$C!UQZER"
MCX^\Z\ 4.0I.BWL!/>P&X1%1AEB9)-<*XXOG<(VH+IH::><PQA\*X2YF8K?-
M%*GU6R*3R5NA][9YN5R\C- 7MHX%@.C8>S6)U1=X?RX,C7\H/RC\\_+U.AOQ
MYN);KDP'DU7I*WG;T'.WPA^?KW.O]YY?5#=B]\<6&.P)4HV9>?*J<+K?;\;*
M9IZ17/WA6[1K_E*R,K^.)LI1==Y0GE.3W'Z2Z"'K4%)"U;)?TU?I:LEU'9R-
MKZ%^?BPM*0]4NOY:4:5P+X^#(#\#ZF-0.EA=H@FWNW-QC5B*I+)T5(2&!*'T
M#5@%/ST$UP1"*3S#KBS'24([.@W0M*HA\+*O<%=;=YKXF[2C%&. -43MH9?F
ML31M8L545Y'N4@_R"J,9SR:,,I:P\"*TPEGR -$_7@.+1/+7TM)(UN Y'HJ=
M@XI@;, 0( (WJ?OJ(B:XW)D/)%"0-22#XI%9S]&XI1!F3X94 +V;\3U=_& \
M7'JW/2Y$EK]YL$);."383Y;"O5<[[3*C43-5O%:(!U$+>N"/QUH90C,(-=G=
MB4Y#K;.B)5]DS(]P_='==.N$+K(<A._BC&Z%>WYT0"MZ$B)*>4",.PY^*BV/
M:-*TC5S*JLSR<OICA9$L04R6H^II&5BM<6%(+]F0>)NNWA$T*7AIV.U+:Y<@
M<NCZH 2178NY!,26$9V9#-E%C#W(<)8B5#?_TG&_N@&,G00A)Y5P3L2>;@WL
MUOY&E%)X@/ZC84M!SWHK6BK/J--J4V)R<#*;6]6]-J-S$O*N<@_[&&-\TFI0
M^T8ZRU$U/?LGHK6H6/M652Y8VV8>?B-V]D,R$WQK:.S&YIBR?X,LB_;*9'0%
M[FB,\'@^U\N34VJT.<3]D-SIO(.:D;/T>R77Z#5;%%!3>>!H>=#2&U$!=C/I
MC 21?!I. <]_::?RFN>?" X0\7Q*DA -6;L.8ZPG":F^AVU1J4)Y/K F(L :
M;$YNC>#A5[T;AYV[;(L:N1PUJ?:%V(V,M :]+2Z#0J/XBG O[>P;H.:/;U,-
M@84D:+D# -T."6-KR2_'M:#%A8YB\9\M(4P 23S>A5.UHLF0;)M%1;$+^Z?\
M>EN#^(I>7)><VHB7L67/(LSS>86H#HT0_\%:=% +F)-H:K;0NEA'WR/5$@>Q
MRK#%DJ>H&KM7:"!5V'>[L!C1[=:-]\?A!"XZDXXDG0,-64AYF.D!9M*WPK%2
M&'?F6J>34<0HWM05LCY<8=@TZ,9#II),[L'; $7?.5\6&?VP/^;2<??^O0LF
M2U]AO0KA#G@U;Q$U&V!7!S&Z:>O-&=RH)+*FJ$B""*6H"G\;.MG;P,1EQ=98
M3,HDBW6(=_G)E$D[I179)KC?!SQ)5HO$2@$_OYYX?:F?)=9K'?S2/L3S>RJ?
MG(<RNQL3?:R3^\%MM6^%>4'=XP*DRJ7C(R96CF/'BK//YJ+#;%VK<@F_O0VJ
MM<U7..7=>CCBHWM?35*>B;(V<<42C-V2P0PB1LR9-[[U#W%H)/V4&2ZP\<C:
M-F/J:%K>_:.M47U C<")W#<AUQI?,[MB1>W(,EP*$-4R0J+2M8.;:)5A$\KH
MGT7EECFKB.2AY8Y0C'75M(ZER(0Y"M$9@]^<#S4(GGQ]8F99<\JZQ1FX6R[Z
M0[I#YFR W9:T811?+V[)^P8W;IX ]4]&95M1TD=Q&5AC2AH%)42"2ERA'5?^
M+B7I1RL2?!)=B<@\"H8=B6.W',AG1Z5?='C"O^7:XP@9)K;NZD^CBUI$C4"P
M(.JJOI*HI!1N+)N=D"-OFBM"@?F7OZ$5I^DFD%<&*9C/40U'EH4!"A@+L)GI
MJU0#N1V'F^XTTHO+9J4H9;FX]BW)"?Q860)GN$":20U/.8ISK\/>O":/$Q[>
MI,BW^D#D*5[!'7021I$?$95,-NMM=9M$IQ4IPY7%).>!;8TI#G!D/(AFZROV
M87?GI)*W6@^IPL[M$,GN!AMK_I!1/X"Q*)L=TLP;WL5-Z8+4M;4N*O=$>)9?
MO=O.;:OU#Z .0MD5YBJ)VND2Q.]G7YBXYF[\$N"2$'.I34XU&2Y *7FR3NQ4
M?3'=6YV5& W30FX'SCQP473M<%+?5D 1J"3[[W\089^[O6K&<TDK\U=CLG^
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M2!EAH(@BMB79BBJP"N$!._NM%(^WWZ&P@"3&V,XW1/ONI16SP:*VB$F*WG3
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M^[5KT+Z%;$;ACX!UFUY04'=]21G(G";V+J"W1*(!5]HNX0L1!!J+5>1K@(7
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M<YK85WB!\FKP[Z+P=U'X7U<4+H)8.T$F7*W6#Y?9I2$G*.$;<&1L[BR:L61
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M6Y;N!D^_QBYY"?</GO\*M^88!7V"-2\]2=-I>>Z#/";F1'30 -63[<WYS%=
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M&@F<9"3$*;AK!IRD07NP293M[7#<E?XNV%Z"'/ZP6&O;6/NU\ Y0V,2,J2T
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MJWMNG!K1I^;*?)?I?//W+Q^<+J5:D1.Z3+)H>^X7CESR.KU1JIRO'WUZH\U
M=ZA*O_%60$&3U>-\)TRX1QY5S;$Y5*Q@HX%O;%CR"IDDSH=MT_0TQ$_ C[M
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M&Y%'Z#+ATJMXBTD_417(9!&31+])<R4G!1AEW*F<7N%,&EY]1G)HD+Y/?')
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M\U=.Z/'A&;CC0($K$);;DGSD] 1^+S9$II:LQ\FE!.+5.%YK'2;8>B1XM_K
M):"U^W5\B6!;D(/NJ/XN\]-^[+X6776/M(]Y]^J,MIE5WKO)AWH5O1:L:_FQ
MA[J<Z@U3.1B5K3Z>_,4=!!/KL2L^QP:[>_+WT"^2M_($%$>TELZ+?6*F(\%N
M"K74*SX'!7!(K<7L&>@,,V(.=XQ/@/;3>@E3,SP;(O,*+0731&;#B>U^^7@U
MB,PAP.OI7I60'M\HC:X8H\!&J$_OOR,(5&8QFXTZUV%*$I=OWV_'U7Z^!H6<
M;VMBBF(RUF%ZS"B+3#NN1+VM5XZQJ(@3<4+?>^($=C2_((^@G#"30=@LV<W#
M;(V4'9:6M:#RIG5 %$LEH!,#1]J AHYTH+R%WU05*;*W!YG=T4:<-=^F.M=H
M,N0$QB<.@536@WFU^^3<_B^448J+&B7W_E.#?HNZ!V/I^QMQ?Y;9>4=ZEL9:
M5ESY-?#X5_&G[]B7&X+.G>OZ=,"NF>)SG\(WW'6$^L"C/\*]=FW9:FZT+JO:
MWY+MK(:S*OSU10=;I"R(X3#3,9N1%D;Y]I82-R@9*.ZZ-G-A[B[$%,3D28[Q
M4,H<2N2VA6#R*P%<*]+?]V[QQ,"NW+#PB4N"CU6QVZYZ_,'':\C&,,_D6H<:
MY0',='*G''A&/02U\+4+XRO)"GQ4#R*3J99 M7 ,>!FU96Q%WZ)+MF?<HCZ^
MA4%O>F:7_K>:O_++NJ@XFS+D:;F+Y4SC-\*'7%D_070'\X:P#O.S+_9&\6@]
M" 7<,6DAPPZ+>36,MY7LE;8RPUSAJ;(#C6T)X#ETCLRZ&8H%;?BBLJ3?!^<3
MR[6A8F#A_'@S30\Z<;GX#!A4]F12Q9WU:?;,<,.5D WW@F/O6]:X8+,$W_)\
M48JG'H>BYZ%;#\+Y8PK^N8_GO<G^U 3=,<.@1^R1CO,C]?Q%\LV,A)RNB0&R
M+O9FL.65@QNU@THKO!9L<\Y3+ND30B[X>L]Y5[FDD9U*/WN?SREMKO9,*6[)
M7*C6D@!8LBA+VDS#;_BQ.7P=%E%F(:H!$S,?2XF,8_AQ^9_&;Y68#=IKX;EM
M#!4T'&<)!)51H9 @L*%*8)%FMYR?\#Z.K5M O/)I>&J"XW^Y8'\9KW^W4!F^
MXVA3O:TX0!"V=!Q$RP-42PX'#W:H".IN\[CYY0K0JH!4H.M(SJ0?B$T4W@%6
M19XO('+5HX!' R;'2?!W%[#/WK>$!P,]5?R729-*<U.Y_8\UPO?3M@D/V!H+
MKEE7&PLO5KE@ZT;*-Q[(C_6_+VU0OYNP+[UTM]M('-GDZX?"TUTNE;47/5)J
M'G],[_7(*=KLY!.<WG+ZL@[]F;]6\.+3!'_RKHNA=K65Z><'"Y 1?5>M9N;=
MXH(.@Z14F3Z$"9!'/%P+BNJ<5@8&TMK)V4B,4#_1%>"F2U!/?O%VJUFX)6M)
M"'D\Y[N]R,/\H_1]!SWT/C+5$,6UR$6%,]\R9D5P2.[4S8J#Z["H1P/*YZ E
MD,#;O)J-W_!&LAO2J,7M YQ9%D1YEN+,>0L6/TE0$]:H##^4UMN>:8/AA#*;
M,R"<B(P%E3E%_LTV]A;)1BR9SOA>H(?"YPX50&8H296R2*Y3GFD)"%*]4!]9
M@W=501]0"#Z(_+-W5LORUC,6\E=R>G?P4UN7G<\'+AUZ@W7QEKUP]_[HXA/A
MW=2\6/@QUMSD'WQ4'IL'>L\6?QC]5G*XQPP9G,,6-+[YVTGU&O:*^YY8(IHR
MZF/H:U4[TDZWB&?\"27^-V&@+0E\@D-!;O^G,-!$WJ3NDY38I.#U)7)A((S1
MCAR:NY4\3J6\>H*-80>9C*X\^C[27&?ZWEU*O5(=<,)^>/XKKS<ZQBS[>P?^
M-*'KC.0X/QDC4S0$T=TE_[2-K'#3$4WKL'3&8<E!\%*3?Y1L(\0&9DX-(QV
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M0P3/P ">Z$RA3)'$1\@7'@[1M+O*99"NQO_,L,*&L6Y=+;3)01X'C[B##65
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M32V5370U=O_6=O2IVW723GJ8V D_2@#0"&5"EV4\[8VIZ!$4)SZ%+>Y";6'
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M94:?\(OV]*W=[^#PRIS^5Z>15$>F!53?9,90TM8+VC)DUZ<1DUJB:J68S-J
M&9".BYW]1QL^)\!S^5OSA30C*)Q55*8[C+*NC6+H*EX._NJA7;+ TXD.L-?3
M:R16N3]J*N1QOSUHCR/);IJ0B6\NX@AV*08%K:I<N![Y)=D #$AEJ$8S]3J#
M@$*$^ERH,1C "F*FVZ^[9EBA#4EPP #4^7?]!TF;O8G3N)8_E'V])KJ#U,'+
M7.TZ-A5B,KOBG]4^:W!7)[XQP9#==Z7A=;G9P1&6NZJ?BW=V 3(N]0[+/S[D
MN%]%3,*>"OW*^TV7F@@[IW87$\^=B#\>+*JP"'PLCGI^ZK0+O9'#.1]E\>IA
M15!QI9V!F\<&[%A2FTQK33S+0>X@F<I+;6EI@E;\(@C0NBDMU2D,"YH*-"Q)
MD=]1[%=PF*HR^VE\EAFW>%9VL LK%,U1GD5RU(T3L<.?5P@I^)T*1V(0BZP"
M$$%V1U6SD*<R'[H#Z!G:@"52HC$WR7!Y#?H[DK>\C/%]3.C^09D>2.A-5.P$
M#U1/+PP@L>"IPK\?VWK8KN__W%I!I)Y^QO11^\];\*FCH./VY!+>U$1P*B$<
M2D'DU:74C^ZQ G3F14]Y.VJ_NNK@*BU:C_C4939D-/AWSI[(J?:N/'?\C<D0
M:33&K\:G!"E\ST16YCXLO>1[!$H*/./&<40U]9ZM],^ULC(/>RQ\[%V^+:!!
M?[C:S6)7S6)YOTNI1?P&#-T*A\QF_A;?,.UA;(.6I%Z*$42+:X]@:ZR)[OA#
MR @TQ$_T]R(T2#Z/B7H7%-O;("7M4%.17(,LQ?DFT#46CO/L;Y&#3%.4;Q03
MNG5\=4GK5!=(39>Y%%_:M?.%B++H*MR &9("0'H?,YUFS(Q"3E!%2 YFZSNB
MD7AK(Z"*@_!;Z)PXY$\M^6< <J.H5$NTUDO)YA_Z6YRO\DFT?!*@L;$J@40,
M%T?.I!PKP&00K.I7B/&\UD]/"$LY',^C@1E]1W)_2=YVEG5R^WY<?*W?;$]?
M5J]O >[N025<#-Z=]8%3[S^:/9%-Q4H.X:9%P&?O:Y48 LKE +']5:J%3\7+
MW-+H\W-]!8ZC2C"R[-.LSF#[>)UE^^<H]C?)J2CS:<P.DB60OS@'MDG2Y 4K
M\%2&VA@9\6G=OA>N"UER3 Q W5OT6(G":H0NBYC&\$V% BZ>6BS(^XSR,O[<
MAN$0.TW#07_)C43V,</\7()M7(ST3!$5X,FT"--4EI1^2V$.+(WGHZ+%V)N&
MXTMV8JDJE"^2&RIX2OD(YS?W%BE,H"Y1/E_5ET!='^'G\G(.(:N9SXMZDO2H
M*W$F,Y_QS417[\&XADY;RL^/JYKK!\SI#2/DT;&$F?_\+KF.F8NB_0/OG\AB
M!_A4YW!^2L8U_^LWGVRO:IGY[]]!5R@^CPKV_W3V]HS$@5#GVSOZ 'B7:$9]
M(/39DDK[7'/*0SAGD74U-W_6B85_2EM2$7>%2XY ,=^JUO-O8[8Q(Y;Y6"&-
M6T> R0CR!\P+@BQ$LWTO%BXS!_\!%_%P]*8%S-;($DDMQ#/CA[5!UX"D-4EY
M<^,P2AV@>8U]_AS7Z22ZX<1:5R<WG2.S\-OKT=ID/DVU'(2S70#>TJ08DSMU
M''I^XT"#L.()E.@/K0+]/RD%G3J%JF<IU!Y>R77R -:H]724'3RSA:?W?F+!
M^T-P3%$2)YM3_9,D3F<\3W2FWW .Y_OTCTHS+Y]>BUJ;>M!=?V&T;-^S?:UN
M/$U]OX+3HY<33)<B!_P3(GWN;&(=O[C%U[\NNS2P]G+5(=_[Y2X.KK=]S4_"
MW>$NI?K"2@NO:K73)^YWE:)Q9RL]:;/?MC-Z;L"VSIDX,*$4H$2Y8%0R-A-3
M.'A5LIX,#I4ITX9T"JAX"=&%\)0.9Z7>(FVI(98R]LJ,H91D8;[AIS+$:(+S
MON$^RG8"V7#AV2[\^P_1 ;C?J_K)[>@M2K+V*TD?\@,F)1'058 NHG"Q,,0$
M7(GH]"R$"HI0M8#?T>DJ1N[D@,_1/P3)7* ;M1NP7@I0W6>B";K>3BA!9*'W
M/;V]S#;9/8+>%_W'Y)S-G +=-F+]>9G /!WU)+)LYHU:29_GV;7C=\M=0D=]
M>L>[AW,3+>)$IM@MF?245,N./]-U6\^@O"O,5,HO&)R@M00>="%OP$QS%DYY
M)QP))"6<#A,;9CE<'^D3'G[WZLZ#FC?$#EOPZ.66ZSR>)0TZ0.L6+%K'C)\"
M\Y6KD!IQ'L^7B@*67DQC<\J,0'BJ-=E,M@\:!2.#.D91A-AIRSK!IGF3G2-*
M;I/D7U%'M/>#$D#['J8FZK@(J1;SUR3QR21^]))M2+A[@P@!'4CL(1C*3.4/
M& :R'R$JV,PMLY#7H$X!PVR\D<(9RL8#NTD7P622"7@Y7\1+3])H_H37:,&G
ME>D!^2E!KH8FF4+"=I+UVY4@9U._\<^F+2:F8_35_RBG'I='/N^X^A=WS"<-
MEU#N\U[R9ZG%2J.OJ/:WK[5'.%Z568%D0EVGAX/(V.S<M=Q_CSMY9W>?_;?
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M5-\P20>9+=LNIAC%,K7(WT/]2OD48KA(].>RO><2&7N'9=:JU-6ZYIJ8MU!
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MRTP2]ELXX!O\O>HR)-KOHZ4Q?_K4]?-^*+EPH3V8JW(W@H@2VRK>#UQIWW$
M<?0-N>*DE6*4ZU6N1JSG2IW4S85/,<$-!B)T#?7^8Z&\NJG:;%L5>1-YD+*3
MY K0)77R:K(M>1P/>.*_37X^@XED&@>1D"-H&%$@'+_%T%8,,YPAS<K J Y*
M6@+R%@ZYV #Z^ ^VTK=/N(L$D)MB+[%-A.U5]SC/X_Q>+$BS0R""!?.Z]K\+
MX'&!Y"G:9LQ%V@1-<AP*EYHKWBJ,1DEVX(*HC;T!HRK4H4GI#4BD8+$PS68L
M06I'Y7*&P@J*%1549ZUB4FB[9.Y/9&;*#'>!G(%$(2)+%BF$:\['UA.=Z0JS
M#\18E^%JT&SJF*#)OH^62M-5V,A.R>\PH[";2$< VI*J6!>J 6V$JGWTB0V8
M'S0[W8_(L>] 4X4;L-U*ZA%70S05TQ=!T;):,''6 _A\)T'LK,I.VH#EVP8-
MD+>WEFZ%:\B;YM_@';]M7(\,A-Q[::HR5X GIF;88ODLI:^X^*P-6 L)WT++
M16F50_T>4"YH*LE^_@++=ST%W0'"3XPH$% ,)8VFW:*^"GPN49X#@U*$:QD*
MDTGHVY:@--EUD^?"#W@O4'E%NY>6;WN&7E\]0E?;U>M2JJ9^I#+]&NM?*.>8
M857X+788>"]&JS?<W_B\981?K#?'NS31JFUWK0-7/'MW]EX2].KY95U?LU#B
M2U]ZR,?6JZA[.;/JF>SA_L9W)!>X5D:ZS:;5(FIEB4]YD+J_/I%KPW*,\?[/
M>T&A;E-)PB@]%*+4OI.2<_)R\@_D-WQF]X"]D,M>OAF*H;(HS<P^2P+?A_T5
M<NWF4S.0]$X">!F1\D5V:'3)[C3#)C"&HHT*(40+Y?H+ZYZ-EQ-*X@ZQ+#D4
MP,LR7X<O\Y??(T5(?U:P\:UG!(:4\P0^H<]$"[HEU5G 7\@7\MC(=,2.UAL^
M?92=Z!\@DS4QC=N_,*#")NN,>C*!!=$%\GZ Q"\0I*%\'N!EJ!-[QZS1TV"B
M3$LIO9E&BCVRF+>4:!H?S\5K,O:2 D DBZE'Q+)I\)52=R&-!9^896.VK@91
M=LDL1Q4J)$T0D4>VF@LU&HT7[,9QGD +YT!,5F=8 ^ETZ<?AA"ZWR9^R/8;B
ME_KS)TPE6= =1,[^;XD>*Q1G(K_]M9-!4T%I";$IM.V=IP$CH7%A X@]67("
MC.S#9M-V1D!+(!J?2].,NS0]U(#2"W\,5??2X++M%Q46-!9:O1$TR])C=SBF
MVZ?.53MX51K6UI6Z5&9>]@N_U3]FPMA>_W!/2\W,E3Y1W5FL14[-2*F.6Q>\
M[NPC=Q7.UZMI;JO5IP9]YZKW6'A56K$.%QY(/XZ:(:W&?+S6$W;PO.% I>$?
M:8G^Z:8+=K4RY<U^]U;>VNDE]23MA?P KN1*D? D:9L\CW(!?\M$0_Z(% 8:
MG1HG>8@)F13]:@A3H<R5WB:EP.TRZPO5H&R#M'H(0HSN',,6&@>W]K.+D;FH
M<['(%(4^$<$V1%-%2 3N&J6)L/1"ZBX[.[0!FR[%J"B^(Z'E?Y"_BZ:TY"\F
M@^[*A'DTK-@)S1.H>%4"V9CTT]!*K#-&V-:S =LF^Q78X5B=GG O8>O;&:"4
MF]=IGU 5$[H7[93/:9,H]$JZ38Y(LWN__:A:!%U]HG@Y=10Z!R8-]Y!M($WI
MX4^8)KV^$J68]A^*,51=L@?"667J;U'.P@6/9-;OS%WQ5Z<IVI 9.\F:E\TP
M)A8*?,'@*4-#19NP-'28@]-A'^Y)DUI1>FPPPF)4B-286*?0BY0=8 (OF4VS
M;/I$\R(":%!B_![E>K0!4^@B<ELP^DH;14OH$#9A&3I%:=R -3*;F<(]4DPF
MI@4]+.$M32+-%IOF,E^WGW<_VO"35]=U-X:J>@;K?.Q(=6:Z*JIJ7E3K#M^#
MMJB\U/=$W<#-;U_-B;Q]>2;QYE[E&>4[GCZ/U#DI/91N.DEI[K,] M6C+=5/
M%)RQ F48+^]>G[Q]@??W.RII(FL+SO;1_ @]O2$S+:FU43_FZQ?>#DK/24P4
M12_:9 ND4T5TG7Y/:5W.H5PFY#(;20S;.V? 1\QF1>DCQ1L&@@%5@J[B1PCX
M(S M/Q\YA$D=<T+9 [<)61T),W7BNKO/2D1Q3W(O?QU8%C31E[2D7L0*"4->
MNP&+P//1B%M)]128 B';"3)3T-_+]('\/-DNU/4P4 FAHC/TQPME.F UFYY)
M$ 8,7R)95D4Q@;P@8DH(L34$$SC&S6S5< H9CF^ SWQK9-.XB-AD*\5G&;J\
M4)Z$V'T9,_T0KTFYE$]%Z#+@Y %#&O<%XN8:4W?%B *':-UX/<5FR)*[#%)$
M2F<@]"#O<3\ D=E*3WE63,F]M+SZP8C]K5W(EN@'O 9,I#(/0"@"'/>2US'C
M"/QFT>?G(J96%$*_TUZ*AE2ZRPZ"D=U(0T6_I>@<VC"(=&H$Y<;8+B]#6\;@
MZ'W(=!J<9*R70[*?ECO.B@JKZXG9(M6<^&5C:-)]A-;K2*6>F3C_Z=_6H_?[
M]5*J;Z>9_WJ_YIH0U&2C^-?[MKC/)\RZ3PQ7[.A(B.8B$\K]C^29:3_]C26U
M\OV]UY]G/O/?1;B!CY'C(/?@Z%FVL))Z#G4T^ )S\@I0MQ3C7QBAYF<2;JCU
MZ"/JD*;8-&2TMW^<@52\9;9:KRVM"07O^J=/\;KQVXB)/O(_Z<QHZV01@4.'
MD7Z$[M1^<LPK &^1C="9E9#]M][9"JU)J'CRG-+@IW^QODSR$"8.;AM=_6]U
M((H_I] <420!")DV1<SE(+8JWN"WHXY,TU/Y]DO709:D2/Z($FF<S%XOR,]>
M%=PT45<F>_@'GV!"'L*P1?#=21%/0_8CZ$*KC^IPR8V=1J2U431)1Y)-F&*G
MA#'%#_W1PBJ\-ODV<[&?*9EZ)F^B"(]Q)Y@10<L310H=KLSTND BR"Y.Y& @
M#Z80J1 8D>A/*6&47GLE1KP@?*6T8MJ&^Q5O*'_%TZ$#^\=3.X\+C<.[*29!
M+#R"K*5XAT%08A$IRF>\3-9_TBC,-9F4Y(%H9B)H,UW-QJ2[BK:D\?+1".*=
M'K1I!U#8^C@*L0N]!WH6XG/F+>K<@]A0_5CU ;BON%?4?E7XR9M]4MVPY6E[
M@!I]>T9!LU[J0+C_DZ-G*\U%AUL:[[RJ/1_%;SC^MG(_M=S?F^U"OXQ49]=I
M9M2EEQWPK16!;O&%2 VCCW5Z=UZ56OT0XY=S&*IM=[BX HR65'J7)C42LU8J
M]J#FB-5<)F2.7#*6'B/9R)]W[A4CU$E:8-N2G73OA&( ;0\499"<E'S%F.@S
MS>LCI"G)!H5S ]'=$?*1=VL5@8#H'(&&+$1(S.LJCRT.X7'@NG/+=:4JG"2/
MSPV/L+50+';]Y&EY'=J!M%->&X^YA7AFEKT!N_B2I"(63!2)D$OJ520_Z+J0
MJ4<R&"3OFB*9@*YI*X(,$P/HS\<R+^@Y"#\%NJ9@A CP24EM-$*[X3/#T#TN
M02CWLF-2QW['L?5P9GM!,\5V:@,I"@J0GIMCZF"B+#T(DIMR^BKBUA%(()*D
M )DRS#1B"]%4\CN45JGDECP6CXK8^IEAMK#^[$XY2X/Q/*XAQG"9(]!<X,]F
MH$XGB#Q<O=M;A^-I.W$WTD2""9IB-VT2/CV^%+8!V][VCB+T)NE#SX%LQ2X$
MY*(857ZH*K-VIG0GS<I^P !W-V"$("5,?8L?+0E^D0:YVB&7L$L8C!3K*=6[
MD^@'!MLOZNC[L#S]S&?@>OZ%NEW'L3H[[AQ<OP_X683]][3%,O+NU^/>J>;#
M.7N]ZCW4 D][5QB4IXHBSHV6GCECZODD9(^Q17N]\R\L==2:_?KBU98YT?&K
MQ"P#C3--=C&>#:<]XT7 Z+S8%-?"<);74:;K$)O0",A=F/"M6<G/Y'_PNU!!
M8+98MPC(0V0RS"#Q="YA&MF]<%+X(;8O=#^4!E(# &KNRMNQX@!JO,&2S&FZ
M0@S?&D.V W5K*J-_-]D[G.)^!*A64M,>OLQ9B75+B96Q:*3\;R5/8>HH>!NP
MG62X["P4!.I)/,"T,BK0+!K-[V-FX")[/$R[&8>'(J "\#,V-=0>P/9I8#V>
M@MH>H!E7HX&HSB8;@J5/_GP0C.<^\%@/D/J3^\VE+I,D,Q"3CKIQ'<@74Q;E
MX&Y$%N8[LODDE#3>][N)$;BGX]0&+)UTZB&QK4>OHS 3GM.I+L:KQ?!I5)G/
M@R BE678.?8U*#2*839HIW[P"?:O6,%3>B;9 ;*74('9I43I*6*_J(O'W8!I
M0$X]S_B87FN;8,@8R)ZN2IM67\#L)D;BH>/ '39M%]IA8FX#IO,ON/H(?1Q4
M92_O@>YPBPOK*)70-9;$\7+V] =#[,[Y ZI:O5=[P\*S>@<4ZR5]0S6XAC/7
M8FUZ7UTKQ^6%N-W]U/G$KL:"$M+SY/KYX*=?Z'L.['-QTN ,]8DJTSB]YH,U
M>W1B? \.=S_ZTGDF7&TE=L:O=OA)<X!;6PMQ3^S9=,,CG)-PU$5CXDR;U(W\
M@:G"C.%-X*?A7 04P<P(U9"7*_8HWJ*M1DD4H$+8QB%0DZAIG9$ 5IA,[)OM
M]G>$9S..D=RRSPYY5B<^_, G2CXK7LUR<,YO&A\I%R^5Z1=+NS5B SD 5J9M
M)G;-Q(0A(#/F$N:&,#]=DRB5-'YCI1',5+QF?+:''N<JA#D%"/J6<\*%RUG+
MG3K5 ^)SJPU.P<,K^!4Z/'B!\3UHG%95(UUR/S/:@'E;=Q_4Z^9-6GHJ8TB)
M"CUVI 2P6G0?\VU+BNHTDS_.6M^ 9:&U%0.XV1X>E;QY!*F 0XD>S6 ^QZD'
M1(IU_H(61'UUMDD72WZ8^A[ ICPD[#Q=153OYL=]V(!E1##?O\5,%PITXA%4
MI:[5ZSZ(B2W]7C$@:$(LF0/#8D$O?NM)*<I5Z;U=410UQ=%^$--+T2 ?(OG>
M$5N_H8K:;>/49BA;Y\@6 +97D&Z?GTBH)#:S^0%93ZR6;7-]FF*IX:Z6A8>>
M^-;Y5J9R1);"P^W06XY/9:Z(=,SB[L'AGMYXBU>'7_F6^Z?KZN@XC%#;G\]R
M/, ]=1?_[!D:D*=9M'>:F*0C]6X6FJI[/U%-N^J :Z:C+I6'YD18"6OO-NK7
MWOUP;HC&&'4@N8/](AIG.<NQ>(ZF'D>)I-V<FZ9 #C:]@N\2S)6LR9V]EB*J
MSH@GJ,AL0/PMAB4I/)_%-$1M1ET7!=W B985NK8^K6EK^4OQ6*IYQ8("]AQ
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MC.V-6M^Y2M>=-63WZ+)O0]WN*]Y.V2IM(:9,++C*\]$[B5BA@ V"B:=?0,T
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M\KO,6 %?54(=[%0'^%(N9K?BF&*"? 2R!/J#@^CIS*WQUSO-*_NC@?[>I+K
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MJ7#WG5:40CFH1C+8)C$K7MP'/^\5>\PZ0&2)*IG53G'UX=<06T)(Y1J2:$M
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MBA!O-FS['O$(D_ T*>R/%D+@ONVL5@VMEPD&S2T;I>(_J/+K,=7<Y=U%>Q,
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MAH&1F9&1F8>=E9WG__&@M@.X+C \8CY/3W<%<(Z+CIZ+CMH-  ( =(QT_S$
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M4,_:(_BXI6&RX]@T$N_KGA!T>MJE, 439*VNCF>@B;_X"=U ]-'R-JW6+ZF
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M+<*$S;#+V[N88;>OE07XV!JB!<E0,E)]_RZL?"APIAA23P5PI$93$F/@A"M
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M(R420L,3"?4**@#\G K8>-IX(/FA%*8PMHF:,<VB=:\!O@L/:LZG O#NA,B
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M=S_VV#S2-I%HVIPQ?5/AB?BNKJ+6"M<KS@+>LW$B"XWEOI) 5 #" 7GTV9&
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M_R1L,()S-]>$_!5Z91U.R 517M6>,?W%N<>PIU/G+<Y7![[\>X&JK?!2$E[
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M&A0""2$8!&,5EBP*%[?GC$3O;_V4\+SQ;_)G[@UAP*5\E63T!HS$74*Y4Y(
MVE&&'=VW7^?O029HK_=RBGGE*Z/?2JV574NW4Y7C%C^UO:1G>Y-U[&@-:0A:
M?!N*16&C>T*^+:+._V!+R+_ID>-)9O]O[+UW5%/=NCZZ%!%!$ 4"4J,4:2*"
M(IW8  $!Z4B+@(B @(!T2%0$I(L(""H1$) :Z9U($Q$A4D.'4*1#0@F!M%_X
M]A[GGK/WOG><>\=OW&^?\?O^>,?(R%AKKKG6?-_G?9XYYWJ7?5H^17MJ2F__
MW7P( KJK(>B^Z(7"F:/J<1O421I ^! H3N9DHAK<1:VR^9)GD=;TVZHZR8G%
MY+N5)K3\;;,,I**<]+ :NL_E&P?> T&T]\KIRGQ3T:YP4WO%G<L(>CKTB\5T
M)%TZ[9V'7:%[>_<4-<Z5LH%L9H]GHLK*Q@,+?(/#:$JEZWYLS&S^8D(RF@9$
M&@XBX+"O4^7H5L\H2/E$;OD,G,DE?:A@-/RGOO^3%[5F]A6^:]!;-TAG0DX_
MUTS4$'@8G)I8=[AU4QST&XJ[W<=/L"N#[( :P$0BLK#PYS=,H8#FS=PU_\&,
M7"9V36Q^-6/PA9<+9$D<#6C58(R^15;]Z%(G_!V ?QG]I/EUD=DHB8BYI@F:
MKYI;1YN)@>XG='H2I8XF>SF3M#4#11^=:>A=&Q47B1BU-=!X85$";Q;S5867
MD:_WDYL)Q83RU>\]/U46P%;;<*(D>)44C+^![4;$;/-?"BPF/E2UN7;ZG$X1
M6K;"7T)KU9^Q47HK81K2P0:?9FKC-P0]%',*&,RJ+4U[&;TL,J38H?[XVNI5
M9$564V-JL 0D4#ITZG>(IO^.0->8?G#Q%!W$1':C4:H'FYBL?FI8M$Y(/+JT
M7E>KKLA(&:7>I %2:Q94EG+<*M%_C:E597&(L$!2._93M;0?C38,3=Y;P??/
MVJ'P-&!&<"%ZAQ+E)7'2VNHJQ-_]<%*9V+I74N?<:\,@;)?\_C:>I=ARY.9&
M]R46T,7U9$G;[[M0XKDKJ5[!)-V< :_R:\Z?)M1*F%A.2[%29:!YX-,:G ':
MLXHOG'"[L8^RZ[[X<6B?A5^P%'@2,%6 ^*VDC,R@=_D#JMQWHWDC<M=."L]6
M/=*@/6,:US=1WC2*YD\4\/,3]Q+\\G'S&/(]_= <%!O98AH5U3G+;WO#Y%V+
MU;)P$B&?3UHOQ[:8>QP+>G-4,.J\JG%Q5WS'9C]"I@KV\ G7%V6XPBT?J'E#
M&A+/1&6&%OS^O8%=B"WR?:?Y-;[?E#)>2Q63_RAE:-"*=-VKGN%9#<?[8^,J
MNR>KIPOICFH=US<YO%87;D%JSY9YMNX5O[,(+:U>RX>LCBO(L%OWSP^%2'[6
M)Y1]N<@Y9F JK;(0P0JZ9A+_- P#T2?N4ED^3(.)6K(BN*9GQ:Y\#;_4O'*S
M6:ZQ*-L<OO7@O'S0O2=([=$'EZ6"->P"=H>W0C.L7^:M*=>*C?ELC6%YOLER
MA7#BP_->ALA][G3VXF178>OHK$U0ZQ#>=H+D&85!:Z?80^P]\0Q?ZYBBW*]:
M*EA+($'7>B:6F<'/1&$@(CC[X2@BCFSDG+.4DA!:N%RMQ]98Q+RE(U(-'-HA
M,\+P=%YJ@S@!XPFP;N7X?NZ=;G]F92(FT^G."8@ YEP@G\MUJ-NVRB:O:<,L
M 6Z"[R*@M0Q'8V8D[IG2 )?2YFVI3Q:+[ ?0H%\');&.TX!%2>@QV$2=T[=4
MDAEQS4-$CI(54.+X7<3[LDX8^A>F&/8-5<T33@.<D>%6U1$A.CFNBJG209@4
M_7O176=\[_R82ZQF#%!2=ROGT0V(/2*B;TM")7:$%;)JV"N;^=GM_H9]-K+9
M:$7S69$U<5<B9X(E1OEMK?I4:V9]4JZV*JF=T'QBAF=3JDK;E7/5T7G4@A*D
M^TPV:O/)_BXE<!2^F DM!1'IP<(HU$%6,&@XA-X'I=& []<;R4F4^7U(M]#1
M0.IRH\5<3RJ5>8)T:1',1S8I#$AM:[-S@0FDL*6;R';Z2*]+W5?O]1- AL2/
MH)?8.R!AHY[?4.%\Z+ +;7Y+ONS[HF,!56F!45\%GW4(I8$VF<@<UZH#/&?N
M4-?F7]* CG.0(=15M_,]C9JQ?G"VXOFL!VFV+)Y'D.#HW:W![#T\WC^\$LQ
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MJ;S.,Q?@B_QTXLE1?TFJ-$,^68%@1;92VOQA',%2J4U((G/2*0]=7HCX1=$
MZ"_X8CMR"L5)C.YJ$>(?].W6-90V['=W:JB!KW?P<3ON,4"?PDY \!8/8;M_
M'#O!GD ]W8C/:V87?)C^Z$'H]5WMVNA)T(IHQEVIL(F7#/B"GM?)NE+6;ON<
MB=5\9N_]^W<@PC3@(6)TY=L4N$$S:&M94042<3S1)7/LMKGHM5>L;[_MJNNH
M!0&,CT)4*<^:Y,FZ?6N^MRZ??N*NL2C=[E4T_O*X"&OD2-?L$7 ]^A$&+=$W
M8GO8M%U-]D?-O*70"_!UZ>W99A3.S)!1,6SM7=LD>' :?_YQ> J;AL+KT;O
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M0HQ".&1^\J<^KNQ[JS%)G#C+NXWLW9<>B'>)B:Z&3"=<N&MWPOCW8S*:B<A
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M&6O4((!JR^NCIC-X2&5:7PLE"6<2S3]GWQO'I5(B-(XT=KR'"2R-;;)S&O!
MKIV#Z.[ CQ*96N'LEU&K&ZR+?GR@%/_+5[A73OHL#_,ZKGN[P:)'?0L&S-^_
MVWEP,5OW78-PTN8U32[S<\W_\?6D_YXQZEO?*L54K,1!3,JJ!QY=X+D_5.UU
MOE2W*;;HF,AP]-PLD1\WR<MQBPH.N"NJQ5I4)_-%2OM,6'FQW[99_@^5<S=>
M.!5:G 0 X-Z)EI1HJ>-_^B3__U>[/[5\GP8\Z5]*@N<G4?JO@C,0.+VI/6EX
MA2$EEHT&9(LB?RV3\70 L:,!G=:4+/CJ/4\*KQ@L\O_5\_[+_D^W /8U59)3
M@#3!M3+!H,&ED@;P3XD?E"S-S7S]&]MSG9MA/5\D?V6T09O*'(/O[Y@2] 7'
MJN0E^*IV;IP=$K9\4CO14'P9%/JK+7+]T--C.P);]&QHI.F%X-60<$$P4GD"
M4K_M=USADWDW(<\0)G+BU*$=9RE4'.#WQ&(!V0(_#.N;JO0,RR;F!^)3-K 5
M?%4K<4RMH[=%5O'-KT_V,$TR38FC@G;0PRA"+#XAKD%[UO %728*5QM&:;"\
M$=WUFSX?%%ZKI/-4P#G/X&/8Y%.-DJPF3F(JWFT&N08AZ:S0@&,:IXCOB<=;
M)CFB#%^J&1VQ+Q%-*WV9Y3$9=GJQ;;N(A'P)/@VWWXB!L?4WB0;,4\^%2.#-
MAOOZ+0?NR*R_>PQ;\EMN76D6>G&':>I-)VJ@D[J4)\UTY\<U8_EC&_KO*+<1
MZ^D >?M?1*+%0@*98Y>J.[7&20,<&0Y*W6RK_/G0\I?]CS&E!T21Z2C8N4X\
M"YS=RC:@_:/>D\$+G#]?B]JL,6=P;08RJ.T@8VG =(JXAA(E.VHYQ(8&[,N[
M4AB1:"11+)*< *[PI\2AZ?GBW$?V7U;$%2I+<WYW'O7;I'#\N7O5%E6OOO/4
M[676DDTM!L G8:)$*-8P$FJ'CZAWPD[PBEI:$:B&%RZN[5IHY('H:J?:^=F[
MV8Y5KYG%!OG.0CV96*MO[W&"78\3R[K>=-CV1G24: )!N\UL*FSBTQO/BV4&
M1.4>$C+-@M@G)*F5^)+$PTM0G*7MK;'7V4:X=PHM^=B7T6KTV B)WI4=[B!$
MXQ!M4R.M+?MA;D/<=?%)]U*"*HO;6SK$/I5>.*WD<.PT+U-. &2UTI=][?@?
MY;+R\#$W7^LACRY6'<]T&7UJ?+;6^W/1G5VPR$6-6(G#<**8U3L:< KVJZZQ
M-0WI$6+E$"@P7Y6M7P&?_5:'(DJ[U[&/F$NOU=:4X]G"6B::+UQK?XPJ_5V;
M0_TY5;GP;2I<0[)>G[=!YW-'\4.3J8OQTNVJ(\_EII-^/X8,*]!5&J,T?AV!
MOT-6(X*QJEVA/NU65)2[EY>SBX2/YQ%GU?'8\!Z=A2_GGFI@B/;!%[)Q4RT8
MD]</WNE5)7;YBK9]PG2"^3748$.3O,3L&77IKRBF)VOP%N[^-_T[DLDQ-MH5
M(1T<\7MKHTT]OYY\WI;A-.RWIP%FSIZ"=130]81YBW,TP)@&'(#/.!U\M*"N
M=8@8JM+$2DJ,?1&Z4#0UY?/%TMMWNS[/;2L+NFVGH]3@TZE3F^8'.X=(I_EI
M@)8.-'/@7['$0WO-])N[3\FDBI)9,0V',QCQ"AN1Q<CB$C;T2++N]^56#QVF
M5Y?:?1%?-M9.S7K&31W&#I+UBG0T2MT#Q9(F<QET 4:;^+3F[36;5#(WEH?*
MA6[%C-;3_6>.O[1'HX?\H!9!%-L@O\O(I@'V^?!MQBQ"$&/)![3E(.Q*B%:_
M[/I9SY.3GURDA=5>?1X_I*2NC'0GVN.EVR:E<:'%E(F!UP9WLYUO?>-W^19D
MSK3FQNH5 &W1%+EY7D?,]##LFNWNZN?H*:9'S'<,1YV7(6/(//3C@2V!] ]!
M<J9Y/RNCRY?KK$/174H/JJ0E9Z*)+#LY5NEA?DGNMC65V9YN%;8TX,4[.I8C
MHE ;4S3 *H&H4[FQ1WQ'I=" G<*!AD_4&:IIH ZEG5RXQ;X:JTTYTD7G89=V
M9=>D(%M8&'@NT),L.KI+)NO3 !@]' ?@+?I(.+IM:G>#!A3;Y<R+[_)L9O\P
M7)>=UR9HB5"?.Q%IP%NXBQ']DL=Q-$"D"XX]AT$MS'B2=FG 4"Z">\7HXH3?
M=/SC[\I(T\TD4LR>Q7ORS3MUXY8 ;/K)?OI6*5%-BR6A:K\MH["0WI-JYJCL
MZ,)52C34?T_H6>Z$PEIXPRK@<E*.8:AH"/:,!IRQANS_EK[>U!/CG<>]ZP*6
M-9+HT3DHHE%UZ<]&O+_L3[2MA!>(\JEG5"8H,7VK>=]DJ5I(I$%Q/TF][?5>
M.4?'8U:#R;LU0I6+VW>8F/#9TPDOX _!1U OR.YY37E9ZFW^YXXM!!B^31OU
M/\M46Y+=JL'73P9CBV6O]DV3-%)SK=J=W)@=QH3C#@O/;3[^>,+-.!K82YUA
M(G,F36NWP4&VQ# CW/LJJ_#9O=0;>DTI0Y)CM0]_A2\T 4AOHB>NJQ5\C"SN
MC$4>6QP:%8IQE1.L+)OFG'B[\T"]\W==M 3#CR9EZD\P71L]').^I>:+':[4
M*>IQ1SHD?JR-'#C_^8;CF%*1YS-X*:(E863,M&8P1!"+%K_[P>]*'EQU?)QQ
MO6#=X%?P+&AMX,ZAVW^C=:'RGCOR\+J'#%O]5.9@&B#F28BB :7/4-OWD_<%
MH1F0?Y9D@$16]#\9>9H.T./P3FYB\ $1I %+ES 'U9A_X#W"<\E,]?VR"L4:
M:*-W5DE=E36U-Q,W8V(EE9611:CI3!I0!JLG69+%^IXDL$%'1U:"KF03B,*-
M#J4&+%Q.YP^-/AX1\$.V(>-IP&&R&>ERB)8G2\"'M9FAM9GH1?78L8&C\[<\
ME&=>;=SO)1F1=(E=FGC_<++:Y3@M_M]E:1]K+-%R2C8GM0?X=CQ'#*FWYB,I
M(72VD(EIT3A6F[+5;/5HZWM?MTQE>:?(^U3'DZ))XYB)J3($.;&+?7\/00-N
M('.S[2PS^'*,==$?J"=N$6_##O-ZOK0L4K@R:IJU,V79#\]?Y3+2#.G=O78@
M-^P\\3S4&UYPS"%R=Y!F(*H-NL?63@-LF+84MD8V2.]VM"O?P!MEM?SYF,C/
M'M& E;?%+.A?D+GCSO2#VA]:5-X@7MR&)LZ;4T4;+8TT0;7_IC-;?]F?829T
M2F0B3LI%W/[?),O(Y^GGU]'/GYR"#TOUTX!K"J0\:#@"9P'=4QW;(#%:P1?I
M_.XI[E#'T^V$_6VZ>NX5;D)24F$7QRRU\XA\,YV#\Z\M(O#69TJ51[5WD&^H
MO$0$B:DY_9&,O=/G5M_<,6GM@$]KP@K-QL?.8"RP")!=@*QM->;R3LR:WXM.
MOA_R:=LB?8TE_-_LO6I!(:(S&S?2#7_/]4-]?N%"M#I]U/+BOBCG\':D"JXN
MM?ONFDETZNESUKGDP3';*=%$.)5?I .ZA=:E 2AQLMN-:Y12,I12>E_AN+K*
M3'N.6;)P;&&R.!.3NAO6/##, P/W(G$1V95?V!3S>&[ OVK\RDJT]H[8X<U!
M?H2HLFS!7Z(V^6.H->R_W?JDNZG"-."[A^S^-"0-F8&&CT\5J!=E4Y:"+M7\
M7_%J_I_81F,!N#DRBYP@58T76VZ)EBC^^?S/_MK@7_;O8VF*^VF0B<O[?Y_X
M_,6TD/?/4?J'AD']=S0,8('U)X,FY1&5$[.<NQ7OKD/.(2?XR/+T>&Z$=X[;
MP(>%,33@P4?VP8V1A18^;B1.ND51,4@A=I?A5M51K6?^ E<_&$@O0,."0JLR
M\4EZ%;7/E=<R-C4?WK?)YU5S:/I(28?,/27J49NOT"G^6>G?GG1/W[2YG+!/
M3:4!UQ5V]EB%O]1TR<SNWR+7Q[F9I3@E^^C4&^K;96Q?T:!GV'!?+'P?<*$!
MQ!,H+)25_/A+5;^&@AOWT"MM=T_!<7N'*+\"RN1SU'6WK=W9/8;9C!J=KSQ>
MK^&,R,ZM8:W+PC/%R$7T<L8AI'F)1EG^%4I'O6>!!@V(I!C#ZR1WT-JS&VS'
M?L$]72A,Y 8DL1^%A> P%*8*&D!FAN*1GPCT7VFA"[]EC[^DJP[/]0>4_Y*+
M!VA "QR+W&<_Z" ':M8N=)8&G%Y4Y/OISEWJ)+QWQLG99)R$>99A(-]<@3 -
MYC7@JVO+G2:$\B[_I\0]5V$H%."M+MQK;=O?>NS;M1HHOB3L]M CA<_IUL>'
M91U-GO^Z)<"P$4WXLA63<P2AN2=D(!QN:6#\GL\BE-<O6J(D._9?L:F_[/],
MD_S;4HAAKCXUUW!7'X %P9MEX7/%U%X(X:+BP?NO-PJW.OX%4?^/SWG_%X/Q
MPIOM4'/K%R"KI]QH0+G%NOL__G6':25OM9<&B#*U0 G,U?3DS@R5#I'%K*K)
MXATZ3 <6N(>N[+ZN*'MET%M#$, ,(LI9(HGLTSOJ)U(?L5/V=+?6? C*UMUV
MZS.MT$V9!XF?;N7$^)PS\$H<:BH4:<=^UJH\?[O6M _Z@2[:M^PN=EUB=;<Y
M)RZ;FR=E[('1V[.:*+Z,,:%?'YM#%: !OUH0NS.&U',-BAVHHQ=@5P+J[^"A
MSQ4^0$S[/88#"Z7?O.8%FH^<ZH^-SL=+$Q[6$/VQQ[M]=RH:K!T^MI2"9)+B
M*X>I[6U[&A*\LS]?4B-*N[T%RGE2?S0R_]"5"27YV:*UPXD++S<?[6>P@[1.
M)M]J2NVW('=[<O9 L/%D?QIP!TTB/Z0!$:KX*<H-R 8>6;.([(%_^0*#!U(8
MJ"AG\#@-^ J?1IR MPH2-ZB9B%WBD!:2)!^ NEEK>8'QF7?]MTX#.6BHQ;N#
MTH2OQJ$[7^&7[ R<D[&X +B;[F[=<I#2"<5N+X7&]WON'E,XPR1?U$A"^SY3
MA$?E&/)+:,0HI^J+-ZFCZDS%?HA2A9]1LVQ!7(DOV!_&.Z)_&*R?4'>;:I*@
MD[7C&-0JW]2/IA *W0GF_(;@*^V0;2E)K O6JP;N3$B>&@^656I;4%-/R(^N
MG%DM*L[I)=AR&4$?P_@.WMC^R_ZR/^SOBSW]?U<53R'JD']F'X-[]-1XI)$&
MO*XFW:0!PU^G]N5U*2?^-<E!L:*FD=!-?QXPX1A=*XP4[E[YQ[\^,^PL$*#T
MYCBGITA'K>&+;Y"F2"E*:CR,,4"5VIPRM2\F/?B0X0?*!;TGDHX>@E!8+=[#
MVJ>6&PRI9.AW3#:U'[&IK8 H@N^?1BI18E"# 0@*$96(+&V%?X^H)J+V.#>+
MX.24 ,-] @V01!@<?!FB8SGSOZO,P5SPN?"5*0*;YSQ4 ]9&)SVJ;I"=&<0^
M*)0)KTV]94=_%/>&J&9;"ZN&-$"DJIP&'!1SS+00A.Z.RQ+A-S:\D7OGMF3Q
M\,0_@LX*=N=/'^B_[-_'_JR@\R28)W>T3K%UU*RJ@)+<T;R;)NF[4CC4B#7U
M)I@-/GRTBP9HB@7G ($6:\IT2N!S=[^#[M;16Y[#WV[&RW*N.T$S+N0)Q@6+
M?T,?FPJ8Q585?UK*M-K7-(\2F%8V9^+=1286-S&1]<K&9;955]RG@CMKS- 8
M-JA7<L'IV+)<[ARSH_.#2%F%83+\94[,5R]NL'QV9++E-^Y=DZE)ZT]KC>AZ
M:B\/><>0M&C2S'J(Z<PN:(\R SU,I '-^W<'?-\J2/.?6>%-6R]3% H+@UZ'
M?5<A9!8&6%A6-]:GK*NZ)6\V_#YO*C\7FS%N@8CK=(QH5=-7^>&BZD+U=ZY^
M@W^RQ=JB'!IR/E]7I])_S#;=L"D/]5\3=>)_A@B8>P8-J$69PE#_A KJU/8+
MI43,W?/-VL,F^1UXBWXA2=Q.1S05Y,JGF2TU86=YV8A'B?_EK +>'?45'#7J
M]J7ZE^R]QU=2G_O:#N^R]=7(P88^/%(/N-:II<[^B^BS7/.^D/\ITN[RO')H
M;E6_]15DZ?Z1\F]KX8F6^T=!8C W-^?VR4.8UQBCAH$GW<;CGS+YYEXWX *4
MD+V-+#-ZC9R&&>83YZOP]=7Y4LQ(YT-O0_U,8B*EHS;3:, )&N!P/<YRR$S$
MF.!B[198G^>]PV5D5XO/_--W9OQE_Q;VOWDM0!K71679H0'B7E[T1!D#I:2C
M?-S^Z;^G$'.XD^?>R1 %^A_\LA2NY/5D++RLFOQ2@X\&?&%+I4;K[NK^T2 ^
M8;2?JB. VJ'04_5/V#?(IBPQAMKD2!<,^D]H0&4>^;4R?&6?_;?;6THL? Z*
MY_FCULS'=)(4=/,,@DB/89.7="0=3: $4T1#!?\?B,#>@V#J;XH1*<*(NMW(
M._X0O,E(3^\E#A72D*MTG)!!4'Q F7:#[-.MO3#M9&OBZQWG9GH/$L@IJE/[
MNQ%-$S@T.2;(D!)$1Y6/+,080NG"K. &)?@&Q0WS)&%,O%4%EN3DNJ^5A3["
MS'FJ^DC!,XKT/"X@7>G1@[-#R24TX"<E4OD'OC9#+_6\H**&Y8I'JE'I]@?0
M5C7Y"C*<!BRRY<-G*^"MKD0H]>EH*E75;HJ0RTZ%B6 A@[<WJ,]RB/"T;?U_
M.!P\9M(R=_*)NQX-$,PFF3#1 ,A)>$$:AL*@AZ/KLLGM"1_#(2M[QV#&D? J
MW;.OKK0N>O4A+=H01V :BS2 U2/$2&PG?.+[H*=&/T]20G+@],**70X-8"O$
MPO<97*'$-?L;5UH-TI-U/C=UP%3#ME1.1YFT&KV9+G;.K9/>6=S6",\(6,L,
M=/*-%S7^N?J8Z\2G]##]P4<[[XQ\['U!\[6BS/:/?]Q:^8Y\UV!$NA?@:8N;
MS,_3_+3,+#-1\2K[ROCA'U?1"S:(KS1@5/L&$3K-'\I" PP::FOB743E;\1]
MNG3?-_/WL)/9-7WOD96%X<?3Y&ZLF+GI_0))T>S<_#Q_E+9G TDX>F^,RF_1
M0@.VCPZ@\*,0;.7!]TRO_O%8BNF#>!&^A1>"[^?3M>JORRCV+8VHK"9_<!4R
M?*LG(=]QS#T8_D+-(H\XU9JB,OEV32QYU//Z+*OZ-<&7)=%*/TY'S.JZ5 36
MK+Z[V'6OP&&Q1K/^'.G=92--/Z&+?_:BP5_V/WV1YA\G=9'CH_]JHA?QCU0N
M +I*]VQA]@C4*H/30?6MQKX_6E1S/)@>?:TM2X%?(W?[@$L3R#$'JQW(M_3H
MX+3U7[-P4M]H4464MVR=+LE,;F%-OF-@N (]'\ TLQNEP3<Z,;;H<X/+PD#T
ME?XQGU<7Y=))JZCC:A[Z*ESIO[U7-B%<:!\^90BH[YN#R9SIOHSO;SOM1?7_
MJK@LR J&;>Q[9#J\?M4L*C8A/,?'ES\NMQFWOOS,[WG5M!?T4AK.SS&VE23E
MH5@W@=K4J#XT8Z<34;PFSI=" ^@ ,)=04\&^=WB$!F#DK$#X$PB2,7'%<).S
MISSEV!>UW&H&[_B1%>@#HH\%=>K7Y36]KLTFC$?2HQZ_]3M>^T.61=F<R7VY
MA6.VET,3'"5G;-A/FA9\>=_98?&S.'NO/)R81-(@6LQ$(+GS"\0&>#I/O^QR
MN="]K.(AB+>)),LAGM& A04S>N<1U,K@0=!6_U>LJT[/D_Y'%.X(>+I]_K<X
M@9MOS'^0A([3$=1Y&KZW-PC'B=. 8NU_/AE!\&"GAHK =][1>??'_-"%YS2@
ME9<(IL)\H61F&K!B1&_#9=JKL_;O;=CMW KD@C^8IC?3Q_X?9[5/'6XZ$N _
M8XN)GAT4:]#LVX"AF4;F1Y(7-KPZ9QH=J:?1= C=VBJ@ =-TY6K5"&V!L%=
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MX9OJP_!A>?85J!U9Z8^[0.U@V:E/I;=C@SW/-2N.P&Z1/2-GLMM&"J++?M.
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M7EV93.)?:^]YT21AZ?"90?MW3WW^;O\WIY1_NFDTA!"J#??0XVG9[XJT[@F
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M=?0W@S=.V1;6-L&.'R^QKZ'4Z3VT[>EI6_SMY\T2J(CJJ$05_":3]3:=C!$
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MK1, 5#<!4&N3B?^$9F!*2#WM]#)RY#?H69;W2Z7\. K7D!T655JQ](?9:#C
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M.A^Y@76F,G)&+N3,:7N.M,?EIBJ>NO9F<GR>J 7W,55L=>_>5GI]+;7Y,V'
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M$P \D5U@]3EH7=?"@H%0T[F_^K$Z\DAEQCQ_E2V1ST1!EBW/04V0]-1/<94
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M'LL=0'SU:F4&,MJ#(A"PD66W3/ <>9S8+RUE\)>/2,6JHB!QQ!>TIV6;5@H
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M&W2(\R:)$PV),>///C09:'"[*:6165]J7ZU='VP;>$KDMF\.[ROG*K#W,:)
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M[1Y?Y4.<6CZZ\D0S[B!6HZ4,@=7^NJ"C;-32(<&R:.F0C[W"(V!W[E'!UTK
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M,QR19Y<G[-Z=^BR>LYH+!->S^;A DE<8;"]8PK\4S%/9!WCI6"Y 0&\ >V'
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MR'&GX([9F/W\UQXUCI)R+N\.^JV[YWIE<!%H_F43B?,/"\N^:@N_D80BB4E
MD#/M*G88QTN\7:?<7FNNV/&F"/TFH>U\SW/5YL\\^Q*:CTM*1B=^F61#\S$!
M$D4&&M"#&58Z<KF."< &\QY>TZ-D6],;'/B*%%:U(0['49E =7?YR%!8=N$T
M6*LIS(,:6KD^:Q-VD3$*H'H3T94:E<L]Y,[KH(T/>;-6^)W>5$ A=T999)=
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M+>M5E+[AYO[&9#K^T,D[M_9(QO)RE-]'BNJ<<D( D+"KG09%\VNUSO,GW07
MZ1*5ZK='6'45;@2SJ8(4FAJN\6K]8:BC'FZ6T5.,JL>,HI2)A8=+2F+=Z\T2
MEK#'7\H?75L65H;1_J%IG MN)',:M5(9F.U_I?.\AF&P+*_'5)U8W;=*[XWK
M21^X'M]>8=$5[E!I![#-V$Y<!:JI<]@WL ;%YIHPYI+L&145H['>-YE^^K/H
M!](N5MW/LH786[!\.>)FYQXHT82FF$!7R9]"YTP,"9DQ7D('QEWJCY?9H$3!
MUPF!;0[A@9H/.+X&Q]/1I^X*GY$5SY_J!!76Z*\ZPGZ'$T#NJ%T ?D?["_&!
MF5\2_3@L[P_P.^:*?HARWT+7M]AO>,$B@O0ZC&\?.YA'>0IOIX]U&4U_VXVU
MQ79,D*]7@!QDFZ9Z ,'%7G%:\VXE#4>=CY^_:X19IFFZT4!::Y8GKMR2+H!O
M)9;CPT4;4AW#%6M5II:^S 3<*[B=L+J^3) 7-0G;[>==;N;()OU]-PJ4'D_Q
M?@\-81')NWB24X.6?_%[E6O5?:0/N?82)XMP9:MO9M!1Q\@N7YT?$+G!^\9W
M^\2_R/OY2;L>^7A-^)C8?2Z>^]]&/>47\>!1W+);+H:3C,V<F1!>[%X<5Z:P
M!ARD"LE7F(J>](ZP^%KSX8MX,/KADHXFKE%11P3['7%0E0D@ENJ/4J[%YA?4
MHK3K\=HE#6&'C<._DU4>1$N8S*8"VP.7&(5,X*Y'&*XXG$B.:K23ZG7?M*GC
MGV.O2C2JBIY FTI(&-EG #; ;7H>L(*&Y;GQ--*)P(9MQQVBZTTC)%S41=Q?
M^KTM?Z5L,VSB:6UQVBUD/S^[P"_T-3IL&T(,Z,=!!S*N14>QI_;:-"V*(62:
MOK/'O4CQXN6%L.!;']BB8ST-,-XPV* SDK54:#?HU_KIIZ9?HZYU+Q<\2";&
MWCP\;2+<7)S-&2_FP!/HF 4$&< :GD@L!4,GT8_&M;NR S;D00_NLH3S#HXF
MW>-7CU[>^_J]_Y'Z)+AVPYN?O&C""Q1#6CJW-4,:,29SLP%[\3ANQ(^JGC;M
MN(Q[YX]H+.[,6TKGC!UW$]%\RO'ZP;/6'UJW@P5J#"^? 3X(;E?2Q+$3.L<8
MD0^8P '_*TM-KM/B)]:75F0OU5:YGBTH:GKL_3K:\US&<2,R%U_B,YX4:!]'
M(/? BC_Y/"VK\OMR]S5H27R98[8!4J5QT#2<O1>( "0^.!I32LJX(5^TIW']
MZDPJW83,&T:'3>UN2491=O_JQDK%5N6S,5>5AISEX3LA;F9I<>AX7SE9;T0K
MHCY9S6RQXCHU^?.1RLH8^Q@.<EXTR_9>(/WOO87WOW.*?W$DV2&8W23KO8>4
MLYNL >U;=.92)$ '&5%T%0>:$=2+%X%.^-=W<]^_A+@J(A$F/NP1VWU:\=?Q
M5\&^CW?XQ\N5Z *N3=:.#2@!S$GPUQ2WAC:B6>,ZD3O]7?_>(S9MEE_N/.-B
M-=[MO="7"0MS)O)6"3CQKL,KR'5&./H]EKSMU3G-_3N<&O'F6VQ[JFK*^,<Z
M"G>!F:2P LG[%A;XSC&R<^?G3VNWK&&NH\TF<A+?6*#R273EVB?YM<?HDHC8
M\KKCWFYY[?<J#I8J775^9?B-UY[O1>A2).R2]^CVUQ_H.HQ9B_VZZ^Q2O$CD
MMA&TEY2#"J*)@N'&>O)N0<X*+Y;KG<0@:3,.-$T(:J_G [UI:OX.J(]D"!^4
MZWJ0,R!_[*9- <%/(=-KU(K?< _P@+"?D=2M-#1/I8-99!LCDS_(OJ5WJZDO
M;]N^6$&XJ#P6C^BP7'A;WPF;)IX<,J[13VU91/ATX)6LA[@\<X;\S$T)\]]1
MU_Y019:&D"Z3TQ1)<E.F!A(L2/)A76$F4'(B(@OJ153PMA CL<?++[D@N<9;
MWSKY5GZ6CNQEG4RR:#%*AA7B7FH/W&EQ_KR7P+-^Y%\SE8]/T]P.?!+A(7IX
M!'@Y(Y)/K,R>&9*T95]5#A2S0$XF7;Q7S@2&#UQXS>57,:[H+&UX2/-&]C".
MTG/3D2Y8\L!CZ+J\&!-X=Q.,0!FG?#S<X:6+L%_0*+.F1N3\]&0">;65L5,Z
MT6\B?A4H.DX30C9LVEXCS2F^$7\$\5PW=2TTE)O5CXW.*CGN$:ZFO(CGT5)T
M/GG$ZG2-TZBZV?D+/*YS:U%(\D5\*.X05G)I7)7"NA1AU3>GKHZ\V[O7B.B$
M.+XRZ7DF@Q?&5R'6HZ0 B@4U+'W<:54R$7TBH;DQOK=F,N2,U#CQ?/XO/XA3
M?JH-Q0%.S!1%_$%<UO#]4/$A("9Y,/JG<N"KO8PC_ZJT\W[S !6[$.0P^AG$
M!A- 0E$$M]];X5Y!+2)"C# E&"IY$7*UO,C$)C3_5$7$)SOQ'KJ>8*E0F.J>
M@^;"6OPJW01__<:'O,&GC3=PW(MJJ3(IHBI96<_/G>E[\>.)^4\GMCE>\'A6
MF1^BV#+:6M<D<J[E_/PAC[(,Z/S 9QQ9?VT; 1V#H:!R&Q,P_(+.1)?'-0E#
MFC#*T" ;O-!___-A@)J=@YN%MZC"AY! 5LI[V>^I]/.,1*(S\@"V:4),]=CF
M)5;G6YA%K.3W(J-$3T$T\AC2][R[H;]D_(0DV\Y!POQYFZR!E?$/%SAC44]9
MQ!S%Q%'LQ'-:?K %)9 5['BK/3C\E= ?*9J9BK4/&\+EC5^%1MPU$7[!%EHF
MUWDQMIR"HQ^8G^)]@G1"#X^<I^QN+_PT_O+=3R-T?_E1=+PTUVU=*\K''ZWB
M7C7=P4@;F"G@UN\P 4'B\D'BCH8&?0WNSF/.UP=P"+IC@(++KV'_!R]LWQ_=
M9WN^0&^E5<QR(8(NH 1=)$Y7,D)@0&IDA,;CR.?CMD](()E L0]N(UL#V"%!
M^]@<N5N7'VEURRQ*#BBDJD&+1QL9G(2C<.D2Q3KLX/N/FH99]KJ=;%M7!C[@
M&NU@&-X!C]ZRJ@,3>*/JOT7?OP6=QT42J7S%,'*Z\IVCC4BV5-K66G&%&M40
M.\>)3A [#(4.DH48P?=P&Z_E*3#\WW<TPVYQHEPU/$LUT^#.^P6U=@^ON.0K
M<4?.=+Z7O"WA:60OOZHT:$D%R1ZMH5-Q83N^\7G.]9+=M>JBHRC_XJ@ Z4?V
M,0F*1=^&=E48VPE0=!'/L3SDK,I8G#LWDC20)]%SA;(V=,?P#%<,1H^#3%AH
MO'H\&  \8?30Z=B(VC;^'5M@.5,62DF%PN38M@? $8*K=<[*E^G7IJCNQ&9K
M,B63D6B:H/;2XZCIL^)S9F(?[/.J.%Y-6H[W0,.XBM??E UDEWOVM1Y)NN/&
M:R89<E)/P@<S X_\<48ZW93,1DW"3V/#7-7I4JEC&P\_96=R2;<Z/CRDTCS+
M=6R\I@5UN"XF<"X+SI_7=:*>^]LS?Q6+2O"EXLO'NYV80*G#JYCZ^U^(WQJ0
M)R^EC]1\YPB#FB9*(UIP$<CRK4>82P5T)8I$Z%O%Y:4 +YTTZ>M4B@E75-O)
M*;T_!KKKMQ@?F8!'' ?4=M\*=*-K\\;0T0%"P^PIIR.?69\S835YD2]6+"8I
M+'D@O@5C 7'^UO]H<&HZ:LRO!2M3UPL)#^I)RP1=&-8>2#$2O2([?&B%]HT4
M&YI+2$%.PD"-1[5S'[8O->*IDEN6FU"SFN\OJ_%['G(O9OAJ;>)$GQ<9B[\R
MXRC0H]E!P\2R_CA^NC;Y+!F*"Q+F^VDMDVS_)&/[?HHZ5V/ ZCNQ#;C(6TX>
MHM11\&Y)1&!6_XL.O2^?8R_-QH-S];^CXX:T^EN/3/&\S/1WG.HH2-<Y>,R!
M_:5[<5':KD:U8T^3HJ.#PPZKL8UH+TU/#(8'=K)!8W8L$<W)"8O6SZUGD_U\
M!Y[8)W".W=Q;'?],O^*D$]O&#+27Q@1DO .9P!\U" 9G_F?D9 1Q_0C]&@S4
MD^*@R.2Z7]#>_*DE)K ?:I&0/W@PQI?J=]TO<9?PJ>;$$UL[0 "U'>N/:]3
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MGJ-,EP[&<9NA!ING;7GI[\I1G6'])?F[,*NWHB.X ,AY]=1!_F7BE%5;+\&
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M@0,>W]<C]:-Z77>N?@;8<W]SO:+_<.=XRX.%H![\?X"&_L<;GULYE_('[K\
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M6KX??) P-ZO&*&A()1?/MY(6T\!BIHJ4J!"W)_"6<IC]D=-GCUXV^&*RM U
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MM#(J!^\_I1VF/(P57AWA\5SPD>GBPN]] A__J:?C#]P_! ?39<,W,_6(=[A
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M:KM;%4AQW5%@V!8V*)!IA2:])LKJUNLME84JRLD_RMS.;WCA!J8]/6KUKS_
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M]-8.=%5@"E*0MD@QB-?$\2,-&X>4/]0-A=K>5C6X?T![]TW]#J,]8H@>^U,
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MSL#P-.N8BL"=^P:[K->^HX[5PY@J3Q[8TY3;G3OZ&8VV;6L9)I2<PR=UUO.
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M_;6,K].[=IA=PHUEZ67+*A[G\="K]RRMX+[;'KA?;- >Z\R?3]Z2\=%!8-J
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M+1]T<>9&=N9TD=2JC3VL;C.ZM3L2M5?>+NGX :U3Q;2FEAD4O+E?)_"%KHH
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MX67YVZ+1/'5.364%O\OF^2#>0V'+N0M35L+V_9CZ14FL],OZ? X=LBSE#8J
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MNS\2%"!=*A/5MG*A>]MJN"]NZ!9YX=71'?(EKZ]<\,K;,*6YH^M-\\_B+A'
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MG;]6X,TIO?8CS+@K=VP#=A6D-.5>QYFW(C[T;N%Q$UVQVWF7?#[AY@]L=.D
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MUHOOCL<.VMOAHX7$*JQR=&U[E*Q]==F)4*WT<R><RY^&=)QZ<7CEGB-,I[W
M3Q2L>'SP D[5<":4Y:XT>7TL^%?2C&QD1. EG%[T1 K+Y-G]LSLEEL<8+U10
M##",CSCIZ%#F=R+?,QK50CMX[)N-===4FJG5&ZN 8Z:L:T5Z)BYZ1N+9[FJ_
M)OZ';)S]HW(OP'"\4;$@QXN>JJO,[26T@%68A$/,SG).[<&JP2;TI*]FJEO
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MH+DQ$>_R)-KI8 4'XEJ220]N?PL[[6P_J(NZA?NRY6=*_ MKA56#)X^3.ZE
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M8*J2;O*W$S@+/)O.\FATFO3=#S2):MH<,:]'Y5K*^Y_&K2\<OURZ7NL?UF,
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MO\()K].'5Y^JDK-TTB^,4G#EO^L^E2 [VDZZ!;7R#O1A3P*0F7C+,JKB9VI
MUEX<XB!*4M1]L_0^E O:J]N_OI.HE7?=<!=-!M@W$(,,@I4K1TH0<3F"NXR\
M"@WI4JX1P]F:YHV/C-82GO";T IU-^F#NM8!&VK]2F("QZRGXP'^#N$P!3PG
MT80>E&<()07WZ.P;PPH@^4JT\T5I0)%0T-'DNJTNL-!,Y\ZQ+V:<^[=/" R8
M2'.&68MVZ"G!,NJ4#S >V!R?&A4M\P =%;FU52/4WR%BQ6-5G<\2/R2F14IQ
M6% "2R+_.HKVIELY+,@%3HV1C$*'5<'AVQ?BXJU_3WT3]A2I1&S7J7\=%%Q<
ME;3E,U"V]O0J)^J1?M&:!I9=!KQD-6.'*IM8HOJ@+:Y3#T<ZDI91<D^)*K0M
MX#0S,3K@4N"ETSI_$"@F+N9"T+CN?=54]-8'VPEDR-R\<2?Q+%3&]P88#M5#
MJW(/0[E<YN'.*LMQLSSAQ^=2;_7VV'M'^]<+;L>>_HJ8SMF05/XA@!%+/VLT
MI#96W4QN?&-T  H;*43>Z.Y)W@-NF'K7%[DB5@@M%:#XZ;PQB,+_ U86Y,(A
M7#N>"^2*SJ)M'%LZ>Q["-1P=>K\U].BM4?N,IRY9D>J6YQIGF-_QL#5:*)N]
MC'J@-P9 SA-T^#FUUV@HGXUOI@^Z\MRX)6]95W :OXV22-NY2H6:M.31<BT.
MQ^#.IB-6YU6/3'_+.JY[)/=;].ZH3\8&<PCQ8+RF@#Y(WUJJB&R_X7X3!:ZZ
MBZZFL\FL:A:LP.>5OX"N8&&%0M[V%Y"E6;+9GS1T5IMS78VPU^L:<S"5O[]I
MJ+Y2D?YUB&Q^^UO >,>@.4>&TH ?6$8AUB=?+0D_)F)']MH=SL'/I(3?F5\2
MY7<<0(1@S709?V4_M,3D(3P\(1DJ&YTJVEQX"$"_YX0?=7NU9]-0>O$.\C3S
MZ/1\_5AE903QVJ=S.V<P-7UU0B5!FG S=)FHDLS9Y4Z2[-&K!S6;VM4F7S8H
MS9>;;]8W4OJ-DG61B$4)#P-L"FL]G9TR1PAH\M^ O*B,: :]YABI$=);USL]
M; =G3CLYF[A<2"T(RPNK]7I?X)BE[:BQ+5[RA,&2:#7*$MXK2+#6$C8*,37(
M97C8@EI^P[3;TL\CW3]H/0]?%5G>\C%QV)+_,[,W:6UXPB.Z,?8D153FLJZM
M&0LZN*87H2 RJ#T",+[:3<7^II6#.19JDX>9@05;U#[%.4;4^'[]<"A=S9H3
M[K\S42%$50MASJL#(#2GYAK OCV\BVN4:;B]'-[+P:3F^A'LU:_MSM&IK$F+
MN=\!5X8<#5Y&A>KOG;/!GGC\O^7 9=OQ_X8M[40U[^L1SK&,$B#48ZHDC+YT
MLHY::3"?RVL3W*N>Q2#@3S^#N8(HA\K\)ID5K0V 7/4M0V+TLY"=S?<F'_Y2
MSRB_T;"ORWCFY];:P6#Q7Q&ED][VMSB:FR8;EWY0-'OO_'[-B DSGG$\%;WU
M76/MANOQF;[40H!-1>2A0P*=+9(DL!>;*A^ZQZR\!#;IU>O^[:>WY!16YO6'
M_MEL)U49]<1W@1L2;12642-M '@0L[3#* F9(JTXK"@E@YU+ 9V!:W30>1F5
MB9.C:0B;L>@+?E'[H;C'?N-[GE'N.FCT5>J<?IK2>%_\<Q^+P8(V81A&:D0=
ML"8CNF/(A/>('U$^,J0^U(B9EBA[<BNPQN&L#"SSD5!NI  P:)2*UDP8&S."
M5B,APJJJ[\6#";/IU<4/)RA:U9;I<7\6SNIDOSM8E]WKN2Y8_+$H>+<R"C$H
M[S#Z2BOU\DG,<Z Q+KVM0VJ\^ZNO\TA_FY/VD/W';PLZ.<X7E7"@/172C:#$
MR!8'\%?"IDG!.EX;LZW,54Z?.+]F875]2Z-PS4:^14C>N?$Z_'0\WVUHR*?E
MQ= 0@V\;^BY[4\;6)TEO46M1NU?4IPNE5)$WIT/A?#-2 UV9'HQ) EX"TS9%
M&\&@QC<^GIW>_%$>=9M!-#YTSM[//+/ME;V]_7X4Z=Z5K%6*/W OBLK+)I=1
M+Q"DN'/)KV?&B$JEJ0<?'?;W/]3E%&DP#IJ\FVFJ--FI\T(GYWQ8=_ _#5]3
MVV>O89\C5I0JBJ=Z8L/*C_+^%-R!#4;3,S%'P:O>OL.;NOI&RH_\4I'>JC0F
MB2H0;*1F(.X"O7B0/'UK&762NGH9-9X@A9JD_]NA=H M\$))NV64_2H0H<62
MM9/C$YO%?V"@\PA[3!9F2(]0A/*1S&0$]O1ITD1]01' +F75X!G(2&#0O^C2
M$.Y +TT=H89CWGL?)PTRV\%N9[TF#9FN=S/Q3O*XXEZ0.84HY"WY CKR_09@
M*T+L;6TPY_^6ZX0,Z/HJ5W5"^ENUEE1PJ$4. OSKGN?LU?8M8$3DM)RW=CRT
M;=\[A?DJ,%C\[CV:*4)'$6M,: *ZW&%+Y,(%X899'E<!AI,I&=HF2A+F;>0R
MIP$)6"&WD:2#7SW4_Z[.@*CYXK*OX)YPL%M]X4[M_,(%BZ&L7V)+B?N)8<NH
MM:+8< KB'LJA2\C5':2I&N7HE<*/&-!=$]/B[5\VBH6V?$I\&LQ;NFH<6G ,
MD#A[-^SU.7;]OOVY._-\,QNS;W^68!X[C,BS_SR-[!T02AY0;\15_>Y(L'(C
M1CXC>#3C9.!CIBP)Z+X-0=@99&*K6\4U/O@TI]&TOJMIK/'ZP,IU,K&_M0,T
MTE"P*,>Q$@X482HDSYN"HJ)' 57X(%;52OE9L/469KT!2&:8A)T/<_>.;QT\
M.]J[,665+U'H6W@U)4=C];Y5<60&'=I^::J7^YKS*!$D-V(KR=,2)2PHW2VK
MY1,?!YD#08'BK][&E !Y.IK]H,%WA.NJ\QI *BQ/%TI7<RV;@!78((H6,9;K
MT.R:O*39VD25@"W IIK!DJO/MDT')'39C&64*_!>-$S+'BMMS$T^@OL#1B,?
M_!'&0<W<J$:Z=#4.TF9..XZHQ\<=2_N$ER?<'_G6MW3QSV?G@FIO/%MO.N&,
MBA_ZE\54B2SA%];+Y 9\OS;O'$*#@CO2F=,\/V.,@4/GM#"L/,PMUR#\9,0=
M;Z_3#5EOU[>*.5+3$++T%3N$Y_4)*JO)@_L6>(/,"&5OD-X49NELWE#AH)+>
M&-FV\A/OR-3A VX*ZYM>>MP^;_"#H@8P$+QF%R X% 0KXMT0D@&0/A\AN(ZP
MIB:I7T*646M(&!;!W+.GT)-Y/T!!N*%.Z6+4'_?,W Q'+PY?W7;M>%)8@%#F
M)]+6&\+F6.KT*/\0O*N;MBNF@-DRFT$?7$9)3P$CFCW)O-X"NW/MV^?#*X:D
M/PT,FNV]AHJ[-*W,+1%*(4IM%4;T!.(^01+VA-%@H2N$ 1?8184E)4U&*4>@
M>%/G?;/NKW&FAG>O?2@+/[Z!>DM%S#/'\?A>"5@^F7=+0*<'X:'-R:ET]DT<
M>&0VH\ZU*;VT7I9F"/EPMW8X^5A4IZ_Y-A>41>@YJ;M2Z;1NVLU3JCU)"&MD
M*&H7M JEMO!)(76WCA#I&N4EP=RD=8YX[7VL?6_VQCQ91E5_,[_$ L_CIGZN
M1F;+N-(R:@71=^G>LZAONXYNB^'-'VCU!_:@YEFK""RAE"A9XP[TFQO6BJD(
MFOX:Q+>"Y2#\:&''&LAE\B"8X5V]C$K!3_42%W766Q'2C3<:_3BA)/5XR)-)
M QAJ]+/4P9\<_29L!NNY ZP@[],9C4_'K8QNVY_;Y*VA=4R-ETW(Z%L(?>UA
M52SQW4W\\0G9, 3D$OT6;!&H'D58W,5)WA V2VM;LMMQE=.W_4HW)@<DE(SM
M#R*]Z_3] C ^ E6_9[(WA*E82T*QFDX1Y[87$-;&_'S6G%O#L;P<Q:KFW7P4
MA@4O,*?H)9-J9Y7=9\&HIL"1VJL',M.=_\A(6GDN[!?_($B^MDL]Z?5GV*1D
MX$-;]8/JRBPS@_&;XFEPN BCH"@>@XN#-7;R+<> YV0R;#)"3JV M?M<DLL)
M=3T=)]>>LAP]IV.K<37OZH&RN=L[-?<PRX%&Q/?VXWX1*954X?HY8$X&17IX
MQ-^'KQ&,K7:]MHP* M!CE)?43(3@8%,//V"!V6%:BM4[^C^U>.Q</'!D35.<
MV*+#!F;I?V$3NEP6&.:P1!X<$GZR/+:,ZLSUF)0AN0*,<LP$-@S/WSU]%'$+
MSC:8I[O^'@?/CF.[KIRXA =*(:Q3;6WN+3V*:^K7VE:=9\Z$2[!"  ,+NJ$U
MB#L^3V'9!8!R/9H]JVA'C2GXO9#UBU=;4^@ZIZ/E&_J\+=6J6_63!&I^D+87
M 7$2,G3/Z6.+V" <K/MM&?5-#85XB43?$PE#AP74Z>D1SU$R+[W^6*:RF$/>
M%[%!NF?9G(10QK"*^SWY*A!J:93F??/.0NI):'IK&+,@-CPACK%:C]"R>AV-
MLUI"XB&)_A_WP?]WJ?3',>O&U/33JM1GI:'\@S6T[FA+1\-H:?7'5[-][38I
M$+ZZKGWZH%0B07;K;P*B*K2%2K/P#DJ+"2@SPVQA@4^C.Z#]A:ZGMJ]:Z#\S
M5W\[ZL=,R\<H>CB*%$I$^%P"CM0Y+,^]1!9J HQU=';-]3&L+'$OYQ5R7W+-
MX-G8+];RM,@?CD%KIW1\GTT1BSU/E+T(U'L3)UQCP;<B?2"/4E,HU7FW^,2O
MI"Z,!O51N$1KT?;>T;"87[L#$/E;O#]LH_%^>:N8>9,7#:CB?1QD/K.'-,-X
MRF )O)[/D.#%,XFF)5#:O.MZV-G+Z"39+=?+/O#FLT8SX1X]PAK[/07SE"L\
MH+*7"FMT1")^%X,O;KU'??N:!?E-LFLY?@9\VV='R@\5.<S0>CR+SQ)9<5:S
M=]%]?R6-O./BK]2KCTYO'O/? R;EEWM6KNB+K;YZ24Y^LF*_P9+[&P4Q\@A&
M#-(?X>4+4ME&J\?WZ!9-LP*Z+D#3][Y.OC05QU[S[]DU9.C=$FY^O#+IQW#P
MQRB?+_::.FX[CM\ ;7^9AJ:A?A*5P<(1H#'*DF@)A=T--D2X"D;FWACHO4B?
MC3GXFJXV)A6AKA+I<N^R!8"&5:'](U@YQU&T--$ '+Y5YES;_B1D2;/>W%B)
M/Y"];N>GF)\%( XR])T?_&L=]CV[.N1/&,.4/\5SKXHV7$:)K:P9^;>Y_!V"
M(W_/N1-5W2,(E_ <8!P@22!XO8>D0-2#$-ZVTA5*Y:HW>F.2UZJY9E;=B?M0
MTSO*_Z/\YR;!S>?&!P6C'PH$)5!<&6*-2B3IL=AE5!-6W(\0RV^B*5=3?,&O
M[8TQ2Z>92A^ZO4T>'Z697<QX+G7^E0KU3RQ[N,M'N(;!QP+]>:PEKTA<X&>)
M N$'>L6EM_C^^^QV\A2?OPM2%\JQ),<7\CW<ZX@%-]M'%YDF]?,'NGW?ZU28
M')@B!>U6$4>A-@H*@0#6P"3/OIH;6/,6(_82F2:2S(SM]4<XI7J]SZ@Z]-Z(
MBXO,53.!V?F6'FL>;!K]?L2_^%]6X-Z?<KP?_&!_X,DD=]65L4?'[J+32/I(
M']130 >C#*QB"=0[2NZ_OS_7KZ[.7!D8&&RY'Q@2N>74Q]D0_+F\&<\<EP#+
MUS]H]2"Z<58<W@I&4,#9$>K5*H&T75>X^]"AKEUEQQ.&^W0U-FU"*:!/^AS[
M&S8<QOGJWKS-K$#GJ0P,X7W%"HI*(;)P_^3LTCPBK6QVB2U>!-A3^/ZTR>.]
MN^AH4OLR2K7Z6E>T8Q6_K%R_(2QR38%>X_9OUS-^[;8:N3+KKRQ:849P[3X<
MSZ%>3G\$,"RL5Q&/(=P$/5UV*=ZIF2+3QV%.[09,S>IJAUT^:ERT8GHA:/(R
M 0C 9SA3%E_AY8#QU3=QCQ1]'\QC+@,5'K &PL-7D3\CW(@E.8'X:"&9&@;(
M;.A))[P^^)DDQY#YWEZ3!WG>.>%63C\YDHQBCK7"^Z/XFQ!4NT>,032)(AUZ
MPL^Y_LPE^+ML@"B9_332L6XD1"TPCEFK0Q0._BU5BI#K4 U24K$O3)U<Y;VV
MR:=3='5W'S_#ED#]7+G.WF#\ UPJ\K[ :!N/AJC9QTP@ASE1[6C[?VV[5%%N
MPA]TQ#4@DF89Q=\R."O\,Z)LZ@/\35!!TQ=V:^D@7TX7?L2BA9M(;7DT=5 V
MDXOQPDO ?Y!;^Q:Z"*F?$B/?J+L<<'<R?!7A[_!I>. NNK-N,5THC6#U9HJH
M>'0J;X*^M('973VO#"NE"X]@^0B9&##L!7[9WD6'"F[3OPW7(S/OU!ED\!]D
M>P3Y!DTA!%GO-QO+E]]%%^BDO=Z#,OC!@K;AX'OY/(2(5EAPT(*->;0<D2A_
M <REX08-A.]^_FTODE_H_DO"0Y7L990@AX50Y/&74K^WSK'^R8__7$N,8OL3
MA6[W^6> _C &?>E$ NWC/Q=\?&/1>@I-37 9^&Z\C*I!GGV-I+*,FMAL,.,-
MA?'$EE$WVH2L911/$0I81CV^>Q?]*OCO;QFA0!:6PL.WN&W"^@LX 3:D=\&4
M:+*,DM '/LA;6P#,+&0>ETSON6S]X[^6G>K 1\#L&K<'8""=&\""#&:;.@83
M><A%0B AD4-)).D17/^HX#XJ0V=4O=X8$Q\8HG'NJ]=BU]/4BATOY_9OF@Y8
M$WTRQV#06I1_C=S&?E"$A4KO0D8<(U@NMT4H\_GW7I?=IJX*+*)]9\3&KI&
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M\(T_5N:X*(BUD^K^)])^-^,DE5TENSDT64$IP'[&JG:86N3.-P$2]:L0.[B
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M+0(J$&RT"GHP#@YX#<%[N=69U^Y<W=F4??-*8/?W;/&I8?8[V_.MXKL?"Z4
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M$3W;_0K'UQ.U_SE=_6>1QC/!_Z<5'2M/GZ)K $&N"9@7KM/X4:.T(L17)&0
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M^\>R6:Q9:YWG>1S']WN<Q\9BN XL:5%=*:W8<MIR"7/R5F+AC\NIXM]'\S>
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M>G[O:?C@$F;MD"@#$.B)@E'FV^SP%/AQ  ?.4B M!^$&?",!-KJ%XB_UP?<
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M7:H!]>(^)*J<?N'K^#)?[.)Z+\P:OJHVT;8'8+'<@57]-$VD7<?OBQY#@=F
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M@Q;  '0)NC\G>4$"GM9QD!I]PY$T9NTT\/+.KI;]*Y0FQBBKXZ3T-VW3N$U
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M?9 G:\RX>7%ELG_EHAOEZ?FG"OR>I+AG$6)PQ^<?1'+$FL X3#N*",51;A)
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MXX0-O\S\>;*\[O+%MV\5+&*N_SYZUC/8/<)L"@K@Q#-58+-NV.\9='/:LGK
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M="7,>7^X@-/YD4LUC\!'BJRVG[OI6N5Z^MNYVWS[!:):';FLK+_AL;^'Q:?
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M]Y!V$>XBX1"KP$):!RGC$UI(FA*Y4"[9$$3R%)YPJ,;?&XY,'?%G//6/V2/
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MXG+R]IZ9+4Y[&Y.C;)F/1X9':IQ,SSVKIDS*I;>+=^"9?'>)%AR3Z4(KT>0
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M>@OS7(7"I:BF3X=D*^-(G?& Z(EC7&QB:&MN$ J@MG1EC&H"H2WW+[\/-OJ
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M!(T'<;Q5Q*&S5*]S5RWS?FY3O&NV^NGG!37+!6WR"$(7'+]CI62:B80DO>^
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M7TV%.BTSGH@O-OL;5]C68Y_AQ)P[6''UH5][1'!PI/'K^S56UU+-?9Y>N81
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MI_Y;S=52);*IGN,DQF6)*X<T_(J':T.-)'"&!*K4L.<2PNN:?)[\T/5RU$Y
M</M39^W]"HHY.69)O6.9C]>B=75,VQ"M]9748>OB<XGTE1A.&FD1T1@:Q "[
M<:Q8T1[AE\ZR&R"3W]ZBOO97WSLL>J!$O"'SS-VWC>=.9QDMM5LE<$$]H-=8
M"A( C.AX(Q@;*MS?LF_K/$)U<UM.@3Y0EO,TLQI[N*C&->58\ON/44?:_S_J
MW@.JJ:YK%PTB(C4BTDN4JE*B2%%*8D-$7D1LB A1BI0($1$!#=D( M(%! 2$
MH("HE$BO$NFB(B)-:AHVBNQ8XI84[LYW[CG_?[_O/><__[GWC''/&&['(&0M
MUIYKKCF?9ZTUYS1N4Y_SX87RF]KEB2+\8M(FP:O9S>]X^RK"NYB_/O*NBQ7&
M^*]]<B'09WWVIY5?I7F[9&JVH4SB+^Z1C!='9=%DK9'"I V?P:YNU%K>WL;3
M[5OY68)U]HSGYK]"FMMU\_N^?SITX;4=H7CRSG26T@0+P'3 .LEFQPOS'I23
MM*#GL+$XZ+B&.7X\C9Z,E6E7GJB[1/8<11U5.CO<J9:%G41JM#2(="/[9?9J
M_F )-R^<%LL9-#7\K#KD !JP@)X!9*=ES!EHF"G>F19O]#0<V)>K+)&-+\O3
M1M^5\#7_NJ/S3FNJR$HYA\A_0)(1C.+67\6EPIB1&.'/Q$HN< 37\I^Z?I.D
MJYN8/)-1*U]3D2RZ;>T&&2(,,=<M$V_P\]L4X"%'@K1;9C35+QB5T7;E_DI7
MXKGAT/(/E<:F*?:A:CF%^-&[<4X[7<]9@?NF1H^D(F$R^8 T<9VR*,+6[B,_
MZ_D=1;3Q93E-AG2OK"*Z_F"VAP/.+<,^8-N30-7G;>8A'5KBS8EA^]V"I-2O
M;!6=QM(9Y"E]YF=A$L6U++9=$D;<C[QA"UNO;NC#&:CKQ4J  RKN9K;);Z60
M7>5GBQ_X91R4GO5ZK.;TQLJ  !F@7Y!CJ=6#MP!_U.0!!JT'&?_;0V_DQ'YP
M.:K-APXCU%OEYT;6R9V>[9VUSW-&K_1<H2MLKCYW$X<!.CQ-80"5),Q'KL<+
MQS8J)6$4 R8?S>S\Z=^N\,4R);;N]$/!%%"(_N9[,7)BR]VGL?-6XW;P)*[A
MEX]W AK":Y(W 1&2(E%CC+0M_*U!;IL4>Q?SIUZD?F?AZ<)*])UWED>"R@Z=
M/,S*4OF]565ZJ^@HUA<%&2$7^6P:Y_9[N /T;1P"8TI48'^^73'7#!;&L\M?
M))68MU<_\1<K[PJVW*65G'7E5FHN91=;KY:KY_Z/A'@Q_K1U/YW4W8A_U4)>
MI>3$L):?[S3TZ.:93U<1OO"_M>DE[H_U?Q![COYU(^0MQIY?T4;@VD\!'?[_
MR-01CZVW6'H-+C/UDTQIFCAW1SHM'B/OB$%)ZW 888X&CH9S RD)ZA42AQWD
M,C.7-&5F5A$RPG#"XX/\C<**.%]SW(J09^&!$ 0?:")83S2T1?P%*@5&<6$I
M^?;O71B"?%\OF><5.2YYI3];;YE?:V"ORXB8"U(X>3U[>]&SGY0)ED!*#91G
MA?6FZ-/%N]%1-!6,%%3<S:X--QYDN< PNIK%-GYG[[;-J] [;%)J[;5#F]5%
MDUT^4GKRT9H0()#X#"M+!]2LU)=+4H3L#N8:F:$3'!GY[IY3G9,I \6Z!8N<
MQJBIFF_2K1^5DX."HZ/;$_C/ %]*LB/;BP. 3DL7X/?I&V_7GS\[WI.BY +A
M82PHP1,'WWO,S$R]K:G\DMUY^%'BP$F+_-U>RONOJ)4B(HNYIV&<CO5=GHAA
M:9/>YB$["8ED)<QFUP^E@N=P\Q@/*<N!3_'>]+O-;6C#G0<K8V)EW\N]?1."
MLX1!L3;5'QV[BJ@G\Q1:.2^@)9#@VM8*"NI+H,UNCQYX&57V5(!?P([@0-.-
M44..F]BOY1^H6P=&'Y(0'A^Y03\Z<.NI]#)<0TX'*L5#?_@G^7;A9BC=EYDB
MJ^')WM(TRC._I' ^@Q:QSJ]H2]?2R[0W:M5-\L+*FHD0&3S 0O,473B?H'BN
M3<!UT@-&_L")KIUV3_P-*_$1$;*%=SP&U/1?S?]V?CO5>R#CG'RKCNC/[\G(
M(W^39L'3;A_N/JT!Q5,/!+TXN_FE1%>N:7@.9PO$9B8M2\SV!093PETZ&WY\
M_1U+3PU\]W)<TG7OG6VOTG(=22FPIQ->07)*"\1L@W9Q'D"Y95^56B*IMS%6
M]H\/>#TYM)$Y<[%Q5CM]WV;+N [$_0WX7RM4F*70QX$_4J0/.$[P.'5%U&5!
M[/\G)1W_IQX2;&$Z*E$+6/P@=_?",E\1_ROQL9] '827(N]'T1?%:UC_S($F
MKL93NT_4W_E^:FG-GZ+0?Q-#*O('QCKK*/(PQU%:LL;.L^K3^.O'YT>/#;59
M%85'Z#F*[J^M=DOXJU'*-R#]3^KUVD!1_>D?+E_^&1FO(=\&YL0B5Q$>5X O
M>M1= /V],/,!=0R[6!V>M(K8'T=UT@A+*7NP</(G ?F%I%;'%8^_ZF8E!>QH
M/> ;4+W%:_19D70A/,C_4>",\%%G)?*N0@,,*J37EP0$?820CXC'^,_JGY_H
M(<OK@&/ES,'UQ-.C@3RCXH7WO;_1%SZ;C>";-ZCWK:%F2T:+D7JP,Y3NY=3K
M2DNAW'70ZQ> R*_!#_+,G&XG&4B*4S+2KO<%V(!1_%(=\&QAY701X9'Y,/I>
MFMC/X[/KK[V.]6.N-5<(0T0*C<6-=]@+9&G>%ICA4;V<D%"9XPAL_=7/3?*.
M-D(W@T,L;E,;BD^)4>::P](GBC^\G$J\>]XE!H<;[Z6!1W#QV+JCM4P:[,D;
MRI;TP;,L1N$3=G'/6%@+NFMFO]]<^_N?K0:V#3>7I;UCFW,^73LJF5*4:K"8
M]Z^)..BHJ4P.$=I"=X*V XMD=F,'3<K4?5?/['8HJ]*.B99S_?#4?7Y[B\S;
M(<.8'%&_WDB#Y7D>E]\$^".C@ T _2FM)NT%(,KS!+]5LG#K>8?'2MAVL3_Y
M9[<1ZDHBUWW&.TD6#,4T!S=)SQT3_Z+[=V!3 >@0!G,QJ9?2N'NDJ'R+R?')
M>K83;V.,X"A:>->_]D[K*F(XLC*R\K\T4!%>??U^CS!A)>@!-(&O&#+NHDLO
M4-\%] K+C ^M(HXW_G]V=$S) >B40GWA=DJX$\=X%"U,%B- !3HP[T^.WE<,
MUKTO7W?MT@ G0<'WCZA8K\2<;^)*8B)"$/83F" ()$/9ASYAY8".@UAZ.E43
MZU?I%IZ-QRJ2AD^OD&[5B-[Q'#8R?7%[M[IUAI<&_AOPX0"K<0D 8YCH.,$&
MV$S(-%9#!@P;E^.)P^?8UY+8)KTG'DWM['+2LGMDI_O"^>WP9OT1EZ\#?Z/N
MAP[MLD60M@MCSP1R@F&4.D 7!D]\9C0N)K %V#B,=;LPH#F3M:W"L7-"QY_X
M YUMN9S@@0W\0ZG#TN_CJ@D\!2_.5>CU$ZB/PX3?/_TL[SSX?"Q&MS(M_L([
MU9&I614OGZ;IZPR%<=22RVN8BATG3(K3*8LPT!0W% P *D(*FF")NT4T*.6A
MQHM'S&8NLEXUWBR-%FSML@A\.U\\G<A?S\\'Z"6KB&=A2_$L TH\KA:YY,Q
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M[$!9 J;GL;_)7\;6JPA+E/%QWYN5,ZHBO_._M>_HDQ=RA@EH@?$YC:>!7J+
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M/6[9MT/GWD1(+WZ9/%DND-P+7 04('V.)R3'W1V>SW+J12OZ&3S^2D7R#(!
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M6L]8H\L&_Y8C#AIM5Y8:FFYFE31E!F1[(K/ILB8(K,-6REMA8? <WB8<[ %
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M#0Y8ZU\6OW*XHJS!%G'MI,M;R]]+^4P@%@4Z&VESK*'1TJ^*&#4HBY& ;M\
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MSI.PAA@P@@VDB7UI026TZQ#_PNC$T?:-;6F[F7T8&Q&CUOY"1T?,\Z@-_F?
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MHQ'/CQ6QE7KPXB?:;2RZ;NJ,>!9$;->EGO'<3-]A(CWG@N)N^2S0R(<'J8(
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MHX\VR.R=2<L :D?7I\JO].'M6^+RUE4<*3GX-"<X[G+V,>V5(^JIF+I+_X"
M2+426-9F/F[J/STO3A<Q?/UU7TU)[;CU#,<2D?>8M/_^C=D_2=\?DP[>NY*%
MV-1\:$=7$_S&]89)KZYF1/B-F7E/_I9TXO^TI[N_VW_Q5/Q?]AOV7/Z7&KB)
M&.6Q$OGIF%@'>NY'4R!NZV<Y_QL&JTAL( VX6\%V4(D'%_0H$%[ZS)ARL<%?
M^_C^?[N\Y^_VM[5_*6.\=ZEG+'0+.XW]=@,)0\%_NPQ3_@V;$?(L!2)EB0+Q
MOI_A0.9LJ5$@7JG2AA[(W/_JQ_\I@/"[_?W:?P=LP4PSI(K+H>=+J= %.]*P
MO]A<J@.+A#\&CP2MF&D.%!7H&<ID*7"O>-3.V]XABO"]/)""CG,S8AS-S6C-
M.:1EP\6,6M) .ZS<S&$0TCD3#U.\@9PPRH+0Y'_WQ6UHB3* \;4"T2<\2!8X
ME9+%60B(=9\F_/A7OOE-^#?AWX1_$_Y-^#?AWX1_$_Y-^#?AWX1_$_Y-^#?A
MWX3_J0G_ZPZBOUBJ0&@[D%F1Y$_BATR@N)\)MMN062\4"" @_6"E],B[PW#?
MBU';%0BA[HP6@CGD:9]!E>RBD^6&M?XNTK5118691+M* N5 0P0M#JESX,!P
M]W5&2+6GSII#L<\L^EQ1"L[_ E!+ 0(4 Q0    ( ,J%#EL)H6O6#ST$ $L$
M0@ 1              "  0    !E;&1N+3(P,C0Q,C,Q+FAT;5!+ 0(4 Q0
M   ( ,J%#EOHP?Y)P94! .49&  1              "  3X]! !E;&1N+3(P
M,C0Q,C,Q+GAS9%!+ 0(4 Q0    ( ,J%#ELDJ,VY9@0  -48   /
M      "  2[3!0!E;&1N+65X,C-?,2YH=&U02P$"% ,4    " #*A0Y;1S/_
MJ>T#   +%0  #P              @ '!UP4 96QD;BUE>#(S7S(N:'1M4$L!
M A0#%     @ RH4.6[NK\-,-"0  #D<   \              ( !V]L% &5L
M9&XM97@S,5\S+FAT;5!+ 0(4 Q0    ( ,J%#EL<9M]A(0D   M(   /
M          "  17E!0!E;&1N+65X,S%?-"YH=&U02P$"% ,4    " #*A0Y;
MCT$2*PT&  #G)0  #P              @ %C[@4 96QD;BUE>#,R7S,N:'1M
M4$L! A0#%     @ RX4.6[[?F@4(!@  -R4   \              ( !G?0%
M &5L9&XM97@S,E\T+FAT;5!+ 0(4 Q0    ( ,N%#EMMN>:*)4 * $4_#0 2
M              "  =+Z!0!I;6<Q,3<Q,S R-C=?,"YJ<&=02P$"% ,4
M" #+A0Y;%0@D@9\P P""*@0 $@              @ $G.Q  :6UG,3$W,3,P
M,C8W7S$N:G!G4$L! A0#%     @ RX4.6SP1K^8[C $ F%H" !(
M     ( !]FL3 &EM9S$Q-S$S,#(V-U\R+FIP9U!+ 0(4 Q0    ( ,N%#EL@
MXLV-.G4! /O3 0 2              "  6'X% !I;6<Q,3<Q,S R-C=?,RYJ
8<&=02P4&      P # #L @  RVT6

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>eldn-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:eldn="http://www.eledon.com/20241231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="eldn-20241231.xsd" xlink:type="simple"/>
    <context id="C_814f6c12-39d8-48c7-97a5-4f0838b03063">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_81e90e3c-c0f5-4f40-8209-ed87e745d4b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_8221208b-b06c-4f4e-8484-c94ceca23b1b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_82dde098-0756-4a72-8753-5533b164777f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_834dcb4b-a7e6-4a63-a26e-6cacde80edc9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_835f8a45-f710-4451-9172-67b1911d289e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_8667a5df-16be-4759-b647-3b7cea2a8885">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:AnelixisTherapeuticsIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-14</startDate>
            <endDate>2020-09-14</endDate>
        </period>
    </context>
    <context id="C_868ad39e-5065-4cf8-9dff-9d2c9a7d135b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_869cb76b-dd81-4314-8818-8ae015c49078">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8a2e70e3-2ed3-407e-a0af-d1a1cd2c2189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_8a905dd9-947f-4771-b0bd-22e599ecb244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8b40a221-b271-45e7-abea-861aa3e69388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_8bba3766-4964-4ab7-92aa-e8434203d2c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXOneNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_8e654e4d-37e7-47fa-95fa-928b05de9595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="C_903fb9de-3a55-4a71-b923-06cf285c9991">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_90ef02a4-12ca-42a1-b6d6-2dc5a6c517a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <context id="C_91faf8d0-851e-4099-aa01-277d6ae86c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_929233e8-37d7-4ad4-af4a-17c57fc92607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_942a2564-5176-4190-a212-2b973ceb1a34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="C_9451594c-6f06-454d-8721-5fd66258a715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-05</startDate>
            <endDate>2023-05-05</endDate>
        </period>
    </context>
    <context id="C_953b5115-083a-4e43-b335-55592f074714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-06</instant>
        </period>
    </context>
    <context id="C_95a8ebd2-ec0a-42f8-b597-f3c09a2afecc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_96eaecbb-fb70-46b6-9d46-a5b4e45e90ec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_976894d0-7795-4a81-a79e-bce2709115dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_97d0a02e-f66e-4785-bdd9-f6ec23959807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_980b621d-2497-459b-aea6-bca6da258067">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:EGenesisIncCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_985693c8-676f-400c-b568-99fadda31a60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_99d14f13-477d-408b-bc26-79d5db50d8a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_99fb4269-13f1-4e54-8343-39a92e170c3a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_9a124087-424a-4448-9099-a03821a98b86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_9a69091e-a043-4048-aac2-1fd5f048fc3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-21</instant>
        </period>
    </context>
    <context id="C_9b1e52ec-b18a-43ab-830e-8986ff39379c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:GuggenheimSecuritiesLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:EquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-20</startDate>
            <endDate>2024-09-20</endDate>
        </period>
    </context>
    <context id="C_9d1c5679-7ad3-40bf-a3c6-7a10ff14887e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a02b7bbf-5219-43e5-a35f-53b985449b45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a0877070-bafd-4ecc-ba7e-d06767488cad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:TimeBasedVestingRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="C_a101b2be-54a1-4e3e-a107-2e740e2bd083">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a1649612-1e62-4a97-af6c-7dc0028db1ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <context id="C_a19cc353-9e67-42d2-ad34-2b95ddbd1abe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_a32ed886-8fef-46ca-80f4-2e27d332c237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">eldn:OticPharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a38140f4-e70a-4ed0-9849-5332d035c44d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a3a07715-3a73-4dad-aa92-b1e0504bed50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a3d14d16-847d-4ad0-a2c1-7bbc3743fb74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a5a3e2c8-59f9-48bb-8c4e-73be100cce2f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a9a6298f-64b0-403f-9753-1954555ffed1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_aa96c567-6409-4b20-bc86-f6e9b7a82fa9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_aee009b0-e9e5-4357-a86f-519c7e46e328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-06</instant>
        </period>
    </context>
    <context id="C_b10e5573-542e-4cad-822f-93a7ae68952b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_b245d8ef-b745-4fa1-9b3e-7439a1b246db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b289a523-bf02-496a-822a-4cb3cec3e3fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b33d77f0-6276-40fa-bd85-4b5a8ba275fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b526d623-851d-4505-bda0-f3f5d7eef6d4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_b53bd15c-c7fb-4b11-aa17-fa905055dc5f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-10</instant>
        </period>
    </context>
    <context id="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b7466cab-5f74-4129-8342-29bcf1a495a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b96fc6ba-37aa-4cd4-a5d5-3bec6407f9e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_badcfa13-507d-429b-9dee-2e0d08eb9c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bc089e60-cdab-4f8a-b783-246e7d7a6af1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">eldn:CommonAndPreferredWarrantsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c0555d1b-b168-446f-b8aa-3b629d5033dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_c0d65a75-73a7-4e65-8ca9-7aa239bd0a7a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_c0e69edb-7d74-4a88-a331-7063c41b32d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c208ba17-2b6e-4d20-979a-92018e7e32ca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_c2abaa52-1d0a-4fbe-81ab-c8a8f777bb72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c2c9a382-79a3-4da2-9405-110cffced194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_c71a399f-d8f4-4adf-af71-acd5010523cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">eldn:CommonAndPreferredWarrantsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c8bb3042-d8d0-4c46-81bd-3419e2c5ac60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:PerformanceBasedVestingRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-20</startDate>
            <endDate>2024-11-20</endDate>
        </period>
    </context>
    <context id="C_c9c85a29-4958-462d-81cd-61348312f2ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-11</instant>
        </period>
    </context>
    <context id="C_c9ddc65a-8b52-48ef-898a-ad6a8da8614d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_cc04c70c-694e-4769-aaa2-e6dd4cce3bb0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cc736700-2f11-4c70-bf4c-ca225ad3a533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-29</instant>
        </period>
    </context>
    <context id="C_cded1be0-5d08-4e82-82d6-d067b4958eae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cf8e646f-26aa-4125-8f19-71c8b7b07c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d0e34266-9d94-4045-9e3a-77a1916c58ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d2875a70-0df4-4171-877a-c58e658fdb69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_d34a853c-0615-409b-9ae6-5bd5c50e65b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d3633a35-1914-4b59-95c7-b92462feeda6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-19</instant>
        </period>
    </context>
    <context id="C_d3a91ef5-d925-4944-988e-a6b6d2a5d9fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_d4a180ea-02bd-45bf-a264-14e6d8208750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d5073177-cf57-43ab-a425-174fa4e3220b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_d59b82b7-5627-447f-ac66-5fb9c579fdfe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_d6bb14ee-c9e1-48c2-ae0d-ce419b3af00d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <context id="C_d72d64e3-d62a-4889-85a3-c71622485ea4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_d73e41e0-eaac-4f7a-8f85-cc17e8daac55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d77b851a-bf31-477b-8902-1719de442c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_d91ae884-2a3f-49df-8b4f-3a13d684a3c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d9bfbaaa-b100-4fc8-b32a-b4ace9e85c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="C_da4527f2-1073-4974-bdac-4a2aee446741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_dd1985ed-08be-42aa-8575-546c5561d12a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e001cf60-2e45-48f9-8cca-188f9699760d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:OneBillionAggregateNetSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e18de94d-dbd0-4d3d-ba53-59c1f412228b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_e2ccd3a2-63bb-47ec-b90f-f9427e33d6b7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e2f48d5e-c74e-4701-855c-ac8c4f15fd2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_e3e45846-797e-4cc7-afc4-00734dc1c256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e551203c-60a1-40e8-b225-d4b5814f0ce2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e61ec573-6c46-4c35-990d-5570f66dbe16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandFourteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e6ea7a2e-1ed7-4d2e-84d7-ac031499af66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:OneBillionAggregateNetSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_e7daa38f-05c1-4b99-a56a-2c538503eda6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e94a88c0-62d2-43ee-872d-543df3558f56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ea3f0ca6-47b7-45eb-83f1-2f6de59e3fc8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_eacde0ed-4c02-4709-92f2-d1a867f74b43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ead3ee91-638a-450a-b9ec-8e6ef46d7412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <context id="C_ebb38758-a918-4acf-8a02-3282e3612134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_eda51110-4aff-4f77-8d77-cdbe3953f41b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandTwentyLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-10</startDate>
            <endDate>2024-07-10</endDate>
        </period>
    </context>
    <context id="C_ef6e410b-a061-4861-8ad7-1774585b21aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2025-08-13</instant>
        </period>
    </context>
    <context id="C_f0263327-04ec-403c-a565-39214d3f5d1b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_f23c46e0-c8ff-4ddb-ac90-024320e43941">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-30</startDate>
            <endDate>2024-10-30</endDate>
        </period>
    </context>
    <context id="C_f24c5a06-77ee-4dae-8ad5-bc7f8a9e6e82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f4538f07-445c-4906-94ce-ef1f81c11a69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_f48d3944-f038-454f-abca-5e5d8376ef70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_f5e378e9-ea4d-4446-a3d6-8653372fe095">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f5f2d779-981c-4cdb-8478-acd05d3606c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f6739b83-64c1-4196-bfa3-188e64be71c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f6bd4419-9bd8-464e-acfd-beb0e29ce4ce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SeriesX1ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f732926d-a8cc-4c74-8a1a-38d77cf24a4e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_fa6b5f79-cd28-4846-8782-687a801dd0e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202307Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fcab1302-ac86-4137-9866-3e47197201e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_fcf8616b-2c3d-4413-a5ce-5cd91ad0ca6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_fd236f0b-9227-41ed-9c2f-f887ba0032a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_fd5b7956-4959-43cd-b4c5-b1fde759c23c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_fe356c11-e5db-4e96-910b-23f6c7c1d931">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_fef3fa93-e31c-43ff-af41-915dfb55b4a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_00ec3738-b3f5-498d-9035-0c48bdd6391a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0147f0c4-d22d-434d-ab8c-fd254e6c658d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_01c9b5c7-df17-42c2-ae7f-2df53dfe3244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="C_023300ef-3b93-4a2f-91f9-c39c33b9e246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_02359b89-94e1-443c-ac29-3c67769f2cb8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="C_06358e90-5416-4479-9715-a95bcd5b9a71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_0723a7a1-cd73-4940-a506-fa467676eccd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_073a4072-2ff4-4bf0-b2f2-2ca40d8d96dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_07a68ee8-82a0-456f-b6d3-9977f22a230f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_08679ab6-cc43-46fb-afd1-83c5b1aabc73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0b035996-e88b-4943-8f18-048510a13840">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0dc4367e-b5ab-45fd-bb01-b6a7fb4da26f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0dce47b6-63c7-4639-ba01-f701282d1487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-29</instant>
        </period>
    </context>
    <context id="C_0dfa6572-7fa2-4beb-9686-2196c62325d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_0e3da0b7-263b-4845-ab86-210db978af57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_10891653-0f3f-4d75-9cd2-9876d5144cac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_112a5426-12b2-4e40-9850-361e43b7c9ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_11604e1d-447f-4412-9cf1-8945676ed077">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandTwentyLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_123dd2d0-784a-4967-948a-9369c11c3f3a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_126dec65-5fb2-4ba4-8e32-3d122533acdf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_133e23b5-720c-48df-8aef-367581072be4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_135b1839-bc7f-467e-abbf-3856e1bcb1f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_13e69911-29ff-4b45-829c-2ae93e92cdf1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_14e122c7-b47c-4847-aa31-c23b1f2dafec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_158bedf1-d0f5-4588-aa11-06610c5badeb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_1799d415-8c33-49ff-820b-a0512ecbe050">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_19e1b622-4072-4fc0-a0fc-410862aa012d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1cbafbb3-bb44-48c7-9275-169d82fbcccc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_1eb7071c-d34e-4235-bcb4-1e3102fea0ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1edc7735-5746-454a-98ed-a4e3221fb98a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="C_1eef9a49-60fd-482b-a231-9fc95faabb9b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1f217616-88b1-493b-aa9a-fb67de956fa7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1f268d5e-cf5e-403a-87e4-658902565516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1fc4725b-505d-42ee-8598-9b1205ab938a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:SeptemberTwoThousandAndTwentyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2067bb42-a2a2-40c2-9cbe-fb3a2abee295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="C_2091d266-9d3c-4b0a-b436-3f24223bba88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_217e35bf-2776-4ae6-b1a7-3ae6aa8a1aff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_21d6ff86-6d7f-4b9d-adfb-5a4f1d7aa8b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_23b4279a-d29c-45cc-a819-b328ff1a900e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-29</startDate>
            <endDate>2024-10-29</endDate>
        </period>
    </context>
    <context id="C_24109039-0361-41e1-a825-54d3c79fb5d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_254d6b43-9430-4433-b644-3ad4de1829ee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-04</startDate>
            <endDate>2024-09-04</endDate>
        </period>
    </context>
    <context id="C_25aac8fb-8999-48c0-9388-bb4417dbd19e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_26899444-530f-4870-a095-0c5c5401b54a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-08</instant>
        </period>
    </context>
    <context id="C_272a92d8-c7c2-4314-90c3-9d41142b0d01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_274b34fb-7eb0-4bfc-a200-1ceb17964d37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_27edf0db-9055-4e22-b38b-18ca7e450835">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_2a66afd3-0d1f-4b4b-9cb7-38a0c6a60d81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2ae5e0b5-102e-4000-812f-5d62270f8a6d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2bbbd4e0-640b-45ce-a5fe-e896670755b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_2cce5c4d-219e-4cc1-af1c-7a19e05a994d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_2d4f29f9-5681-4ad7-bf0a-2f27534f1c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_2f08b426-f498-4cef-82ca-9a6f0e57cf67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:TimeBasedAndPerformanceBasedVestingRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="C_2fbd8e54-c07a-4e1c-b971-6c9f65cf8c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_306cf456-d3e1-471c-88e6-bff01256a178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_30f84d62-e30b-473f-9c61-8ef1e1832085">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_320ec943-bc2b-449e-8081-892254217c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-08</startDate>
            <endDate>2024-07-08</endDate>
        </period>
    </context>
    <context id="C_32469e8b-bd12-46a1-aa1e-6207f9cfe051">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3599cba8-8efc-4581-af6d-86c0dfa8c474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_368c6272-dda1-47db-a6e7-2d38cfded7e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-06</instant>
        </period>
    </context>
    <context id="C_37cfa2dd-f2e8-40b3-b4ed-4aaa93f648d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3991e991-873c-4c8a-a9a0-9c14307b5dc0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_39ebfb29-081c-4957-9c07-bd845544fac6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3af4da93-98a8-414a-b035-34ccd64d6382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3f5369ce-0e85-4351-974f-ce7061c1e396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_4117a814-e099-4153-b353-7f02194ab5a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-14</instant>
        </period>
    </context>
    <context id="C_412fba80-a3f2-4e2e-a9dc-8ece19b8f909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-29</startDate>
            <endDate>2024-10-29</endDate>
        </period>
    </context>
    <context id="C_41f23dcf-6538-4d0e-8ab7-5ea52de4f018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_41f693fb-c3db-4b97-a334-95618d32533c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_44e95282-fdaa-4791-b948-243de3cf859c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_45654a12-fdcb-4ab8-aa38-1e9adb0677f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_463fd8a9-edbf-489e-aaf7-3a59cf541462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="C_46b5adb0-3c28-4e8a-a89e-80ec27d1c833">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:FiveHundredMillionAggregateNetSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_47180cae-052a-4fcf-aff0-dd86481a6ea5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_471dec7e-d30c-458a-93d0-bda067fa6254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-29</startDate>
            <endDate>2024-10-29</endDate>
        </period>
    </context>
    <context id="C_478dbeb4-70d8-4365-82b4-495e16a9644d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="C_4815e24c-4159-4500-b666-85aff53dcfc5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:FiveHundredMillionAggregateNetSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_482d4d7b-2e9a-44ff-9fde-c5756f5cc547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_48ea6ed9-0d04-4f10-a10e-a2919aae308d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_496b6f07-43d9-4f3d-abc8-59c28e2608e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_4b4a0a48-83b4-4a31-a7d8-6183de985fc4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4c665ca9-bab8-40bc-b5cb-2233b3df82bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="C_4d0808f1-2220-4b2f-9620-f1ac2986d605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4e5c52f4-44ed-4d03-b98e-acba67aad85d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4e98b79e-91fc-4e20-9732-817693c930ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4f05b713-9469-4acf-b62a-b4a410770fdc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_4f78b74c-03a0-4b7c-8ace-e89af1719000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="C_4fc8440b-61a6-4b7b-8aa2-aa0f00a4ad4f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_50d65f8a-54ee-42c3-8b17-0043d0fbcc9c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_50e1d626-a270-4890-bdf3-98ed401c6ece">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_51337a7e-dc7e-43f7-9229-34f04adbdb0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_5139fbdc-2a80-417c-851b-8e6f70ab7358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_534c07a6-4f81-40db-bf98-8c91a0f6d3a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:PerformanceBasedVestingRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-13</startDate>
            <endDate>2024-06-13</endDate>
        </period>
    </context>
    <context id="C_5399ff8f-db17-415f-bfac-019c294b34eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_5479bff8-22b2-4dea-8a74-3bba75d07bd5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_55014fe0-62df-4c18-b96a-3dfee38784c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_550f904f-a665-4c4c-a926-3bccfcba9c6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SeriesX1ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="C_57faa905-6146-4e17-b55a-72db880840e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_5811ade9-283f-4370-8161-f228fe085c9f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXAndSeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_584b9a09-2946-4d4b-8bd8-27f45b3d9605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_58cde265-0a3e-4c69-87c1-a6052820869a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_5953effb-3051-4f13-ace1-184eb0e02dcb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5b4148f0-d4f9-403c-af32-f52bc3bd07f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_5bac50df-0bf9-4fac-8dc9-1288781f48d4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_5dc4d3d6-be01-4bf6-aebf-77b1734fcf32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5e4181d3-32bb-4105-807d-d8ddef98922a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_5fed5aba-bded-4202-86e4-abacffb2f839">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6064f4bc-c353-4924-b4c3-bc53d3720064">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_6081fd86-dcbc-49fe-ac41-4cb855d48774">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_60bed74c-0075-4313-9b4a-3fbb4bcd7484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_625d824a-477d-49cd-8fc7-67814f7675af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_6312f08b-35c4-4f52-9485-e4c1a9839b7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-04</instant>
        </period>
    </context>
    <context id="C_63e0c2a9-691e-4547-a6ac-0d3fdf91d1aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_6430dce4-296d-43c0-8a5c-29414ed1adfc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_647ab198-415d-40e9-bf66-98868d7ffd37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_68b6bf49-13a1-4dad-b84d-1a3baa6fc701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6aa424ab-8817-4180-b5c7-60582405c85e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_6c58a12b-7549-4626-92cd-993c292715da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6e303928-4d0c-4180-838a-ad93da24f889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="C_6e372f90-3029-4434-82dd-cdd9e2a4e75d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:AnelixisTherapeuticsLlcAndOticPharmaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_6ebbbef7-421a-4712-a110-6e65b3cc06a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_70083239-1fc0-451c-a02f-8a7644368a3a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_703721ac-e233-4584-a2ed-617913379b0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_75369811-d279-4dfd-81ed-953e9c67bff2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-19</startDate>
            <endDate>2024-04-19</endDate>
        </period>
    </context>
    <context id="C_7736993d-d675-48ac-bc9d-ee436b89e189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_77fcb03b-d40c-4c83-a674-4d30ef20d74d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_78ce3cbc-2a87-434a-8808-3ae02d70968a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-09</instant>
        </period>
    </context>
    <context id="C_78d65748-c663-4c56-aa09-66c64ed912e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="C_79dd679d-8ad0-49ca-9c6c-b276bb345850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7aba1847-593e-4b0d-b134-5757cbcbdffb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-12</startDate>
            <endDate>2022-08-12</endDate>
        </period>
    </context>
    <context id="C_7b6aa460-03c5-4aa2-a129-7a2742c51c6c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-07</instant>
        </period>
    </context>
    <context id="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7be301e3-88b5-4832-845c-9d8ac104e793">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="C_7c4a8f01-0913-45fc-a8e1-2c98ad756cf8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_7df810c1-d21e-4e6b-a46f-01bf18c4ed77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="C_7e567fbb-8b59-43a4-a885-68d6c65b7935">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7e668069-76a8-40b4-854c-5268227f0ca1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7ebd9556-342d-4273-9d4e-cbafb9ae6e10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_7f10a0e1-7bb1-4217-8c81-fe3de5a1918e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Segment">
        <measure>eldn:Segment</measure>
    </unit>
    <unit id="U_Milestone">
        <measure>eldn:Milestone</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_7944eb07-0907-4bba-9467-ff3806cfd616">true</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_509b0020-a55d-422b-b129-923a0e0592fe">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_f0f2f6d8-6ab9-4220-9be8-9d9463520cc2">0001404281</dei:EntityCentralIndexKey>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      id="F_9a89652e-6946-4431-87fe-50db88208800"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      id="F_7db7a889-a436-4319-b161-e52ce75ec2b4"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_51220781-3cc8-4cb6-858a-6cda531d29d7">http://fasb.org/srt/2025#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="INF"
      id="F_49cee393-18e3-4648-b5d8-3eb7be1b8087"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:PreferredStockValue
      contextRef="C_cf8e646f-26aa-4125-8f19-71c8b7b07c17"
      id="F_5853a7a4-cb72-4798-821a-733264c3ef61"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_eacde0ed-4c02-4709-92f2-d1a867f74b43"
      id="F_c28ce8de-197a-4f3f-9904-8e00f34bd0bf"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      id="F_87be77a3-13bd-421e-9cd7-c93000cef4f1"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_badcfa13-507d-429b-9dee-2e0d08eb9c29"
      id="F_159afcc3-d066-4b5b-b4ad-7e01474c1944"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_c9ddc65a-8b52-48ef-898a-ad6a8da8614d"
      id="F_216519ab-59aa-4af1-9fab-606834bbb418"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      id="F_0af8023e-7ef3-4515-a7a7-678b84c987ec"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_4e98b79e-91fc-4e20-9732-817693c930ab"
      id="F_6bb67e40-7995-438a-8c0a-20c0a769173d"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_25aac8fb-8999-48c0-9388-bb4417dbd19e"
      id="F_c377af31-8b8b-42b5-9eae-9f9fb6815960"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      id="F_c6895469-f099-4775-83e9-d61a31e2f6fe"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_3599cba8-8efc-4581-af6d-86c0dfa8c474"
      id="F_7a49ba59-b1e6-4d93-bc53-ad26ea9e9103"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_b96fc6ba-37aa-4cd4-a5d5-3bec6407f9e1"
      id="F_3ecf4669-c43c-48e7-8139-38d3d48178bf"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      id="F_b7cc2b0b-bf5a-4561-9ed3-8272893f1903"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_d5073177-cf57-43ab-a425-174fa4e3220b"
      id="F_2a99917e-c2e2-45cf-b60a-d41b5d89eba1"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_c2c9a382-79a3-4da2-9405-110cffced194"
      id="F_f2ebfc2b-8b13-4228-bc2d-fad05f7d9efa"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      id="F_1303f048-cd42-4ee1-9b21-e85795fc53bb"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_7c4a8f01-0913-45fc-a8e1-2c98ad756cf8"
      id="F_6bc77dc0-e7bb-4f64-9a27-5fac7e301766"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_5e4181d3-32bb-4105-807d-d8ddef98922a"
      id="F_0dada35c-b9ab-4d7c-908e-93714dd5302f"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      id="F_c911075b-c1e4-44d9-bc77-3ee81c355044"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_6aa424ab-8817-4180-b5c7-60582405c85e"
      id="F_340180a0-3a27-4a0d-8de8-cd273d95f58c"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_e2f48d5e-c74e-4701-855c-ac8c4f15fd2c"
      id="F_cd553f55-0d93-4b97-8756-5443f53b6f9b"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      id="F_aac64cdf-40ce-4e29-82c3-c243c042d20f"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_81e90e3c-c0f5-4f40-8209-ed87e745d4b3"
      id="F_987f1dac-17cd-48c8-99fd-7394ead1371b"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_a9a6298f-64b0-403f-9753-1954555ffed1"
      id="F_f28eec08-2fa6-4243-b694-0b4d71ef0a06"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      id="F_a65f2652-7b7d-4f58-9664-7b9d2fb6a05a"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_6081fd86-dcbc-49fe-ac41-4cb855d48774"
      id="F_3435e4db-2763-4d2f-8c7a-737f3a13270a"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0dfa6572-7fa2-4beb-9686-2196c62325d5"
      id="F_2951b263-900f-4b8d-a786-60aa356956ac"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      id="F_53bb6073-43e0-4db5-9b19-9926bcc63d4a"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_7ebd9556-342d-4273-9d4e-cbafb9ae6e10"
      id="F_0bb67f5b-fcbc-4b89-907c-5702aef7f8c6"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_58cde265-0a3e-4c69-87c1-a6052820869a"
      id="F_586405c0-5bfb-4612-b423-2372508e93d4"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      id="F_bb70f791-1438-45ad-a7f7-20802b5dd599"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_0ff43625-7109-40d7-9376-e45fc443a49f">10-K/A</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_314f8320-0215-4fd7-8a7a-788a446fa044">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_6cd874dc-f20d-4551-8844-d7a2abe9d181">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_84d71443-7e4c-48c1-9904-1ba6d54bc387">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_883c6648-de0a-4474-8026-30a67f47e789">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_164abffb-ce49-445e-8f17-da7aa8b91379">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_573c911a-0960-4433-acc8-c54e3ce18210">001-36620</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_e93c73ae-18be-4e72-965f-ca3d66752850">ELEDON PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_3a579729-160e-4b95-8d00-914e92f7532a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_5db5ee90-fa5e-49ee-a099-f198cf221d8a">20-1000967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_e45890fb-6dd7-4866-9e5a-c6e5baf8ace8">19800 MacArthur Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_e2e45139-d270-4a6b-bfb3-df0e718d616b">Suite 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_7595b205-d68e-4576-b404-ff80dc66e198">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_f8d27dd1-3e24-44c3-abdf-d12d16d4dac4">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_57f1b84c-89b3-42cd-8863-4771abe1c0db">92612</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_8d707af6-349b-4f4e-a28a-7d5db5372ab4">(949) </dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_ab6c9074-04fc-437a-aa02-3087abf38fa9">238-8090</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_528020e1-f38f-4f5b-ae26-07114fb10595">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_76865578-c1d7-41dd-964d-86e019f1b32f">ELDN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_f08a6672-9ad9-445d-9a15-33aca6df55ad">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_33bf5355-c1db-450d-b607-b85d5c2c31f5">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_dc06e0e6-35ac-47d5-ab69-20acd9b77bc4">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_9ef2bd09-c4bd-4f63-b304-e4bd2abb5660">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_8849de84-ad4a-4d0f-ad51-ec5d9492ab53">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_1a4f8560-33e4-45ec-a855-afbce4ec62ae">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_94e1fd86-d4ba-4a1a-8811-6da61532f7d0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_64b9172b-bde3-406e-95fe-fd16f72f865e">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_08edf177-24ca-4fac-b619-c33a8bbad1f6">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_fd74ac3b-4b5b-4600-bd30-cc47a6b56679">true</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentFinStmtRestatementRecoveryAnalysisFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_680ee18b-bde1-49ac-a82c-90eb00577aa8">true</dei:DocumentFinStmtRestatementRecoveryAnalysisFlag>
    <dei:EntityShellCompany
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_a691a516-08a9-4a66-aa21-3bde33639c94">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_3af4da93-98a8-414a-b035-34ccd64d6382"
      decimals="0"
      id="F_ad2cb2f7-f925-4dca-a521-f3bb355dad8e"
      unitRef="U_USD">64885717</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_ef6e410b-a061-4861-8ad7-1774585b21aa"
      decimals="INF"
      id="F_d96c3a31-2b16-491b-9e0c-f565f7a39d0a"
      unitRef="U_shares">59881775</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_ae63a6a1-f721-419d-a209-8487f9cb0e78">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Portions of the registrant&#x2019;s definitive proxy statement for its 2025 Annual Meeting of Stockholders, that was filed with the Securities and Exchange Commission on April 29, 2025, are incorporated by reference into Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K.&lt;/span&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AmendmentDescription
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_14fee835-3207-42e9-8a4f-712b4041c2d0">In this Amendment No. 1 on Form 10-K/A (&#x201c;Amendment No. 1&#x201d;), unless the context requires otherwise, &#x201c;Eledon&#x201d;, the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;our&#x201d;, and &#x201c;us&#x201d; means Eledon Pharmaceuticals, Inc. (formerly Novus Therapeutics, Inc.) and all of its wholly-owned subsidiaries.This Amendment No. 1 amends the Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc. for the fiscal year ended December 31, 2024, as filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March 20, 2025 (the &#x201c;Original Report&#x201d;) to restate for the effects of material errors in the previously issued financial statements as of and for the years ended December 31, 2024 and 2023.   See Note 1. Description of Business (As Restated) and Note 12. Restatement of Previously Issued Consolidated Financial Statements of the Notes to Financial Statements included in this Amendment No. 1 for additional information and reconciliation of the previously reported amounts to the restated amounts.The Company has not filed, and does not intend to file, amendments to the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024, June 30, 2024 or September 30, 2024 (the &#x201c;Impacted 2024 Quarterly Reports&#x201d;), which will be restated prospectively with the corresponding 2025 quarterly filings. Accordingly, investors should rely only on the financial information and other disclosures regarding these restated periods in this Amendment No. 1 or in future filings with the SEC (as applicable), and not on any previously issued or filed reports, earnings releases or similar communications relating to these periods. The financial information that has been previously filed or otherwise reported for the periods covered by the Original Report and the Impacted 2024 Quarterly Reports is superseded by the information in this Amendment No. 1 (as to the fiscal years ended December 31, 2024 and December 31, 2023 included in the Original Report, and, solely with respect to the information included under the caption &#x201c;Restatement of Interim Financial Information&#x201d; in Note 12 of the Notes to Consolidated Financial Statements included in this Amendment No. 1, as to the information included in the Impacted 2024 Quarterly Reports) as well as by the restated financial information related to the quarters ended March 31, 2024, June 30, 2024 and September 30, 2024 that will be included prospectively in the corresponding 2025 quarterly filings.  The Company also expects to file an amendment to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the &#x201c;2025 Form 10-Q&#x201d; and, together with the Original Report and the Impacted 2024 Quarterly Reports, the &#x201c;Impacted Reports&#x201d;) to restate the unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2025 and March 31, 2024 included in the 2025 Form 10-Q with respect to the material errors described in Note 1 and Note 12 under the caption &#x201c;Restatement of Previously Issued Consolidated Financial Statements.&#x201d; The errors did not result in any impact on the Company&#x2019;s cash and short-term investment position, liquidity, or results of operations.This Amendment No. 1 presents the Original Report, as amended and restated to date, with further modifications as necessary to reflect the restatement described herein. The following items have been amended to reflect the restatement:&#x2022;Item 1A. Risk Factors&#x2022;Item 8. Financial Statements and Supplementary Data&#x2022;Item 9A. Controls and ProceduresThe information required by Items 10, 11, 12, 13 and 14 of Part III of this Report is incorporated by reference to the Company&#x2019;s definitive proxy statement, which was filed with the SEC on April 29, 2025 (the &#x201c;2025 Proxy Statement&#x201d;). The information contained in the 2025 Proxy Statement is not impacted by the restatement described herein. In addition, in accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), Item 15 of Part IV of the Original Report is being amended and restated solely to include as exhibits the certifications of our principal executive officer and principal financial officer required by Rule 13a-14(a) under the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350). Except as otherwise expressly noted herein, this Amendment No. 1 does not amend, modify or update any other information set forth in the Original Report. Furthermore, this Amendment No. 1 does not change any previously reported financial results, except as necessary to reflect the restatement described herein, nor does it reflect events occurring after the filing date of the Original Report. Information not affected by this Amendment No. 1 remains unchanged and reflects the disclosures made at the time the Original Report was filed. Accordingly, this Amendment No. 1 should be read in conjunction with our filings made with the SEC subsequent to the filing of the Original Report, including any amendment to those filings.</dei:AmendmentDescription>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_71806869-9f6e-4100-87c8-4df4f85c8c78">&lt;p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Item 1C. Cybersecurity.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Strategy and Oversight&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and data related to our clinical studies and employees, or our information systems and the data contained therein.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We retain a Chief Information Consultant to collaborate with the company, including the Chief Financial Officer, and Executive Leadership Team, to help identify, assess and manage the company&#x2019;s cybersecurity threats and risks. This group identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example, automated tools, subscribing to reports and services that identify cybersecurity threats, analyzing reports of threats and actors, and evaluating threats reported to us. We also use a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;third-party&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; security management vendor to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depending on the environment, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our information systems, including, for example, incident detection and response policy, route risk assessments, data encryption, network security controls, data segregation, access controls, physical security, asset management, tracking and disposal, systems monitoring, penetration testing, and cybersecurity insurance. As part of our information security program, we provide mandatory periodic training for all employees on how to identify potential cybersecurity risks and protect our resources and information. This training is supplemented by firmwide testing initiatives, including periodic phishing tests.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our assessment and management of material risks from cybersecurity threats are &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrated&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; into our overall risk management processes.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; For example, the Chief Information Consultant works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. In addition, our &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To date, we do not believe that known risks from cybersecurity threats, including as a result of any previous cybersecurity incidents that we are aware of, have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;materially affected&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. However, we can give no assurance that we have detected or protected against all such cybersecurity incidents or threats. For a description of the risks from cybersecurity threats that may materially affect us and how they may do so, see our risk factors under Part I. Item 1A. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk Factors&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in this Annual Report on Form 10-K, including the risk factor titled &#x201c;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We depend on our information systems and those of our third-party collaborators, service providers, contractors or consultants&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which may fail or suffer cybersecurity incidents that could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Governance&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board addresses our cybersecurity risk management as part of its general oversight function. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;risks &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_e97c9497-644c-41d2-8b38-af23bcbf74a9">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_e98dc4d9-9626-4195-a2a8-2d9e88b0f906">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our assessment and management of material risks from cybersecurity threats are &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrated&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; into our overall risk management processes.&lt;/span&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_69d2104e-354a-4658-b6fa-5fd6ad0ed0af">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_d109f845-d4d9-43d6-b23c-b65558e02dbc">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_dce23013-1974-4fa0-bc83-33bc4066e486">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_a65a0bf6-b2bd-4b3f-9993-db7028aeab45">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_e3420dda-c0ee-4942-a6f6-63dc8a2b1f8c">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Governance&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board addresses our cybersecurity risk management as part of its general oversight function. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;risks &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_2b514667-7ccc-4c2a-b4a2-d7f8ac933f69">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;risks &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;from cybersecurity threats.&lt;/span&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_5de1dd25-9bf1-45c4-a9fc-7942b03ca187">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_2ed960ef-b957-4a05-aaa1-a2fb676698ff">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_f6e58ff5-f0ce-4854-a469-39a67d4af9ba">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_791ef562-86cd-465c-9081-bb232a82bc43">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.&lt;/span&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_6c78b257-0bc1-4b46-9bd9-5e1a9fb178f5">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_eab47a41-4d18-4eaf-bf9f-2c0cc191de73">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f"
      id="F_70daaf9f-17d4-414c-9859-6775f1475cbd">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f"
      id="F_fa3681eb-4d33-43c5-90f0-7f756e385b8b">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f"
      id="F_87b77f6b-cd7a-407d-bd61-9ea2b04acfdc">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_a5496bd4-2db9-40ae-a1c9-e794f1615a0f"
      id="F_26b42070-4a38-4aaa-9f20-5bbb2c36768a">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_bc323d64-f566-474b-8998-db7c266905b9">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_28d5f453-25ec-4b58-a82a-b8058765d103">173</dei:AuditorFirmId>
    <dei:AuditorFirmId
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      id="F_39bea8dc-acef-45cb-8713-fe8bacc8fd52">170</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_237bc1c3-351a-418d-b095-6ebfcf230aa3">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheet of Eledon Pharmaceuticals, Inc. (the "Company") as of December 31, 2024, and the related consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders&#x2019; equity (deficit), and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Explanatory Paragraph &#x2013; Restatement&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed in Note 12 to the financial statements, the 2024 financial statements have been restated to correct a misstatement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basis for Opinion&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Critical Audit Matter&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.  The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#ff0000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Classification and Valuation of Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As described in Note 2, Summary of Significant Accounting Policies, and Note 8, Stockholder&#x2019;s Equity, to the consolidated financial statements, the Company accounts for issued pre-funded warrants either as a liability or equity in accordance with ASC 815-40, Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period with any change in the fair value of the warrants recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. The Common Warrants and the Subsequent Closing Warrants (as defined in Note 8) issued in the 2023 Private Placement are liability classified and recorded at fair value&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;using the Black-Scholes option-pricing model at issuance, with any subsequent changes in fair value recognized in the consolidated statements of operations. Determining the proper classification of pre-funded warrants as either a derivative liability or as equity instruments requires significant management judgment in assessing the specific terms and conditions. The valuation of the derivative liability for liability classified pre-funded warrants also requires management judgment in determining the fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The classification and valuation of warrants was determined to be a critical audit matter because of the complexity and significant judgment involved in determining the accounting for the pre-funded warrants and the significant audit effort, including the use of specialists, in assessing management&#x2019;s conclusions and inputs to its calculation of fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our audit procedures to evaluate the classification and fair market value of the pre-funded warrants included:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Obtaining and inspecting the securities purchase agreements to evaluate the contractual terms of the pre-funded warrants.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Evaluating management's technical accounting analysis on the classification of the pre-funded warrants.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Consulting with specialists on the classification and valuation of the pre-funded warrants.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Developing an independent expectation of the valuation of the liability-classified warrants to compare to management&#x2019;s valuation.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Consolidated Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheet of Eledon Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) as of December 31, 2023, the related consolidated statements of operations and comprehensive loss, convertible stock and stockholders&#x2019; equity (deficit) and cash flows for the year then ended, and the related notes (collectively referred to as the &#x201c;consolidated financial statements&#x201d;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_09c7985a-ba50-4650-871e-a2f38eadedaa">Crowe LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_191f7a1d-f0f2-4883-a8d7-a7dc5ffc45b2">Los Angeles, CA</dei:AuditorLocation>
    <dei:AuditorName
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      id="F_fe1c0535-66fe-4cef-96ba-31eed1f3623f">KMJ Corbin &amp; Company LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      id="F_a1dbea2b-9057-4e14-8146-b6bcd9ce2622">Glendora, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_6f8df1bd-07e0-442f-b3d2-085c969abb1d"
      unitRef="U_USD">20549000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_1908b2bb-7a23-45a1-ad0b-1f15a307209d"
      unitRef="U_USD">4612000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_956ff5cc-2cdd-498e-98f4-002f47d8b921"
      unitRef="U_USD">119629000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_6a75f223-97a9-48d4-ba40-2d621370488d"
      unitRef="U_USD">46490000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_5bdd7e26-1363-4418-b7aa-3a6006d41e94"
      unitRef="U_USD">3552000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_f48b62c8-7279-4a6f-8628-0c149ad35d64"
      unitRef="U_USD">5027000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_f9e8c848-c6a8-4b4d-95cb-95b88fe5adf9"
      unitRef="U_USD">143730000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_1a16807c-92bb-4aed-b798-86554a423c37"
      unitRef="U_USD">56129000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_06149a75-5238-4750-8174-b7c198dcea05"
      unitRef="U_USD">926000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_bcfdf2f6-6156-4263-a3e8-fd00672c2017"
      unitRef="U_USD">365000</us-gaap:OperatingLeaseRightOfUseAsset>
    <eldn:InProcessResearchAndDevelopment
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_12a92682-ce69-4050-bc72-97830e341c4f"
      unitRef="U_USD">32386000</eldn:InProcessResearchAndDevelopment>
    <eldn:InProcessResearchAndDevelopment
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_f734c20b-75cd-4057-b109-8ae0794496c8"
      unitRef="U_USD">32386000</eldn:InProcessResearchAndDevelopment>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_41caf978-8139-4341-8cf5-6b5b324118c1"
      unitRef="U_USD">363000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_32d402ea-4778-4548-9dc5-ecc2dfd30f9e"
      unitRef="U_USD">186000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_9b119ac6-c7bb-4249-8f72-dcb26380c851"
      unitRef="U_USD">177405000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_9c4b6dc1-192a-4011-8b13-4c7987ffb08f"
      unitRef="U_USD">89066000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_6352198b-a33e-4463-899d-b540a81edb6d"
      unitRef="U_USD">5833000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_7bc22f53-b94b-40f2-ac78-8b56832f72fa"
      unitRef="U_USD">967000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_9b5f2506-7146-404e-8bbe-5a3bc518a60f"
      unitRef="U_USD">314000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_108f0cdf-fa5f-435a-9f48-8e66bfd36bc5"
      unitRef="U_USD">383000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_8dcb8c94-5ef4-4f32-94f6-afed44393d5e"
      unitRef="U_USD">5430000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_b4de91b5-dee1-4cc7-9b61-28b10daa612c"
      unitRef="U_USD">2545000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_a8b84219-e90b-4648-bb89-528fc9ca6ab2"
      unitRef="U_USD">11577000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_77c94b1f-921b-4f50-8659-88bf59dd0e17"
      unitRef="U_USD">3895000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_2338d0ab-5c25-40d2-b8cc-e8726e2c1823"
      unitRef="U_USD">2183000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_579742ef-0e6e-4f73-a3de-bc1c2af41632"
      unitRef="U_USD">1752000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_46900c23-675b-421d-a14f-1a71583dd00d"
      unitRef="U_USD">640000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_a4759fab-8a83-4fab-827c-bfa98c8aa4f1"
      unitRef="U_USD">44865000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_39ca4604-b05c-4156-8bab-3720206fe902"
      unitRef="U_USD">76211000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:Liabilities
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_e833f28a-6940-4cfb-bab9-3b199ae3f2be"
      unitRef="U_USD">59265000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_cc99b33a-e0f0-4487-a7ea-b97baf7c0732"
      unitRef="U_USD">81858000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_217e35bf-2776-4ae6-b1a7-3ae6aa8a1aff"
      decimals="INF"
      id="F_37a035c0-dfeb-431c-a547-567568509610"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_d33d6a34-ef75-4224-b889-4ea42b34557c"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_8273b344-4683-4b6f-8285-65c3a89537b0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_f966ae95-1500-4239-b8b8-8b477973cc51"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_d9b7e732-7a9a-4309-a397-7f837dd21265"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_a07000c3-5011-4e74-9685-8c4b7aba4935"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_fb0a5930-0106-4f75-883c-99f66c2718dd"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_71d03a4f-7ed9-4a75-a261-ead672c32370"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_9ccdad73-24b8-4463-8300-2b701792fbca"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_161385ce-506e-4980-9e6a-53123ecb1eee"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="-3"
      id="F_e2d586f5-fb52-4f3e-884f-21236443d1c9"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="-3"
      id="F_f67006eb-3f17-46d4-a253-8b5ccb72cde6"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_c9a48cd1-e7cc-4f70-87bc-6c20b80d6b74"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_4ea7e820-97a5-4d28-9787-0c4dd570c34c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_1a099c11-f99a-4476-b55b-60ce94a93bc1"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_fe088520-43e1-41ad-9136-6ed63a003c16"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_cb75b510-f58b-4208-912b-61ec20874fdf"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_2fd4b4b4-6af6-4166-9d57-942406b5a55a"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_d11f5400-4632-40a9-805e-fc073c06358b"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_19cfa5da-6ace-4693-8e98-8b017e7ac1b1"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="-3"
      id="F_25e9e52f-4e41-437d-969d-c715615c1a8f"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="-3"
      id="F_a1ee4ddc-3ebd-4a65-a14f-26e76f741fe7"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_5fa65db2-2585-4631-ac20-46b61ff6bdee"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="INF"
      id="F_917da941-bbc4-4a41-884e-24733db66a32"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_f5fbf1b1-f01b-4cac-9be2-08625653b8d1"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="INF"
      id="F_3bc403cf-c650-404b-aa4a-5755537e792c"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_ab499240-2651-4a96-b26f-f934ea9ea8a4"
      unitRef="U_shares">59789275</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_acbbd2d6-7e01-4e7a-901d-0e4058de56f5"
      unitRef="U_shares">59789275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="INF"
      id="F_a88442d3-722c-4be9-8225-348b9b1a0472"
      unitRef="U_shares">24213130</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="INF"
      id="F_af2b9e89-9e84-4287-bc95-f32e0960b3ec"
      unitRef="U_shares">24213130</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_90ce1e1d-9238-4271-a9c1-35ed6b6ef692"
      unitRef="U_USD">60000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_a5fe4e60-0806-4d2a-9cc0-09b34a5f9671"
      unitRef="U_USD">24000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_31066fba-87e9-4e98-9a4f-4fd42e67292f"
      unitRef="U_USD">417946000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_35f904ea-fd38-49af-8b3a-62a5a56d40f2"
      unitRef="U_USD">270892000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_05553df1-6a94-442e-836b-7e7d634d78a4"
      unitRef="U_USD">26000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_1540b00c-829e-450d-8ceb-5aa35822f80c"
      unitRef="U_USD">-355586000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_a01c4fed-dd1b-4568-a666-782450b17ec5"
      unitRef="U_USD">-319402000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_0c95f407-baea-464a-a507-34a2119dd4fc"
      unitRef="U_USD">62446000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_97e3f323-9b75-4bfa-8ace-625b5369af86"
      unitRef="U_USD">-48486000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_c8676d41-f96d-42c5-a57e-aec15488d237"
      unitRef="U_USD">177405000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_1dafdfcb-42e9-487c-8085-5a7359823239"
      unitRef="U_USD">89066000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_2d05347e-9c92-47ef-8743-2cd8d03c7fe7"
      unitRef="U_USD">51964000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_7ce8ec93-08e3-4e8b-865a-777e9d4f6b3f"
      unitRef="U_USD">30312000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_3b793163-4600-41da-811d-3c3bf5d8c39f"
      unitRef="U_USD">18613000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_f48c5164-4ca0-4be3-bd77-0cfaa3bce718"
      unitRef="U_USD">12688000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_b2224f0d-179d-4372-8ba3-60333d591745"
      unitRef="U_USD">70577000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_a90405ac-aec2-4b55-8633-0e10cc5b598c"
      unitRef="U_USD">43000000</us-gaap:OperatingExpenses>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_b9ed97ef-8086-48fe-9281-12d8719e660b"
      unitRef="U_USD">3924000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_bc422591-4686-4e72-9306-1c280e23a039"
      unitRef="U_USD">2674000</us-gaap:OtherNonoperatingIncomeExpense>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_585793ae-896f-4acd-af74-99000ed0a6e3"
      unitRef="U_USD">-30900000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_6d97d5fc-367c-438f-b82c-07c2b71be235"
      unitRef="U_USD">76211000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_135e4d92-0aa3-4fa7-bcba-60baa4882968"
      unitRef="U_USD">-35753000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_b7b366ea-3a42-48e6-83ba-a1b07bc06b4e"
      unitRef="U_USD">-116537000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_5f7d8c35-56e7-431b-aac0-522fa4bc46ac"
      unitRef="U_USD">431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_1653b45a-6239-46cf-b46e-becbf1dee545"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_21a904bb-85c2-4ed1-a779-f6fd440e2786"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="2"
      id="F_47cf2248-dcc4-4e56-8826-707476784fc0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="2"
      id="F_23817ed7-b2f8-4646-ac2c-b9654798881f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="2"
      id="F_b72f65a8-b7a0-4959-bcc7-9581fd57e8ef"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="2"
      id="F_20878036-9008-4bb3-a6c8-544a70e6ff29"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="0"
      id="F_98ce297f-72f5-4800-9f25-c04814f7c11b"
      unitRef="U_shares">48543787</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="0"
      id="F_48e48405-be63-43f5-a6b0-cb4f65f7dc60"
      unitRef="U_shares">48543787</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="0"
      id="F_749ad1ab-17d7-46fe-9f02-52f97219d59d"
      unitRef="U_shares">24619197</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="0"
      id="F_95aab2d1-e11a-40fa-9a94-b97b4e3155be"
      unitRef="U_shares">24619197</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="2"
      id="F_621a7e3d-73d9-429b-9175-045e6b26360f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-36.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="2"
      id="F_cc3f500e-089e-491a-87f2-3e028f06bd37"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-36.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="2"
      id="F_ef495554-bba2-407d-bf93-5c9c3d9de31a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-207.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="2"
      id="F_23bc2ec8-ea73-45e6-ae6a-3a310fd83c8a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-207.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="0"
      id="F_93a77664-9e5b-4e96-9f30-0c74d695aed8"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="0"
      id="F_9ebe5e9f-eeb0-49cf-8bf5-c15f0c30e6ff"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="0"
      id="F_4dbd12e6-35be-40ae-8930-e8afeea80567"
      unitRef="U_shares">118268</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="0"
      id="F_0120be94-985d-454a-bb45-64ecdb90c880"
      unitRef="U_shares">118268</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="INF"
      id="F_3575f098-81f7-46e7-804e-359c58af10c9"
      unitRef="U_shares">117970</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="-3"
      id="F_fc07868b-2059-44f2-ad6d-bdd1dc04e178"
      unitRef="U_USD">57378000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="INF"
      id="F_ce8723d0-5380-4145-8e80-e4714c47a165"
      unitRef="U_shares">6204</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="-3"
      id="F_f7fab98e-63b4-439e-a26c-9039b4073a08"
      unitRef="U_USD">3017000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_625d824a-477d-49cd-8fc7-67814f7675af"
      decimals="INF"
      id="F_523f3521-4cca-4684-af16-aff8532b14bb"
      unitRef="U_shares">13776788</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_625d824a-477d-49cd-8fc7-67814f7675af"
      decimals="-3"
      id="F_939f1bab-21ec-41e1-97aa-555a55a9993d"
      unitRef="U_USD">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f48d3944-f038-454f-abca-5e5d8376ef70"
      decimals="-3"
      id="F_631fb343-f47e-40ef-93fa-1f07f1e2ed34"
      unitRef="U_USD">226639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_da4527f2-1073-4974-bdac-4a2aee446741"
      decimals="-3"
      id="F_002b3409-6378-4410-a21c-70cbacc035df"
      unitRef="U_USD">-202865000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_703721ac-e233-4584-a2ed-617913379b0c"
      decimals="-3"
      id="F_32b306fe-2533-4501-a7b0-05e35d9876d7"
      unitRef="U_USD">23788000</us-gaap:StockholdersEquity>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares
      contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97"
      decimals="INF"
      id="F_c84fdb52-f163-4e03-a6a6-7c79d7c91332"
      unitRef="U_shares">8730168</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97"
      decimals="-3"
      id="F_3727e2b9-78e0-44aa-91cf-34db11dd6bba"
      unitRef="U_USD">9000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_0b035996-e88b-4943-8f18-048510a13840"
      decimals="-3"
      id="F_3f9d8551-dceb-49f5-bd7a-c19b6e60ccc1"
      unitRef="U_USD">33008000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_a3e5e067-a56c-4fa5-b4a1-1fde41bd987b"
      unitRef="U_USD">33017000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares
      contextRef="C_9a124087-424a-4448-9099-a03821a98b86"
      decimals="INF"
      id="F_23e0a552-4347-43d8-8ceb-311a3c6d1044"
      unitRef="U_shares">-1782</eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue
      contextRef="C_9a124087-424a-4448-9099-a03821a98b86"
      decimals="-3"
      id="F_280e040a-19ca-45e5-b356-65b8aae3a832"
      unitRef="U_USD">-866000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares
      contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97"
      decimals="INF"
      id="F_6ab54fe7-7dc0-489b-857a-1fabceed0b65"
      unitRef="U_shares">99000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue
      contextRef="C_0b035996-e88b-4943-8f18-048510a13840"
      decimals="-3"
      id="F_63870446-a010-4fa7-a3ac-45031374c460"
      unitRef="U_USD">866000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_a259d38a-274b-464e-a283-bf92b21e1492"
      unitRef="U_USD">866000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockValue>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares
      contextRef="C_70083239-1fc0-451c-a02f-8a7644368a3a"
      decimals="INF"
      id="F_c53e0e6e-8051-459d-a0c7-b5411d4ee912"
      unitRef="U_shares">-7884</eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue
      contextRef="C_70083239-1fc0-451c-a02f-8a7644368a3a"
      decimals="-3"
      id="F_6829c7e5-bf74-4887-bbd8-359e04ed0530"
      unitRef="U_USD">-3835000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares
      contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97"
      decimals="INF"
      id="F_d41e7506-7fa4-4d56-9fed-eb0afd8e8c57"
      unitRef="U_shares">437977</eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue
      contextRef="C_0b035996-e88b-4943-8f18-048510a13840"
      decimals="-3"
      id="F_ac92b5c0-4ffc-4fe9-872c-208b556e8b34"
      unitRef="U_USD">3834000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_24ad16db-ed6a-4fc2-8006-e84c8c665f1d"
      unitRef="U_USD">3834000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares
      contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97"
      decimals="INF"
      id="F_3d09ebac-4866-4719-addf-58e29a05cea5"
      unitRef="U_shares">1154197</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue
      contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97"
      decimals="-3"
      id="F_9dadcb91-145d-4996-b635-c620e3e317e9"
      unitRef="U_USD">1000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_31b34de9-6a17-4422-8468-d737bed3bfc7"
      unitRef="U_USD">1000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="C_3f15fecb-ecce-4a98-8435-f2cbfd0d6e97"
      decimals="INF"
      id="F_74a7f9ef-7ad9-464a-82e5-9a7f327598db"
      unitRef="U_shares">15000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0b035996-e88b-4943-8f18-048510a13840"
      decimals="-3"
      id="F_d4a99e88-350e-4c33-8848-f964f4ecdaa3"
      unitRef="U_USD">6545000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_98d1bdb0-4d36-48a4-a8ac-ccc63debf5f9"
      unitRef="U_USD">6545000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_0e3da0b7-263b-4845-ab86-210db978af57"
      decimals="-3"
      id="F_bebf4141-ed42-440b-ad93-34e74eabeac2"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_7835df00-b7f8-475e-a065-380747f29a05"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_5c735aab-8288-42c4-9177-ce9f6dc66f56"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="-3"
      id="F_40e7f747-fe58-4d60-a07f-e99e43df6f00"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_440e6118-ce50-4935-b77f-6ca627c67bf7"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="-3"
      id="F_15ec244f-b416-48eb-bd9e-b3198065906d"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_24109039-0361-41e1-a825-54d3c79fb5d1"
      decimals="INF"
      id="F_cdb87fbf-4145-444d-822f-9fc1195c4410"
      unitRef="U_shares">24213130</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_24109039-0361-41e1-a825-54d3c79fb5d1"
      decimals="-3"
      id="F_a202c385-eadd-4f6f-a132-a9aab3e2b43d"
      unitRef="U_USD">24000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_985693c8-676f-400c-b568-99fadda31a60"
      decimals="-3"
      id="F_5ac1b208-963d-4814-af5e-59f3c309d87b"
      unitRef="U_USD">270892000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_aa96c567-6409-4b20-bc86-f6e9b7a82fa9"
      decimals="-3"
      id="F_9c09f361-821b-470c-adb6-ec2a1925805f"
      unitRef="U_USD">-319402000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_5c47fcd1-3146-4026-81ec-e12b70308417"
      unitRef="U_USD">-48486000</us-gaap:StockholdersEquity>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="INF"
      id="F_0fe023ff-1561-4a81-91a0-ce0d0a8eec83"
      unitRef="U_shares">13110484</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="-3"
      id="F_ba599328-80a5-4d61-8fbc-a75a09eb0f66"
      unitRef="U_USD">13000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf"
      decimals="-3"
      id="F_e5eb3f52-69f8-4192-843f-46b1c25216fa"
      unitRef="U_USD">48051000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_697b370a-375a-4351-b18b-1c221940b6ce"
      unitRef="U_USD">48064000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="INF"
      id="F_526ef8b0-8476-43e8-a4a0-2b7405488bb2"
      unitRef="U_shares">2636488</eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares>
    <eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="-3"
      id="F_f037c323-1ab5-4a3a-bfde-6738a8cc1006"
      unitRef="U_USD">3000</eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue
      contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf"
      decimals="-3"
      id="F_1ebad9d0-da48-4cdb-bb39-2e70b82d4691"
      unitRef="U_USD">6152000</eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_8c373bcf-dc60-4454-94c2-a3cc741bd7b5"
      unitRef="U_USD">6155000</eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="INF"
      id="F_3cff72f3-eb50-4d02-b6ff-23f36a44d5a1"
      unitRef="U_shares">1423000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="-3"
      id="F_03c5d9f8-1eab-41ca-b142-161d8c65e22c"
      unitRef="U_USD">1000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_6b3e6ab1-b397-4330-b8c8-62b8e20301ff"
      unitRef="U_USD">1000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue>
    <eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="INF"
      id="F_4b6f222e-0edb-483a-8661-f4ea996f90cf"
      unitRef="U_shares">18356173</eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares>
    <eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="-3"
      id="F_d14b5904-d27d-43ca-bfb7-fe540e029788"
      unitRef="U_USD">18000</eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue
      contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf"
      decimals="-3"
      id="F_04995872-45d5-4447-8594-cfebf714cdbb"
      unitRef="U_USD">79515000</eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_f109697a-4cc8-458b-8acf-91524b26f744"
      unitRef="U_USD">79533000</eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="INF"
      id="F_35f88a6a-22c2-4263-9761-5fa6c76992ba"
      unitRef="U_shares">50000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_f71931db-47f3-45f3-a6b3-4f52064f1a3d"
      decimals="-3"
      id="F_d45d1397-b758-468a-98ec-29e2eb61f51d"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf"
      decimals="-3"
      id="F_0d14e77c-9905-495d-86a1-6b15184d42ae"
      unitRef="U_USD">214000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_0117da66-8b50-4c9f-94a0-856e088b3127"
      unitRef="U_USD">215000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_fde0e6a3-7277-4d59-8d5d-4fe009899cbf"
      decimals="-3"
      id="F_a5c20df3-a278-47c3-a5b6-d18906196f18"
      unitRef="U_USD">13122000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_0af11a37-8f53-450c-a9f7-f8e597b612e9"
      unitRef="U_USD">13122000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_d4a180ea-02bd-45bf-a264-14e6d8208750"
      decimals="-3"
      id="F_8ed5d92b-7cb7-4e7a-8b02-e7d89272d714"
      unitRef="U_USD">26000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_78d80fc7-f4df-4369-9fc0-e0663287d038"
      unitRef="U_USD">26000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_4fc8440b-61a6-4b7b-8aa2-aa0f00a4ad4f"
      decimals="-3"
      id="F_0de407de-f5c2-42eb-bb6a-1f5d9e8d5766"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_04ad097f-aa77-433a-8c81-0fdd096a90b2"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_b99f4417-a579-424d-bceb-63a23a9cce93"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="-3"
      id="F_3f2fa3bd-a60c-4424-b4d2-cec537a5a243"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_02fd66d6-0e07-49c2-9cb6-7ed9d9eee791"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="-3"
      id="F_c2bc2a0b-fe81-464d-98ee-c2e5084512ba"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_f24c5a06-77ee-4dae-8ad5-bc7f8a9e6e82"
      decimals="INF"
      id="F_93fd4f86-7387-4116-895c-e42e67f804f7"
      unitRef="U_shares">59789275</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_f24c5a06-77ee-4dae-8ad5-bc7f8a9e6e82"
      decimals="-3"
      id="F_a44beb69-0c16-4a65-a556-7c94c9c738af"
      unitRef="U_USD">60000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_112a5426-12b2-4e40-9850-361e43b7c9ab"
      decimals="-3"
      id="F_5f6c0556-74ba-47a7-8819-628ad1b0a33c"
      unitRef="U_USD">417946000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_7736993d-d675-48ac-bc9d-ee436b89e189"
      decimals="-3"
      id="F_3b1070c8-3ad8-4f53-a41a-cc2517b799ce"
      unitRef="U_USD">26000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a5a3e2c8-59f9-48bb-8c4e-73be100cce2f"
      decimals="-3"
      id="F_537d92ee-ed7c-4e39-8951-106de3829470"
      unitRef="U_USD">-355586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_01d8fae8-44bf-46d5-b11f-c67a1529739b"
      unitRef="U_USD">62446000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_3a016639-ee1c-4857-bfa8-a770abff3001"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_ab8d7fbe-5963-4ddf-9bb5-f008674892d2"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_ef299f73-9286-4a45-be3a-c862945f426b"
      unitRef="U_USD">10000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_54ecc01e-3c74-4298-bfed-0233cd849092"
      unitRef="U_USD">359000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_1501f6bb-fb46-4520-af5d-e7280f362b18"
      unitRef="U_USD">374000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <eldn:AccretionOnInvestmentDiscounts
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_43211058-3745-4785-b65e-731317890a8f"
      unitRef="U_USD">-2799000</eldn:AccretionOnInvestmentDiscounts>
    <eldn:AccretionOnInvestmentDiscounts
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_084468dc-3a43-44c8-bb24-0cbbd5912cb8"
      unitRef="U_USD">-1203000</eldn:AccretionOnInvestmentDiscounts>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_5ecc2efd-66f5-4b7b-a5ee-3c796a8a6f78"
      unitRef="U_USD">13122000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_edbb23c8-9858-4b21-a471-c40d579f4016"
      unitRef="U_USD">6545000</us-gaap:AllocatedShareBasedCompensationExpense>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_ebea1eee-2feb-4592-8d74-02c0f0f00152"
      unitRef="U_USD">-30900000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_07d68179-fe81-498d-b911-a9301eebbbed"
      unitRef="U_USD">76211000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_e0b290b4-6cdf-43c1-8a64-a0399e9405ef"
      unitRef="U_USD">431000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_279ce85a-df36-4928-8d75-94a61d95f2b9"
      unitRef="U_USD">-1298000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_52f2b7e0-7b71-458a-b507-da68a07682f0"
      unitRef="U_USD">1954000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <eldn:AccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_5d278986-6f45-473f-9d49-1e817e53acc9"
      unitRef="U_USD">7751000</eldn:AccountsPayableAccruedExpensesAndOtherLiabilities>
    <eldn:AccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_4a73ae0f-4b7e-4b3b-83eb-6aa345c2033c"
      unitRef="U_USD">-2600000</eldn:AccountsPayableAccruedExpensesAndOtherLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_859cbd29-4162-4344-8db2-3dd069a2c203"
      unitRef="U_USD">-339000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_9feca346-0c9d-467a-81be-1a198ff61c65"
      unitRef="U_USD">-363000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_8d7c1a1a-d80f-41ce-9e84-4d31286164d3"
      unitRef="U_USD">-47271000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_c94b1bee-7b87-49e3-a07f-0d33728b810e"
      unitRef="U_USD">-39527000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_ee9d1da7-310d-45e6-8a84-3242ca572612"
      unitRef="U_USD">156131000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_2a355387-d743-4258-a976-81230f86ada5"
      unitRef="U_USD">78287000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_15c17476-9afb-4d4a-8ae8-bc03d8bc98c2"
      unitRef="U_USD">85817000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_b6c26281-b827-4585-bd11-83625d076220"
      unitRef="U_USD">33000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_4556050e-c3ea-4241-af6f-eff9ac348a78"
      unitRef="U_USD">-70314000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_6dc2acef-d95f-45c9-b7b1-5003d5a3fdce"
      unitRef="U_USD">-45287000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_325189bf-780f-4d4e-bad2-1cb2cb1d5212"
      unitRef="U_USD">133307000</eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet>
    <eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_f097b9e8-47ab-4885-9a2f-3e4d29949f45"
      unitRef="U_USD">33017000</eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_8b7b7654-2c5b-4504-a00d-9e805657d2e2"
      unitRef="U_USD">215000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_0d0b2fd5-804a-4342-8608-6009040a9fd6"
      unitRef="U_USD">133522000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_04504901-0d6c-4feb-8026-bb23d96e3176"
      unitRef="U_USD">33017000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_8f3fd69b-af48-40bf-9938-111479b02bc9"
      unitRef="U_USD">15937000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_05bad1da-c1bb-4644-b333-bfc54d945810"
      unitRef="U_USD">-51797000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_ee01e893-0c49-40fd-b00d-7ae456c2903f"
      unitRef="U_USD">4612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_703721ac-e233-4584-a2ed-617913379b0c"
      decimals="-3"
      id="F_36f7e884-2098-4e6d-b81a-63313615c706"
      unitRef="U_USD">56409000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_24536c63-e820-45e0-9cd4-fd3e3d8052e9"
      unitRef="U_USD">20549000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_609c4853-0757-43b7-a74f-ac060c9b9134"
      unitRef="U_USD">4612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <eldn:CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_bc2d5bc2-63e7-4aa3-849b-0c14c4087069"
      unitRef="U_USD">1000</eldn:CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock>
    <eldn:UnrealizedGainOnAvailableForSaleSecurities
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_56b1b134-bed4-49f5-b938-de66454956e0"
      unitRef="U_USD">26000</eldn:UnrealizedGainOnAvailableForSaleSecurities>
    <eldn:IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_6f88f995-9e4a-4f91-b0e5-86f0e8e49b6b"
      unitRef="U_USD">920000</eldn:IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease>
    <eldn:SettlementOfWarrantLiabilityIntoCommonStockDueToExercise
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_12a1efeb-0304-424c-97fa-126fdba00ab0"
      unitRef="U_USD">446000</eldn:SettlementOfWarrantLiabilityIntoCommonStockDueToExercise>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_f019b7d1-4cfa-40d6-9e5f-1fd46bf3fdde">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 1. Description of Business (As Restated)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 Ligand (&#x201c;CD40L&#x201d;) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (&#x201c;ALS&#x201d;). The Company&#x2019;s lead compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that we believe has broad therapeutic potential. Unless otherwise indicated, references to the terms &#x201c;Eledon,&#x201d; &#x201c;our,&#x201d; &#x201c;us,&#x201d; &#x201c;we,&#x201d; or the &#x201c;Company&#x201d; refer to Eledon Pharmaceuticals, Inc. and its wholly owned subsidiaries, on a consolidated basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 14, 2020&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, Eledon acquired Anelixis Therapeutics, Inc. (&#x201c;Anelixis&#x201d;), a privately held clinical stage biotechnology company developing a next generation anti-CD40L antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases. The Company maintains its corporate headquarters in Irvine, California and has research and development facilities in Burlington, Massachusetts.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restatement of Previously Issued Consolidated Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.393%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.111%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the course of preparing the Company&#x2019;s Condensed Consolidated Financial Statements as of and for the three and six months ended June 30, 2025, the Company reassessed the rights and preferences of its Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; par value (&#x201c;Preferred Stock&#x201d;), and concluded that, because they are substantially identical to those of its common stock, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; par value, the Preferred Stock should be treated as a separate class of common stock for purposes of calculating earnings per share in accordance with &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accounting Standards Codification (&#x201c;ASC&#x201d;) 260-10, &#x201c;Earnings Per Share.&#x201d; As a result, the Company determined that it should have presented earnings per share under the two-class method in prior reporting periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.391%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Additionally, in connection with this reassessment, the Company concluded that it had incorrectly classified the Preferred Stock as permanent equity in the consolidated balance sheets. The Preferred Stock includes a provision that, upon the occurrence of a fundamental transaction (which includes a third-party tender or exchange offer) in which more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; percent of the common stockholders receive cash or other assets, the holders of Preferred Stock, upon any subsequent conversion, are entitled to receive the same form of consideration, even if they did not participate in the original transaction. Because this feature may result in settlement in cash or other non-equity consideration upon an event outside the Company&#x2019;s control, the Preferred Stock does not meet the criteria for permanent equity classification and is instead classified as temporary equity under ASC 480-10-S99-3A. Although a tender offer is not considered probable as of the current reporting date and redemption is not deemed probable, the existence of this provision requires classification as temporary equity. The Preferred Stock is not subsequently remeasured to its redemption value because redemption is not considered probable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain consolidated financial statements and financial information are presented herein as restated. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;See Note 12&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restatement of Previously Issued Consolidated Financial Statements &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;for further information.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1
      contextRef="C_8667a5df-16be-4759-b647-3b7cea2a8885"
      id="F_f8b3c584-53ab-4fc3-82b2-07d12a0b6605">2020-09-14</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_8bba3766-4964-4ab7-92aa-e8434203d2c8"
      decimals="3"
      id="F_7b0622d5-758f-46cd-beb6-91cb8794f54a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_482d4d7b-2e9a-44ff-9fde-c5756f5cc547"
      decimals="3"
      id="F_ab9818e0-05de-4392-a08f-23729e24d3a8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68"
      decimals="3"
      id="F_cd8bbebe-250b-4101-8ad3-530f794f1f91"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets
      contextRef="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68"
      decimals="2"
      id="F_d38b581e-488c-4ff5-a1ad-6b63f8e73123"
      unitRef="U_pure">0.50</eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_8a65c62d-aa80-49ca-a5e9-5feb7068f66e">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#x201c;Otic&#x201d;). Otic owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#x2019;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#x2019;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#x2019;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#x2019;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#x201c;ROU&#x201d;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid investments with original maturities of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months or less&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; when purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds, U.S. government securities and U.S. government agency securities. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, all of the Company&#x2019;s long-lived assets were located in the United States. The Company&#x2019;s products will require approval from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#x2019;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;all &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reportable Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#x2019;s Chief Executive Officer and the Company has determined that it operates in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impairments of long-lived assets have been identified during the years presented.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;In-Process Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts allocated to in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#x2019;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;amp;D was impaired for any of the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#x2019;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#x2019;s prior period accrued estimates for clinical trial activities through December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss Per Share (As Restated)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted net loss per share are calculated using the two-class method in accordance with ASC Topic 260, Earnings Per Share. The two-class method allocates undistributed losses to the Company&#x2019;s outstanding common stock, and the Preferred Stock, based on each class&#x2019;s proportionate share of the total weighted-average shares outstanding. Since the Company has never declared dividends, net loss and undistributed losses are equivalent.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. The process is used for both common stock and Preferred Stock. As the rights and preferences of the Preferred Stock are substantially identical to each other, they are considered a single class of common stock for earnings per share purposes.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#x2019;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023 includ&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;e &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,443,755&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,776,270&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; respectively, shares underlying pre-funded warrants to purchase common shares. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share), these shares are deemed to be issued for purposes of basic earnings per share.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The calculation of basic and diluted earnings per share for our common stock and Preferred Stock is as follows:&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:60.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:16.279999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:15.940000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(As Restated)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,543,787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,619,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,268&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss used in the calculation of basic and diluted loss per share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss available to common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91,987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share, common stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss available to Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,192&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;207.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a summary as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:57.76%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options outstanding and other equity awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,007,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,909,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common and preferred warrants outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,567,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,577,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,575,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,486,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;) are measured and recognized based on the quoted market price of our common stock on the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant judgment is required in determining the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#x201c;not more likely than not&#x201d; that a tax benefit will be sustained, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#x2019;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. &lt;/span&gt;&lt;span style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;second step is to measure the tax benefit as the largest amount that is &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;more &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% likely of being realized upon settlement.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 7. Income Taxes &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of the Notes to Financial Statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrant Liabilities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for issued warrants either as a liability or equity in accordance with ASC 815-40 Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (&#x201c;ASC 815-40&#x201d;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#x2019; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;early adoptions&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; permitted. The Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ASU 2023-07, effective &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t impact the consolidated financial statements. See Note 10, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for disclosures related to the adoption of ASU 2023-07.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements Issued But Not Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#x2019;s present or future financial position, results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_74ed45d1-a61d-4fe9-994b-e0b3e8051eb9">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#x201c;Otic&#x201d;). Otic owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#x2019;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#x2019;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;</eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="C_6e372f90-3029-4434-82dd-cdd9e2a4e75d"
      decimals="INF"
      id="F_5707aec0-808f-4550-962b-eb7a8d2b04ec"
      unitRef="U_pure">1</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="C_a32ed886-8fef-46ca-80f4-2e27d332c237"
      decimals="INF"
      id="F_28dc08fe-94af-4905-a339-eff05f03490d"
      unitRef="U_pure">1</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:UseOfEstimates
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_d1035bc6-2bc3-405b-8030-cd3eac3e3445">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#x2019;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#x2019;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#x201c;ROU&#x201d;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_27b32f83-4a0c-4f93-843e-8dfc727c22e7">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_a3cd47bf-8a10-40a6-802a-65e17b64c7fa">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid investments with original maturities of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months or less&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; when purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds, U.S. government securities and U.S. government agency securities. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_339aaf1f-bf51-4ada-b267-8c1746678ef7">three months or less</eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod>
    <eldn:RisksAndUncertaintiesPolicyTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_d717e096-86a6-4d1f-8e22-6f997654b534">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, all of the Company&#x2019;s long-lived assets were located in the United States. The Company&#x2019;s products will require approval from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#x2019;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;all &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.&lt;/span&gt;&lt;/p&gt;</eldn:RisksAndUncertaintiesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_54585fe9-f0a9-42ed-b446-089772ba0b86">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reportable Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#x2019;s Chief Executive Officer and the Company has determined that it operates in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="INF"
      id="F_2d631344-f273-4fd8-9599-76948093dcdf"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_9e3bd518-2fd9-4f41-8a2d-b5bd3875f7f0">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impairments of long-lived assets have been identified during the years presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="INF"
      id="F_64df13c3-cb22-47fa-a939-949ba21b9ad4"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="INF"
      id="F_45b04960-66bd-45a6-9e5c-4d932c6a7d17"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:InProcessResearchAndDevelopmentPolicy
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_ec021d43-66c3-4ab5-bccd-3429aa1e3683">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;In-Process Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts allocated to in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#x2019;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;amp;D was impaired for any of the periods presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_ea377e56-5321-4fe4-863a-4bf008c82e02">&lt;p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#x2019;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#x2019;s prior period accrued estimates for clinical trial activities through December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_cf38e618-0730-474b-a5d0-8841d747e7a7">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss Per Share (As Restated)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted net loss per share are calculated using the two-class method in accordance with ASC Topic 260, Earnings Per Share. The two-class method allocates undistributed losses to the Company&#x2019;s outstanding common stock, and the Preferred Stock, based on each class&#x2019;s proportionate share of the total weighted-average shares outstanding. Since the Company has never declared dividends, net loss and undistributed losses are equivalent.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. The process is used for both common stock and Preferred Stock. As the rights and preferences of the Preferred Stock are substantially identical to each other, they are considered a single class of common stock for earnings per share purposes.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#x2019;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023 includ&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;e &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,443,755&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,776,270&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; respectively, shares underlying pre-funded warrants to purchase common shares. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share), these shares are deemed to be issued for purposes of basic earnings per share.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The calculation of basic and diluted earnings per share for our common stock and Preferred Stock is as follows:&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:60.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:16.279999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:15.940000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(As Restated)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,543,787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,619,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,268&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss used in the calculation of basic and diluted loss per share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss available to common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91,987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share, common stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss available to Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,192&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;207.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a summary as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:57.76%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options outstanding and other equity awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,007,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,909,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common and preferred warrants outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,567,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,577,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,575,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,486,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_8a905dd9-947f-4771-b0bd-22e599ecb244"
      decimals="0"
      id="F_3c9c8210-e1fc-4dec-be2a-df6e439755b1"
      unitRef="U_shares">12443755</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_2cce5c4d-219e-4cc1-af1c-7a19e05a994d"
      decimals="0"
      id="F_0c886242-20fd-41a3-b71e-1e72364329b2"
      unitRef="U_shares">5776270</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_b3b1d995-4d25-4b66-b36e-2fb4842e5a95">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share), these shares are deemed to be issued for purposes of basic earnings per share.&lt;/span&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The calculation of basic and diluted earnings per share for our common stock and Preferred Stock is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:60.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:16.279999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:15.940000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(As Restated)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,543,787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,619,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,268&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss used in the calculation of basic and diluted loss per share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss available to common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91,987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share, common stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss available to Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,192&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;207.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_cded1be0-5d08-4e82-82d6-d067b4958eae"
      decimals="3"
      id="F_c06ddc19-43da-4281-8bee-07d2d760ff8b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="0"
      id="F_eb362159-2cde-41f7-8e42-5ef5549ea73c"
      unitRef="U_shares">48543787</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="0"
      id="F_e24009e4-3dc3-46b7-8d09-f26a51fe820d"
      unitRef="U_shares">48543787</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="0"
      id="F_6e0afbd8-6c3e-40d3-b617-45475b758f5e"
      unitRef="U_shares">24619197</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="0"
      id="F_7c2ab5cf-1959-4e90-ada0-c5ce700e99fa"
      unitRef="U_shares">24619197</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="0"
      id="F_c1f3be3a-ec11-49e2-b013-8bd2e045357c"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="0"
      id="F_4638c5f4-6b7a-4921-8d04-32385a54ca1a"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="0"
      id="F_02a6b408-af9d-4381-96fc-718aec6aa4d8"
      unitRef="U_shares">118268</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="0"
      id="F_19c32688-d6a9-49dd-8bd0-8d4c163b7d3d"
      unitRef="U_shares">118268</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_de387fb1-cf9e-4e64-934e-b68664a936f2"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_825bb0da-ed3a-4666-8be9-330877640548"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="-3"
      id="F_8d459bfe-79b1-4052-bc45-70b0b4ed3a20"
      unitRef="U_USD">-31992000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="-3"
      id="F_638055b4-6721-4571-b167-e29c8073b7de"
      unitRef="U_USD">-91987000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="2"
      id="F_f9ad3498-6e49-459a-a2e0-b8c09d55012f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="2"
      id="F_1e3e3c58-56e0-4852-8e21-2bf288119443"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="2"
      id="F_e24d2a78-7632-4682-96e4-e06f0fffe045"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="2"
      id="F_6136d952-c019-4854-a3a8-39733003ae00"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="-3"
      id="F_ed6cad2e-a38b-4355-ba8c-0d82e11b2b33"
      unitRef="U_USD">-4192000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="-3"
      id="F_435ca709-3d7e-4a53-85cc-ebfbb216ecc6"
      unitRef="U_USD">-24550000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="2"
      id="F_72942157-97b5-4826-a39e-82a22d69d8e5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-36.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="2"
      id="F_950e8dec-fc1e-4496-820e-599fa70deb58"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-36.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="2"
      id="F_86903f68-7bfe-4f9a-8aec-063bb6cd061c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-207.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="2"
      id="F_536ba4c4-0660-44b9-9777-2501ee7b3730"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-207.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_12193c9a-b38d-4f10-b14b-664ad0e5d231">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a summary as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.&lt;/span&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:57.76%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options outstanding and other equity awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,007,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,909,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common and preferred warrants outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,567,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,577,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,575,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,486,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_63e0c2a9-691e-4547-a6ac-0d3fdf91d1aa"
      decimals="0"
      id="F_0185f435-99f2-4a2c-9d76-7ff82cf836af"
      unitRef="U_shares">6007789</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_e94a88c0-62d2-43ee-872d-543df3558f56"
      decimals="0"
      id="F_5e98d034-dae1-4dc0-8078-55bc3a1f1aef"
      unitRef="U_shares">14909155</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_c71a399f-d8f4-4adf-af71-acd5010523cd"
      decimals="0"
      id="F_09e11daf-af09-4e1c-8c94-6912da8c555a"
      unitRef="U_shares">18567751</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_bc089e60-cdab-4f8a-b783-246e7d7a6af1"
      decimals="0"
      id="F_37900f6b-4dc1-420b-8eda-316731cca7f5"
      unitRef="U_shares">18577332</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="0"
      id="F_89d6ec8b-9a50-476e-965d-46bad5fa938f"
      unitRef="U_shares">24575540</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="0"
      id="F_fc0a8318-b7e9-4548-8715-48b6812f719a"
      unitRef="U_shares">33486487</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_a28d014b-4249-4ed8-8416-168c2867f5c3">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;) are measured and recognized based on the quoted market price of our common stock on the date of grant.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_256e544c-65a9-4eb5-b112-495257912c89">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant judgment is required in determining the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#x201c;not more likely than not&#x201d; that a tax benefit will be sustained, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#x2019;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. &lt;/span&gt;&lt;span style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;second step is to measure the tax benefit as the largest amount that is &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;more &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% likely of being realized upon settlement.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 7. Income Taxes &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of the Notes to Financial Statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <eldn:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="INF"
      id="F_2a894d82-d2de-44cc-883c-175723871738"
      unitRef="U_USD">0</eldn:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit>
    <us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_4e0f3a39-0db4-4368-a387-7bc28b56a840">The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.</us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement>
    <eldn:IncomeTaxExaminationLikelihoodOfFavorableSettlement
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_47949667-c7a2-4f4f-ae44-7ea3edf96f0a"
      unitRef="U_pure">0.50</eldn:IncomeTaxExaminationLikelihoodOfFavorableSettlement>
    <us-gaap:StockholdersEquityPolicyTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_4b7d3205-54b1-421b-b676-35da0d360d0b">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrant Liabilities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for issued warrants either as a liability or equity in accordance with ASC 815-40 Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (&#x201c;ASC 815-40&#x201d;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_463c1cf0-abff-4464-b663-53969ee707b6">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#x2019; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;early adoptions&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; permitted. The Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ASU 2023-07, effective &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t impact the consolidated financial statements. See Note 10, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for disclosures related to the adoption of ASU 2023-07.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements Issued But Not Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#x2019;s present or future financial position, results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption
      contextRef="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f"
      id="F_1158294c-babc-432f-973f-d300e89afeb5">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f"
      id="F_16ef8141-b1c6-47ca-ad00-e41383e8166b">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f"
      id="F_508ce448-47ca-48f3-9558-3c39d4e498e3">2024-12-31</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_fb82ec1a-3569-4ce6-9f80-1cecabb8710f"
      id="F_7712dc1d-a9a4-4011-822b-bcc63ba16768">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_e721086c-0fcc-4ce2-83d7-36ebe8c140a8">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 3. Short-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The objectives of the Company&#x2019;s investment policy are to preserve principal, meet the Company's liquidity requirements and safeguard invested funds. Short-term investments consist of U.S. government securities and U.S. government agency securities. The Company has classified these investments as available-for-sale securities, as the sale of such investments may be required prior to maturity to implement management strategies, and therefore has classified all&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;investments with maturity dates beyond three months at the date of purchase as current assets in the accompanying consolidated balance sheets. Any premium or discount arising at purchase is amortized and/or accreted to interest income as an adjustment to yield using the straight-line method over the life of the instrument. The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts to maturity. Investments are reported at their estimated fair value. Unrealized gains and losses are included in accumulated other comprehensive loss as a component of stockholders' equity until realized.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following is a summary of short-term investments, which were classified as available-for-sale securities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:32.294%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;All of the Company's available-for-sale securities have a stated maturity of less than one year.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_1753d653-be46-4852-9a45-857b5520d354">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following is a summary of short-term investments, which were classified as available-for-sale securities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:32.294%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_869cb76b-dd81-4314-8818-8ae015c49078"
      decimals="-3"
      id="F_3c55d5ac-7d24-40e4-8b7a-b202dea57199"
      unitRef="U_USD">119603000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_869cb76b-dd81-4314-8818-8ae015c49078"
      decimals="-3"
      id="F_9b7dd9af-8543-4413-b863-6ef34c11e4ff"
      unitRef="U_USD">55000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_869cb76b-dd81-4314-8818-8ae015c49078"
      decimals="-3"
      id="F_cd543d03-1618-4b59-bf3f-233d7810a5eb"
      unitRef="U_USD">29000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_869cb76b-dd81-4314-8818-8ae015c49078"
      decimals="-3"
      id="F_bc8bbb18-5673-4a0e-8b63-ccb959e9b773"
      unitRef="U_USD">119629000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_6e365deb-3766-4ea2-8506-3426dfadc980"
      unitRef="U_USD">119603000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_798e55ed-4a24-48b6-bbf9-1727a753b681"
      unitRef="U_USD">55000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_ffa60f7e-ce36-488c-9ef6-fd3c9e0a84dd"
      unitRef="U_USD">29000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_f11e2ce9-1f81-46fd-899e-ec6b26375ea4"
      unitRef="U_USD">119629000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5953effb-3051-4f13-ace1-184eb0e02dcb"
      decimals="-3"
      id="F_a4cc6622-8b5d-4870-977c-8f453da0c626"
      unitRef="U_USD">33213000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_5953effb-3051-4f13-ace1-184eb0e02dcb"
      decimals="-3"
      id="F_c96f82b9-4783-4277-a9e2-c07564f385c1"
      unitRef="U_USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_5953effb-3051-4f13-ace1-184eb0e02dcb"
      decimals="-3"
      id="F_6cc13983-a4be-4c6d-a8e3-025de848110e"
      unitRef="U_USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5953effb-3051-4f13-ace1-184eb0e02dcb"
      decimals="-3"
      id="F_861f1619-e2e9-4d9c-b202-50357c8f627c"
      unitRef="U_USD">33213000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_79dd679d-8ad0-49ca-9c6c-b276bb345850"
      decimals="-3"
      id="F_d76b504e-1373-4b8a-b97e-8ddd26b44d65"
      unitRef="U_USD">13277000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_79dd679d-8ad0-49ca-9c6c-b276bb345850"
      decimals="-3"
      id="F_4e94f390-9eab-44d2-95f5-18893496ba5d"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_79dd679d-8ad0-49ca-9c6c-b276bb345850"
      decimals="-3"
      id="F_3a64f960-7c77-464f-80a1-03b1007ed496"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_79dd679d-8ad0-49ca-9c6c-b276bb345850"
      decimals="-3"
      id="F_1fbac446-b45e-47b9-88ff-f36dff4cd56c"
      unitRef="U_USD">13277000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_4a1e3dce-8dc3-467c-916b-9761a37b4dee"
      unitRef="U_USD">46490000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_ca980ade-71d1-4d60-b820-de814880b19c"
      unitRef="U_USD">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_9b1d1e31-a8da-4e3f-98a2-cea8420139ba"
      unitRef="U_USD">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_44218f71-c063-4280-8d6b-7b0ca5c66d79"
      unitRef="U_USD">46490000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_cff65c21-ed80-409c-96d8-1dd3cb30fb3e">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 4. Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial assets and liabilities are recorded at fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company classifies fair value measurements using a three-level hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1&#x2014;Quoted market prices (unadjusted) in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2&#x2014;Observable inputs other than quoted market prices included in Level 1, such as quoted market prices for markets that are not active or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, including certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. These fair values are obtained from independent pricing services which utilize Level 1 and Level 2 inputs.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:33.387%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;137,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;138,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:33.387%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrant Liabilities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company's warrant liabilities &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(see &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 8. Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:27.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:6.879%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.199%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.439%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:27.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:6.879%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.199%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.439%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:6.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:28.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Settlement of warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes the reversal of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in warrant liabilities associated with the Subsequent Closing Warrants (as defined in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 8. Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), which expired and or settled as of year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_5113d52e-845e-48b5-8fc6-d37155603a26">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:33.387%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;137,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;138,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:33.387%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_5fed5aba-bded-4202-86e4-abacffb2f839"
      decimals="-3"
      id="F_7c468a8d-2261-4afc-acc9-57418760abc7"
      unitRef="U_USD">1215000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_21d6ff86-6d7f-4b9d-adfb-5a4f1d7aa8b8"
      decimals="-3"
      id="F_e0d0e814-27ff-43a6-b158-af5792ad3c85"
      unitRef="U_USD">1215000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_95a8ebd2-ec0a-42f8-b597-f3c09a2afecc"
      decimals="-3"
      id="F_198ccddc-0ab8-4f61-9bf0-52faf2bef5d0"
      unitRef="U_USD">17464000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_37cfa2dd-f2e8-40b3-b4ed-4aaa93f648d9"
      decimals="-3"
      id="F_6ff7770f-d127-4854-a4f9-0b4d9e72bb48"
      unitRef="U_USD">17464000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_1799d415-8c33-49ff-820b-a0512ecbe050"
      decimals="-3"
      id="F_9ceea0d5-45d7-49a3-8767-b25475dda279"
      unitRef="U_USD">1215000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_08679ab6-cc43-46fb-afd1-83c5b1aabc73"
      decimals="-3"
      id="F_67e1437a-e79e-4818-94d4-6b8a0cf69b33"
      unitRef="U_USD">17464000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_a02b7bbf-5219-43e5-a35f-53b985449b45"
      decimals="-3"
      id="F_3b2aa3b2-16b5-4d85-b513-57e0fdfccefa"
      unitRef="U_USD">18679000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_48ea6ed9-0d04-4f10-a10e-a2919aae308d"
      decimals="-3"
      id="F_f200c814-70ac-474e-af67-0b75857285a4"
      unitRef="U_USD">119629000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_50e1d626-a270-4890-bdf3-98ed401c6ece"
      decimals="-3"
      id="F_c4c84050-ab48-457f-b306-06e58f02a24d"
      unitRef="U_USD">119629000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_08679ab6-cc43-46fb-afd1-83c5b1aabc73"
      decimals="-3"
      id="F_18f5fb16-4b5a-484d-b3e3-135ad607bba4"
      unitRef="U_USD">119629000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_a02b7bbf-5219-43e5-a35f-53b985449b45"
      decimals="-3"
      id="F_0b1f5e8a-9a20-4165-9b0a-18ac7cba212b"
      unitRef="U_USD">119629000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1799d415-8c33-49ff-820b-a0512ecbe050"
      decimals="-3"
      id="F_16ce117e-604f-40b5-a12d-526553f2d1cd"
      unitRef="U_USD">1215000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_08679ab6-cc43-46fb-afd1-83c5b1aabc73"
      decimals="-3"
      id="F_3133d5a9-ae60-4576-b8b5-0b6e8fb7d6f4"
      unitRef="U_USD">137093000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_a02b7bbf-5219-43e5-a35f-53b985449b45"
      decimals="-3"
      id="F_5742a498-c912-4c23-819c-8f4d91731192"
      unitRef="U_USD">138308000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_fcab1302-ac86-4137-9866-3e47197201e3"
      decimals="-3"
      id="F_553ac30b-c7c0-42cc-89db-efca565e5c1b"
      unitRef="U_USD">4246000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_f5e378e9-ea4d-4446-a3d6-8653372fe095"
      decimals="-3"
      id="F_06e44c3a-4b77-4f2a-ad40-dc604a5177a5"
      unitRef="U_USD">4246000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_fcf8616b-2c3d-4413-a5ce-5cd91ad0ca6f"
      decimals="-3"
      id="F_eeefdfd0-986e-441c-8117-8b9f0637f641"
      unitRef="U_USD">4246000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_32469e8b-bd12-46a1-aa1e-6207f9cfe051"
      decimals="-3"
      id="F_12cb7248-0f6e-4d6f-a0eb-b7402e528375"
      unitRef="U_USD">4246000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_9d1c5679-7ad3-40bf-a3c6-7a10ff14887e"
      decimals="-3"
      id="F_fe1921bc-ea0e-4003-90d0-f634b49a24eb"
      unitRef="U_USD">33213000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_0723a7a1-cd73-4940-a506-fa467676eccd"
      decimals="-3"
      id="F_fb6252d5-aea3-4446-b89c-87a02941b14f"
      unitRef="U_USD">33213000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_19e1b622-4072-4fc0-a0fc-410862aa012d"
      decimals="-3"
      id="F_adc4f7d6-28fb-4cff-90e4-b8e38e18bbbd"
      unitRef="U_USD">13277000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_fef3fa93-e31c-43ff-af41-915dfb55b4a7"
      decimals="-3"
      id="F_778372a0-a004-4a7d-8fee-50ba444e705e"
      unitRef="U_USD">13277000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_44e95282-fdaa-4791-b948-243de3cf859c"
      decimals="-3"
      id="F_c0f29e01-b159-4428-b1cd-739b470d3e24"
      unitRef="U_USD">46490000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_32469e8b-bd12-46a1-aa1e-6207f9cfe051"
      decimals="-3"
      id="F_8203d4af-8d4d-439a-bcf4-59e130c7cf25"
      unitRef="U_USD">46490000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_fcf8616b-2c3d-4413-a5ce-5cd91ad0ca6f"
      decimals="-3"
      id="F_a19f403e-83cd-47d0-a905-ca00cbb5d6c4"
      unitRef="U_USD">4246000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_44e95282-fdaa-4791-b948-243de3cf859c"
      decimals="-3"
      id="F_6c0311cd-fb2c-4dbd-89e4-9fb46693a6fc"
      unitRef="U_USD">46490000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_32469e8b-bd12-46a1-aa1e-6207f9cfe051"
      decimals="-3"
      id="F_f23b5f23-0e9f-4cae-88eb-ed57a38dbb5a"
      unitRef="U_USD">50736000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_0737bea5-99a7-4511-8e66-44f703320d25">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company's warrant liabilities &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(see &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 8. Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:27.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:6.879%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.199%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.439%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:27.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:6.879%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.199%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.439%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_6c58a12b-7549-4626-92cd-993c292715da"
      decimals="-3"
      id="F_89f95c1f-5e63-4c84-879a-9f06fa499717"
      unitRef="U_USD">44865000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_30f84d62-e30b-473f-9c61-8ef1e1832085"
      decimals="-3"
      id="F_d9d7891b-60e2-4cfd-a0d5-887627faeff4"
      unitRef="U_USD">44865000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_2bbbd4e0-640b-45ce-a5fe-e896670755b5"
      decimals="-3"
      id="F_6d63d336-9024-4868-a5b7-c9511113985d"
      unitRef="U_USD">76211000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_976894d0-7795-4a81-a79e-bce2709115dd"
      decimals="-3"
      id="F_ba65a803-9485-4897-a68e-01890b244369"
      unitRef="U_USD">76211000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_1848f1d9-1f4f-42c8-b503-80c484732999">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:6.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:28.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Settlement of warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_976894d0-7795-4a81-a79e-bce2709115dd"
      decimals="-3"
      id="F_ecf57b29-6072-4e8e-b308-9af4c27a077d"
      unitRef="U_USD">76211000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_834dcb4b-a7e6-4a63-a26e-6cacde80edc9"
      decimals="-3"
      id="F_21338f6a-dc25-4aaa-8a15-01d3d76802ae"
      unitRef="U_USD">-30900000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:SettlementOfWarrantLiability
      contextRef="C_834dcb4b-a7e6-4a63-a26e-6cacde80edc9"
      decimals="-3"
      id="F_4ed7b4a4-3ab3-4e7a-b5cd-ba76b3b099c6"
      unitRef="U_USD">446000</eldn:SettlementOfWarrantLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_30f84d62-e30b-473f-9c61-8ef1e1832085"
      decimals="-3"
      id="F_9da32012-7fca-4815-aa61-22bde4fb31f6"
      unitRef="U_USD">44865000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-5"
      id="F_1938e13a-1610-4f97-8b40-e292a24fd6a1"
      unitRef="U_USD">59100000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal>
    <eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_565f9814-fef3-4efb-83c1-1157ca46e8f2">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 5. Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:56.709%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.697%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.956%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid clinical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;693&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other liabilities consisted of the following as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.119999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.119999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued clinical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,601&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses and other liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_7d0fc516-21b3-47a3-ab69-d62d2aff2eb3">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:56.709%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.697%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.956%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid clinical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;693&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <eldn:PrepaidClinicalExpense
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_1036d0fd-f1e8-4c12-a3ec-f62dd57e17bd"
      unitRef="U_USD">1915000</eldn:PrepaidClinicalExpense>
    <eldn:PrepaidClinicalExpense
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_a06cd4e6-ae1f-417e-863f-ac8ed6dcebd8"
      unitRef="U_USD">4128000</eldn:PrepaidClinicalExpense>
    <us-gaap:PrepaidInsurance
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_b83cba81-2dce-4031-a4b2-6aa1af663464"
      unitRef="U_USD">693000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_48cd9820-6cab-46e3-8111-60caae7660b1"
      unitRef="U_USD">624000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_307a051b-0337-4946-93a7-4e5941979a12"
      unitRef="U_USD">215000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_6b77129e-5b0d-4731-b501-ef1594e3ed6a"
      unitRef="U_USD">185000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_aa491fb5-ba3e-42ee-85df-1b8bec0761f4"
      unitRef="U_USD">729000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_35f0ab61-f8a0-4cee-b953-a1f95278772e"
      unitRef="U_USD">90000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_6d90bb84-dce7-416f-bcf5-362d230f2dcb"
      unitRef="U_USD">3552000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_068c2eef-a1bc-4c5a-933b-6c7e4fa40519"
      unitRef="U_USD">5027000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_0b855a18-5293-402b-984a-850826beb250">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other liabilities consisted of the following as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.119999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.119999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued clinical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,601&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses and other liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock>
    <eldn:AccruedClinicalCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_01857d0b-8fbb-4b9f-8be8-bc2fb9cb05b7"
      unitRef="U_USD">3642000</eldn:AccruedClinicalCurrent>
    <eldn:AccruedClinicalCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_4cee5a07-eda5-4b31-9b7f-932532b1544e"
      unitRef="U_USD">451000</eldn:AccruedClinicalCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_8eaa0894-2bf0-4cbc-9edf-4bdc8f5634a4"
      unitRef="U_USD">1601000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_ced85266-fade-498d-bd4d-2bf5038c7ca9"
      unitRef="U_USD">2003000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_6c441e72-8bbf-4286-bda1-c644c62d4f1e"
      unitRef="U_USD">140000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_d1663e0c-da17-4537-8339-f7ea50297f91"
      unitRef="U_USD">47000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_c369cb4d-3858-4d04-b896-882c3f1ccacd"
      unitRef="U_USD">47000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_1a1786b2-3ee9-403a-9d2f-21dd761a79ed"
      unitRef="U_USD">44000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_f12662bf-2c68-42c3-9570-90d749ae74af"
      unitRef="U_USD">5430000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_24a385b7-f6ac-4319-960d-91f8ee9c8074"
      unitRef="U_USD">2545000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_07046c25-12dd-45bb-83f3-df514a6a67a0">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 6. Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Operating Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company leases office space under various operating leases. Total rent expense for all operating leases in the consolidated statements of operations and comprehensive loss was approximately&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for each of the years ended December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 19, 2024, the Company entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;38-month&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating lease for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,817&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office space in Irvine, California, that expires on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Irvine Lease Agreement&#x201d;). On April 19, 2024, in conjunction with the Irvine Lease Agreement, the Company terminated an existing operating lease for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,197&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office space in Irvine, California, that was set to expire on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. On April 19, 2024, the effective date of the Irvine Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 4, 2024, the Company entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;36-month&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating lease for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,138&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office space in Burlington, Massachusetts, that expires on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 21, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Burlington Lease Agreement&#x201d;). The existing lease expired on November 20, 2024. On November 21, 2024, the effective date of the Burlington Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company determines if a contract contains a lease at inception. Our office leases have a remaining term of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and do not include options to extend the leases for additional periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities as adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, we estimate incremental secured borrowing rates corresponding to the maturities of the leases. As we have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; outstanding debt nor committed credit facilities, secured or otherwise, we estimate this rate based on prevailing financial market conditions, comparable company and credit analysis, and management&#x2019;s judgment.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our leases contain rent escalations over the lease term. We recognize expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;While we do not currently have any lease agreement with lease and non-lease components, we elected to account for lease and non-lease components as separate components.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term disclosures include only those leases with a term greater than one month and 12 months or less, and expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less, that do not include an option to purchase the underlying asset that we are reasonably certain to exercise, are not recorded on the consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The total operating lease expense were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.833%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.203000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.203000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(a)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(a) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Includes variable operating lease expenses, which are immaterial.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other supplemental cash flow information related to leases were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.299999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.860000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement of lease liability:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.433%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:70.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.941%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:24.544999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,087&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less current portion of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;314&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Grants and Licenses&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;ALS Therapy Development Foundation, Inc. License Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2015, Anelixis executed a License Agreement (the &#x201c;Agreement&#x201d;), which is an exclusive patent rights agreement with ALS Therapy Development Foundation, Inc. (&#x201c;ALS TDI&#x201d;) for certain patents and &#x201c;know-how&#x201d; of ALS TDI. This agreement continues until the licensee terminates the agreement with ninety days written notice. The Agreement requires license fees payable to ALS TDI, subject to the achievement of certain milestones and other conditions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The first and second milestones of the Agreement are the dosing of the first subjects in a first toxicity study in non-human primates and the dosing of the first patient in a Phase I Clinical Trial, respectively. Both of these milestones were achieved as of December 31, 2018 and 2017. The fee due for the achievement of these milestones was&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million each. During 2018 and 2017, Anelixis issued $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million wort&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;h of its common stock in lieu of making a cash payment. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; milestones achieved during &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024 or 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Agreement was amended and restated in February 2020, and a first amendment to the restated license agreement was executed in September 2020. As amended in September 2020, the remaining milestone payments for a first licensed product total&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In the event that the Company develops a second licensed product, the Company is obligated to pay up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; additional milestone payments.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition to the milestone payments, the Company is required to pay ALS TDI an amended annual license maintenance fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million beginning on the earlier of January 1, 2022, the Company&#x2019;s first sublicense, or change in control, as defined in the Agreement. The Company has made a&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;million annual license maintenance fee in each year since 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Furthermore, the Company is required to pay ALS TDI fees based on reaching certain levels of annual net sales of any product produced with t&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;he patent rights. A royalty in the low single digits will be due on aggregate net sales. Upon the first calendar year of reaching $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in aggregate net sales, the Company will be required to pay ALS TDI a one-time milestone payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Upon the first calendar year of reaching $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion in aggregate net sales, the Company is obligated to pay ALS TDI a one-time milestone payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Lonza Sales AG Inc. License Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In September 2018, Anelixis executed a License Agreement (the &#x201c;Lonza Agreement&#x201d;), which is a manufacturing know-how rights agreement with Lonza Sales AG Inc. (&#x201c;Lonza&#x201d;) for the use of certain processes and know-how related to the manufacture of tegoprubart. The Lonza Agreement continues until the later of the last Valid Claim (as defined therein) or ten years from the First Commercial Sale of tegoprubart, as defined and subject to the conditions therein. A royalty in the low single digits will be due on aggregate net sales of tegoprubart that is manufactured by Lonza or any other third-party or licensee.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;eGenesis, Inc. Collaboration Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In September 2022, and subsequently amended in January 2023, Eledon executed a non-exclusive collaborative research agreement with eGenesis, Inc. (the &#x201c;eGenesis Agreement&#x201d;), under which eGenesis will gain access to tegoprubart for eGenesis&#x2019; ongoing preclinical research and development xenotransplant studies of human-compatible organs and cells for the treatment of organ failure. eGenesis will pay Eledon for supplies of tegoprubart based on the number of study days per animal needed for the eGenesis preclinical xenotransplant studies to offset manufacturing expenses. As of year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company offset $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of manufacturing expenses. The eGenesis agreement continues until September 2025, unless terminated earlier by either party.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Legal Matters&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company and its subsidiaries are not a party to or the subject of any claim or lawsuit that individually or in the aggregate is anticipated to have a material effect on the Company&#x2019;s results of operations, financial condition or cash flows.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Indemnifications&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnification. The Company&#x2019;s exposure under these agreements is unknown because it involves future claims that may be made against the Company but have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future because of these indemnification obligations. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; amounts associated with such indemnifications have been recorded to date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; contingent liabilities requiring accrual at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-5"
      id="F_9cc2888b-7212-4e28-8321-e478491d07e8"
      unitRef="U_USD">400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-5"
      id="F_91663755-92b8-4a3b-9680-75c1b9d3ff07"
      unitRef="U_USD">400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_d3633a35-1914-4b59-95c7-b92462feeda6"
      id="F_8792d787-5934-44b7-9482-8ce7f19a63f8">P38M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <eldn:AreaOfOfficeSpace
      contextRef="C_75369811-d279-4dfd-81ed-953e9c67bff2"
      decimals="INF"
      id="F_f6502260-34d2-4430-910d-e86c9ed32c56"
      unitRef="U_sqft">5817</eldn:AreaOfOfficeSpace>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_75369811-d279-4dfd-81ed-953e9c67bff2"
      id="F_670c76ed-289f-46f9-b28d-630ea038d06e">2027-06-30</us-gaap:LeaseExpirationDate1>
    <eldn:AreaOfOfficeSpace
      contextRef="C_b10e5573-542e-4cad-822f-93a7ae68952b"
      decimals="INF"
      id="F_09459e19-d780-4a20-9b33-9641314240af"
      unitRef="U_sqft">5197</eldn:AreaOfOfficeSpace>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_7aba1847-593e-4b0d-b134-5757cbcbdffb"
      id="F_ad8d5c69-6a7a-4e8e-90c7-876dd324f071">2024-12-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_d3633a35-1914-4b59-95c7-b92462feeda6"
      decimals="-5"
      id="F_3334cc4e-e6c1-43d5-b30f-d449ad234431"
      unitRef="U_USD">500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_6312f08b-35c4-4f52-9485-e4c1a9839b7c"
      id="F_711a92a6-3ece-485d-bdb3-7cbe1dae00d5">P36M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <eldn:AreaOfOfficeSpace
      contextRef="C_254d6b43-9430-4433-b644-3ad4de1829ee"
      decimals="INF"
      id="F_126abc90-e3e7-4170-9579-2e4a689b55ac"
      unitRef="U_sqft">6138</eldn:AreaOfOfficeSpace>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_254d6b43-9430-4433-b644-3ad4de1829ee"
      id="F_7fc609e2-55c1-4cc2-91bb-d4c023546698">2027-11-21</us-gaap:LeaseExpirationDate1>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_9a69091e-a043-4048-aac2-1fd5f048fc3f"
      decimals="-5"
      id="F_b51113ba-8f01-48cc-8fd7-760b77db1fe3"
      unitRef="U_USD">500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_9a69091e-a043-4048-aac2-1fd5f048fc3f"
      decimals="-5"
      id="F_50ce70b3-ea02-4aee-b1b2-5068a8f8f9e2"
      unitRef="U_USD">500000</us-gaap:OperatingLeaseLiability>
    <eldn:LesseeOperatingLeaseRemainingTermOfContract
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_15ef3a70-4c5b-4944-9715-31c2b91a3a5c">P3Y</eldn:LesseeOperatingLeaseRemainingTermOfContract>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_107fbe02-f35e-4c34-9875-72619b0e81a4"
      unitRef="U_USD">0</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_6bafce89-c748-4481-bf2f-59fcd9276c8a">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The total operating lease expense were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.833%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.203000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.203000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(a)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(a) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Includes variable operating lease expenses, which are immaterial.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_66d34ea2-f928-4a58-bdc6-436fa0794584"
      unitRef="U_USD">407000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_49a49638-7a08-445e-b3ef-5051791021ea"
      unitRef="U_USD">400000</us-gaap:OperatingLeaseCost>
    <eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_3c1c914b-4b0d-48b6-9e4b-7483679bec9d">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other supplemental cash flow information related to leases were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.299999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.860000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement of lease liability:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.433%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_4f04c557-31eb-43b7-86e1-e23b6105b5da"
      unitRef="U_USD">378000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_b0483af9-81a4-499e-8e39-f213f2399842"
      unitRef="U_USD">378000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      id="F_89e00e45-97b4-44a3-9846-05258da43da2">P2Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      id="F_20cde874-ab79-4f4a-8082-1747a6151bd7">P1Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="4"
      id="F_c7ef1b14-9eeb-4c2b-a277-f426041b99ba"
      unitRef="U_pure">0.0946</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="4"
      id="F_3c2a7779-99ad-446b-8e1b-6d4162ccc861"
      unitRef="U_pure">0.0249</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_302e0426-06f8-400e-8ff4-65a4e354dd95">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:70.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.941%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:24.544999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,087&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less current portion of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;314&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_9ab70cd0-2cf7-4eb0-9932-74e7e2fd4507"
      unitRef="U_USD">391000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_8f31200c-e4df-4b01-aeb7-95c6abffdbd0"
      unitRef="U_USD">403000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_78f8c6dc-1883-4a3e-8abb-4d1be8300afa"
      unitRef="U_USD">293000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_b9539bf1-fe1e-412e-8fdc-bdb4b76ffcb2"
      unitRef="U_USD">1087000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_762840ad-fddc-458a-9a9e-ab5f34c61259"
      unitRef="U_USD">133000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_a07d47d1-0bf6-4515-8c3c-ddf8a054333a"
      unitRef="U_USD">954000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_5c645e57-31c8-4fae-b001-2be05a9f680b"
      unitRef="U_USD">314000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_31f3ab52-7ff3-4042-aff1-0b2468c2f9ad"
      unitRef="U_USD">640000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <eldn:FeeDueForMilestonesAchieved
      contextRef="C_c208ba17-2b6e-4d20-979a-92018e7e32ca"
      decimals="-5"
      id="F_e62e8835-104a-4348-9462-9a8341c1f58b"
      unitRef="U_USD">1000000</eldn:FeeDueForMilestonesAchieved>
    <eldn:FeeDueForMilestonesAchieved
      contextRef="C_91faf8d0-851e-4099-aa01-277d6ae86c25"
      decimals="-5"
      id="F_5b43aec2-b3da-489f-ad25-07465aca9f74"
      unitRef="U_USD">1000000</eldn:FeeDueForMilestonesAchieved>
    <us-gaap:StockIssued1
      contextRef="C_77fcb03b-d40c-4c83-a674-4d30ef20d74d"
      decimals="-5"
      id="F_41e62d48-2e57-4554-ad20-875313011e2b"
      unitRef="U_USD">1000000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="C_01c9b5c7-df17-42c2-ae7f-2df53dfe3244"
      decimals="-5"
      id="F_1329e3c5-1c15-4f08-b034-3bba8a0545e9"
      unitRef="U_USD">1000000</us-gaap:StockIssued1>
    <eldn:NumberOfMilestonesAchieved
      contextRef="C_97d0a02e-f66e-4785-bdd9-f6ec23959807"
      decimals="INF"
      id="F_314d10fd-4fc3-4355-9510-6172cca90b41"
      unitRef="U_Milestone">0</eldn:NumberOfMilestonesAchieved>
    <eldn:NumberOfMilestonesAchieved
      contextRef="C_45654a12-fdcb-4ab8-aa38-1e9adb0677f1"
      decimals="INF"
      id="F_d3a67182-939d-4efd-94b6-58ea47c9e0a3"
      unitRef="U_Milestone">0</eldn:NumberOfMilestonesAchieved>
    <eldn:RemainingMilestonePaymentsForFirstLicensedProduct
      contextRef="C_a3a07715-3a73-4dad-aa92-b1e0504bed50"
      decimals="-5"
      id="F_7ada0c7d-733c-46dc-9254-82c5e37c1d88"
      unitRef="U_USD">6000000</eldn:RemainingMilestonePaymentsForFirstLicensedProduct>
    <eldn:RegulatoryMilestonePaymentsObligation
      contextRef="C_d0e34266-9d94-4045-9e3a-77a1916c58ff"
      decimals="INF"
      id="F_a8eb2d0d-1267-40bd-8b6b-9afb3a65f37b"
      unitRef="U_USD">2500000</eldn:RegulatoryMilestonePaymentsObligation>
    <eldn:AnnualLicenseMaintenanceFee
      contextRef="C_a101b2be-54a1-4e3e-a107-2e740e2bd083"
      decimals="-5"
      id="F_47eec310-424c-443a-b776-805cd1173ce4"
      unitRef="U_USD">100000</eldn:AnnualLicenseMaintenanceFee>
    <eldn:AnnualLicenseMaintenanceFee
      contextRef="C_97d0a02e-f66e-4785-bdd9-f6ec23959807"
      decimals="-5"
      id="F_301b9681-1047-4de2-bd55-21d3b52d7fae"
      unitRef="U_USD">100000</eldn:AnnualLicenseMaintenanceFee>
    <eldn:AnnualLicenseMaintenanceFee
      contextRef="C_45654a12-fdcb-4ab8-aa38-1e9adb0677f1"
      decimals="-5"
      id="F_fa961710-ed1b-4898-b2cd-99893160abc9"
      unitRef="U_USD">100000</eldn:AnnualLicenseMaintenanceFee>
    <eldn:AnnualLicenseMaintenanceFee
      contextRef="C_814f6c12-39d8-48c7-97a5-4f0838b03063"
      decimals="-5"
      id="F_db98a9ac-aecc-4fe6-8862-3fb83337f1e9"
      unitRef="U_USD">100000</eldn:AnnualLicenseMaintenanceFee>
    <eldn:AggregateNetSalesAchievement
      contextRef="C_4815e24c-4159-4500-b666-85aff53dcfc5"
      decimals="-5"
      id="F_889ed867-3f2f-46ef-ae8f-d6cf8df6cd07"
      unitRef="U_USD">500000000</eldn:AggregateNetSalesAchievement>
    <us-gaap:RoyaltyGuaranteesCommitmentsAmount
      contextRef="C_46b5adb0-3c28-4e8a-a89e-80ec27d1c833"
      decimals="-5"
      id="F_de1634fc-28a2-451d-997f-a3b4bd493611"
      unitRef="U_USD">15000000</us-gaap:RoyaltyGuaranteesCommitmentsAmount>
    <eldn:AggregateNetSalesAchievement
      contextRef="C_e6ea7a2e-1ed7-4d2e-84d7-ac031499af66"
      decimals="-8"
      id="F_dc72bfb1-1169-4def-857a-758f435a7de9"
      unitRef="U_USD">1000000000</eldn:AggregateNetSalesAchievement>
    <us-gaap:RoyaltyGuaranteesCommitmentsAmount
      contextRef="C_e001cf60-2e45-48f9-8cca-188f9699760d"
      decimals="-5"
      id="F_1a850fa1-e497-499a-b953-57c2d7ec34b8"
      unitRef="U_USD">30000000</us-gaap:RoyaltyGuaranteesCommitmentsAmount>
    <eldn:ManufacturingExpensesOffset
      contextRef="C_980b621d-2497-459b-aea6-bca6da258067"
      decimals="-5"
      id="F_644aabc1-646b-4aad-88d1-0f343d949379"
      unitRef="U_USD">100000</eldn:ManufacturingExpensesOffset>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_9bbaa886-efd4-4bb3-9f17-00702b403056"
      unitRef="U_USD">0</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <eldn:ContingentLiability
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_568b5a34-9af0-44af-a70f-6ed6a2c30463"
      unitRef="U_USD">0</eldn:ContingentLiability>
    <eldn:ContingentLiability
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="INF"
      id="F_f0e776f8-55fc-41dd-9422-65f05ab9d1f3"
      unitRef="U_USD">0</eldn:ContingentLiability>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_fa847f77-1728-43f2-9f49-6cef3f950b06">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 7. Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Loss before income taxes are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Losses before income taxes:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant judgment is required in determining the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Based on its review, the Company concluded that it was more likely than not that they would not realize the benefit of a portion of its deferred tax assets in the future. This conclusion was based on historical and projected operating performance, as well as the Company&#x2019;s expectation that its operations will not generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets within the statutory carryover periods. Therefore, the Company has a valuation allowance on its deferred tax assets as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the U.S. federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.913%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.783000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.422%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income taxes, net of federal tax benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;908&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,819&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Permanent items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State rate differential&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;NOL true-up&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;566&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,137&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,740&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,560&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,202&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accruals and reserves&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;366&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research expenditures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,809&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,085&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,056&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,319&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,623&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,183&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:61.448%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.277000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.277000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross unrecognized tax benefits at the beginning of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions from tax positions taken in the current year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions from tax positions taken in prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross unrecognized tax benefits at the end of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,232&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The deferred income tax assets have been offset by a valuation allowance, as realization is dependent on future earnings, if any, the timing and amount of which are uncertain. The net valuatio&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;n allowance increased by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023 to December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The net valuation allowance increased by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2022 to December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s accounting for deferred taxes involves the evaluation of a number of factors concerning the realizability of its net deferred tax assets. The Company primarily considered such factors as its history of operating losses, the nature of the Company&#x2019;s deferred tax assets, and the timing, likelihood, and amount, if any, of future taxable income during the periods in which those temporary differences and carryforwards become deductible. At present, the Company does not believe that it is more likely than not that the deferred tax assets will be realized; accordingly, a valuation allowance has been established.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had federal net operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, available to reduce future taxable income. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company also has state net operating loss carryforwards of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. Both the federal and state net operating loss carryforwards incurred before 2018 begin expiring in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2035&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;if not utilized. The federal net operating losses incurred since 2018 of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million do not expire. The state net operating losses begin to expire in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2035&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had federal research and development tax credit carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. If not utilized, the carryforwards will begin expiring in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2036&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has state research and development credit carryforwards or approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, which will begin expiring in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2030&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; if not utilized&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to Internal Revenue Code (IRC) Sections 382 and 383, annual use of the Company&#x2019;s net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% occurs within a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; period. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has not completed an IRC Section 382/383 analysis regarding the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;limitation &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of net operating loss and research and development credit carryforwards. Due to the existence of the valuation allowance, future changes in the Company&#x2019;s unrecognized tax benefits will not impact the Company&#x2019;s effective tax rate.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s ability to use its remaining net operating loss and tax credit carryforwards may be further limited if the Company experiences a Section 382 ownership change in connection with future changes in our stock ownership.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the United States, the Company files income tax returns in the U.S. Federal jurisdiction, California and Massachusetts. The Company&#x2019;s tax years for 2018 and forward are subject to examination by the Federal and California tax authorities due to the carryforward of unutilized net operating losses and research and development credits.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s policy is to recognize interest expense and penalties related to income tax matters as a component of income tax expense. There was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accrued interest and penalties associated with uncertain tax positions as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t recorded any interest or penalties in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024 or 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_2a6082c5-97f2-4691-a772-119407fe36ef">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Loss before income taxes are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Losses before income taxes:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_26b5bdec-d421-4dc6-a5ba-0d24053bd2ff"
      unitRef="U_USD">-35951000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_f8f35955-a1cf-494d-86d7-02c94207daf6"
      unitRef="U_USD">-116736000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_c4f7f1a5-9db1-4cb8-978a-d06cfe4d71f4"
      unitRef="U_USD">198000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_794abb90-09b1-4fdf-8d58-e535b80f1161"
      unitRef="U_USD">199000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_d8afa6e8-8f5b-42b2-b925-465417321f1d"
      unitRef="U_USD">-35753000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_d0f2bce4-5eb0-49e0-89da-48c5b56b493c"
      unitRef="U_USD">-116537000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_5404a62f-3dc6-4142-9ddc-188eb4082c55">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_9eda4d71-ebf2-419f-b1b2-8fe5b4844fe2"
      unitRef="U_USD">431000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_3a6d5abc-1472-46ce-b8df-7f4dc1a1a9d4"
      unitRef="U_USD">431000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_5b25a551-9041-49af-aec2-ee065d7ce469"
      unitRef="U_USD">431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_ce245383-9a5a-445a-8d7f-3b303f5fa4e7">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the U.S. federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.913%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.783000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.422%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income taxes, net of federal tax benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;908&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,819&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Permanent items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State rate differential&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;NOL true-up&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;566&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,137&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_10739608-a2e7-45e2-a789-1273e4a75693"
      unitRef="U_USD">-7508000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_7c928c5d-8811-4659-b355-a17c53ee2759"
      unitRef="U_USD">-24473000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <eldn:StateIncomeTaxesNetOfFederalTaxBenefits
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_1b627d60-8c6c-41fc-94e8-311a2b4d1232"
      unitRef="U_USD">-908000</eldn:StateIncomeTaxesNetOfFederalTaxBenefits>
    <eldn:StateIncomeTaxesNetOfFederalTaxBenefits
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_26db604d-8423-45f5-bea3-4fc8bb731432"
      unitRef="U_USD">-3170000</eldn:StateIncomeTaxesNetOfFederalTaxBenefits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_c4cde875-b746-4a4c-bc36-be341634a624"
      unitRef="U_USD">2358000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_18f3e8f0-45ce-4268-85bd-47050b88084c"
      unitRef="U_USD">972000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_18c3eebc-1ae3-4788-a670-dc71475ec161"
      unitRef="U_USD">2819000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_0b22b7c2-1ecc-48c1-b128-8091c2542744"
      unitRef="U_USD">728000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <eldn:IncomeTaxReconciliationPermanentItems
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_760eea96-c380-493b-acba-16f66db20b82"
      unitRef="U_USD">12000</eldn:IncomeTaxReconciliationPermanentItems>
    <eldn:IncomeTaxReconciliationPermanentItems
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_699d6e6e-d970-403f-87ee-233f21cdc5c8"
      unitRef="U_USD">9000</eldn:IncomeTaxReconciliationPermanentItems>
    <eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_6028a22b-e878-4b7a-9f29-09016d4b265f"
      unitRef="U_USD">-7273000</eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_9f3835c5-0469-40c1-b9f1-5c5b294f2569"
      unitRef="U_USD">18078000</eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:IncomeTaxReconciliationStateTaxRateDifferential
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_c550b74a-dd3f-4f7f-beef-bf7fc7a6267b"
      unitRef="U_USD">490000</eldn:IncomeTaxReconciliationStateTaxRateDifferential>
    <eldn:IncomeTaxReconciliationStateTaxRateDifferential
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_d34f8f97-c632-45f2-a4e3-4fe9247ebd7e"
      unitRef="U_USD">32000</eldn:IncomeTaxReconciliationStateTaxRateDifferential>
    <eldn:NOLTrueUp
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_151caad9-750e-4292-a913-1f88b52f35d0"
      unitRef="U_USD">-4000</eldn:NOLTrueUp>
    <eldn:NOLTrueUp
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_b8cc7432-1185-4028-880a-8912527a26a8"
      unitRef="U_USD">2000</eldn:NOLTrueUp>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_730c0585-6431-462d-a132-a03784e56ef2"
      unitRef="U_USD">24000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_77ae1b42-c650-4bf4-b32d-55bba996bfa6"
      unitRef="U_USD">566000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_49f9a72f-d37c-41db-adb0-1e944597acf5"
      unitRef="U_USD">15137000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_2a2945bf-a448-4255-bfbe-e3fd00400604"
      unitRef="U_USD">9200000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_20eeb237-795e-4a65-ba47-3d2ebe22fcfe"
      unitRef="U_USD">431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_4769c9d3-8362-4beb-9d1e-7a7acda9e674"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_d4244896-2a60-4b5a-9db1-e62dde1e8c8f">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,740&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,560&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,202&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accruals and reserves&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;366&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research expenditures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,809&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,085&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,056&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,319&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,623&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,183&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_457fbe6c-475c-4ad4-8c11-25c790151196"
      unitRef="U_USD">22740000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_d1bac235-e980-4e94-835f-ff206afef15a"
      unitRef="U_USD">18089000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_6f08ea28-b279-4758-9745-a31deb22d14c"
      unitRef="U_USD">5560000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_5fb900b2-77e0-4831-82e3-2479682a41c6"
      unitRef="U_USD">3202000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_ec867dd5-3ade-4563-838c-3704ac5ca62a"
      unitRef="U_USD">366000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_1fd86db6-4110-4843-871a-d5dcd5952139"
      unitRef="U_USD">475000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_73fad6f0-b4f2-4988-ba23-91573edf495f"
      unitRef="U_USD">18809000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_b4973c93-f0e7-4580-bebb-ada2b9172f0c"
      unitRef="U_USD">10567000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_03cfecd9-cf53-475c-bf81-96c14976f366"
      unitRef="U_USD">3281000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_a5855195-9f8b-4378-9e8c-efee7ad18f3f"
      unitRef="U_USD">3085000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <eldn:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_ad6abb28-2932-4cc1-af6d-52237ae2fdb3"
      unitRef="U_USD">1056000</eldn:DeferredTaxAssetsDepreciationAndAmortization>
    <eldn:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_58b81bcd-1b13-4feb-9e1f-25e1d4e86b42"
      unitRef="U_USD">1319000</eldn:DeferredTaxAssetsDepreciationAndAmortization>
    <eldn:DeferredTaxAssetsLeaseLiability
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_daec3b04-4e62-4bd0-8223-8684893a17e4"
      unitRef="U_USD">225000</eldn:DeferredTaxAssetsLeaseLiability>
    <eldn:DeferredTaxAssetsLeaseLiability
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_7c5c2d1f-ba3e-4218-aad1-1156eaa2c18f"
      unitRef="U_USD">91000</eldn:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_1f0a44c3-82aa-41c8-ba63-279235c475f5"
      unitRef="U_USD">52037000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_46759fb1-db2d-459f-b537-d375a4c46708"
      unitRef="U_USD">36828000</us-gaap:DeferredTaxAssetsGross>
    <eldn:DeferredTaxAssetsRightOfUseAsset
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_01114c6c-c6b8-4090-8bfc-9a68b532cf4f"
      unitRef="U_USD">218000</eldn:DeferredTaxAssetsRightOfUseAsset>
    <eldn:DeferredTaxAssetsRightOfUseAsset
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_aad4acab-b4c3-4778-84c3-0df812824497"
      unitRef="U_USD">87000</eldn:DeferredTaxAssetsRightOfUseAsset>
    <eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_0fe3567b-e289-4691-a9d2-2abeda5a96be"
      unitRef="U_USD">7623000</eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment>
    <eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_3a7f24f9-a4e5-4916-b15c-769b8b873d29"
      unitRef="U_USD">7682000</eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_ffe73aa3-6bb8-488c-915d-265dd2677923"
      unitRef="U_USD">7841000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_1ddd71de-7be6-4689-899f-dcb40694d24a"
      unitRef="U_USD">7769000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_47e5746c-f3c6-44be-b2f8-4de762f8698d"
      unitRef="U_USD">46379000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_dbfdd4d0-1a33-4fc0-9e75-57b4f2edd418"
      unitRef="U_USD">30811000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_764b8da3-fdbc-4889-abb0-870081e9776a"
      unitRef="U_USD">2183000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_f3ff8f4b-3e9f-4c70-a526-235f6fcb356d"
      unitRef="U_USD">1752000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_31917eea-c5d9-42df-8e90-4d5d8a46704f">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:61.448%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.277000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.277000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross unrecognized tax benefits at the beginning of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions from tax positions taken in the current year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions from tax positions taken in prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross unrecognized tax benefits at the end of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,232&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_ddd2be48-de9a-4efa-b935-527e8b507eb7"
      unitRef="U_USD">3636000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_703721ac-e233-4584-a2ed-617913379b0c"
      decimals="-3"
      id="F_748dd557-ca1b-4029-a7b4-1b40abe0db59"
      unitRef="U_USD">2664000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_39619e94-e351-4147-ba8f-7f1e8ae97b04"
      unitRef="U_USD">2596000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_d7000276-a4f2-4b40-85a9-7a17d1dc15be"
      unitRef="U_USD">972000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_71c5021f-a32f-448f-907a-92badc33b87a"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_a12659f1-967b-49e1-a381-e0a60a5fa6ea"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_0c43b15a-54f8-4e54-8b57-74427ba7d48c"
      unitRef="U_USD">6232000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_d9ceb0e7-2a0a-438a-923f-ab36176c4781"
      unitRef="U_USD">3636000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-5"
      id="F_c93916fc-33cd-4165-bae9-9daca0ff02fd"
      unitRef="U_USD">15600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-5"
      id="F_3df13df2-ab6c-415b-8895-328b8acad629"
      unitRef="U_USD">9100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_2fbd8e54-c07a-4e1c-b971-6c9f65cf8c76"
      decimals="-5"
      id="F_fcc26a50-ab11-41af-95e0-017088fde1c6"
      unitRef="U_USD">88700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_b33d77f0-6276-40fa-bd85-4b5a8ba275fe"
      decimals="-5"
      id="F_59938733-957a-4e57-b87d-da0f55f01cd4"
      unitRef="U_USD">68900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_2a66afd3-0d1f-4b4b-9cb7-38a0c6a60d81"
      decimals="-5"
      id="F_438ac45d-9f19-4948-87cb-f8ce6e800561"
      unitRef="U_USD">37700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_13e69911-29ff-4b45-829c-2ae93e92cdf1"
      decimals="-5"
      id="F_3d4e821e-a061-42d7-b4ae-d4ba7c141544"
      unitRef="U_USD">30100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <eldn:NetOperatingLossCarryforwardsExpirationPeriod
      contextRef="C_50d65f8a-54ee-42c3-8b17-0043d0fbcc9c"
      id="F_e8e99bf5-4711-41a8-8b0b-42196baf6fb4">2035</eldn:NetOperatingLossCarryforwardsExpirationPeriod>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="C_2fbd8e54-c07a-4e1c-b971-6c9f65cf8c76"
      decimals="-5"
      id="F_986693e6-b709-4cc5-8524-d6b5fbb05799"
      unitRef="U_USD">87900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <eldn:NetOperatingLossCarryforwardsExpirationPeriod
      contextRef="C_ea3f0ca6-47b7-45eb-83f1-2f6de59e3fc8"
      id="F_1c82677e-d771-4474-8f4b-8031f96f54e4">2035</eldn:NetOperatingLossCarryforwardsExpirationPeriod>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_2fbd8e54-c07a-4e1c-b971-6c9f65cf8c76"
      decimals="-5"
      id="F_97c6411e-1df4-46a2-8280-4c4f3a821a73"
      unitRef="U_USD">8000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_b33d77f0-6276-40fa-bd85-4b5a8ba275fe"
      decimals="-5"
      id="F_47e9ab2d-0780-47d9-9d9a-62a09055e0ac"
      unitRef="U_USD">4000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <eldn:TaxCreditCarryforwardExpirationPeriod
      contextRef="C_50d65f8a-54ee-42c3-8b17-0043d0fbcc9c"
      id="F_3473415d-6b39-4553-bcc5-a9b5dd638718">2036</eldn:TaxCreditCarryforwardExpirationPeriod>
    <eldn:TaxCreditCarryforwardExpirationDescription
      contextRef="C_929233e8-37d7-4ad4-af4a-17c57fc92607"
      id="F_9d810203-901d-4492-8bc0-00aa77b0dd57">As of December 31, 2024 and 2023, the Company has state research and development credit carryforwards or approximately $2.6 million and $1.5 million, respectively, which will begin expiring in 2030 if not utilized</eldn:TaxCreditCarryforwardExpirationDescription>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_2a66afd3-0d1f-4b4b-9cb7-38a0c6a60d81"
      decimals="-5"
      id="F_a010c24e-e5b5-4605-a399-a46e39b025ee"
      unitRef="U_USD">2600000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_13e69911-29ff-4b45-829c-2ae93e92cdf1"
      decimals="-5"
      id="F_63f379aa-5f77-4dd7-8338-d790f8276735"
      unitRef="U_USD">1500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <eldn:TaxCreditCarryforwardExpirationPeriod
      contextRef="C_929233e8-37d7-4ad4-af4a-17c57fc92607"
      id="F_ef8738b1-f29f-45f3-bc9e-81b3f2f31d59">2030</eldn:TaxCreditCarryforwardExpirationPeriod>
    <eldn:PercentageOfCumulativeChangeInOwnership
      contextRef="C_647ab198-415d-40e9-bf66-98868d7ffd37"
      decimals="INF"
      id="F_8756da1d-398c-474c-b062-6a67e9a037e3"
      unitRef="U_pure">0.50</eldn:PercentageOfCumulativeChangeInOwnership>
    <eldn:PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_6b661a91-2c8c-478f-a2a3-2bddb9ea5240">P3Y</eldn:PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_3043952b-62ff-441d-8e77-e52d897e47f4"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="INF"
      id="F_123ca131-8f97-48da-8aee-37f4aa16be3b"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="INF"
      id="F_d422efb5-43be-41de-a693-8b56f8a4cf43"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="INF"
      id="F_b62d1154-e3a8-45c2-b92a-9b285dd0c212"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_2553cacf-11e1-45ab-938c-63a2fcfd0436">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 8. Stockholders&#x2019; Equity (As Restated)&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; authorized shares of preferred stock with a par value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; non-voting convertible preferred stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares designated; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares issued and outstand&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ing at December 31, 2024 and 2023, and &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares designated; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares issued and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; outstanding at December 31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Each share of the Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; or X non-voting convertible preferred stock (the &#x201c;Preferred Stock&#x201d;) is convertible into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55.5556&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock, at the option of the holder at any time, subject to certain limitations, including, that the holder will be prohibited from converting the Preferred Stock into common stock if, as a result of such conversion, the holder, together with its affiliates, would beneficially own a number of shares of common stock above a conversion blocker, which is initially set at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% or &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the total common stock then issued and outstanding immediately following the conversion of such shares of Series X Preferred Stock or Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Preferred Stock, respectively. The holder of the Preferred Stock is entitled to receive dividends on shares of the Preferred Stock equal (on an as-if-converted-to-common-stock basis and without regard to any beneficial ownership limitations) to and in the same form as dividends actually paid on shares of the common stock. No other dividends will be paid on shares of the Preferred Stock. In the event of any liquidation, dissolution or winding up, the holder of the Preferred Stock will be entitled to receive out of the assets, whether capital or surplus, the same amount that a holder of common stock would receive if the Preferred Stock were fully converted to common stock, which amounts shall be paid pari passu with all holders of common stock. Shares of the Preferred Stock will generally have no voting rights, except as required by law and except that the consent of a majority of the holders of either series of outstanding Preferred Stock will be required to amend the terms of such series.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Preferred Stock includes a provision that, in the event of a tender or exchange offer by a third party in which more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the common stockholders receive cash or other assets, allows holders of Preferred Stock, upon any subsequent conversion, to redeem their shares for the same form of consideration. Because this redemption right may be triggered by an event outside the Company&#x2019;s control and could result in settlement in cash, the Preferred Stock is classified as temporary equity. As of the current reporting date, a tender offer is not probable, and the preferred stock is not deemed probable of becoming redeemable. Because redemption is not considered probable, the Preferred Stock is not subsequently remeasured to its redemption value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2022 Exchange Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 11, 2022, the Company entered into an exchange agreement (the &#x201c;Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Exchange Agreement&#x201d;) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., MSI BVF SPV, L.L.C. (collectively, the &#x201c;BVF Exchanging Stockholders&#x201d;), pursuant to which the Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Exchanging Stockholders exchanged (the &#x201c;Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Exchange&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;550,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,899.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Ser&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ies X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Non-Voting Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 28, 2023, the Company entered into a Securities Purchase Agreement (the &#x201c;2023 Securities Purchase Agreement&#x201d;) with certain investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#x201c;2023 Private Placement&#x201d;) (i) in an initial closing, (a) an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,151,518&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares (the &#x201c;Shares&#x201d;) of the Company&#x2019;s common stock, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; par value per share, or pre-funded warrants in lieu thereof (the &#x201c;Pre-Funded Warrants&#x201d;), and (b) common stock warrants exercisable into an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,151,518&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (or Pre-Funded Warrants in lieu thereof) (the &#x201c;Common Warrants&#x201d; and, together with the Pre-Funded Warrants, the &#x201c;Warrants&#x201d;); (ii) in a second closing (the &#x201c;Second Closing&#x201d;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,202,024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (or Pre-Funded Warrants); and (iii) in a third closing (the &#x201c;Third Closing&#x201d;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,252,530&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (or Pre-Funded Warrants), in each case subject to customary adjustments as provided in the 2023 Securities Purchase Agreement, Pre-Funded Warrant or Common Warrant, as applicable. Each Common Warrant has an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and expires five years after issuance. The Pre-Funded Warrants are exercisable immediately and until exercised in full, with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Pre-Funded Warrants and Common Warrants are subject to specified beneficial ownership limitations, which are generally set at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% unless otherwise permitted. The Shares, the Warrants, and the shares of common stock issuable upon the exercise of the Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 5, 2023, the initial closing occurred, and the Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting offering costs, in exchange for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,730,168&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock and Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,421,350&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 8, 2024, the Second Closing occurred, and the Company received gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting offering costs, in exchange for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;909,088&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 30, 2024, and October 1, 2024, the Third Closing occurred, and the Company received gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting offering costs, in exchange for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,727,400&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the 2023 Private Placement, the Company filed on May 18, 2023, a registration statement on Form S-3 (the &#x201c;2023 Registration Statement&#x201d;) with the SEC to register for resale the Shares and the shares of common stock issuable upon the exercise of the Warrants. The 2023 Registration Statement became effective on June 2, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2024, the Company concluded that the Common Warrants, and the potential issuance of Pre-Funded Warrants in lieu of additional shares of common stock in the Second Closing and Third Closing (the &#x201c;Subsequent Closing Warrants&#x201d;) do not meet the conditions to be classified as equity instruments under ASC 815-40 and must instead be recorded as liabilities on the Company&#x2019;s consolidated balance sheets at their fair value and remeasured at fair value for each subsequent reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The valuation of the Common Warrants and the Subsequent Closing Warrants is adjusted to fair value (Level 3) at each balance sheet date until the Common Warrants and the Subsequent Closing Warrants are settled or expired.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, and as of the issuance date:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:47.149%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.823999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:23.064999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;96.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life of options (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Share price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2023 Conversion Agreement of Non-Voting Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;O&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;n May 16, 2023, Cormorant Global Healthcare Master Fund LP provided notice to convert (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,782&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Series X Non-Voting Convertible Preferred Stock for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;99,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X Non-Voting Convertible Preferred Stock, and (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,883.586&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Non-Voting Convertible Preferred Stock for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;437,977&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Non-Voting Convertible Preferred Stock. The conversion was completed on May 23, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2024 Securities Purchase Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 6, 2024, the Company entered into a Securities Purchase Agreement (the &#x201c;2024 Securities Purchase Agreement&#x201d;) with certain institutional and accredited investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#x201c;2024 Private Placement&#x201d;) an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,110,484&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares (the &#x201c;2024 Shares&#x201d;) of the Company&#x2019;s common stock, at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.37&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, and pre-funded warrants (the &#x201c;2024 Pre-Funded Warrants&#x201d;) at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.369&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per underlying share, which are exercisable to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,989,516&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. The 2024 Pre-Funded Warrants were issued in lieu of shares of common stock and are exercisable immediately and until exercised in full. The 2024 Pre-Funded Warrants are subject to specified beneficial ownership limitations (equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% or &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% as determined by holder of each such warrant) of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% unless otherwise permitted. The 2024 Shares, the 2024 Pre-Funded Warrants, and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2024 Pre-Funded Warrants were classified as a component of permanent stockholders&#x2019; equity within additional paid-in-capital. The 2024 Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#x2019;s common stock and meet the equity classification criteria. In addition, the 2024 Pre-Funded Warrants do not provide any guarantee of value or return.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2024 Private Placement resulted in gross proceeds to the Company of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting offering costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the 2024 Private Placement, the Company filed on May 24, 2024, a registration statement on Form S-3 (the &#x201c;2024 Registration Statement&#x201d;) with the SEC to register for resale the 2024 Shares and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants. The 2024 Registration Statement became effective on June 5, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2024 Equity Distribution Agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 20, 2024, the Company entered into an Open Market Sale Agreement (the &#x201c;Sales Agreement&#x201d;) with Guggenheim Securities, LLC (&#x201c;Guggenheim Securities&#x201d;) to sell shares of the Company&#x2019;s common stock, having aggregate sales proceeds of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, from time to time, through an &#x201c;at the market&#x201d; equity offering program under which Guggenheim Securities will act as sales agent. In connection with the Sales Agreement, the Company filed on September 20, 2024 a registration statement on Form S-3 containing a prospectus and prospectus supplement (the &#x201c;Shelf Registration Statement&#x201d;) with the SEC. The Shelf Registration Statement became effective on October 2, 2024. As of the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;year ended December 31, 2024, the Company has not sold any shares under the Sales Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2024 Underwritten Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 29, 2024, the Company entered into an underwriting agreement with Leerink Partners, LLC, as representative of the several underwriters named therein (the &#x201c;Underwriters&#x201d;) in connection with the underwritten offering, issuance and sale by the Company (the &#x201c;2024 Underwritten Offering&#x201d;) of&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,356,173&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock, at an offering price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.65&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, and pre-funded warrants at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.649&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per pre-funded warrant, which are exercisable to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,931,507&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share (the &#x201c;Offering Pre-Funded Warrants&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Offering Pre-Funded Warrants were classified as a component of permanent stockholders&#x2019; equity within additional paid-in-capital. The Offering Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#x2019;s common stock and meet the equity classification criteria. In addition, the Offering Pre-Funded Warrants do not provide any guarantee of value or return.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2024 Underwritten Offering closed on October 30, 2024 and resulted in gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;79.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting underwriting discounts and commissions and offering expenses. The 2024 Underwritten Offering was made pursuant to the Shelf Registration Statement and a prospectus supplement relating to the 2024 Underwritten Offering dated October 29, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A holder of the Offering Pre-Funded Warrants (together with its affiliates) may not exercise any portion of an Offering Pre-Funded Warrant to the extent that the that, after giving effect to such exercise, the holder (together with the holder&#x2019;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#x2019;s affiliates) would beneficially own in excess of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% (or, at the holder&#x2019;s option upon issuance, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%) of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of such Offering Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Exercise of Pre-Funded Warrants from 2023 Securities Purchase Agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 10, 2023, Armistice Capital Master Fund Ltd. (the &#x201c;Exercising Stockholder&#x201d;) exercised Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;501,197&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 14, 2023, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;501,197&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 2, 2023, the Exercising Stockholder exercised Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;653,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On November 6, 2023, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;653,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 30, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;600,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On January 30, 2024, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;600,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 7, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;583,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On May 9, 2024, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;583,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 11, 2024, the Exercising Stockholder exercised their remaining Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;240,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 11, 2024, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;240,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Common Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants were exercisable into common stock (after rounding for fractional shares and subject to beneficial ownership limitations).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the warrants to purchase common stock activity:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:40.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Roll-Forward of Warrant Activity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Common Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,788,032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,776,270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,564,302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,921,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,921,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,423,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,423,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled/Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,778,451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,274,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:40.492%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.297%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.837%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.836%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Date Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Shares of Common Stock Issuable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Expiration Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;247,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;September 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;298,692&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;September 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,151,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;May 5, 2028&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2021 pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;509,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,844,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024 Securities Purchase Agreement pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,989,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024 Underwritten Offering pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,931,507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Preferred Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, there were&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants exercisable into Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Preferred Stock which are convertible into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,789,301&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:54.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:41.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Roll-Forward of Series X&lt;/span&gt;&lt;span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;&#160;Convertible Preferred Warrant Activity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assumed and replaced&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled/Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Preferred Warrants were issued on September 14, 2020, with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.96&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and an expiration date of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_bdf65ed3-578d-4020-af63-01b8bb65437a"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_2916ff36-5ae3-48df-be52-30189fe8e69a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_a518e81b-acee-4c26-a1bf-266f87f3c691"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_03fa5a9a-da65-4a09-a217-5fbfdbfa0044"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_e731b35a-ea44-43a4-8c5c-7dc9b1f8a393"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_0bbb0365-0780-4274-981f-8dd96a5f61d3"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_315c0dbd-0a69-4efe-9cb6-5e597be831b5"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_e97f73d7-739f-4a66-8721-822156463bb6"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_296a3573-63a3-41eb-8203-540651d9d9f5"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_e49d23ce-7ecb-4b3e-a31c-ac1ef84fa00d"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_ce1fb67e-568b-49a3-b1e2-9c4f215a28d4"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_cb74f4f3-92c8-4f2e-864a-32603404fa11"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_508d514c-f9d4-4590-8f3a-6ea4a105f6ef"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_b0409420-ab4c-40c8-ad06-9526179d63e9"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_a3d14d16-847d-4ad0-a2c1-7bbc3743fb74"
      decimals="INF"
      id="F_ef8982e1-e7c3-48b7-a160-15dfa4a14cd9"
      unitRef="U_shares">55.5556</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_cc04c70c-694e-4769-aaa2-e6dd4cce3bb0"
      decimals="INF"
      id="F_1f0690b0-739e-42c7-ab57-d599f4dc577d"
      unitRef="U_shares">55.5556</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <eldn:ConversionOfPreferredStockConversionBlockerPercent
      contextRef="C_60bed74c-0075-4313-9b4a-3fbb4bcd7484"
      decimals="4"
      id="F_8535d7aa-f30a-4662-9ee5-556119946294"
      unitRef="U_pure">0.0999</eldn:ConversionOfPreferredStockConversionBlockerPercent>
    <eldn:ConversionOfPreferredStockConversionBlockerPercent
      contextRef="C_fd236f0b-9227-41ed-9c2f-f887ba0032a9"
      decimals="4"
      id="F_5ad02dde-6958-45de-8b1e-a6c8e9f58ea5"
      unitRef="U_pure">0.0999</eldn:ConversionOfPreferredStockConversionBlockerPercent>
    <eldn:ConversionOfPreferredStockConversionBlockerPercent
      contextRef="C_b245d8ef-b745-4fa1-9b3e-7439a1b246db"
      decimals="3"
      id="F_ec1dc148-8d21-4319-b4a1-ee8571879dde"
      unitRef="U_pure">0.099</eldn:ConversionOfPreferredStockConversionBlockerPercent>
    <eldn:ConversionOfPreferredStockConversionBlockerPercent
      contextRef="C_14e122c7-b47c-4847-aa31-c23b1f2dafec"
      decimals="3"
      id="F_6dd3eda7-c849-478a-a43a-d7f66ec9bf6e"
      unitRef="U_pure">0.099</eldn:ConversionOfPreferredStockConversionBlockerPercent>
    <eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="2"
      id="F_d282fe75-0aa5-4ca9-b852-c4526926c0c0"
      unitRef="U_pure">0.50</eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_550f904f-a665-4c4c-a926-3bccfcba9c6b"
      decimals="INF"
      id="F_f8126ed4-a688-4fef-a66a-9803bb3c7736"
      unitRef="U_shares">550000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_f6bd4419-9bd8-464e-acfd-beb0e29ce4ce"
      decimals="INF"
      id="F_80dc29cb-e556-4129-b518-6effdff91c11"
      unitRef="U_shares">9899.99</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_99fb4269-13f1-4e54-8343-39a92e170c3a"
      decimals="INF"
      id="F_fcc3c70b-2dfb-4069-8c6c-3605ff808826"
      unitRef="U_shares">15151518</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_99fb4269-13f1-4e54-8343-39a92e170c3a"
      decimals="INF"
      id="F_0fc7f544-49c7-4bf8-9eca-436402c99538"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_99fb4269-13f1-4e54-8343-39a92e170c3a"
      decimals="INF"
      id="F_3a385674-4d11-4c3a-b700-ed52962324cf"
      unitRef="U_shares">15151518</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_fd5b7956-4959-43cd-b4c5-b1fde759c23c"
      decimals="INF"
      id="F_bbc60d85-28e7-491c-9394-449652e7a5d4"
      unitRef="U_shares">20202024</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_07a68ee8-82a0-456f-b6d3-9977f22a230f"
      decimals="INF"
      id="F_45e27183-e107-4a4d-8cc0-10ccb584a6af"
      unitRef="U_shares">25252530</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_7f10a0e1-7bb1-4217-8c81-fe3de5a1918e"
      decimals="2"
      id="F_4af5a7fa-3731-47c1-bb4e-078b02a8f7c9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_e18de94d-dbd0-4d3d-ba53-59c1f412228b"
      decimals="3"
      id="F_ac660010-6d2f-43d1-a3cd-7341e8147aba"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_02359b89-94e1-443c-ac29-3c67769f2cb8"
      decimals="4"
      id="F_1fe60dd7-7e4c-47c9-a747-26b56e40dcf6"
      unitRef="U_pure">0.0999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_78d65748-c663-4c56-aa09-66c64ed912e1"
      decimals="4"
      id="F_ac40f25a-8c09-4afa-a190-f464fc529696"
      unitRef="U_pure">0.0999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage
      contextRef="C_4c665ca9-bab8-40bc-b5cb-2233b3df82bc"
      decimals="4"
      id="F_2d7e8491-6482-41a4-ac06-df17b05f0cb7"
      unitRef="U_pure">0.1999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage
      contextRef="C_6e303928-4d0c-4180-838a-ad93da24f889"
      decimals="4"
      id="F_f7935d59-8e1f-4b4b-936d-1564d8b562d3"
      unitRef="U_pure">0.1999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_9451594c-6f06-454d-8721-5fd66258a715"
      decimals="-5"
      id="F_659c3a15-0cfb-4c80-955d-f26e9c2b413f"
      unitRef="U_USD">35000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet
      contextRef="C_9451594c-6f06-454d-8721-5fd66258a715"
      decimals="-5"
      id="F_284244a6-17aa-4ee5-83f7-f210c4cee95d"
      unitRef="U_USD">33000000</eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_942a2564-5176-4190-a212-2b973ceb1a34"
      decimals="0"
      id="F_6cea88d5-7ae6-4967-bc03-67295bf618d6"
      unitRef="U_shares">8730168</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_8e654e4d-37e7-47fa-95fa-928b05de9595"
      decimals="0"
      id="F_d7074705-9e75-46f7-b61b-2da5624a1049"
      unitRef="U_shares">6421350</us-gaap:CommonStockSharesIssued>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_320ec943-bc2b-449e-8081-892254217c23"
      decimals="-5"
      id="F_3aba21fe-b318-400a-9c6e-82e9f28a0f0c"
      unitRef="U_USD">2100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
      contextRef="C_320ec943-bc2b-449e-8081-892254217c23"
      decimals="-5"
      id="F_27742a8e-112e-4089-9106-079966a7e827"
      unitRef="U_USD">2000000</eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_26899444-530f-4870-a095-0c5c5401b54a"
      decimals="0"
      id="F_c6e6e83b-c1bf-4a76-935d-1e2bdc051e3b"
      unitRef="U_shares">909088</us-gaap:CommonStockSharesIssued>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_d59b82b7-5627-447f-ac66-5fb9c579fdfe"
      decimals="-5"
      id="F_6c87b69c-7581-444d-9b10-1bd2eb6a48c3"
      unitRef="U_USD">4000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_463fd8a9-edbf-489e-aaf7-3a59cf541462"
      decimals="-5"
      id="F_50a91529-d4ec-4a32-8ba2-0be8f66bfec2"
      unitRef="U_USD">4000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
      contextRef="C_d59b82b7-5627-447f-ac66-5fb9c579fdfe"
      decimals="-5"
      id="F_095e9a14-f308-48b9-b4d4-65d3353980b6"
      unitRef="U_USD">3800000</eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts>
    <eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
      contextRef="C_463fd8a9-edbf-489e-aaf7-3a59cf541462"
      decimals="-5"
      id="F_27b106b3-04fe-4c9a-8fd0-d5fce603eafa"
      unitRef="U_USD">3800000</eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_5bac50df-0bf9-4fac-8dc9-1288781f48d4"
      decimals="0"
      id="F_4c190a72-9fff-474d-9deb-933367c49a59"
      unitRef="U_shares">1727400</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_478dbeb4-70d8-4365-82b4-495e16a9644d"
      decimals="0"
      id="F_827cebbe-58db-4d70-8286-a4a066648a0f"
      unitRef="U_shares">1727400</us-gaap:CommonStockSharesIssued>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9"
      id="F_e03c8242-6937-420b-8295-17be74984cca">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, and as of the issuance date:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:47.149%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.823999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:3.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:23.064999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;96.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life of options (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Share price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9"
      decimals="3"
      id="F_ac77b033-3f01-4dfd-b9f3-a2f9dee35d82"
      unitRef="U_pure">0.964</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_4f05b713-9469-4acf-b62a-b4a410770fdc"
      decimals="3"
      id="F_051980a0-9a09-4971-ad78-a1a895fd2a51"
      unitRef="U_pure">0.891</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_4f05b713-9469-4acf-b62a-b4a410770fdc"
      decimals="3"
      id="F_42441149-04f1-43d2-bc3e-543bf9b24736"
      unitRef="U_pure">0.943</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9"
      decimals="3"
      id="F_1adae245-f8fa-4bd1-bc7c-ac5a753fef1f"
      unitRef="U_pure">0.044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_4f05b713-9469-4acf-b62a-b4a410770fdc"
      decimals="3"
      id="F_26254f62-b93f-441f-9ec9-22b1d02ac582"
      unitRef="U_pure">0.038</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_4f05b713-9469-4acf-b62a-b4a410770fdc"
      decimals="3"
      id="F_af829974-27f8-4bb0-af4c-7c750008657b"
      unitRef="U_pure">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_9843be81-0c96-414e-9e7e-97d93fc8b5f9"
      id="F_30ccc539-a660-4fe8-b2f5-f2068f74eca4">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_99d14f13-477d-408b-bc26-79d5db50d8a2"
      id="F_519dda44-9a03-4b2f-a8f5-4f121f43cd8b">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0147f0c4-d22d-434d-ab8c-fd254e6c658d"
      id="F_d6c98cad-703a-4008-a187-989c441deca9">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharePrice
      contextRef="C_e2ccd3a2-63bb-47ec-b90f-f9427e33d6b7"
      decimals="INF"
      id="F_49964a6e-1107-4d5f-ac65-e395c31cfd52"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.14</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_274b34fb-7eb0-4bfc-a200-1ceb17964d37"
      decimals="INF"
      id="F_af3b3dce-9846-46a9-a981-8021dea15f84"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.8</us-gaap:SharePrice>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_ead3ee91-638a-450a-b9ec-8e6ef46d7412"
      decimals="INF"
      id="F_bf31efd1-9739-45fa-a4ae-d9883c24bb25"
      unitRef="U_shares">1782</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_90ef02a4-12ca-42a1-b6d6-2dc5a6c517a1"
      decimals="INF"
      id="F_21f997e4-7c60-4a22-ac73-6e5fe176d579"
      unitRef="U_shares">99000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_a1649612-1e62-4a97-af6c-7dc0028db1ef"
      decimals="INF"
      id="F_3aaea1d8-7380-46ba-8b47-558158cd1c0d"
      unitRef="U_shares">7883.586</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_d6bb14ee-c9e1-48c2-ae0d-ce419b3af00d"
      decimals="INF"
      id="F_6773a2c0-b9a2-4d6d-bab1-d89f7b03e224"
      unitRef="U_shares">437977</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_4f78b74c-03a0-4b7c-8ace-e89af1719000"
      decimals="0"
      id="F_0acdb35b-d702-4200-8c42-4a84ab15a767"
      unitRef="U_shares">13110484</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_368c6272-dda1-47db-a6e7-2d38cfded7e4"
      decimals="2"
      id="F_93d62d9e-0d7d-4161-8485-1f292b9395ea"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.37</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_953b5115-083a-4e43-b335-55592f074714"
      decimals="3"
      id="F_89221519-c0ab-4dc7-b8b6-4fb1312a4b86"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.369</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_953b5115-083a-4e43-b335-55592f074714"
      decimals="0"
      id="F_3728e568-5157-417c-a28d-2eab8c134f50"
      unitRef="U_shares">7989516</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_953b5115-083a-4e43-b335-55592f074714"
      decimals="3"
      id="F_f69df320-7351-4c9b-8eda-f4eb42768819"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_1edc7735-5746-454a-98ed-a4e3221fb98a"
      decimals="4"
      id="F_bfdf59dd-1024-4ec5-80c3-3fe8e5ddc9ec"
      unitRef="U_pure">0.0499</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_7be301e3-88b5-4832-845c-9d8ac104e793"
      decimals="4"
      id="F_0eab92c3-6579-41fd-8345-0d8b0ba2925d"
      unitRef="U_pure">0.0999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage
      contextRef="C_7be301e3-88b5-4832-845c-9d8ac104e793"
      decimals="4"
      id="F_6872b42e-bbdb-4434-ba46-8b3a1dd4ec4e"
      unitRef="U_pure">0.1999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_4f78b74c-03a0-4b7c-8ace-e89af1719000"
      decimals="-5"
      id="F_9f700165-d908-4795-a2d4-e940814cc641"
      unitRef="U_USD">50000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
      contextRef="C_4f78b74c-03a0-4b7c-8ace-e89af1719000"
      decimals="-5"
      id="F_79cf9a96-4a84-4b57-a4c7-d70c20529ca4"
      unitRef="U_USD">48100000</eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_9b1e52ec-b18a-43ab-830e-8986ff39379c"
      decimals="-5"
      id="F_00f485fc-2a62-4575-b347-03df53a3a410"
      unitRef="U_USD">75000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_412fba80-a3f2-4e2e-a9dc-8ece19b8f909"
      decimals="0"
      id="F_88c0f574-fa36-4148-895a-ca934cd8bd7f"
      unitRef="U_shares">18356173</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_cc736700-2f11-4c70-bf4c-ca225ad3a533"
      decimals="2"
      id="F_5ab790cd-250f-4026-bb1f-e4084ed6273e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.65</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0dce47b6-63c7-4639-ba01-f701282d1487"
      decimals="3"
      id="F_ea4e6315-b6cd-4608-96db-d9621ca1ba9c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.649</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_cc736700-2f11-4c70-bf4c-ca225ad3a533"
      decimals="0"
      id="F_46b582d0-9710-4763-aa3d-982423c564d6"
      unitRef="U_shares">4931507</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_cc736700-2f11-4c70-bf4c-ca225ad3a533"
      decimals="3"
      id="F_c08a7c74-b11d-411f-b212-bce4be167aba"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eldn:ProceedsFromIssuanceOffering
      contextRef="C_f23c46e0-c8ff-4ddb-ac90-024320e43941"
      decimals="-6"
      id="F_5d160ce2-0cee-43f9-b589-6a1787cf7cc5"
      unitRef="U_USD">85000000</eldn:ProceedsFromIssuanceOffering>
    <eldn:ProceedsFromIssuanceOfNetOfOfferingCosts
      contextRef="C_f23c46e0-c8ff-4ddb-ac90-024320e43941"
      decimals="-5"
      id="F_5a8be0a8-a12c-400c-83c5-1185039c2b29"
      unitRef="U_USD">79500000</eldn:ProceedsFromIssuanceOfNetOfOfferingCosts>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_23b4279a-d29c-45cc-a819-b328ff1a900e"
      decimals="4"
      id="F_b17cccbd-e531-4650-ad05-57216b671685"
      unitRef="U_pure">0.0499</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_471dec7e-d30c-458a-93d0-bda067fa6254"
      decimals="4"
      id="F_afc281e4-b012-4569-91ce-adc1b2ecc752"
      unitRef="U_pure">0.0999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_b53bd15c-c7fb-4b11-aa17-fa905055dc5f"
      decimals="INF"
      id="F_0f11de2d-01cc-4288-a560-a9c4fab218f2"
      unitRef="U_shares">501197</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_b53bd15c-c7fb-4b11-aa17-fa905055dc5f"
      decimals="3"
      id="F_fa750470-6e97-49b7-bc33-3904ca39044c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_7df810c1-d21e-4e6b-a46f-01bf18c4ed77"
      decimals="INF"
      id="F_ea299a8e-87ec-4e6d-8666-e0d33834ca1b"
      unitRef="U_shares">501197</us-gaap:CommonStockSharesIssued>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_d9bfbaaa-b100-4fc8-b32a-b4ace9e85c13"
      decimals="INF"
      id="F_fc589547-1085-47e2-8710-c5c2b299c79a"
      unitRef="U_shares">653000</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_d9bfbaaa-b100-4fc8-b32a-b4ace9e85c13"
      decimals="3"
      id="F_6712fdff-5bd1-4493-924d-b1adbc94f65d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_aee009b0-e9e5-4357-a86f-519c7e46e328"
      decimals="INF"
      id="F_96871949-e078-4144-a120-eff3e21d047f"
      unitRef="U_shares">653000</us-gaap:CommonStockSharesIssued>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_2067bb42-a2a2-40c2-9cbe-fb3a2abee295"
      decimals="INF"
      id="F_dbf6ccd4-073d-4c74-aa0c-859a21fc8189"
      unitRef="U_shares">600000</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_2067bb42-a2a2-40c2-9cbe-fb3a2abee295"
      decimals="3"
      id="F_a746884a-155a-4164-b7f3-54c176749e47"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_2067bb42-a2a2-40c2-9cbe-fb3a2abee295"
      decimals="INF"
      id="F_cd8a5789-130d-4e5a-8a0c-632ac4abad5d"
      unitRef="U_shares">600000</us-gaap:CommonStockSharesIssued>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_7b6aa460-03c5-4aa2-a129-7a2742c51c6c"
      decimals="INF"
      id="F_567a3015-73f6-47f4-8d80-615966c6e7c3"
      unitRef="U_shares">583000</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_7b6aa460-03c5-4aa2-a129-7a2742c51c6c"
      decimals="3"
      id="F_a685facd-d01f-42e5-86dd-331984a188e6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_78ce3cbc-2a87-434a-8808-3ae02d70968a"
      decimals="INF"
      id="F_559fe00a-92cc-468f-bb76-1df7e4b90f1f"
      unitRef="U_shares">583000</us-gaap:CommonStockSharesIssued>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_c9c85a29-4958-462d-81cd-61348312f2ed"
      decimals="INF"
      id="F_f9f5f6ad-7484-4d2e-85dd-dff9b879fcbd"
      unitRef="U_shares">240000</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_c9c85a29-4958-462d-81cd-61348312f2ed"
      decimals="3"
      id="F_5d3c97cf-46e0-42c7-bf7e-f40a633536cb"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_c9c85a29-4958-462d-81cd-61348312f2ed"
      decimals="INF"
      id="F_35abaf8c-60cf-4467-92f8-1988c5985098"
      unitRef="U_shares">240000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_f24c5a06-77ee-4dae-8ad5-bc7f8a9e6e82"
      decimals="INF"
      id="F_20d14dc0-be7a-47af-a321-dcdea52fdcf1"
      unitRef="U_shares">33052744</us-gaap:ClassOfWarrantOrRightOutstanding>
    <eldn:ScheduleOfWarrantActivityTableTextBlock
      contextRef="C_5479bff8-22b2-4dea-8a74-3bba75d07bd5"
      id="F_baf24390-7be4-462d-bb75-c22b2c95ce6f">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the warrants to purchase common stock activity:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:40.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Roll-Forward of Warrant Activity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Common Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,788,032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,776,270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,564,302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,921,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,921,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,423,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,423,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled/Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,778,451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,274,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</eldn:ScheduleOfWarrantActivityTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_073a4072-2ff4-4bf0-b2f2-2ca40d8d96dd"
      decimals="INF"
      id="F_d56c4b34-01ef-4d1a-8ecb-2f273d93282c"
      unitRef="U_shares">15788032</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_e7daa38f-05c1-4b99-a56a-2c538503eda6"
      decimals="INF"
      id="F_c8863c6f-3a01-40be-a394-c69694077215"
      unitRef="U_shares">5776270</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_f6739b83-64c1-4196-bfa3-188e64be71c2"
      decimals="INF"
      id="F_fae3e350-64e5-40ce-b935-bb8bf2b6f2bf"
      unitRef="U_shares">21564302</us-gaap:ClassOfWarrantOrRightOutstanding>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
      contextRef="C_7e668069-76a8-40b4-854c-5268227f0ca1"
      decimals="INF"
      id="F_e988749c-df98-47ca-833f-c09952594207"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
      contextRef="C_6064f4bc-c353-4924-b4c3-bc53d3720064"
      decimals="INF"
      id="F_9a976804-3f23-42c1-b623-6cbc96f0b6dd"
      unitRef="U_shares">12921023</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
      contextRef="C_d73e41e0-eaac-4f7a-8f85-cc17e8daac55"
      decimals="INF"
      id="F_5976319f-82c2-4a7a-ac3f-bc01e60dadec"
      unitRef="U_shares">12921023</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
      contextRef="C_7e668069-76a8-40b4-854c-5268227f0ca1"
      decimals="INF"
      id="F_96072613-c4ae-4f98-b10b-3d4ccc5eed7b"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
      contextRef="C_6064f4bc-c353-4924-b4c3-bc53d3720064"
      decimals="INF"
      id="F_ed3aa0c5-dfa7-4edc-ac6a-44a33a98c610"
      unitRef="U_shares">1423000</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
      contextRef="C_d73e41e0-eaac-4f7a-8f85-cc17e8daac55"
      decimals="INF"
      id="F_f4f9ac55-dbd8-4ac1-8f80-5e8d8186631c"
      unitRef="U_shares">1423000</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired
      contextRef="C_7e668069-76a8-40b4-854c-5268227f0ca1"
      decimals="INF"
      id="F_60db0a73-64cd-496b-bfd8-f30e7e35d544"
      unitRef="U_shares">9581</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired
      contextRef="C_6064f4bc-c353-4924-b4c3-bc53d3720064"
      decimals="INF"
      id="F_6bb07d51-dfa5-4629-9ec3-870f0717f5b9"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired
      contextRef="C_d73e41e0-eaac-4f7a-8f85-cc17e8daac55"
      decimals="INF"
      id="F_d1e42ff3-e825-43cd-b8ea-6fc66a890866"
      unitRef="U_shares">9581</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_a38140f4-e70a-4ed0-9849-5332d035c44d"
      decimals="INF"
      id="F_8b69733c-b1f6-42ee-a66e-fc82be029fef"
      unitRef="U_shares">15778451</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_e3e45846-797e-4cc7-afc4-00734dc1c256"
      decimals="INF"
      id="F_0b3c8f7f-f1c9-4021-a685-9a24d56d421b"
      unitRef="U_shares">17274293</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_c0e69edb-7d74-4a88-a331-7063c41b32d0"
      decimals="INF"
      id="F_033219a7-8cf8-4a09-b7d5-3b515c7758a3"
      unitRef="U_shares">33052744</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_d1b873e7-835b-4300-8a67-1a6859f582e4">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:40.492%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.297%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.837%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.836%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Date Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Shares of Common Stock Issuable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Expiration Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;247,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;September 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;298,692&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;September 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,151,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;May 5, 2028&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2021 pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;509,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,844,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024 Securities Purchase Agreement pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,989,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024 Underwritten Offering pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,931,507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_47180cae-052a-4fcf-aff0-dd86481a6ea5"
      decimals="INF"
      id="F_af75aa62-cb8c-4c38-8d95-3d86907850dc"
      unitRef="U_shares">5586</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_47180cae-052a-4fcf-aff0-dd86481a6ea5"
      decimals="2"
      id="F_b2059784-393e-483a-bc3f-6c065f49b01b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18.9</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_47180cae-052a-4fcf-aff0-dd86481a6ea5"
      id="F_c87b3f04-51e3-4c29-8b5f-f4951b8a31e0">2025-07-14</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_c2abaa52-1d0a-4fbe-81ab-c8a8f777bb72"
      decimals="INF"
      id="F_dd8a204b-6923-4667-ba1e-39b7cd580eec"
      unitRef="U_shares">3591</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_c2abaa52-1d0a-4fbe-81ab-c8a8f777bb72"
      decimals="2"
      id="F_587adb3f-fd6b-4a20-bbaf-f01bfd4f7801"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18.9</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_c2abaa52-1d0a-4fbe-81ab-c8a8f777bb72"
      id="F_6df5faa4-8b59-4a9a-a843-e65bdabf31c1">2025-07-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_6ebbbef7-421a-4712-a110-6e65b3cc06a4"
      decimals="INF"
      id="F_3376c62f-71d0-4968-a22e-995b66f6315a"
      unitRef="U_shares">247264</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_6ebbbef7-421a-4712-a110-6e65b3cc06a4"
      decimals="2"
      id="F_fbc3290b-a31a-4c3d-8c6f-21759f0a3aa4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_6ebbbef7-421a-4712-a110-6e65b3cc06a4"
      id="F_f7bfdd7c-e9af-4b06-8bfd-1af379a17d09">2025-07-14</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_2ae5e0b5-102e-4000-812f-5d62270f8a6d"
      decimals="INF"
      id="F_f4e8aed2-4f11-46fe-bd92-899132df15aa"
      unitRef="U_shares">71800</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_2ae5e0b5-102e-4000-812f-5d62270f8a6d"
      decimals="2"
      id="F_97940635-3095-43f9-87fe-94ed284002c3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_2ae5e0b5-102e-4000-812f-5d62270f8a6d"
      id="F_8f8ea1c8-023e-479b-91d7-cb76fe98d71c">2025-07-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_1fc4725b-505d-42ee-8598-9b1205ab938a"
      decimals="INF"
      id="F_9d5a8344-ddc4-4b67-9657-3389c88b2206"
      unitRef="U_shares">298692</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_1fc4725b-505d-42ee-8598-9b1205ab938a"
      decimals="2"
      id="F_6f538729-9da5-44a0-adf9-8c85251dfc6c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.08</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_1fc4725b-505d-42ee-8598-9b1205ab938a"
      id="F_5ae8c080-f0da-495a-961d-fc9834f44317">2025-09-14</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_1f217616-88b1-493b-aa9a-fb67de956fa7"
      decimals="INF"
      id="F_43963401-7107-4a13-9c1c-c8e12130211b"
      unitRef="U_shares">15151518</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_1f217616-88b1-493b-aa9a-fb67de956fa7"
      decimals="2"
      id="F_80064116-3aae-422a-9984-7e40ac056f93"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_1f217616-88b1-493b-aa9a-fb67de956fa7"
      id="F_65460197-e310-428e-8b04-c6417eb272c6">2028-05-05</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_f5f2d779-981c-4cdb-8478-acd05d3606c9"
      decimals="INF"
      id="F_a53c7799-418d-4983-8f84-80598da1e235"
      unitRef="U_shares">509117</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_f5f2d779-981c-4cdb-8478-acd05d3606c9"
      decimals="3"
      id="F_1313f5a9-eb59-4b3c-9179-9c210d989532"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_f5f2d779-981c-4cdb-8478-acd05d3606c9"
      id="F_8fb93037-7ecf-43a2-b41d-cd93126697ff">2030-12-31</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_41f23dcf-6538-4d0e-8ab7-5ea52de4f018"
      decimals="INF"
      id="F_2ef1c34c-cbde-4895-b298-24468a73a83e"
      unitRef="U_shares">3844153</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_41f23dcf-6538-4d0e-8ab7-5ea52de4f018"
      decimals="3"
      id="F_d7eb2044-a1ef-41ae-b051-05345d3ce86b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_7e567fbb-8b59-43a4-a885-68d6c65b7935"
      decimals="INF"
      id="F_0595dde2-4b7b-489d-ad2e-21ae31aa4459"
      unitRef="U_shares">7989516</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_7e567fbb-8b59-43a4-a885-68d6c65b7935"
      decimals="3"
      id="F_6eede576-31f2-48cf-a485-88b311788b8c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_00ec3738-b3f5-498d-9035-0c48bdd6391a"
      decimals="INF"
      id="F_242933f7-3a9f-42ae-bf46-7ffb01d120af"
      unitRef="U_shares">4931507</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_00ec3738-b3f5-498d-9035-0c48bdd6391a"
      decimals="3"
      id="F_40c626d1-dc67-4ccb-a577-6d1a2df8c3a5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_c0e69edb-7d74-4a88-a331-7063c41b32d0"
      decimals="INF"
      id="F_92fa408d-b2aa-478e-872b-87b8159a7abd"
      unitRef="U_shares">33052744</us-gaap:ClassOfWarrantOrRightOutstanding>
    <eldn:ScheduleOfWarrantActivityTableTextBlock
      contextRef="C_57faa905-6146-4e17-b55a-72db880840e2"
      id="F_2709887c-828c-4e1a-80e0-c40c9b9234c6">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, there were&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants exercisable into Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Preferred Stock which are convertible into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,789,301&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:54.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:41.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Roll-Forward of Series X&lt;/span&gt;&lt;span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;&#160;Convertible Preferred Warrant Activity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assumed and replaced&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled/Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</eldn:ScheduleOfWarrantActivityTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_868ad39e-5065-4cf8-9dff-9d2c9a7d135b"
      decimals="INF"
      id="F_a059ccb9-cc57-47cf-9292-1fd4b44e01d6"
      unitRef="U_shares">50207.419</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_868ad39e-5065-4cf8-9dff-9d2c9a7d135b"
      decimals="INF"
      id="F_e026f5cb-3f5b-4369-bf4c-b77803a81b63"
      unitRef="U_shares">2789301</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_5dc4d3d6-be01-4bf6-aebf-77b1734fcf32"
      decimals="INF"
      id="F_5c55e08e-3f7a-4126-a555-d59577eb0f22"
      unitRef="U_shares">50207.419</us-gaap:ClassOfWarrantOrRightOutstanding>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced
      contextRef="C_1f268d5e-cf5e-403a-87e4-658902565516"
      decimals="INF"
      id="F_a9b94621-24ef-405a-b6eb-a87081436b1f"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
      contextRef="C_1f268d5e-cf5e-403a-87e4-658902565516"
      decimals="INF"
      id="F_1cca46a8-e1a1-4feb-8744-198a252a4794"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired
      contextRef="C_1f268d5e-cf5e-403a-87e4-658902565516"
      decimals="INF"
      id="F_dc809dc7-55da-4985-8198-805b33276c5f"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_dd1985ed-08be-42aa-8575-546c5561d12a"
      decimals="INF"
      id="F_e469ec4a-0906-4ca6-9cab-6d9be9bce201"
      unitRef="U_shares">50207.419</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_4117a814-e099-4153-b353-7f02194ab5a1"
      decimals="2"
      id="F_be5e5825-23ef-442e-9b87-29520ae9f255"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_4117a814-e099-4153-b353-7f02194ab5a1"
      id="F_8529d840-7193-438d-ae2f-d16599f5a25d">2025-09-14</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_270d7590-1658-47b0-b163-cb102b7d10b8">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 9. Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock Option Plans&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For stock options granted to the Company&#x2019;s board of directors (the &#x201c;Board&#x201d;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months that vested stock options granted to Board members may be exercised upon termination. &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The expected dividend assumption was based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;) are measured and recognized based on the quoted market price of our common stock on the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 10, 2024, the Company held its Annual Meeting of Stockholders (the &#x201c;Annual Meeting&#x201d;). At the Annual Meeting, the Company&#x2019;s stockholders approved an amendment to the Company's 2020 Long Term Incentive Plan (the &#x201c;2020 Plan&#x201d;). The 2020 Plan, as amended, (i) reflects an increase in the limit on the aggregate number of shares of the Company&#x2019;s common stock that may be delivered pursuant to all awards granted under the 2020 Incentive Plan by an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,500,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares so that the new aggregate share limit under the 2020 Plan is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,960,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares, and (ii) extends the date through which the Company may grant new awards under the 2020 Plan from November 15, 2030 to April 28, 2034.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 1, 2023, the Company issued stock option awards to its employees with both time-based and performance-based vesting requirements, totaling &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,381,857&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; stock options, with &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,476,372&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of the granted stock options subject to the Company&#x2019;s customary time-based vesting schedule. The remaining &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,905,485&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; stock options granted are subject to both customary time-based vesting requirements and performance-based vesting requirements that are based on the same clinical development milestones applicable to the Second Closing and Third Closing of the 2023 Private Placement as specified in the 2023 Securities Purchase Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the Company amended the performance-based vesting requirements with its named executive officers and other employees that upon the Second Closing and Third Closing, a full or prorated amount of each closing installment shall vest based on the percentage of funding received relative to the total funding opportunity represented by the investors&#x2019; Second Closing and Third Closing subscription amounts. On June 13, 2024 and November 20, 2024, the performance-based vesting requirement based on the milestones applicable to the Second Closing and Third Closing were satisfied and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,763,085&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; stock options were issued.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2014 Stock Incentive Plan (the &#x201c;2014 Plan&#x201d;) was closed to new grants following the approval of the 2020 Plan, and therefore, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares reserved for issuance under the 2014 Plan as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The number of shares reserved for issuance under the 2020 Plan and Employee Stock Purchase Plan was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,373,242&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,077&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares, respectively, as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:40.708%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.762%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.282%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.762%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.282%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Shares&lt;br/&gt;Issuable&lt;br/&gt;Under Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,218,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,026,451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;862,631&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.07&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,381,853&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;235&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;622,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.30&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316,465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,637,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options vested and expected to vest as of&lt;br/&gt;&#160;&#160;&#160;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,637,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options exercisable as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,667,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that had exercise prices that were lower than the fair value per share of the common stock on the date of exercise. The aggregate intrinsic value of options exercised during the year ended December 31, 2024 was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:42.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:26.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:26.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;101.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life of options (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Estimated dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The per share weighted average grant date fair value of stock options granted during the years ended December 31, 2024 and 2023 was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.93&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.60&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the RSU activity, as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Shares&lt;br/&gt;Issuable&lt;br/&gt;Under RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total compensation expense related to all of the Company&#x2019;s stock-based awards for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 was comprised of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.47%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.304%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.304%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation classified as:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested equity awards wa&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which is expected to be recognized over an estimated weighted-average period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod
      contextRef="C_2d4f29f9-5681-4ad7-bf0a-2f27534f1c56"
      id="F_5abdba55-b089-400c-8229-1b75240600ae">For stock options granted to the Company&#x2019;s board of directors (the &#x201c;Board&#x201d;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of 12 to 18 months that vested stock options granted to Board members may be exercised upon termination. </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_d34a853c-0615-409b-9ae6-5bd5c50e65b2"
      id="F_e1aab80a-4815-4142-a6fe-f5eec372a748">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_4d0808f1-2220-4b2f-9620-f1ac2986d605"
      id="F_0e7ec50f-1144-4161-bb97-73d764caf5e0">P18M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_eda51110-4aff-4f77-8d77-cdbe3953f41b"
      decimals="INF"
      id="F_53e1ffba-5d2f-4478-a895-3823b247bd7b"
      unitRef="U_shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized
      contextRef="C_eda51110-4aff-4f77-8d77-cdbe3953f41b"
      decimals="INF"
      id="F_83f24e6f-04df-43f6-a2ce-8e1077e5f5b1"
      unitRef="U_shares">17960000</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_2f08b426-f498-4cef-82ca-9a6f0e57cf67"
      decimals="INF"
      id="F_895ff8a9-b47d-498f-a5d2-b6de561a73f3"
      unitRef="U_shares">7381857</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_a0877070-bafd-4ecc-ba7e-d06767488cad"
      decimals="INF"
      id="F_b95ca9a6-69a5-4411-8573-ba09461df919"
      unitRef="U_shares">1476372</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_2f08b426-f498-4cef-82ca-9a6f0e57cf67"
      decimals="INF"
      id="F_fad8e743-4744-4242-a3a1-393d90ef3118"
      unitRef="U_shares">5905485</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_534c07a6-4f81-40db-bf98-8c91a0f6d3a6"
      decimals="INF"
      id="F_ccec66df-a8ac-42d5-9e16-9ce5a95e6fa4"
      unitRef="U_shares">5763085</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_c8bb3042-d8d0-4c46-81bd-3419e2c5ac60"
      decimals="INF"
      id="F_cc3f7a48-be33-4dbc-8611-4b51b41fd286"
      unitRef="U_shares">5763085</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_e61ec573-6c46-4c35-990d-5570f66dbe16"
      decimals="INF"
      id="F_05443e49-badf-47f8-b9d8-c79be32e9c5b"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_11604e1d-447f-4412-9cf1-8945676ed077"
      decimals="INF"
      id="F_ca981868-0565-46a4-910a-a7f6f4781c31"
      unitRef="U_shares">6373242</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_41f693fb-c3db-4b97-a334-95618d32533c"
      decimals="INF"
      id="F_a967c949-08f0-4005-861c-3a1d87407f8b"
      unitRef="U_shares">24077</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_690d71fb-6168-4e44-aa19-2222db4905b6">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:40.708%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.762%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.282%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.762%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.282%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Shares&lt;br/&gt;Issuable&lt;br/&gt;Under Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,218,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,026,451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;862,631&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.07&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,381,853&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;235&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;622,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.30&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316,465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,637,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options vested and expected to vest as of&lt;br/&gt;&#160;&#160;&#160;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,637,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options exercisable as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,667,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_703721ac-e233-4584-a2ed-617913379b0c"
      decimals="INF"
      id="F_4ce86a9b-f63c-4686-b320-392a542ccfd9"
      unitRef="U_shares">5218033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_703721ac-e233-4584-a2ed-617913379b0c"
      decimals="2"
      id="F_65709970-a33b-480a-a0ed-519b6baf569e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_8221208b-b06c-4f4e-8484-c94ceca23b1b"
      id="F_ef1decf9-16e7-4378-a265-b54fd83397a8">P8Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="INF"
      id="F_0a923529-1db9-4d30-a29f-397cbf4e4433"
      unitRef="U_shares">11026451</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="2"
      id="F_85315282-8d6a-479d-93f2-72be7a7e9932"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.1</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="INF"
      id="F_2e6afa7d-f070-4212-9ba7-543815f04a4f"
      unitRef="U_shares">862631</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="2"
      id="F_fa59597c-4093-460f-85eb-1a3a0928341e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="INF"
      id="F_6eee271d-6f80-43d8-8b71-f2bf6ee6084b"
      unitRef="U_shares">15381853</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="2"
      id="F_3cce648d-d39c-4072-883b-3d812fa39591"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      id="F_55d81e17-462c-44c3-9e49-1a118555c21a">P8Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_f4ffabf2-168a-4abc-a1f6-b22b5d36ae32"
      unitRef="U_USD">235000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="INF"
      id="F_a48e9553-46b7-48d0-a7ff-0f241782f695"
      unitRef="U_shares">622000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="2"
      id="F_e95e1324-049a-40a9-9d47-74124cdf9597"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="INF"
      id="F_c1309e7f-d3b9-4616-9548-0e6ac262f63f"
      unitRef="U_shares">50000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="2"
      id="F_5f9bff5c-0d52-4ee7-abbb-a2e593956ad9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.3</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="INF"
      id="F_5b74cd90-4f84-4fde-a278-0dda74eaffbd"
      unitRef="U_shares">316465</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="2"
      id="F_8fa8d7bb-e3a6-49f9-a61f-2ab86ca9db66"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_8de1d018-02d9-41ad-9faf-b8bda6c4e741"
      unitRef="U_shares">15637388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="2"
      id="F_032bf373-bdab-4df3-9028-7e77d85c2394"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_a07e0d58-3668-47dc-813a-1aa7eb552434">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_00d56ad1-1e9c-4082-841f-5921f6ffbf86"
      unitRef="U_USD">20628000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_17f01a6e-bb97-447c-8b6a-a13ece018b0e"
      unitRef="U_shares">15637388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="2"
      id="F_2bd2f391-8bbb-46fe-b42d-c6e55bc70edf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_87da72de-cd30-49d8-9cda-041412392285">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_852cffcd-1b1a-4ab1-b4c1-48f9f0303b87"
      unitRef="U_USD">20628000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="INF"
      id="F_2e846af4-df10-429a-a09a-1dcf4ca1f053"
      unitRef="U_shares">8667177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="2"
      id="F_3f7f83c7-86f3-4f1d-a432-789ff6e81ff8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_ac0b1079-a621-44f2-894b-2363affabde7">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_03e744c1-bdc2-4818-8bdc-9479a59a8069"
      unitRef="U_USD">7898000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-5"
      id="F_80260ae4-4f65-4f50-b8c5-5f8eac4750cd"
      unitRef="U_USD">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_5691c8eb-8ba1-4aba-9b8b-d3ff85829778">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:42.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:26.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:26.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;101.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life of options (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Estimated dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="3"
      id="F_7f623413-fa0e-4fc4-8ab4-e2a2340485fb"
      unitRef="U_pure">1.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="3"
      id="F_99e1e962-c86d-48ba-975d-e3d835d0f490"
      unitRef="U_pure">0.905</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="3"
      id="F_31c2ca25-41cf-4fb9-9a25-6d558969173d"
      unitRef="U_pure">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="3"
      id="F_be56f339-c947-4f52-bebc-141dbd9a1763"
      unitRef="U_pure">0.037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_0f35d3d3-f2e7-442b-9db4-09360198e8ca">P6Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      id="F_c3ebbfe9-1ad1-4954-8657-32609095980c">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="2"
      id="F_caadd450-ae88-4de7-8226-fbf950003f1f"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="2"
      id="F_d9ddf396-fc90-4582-bb3a-3ab8734ffd56"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="2"
      id="F_1db8a0c7-7c06-4075-8e6d-02072cfb99cd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="2"
      id="F_1e7a79ac-95a2-4e80-88dd-935800c6f2b3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_734fb079-45ce-465d-8aee-925501ad89a8">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the RSU activity, as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Shares&lt;br/&gt;Issuable&lt;br/&gt;Under RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_135b1839-bc7f-467e-abbf-3856e1bcb1f4"
      decimals="INF"
      id="F_536c2b38-3990-4afd-ba03-bf508645d75c"
      unitRef="U_shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice
      contextRef="C_135b1839-bc7f-467e-abbf-3856e1bcb1f4"
      decimals="2"
      id="F_80b2f08d-2a39-45d6-b6b5-ca9922f8cdaf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.47</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_f732926d-a8cc-4c74-8a1a-38d77cf24a4e"
      decimals="INF"
      id="F_164f0aea-6989-435c-8f30-6e9b26af8fd8"
      unitRef="U_shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice
      contextRef="C_f732926d-a8cc-4c74-8a1a-38d77cf24a4e"
      decimals="2"
      id="F_f35364f0-0e9c-4d92-b4f2-3acd0251d743"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.47</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_4e5c52f4-44ed-4d03-b98e-acba67aad85d"
      decimals="INF"
      id="F_8fa6b3c6-c145-41f5-825f-7c4bcf489b08"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice
      contextRef="C_4e5c52f4-44ed-4d03-b98e-acba67aad85d"
      decimals="0"
      id="F_99ebdccb-affa-45f7-a548-66a44c7cae1c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_1eb7071c-d34e-4235-bcb4-1e3102fea0ef"
      decimals="INF"
      id="F_49857fa0-d2c1-4d60-9999-cbefbb5f2b3b"
      unitRef="U_shares">46000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_1eb7071c-d34e-4235-bcb4-1e3102fea0ef"
      decimals="2"
      id="F_ff1fe6b0-9fd9-4ab5-8801-e5d0c8aa86df"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.97</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_55014fe0-62df-4c18-b96a-3dfee38784c1"
      decimals="INF"
      id="F_ae1f657d-c565-463e-b5e5-38293107c11a"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice
      contextRef="C_55014fe0-62df-4c18-b96a-3dfee38784c1"
      decimals="0"
      id="F_72b262e3-032f-44f8-a1a6-db65830baebf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_4b4a0a48-83b4-4a31-a7d8-6183de985fc4"
      decimals="INF"
      id="F_716f50af-bca7-479d-adb4-cb72b0a7118a"
      unitRef="U_shares">46000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice
      contextRef="C_4b4a0a48-83b4-4a31-a7d8-6183de985fc4"
      decimals="2"
      id="F_fe44a730-d970-4fe2-ba9c-5873be7cf2fe"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.97</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_465d5b54-cbb0-4717-baa1-37586183d7b4">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total compensation expense related to all of the Company&#x2019;s stock-based awards for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 was comprised of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.47%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.304%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.304%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation classified as:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_5b4148f0-d4f9-403c-af32-f52bc3bd07f6"
      decimals="-3"
      id="F_9fabcaca-573d-45e1-a378-4cfd769006e6"
      unitRef="U_USD">4277000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0dc4367e-b5ab-45fd-bb01-b6a7fb4da26f"
      decimals="-3"
      id="F_d189e292-e3f5-413f-b5c5-fd96404e3fb4"
      unitRef="U_USD">1491000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_b289a523-bf02-496a-822a-4cb3cec3e3fc"
      decimals="-3"
      id="F_b43cdde8-5dce-40b0-8420-7a8f8c4dbb6c"
      unitRef="U_USD">8845000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1cbafbb3-bb44-48c7-9275-169d82fbcccc"
      decimals="-3"
      id="F_5075b569-00b7-4bca-ba5f-ba5154b7e35f"
      unitRef="U_USD">5054000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="-3"
      id="F_a8fe8499-253b-4468-90a8-32e59e3421f9"
      unitRef="U_USD">13122000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_48a094ae-c878-4cfe-b55f-80b8e044e1ef"
      decimals="-3"
      id="F_f1cd718f-cc35-417e-a1bf-979e78b5605e"
      unitRef="U_USD">6545000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-5"
      id="F_61bae522-7ae3-44dc-af97-28e8267e8b6c"
      unitRef="U_USD">17600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_17cb9da2-96ae-4657-83ce-fa51974ca6e7">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_2517bc10-42c7-4f9d-b5e0-e789a6e173f2">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. Segment Reporting&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company currently operates and manages its business as &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segment, to develop therapies to protect transplanted organs and prevent rejection. The Company's chief operating decision maker (the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201c;CODM&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;), is the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_51220781-3cc8-4cb6-858a-6cda531d29d7;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;chief executive officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_49cee393-18e3-4648-b5d8-3eb7be1b8087;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;single&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segment entity, &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant segment expenses, as provided to the CODM, are presented as the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:70.026%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.078000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.078000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tegoprubart - kidney transplantation programs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tegoprubart - other development programs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,186&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Manufacturing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,448&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel-related&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,930&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment and net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      decimals="INF"
      id="F_7527155e-ec9e-456f-95e7-d23701138414"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:FactorsUsedToIdentifyEntitysReportableSegments
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_5f8da7c8-f73f-427a-8280-3828bcbdb438">The financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.</us-gaap:FactorsUsedToIdentifyEntitysReportableSegments>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_52d2d798-3a56-49e6-ae3d-7389452fc750">the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. Significant segment expenses, as provided to the CODM, are presented as the following:</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_76ac7946-5c89-4b53-9d46-795811f2ceca">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant segment expenses, as provided to the CODM, are presented as the following:&lt;/span&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:70.026%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.078000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.078000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tegoprubart - kidney transplantation programs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tegoprubart - other development programs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,186&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Manufacturing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,448&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel-related&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,930&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment and net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <eldn:Tegoprubart-KidneyTransplantationPrograms
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_09843e49-44bc-40bd-94cc-b7760a1c701b"
      unitRef="U_USD">27452000</eldn:Tegoprubart-KidneyTransplantationPrograms>
    <eldn:Tegoprubart-KidneyTransplantationPrograms
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_58902951-6484-416a-96ee-4516115f9f10"
      unitRef="U_USD">11940000</eldn:Tegoprubart-KidneyTransplantationPrograms>
    <eldn:Tegoprubart-OtherDevelopmentPrograms
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_645cbbf2-5457-4ce0-9c8f-93e94a223bc3"
      unitRef="U_USD">306000</eldn:Tegoprubart-OtherDevelopmentPrograms>
    <eldn:Tegoprubart-OtherDevelopmentPrograms
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_de2cad68-59c4-4738-8122-3d02efb279a8"
      unitRef="U_USD">3186000</eldn:Tegoprubart-OtherDevelopmentPrograms>
    <us-gaap:ManufacturingCosts
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_ad9930f2-9599-40d8-8ffe-13de5bed4c12"
      unitRef="U_USD">12448000</us-gaap:ManufacturingCosts>
    <us-gaap:ManufacturingCosts
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_6a8abc7a-bcad-4009-886a-5887e6bb928b"
      unitRef="U_USD">8048000</us-gaap:ManufacturingCosts>
    <eldn:Personnel-RelatedExpenses
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_9c626ecc-b7ea-4091-826e-c8833dcfd343"
      unitRef="U_USD">10706000</eldn:Personnel-RelatedExpenses>
    <eldn:Personnel-RelatedExpenses
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_8de1e641-5192-4f46-b6a9-648f625af12b"
      unitRef="U_USD">8351000</eldn:Personnel-RelatedExpenses>
    <us-gaap:ShareBasedCompensation
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_15924408-fbc5-4f8c-abe2-3754c3755a87"
      unitRef="U_USD">13122000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_a993aa55-043e-47cc-be89-2592fc6ec961"
      unitRef="U_USD">6545000</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_d2054701-673c-4b62-b878-455d45336c7f"
      unitRef="U_USD">6543000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_a019045a-614b-458a-b98e-2a55cfce9f80"
      unitRef="U_USD">4930000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_68a33a76-4db9-4b90-b475-7379e7b26571"
      unitRef="U_USD">70577000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_c1b2733f-f5e2-40d3-8777-0b9aa63f830a"
      unitRef="U_USD">43000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_98d34765-9c0d-4e71-8f81-539ca7c78e8c"
      unitRef="U_USD">-70577000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_24d158d4-3666-4fd5-a684-1fdaa8bfde29"
      unitRef="U_USD">-43000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_cc43c840-9e0b-4da9-946b-5ec61ee258b6"
      unitRef="U_USD">3924000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_3ec8a5ad-d687-42ac-a9c6-d2709b6565da"
      unitRef="U_USD">2674000</us-gaap:OtherNonoperatingIncomeExpense>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_d2cef754-f051-40c1-83cc-7116b605538d"
      unitRef="U_USD">-30900000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_64b24c9d-74e8-4499-b3e0-3bec71fa404e"
      unitRef="U_USD">76211000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_36dfe4e2-d12e-4645-8d2f-8ddcf51a2fd6"
      unitRef="U_USD">431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_38d660ba-9c8c-4aaa-8f57-1134c8023ce4"
      decimals="-3"
      id="F_c82b2569-503a-42e2-8b56-3cfe64645fcf"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_ebb38758-a918-4acf-8a02-3282e3612134"
      decimals="-3"
      id="F_b4e3ed88-4cfa-40fa-9c48-f1ef5b1d899e"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_71ed61e5-3513-45a2-bc03-cbc0c2970237">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 11. Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has evaluated events subsequent to December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; through the filing date of this Annual Report on Form 10-K. Any material subsequent events that occurred during this time have been properly recognized or disclosed in the consolidated financial statements and accompanying notes.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ErrorCorrectionTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_fd41f0db-b004-41e1-971b-54e00e5662df">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 12. Restatement of Previously Issued Consolidated Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.391%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the course of preparing the Company&#x2019;s Condensed Consolidated Financial Statements as of and for the three and six months ended June 30, 2025, the Company reassessed the rights and preferences of its Preferred Stock, and concluded&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;that, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;because they are substantially identical to those of its common stock, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; par value, the Preferred Stock should be treated as a separate class of common stock for purposes of calculating earnings per share in accordance with ASC 260-10, &#x201c;Earnings Per Share.&#x201d; As a result, the Company determined that it should have presented earnings per share under the two-class method in prior reporting periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.393%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.111%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Additionally, in connection with this reassessment, the Company concluded that it had incorrectly classified the Preferred Stock as permanent equity in the consolidated balance sheets. The Preferred Stock includes a provision that, upon the occurrence of a fundamental transaction (which includes a third-party tender or exchange offer) in which more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; percent of the common stockholders receive cash or other assets, entitles holders of Preferred Stock, upon any subsequent conversion, are entitled to receive the same form of consideration, even if they did not participate in the original transaction. Because this feature may result in settlement in cash or other non-equity consideration upon an event outside the Company&#x2019;s control, the Preferred Stock does not meet the criteria for permanent equity classification and is instead classified as temporary equity under ASC 480-10-S99-3A. Although a tender offer is not considered probable as of the current reporting date and redemption is not deemed probable, the existence of this provision requires classification as temporary equity. The Preferred Stock is not subsequently remeasured to its redemption value because redemption is not considered probable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.405%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;margin-right:1.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a result of these conclusions, the Company determined that a correction was necessary with respect to the classification of Preferred Stock as temporary equity and the presentation of earnings per share under the two-class method.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.405%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accordingly, the accompanying financial statements as of and for the year ended December 31, 2024 and December 31, 2023, and related notes hereto, have been restated to correct the classification of the Preferred Stock as temporary equity and to include EPS calculations under the two-class method.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.405%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.333%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The impact of the correction of the misstatements is summarized below (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;117,970&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,204&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2023 and 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity (deficit):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;117,970&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_5853a7a4-cb72-4798-821a-733264c3ef61;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_c28ce8de-197a-4f3f-9904-8e00f34bd0bf;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_87be77a3-13bd-421e-9cd7-c93000cef4f1;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,204&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2023 and 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_159afcc3-d066-4b5b-b4ad-7e01474c1944;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_216519ab-59aa-4af1-9fab-606834bbb418;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0af8023e-7ef3-4515-a7a7-678b84c987ec;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;326,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;270,892&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity (deficit)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2024 and 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2024 and 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2024 and 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_6bb67e40-7995-438a-8c0a-20c0a769173d;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_c377af31-8b8b-42b5-9eae-9f9fb6815960;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_c6895469-f099-4775-83e9-d61a31e2f6fe;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2024 and 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_7a49ba59-b1e6-4d93-bc53-ad26ea9e9103;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_3ecf4669-c43c-48e7-8139-38d3d48178bf;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_b7cc2b0b-bf5a-4561-9ed3-8272893f1903;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;473,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;417,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended&lt;br/&gt;&#160;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;207.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,268&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended&lt;br/&gt;&#160;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restatement of Interim Financial Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The misstatements described above were also material to the Company's unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2024, as of and for the three and six months ended June 30, 2024 and as of and for the three and nine months ended September 30, 2024. The Company has restated its unaudited Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations and Comprehensive Loss, and Condensed&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) for the quarterly and year to date periods ended March 31, 2024, June 30, 2024 and September 30, 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The restated impact of the correction of the misstatements is summarized below (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at March 31, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity (deficit):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at March 31, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_2a99917e-c2e2-45cf-b60a-d41b5d89eba1;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_f2ebfc2b-8b13-4228-bc2d-fad05f7d9efa;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_1303f048-cd42-4ee1-9b21-e85795fc53bb;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_6bc77dc0-e7bb-4f64-9a27-5fac7e301766;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0dada35c-b9ab-4d7c-908e-93714dd5302f;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_c911075b-c1e4-44d9-bc77-3ee81c355044;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;328,280&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;272,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity (deficit)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,422&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Three Months&lt;br/&gt;Ended March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at June 30, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity (deficit):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at June 30, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_340180a0-3a27-4a0d-8de8-cd273d95f58c;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_cd553f55-0d93-4b97-8756-5443f53b6f9b;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_aac64cdf-40ce-4e29-82c3-c243c042d20f;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_987f1dac-17cd-48c8-99fd-7394ead1371b;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_f28eec08-2fa6-4243-b694-0b4d71ef0a06;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_a65f2652-7b7d-4f58-9664-7b9d2fb6a05a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;379,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;323,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity (deficit)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:46.359%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.641%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Three Months&lt;br/&gt;Ended June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Six Months&lt;br/&gt;Ended June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at September 30, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at September 30, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_3435e4db-2763-4d2f-8c7a-737f3a13270a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_2951b263-900f-4b8d-a786-60aa356956ac;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_53bb6073-43e0-4db5-9b19-9926bcc63d4a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0bb67f5b-fcbc-4b89-907c-5702aef7f8c6;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_586405c0-5bfb-4612-b423-2372508e93d4;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_bb70f791-1438-45ad-a7f7-20802b5dd599;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;386,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;331,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:46.359%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.641%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Three Months&lt;br/&gt;Ended September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Nine Months&lt;br/&gt;Ended September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss attributable to common shares - diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stocks - basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;852&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss attributable to Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stocks - diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,856&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:ErrorCorrectionTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68"
      decimals="3"
      id="F_d533dba1-5e3b-43dc-8962-cadfec76962a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets
      contextRef="C_a284c92d-78c0-4626-8cd3-ef8d2e25cb68"
      decimals="2"
      id="F_522c1865-497c-4ef3-9e80-e46c72342f9f"
      unitRef="U_pure">0.50</eldn:PercentageOfCommonStockholdersReceiveCashAndOtherAssets>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
      contextRef="C_fa7b51a6-ebd0-4f6f-8ee5-211b04aeed7c"
      id="F_d08340e2-ee64-4ff2-a7f7-d5b6d25fb7b3">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The impact of the correction of the misstatements is summarized below (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;117,970&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,204&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2023 and 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity (deficit):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;117,970&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2023 and 2022, respectively&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_5853a7a4-cb72-4798-821a-733264c3ef61;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_c28ce8de-197a-4f3f-9904-8e00f34bd0bf;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_87be77a3-13bd-421e-9cd7-c93000cef4f1;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,204&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2023 and 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_159afcc3-d066-4b5b-b4ad-7e01474c1944;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_216519ab-59aa-4af1-9fab-606834bbb418;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0af8023e-7ef3-4515-a7a7-678b84c987ec;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;326,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;270,892&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity (deficit)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2024 and 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2024 and 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2024 and 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_6bb67e40-7995-438a-8c0a-20c0a769173d;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_c377af31-8b8b-42b5-9eae-9f9fb6815960;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_c6895469-f099-4775-83e9-d61a31e2f6fe;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at December 31, 2024 and 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_7a49ba59-b1e6-4d93-bc53-ad26ea9e9103;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_3ecf4669-c43c-48e7-8139-38d3d48178bf;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_b7cc2b0b-bf5a-4561-9ed3-8272893f1903;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;473,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;417,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended&lt;br/&gt;&#160;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;207.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,268&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended&lt;br/&gt;&#160;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The restated impact of the correction of the misstatements is summarized below (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at March 31, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity (deficit):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at March 31, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_2a99917e-c2e2-45cf-b60a-d41b5d89eba1;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_f2ebfc2b-8b13-4228-bc2d-fad05f7d9efa;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_1303f048-cd42-4ee1-9b21-e85795fc53bb;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at March 31, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_6bc77dc0-e7bb-4f64-9a27-5fac7e301766;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0dada35c-b9ab-4d7c-908e-93714dd5302f;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_c911075b-c1e4-44d9-bc77-3ee81c355044;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;328,280&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;272,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity (deficit)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,422&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Three Months&lt;br/&gt;Ended March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at June 30, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity (deficit):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at June 30, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_340180a0-3a27-4a0d-8de8-cd273d95f58c;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_cd553f55-0d93-4b97-8756-5443f53b6f9b;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_aac64cdf-40ce-4e29-82c3-c243c042d20f;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_987f1dac-17cd-48c8-99fd-7394ead1371b;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_f28eec08-2fa6-4243-b694-0b4d71ef0a06;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_a65f2652-7b7d-4f58-9664-7b9d2fb6a05a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;379,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;323,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity (deficit)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:46.359%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.641%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Three Months&lt;br/&gt;Ended June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Six Months&lt;br/&gt;Ended June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:52.669%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of &lt;br/&gt;September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Restatement Impact&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at September 30, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible preferred stock, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares authorized at September 30, 2024 and December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_3435e4db-2763-4d2f-8c7a-737f3a13270a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_2951b263-900f-4b8d-a786-60aa356956ac;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_53bb6073-43e0-4db5-9b19-9926bcc63d4a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;par value, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares designated; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;shares issued and outstanding at September 30, 2024 and December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0bb67f5b-fcbc-4b89-907c-5702aef7f8c6;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_586405c0-5bfb-4612-b423-2372508e93d4;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_bb70f791-1438-45ad-a7f7-20802b5dd599;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additional paid-in capital&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;386,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;331,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:46.359%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.641%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.381%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.964%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Three Months&lt;br/&gt;Ended September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Nine Months&lt;br/&gt;Ended September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss attributable to common shares - diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Diluted earnings per share of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stocks - basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;852&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss attributable to Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stocks - diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,856&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Diluted earnings per share of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares outstanding of Series X and Series X&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;non-voting convertible preferred stock, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_d5c8b624-96b7-45f1-b580-df376cc2eb85"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_5139fbdc-2a80-417c-851b-8e6f70ab7358"
      decimals="INF"
      id="F_2bececed-0dfa-4d52-aee8-9fb7011c44f2"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_39705e1f-831d-4514-9e2a-d7638ddb966d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="INF"
      id="F_7eb84436-2ae3-43aa-975b-37fda47d6b93"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_e2bb7a99-279f-4197-9f2b-acbc89cdb9e9"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="INF"
      id="F_6bce14b5-bc35-4824-814f-a5a3f0f8c7df"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_bfae1464-9754-4084-8f40-55bc11baf9eb"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_4f9abaab-8bc0-4007-af47-46ee144921ce"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="INF"
      id="F_5ef87a10-7ea2-4484-b82b-0899cdc00d3a"
      unitRef="U_shares">117970</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="INF"
      id="F_d6f9260c-bb47-4b3d-95cf-cad8fb6fc217"
      unitRef="U_shares">117970</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_cf8e646f-26aa-4125-8f19-71c8b7b07c17"
      decimals="-3"
      id="F_665988d1-6740-4942-8adb-ae921e7246eb"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_eacde0ed-4c02-4709-92f2-d1a867f74b43"
      decimals="-3"
      id="F_fa65f308-ace5-4c51-8894-284f83702ee1"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="-3"
      id="F_729b32e2-65c2-49ee-bb64-a66fbb57d869"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_31fae4b2-52f1-4f5a-b59b-971ddf246443"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="INF"
      id="F_1ff88ae9-dc16-41c7-a414-ee902d61d0c2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_74d356e8-0ab2-4abf-9438-ab97d0888cb0"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="INF"
      id="F_49776d42-3eda-4bd2-bd45-42883a314ddc"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_3083d76c-dd75-45c0-9691-23b1c0c9a757"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_22849508-8c5f-44ed-9d63-974263199092"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="INF"
      id="F_8ae84f01-63b3-4fff-bb2d-0d12176bb556"
      unitRef="U_shares">6204</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="INF"
      id="F_ec4344d7-3ff4-4001-bd44-b82887a4b4e0"
      unitRef="U_shares">6204</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_badcfa13-507d-429b-9dee-2e0d08eb9c29"
      decimals="-3"
      id="F_2ff512c0-ba02-4ed7-a87e-00b87ef8cccb"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_c9ddc65a-8b52-48ef-898a-ad6a8da8614d"
      decimals="-3"
      id="F_802d8464-20d0-42f3-95a9-b63c379109f5"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="-3"
      id="F_2ae63ab0-9525-4336-a658-65d42fc90fd4"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_d2f95c36-2912-42d1-b815-85af4f9a4a19"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_5139fbdc-2a80-417c-851b-8e6f70ab7358"
      decimals="INF"
      id="F_96711a7e-14c6-469e-bd62-29615aca27cd"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_48acf8ab-8fa0-4d86-a57a-48c3b84217fe"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="INF"
      id="F_7d830f40-1a2e-41c9-965d-eb247b8e6b93"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_2500f0e1-e104-48b7-bf84-44e26bd15e60"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="INF"
      id="F_471c9448-11dc-4b63-95de-2eff30bb918e"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_5d533923-cf8f-42f9-8b64-ddde9329d533"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_b84aa5a3-545b-4005-9d3a-5c3641127e1b"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="INF"
      id="F_621767d5-bfa8-4d21-94e9-a61609b1ef83"
      unitRef="U_shares">117970</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_903fb9de-3a55-4a71-b923-06cf285c9991"
      decimals="INF"
      id="F_0b6aa5e2-f949-4bf8-977e-c6b00684b7fb"
      unitRef="U_shares">117970</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_cfa2d55a-09c2-4124-ba29-d923c2cc3b7d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="INF"
      id="F_0eb9a227-7525-41d4-83b3-4587e3b9811c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_48f1ecc3-0ad2-4d92-b76e-3710a276fabf"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="INF"
      id="F_fa9a1f9e-62e2-4f37-8aad-f84cb17b4faa"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_9f7bce03-8fe8-4a7f-8236-fb71ca9db6ff"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_72b04844-ffbb-4334-b76e-77138be405d9"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="INF"
      id="F_b7a2c2cd-ffa7-4d9f-a57c-b03bd147e9d9"
      unitRef="U_shares">6204</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_b7466cab-5f74-4129-8342-29bcf1a495a6"
      decimals="INF"
      id="F_1e09418d-ef8e-4f8c-853b-5cdd1478669e"
      unitRef="U_shares">6204</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_272a92d8-c7c2-4314-90c3-9d41142b0d01"
      decimals="-3"
      id="F_66ca4312-bb98-4b78-9263-6226875e759c"
      unitRef="U_USD">326586000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_e551203c-60a1-40e8-b225-d4b5814f0ce2"
      decimals="-3"
      id="F_b70a61e3-a8d6-4407-b3e4-9fc0cfe349f1"
      unitRef="U_USD">-55694000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_09e45218-7dd6-4698-939c-097668215e9f"
      unitRef="U_USD">270892000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:StockholdersEquity
      contextRef="C_272a92d8-c7c2-4314-90c3-9d41142b0d01"
      decimals="-3"
      id="F_0f9a3326-6a9b-47d7-b642-3dfdf8c07fc6"
      unitRef="U_USD">7208000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_e551203c-60a1-40e8-b225-d4b5814f0ce2"
      decimals="-3"
      id="F_dabf7ab9-0330-428b-b188-9a6afc73e0bb"
      unitRef="U_USD">-55694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1eef9a49-60fd-482b-a231-9fc95faabb9b"
      decimals="-3"
      id="F_c590fb1a-790c-4307-ba68-232a255d40cf"
      unitRef="U_USD">-48486000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_217e35bf-2776-4ae6-b1a7-3ae6aa8a1aff"
      decimals="INF"
      id="F_37543765-ffc4-4de0-a63f-d4d00b57148c"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_1e6e4e42-4159-452e-b5bf-320073f7137e"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_2ec35dbd-c6b9-4940-b5d4-20c428c49a6e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_4e4d265b-399e-4e0f-a112-99616d9d7d3d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_3008785b-674c-443a-948e-dd3d7928464a"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_dc10896c-53bd-4ade-b0a4-7ea8f2804b28"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_2bae0912-0609-4a54-8d09-8d53ea449ebc"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_9f585e51-4a02-4814-bf63-a1d965697fc2"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_ad504129-dc36-429e-9cff-27ad808f1024"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_a95b0d9a-9abc-47b7-aa8e-ee7192b2b2c2"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_4e98b79e-91fc-4e20-9732-817693c930ab"
      decimals="-3"
      id="F_756d68ff-253b-4bd0-ad3a-28f8f02350c8"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_25aac8fb-8999-48c0-9388-bb4417dbd19e"
      decimals="-3"
      id="F_89b538d3-10e6-416a-8ea5-41a27a00d60f"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="-3"
      id="F_f380ba07-5473-4438-b632-fb34e8e40b5f"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_7ccfce52-3946-4188-acca-62bf7e900acc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_bcfedb91-eda8-4ed3-95f8-76459badb018"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_37c817c7-fe67-4f04-8dda-4b4b2824bb51"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_87e053f0-1fed-4548-9ca7-ae0e8dff01ab"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_ef5f2c05-a1df-40b1-adc2-9c52a6f9637c"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_e75c41ab-fc41-4b8a-aa0a-e1ef0e76ceed"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_729969df-a14f-41d5-9334-6ee32dca39ad"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_eae48fd2-ebc0-41ba-961b-fd19e2001357"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_3599cba8-8efc-4581-af6d-86c0dfa8c474"
      decimals="-3"
      id="F_b3a474c0-c8db-435b-9c4a-b77cc743da5b"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_b96fc6ba-37aa-4cd4-a5d5-3bec6407f9e1"
      decimals="-3"
      id="F_0d32b722-be23-4704-9745-047877d4a414"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="-3"
      id="F_8168450a-606d-4cb8-992b-fc0e44a9fc84"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_217e35bf-2776-4ae6-b1a7-3ae6aa8a1aff"
      decimals="INF"
      id="F_1c3db165-ad5e-45b9-965a-c8568f4d39ed"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_d0d50e60-e77c-4eec-8fa7-7ab9ea8494df"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_13c79936-0f65-4a7e-8c1c-d88e476969f0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_43ee66f7-988b-4d42-9c39-c88760021b47"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_a4b9b0cb-b71c-42ca-a103-cecf7c4dd591"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_809e6e44-2a8d-457b-ba77-889fdbda3255"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_566bece9-5eb3-45a5-9067-7d5d61e47b01"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_123dd2d0-784a-4967-948a-9369c11c3f3a"
      decimals="INF"
      id="F_f206e532-c129-4877-979b-f268c4b15ecd"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_80087297-b9be-4090-940a-ffa2a70a6a4c"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_538fee67-f70b-4d6c-9b75-ed4606d7950d"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_c79fd526-90c7-4990-9041-4663cb797220"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_9675f328-9974-4e6f-b1f6-c9ab7d7d6e09"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_830c46b2-2ad5-4cf7-ac04-fbb7463b371b"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_e203700e-97d2-497f-a561-cbac8901f53c"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_0d4419a0-5569-4b84-bf19-343c57361f88"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_82dde098-0756-4a72-8753-5533b164777f"
      decimals="INF"
      id="F_fa63c90f-f26e-4f92-a671-9cecbf3e5a93"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_fad76950-f992-4aff-bf0f-03f1a09374ae"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_7731f399-e547-4173-83de-30d224f26c75"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_d91ae884-2a3f-49df-8b4f-3a13d684a3c4"
      decimals="-3"
      id="F_fa4b03ba-6908-4f05-9e94-0bcf8da0027f"
      unitRef="U_USD">473640000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_96eaecbb-fb70-46b6-9d46-a5b4e45e90ec"
      decimals="-3"
      id="F_d8fbbc2d-7a75-4220-8659-6b739f32ddbf"
      unitRef="U_USD">-55694000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_222fc5ee-732a-434d-a402-c52f0250d01b"
      unitRef="U_USD">417946000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:StockholdersEquity
      contextRef="C_d91ae884-2a3f-49df-8b4f-3a13d684a3c4"
      decimals="-3"
      id="F_6fa9726d-1c1e-4093-ad61-b29544b80365"
      unitRef="U_USD">118140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_96eaecbb-fb70-46b6-9d46-a5b4e45e90ec"
      decimals="-3"
      id="F_4000b572-3777-459d-b0ab-6642d9466add"
      unitRef="U_USD">-55694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b693d0f0-a45f-453e-a2bb-f555ee43c70f"
      decimals="-3"
      id="F_6108df94-5a99-4667-bb95-044615b9ec8c"
      unitRef="U_USD">62446000</us-gaap:StockholdersEquity>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_3991e991-873c-4c8a-a9a0-9c14307b5dc0"
      decimals="2"
      id="F_a90637d8-9854-4f3c-8b15-313aac0a75dc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-4.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_3991e991-873c-4c8a-a9a0-9c14307b5dc0"
      decimals="2"
      id="F_7d5d632c-d366-4162-a386-94f6330dff11"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-4.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="2"
      id="F_220736a5-dfd0-48bc-a81d-daa61176f5ee"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_39ebfb29-081c-4957-9c07-bd845544fac6"
      decimals="2"
      id="F_ae10671d-ee8d-427f-8813-7f5e731423aa"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="2"
      id="F_ff3bf7e2-6536-4a97-aaaa-83db4535c88a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-207.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="2"
      id="F_f9884bae-d11d-4e88-94b0-19f09ae21d3c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-207.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="0"
      id="F_c281bc88-75ed-4465-852f-600320dc6d94"
      unitRef="U_shares">118268</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_5811ade9-283f-4370-8161-f228fe085c9f"
      decimals="0"
      id="F_3d079a98-0488-413d-b09d-109d7356343e"
      unitRef="U_shares">118268</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_5399ff8f-db17-415f-bfac-019c294b34eb"
      decimals="2"
      id="F_cff7c2f8-fcf5-4d74-9593-ee9d3d7f7a72"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_5399ff8f-db17-415f-bfac-019c294b34eb"
      decimals="2"
      id="F_f040a969-8476-4c26-8357-5801a62907f2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="2"
      id="F_713654e4-bc84-4f99-8adf-bf415f0590ad"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_6f45c048-ced2-480f-ab9e-84d2ecb9ad33"
      decimals="2"
      id="F_17cd2686-60da-4deb-8a5d-a8e9be709e41"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="2"
      id="F_9f064b9e-c471-4f4f-b349-1cad5fe5d91f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-36.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="2"
      id="F_98b8d3fb-3723-471a-9212-121fe5957844"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-36.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="0"
      id="F_7488b15b-11eb-4db6-b276-8fbc0395bd47"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_27edf0db-9055-4e22-b38b-18ca7e450835"
      decimals="0"
      id="F_9110b11c-f8cf-403c-b5c5-7dff7b6939b3"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_f7cd8b63-ab7e-4793-bc5d-067ba8422f26"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_d77b851a-bf31-477b-8902-1719de442c66"
      decimals="INF"
      id="F_69b69135-51aa-49ad-91b9-76af78b157d8"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_75f4b60b-a0b5-425d-b72a-b681c200bf98"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      decimals="INF"
      id="F_3e775ffd-8c0a-4d2d-9744-4d415e1875ae"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_167d426c-d249-476a-92d6-bff5e79f282f"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      decimals="INF"
      id="F_19ded6f6-addd-4b2d-a03c-c6e3f8e476ba"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_54a88389-1e29-49df-90fa-10a9f379acb4"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      decimals="INF"
      id="F_d524f863-da3a-403b-8349-cdd5c95abc23"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      decimals="INF"
      id="F_68226f5b-fc68-4f26-9670-c869803fb979"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_a02123cc-ab18-479c-b50e-849c4ca18dfe"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_d5073177-cf57-43ab-a425-174fa4e3220b"
      decimals="-3"
      id="F_f4c5ac1a-ad46-45cf-a5d2-b37639ce4680"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_c2c9a382-79a3-4da2-9405-110cffced194"
      decimals="-3"
      id="F_33933a10-6460-4a90-93b9-553ad81b6369"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      decimals="-3"
      id="F_2d2af216-ae72-49e9-9b2e-cbc643805762"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_1f3cea41-094a-4d23-b633-ab978ec17e1e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      decimals="INF"
      id="F_b00c4294-563e-4d5f-bab3-c5ee1322bee4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_23fada61-9339-463c-827e-a22d1c6a84ee"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      decimals="INF"
      id="F_5b7b9356-943e-47c4-bf34-f1eab60374fd"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_e324b6e1-1aa6-49ec-9fa6-5b2c23be2e8e"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      decimals="INF"
      id="F_8f965b1c-7c32-406a-8f12-218e2e72fdfd"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      decimals="INF"
      id="F_520a1b4e-d4ce-475e-86d7-d7e2f87ff5bc"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_f9c4a121-0dae-4019-b564-2c52d7287849"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7c4a8f01-0913-45fc-a8e1-2c98ad756cf8"
      decimals="-3"
      id="F_43a4fe62-b3a9-4fb9-b3a0-dcd1f51b24a4"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_5e4181d3-32bb-4105-807d-d8ddef98922a"
      decimals="-3"
      id="F_e354a55d-64e5-4af8-9f1c-39c1c60a9ced"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      decimals="-3"
      id="F_8c97a506-0f42-498f-9366-69801b8deafc"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_7d1a5a7e-ec31-4191-8d31-c1ef5d7b7d67"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_d77b851a-bf31-477b-8902-1719de442c66"
      decimals="INF"
      id="F_feeadb83-a9c9-426f-98b1-4402100c1388"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_e489da95-7f99-46d8-a746-0d80b5188146"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      decimals="INF"
      id="F_b9c93e53-736f-4c0d-b9d0-35c0ad678995"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_4964d6bf-d3fa-46dd-9603-b5f39d87e5be"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      decimals="INF"
      id="F_7d82cd09-98da-4fa8-8443-596f6f1b04f2"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_ba5700b4-ad28-44b0-81db-7d12b2488d52"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      decimals="INF"
      id="F_60ca2a21-88fb-4334-940a-62f54f091632"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_158bedf1-d0f5-4588-aa11-06610c5badeb"
      decimals="INF"
      id="F_4e771937-0ad3-4707-afb0-e182e49b3aed"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_d266be15-2097-455c-a87e-0f5bcd7a6465"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_9d6a3cde-a77a-4c22-a87d-ef3289135f0f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      decimals="INF"
      id="F_329aecf7-bc43-4caf-8d18-35ef3d0cb35f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_3381a0a0-9ee1-4e64-8205-d3ce2674edee"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      decimals="INF"
      id="F_9e10801d-7519-4135-aaaf-7c7f18560309"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_db9f6e06-b244-4c37-b6ab-b06439d5e07f"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      decimals="INF"
      id="F_b4525d36-f34c-4878-8bd8-c6779f7e0a53"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_835f8a45-f710-4451-9172-67b1911d289e"
      decimals="INF"
      id="F_57050bcd-c6af-49f9-aedc-e0d685ea25cf"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_fb5b555b-d49a-41f9-ae29-2da74944ca8b"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_133e23b5-720c-48df-8aef-367581072be4"
      decimals="-3"
      id="F_0710b8de-5644-4d38-93c5-e99b6bad1320"
      unitRef="U_USD">328280000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_496b6f07-43d9-4f3d-abc8-59c28e2608e3"
      decimals="-3"
      id="F_b967598d-16d2-4b44-ae16-f3f77f9fc4a2"
      unitRef="U_USD">-55694000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_584b9a09-2946-4d4b-8bd8-27f45b3d9605"
      decimals="-3"
      id="F_e0513da6-243c-489e-ac9e-0cd07d4654af"
      unitRef="U_USD">272586000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:StockholdersEquity
      contextRef="C_133e23b5-720c-48df-8aef-367581072be4"
      decimals="-3"
      id="F_e5653903-8b2d-4105-b28d-61e68ef3c654"
      unitRef="U_USD">-14728000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_496b6f07-43d9-4f3d-abc8-59c28e2608e3"
      decimals="-3"
      id="F_6eb62c71-a479-4340-8242-10a132c5d6b7"
      unitRef="U_USD">-55694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_584b9a09-2946-4d4b-8bd8-27f45b3d9605"
      decimals="-3"
      id="F_0142b32b-b20e-422a-afeb-1e7fbc27aa76"
      unitRef="U_USD">-70422000</us-gaap:StockholdersEquity>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_306cf456-d3e1-471c-88e6-bff01256a178"
      decimals="2"
      id="F_a482bc17-8c2a-4c71-bdf5-eec0d89ba2b4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_306cf456-d3e1-471c-88e6-bff01256a178"
      decimals="2"
      id="F_812161b7-706a-4807-afd4-6915df31057e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_68b6bf49-13a1-4dad-b84d-1a3baa6fc701"
      decimals="2"
      id="F_90bbf0dd-ae91-4193-8d8f-6e095625c923"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_68b6bf49-13a1-4dad-b84d-1a3baa6fc701"
      decimals="2"
      id="F_a1437eba-4777-46e7-ab0a-067a3025b187"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_fa6b5f79-cd28-4846-8782-687a801dd0e7"
      decimals="2"
      id="F_06479add-ce6a-460e-8043-b384d48e58b6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-36.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_fa6b5f79-cd28-4846-8782-687a801dd0e7"
      decimals="2"
      id="F_70e69d78-1b73-41b7-a225-9727b2fa5c70"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-36.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_fa6b5f79-cd28-4846-8782-687a801dd0e7"
      decimals="0"
      id="F_5959fe68-3790-4d58-b38a-fc68aa78a3a0"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_fa6b5f79-cd28-4846-8782-687a801dd0e7"
      decimals="0"
      id="F_3459b488-7b2b-4e73-a744-717756ba0aba"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_8f060f7a-06fe-4ff9-ba65-1a9ffc397dc8"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_06358e90-5416-4479-9715-a95bcd5b9a71"
      decimals="INF"
      id="F_7e46650b-9470-496b-8282-b78bda605512"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_821a9ac6-2b4e-4867-85b3-45b9778911f4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      decimals="INF"
      id="F_f2e8a2c5-4c34-4093-923b-c40e5e878fbe"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_c1c0a277-fc6b-49b9-9f20-67cc8b5dcfa7"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      decimals="INF"
      id="F_bc9aecd7-a0b6-4739-8c04-08d7683655ce"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_cc8f5fde-f3a6-479d-bec2-c3aabec1e04d"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      decimals="INF"
      id="F_9a097077-6cd9-4efd-8349-1fb2f031d034"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      decimals="INF"
      id="F_9146c003-7bb0-465b-9c14-d0bae7a4205c"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_d0932cc3-794a-4192-bdc4-90e23e8019f8"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_6aa424ab-8817-4180-b5c7-60582405c85e"
      decimals="-3"
      id="F_2b946dbc-d5c0-42dd-b21c-53b676807475"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_e2f48d5e-c74e-4701-855c-ac8c4f15fd2c"
      decimals="-3"
      id="F_f0946ea8-110c-4ebd-827f-c7efdaa5e643"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      decimals="-3"
      id="F_664a1a75-04ba-4f32-a39a-d25b79d6a024"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_03b2a915-5500-4b43-8fb0-c51ddb2264a7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      decimals="INF"
      id="F_541f7342-1c21-4a47-8fc5-90be638ecc78"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_22ca762b-043d-42d3-a63f-ff6f0e44a60c"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      decimals="INF"
      id="F_718715f0-1dbc-4b8b-b3ac-d61781bd9312"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_94b373d3-8331-48bf-8212-611af6cc3b25"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      decimals="INF"
      id="F_b1d0eb11-872f-4d92-9166-028b4ac31dc7"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      decimals="INF"
      id="F_b8212f93-cdf5-4661-9a81-638175a8625b"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_d1454aba-c93d-428b-9c83-26e78228e59d"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_81e90e3c-c0f5-4f40-8209-ed87e745d4b3"
      decimals="-3"
      id="F_27990713-f97f-4b29-9d40-0c4f385ad1c3"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_a9a6298f-64b0-403f-9753-1954555ffed1"
      decimals="-3"
      id="F_f4697220-585c-4389-9fde-72d71bd80708"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      decimals="-3"
      id="F_99ffc34b-fc28-43d8-bb8a-70be3adf3552"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_17392be0-153d-4a93-bba5-b942e10fd81a"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_06358e90-5416-4479-9715-a95bcd5b9a71"
      decimals="INF"
      id="F_cf7ae36f-f9d5-4dbb-96a3-b0d6dbf22cf6"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_dbcf100f-05bc-4f24-a32c-0413ff30dcfe"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      decimals="INF"
      id="F_aaff0366-5d77-408c-9aef-1beafa79d264"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_48aaa48a-008c-4715-b870-d2e6f41bca92"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      decimals="INF"
      id="F_c2ba38c5-8f47-421d-bc90-6fe8d8bbb5cb"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_a25c343c-65c9-4ffb-8cc4-b8bbf8d362f9"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      decimals="INF"
      id="F_d64d60dc-1d59-4f5f-a756-394abb49288e"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_2c437fe0-cb8a-4b6d-98a0-83344d1291a5"
      decimals="INF"
      id="F_9bf89f35-0362-4d6f-a646-854da53a5762"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_2081faef-ea12-4243-bcc7-02f550419022"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_4ed9fd15-4c13-435f-9279-fd62e3a1368a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      decimals="INF"
      id="F_a319422e-972a-40ba-a998-cf8177e032e5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_67294f36-e2f3-45fa-8e93-c410623e0bfa"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      decimals="INF"
      id="F_0c985389-1402-4d31-b7d8-0bd72ea56151"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_df5d2dc2-3126-411e-9b81-45030d684257"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      decimals="INF"
      id="F_31398114-36b2-4caf-b87f-53dd2c30fece"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_023300ef-3b93-4a2f-91f9-c39c33b9e246"
      decimals="INF"
      id="F_75a85c40-341e-42b4-a31e-907d044b4cb8"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_37246569-8880-4a23-bc6a-83233afbcc48"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_c0d65a75-73a7-4e65-8ca9-7aa239bd0a7a"
      decimals="-3"
      id="F_35eb6b01-8354-43bc-8537-115bbe4c95da"
      unitRef="U_USD">379400000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_51337a7e-dc7e-43f7-9229-34f04adbdb0b"
      decimals="-3"
      id="F_2b63a028-a921-49e5-986f-7d5483c306d6"
      unitRef="U_USD">-55694000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_3af4da93-98a8-414a-b035-34ccd64d6382"
      decimals="-3"
      id="F_f98a22fa-0286-4b96-bdf5-68f212d70049"
      unitRef="U_USD">323706000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:StockholdersEquity
      contextRef="C_c0d65a75-73a7-4e65-8ca9-7aa239bd0a7a"
      decimals="-3"
      id="F_ae2cd256-16fa-40f8-82ac-b68a7a985288"
      unitRef="U_USD">-8501000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_51337a7e-dc7e-43f7-9229-34f04adbdb0b"
      decimals="-3"
      id="F_7fdbbb67-73df-4472-bf22-23cbe3e656e3"
      unitRef="U_USD">-55694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3af4da93-98a8-414a-b035-34ccd64d6382"
      decimals="-3"
      id="F_809c7921-e90b-496d-951b-40c35ac4c5e4"
      unitRef="U_USD">-64195000</us-gaap:StockholdersEquity>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_10891653-0f3f-4d75-9cd2-9876d5144cac"
      decimals="2"
      id="F_0329fce8-3cd3-4898-bbda-7dc3b5551b4b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_10891653-0f3f-4d75-9cd2-9876d5144cac"
      decimals="2"
      id="F_932b557a-ef2f-4b9b-9f6b-198bb094dfe8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_8a2e70e3-2ed3-407e-a0af-d1a1cd2c2189"
      decimals="2"
      id="F_b9146b80-0b36-40d6-a910-089bdebb5345"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_8a2e70e3-2ed3-407e-a0af-d1a1cd2c2189"
      decimals="2"
      id="F_20ce1306-4968-4eec-9fd7-308b5c3992ae"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_6430dce4-296d-43c0-8a5c-29414ed1adfc"
      decimals="2"
      id="F_92badeb1-222b-4ac6-a038-0fb0046e835c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.9</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_6430dce4-296d-43c0-8a5c-29414ed1adfc"
      decimals="2"
      id="F_f6b197a1-1bde-4a5d-9a79-4d02371898ee"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.9</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_c0555d1b-b168-446f-b8aa-3b629d5033dc"
      decimals="2"
      id="F_7240d684-c2d2-4dff-a208-622f6af6bb06"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_c0555d1b-b168-446f-b8aa-3b629d5033dc"
      decimals="2"
      id="F_43ee9c9e-4c64-46c8-a0fe-89c62c82c31f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_fe356c11-e5db-4e96-910b-23f6c7c1d931"
      decimals="2"
      id="F_3ce52e45-27c1-4cae-80ff-0c2fdedbd7a2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-51.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_fe356c11-e5db-4e96-910b-23f6c7c1d931"
      decimals="2"
      id="F_b93a00d7-3e96-4134-9f35-cb7c835a40de"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-51.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1"
      decimals="2"
      id="F_92039c64-02c3-4cc4-af78-3293f336c07f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-89.6</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1"
      decimals="2"
      id="F_ba34e7b6-19f0-4b0c-ac89-1c57d3a1e268"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-89.6</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_fe356c11-e5db-4e96-910b-23f6c7c1d931"
      decimals="0"
      id="F_339a224e-29eb-43f5-a976-210a935334ca"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_fe356c11-e5db-4e96-910b-23f6c7c1d931"
      decimals="0"
      id="F_06cb61bf-2ed8-46a4-a3fe-3c566529a08f"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1"
      decimals="0"
      id="F_ab97e132-3711-469b-aa88-26966e0563d3"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_54b1f6d3-43dd-4b53-894a-66cc31c9a1e1"
      decimals="0"
      id="F_0d4d1997-a005-446f-ab35-b641bddb3868"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_a19cc353-9e67-42d2-ad34-2b95ddbd1abe"
      decimals="INF"
      id="F_df1a060f-0f66-40c9-8c76-4523f0b57da4"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_cacb72f9-6fc7-4b41-be6b-4c917c97e02b"
      unitRef="U_shares">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      decimals="INF"
      id="F_8e126c93-3c93-440f-a09e-f5b0ac5fb547"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_6fe8a9aa-7454-447b-84be-6dbeae82d1f0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_8b7e361c-f6ea-4cf0-b68a-b9b3ceb7e24e"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      decimals="INF"
      id="F_4b3b7768-1c2c-4ba5-b4d8-4aa574253439"
      unitRef="U_shares">515000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_0086ed46-e4c3-43e0-a022-8085de9e36ca"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      decimals="INF"
      id="F_9984ff40-e7ba-48b1-820d-041e47225b7c"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      decimals="INF"
      id="F_94b60f3c-c0c6-4b4b-b7a4-a33f857c754c"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_80e1d659-af9f-48e3-b7b9-9bb83319f99a"
      unitRef="U_shares">110086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_6081fd86-dcbc-49fe-ac41-4cb855d48774"
      decimals="-3"
      id="F_8f4ec16e-c679-4041-9158-c99885f3211c"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_0dfa6572-7fa2-4beb-9686-2196c62325d5"
      decimals="-3"
      id="F_c4339764-c319-4b18-8e03-e8f609771c5d"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      decimals="-3"
      id="F_adbc7ec8-d184-444d-8aba-7b9c46e8443d"
      unitRef="U_USD">53543000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_e0ae6e55-ab3c-40fe-b77f-67007ea4475a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      decimals="INF"
      id="F_bedeffee-8eaf-4b35-861e-b2b984afd8e2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_c59d028f-cdc7-4d87-87fa-a94e4aff0d78"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      decimals="INF"
      id="F_aa3af9c2-e9c6-4379-8d74-99f4c7f27415"
      unitRef="U_shares">10000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_b43af5ea-9467-4d7c-92ec-53c769f56ea6"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      decimals="INF"
      id="F_4e171f38-f4ff-4824-8cfa-54a9bdf929f6"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      decimals="INF"
      id="F_31cd0082-9365-4da8-b47d-0c8d1609c2d2"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_9b930572-0a22-4e00-94d6-225462ceda47"
      unitRef="U_shares">4422</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7ebd9556-342d-4273-9d4e-cbafb9ae6e10"
      decimals="-3"
      id="F_ed5030cf-c03c-4c18-8dac-3f5b40c5acf7"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_58cde265-0a3e-4c69-87c1-a6052820869a"
      decimals="-3"
      id="F_eff35eca-08b5-4761-b625-13df83a5c088"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      decimals="-3"
      id="F_5865de58-4306-4215-89e2-d99a0d949121"
      unitRef="U_USD">2151000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_a19cc353-9e67-42d2-ad34-2b95ddbd1abe"
      decimals="INF"
      id="F_112a70aa-6bfe-46f6-a990-96497d8a2896"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6a9c58e8-9742-4c63-9455-d3d5d0fbc76b"
      decimals="INF"
      id="F_a9d3cb8b-9f72-4faf-b7ef-f00f6989ab35"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_561a0490-dff0-4cd6-860b-447686d650e0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      decimals="INF"
      id="F_5876229c-f098-42d5-832f-bf1136561866"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      decimals="INF"
      id="F_9cba6729-e9d8-4243-bbf1-5b1e99593b5a"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_27a32e78-cb04-46da-aab1-2b1060394e3d"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      decimals="INF"
      id="F_62201e14-e56b-4f1f-9ba5-1afbf560066c"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_8c4ea1ab-89fa-48a9-acf1-f2efe93d0b5b"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_47017741-a7c3-4cb8-98d1-0386aacdfe5c"
      decimals="INF"
      id="F_efd19ca0-49f9-46a4-8917-62238b2b3ab6"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_2091d266-9d3c-4b0a-b436-3f24223bba88"
      decimals="INF"
      id="F_0f35cfd5-bf66-421b-bdb3-746c8e795f71"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_d9d23e26-1a3f-448f-ba54-3beb35576471"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      decimals="INF"
      id="F_0ff67ca9-1e9d-4c4a-9340-9b9c543cc42c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_4764e025-57f7-4159-ba5c-dc4796264e24"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      decimals="INF"
      id="F_e04313d0-8399-4cf3-9f61-2fc4530732d6"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_0a2e2ff5-beaa-493f-a859-01b6fff3cb46"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      decimals="INF"
      id="F_aa4118a1-2728-4320-b793-a607058dd2c1"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_42b8ea9f-ce19-4e11-b2c6-b4d61fd85e0f"
      decimals="INF"
      id="F_bfd48b3c-c39e-43ab-9046-94279d088d6a"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_7bb7b7fa-3e11-41de-be73-b3cce8e0267e"
      decimals="INF"
      id="F_f2b88f04-1d6c-4c6e-ba17-8bab158f3b18"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_8b40a221-b271-45e7-abea-861aa3e69388"
      decimals="-3"
      id="F_c26a618f-247c-417e-a8ca-95ce88bb02be"
      unitRef="U_USD">386884000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_126dec65-5fb2-4ba4-8e32-3d122533acdf"
      decimals="-3"
      id="F_47d8e516-ef79-491e-a595-bf1867fd2771"
      unitRef="U_USD">-55694000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:AdditionalPaidInCapitalPreferredStock
      contextRef="C_b526d623-851d-4505-bda0-f3f5d7eef6d4"
      decimals="-3"
      id="F_4b5e5e69-bee7-4467-9b9a-e885ae5933d6"
      unitRef="U_USD">331190000</us-gaap:AdditionalPaidInCapitalPreferredStock>
    <us-gaap:StockholdersEquity
      contextRef="C_8b40a221-b271-45e7-abea-861aa3e69388"
      decimals="-3"
      id="F_c9c1a36d-24e3-4123-b79b-dd3f977db455"
      unitRef="U_USD">76058000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_126dec65-5fb2-4ba4-8e32-3d122533acdf"
      decimals="-3"
      id="F_1351b12c-fa77-422a-b013-2765a254ce09"
      unitRef="U_USD">-55694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b526d623-851d-4505-bda0-f3f5d7eef6d4"
      decimals="-3"
      id="F_a3fa9bdc-9830-4024-aef8-5125edc28131"
      unitRef="U_USD">20364000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_d3a91ef5-d925-4944-988e-a6b6d2a5d9fe"
      decimals="-3"
      id="F_0aabfb9a-0cab-41c6-9901-be0e23041183"
      unitRef="U_USD">-17504000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_d2875a70-0df4-4171-877a-c58e658fdb69"
      decimals="-3"
      id="F_63e36139-a3e5-4176-8c99-a8778f67f371"
      unitRef="U_USD">-15703000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_f0263327-04ec-403c-a565-39214d3f5d1b"
      decimals="-3"
      id="F_dacf846d-76bb-449d-ba1d-faa7209c609d"
      unitRef="U_USD">-61086000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_3f5369ce-0e85-4351-974f-ce7061c1e396"
      decimals="-3"
      id="F_09ec60d4-1b98-480e-9161-5b321d65404b"
      unitRef="U_USD">-53230000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_d3a91ef5-d925-4944-988e-a6b6d2a5d9fe"
      decimals="2"
      id="F_ca9f4d96-85fb-46fc-b86f-be4f66f8532b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_d2875a70-0df4-4171-877a-c58e658fdb69"
      decimals="2"
      id="F_54759b4e-4f77-4f15-b78d-182a82c7572c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_f0263327-04ec-403c-a565-39214d3f5d1b"
      decimals="2"
      id="F_08ae77ec-1e36-479d-8bd3-a7ed0715d80c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_3f5369ce-0e85-4351-974f-ce7061c1e396"
      decimals="2"
      id="F_9ce11896-f92b-40d4-a54c-f497b28cb805"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4"
      decimals="-3"
      id="F_7de1f2ee-513e-4144-bc2c-0b503dccc729"
      unitRef="U_USD">6666000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69"
      decimals="-3"
      id="F_101d38d7-4f39-4800-a570-38948e3faec6"
      unitRef="U_USD">852000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4"
      decimals="2"
      id="F_47fd73b3-1375-40d7-9bcb-5750b6308483"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">58.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69"
      decimals="2"
      id="F_680c959e-8671-4e3f-a751-9bf00f4f977b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4"
      decimals="0"
      id="F_8090e972-deb0-43eb-8842-d24099c20836"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69"
      decimals="0"
      id="F_7df83913-3be6-49e2-85ec-7e24f8574bcb"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4"
      decimals="-3"
      id="F_b87a80db-b190-4a1f-9afc-3c380ca0c566"
      unitRef="U_USD">-1801000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69"
      decimals="-3"
      id="F_d2f8885a-df1e-4e65-b54a-9edfae74937b"
      unitRef="U_USD">-7856000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4"
      decimals="2"
      id="F_99f47fb8-76a1-4bd1-94d1-fc76b919fe47"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-15.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69"
      decimals="2"
      id="F_a8f12eba-19d2-4b41-939a-1818e7128c84"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-68.6</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_d72d64e3-d62a-4889-85a3-c71622485ea4"
      decimals="0"
      id="F_bac895b4-7813-4cd5-becc-b067528e0fa8"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_f4538f07-445c-4906-94ce-ef1f81c11a69"
      decimals="0"
      id="F_c271ec97-0b1a-496e-9cd1-bfca67d98a9d"
      unitRef="U_shares">114508</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
